SMILES,TITLE,pert_iname,vendor,catalog_no,vendor_name,Hybrid2,docked_fragment,Mpro-_dock,site
C[NH2+]Cc1cc(n(c1)S(=O)(=O)c2cccnc2)c3ccccc3F,BRD-K32768103-051-02-6,vonoprazan,Selleck,S8016,TAK-438,-14.130920,x0678,0.56353,active-noncovalent
C[NH2+]Cc1cc(n(c1)S(=O)(=O)c2cccnc2)c3ccccc3F,BRD-K32768103-051-03-4,vonoprazan,Selleck,S8016,Vonoprazan Fumarate (TAK-438),-14.130920,x0678,0.56353,active-noncovalent
Cc1c(sc(n1)c2cccnc2)C(=O)Nc3ccccc3c4cn5c(csc5[nH+]4)C[NH+]6CCOCC6,BRD-K48452630-001-01-8,SRT2104,Selleck,S7792,SRT2104 (GSK2245840),-12.776212,x0161,6.896312,active-noncovalent
Cc1c(sc(n1)c2cccnc2)C(=O)Nc3ccccc3c4cn5c(csc5[nH+]4)C[NH+]6CCOCC6,BRD-K48452630-001-02-6,SRT2104,MedChemEx,HY-15262,SRT 2104,-12.776212,x0161,6.896312,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)[NH2+]Cc4cccnc4,BRD-K50325075-001-03-9,UCL-2077,Tocris,2661,UCL 2077,-12.759785,x0678,3.249948,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)[NH2+]Cc4cccnc4,BRD-K50325075-001-02-1,UCL-2077,Tocris,2661,UCL 2077,-12.759785,x0678,3.249948,active-noncovalent
c1cc(cnc1)[C@H]2[C@@H]3CC=C[C@@H]3c4cc(cc(c4N2)F)F,BRD-A57886255-001-02-9,golgicide-A,Selleck,S7266,Golgicide A,-12.594658,x0678,-0.60966,active-noncovalent
c1cc(cnc1)[C@H]2[C@@H]3CC=C[C@@H]3c4cc(cc(c4N2)F)F,BRD-A57886255-001-01-1,golgicide-a,Tocris,3584,Golgicide A,-12.594658,x0678,-0.60966,active-noncovalent
COc1cc(ccc1c2[nH]c3c(n2)cccn3)[S@@](=O)C,BRD-A22081593-001-11-1,sulmazole,Prestwick,Prestw-641,Sulmazole,-12.465656,x0678,0.45049,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,BRD-K06182768-001-04-9,A-366,Tocris,5163,A 366,-12.457256,x1077,1.558067,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,BRD-K06182768-001-01-5,A-366,MedChemEx,HY-12583,A-366,-12.457256,x1077,1.558067,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,BRD-K06182768-001-06-4,A-366,MedChemEx,HY-12583,A-366,-12.457256,x1077,1.558067,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,BRD-K06182768-001-02-3,A-366,Tocris,5163,A-366,-12.457256,x1077,1.558067,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,BRD-K06182768-001-03-1,A-366,MedChemEx,HY-12583,A-366,-12.457256,x1077,1.558067,active-noncovalent
c1cc(c(c2c1[C@@H](O[C@@H](C2)C34CC5CC(C3)CC(C5)C4)C[NH3+])O)O,BRD-K72226571-003-01-2,A77636,Tocris,1701,A 77636 hydrochloride,-12.421812,x0749,-0.226401,active-covalent
c1ccc2c(c1)c3c4c(c5c6ccccc6[nH]c5c3[nH]2)C(=O)NC4=O,BRD-K72726508-001-02-1,arcyriaflavin-a,Tocris,2457,Arcyriaflavin A,-12.239515,x0678,1.854395,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6[nH]c5c3[nH]2)C(=O)NC4=O,BRD-K72726508-001-03-9,arcyriaflavin-a,Tocris,2457,Arcyriaflavin A,-12.239515,x0678,1.854395,active-noncovalent
CN1C(=O)c2c(nn(c2Nc3ccccc3)Cc4ccc(cc4)c5cccc(n5)F)N6C1=[NH+][C@H]7[C@@H]6CCC7,BRD-K77987496-011-01-9,ITI214,MedChemEx,HY-12501A,ITI214,-12.193553,x0434,9.331999,active-noncovalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O,BRD-K55591206-001-18-1,epigallocatechin-gallate-(-),Selleck,S2250,(-)-Epigallocatechin Gallate,-12.171526,x0831,1.923191,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O,BRD-K55591206-001-19-9,epigallocatechin-gallate-(-),Selleck,S2250,(-)-Epigallocatechin gallate,-12.171526,x0831,1.923191,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O,BRD-K55591206-001-20-7,epigallocatechin-gallate-(-),MedChemEx,HY-13653,(-)-Epigallocatechin Gallate,-12.171526,x0831,1.923191,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O,BRD-K55591206-001-22-3,epigallocatechin-gallate-(-),MedChemEx,HY-13653,(-)-Epigallocatechin Gallate,-12.171526,x0831,1.923191,active-covalent
Cc1c(c2cc(ccc2n1CC(=O)[O-])F)Cc3ccc4ccccc4n3,BRD-K36463073-001-02-1,OC000459,Selleck,S2822,OC000459,-12.096975,x0830,1.395827,active-covalent
Cc1c(c2cc(ccc2n1CC(=O)[O-])F)Cc3ccc4ccccc4n3,BRD-K36463073-001-03-9,OC000459,MedChemEx,HY-15342,OC000459,-12.096975,x0830,1.395827,active-covalent
Cc1c(c2cc(ccc2n1CC(=O)[O-])F)Cc3ccc4ccccc4n3,BRD-K36463073-001-01-3,OC000459,Selleck,S2822,OC000459,-12.096975,x0830,1.395827,active-covalent
c1cc(c(cc1I)F)Nc2cnccc2C(=O)NC[C@@H](CO)O,BRD-K89014967-001-04-3,AS-703026,Selleck,S1475,Pimasertib (AS-703026),-12.051374,x0678,1.766209,active-noncovalent
c1cc(ccc1/C=C/c2cc(cc(c2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,BRD-K43236057-001-07-1,polydatin,Selleck,S2390,Polydatin(Piceid),-11.783890,x0161,3.159029,active-noncovalent
c1cc(ccc1/C=C/c2cc(cc(c2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,BRD-K43236057-001-09-7,polydatin,Selleck,S2390,Polydatin,-11.783890,x0161,3.159029,active-noncovalent
c1cc(ccc1c2ccc3cc(c(cc3c2)C45CC6CC(C4)CC(C6)C5)O)C(=O)[O-],BRD-K09619322-001-03-8,CD-1530,Tocris,2554,CD 1530,-11.759232,x0104,6.23101,active-noncovalent
CC(C)[NH2+]C[C@H](COc1cccc2c1cccc2)O,BRD-K92830582-003-10-5,propranolol-(R),Tocris,835,(R)-(+)-Propranolol hydrochloride,-11.744864,x0195,0.161161,active-noncovalent
Cc1c(cnc(n1)C)OC[C@]2(C[C@H]2C(=O)Nc3ccc(cn3)F)c4cccc(c4)F,BRD-K78666663-001-01-6,lemborexant,MedChemEx,HY-16725,Lemborexant,-11.741239,x0678,3.028779,active-noncovalent
c1cc(cnc1)/C=C/C(=O)c2ccncc2,BRD-K58413118-001-01-8,3PO,MedChemEx,HY-19824,3PO,-11.732655,x0678,-1.094131,active-noncovalent
CO/[NH+]=C(\N)/c1ccc(cc1)c2oc(cc2)c3ccc(cc3)/C(=[NH+]/OC)/N,BRD-K68805147-001-01-8,pafuramidine,MedChemEx,HY-14932,Pafuramidine,-11.567801,x0104,9.376078,active-noncovalent
c1cc(c(cc1[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O)O)O,BRD-K50660797-001-04-4,epicatechin-gallate-(-),AnalytiCon,NP-002326,,-11.565519,x0678,1.459131,active-noncovalent
c1cc(c(cc1[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O)O)O,BRD-K50660797-001-05-1,epicatechin-gallate-(-),MedChemEx,HY-N0002,(-)-Epicatechin gallate,-11.565519,x0678,1.459131,active-noncovalent
CCc1cc2c(s1)-n3c(nnc3C=N[C@H]2c4ccccc4Cl)C,BRD-K68232413-001-01-2,etizolam,MedChemEx,HY-B0677,Etizolam,-11.564081,x0708,0.50805,active-covalent
c1ccc(cc1)Oc2nc3c(c(n2)NC4CCCCC4)[nH]cn3,BRD-K10575656-034-01-0,MRS3777,Tocris,2403,MRS 3777 hemioxalate,-11.546358,x0678,0.419307,active-noncovalent
c1ccc(cc1)Oc2nc3c(c(n2)NC4CCCCC4)[nH]cn3,BRD-M86143595-034-03-4,MRS-3777,Tocris,2403,MRS 3777 hemioxalate,-11.546358,x0678,0.419307,active-noncovalent
c1ccc(cc1)OCc2ccc(cc2)CCC[NH+]3CCOCC3,BRD-K44942188-001-09-1,fomocaine,ChemDiv,1822-0278,,-11.528082,x0104,3.276085,active-noncovalent
C[N@H+]1CCc2cccc-3c2[C@@H]1Cc4c3c(c(cc4)O)O,BRD-A35931254-003-04-3,r(-)-apomorphine,MicroSource,1500129,APOMORPHINE HYDROCHLORIDE,-11.522030,x0195,-0.433611,active-noncovalent
Cc1c(c2ccccc2[nH]1)CC[NH2+]Cc3ccc(cc3)CCC(=O)N=O,BRD-K02130563-001-12-2,panobinostat,Selleck,S1030,Panobinostat,-11.509398,x0967,3.45696,active-noncovalent
Cc1c(c2ccccc2[nH]1)CC[NH2+]Cc3ccc(cc3)CCC(=O)N=O,BRD-K02130563-001-14-8,panobinostat,MedChemEx,HY-10224,Panobinostat,-11.509398,x0967,3.45696,active-noncovalent
Cc1c(c2ccccc2[nH]1)CC[NH2+]Cc3ccc(cc3)CCC(=O)N=O,BRD-K02130563-001-15-5,panobinostat,MedChemEx,HY-10224,Panobinostat,-11.509398,x0967,3.45696,active-noncovalent
Cc1c(c2ccccc2[nH]1)CC[NH2+]Cc3ccc(cc3)CCC(=O)N=O,BRD-K02130563-001-11-4,panobinostat,Selleck,S1030,Panobinostat (LBH589),-11.509398,x0967,3.45696,active-noncovalent
C[C@@]12CCc3c(cco3)[C@H]1CC[C@]45[C@H]2CC[C@H](C4)[C@](C5)(CO)O,BRD-K46741531-001-02-4,cafestol,Enzo,NP418,Cafestol,-11.504668,x0749,0.145644,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,BRD-K42095107-001-18-9,daidzein,Enzo,T110,Daidzein,-11.492462,x0749,3.003708,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,BRD-K42095107-001-16-3,daidzein,Selleck,S1849,Daidzein,-11.492462,x0749,3.003708,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,BRD-K42095107-001-22-1,daidzein,Tocris,1417,Daidzein,-11.492462,x0749,3.003708,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,BRD-K42095107-001-17-1,daidzein,Tocris,1417,Daidzein,-11.492462,x0749,3.003708,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,BRD-K42095107-001-21-3,daidzein,Selleck,S1849,Daidzein,-11.492462,x0749,3.003708,active-covalent
c1cc(cc2c1cc(cc2)C(=O)[O-])c3ccc(c(c3)C45CC6CC(C4)CC(C6)C5)O,BRD-K28907958-001-05-0,CD-437,Tocris,1549,CD 437,-11.491298,x0161,6.061302,active-noncovalent
c1cc(cc2c1cc(cc2)C(=O)[O-])c3ccc(c(c3)C45CC6CC(C4)CC(C6)C5)O,BRD-K28907958-001-04-3,CD-437,Tocris,1549,CD 437,-11.491298,x0161,6.061302,active-noncovalent
c1cc(ccc1C2=Cc3ccc(cc3OC2)O)O,BRD-K74671368-001-01-8,idronoxil,Sigma,MFCD06636630,3-(4-hydroxyphenyl)-2H-chromen-7-ol,-11.462839,x0749,1.968427,active-covalent
c1cc(ccc1c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)O,BRD-K54330070-001-15-4,SB-202190,Selleck,S1077,SB202190 (FHPI),-11.455310,x0434,2.481209,active-noncovalent
c1cc(ccc1c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)O,BRD-K54330070-001-16-2,SB-202190,Tocris,1264,SB 202190,-11.455310,x0434,2.481209,active-noncovalent
c1cc(ccc1c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)O,BRD-K54330070-001-19-6,SB-202190,Tocris,1264,SB 202190,-11.455310,x0434,2.481209,active-noncovalent
CC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,BRD-K67013324-001-04-9,luzindole,Tocris,877,Luzindole,-11.436106,x0749,-0.451491,active-covalent
CC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,BRD-K67013324-001-03-1,luzindole,Tocris,877,Luzindole,-11.436106,x0749,-0.451491,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH2+]C/C=C/c3ccc(cc3)Br,BRD-K27737647-300-08-9,H-89,Tocris,2910,H 89 dihydrochloride,-11.430328,x0678,1.797919,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH2+]C/C=C/c3ccc(cc3)Br,BRD-K27737647-300-04-8,H-89,Tocris,2910,H 89 dihydrochloride,-11.430328,x0678,1.797919,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH2+]C/C=C/c3ccc(cc3)Br,BRD-K27737647-300-03-0,H-89,Selleck,S1582,H 89 2HCl,-11.430328,x0678,1.797919,active-noncovalent
c1cc(ccc1Nc2cc3c(cc2Nc4ccc(cc4)F)C(=O)NC3=O)F,BRD-K32292990-001-04-4,CGP-53353,Tocris,2442,CGP 53353,-11.413448,x0678,1.014022,active-noncovalent
c1cc(ccc1Nc2cc3c(cc2Nc4ccc(cc4)F)C(=O)NC3=O)F,BRD-K32292990-001-03-6,CGP-53353,Tocris,2442,CGP 53353,-11.413448,x0678,1.014022,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccc(cc4)C(=O)NO)C1,BRD-K00627859-003-03-7,tubastatin-a,Selleck,S2627,Tubastatin A HCl,-11.396202,x0195,0.149513,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccc(cc4)C(=O)NO)C1,BRD-K00627859-001-06-4,tubastatin-a,Selleck,S8049,Tubastatin A,-11.396202,x0195,0.149513,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccc(cc4)C(=O)NO)C1,BRD-K00627859-001-07-2,tubastatin-a,Selleck,S8049,Tubastatin A,-11.396202,x0195,0.149513,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,BRD-K29905972-001-12-1,axitinib,Tocris,4350,Axitinib,-11.394080,x0104,4.569163,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,BRD-K29905972-001-08-9,axitinib,Selleck,S1005,Axitinib,-11.394080,x0104,4.569163,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,BRD-K29905972-001-06-3,axitinib,Selleck,S1005,Axitinib,-11.394080,x0104,4.569163,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,BRD-K29905972-001-11-3,axitinib,Adooq,A10103,N-methyl-2-({3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide,-11.394080,x0104,4.569163,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,BRD-K29905972-001-10-5,axitinib,Selleck,S1005,axitinib,-11.394080,x0104,4.569163,active-noncovalent
c1c[nH]c2c1c(c(c[nH+]2)C(=O)N)NC3[C@@H]4CC5C[C@H]3CC(C4)(C5)O,BRD-A14577621-001-01-5,peficitinib,Selleck,S7650,"Peficitinb (ASP015K, JNJ-54781532)",-11.379725,x0161,0.205033,active-noncovalent
C[C@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],BRD-K75410565-001-02-9,flurizan,Tocris,4495,Flurizan,-11.357160,x0678,1.7205,active-noncovalent
C[C@]12CC[C@H]3c4ccc(cc4CC[C@@H]3[C@H]1C[C@@H]([C@@H]2O)O)O,BRD-A63433173-001-02-1,estriol,MicroSource,1504520,EPIESTRIOL,-11.353638,x0749,1.896488,active-covalent
CCOC(=O)NNc1c2ccccc2cnn1,BRD-K68553471-003-12-3,todralazine,MicroSource,1501174,TODRALAZINE HYDROCHLORIDE,-11.343122,x0678,-0.127023,active-noncovalent
c1ccc2c(c1)ncc(n2)NS(=O)(=O)c3ccc(cc3)N,BRD-K71133585-236-14-4,sulfaquinoxaline,MicroSource,1501145,SULFAQUINOXALINE SODIUM,-11.320952,x0678,-0.44607,active-noncovalent
c1ccc2c(c1)ccc3c2cc(c4c3cccc4)N,BRD-K00656370-001-10-5,6-aminochrysene,Sigma,MFCD00003699,6-chrysenamine,-11.298630,x0749,-1.207984,active-covalent
Cn1cc2c3c1cccc3[C@H]4C[C@@H](C[N@H+]([C@@H]4C2)C)NS(=O)(=O)N(C)C,BRD-K91336023-003-01-0,mesulergine,Enzo,AC834,Mesulergine HCl,-11.295732,x0195,1.195673,active-noncovalent
c1c(cc(c(c1O)O)O)c2c(cc3c(cc(cc3[o+]2)O)O)O,BRD-K79107392-003-02-2,delphinidin,Cayman,11012,"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium chloride",-11.289549,x0749,1.40684,active-covalent
c1c(cc(c(c1O)O)O)c2c(cc3c(cc(cc3[o+]2)O)O)O,BRD-K79107392-003-01-4,delphinidin,Cayman,11012,,-11.289549,x0749,1.40684,active-covalent
C[N@@H+]1CCc2cccc-3c2[C@H]1Cc4c3c(c(cc4)O)O,BRD-K76022557-001-03-9,r(-)-apomorphine,Selleck,S4350,R-(-)-Apomorphine HCl Hemihydrate,-11.281105,x0195,0.551533,active-noncovalent
C[N@@H+]1CCc2cccc-3c2[C@H]1Cc4c3c(c(cc4)O)O,BRD-K76022557-003-02-7,r(-)-apomorphine,Tocris,2073,(R)-(-)-Apomorphine hydrochloride,-11.281105,x0195,0.551533,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccccc4)C1,BRD-K29713308-077-04-1,"mebhydroline-1,5-naphtalenedisulfonate",Prestwick,Prestw-455,"Mebhydroline 1,5-naphtalenedisulfonate",-11.277544,x0195,-0.530432,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccccc4)C1,BRD-K29713308-001-01-7,mebhydrolin,MicroSource,1501116,MEBHYDROLIN,-11.277544,x0195,-0.530432,active-noncovalent
c1cc(ccc1c2ccc(o2)c3ccc(cc3)C(=[NH2+])N)C(=[NH2+])N,BRD-K77758223-300-01-1,furamidine,Tocris,5202,Furamidine dihydrochloride,-11.259153,x0395,4.282551,active-noncovalent
c1cc(ccc1C[C@@H]2c3cc(c(cc3CC[NH2+]2)O)O)O,BRD-A55204514-003-01-2,higenamine,Accela,SY029900,"1-(4-hydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol hydrochloride",-11.253945,x0195,-0.269596,active-noncovalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,BRD-K43797669-001-28-8,genistein,Selleck,S1342,Genistein,-11.252321,x0749,2.774267,active-covalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,BRD-K43797669-001-31-2,genistein,Tocris,1110,Genistein,-11.252321,x0749,2.774267,active-covalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,BRD-K43797669-001-30-4,genistein,MicroSource,210296,GENISTEIN,-11.252321,x0749,2.774267,active-covalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,BRD-K43797669-001-29-6,genistein,Tocris,1110,Genistein,-11.252321,x0749,2.774267,active-covalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O,BRD-K89152108-236-07-6,liothyronine,Selleck,S4217,Liothyronine Sodium,-11.238697,x0678,2.059945,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O,BRD-K89152108-236-06-8,liothyronine,MicroSource,1502047,LIOTHYRONINE (L- isomer) SODIUM,-11.238697,x0678,2.059945,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O,BRD-K89152108-236-05-0,liothyronine,Selleck,S4217,Liothyronine Sodium,-11.238697,x0678,2.059945,active-noncovalent
c1ccc2c(c1)cccc2C[C@@H]3c4cc(c(cc4CC[NH2+]3)O)O,BRD-A26458246-004-02-1,CKD-712,MedChemEx,HY-15477,YS-49,-11.237705,x0195,-0.276368,active-noncovalent
c1ccc2c(c1)cccc2C[C@@H]3c4cc(c(cc4CC[NH2+]3)O)O,BRD-A26458246-004-01-3,CKD-712,MedChemEx,HY-15477,YS-49,-11.237705,x0195,-0.276368,active-noncovalent
c1cc(c(cc1/C=C/c2cc(cc(c2)O)O)O)O,BRD-K91509126-001-25-1,piceatannol,Selleck,S3026,Piceatannol,-11.220980,x0749,0.067257,active-covalent
c1cc(c(cc1/C=C/c2cc(cc(c2)O)O)O)O,BRD-K91509126-001-24-4,piceatannol,Tocris,1554,Piceatannol,-11.220980,x0749,0.067257,active-covalent
c1cc(c(cc1/C=C/c2cc(cc(c2)O)O)O)O,BRD-K91509126-001-23-6,piceatannol,Selleck,S3026,Piceatannol,-11.220980,x0749,0.067257,active-covalent
C=Cc1cc(cc2c1oc(n2)c3ccc(c(c3)F)O)O,BRD-K87316765-001-01-4,prinaberel,MedChemEx,HY-14933,Prinaberel,-11.213451,x0749,1.444244,active-covalent
c1cc(ccc1c2c[nH]nc2)[C@@](C[NH3+])(c3ccc(cc3)Cl)O,BRD-K32127727-001-03-4,AT13148,MedChemEx,HY-16071,AT13148,-11.206308,x1077,0.17107,active-noncovalent
c1cc(ccc1c2c[nH]nc2)[C@@](C[NH3+])(c3ccc(cc3)Cl)O,BRD-K32127727-001-04-2,AT13148,Selleck,S7563,AT13148,-11.206308,x1077,0.17107,active-noncovalent
c1cc(ccc1c2c[nH]nc2)[C@@](C[NH3+])(c3ccc(cc3)Cl)O,BRD-K32127727-001-02-6,AT13148,MedChemEx,HY-16071,(S)-1-(4-(1H-pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethan-1-ol,-11.206308,x1077,0.17107,active-noncovalent
c1cc(ccc1c2c[nH]nc2)[C@@](C[NH3+])(c3ccc(cc3)Cl)O,BRD-K32127727-001-01-8,AT13148,MedChemEx,HY-16071,AT13148,-11.206308,x1077,0.17107,active-noncovalent
CCCC[NH+](CCCC)C[C@@H](c1cc(cc\2c1-c3ccc(cc3/C2=C/c4ccc(cc4)Cl)Cl)Cl)O,BRD-A05926236-001-05-3,lumefantrine,Enamine,Z1541758602,,-11.202807,x0161,7.005849,active-noncovalent
CCCC[NH+](CCCC)C[C@@H](c1cc(cc\2c1-c3ccc(cc3/C2=C/c4ccc(cc4)Cl)Cl)Cl)O,BRD-A05926236-001-03-8,lumefantrine,MedChemEx,HY-B0803,Lumefantrine,-11.202807,x0161,7.005849,active-noncovalent
CCCC[NH+](CCCC)C[C@@H](c1cc(cc\2c1-c3ccc(cc3/C2=C/c4ccc(cc4)Cl)Cl)Cl)O,BRD-A05926236-001-04-6,lumefantrine,MedChemEx,HY-B0803,Lumefantrine,-11.202807,x0161,7.005849,active-noncovalent
c1cc(ccc1[C@@H]2Cc3ccc(cc3OC2)O)O,BRD-K54847683-001-04-0,equol,Selleck,S2450,Equol,-11.198337,x0749,-0.411931,active-covalent
c1cc(ccc1[C@@H]2Cc3ccc(cc3OC2)O)O,BRD-K54847683-001-03-2,equol,Selleck,S2450,Equol,-11.198337,x0749,-0.411931,active-covalent
c1cc(cc(c1)O)c2ccc(cc2)[C@H]3C[C@@H]3[NH3+],BRD-K26349472-001-02-1,OG-L002,Selleck,S7237,OG-L002,-11.191685,x0749,2.5187,active-covalent
c1cc(cc(c1)O)c2ccc(cc2)[C@H]3C[C@@H]3[NH3+],BRD-K26349472-001-01-3,OG-L002,Selleck,S7237,OG-L002,-11.191685,x0749,2.5187,active-covalent
c1ccc(cc1)CNC(=O)c2csc(n2)Nc3ccncn3,BRD-K03164761-001-02-1,thiazovivin,Selleck,S1459,Thiazovivin,-11.191407,x0678,5.078568,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)SC[C@H](C(=O)[O-])[NH3+],BRD-K09774593-001-01-7,S-Trityl-L-cysteine,Tocris,2191,S-Trityl-L-cysteine,-11.188899,x0678,0.640313,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3ccnc4c3cc(c(c4)OCC5(CC5)[NH3+])OC,BRD-K36949735-001-01-1,anlotinib,MedChemEx,HY-19716,Anlotinib,-11.164289,x0161,3.477052,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3[nH]c4ccccc4n3,BRD-K79132813-001-09-0,pibenzimol,Vitas-M,STK098943,,-11.147039,x0678,0.985917,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2ccs4)CC1,BRD-K75958195-037-09-4,pizotifen,MicroSource,1505003,PIZOTYLINE MALATE,-11.140948,x0195,0.075642,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2ccs4)CC1,BRD-K75958195-037-08-6,pizotifen,Selleck,S1394,Pizotifen Malate,-11.140948,x0195,0.075642,active-noncovalent
Cc1c([nH]cn1)CN2CCc3c(c4ccccc4n3C)C2=O,BRD-K46742498-003-11-0,alosetron,Enzo,AC3010,ALOSETRON HYDROCHLORIDE,-11.133524,x0195,-0.845207,active-noncovalent
c1ccc2c(c1)c(cn2Cc3ccc(cc3)Cl)C(=O)C(=O)Nc4ccncc4,BRD-K74057757-001-01-9,indibulin,Vitas-M,STK783524,,-11.127198,x0104,2.687581,active-noncovalent
c1cc(ccc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O,BRD-K01493881-001-29-4,apigenin,Tocris,1227,Apigenin,-11.106043,x0749,0.763497,active-covalent
c1cc(ccc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O,BRD-K01493881-001-28-6,apigenin,Selleck,S2262,Apigenin,-11.106043,x0749,0.763497,active-covalent
CCc1c(c2c(n1Cc3ccccc3)cccc2OCC(=O)[O-])C(=O)C(=O)N,BRD-K09711437-001-04-3,varespladib,Selleck,S1110,Varespladib (LY315920),-11.100426,x0830,3.363288,active-covalent
Cc1cc(cc2c1[nH]c(n2)c3c(cc[nH]c3=O)NC[C@H](c4cccc(c4)Cl)O)N5CCOCC5,BRD-K34581968-001-04-6,BMS-536924,MedChemEx,HY-10262,BMS-536924,-11.097097,x0678,3.833676,active-noncovalent
Cc1cc(cc2c1[nH]c(n2)c3c(cc[nH]c3=O)NC[C@H](c4cccc(c4)Cl)O)N5CCOCC5,BRD-K34581968-001-05-3,BMS-536924,Tocris,4774,BMS 536924,-11.097097,x0678,3.833676,active-noncovalent
c1ccc(cc1)Nc2cc3c(cc2Nc4ccccc4)C(=O)NC3=O,BRD-K13087974-001-03-3,CGP-52411,Tocris,3360,CGP 52411,-11.088956,x0678,0.352905,active-noncovalent
c1ccc(cc1)Nc2cc3c(cc2Nc4ccccc4)C(=O)NC3=O,BRD-K13087974-001-02-5,CGP-52411,Tocris,3360,CGP 52411,-11.088956,x0678,0.352905,active-noncovalent
c1cc(cnc1)C(=O)NCCCC(=O)[O-],BRD-K56691760-001-01-2,pikamilone,Enamine,Z235541930,,-11.080033,x0678,-1.224362,active-noncovalent
Cc1ccc(c(c1)n2cnc3c2ccc(c3)C(=O)NCc4ccccc4Cl)C,BRD-K36804890-001-01-9,NAB-2,Tocris,5131,NAB 2,-11.069983,x0161,5.418433,active-noncovalent
C[NH+](C)CCCNC(=O)c1ccc(cc1)c2cc3cccnc3c(c2)O,BRD-K25611237-001-02-1,ML324,MedChemEx,HY-12725,ML324,-11.068521,x0104,4.389913,active-noncovalent
CC(C)(C)[NH2+]C[C@H](COc1cccc2c1CCCC2=O)O,BRD-K73323637-003-10-9,levobunolol-(+),Prestwick,Prestw-857,(+) -Levobunolol hydrochloride,-11.054565,x0104,0.124024,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]C[C@@H](c2ccc(cc2)O)O,BRD-A86414188-003-02-3,ractopamine,MicroSource,1502332,RACTOPAMINE HYDROCHLORIDE,-11.050797,x0434,-0.252176,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]C[C@@H](c2ccc(cc2)O)O,BRD-A86414188-003-01-5,ractopamine,Selleck,S4351,Ractopamine HCl,-11.050797,x0434,-0.252176,active-noncovalent
CC#CCn1c2c(nc1[N@]3CCC[C@H](C3)[NH3+])n(c(=O)n(c2=O)Cc4nc(c5ccccc5n4)C)C,BRD-K96550715-001-04-2,linagliptin,Selleck,S3031,Linagliptin (BI-1356),-11.039680,x0104,8.705633,active-noncovalent
CC#CCn1c2c(nc1[N@]3CCC[C@H](C3)[NH3+])n(c(=O)n(c2=O)Cc4nc(c5ccccc5n4)C)C,BRD-K96550715-001-03-4,linagliptin,MicroSource,1506323,LINAGLIPTIN,-11.039680,x0104,8.705633,active-noncovalent
CC#CCn1c2c(nc1[N@]3CCC[C@H](C3)[NH3+])n(c(=O)n(c2=O)Cc4nc(c5ccccc5n4)C)C,BRD-K96550715-001-02-6,linagliptin,Selleck,S3031,Linagliptin,-11.039680,x0104,8.705633,active-noncovalent
CC#CCn1c2c(nc1[N@]3CCC[C@H](C3)[NH3+])n(c(=O)n(c2=O)Cc4nc(c5ccccc5n4)C)C,BRD-K96550715-003-01-4,linagliptin,MicroSource,1503880,LINAGLIPTIN HYDROCHLORIDE,-11.039680,x0104,8.705633,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1C[C@H]([C@@H]2O)O)O,BRD-K17016787-001-16-7,estriol,MicroSource,1500285,ESTRIOL,-11.034577,x0749,1.447041,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1C[C@H]([C@@H]2O)O)O,BRD-K17016787-001-15-9,estriol,Selleck,S2466,Estriol,-11.034577,x0749,1.447041,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1C[C@H]([C@@H]2O)O)O,BRD-K17016787-001-13-4,estriol,Selleck,S2466,Estriol,-11.034577,x0749,1.447041,active-covalent
CC1(Cc2c(c(c(n2C1)CC(=O)[O-])c3ccc(cc3)Cl)c4ccccc4)C,BRD-K08439945-001-03-9,licofelone,Adooq,A11697,"[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid",-11.020183,x0830,2.477049,active-covalent
CC1(Cc2c(c(c(n2C1)CC(=O)[O-])c3ccc(cc3)Cl)c4ccccc4)C,BRD-K08439945-001-02-1,licofelone,Selleck,S2121,Licofelone,-11.020183,x0830,2.477049,active-covalent
CC1(Cc2c(c(c(n2C1)CC(=O)[O-])c3ccc(cc3)Cl)c4ccccc4)C,BRD-K08439945-001-01-3,licofelone,Selleck,S2121,Licofelone,-11.020183,x0830,2.477049,active-covalent
CC#C[C@@H](CC(=O)[O-])c1ccc(cc1)OCc2cccc(c2)c3ccc(cc3)C(F)(F)F,BRD-K43802723-340-01-9,AMG-837,MedChemEx,HY-13967B,AMG 837 (calcium hydrate),-11.004150,x0104,12.181106,active-noncovalent
c1cc2c(cc1C3CCCCC3)c4c5n2CC[NH2+][C@H]5CCC4,BRD-A52660433-066-02-1,tetrindole,Tocris,723,Tetrindole mesylate,-10.997774,x0104,3.012327,active-noncovalent
c1cc2c(cc1C3CCCCC3)c4c5n2CC[NH2+][C@H]5CCC4,BRD-A52660433-066-03-9,tetrindole,Tocris,723,Tetrindole mesylate,-10.997774,x0104,3.012327,active-noncovalent
c1cc(cnc1)NC(=O)CCCCCCC(=O)NO,BRD-K11663430-001-04-9,pyroxamide,Cayman,13870,N~1~-hydroxy-N~8~-(3-pyridinyl)octanediamide,-10.989407,x0678,0.034456,active-noncovalent
c1cc(cnc1)NC(=O)CCCCCCC(=O)NO,BRD-K11663430-001-03-1,pyroxamide,Tocris,4403,Pyroxamide,-10.989407,x0678,0.034456,active-noncovalent
c1cc(cnc1)NC(=O)CCCCCCC(=O)NO,BRD-K11663430-001-02-3,pyroxamide,Cayman,13870,,-10.989407,x0678,0.034456,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NCc4[nH]c5c(n4)cccn5)CC[C@@H]6[C@@]3(C=C(C(=O)N6C)F)C,BRD-K38868394-001-01-3,MK-0773,MedChemEx,HY-11027,MK-0773,-10.988971,x0161,10.539925,active-noncovalent
C[N@H+]1CCc2cc3c(cc2[C@@H]1[C@@H]4c5ccc(c(c5C(=O)O4)OC)OC)OCO3,BRD-K02715688-001-02-1,"hydrastine-(1r,-9s)",MicroSource,1500687,"HYDRASTINE (1R, 9S)",-10.987147,x0195,2.714846,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O,BRD-K18910433-001-42-4,estradiol,Selleck,S1709,Estradiol,-10.985424,x0749,3.252627,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O,BRD-K18910433-001-43-2,estradiol,MicroSource,1500282,ESTRADIOL,-10.985424,x0749,3.252627,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O,BRD-K18910433-001-36-6,estradiol,Selleck,S1709,Estradiol,-10.985424,x0749,3.252627,active-covalent
c1cc(ccc1CCO)OCCn2ccnc2,BRD-K84883208-001-01-1,MR-948,Enamine,Z1578869664,2-(4-(2-(1H-imidazol-1-yl)ethoxy)phenyl)ethan-1-ol,-10.974442,x0678,-0.05443,active-noncovalent
CC/C(=C(/c1ccc(cc1)/C=C/C(=O)[O-])\c2ccc3c(c2)cn[nH]3)/c4ccc(cc4Cl)F,BRD-K61923022-001-02-4,GDC-0810,MedChemEx,HY-12864,GDC-0810,-10.970829,x1077,4.418924,active-noncovalent
CCO[C@@H](Cc1ccc(cc1)OCCn2c(ccc2c3ccc(cc3)SC)C)C(=O)[O-],BRD-K79878800-001-01-0,saroglitazar,Synnovator,PBLJ6347,,-10.959909,x0072,4.661958,active-noncovalent
c1c2c(c(c(c1F)N3CC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-A93964801-001-15-1,clinafloxacin,Selleck,S4006,Clinafloxacin (PD127391),-10.959001,x0749,2.693324,active-covalent
c1c2c(c(c(c1F)N3CC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-A93964801-001-14-4,clinafloxacin,Selleck,S4006,Clinafloxacin (PD127391),-10.959001,x0749,2.693324,active-covalent
c1c2c(c(c(c1F)N3CC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-A93964801-003-02-5,clinafloxacin,Selleck,S4315,Clinafoxacin HCl,-10.959001,x0749,2.693324,active-covalent
c1c2c(c(c(c1F)N3CC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-A93964801-003-03-3,clinafloxacin,MicroSource,1504834,CLINAFOXACIN HYDROCHLORIDE,-10.959001,x0749,2.693324,active-covalent
C[C@H](/C=C/[C@@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C\3/C[C@H](C[C@@H](C3=C)O)O)C,BRD-K82928892-001-03-3,doxercalciferol,Selleck,S1467,Doxercalciferol,-10.957501,x0161,7.138342,active-noncovalent
C[C@H](/C=C/[C@@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C\3/C[C@H](C[C@@H](C3=C)O)O)C,BRD-K82928892-001-02-5,doxercalciferol,Selleck,S1467,Doxercalciferol (Hectorol),-10.957501,x0161,7.138342,active-noncovalent
c1ccc2c(c1)c(c[nH]2)Cc3c[nH]c4c3cccc4,BRD-K37846922-001-09-4,"3,3'-diindolylmethane",Enzo,GR207,Diindolylmethane,-10.956906,x0072,-1.007995,active-noncovalent
c1cc(c(c(c1)F)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)F,BRD-K79856806-001-01-0,TA-01,MedChemEx,HY-100114,TA-01,-10.956722,x0434,2.427863,active-noncovalent
C[NH+](C)CCC=C1c2ccccc2C=Cc3c1cccc3,BRD-K42348709-003-13-1,cyclobenzaprine,MicroSource,1503207,CYCLOBENZAPRINE HYDROCHLORIDE,-10.952331,x0874,-0.924552,active-noncovalent
c1cc(ccc1N/C(=[NH+]\C(=[NH+]/CCCCCCNC(=[NH2+])/[NH+]=C(/N)\Nc2ccc(cc2)Cl)\N)/N)Cl,BRD-K52256627-300-06-6,chlorhexidine,MicroSource,1500177,CHLORHEXIDINE DIHYDROCHLORIDE,-10.944046,x0678,4.236789,active-noncovalent
c1ccc2c(c1)cc(s2)Cc3cc(ccc3F)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K51247865-001-01-2,ipragliflozin-l-proline,MedChemEx,HY-14894,Ipragliflozin,-10.925068,x0195,2.811833,active-noncovalent
c1cc(ccc1C[C@@H](C#N)c2ccc(cc2)O)O,BRD-A27143604-001-02-0,diarylpropionitrile,Tocris,1494,DPN,-10.914790,x0749,-0.728061,active-covalent
C/C(=C/1\c2ccccc2C[C@@H]1CC[NH+](C)C)/c3ccccn3,BRD-K83192048-050-02-7,dimethindene-(S)-(+),Tocris,1425,(S)-(+)-Dimethindene maleate,-10.895865,x0749,-0.204523,active-covalent
C/C(=C/1\c2ccccc2C[C@@H]1CC[NH+](C)C)/c3ccccn3,BRD-K83192048-050-03-5,dimethindene-(S)-(+),Tocris,1425,"(2Z)-2-butenedioic acid compound with N,N-dimethyl-2-{3-[(1S)-1-(2-pyridinyl)ethyl]-1H-inden-2-yl}ethanamine (1:1)",-10.895865,x0749,-0.204523,active-covalent
C/C(=C/1\c2ccccc2C[C@@H]1CC[NH+](C)C)/c3ccccn3,BRD-A54141700-001-01-5,dimetindene,AMS,A002862705,"N,N-dimethyl-2-{3-[1-(2-pyridinyl)ethyl]-1H-inden-2-yl}ethanamine",-10.895865,x0749,-0.163706,active-covalent
Cc1c(c2ccccc2n1CCC(=O)[O-])Cn3ccnc3,BRD-K20738689-001-01-2,dazmegrel,Vitas-M,STK094650,,-10.888386,x0830,0.319318,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])O[C@@H]4[C@@H]([C@H]([C@H]([C@@H](O4)CO)O)O)O)O)O,BRD-A63780829-001-11-4,hyperin,ChemDiv,0407-0014,,-10.881234,x0874,3.06613,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cccc3,BRD-K38436528-003-25-3,imipramine,Selleck,S4377,Imipramine HCl,-10.859057,x0195,-0.391398,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cccc3,BRD-K38436528-003-26-1,imipramine,MicroSource,1500348,IMIPRAMINE HYDROCHLORIDE,-10.859057,x0195,-0.391398,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cccc3,BRD-K38436528-003-27-9,imipramine,Selleck,S4377,IMipraMine hydrochloride,-10.859057,x0195,-0.391398,active-noncovalent
c1cc(c(cc1c2ccc(c(c2Cl)O)CN=O)F)O,BRD-K61642990-001-02-8,FERb-033,Tocris,3523,FERb 033,-10.850969,x0678,1.585873,active-noncovalent
c1cc(c(cc1c2ccc(c(c2Cl)O)CN=O)F)O,BRD-K61642990-001-01-0,FERb-033,Tocris,3523,FERb 033,-10.850969,x0678,1.585873,active-noncovalent
c1cc(ccc1c2nc3cc(cc(c3o2)Br)O)O,BRD-K08223200-001-01-1,WAY-200070,Tocris,3366,WAY 200070,-10.846251,x0749,0.406235,active-covalent
c1cc(ccc1c2nc3cc(cc(c3o2)Br)O)O,BRD-K08223200-001-02-9,WAY-200070,Tocris,3366,WAY 200070,-10.846251,x0749,0.406235,active-covalent
CC[NH+](CC)CCOc1ccccc1C(=O)CCc2ccccc2,BRD-K84971356-001-01-4,etafenone,Vitas-M,STK321191,1-{2-[2-(diethylamino)ethoxy]phenyl}-3-phenyl-1-propanone,-10.845141,x0104,2.797715,active-noncovalent
CC(C)(c1ccn2c(c[nH+]c2c1F)c3ccc(c(c3)c4ccc(cc4C#N)F)F)O,BRD-K87941707-001-01-0,TP-003,Tocris,4414,TP 003,-10.843095,x0161,3.977211,active-noncovalent
CC(C)(C)CC[NH+]1C[C@@H]2[C@H](C1)C2CNC(=O)c3cc(cc(c3)Cl)Cl,BRD-K92995792-003-02-9,ML-218,Tocris,4507,ML 218 hydrochloride,-10.839355,x0104,4.419221,active-noncovalent
Cc1[nH]c2ccc(cc2n1)n3c(c(cn3)C(=O)c4cc5ccccc5[nH]4)N,BRD-K11683436-001-01-7,CH-5183284,Selleck,S7665,CH5183284 (Debio-1347),-10.834774,x0161,6.449326,active-noncovalent
Cc1[nH]c2ccc(cc2n1)n3c(c(cn3)C(=O)c4cc5ccccc5[nH]4)N,BRD-K11683436-001-02-5,CH-5183284,Cayman,17120,(5-amino-1-(2-methyl-1H-benzo[d]imidazol-6-yl)-1H-pyrazol-4-yl)(1H-indol-2-yl)methanone,-10.834774,x0161,6.449326,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],BRD-A13946108-001-17-1,sulindac,Tocris,1707,Sulindac,-10.827938,x0830,3.106846,active-covalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],BRD-A13946108-001-16-3,sulindac,Selleck,S2007,Sulindac,-10.827938,x0830,3.106846,active-covalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],BRD-A13946108-001-19-7,sulindac,Selleck,S2007,Sulindac (Clinoril),-10.827938,x0830,3.106846,active-covalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],BRD-A13946108-001-18-9,sulindac,MicroSource,1500556,SULINDAC,-10.827938,x0830,3.106846,active-covalent
c1ccc(cc1)[C@]2(CCC(=O)NC2=O)C3CC[NH+](CC3)Cc4ccc(cc4)I,BRD-A46813902-001-01-6,iododexetimide,MedChemEx,HY-12426,mAChR-IN-1,-10.817308,x1077,2.770249,active-noncovalent
c1ccc(cc1)CNc2c3c([nH]cn3)ncn2,BRD-K62929068-001-16-5,6-benzylaminopurine,Prestwick,Prestw-189,"Aminopurine, 6-benzyl",-10.815964,x0749,-1.974887,active-covalent
CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C3CC[NH+](CC3)C,BRD-K61337602-003-02-1,naratriptan,Selleck,S1488,Naratriptan,-10.814455,x1077,0.793372,active-noncovalent
CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C3CC[NH+](CC3)C,BRD-K61337602-003-03-9,naratriptan,Selleck,S1488,Naratriptan HCl,-10.814455,x1077,0.793372,active-noncovalent
c1cc(c(cc1O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],BRD-K11590034-002-02-6,morin,Selleck,S2325,Morin Hydrate,-10.805906,x0749,0.747847,active-covalent
c1cc(c(cc1O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],BRD-K11590034-002-03-4,morin,Selleck,S2325,Morin hydrate (Aurantica),-10.805906,x0749,0.747847,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(Cc5c[nH]nc5C4)C,BRD-K46791647-001-01-2,stanozolol,Prestwick,Prestw-1161,Stanozolol,-10.803458,x0749,2.077357,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)CCCn2c3ccccc3c4c2cccc4,BRD-K70490179-300-01-2,rimcazole,Tocris,1497,Rimcazole dihydrochloride,-10.797787,x0195,2.186043,active-noncovalent
c1ccc(cc1)COCCCc2cnc[nH]2,BRD-K77171813-034-01-8,proxyfan,Tocris,2477,Proxyfan maleate,-10.796000,x0678,-1.827523,active-noncovalent
c1ccc(cc1)COCCCc2cnc[nH]2,BRD-K77171813-034-02-6,proxyfan,Tocris,2477,Proxyfan oxalate,-10.796000,x0678,-1.827523,active-noncovalent
c1cc(ccc1C[N@](c2c(cc(cn2)C(F)(F)F)Cl)S(=O)(=O)c3ccc(cc3)C(=O)[O-])OC(F)(F)F,BRD-K87973152-001-01-3,RQ-00203078,Tocris,5388,RQ 00203078,-10.795522,x0678,5.956387,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,BRD-K99616396-001-05-1,motesanib,MedChemEx,HY-10228,Motesanib,-10.789137,x0678,3.524839,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,BRD-K99616396-316-04-6,motesanib,Selleck,S1032,Motesanib Diphosphate (AMG-706),-10.789137,x0678,3.524839,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,BRD-K99616396-316-06-1,motesanib,MedChemEx,HY-10229,Motesanib (Diphosphate),-10.789137,x0678,3.524839,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,BRD-K99616396-001-06-9,motesanib,MedChemEx,HY-10228,Motesanib,-10.789137,x0678,3.524839,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,BRD-K99616396-316-05-3,motesanib,Selleck,S1032,Motesanib Diphosphate,-10.789137,x0678,3.524839,active-noncovalent
c1cc(c(cc1/C=C/C(=O)c2ccc(cc2O)O)O)O,BRD-K17497770-001-04-4,butein,Selleck,S8036,Butein,-10.785174,x1093,-0.643427,active-noncovalent
c1cc(c(cc1/C=C/C(=O)c2ccc(cc2O)O)O)O,BRD-K17497770-001-03-6,butein,Selleck,S8036,Butein,-10.785174,x1093,-0.643427,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccc(c2)O,BRD-K66019333-096-02-0,oxantel,MicroSource,1505982,OXANTEL PAMOATE,-10.779531,x0678,0.150644,active-noncovalent
c1ccc(cc1)/C=C/c2ccnc(n2)N,BRD-K77915400-001-01-6,TCN-238,Tocris,4259,TCN 238,-10.770400,x0749,-0.295809,active-covalent
c1cc(cnc1)C(=O)NCCON(=O)=O,BRD-K97752965-001-15-6,nicorandil,MicroSource,1506025,NICORANDIL,-10.763849,x0678,-1.19929,active-noncovalent
c1cc(cnc1)C(=O)NCCON(=O)=O,BRD-K97752965-001-13-1,nicorandil,Selleck,S1971,Nicorandil,-10.763849,x0678,-1.19929,active-noncovalent
c1cc(cnc1)C(=O)NCCON(=O)=O,BRD-K97752965-001-16-4,nicorandil,Selleck,S1971,Nicorandil (Ikorel),-10.763849,x0678,-1.19929,active-noncovalent
c1cc(cnc1)C(=O)NCCON(=O)=O,BRD-K97752965-001-14-9,nicorandil,Tocris,2147,Nicorandil,-10.763849,x0678,-1.19929,active-noncovalent
c1ccc2c(c1)Sc3cccc(c3S2)c4cc(=O)cc(o4)N5CCOCC5,BRD-K25311561-001-09-9,KU-55933,Selleck,S1092,KU-55933 (ATM Kinase Inhibitor),-10.763680,x0195,3.320421,active-noncovalent
c1ccc2c(c1)Sc3cccc(c3S2)c4cc(=O)cc(o4)N5CCOCC5,BRD-K25311561-001-10-7,KU-55933,Tocris,3544,KU 55933,-10.763680,x0195,3.320421,active-noncovalent
COc1ccc2c(c1)c3ccnc(c3[nH]2)c4cccc5c4cccc5,BRD-K28571773-001-01-6,SP-141,Tocris,5332,SP 141,-10.760232,x0946,0.805184,active-noncovalent
COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K78841970-001-14-6,aspartame,Sigma,A1320000,(3S)-3-amino-4-{[(1S)-1-benzyl-2-methoxy-2-oxoethyl]amino}-4-oxobutanoic acid,-10.743473,x0830,-0.184803,active-covalent
COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K78841970-001-11-2,aspartame,Selleck,S2036,Aspartame,-10.743473,x0830,-0.184803,active-covalent
COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K78841970-001-13-8,aspartame,Selleck,S2036,Aspartame,-10.743473,x0830,-0.184803,active-covalent
COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K78841970-001-12-0,aspartame,MicroSource,1505306,ASPARTAME,-10.743473,x0830,-0.184803,active-covalent
c1cc(ccc1[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O)O,BRD-A50684349-066-11-7,fenoldopam,MicroSource,1505539,FENOLDOPAM MESYLATE,-10.734211,x1418,-1.326652,active-covalent
c1cc(ccc1[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O)O,BRD-A50684349-003-02-9,fenoldopam,Tocris,1659,Fenoldopam hydrochloride,-10.734211,x1418,-1.326652,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,BRD-K41256143-001-12-7,dehydroepiandrosterone,Selleck,S2604,Dehydroepiandrosterone (DHEA),-10.734205,x0749,2.24087,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,BRD-K41256143-001-13-5,dehydroepiandrosterone,MicroSource,1505083,PRASTERONE,-10.734205,x0749,2.24087,active-covalent
c1cc(ccc1Nc2c3c(ncnc3[nH]n2)N)F,BRD-K42500029-001-06-8,CGP-57380,Tocris,2731,CGP 57380,-10.734002,x0678,-0.799509,active-noncovalent
c1cc(ccc1Nc2c3c(ncnc3[nH]n2)N)F,BRD-K42500029-001-03-5,CGP-57380,Selleck,S7421,CGP 57380,-10.734002,x0678,-0.799509,active-noncovalent
c1cc(ccc1Nc2c3c(ncnc3[nH]n2)N)F,BRD-K42500029-001-04-3,CGP-57380,Tocris,2731,CGP 57380,-10.734002,x0678,-0.799509,active-noncovalent
COc1nc(ccn1)c2n(cnc2c3ccc(cc3)F)[C@H]4CC[C@@H](CC4)O,BRD-K82091397-001-03-0,SB-239063,Tocris,1962,SB 239063,-10.733989,x0678,2.439401,active-noncovalent
c1cc(ccc1[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-])O,BRD-K08832567-001-11-5,naringenin,Selleck,S2394,Naringenin,-10.727943,x0749,-0.712157,active-covalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K56155962-001-16-2,ergocalciferol,Selleck,S4035,Vitamin D2,-10.727814,x0104,6.450594,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K56155962-001-11-3,ergocalciferol,Selleck,S4035,Vitamin D2 (Ergocalciferol),-10.727814,x0104,6.450594,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K56155962-001-15-4,ergocalciferol,MicroSource,1500276,ERGOCALCIFEROL,-10.727814,x0104,6.450594,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K56155962-001-12-1,ergocalciferol,Sigma,MFCD00166988,"(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol",-10.727814,x0104,6.450594,active-noncovalent
c1cc(ccc1C23C[C@H]4C[C@@H](C2)CC(C4)(C3)C(=O)NCc5ccncc5)Cl,BRD-A70814879-003-02-6,ABC-294640,Enzo,AC1558,ABC294640 HCl,-10.723454,x0749,1.899779,active-covalent
c1cc(ccc1C23C[C@H]4C[C@@H](C2)CC(C4)(C3)C(=O)NCc5ccncc5)Cl,BRD-A70814879-001-01-2,ABC-294640,Selleck,S7174,ABC294640,-10.723454,x0749,1.899779,active-covalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@H]2CC[C@]4([C@H]3CCC4=O)C)O,BRD-K42756753-001-01-9,epiandrosterone,Selleck,S2832,Epiandrosterone,-10.719960,x0749,0.432456,active-covalent
c1cc(c(cc1F)O)c2ccc(o2)/C=C\3/C(=O)[N-]C(=O)S3,BRD-K14988953-001-04-4,AS-252424,Selleck,S2671,AS-252424,-10.718079,x0107,0.721016,active-noncovalent
c1cc(c(cc1F)O)c2ccc(o2)/C=C\3/C(=O)[N-]C(=O)S3,BRD-K14988953-001-03-6,AS-252424,Selleck,S2671,AS-252424,-10.718079,x0107,0.721016,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4,BRD-A41692738-001-07-6,TGX-221,Selleck,S1169,TGX-221,-10.715137,x0195,5.011607,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4,BRD-A41692738-001-10-0,TGX-221,Selleck,S1169,TGX-221,-10.715137,x0195,5.011607,active-noncovalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,BRD-K80738081-001-42-7,resveratrol,Selleck,S1396,Resveratrol,-10.714994,x0749,-1.009263,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,BRD-K80738081-001-43-5,resveratrol,Tocris,1418,Resveratrol,-10.714994,x0749,-1.009263,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,BRD-K80738081-001-44-3,resveratrol,Selleck,S1396,Resveratrol,-10.714994,x0749,-1.009263,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,BRD-K80738081-001-47-6,resveratrol,Tocris,1418,Resveratrol,-10.714994,x0749,-1.009263,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,BRD-K80738081-001-46-8,resveratrol,MedChemEx,HY-16561,Resveratrol,-10.714994,x0749,-1.009263,active-covalent
CC(=O)Oc1ccccc1C(=O)Oc2ccccc2C(=O)[O-],BRD-K46585355-001-14-3,acetylsalicylsalicylic-acid,Prestwick,Prestw-98,Acetylsalicylsalicylic acid,-10.713825,x0195,0.967367,active-noncovalent
Cc1c(c(c(cn1)CSSCc2cnc(c(c2CO)O)C)CO)O,BRD-K82181219-001-04-3,pyritinol,MicroSource,1505762,PYRITINOL,-10.710277,x0678,2.855932,active-noncovalent
c1cnc(nc1)NCc2ccc(cc2)CNc3ncccn3,BRD-K25143390-001-01-0,MSX-122,MedChemEx,HY-13696,MSX-122,-10.709395,x0072,2.971716,active-noncovalent
CC(C)(C)[C@@H](C(=O)N1CCc2cc(c(cc2C1)OC)OC)[NH2+]Cc3ccncc3,BRD-K29424831-003-02-1,TCS-OX2-29,Tocris,3371,TCS OX2 29,-10.707070,x0678,2.470307,active-noncovalent
c1ccc(cc1)C(=O)Nc2cc3cc[nH]c3cn2,BRD-K10878147-001-02-2,OAC1,Selleck,S7217,OAC1,-10.690377,x0749,0.391624,active-covalent
c1ccc(cc1)C(=O)Nc2cc3cc[nH]c3cn2,BRD-K10878147-001-03-0,OAC1,Tocris,4887,OAC-1,-10.690377,x0749,0.391624,active-covalent
c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5,BRD-K33379087-001-07-5,tivantinib,MedChemEx,HY-50686,Tivantinib,-10.690360,x0195,1.263947,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1[C@H]([C@H]([C@@H]2O)O)O)O,BRD-K75445017-001-01-1,estetrol,Sigma,SML1523,"(15alpha,16alpha,17beta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol",-10.688125,x0749,0.381015,active-covalent
c1ccc2c(c1)C(=O)C(=Cc3cccnc3)C2=O,BRD-K32456483-001-04-9,PRT4165,MedChemEx,HY-19817,PRT4165,-10.681190,x0749,-0.357557,active-covalent
c1ccc2c(c1)C(=O)C(=Cc3cccnc3)C2=O,BRD-K32456483-001-02-3,PRT4165,MedChemEx,HY-19817,PRT4165,-10.681190,x0749,-0.357557,active-covalent
c1ccc2c(c1)C(=O)C(=Cc3cccnc3)C2=O,BRD-K32456483-001-03-1,PRT4165,Tocris,5047,PRT 4165,-10.681190,x0749,-0.357557,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],BRD-K69907333-001-07-2,flurbiprofen-(S)-(+),Selleck,S1679,Flurbiprofen,-10.678944,x0830,0.240075,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],BRD-K69907333-001-10-6,flurbiprofen-(S)-(+),Selleck,S1679,(S)-(+)-Flurbiprofen,-10.678944,x0830,0.240075,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],BRD-A86044036-001-27-3,flurbiprofen-(+/-),MicroSource,1500308,FLURBIPROFEN,-10.678944,x0830,0.240075,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],BRD-A86044036-001-26-5,flurbiprofen-(+/-),Tocris,1769,Flurbiprofen,-10.678944,x0830,0.240075,active-covalent
CCCNc1ccc2[nH+]cc(n2n1)c3ccc4c(c3)cn[nH]4,BRD-K76259716-019-01-1,CHR-6494,Tocris,5326,CHR 6494 trifluoroacetate,-10.676763,x0434,2.052323,active-noncovalent
CCCNc1ccc2[nH+]cc(n2n1)c3ccc4c(c3)cn[nH]4,BRD-K76259716-001-01-9,CHR-6494,MedChemEx,HY-15217,CHR-6494,-10.676763,x0434,2.052323,active-noncovalent
Cc1ncc(c(n1)N)C[N@H+]2CCC(=CC2)c3ccccc3,BRD-K79684402-300-02-8,Ro-10-5824,Tocris,2329,Ro 10-5824 dihydrochloride,-10.673193,x0946,0.245897,active-noncovalent
Cc1ncc(c(n1)N)C[N@H+]2CCC(=CC2)c3ccccc3,BRD-K79684402-300-03-6,Ro-10-5824,Tocris,2329,Ro 10-5824 dihydrochloride,-10.673193,x0946,0.245897,active-noncovalent
C[C@H](CNc1nccc(n1)c2cn(nc2c3cc(cc(c3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC,BRD-A56085258-001-01-8,LGX818,Selleck,S7108,LGX818,-10.669018,x0161,6.89739,active-noncovalent
C=CC[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)O,BRD-A64227845-004-09-3,SKF-77434,Tocris,1662,SKF 77434 hydrobromide,-10.665993,x1077,0.14176,active-noncovalent
c1cc(cc(c1)F)N(Cc2cc(c(c(c2)F)F)F)C(=O)O[C@H]3C[NH+]4CCC3CC4,BRD-K59390331-045-01-5,tarafenacin,MedChemEx,HY-14825A,Tarafenacin (D-tartrate),-10.658381,x1093,3.25099,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N2CC[NH+](CC2)C3CC[NH+](CC3)CC(=O)[O-],BRD-K12120659-305-02-2,GR-144053,Tocris,1263,GR 144053 trihydrochloride,-10.657013,x0395,3.284269,active-noncovalent
CC(C)(C)NS(=O)(=O)c1cc(cnc1)c2cc(c3nc(nn3c2)N)F,BRD-K01377300-001-02-9,CZC24832,Tocris,4674,CZC 24832,-10.656200,x0161,2.239836,active-noncovalent
CC(C)(C)NS(=O)(=O)c1cc(cnc1)c2cc(c3nc(nn3c2)N)F,BRD-K01377300-001-01-1,CZC24832,Selleck,S7018,CZC24832,-10.656200,x0161,2.239836,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)Nc3ccc(cc3)C(=O)[O-],BRD-K58794715-001-02-6,bentiromide,Selleck,S4388,bentiromide,-10.649840,x0678,3.198565,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)Nc3ccc(cc3)C(=O)[O-],BRD-K58794715-001-01-8,bentiromide,Selleck,S4388,Bentiromide,-10.649840,x0678,3.198565,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O,BRD-K72327355-001-13-9,baicalein,Selleck,S2268,Baicalein,-10.648987,x0749,0.838542,active-covalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O,BRD-K72327355-001-14-7,baicalein,Tocris,1761,Baicalein,-10.648987,x0749,0.838542,active-covalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O,BRD-K72327355-001-15-4,baicalein,Selleck,S2268,Baicalein,-10.648987,x0749,0.838542,active-covalent
C[C@@H](CO)NC(=O)[C@@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,BRD-A26387268-050-04-4,ergonovine,MicroSource,1500277,ERGONOVINE MALEATE,-10.648913,x0104,1.226107,active-noncovalent
CC(C)(c1cccnc1)C(=O)c2cccnc2,BRD-K46862739-001-14-3,metyrapone,MedChemEx,HY-B1232,Metyrapone,-10.638231,x0678,-1.10533,active-noncovalent
CC(C)(c1cccnc1)C(=O)c2cccnc2,BRD-K46862739-001-13-5,metyrapone,MicroSource,1506014,METYRAPONE,-10.638231,x0678,-1.10533,active-noncovalent
CC(C)(c1cccnc1)C(=O)c2cccnc2,BRD-K46862739-001-15-0,metyrapone,Tocris,3292,Metyrapone,-10.638231,x0678,-1.10533,active-noncovalent
C[N@@H+]1CCC2=C(C1)c3ccccc3Cc4c2cccc4,BRD-K36732695-001-01-9,setiptiline,MedChemEx,HY-32329,Setiptiline,-10.631288,x0072,-1.009869,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])c2ccc(c(c2)C34CC5CC(C3)CC(C5)C4)O,BRD-K00152668-001-01-5,adarotene,MedChemEx,HY-14808,Adarotene,-10.630851,x0104,5.313127,active-noncovalent
COc1ccccc1OC[C@H](COC(=O)N)O,BRD-A31521121-001-26-4,methocarbamol,MicroSource,1500397,METHOCARBAMOL,-10.630556,x0678,-0.812194,active-noncovalent
COc1ccccc1OC[C@H](COC(=O)N)O,BRD-A31521121-001-25-6,methocarbamol,Selleck,S1736,Methocarbamol,-10.630556,x0678,-0.812194,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](Cc3c(cc(cc3O2)O)O)O)O)O,BRD-K58736316-001-09-5,cianidanol,MicroSource,210205,CIANIDANOL,-10.630308,x0749,-0.403489,active-covalent
c1cc(c(c(c1)Cl)Cl)c2nnnn2Cc3cccnc3,BRD-K13223831-003-01-7,A-438079,Tocris,2972,A 438079 hydrochloride,-10.628376,x0678,1.407211,active-noncovalent
c1ccc(cc1)c2cccc(c2N3CCC[C@H](C3)[NH3+])/C=C\4/C(=O)[N-]C(=O)S4,BRD-K21908111-001-01-8,AZD1208,MedChemEx,HY-15604,AZD1208,-10.626678,x0678,0.612422,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@H](C5)C[NH+]6CCC6)ncnc4N,BRD-K24696047-001-02-3,NVP-AEW541,Selleck,S1034,NVP-AEW541,-10.623516,x0395,7.93853,active-noncovalent
c1ccc(c(c1)c2cc(c3c(c2)nc([nH]3)C4=NOC5(C4)CCCCC5)C(F)(F)F)C(F)(F)F,BRD-K05262258-001-01-3,TC-I-2014,Tocris,5410,TC-I 2014,-10.622856,x0161,5.993634,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C\[O-])/C(=O)C4)C,BRD-A23637604-001-04-1,oxymetholone,Selleck,S4087,Oxymetholone,-10.615410,x0749,2.975421,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)O,BRD-K48195008-001-18-1,ethinyl-estradiol,Selleck,S1625,Ethinyl Estradiol,-10.615116,x0749,1.392281,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)O,BRD-K48195008-001-17-3,ethinyl-estradiol,Selleck,S1625,Ethinyl Estradiol,-10.615116,x0749,1.392281,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)O,BRD-K48195008-001-19-9,ethinyl-estradiol,MicroSource,1500291,ETHINYL ESTRADIOL,-10.615116,x0749,1.392281,active-covalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,BRD-K28143534-003-26-7,cyproheptadine,MicroSource,1505973,CYPROHEPTADINE HYDROCHLORIDE,-10.612666,x0195,0.248705,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,BRD-K28143534-001-02-2,cyproheptadine,MicroSource,1505973,CYPROHEPTADINE HYDROCHLORIDE,-10.612666,x0195,0.248705,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,BRD-K28143534-003-24-2,cyproheptadine,Selleck,S2044,Cyproheptadine HCl,-10.612666,x0195,0.248705,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,BRD-K28143534-003-25-9,cyproheptadine,Tocris,996,Cyproheptadine hydrochloride,-10.612666,x0195,0.248705,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)Nc4ccccc4)C)C,BRD-K46580984-001-02-8,phenserine,Enzo,AC909,(-)-N-Phenylcarbamoyleseroline,-10.606596,x0104,2.521094,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)Nc4ccccc4)C)C,BRD-K46580984-001-03-6,phenserine,Sigma,MFCD00672748,"(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate",-10.606596,x0104,2.521094,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Cl)c2ccccn2,BRD-A04553218-050-16-2,chlorphenamine,Selleck,S1816,Chlorpheniramine Maleate,-10.602145,x0072,-0.235222,active-noncovalent
C[C@H](Cc1ccc(c(c1)O)O)[C@@H](C)Cc2ccc(c(c2)O)O,BRD-A87130939-001-07-9,masoprocol,Enzo,EI101,NDGA,-10.599864,x0678,-0.277637,active-noncovalent
c1ccc(cc1)c2cccc(c2)c3c(cnn3O)C4CC[NH2+]CC4,BRD-K07460388-019-01-6,PHP-501,Tocris,4466,PHP 501 trifluoroacetate,-10.599149,x0678,0.697308,active-noncovalent
Cc1cc(on1)C(=O)Nc2cccc(c2)C(=O)Nc3cccc(c3)C(F)(F)F,BRD-K83492904-001-01-9,T-5601640,Tocris,5269,T 5601640,-10.593467,x0161,7.773734,active-noncovalent
COC(=O)c1cc2c(cc(cc2n1O)c3ccccc3)C(F)(F)F,BRD-K05653025-001-01-5,NHI-2,Tocris,5363,NHI 2,-10.586697,x0195,2.178147,active-noncovalent
Cc1ccnc(n1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K93524252-001-24-7,sulfamerazine,MicroSource,1500547,SULFAMERAZINE,-10.585939,x0072,-0.157096,active-noncovalent
Cc1ccnc(n1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K93524252-001-23-9,sulfamerazine,Selleck,S3132,Sulfamerazine,-10.585939,x0072,-0.157096,active-noncovalent
Cc1cc(c(cc1C)N(=O)=O)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(cc4)C(=O)[O-])C,BRD-K73383190-001-03-1,C646,Selleck,S7152,C646,-10.584769,x0161,6.306158,active-noncovalent
Cc1cc(c(cc1C)N(=O)=O)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(cc4)C(=O)[O-])C,BRD-K73383190-001-02-3,C646,Selleck,S7152,C646,-10.584769,x0161,6.306158,active-noncovalent
Cn1ccc2c1cc3c(c2)N(CC3)C(=O)Nc4cccnc4,BRD-K36395411-003-02-2,SB-206553,Tocris,1661,SB 206553 hydrochloride,-10.582663,x0107,0.112216,active-noncovalent
Cn1ccc2c1cc3c(c2)N(CC3)C(=O)Nc4cccnc4,BRD-K36395411-003-03-0,SB-206553,Tocris,1661,SB 206553 hydrochloride,-10.582663,x0107,0.112216,active-noncovalent
Cc1cnc(c2n1nc(n2)[C@@H]3C[C@H]3c4c(n5ccc6c(c5n4)cccn6)C)C,BRD-K38145871-001-01-8,PDE10-IN-1,MedChemEx,HY-12813,PDE10-IN-1,-10.581775,x0104,8.050085,active-noncovalent
c1cc(ccc1c2coc3c(c2=O)ccc(c3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,BRD-K89048337-001-06-9,puerarin,Selleck,S2346,Puerarin,-10.581175,x0161,2.977769,active-noncovalent
CCCCC/[NH+]=c/1\ccn(c2c1cccc2)Cc3ccccc3,BRD-K52113681-003-02-1,CP-339818,Tocris,1399,CP 339818 hydrochloride,-10.577728,x0195,1.254518,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O,BRD-K81839095-001-30-1,estrone,MicroSource,1500286,ESTRONE,-10.575466,x0749,1.460176,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O,BRD-K81839095-001-25-1,estrone,Selleck,S1665,Estrone,-10.575466,x0749,1.460176,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O,BRD-K81839095-001-29-3,estrone,Selleck,S1665,Estrone,-10.575466,x0749,1.460176,active-covalent
Cc1cc(cnc1)c2cc(c(cn2)c3nccs3)C(=O)NCc4ccc(c(n4)OC)OC,BRD-K95828359-001-01-0,MK-3697,MedChemEx,HY-12301,MK-3697,-10.562616,x0678,7.81388,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC3c4ccccc4CCc5c3cccc5,BRD-A65797496-048-09-3,deptropine,Prestwick,Prestw-1013,Deptropine citrate,-10.555782,x0195,0.923496,active-noncovalent
c1cc(c(c(c1)Cl)CSc2nnc(s2)c3cnccn3)Cl,BRD-K88570498-001-01-9,yoda-1,Tocris,5586,Yoda 1,-10.555302,x0678,1.081618,active-noncovalent
c1cnccc1c2[nH]nc(n2)c3ccnc(c3)C#N,BRD-K77561571-001-01-1,topiroxostat,MedChemEx,HY-14874,Topiroxostat,-10.553616,x0195,-0.569411,active-noncovalent
Cc1cccc2c1ccc-3c2C(=O)C(=O)c4c3occ4C,BRD-K34073885-001-07-7,tanshinone-i,Selleck,S2364,Tanshinone I,-10.552562,x0749,1.51903,active-covalent
Cc1cccc2c1ccc-3c2C(=O)C(=O)c4c3occ4C,BRD-K34073885-001-09-3,tanshinone-i,Selleck,S2364,Tanshinone I,-10.552562,x0749,1.51903,active-covalent
c1cc(ccc1C(=O)Oc2ccc3cc(ccc3c2)C(=[NH2+])N)NC(=[NH2+])N,BRD-K06674495-334-05-7,nafamostat,Tocris,3081,Nafamostat mesylate,-10.550766,x1077,5.956454,active-noncovalent
c1cc(ccc1C(=O)Oc2ccc3cc(ccc3c2)C(=[NH2+])N)NC(=[NH2+])N,BRD-K06674495-334-04-0,nafamostat,Selleck,S1386,Nafamostat mesylate,-10.550766,x1077,5.956454,active-noncovalent
c1cc(ccc1C(=O)Oc2ccc3cc(ccc3c2)C(=[NH2+])N)NC(=[NH2+])N,BRD-K06674495-334-03-2,nafamostat,Selleck,S1386,Nafamostat Mesylate,-10.550766,x1077,5.956454,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OCCCCc2[n-]nnn2,BRD-K74765201-001-16-7,tomelukast,Enzo,RA101,LY-171883,-10.546258,x0678,1.397737,active-noncovalent
c1ccc(cc1)c2nc(sn2)N3CCN(CC3)C(=O)Nc4ccccc4,BRD-K47376733-001-08-1,JNJ-1661010,Selleck,S2828,JNJ-1661010,-10.544195,x0161,7.41746,active-noncovalent
c1ccc(cc1)c2nc(sn2)N3CCN(CC3)C(=O)Nc4ccccc4,BRD-K47376733-001-09-9,JNJ-1661010,Tocris,3262,JNJ 1661010,-10.544195,x0161,7.41746,active-noncovalent
COc1ccc(cc1)C[NH2+]Cc2cccc3c2cccc3,BRD-K33743361-003-02-6,ML133,Selleck,S2825,ML133 HCl,-10.541782,x0104,0.48885,active-noncovalent
CN1c2ccccc2C(=O)N(c3c1cccc3)CC[NH+](C)C,BRD-K79145749-003-02-2,dibenzepine,Selleck,S4319,Dibenzepine HCl,-10.534156,x0195,-0.198245,active-noncovalent
Cc1cccc(c1)Nc2nc(cs2)c3ccncc3,BRD-K85479953-001-11-3,STF-62247,Selleck,S1041,STF-62247,-10.525797,x1093,0.174181,active-noncovalent
Cc1cccc(c1)Nc2nc(cs2)c3ccncc3,BRD-K85479953-001-12-1,STF-62247,Selleck,S1041,STF-62247,-10.525797,x1093,0.174181,active-noncovalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CC[NH2+]CC4,BRD-K22385716-001-03-3,LY303511,Tocris,2418,LY 303511,-10.525321,x0434,2.272851,active-noncovalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CC[NH2+]CC4,BRD-K22385716-001-02-5,LY303511,Tocris,2418,LY 303511,-10.525321,x0434,2.272851,active-noncovalent
C[C@@H](Cc1ccc(cc1)O)[NH2+]C[C@@H](c2cc(cc(c2)O)O)O,BRD-A97104540-004-15-0,fenoterol,MicroSource,1501007,FENOTEROL HYDROBROMIDE,-10.524625,x0678,0.97631,active-noncovalent
c1ccc(cc1)c2ccc(cc2)C(=O)CCC(=O)[O-],BRD-K12513978-001-24-1,fenbufen,MicroSource,1501008,FENBUFEN,-10.521091,x0749,0.201527,active-covalent
Cc1cc(cc(c1NC(=O)c2ccc(o2)c3cc(ccc3Cl)Cl)C)C[NH3+],BRD-K80666802-003-01-0,CYM-50358,Tocris,4679,CYM 50358 hydrochloride,-10.507250,x1093,4.783566,active-noncovalent
CC[NH+]1CCN(CC1)c2cc(c3c(n2)CCCCCC3)c4ccc(cc4)F,BRD-K25943794-001-02-3,blonanserin,Selleck,S2112,Blonanserin (Lonasen),-10.503704,x0434,2.783838,active-noncovalent
c1cc(cc(c1)F)CC[N@@H+]2[C@H]3[C@@H]4[C@H]5C[C@H]6[C@@H]4[C@@]2([C@@H]7[C@H]6[C@H]5[C@@H]73)O,BRD-A13964793-001-02-6,TC1,Tocris,2669,TC 1,-10.502048,x0678,0.725255,active-noncovalent
C[NH2+]CCCC12CCC(c3c1cccc3)c4c2cccc4,BRD-K25433859-003-25-4,maprotiline,MicroSource,1500373,MAPROTILINE HYDROCHLORIDE,-10.499575,x0195,0.111384,active-noncovalent
C[NH2+]CCCC12CCC(c3c1cccc3)c4c2cccc4,BRD-K25433859-003-23-9,maprotiline,Selleck,S2517,Maprotiline HCl,-10.499575,x0195,0.111384,active-noncovalent
C[NH2+]CCCC12CCC(c3c1cccc3)c4c2cccc4,BRD-K25433859-003-24-7,maprotiline,Tocris,935,Maprotiline hydrochloride,-10.499575,x0195,0.111384,active-noncovalent
COc1ccc(cc1O)[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-],BRD-K30553453-001-13-2,hesperetin,Selleck,S2308,Hesperetin,-10.497662,x0749,-0.021782,active-covalent
C[C@H](CNC(=O)c1cccnc1)NC(=O)c2cccnc2,BRD-A86871940-001-01-9,nicaraven,Selleck,S4265,Nicaraven,-10.497327,x0678,0.932018,active-noncovalent
CC(C)NC(=[NH2+])N/C(=[NH+]\c1ccc(c(c1)Cl)Cl)/N,BRD-K25494650-003-01-8,chlorproguanil,AMS,A000012202,,-10.496804,x0104,-1.129916,active-noncovalent
c1cc2c(cc1Cl)n(c(=O)s2)CC(=O)N3CC[NH+](CC3)CCO,BRD-K27293958-001-01-5,tiaramide,Sigma,PH010339,"5-chloro-3-{2-[4-(2-hydroxyethyl)-1-piperazinyl]-2-oxoethyl}-1,3-benzothiazol-2(3H)-one",-10.492104,x0161,1.407879,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)C(=O)Nc3cccnc3,BRD-K22477529-001-02-7,STF-31,Tocris,4484,STF 31,-10.489787,x0387,4.602523,active-noncovalent
c1cc(ccc1c2coc3c(c2=O)ccc(c3[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,BRD-A07815743-001-01-1,kakonein,Vitas-M,STL146384,,-10.485851,x0161,2.67046,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1c2ccc(cc2[nH+]c3c1cc(cc3)OC)Cl,BRD-A45889380-300-06-3,mepacrine,Selleck,S4255,Quinacrine 2HCl,-10.479791,x0195,2.739364,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1c2ccc(cc2[nH+]c3c1cc(cc3)OC)Cl,BRD-A45889380-300-07-1,mepacrine,MicroSource,1500522,QUINACRINE HYDROCHLORIDE,-10.479791,x0195,2.739364,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1c2ccc(cc2[nH+]c3c1cc(cc3)OC)Cl,BRD-A45889380-300-08-9,mepacrine,Selleck,S4255,Quinacrine 2HCl,-10.479791,x0195,2.739364,active-noncovalent
Cc1c2cc(ccc2n(c1c3ccc(cc3)O)Cc4ccc(cc4)OCC[NH+]5CCCCCC5)O,BRD-K90195324-015-01-1,bazedoxifene,Tocris,5263,Bazedoxifene acetate,-10.477118,x0161,5.666655,active-noncovalent
Cc1c2cc(ccc2n(c1c3ccc(cc3)O)Cc4ccc(cc4)OCC[NH+]5CCCCCC5)O,BRD-K90195324-003-03-3,bazedoxifene,Selleck,S2128,Bazedoxifene HCl,-10.477118,x0161,5.666655,active-noncovalent
Cc1c2cc(ccc2n(c1c3ccc(cc3)O)Cc4ccc(cc4)OCC[NH+]5CCCCCC5)O,BRD-K90195324-003-02-5,bazedoxifene,Selleck,S2128,Bazedoxifene HCl,-10.477118,x0161,5.666655,active-noncovalent
Cn1c2cc(sc2c3c1c(=O)n(nc3)Cc4cccc(c4)N)[S@@](=O)C,BRD-A18279961-001-01-2,TEPP-46,MedChemEx,HY-18657,TEPP-46,-10.473345,x0104,3.423131,active-noncovalent
Cn1c2cc(sc2c3c1c(=O)n(nc3)Cc4cccc(c4)N)[S@@](=O)C,BRD-A18279961-001-02-0,TEPP-46,MedChemEx,HY-18657,TEPP-46,-10.473345,x0104,3.423131,active-noncovalent
C[C@]1(CCSC(=[NH2+])N1)c2cc(c(cc2F)F)c3cncnc3,BRD-K94534639-001-02-5,LY2811376,Selleck,S1528,LY2811376,-10.471333,x0678,-0.41874,active-noncovalent
Cc1cc(cc(c1)C(=O)OC2C[C@H]3CC[C@@H](C2)[NH+]3C)C,BRD-A84389633-001-05-7,"tropanyl-3,5-dimethylbenzoate",Tocris,641,"Tropanyl-3,5-dimethylbenzoate",-10.465230,x0161,0.156111,active-noncovalent
COC(=O)[C@H](c1ccccc1Cl)[N@H+]2CCc3c(ccs3)C2,BRD-K27721098-065-09-4,clopidogrel,MicroSource,1503710,CLOPIDOGREL SULFATE,-10.458050,x0749,-0.656186,active-covalent
COC(=O)[C@H](c1ccccc1Cl)[N@H+]2CCc3c(ccs3)C2,BRD-K27721098-065-10-2,clopidogrel,Selleck,S1415,Clopidogrel (Plavix),-10.458050,x0749,-0.656186,active-covalent
COC(=O)[C@H](c1ccccc1Cl)[N@H+]2CCc3c(ccs3)C2,BRD-K27721098-065-08-6,clopidogrel,Selleck,S1415,Clopidogrel,-10.458050,x0749,-0.656186,active-covalent
c1cc2c3c(c1)C(=O)N(C[C@H]3CCC2)[C@@H]4C[NH+]5CCC4CC5,BRD-K08924299-003-06-1,palonosetron,Selleck,S3050,Palonosetron HCl,-10.455042,x0195,1.024573,active-noncovalent
c1ccc(cc1)n2cc(cc(c2=O)c3ccccc3C#N)c4ccccn4,BRD-K41438959-001-01-7,perampanel,MedChemEx,HY-14745,Perampanel,-10.445380,x0678,3.043778,active-noncovalent
CCCOc1ccccc1c2[nH]c(=O)c3c(n2)n[nH]n3,BRD-K16542329-001-14-3,zaprinast,MicroSource,1501199,ZAPRINAST,-10.444923,x0678,-0.681199,active-noncovalent
CCCOc1ccccc1c2[nH]c(=O)c3c(n2)n[nH]n3,BRD-K16542329-001-16-8,zaprinast,Tocris,947,Zaprinast,-10.444923,x0678,-0.681199,active-noncovalent
CCCOc1ccccc1c2[nH]c(=O)c3c(n2)n[nH]n3,BRD-K16542329-001-13-5,zaprinast,Tocris,947,Zaprinast,-10.444923,x0678,-0.681199,active-noncovalent
COc1ccccc1C2(CC[NH+](CC2)CCCn3c4ccccc4c5c3cccc5)O,BRD-K85015012-003-03-7,NNC-05-2090,Tocris,2747,NNC 05-2090 hydrochloride,-10.444371,x0874,4.078104,active-noncovalent
COc1ccccc1C2(CC[NH+](CC2)CCCn3c4ccccc4c5c3cccc5)O,BRD-K85015012-003-02-9,NNC-05-2090,Tocris,2747,NNC 05-2090 hydrochloride,-10.444371,x0874,4.078104,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cccc2,BRD-K73700643-001-11-2,N-acetyltryptamine,Tocris,357,N-Acetyltryptamine,-10.443379,x0195,-2.011407,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cccc2,BRD-K73700643-001-13-8,N-acetyltryptamine,Tocris,357,N-Acetyltryptamine,-10.443379,x0195,-2.011407,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4ccc(cc4Cl)Cl,BRD-K59184148-001-22-4,SB-216763,Tocris,1616,SB 216763,-10.443048,x0161,0.791729,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4ccc(cc4Cl)Cl,BRD-K59184148-001-21-6,SB-216763,Selleck,S1075,SB216763,-10.443048,x0161,0.791729,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C[C@@H]5[C@H](C4)S5)C,BRD-K02314383-001-01-3,epitiostanol,Prestwick,Prestw-1006,Epitiostanol,-10.442616,x0749,1.979051,active-covalent
c1c(cc(c(c1O)O)O)CNC(=S)/C=C/c2cc(c(c(c2)Br)O)O,BRD-K54098378-001-02-4,NT157,MedChemEx,HY-100037,NT157,-10.439401,x1093,-0.847896,active-noncovalent
c1c(cc(c(c1O)O)O)CNC(=S)/C=C/c2cc(c(c(c2)Br)O)O,BRD-K54098378-001-01-6,NT157,MedChemEx,HY-100037,NT157,-10.439401,x1093,-0.847896,active-noncovalent
CCc1c2cc(ccc2[nH]c1C(=O)NCCc3ccc(cc3)N4CCCCC4)Cl,BRD-K57597776-001-01-2,org-27569,Selleck,S1534,Org 27569,-10.433810,x0104,4.640816,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O)O)O,BRD-K94649603-001-10-6,taxifolin,Selleck,S2366,Taxifolin (Dihydroquercetin),-10.427279,x0749,0.856393,active-covalent
c1cc(c(cc1[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O)O)O,BRD-K94649603-001-11-4,taxifolin,Selleck,S2366,Taxifolin (Dihydroquercetin),-10.427279,x0749,0.856393,active-covalent
CCCc1c(nn(c1c2ccc(cc2)O)c3ccc(cc3)O)c4ccc(cc4)O,BRD-K00312224-001-09-5,PPT,Tocris,1426,PPT,-10.424705,x0678,2.240112,active-noncovalent
CCCc1c(nn(c1c2ccc(cc2)O)c3ccc(cc3)O)c4ccc(cc4)O,BRD-K00312224-001-10-3,PPT,Tocris,1426,PPT,-10.424705,x0678,2.240112,active-noncovalent
C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C,BRD-K36055864-001-20-0,cycloheximide,Sigma,MFCD00082346,"4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}-2,6-piperidinedione",-10.421345,x0678,-0.056673,active-noncovalent
C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C,BRD-K36055864-001-19-2,cycloheximide,MicroSource,1502112,CYCLOHEXIMIDE,-10.421345,x0678,-0.056673,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cccc3,BRD-K37694030-003-11-9,doxepin,Tocris,508,Doxepin hydrochloride,-10.418590,x0195,-0.763169,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cccc3,BRD-K37694030-003-12-7,doxepin,MicroSource,1500264,DOXEPIN HYDROCHLORIDE,-10.418590,x0195,-0.763169,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K62779383-001-07-1,cholecalciferol,Selleck,S4063,Vitamin D3,-10.417953,x0104,5.515264,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K62779383-001-08-9,cholecalciferol,MicroSource,1500838,CHOLECALCIFEROL,-10.417953,x0104,5.515264,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K62779383-001-05-5,cholecalciferol,Selleck,S4063,Vitamin D3 (Cholecalciferol),-10.417953,x0104,5.515264,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O,BRD-K89561498-001-02-5,SN-38,Tocris,2684,SN 38,-10.417257,x0161,3.674183,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O,BRD-K89561498-001-03-3,SN-38,Tocris,2684,SN 38,-10.417257,x0161,3.674183,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O,BRD-K89561498-001-01-7,SN-38,Selleck,S4908,SN-38,-10.417257,x0161,3.674183,active-noncovalent
C[N@H+]1Cc2cc(ccc2[C@@H](C1)c3ccc(c(c3)Cl)Cl)OC,BRD-A51078674-003-01-0,diclofensine,MedChemEx,HY-18610,Diclofensine (hydrochloride),-10.417254,x0104,0.21284,active-noncovalent
Cc1nnc(s1)NS(=O)(=O)c2ccc(cc2)N,BRD-K31682896-001-24-0,sulfamethizole,MicroSource,1500549,SULFAMETHIZOLE,-10.416670,x0678,-0.404402,active-noncovalent
Cc1nnc(s1)NS(=O)(=O)c2ccc(cc2)N,BRD-K31682896-001-23-2,sulfamethizole,Selleck,S1957,Sulfamethizole,-10.416670,x0678,-0.404402,active-noncovalent
C[C@@H]1CCc2c3n1cc(c(=O)c3cc(c2N4CCC(CC4)O)F)C(=O)[O-],BRD-A24397426-001-09-6,nadifloxacin,Selleck,S3105,Nadifloxacin,-10.409428,x0195,2.391951,active-noncovalent
C[C@@H]1CCc2c3n1cc(c(=O)c3cc(c2N4CCC(CC4)O)F)C(=O)[O-],BRD-A24397426-001-10-4,nadifloxacin,MicroSource,1502312,NADIFLOXACIN,-10.409428,x0195,2.391951,active-noncovalent
c1ccc(c(c1)C(=O)OC[C@@H](CO)O)Nc2ccnc3c2cccc3C(F)(F)F,BRD-A23418262-001-01-5,floctafenine,Carbosynth,FF23305,"2,3-dihydroxypropyl 2-{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate",-10.407729,x0195,2.951552,active-noncovalent
c1ccc(cc1)n2cc(c3c2cccc3)/C=C(\C#N)/C(=O)[O-],BRD-K19558579-001-01-0,UK-5099,Tocris,4186,UK 5099,-10.405793,x0678,0.126114,active-noncovalent
C[C@H]1Cc2ccc3c(c2C(=O)C1)C(=O)c4cccc(c4C3=O)[O-],BRD-K92524032-001-02-1,ochromycinone,AnalytiCon,NP-003940,,-10.405521,x0749,2.478725,active-covalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CCOCC4,BRD-K27305650-001-16-6,LY294002,Selleck,S1105,LY294002,-10.403945,x0195,2.744293,active-noncovalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CCOCC4,BRD-K27305650-003-02-2,LY294002,Tocris,1130,LY 294002 hydrochloride,-10.403945,x0195,2.744293,active-noncovalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CCOCC4,BRD-K27305650-003-03-0,LY294002,Tocris,1130,LY 294002 hydrochloride,-10.403945,x0195,2.744293,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,BRD-K89732114-300-13-9,trifluoperazine,Selleck,S3201,Trifluoperazine 2HCl,-10.390505,x0195,3.006097,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,BRD-K89732114-300-14-7,trifluoperazine,MicroSource,1500591,TRIFLUOPERAZINE HYDROCHLORIDE,-10.390505,x0195,3.006097,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,BRD-K89732114-300-15-4,trifluoperazine,Selleck,S3201,Trifluoperazine 2HCl,-10.390505,x0195,3.006097,active-noncovalent
c1ccc2c(c1)ccc(n2)N3CC[NH2+]CC3,BRD-K77925998-050-14-3,quipazine,MicroSource,1503420,QUIPAZINE MALEATE,-10.385775,x0749,-0.83989,active-covalent
c1ccc2c(c1)ccc(n2)N3CC[NH2+]CC3,BRD-K77925998-332-04-6,quipazine,Tocris,629,Quipazine dimaleate,-10.385775,x0749,-0.83989,active-covalent
c1ccc2c(c1)ccc(n2)N3CC[NH2+]CC3,BRD-K77925998-364-01-5,quipazine,Selleck,S4409,Quipazine Maleate,-10.385775,x0749,-0.83989,active-covalent
c1ccc(cc1)Cn2c3ccccc3c(n2)OCC(=O)[O-],BRD-K19515365-001-02-6,bendazac,Key,KS-1230,[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid,-10.383814,x0678,0.062393,active-noncovalent
c1cc2c(c[nH]c2c(c1)C(=O)N3CC[NH+](CC3)CCc4ccc(cc4)F)C#N,BRD-K43837174-003-02-1,pruvanserin,Tocris,4470,EMD 281014 hydrochloride,-10.383598,x0104,3.708628,active-noncovalent
c1cc2c(c[nH]c2c(c1)C(=O)N3CC[NH+](CC3)CCc4ccc(cc4)F)C#N,BRD-K43837174-003-01-3,pruvanserin,Sigma,MFCD08056253,7-(4-(4-fluorophenethyl)piperazine-1-carbonyl)-1H-indole-3-carbonitrile hydrochloride,-10.383598,x0104,3.708628,active-noncovalent
C[C@@H](c1ccc-2c(c1)Cc3c2cccc3)C(=O)[O-],BRD-A94965935-001-01-6,cicloprofen,Enamine,Z2299360563,2-(9H-fluoren-2-yl)propanoic acid,-10.382397,x0749,0.509349,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,BRD-K97399794-335-06-4,quercetin,Selleck,S2347,Quercetin dihydrate (Sophoretin),-10.377850,x0749,0.885985,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,BRD-K97399794-001-14-6,quercetin,Selleck,S2391,Quercetin,-10.377850,x0749,0.885985,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,BRD-K97399794-001-15-3,quercetin,Tocris,1125,Quercetin,-10.377850,x0749,0.885985,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,BRD-K97399794-335-05-6,quercetin,Selleck,S2347,Quercetin Dihydrate,-10.377850,x0749,0.885985,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,BRD-K97399794-001-16-1,quercetin,Selleck,S2391,Quercetin (Sophoretin),-10.377850,x0749,0.885985,active-covalent
c1ccc2c(c1)cccc2CC3=[NH+]CCN3,BRD-K77641333-003-26-3,naphazoline,Selleck,S2519,Naphazoline HCl,-10.375788,x0195,-1.377559,active-noncovalent
c1ccc2c(c1)cccc2CC3=[NH+]CCN3,BRD-K77641333-003-27-1,naphazoline,MicroSource,1500424,NAPHAZOLINE HYDROCHLORIDE,-10.375788,x0195,-1.377559,active-noncovalent
c1cc(ccc1CCC(=O)c2c(cc(cc2O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,BRD-K24601397-001-01-1,phlorizin,Selleck,S2343,Phlorizin,-10.370809,x0678,4.527809,active-noncovalent
Cn1c(c([nH]c1=S)Cc2c[nH]c3c2cccc3)O,BRD-A36318220-001-08-8,necrostatin-1,Selleck,S8037,Necrostatin-1,-10.369701,x0678,-1.644715,active-noncovalent
Cn1c(c([nH]c1=S)Cc2c[nH]c3c2cccc3)O,BRD-A36318220-001-11-2,necrostatin-1,Selleck,S8037,Necrostatin-1,-10.369701,x0678,-1.644715,active-noncovalent
Cn1c(c([nH]c1=S)Cc2c[nH]c3c2cccc3)O,BRD-A36318220-001-09-6,necrostatin-1,Tocris,2324,Necrostatin-1,-10.369701,x0678,-1.644715,active-noncovalent
Cn1c(c([nH]c1=S)Cc2c[nH]c3c2cccc3)O,BRD-A36318220-001-12-0,necrostatin-1,Tocris,2324,Necrostatin-1,-10.369701,x0678,-1.644715,active-noncovalent
c1c2c(c(c(c1F)N3CCCC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-K10196357-003-02-0,besifloxacin,Selleck,S3055,Besifloxacin HCl (Besivance),-10.369646,x1334,5.091418,active-covalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)N)C,BRD-K11640013-236-10-1,sulfamethazine,Prestwick,Prestw-775,Sulfamethazine sodium salt,-10.365470,x0072,-0.155322,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)N)C,BRD-K11640013-001-15-8,sulfamethazine,MicroSource,1500548,SULFAMETHAZINE,-10.365470,x0072,-0.155322,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)N)C,BRD-K11640013-001-14-1,sulfamethazine,Selleck,S3133,Sulfamethazine,-10.365470,x0072,-0.155322,active-noncovalent
Cn1cc2c3c1cccc3[C@@H]4C[C@@H](C[N@@H+]([C@H]4C2)C)CNC(=O)OCc5ccccc5,BRD-A72309220-001-04-1,metergoline,MicroSource,300565,METERGOLINE,-10.363646,x0104,4.674333,active-noncovalent
Cc1cc(c2c3c1c4c(cc(c5c4c6c3c7c(c2O)c(cc(=O)c7c8c6c(c5O)c(cc8=O)[O-])[O-])O)C)O,BRD-K29673530-001-05-4,hypericin,Enzo,EI226,Hypericin,-10.361643,x0749,8.077497,active-covalent
c1cc(c(cc1Cl)Cl)c2cc(c(c(c2)CP(=O)([O-])[O-])O)C[C@@H](C(=O)[O-])[NH3+],BRD-K82266792-001-02-1,SDZ-220-040,Tocris,1251,SDZ 220-040,-10.361155,x0749,1.460834,active-covalent
c1cc(cc(c1)N)c2cc3c([nH]2)ncnc3Oc4cccc(c4)O,BRD-K94176593-362-01-7,TWS-119,Tocris,3835,TWS 119,-10.360308,x0678,1.32963,active-noncovalent
c1cc(cc(c1)N)c2cc3c([nH]2)ncnc3Oc4cccc(c4)O,BRD-K94176593-001-09-4,TWS-119,Selleck,S1590,TWS119,-10.360308,x0678,1.32963,active-noncovalent
Cn1cc([nH+]c1C2CCN(CC2)c3c4c[nH]nc4ncn3)c5ccc(c(c5)C(F)(F)F)F,BRD-K21833260-075-02-9,LY2584702,Adooq,A15527,"4-(4-(4-(4-fluoro-3-(trifluoromethyl)phenyl)-1-methyl-1H-imidazol-2-yl)piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidine 4-methylbenzenesulfonate",-10.358316,x0161,4.974578,active-noncovalent
Cn1cc([nH+]c1C2CCN(CC2)c3c4c[nH]nc4ncn3)c5ccc(c(c5)C(F)(F)F)F,BRD-K21833260-075-01-1,LY2584702,Selleck,S7704,LY2584702 Tosylate,-10.358316,x0161,4.974578,active-noncovalent
CC[C@@H](c1ccc(c(c1)F)F)n2c(c([nH]c2=S)c3ccno3)C(=O)OC,BRD-K41895652-001-01-8,JNJ-27141491,Tocris,5176,JNJ 27141491,-10.350121,x0678,1.434194,active-noncovalent
Cc1ccc(c(c1)Oc2ccncc2C(=O)N3CC[N@](c4c3cccc4)C5CC5)C,BRD-K16939217-001-01-3,TC-G-1005,Tocris,5129,TC-G 1005,-10.346515,x0107,2.232996,active-noncovalent
C=CC(=O)N1CCN(CC1)C(=O)CNc2cc(c(cc2O)Cl)I,BRD-K90756851-001-01-1,K-Ras(G12C)-inhibitor-12,MedChemEx,HY-18707,K-Ras(G12C) inhibitor 12,-10.343950,x0195,0.701434,active-noncovalent
C=CC(=O)N1CCN(CC1)C(=O)CNc2cc(c(cc2O)Cl)I,BRD-K90756851-001-02-9,K-Ras(G12C)-inhibitor-12,MedChemEx,HY-18707,K-Ras(G12C) inhibitor 12,-10.343950,x0195,0.701434,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)C3=Nc4ccccc4C3=O,BRD-K17894950-001-14-3,indirubin,Selleck,S2386,Indirubin,-10.343945,x0195,-0.965437,active-noncovalent
C[C@@H](c1ccc2c3cc(ccc3[nH]c2c1)Cl)C(=O)[O-],BRD-A17411484-001-11-9,carprofen,MicroSource,1502006,CARPROFEN,-10.343470,x0749,-0.456877,active-covalent
C[C@@H](c1ccc2c3cc(ccc3[nH]c2c1)Cl)C(=O)[O-],BRD-A17411484-001-10-1,carprofen,Selleck,S4136,Carprofen,-10.343470,x0749,-0.456877,active-covalent
C[NH+](C)[C@@H]1CCc2c(c3cc(ccc3[nH]2)NC(=O)c4ccc(cc4)F)C1,BRD-K95899059-003-02-8,LY344864,Tocris,2451,LY 344864 hydrochloride,-10.343363,x0104,5.869195,active-noncovalent
C[NH+](C)[C@@H]1CCc2c(c3cc(ccc3[nH]2)NC(=O)c4ccc(cc4)F)C1,BRD-K95899059-003-03-6,LY344864,Tocris,2451,LY 344864 hydrochloride,-10.343363,x0104,5.869195,active-noncovalent
c1c(cncc1Br)C(=O)N2CCC(CC2)[NH+]3CCCC3,BRD-K21906513-001-04-0,UNC669,Selleck,S7373,UNC669,-10.343193,x0107,-0.155649,active-noncovalent
c1c(cncc1Br)C(=O)N2CCC(CC2)[NH+]3CCCC3,BRD-K21906513-001-03-2,UNC669,Selleck,S7373,UNC669,-10.343193,x0107,-0.155649,active-noncovalent
c1ccc(cc1)C(=O)c2cccc(c2N)CC(=O)[O-],BRD-K82122102-323-01-1,amfenac,Selleck,S4149,Amfenac Sodium Monohydrate,-10.338215,x0830,0.365195,active-covalent
c1cc(c(cc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O)O,BRD-K05236810-001-19-0,luteolin,Selleck,S2320,Luteolin,-10.337856,x0749,1.514083,active-covalent
c1cc(ccc1C(=O)C2CC2)OCCCc3cnc[nH]3,BRD-K01767299-050-02-1,ciproxifan,Selleck,S2813,Ciproxifan,-10.334455,x0678,-0.505421,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N)O,BRD-K09291936-001-13-3,9-aminocamptothecin,Sigma,MFCD00909855,"(4S)-10-amino-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",-10.332307,x0161,2.868385,active-noncovalent
CC[C@H](C(=O)OC1C[C@H]2CC[C@@H](C1)[NH+]2C)Oc3ccc(cc3)Cl,BRD-A92933783-050-01-6,SM-21,Tocris,751,SM-21 maleate,-10.327953,x0195,1.366351,active-noncovalent
CCc1cncnc1N2CC[NH+](CC2)Cc3[nH]c4cc(ccc4n3)C(F)(F)F,BRD-K14711741-001-05-4,PF-4708671,Tocris,4032,PF 4708671,-10.327504,x0161,2.170578,active-noncovalent
CCc1cncnc1N2CC[NH+](CC2)Cc3[nH]c4cc(ccc4n3)C(F)(F)F,BRD-K14711741-001-02-1,PF-4708671,Selleck,S2163,PF-4708671,-10.327504,x0161,2.170578,active-noncovalent
c1ccc(cc1)COc2ccc(cc2C(=O)Nc3cccnc3)c4ccnc(c4)F,BRD-K30185465-001-03-0,GSK2578215A,Tocris,4629,GSK2578215A,-10.321705,x0107,3.951987,active-noncovalent
CC[C@@](c1ccccc1)(c2cccc(c2)C(F)(F)F)O,BRD-A44181516-001-01-8,flumecinol,Enamine,Z2301518221,1-phenyl-1-[3-(trifluoromethyl)phenyl]-1-propanol,-10.321628,x0749,-0.670131,active-covalent
c1cc(ccc1N)S(=O)(=O)Nc2ccc(nn2)Cl,BRD-K32021043-001-14-3,sulfachlorpyridazine,MicroSource,1501142,SULFACHLORPYRIDAZINE,-10.319646,x0678,0.284966,active-noncovalent
c1cc(=O)oc2c1cc(c(c2)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K36270037-001-01-7,esculin,Selleck,S2258,Esculin,-10.316544,x0678,0.414909,active-noncovalent
C[NH2+]CCC=C1c2ccccc2C=Cc3c1cccc3,BRD-K63165456-001-10-8,norcyclobenzaprine,Prestwick,Prestw-513,Norcyclobenzaprine,-10.315610,x0874,-1.160165,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,BRD-K32318651-001-21-1,acyclovir,Selleck,S1807,Aciclovir,-10.303643,x0397,-0.230045,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,BRD-K32318651-001-22-9,acyclovir,Tocris,2513,Acyclovir,-10.303643,x0397,-0.230045,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,BRD-K32318651-001-26-0,acyclovir,Tocris,2513,Acyclovir,-10.303643,x0397,-0.230045,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,BRD-K32318651-001-24-5,acyclovir,Selleck,S1807,Acyclovir (Aciclovir),-10.303643,x0397,-0.230045,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,BRD-K32318651-001-23-7,acyclovir,MicroSource,1503603,ACYCLOVIR,-10.303643,x0397,-0.230045,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-001-14-6,amoxicillin,Selleck,S3015,Amoxicillin (Amoxycillin),-10.303358,x0831,1.413937,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-236-04-9,amoxicillin,Selleck,S2565,Amoxicillin Sodium,-10.303358,x0831,1.413937,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-001-16-1,amoxicillin,MicroSource,1500120,AMOXICILLIN,-10.303358,x0831,1.413937,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-236-03-1,amoxicillin,MedChemEx,HY-B0467,Amoxicillin (sodium),-10.303358,x0831,1.413937,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-001-15-3,amoxicillin,Selleck,S3015,Amoxicillin,-10.303358,x0831,1.413937,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,BRD-K55044200-236-02-3,amoxicillin,Selleck,S2565,Amoxicillin sodium (Amox),-10.303358,x0831,1.413937,active-covalent
CCCC(=O)c1cc(ccc1OC[C@H](C[NH2+]C(C)(C)C)O)F,BRD-A27274504-001-01-6,butofilolol,Sigma,MFCD00864575,1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl}-1-butanone,-10.292184,x0195,0.386788,active-noncovalent
CC(C)c1cc(c(cc1O)O)C(=O)N2Cc3ccc(cc3C2)CN4CC[NH+](CC4)C,BRD-K58435339-001-06-3,AT13387,Selleck,S1163,Onalespib (AT13387),-10.289753,x0104,4.644742,active-noncovalent
CC(C)c1cc(c(cc1O)O)C(=O)N2Cc3ccc(cc3C2)CN4CC[NH+](CC4)C,BRD-K58435339-001-03-0,AT13387,Selleck,S1163,AT13387,-10.289753,x0104,4.644742,active-noncovalent
CCNC1=[NH+]c2ccc(cc2[C@@](O1)(C)c3ccccc3)Cl,BRD-A60821666-001-01-6,etifoxine,MedChemEx,HY-16579A,Etifoxine,-10.287774,x0305,-0.748797,active-noncovalent
CCNC1=[NH+]c2ccc(cc2[C@@](O1)(C)c3ccccc3)Cl,BRD-A60821666-003-01-2,etifoxine,MedChemEx,HY-16579,Etifoxine (hydrochloride),-10.287774,x0305,-0.748797,active-noncovalent
CCNC1=[NH+]c2ccc(cc2[C@@](O1)(C)c3ccccc3)Cl,BRD-A60821666-003-02-0,etifoxine,MedChemEx,HY-16579,Etifoxine (hydrochloride),-10.287774,x0305,-0.748797,active-noncovalent
c1ccc2c(c1)C(=O)OC2(c3ccc(cc3)O)c4ccc(cc4)O,BRD-K19227686-001-18-6,phenolphthalein,MicroSource,1500480,PHENOLPHTHALEIN,-10.282137,x0770,1.412683,active-covalent
c1cc2c(cccn2)c(c1)n3c(c(cn3)C(=O)NC(=[NH2+])N)C4CC4,BRD-K43992824-300-01-0,zoniporide,Tocris,2727,Zoniporide dihydrochloride,-10.277856,x0874,2.086341,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K92073408-001-14-0,norethindrone,Selleck,S4040,Norethindrone,-10.277848,x0749,1.540983,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K92073408-001-15-7,norethindrone,Selleck,S4040,Norethindrone,-10.277848,x0749,1.540983,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K92073408-001-16-5,norethindrone,MicroSource,1500437,NORETHINDRONE,-10.277848,x0749,1.540983,active-covalent
CC(C)(C)c1cc(c(cc1O)C(C)(C)C)O,BRD-K95603879-001-07-5,BHQ,Tocris,1236,BHQ,-10.273196,x0749,-0.528111,active-covalent
CCC[N@@H+]1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4c3c2ccc4)CSC,BRD-K60770992-066-25-0,pergolide,Selleck,S4000,Pergolide mesylate,-10.273161,x1392,0.800917,active-covalent
CCC[N@@H+]1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4c3c2ccc4)CSC,BRD-K60770992-066-26-8,pergolide,Selleck,S4000,Pergolide mesylate,-10.273161,x1392,0.800917,active-covalent
C=c1c(=O)/c(=C\NNC(=O)c2ccncc2)/c(c[nH]1)CO,BRD-K42019693-001-01-5,pyridoxal-isonicotinoyl-hydrazone,Cayman,19357,Pyridoxal isonicotinoyl hydrazone,-10.271133,x1093,1.037118,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]C3CCC(CC3)[NH3+],BRD-K59711701-300-02-1,ORY-1001,MedChemEx,HY-12782,ORY-1001,-10.260633,x0678,-1.158656,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]C3CCC(CC3)[NH3+],BRD-K59711701-300-01-3,ORY-1001,Selleck,S7795,ORY-1001 (RG-6016),-10.260633,x0678,-1.158656,active-noncovalent
c1cc2c(=O)cc(oc2c(c1)c3ccc(cc3)N)N4CCOCC4,BRD-K97365803-001-03-9,PI-828,Tocris,2814,PI 828,-10.258333,x0434,3.134609,active-noncovalent
c1cc2c(=O)cc(oc2c(c1)c3ccc(cc3)N)N4CCOCC4,BRD-K97365803-001-02-1,PI-828,Tocris,2814,PI 828,-10.258333,x0434,3.134609,active-noncovalent
c1cc2c(=O)cc(oc2c(c1)c3ccc(cc3)N)N4CCOCC4,BRD-K97365803-001-04-7,PI-828,Tocris,2814,8-(4-aminophenyl)-2-(4-morpholinyl)-4H-chromen-4-one,-10.258333,x0434,3.134609,active-noncovalent
CC(C)c1ccc2c(c1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C[NH3+])C,BRD-K62289640-003-02-7,lylamine,Tocris,2139,Leelamine hydrochloride,-10.254182,x0749,-0.397056,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O,BRD-K01614093-001-05-9,dihydromyricetin,MedChemEx,HY-N0112,Dihydromyricetin,-10.253414,x0749,1.272688,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O,BRD-K01614093-001-02-6,dihydromyricetin,Selleck,S2399,Dihydromyricetin,-10.253414,x0749,1.272688,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O,BRD-K01614093-001-04-2,dihydromyricetin,MedChemEx,HY-N0112,Dihydromyricetin,-10.253414,x0749,1.272688,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O,BRD-K01614093-001-03-4,dihydromyricetin,Selleck,S2399,Dihydromyricetin (Ampeloptin),-10.253414,x0749,1.272688,active-covalent
C[N+]12CCC(CC1)[C@@H](C2)OC(=O)C(c3ccccc3)(c4ccccc4)O,BRD-A46066006-004-22-6,clidinium,MicroSource,1500192,CLIDINIUM BROMIDE,-10.250352,x1093,1.134339,active-noncovalent
c1cc(ccc1Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4CCOC4,BRD-K53765467-001-02-1,empagliflozin,Selleck,S8022,Empagliflozin (BI 10773),-10.249493,x0874,4.605141,active-noncovalent
c1cc(c(c(c1C(=O)c2cc(c(c(c2)O)O)O)O)O)O,BRD-K65716359-001-02-1,exifone,Enzo,AC1540,Exifone,-10.247484,x0395,-0.279406,active-noncovalent
c1cc(c(c(c1C(=O)c2cc(c(c(c2)O)O)O)O)O)O,BRD-K65716359-001-04-7,exifone,Sigma,MFCD00082966,"(2,3,4-trihydroxyphenyl)(3,4,5-trihydroxyphenyl)methanone",-10.247484,x0395,-0.279406,active-noncovalent
COc1cc2c(cc1OC)[C@@H](N=NC(=O)C2)c3ccc(cc3)N,BRD-K42859542-001-03-3,CFM-2,Tocris,1082,CFM-2,-10.245515,x0195,-0.188519,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC=C3[C@H]1CCC2=O)O,BRD-A88080608-001-04-2,equilin,MicroSource,1500275,EQUILIN,-10.244355,x0749,0.356161,active-covalent
Cc1nc2c(nc(nc2n1C(C)C)N3CCOCC3)c4cnc(nc4)N,BRD-K98795921-001-01-7,SB-2343,MedChemEx,HY-16585,VS-5584,-10.243778,x0678,2.841837,active-noncovalent
C[NH+](C)CCCn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,BRD-K31342827-001-13-8,GF109203X,Tocris,741,GF 109203X,-10.235867,x1412,2.824342,active-covalent
C[NH+](C)CCCn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,BRD-K31342827-001-15-3,GF109203X,Tocris,741,GF 109203X,-10.235867,x1412,2.824342,active-covalent
C[NH+]1CCC(CC1)c2c[nH]c3c2cc(cc3)O,BRD-K17868609-001-04-3,BRL-54443,Selleck,S2852,BRL-54443,-10.234673,x0104,-0.682778,active-noncovalent
C[NH+]1CCC(CC1)c2c[nH]c3c2cc(cc3)O,BRD-K17868609-001-05-0,BRL-54443,Tocris,1129,BRL 54443,-10.234673,x0104,-0.682778,active-noncovalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)[O-])C(F)(F)F,BRD-K98763141-001-30-8,niflumic-acid,MicroSource,1502015,NIFLUMIC ACID,-10.234092,x0072,-0.893626,active-noncovalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)[O-])C(F)(F)F,BRD-K98763141-001-29-0,niflumic-acid,Selleck,S3018,Niflumic acid,-10.234092,x0072,-0.893626,active-noncovalent
CC(C)c1ccc2c(c1)[C@@H](Cc3ccc(cc3S2)F)N4CC[NH+](CC4)CCO,BRD-A07704283-001-01-3,isofloxythepin,Specs,AE-641/00600032,,-10.232785,x0072,2.301075,active-noncovalent
c1cc(cc2c1ccc(n2)/C=C/C(=O)c3ccncc3)C(F)(F)F,BRD-K28010364-001-01-0,PFK-158,MedChemEx,HY-12203,PFK-158,-10.228459,x0195,5.147495,active-noncovalent
C[C@H](CCC(=O)[O-])[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-K04497194-001-02-1,lithocholic-acid,Selleck,S4003,Lithocholic acid,-10.223473,x0072,2.673553,active-noncovalent
CCc1ccc(cc1)Cc2ccc3c(c2)[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC3,BRD-K96344439-002-02-7,tofogliflozin,MedChemEx,HY-13413,Tofogliflozin (hydrate),-10.222880,x0107,2.952733,active-noncovalent
CCc1ccc(cc1)Cc2ccc3c(c2)[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC3,BRD-K96344439-002-01-9,tofogliflozin,MedChemEx,HY-13413,Tofogliflozin (hydrate),-10.222880,x0107,2.952733,active-noncovalent
c1ccc(cc1)c2c3ccccc3c(nn2)Nc4cccc(c4)Cl,BRD-K90524085-001-08-6,MY-5445,Tocris,432,MY-5445,-10.220787,x0195,2.432909,active-noncovalent
c1ccc(cc1)c2c3ccccc3c(nn2)Nc4cccc(c4)Cl,BRD-K90524085-001-07-8,MY-5445,Tocris,432,MY-5445,-10.220787,x0195,2.432909,active-noncovalent
C[N@H+]1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,BRD-K87909389-003-04-2,alvocidib,Tocris,3094,Flavopiridol hydrochloride,-10.214050,x0195,1.782476,active-noncovalent
C[N@H+]1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,BRD-K87909389-003-03-4,alvocidib,Selleck,S2679,Flavopiridol HCl,-10.214050,x0195,1.782476,active-noncovalent
c1ccc(cc1)CCCNc2ccc(cc2C(=O)[O-])N(=O)=O,BRD-K89272762-001-12-7,NPPB,Tocris,593,NPPB,-10.211312,x1093,0.966861,active-noncovalent
c1ccc(cc1)CCCNc2ccc(cc2C(=O)[O-])N(=O)=O,BRD-K89272762-001-13-5,NPPB,Tocris,593,NPPB,-10.211312,x1093,0.966861,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(cc(cc3o2)O)[O-],BRD-K22861715-001-17-4,chrysin,Selleck,S2281,Chrysin,-10.210646,x0749,0.814754,active-covalent
C[NH+](C)C[C@@H](Cn1c2ccc(cc2c3c1ccc(c3)Br)Br)O,BRD-A18579359-001-04-9,wiskostatin,Tocris,4434,Wiskostatin,-10.209465,x0195,-0.587521,active-noncovalent
c1ccc2c(c1)c(n[nH]c2=O)Cc3ccc(c(c3)C(=O)N4CCN(CC4)C(=O)C5CC5)F,BRD-K02113016-001-19-6,olaparib,Selleck,S1060,Olaparib,-10.208745,x0161,5.052301,active-noncovalent
c1ccc2c(c1)c(n[nH]c2=O)Cc3ccc(c(c3)C(=O)N4CCN(CC4)C(=O)C5CC5)F,BRD-K02113016-001-15-4,olaparib,Selleck,S1060,"Olaparib (AZD2281, Ku-0059436)",-10.208745,x0161,5.052301,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K49522529-001-03-7,alfacalcidol,Selleck,S1468,Alfacalcidol,-10.207401,x0104,5.314983,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K49522529-001-02-9,alfacalcidol,Selleck,S1468,Alfacalcidol,-10.207401,x0104,5.314983,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K49522529-001-01-1,alfacalcidol,MedChemEx,HY-10003,Alfacalcidol,-10.207401,x0104,5.314983,active-noncovalent
Cc1c(n2c(n1)c(cc(n2)Cl)NCCNC(=O)C)c3cccc(c3)S(=O)(=O)N(C)C,BRD-K26726854-001-01-0,MI-14,Tocris,5604,MI 14,-10.206423,x0104,6.1983,active-noncovalent
C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N,BRD-K31283835-001-08-4,tofacitinib,Selleck,S2789,"Tofacitinib (CP-690550,Tasocitinib)",-10.203341,x1077,1.178263,active-noncovalent
C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N,BRD-K31283835-048-03-6,tofacitinib,Tocris,4556,CP 690550 citrate,-10.203341,x1077,1.178263,active-noncovalent
C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N,BRD-K31283835-048-04-4,tofacitinib,Selleck,S5001,Tofacitinib (CP-690550) Citrate,-10.203341,x1077,1.178263,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2nccc4)CC1,BRD-K77821588-364-01-2,azatadine,Selleck,S3186,Azatadine dimaleate,-10.202832,x0195,0.316259,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2nccc4)CC1,BRD-K77821588-050-01-7,azatadine,MicroSource,1503862,AZATADINE MALEATE,-10.202832,x0195,0.316259,active-noncovalent
c1cc2cc3cccc(c3c(c2c(c1)O)O)O,BRD-K51807679-001-06-8,dithranol,Sigma,D2953000,"1,8,9-anthracenetriol",-10.201751,x0195,-0.595053,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)c3c(c4ccccc4[nH]3)N=O,BRD-K19136521-001-08-9,indirubin-3-monoxime,Tocris,1813,Indirubin-3'-oxime,-10.200515,x0678,-0.398489,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4C(=O)[O-],BRD-K58772419-001-08-8,AZD6482,Tocris,4839,AZD 6482,-10.198004,x0195,6.846528,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4C(=O)[O-],BRD-K58772419-001-07-0,AZD6482,Selleck,S1462,AZD6482,-10.198004,x0195,6.846528,active-noncovalent
c1ccc(cc1)c2ccc3c(c2)c4c([nH]3)[C@@H](CCC4)[NH2+]CCO,BRD-A25043798-001-01-2,casin,Tocris,5050,CASIN,-10.194621,x0104,2.160827,active-noncovalent
COc1ccc(cc1C23CC4CC(C2)CC(C4)C3)c5ccc6cc(ccc6c5)C(=O)[O-],BRD-K33127281-001-05-6,adapalene,MicroSource,1502376,ADAPALENE,-10.193730,x0104,6.904617,active-noncovalent
COc1ccc(cc1C23CC4CC(C2)CC(C4)C3)c5ccc6cc(ccc6c5)C(=O)[O-],BRD-K33127281-001-04-9,adapalene,Selleck,S1276,Adapalene,-10.193730,x0104,6.904617,active-noncovalent
COc1ccc(cc1C23CC4CC(C2)CC(C4)C3)c5ccc6cc(ccc6c5)C(=O)[O-],BRD-K33127281-001-06-4,adapalene,Tocris,2852,Adapalene,-10.193730,x0104,6.904617,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)O)NC(=O)c3cccc(c3)N(C)C,BRD-K73789395-001-10-7,ZM-336372,Tocris,1321,ZM 336372,-10.193404,x0161,8.440387,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)O)NC(=O)c3cccc(c3)N(C)C,BRD-K73789395-001-14-9,ZM-336372,Tocris,1321,ZM 336372,-10.193404,x0161,8.440387,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)O)NC(=O)c3cccc(c3)N(C)C,BRD-K73789395-001-13-1,ZM-336372,Selleck,S2720,ZM 336372,-10.193404,x0161,8.440387,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)O)NC(=O)c3cccc(c3)N(C)C,BRD-K73789395-001-09-9,ZM-336372,Selleck,S2720,ZM 336372,-10.193404,x0161,8.440387,active-noncovalent
CN1c2ccccc2C(=O)N3[C@H]1c4c(c5ccccc5[nH]4)CC3,BRD-A68631409-001-05-4,evodiamine,Selleck,S2382,Evodiamine,-10.184712,x1093,-0.053075,active-noncovalent
CN1c2ccccc2C(=O)N3[C@H]1c4c(c5ccccc5[nH]4)CC3,BRD-A68631409-001-06-2,evodiamine,Selleck,S2382,Evodiamine (Isoevodiamine),-10.184712,x1093,-0.053075,active-noncovalent
COc1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,BRD-K53156626-001-01-3,7-methoxytacrine,Enamine,Z2327883841,"7-methoxy-1,2,3,4-tetrahydro-9-acridinylamine",-10.180806,x0749,0.030214,active-covalent
Cc1cccc(c1)NC(=O)/N=c\2/c(=O)n(c3c(c(n2)c4ccccc4)CCC=C3)C,BRD-K34277641-001-01-2,L-365260,Tocris,2767,"(R)-1-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-m-tolylurea",-10.180580,x0678,3.209292,active-noncovalent
COc1ccc(nn1)NS(=O)(=O)c2ccc(cc2)N,BRD-K00938507-001-17-8,sulfamethoxypyridazine,MicroSource,1501156,SULFAMETHOXYPYRIDAZINE,-10.180480,x0678,0.088586,active-noncovalent
COc1ccc(nn1)NS(=O)(=O)c2ccc(cc2)N,BRD-K00938507-001-16-0,sulfamethoxypyridazine,Selleck,S4250,Sulfamethoxypyridazine,-10.180480,x0678,0.088586,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)COC)F,BRD-K09549677-300-04-2,mibefradil,Tocris,2198,Mibefradil dihydrochloride,-10.180197,x0874,7.551404,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)COC)F,BRD-K09549677-300-03-4,mibefradil,Tocris,2198,Mibefradil dihydrochloride,-10.180197,x0874,7.551404,active-noncovalent
c1ccc(cc1)CCNc2ccccc2C(=O)[O-],BRD-K91422571-001-01-8,tromaril,Enamine,Z381346304,,-10.179571,x0749,-0.078911,active-covalent
C[NH+](C)CC/C=C/1\c2ccccc2CSc3c1cccc3,BRD-K54759182-003-08-0,dosulepin,Prestwick,Prestw-488,Dosulepin hydrochloride,-10.176539,x0195,-0.710625,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCC3CC[NH2+]CC3,BRD-K64973364-001-01-4,indalpine,Sigma,PH011694,3-[2-(4-piperidinyl)ethyl]-1H-indole,-10.172886,x0072,-1.694064,active-noncovalent
Cc1cc(no1)NC(=O)Nc2cc(c(cc2OC)OC)Cl,BRD-K71731651-001-05-0,PNU-120596,Tocris,2498,PNU 120596,-10.172806,x0678,1.355148,active-noncovalent
Cc1cc(no1)NC(=O)Nc2cc(c(cc2OC)OC)Cl,BRD-K71731651-001-04-3,PNU-120596,Tocris,2498,PNU 120596,-10.172806,x0678,1.355148,active-noncovalent
Cc1cc(no1)NC(=O)Nc2cc(c(cc2OC)OC)Cl,BRD-K71731651-001-03-5,PNU-120596,Selleck,S2629,PNU-120596,-10.172806,x0678,1.355148,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,BRD-K52080565-001-09-2,nandrolone,MedChemEx,HY-17432,Nandrolone,-10.166504,x0749,1.211301,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,BRD-K52080565-001-10-0,nandrolone,MedChemEx,HY-17432,Nandrolone,-10.166504,x0749,1.211301,active-covalent
COc1ccc(c(c1)OC)/C=C/2\CCCN=C2c3cccnc3,BRD-K14235254-001-01-2,GTS21,ChemDiv,Y010-1225,,-10.163243,x0107,0.075625,active-noncovalent
COc1ccc(cc1)c2coc3cc(cc(c3c2=O)[O-])O,BRD-K73303757-001-21-6,4-methylgenistein,Selleck,S2377,Biochanin A,-10.159066,x0749,4.83945,active-covalent
c1ccc2c(c1)ccc(c2Cc3c4ccccc4ccc3O)O,BRD-K73524797-001-01-1,ST-1859,Enamine,Z56948405,,-10.155929,x0749,-0.208232,active-covalent
c1ccc2c(c1)c(c[nH]2)CCCC(=O)[O-],BRD-K43187796-001-02-3,3-indolebutyric-acid,Selleck,S2253,3-Indolebutyric acid (IBA),-10.152559,x0072,-2.166793,active-noncovalent
c1ccc(cc1)COC(=O)CCC(=O)C[NH3+],BRD-K59998349-003-01-4,aminolevulinic-acid-benzyl-ester,ChemImpex,20989,,-10.151463,x0678,-1.188508,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K79753741-001-01-7,UBP-302,Tocris,2079,UBP 302,-10.146521,x0678,2.075134,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-A45499626-001-03-6,UBP-296,Tocris,2078,UBP 296,-10.146521,x0678,2.075134,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K79753741-001-02-5,UBP-302,Tocris,2079,UBP 302,-10.146521,x0678,2.075134,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K79753741-001-03-3,UBP-302,Tocris,2079,"2-[(3-[(2S)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)methyl]benzoic acid",-10.146521,x0678,2.075134,active-noncovalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,BRD-K00535541-001-04-8,9-aminoacridine,Selleck,S4303,9-Aminoacridine,-10.145630,x0749,-0.682995,active-covalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,BRD-M49658242-001-04-1,acrisorcin,MicroSource,1504218,ACRISORCIN,-10.145630,x0749,-0.682995,active-covalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,BRD-K00535541-001-05-5,9-aminoacridine,MicroSource,1500810,AMINACRINE,-10.145630,x0749,-0.682995,active-covalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,BRD-K00535541-001-06-3,9-aminoacridine,Selleck,S4303,9-Aminoacridine;9-Aminoacridine;Aminoacrid,-10.145630,x0749,-0.682995,active-covalent
CN(C)c1ccc(cc1)/C=C/2\CCCN=C2c3cccnc3,BRD-K26573499-300-02-1,DMAB-anabaseine,Tocris,2241,DMAB-anabaseine dihydrochloride,-10.145158,x0107,1.592412,active-noncovalent
CN(C)c1ccc(cc1)/C=C/2\CCCN=C2c3cccnc3,BRD-K26573499-300-03-9,DMAB-anabaseine,Tocris,2241,DMAB-anabaseine dihydrochloride,-10.145158,x0107,1.592412,active-noncovalent
Cc1c(c(n(n1)c2ccccc2)C)/C=N/N3CC[NH+](CC3)Cc4ccccc4,BRD-K99741577-001-02-5,SANT-1,Tocris,1974,SANT-1,-10.139997,x1077,3.099069,active-noncovalent
Cc1c(c(n(n1)c2ccccc2)C)/C=N/N3CC[NH+](CC3)Cc4ccccc4,BRD-K99741577-001-01-7,SANT-1,Selleck,S7092,SANT-1,-10.139997,x1077,3.099069,active-noncovalent
Cc1c(c(n(n1)c2ccccc2)C)/C=N/N3CC[NH+](CC3)Cc4ccccc4,BRD-K99741577-001-03-3,SANT-1,Tocris,1974,SANT-1,-10.139997,x1077,3.099069,active-noncovalent
c1cc(ccc1c2ccc3c(c2)cco3)n4c(n[nH]c4=O)C[C@@H]5CCN(C5)C(=O)C6CC6,BRD-K95123482-001-01-6,GSK2194069,Tocris,5303,GSK 2194069,-10.139313,x0104,4.440884,active-noncovalent
c1c2c(c(c(c1F)N3C[C@H](C4(C3)CC4)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])[C@@H]5C[C@@H]5F,BRD-K10836013-001-01-3,sitafloxacin,Selleck,S2152,Sitafloxacin Hydrate,-10.137216,x0749,3.657235,active-covalent
Cc1c(nc2n1Cc3c(cccc3Cl)N2)O,BRD-K63631219-001-01-6,quazinone,AMS,A000382058,"(3R)-6-chloro-3-methyl-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one",-10.131096,x0195,-1.522602,active-noncovalent
C[N@H+]1CCC[C@H](C1)CN2c3ccccc3Sc4c2cccc4,BRD-A82772293-001-03-2,mepazine,ChemDiv,S008-0093,,-10.129505,x0195,-0.219657,active-noncovalent
COc1cc2c(cc1O)occ(c2=O)c3ccc(cc3)O,BRD-K78303961-001-02-3,glycitein,Cayman,14162,,-10.129480,x0749,3.94065,active-covalent
COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,BRD-K35586044-003-14-7,yohimbine,Selleck,S2373,Yohimbine HCl,-10.129053,x0104,2.062083,active-noncovalent
COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,BRD-K35586044-003-16-2,yohimbine,MicroSource,1500663,YOHIMBINE HYDROCHLORIDE,-10.129053,x0104,2.062083,active-noncovalent
COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,BRD-K35586044-003-15-4,yohimbine,Tocris,1127,Yohimbine hydrochloride,-10.129053,x0104,2.062083,active-noncovalent
[H]/N=C\1/C=CC(=C(c2ccc(cc2)N)c3ccc(cc3)N)C=C1C,BRD-K26362911-003-01-1,basic-fuchsin,SantaCruz,sc-203731,Basic Fuchsin,-10.127342,x0831,0.840928,active-covalent
c1ccc2c(c1)c(n[nH]2)/C=C/c3ccc(cc3)C(=O)N4CC[NH2+]CC4,BRD-K21718444-001-06-8,KW-2449,Selleck,S2158,KW-2449,-10.123824,x0874,5.287266,active-noncovalent
CCOC(=O)c1c(c2c3cc(ccc3[nH]c2cn1)OCc4ccccc4)COC,BRD-K33882852-003-03-6,ZK-93423,Tocris,1994,ZK 93423 hydrochloride,-10.123732,x0104,3.85338,active-noncovalent
CCOC(=O)c1c(c2c3cc(ccc3[nH]c2cn1)OCc4ccccc4)COC,BRD-K33882852-003-02-8,ZK-93423,Tocris,1994,ZK 93423 hydrochloride,-10.123732,x0104,3.85338,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c(n2)c4ccc(o4)CO,BRD-K60476892-001-16-1,YC-1,Tocris,4307,YC 1,-10.119238,x0195,1.37622,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c(c(c2=O)C(=O)NCC(=O)[O-])[O-],BRD-K98251413-001-06-5,IOX2,Tocris,4451,IOX 2,-10.118774,x0195,2.272181,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c(c(c2=O)C(=O)NCC(=O)[O-])[O-],BRD-K98251413-001-04-0,IOX2,Selleck,S2919,IOX2,-10.118774,x0195,2.272181,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCCCn4c(c5c(c4O)CCCC5)O,BRD-K85503079-001-02-8,perospirone,AKSci,M813,,-10.118122,x0161,6.244096,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCCCn4c(c5c(c4O)CCCC5)O,BRD-K85503079-001-01-0,perospirone,Prestwick,Prestw-1770,Perospirone,-10.118122,x0161,6.244096,active-noncovalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)OCc3cccs3)[NH3+],BRD-A17428743-003-10-8,BW-723C86,Tocris,1059,BW 723C86 hydrochloride,-10.117145,x0749,-0.13852,active-covalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)OCc3cccs3)[NH3+],BRD-A17428743-003-09-0,BW-723C86,Tocris,1059,BW 723C86 hydrochloride,-10.117145,x0749,-0.13852,active-covalent
C[NH+]1CCN(CC1)c2c(cc3c4c2SCCn4cc(c3=O)C(=O)[O-])F,BRD-K62374253-001-07-8,rufloxacin,MicroSource,1502335,RUFLOXACIN HYDROCHLORIDE,-10.116451,x0195,2.668291,active-noncovalent
C[C@H](c1ccc(cc1)Br)C(=O)OC2C[C@H]3CC[C@@H](C2)[NH+]3C,BRD-A70268693-050-01-2,PG-9,Tocris,750,PG-9 maleate,-10.110547,x0104,0.233146,active-noncovalent
c1cc2c(cc1F)[C@@]3(C[C@H](O2)C(=O)N)C(=O)NC(=O)N3,BRD-A63752151-001-01-2,fidarestat,Vitas-M,STK692948,,-10.109543,x0195,0.637041,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CCC[NH+]3CCC(CC3)n4c5ccc(cc5[nH]c4=O)Cl,BRD-K38305202-001-18-2,domperidone,MicroSource,2300212,DOMPERIDONE,-10.107753,x1077,3.847341,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CCC[NH+]3CCC(CC3)n4c5ccc(cc5[nH]c4=O)Cl,BRD-K38305202-001-17-4,domperidone,Tocris,2536,Domperidone,-10.107753,x1077,3.847341,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CCC[NH+]3CCC(CC3)n4c5ccc(cc5[nH]c4=O)Cl,BRD-K38305202-001-16-6,domperidone,Selleck,S2461,Domperidone,-10.107753,x1077,3.847341,active-noncovalent
Cc1c(cccc1Nc2c(cccn2)C(=O)[O-])C(F)(F)F,BRD-K99984802-100-12-7,flunixin-meglumin,Selleck,S2108,Flunixin Meglumin,-10.107270,x0195,0.164888,active-noncovalent
Cc1c(cccc1Nc2c(cccn2)C(=O)[O-])C(F)(F)F,BRD-K99984802-100-13-5,flunixin-meglumin,MicroSource,1505113,FLUNIXIN MEGLUMINE,-10.107270,x0195,0.164888,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)Cc2nc(on2)c3ccc4c(c3)c(c[nH]4)CC[NH3+],BRD-K18816859-001-02-2,L-694247,Tocris,781,"L-694,247",-10.105589,x0107,6.041358,active-noncovalent
Cc1c(c(n[nH]1)C)Cc2c(c3c(=O)n(c(=O)n(c3s2)CC(C)C)C)C(=O)N4C[C@@H](CO4)O,BRD-K42325600-001-01-8,AR-C155858,MedChemEx,HY-13248,AR-C155858,-10.105435,x1077,3.155029,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc(c2F)F)C(=O)NOC[C@@H](CO)O,BRD-K49865102-001-08-4,PD-0325901,Selleck,S1036,PD0325901,-10.102144,x0434,2.668961,active-noncovalent
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,BRD-K22525962-001-05-0,dihydrotestosterone,MedChemEx,HY-A0120,Dihydrotestosterone,-10.097753,x0749,3.137033,active-covalent
c1ccc(cc1)COc2ccc(cc2Cl)CC(=O)[O-],BRD-K26556907-001-01-8,benzofenac,Sigma,PH006029,[4-(benzyloxy)-3-chlorophenyl]acetic acid,-10.096598,x0830,0.01076,active-covalent
Cc1cccc(n1)c2c(cn[nH]2)c3ccc(c(c3)c4cnn(c4)CCO)F,BRD-K83904070-001-01-1,R-268712,Tocris,5288,R 268712,-10.096083,x0161,4.665062,active-noncovalent
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5c[nH]nc5c4)N6CCOCC6,BRD-K76719364-001-06-6,GS-9973,MedChemEx,HY-15968,GS-9973,-10.093522,x0678,5.086839,active-noncovalent
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5c[nH]nc5c4)N6CCOCC6,BRD-K76719364-001-04-1,GS-9973,MedChemEx,HY-15968,GS-9973,-10.093522,x0678,5.086839,active-noncovalent
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5c[nH]nc5c4)N6CCOCC6,BRD-K76719364-001-02-5,GS-9973,Selleck,S7523,Entospletinib (GS-9973),-10.093522,x0678,5.086839,active-noncovalent
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5c[nH]nc5c4)N6CCOCC6,BRD-K76719364-001-01-7,GS-9973,Selleck,S7523,GS-9973,-10.093522,x0678,5.086839,active-noncovalent
c1ccc(cc1)CCOC(=O)/C=C/c2ccc(c(c2)O)O,BRD-K96188950-001-15-1,caffeic-acid-phenethyl-ester,Selleck,S7414,Caffeic Acid Phenethyl Ester,-10.092237,x0678,1.121555,active-noncovalent
c1ccc(cc1)CCOC(=O)/C=C/c2ccc(c(c2)O)O,BRD-K96188950-001-16-9,caffeic-acid-phenethyl-ester,Tocris,2743,Caffeic acid phenethyl ester,-10.092237,x0678,1.121555,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,BRD-K92467929-001-01-1,oxandrolone,MedChemEx,HY-B0707,Oxandrolone,-10.088489,x0749,2.412553,active-covalent
c1ccc(cc1)c2cc3c(c[nH]c3nc2)c4ccc(c(c4)C5CCCC5)C(=O)[O-],BRD-K14991967-001-02-6,GSK650394,Tocris,3572,GSK 650394,-10.086538,x0195,5.256676,active-noncovalent
c1ccc(cc1)c2cc3c(c[nH]c3nc2)c4ccc(c(c4)C5CCCC5)C(=O)[O-],BRD-K14991967-001-03-4,GSK650394,Tocris,3572,GSK 650394,-10.086538,x0195,5.256676,active-noncovalent
c1ccc(cc1)c2cc3c(c[nH]c3nc2)c4ccc(c(c4)C5CCCC5)C(=O)[O-],BRD-K14991967-001-04-2,GSK650394,MedChemEx,HY-15192,GSK 650394,-10.086538,x0195,5.256676,active-noncovalent
COC(=O)[C@H](Cc1ccc(cc1)N(=O)=O)NC(=O)c2cccc3c2cccc3,BRD-K78720403-001-02-4,SB-328437,Tocris,3650,SB 328437,-10.085258,x0434,2.8338,active-noncovalent
COC(=O)[C@H](Cc1ccc(cc1)N(=O)=O)NC(=O)c2cccc3c2cccc3,BRD-K78720403-001-01-6,SB-328437,Tocris,3650,SB 328437,-10.085258,x0434,2.8338,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCc4c[nH]cn4)Br,BRD-K49669041-001-08-4,BX-912,Selleck,S1275,BX-912,-10.081553,x0195,2.590815,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCCC2=O)O,BRD-K31812033-003-11-0,levobunolol,Prestwick,Prestw-847,(-) -Levobunolol hydrochloride,-10.079726,x0104,-0.104391,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCCC2=O)O,BRD-A46876182-003-02-8,levobunolol-(+/-),MicroSource,1505551,LEVOBUNOLOL HYDROCHLORIDE,-10.079726,x0104,-0.104391,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCCC2=O)O,BRD-K31812033-003-10-2,levobunolol,Enzo,AC3158,LEVOBUNOLOL HYDROCHLORIDE,-10.079726,x0104,-0.104391,active-noncovalent
Cc1c(n2cccnc2n1)c3csc(n3)Nc4c(cc(cc4Br)OC)Br,BRD-K83834509-001-01-1,PTC-209,Selleck,S7372,PTC-209,-10.079254,x0830,2.829403,active-covalent
Cc1c(n2cccnc2n1)c3csc(n3)Nc4c(cc(cc4Br)OC)Br,BRD-K83834509-001-03-7,PTC-209,MedChemEx,HY-15888,PTC-209,-10.079254,x0830,2.829403,active-covalent
Cc1c(n2cccnc2n1)c3csc(n3)Nc4c(cc(cc4Br)OC)Br,BRD-K83834509-001-02-9,PTC-209,Selleck,S7372,PTC-209,-10.079254,x0830,2.829403,active-covalent
C[NH2+]CC[C@@H](c1cccs1)Oc2cccc3c2cccc3,BRD-K71103788-003-11-2,duloxetine,Selleck,S2084,Duloxetine HCl,-10.075495,x0749,0.676224,active-covalent
C[NH2+]CC[C@@H](c1cccs1)Oc2cccc3c2cccc3,BRD-K71103788-003-12-0,duloxetine,MicroSource,1505387,DULOXETINE HYDROCHLORIDE,-10.075495,x0749,0.676224,active-covalent
C[NH2+]CC[C@@H](c1cccs1)Oc2cccc3c2cccc3,BRD-K71103788-003-13-8,duloxetine,Tocris,4798,(S)-Duloxetine hydrochloride,-10.075495,x0749,0.676224,active-covalent
B(c1ccc(cc1)CSC(=[NH2+])N)(O)O,BRD-K14646328-004-01-6,BC-11,Tocris,4372,BC 11 hydrobromide,-10.074545,x0195,-1.230385,active-noncovalent
C[NH+](C)CCCOc1c2ccccc2n(n1)Cc3ccccc3,BRD-K28542495-003-13-5,benzydamine,MicroSource,1505975,BENZYDAMINE HYDROCHLORIDE,-10.069408,x0104,2.078609,active-noncovalent
C[NH+](C)CCCOc1c2ccccc2n(n1)Cc3ccccc3,BRD-K28542495-003-12-7,benzydamine,Selleck,S4165,Benzydamine HCl,-10.069408,x0104,2.078609,active-noncovalent
C[N@H+]1C/C=C/CCOc2cccc(c2)-c3ccnc(n3)Nc4cccc(c4)C1,BRD-K14560436-001-01-4,TG-02,MedChemEx,HY-15166,SB1317,-10.065139,x0104,5.764742,active-noncovalent
Cc1cccc2c1CC[C@@H](C[C@@H]2O)C[NH+]3CCC(CC3)c4c(cccc4Cl)Cl,BRD-K08333979-003-01-3,SB-612111,Tocris,3573,SB 612111 hydrochloride,-10.064910,x1077,4.421591,active-noncovalent
CN(C)c1ccc(cc1)c2[nH]c3c(c(c[nH+]c3n2)Cl)N4CC[NH+](CC4)CC(=O)Nc5nccs5,BRD-K57136142-001-02-4,CCT129202,Selleck,S1519,CCT129202,-10.063004,x0161,5.959068,active-noncovalent
CN(C)c1ccc(cc1)c2[nH]c3c(c(c[nH+]c3n2)Cl)N4CC[NH+](CC4)CC(=O)Nc5nccs5,BRD-K57136142-001-03-2,CCT129202,Selleck,S1519,CCT129202,-10.063004,x0161,5.959068,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)[C@@H]3CCc4c(nc[nH]4)C3,BRD-K85046107-003-01-2,ramosetron,MedChemEx,HY-B0595,Ramosetron (Hydrochloride),-10.062973,x0678,-1.615467,active-noncovalent
c1ccc(cc1)c2ccc(cc2)[C@@H](c3ccccc3)n4ccnc4,BRD-A94543220-001-24-7,bifonazole,MicroSource,1505309,BIFONAZOLE,-10.061692,x0072,0.909382,active-noncovalent
c1ccc(cc1)c2ccc(cc2)[C@@H](c3ccccc3)n4ccnc4,BRD-A94543220-001-23-9,bifonazole,Selleck,S1854,Bifonazole,-10.061692,x0072,0.909382,active-noncovalent
B(c1ccc(cc1)C[C@@H](C(=O)[O-])[NH3+])(O)O,BRD-K50122911-001-01-2,boronophenylalanine,Sigma,MFCD01075172,(2S)-2-amino-3-[4-(dihydroxyboryl)phenyl]propanoic acid,-10.061302,x0107,-0.748604,active-noncovalent
B(c1ccc(cc1)C[C@@H](C(=O)[O-])[NH3+])(O)O,BRD-K50122911-001-02-0,boronophenylalanine,Acros,35892,,-10.061302,x0107,-0.748604,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)CCCC(=O)Nc3ccc(cc3)O)F,BRD-K54095730-001-03-1,CMPD-1,Tocris,2186,CMPD-1,-10.060765,x0749,3.471404,active-covalent
c1ccc(c(c1)c2ccc(cc2)CCCC(=O)Nc3ccc(cc3)O)F,BRD-K54095730-001-04-9,CMPD-1,Tocris,2186,CMPD-1,-10.060765,x0749,3.471404,active-covalent
Cn1cc(cc1C(=O)[O-])C(=O)c2cccc3c2cccc3,BRD-K91234829-001-01-7,napirimus,Enamine,Z2301235074,1-methyl-4-(1-naphthoyl)-1H-pyrrole-2-carboxylic acid,-10.058837,x0830,-0.274264,active-covalent
Cc1ccc(c(c1)OCCCC(C)(C)C(=O)[O-])C,BRD-K11129031-001-27-5,gemfibrozil,MicroSource,1500313,GEMFIBROZIL,-10.056758,x0749,0.191027,active-covalent
Cc1ccc(c(c1)OCCCC(C)(C)C(=O)[O-])C,BRD-K11129031-001-26-7,gemfibrozil,Selleck,S1729,Gemfibrozil,-10.056758,x0749,0.191027,active-covalent
Cc1c(oc(n1)NS(=O)(=O)c2ccc(cc2)N)C,BRD-K19742012-001-02-3,sulfamoxole,Sigma,MFCD00005303,"4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide",-10.055438,x0678,0.383091,active-noncovalent
Cc1c(oc(n1)NS(=O)(=O)c2ccc(cc2)N)C,BRD-K19742012-001-01-5,sulfamoxole,SantaCruz,sc-236952,,-10.055438,x0678,0.383091,active-noncovalent
C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)C,BRD-K56429665-001-09-6,calcipotriol,MedChemEx,HY-10001,Calcipotriol,-10.054131,x0161,4.593069,active-noncovalent
C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)C,BRD-K56429665-001-07-0,calcipotriol,Tocris,2700,Calcipotriol,-10.054131,x0161,4.593069,active-noncovalent
C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)C,BRD-K56429665-002-01-1,calcipotriol,MedChemEx,HY-10001A,Calcipotriol (monohydrate),-10.054131,x0161,4.593069,active-noncovalent
Cc1nccn1C[C@H]2CCc3c(c4ccccc4n3C)C2=O,BRD-A19736161-001-06-7,ondansetron,MicroSource,1502501,ONDANSETRON,-10.053156,x0195,0.167655,active-noncovalent
Cc1nccn1C[C@H]2CCc3c(c4ccccc4n3C)C2=O,BRD-A19736161-003-14-7,ondansetron,Selleck,S1390,Ondansetron HCl,-10.053156,x0195,0.167655,active-noncovalent
Cc1nccn1C[C@H]2CCc3c(c4ccccc4n3C)C2=O,BRD-A19736161-001-05-9,ondansetron,Selleck,S1996,Ondansetron (Zofran),-10.053156,x0195,0.167655,active-noncovalent
c1ccc(cc1)NC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K34533029-001-08-5,tyrphostin-AG-494,Tocris,619,AG 494,-10.051237,x0104,0.671562,active-noncovalent
Cc1ccccc1O[C@H](CC[NH2+]C)c2ccccc2,BRD-K20141153-003-13-7,atomoxetine,Tocris,2011,Tomoxetine hydrochloride,-10.050564,x0749,-0.791579,active-covalent
Cc1ccccc1O[C@H](CC[NH2+]C)c2ccccc2,BRD-K20141153-003-12-9,atomoxetine,Selleck,S3175,Atomoxetine HCl,-10.050564,x0749,-0.791579,active-covalent
Cc1ccccc1O[C@H](CC[NH2+]C)c2ccccc2,BRD-K20141153-001-01-6,atomoxetine,MicroSource,1505385,ATOMOXETINE HYDROCHLORIDE,-10.050564,x0749,-0.791579,active-covalent
c1cc(c(cc1)Cl)C[NH2+]C[C@H]2CC[C@@H](CC2)C[NH2+]Cc3c(cccc3)Cl,BRD-K77012840-300-01-6,AY-9944,Tocris,1639,AY 9944 dihydrochloride,-10.047373,x0161,6.848583,active-noncovalent
c1ccc2c(c1)c(c(c(n2)C3CC3)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c4ccc(cc4)F,BRD-K75958547-238-01-0,pitavastatin,Selleck,S1759,Pitavastatin Calcium,-10.041875,x0195,4.866674,active-noncovalent
c1ccc2c(c1)c(c(c(n2)C3CC3)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c4ccc(cc4)F,BRD-K75958547-238-02-8,pitavastatin,Tocris,4942,Pitavastatin calcium,-10.041875,x0195,4.866674,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3c[nH]c4c3cccc4,BRD-K50866992-003-10-3,tropisetron,Selleck,S1898,Tropisetron,-10.039702,x0749,0.480108,active-covalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3c[nH]c4c3cccc4,BRD-K50866992-003-09-5,tropisetron,Tocris,2459,Tropisetron hydrochloride,-10.039702,x0749,0.480108,active-covalent
Cc1nc(n(n1)C(C)C)c2cn3c([nH+]2)-c4ccc(cc4OCC3)c5cnn(c5)C(C)(C)C(=O)N,BRD-K44844162-001-01-6,taselisib,MedChemEx,HY-13898,GDC-0032,-10.039515,x0104,9.607964,active-noncovalent
c1ccc(cc1)COCc2cc(c(c3c2cccn3)O)C[NH+]4CCCC4,BRD-K73610817-001-09-7,UC-112,Tocris,5251,UC 112,-10.039283,x0104,1.525063,active-noncovalent
c1cc(ccc1[C@H]2[C@H]3CCC[C@H]3c4cc(ccc4O2)O)O,BRD-K80608265-001-01-6,erteberel,Selleck,S1598,,-10.036065,x0749,0.197099,active-covalent
c1ccc(cc1)C(=O)COc2cccc3c2cc[nH]c3=O,BRD-K77950083-001-02-5,UPF-1069,Selleck,S8038,UPF 1069,-10.033399,x1093,1.499499,active-noncovalent
c1ccc(cc1)C(=O)COc2cccc3c2cc[nH]c3=O,BRD-K77950083-001-04-1,UPF-1069,Tocris,3736,UPF 1069,-10.033399,x1093,1.499499,active-noncovalent
c1ccc(cc1)C(=O)COc2cccc3c2cc[nH]c3=O,BRD-K77950083-001-03-3,UPF-1069,Tocris,3736,UPF 1069,-10.033399,x1093,1.499499,active-noncovalent
c1cc(c(cc1I)F)Nc2c(cc(c(c2F)F)Br)C(=O)NOC[C@@H](CO)O,BRD-A57798112-001-03-7,PD-318088,Selleck,S1568,PD318088,-10.032454,x0434,3.565476,active-noncovalent
c1cc(c2c(c1NCC[NH3+])C(=O)c3ccncc3C2=O)NCC[NH3+],BRD-K48304345-332-02-4,pixantrone,MedChemEx,HY-13727A,Pixantrone (dimaleate),-10.030553,x0195,1.651795,active-noncovalent
c1cc(c2c(c1NCC[NH3+])C(=O)c3ccncc3C2=O)NCC[NH3+],BRD-K48304345-332-01-6,pixantrone,MedChemEx,HY-13727A,Pixantrone (dimaleate),-10.030553,x0195,1.651795,active-noncovalent
c1ccc2c(c1)c(=O)n-3c(n2)C(=O)c4c3cccc4,BRD-K76973696-001-12-6,tryptanthrin,Enzo,NP467,Tryptanthrin,-10.029137,x0749,0.863689,active-covalent
c1ccc2c(c1)c3cccc(c3s2)c4cccc5c4oc(cc5=O)N6CCOCC6,BRD-K00337317-001-06-6,NU-7441,Selleck,S2638,NU7441 (KU-57788),-10.028452,x0195,3.436485,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(=O)cc(oc4c3)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K94436377-001-11-0,diosmin,Selleck,S2292,Diosmin,-10.027965,x0161,8.485631,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(=O)cc(oc4c3)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K94436377-001-12-8,diosmin,Selleck,S2292,Diosmin,-10.027965,x0161,8.485631,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(=O)cc(oc4c3)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K94436377-001-10-2,diosmin,MicroSource,1503219,DIOSMIN,-10.027965,x0161,8.485631,active-noncovalent
CCOC(=O)c1c(c2c(cn1)[nH]c3c2c(ccc3)OC(C)C)C,BRD-K68392338-003-02-0,ZK-93426,Tocris,1996,ZK 93426 hydrochloride,-10.023772,x0195,1.932859,active-noncovalent
CCOC(=O)c1c(c2c(cn1)[nH]c3c2c(ccc3)OC(C)C)C,BRD-K68392338-003-03-8,ZK-93426,Tocris,1996,ZK 93426 hydrochloride,-10.023772,x0195,1.932859,active-noncovalent
Cc1ccc2c(c1)c3c4n2CC[NH2+][C@H]4CCC3,BRD-A54490543-066-11-9,pirlindole,Tocris,724,Pirlindole mesylate,-10.021654,x0195,-0.422904,active-noncovalent
c1ccc2c(c1)c(ccn2)c3cnn4c3ncc(c4)c5ccc(cc5)N6CC[NH2+]CC6,BRD-K04853698-376-01-4,LDN193189,MedChemEx,HY-12071A,LDN193189 (Hydrochloride),-10.017220,x0104,8.83486,active-noncovalent
Cc1c(nc([nH]c1=O)Nc2nc(c3ccc(cc3n2)OC)C)C,BRD-K48905682-001-11-1,madrasin,PrincetonBio,OSSM_012298,Madrasin,-10.015828,x0678,3.288626,active-noncovalent
Cn1cccc1/C=C\2/c3ccccc3C(=O)NC2=O,BRD-K61665160-001-01-5,BYK-204165,Tocris,3734,BYK 204165,-10.014102,x0749,-1.333543,active-covalent
Cn1cccc1/C=C\2/c3ccccc3C(=O)NC2=O,BRD-K61665160-001-02-3,BYK-204165,Tocris,3734,BYK 204165,-10.014102,x0749,-1.333543,active-covalent
c1cc(ccc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O,BRD-K12807006-001-19-3,kaempferol,Selleck,S2314,Kaempferol,-10.012438,x0749,0.622343,active-covalent
c1cc(ccc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O,BRD-K12807006-001-18-5,kaempferol,Tocris,3603,Kaempferol,-10.012438,x0749,0.622343,active-covalent
c1cc(ccc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O,BRD-K12807006-001-17-7,kaempferol,Selleck,S2314,Kaempferol,-10.012438,x0749,0.622343,active-covalent
CCc1cc(c(cc1F)Oc2ccc(cc2F)C(=O)N)O,BRD-K72078047-001-01-7,MUT056399,MedChemEx,HY-18169,MUT056399,-10.010752,x0678,0.021249,active-noncovalent
Cc1ccc2c(c1C)n(c3ccccc3c2=O)CCC[NH3+],BRD-K11927976-050-04-5,ER-27319,Tocris,2471,"(2Z)-2-butenedioic acid compound with 10-(3-aminopropyl)-3,4-dimethyl-9(10H)-acridinone (1:1)",-10.010362,x0749,1.250139,active-covalent
Cc1ccc2c(c1C)n(c3ccccc3c2=O)CCC[NH3+],BRD-K11927976-050-02-9,ER-27319,Tocris,2471,ER 27319 maleate,-10.010362,x0749,1.250139,active-covalent
Cc1ccc2c(c1C)n(c3ccccc3c2=O)CCC[NH3+],BRD-K11927976-050-03-7,ER-27319,Tocris,2471,ER 27319 maleate,-10.010362,x0749,1.250139,active-covalent
c1cc(cc(c1)OCC[NH+]2CCCCC2)c3c4cc(ccc4n[nH]3)c5[nH]ncn5,BRD-K45746021-003-01-9,CC-401,MedChemEx,HY-13022,CC-401 (hydrochloride),-10.009756,x0107,3.155975,active-noncovalent
Cc1ccc(cc1Cc2ccc(s2)c3ccc(cc3)F)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K90868879-001-02-0,canagliflozin,Selleck,S2760,Canagliflozin,-10.009044,x0161,3.998637,active-noncovalent
Cc1ccc(cc1Cc2ccc(s2)c3ccc(cc3)F)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K90868879-001-03-8,canagliflozin,MicroSource,1506315,CANAGLIFLOZIN,-10.009044,x0161,3.998637,active-noncovalent
CC1(CCN(CC1)c2cnc(c(n2)N)c3cccc(c3Cl)Cl)[NH3+],BRD-K00818915-003-01-8,SHP099,MedChemEx,HY-100388A,SHP099 (hydrochloride),-10.004807,x0678,3.312357,active-noncovalent
Cc1c2cc(ccc2n(c1CC(C)(C)C(=O)[O-])Cc3ccc(cc3)Cl)F,BRD-K89402695-001-02-3,L-655240,Tocris,1698,"L-655,240",-10.004412,x0708,1.707694,active-covalent
Cc1c2cc(ccc2n(c1CC(C)(C)C(=O)[O-])Cc3ccc(cc3)Cl)F,BRD-K89402695-001-03-1,L-655240,Tocris,1698,"L-655,240",-10.004412,x0708,1.707694,active-covalent
COc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3cc(cc(c3)F)c4cccnc4,BRD-K15424032-001-04-4,SB-228357,Tocris,1375,SB 228357,-10.004124,x0161,6.268932,active-noncovalent
COc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3cc(cc(c3)F)c4cccnc4,BRD-K15424032-001-03-6,SB-228357,Tocris,1375,SB 228357,-10.004124,x0161,6.268932,active-noncovalent
c1ccc(cc1)[C@@H](Cc2ccccn2)[NH3+],BRD-A94033181-001-01-4,AZD6765,Enamine,EN300-123342,,-9.999926,x0749,-1.569263,active-covalent
CCCCCCN(CCCCCC)C(=O)Cc1c2cc(ccc2[nH]c1c3ccc(cc3)Cl)Cl,BRD-K66093087-001-04-9,FGIN-1-43,Tocris,659,FGIN-1-43,-9.999490,x0161,5.378633,active-noncovalent
CCCCCCN(CCCCCC)C(=O)Cc1c2cc(ccc2[nH]c1c3ccc(cc3)Cl)Cl,BRD-K66093087-001-03-1,FGIN-1-43,Tocris,659,FGIN-1-43,-9.999490,x0161,5.378633,active-noncovalent
c1ccc2c(c1)ccc(c2SSc3c4ccccc4ccc3O)O,BRD-K38727704-001-03-2,IPA-3,Selleck,S7093,IPA-3,-9.994905,x0195,0.799788,active-noncovalent
c1ccc2c(c1)ccc(c2SSc3c4ccccc4ccc3O)O,BRD-K38727704-001-02-4,IPA-3,Tocris,3622,IPA 3,-9.994905,x0195,0.799788,active-noncovalent
c1ccc2c(c1)ccc(c2SSc3c4ccccc4ccc3O)O,BRD-K38727704-001-01-6,IPA-3,Selleck,S7093,IPA-3,-9.994905,x0195,0.799788,active-noncovalent
Cc1cccn2c1nc(c(c2=O)/C=C(\C#N)/c3nc4ccccc4s3)Oc5ccc(cc5)F,BRD-K68474505-001-01-9,CCG-63808,MedChemEx,HY-70075,CCG-63808,-9.994629,x0161,5.659299,active-noncovalent
Cc1cccn2c1nc(c(c2=O)/C=C(\C#N)/c3nc4ccccc4s3)Oc5ccc(cc5)F,BRD-K68474505-001-02-7,CCG-63808,MedChemEx,HY-70075,CCG-63808,-9.994629,x0161,5.659299,active-noncovalent
c1ccc2c(c1)C[NH2+][C@H]3[C@H]2c4cc(c(cc4CC3)O)O,BRD-K31471398-003-01-5,dihydrexidine,Tocris,884,Dihydrexidine hydrochloride,-9.993713,x0195,-0.821637,active-noncovalent
CC[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3C4CC4)C(=O)[O-],BRD-K76534306-001-22-7,enrofloxacin,MicroSource,1503721,ENROFLOXACIN,-9.992853,x0749,5.289135,active-covalent
CC[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3C4CC4)C(=O)[O-],BRD-K76534306-001-21-9,enrofloxacin,Selleck,S3059,Enrofloxacin,-9.992853,x0749,5.289135,active-covalent
c1cc(ccc1c2[nH]c(=O)c3c(n2)CCSC3)C(F)(F)F,BRD-K12762134-001-10-4,XAV-939,Tocris,3748,XAV 939,-9.992168,x0678,1.881128,active-noncovalent
c1cc(ccc1c2[nH]c(=O)c3c(n2)CCSC3)C(F)(F)F,BRD-K12762134-001-07-0,XAV-939,Tocris,3748,XAV 939,-9.992168,x0678,1.881128,active-noncovalent
c1cc(ccc1c2[nH]c(=O)c3c(n2)CCSC3)C(F)(F)F,BRD-K12762134-001-06-2,XAV-939,Selleck,S1180,XAV-939,-9.992168,x0678,1.881128,active-noncovalent
c1ccc2c(c1)c(c3c([nH+]2)CCC[C@H]3O)N,BRD-A98299281-050-09-6,"hydroxytacrine-maleate-(r,s)",Prestwick,Prestw-448,"Hydroxytacrine maleate (R,S)",-9.990036,x0195,-1.4577,active-noncovalent
CC(=O)c1c(c2n(c1O)C([C@H]3[C@@H]2c4c[nH]c5c4c(ccc5)C3)(C)C)O,BRD-A10420615-001-05-1,cyclopiazonic-acid,Tocris,1235,"(6aR,10Z,11aS,11bR)-10-(1-hydroxyethylidene)-7,7-dimethyl-6a,7,11a,11b-tetrahydro-6H-pyrrolo[1',2':2,3]isoindolo[4,5,6-cd]indol",-9.989053,x0195,0.337631,active-noncovalent
CC(=O)c1c(c2n(c1O)C([C@H]3[C@@H]2c4c[nH]c5c4c(ccc5)C3)(C)C)O,BRD-A10420615-001-04-4,cyclopiazonic-acid,Tocris,1235,Cyclopiazonic acid,-9.989053,x0195,0.337631,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)CCCSC(=[NH2+])N,BRD-K06543683-066-03-9,bisindolylmaleimide-ix,Tocris,2002,Ro 31-8220 mesylate,-9.986578,x0874,3.929221,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)CCCSC(=[NH2+])N,BRD-K06543683-066-02-1,bisindolylmaleimide-ix,Selleck,S7207,Ro 31-8220 Mesylate,-9.986578,x0874,3.929221,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)CCCSC(=[NH2+])N,BRD-K06543683-066-04-7,bisindolylmaleimide-ix,Selleck,S7207,Ro 31-8220 Mesylate,-9.986578,x0874,3.929221,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)CCCSC(=[NH2+])N,BRD-K06543683-066-05-4,bisindolylmaleimide-ix,Tocris,2002,Ro 31-8220 mesylate,-9.986578,x0874,3.929221,active-noncovalent
c1cc(c2cccnc2c1)c3cnn4c3ncc(c4)c5ccc(cc5)N6CC[NH2+]CC6,BRD-K59831625-001-02-4,LDN-212854,Selleck,S7147,LDN-212854,-9.985906,x0104,10.71106,active-noncovalent
c1cc(c2cccnc2c1)c3cnn4c3ncc(c4)c5ccc(cc5)N6CC[NH2+]CC6,BRD-K59831625-001-01-6,LDN-212854,Selleck,S7147,LDN-212854,-9.985906,x0104,10.71106,active-noncovalent
c1ccc(cc1)/C=C/2\[C@@H](c3ccccc3C2=O)[NH2+]C4CCCCC4,BRD-A08840375-001-01-3,CID-5458317,EMDBio,317496-10MG,"Dual Specificity Protein Phosphatase 1/6 Inhibitor, BCI",-9.983709,x0195,1.148564,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@@H](CC[C@]3([C@H]1C5)O)/N=N/C(=O)c6ccccc6)O,BRD-K70898774-001-05-0,naloxone-benzoylhydrazone,Tocris,1419,"N'-((4R,4aS,12bR)-3-allyl-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)benzohydrazide",-9.982453,x0678,2.883199,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@@H](CC[C@]3([C@H]1C5)O)/N=N/C(=O)c6ccccc6)O,BRD-K70898774-001-03-5,naloxone-benzoylhydrazone,Tocris,1419,Naloxone benzoylhydrazone,-9.982453,x0678,2.883199,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@@H](CC[C@]3([C@H]1C5)O)/N=N/C(=O)c6ccccc6)O,BRD-K70898774-001-04-3,naloxone-benzoylhydrazone,Tocris,1419,Naloxone benzoylhydrazone,-9.982453,x0678,2.883199,active-noncovalent
CCN(c1c(nc(c(n1)N)C(=O)NC(=[NH2+])N)Cl)C(C)C,BRD-K88120876-001-09-8,EIPA,Tocris,3378,EIPA,-9.981775,x0678,1.445405,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl,BRD-A91699651-316-10-9,chloroquine,MicroSource,1500179,CHLOROQUINE DIPHOSPHATE,-9.980066,x0874,0.784276,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl,BRD-A91699651-316-09-1,chloroquine,Selleck,S4157,Chloroquine Phosphate,-9.980066,x0874,0.784276,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl,BRD-A91699651-316-11-7,chloroquine,Selleck,S4157,Chloroquine Phosphate,-9.980066,x0874,0.784276,active-noncovalent
c1ccc2c(c1)-c3cncn3[C@H]2C[C@H](C4CCCCC4)O,BRD-A62133859-001-03-7,NLG919,MedChemEx,HY-13983,NLG919,-9.970563,x0434,-0.047893,active-noncovalent
c1ccc2c(c1)-c3cncn3[C@H]2C[C@H](C4CCCCC4)O,BRD-A62133859-001-04-5,NLG919,MedChemEx,HY-13983,IDO-IN-7,-9.970563,x0434,-0.047893,active-noncovalent
c1ccc2c(c1)-c3cncn3[C@H]2C[C@H](C4CCCCC4)O,BRD-A62133859-001-01-1,NLG919,Selleck,S7111,NLG919,-9.970563,x0434,-0.047893,active-noncovalent
c1ccc2c(c1)-c3cncn3[C@H]2C[C@H](C4CCCCC4)O,BRD-A62133859-001-02-9,NLG919,Selleck,S7111,NLG919,-9.970563,x0434,-0.047893,active-noncovalent
CC(C)(C#N)c1ccc(cc1)n2c3c4cc(ccc4ncc3n(c2=O)C)c5cc6ccccc6nc5,BRD-K12184916-001-19-6,NVP-BEZ235,Selleck,S1009,BEZ235 (NVP-BEZ235),-9.968787,x0161,7.928349,active-noncovalent
CC(C)(C#N)c1ccc(cc1)n2c3c4cc(ccc4ncc3n(c2=O)C)c5cc6ccccc6nc5,BRD-K12184916-001-15-4,NVP-BEZ235,Selleck,S1009,"BEZ235 (NVP-BEZ235, Dactolisib)",-9.968787,x0161,7.928349,active-noncovalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)Cl)C[NH+]4CCCC4,BRD-K04704168-003-15-0,clemizole,Tocris,5371,Clemizole hydrochloride,-9.968238,x0195,0.533558,active-noncovalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)Cl)C[NH+]4CCCC4,BRD-K04704168-003-14-3,clemizole,MicroSource,1505990,CLEMIZOLE HYDROCHLORIDE,-9.968238,x0195,0.533558,active-noncovalent
CC(C)[NH2+]C[C@H](COc1ccc(cc1)CC(=O)N)O,BRD-K68075732-001-11-8,atenolol-(+),Selleck,S4301,(R)-(+)-Atenolol,-9.966724,x0104,0.3718,active-noncovalent
CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O,BRD-K22064724-001-02-6,napabucasin,Tocris,5522,Napabucasin,-9.965898,x0749,1.91126,active-covalent
CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O,BRD-K22064724-001-01-8,napabucasin,MedChemEx,HY-13919,Napabucasin,-9.965898,x0749,1.91126,active-covalent
CSc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3cccnc3,BRD-K14807180-001-02-5,SB-221284,Tocris,1379,SB 221284,-9.965459,x0195,1.474842,active-noncovalent
C[C@@H]1n2c3cc(c(cc3c(=O)c(c2S1)C(=O)[O-])F)N4CC[NH2+]CC4,BRD-A61633223-001-02-8,ulifloxacin,Ark,AK-56509,"6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid",-9.963349,x0749,4.447008,active-covalent
C[C@@H]1n2c3cc(c(cc3c(=O)c(c2S1)C(=O)[O-])F)N4CC[NH2+]CC4,BRD-A61633223-001-01-0,ulifloxacin,AKSci,I873,,-9.963349,x0749,4.447008,active-covalent
Cc1ccccc1n2c(nc3cccc(c3c2=O)C)Cn4c5c(cn4)c(ncn5)N,BRD-K30977212-001-02-8,PIK-293,Selleck,S2207,PIK-293,-9.954947,x1077,3.043837,active-noncovalent
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4,BRD-K70163715-300-04-0,vatalanib,Selleck,S1101,Vatalanib (PTK787) 2HCl,-9.954937,x0195,3.436043,active-noncovalent
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4,BRD-K70163715-300-05-7,vatalanib,Selleck,S1101,Vatalanib dihydrochloride (PTK787),-9.954937,x0195,3.436043,active-noncovalent
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4,BRD-K70163715-036-01-6,vatalanib,Tocris,5680,Vatalanib succinate,-9.954937,x0195,3.436043,active-noncovalent
CCOc1ccc2c(c1)nc([nH]2)SCC[NH+]3CCOCC3,BRD-K37793595-003-01-7,afobazole,MedChemEx,HY-14895A,Afobazole (hydrochloride),-9.953567,x0161,0.685118,active-noncovalent
Cc1c(sc[n+]1Cc2cnc(nc2N)C)CCO,BRD-K95785345-300-14-8,thiamine,Selleck,S3211,Thiamine HCl (Vitamin B1),-9.952252,x0678,1.080231,active-noncovalent
Cc1c(sc[n+]1Cc2cnc(nc2N)C)CCO,BRD-K95785345-300-15-5,thiamine,MicroSource,1505464,THIAMINE,-9.952252,x0678,1.080231,active-noncovalent
c1cc2c(cc1N(=O)=O)[nH]c(n2)COCc3[nH]c4cc(ccc4n3)N(=O)=O,BRD-K72063794-003-01-0,VU591,Tocris,4197,VU 591 hydrochloride,-9.951073,x0104,5.800185,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,BRD-K88510285-001-17-8,bortezomib,Selleck,S1013,bortezomib,-9.949553,x0107,2.447603,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,BRD-K88510285-001-25-1,bortezomib,Selleck,S1013,Bortezomib,-9.949553,x0107,2.447603,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,BRD-K88510285-001-18-6,bortezomib,MedChemEx,HY-10227,Bortezomib,-9.949553,x0107,2.447603,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,BRD-K88510285-001-11-1,bortezomib,Selleck,S1013,Bortezomib (PS-341),-9.949553,x0107,2.447603,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,BRD-K88510285-001-22-8,bortezomib,Selleck,S1013,Bortezomib,-9.949553,x0107,2.447603,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-A34255068-001-32-9,rolipram,Selleck,S1430,Rolipram,-9.948129,x0749,0.540596,active-covalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-A34255068-001-38-6,rolipram,Tocris,905,Rolipram,-9.948129,x0749,0.540596,active-covalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-A34255068-001-33-7,rolipram,Tocris,905,Rolipram,-9.948129,x0749,0.540596,active-covalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-A34255068-001-34-5,rolipram,MicroSource,1505683,ROLIPRAM,-9.948129,x0749,0.540596,active-covalent
c1ccc(cc1)[C@H]2CCc3cc(ccc3[C@H]2c4ccc(cc4)OCC[NH+]5CCCC5)O,BRD-M93148412-001-01-8,lasofoxifene,MedChemEx,HY-A0038,Lasofoxifene (Tartrate),-9.945914,x0874,4.360757,active-noncovalent
c1ccc(cc1)[C@H]2CCc3cc(ccc3[C@H]2c4ccc(cc4)OCC[NH+]5CCCC5)O,BRD-M93148412-001-02-6,lasofoxifene,MedChemEx,HY-A0038,Lasofoxifene (Tartrate),-9.945914,x0874,4.360757,active-noncovalent
c1ccc(cc1)CC/[NH+]=C(/N)\[NH+]=C(N)N,BRD-K11399644-003-10-5,phenformin,MicroSource,1505983,PHENFORMIN HYDROCHLORIDE,-9.942698,x0104,-1.432677,active-noncovalent
c1ccc(cc1)CC/[NH+]=C(/N)\[NH+]=C(N)N,BRD-K11399644-003-09-7,phenformin,Selleck,S2542,Phenformin HCl,-9.942698,x0104,-1.432677,active-noncovalent
c1ccc(cc1)CC/[NH+]=C(/N)\[NH+]=C(N)N,BRD-K11399644-003-11-3,phenformin,MicroSource,1501059,PHENFORMIN HYDROCHLORIDE,-9.942698,x0104,-1.432677,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K32273377-001-16-1,sulfadiazine,MicroSource,1500546,SULFADIAZINE,-9.942277,x0072,-0.305065,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K32273377-001-15-3,sulfadiazine,Selleck,S1770,Sulfadiazine,-9.942277,x0072,-0.305065,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K32273377-001-17-9,sulfadiazine,Enamine,Z104472626,,-9.942277,x0072,-0.305065,active-noncovalent
CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O,BRD-K45330754-001-22-5,diethylstilbestrol,MicroSource,1500244,DIETHYLSTILBESTROL,-9.939643,x0678,2.933954,active-noncovalent
CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O,BRD-K45330754-001-21-7,diethylstilbestrol,Selleck,S1859,Diethylstilbestrol,-9.939643,x0678,2.933954,active-noncovalent
CC[C@H](c1ccc(cc1)N2Cc3ccccc3C2=O)C(=O)[O-],BRD-A16296925-001-01-3,indobufen,AKSci,65627,,-9.939607,x0678,3.210015,active-noncovalent
c1ccc2c(c1)CCC[C@H]2Nc3[nH]c4ccccc4n3,BRD-K34624869-003-01-6,NS-8593,Tocris,4597,NS 8593 hydrochloride,-9.938129,x0195,-0.688584,active-noncovalent
c1cc(c(cc1I)F)Nc2c(cc(c(c2F)F)CN3C(=O)CCCO3)C(=O)NOCCO,BRD-K64538373-001-01-4,Ro-4987655,MedChemEx,HY-14719,RO4987655,-9.936168,x0749,5.605916,active-covalent
C1C2CC3CC1CC(C2)(C3)C[NH2+]CCCCC[NH3+],BRD-K80060353-303-03-9,IEM1754,Selleck,S2860,IEM 1754 dihydrobroMide,-9.934278,x0678,0.482094,active-noncovalent
C1C2CC3CC1CC(C2)(C3)C[NH2+]CCCCC[NH3+],BRD-K80060353-303-02-1,IEM1754,Selleck,S2860,IEM 1754 dihydrobroMide,-9.934278,x0678,0.482094,active-noncovalent
Cc1cccc(n1)C#Cc2ccccc2,BRD-K60690191-001-03-3,MPEP,Selleck,S2809,MPEP,-9.933843,x0749,0.322407,active-covalent
Cc1cccc(n1)C#Cc2ccccc2,BRD-K60690191-003-09-6,MPEP,Tocris,1212,MPEP hydrochloride,-9.933843,x0749,0.322407,active-covalent
Cc1cccc(n1)C#Cc2ccccc2,BRD-K60690191-003-11-2,MPEP,Tocris,1212,MPEP hydrochloride,-9.933843,x0749,0.322407,active-covalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)N(C)C(=O)c9ccccc9)OC,BRD-K13646352-001-03-8,midostaurin,Enzo,EI370,PKC-412,-9.931092,x0161,7.42285,active-noncovalent
COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,BRD-K77474816-003-14-1,rauwolscine,Tocris,891,Rauwolscine hydrochloride,-9.930837,x0104,2.613872,active-noncovalent
COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,BRD-K77474816-003-13-3,rauwolscine,Tocris,891,Rauwolscine hydrochloride,-9.930837,x0104,2.613872,active-noncovalent
C[C@](Cc1ccccc1)(c2ccccc2)NC(=O)C[NH3+],BRD-A36074203-003-07-6,remacemide,Tocris,1622,Remacemide hydrochloride,-9.928029,x0749,-1.301259,active-covalent
CCOC(=O)c1ccc(cc1)OCCC2CCN(CC2)c3ccc(nn3)C,BRD-K22261391-001-01-2,pirodavir,MedChemEx,HY-13784,Pirodavir,-9.927286,x0161,7.959284,active-noncovalent
Cc1nnc2n1-c3ccc(cc3[C@@H](N=C2)c4ccccc4Cl)Cl,BRD-K76890464-001-02-3,triazolam,Enzo,AC3278,TRIAZOLAM (DEA license),-9.922110,x1077,0.257295,active-noncovalent
c1ccc(cc1)C#Cc2c(nc3cccnc3n2)OCC[NH+]4CCCC4,BRD-K38272302-001-02-7,GK921,MedChemEx,HY-12337,GK921,-9.921986,x0678,3.181008,active-noncovalent
c1ccc(cc1)C#Cc2c(nc3cccnc3n2)OCC[NH+]4CCCC4,BRD-K38272302-001-01-9,GK921,MedChemEx,HY-12337,GK921,-9.921986,x0678,3.181008,active-noncovalent
COP(=S)(OC)Oc1ccc(cc1)Sc2ccc(cc2)OP(=S)(OC)OC,BRD-K51805276-001-09-3,temefos,MicroSource,330062,TEMEFOS,-9.921123,x0161,5.95893,active-noncovalent
c1ccc(cc1)[C@@H]2OC[C@@H]3[C@@H](O2)[C@@H]([C@H]([C@@H](O3)O)O)O,BRD-A00376169-001-01-6,KBG,SantaCruz,sc-284473,,-9.920143,x0749,0.151672,active-covalent
CC[C@H](c1ccc(cc1)O)[C@@H](CC)c2ccc(cc2)O,BRD-K69253806-001-03-8,hexestrol,Selleck,S2473,Hexestrol (Bibenzyl),-9.918437,x0678,0.206733,active-noncovalent
CC[C@H](c1ccc(cc1)O)[C@@H](CC)c2ccc(cc2)O,BRD-K69253806-001-02-0,hexestrol,Selleck,S2473,Hexestrol,-9.918437,x0678,0.206733,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCN(CC3)C(=O)CO,BRD-K47554101-001-01-2,eperezolid,MedChemEx,HY-10393,Eperezolid,-9.916245,x0104,6.055885,active-noncovalent
c1ccc(cc1)c2c(c2=O)c3ccccc3,BRD-K51730347-001-06-4,diphencyprone,Sigma,42910,"2,3-diphenyl-2-cyclopropen-1-one",-9.914463,x0749,-1.35449,active-covalent
c1ccc(cc1)c2c(c2=O)c3ccccc3,BRD-K51730347-001-05-6,diphencyprone,Vitas-M,STK289679,,-9.914463,x0749,-1.35449,active-covalent
Cc1cc(n(c(=O)c1/C(=N/c2ccccc2N)/C)[O-])[O-],BRD-K36274133-001-02-0,SUN-B-8155,Tocris,2550,SUN-B 8155,-9.914457,x0749,0.647757,active-covalent
Cc1cc(n(c(=O)c1/C(=N/c2ccccc2N)/C)[O-])[O-],BRD-K36274133-001-01-2,SUN-B-8155,Tocris,2550,SUN-B 8155,-9.914457,x0749,0.647757,active-covalent
C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-],BRD-K32531356-001-01-9,ammonium-perfluorocaprylate,Enamine,Z104477538,,-9.914093,x0678,0.803803,active-noncovalent
Cn1c(=O)cc2c(c1c3cccc(c3)N(C)C)c(=O)n([nH]2)c4ccccc4Cl,BRD-K79710622-001-01-1,GKT137831,MedChemEx,HY-12298,GKT137831,-9.913996,x0195,3.724327,active-noncovalent
Cn1c(=O)cc2c(c1c3cccc(c3)N(C)C)c(=O)n([nH]2)c4ccccc4Cl,BRD-K79710622-001-02-9,GKT137831,Selleck,S7171,GKT137831,-9.913996,x0195,3.724327,active-noncovalent
Cn1c(=O)cc2c(c1c3cccc(c3)N(C)C)c(=O)n([nH]2)c4ccccc4Cl,BRD-K79710622-001-03-7,GKT137831,MedChemEx,HY-12298,GKT137831,-9.913996,x0195,3.724327,active-noncovalent
CCC[NH2+]C[C@@H](COc1ccccc1C(=O)CCc2ccccc2)O,BRD-A26334849-001-06-2,propafenone,Selleck,S2500,Propafenone HCl,-9.911856,x0195,1.56788,active-noncovalent
CCC[NH2+]C[C@@H](COc1ccccc1C(=O)CCc2ccccc2)O,BRD-A26334849-003-23-3,propafenone,MicroSource,1503935,PROPAFENONE HYDROCHLORIDE,-9.911856,x0195,1.56788,active-noncovalent
C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,BRD-A43598550-001-09-4,3-alpha-Hydroxy-5-beta-androstan-17-one,Prestwick,Prestw-697,3-alpha-Hydroxy-5-beta-androstan-17-one,-9.911406,x0749,0.491146,active-covalent
c1ccc(c(c1)/C=N/NC(=O)c2ccccc2O)O,BRD-K78496197-001-03-9,SCS,Tocris,2143,SCS,-9.911241,x0678,-0.5297,active-noncovalent
c1ccc(c(c1)/C=N/NC(=O)c2ccccc2O)O,BRD-K78496197-001-04-7,SCS,Tocris,2143,SCS,-9.911241,x0678,-0.5297,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)OCC1c2ccccc2-c3c1cccc3,BRD-K15327298-001-05-5,fmoc-l-leucine,Sigma,MFCD00204311,(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-methylpentanoic acid,-9.910428,x0678,1.239048,active-noncovalent
CCn1c(=O)cnc2c1N[C@@H](C=N2)c3ccc(nc3C)c4[nH]cnn4,BRD-K16755045-001-01-1,CC-115,MedChemEx,HY-16962,CC-115,-9.908921,x0072,1.620767,active-noncovalent
CCn1c(=O)cnc2c1N[C@@H](C=N2)c3ccc(nc3C)c4[nH]cnn4,BRD-K16755045-003-01-7,CC-115,MedChemEx,HY-16962A,CC-115 (hydrochloride),-9.908921,x0072,1.620767,active-noncovalent
CCn1c(=O)cnc2c1N[C@@H](C=N2)c3ccc(nc3C)c4[nH]cnn4,BRD-K16755045-003-02-5,CC-115,MedChemEx,HY-16962A,CC-115 (hydrochloride),-9.908921,x0072,1.620767,active-noncovalent
C[C@]12CCC(=O)C(=O)[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,BRD-A26503646-001-18-2,formestane,Selleck,S2208,Formestane,-9.908145,x0749,0.272214,active-covalent
C[C@]12CCC(=O)C(=O)[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,BRD-A26503646-001-16-6,formestane,MicroSource,1504116,FORMESTANE,-9.908145,x0749,0.272214,active-covalent
c1ccnc(c1)C#CCCc2cn3cc(ccc3[nH+]2)F,BRD-K64838454-001-01-0,dipraglurant,MedChemEx,HY-14859,Dipraglurant,-9.907878,x1093,0.530245,active-noncovalent
c1ccc2c(c1)C[NH+](C2)CC3=[NH+]c4cccc5c4c(n[nH]c5=O)N3,BRD-K05444225-001-02-5,E7449,MedChemEx,HY-12418,E7449,-9.906825,x1093,-0.259516,active-noncovalent
c1ccc2c(c1)C[NH+](C2)CC3=[NH+]c4cccc5c4c(n[nH]c5=O)N3,BRD-K05444225-001-01-7,E7449,MedChemEx,HY-12418,E7449,-9.906825,x1093,-0.259516,active-noncovalent
c1ccc2c(c1)C[NH+](C2)CC3=[NH+]c4cccc5c4c(n[nH]c5=O)N3,BRD-K05444225-001-03-3,E7449,MedChemEx,HY-12418,E7449,-9.906825,x1093,-0.259516,active-noncovalent
Cc1ccc(c(c1)C)Sc2ccccc2N3CC[NH2+]CC3,BRD-K53963539-004-02-0,vortioxetine,Selleck,S8021,Vortioxetine (Lu AA21004) HBr,-9.906278,x0195,0.14336,active-noncovalent
Cc1ccc(c(c1)C)Sc2ccccc2N3CC[NH2+]CC3,BRD-K53963539-001-01-8,vortioxetine,MicroSource,1506319,VORTIOXETINE,-9.906278,x0195,0.14336,active-noncovalent
Cn1cc([nH+]c1c2ccc(cc2)OC[C@H](C[NH2+]CCOc3ccc(c(c3)C(=O)N)O)O)C(F)(F)F,BRD-A31575449-066-07-8,CGP-20712A,Sigma,C231,2-hydroxy-5-{2-[(2-hydroxy-3-{4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy}propyl)amino]ethoxy}benzamide methanesulfonate,-9.904745,x0161,7.003531,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)/C=C(\C#N)/c3ccccc3Br,BRD-K75748943-300-01-3,DG-172,Tocris,5566,DG 172 dihydrochloride,-9.902700,x0104,7.15419,active-noncovalent
CC(C)n1c2c(c(n1)c3cc4cc(ccc4[nH]3)O)c(ncn2)N,BRD-K87112191-001-05-2,PP242,Selleck,S2218,Torkinib (PP242),-9.901163,x0678,1.850717,active-noncovalent
CC(C)n1c2c(c(n1)c3cc4cc(ccc4[nH]3)O)c(ncn2)N,BRD-K87112191-001-06-0,PP242,Tocris,4257,PP 242,-9.901163,x0678,1.850717,active-noncovalent
CC(C)n1c2c(c(n1)c3cc4cc(ccc4[nH]3)O)c(ncn2)N,BRD-K87112191-001-04-5,PP242,Selleck,S2218,PP242,-9.901163,x0678,1.850717,active-noncovalent
Cc1n(c2c([n+]1Cc3cnccn3)C(=O)c4ccccc4C2=O)CCOC,BRD-K76703230-004-04-1,YM-155,Selleck,S1130,YM155 (Sepantronium Bromide),-9.900012,x0678,2.290166,active-noncovalent
Cc1n(c2c([n+]1Cc3cnccn3)C(=O)c4ccccc4C2=O)CCOC,BRD-K76703230-004-03-3,YM-155,MedChemEx,HY-10194,YM-155,-9.900012,x0678,2.290166,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,BRD-K39707084-001-05-8,lynestrenol,Sigma,MFCD00051135,(17beta)-17-ethynylestr-4-en-17-ol,-9.898431,x0749,1.245462,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,BRD-K39707084-001-04-1,lynestrenol,Prestwick,Prestw-95,Lynestrenol,-9.898431,x0749,1.245462,active-covalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)COCCOC(C)C)O,BRD-A89175223-051-14-8,bisoprolol,MicroSource,1505704,BISOPROLOL FUMARATE,-9.897141,x0161,3.366996,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)COCCOC(C)C)O,BRD-A89175223-051-15-5,bisoprolol,Tocris,914,(?)-Bisoprolol hemifumarate,-9.897141,x0161,3.366996,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)COCCOC(C)C)O,BRD-A89175223-051-16-3,bisoprolol,Selleck,S1206,Bisoprolol,-9.897141,x0161,3.366996,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)COCCOC(C)C)O,BRD-A89175223-051-13-0,bisoprolol,Selleck,S1206,Bisoprolol fumarate,-9.897141,x0161,3.366996,active-noncovalent
c1ccc2c(c1)[C@]34CC[N@@H+]5[C@H]3C[C@@H]6[C@@H]7[C@@H]4N2C(=O)C[C@@H]7OCC=C6C5,BRD-A09094913-065-01-0,strychnine,MicroSource,1500651,STRYCHNINE SULFATE,-9.895838,x0195,0.955586,active-noncovalent
c1ccc(cc1)c2cc3c(c4cc(ccc4[nH]3)O)c5c2C(=O)NC5=O,BRD-K82823804-001-04-1,PD-407824,Tocris,2694,PD 407824,-9.895704,x0195,2.629105,active-noncovalent
c1ccc(cc1)c2cc3c(c4cc(ccc4[nH]3)O)c5c2C(=O)NC5=O,BRD-K82823804-001-05-8,PD-407824,Tocris,2694,PD 407824,-9.895704,x0195,2.629105,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)c3csc4c3c(c(c(=O)[nH]4)C#N)[O-])O,BRD-K41918892-001-05-9,A-769662,Selleck,S2697,A-769662,-9.895056,x0678,3.423905,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)c3csc4c3c(c(c(=O)[nH]4)C#N)[O-])O,BRD-K41918892-001-06-7,A-769662,Tocris,3336,A 769662,-9.895056,x0678,3.423905,active-noncovalent
COC(=O)c1ccccc1c2c3ccc(cc3[o+]c4c2ccc(c4)N)N,BRD-K47169076-003-01-6,rhodamine-123,Cayman,16672,"3,6-diamino-9-(2-(methoxycarbonyl)phenyl)xanthylium chloride",-9.888324,x0830,2.934008,active-covalent
C[NH2+]CCCC1c2ccccc2C=Cc3c1cccc3,BRD-K42098891-003-20-5,protriptyline,MicroSource,1505984,PROTRYPTYLINE HYDROCHLORIDE,-9.887832,x0072,-1.591211,active-noncovalent
c1cc(ccc1/C=C/C(=O)c2ccc(cc2O)O)O,BRD-K33583600-001-16-1,isoliquiritigenin,Selleck,S2404,Isoliquiritigenin,-9.885802,x0072,-0.672512,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cccc(c2)C(F)(F)F,BRD-K44067360-001-29-5,flufenamic-acid,Selleck,S4268,Flufenamic acid,-9.884418,x1093,-0.135533,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cccc(c2)C(F)(F)F,BRD-K44067360-001-30-3,flufenamic-acid,MicroSource,1501015,FLUFENAMIC ACID,-9.884418,x1093,-0.135533,active-noncovalent
Cn1c2ccccc2c3c1CC[NH2+]CC3,BRD-K16551401-003-03-4,PNU-22394,Tocris,2201,PNU 22394 hydrochloride,-9.883717,x0195,0.203032,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc2ccccc2c1)O,BRD-A87715314-003-14-4,pronethalol,Tocris,829,Pronethalol hydrochloride,-9.883446,x0161,-1.033584,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc2ccccc2c1)O,BRD-A87715314-003-15-1,pronethalol,MicroSource,1503628,PRONETALOL HYDROCHLORIDE,-9.883446,x0161,-1.033584,active-noncovalent
C/C(=[NH+]/Cc1cccc(c1)C[NH3+])/N,BRD-K30237152-300-02-5,1400W,Tocris,1415,1400W dihydrochloride,-9.883380,x0195,-1.751057,active-noncovalent
c1ccc2c(c1)CCN(C2)C(=[NH2+])N,BRD-K80419150-001-02-4,debrisoquin,PrincetonBio,OSSK_732122,"3,4-dihydro-2(1H)-isoquinolinecarboximidamide",-9.881007,x0195,0.879571,active-noncovalent
c1ccc2c(c1)CCN(C2)C(=[NH2+])N,BRD-K80419150-065-03-7,debrisoquin,MicroSource,1506066,DEBRISOQUIN SULFATE,-9.881007,x0195,0.879571,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C,BRD-K17368287-001-18-3,adrenosterone,MedChemEx,HY-17462,Adrenosterone,-9.878235,x0749,0.722504,active-covalent
CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,BRD-K35245662-001-01-2,ciclesonide,Enzo,AC3062,CICLESONIDE,-9.877670,x1077,9.18552,active-noncovalent
c1ccc2cc(ccc2c1)CC[N@H+]3CCC(=CC3)c4cccc(c4)C(F)(F)F,BRD-K88358234-003-04-8,xaliproden,Tocris,2491,Xaliproden hydrochloride,-9.877141,x0161,5.061941,active-noncovalent
c1ccc2cc(ccc2c1)CC[N@H+]3CCC(=CC3)c4cccc(c4)C(F)(F)F,BRD-K88358234-003-05-5,xaliproden,Tocris,2491,Xaliproden hydrochloride,-9.877141,x0161,5.061941,active-noncovalent
CCc1cc(c(cc1O)O)c2c(c([nH]n2)C)c3ccc4c(c3)OCCO4,BRD-K65503129-001-06-3,CCT018159,Tocris,2435,CCT 018159,-9.872569,x0195,0.24096,active-noncovalent
CCc1cc(c(cc1O)O)c2c(c([nH]n2)C)c3ccc4c(c3)OCCO4,BRD-K65503129-001-07-1,CCT018159,Tocris,2435,CCT 018159,-9.872569,x0195,0.24096,active-noncovalent
CCCC(CCC)C(=O)NCc1ccc2c(c1)cnn2c3ccccc3OC,BRD-K51265828-001-01-0,M-25,Tocris,4917,M 25,-9.869954,x0104,5.162117,active-noncovalent
Cc1cc(cc2c1O[C@](CC2)(C)CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)O,BRD-K85776940-001-01-9,delta-Tocotrienol,AnalytiCon,NP-013307,,-9.866880,x0967,3.52042,active-noncovalent
C[C@@H](c1ccc2c(c1)Cc3cccnc3O2)C(=O)[O-],BRD-A64610707-001-05-1,pranoprofen,Selleck,S1960,Pranoprofen,-9.864224,x0749,0.978196,active-covalent
C[C@@H](c1ccc2c(c1)Cc3cccnc3O2)C(=O)[O-],BRD-A64610707-001-03-6,pranoprofen,Selleck,S1960,Pranoprofen,-9.864224,x0749,0.978196,active-covalent
C[C@@H](c1ccc2c(c1)Cc3cccnc3O2)C(=O)[O-],BRD-A64610707-001-04-4,pranoprofen,MicroSource,1502324,PRANOPROFEN,-9.864224,x0749,0.978196,active-covalent
c1cc(ccc1CNC(=[NH2+])SCCCc2cnc[nH]2)Cl,BRD-K71430621-303-02-3,clobenpropit,Tocris,752,Clobenpropit dihydrobromide,-9.861518,x0678,-1.126214,active-noncovalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,BRD-A19661776-003-27-6,mianserin,MicroSource,2300292,MIANSERIN HYDROCHLORIDE,-9.861363,x0072,-1.136326,active-noncovalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,BRD-A19661776-003-28-4,mianserin,Selleck,S1382,Mianserin hydrochloride,-9.861363,x0072,-1.136326,active-noncovalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,BRD-A19661776-003-25-0,mianserin,Selleck,S1382,Mianserin HCl,-9.861363,x0072,-1.136326,active-noncovalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,BRD-A19661776-003-26-8,mianserin,Tocris,997,Mianserin hydrochloride,-9.861363,x0072,-1.136326,active-noncovalent
C[C@@H](Cn1c2c3cc(ccc3ncc2n(c1=O)C)c4cc(cnc4)C(C)(C)O)OC,BRD-K82967180-001-01-6,LY3023414,MedChemEx,HY-12513,LY3023414,-9.854416,x0195,4.989073,active-noncovalent
CCC[N@H+]1CCO[C@@H]2[C@@H]1COc3c2cc(cc3)O,BRD-K38797369-003-01-1,PD-128907,Selleck,S2168,PD128907 HCl,-9.853157,x0195,-0.212959,active-noncovalent
Cc1ccc2c(c1)n3c(c[nH+]c3c(n2)NCC[NH3+])C,BRD-K13566078-001-02-3,BMS-345541,Selleck,S8044,BMS-345541,-9.849402,x0195,0.277643,active-noncovalent
Cc1ccc2c(c1)n3c(c[nH+]c3c(n2)NCC[NH3+])C,BRD-K13566078-003-06-0,BMS-345541,Tocris,4806,BMS 345541,-9.849402,x0195,0.277643,active-noncovalent
c1ccc2cc3c(cc2c1)c(=O)n(cn3)N,BRD-K31329721-001-08-2,centazolone,Enamine,Z56813658,3-aminobenzo[g]quinazolin-4(3H)-one,-9.845895,x0195,-0.900024,active-noncovalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4cccnc4)NCCC(=O)[O-],BRD-K82484347-001-02-0,GSK-J2,Tocris,4688,GSK J2,-9.844858,x0107,4.182329,active-noncovalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4cccnc4)NCCC(=O)[O-],BRD-K82484347-001-01-2,GSK-J2,MedChemEx,HY-15648A,GSK-J2,-9.844858,x0107,4.182329,active-noncovalent
CCCCC(=O)O[C@@]1(CC[C@H]2[C@@]1(C[C@@H]([C@@H]3[C@@H]2CCC4=CC(=O)CC[C@]34C)O)C)[C@H](C=O)O,BRD-A25143711-001-02-2,hydrocortisone-valerate,MicroSource,1505438,HYDROCORTISONE VALERATE,-9.843996,x1077,4.159354,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-K65856711-001-03-6,rolipram-S(+),Selleck,S2127,S- (+)-Rolipram,-9.842790,x0749,0.215192,active-covalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,BRD-K65856711-001-04-4,rolipram-S(+),Tocris,1350,(S)-(+)-Rolipram,-9.842790,x0749,0.215192,active-covalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)C3CCCC3,BRD-K01824921-001-18-5,DPCPX,Tocris,439,DPCPX,-9.842395,x0678,0.38062,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O,BRD-A09828896-004-11-0,SKF-81297,Tocris,1447,SKF 81297 hydrobromide,-9.841992,x1392,-1.794581,active-covalent
c1ccc(cc1)[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O,BRD-A09828896-004-12-8,SKF-81297,Tocris,1447,SKF 81297 hydrobromide,-9.841992,x1392,-1.794581,active-covalent
CCn1cc(c(=O)c2c1c(c(c(c2)F)[N@]3CC[NH2+][C@@H](C3)C)F)C(=O)[O-],BRD-A75850590-213-01-0,lomefloxacin,MicroSource,1502037,LOMEFLOXACIN,-9.841339,x0749,4.831072,active-covalent
CCn1cc(c(=O)c2c1c(c(c(c2)F)[N@]3CC[NH2+][C@@H](C3)C)F)C(=O)[O-],BRD-A75850590-003-09-8,lomefloxacin,Selleck,S2539,Lomefloxacin HCl,-9.841339,x0749,4.831072,active-covalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O,BRD-A32796301-001-01-6,4-galactosyllactose,Key,MD-0231,4-O-(4-O-beta-D-galactopyranosyl-beta-D-galactopyranosyl)-D-glucopyranose,-9.840419,x0161,9.860323,active-noncovalent
CN(C)C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c2ccc(cc2)[NH+]=C(N)N,BRD-K43806473-066-03-9,camostat-mesilate,Tocris,3193,Camostat mesylate,-9.839316,x0395,10.607838,active-noncovalent
CN(C)C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c2ccc(cc2)[NH+]=C(N)N,BRD-K43806473-066-02-1,camostat-mesilate,Selleck,S2874,Camostat Mesilate,-9.839316,x0395,10.607838,active-noncovalent
c1cc(cnc1)[C@@H]2CCCC[NH2+]2,BRD-A24284985-001-09-9,anabasine,Enzo,AC1068,"(R,S)-3-(2-Piperidinyl) pyridine [(-)-Anabasine]",-9.837004,x0678,-2.863494,active-noncovalent
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34C[C@H]5C[C@@H](C3)CC(C5)(C4)O)[NH3+],BRD-A81513827-001-03-6,saxagliptin,Selleck,S1540,Saxagliptin,-9.835773,x0749,0.949373,active-covalent
c1cc(ccc1CCNC(=[NH2+])SCCCc2cnc[nH]2)I,BRD-K51918615-303-02-9,iodophenpropit,Tocris,779,Iodophenpropit dihydrobromide,-9.834923,x0107,-0.62164,active-noncovalent
C[N@H+]1CCC2=C(C1)[C@@H](c3c2cccc3)c4ccccc4,BRD-A33178345-001-02-2,phenindamine,AMS,A001025678,"2-methyl-9-phenyl-2,3,4,9-tetrahydro-1H-indeno[2,1-c]pyridine",-9.834886,x1418,0.39297,active-covalent
C[N@H+]1CCC2=C(C1)[C@@H](c3c2cccc3)c4ccccc4,BRD-A33178345-001-01-4,phenindamine,AMS,A001025678,"2-methyl-9-phenyl-2,3,4,9-tetrahydro-1H-indeno[2,1-c]pyridine",-9.834886,x1418,0.39297,active-covalent
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K84163249-001-03-5,ercalcitriol,MedChemEx,HY-32350,Ercalcitriol,-9.834070,x0104,7.488061,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K84163249-001-01-9,ercalcitriol,MedChemEx,HY-32350,Ercalcitriol,-9.834070,x0104,7.488061,active-noncovalent
Cn1cc2c3c1cccc3[C@H]4C[C@H](C[N@H+]([C@@H]4C2)C)CNC(=O)OCc5ccccc5,BRD-K56699285-001-23-5,metergoline,Tocris,590,Metergoline,-9.831735,x0678,3.214119,active-noncovalent
Cn1cc2c3c1cccc3[C@H]4C[C@H](C[N@H+]([C@@H]4C2)C)CNC(=O)OCc5ccccc5,BRD-K56699285-001-24-3,metergoline,Tocris,590,Metergoline,-9.831735,x0678,3.214119,active-noncovalent
C[C@@H]1CN(CCN1C(=O)C(=O)c2c[nH]c3c2c(ccn3)OC)C(=O)c4ccccc4,BRD-K55773932-001-03-8,BMS-806,Selleck,S2632,BMS-806 (BMS 378806),-9.830076,x0107,3.250546,active-noncovalent
C[C@@H]1CN(CCN1C(=O)C(=O)c2c[nH]c3c2c(ccn3)OC)C(=O)c4ccccc4,BRD-K55773932-001-02-0,BMS-806,Selleck,S2632,BMS-378806,-9.830076,x0107,3.250546,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-300-08-6,naftopidil,Selleck,S1387,Naftopidil DiHCl,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-001-07-2,naftopidil,MicroSource,1506024,NAFTOPIDIL,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-003-16-9,naftopidil,Tocris,597,Naftopidil dihydrochloride,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-001-06-4,naftopidil,Selleck,S2126,Naftopidil,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-300-09-4,naftopidil,Selleck,S1387,Naftopidil Dihydrochloride,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-003-17-7,naftopidil,Tocris,597,Naftopidil hydrochloride,-9.827548,x0161,2.978958,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,BRD-A01787639-001-08-0,naftopidil,Selleck,S2126,Naftopidil (Flivas),-9.827548,x0161,2.978958,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,BRD-A10070317-003-29-1,propranolol,Tocris,624,Propranolol hydrochloride,-9.823749,x0104,-0.250867,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,BRD-A10070317-003-30-9,propranolol,MicroSource,1505270,PROPRANOLOL HYDROCHLORIDE (+/-),-9.823749,x0104,-0.250867,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,BRD-K13994703-003-15-8,propranolol-(S),Tocris,834,(S)-(-)-Propranolol hydrochloride,-9.823749,x0104,-0.250867,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,BRD-A10070317-003-28-3,propranolol,Selleck,S4076,Propranolol HCl,-9.823749,x0104,-0.250867,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,BRD-K13994703-003-16-6,propranolol-(S),MicroSource,1500514,DEXPROPRANOLOL HYDROCHLORIDE,-9.823749,x0104,-0.250867,active-noncovalent
Cc1ccc2c(c1)[C@H]3C[N@@H+](CC[C@H]3N2)C,BRD-K33839500-001-01-0,stobadine,Enamine,EN300-191957,"(4aR,9bS)-2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole",-9.823352,x0195,-0.926225,active-noncovalent
Cn1cc(cn1)c2ccc3[nH+]cc(n3n2)Cc4ccc5c(c4)cccn5,BRD-K77943374-001-02-8,NVP-BVU972,Selleck,S2761,NVP-BVU972,-9.820287,x1418,3.763452,active-covalent
C[NH+](C)CCNc1c2c(c3ccc(cc3n1)O)-c4ccccc4C2=O,BRD-K09426783-300-01-0,TAS-103,MedChemEx,HY-13758A,TAS-103 (dihydrochloride),-9.819729,x0195,0.527552,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)N3Cc4ccccc4NC3=O,BRD-K31633810-003-02-8,DAU-5884,Tocris,2096,DAU 5884 hydrochloride,-9.819455,x0749,0.402077,active-covalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)N3Cc4ccccc4NC3=O,BRD-K31633810-003-03-6,DAU-5884,Tocris,2096,DAU 5884 hydrochloride,-9.819455,x0749,0.402077,active-covalent
c1cc2c(cc1NC(=[NH2+])N)c3c([nH]2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,BRD-K64748124-300-01-7,GNTI,Tocris,1282,GNTI dihydrochloride,-9.819454,x0072,5.061826,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)Cn3cncn3,BRD-K75699339-057-10-7,rizatriptan,Tocris,5136,Rizatriptan benzoate,-9.819012,x0072,-0.743638,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)Cn3cncn3,BRD-K75699339-057-08-1,rizatriptan,MicroSource,1505189,RIZATRIPTAN BENZOATE,-9.819012,x0072,-0.743638,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)Cn3cncn3,BRD-K75699339-057-07-3,rizatriptan,Selleck,S1607,Rizatriptan Benzoate,-9.819012,x0072,-0.743638,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)Cn3cncn3,BRD-K75699339-057-09-9,rizatriptan,Selleck,S1607,Rizatriptan Benzoate (Maxalt),-9.819012,x0072,-0.743638,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)C[C@H]3COC(=O)N3,BRD-K54314721-001-09-4,zolmitriptan,Selleck,S1649,Zolmitriptan,-9.818854,x0072,-0.472625,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)C[C@H]3COC(=O)N3,BRD-K54314721-001-11-0,zolmitriptan,Tocris,4657,Zolmitriptan,-9.818854,x0072,-0.472625,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)C[C@H]3COC(=O)N3,BRD-K54314721-001-10-2,zolmitriptan,MicroSource,1505281,ZOLMITRIPTAN,-9.818854,x0072,-0.472625,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)[O-],BRD-K82562631-236-04-6,tolmetin,MicroSource,1500582,TOLMETIN SODIUM,-9.818548,x0830,-0.254298,active-covalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)[O-],BRD-K82562631-325-04-7,tolmetin,Selleck,S4360,Tolmetin Sodium,-9.818548,x0830,-0.254298,active-covalent
CC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CC[NH+](CC3)C)(C)C,BRD-K64800655-001-07-4,PHA-793887,Selleck,S1487,PHA-793887,-9.817928,x0195,4.472404,active-noncovalent
CC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CC[NH+](CC3)C)(C)C,BRD-K64800655-001-09-0,PHA-793887,Selleck,S1487,PHA-793887,-9.817928,x0195,4.472404,active-noncovalent
CCOC(=O)Cc1ccc(cc1)c2ccccc2,BRD-K26404903-001-01-5,felbinac-ethyl,AMS,A000379137,"ethyl [1,1'-biphenyl]-4-ylacetate",-9.816342,x0749,3.269977,active-covalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)C(F)(F)F,BRD-K63675182-003-23-6,triflupromazine,MicroSource,1503118,TRIFLUPROMAZINE HYDROCHLORIDE,-9.813185,x0161,0.483892,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)C(F)(F)F,BRD-K63675182-003-22-8,triflupromazine,Selleck,S4372,Triflupromazine HCl,-9.813185,x0161,0.483892,active-noncovalent
CCC1(Cc2ccccc2C1)c3c[nH]cn3,BRD-K39252998-003-02-3,atipamezole,Tocris,2937,Atipamezole hydrochloride,-9.809377,x0749,-2.674078,active-covalent
CCC1(Cc2ccccc2C1)c3c[nH]cn3,BRD-K39252998-003-01-5,atipamezole,MedChemEx,HY-12380,Atipamezole (hydrochloride),-9.809377,x0749,-2.674078,active-covalent
CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O,BRD-K97472745-001-01-8,gestrinone,Prestwick,Prestw-1267,Gestrinone,-9.808918,x0749,2.601533,active-covalent
c1cc(ccc1C[NH+]2CCOCC2)C(=O)N3CC[NH+](CC3)C4CC4,BRD-K79595931-312-01-3,bavisant,MedChemEx,HY-14880B,Bavisant (dihydrochloride hydrate),-9.808836,x0946,3.228145,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],BRD-K78513633-001-14-0,lonidamine,Tocris,1646,Lonidamine,-9.807531,x0678,0.220201,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],BRD-K78513633-001-13-2,lonidamine,Selleck,S2610,Lonidamine,-9.807531,x0678,0.220201,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],BRD-K78513633-001-16-5,lonidamine,Tocris,1646,Lonidamine,-9.807531,x0678,0.220201,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],BRD-K78513633-001-15-7,lonidamine,MicroSource,1503225,LONIDAMINE,-9.807531,x0678,0.220201,active-noncovalent
CC(C)(C)c1ccc2cc(c(cc2c1)C#N)C#N,BRD-K89329876-001-07-8,BRD-9876,Tocris,5454,BRD 9876,-9.807121,x0749,-0.377201,active-covalent
CCn1c2ccccc2c3c1ccc(c3)C[NH2+]C,BRD-K44400149-003-01-1,PhiKan-083,Tocris,4326,PhiKan 083,-9.805827,x0195,-0.305911,active-noncovalent
c1cc(cc(c1)O)c2nc3c4cccnc4oc3c(n2)N5CCOCC5,BRD-K67868012-003-02-3,PI-103,Tocris,2930,PI 103 hydrochloride,-9.803667,x0749,4.107061,active-covalent
c1cc(cc(c1)O)c2nc3c4cccnc4oc3c(n2)N5CCOCC5,BRD-K67868012-001-07-6,PI-103,Selleck,S1038,PI-103,-9.803667,x0749,4.107061,active-covalent
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,BRD-K79402892-001-07-5,sitosterol,Selleck,S2273,?-Sitosterol,-9.803485,x0104,6.82852,active-noncovalent
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,BRD-K79402892-001-06-7,sitosterol,Selleck,S2273,??-Sitosterol,-9.803485,x0104,6.82852,active-noncovalent
c1c(cc(c(c1O)O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],BRD-K43149758-001-22-7,myricetin,Selleck,S2326,Myricetin,-9.803391,x0749,1.853979,active-covalent
c1c(cc(c(c1O)O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],BRD-K43149758-001-23-5,myricetin,Selleck,S2326,Myricetin (Cannabiscetin),-9.803391,x0749,1.853979,active-covalent
C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O,BRD-K86118762-001-05-9,linsitinib,Selleck,S1091,OSI-906 (Linsitinib),-9.801770,x0161,6.194384,active-noncovalent
C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O,BRD-K86118762-001-01-8,linsitinib,Selleck,S1091,OSI-906 (Linsitinib),-9.801770,x0161,6.194384,active-noncovalent
C[NH+](C)CCN(Cc1ccccc1)c2ccccn2,BRD-K57033106-003-19-7,tripelennamine,Selleck,S3146,Tripelennamine HCl,-9.801753,x0749,1.260324,active-covalent
C[NH+](C)CCN(Cc1ccccc1)c2ccccn2,BRD-K57033106-048-04-4,tripelennamine,MicroSource,1500597,TRIPELENNAMINE CITRATE,-9.801753,x0749,1.260324,active-covalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3cc(cc(c3)Cl)Cl,BRD-A85587465-001-03-3,bemesetron,Tocris,640,MDL 72222,-9.800955,x0161,1.271448,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3cc(cc(c3)Cl)Cl,BRD-A85587465-001-04-1,bemesetron,Tocris,640,MDL 72222,-9.800955,x0161,1.271448,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2Sc3c1cc(cc3)Cl,BRD-K36207157-001-07-0,chlorprothixene,Selleck,S1771,Chlorprothixene,-9.799965,x0104,-0.368425,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2Sc3c1cc(cc3)Cl,BRD-K36207157-001-08-8,chlorprothixene,Selleck,S1771,Chlorprothixene,-9.799965,x0104,-0.368425,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2Sc3c1cc(cc3)Cl,BRD-K36207157-001-09-6,chlorprothixene,MicroSource,1503203,CHLORPROTHIXENE HYDROCHLORIDE,-9.799965,x0104,-0.368425,active-noncovalent
CCC[N@@H+]1CCO[C@H]2[C@@H]1COc3c2cc(cc3)O,BRD-K20260086-001-01-6,PD-128907,Selleck,S2168,PD128907 HCl,-9.794686,x0195,-0.479612,active-noncovalent
C[NH+]1CCN(CC1)c2cc(nc(n2)N)c3ccccc3,BRD-K90082312-001-01-5,VUF10460,Tocris,4769,VUF 10460,-9.794000,x0104,-0.271049,active-noncovalent
Cc1c(c2ccccc2[nH]1)CCNC(=O)c3cccs3,BRD-K81572616-001-01-9,CK-636,Selleck,S7497,CK-636,-9.793570,x1386,0.461594,active-covalent
Cc1c(c2ccccc2[nH]1)CCNC(=O)c3cccs3,BRD-K81572616-001-02-7,CK-636,Selleck,S7497,CK-636,-9.793570,x1386,0.461594,active-covalent
COc1cc(ccc1OC(F)F)c2ccc(=O)[nH]n2,BRD-K37561857-001-17-1,zardaverine,Tocris,1046,Zardaverine,-9.793176,x0749,1.025428,active-covalent
COc1cc(ccc1OC(F)F)c2ccc(=O)[nH]n2,BRD-K37561857-001-15-5,zardaverine,Tocris,1046,Zardaverine,-9.793176,x0749,1.025428,active-covalent
COc1cc(ccc1OC(F)F)c2ccc(=O)[nH]n2,BRD-K37561857-001-18-9,zardaverine,Tocris,1046,Zardaverine,-9.793176,x0749,1.025428,active-covalent
CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N3CCC[C@H]3C(=O)N,BRD-K93869735-001-01-1,taltirelin,MedChemEx,HY-B0596,Taltirelin,-9.792715,x0678,2.41813,active-noncovalent
CN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c(c[nH]c4nc3)c5ccc6c(c5)cc[nH]6,BRD-K66908976-001-01-8,URMC-099,MedChemEx,HY-12599,URMC-099,-9.792511,x0104,10.328403,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4ccc5c(c4)nsn5,BRD-K95901403-001-04-5,XL-147,Selleck,S1118,XL-147 analog,-9.792378,x0678,3.603794,active-noncovalent
c1cc(cc(c1)Cl)[C@@H](c2ccc3c(c2)nc[nH]3)n4ccnc4,BRD-A57133765-300-01-7,liarozole,Tocris,2705,Liarozole dihydrochloride,-9.791400,x0195,-1.090018,active-noncovalent
B(c1ccccc1)(c2ccccc2)OCC[NH3+],BRD-K13346085-001-04-7,2-APB,Tocris,1224,2-APB,-9.791046,x0072,-1.884311,active-noncovalent
C1C[C@@H]2[C@@H]3CCC[N@H+]4[C@H]3[C@H](CCC4)CN2C(=O)C1,BRD-K25312248-001-01-5,matrine,Selleck,S2322,(+)-Matrine,-9.790839,x0195,-0.61853,active-noncovalent
c1cc(ccc1c2c[nH]nc2)C3(CC[NH2+]CC3)c4ccc(cc4)Cl,BRD-K12040459-001-06-0,AT7867,Selleck,S1558,AT7867,-9.787711,x1077,-0.457373,active-noncovalent
c1cc(ccc1c2c[nH]nc2)C3(CC[NH2+]CC3)c4ccc(cc4)Cl,BRD-K12040459-001-07-8,AT7867,Selleck,S1558,AT7867,-9.787711,x1077,-0.457373,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](c1ccccc1)C(=O)OC2CCCC2,BRD-K92241597-001-05-2,tosedostat,Selleck,S1522,Tosedostat (CHR2797),-9.787008,x0434,2.847771,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](c1ccccc1)C(=O)OC2CCCC2,BRD-K92241597-001-06-0,tosedostat,Tocris,3595,CHR 2797,-9.787008,x0434,2.847771,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](c1ccccc1)C(=O)OC2CCCC2,BRD-K92241597-001-09-4,tosedostat,Selleck,S1522,Tosedostat (CHR2797),-9.787008,x0434,2.847771,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](c1ccccc1)C(=O)OC2CCCC2,BRD-K92241597-001-11-0,tosedostat,Tocris,3595,CHR 2797,-9.787008,x0434,2.847771,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)CCc2[nH]c(=O)c3ccccc3n2,BRD-K24283677-001-01-9,ME-0328,Tocris,5054,ME 0328,-9.786962,x1093,0.214314,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)CCc2[nH]c(=O)c3ccccc3n2,BRD-A63444178-001-01-5,ME0328,Selleck,S7438,ME0328,-9.786962,x1093,0.214314,active-noncovalent
Cc1ccc(c2c1CCC2)OC[C@H]([C@H](C)[NH2+]C(C)C)O,BRD-K74603273-003-01-1,"ICI-118,551",Tocris,821,"ICI 118,551 hydrochloride",-9.786823,x0195,1.356795,active-noncovalent
c1ccc(cc1)C[C@H](CS)C(=O)NCC(=O)[O-],BRD-A56012032-001-15-5,thiorphan,Sigma,T6031,[(2-benzyl-3-sulfanylpropanoyl)amino]acetic acid,-9.784503,x0678,-0.432028,active-noncovalent
c1ccc(cc1)C[C@H](CS)C(=O)NCC(=O)[O-],BRD-A56012032-001-14-8,thiorphan,Enzo,PI113,Thiorphan (DL),-9.784503,x0678,-0.432028,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccncc1c2ccc(c3c2cccc3)C#N,BRD-K36741660-001-01-1,verinurad,MedChemEx,HY-16733,Verinurad,-9.784450,x0830,1.040193,active-covalent
C[NH+](C)CCC=C1c2ccccc2CCc3c1cccc3,BRD-K53737926-003-25-2,amitriptyline,Selleck,S3183,Amitriptyline HCl,-9.784410,x0874,0.076784,active-noncovalent
C[NH+](C)CCC=C1c2ccccc2CCc3c1cccc3,BRD-K53737926-003-27-8,amitriptyline,MicroSource,1500117,AMITRIPTYLINE HYDROCHLORIDE,-9.784410,x0874,0.076784,active-noncovalent
c1c(csc1COc2c3c([nH]cn3)nc(n2)N)Br,BRD-K27955832-001-05-2,lomeguatrib,Tocris,4359,Lomeguatrib,-9.783179,x0749,-1.303799,active-covalent
c1c(csc1COc2c3c([nH]cn3)nc(n2)N)Br,BRD-K27955832-001-02-9,lomeguatrib,Selleck,S8056,Lomeguatrib,-9.783179,x0749,-1.303799,active-covalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O,BRD-A45419686-001-02-3,L-Ascorbyl-6-palmitate,Selleck,S2532,L-Ascorbyl 6-palmitate,-9.782143,x0967,3.234394,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O,BRD-A45419686-001-04-9,L-Ascorbyl-6-palmitate,MicroSource,1505742,ASCORBYL PALMITATE,-9.782143,x0967,3.234394,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O,BRD-A45419686-001-03-1,L-Ascorbyl-6-palmitate,Selleck,S2532,L-Ascorbyl 6-palmitate,-9.782143,x0967,3.234394,active-noncovalent
C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(CO)O,BRD-A27376179-001-01-3,lestaurtinib,EMDBio,219499-5MG,CEP-701,-9.778948,x0195,6.552115,active-noncovalent
c1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)[O-],BRD-K81458380-001-04-9,CX-4945,Selleck,S2248,CX-4945 (Silmitasertib),-9.778694,x0434,1.371475,active-noncovalent
Cc1ccccc1/N=N/c2ccc(c(c2)C)/N=N/c3c4ccccc4ccc3O,BRD-K65989725-001-01-3,sudan-iv,Vitas-M,STL069551,,-9.778320,x0104,7.06638,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Br)c2ccccn2,BRD-A68723818-050-31-7,brompheniramine,Selleck,S2585,Brompheniramine hydrogen maleate,-9.775172,x0072,0.292511,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Br)c2ccccn2,BRD-A68723818-050-32-5,brompheniramine,MicroSource,1503985,BROMPHENIRAMINE MALEATE,-9.775172,x0072,0.292511,active-noncovalent
C[C@@H](c1ccc2c(c1)CC(=O)c3ccccc3S2)C(=O)[O-],BRD-A00578795-001-04-3,zaltoprofen,Selleck,S3008,Zaltoprofen,-9.774978,x0072,0.931726,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)c2ccccc2O,BRD-A34751532-001-06-9,homosalate,MicroSource,1505020,HOMOSALATE,-9.773002,x0195,-0.262513,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O,BRD-K58277159-001-01-7,NPC-01,Sigma,MFCD00051131,"(11beta)-11-hydroxyandrost-4-ene-3,17-dione",-9.772391,x0749,2.204687,active-covalent
CC(C)Nc1cc(c(cn1)Cl)c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl,BRD-K28965160-001-01-1,BVD-523,MedChemEx,HY-15816,VRT752271,-9.771790,x0161,8.532712,active-noncovalent
Cc1c2c(n[nH]1)Nc3cc(c(cc3C(=N2)c4ccccc4Cl)F)OC,BRD-K32942258-001-02-5,RG1530,MedChemEx,HY-13737,R1530,-9.771587,x0195,0.58852,active-noncovalent
Cc1c2c(n[nH]1)Nc3cc(c(cc3C(=N2)c4ccccc4Cl)F)OC,BRD-K32942258-001-01-7,RG1530,MedChemEx,HY-13737,R1530,-9.771587,x0195,0.58852,active-noncovalent
Cc1c2c(n[nH]1)Nc3cc(c(cc3C(=N2)c4ccccc4Cl)F)OC,BRD-K32942258-001-04-1,RG1530,MedChemEx,HY-13737,R1530,-9.771587,x0195,0.58852,active-noncovalent
Cc1c2c(n[nH]1)Nc3cc(c(cc3C(=N2)c4ccccc4Cl)F)OC,BRD-K32942258-001-03-3,RG1530,Tocris,4885,R 1530,-9.771587,x0195,0.58852,active-noncovalent
c1ccc2cnc(cc2c1)C3=[NH+]CCN3,BRD-K56115039-003-02-1,BU226,Tocris,1091,BU 226 hydrochloride,-9.771079,x0195,-0.904366,active-noncovalent
C[C@@]12CC[C@@H]3[C@@H]([C@@H]1CC=C2)CC[C@H]4[C@]3(CCC(=O)C4)C,BRD-A64011898-001-01-0,androstenone,SantaCruz,sc-227030,5 -Androst-16-en-3-one,-9.770131,x0749,0.155223,active-covalent
C[NH2+]CCCN1c2ccccc2CCc3c1cccc3,BRD-K60762818-003-25-2,desipramine,MicroSource,1500227,DESIPRAMINE HYDROCHLORIDE,-9.767564,x0072,1.071233,active-noncovalent
C[NH2+]CCCN1c2ccccc2CCc3c1cccc3,BRD-K60762818-003-26-0,desipramine,Sigma,MFCD00058108,"3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methyl-1-propanamine hydrochloride",-9.767564,x0072,1.071233,active-noncovalent
COc1cccc(c1N)c2cc(=O)c3ccccc3o2,BRD-K62810658-001-15-5,PD-98059,Tocris,1213,PD 98059,-9.764787,x0195,0.472755,active-noncovalent
COc1cccc(c1N)c2cc(=O)c3ccccc3o2,BRD-K62810658-001-12-2,PD-98059,Tocris,1213,PD 98059,-9.764787,x0195,0.472755,active-noncovalent
COc1cccc(c1N)c2cc(=O)c3ccccc3o2,BRD-K62810658-001-11-4,PD-98059,Selleck,S1177,PD98059,-9.764787,x0195,0.472755,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1C[C@@H]([C@@H](C2)O)O)O,BRD-A87606379-001-22-4,nadolol,MicroSource,1503260,NADOLOL,-9.761443,x0104,0.912689,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1C[C@@H]([C@@H](C2)O)O)O,BRD-A87606379-001-23-2,nadolol,Sigma,MFCD00079476,"(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalenediol",-9.761443,x0104,0.912689,active-noncovalent
C[N@@H+]1Cc2ccccc2[C@H]3[C@H]1Cc4c[nH]c5c4c3ccc5,BRD-K79353516-001-04-3,CY208-243,Tocris,1249,CY 208-243,-9.759704,x0749,-1.38025,active-covalent
C[N@@H+]1Cc2ccccc2[C@H]3[C@H]1Cc4c[nH]c5c4c3ccc5,BRD-K79353516-001-05-0,CY208-243,Tocris,1249,"(6aR,12bR)-7-methyl-4,6,6a,7,8,12b-hexahydroindolo[4,3-ab]phenanthridine",-9.759704,x0749,-1.38025,active-covalent
COc1ccc(cc1)c2coc3cc(ccc3c2=O)O,BRD-K55567017-001-12-3,formononetin,Selleck,S2299,Formononetin,-9.758073,x0749,3.957707,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)OC,BRD-K31920458-001-22-8,mestranol,Selleck,S2125,Mestranol,-9.755615,x0749,3.03684,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)OC,BRD-K31920458-001-23-6,mestranol,MicroSource,1500388,MESTRANOL,-9.755615,x0749,3.03684,active-covalent
c1ccc(c(c1)[C@@H]2[C@@H](CO[C@@H](O2)C(F)(F)F)C/C=C\CCCC(=O)[O-])O,BRD-K29133151-001-03-2,"ICI-185,282",Tocris,836,"ICI 185,282",-9.753593,x0678,3.080713,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K58160573-001-05-4,dapagliflozin,Selleck,S1548,Dapagliflozin,-9.752493,x0874,3.581116,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K58160573-001-04-7,dapagliflozin,MicroSource,1506320,DAPAGLIFLOZIN,-9.752493,x0874,3.581116,active-noncovalent
C[C@@H](c1ccc(s1)C(=O)c2ccccc2)C(=O)[O-],BRD-A72988804-001-10-3,tiaprofenic-acid,Prestwick,Prestw-496,Tiaprofenic acid,-9.752036,x0678,0.343257,active-noncovalent
C[C@@H](c1ccc(s1)C(=O)c2ccccc2)C(=O)[O-],BRD-A72988804-001-11-1,tiaprofenic-acid,Sigma,MFCD00866089,2-(5-benzoyl-2-thienyl)propanoic acid,-9.752036,x0678,0.343257,active-noncovalent
c1cc2c(cc[nH+]c2cc1Cl)NCCNc3cc[nH+]c4c3ccc(c4)Cl,BRD-K73799155-001-01-5,NSC5844,MedChemEx,HY-100033,NSC5844,-9.751589,x0104,1.628284,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2O)OC(=O)c5ccccc5,BRD-A74765037-001-01-1,estradiol-benzoate,MicroSource,1501182,ESTRADIOL BENZOATE,-9.751526,x0161,7.89845,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)Sc3ccccc3,BRD-K51318897-001-14-6,fenbendazole,Selleck,S2468,Fenbendazole,-9.749841,x0072,1.110715,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)Sc3ccccc3,BRD-K51318897-001-15-3,fenbendazole,MicroSource,1501016,FENBENDAZOLE,-9.749841,x0072,1.110715,active-noncovalent
C[C@H]1COC2=C1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K33336844-001-11-1,cryptotanshinone,MedChemEx,HY-N0174,Cryptotanshinone,-9.748426,x0749,0.924972,active-covalent
C[C@H]1COC2=C1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K33336844-001-12-9,cryptotanshinone,Selleck,S2285,Cryptotanshinone,-9.748426,x0749,0.924972,active-covalent
C[C@H]1COC2=C1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K33336844-001-09-5,cryptotanshinone,Selleck,S2285,Cryptotanshinone,-9.748426,x0749,0.924972,active-covalent
C[C@H]1COC2=C1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K33336844-001-10-3,cryptotanshinone,MedChemEx,HY-N0174,Cryptotanshinone,-9.748426,x0749,0.924972,active-covalent
CNC(=O)c1ccc2cc(ccc2c1)[C@@]3(CCn4c3cnc4)O,BRD-K00674894-001-01-4,orteronel,Selleck,S1195,TAK-700 (Orteronel),-9.747026,x0104,0.681479,active-noncovalent
CC(C)(c1ccc(cc1)O)c2ccc(cc2)O,BRD-K41494493-001-13-8,bisphenol-a,Sigma,42088,"4,4'-(propane-2,2-diyl)diphenol",-9.745298,x0072,-1.557975,active-noncovalent
c1ccc(c(c1)c2cc(cc(c2)CP(=O)([O-])[O-])C[C@@H](C(=O)[O-])[NH3+])Cl,BRD-K27168049-001-02-8,SDZ-220-581,Tocris,1250,SDZ 220-581,-9.744349,x1392,0.976354,active-covalent
c1ccc(c(c1)c2cc(cc(c2)CP(=O)([O-])[O-])C[C@@H](C(=O)[O-])[NH3+])Cl,BRD-K27168049-001-03-6,SDZ-220-581,Tocris,1250,SDZ 220-581,-9.744349,x1392,0.976354,active-covalent
c1cc(cc(c1)O)CNC(=O)Nc2nc(cs2)c3ccncc3,BRD-K19333160-001-01-3,RKI-1447,Selleck,S7195,RKI-1447,-9.743959,x0678,2.311017,active-noncovalent
c1cc(cc(c1)O)CNC(=O)Nc2nc(cs2)c3ccncc3,BRD-K19333160-300-01-9,RKI-1447,Tocris,5061,RKI 1447 dihydrochloride,-9.743959,x0678,2.311017,active-noncovalent
CC[C@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-A46136514-001-01-2,butibufen,Carbosynth,FB19394,2-(4-isobutylphenyl)butanoic acid,-9.743702,x0678,-1.299287,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC3(CC2)CNC(=O)O3,BRD-K26739552-003-14-7,fenspiride,Selleck,S4090,Fenspiride HCl,-9.741241,x0678,-0.176245,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC3(CC2)CNC(=O)O3,BRD-K26739552-003-15-4,fenspiride,MicroSource,1501021,FENSPIRIDE HYDROCHLORIDE,-9.741241,x0678,-0.176245,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4c5ccccc5)C)O,BRD-K07395323-001-01-0,17-PA,Tocris,2681,17-PA,-9.739073,x0161,4.159848,active-noncovalent
C[C@@H](c1cccc(c1)Oc2ccccc2)C(=O)[O-],BRD-A81129465-238-01-0,fenoprofen,Selleck,S1823,Fenoprofen Calcium,-9.739006,x0678,-0.292835,active-noncovalent
C[C@@H](c1cccc(c1)Oc2ccccc2)C(=O)[O-],BRD-A81129465-001-03-8,fenoprofen,MicroSource,1501011,FENOPROFEN,-9.739006,x0678,-0.292835,active-noncovalent
C[C@@H](c1cccc(c1)Oc2ccccc2)C(=O)[O-],BRD-A81129465-001-04-6,fenoprofen,Selleck,S3027,Fenoprofen calcium hydrate,-9.739006,x0678,-0.292835,active-noncovalent
c1c(ccc(c1)Cl)S(=O)(=O)[C@]2(CC[C@H](CC2)CCC(=O)[O-])c3c(ccc(c3)F)F,BRD-K18850819-001-04-6,MK-0752,Selleck,S2660,MK-0752,-9.735870,x0195,3.123854,active-noncovalent
CC1CC[NH+](CC1)CCCC(=O)c2ccc(cc2)F,BRD-K92984783-003-05-7,melperone,Tocris,2495,Melperone hydrochloride,-9.735436,x0104,0.618802,active-noncovalent
CC1CC[NH+](CC1)CCCC(=O)c2ccc(cc2)F,BRD-K92984783-003-06-5,melperone,Tocris,2495,Melperone hydrochloride,-9.735436,x0104,0.618802,active-noncovalent
C[N@H+]1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,BRD-K51791723-003-01-7,P276-00,Selleck,S8058,P276-00,-9.734779,x1385,1.054387,active-covalent
Cc1ccc2c(c1)c3c(n2CCc4ccc(nc4)C)CC[N@H+](C3)C,BRD-K55703048-300-01-6,latrepirdine,Adooq,A10312,"2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole dihydrochloride",-9.734228,x0104,0.525298,active-noncovalent
Cc1ccc2c(c1)c3c(n2CCc4ccc(nc4)C)CC[N@H+](C3)C,BRD-K55703048-001-07-7,latrepirdine,ChemDiv,H025-0000,,-9.734228,x0104,0.525298,active-noncovalent
Cc1ccc2c(c1)c3c(n2CCc4ccc(nc4)C)CC[N@H+](C3)C,BRD-K55703048-300-02-4,latrepirdine,Tocris,3201,Dimebon dihydrochloride,-9.734228,x0104,0.525298,active-noncovalent
c1cc(cc(c1)Cl)N/C(=[NH+]\C(=[NH2+])N)/N,BRD-K36965586-003-08-8,m-Chlorophenylbiguanide,Tocris,440,m-Chlorophenylbiguanide hydrochloride,-9.733343,x0195,-2.386488,active-noncovalent
c1ccc(cc1)COc2c3c(nc[nH]3)nc(n2)N,BRD-K92041145-001-09-5,O6-Benzylguanine,CombiBlocks,OR-2126,,-9.733213,x0749,-1.608282,active-covalent
c1ccc(cc1)[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-],BRD-K94689771-001-09-0,pinocembrin,Enzo,NP233,Pinocembrin,-9.732360,x0749,-1.276983,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CC[C@@H]4[C@@H]3CCC(=C4)N=O,BRD-K42504537-001-01-6,norelgestromin,MedChemEx,HY-G0018,Norgestimate metabolite Norelgestromin,-9.730318,x0749,2.674316,active-covalent
Cn1c(ccc1/C=C/C(=O)c2cccc(c2)F)CCC(=O)N=O,BRD-K24031866-001-03-9,MC1568,MedChemEx,HY-16914,MC1568,-9.729635,x0072,2.321383,active-noncovalent
Cn1c(ccc1/C=C/C(=O)c2cccc(c2)F)CCC(=O)N=O,BRD-K24031866-001-02-1,MC1568,Selleck,S1484,MC1568,-9.729635,x0072,2.321383,active-noncovalent
Cn1c(ccc1/C=C/C(=O)c2cccc(c2)F)CCC(=O)N=O,BRD-K24031866-001-01-3,MC1568,Selleck,S1484,MC1568,-9.729635,x0072,2.321383,active-noncovalent
c1ccc2c(c1)ccn3c2nc(cc3=O)N4CCOCC4,BRD-K19655798-001-01-9,compound-401,Tocris,3271,Compound 401,-9.728454,x0195,1.150875,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2cc3cc(ccc3[nH]2)Cl,BRD-K17774839-001-02-9,JNJ-7777120,Selleck,S2905,JNJ-7777120,-9.727457,x0107,0.437451,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2cc3cc(ccc3[nH]2)Cl,BRD-K17774839-001-03-7,JNJ-7777120,Tocris,4021,JNJ 7777120,-9.727457,x0107,0.437451,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])O)C2=O,BRD-K58685305-001-20-4,emodin,Selleck,S2295,Emodin,-9.725954,x0749,1.206935,active-covalent
c1ccc2c(c1)C(=O)c3ccccc3C2=O,BRD-K15957397-001-04-2,anthraquinone,Vitas-M,STK398385,,-9.725620,x0749,-0.332866,active-covalent
CN(CCCNC(=O)[C@H]1CCCO1)c2nc3cc(c(cc3c(n2)N)OC)OC,BRD-A09056319-003-07-7,alfuzosin,Selleck,S1409,Alfuzosin HCl,-9.724016,x0104,4.816216,active-noncovalent
CN(CCCNC(=O)[C@H]1CCCO1)c2nc3cc(c(cc3c(n2)N)OC)OC,BRD-A09056319-003-08-5,alfuzosin,MicroSource,1505263,ALFUZOSIN HYDROCHLORIDE,-9.724016,x0104,4.816216,active-noncovalent
C[C@@](Cc1ccccc1)(c2ccccc2)[NH3+],BRD-A09368919-001-01-7,FPL-12495,Enamine,Z2379179579,"1,2-diphenyl-2-propanamine",-9.724012,x0195,-1.549105,active-noncovalent
CC1(CCC(c2c1ccc(c2)C3(OCCO3)c4ccc(cc4)C(=O)[O-])(C)C)C,BRD-K25991633-001-01-9,BMS-649,Tocris,3411,SR 11237,-9.723873,x0161,1.546445,active-noncovalent
CC1(CCC(c2c1ccc(c2)C3(OCCO3)c4ccc(cc4)C(=O)[O-])(C)C)C,BRD-K25991633-001-02-7,BMS-649,Tocris,3411,SR 11237,-9.723873,x0161,1.546445,active-noncovalent
CC[NH+](CC)CCNc1ccc(c2c1c(=O)c3ccccc3s2)CO,BRD-K50406511-001-26-0,hycanthone,MicroSource,1503239,HYCANTHONE,-9.723572,x0104,4.431831,active-noncovalent
Cc1ccc(c(n1)/N=N/c2ccccc2)O,BRD-K98157055-001-10-9,SIB-1757,Tocris,1215,SIB 1757,-9.723178,x0749,-0.326843,active-covalent
c1cc(ccc1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,BRD-K08037784-001-12-6,arbutin,Selleck,S2263,Arbutin,-9.722437,x0678,-0.599496,active-noncovalent
COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C,BRD-K68346641-001-02-2,amsacrine,MicroSource,1503256,AMSACRINE,-9.721684,x0195,3.592998,active-noncovalent
COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C,BRD-K68346641-001-01-4,amsacrine,Enzo,AC2018,Amsacrine,-9.721684,x0195,3.592998,active-noncovalent
[H]/N=c\1/cc2cccc3c(=O)n(c(=O)c(c1)[C@@H]23)CC[NH+](C)C,BRD-K56334280-001-05-1,amonafide,Selleck,S1367,Amonafide,-9.721275,x0195,0.914151,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)[C@H](c2ccccc2)O,BRD-A27370296-001-02-2,cyclandelate,Selleck,S4189,Cyclandelate,-9.718907,x0195,-0.482362,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)[C@H](c2ccccc2)O,BRD-A27370296-001-03-0,cyclandelate,MicroSource,1505082,CYCLANDELATE,-9.718907,x0195,-0.482362,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)[C@H](c2ccccc2)O,BRD-A27370296-001-04-8,cyclandelate,Selleck,S4189,Cyclandelate,-9.718907,x0195,-0.482362,active-noncovalent
c1cc2c3c(c1)c4c(n3CC[NH2+]C2)CCCC4,BRD-K55430733-003-02-4,WAY-629,Tocris,2173,WAY 629 hydrochloride,-9.717195,x0195,0.276146,active-noncovalent
c1cc(c(cc1C(=O)Nc2cnc(nc2)Cl)F)F,BRD-K59839632-001-01-0,ICA-069673,Tocris,4305,ICA 069673,-9.714758,x0678,0.373336,active-noncovalent
CCCC(=O)Nc1ccc(c(c1)C(=O)C)OC[C@H](C[NH2+]C(C)C)O,BRD-A29260609-003-26-0,acebutolol,MicroSource,1500665,ACEBUTOLOL HYDROCHLORIDE,-9.713871,x0104,4.214701,active-noncovalent
CCCC(=O)Nc1ccc(c(c1)C(=O)C)OC[C@H](C[NH2+]C(C)C)O,BRD-A29260609-003-25-2,acebutolol,Selleck,S4010,Acebutolol HCl,-9.713871,x0104,4.214701,active-noncovalent
c1cc(c(c2c1[C@H]3c4cc(c(cc4C[C@]3(CO2)O)O)O)O)O,BRD-K78342372-001-02-4,hematoxylin,Selleck,S2384,Hematoxylin,-9.711901,x0195,-0.812944,active-noncovalent
c1cc(c(c2c1[C@H]3c4cc(c(cc4C[C@]3(CO2)O)O)O)O)O,BRD-K78342372-001-03-2,hematoxylin,Selleck,S2384,Hematoxylin (Hydroxybrazilin),-9.711901,x0195,-0.812944,active-noncovalent
c1ccc(cc1)C(=O)Nc2ccc3c(c2)cc[nH]3,BRD-K18305454-001-07-4,OAC2,MedChemEx,HY-12884,OAC2,-9.711063,x0749,1.961773,active-covalent
c1cc(ccc1CCC(=O)c2c(cc(cc2O)O)O)O,BRD-K15563106-001-18-0,phloretin,Selleck,S2342,Phloretin,-9.710749,x1093,-1.44435,active-noncovalent
CC[n+]1c2cc(ccc2c3ccc(cc3c1c4ccccc4)N)N,BRD-K28354016-004-11-7,homidium,MicroSource,1503806,HOMIDIUM BROMIDE,-9.710552,x0195,1.306724,active-noncovalent
COc1cc(cc(c1)OC)NC(=O)c2ccc(o2)c3ccc(cc3)Cl,BRD-K28570407-001-04-6,A-803467,Tocris,2976,A 803467,-9.708751,x0161,6.466524,active-noncovalent
COc1cc(cc(c1)OC)NC(=O)c2ccc(o2)c3ccc(cc3)Cl,BRD-K28570407-001-02-0,A-803467,Selleck,S2785,A-803467,-9.708751,x0161,6.466524,active-noncovalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,BRD-K81473089-003-25-3,tacrine,Tocris,965,Tacrine hydrochloride,-9.708664,x0749,-0.8857,active-covalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,BRD-K81473089-003-26-1,tacrine,MicroSource,2300104,TACRINE HYDROCHLORIDE,-9.708664,x0749,-0.8857,active-covalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,BRD-K81473089-003-24-6,tacrine,Selleck,S4357,Tacrine HCl,-9.708664,x0749,-0.8857,active-covalent
c1cc(ccc1c2c(c3ccc(cc3s2)O)C(=O)c4ccc(cc4)OCC[NH+]5CCCCC5)O,BRD-K63828191-003-33-9,raloxifene,Tocris,2280,Raloxifene hydrochloride,-9.704288,x0161,5.508389,active-noncovalent
c1cc(ccc1c2c(c3ccc(cc3s2)O)C(=O)c4ccc(cc4)OCC[NH+]5CCCCC5)O,BRD-K63828191-003-32-1,raloxifene,Selleck,S1227,Raloxifene HCl,-9.704288,x0161,5.508389,active-noncovalent
c1cc(ccc1c2c(c3ccc(cc3s2)O)C(=O)c4ccc(cc4)OCC[NH+]5CCCCC5)O,BRD-K63828191-003-35-4,raloxifene,Tocris,2280,Raloxifene hydrochloride,-9.704288,x0161,5.508389,active-noncovalent
c1cc(ccc1c2c(c3ccc(cc3s2)O)C(=O)c4ccc(cc4)OCC[NH+]5CCCCC5)O,BRD-K63828191-003-34-7,raloxifene,MicroSource,1505622,RALOXIFENE HYDROCHLORIDE,-9.704288,x0161,5.508389,active-noncovalent
c1ccc2c(c1)nc-3c4c(=O)cc([nH]c4c(=O)cc3o2)C(=O)[O-],BRD-K65992024-001-01-5,pirenoxine,AKSci,H039,,-9.702729,x0749,1.791596,active-covalent
Cc1c2ccc(c(c2c[n+]3c1-c4cc(c(cc4CC3)OC)OC)OC)OC,BRD-K67186445-001-02-1,dehydrocorydaline,MedChemEx,HY-N0674,Dehydrocorydaline,-9.700160,x0161,3.304695,active-noncovalent
Cc1c2ccc(c(c2c[n+]3c1-c4cc(c(cc4CC3)OC)OC)OC)OC,BRD-K67186445-001-01-3,dehydrocorydaline,MedChemEx,HY-N0674,"2,3,9,10-tetramethoxy-13-methyl-5H,6H-isoquino[3,2-a]isoquinolinium",-9.700160,x0161,3.304695,active-noncovalent
c1ccc(c(c1)C[NH2+]Cc2ccc(cc2)c3ccnc4c3cc[nH]4)F,BRD-K98736329-300-01-5,OXA-06,Tocris,5182,OXA 06 dihydrochloride,-9.694568,x1077,1.522121,active-noncovalent
C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,BRD-K99615199-001-18-5,medroxyprogesterone,MedChemEx,HY-B0648,Medroxyprogesterone,-9.692704,x0749,1.680111,active-covalent
c1ccc(c(c1)C(=O)OC[C@@H](CO)O)Nc2ccnc3c2ccc(c3)Cl,BRD-A38076815-003-10-3,glafenine,Selleck,S4362,Glafenine HCl,-9.691914,x0107,1.842393,active-noncovalent
c1ccc(c(c1)C(=O)OC[C@@H](CO)O)Nc2ccnc3c2ccc(c3)Cl,BRD-A38076815-001-04-0,glafenine,MicroSource,1500996,GLAFENINE,-9.691914,x0107,1.842393,active-noncovalent
Cc1cc(nc(c1N)C#Cc2cccc(c2)F)C,BRD-K77911775-003-01-8,ADX-10059,Tocris,4416,ADX 10059 hydrochloride,-9.691592,x0749,0.637403,active-covalent
C[C@@H]1CCC[N@H+]1CCc2cc3cc(ccc3o2)c4ccc(cc4)C#N,BRD-K22749967-046-02-3,ABT-239,Axon,1510,,-9.690766,x0161,3.817131,active-noncovalent
c1cc2c(ccc(n2)NCC[NH2+]CCO)c(c1)NC(=O)CC34CC5CC(C3)CC(C5)C4,BRD-K09907507-300-01-4,AZ-10606120,Tocris,3323,AZ 10606120 dihydrochloride,-9.688072,x0104,7.728884,active-noncovalent
c1ccc2c(c1)CCN3[C@@H]2CN(CC3=O)C(=O)C4CCCCC4,BRD-A21858158-001-23-5,praziquantel,MicroSource,1500494,PRAZIQUANTEL,-9.687691,x0195,0.903948,active-noncovalent
c1ccc2c(c1)CCN3[C@@H]2CN(CC3=O)C(=O)C4CCCCC4,BRD-A21858158-001-22-7,praziquantel,Selleck,S1691,Praziquantel,-9.687691,x0195,0.903948,active-noncovalent
CCCCC[C@@H](c1cccc(c1)OCc2ccc3ccccc3n2)O,BRD-A68281735-001-18-6,REV-5901,Enzo,EI209,REV-5901,-9.686962,x0161,3.373713,active-noncovalent
c1ccc(cc1)CNC(=O)Cn2ccnc2N(=O)=O,BRD-K56156805-001-09-6,benznidazole,Toronto,B197925,Benznidazole,-9.686180,x1093,-0.301184,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K77175907-001-08-0,calcifediol,Adooq,A11367,"(3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol",-9.685010,x0104,8.344453,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K77175907-002-01-3,calcifediol,MedChemEx,HY-32351A,Calcifediol (monohydrate),-9.685010,x0104,8.344453,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K77175907-001-10-6,calcifediol,Selleck,S1469,Calcifediol,-9.685010,x0104,8.344453,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K77175907-001-06-4,calcifediol,Selleck,S1469,Calcifediol,-9.685010,x0104,8.344453,active-noncovalent
c1cc(cc(c1)I)C[NH+]=C(N)N,BRD-K43860855-065-10-1,iobenguane,Prestwick,Prestw-490,Iobenguane sulfate,-9.684940,x0195,-1.508049,active-noncovalent
c1cc(cc(c1)I)C[NH+]=C(N)N,BRD-K43860855-065-11-9,iobenguane,Axon,1750,,-9.684940,x0195,-1.508049,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,BRD-K54262262-001-12-4,monobenzone,Sigma,1445506,4-(benzyloxy)phenol,-9.683814,x0072,-1.323426,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,BRD-K54262262-001-10-8,monobenzone,MicroSource,1503031,MONOBENZONE,-9.683814,x0072,-1.323426,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,BRD-K54262262-001-11-6,monobenzone,Selleck,S1652,Monobenzone (Benoquin),-9.683814,x0072,-1.323426,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,BRD-K54262262-001-09-0,monobenzone,Selleck,S1652,Monobenzone,-9.683814,x0072,-1.323426,active-noncovalent
C[C@H](c1ccnc2n1ncn2)Oc3ccc(cc3)Cl,BRD-A65793993-001-01-6,BTS-72664,Key,1D-092,"7-[1-(4-chlorophenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidine",-9.683633,x0749,0.110325,active-covalent
CCCNC(=O)N1[C@H](c2cc3c(cc2C(=N1)c4ccc(cc4)N)OCO3)C,BRD-A77218119-001-03-5,SYM-2206,Tocris,961,SYM 2206,-9.681863,x0708,1.73176,active-covalent
CCCNC(=O)N1[C@H](c2cc3c(cc2C(=N1)c4ccc(cc4)N)OCO3)C,BRD-A77218119-001-04-3,SYM-2206,Tocris,961,"8-(4-aminophenyl)-5-methyl-N-propyl[1,3]dioxolo[4,5-g]phthalazine-6(5H)-carboxamide",-9.681863,x0708,1.73176,active-covalent
CCCCc1[nH+]cc(n1Cc2ccc(cc2)C(=O)[O-])/C=C(\Cc3cccs3)/C(=O)[O-],BRD-K67977190-066-02-3,eprosartan,Selleck,S4102,Eprosartan Mesylate,-9.675870,x0678,3.910428,active-noncovalent
CCCCc1[nH+]cc(n1Cc2ccc(cc2)C(=O)[O-])/C=C(\Cc3cccs3)/C(=O)[O-],BRD-K67977190-066-03-1,eprosartan,Selleck,S4102,Eprosartan Mesylate,-9.675870,x0678,3.910428,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Cl)C(=O)[O-])[NH3+],BRD-K20338176-001-16-9,cefaclor,Selleck,S1499,Cefaclor (Ceclor),-9.675651,x0830,1.250269,active-covalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Cl)C(=O)[O-])[NH3+],BRD-K20338176-001-17-7,cefaclor,MicroSource,1500771,CEFACLOR,-9.675651,x0830,1.250269,active-covalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Cl)C(=O)[O-])[NH3+],BRD-K20338176-001-18-5,cefaclor,Selleck,S1499,Cefaclor (Ceclor),-9.675651,x0830,1.250269,active-covalent
c1ccc2c(c1)N(c3cc(ccc3S2)C(F)(F)F)CCC[NH+]4CCN(CC4)CCO,BRD-K55127134-300-11-2,fluphenazine,MicroSource,1500994,FLUPHENAZINE HYDROCHLORIDE,-9.674680,x0161,3.017633,active-noncovalent
c1ccc2c(c1)Nc3ccccc3S2,BRD-K59597909-001-20-0,phenothiazine,Selleck,S4251,Phenothiazine,-9.673660,x0749,-0.599137,active-covalent
c1ccc2c(c1)Nc3ccccc3S2,BRD-K59597909-001-17-6,phenothiazine,Selleck,S4251,Phenothiazine,-9.673660,x0749,-0.599137,active-covalent
c1ccc2c(c1)Nc3ccccc3S2,BRD-K59597909-001-19-2,phenothiazine,MicroSource,1506171,PHENOTHIAZINE,-9.673660,x0749,-0.599137,active-covalent
c1ccc(cc1)c2c(oc(n2)CCC(=O)[O-])c3ccccc3,BRD-K25394294-001-13-1,oxaprozin,Selleck,S4230,Oxaprozin,-9.672239,x0678,0.843342,active-noncovalent
c1ccc(cc1)c2c(oc(n2)CCC(=O)[O-])c3ccccc3,BRD-K25394294-001-14-9,oxaprozin,MicroSource,1505267,OXAPROZIN,-9.672239,x0678,0.843342,active-noncovalent
c1cc(ccc1c2csc(n2)Nc3ccc(cc3)O)Cl,BRD-K20755323-001-07-5,SKI-II,Selleck,S7176,SKI II,-9.671947,x1093,1.909609,active-noncovalent
c1cc(ccc1c2csc(n2)Nc3ccc(cc3)O)Cl,BRD-K20755323-001-06-7,SKI-II,Tocris,2097,SKI II,-9.671947,x1093,1.909609,active-noncovalent
c1cc(ccc1c2csc(n2)Nc3ccc(cc3)O)Cl,BRD-K20755323-001-05-9,SKI-II,Selleck,S7176,SKI II,-9.671947,x1093,1.909609,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCN3C(=O)c4ccccc4C3=O,BRD-K69195780-004-08-4,NAN-190,Tocris,553,NAN-190 hydrobromide,-9.671356,x0874,5.486334,active-noncovalent
COc1ccc2c(c1)c(c[nH]2)C3=CC[NH2+]CC3,BRD-K00234327-036-05-1,RU-24969,Tocris,912,RU 24969 hemisuccinate,-9.670182,x0195,-0.003334,active-noncovalent
COc1ccc2c(c1)c(c[nH]2)C3=CC[NH2+]CC3,BRD-K00234327-001-03-0,RU-24969,MedChemEx,HY-16688,RU 24969,-9.670182,x0195,-0.003334,active-noncovalent
COc1ccc2c(c1)c(c[nH]2)C3=CC[NH2+]CC3,BRD-K00234327-001-04-8,RU-24969,MedChemEx,HY-16688,RU 24969,-9.670182,x0195,-0.003334,active-noncovalent
COc1cc(ccc1O)[C@@H]2[C@H](Oc3ccc(cc3O2)[C@@H]4[C@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,BRD-K80353138-001-12-1,silibinin,MicroSource,1505256,SILIBININ,-9.670175,x0104,6.968444,active-noncovalent
COc1cc(ccc1O)[C@@H]2[C@H](Oc3ccc(cc3O2)[C@@H]4[C@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,BRD-K80353138-001-16-2,silibinin,Selleck,S2357,Silibinin,-9.670175,x0104,6.968444,active-noncovalent
COc1cc(ccc1O)[C@@H]2[C@H](Oc3ccc(cc3O2)[C@@H]4[C@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,BRD-K80353138-001-13-9,silibinin,Selleck,S2357,Silibinin (Silybin),-9.670175,x0104,6.968444,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,BRD-K83551379-001-02-6,levodropropizine,Selleck,S4131,Levodropropizine,-9.670128,x0749,-0.375974,active-covalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,BRD-A29349577-001-24-8,dropropizine,Selleck,S4138,Dropropizine,-9.670128,x0749,-0.375974,active-covalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,BRD-A29349577-001-22-2,dropropizine,Selleck,S4138,Dropropizine,-9.670128,x0749,-0.375974,active-covalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,BRD-K83551379-001-01-8,levodropropizine,Selleck,S4131,Levodropropizine,-9.670128,x0749,-0.375974,active-covalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,BRD-A29349577-001-23-0,dropropizine,MicroSource,1501004,DROPROPIZINE,-9.670128,x0749,-0.375974,active-covalent
COc1ccc2c(ccnc2c1)NC(=O)Nc3cccc(n3)C(F)(F)F,BRD-K70329400-001-02-5,A-1070722,Tocris,4431,A 1070722,-9.668767,x0104,4.06142,active-noncovalent
c1cc2c(cc1C[NH+]3CCOCC3)[nH]c(n2)c4c(c[nH]n4)NC(=O)NC5CC5,BRD-K24576554-001-04-8,AT-9283,Selleck,S1134,AT9283,-9.668016,x0161,3.993569,active-noncovalent
Cc1cccc(c1NC(=O)CN2CCCC2=O)C,BRD-K65678996-001-05-5,nefiracetam,MicroSource,1502315,NEFIRACETAM,-9.661541,x0678,-0.706852,active-noncovalent
Cc1cccc(c1NC(=O)CN2CCCC2=O)C,BRD-K65678996-001-04-8,nefiracetam,Selleck,S1969,Nefiracetam,-9.661541,x0678,-0.706852,active-noncovalent
Cc1cccc(c1NC(=O)CN2CCCC2=O)C,BRD-K65678996-001-09-7,nefiracetam,Tocris,2851,Nefiracetam,-9.661541,x0678,-0.706852,active-noncovalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-33-2,phenindione,MedChemEx,HY-B0325,Phenindione,-9.660164,x0749,1.590353,active-covalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-29-0,phenindione,Selleck,S1921,Phenindione (Rectadione),-9.660164,x0749,1.590353,active-covalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-27-4,phenindione,Selleck,S1921,Phenindione,-9.660164,x0749,1.590353,active-covalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-31-6,phenindione,Sigma,1522006,3-hydroxy-2-phenyl-1H-inden-1-one,-9.660164,x0749,1.590353,active-covalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-32-4,phenindione,MedChemEx,HY-B0325,Phenindione,-9.660164,x0749,1.590353,active-covalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K70592963-001-28-2,phenindione,MicroSource,1500477,PHENINDIONE,-9.660164,x0749,1.590353,active-covalent
COc1cc(cc(c1O)CSc2nc3ccccc3s2)/C=C(\C#N)/C(=O)N,BRD-K87919739-001-07-5,tyrphostin-AG-825,Tocris,1555,AG 825,-9.659269,x0749,3.521039,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)/[NH+]=C/N3CCCCCC3)C(=O)[O-])C,BRD-K41051431-001-02-4,amdinocillin,Sigma,MFCD00056869,"(2S,5R,6R)-6-{[(E)-1-azepanylmethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",-9.659259,x0831,0.590602,active-covalent
CCC[N@@H+]1CCC[C@@H](C1)c2cccc(c2)O,BRD-K02908048-003-06-4,preclamol,SantaCruz,sc-253355,,-9.658097,x0195,-1.33248,active-noncovalent
CCOC(=O)COc1ccc2c(c1)C[C@H](CC2)[NH2+]C[C@@H](c3cccc(c3)Cl)O,BRD-K24610819-003-01-8,amibegron,Sigma,MFCD00886563,"ethyl [((7S)-7-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-5,6,7,8-tetrahydro-2-naphthalenyl)oxy]acetate hydrochloride",-9.657269,x0161,4.280067,active-noncovalent
CCOC(=O)COc1ccc2c(c1)C[C@H](CC2)[NH2+]C[C@@H](c3cccc(c3)Cl)O,BRD-K24610819-003-02-6,amibegron,Tocris,3986,SR 58611A,-9.657269,x0161,4.280067,active-noncovalent
c1cc(ccc1CC/C(=C\F)/C[NH3+])F,BRD-K52598503-003-02-9,mofegiline,MedChemEx,HY-16677A,Mofegiline (hydrochloride),-9.656326,x0749,-0.90758,active-covalent
c1cc(ccc1CC/C(=C\F)/C[NH3+])F,BRD-K52598503-003-01-1,mofegiline,MedChemEx,HY-16677A,Mofegiline (hydrochloride),-9.656326,x0749,-0.90758,active-covalent
c1cc(ccc1/C=C\2/C(=O)NC(=[NH2+])S2)O,BRD-K55420858-001-02-8,mirin,Tocris,3190,Mirin,-9.653940,x0678,-0.559075,active-noncovalent
c1ccc(cc1)COC(=O)c2ccccc2,BRD-K52072429-001-12-9,benzyl-benzoate,MedChemEx,HY-B0935,Benzyl benzoate,-9.652701,x0749,-1.260888,active-covalent
c1ccc(cc1)COC(=O)c2ccccc2,BRD-K52072429-001-10-3,benzyl-benzoate,MicroSource,1503002,BENZYL BENZOATE,-9.652701,x0749,-1.260888,active-covalent
c1ccc(cc1)COC(=O)c2ccccc2,BRD-K52072429-001-11-1,benzyl-benzoate,Sigma,B6630,benzyl benzoate,-9.652701,x0749,-1.260888,active-covalent
c1ccc2c(c1)cc(s2)c3ccnc(n3)Nc4ccc(cc4)C(=O)N5CCC(CC5)[NH+]6CCCC6,BRD-K14618467-003-02-6,IKK-16,Tocris,2539,IKK 16,-9.651804,x0161,13.901079,active-noncovalent
c1ccc2c(c1)cc(s2)c3ccnc(n3)Nc4ccc(cc4)C(=O)N5CCC(CC5)[NH+]6CCCC6,BRD-K14618467-001-04-6,IKK-16,Selleck,S2882,IKK-16 (IKK Inhibitor VII),-9.651804,x0161,13.901079,active-noncovalent
c1ccc2c(c1)cc(s2)c3ccnc(n3)Nc4ccc(cc4)C(=O)N5CCC(CC5)[NH+]6CCCC6,BRD-K14618467-003-03-4,IKK-16,Tocris,2539,IKK 16,-9.651804,x0161,13.901079,active-noncovalent
CCOc1ccc2c(c1)c(c3ccc(cc3[nH+]2)N)N,BRD-K24715592-406-02-1,ethacridine-lactate-monohydrate,Selleck,S4196,Ethacridine lactate monohydrate,-9.650339,x0749,2.246255,active-covalent
CCOc1ccc2c(c1)c(c3ccc(cc3[nH+]2)N)N,BRD-K24715592-043-02-2,ethacridine-lactate-monohydrate,MicroSource,1505168,ETHACRIDINE LACTATE,-9.650339,x0749,2.246255,active-covalent
CCOc1ccc2c(c1)c(c3ccc(cc3[nH+]2)N)N,BRD-K24715592-406-01-3,ethacridine-lactate-monohydrate,Selleck,S4196,Ethacridine lactate monohydrate,-9.650339,x0749,2.246255,active-covalent
C=CCc1ccc(c(c1)c2ccc(c(c2)CC=C)O)O,BRD-K98493452-001-14-9,honokiol,Selleck,S2310,Honokiol,-9.649654,x0195,-0.08568,active-noncovalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,BRD-K90333595-066-16-1,phentolamine,Selleck,S2038,Phentolamine Mesylate,-9.647328,x0195,-0.221598,active-noncovalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,BRD-K90333595-003-22-2,phentolamine,Enzo,AC121,Phentolamine,-9.647328,x0195,-0.221598,active-noncovalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,BRD-K90333595-066-17-9,phentolamine,Selleck,S2038,Phentolamine Mesylate,-9.647328,x0195,-0.221598,active-noncovalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,BRD-K90333595-003-21-4,phentolamine,MicroSource,1500691,PHENTOLAMINE HYDROCHLORIDE,-9.647328,x0195,-0.221598,active-noncovalent
c1c(nc[nH]1)C[C@H](C(=O)[O-])[NH3+],BRD-K36449075-001-01-0,copper-histidine,Enzo,AC1014,D-Histidine,-9.647011,x0397,-1.848435,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],BRD-A68509429-003-03-9,ethylnorepinephrine,MicroSource,1504088,ETHYLNOREPINEPHRINE HYDROCHLORIDE,-9.646006,x0195,-1.374392,active-noncovalent
c1ccc(cc1)NNC(=O)c2ccncc2,BRD-K99149715-001-01-6,plurisin-#1,Selleck,S8076,PluriSIn #1 (NSC 14613),-9.645025,x0749,-0.804081,active-covalent
c1ccc(cc1)NNC(=O)c2ccncc2,BRD-K99149715-001-02-4,plurisin-#1,Selleck,S8076,PluriSIn #1 (NSC 14613),-9.645025,x0749,-0.804081,active-covalent
c1ccc(cc1)NNC(=O)c2ccncc2,BRD-K99149715-001-03-2,plurisin-#1,Tocris,4847,PluriSln 1,-9.645025,x0749,-0.804081,active-covalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4ccccn4)NCCC(=O)[O-],BRD-K32847255-001-01-1,GSK-J1,MedChemEx,HY-15648,GSK-J1,-9.643823,x1077,5.709632,active-noncovalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4ccccn4)NCCC(=O)[O-],BRD-K32847255-001-02-9,GSK-J1,Tocris,4593,GSK J1,-9.643823,x1077,5.709632,active-noncovalent
C[N@H+]1CCC[C@@H]1c2cccnc2,BRD-A93695607-322-01-7,nicotine,Selleck,S4370,Nicotine Ditartrate,-9.642485,x0678,-2.26734,active-noncovalent
C[N@H+]1CCC[C@@H]1c2cccnc2,BRD-A93695607-322-02-5,nicotine,Selleck,S4370,nicotine ditartrate,-9.642485,x0678,-2.26734,active-noncovalent
c1ccc2c(c1)cc(c(c2Cc3c4ccccc4cc(c3O)C(=O)[O-])O)C(=O)[O-],BRD-K82118441-001-03-7,pyrantel,Sigma,MFCD00004079,"4,4'-methylenebis(3-hydroxy-2-naphthoic acid)",-9.639339,x0830,2.058951,active-covalent
CC(C)Oc1cc(ccc1C2=[NH+][C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)c4ccc(cc4)Cl)c5ccc(cc5)Cl)OC,BRD-K73255294-001-02-8,nutlin-3,Tocris,3984,Nutlin-3,-9.638498,x1077,7.082031,active-noncovalent
Cc1c2cc(ccc2n[nH]1)c3cc(cnc3)OC[C@H](Cc4ccccc4)[NH3+],BRD-K78177893-001-02-4,A-674563,Selleck,S2670,A-674563,-9.633895,x0107,3.01297,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,BRD-K89997465-003-43-0,chlorpromazine,Selleck,S2456,Chlorpromazine HCl,-9.633637,x0161,0.366644,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,BRD-K89997465-003-44-8,chlorpromazine,Selleck,S2456,Chlorpromazine (Sonazine),-9.633637,x0161,0.366644,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,BRD-K89997465-001-10-3,chlorpromazine,MicroSource,1500184,CHLORPROMAZINE,-9.633637,x0161,0.366644,active-noncovalent
CCOc1ccccc1/N=N/c2c([nH]n(c2=O)c3nc(cs3)c4ccccc4)C,BRD-K07442505-001-03-6,BAM7,Selleck,S7105,BAM7,-9.632661,x0104,8.060823,active-noncovalent
c1cc(ccc1C#N)N2CCN(CC2)C(=O)COc3ccc4c(c3)c(c[nH]4)CC[NH3+],BRD-K31092604-003-03-5,donitriptan,Tocris,3665,Donitriptan hydrochloride,-9.632194,x0104,6.022067,active-noncovalent
C[C@]12c3ccccc3C[C@H]([NH2+]1)c4c2cccc4,BRD-K23163214-051-01-9,dizocilpine-(-),Selleck,S2876,(-)-MK 801 Maleate,-9.631378,x0072,-0.074089,active-noncovalent
C[C@]12c3ccccc3C[C@H]([NH2+]1)c4c2cccc4,BRD-K23163214-050-15-1,dizocilpine-(-),Tocris,955,(-)-MK 801 maleate,-9.631378,x0072,-0.074089,active-noncovalent
C[C@H](c1ccccc1)Nc2c3cc([nH]c3ncn2)c4ccc(cc4)O,BRD-K10115470-001-01-8,PKI-166,Sigma,SML1095,"4-(4-{[(1R)-1-phenylethyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenol",-9.631264,x0946,3.159422,active-noncovalent
CN([C@H](C[NH+]1CCCC1)c2ccccc2)C(=O)Cc3ccc(c(c3)Cl)Cl,BRD-K73290745-003-02-6,ICI-199441,Tocris,778,"ICI 199,441 hydrochloride",-9.630332,x1093,2.062447,active-noncovalent
CN([C@H](C[NH+]1CCCC1)c2ccccc2)C(=O)Cc3ccc(c(c3)Cl)Cl,BRD-K73290745-003-03-4,ICI-199441,Tocris,778,"ICI 199,441 hydrochloride",-9.630332,x1093,2.062447,active-noncovalent
CC1(C(=O)N(C(=O)N1CCCCO)c2ccc(c(c2)C(F)(F)F)C#N)C,BRD-K62762455-001-01-3,RU-58841,MedChemEx,HY-10561,RU 58841,-9.630137,x0749,2.607344,active-covalent
c1ccc(cc1)S(=O)(=O)c2cc3cccc(c3nc2)N4CC[NH2+]CC4,BRD-K78941306-001-02-4,SB-742457,Selleck,S2894,SB742457,-9.629297,x0195,2.173701,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2cc3cccc(c3nc2)N4CC[NH2+]CC4,BRD-K78941306-001-03-2,SB-742457,Selleck,S2894,SB-742457,-9.629297,x0195,2.173701,active-noncovalent
Cc1ccc(c(c1)OC[C@H](C[NH2+]C(C)C)O)Cl,BRD-A95802703-001-01-0,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,Enamine,Z1672746675,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,-9.622923,x0195,-1.040045,active-noncovalent
c1ccc2c(c1)cc3ccccc3c2C(=O)N4CCC(CC4)[N@@H+]5CCC[C@H](C5)C(=O)N6CCOCC6,BRD-K26921335-003-01-2,CP-640186,MedChemEx,HY-15259A,CP-640186 (hydrochloride),-9.622921,x0161,6.52006,active-noncovalent
CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,BRD-K78352627-001-02-6,nandrolone-decanoate,MedChemEx,HY-13698,Nandrolone decanoate,-9.619976,x0161,8.446896,active-noncovalent
CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,BRD-K78352627-001-01-8,nandrolone-decanoate,MedChemEx,HY-13698,Nandrolone decanoate,-9.619976,x0161,8.446896,active-noncovalent
COc1cc2c(cc1OC)N3[C@@H]4[C@]25CC[N@@H+]6[C@H]5C[C@@H]7[C@H]4[C@H](CC3=O)OCC=C7C6,BRD-A41995253-330-02-2,brucine,Selleck,S4390,brucine,-9.618737,x0195,2.562789,active-noncovalent
COc1cc2c(cc1OC)N3[C@@H]4[C@]25CC[N@@H+]6[C@H]5C[C@@H]7[C@H]4[C@H](CC3=O)OCC=C7C6,BRD-A41995253-330-01-4,brucine,Selleck,S4390,Brucine,-9.618737,x0195,2.562789,active-noncovalent
COc1cc2c(cc1OC)N3[C@@H]4[C@]25CC[N@@H+]6[C@H]5C[C@@H]7[C@H]4[C@H](CC3=O)OCC=C7C6,BRD-A41995253-001-04-5,brucine,MicroSource,1500822,BRUCINE,-9.618737,x0195,2.562789,active-noncovalent
B1(c2ccc(cc2CO1)Oc3ccc(cc3)C#N)O,BRD-K43230258-001-01-4,crisaborole,MedChemEx,HY-10978,AN-2728,-9.617744,x1093,0.45179,active-noncovalent
Cc1ccc2c(c1)C(=O)[C@@]3(CCN(C3=[NH+]2)c4ccccc4)O,BRD-K61295575-001-03-6,blebbistatin-(-),Selleck,S7099,(-)-Blebbistatin,-9.617001,x0195,0.142535,active-noncovalent
COc1cc2c(cc1OC)C(=O)[C@H](C2)CC3CC[NH+](CC3)Cc4ccccc4,BRD-A49160188-003-11-9,donepezil,Selleck,S2462,Donepezil HCl (Aricept),-9.616495,x0104,7.849714,active-noncovalent
COc1cc2c(cc1OC)C(=O)[C@H](C2)CC3CC[NH+](CC3)Cc4ccccc4,BRD-A49160188-003-12-7,donepezil,MicroSource,1504403,DONEPEZIL HYDROCHLORIDE,-9.616495,x0104,7.849714,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,BRD-K12329651-001-18-8,androsterone,Prestwick,Prestw-411,Androsterone,-9.616280,x0749,0.851918,active-covalent
C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@]2(C)O)CC[C@@H]4[C@]3(CC(=C(C4)O)C=O)C,BRD-A93291428-001-02-0,oxymetholone,Selleck,S4087,Oxymetholone,-9.616058,x1077,2.054927,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(C3CC[NH2+]CC3)O,BRD-K97061094-001-21-4,azacyclonol,Selleck,S3196,Azacyclonol,-9.615924,x1418,-1.311391,active-covalent
c1ccc(cc1)C(c2ccccc2)(C3CC[NH2+]CC3)O,BRD-K97061094-001-20-6,azacyclonol,Selleck,S3196,Azacyclonol,-9.615924,x1418,-1.311391,active-covalent
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C,BRD-K60585088-001-01-5,paricalcitol,MedChemEx,HY-50919,Paricalcitol,-9.615711,x0104,6.202452,active-noncovalent
c1ccc(cc1)c2cc([nH]c(=O)c2C#N)c3cc(ccc3O)Br,BRD-K08902330-001-01-3,TCS-PIM-1-1,Tocris,2979,TCS PIM-1 1,-9.615360,x0195,0.171119,active-noncovalent
CC(C)n1c2c(c(n1)C#Cc3ccccc3)c(ncn2)N,BRD-K63253858-001-01-5,SPP-86,Tocris,5391,SPP 86,-9.614809,x0678,0.679026,active-noncovalent
c1cc(cc(c1)N2CC[NH+](CC2)CCNC(=O)N)C(F)(F)F,BRD-K44091134-001-01-9,fluprazine,Enamine,Z432843176,N-(2-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)urea,-9.612432,x0161,1.210968,active-noncovalent
CN1c2ccc(cc2[C@@H](N=CC1=O)c3ccccc3)Cl,BRD-K16508793-001-05-9,diazepam,Enzo,AC3093,DIAZEPAM (DEA license),-9.608867,x1077,-0.10396,active-noncovalent
c1cc(ccc1n2cc(c(=O)c3c2cc(c(c3)F)N4CC[NH2+]CC4)C(=O)[O-])F,BRD-K08525451-003-05-2,sarafloxacin,Selleck,S1977,Sarafloxacin HCl,-9.608677,x0434,4.812564,active-noncovalent
c1cc(ccc1n2cc(c(=O)c3c2cc(c(c3)F)N4CC[NH2+]CC4)C(=O)[O-])F,BRD-K08525451-003-06-0,sarafloxacin,MicroSource,1505314,SARAFLOXACIN HYDROCHLORIDE,-9.608677,x0434,4.812564,active-noncovalent
Cc1c(cccc1C(F)(F)F)Cn2c(nc3c2cc(cc3C(=O)[O-])N4CCOCC4)C,BRD-K49215523-001-04-2,GSK2636771,Selleck,S8002,GSK2636771,-9.607597,x0195,4.250839,active-noncovalent
Cc1c(cccc1C(F)(F)F)Cn2c(nc3c2cc(cc3C(=O)[O-])N4CCOCC4)C,BRD-K49215523-001-05-9,GSK2636771,Selleck,S8002,GSK2636771,-9.607597,x0195,4.250839,active-noncovalent
c1ccnc(c1)NCc2ccc(cc2)CNc3ccccn3,BRD-K25359048-001-02-6,WZ811,Selleck,S2912,WZ811,-9.606249,x0107,1.923349,active-noncovalent
Cc1c(c2ccccn2c1C(=O)c3ccc(c(c3)C(=O)[O-])N)OC,BRD-K65890018-236-01-1,SSR128129E,Selleck,S7167,SSR128129E,-9.605569,x0967,2.029438,active-noncovalent
c1cc(c(cc1/N=N/c2ccc(c(c2)C(=O)[O-])O)C(=O)[O-])O,BRD-K57853941-304-02-5,olsalazine,Selleck,S4041,Olsalazine Sodium,-9.605501,x0749,4.426299,active-covalent
c1cc(c(cc1/N=N/c2ccc(c(c2)C(=O)[O-])O)C(=O)[O-])O,BRD-K57853941-304-03-3,olsalazine,MicroSource,1502389,OLSALAZINE SODIUM,-9.605501,x0749,4.426299,active-covalent
CC1(CCC(c2c1cc3c(c2)N(c4ccccc4C(=N3)c5ccc(cc5)C(=O)[O-])C)(C)C)C,BRD-K06593056-001-04-8,LE-135,Tocris,2021,LE 135,-9.604280,x0104,5.359834,active-noncovalent
CC1(CCC(c2c1cc3c(c2)N(c4ccccc4C(=N3)c5ccc(cc5)C(=O)[O-])C)(C)C)C,BRD-K06593056-001-05-5,LE-135,Tocris,2021,LE 135,-9.604280,x0104,5.359834,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-21-5,ampicillin,Selleck,S3170,Ampicillin sodium,-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-24-9,ampicillin,MedChemEx,HY-B0522A,Ampicillin (sodium),-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-341-05-6,ampicillin,Selleck,S4148,Ampicillin Trihydrate,-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-341-07-2,ampicillin,Selleck,S4148,Ampicillin Trihydrate,-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-23-1,ampicillin,MedChemEx,HY-B0522A,Ampicillin (sodium),-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-22-3,ampicillin,Sigma,MFCD00064313,"sodium (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-19-9,ampicillin,Selleck,S3170,Ampicillin sodium,-9.604071,x0831,2.141502,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,BRD-K68432770-236-20-7,ampicillin,MicroSource,1500123,AMPICILLIN SODIUM,-9.604071,x0831,2.141502,active-covalent
c1cc(ccc1Nc2nccc(n2)N3CCCc4c3ccc(c4)O)S(=O)(=O)NCC5CC5,BRD-K94659840-001-01-7,pyrintegrin,Tocris,4978,Pyrintegrin,-9.601891,x0161,6.383343,active-noncovalent
C[C@@H](c1cccc(c1)Br)/N=N/C(=O)[C@H]2[C@@H](CNC2=O)c3ccccc3,BRD-K81548480-001-01-2,AC-264613,Tocris,3370,AC 264613,-9.600739,x0831,1.725997,active-covalent
C[C@@H](c1cccc(c1)Br)/N=N/C(=O)[C@H]2[C@@H](CNC2=O)c3ccccc3,BRD-K81548480-001-02-0,AC-264613,Tocris,3370,AC 264613,-9.600739,x0831,1.725997,active-covalent
COc1ccc2c(ccnc2c1)OCc3nnc4n3nc(cc4)c5ccccc5,BRD-K32285926-001-02-1,AMG-208,MedChemEx,HY-12035,AMG-208,-9.600263,x0195,3.043875,active-noncovalent
[H]/N=C\1/[C@H]([C@@H](c2c(nn(c2O1)C)C)c3ccc(cc3)C(F)(F)F)C#N,BRD-A40257118-001-02-0,BQU57,MedChemEx,HY-12875,BQU57,-9.599390,x0749,0.618214,active-covalent
[H]/N=C\1/[C@H]([C@@H](c2c(nn(c2O1)C)C)c3ccc(cc3)C(F)(F)F)C#N,BRD-A40257118-001-01-2,BQU57,MedChemEx,HY-12875,BQU57,-9.599390,x0749,0.618214,active-covalent
CC(C)c1ccc(c(c1)c2c(=O)[nH]c3ccccc3n2)NC(=O)c4cccs4,BRD-K48188942-001-03-7,ML-281,Tocris,4880,ML 281,-9.597235,x0831,2.558363,active-covalent
c1ccc(cc1)CCNc2nc(cs2)c3ccccc3,BRD-K60798049-001-03-8,fanetizole,Enamine,Z48859353,"N-(2-phenylethyl)-N-(4-phenyl-1,3-thiazol-2-yl)amine",-9.592484,x0434,-0.063811,active-noncovalent
CCCCCCN(CCCCCC)C(=O)Cc1c2ccccc2[nH]c1c3ccc(cc3)F,BRD-K09778810-001-10-6,FGIN-1-27,Tocris,658,FGIN-1-27,-9.589483,x0161,4.896389,active-noncovalent
CCCCCCN(CCCCCC)C(=O)Cc1c2ccccc2[nH]c1c3ccc(cc3)F,BRD-K09778810-001-11-4,FGIN-1-27,Tocris,658,FGIN-1-27,-9.589483,x0161,4.896389,active-noncovalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC,BRD-K44408410-001-21-8,2-methoxyestradiol,Tocris,1807,2-Methoxyestradiol,-9.589324,x0749,0.90287,active-covalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC,BRD-K44408410-001-17-6,2-methoxyestradiol,Tocris,1807,2-Methoxyestradiol,-9.589324,x0749,0.90287,active-covalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC,BRD-K44408410-001-22-6,2-methoxyestradiol,Selleck,S1233,2-Methoxyestradiol (2-MeOE2),-9.589324,x0749,0.90287,active-covalent
Cc1nnc2n1nc(cc2)c3cccc(c3)C(F)(F)F,BRD-K00662280-001-10-2,CL-218872,Tocris,1709,CL 218872,-9.588747,x0749,0.496702,active-covalent
Cc1nnc2n1nc(cc2)c3cccc(c3)C(F)(F)F,BRD-K00662280-001-09-4,CL-218872,Tocris,1709,CL 218872,-9.588747,x0749,0.496702,active-covalent
CC(C)c1ccc(cc1)N(Cc2ccc(cc2)N(C)C)C(=O)[C@@H]3CCCc4c3cc(cc4)OC,BRD-A00559310-003-02-9,W-54011,Tocris,5455,W 54011,-9.588084,x0434,5.419119,active-noncovalent
CC(C)c1ccc(cc1)N(Cc2ccc(cc2)N(C)C)C(=O)[C@@H]3CCCc4c3cc(cc4)OC,BRD-A00559310-003-01-1,W-54011,MedChemEx,HY-16992A,W-54011,-9.588084,x0434,5.419119,active-noncovalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N,BRD-K20290250-001-02-1,BIX-02188,Selleck,S1530,BIX 02188,-9.587477,x0830,3.19328,active-covalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N,BRD-K20290250-001-01-3,BIX-02188,Selleck,S1530,BIX 02188,-9.587477,x0830,3.19328,active-covalent
c1cc2c(cc1C(=O)[O-])CC[C@H]3C2=NN([C@H]3C4CCCC4)c5ccc(c(c5)Cl)C#N,BRD-K51041191-001-01-4,PF-03882845,Sigma,PZ0031,"(S)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-2,3,4,5-tetrahydro-1H-benzo[g]indazole-7-carboxylic acid",-9.584240,x0072,3.755108,active-noncovalent
c1ccc2c(c1)c(c(nc2Cl)C(=O)NCC(=O)[O-])O,BRD-K56807945-001-01-2,FG-2216,MedChemEx,HY-15641,FG-2216,-9.583687,x0830,0.767948,active-covalent
c1cc2c(cc1O)[C@@]34CCCC[C@]3([C@@H](C2)[N@H+](CC4)CC5CCC5)O,BRD-K42417338-045-01-9,butorphanol-(+)-tartrate,Enzo,AC3040,BUTORPHANOL-(+)-TARTRATE (DEA license),-9.583044,x0072,0.274361,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@](O2)(C)CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C,BRD-A82892199-001-04-1,alpha-tochopherol,MicroSource,310039,alpha-TOCHOPHEROL [4 mM],-9.583036,x0161,7.297635,active-noncovalent
C[C@]12CC[C@H]3[C@@H]([C@H]1CC[C@]2(C#C)O)CCC4=C3CCC(=O)C4,BRD-A00758722-001-04-9,noretynodrel,MicroSource,1500439,NORETHYNODREL,-9.583004,x0749,0.522822,active-covalent
COc1cc2c(cc1OC)n(cn2)c3cc(c(s3)C(=O)N)OCc4ccccc4C(F)(F)F,BRD-K90382497-001-10-7,GW-843682X,Tocris,2977,GW 843682X,-9.581621,x0161,5.158975,active-noncovalent
COc1cc2c(cc1OC)n(cn2)c3cc(c(s3)C(=O)N)OCc4ccccc4C(F)(F)F,BRD-K90382497-001-13-1,GW-843682X,Tocris,2977,GW 843682X,-9.581621,x0161,5.158975,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)C2=O,BRD-K04851519-001-06-8,aloe-emodin,Selleck,S2259,Aloe-emodin,-9.581317,x0749,1.189861,active-covalent
Cc1ccc2c(c1)C(=O)[C@@]3(CCN(C3=[NH+]2)c4ccccc4)O,BRD-A75817871-001-06-7,blebbistatin-(+/-),Tocris,1760,(?)-Blebbistatin,-9.580956,x0195,1.262414,active-noncovalent
c1ccc2c(c1)c3c([nH]2)-c4nc5ccccc5c(=O)n4CC3,BRD-K94723713-001-10-6,rutaecarpine,Selleck,S2349,Rutaecarpine,-9.580831,x0678,1.086014,active-noncovalent
Cn1c(=O)c(c(nc1NC[C@H](Cc2ccccc2)[NH3+])c3ccncc3)c4ccc5ccccc5c4,BRD-K86673452-001-02-5,AMG-548,Tocris,3920,AMG 548,-9.579217,x0104,7.552876,active-noncovalent
Cn1c(=O)c(c(nc1NC[C@H](Cc2ccccc2)[NH3+])c3ccncc3)c4ccc5ccccc5c4,BRD-K86673452-001-01-7,AMG-548,Tocris,3920,(S)-2-((2-amino-3-phenylpropyl)amino)-3-methyl-5-(naphthalen-2-yl)-6-(pyridin-4-yl)pyrimidin-4(3H)-one,-9.579217,x0104,7.552876,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@H]3CC(=O)NC3,BRD-K75516118-001-04-1,rolipram-R(-),Tocris,1349,(R)-(-)-Rolipram,-9.575525,x0749,0.784718,active-covalent
COc1ccc(cc1OC2CCCC2)[C@H]3CC(=O)NC3,BRD-K75516118-001-03-3,rolipram-R(-),Tocris,1349,(R)-(-)-Rolipram,-9.575525,x0749,0.784718,active-covalent
C1CCC(CC1)/[NH+]=C(\NC23CC4CC(C2)CC(C4)C3)/N5CCOCC5,BRD-K12769093-003-01-3,PNU-37883,Tocris,2095,PNU 37883 hydrochloride,-9.572372,x0678,0.763066,active-noncovalent
C1CCC(CC1)/[NH+]=C(\NC23CC4CC(C2)CC(C4)C3)/N5CCOCC5,BRD-K12769093-003-02-1,PNU-37883,Tocris,2095,PNU 37883 hydrochloride,-9.572372,x0678,0.763066,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccc(cc3[nH]c2O)c4ccccc4)CCC(=O)[O-],BRD-K91106808-001-02-0,SU-16f,Tocris,3304,SU 16f,-9.570639,x0161,7.676448,active-noncovalent
c1(n[n-]nn1)[C@H](C(=O)[O-])[NH3+],BRD-A14757586-001-03-2,tetrazol-5-yl-glycine-(RS),Tocris,312,(RS)-(Tetrazol-5-yl)glycine,-9.570541,x0397,-0.469472,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2ccc(cc2)N)C,BRD-K50859149-001-19-5,sulfafurazole,MicroSource,1500555,SULFISOXAZOLE,-9.569996,x0678,-0.30029,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2ccc(cc2)N)C,BRD-K50859149-001-17-9,sulfafurazole,Selleck,S1916,Sulfisoxazole,-9.569996,x0678,-0.30029,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2ccc(cc2)N)C,BRD-K50859149-001-18-7,sulfafurazole,Tocris,731,Sulfisoxazole,-9.569996,x0678,-0.30029,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2cc(ccc2C#N)F)N3CCC[C@@H](C3)[NH3+],BRD-A88369366-001-01-7,trelagliptin,Selleck,S7513,Trelagliptin,-9.569387,x0434,1.324774,active-noncovalent
CC[N@@+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,BRD-A53561827-004-23-1,pipenzolate,MicroSource,1503053,PIPENZOLATE BROMIDE,-9.568846,x0195,1.352111,active-noncovalent
CC[N@@+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,BRD-A53561827-004-22-3,pipenzolate,Selleck,S4347,Pipenzolate Bromide,-9.568846,x0195,1.352111,active-noncovalent
c1c(cc(c2c1C[C@H](CC2)n3c(c[nH]c3=S)C[NH3+])F)F,BRD-K09126848-003-02-7,nepicastat,Sigma,SML0940,"(S)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1H-imidazole-2-thiol hydrochloride",-9.567325,x0678,-0.540151,active-noncovalent
c1c(cc(c2c1C[C@H](CC2)n3c(c[nH]c3=S)C[NH3+])F)F,BRD-K09126848-003-01-9,nepicastat,MedChemEx,HY-13289A,Nepicastat (hydrochloride),-9.567325,x0678,-0.540151,active-noncovalent
c1c(cc(c2c1C[C@H](CC2)n3c(c[nH]c3=S)C[NH3+])F)F,BRD-K09126848-003-03-5,nepicastat,MedChemEx,HY-13289A,Nepicastat (hydrochloride),-9.567325,x0678,-0.540151,active-noncovalent
c1ccc(cc1)CC[NH2+]Cc2ccccc2,BRD-K13473780-001-02-1,benethamine,Enamine,Z57055797,,-9.567063,x0072,-0.965655,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K35189033-001-29-5,levonorgestrel,Selleck,S1727,Levonorgestrel,-9.566316,x0749,3.520172,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K35189033-001-28-7,levonorgestrel,Tocris,4833,Levonorgestrel,-9.566316,x0749,3.520172,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K35189033-001-30-3,levonorgestrel,Selleck,S1727,Levonorgestrel,-9.566316,x0749,3.520172,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K35189033-001-26-1,levonorgestrel,MicroSource,1502355,LEVONORGESTREL,-9.566316,x0749,3.520172,active-covalent
c1ccc(c(c1)c2nc(no2)c3cccc(c3)C(=O)[O-])F,BRD-K94830329-001-03-0,ataluren,Selleck,S6003,Ataluren (PTC124),-9.564470,x0749,3.35554,active-covalent
C[C@H](c1ccc2cc(ccc2c1)OC)C(=O)Oc3ccc(cc3)C(=S)N,BRD-A52551912-001-02-9,ATB-346,MedChemEx,HY-15028,ATB-346,-9.563510,x0161,2.704202,active-noncovalent
C[C@H](c1ccc2cc(ccc2c1)OC)C(=O)Oc3ccc(cc3)C(=S)N,BRD-A52551912-001-01-1,ATB-346,MedChemEx,HY-15028,ATB-346,-9.563510,x0161,2.704202,active-noncovalent
c1ccc2cc(c(cc2c1)C(=O)/N=N/Cc3ccc(c(c3)O)O)O,BRD-K87718015-001-01-9,dynasore,Selleck,S8047,Dynasore,-9.563156,x0195,0.605744,active-noncovalent
c1ccc2cc(c(cc2c1)C(=O)/N=N/Cc3ccc(c(c3)O)O)O,BRD-K87718015-001-02-7,dynasore,Selleck,S8047,Dynasore,-9.563156,x0195,0.605744,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]CCc3c2cc(c(c3)O)O,BRD-A88548664-004-02-7,SKF-38393,Tocris,922,SKF 38393 hydrobromide,-9.561873,x1418,-1.68357,active-covalent
c1cnc(c2c1n(cn2)[C@@H]3C=C([C@H]([C@H]3O)O)CO)N,BRD-K77791657-003-01-7,3-deazaneplanocin-A,Selleck,S7120,3-deazaneplanocin A (DZNeP) HCl,-9.561747,x0195,-0.353317,active-noncovalent
c1cnc(c2c1n(cn2)[C@@H]3C=C([C@H]([C@H]3O)O)CO)N,BRD-K77791657-001-01-1,3-deazaneplanocin-A,Selleck,S7120,3-Deazaneplanocin A (DZNeP),-9.561747,x0195,-0.353317,active-noncovalent
COC(=O)c1csc(n1)C(=O)c2c[nH]c3c2cccc3,BRD-K60298136-001-03-3,ITE,Tocris,1803,ITE,-9.561477,x0678,0.964467,active-noncovalent
Cc1ccc2c(c1)c(c(c(=O)[nH]2)C3=NN([C@@H](C3)c4ccc(cc4)Br)C(=O)CCC(=O)[O-])c5ccccc5,BRD-A67976398-001-01-6,DQP-1105,Tocris,4491,DQP 1105,-9.560537,x0874,7.101951,active-noncovalent
Cc1cccc(n1)c2c(c[nH]n2)c3ccc4c(n3)cccn4,BRD-K80480517-001-02-4,repsox,Selleck,S7223,RepSox,-9.559493,x0397,0.102325,active-noncovalent
Cc1cccc(n1)c2c(c[nH]n2)c3ccc4c(n3)cccn4,BRD-K80480517-001-04-0,repsox,Tocris,3742,RepSox,-9.559493,x0397,0.102325,active-noncovalent
CCc1c(c2ccccc2o1)C(=O)c3ccc(cc3)OCC(=O)[O-],BRD-K66437909-001-01-0,KT-433,Sigma,MFCD00901289,{4-[(2-ethyl-1-benzofuran-3-yl)carbonyl]phenoxy}acetic acid,-9.558836,x0072,3.339265,active-noncovalent
c1cc(c(cc1c2c(c(=O)c3ccc(cc3o2)O)[O-])O)O,BRD-K31836715-001-06-8,fisetin,Selleck,S2298,Fisetin (Fustel),-9.558637,x0749,1.10974,active-covalent
c1cc(c(cc1c2c(c(=O)c3ccc(cc3o2)O)[O-])O)O,BRD-K31836715-001-05-0,fisetin,Selleck,S2298,Fisetin,-9.558637,x0749,1.10974,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,BRD-K12872829-001-01-0,allylestrenol,ChemImpex,28191,(17beta)-17-allylestr-4-en-17-ol,-9.558498,x0749,2.037395,active-covalent
c1cc(c(cc1C[C@H](C(=O)[O-])OC(=O)/C=C/c2ccc(c(c2)O)O)O)O,BRD-K20313525-001-04-6,rosmarinic-acid,Tocris,630,Rosmarinic acid,-9.556393,x0107,1.822793,active-noncovalent
C[C@@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)[NH2+]C)C)C)O)[NH2+]C,BRD-K27799744-001-02-8,cyclovirobuxin-d,Selleck,S2402,Cyclovirobuxin D (Bebuxine),-9.553797,x0749,3.822775,active-covalent
C[C@@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)[NH2+]C)C)C)O)[NH2+]C,BRD-K27799744-001-03-6,cyclovirobuxin-d,Selleck,S2402,Cyclovirobuxin D,-9.553797,x0749,3.822775,active-covalent
CCC(=O)NS(=O)(=O)c1ccc(cc1)c2c(onc2c3ccccc3)C,BRD-K13800121-001-01-5,parecoxib,MedChemEx,HY-17474,Parecoxib,-9.553621,x0161,3.033468,active-noncovalent
Cc1cc(c(c(c1)C)C2=NO[C@@H]3[C@H]2[C@H]4CC[C@@H]3C4)C,BRD-A64319165-001-07-0,SN-2,Tocris,4907,SN 2,-9.552051,x0749,-0.707048,active-covalent
Cn1cc(cn1)c2cnn3c2nc(c(c3N)Br)[C@@H]4CCC[NH2+]C4,BRD-K75009076-001-01-3,SCH-900776,Selleck,S2735,MK-8776 (SCH 900776),-9.551287,x0195,1.013154,active-noncovalent
Cn1cc(cn1)c2cnn3c2nc(c(c3N)Br)[C@@H]4CCC[NH2+]C4,BRD-K75009076-001-02-1,SCH-900776,Selleck,S2735,MK-8776 (SCH 900776),-9.551287,x0195,1.013154,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)CSc3ccncc3)/C(=O)N2[C@H]1C(=O)[O-],BRD-K49880111-236-10-0,cephapirin,Selleck,S4393,Cephapirin Sodium,-9.547893,x0830,4.6521,active-covalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)CSc3ccncc3)/C(=O)N2[C@H]1C(=O)[O-],BRD-K49880111-236-09-2,cephapirin,MicroSource,1500167,CEPHAPIRIN SODIUM,-9.547893,x0830,4.6521,active-covalent
c1cc(ccc1C(c2ccc(cc2)C(F)(F)F)OCC[N@H+]3CCC=C(C3)C(=O)[O-])C(F)(F)F,BRD-K67680372-003-03-4,CI-966,Tocris,1296,CI 966 hydrochloride,-9.545257,x0678,4.03775,active-noncovalent
c1cc(ccc1C(c2ccc(cc2)C(F)(F)F)OCC[N@H+]3CCC=C(C3)C(=O)[O-])C(F)(F)F,BRD-K67680372-003-02-6,CI-966,Tocris,1296,CI 966 hydrochloride,-9.545257,x0678,4.03775,active-noncovalent
c1ccc(c(c1)C2(CCC(CC2)(F)F)c3ccc(cc3)O)F,BRD-K53788420-001-01-1,AC-186,Tocris,5053,AC 186,-9.544689,x1392,0.591082,active-covalent
Cc1c(ssc1=S)c2cnccn2,BRD-K86972824-001-02-2,oltipraz,MicroSource,1502317,OLTIPRAZ,-9.544348,x1418,-0.572158,active-covalent
Cc1c(ssc1=S)c2cnccn2,BRD-K86972824-001-01-4,oltipraz,MicroSource,1502317,OLTIPRAZ,-9.544348,x1418,-0.572158,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)[C@@H](CCCCCC(=O)[O-])c2ccccc2)C,BRD-A60765580-001-01-8,seratrodast,MicroSource,1502336,SERATRODAST,-9.544056,x0830,1.73207,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)[C@@H](CCCCCC(=O)[O-])c2ccccc2)C,BRD-A60765580-001-03-4,seratrodast,MedChemEx,HY-B0774,Seratrodast,-9.544056,x0830,1.73207,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)[C@@H](CCCCCC(=O)[O-])c2ccccc2)C,BRD-A60765580-001-02-6,seratrodast,MedChemEx,HY-B0774,Seratrodast,-9.544056,x0830,1.73207,active-covalent
C[C@H]1c2ccccc2C[N@@H+]1CC3=[NH+]CCN3,BRD-A67949680-050-01-7,BRL-44408,Tocris,1133,BRL 44408 maleate,-9.541772,x0678,-1.736745,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)c(ccn2)c4ccncc4,BRD-K06750613-001-07-3,GSK1059615,Selleck,S1360,GSK1059615,-9.541095,x0195,2.072215,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)c(ccn2)c4ccncc4,BRD-K06750613-001-04-0,GSK1059615,Selleck,S1360,GSK1059615,-9.541095,x0195,2.072215,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,BRD-A55393291-001-09-9,testosterone,MicroSource,307023,TESTOSTERONE,-9.540448,x0749,2.173349,active-covalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@H]([C@H]([C@H](COP(=O)([O-])[O-])O)O)O,BRD-K58734774-236-02-2,riboflavin-5-phosphate-sodium,MicroSource,1505763,RIBOFLAVIN 5-PHOSPHATE SODIUM,-9.540203,x0195,3.99374,active-noncovalent
c1ccc2c(c1)nc3c(n[nH]c3n2)N,BRD-K87932577-001-02-4,CDK1-5-inhibitor,Tocris,1937,NSC 693868,-9.539415,x1077,-2.0954,active-noncovalent
C/C=C(/C(=C/C)/c1ccc(cc1)O)\c2ccc(cc2)O,BRD-K95309561-001-24-7,dienestrol,MicroSource,1500241,DIENESTROL,-9.537957,x0749,0.265088,active-covalent
c1ccc(cc1)C[NH+]2CCC3(CCc4c3cccc4)CC2,BRD-K83322645-050-01-9,L-693403,Tocris,426,"L-693,403 maleate",-9.536598,x1093,0.022015,active-noncovalent
CCN(c1ccccc1)c2cc([n+](c(n2)C)C)NC,BRD-K18678457-003-02-8,ZD-7288,Tocris,1000,ZD 7288,-9.535992,x0678,-0.416359,active-noncovalent
CCN(c1ccccc1)c2cc([n+](c(n2)C)C)NC,BRD-K18678457-003-03-6,ZD-7288,Tocris,1000,ZD 7288,-9.535992,x0678,-0.416359,active-noncovalent
COc1ccc(cc1)Nc2nccc(n2)NCCO,BRD-K99174507-003-03-8,cardiogenol-c,Tocris,3851,Cardiogenol C hydrochloride,-9.535964,x0678,0.763872,active-noncovalent
COc1ccc(cc1)Nc2nccc(n2)NCCO,BRD-K99174507-003-02-0,cardiogenol-c,Tocris,3851,Cardiogenol C hydrochloride,-9.535964,x0678,0.763872,active-noncovalent
c1ccc(cc1)c2c3c(c4ccccc4o3)n[nH]2,BRD-K16664969-001-04-1,GTP-14564,Tocris,2086,GTP 14564,-9.532358,x0434,-0.748482,active-noncovalent
c1ccc(cc1)c2c3c(c4ccccc4o3)n[nH]2,BRD-K16664969-001-03-3,GTP-14564,Tocris,2086,GTP 14564,-9.532358,x0434,-0.748482,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F,BRD-K56343971-001-12-2,vemurafenib,MedChemEx,HY-12057,vemurafinib,-9.531456,x0195,4.195318,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F,BRD-K56343971-001-14-8,vemurafenib,Selleck,S1267,Vemurafenib,-9.531456,x0195,4.195318,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F,BRD-K56343971-001-10-6,vemurafenib,Selleck,S1267,"Vemurafenib (PLX4032, RG7204)",-9.531456,x0195,4.195318,active-noncovalent
c1cc(ccc1CNc2c3cc(ccc3ncn2)F)F,BRD-K84964099-001-02-9,spautin-1,Tocris,5197,Spautin 1,-9.531191,x0749,-0.598123,active-covalent
c1cc(ccc1OCCCCCCN/C(=N\C#N)/Nc2cc[nH+]cc2)Cl,BRD-K69832040-001-01-9,GMX1778,MedChemEx,HY-10079,GMX1778,-9.529283,x0161,3.174911,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2ccc(cc2)CCc3ccc(c(c3)Cl)Cl,BRD-K34657753-001-01-9,PD-118057,Sigma,MFCD08705328,"2-{4-[2-(3,4-dichlorophenyl)ethyl]anilino}benzoic acid",-9.527108,x0195,3.879684,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccc(cc3)O)[O-],BRD-A33749298-001-18-3,oxyphenbutazone,MicroSource,1500455,OXYPHENBUTAZONE,-9.525076,x0678,0.734029,active-noncovalent
c1ccc2c(c1)C(OS2(=O)=O)(c3ccc(cc3)O)c4ccc(cc4)O,BRD-K79892937-001-02-5,phenolsulfonphthalein,MicroSource,1500769,PHENOLSULFONPHTHALEIN,-9.524931,x0770,1.762154,active-covalent
c1ccc(cc1)c2c(c3ccccn3n2)c4cc5c([nH]nc5nn4)N,BRD-K68756823-001-10-5,FR-180204,Tocris,3706,FR 180204,-9.524750,x0678,1.955788,active-noncovalent
c1ccc(cc1)c2c(c3ccccn3n2)c4cc5c([nH]nc5nn4)N,BRD-K68756823-001-07-1,FR-180204,Tocris,3706,FR 180204,-9.524750,x0678,1.955788,active-noncovalent
c1ccc(cc1)CN(C2CCCCC2)C(=O)c3ccc(cc3)Cl,BRD-K87691185-001-01-2,FPS-ZM1,MedChemEx,HY-19370,FPS-ZM1,-9.524418,x0678,0.640851,active-noncovalent
c1ccc(cc1)C[C@H](c2ccccc2)[NH+]3CCCCC3,BRD-A86415025-050-01-0,"1-(1,2-Diphenylethyl)piperidine-(+/-)",Tocris,360,"(?)-1-(1,2-Diphenylethyl)piperidine maleate",-9.524290,x0161,-0.907271,active-noncovalent
C[C@@]12CCC(=O)C=C1CC[C@H]3[C@H]2CC[C@@]4([C@H]3CC[C@]4(C#C)O)C,BRD-A29111201-001-04-8,ethisterone,MicroSource,1503221,ETHISTERONE,-9.523010,x0072,1.966886,active-noncovalent
c1ccc(cc1)C[NH+]2CCN(CC2)C(=O)c3cc4ccccc4o3,BRD-K99077012-001-01-9,befuraline,Enamine,Z27763746,1-(1-benzofuran-2-ylcarbonyl)-4-benzylpiperazine,-9.522125,x0104,1.999308,active-noncovalent
COc1ccc(cc1O)c2cc(=O)c3c(cc(cc3o2)O)[O-],BRD-K26862302-001-05-2,diosmetin,Selleck,S2380,Diosmetin,-9.520951,x0749,1.067518,active-covalent
CC(C)c1ccc2c(c1)c(=O)c3cc(c(nc3o2)N)C(=O)[O-],BRD-K29530284-001-07-0,amlexanox,Tocris,4857,Amlexanox,-9.520159,x0072,3.722925,active-noncovalent
CC(C)c1ccc2c(c1)c(=O)c3cc(c(nc3o2)N)C(=O)[O-],BRD-K29530284-001-06-2,amlexanox,MicroSource,1502377,AMLEXANOX,-9.520159,x0072,3.722925,active-noncovalent
CC[C@H](c1ccc(cc1)O)[C@H](CC)c2ccc(cc2)O,BRD-A01078468-001-14-8,hexestrol,MicroSource,1500632,HEXESTROL,-9.519726,x0749,0.140239,active-covalent
c1cc(oc1)[C@H]2Cc3c(cnc(n3)N)C(=O)C2,BRD-A75015151-001-07-7,NKY-80,Tocris,5071,NKY 80,-9.516014,x0749,-0.54342,active-covalent
c1cc2c(nc1)-c3c(c4cc(ccc4[nH]3)Br)CC(=O)N2,BRD-K03273112-001-01-8,1-azakenpaullone,Selleck,S7193,1-Azakenpaullone,-9.514343,x0678,0.759754,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)SC,BRD-A84481105-003-31-3,thioridazine,Selleck,S4374,Thioridazine HCl,-9.513909,x0104,1.518306,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)SC,BRD-A84481105-003-32-1,thioridazine,MicroSource,1500575,THIORIDAZINE HYDROCHLORIDE,-9.513909,x0104,1.518306,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,BRD-K84036904-001-08-8,17-alpha-methyltestosterone,MedChemEx,HY-A0121,17-Methyltestosterone,-9.511111,x0749,2.437527,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,BRD-K84036904-001-09-6,17-alpha-methyltestosterone,MedChemEx,HY-A0121,17?-Methyltestosterone,-9.511111,x0749,2.437527,active-covalent
C[NH2+][C@H]1CC[C@@H](CC1)N(C(=O)c2sc3c(c2Cl)cccc3)Cc4cc(ccc4)c5ccncc5,BRD-K99433989-001-01-3,SAG,Tocris,4366,SAG,-9.509186,x0678,3.618986,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)OC(O2)(F)F,BRD-K63915849-001-03-7,AS-604850,Selleck,S2681,AS-604850,-9.508310,x0967,1.246119,active-noncovalent
c1c2c(cc(c1F)N3CC[NH2+]CC3)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-K04804440-001-08-7,ciprofloxacin,Selleck,S2027,Ciprofloxacin (Cipro),-9.507915,x0749,3.935339,active-covalent
c1c2c(cc(c1F)N3CC[NH2+]CC3)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-K04804440-001-13-7,ciprofloxacin,Selleck,S2027,Ciprofloxacin (Cipro),-9.507915,x0749,3.935339,active-covalent
c1c2c(cc(c1F)N3CC[NH2+]CC3)n(cc(c2=O)C(=O)[O-])C4CC4,BRD-K04804440-001-09-5,ciprofloxacin,MicroSource,1503614,CIPROFLOXACIN,-9.507915,x0749,3.935339,active-covalent
CC(C)COC[C@H](CN(Cc1ccccc1)c2ccccc2)[NH+]3CCCC3,BRD-A91008255-003-25-5,bepridil,Sigma,MFCD00065498,N-benzyl-N-[3-isobutoxy-2-(1-pyrrolidinyl)propyl]aniline hydrochloride,-9.507546,x0678,2.237501,active-noncovalent
CC(C)COC[C@H](CN(Cc1ccccc1)c2ccccc2)[NH+]3CCCC3,BRD-A91008255-003-24-8,bepridil,MicroSource,1503106,BEPRIDIL HYDROCHLORIDE,-9.507546,x0678,2.237501,active-noncovalent
CC(C)COC[C@H](CN(Cc1ccccc1)c2ccccc2)[NH+]3CCCC3,BRD-A91008255-003-26-3,bepridil,Tocris,4117,Bepridil hydrochloride,-9.507546,x0678,2.237501,active-noncovalent
Cc1coc-2c1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K00141480-001-15-4,tanshinone-iia,Selleck,S2365,Tanshinone IIA (Tanshinone B),-9.505550,x0749,0.711652,active-covalent
Cc1coc-2c1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,BRD-K00141480-001-14-7,tanshinone-iia,Selleck,S2365,Tanshinone IIA,-9.505550,x0749,0.711652,active-covalent
C[NH+]1CCN(CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)SC,BRD-A07932845-050-16-6,metitepine,Tocris,582,Methiothepin maleate,-9.503560,x0874,1.539697,active-noncovalent
C[NH+]1CCN(CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)SC,BRD-A07932845-066-11-3,metitepine,MicroSource,1503637,METITEPINE MESYLATE,-9.503560,x0874,1.539697,active-noncovalent
C[NH+]1CCN(CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)SC,BRD-A07932845-050-15-8,metitepine,Tocris,582,Methiothepin maleate,-9.503560,x0874,1.539697,active-noncovalent
[C@H]([C@@H]([C@@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O,BRD-K60150658-432-01-5,glucaric-acid,Sigma,MFCD00150704,"calcium (2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate tetrahydrate",-9.503366,x0397,0.606435,active-noncovalent
c1cc2c(c(c1)OC[C@@H]3C[NH2+]CCO3)CC=C2,BRD-A59747053-003-01-3,indeloxazine,Sigma,PH013704,2-[(1H-inden-7-yloxy)methyl]morpholine hydrochloride,-9.502079,x0195,-1.676191,active-noncovalent
c1ccc(cc1)c2cc3c(ccn4c3n[nH]c4=O)nc2c5ccc(cc5)C6(CCC6)[NH3+],BRD-K68065987-300-09-1,MK-2206,Selleck,S1078,MK-2206 2HCl,-9.500685,x0161,5.327227,active-noncovalent
Cc1cc(c(cc1O)Nc2c3ccc(cc3ncn2)OCc4ccccc4)F,BRD-K67831364-003-04-1,ZM-323881,Tocris,2475,ZM 323881 hydrochloride,-9.500359,x0161,4.937116,active-noncovalent
Cc1cc(c(cc1O)Nc2c3ccc(cc3ncn2)OCc4ccccc4)F,BRD-K67831364-003-03-3,ZM-323881,Selleck,S2896,ZM 323881 HCl,-9.500359,x0161,4.937116,active-noncovalent
Cc1cc(c(cc1O)Nc2c3ccc(cc3ncn2)OCc4ccccc4)F,BRD-K67831364-003-05-8,ZM-323881,Tocris,2475,ZM 323881 hydrochloride,-9.500359,x0161,4.937116,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+],BRD-K08327065-065-04-3,kanamycin,MedChemEx,HY-16566A,Kanamycin (sulfate),-9.500005,x0107,5.281313,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+],BRD-K08327065-065-06-8,kanamycin,MicroSource,1500360,KANAMYCIN A SULFATE,-9.500005,x0107,5.281313,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+],BRD-K08327065-065-05-0,kanamycin,MedChemEx,HY-16566A,Kanamycin (sulfate),-9.500005,x0107,5.281313,active-noncovalent
CS(=O)(=O)Nc1c(ccc2c1CCC[C@H]2C3=[NH+]CCN3)O,BRD-A83650191-004-02-8,A61603,Tocris,1052,A 61603 hydrobromide,-9.497537,x1385,1.046454,active-covalent
CS(=O)(=O)Nc1c(ccc2c1CCC[C@H]2C3=[NH+]CCN3)O,BRD-K13142315-004-01-2,A-61603,Tocris,1052,"N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide hydrobromide",-9.497537,x1385,1.046454,active-covalent
C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](c3ccccc3)O)C,BRD-A43999749-004-04-1,homatropine-methylbromide,MicroSource,1500333,HOMATROPINE METHYLBROMIDE,-9.496749,x0072,-0.291234,active-noncovalent
COc1ccccc1OC[C@@H](CO)O,BRD-A90515964-001-15-7,guaifenesin,Selleck,S1740,Guaifenesin,-9.496183,x0195,-0.632939,active-noncovalent
COc1ccccc1OC[C@@H](CO)O,BRD-A90515964-001-16-5,guaifenesin,MicroSource,1500321,GUAIFENESIN,-9.496183,x0195,-0.632939,active-noncovalent
c1cc(ccc1N(=O)=O)Oc2cc(cc(c2)Oc3ccc(cc3)N(=O)=O)C(=O)[O-],BRD-K98143539-001-02-2,compound-w,Tocris,2654,Compound W,-9.494440,x0678,3.965951,active-noncovalent
Cc1ccc(cc1)c2c3c([nH]n2)C(=O)N([C@@H]3c4cccc(c4)O)c5ccc(cc5)C(=O)[O-],BRD-A59391172-001-07-7,CID-16020046,Tocris,4959,CID 16020046,-9.493827,x0104,3.84176,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)/N=N/C(C#N)C#N,BRD-K03095347-001-06-1,levosimendan,MicroSource,1502356,LEVOSIMENDAN,-9.492462,x0749,0.322281,active-covalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)/N=N/C(C#N)C#N,BRD-K03095347-001-05-3,levosimendan,Selleck,S2446,Levosimendan,-9.492462,x0749,0.322281,active-covalent
CC#CCOC(=O)c1c([nH+]c2c(c1N)c3c(s2)C[C@H](CC3)O)C,BRD-A22707317-001-10-8,SB-205384,Tocris,1512,SB 205384,-9.492442,x0195,1.641127,active-noncovalent
CC#CCOC(=O)c1c([nH+]c2c(c1N)c3c(s2)C[C@H](CC3)O)C,BRD-A22707317-001-11-6,SB-205384,Tocris,1512,SB 205384,-9.492442,x0195,1.641127,active-noncovalent
CC1(NC(=[NH2+])[NH+]=C(N1OCCCOc2cc(c(cc2Cl)Cl)Cl)N)C,BRD-K45973863-001-01-4,WR99210,Sigma,MFCD01679034,"6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine",-9.491848,x1077,0.53059,active-noncovalent
c1cc(c(cc1c2c(cc3c(cc(cc3[o+]2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,BRD-K51337109-003-01-3,kuromanin,MedChemEx,HY-N0640,Kuromanin (chloride),-9.491004,x0749,2.313624,active-covalent
C[C@@H](Cc1ccc(cc1)Cl)C(=C)N=O,BRD-K32143970-001-01-9,AP-18,Tocris,3296,AP 18,-9.489348,x0749,-1.433933,active-covalent
c1cc2c(cc1c3cn(nc3c4ccncc4)CCO)CC[C@@H]2N=O,BRD-K67578145-001-12-1,GDC-0879,Selleck,S1104,GDC-0879,-9.489038,x0678,2.66367,active-noncovalent
c1cc2c(cc1c3cn(nc3c4ccncc4)CCO)CC[C@@H]2N=O,BRD-K67578145-001-09-7,GDC-0879,Selleck,S1104,GDC-0879,-9.489038,x0678,2.66367,active-noncovalent
c1cc2c(cc1c3cn(nc3c4ccncc4)CCO)CC[C@@H]2N=O,BRD-K67578145-001-10-5,GDC-0879,Tocris,4453,GDC 0879,-9.489038,x0678,2.66367,active-noncovalent
Cc1c(cnn1c2nc(cs2)c3cccc(c3)C(F)(F)F)C(=O)NCCCO,BRD-K94623186-001-01-5,RWJ-50271,Tocris,4227,RWJ 50271,-9.487402,x0161,6.951933,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,BRD-A64977602-001-15-9,mirtazapine,MicroSource,1506333,MIRTAZAPINE,-9.484286,x0072,-1.709209,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,BRD-A64977602-001-14-2,mirtazapine,Tocris,2018,Mirtazapine,-9.484286,x0072,-1.709209,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,BRD-A64977602-001-13-4,mirtazapine,Selleck,S2016,Mirtazapine,-9.484286,x0072,-1.709209,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,BRD-A64977602-001-16-7,mirtazapine,Tocris,2018,Mirtazapine,-9.484286,x0072,-1.709209,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=C[C@]34C)O,BRD-A53151380-001-01-2,prednisolone-tebutate,MicroSource,1505451,PREDNISOLONE TEBUTATE,-9.484262,x0161,3.741579,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)C(=O)c3c4ccc(cc4sc3c5ccc(cc5)O)O,BRD-K94832621-001-02-3,Y-134,Tocris,2676,Y 134,-9.483355,x0678,6.041525,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)C(=O)c3c4ccc(cc4sc3c5ccc(cc5)O)O,BRD-K94832621-001-03-1,Y-134,Tocris,2676,Y 134,-9.483355,x0678,6.041525,active-noncovalent
CC[N+](CC)(Cc1ccccc1)CC(=O)Nc2c(cccc2C)C,BRD-K34122555-057-11-5,denatonium-benzoate,MicroSource,1505987,DENATONIUM BENZOATE,-9.482736,x0161,1.051155,active-noncovalent
COC1CCN(CC1)C(=O)c2cc(ccc2F)Cc3c4ccccc4c(=O)[nH]n3,BRD-K85014146-001-02-5,AZD2461,Selleck,S7029,AZD2461,-9.481410,x0161,2.173248,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3=CC[N@H+](CC3)CCCC(=O)c4ccc(cc4)F,BRD-K97158071-001-17-3,droperidol,Selleck,S4096,Droperidol,-9.478012,x0107,3.452565,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3=CC[N@H+](CC3)CCCC(=O)c4ccc(cc4)F,BRD-K97158071-001-18-1,droperidol,MicroSource,1501002,DROPERIDOL,-9.478012,x0107,3.452565,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(C(=O)N)[NH+]3CCCCC3)F,BRD-K26801045-001-02-9,pipamperone,MicroSource,1505690,PIPAMPERONE,-9.476883,x0161,3.916812,active-noncovalent
c1cc(nc(c1C(F)(F)F)Cl)N2CC[NH2+]CC2,BRD-K07409305-001-01-1,Org-12962,Key,KD-0713,1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine,-9.476280,x0749,0.625561,active-covalent
CCOC(=O)[C@](C)(Cc1ccc(c(c1)O)O)[NH3+],BRD-K82259334-003-02-7,methyldopate,Prestwick,Prestw-1038,Methyldopate hydrochloride,-9.474243,x0678,-1.145232,active-noncovalent
c1ccc2c(c1)c(=O)c(co2)C/N=N/C(=S)N,BRD-M17926088-001-01-3,FPA-124,Tocris,2926,FPA 124,-9.471546,x0678,-0.615096,active-noncovalent
c1ccc2c(c1)c(=O)c(co2)C/N=N/C(=S)N,BRD-M17926088-001-02-1,FPA-124,Tocris,2926,4-oxo-4H-chromene-3-carbaldehyde thiosemicarbazone compound with dichlorocopper (1:1),-9.471546,x0678,-0.615096,active-noncovalent
C[NH+]1C[C@H]2CC(C[C@H]2C1)COc3cc4c(cc3OC)c(ncn4)Nc5ccc(c(c5F)Cl)Cl,BRD-K03765900-001-01-9,XL-647,MedChemEx,HY-13314,XL-647,-9.470898,x0104,9.664274,active-noncovalent
c1ccc(c(c1)NC(=O)N[C@@H]2CCN(C2)c3ccc(cn3)C(F)(F)F)Br,BRD-K65991129-001-02-9,SB-705498,Selleck,S2773,SB705498,-9.470862,x0161,6.411264,active-noncovalent
c1ccc2c(c1)C3=[NH+]CCN3[C@@]2(c4ccc(cc4)Cl)O,BRD-A68464583-001-02-5,mazindol,MedChemEx,HY-15279,Mazindol,-9.469434,x0195,-0.751648,active-noncovalent
CCNC(=O)N1CC[NH+](CC1)CCCC(c2ccc(cc2)F)c3ccc(cc3)F,BRD-K52397688-003-06-4,amperozide,Enzo,AC1367,Amperozide,-9.468991,x0434,6.204923,active-noncovalent
CC(=O)Oc1cccc2c1C(=O)c3c(cc(cc3OC(=O)C)C(=O)[O-])C2=O,BRD-K69122748-001-09-3,diacerein,Selleck,S4267,Diacerein,-9.468814,x0749,2.995432,active-covalent
CC(=O)Oc1cccc2c1C(=O)c3c(cc(cc3OC(=O)C)C(=O)[O-])C2=O,BRD-K69122748-001-10-1,diacerein,MicroSource,1502010,DIACERIN,-9.468814,x0749,2.995432,active-covalent
CC(=O)Oc1cccc2c1C(=O)c3c(cc(cc3OC(=O)C)C(=O)[O-])C2=O,BRD-K69122748-001-11-9,diacerein,Selleck,S4267,Diacerein,-9.468814,x0749,2.995432,active-covalent
c1ccc(cc1)CNC(=O)Cc2ccc(cn2)c3ccc(cc3)OCC[NH+]4CCOCC4,BRD-K29968218-001-03-2,KX2-391,Selleck,S2700,KX2-391,-9.468529,x0104,12.247292,active-noncovalent
c1cc(cc(c1)[C@@]2(c3cccc(c3[C@H]([NH2+]2)N)F)c4ccnc(c4)C(F)F)c5cncnc5,BRD-A54654253-001-01-8,AZD3839,Selleck,S7731,AZD3839,-9.467543,x0678,4.630359,active-noncovalent
c1cc(ccc1c2c[nH]cc(c2=O)C(=O)Nc3ccc(c(c3)F)Oc4ccnc(c4Cl)N)F,BRD-K27182532-001-02-3,metatinib,Selleck,S2201,BMS-794833,-9.466895,x0104,14.113226,active-noncovalent
C[n+]1c2cc(ccc2cc3c1cc(cc3)N)N,BRD-M87138257-003-01-1,acriflavine,Sigma,MFCD00064307,"3,6-diamino-10-methylacridinium chloride compound with 3,6-acridinediamine (1:1)",-9.463461,x0749,0.931244,active-covalent
C[n+]1c2cc(ccc2cc3c1cc(cc3)N)N,BRD-K97874492-003-12-3,acriflavinium,MicroSource,1500618,ACRIFLAVINIUM HYDROCHLORIDE,-9.463461,x0749,0.931244,active-covalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)[O-])O)O)O,BRD-K81672972-001-03-1,dinoprost,Enzo,PG008,Dinoprost,-9.463255,x0195,2.906815,active-noncovalent
COc1ccc2c(c1)/C(=C/c3c[nH]cn3)/C(=O)N2,BRD-K94883909-001-18-5,SU9516,Tocris,2907,SU 9516,-9.462580,x0749,0.32471,active-covalent
COc1ccc2c(c1)/C(=C/c3c[nH]cn3)/C(=O)N2,BRD-K94883909-001-17-7,SU9516,MedChemEx,HY-18629,SU9516,-9.462580,x0749,0.32471,active-covalent
c1ccc2c(c1)/C(=C/CC[NH+]3CCN(CC3)CCO)/c4cc(ccc4S2)Cl,BRD-K28761384-300-01-0,zuclopenthixol,Prestwick,Prestw-998,Zuclopenthixol dihydrochloride,-9.462299,x0161,3.323583,active-noncovalent
c1cc(ccc1C#N)[C@H]2CCCc3n2cnc3,BRD-A25619068-003-03-4,fadrozole,SantaCruz,sc-252819,,-9.461576,x0161,-0.484884,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,BRD-A97701745-001-16-0,pindolol,MicroSource,1500488,PINDOLOL,-9.460906,x0104,1.677497,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,BRD-A97701745-001-15-2,pindolol,Tocris,994,Pindolol,-9.460906,x0104,1.677497,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,BRD-A97701745-001-14-5,pindolol,Selleck,S4406,Pindolol,-9.460906,x0104,1.677497,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,BRD-K95598440-001-09-3,pindolol-(-),Tocris,1060,(S)-(-)-Pindolol,-9.460906,x0104,1.677497,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,BRD-K03039262-001-03-7,ergosterol,Selleck,S2297,Ergosterol,-9.460039,x0161,6.672119,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,BRD-K03039262-001-04-5,ergosterol,Selleck,S2297,Ergosterol,-9.460039,x0161,6.672119,active-noncovalent
c1ccn2c(c1)[nH+]cc2C3=C(C(=O)NC3=O)c4cn5c6c4cc(cc6CN(CC5)C(=O)N7CCCCC7)F,BRD-K78055238-001-01-8,LY2090314,MedChemEx,HY-16294,LY2090314,-9.459563,x0161,5.552997,active-noncovalent
CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3c1cccc3)C(C)C,BRD-K90885812-004-24-2,propantheline,MicroSource,1500511,PROPANTHELINE BROMIDE,-9.459325,x0195,1.734408,active-noncovalent
c1ccc2c(c1)C(=O)c3ccc(c(c3C2=O)[O-])O,BRD-K73191876-001-12-0,alizarin,Selleck,S2526,Alizarin,-9.459037,x0195,0.394873,active-noncovalent
c1ccc2c(c1)C(=O)c3ccc(c(c3C2=O)[O-])O,BRD-K73191876-001-11-2,alizarin,Selleck,S2526,Alizarin,-9.459037,x0195,0.394873,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(C[C@H](C(=O)[C@H]4O5)C#N)C,BRD-A04497688-001-04-2,trilostane,Selleck,S1404,Trilostane,-9.456862,x0749,3.216621,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(C[C@H](C(=O)[C@H]4O5)C#N)C,BRD-A04497688-001-05-9,trilostane,MicroSource,1504566,TRILOSTANE,-9.456862,x0749,3.216621,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(C[C@H](C(=O)[C@H]4O5)C#N)C,BRD-A04497688-001-03-4,trilostane,MedChemEx,HY-14281,Trilostane,-9.456862,x0749,3.216621,active-covalent
c1ccc2c(c1)c(=O)c3cccc4nnc2[C@H]34,BRD-K01567962-001-23-0,pyrazolanthrone,Selleck,S1460,SP600125,-9.455590,x0195,0.282749,active-noncovalent
c1ccc2c(c1)c(=O)c3cccc4nnc2[C@H]34,BRD-K01567962-001-24-8,pyrazolanthrone,Tocris,1496,SP 600125,-9.455590,x0195,0.282749,active-noncovalent
CCC(CC)(CC(=O)Nc1cccc(c1)/C=C/c2nc(cs2)C3CCC3)C(=O)[O-],BRD-K53720352-001-05-7,cinalukast,Tocris,2025,Cinalukast,-9.455110,x0161,10.057045,active-noncovalent
CCC(CC)(CC(=O)Nc1cccc(c1)/C=C/c2nc(cs2)C3CCC3)C(=O)[O-],BRD-K53720352-001-04-0,cinalukast,Tocris,2025,"4-{3-[(E)-2-(4-cyclobutyl-1,3-thiazol-2-yl)ethenyl]anilino}-2,2-diethyl-4-oxobutanoic acid",-9.455110,x0161,10.057045,active-noncovalent
CCC(CC)(CC(=O)Nc1cccc(c1)/C=C/c2nc(cs2)C3CCC3)C(=O)[O-],BRD-K53720352-001-03-2,cinalukast,Tocris,2025,Cinalukast,-9.455110,x0161,10.057045,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,BRD-K93900986-001-15-0,stetaderm,Sigma,MFCD00003652,"(11alpha)-11-hydroxypregn-4-ene-3,20-dione",-9.453985,x0749,2.404142,active-covalent
Cc1ccccc1CN2CC3=C(CCN(C3=O)Cc4ccccc4)N5C2=[NH+]CC5,BRD-K01115818-001-01-0,TIC10,Selleck,S7963,TIC10,-9.451942,x0195,4.213315,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,BRD-A78322124-003-18-1,dobutamine,MedChemEx,HY-15746,Dobutamine (hydrochloride),-9.449571,x0678,-0.701696,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,BRD-A78322124-003-14-0,dobutamine,Tocris,515,Dobutamine hydrochloride,-9.449571,x0678,-0.701696,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,BRD-A78322124-003-15-7,dobutamine,MedChemEx,HY-15746,Dobutamine (hydrochloride),-9.449571,x0678,-0.701696,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,BRD-A78322124-003-17-3,dobutamine,Tocris,515,"4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)-1,2-benzenediol hydrochloride",-9.449571,x0678,-0.701696,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,BRD-A78322124-003-16-5,dobutamine,Tocris,515,Dobutamine hydrochloride,-9.449571,x0678,-0.701696,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@]2(C#C)O)CCC4=Cc5c(cno5)C[C@]34C,BRD-A92537424-001-04-7,danazol,MicroSource,1500220,DANAZOL,-9.449312,x0749,2.405158,active-covalent
CCCOc1ccn2c(c1)c(cc2C(=O)C)c3ccccc3S(=O)(=O)C,BRD-K48062199-001-01-8,GSK2801,MedChemEx,HY-15658,GSK2801,-9.446163,x0708,2.797379,active-covalent
c1cc(ccc1[C@@H]2[C@H](C(=O)N2c3ccc(cc3)F)CC[C@@H](c4ccc(cc4)F)O)O,BRD-K42260897-001-09-2,ezetimibe,Selleck,S1655,Ezetimibe,-9.445126,x1077,2.039856,active-noncovalent
c1cc(ccc1[C@@H]2[C@H](C(=O)N2c3ccc(cc3)F)CC[C@@H](c4ccc(cc4)F)O)O,BRD-K42260897-001-07-6,ezetimibe,Selleck,S1655,Ezetimibe (Zetia),-9.445126,x1077,2.039856,active-noncovalent
c1cc(ccc1[C@@H]2[C@H](C(=O)N2c3ccc(cc3)F)CC[C@@H](c4ccc(cc4)F)O)O,BRD-K42260897-001-08-4,ezetimibe,Adooq,A10379,"(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone",-9.445126,x1077,2.039856,active-noncovalent
c1ccc(cc1)C(=O)Nc2nc3ccc(cc3s2)NC(=O)C45CC6CC(C4)CC(C6)C5,BRD-K01573278-001-03-9,NVP-231,Tocris,3960,NVP 231,-9.444038,x0104,11.314102,active-noncovalent
c1ccc(cc1)C(=O)Nc2nc3ccc(cc3s2)NC(=O)C45CC6CC(C4)CC(C6)C5,BRD-K01573278-001-02-1,NVP-231,MedChemEx,HY-13945,NVP 231,-9.444038,x0104,11.314102,active-noncovalent
c1cc(ccc1[C@@H]2[C@H](C(=O)N2c3ccc(cc3)F)CC[C@H](c4ccc(cc4)F)O)O,BRD-A41519720-001-04-8,ezetimibe,MicroSource,1505203,EZETIMIBE,-9.443610,x0161,2.152472,active-noncovalent
Cc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3ccc(nc3)Oc4cccnc4C,BRD-K99968849-300-01-4,SB-243213,Tocris,3527,SB 243213 dihydrochloride,-9.443547,x0161,6.030175,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(CCCl)CCCl,BRD-K87827419-001-14-3,melphalan,MicroSource,1500382,MELPHALAN,-9.443293,x0107,1.524668,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(CCCl)CCCl,BRD-K87827419-001-16-8,melphalan,MicroSource,1500382,MELPHALAN,-9.443293,x0107,1.524668,active-noncovalent
Cc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,BRD-A27732521-003-07-5,tolperisone,Selleck,S4200,Tolperisone HCl,-9.442404,x0104,-0.06176,active-noncovalent
Cc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,BRD-A27732521-003-08-3,tolperisone,MicroSource,1501194,TOLPERISONE HYDROCHLORIDE,-9.442404,x0104,-0.06176,active-noncovalent
c1ccc(c(c1)C(=O)/C=C/[N@H+]2C[C@H]3C[C@@H]2C[N@]3c4ccccn4)O,BRD-K61524559-001-01-3,PFI-3,Tocris,5072,PFI 3,-9.441746,x1093,3.390074,active-noncovalent
C[C@]1(CCCN1c2nc(c3cccn3n2)Nc4cc([nH]n4)C5CC5)C(=O)Nc6ccc(nc6)F,BRD-K13049116-001-04-0,BMS-754807,MedChemEx,HY-10200,BMS-754807,-9.440411,x0678,5.295286,active-noncovalent
C[C@]1(CCCN1c2nc(c3cccn3n2)Nc4cc([nH]n4)C5CC5)C(=O)Nc6ccc(nc6)F,BRD-K13049116-001-05-7,BMS-754807,Selleck,S1124,BMS-754807,-9.440411,x0678,5.295286,active-noncovalent
C[C@]1(CCCN1c2nc(c3cccn3n2)Nc4cc([nH]n4)C5CC5)C(=O)Nc6ccc(nc6)F,BRD-K13049116-001-03-2,BMS-754807,Selleck,S1124,BMS-754807,-9.440411,x0678,5.295286,active-noncovalent
C[N@]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-K71926323-001-14-6,marbofloxacin,Selleck,S1464,Marbofloxacin,-9.439663,x0195,6.217214,active-noncovalent
C[N@]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-K71926323-001-12-0,marbofloxacin,Selleck,S1464,Marbofloxacin,-9.439663,x0195,6.217214,active-noncovalent
C[N@]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-K71926323-001-13-8,marbofloxacin,MicroSource,1506324,MARBOFLOXACIN,-9.439663,x0195,6.217214,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@H]([C@H]([C@H](CO)O)O)O,BRD-K70246307-001-04-1,riboflavin,MicroSource,1505347,RIBOFLAVIN,-9.437819,x0759,2.81227,active-covalent
COc1ccc(cc1)Cn2ccc3c2cc(cc3)C(=O)NO,BRD-K88742110-001-08-7,PCI-34051,Selleck,S2012,PCI-34051,-9.436438,x0195,-0.59813,active-noncovalent
COc1ccc(cc1)Cn2ccc3c2cc(cc3)C(=O)NO,BRD-K88742110-001-07-9,PCI-34051,Selleck,S2012,PCI-34051,-9.436438,x0195,-0.59813,active-noncovalent
COc1ccc(cc1)Cn2ccc3c2cc(cc3)C(=O)NO,BRD-K88742110-001-09-5,PCI-34051,Tocris,4643,PCI 34051,-9.436438,x0195,-0.59813,active-noncovalent
c1cc(ccc1[C@@H]2CC(=O)c3ccc(cc3O2)O)O,BRD-K34328244-001-01-4,MF-101,InterBioScreen,STOCK1N-11167,,-9.436436,x0749,-1.036284,active-covalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1c3ccccc3[nH]2)O,BRD-A50675490-001-01-0,carazolol,Cayman,18628,1-(9H-carbazol-4-yloxy)-3-(isopropylamino)-2-propanol,-9.434849,x0104,0.582233,active-noncovalent
C[n+]1cc2c(ccc3c2OCO3)c4c1c5cc6c(cc5cc4)OCO6,BRD-K66898851-003-03-3,sanguinarium-chloride,Sigma,S5890,"13-methyl[1,3]benzodioxolo[5,6-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium chloride",-9.434637,x0749,3.506699,active-covalent
C[n+]1cc2c(ccc3c2OCO3)c4c1c5cc6c(cc5cc4)OCO6,BRD-K66898851-003-02-5,sanguinarium-chloride,MicroSource,310035,SANGUINARIUM CHLORIDE,-9.434637,x0749,3.506699,active-covalent
COc1ccc(cc1OC)CCO[C@@H]2CCCC[C@H]2[N@H+]3CC[C@H](C3)O,BRD-K19741547-003-01-7,vernakalant,MedChemEx,HY-14183,Vernakalant (Hydrochloride),-9.433910,x0946,2.851264,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2ccccc2C#N)N3CCC[C@@H](C3)[NH3+],BRD-A27084604-057-01-0,alogliptin,MicroSource,1506318,ALOGLIPTIN BENZOATE,-9.431739,x0434,1.10524,active-noncovalent
c1ccc2c(c1)ccc3c2oc(cc3=O)N4CCOCC4,BRD-K09537769-001-06-5,NU-7026,MedChemEx,HY-15719,NU 7026,-9.431209,x0195,0.899149,active-noncovalent
c1ccc2c(c1)ccc3c2oc(cc3=O)N4CCOCC4,BRD-K09537769-001-04-0,NU-7026,Tocris,2828,NU 7026,-9.431209,x0195,0.899149,active-noncovalent
c1ccc2c(c1)ccc3c2oc(cc3=O)N4CCOCC4,BRD-K09537769-001-03-2,NU-7026,Selleck,S2893,NU7026,-9.431209,x0195,0.899149,active-noncovalent
c1cc(ccc1C/N=N/C(=O)N)Oc2ccc(cc2)F,BRD-K70912147-001-01-8,co-102862,Tocris,2642,Co 102862,-9.429238,x0161,0.673919,active-noncovalent
Cc1cc(c2ccccc2[n+]1CCCCCCCCCC[n+]3c(cc(c4c3cccc4)N)C)N,BRD-K77685957-300-08-3,dequalinium,Selleck,S4066,Dequalinium chloride,-9.428643,x1077,7.861933,active-noncovalent
Cc1cc(c2ccccc2[n+]1CCCCCCCCCC[n+]3c(cc(c4c3cccc4)N)C)N,BRD-K77685957-300-09-1,dequalinium,MicroSource,1503127,DEQUALINIUM CHLORIDE,-9.428643,x1077,7.861933,active-noncovalent
c1cc(ccc1/[NH+]=C(/N)\NC2C3CC4CC(C3)CC2C4)I,BRD-K82421491-001-02-6,IPAG,Tocris,544,IPAG,-9.427999,x0946,-0.068595,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC(=O)[O-],BRD-K91740057-001-19-8,felbinac,MicroSource,1506160,FELBINAC,-9.427928,x0749,1.255304,active-covalent
c1ccc(cc1)OCCC[N+]23CCC(CC2)[C@H](C3)OC(=O)C(c4cccs4)(c5cccs5)O,BRD-K74363950-004-01-0,aclidinium,Selleck,S4031,Aclidinium Bromide,-9.427677,x0161,7.232483,active-noncovalent
Cc1ccc2c(c1)n(c(=O)nc2c3ccccc3)C(C)C,BRD-K54339150-001-01-8,proquazone,AMS,A001576823,1-isopropyl-7-methyl-4-phenyl-2(1H)-quinazolinone,-9.426495,x0434,0.556697,active-noncovalent
COc1ccc(cc1)c2cnc3c(cnn3c2)c4cccc5c4cccn5,BRD-K33892651-001-03-2,ML347,Tocris,4945,ML 347,-9.426319,x0104,2.477572,active-noncovalent
COc1ccc(cc1)c2cnc3c(cnn3c2)c4cccc5c4cccn5,BRD-K33892651-001-02-4,ML347,Selleck,S7148,ML347,-9.426319,x0104,2.477572,active-noncovalent
Cc1cccc(c1C)OC[C@H](C[NH2+]C(C)(C)C)O,BRD-A21446384-001-01-1,xibenolol,PrincetonBio,OSSK_690214,"1-(tert-butylamino)-3-(2,3-dimethylphenoxy)-2-propanol",-9.426226,x0104,-0.311863,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)O)O,BRD-K39693230-001-01-2,N-salicoylaminophenol,CombiBlocks,QA-6673,,-9.424944,x0749,-1.055634,active-covalent
Cc1ccccc1n2c(nc3ccc(cc3c2=O)N)CF,BRD-K69247067-001-01-8,afloqualone,AKSci,67719,,-9.424483,x0749,2.476371,active-covalent
Cc1c(nc(nc1N2CCc3ccccc3[C@@H]2C)Nc4ccc(cc4)F)C,BRD-A51497544-001-01-4,revaprazan,AvaChem,2997,"N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine",-9.420653,x0195,2.611863,active-noncovalent
CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc3c1cccc3,BRD-K09859624-004-10-4,methantheline,Prestwick,Prestw-1066,Methantheline bromide,-9.419333,x0195,2.306733,active-noncovalent
C[NH+](C)CCCn1c2ccc(c3c2c(n1)-c4cc(ccc4N3)OC)N(=O)=O,BRD-K42607789-001-01-2,pyrazoloacridine,Sigma,MFCD00667221,"3-(9-methoxy-5-nitropyrazolo[3,4,5-kl]acridin-2(6H)-yl)-N,N-dimethyl-1-propanamine",-9.419282,x0195,2.706256,active-noncovalent
C=CCCCCCCCCC(=O)[O-],BRD-K19189338-001-03-2,undecylenic-acid,MicroSource,1505468,UNDECYLENIC ACID,-9.418491,x0678,-0.018448,active-noncovalent
C=CCCCCCCCCC(=O)[O-],BRD-K19189338-001-05-7,undecylenic-acid,MedChemEx,HY-B0914,10-Undecenoic acid,-9.418491,x0678,-0.018448,active-noncovalent
CC[NH+](CC)CCn1c2ccccc2nc(c1=O)Cc3ccc(cc3)OC,BRD-K65900713-003-01-0,caroverine,Sigma,MFCD01684929,1-[2-(diethylamino)ethyl]-3-(4-methoxybenzyl)-2(1H)-quinoxalinone hydrochloride,-9.418475,x0104,2.770705,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Oc2cccc(c2)CON(=O)=O,BRD-K08807999-001-02-4,NO-ASA,Enzo,AC1544,NO-ASA,-9.416669,x0749,1.11131,active-covalent
c1cc(cc(c1)Cl)OC[C@@H](/C=C/[C@H]2[C@@H](C[C@@H]([C@@H]2C/C=C\CCCC(=O)[O-])O)O)O,BRD-K17850764-236-11-9,cloprostenol-(+/-),Tocris,2295,(?)-Cloprostenol sodium salt,-9.416366,x0678,4.737148,active-noncovalent
Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C,BRD-K30480208-001-18-5,torasemide,MicroSource,1505211,TORSEMIDE,-9.416163,x0107,0.929432,active-noncovalent
Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C,BRD-K30480208-001-17-7,torasemide,Selleck,S1698,Torsemide,-9.416163,x0107,0.929432,active-noncovalent
c1c(nc[nH]1)/C=C\C(=O)[O-],BRD-K25146005-001-01-0,cis-urocanic acid,Sigma,MFCD11045310,(2Z)-3-(1H-imidazol-4-yl)-2-propenoic acid,-9.415903,x0397,-1.132483,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-A49172652-001-26-3,lansoprazole,Selleck,S1354,Lansoprazole,-9.415019,x0195,1.423188,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-A49172652-001-27-1,lansoprazole,Tocris,2582,Lansoprazole,-9.415019,x0195,1.423188,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-A49172652-001-28-9,lansoprazole,MicroSource,1503926,LANSOPRAZOLE,-9.415019,x0195,1.423188,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-K05900209-001-02-6,dexlansoprazole,MicroSource,1504282,DEXLANSOPRAZOLE,-9.415019,x0195,1.423188,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-K05900209-001-03-4,dexlansoprazole,Selleck,S4099,Dexlansoprazole,-9.415019,x0195,1.423188,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,BRD-K05900209-001-01-8,dexlansoprazole,Selleck,S4099,Dexlansoprazole,-9.415019,x0195,1.423188,active-noncovalent
C[N@@H+]1C[C@@H]2C[C@H]1C[N@@]2c3cc4c(cc3F)c(=O)c(cn4C5CC5)C(=O)[O-],BRD-K45916615-066-02-5,danofloxacin,Selleck,S3058,Danofloxacin Mesylate,-9.414551,x0104,1.099705,active-noncovalent
c1ccc(cc1)Cn2c(=O)n(sc2=O)c3cccc4c3cccc4,BRD-K81330143-001-04-8,tideglusib,Selleck,S2823,Tideglusib,-9.413855,x0678,0.786593,active-noncovalent
c1ccc(cc1)Cn2c(=O)n(sc2=O)c3cccc4c3cccc4,BRD-K81330143-001-02-2,tideglusib,Selleck,S2823,Tideglusib,-9.413855,x0678,0.786593,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)c3c4c(ncnc4n(n3)C5CCCC5)N,BRD-K71223042-001-01-5,PCI-29732,Tocris,5012,PCI 29732,-9.412631,x0104,5.135911,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)c3c(=O)c4ccc(cc4[nH]c3[O-])Cl,BRD-K08109516-001-07-8,L-701324,Tocris,907,"L-701,324",-9.412169,x0161,2.046283,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)c3c(=O)c4ccc(cc4[nH]c3[O-])Cl,BRD-K08109516-001-08-6,L-701324,Tocris,907,"L-701,324",-9.412169,x0161,2.046283,active-noncovalent
c1ccc(cc1)OC(=O)c2ccc(cc2O)N,BRD-K73157543-001-04-1,phenyl-aminosalicylate,MicroSource,305025,PHENYL AMINOSALICYLATE,-9.412144,x0678,-1.31986,active-noncovalent
CCCC[NH+](CCCC)CC[C@@H](c1cc2c(cc(cc2Cl)Cl)c3c1ccc(c3)C(F)(F)F)O,BRD-A51964809-003-12-6,halofantrine,Enzo,AC2004,Halofantrine HCl,-9.411906,x0161,4.744354,active-noncovalent
Cc1cccc(c1NC(=O)/[NH+]=C\2/CCCN2C)C,BRD-K79633074-001-01-8,xilobam,Enamine,Z203043368,,-9.410540,x0678,-1.038836,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])O)O,BRD-K34730807-001-17-6,levodopa,Selleck,S1726,Levodopa (Sinemet),-9.410147,x0107,-1.872855,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])O)O,BRD-K34730807-001-16-8,levodopa,MicroSource,2300205,LEVODOPA,-9.410147,x0107,-1.872855,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])O)O,BRD-K34730807-001-15-0,levodopa,Selleck,S1726,Levodopa (Sinemet),-9.410147,x0107,-1.872855,active-noncovalent
CCOc1ccc(cc1)Nc2nc(cs2)c3c(nc4n3cccc4)C,BRD-K38860038-001-02-0,JK-184,Tocris,3341,JK 184,-9.409678,x0104,2.915739,active-noncovalent
CCOc1ccc(cc1)Nc2nc(cs2)c3c(nc4n3cccc4)C,BRD-K38860038-001-01-2,JK-184,Tocris,3341,JK 184,-9.409678,x0104,2.915739,active-noncovalent
CCOc1ccc(cc1)Nc2nc(cs2)c3c(nc4n3cccc4)C,BRD-K38860038-001-03-8,JK-184,Tocris,3341,"N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-amine",-9.409678,x0104,2.915739,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC(=O)Nc3ccccn3,BRD-K96206066-001-07-9,difenpiramide,Enamine,Z60744762,"2-[1,1'-biphenyl]-4-yl-N-(2-pyridinyl)acetamide",-9.409120,x0161,2.918444,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,BRD-K73107279-003-11-7,levamisole,Selleck,S1939,(-)-Tetramisole,-9.408648,x1093,-1.878644,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,BRD-K73107279-003-12-5,levamisole,MicroSource,1503245,LEVAMISOLE HYDROCHLORIDE,-9.408648,x1093,-1.878644,active-noncovalent
c1ccc2c(c1)c(=O)c3ccccc3o2,BRD-K27135764-001-08-7,xanthone,Selleck,S2372,Xanthone,-9.408072,x0749,-0.257928,active-covalent
CCC(=C)C(=O)c1ccc(c(c1Cl)Cl)OCC(=O)[O-],BRD-K63630713-001-25-8,etacrynic-acid,MicroSource,1500287,ETHACRYNIC ACID,-9.406878,x0678,-0.383457,active-noncovalent
c1c([nH]cn1)C2CCN(CC2)C(=S)NC3CCCCC3,BRD-K63874012-001-03-7,thioperamide,Tocris,644,Thioperamide maleate,-9.405118,x0072,-1.053634,active-noncovalent
c1c([nH]cn1)C2CCN(CC2)C(=S)NC3CCCCC3,BRD-K63874012-001-02-9,thioperamide,Tocris,644,Thioperamide,-9.405118,x0072,-1.053634,active-noncovalent
c1cc(c(cc1/C=C/C(=O)O[C@@H]2C[C@@](C[C@H]([C@H]2O)O)(C(=O)[O-])O)O)O,BRD-K47114202-001-15-3,chlorogenic-acid,Selleck,S2280,Chlorogenic Acid,-9.403543,x0749,1.192896,active-covalent
c1cc(c(cc1/C=C/C(=O)O[C@@H]2C[C@@](C[C@H]([C@H]2O)O)(C(=O)[O-])O)O)O,BRD-K47114202-001-14-6,chlorogenic-acid,Selleck,S2280,Chlorogenic acid,-9.403543,x0749,1.192896,active-covalent
c1cc(sc1)C(=O)c2c3cc(ccc3n(c2O)C(=O)N)Cl,BRD-A87479750-001-02-7,tenidap,Tocris,2580,Tenidap,-9.399836,x1418,-0.798236,active-covalent
c1cc(sc1)C(=O)c2c3cc(ccc3n(c2O)C(=O)N)Cl,BRD-A87479750-001-03-5,tenidap,Tocris,2580,Tenidap,-9.399836,x1418,-0.798236,active-covalent
CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@H](CC)[NH3+],BRD-K40581315-034-01-5,butabindide,Tocris,1323,Butabindide oxalate,-9.398643,x0678,0.814765,active-noncovalent
C[N@](c1ccc(cc1)NC(=O)Nc2ccccc2)S(=O)(=O)c3cnn(c3)c4ccc(cc4)F,BRD-K01492390-001-01-9,BTT-3033,Tocris,4724,BTT 3033,-9.395916,x0161,7.357133,active-noncovalent
c1ccc2c(c1)CN3C(=O)c4ccccc4CN3C2=O,BRD-K80076813-001-08-8,diftalone,Vitas-M,STL175186,"phthalazino[2,3-b]phthalazine-5,12(7H,14H)-dione",-9.394883,x0749,0.608096,active-covalent
c1c(cc(cc1C(F)(F)F)C(F)(F)F)c2ncn(n2)/C=C\C(=O)N3CC(C3)(F)F,BRD-K75352575-001-01-3,KPT-276,Selleck,S7251,KPT-276,-9.394169,x0195,3.136547,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH+](CC3)Cc4cc(cnc4)c5ccc(cc5)F,BRD-K34870043-001-01-8,adoprazine,MedChemEx,HY-14782,Adoprazine,-9.393971,x0161,7.766082,active-noncovalent
c1cc(cc(c1)n2c(=O)ccc3c2c4cc(ccc4nc3)c5ccc(nc5)N)C(F)(F)F,BRD-K68174511-001-06-6,torin-2,Selleck,S2817,Torin 2,-9.393524,x0678,4.198251,active-noncovalent
c1cc(cc(c1)n2c(=O)ccc3c2c4cc(ccc4nc3)c5ccc(nc5)N)C(F)(F)F,BRD-K68174511-001-08-2,torin-2,Tocris,4248,Torin 2,-9.393524,x0678,4.198251,active-noncovalent
c1ccc2c(c1)/C(=C/CC[NH+]3CCN(CC3)CCO)/c4cc(ccc4S2)C(F)(F)F,BRD-K70487031-001-02-8,flupentixol,Enzo,AC750,cis-(Z)-Flupenthixol 2HCl,-9.392056,x0161,4.235934,active-noncovalent
Cn1cc(c2c1cccc2)C[C@H](C(=O)[O-])[NH3+],BRD-K93255255-001-02-1,indoximod,Cayman,16456,,-9.391203,x0195,0.942227,active-noncovalent
CC[C@H](c1ccc(o1)C)Nc2c(c(=O)c2=O)Nc3cccc(c3O)C(=O)N(C)C,BRD-K82850175-001-01-1,navarixin,MedChemEx,HY-10198,SCH 527123,-9.390433,x0195,3.630902,active-noncovalent
CCOC(=O)c1ccc(cc1)N(C)c2csc(n2)c3ccccc3,BRD-K28567778-001-02-7,neuropathiazol,Tocris,5186,Neuropathiazol,-9.388290,x0104,3.504415,active-noncovalent
c1cc(cnc1)CSc2ncccn2,BRD-K10415035-001-04-4,tasuldine,Labotest,LT02086585,2-[(3-pyridinylmethyl)sulfanyl]pyrimidine,-9.387920,x0678,-1.408943,active-noncovalent
c1cc(cnc1)CSc2ncccn2,BRD-K10415035-001-03-6,tasuldine,Vitas-M,STK829713,,-9.387920,x0678,-1.408943,active-noncovalent
COc1cc2c(cc1C(=O)NC[C@H]3CCC[N@@H+]3CC=C)nn[nH]2,BRD-A03061970-003-07-3,alizapride,Selleck,S4257,Alizapride HCl,-9.387300,x0107,0.333682,active-noncovalent
c1ccc2c(c1)[NH+]=C(c3cc(ccc3O2)Cl)N4CC[NH2+]CC4,BRD-K02265150-001-26-5,amoxapine,MicroSource,2300161,AMOXAPINE,-9.387011,x0749,0.510658,active-covalent
c1ccc2c(c1)[NH+]=C(c3cc(ccc3O2)Cl)N4CC[NH2+]CC4,BRD-K02265150-001-25-7,amoxapine,Selleck,S4218,Amoxapine,-9.387011,x0749,0.510658,active-covalent
c1ccc2c(c1)[NH+]=C(c3cc(ccc3O2)Cl)N4CC[NH2+]CC4,BRD-K02265150-001-27-3,amoxapine,Selleck,S4218,Amoxapine,-9.387011,x0749,0.510658,active-covalent
c1ccc2c(c1)CC[C@H](C2=O)C[NH2+]CCc3ccc(cc3)O,BRD-A24429032-003-03-2,BE-2254,Biotrend,BN0248,"2-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)-3,4-dihydro-1(2H)-naphthalenone hydrochloride",-9.386230,x1093,-0.367716,active-noncovalent
c1ccc2c(c1)CC[C@H](C2=O)C[NH2+]CCc3ccc(cc3)O,BRD-A24429032-003-02-4,BE-2254,Tocris,535,HEAT hydrochloride,-9.386230,x1093,-0.367716,active-noncovalent
c1ccc(cc1)N/C(=[NH+]\c2ccccc2)/N,BRD-K12362304-001-07-3,diphenylguanidine,Vitas-M,STK802182,,-9.385555,x0749,-0.656268,active-covalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-389-04-0,dovitinib,Selleck,S2769,Dovitinib Dilactic acid (TKI258 Dilactic aci,-9.384596,x0161,7.610374,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-389-03-2,dovitinib,Selleck,S2769,Dovitinib (TKI-258) Dilactic Acid,-9.384596,x0161,7.610374,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-406-01-8,dovitinib,Selleck,S7765,Dovitinib (TKI258) Lactate,-9.384596,x0161,7.610374,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-001-06-6,dovitinib,Selleck,S1018,"Dovitinib (TKI-258, CHIR-258)",-9.384596,x0161,7.610374,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-043-01-9,dovitinib,Selleck,S7765,2-hydroxypropanoic acid compound with 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2-quinolinol (1:1),-9.384596,x0161,7.610374,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,BRD-K85402309-001-07-4,dovitinib,Selleck,S1018,Dovitinib (TKI-258),-9.384596,x0161,7.610374,active-noncovalent
Cc1ccccc1n2c(nc3cccc(c3c2=O)C)Cn4c5c(c(n4)c6cccc(c6)O)c(ncn5)N,BRD-K50631926-001-02-3,PIK-294,Selleck,S2227,PIK-294,-9.383097,x0161,6.291946,active-noncovalent
COc1ccc(cc1)n2c(cc(n2)C(F)(F)F)c3ccc(cc3)Cl,BRD-K14767410-001-02-3,SC-560,Tocris,1550,SC 560,-9.382140,x1093,1.42345,active-noncovalent
COc1ccc(cc1)n2c(cc(n2)C(F)(F)F)c3ccc(cc3)Cl,BRD-K14767410-001-03-1,SC-560,Tocris,1550,SC 560,-9.382140,x1093,1.42345,active-noncovalent
c1cc(ccc1C(=O)[O-])OCCn2ccnc2,BRD-K82767007-001-01-1,dazoxiben,AKSci,K385,,-9.382040,x0749,-1.337547,active-covalent
c1ccc(c(c1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,BRD-K64614248-001-12-3,salicin,MicroSource,1502255,SALICIN,-9.380294,x0678,0.521346,active-noncovalent
c1ccc(c(c1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,BRD-K64614248-001-11-5,salicin,Selleck,S2351,Salicin,-9.380294,x0678,0.521346,active-noncovalent
c1c2c3c4c(cc(c(c4oc2=O)O)O)c(=O)oc3c(c1O)O,BRD-K30466858-001-09-6,ellagic-acid,MicroSource,1502245,ELLAGIC ACID,-9.379889,x0195,1.100985,active-noncovalent
c1c2c3c4c(cc(c(c4oc2=O)O)O)c(=O)oc3c(c1O)O,BRD-K30466858-001-08-8,ellagic-acid,Selleck,S1327,Ellagic acid,-9.379889,x0195,1.100985,active-noncovalent
c1c2c3c4c(cc(c(c4oc2=O)O)O)c(=O)oc3c(c1O)O,BRD-K30466858-001-10-4,ellagic-acid,Selleck,S1327,Ellagic acid,-9.379889,x0195,1.100985,active-noncovalent
CCC[NH+](CCC)[C@H]1CCc2cccc(c2C1)O,BRD-A48015106-004-08-9,8-hydroxy-DPAT,Tocris,529,8-Hydroxy-DPAT hydrobromide,-9.379035,x0195,-1.029992,active-noncovalent
COC(=O)C[C@H]1CC(=NO1)c2ccc(cc2)O,BRD-A94055480-001-01-5,ISO-1,Tocris,4288,ISO 1,-9.377195,x0749,0.032071,active-covalent
CCCCC/C=C\C=C\CCCCCCCCC(=O)[O-],BRD-K26222048-001-01-7,"trans-10,cis-12-Conjugated-linoleic-acid",Cayman,90145,,-9.376455,x0104,5.130482,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)NO,BRD-A90926615-001-02-7,adrafinil,MedChemEx,HY-17549,Adrafinil,-9.376151,x0678,0.987589,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)NO,BRD-A90926615-001-01-9,adrafinil,MedChemEx,HY-17549,Adrafinil,-9.376151,x0678,0.987589,active-noncovalent
c1cc2c(cc1C[NH+]3CCN(CC3)C(=O)Nc4cnccc4Cl)OC(O2)(F)F,BRD-K70330032-001-01-1,JNJ-42165279,MedChemEx,HY-19636,JNJ-42165279,-9.376109,x0107,4.230158,active-noncovalent
c1cc(ccc1/C=C/c2ccc(cc2O)C(=[NH2+])N)C(=[NH2+])N,BRD-K62186992-334-02-8,hydroxystilbamidine,Enzo,ENZ-52253,Hydroxystilbamidine (ultra pure),-9.374925,x0874,6.895026,active-noncovalent
CCc1cccc2c1[nH]c3c2CCO[C@@]3(CC)CC(=O)[O-],BRD-A74667430-001-23-6,etodolac,MicroSource,1501005,ETODOLAC,-9.373430,x0749,0.734239,active-covalent
CCc1cccc2c1[nH]c3c2CCO[C@@]3(CC)CC(=O)[O-],BRD-A74667430-001-25-1,etodolac,Selleck,S1328,Etodolac,-9.373430,x0749,0.734239,active-covalent
c1cc(cc(c1)Oc2ccc(cn2)C(F)(F)F)CC3CCN(CC3)C(=O)Nc4cccnc4,BRD-K68997413-001-06-9,PF-3845,Tocris,4175,PF 3845,-9.372594,x0195,8.248158,active-noncovalent
c1cc(cc(c1)Oc2ccc(cn2)C(F)(F)F)CC3CCN(CC3)C(=O)Nc4cccnc4,BRD-K68997413-001-05-1,PF-3845,Selleck,S2666,PF-3845,-9.372594,x0195,8.248158,active-noncovalent
CC(=O)NCCCOc1ccc(cc1)C(=O)N2CCC(CC2)N3c4ccccc4CCC3=O,BRD-K19426040-001-01-1,OPC-21268,Sigma,MFCD00903893,"N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)piperidine-1-carbonyl)phenoxy)propyl)acetamide",-9.372251,x0161,9.214052,active-noncovalent
CC(=O)NCCCOc1ccc(cc1)C(=O)N2CCC(CC2)N3c4ccccc4CCC3=O,BRD-K19426040-001-02-9,OPC-21268,Tocris,3924,OPC 21268,-9.372251,x0161,9.214052,active-noncovalent
CC(C)(C)[NH2+]Cc1cc(c2c(c1O)CCCC2)Nc3ccnc4c3ccc(c4)Cl,BRD-K13664493-316-02-5,naphthoquine-phosphate,MedChemEx,HY-17036,Naphthoquine (phosphate),-9.372123,x0678,1.111247,active-noncovalent
CC(C)(C)[NH2+]Cc1cc(c2c(c1O)CCCC2)Nc3ccnc4c3ccc(c4)Cl,BRD-K13664493-316-01-7,naphthoquine-phosphate,MedChemEx,HY-17036,Naphthoquine (phosphate),-9.372123,x0678,1.111247,active-noncovalent
CC(C)(C)[NH2+]Cc1cc(c2c(c1O)CCCC2)Nc3ccnc4c3ccc(c4)Cl,BRD-K13664493-316-03-3,naphthoquine-phosphate,MedChemEx,HY-17036,Naphthoquine (phosphate),-9.372123,x0678,1.111247,active-noncovalent
CCn1c2ccccc2n(c1=O)[C@H]3CCC[N@](C3)c4nccc(n4)c5cc6ccccc6o5,BRD-K26041695-001-02-5,TC-F-2,Tocris,4355,TC-F 2,-9.372011,x0161,9.66547,active-noncovalent
CC(C)NC(=O)N1CC[C@@H](C1)NC2=[NH+]c3cc(ccc3N(c4c2cc(cc4)Cl)CC(F)F)F,BRD-K28132190-001-02-0,NVS-PAK1-1,MedChemEx,HY-100519,NVS-PAK1-1,-9.371656,x0678,3.989881,active-noncovalent
CCCC1(CCC2(CC1)CC[N@@H+](C2)CCC[NH+](CC)CC)CCC,BRD-K38527262-300-01-0,atiprimod,Tocris,4580,"3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine dihydrochloride",-9.370800,x0104,2.601796,active-noncovalent
Cc1c2c(c(s1)C)C(=CCC2)c3c[nH]cn3,BRD-K27010807-050-01-3,TC-G-1000,Tocris,5021,TC-G 1000,-9.370176,x0195,-2.071837,active-noncovalent
CCOc1cc(cnc1)/C=C/CC[NH2+]C,BRD-K24227647-364-02-3,TC2559,Tocris,2737,(2E)-2-butenedioic acid compound with (3E)-4-(5-ethoxy-3-pyridinyl)-N-methyl-3-buten-1-amine (2:1),-9.369229,x0397,1.597342,active-noncovalent
CCOc1cc(cnc1)/C=C/CC[NH2+]C,BRD-K24227647-364-01-5,TC2559,Tocris,2737,TC 2559 difumarate,-9.369229,x0397,1.597342,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,BRD-A46393198-003-16-6,tetramisole,MicroSource,1505679,TETRAMIZOLE HYDROCHLORIDE,-9.368332,x1093,-1.904203,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,BRD-A46393198-003-15-8,tetramisole,Selleck,S4094,Tetramisole HCl,-9.368332,x1093,-1.904203,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-001-05-0,amlodipine,Selleck,S1905,Amlodipine (Norvasc),-9.366956,x0678,2.934608,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-074-10-7,amlodipine,Tocris,2571,Amlodipine besylate,-9.366956,x0678,2.934608,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-001-03-5,amlodipine,Selleck,S1905,Amlodipine,-9.366956,x0678,2.934608,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-074-06-5,amlodipine,Selleck,S1813,Amlodipine besylate (Norvasc),-9.366956,x0678,2.934608,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-074-09-9,amlodipine,MicroSource,1505202,AMLODIPINE BESYLATE,-9.366956,x0678,2.934608,active-noncovalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1COCC[NH3+])C(=O)OC)c2ccccc2Cl,BRD-A22032524-074-07-3,amlodipine,Tocris,2571,Amlodipine besylate,-9.366956,x0678,2.934608,active-noncovalent
CC(C)(C(=O)[O-])OCc1c2ccccc2n(n1)Cc3ccccc3,BRD-K36467523-001-02-8,bindarit,Selleck,S3032,Bindarit,-9.366777,x0678,2.153188,active-noncovalent
C[NH2+]CCC=C1c2ccccc2CCc3c1cccc3,BRD-K91263825-003-21-4,nortriptyline,MicroSource,1500442,NORTRIPTYLINE HYDROCHLORIDE,-9.365887,x0072,-1.127926,active-noncovalent
C[N@@H+]1[C@H]2C[C@@H](C[C@@H]1[C@H](C2)O)OC(=O)[C@H](CO)c3ccccc3,BRD-A29623586-001-01-3,anisodamine,MicroSource,300047,ANISODAMINE HYDROBROMIDE,-9.365223,x0749,0.020989,active-covalent
C[NH+]1CCN(CC1)c2cccc(c2)Nc3nc4c(cccn4n3)c5ccc(cc5)S(=O)(=O)C,BRD-K37237504-001-02-7,CEP-33779,Selleck,S2806,CEP-33779,-9.364603,x0195,8.894898,active-noncovalent
C[NH+]1CCN(CC1)c2cccc(c2)Nc3nc4c(cccn4n3)c5ccc(cc5)S(=O)(=O)C,BRD-K37237504-001-03-5,CEP-33779,Selleck,S2806,CEP33779,-9.364603,x0195,8.894898,active-noncovalent
c1cc(ccc1CCNC(=S)N2CCCc3cc(c(cc3C2)O)O)Cl,BRD-K44849676-001-11-3,capsazepine,Tocris,464,Capsazepine,-9.364472,x1093,1.9107,active-noncovalent
c1cc(ccc1CCNC(=S)N2CCCc3cc(c(cc3C2)O)O)Cl,BRD-K44849676-001-10-5,capsazepine,Tocris,464,Capsazepine,-9.364472,x1093,1.9107,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K27316855-001-15-8,calcitriol,Selleck,S1466,Calcitriol,-9.360444,x0104,7.278868,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K27316855-001-13-3,calcitriol,Selleck,S1466,Calcitriol (Rocaltrol),-9.360444,x0104,7.278868,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K27316855-001-19-0,calcitriol,Selleck,S1466,Calcitriol,-9.360444,x0104,7.278868,active-noncovalent
C[C@]12CC[C@@H](CC1=CC[C@H]3[C@@H]2CC[C@]4([C@@H]3CC=C4n5cnc6c5cccc6)C)O,BRD-A07986123-001-02-8,galeterone,Selleck,S2803,Galeterone,-9.359307,x1077,5.459044,active-noncovalent
c1cc2c(cc1Cl)c3c(o2)c(=O)[nH]c(n3)[C@@H]4CCC[NH2+]4,BRD-K12511835-003-01-2,BMS-863233,MedChemEx,HY-15260A,XL413 (hydrochloride),-9.357981,x0195,-0.566487,active-noncovalent
c1cc2c(cc1Cl)c3c(o2)c(=O)[nH]c(n3)[C@@H]4CCC[NH2+]4,BRD-K12511835-003-02-0,BMS-863233,MedChemEx,HY-15260A,XL413 (hydrochloride),-9.357981,x0195,-0.566487,active-noncovalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH+](CC3)C)C(=O)[O-],BRD-K55034111-066-17-1,pefloxacin,MicroSource,1505305,PEFLOXACINE MESYLATE,-9.355707,x0749,4.797441,active-covalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH+](CC3)C)C(=O)[O-],BRD-K55034111-066-16-3,pefloxacin,Selleck,S1855,Pefloxacin Mesylate,-9.355707,x0749,4.797441,active-covalent
Cn1cc(c(n1)c2ccc(cc2)OCc3ccc4ccccc4n3)c5ccncc5,BRD-K31519811-001-02-2,PF-02545920,Selleck,S2687,,-9.352696,x0161,6.076531,active-noncovalent
C[N@@H+]1CCCC[C@H]1Cn2cc(c3c2cccc3)C(=O)c4cc(ccc4I)N(=O)=O,BRD-A66116161-001-02-3,AM-1241,Selleck,S1544,AM1241,-9.352086,x0104,5.060391,active-noncovalent
c1ccc(c(c1)C[N@H+]2CCc3c(ccs3)C2)Cl,BRD-K00603606-003-23-2,ticlopidine,Selleck,S1984,Ticlopidine HCl,-9.350121,x0749,-1.74808,active-covalent
c1ccc(c(c1)C[N@H+]2CCc3c(ccs3)C2)Cl,BRD-K00603606-003-24-0,ticlopidine,MicroSource,1505677,TICLOPIDINE HYDROCHLORIDE,-9.350121,x0749,-1.74808,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)CCCCC#CCCCC#CCO)C,BRD-K08290224-001-14-5,docebenone,Enzo,EI216,Docebenone,-9.349504,x0161,2.715103,active-noncovalent
c1cc(cnc1)Cc2ccc3c(c2)cc(o3)C(=O)[O-],BRD-K55529781-236-03-8,furegrelate,Cayman,70540,sodium 5-(3-pyridinylmethyl)-1-benzofuran-2-carboxylate,-9.349466,x0072,-0.513858,active-noncovalent
CC(C)NC(=[NH2+])N/C(=[NH+]\c1ccc(cc1)Cl)/N,BRD-K28183345-003-11-4,proguanil,MicroSource,1504211,CHLOROGUANIDE HYDROCHLORIDE,-9.348683,x0104,-0.962351,active-noncovalent
c1cc(c2c(c1C(=O)N)C[C@H](CO2)[NH+](C3CCC3)C4CCC4)F,BRD-K26169680-003-01-9,robalzotan,Tocris,3282,NAD 299 hydrochloride,-9.348658,x0434,1.673725,active-noncovalent
c1cc(ccc1/C=C\2/C(=O)[N-]C(=O)S2)OCC(=O)[O-],BRD-K81935556-001-01-0,TCS-3035,Tocris,4244,TCS 3035,-9.348617,x0678,0.668832,active-noncovalent
C[NH+]1CCN(CC1)c2nc3ccccc3c(n2)C4=C(C(=O)NC4=O)c5c[nH]c6c5cccc6,BRD-K16761703-001-03-8,sotrastaurin,Selleck,S2791,Sotrastaurin,-9.348500,x1077,5.068157,active-noncovalent
C[C@@H](C(=O)NCC(=O)[O-])SC(=O)c1cccs1,BRD-A04506385-001-01-2,stepronin,AKSci,H988,,-9.348361,x0678,-0.169289,active-noncovalent
CNC(=O)c1cccc2c1ccc(c2)Oc3ccnc4c3cc(c(c4)OCC5(CC5)[NH3+])OC,BRD-K31309378-001-01-5,lucitanib,MedChemEx,HY-15391,E-3810,-9.345954,x0678,8.279844,active-noncovalent
CC(C)Oc1ccc(cc1)Cc2ccc(cc2)NC3=[NH+]CCN3,BRD-K77220725-003-01-5,Ro-1138452,Tocris,4268,Ro 1138452 hydrochloride,-9.345444,x0195,2.262499,active-noncovalent
C[NH2+][C@H]1CCC[N@](C1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,BRD-A47790386-001-02-8,balofloxacin,Selleck,S2064,Balofloxacin,-9.345179,x1385,4.343602,active-covalent
C[NH2+][C@H]1CCC[N@](C1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,BRD-A47790386-001-03-6,balofloxacin,Selleck,S2064,Balofloxacin,-9.345179,x1385,4.343602,active-covalent
CC(C)(C)Cn1c2c(ccc(n2)c3c([nH]c(n3)C(C)(C)C)c4ccc(cc4)F)nc1N,BRD-K59227464-334-03-2,LY2228820,Selleck,S1494,LY2228820,-9.344195,x0397,3.118697,active-noncovalent
CC(C)(C)Cn1c2c(ccc(n2)c3c([nH]c(n3)C(C)(C)C)c4ccc(cc4)F)nc1N,BRD-K59227464-334-02-4,LY2228820,Selleck,S1494,LY2228820,-9.344195,x0397,3.118697,active-noncovalent
c1cc(ccc1c2c3cc(ccc3no2)c4ccnc(n4)N)Cl,BRD-K48832421-001-02-2,PIM-1-Inhibitor-2,Tocris,3589,PIM-1 Inhibitor 2,-9.343785,x0195,2.299584,active-noncovalent
c1cc(ccc1c2c3cc(ccc3no2)c4ccnc(n4)N)Cl,BRD-K48832421-001-01-4,PIM-1-Inhibitor-2,Tocris,3589,PIM-1 Inhibitor 2,-9.343785,x0195,2.299584,active-noncovalent
C[NH+](C)CC[C@]1(Cc2ccccc2C(=O)O1)c3ccc(cc3)Cl,BRD-A49544621-003-02-8,AC-7954-(+/-),Tocris,2484,(?)-AC 7954 hydrochloride,-9.343503,x0678,0.019139,active-noncovalent
C[NH+](C)CC[C@]1(Cc2ccccc2C(=O)O1)c3ccc(cc3)Cl,BRD-A49544621-003-03-6,AC-7954-(+/-),Tocris,2484,(+/-)-AC 7954 hydrochloride,-9.343503,x0678,0.019139,active-noncovalent
C[C@H]1CCc2cc(cc3c2n1cc(c3=O)C(=O)[O-])F,BRD-A69777949-001-25-9,flumequine,MicroSource,1500992,FLUMEQUINE,-9.342581,x0195,0.274755,active-noncovalent
C[C@H]1CCc2cc(cc3c2n1cc(c3=O)C(=O)[O-])F,BRD-A69777949-001-24-2,flumequine,Selleck,S3181,Flumequine,-9.342581,x0195,0.274755,active-noncovalent
CC(=O)N[C@H](COC)C(=O)NCc1ccccc1,BRD-K68232650-001-02-2,lacosamide,Enzo,550-527,LACOSAMIDE,-9.341306,x0678,0.031007,active-noncovalent
Cn1cc(cn1)c2cc(ccn2)Oc3cc(c(cc3F)NC(=O)C4(CC4)C(=O)Nc5ccccc5)F,BRD-K49246350-001-01-1,DCC-2618,MedChemEx,HY-15240,c-Kit-IN-1,-9.340615,x0161,9.242647,active-noncovalent
CCc1ccccc1OC[C@H](C[NH2+][C@H]2CCCc3c2cccc3)O,BRD-K35430135-003-02-3,SR-59230A,Tocris,1511,SR 59230A hydrochloride,-9.340592,x0104,0.67591,active-noncovalent
CCc1ccccc1OC[C@H](C[NH2+][C@H]2CCCc3c2cccc3)O,BRD-K35430135-003-03-1,SR-59230A,Tocris,1511,SR 59230A hydrochloride,-9.340592,x0104,0.67591,active-noncovalent
c1ccc2c(c1)cc3ccccc3c2C(=O)[O-],BRD-K62607075-001-03-6,9-anthracenecarboxylic-acid,Tocris,963,9-AC,-9.340424,x0195,-0.761674,active-noncovalent
c1ccc(c(c1)c2nc(n(n2)c3ccc(cc3)C(=O)[O-])c4ccccc4O)O,BRD-K97010173-001-04-1,deferasirox,Selleck,S1712,Deferasirox,-9.340232,x0195,3.325718,active-noncovalent
CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)O,BRD-K14395568-001-17-1,NECA,Tocris,1691,NECA,-9.339545,x0195,1.149318,active-noncovalent
CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)O,BRD-K14395568-001-16-3,NECA,Tocris,1691,NECA,-9.339545,x0195,1.149318,active-noncovalent
c1cc(c(cc1Cl)Cl)[C@@H]2CS/C(=C(/C#N)\n3ccnc3)/S2,BRD-K71058253-001-01-9,luliconazole,Selleck,S4258,Luliconazole,-9.338475,x0678,1.562865,active-noncovalent
C[C@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-K09471561-001-20-8,levofloxacin,Selleck,S1940,Levofloxacin,-9.338314,x0195,2.524483,active-noncovalent
C[C@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-K09471561-001-18-2,levofloxacin,MicroSource,1504260,LEVOFLOXACIN,-9.338314,x0195,2.524483,active-noncovalent
CN(C)C(=O)c1cc(cnc1)c2cc3c(c[nH]c3nc2)c4ccccc4OC,BRD-K72514671-001-01-4,PPY-A,Tocris,4730,PPY A,-9.337721,x0104,3.17005,active-noncovalent
c1ccc(c(c1)C(=O)Oc2ccccc2C(=O)[O-])O,BRD-K48892307-001-05-8,sasapyrine,MicroSource,200331,SALSALATE,-9.337203,x0749,-0.240217,active-covalent
c1ccc(c(c1)C(=O)Oc2ccccc2C(=O)[O-])O,BRD-K48892307-001-04-1,sasapyrine,Selleck,S4188,Sasapyrine,-9.337203,x0749,-0.240217,active-covalent
c1cc2c(c(c1)C(F)(F)F)nn(c2c3ccc(cc3)F)Cc4ccc(cc4Cl)F,BRD-K54520417-001-01-2,LXR-623,MedChemEx,HY-10629,LXR-623,-9.337075,x0195,2.131178,active-noncovalent
C[NH+]1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4ccc(cc4F)Br,BRD-K77625799-001-07-7,vandetanib,Selleck,S1046,Vandetanib (ZD6474),-9.335220,x0104,7.877265,active-noncovalent
CCCC[NH+]1CCC(CC1)CCC(=O)c2cc(c(cc2OC)N)Cl,BRD-K46142322-003-02-4,RS-67333,Tocris,989,RS 67333 hydrochloride,-9.334247,x0161,2.295918,active-noncovalent
c1ccc(cc1)NC(=O)N[C@H]2C[C@@H](Nc3c2c(cc(c3)Cl)Cl)C(=O)[O-],BRD-K74284736-001-02-3,L-689560,Tocris,742,"L-689,560",-9.334015,x0434,1.264616,active-noncovalent
c1ccc(cc1)NC(=O)N[C@H]2C[C@@H](Nc3c2c(cc(c3)Cl)Cl)C(=O)[O-],BRD-K74284736-001-03-1,L-689560,Tocris,742,"L-689,560",-9.334015,x0434,1.264616,active-noncovalent
C[NH+]1CCN(CC1)c2c(nc3ccccc3n2)Cl,BRD-K11046126-001-02-0,VUF10166,Selleck,S2865,VUF 10166,-9.333606,x0749,0.854416,active-covalent
CCC(=O)NCC[C@@H]1CCc2c1c3c(cc2)OCC3,BRD-K28761891-001-10-1,ramelteon,MicroSource,1505817,RAMELTEON,-9.332843,x0104,-0.012259,active-noncovalent
CCC(=O)NCC[C@@H]1CCc2c1c3c(cc2)OCC3,BRD-K28761891-001-09-3,ramelteon,Selleck,S1259,Ramelteon,-9.332843,x0104,-0.012259,active-noncovalent
c1cc(c(c(c1CNNC(=O)[C@@H](CO)[NH3+])O)O)O,BRD-A61194565-003-27-0,benserazide,Selleck,S2453,Benserazide HCl,-9.332733,x0104,-1.435634,active-noncovalent
c1cc(c(c(c1CNNC(=O)[C@@H](CO)[NH3+])O)O)O,BRD-A61194565-003-28-8,benserazide,MicroSource,1500137,BENSERAZIDE HYDROCHLORIDE,-9.332733,x0104,-1.435634,active-noncovalent
C[C@@H](c1ccc(cc1)C[C@H]2CCCC2=O)C(=O)[O-],BRD-A43082555-001-01-1,loxoprofen,MedChemEx,HY-B0578,Loxoprofen,-9.331327,x0678,-0.633313,active-noncovalent
C[C@@H](c1ccc(cc1)C[C@H]2CCCC2=O)C(=O)[O-],BRD-A43082555-001-02-9,loxoprofen,MicroSource,1502386,LOXOPROFEN,-9.331327,x0678,-0.633313,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]C3CC[NH2+]CC3,BRD-K33521504-300-02-4,GSK-LSD-1,Tocris,5361,GSK LSD 1 dihydrochloride,-9.330963,x0749,-1.275333,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-A14886633-001-01-6,norgestrel,MicroSource,1500441,NORGESTREL,-9.329967,x0749,4.16126,active-covalent
C[N@H+]1CC[C@@H]2C[N@@]3CCc4c3c(ccc4)[C@@H]2C1,BRD-K31339597-051-02-0,SDZ-SER-082,Tocris,1255,SDZ SER 082 fumarate,-9.329713,x0195,-0.695587,active-noncovalent
Cc1cccc(c1)NC(=O)C[NH+]2CCC(CC2)c3ccccn3,BRD-K62066682-300-01-0,A-412997,Tocris,4552,A 412997 dihydrochloride,-9.328516,x0104,4.054005,active-noncovalent
Cc1c(cc(cc1F)C(=O)NC2CC2)c3c(cn4c(c3F)nnc4C(C)(C)C)F,BRD-K44731351-001-01-6,AL-8697,Tocris,4753,AL 8697,-9.326617,x0161,3.207835,active-noncovalent
Cc1ccc2c(c1)[C@@H]3C[N@H+](CC[C@@H]3N2)C,BRD-A85069489-300-01-4,stobadine,Enamine,EN300-02336,"2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole dihydrochloride",-9.324917,x0195,-1.149718,active-noncovalent
Cc1ccc2c(c1)[C@@H]3C[N@H+](CC[C@@H]3N2)C,BRD-A85069489-001-01-8,stobadine,ChemBridge,5373119,,-9.324917,x0195,-1.149718,active-noncovalent
c1ccc(cc1)OC(=O)c2ccccc2O,BRD-K44091963-001-01-5,phenyl-salicylate,Enamine,Z57206005,,-9.324636,x0749,-1.283359,active-covalent
C[NH+](C)Cc1ccc(cc1)c2nc3cccc4c3n2CCNC4=O,BRD-K00615600-001-13-7,AG-14361,Selleck,S2178,AG14361,-9.323046,x0161,2.678853,active-noncovalent
C[NH+](C)Cc1ccc(cc1)c2nc3cccc4c3n2CCNC4=O,BRD-K00615600-001-12-9,AG-14361,Selleck,S2178,AG-14361,-9.323046,x0161,2.678853,active-noncovalent
C[N@H+]1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@@H](c3ccccc3)O,BRD-K66206289-003-20-5,lobeline,Tocris,1077,(-)-Lobeline hydrochloride,-9.322324,x0749,1.732565,active-covalent
C[N@H+]1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@@H](c3ccccc3)O,BRD-K66206289-003-21-3,lobeline,MedChemEx,HY-B0979,Lobeline (hydrochloride),-9.322324,x0749,1.732565,active-covalent
C[N@H+]1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@@H](c3ccccc3)O,BRD-K66206289-065-01-4,lobeline,Sigma,MFCD00135592,"sulfuric acid compound with 2-{(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methyl-2-piperidinyl}-1-phenylethanone (1:2)",-9.322324,x0749,1.732565,active-covalent
C[N@H+]1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@@H](c3ccccc3)O,BRD-K66206289-003-22-1,lobeline,MedChemEx,HY-B0979,Lobeline (hydrochloride),-9.322324,x0749,1.732565,active-covalent
Cn1cc(c2c1cccc2)/C=C\3/c4c(cccn4)NC3=O,BRD-K41312087-001-01-9,GW-441756,Selleck,S2891,GW441756,-9.322012,x1093,0.221848,active-noncovalent
Cn1cc(c2c1cccc2)/C=C\3/c4c(cccn4)NC3=O,BRD-K41312087-001-02-7,GW-441756,Tocris,2238,GW 441756,-9.322012,x1093,0.221848,active-noncovalent
Cc1nnc(o1)c2ccc3c(c2)c(co3)c4ccc(cc4)[S@@](=O)C,BRD-A50028488-001-02-4,TCS2002,Tocris,3869,TCS 2002,-9.321280,x0195,2.901548,active-noncovalent
Cc1nnc(o1)c2ccc3c(c2)c(co3)c4ccc(cc4)[S@@](=O)C,BRD-A50028488-001-01-6,TCS2002,Tocris,3869,TCS 2002,-9.321280,x0195,2.901548,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc(c(c6c5c4[C@H](CC6)[NH3+])C)F)O,BRD-K92150287-066-01-2,exatecan-mesylate,MedChemEx,HY-13631A,Exatecan (Mesylate),-9.319754,x0104,6.22658,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc(c(c6c5c4[C@H](CC6)[NH3+])C)F)O,BRD-K92150287-066-02-0,exatecan-mesylate,MedChemEx,HY-13631A,Exatecan (Mesylate),-9.319754,x0104,6.22658,active-noncovalent
c1ccc(cc1)C2CC[NH+](CC2)[C@@H]3CCCC[C@H]3O,BRD-K14765469-003-13-0,vesamicol,Tocris,653,(+/-)-Vesamicol hydrochloride,-9.319476,x0104,0.088278,active-noncovalent
c1ccc(cc1)C2CC[NH+](CC2)[C@@H]3CCCC[C@H]3O,BRD-K14765469-003-12-2,vesamicol,Tocris,653,(?)-Vesamicol hydrochloride,-9.319476,x0104,0.088278,active-noncovalent
CC[C@@H](/C(=C/c1ccc(cc1)F)/C)N=O,BRD-K70744942-001-01-2,A-967079,Tocris,4716,A 967079,-9.319243,x0678,-1.374177,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,BRD-K97197005-001-03-2,gestodene,Selleck,S1376,Gestodene,-9.319020,x0749,2.7316,active-covalent
C[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3c4ccc(cc4)F)C(=O)[O-],BRD-K73923631-003-02-9,difloxacin,MicroSource,1502359,DIFLOXACIN HYDROCHLORIDE,-9.318671,x0195,5.137875,active-noncovalent
C[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3c4ccc(cc4)F)C(=O)[O-],BRD-K73923631-003-01-1,difloxacin,Selleck,S4384,Difloxacin HCl,-9.318671,x0195,5.137875,active-noncovalent
CCC[N@@H+]1CCO[C@H]2[C@H]1COc3c2cc(cc3)O,BRD-K62456038-003-07-1,PD-128907,Tocris,1243,(+)-PD 128907 hydrochloride,-9.317713,x0195,-0.49189,active-noncovalent
Cc1cc(nc2c1cccc2)N3CCCCC3,BRD-K80021413-001-08-8,ML204,MedChemEx,HY-12949,ML204,-9.317640,x0195,-0.415697,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O)C,BRD-K60005752-001-01-9,S-111,MedChemEx,HY-N0797,(20S)-Protopanaxadiol,-9.317621,x0161,4.997224,active-noncovalent
Cc1ccc(cc1)[C@]23C[C@H]2C[NH2+]C3,BRD-A24208517-003-01-8,bicifadine,Tocris,4357,Bicifadine hydrochloride,-9.315760,x0161,-0.287771,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3cccc4c3cccc4)c(ncn2)N,BRD-K29542628-001-03-9,1-naphthyl-PP1,Tocris,3063,1-Naphthyl PP1,-9.314613,x0830,0.686518,active-covalent
CC(C)(C)n1c2c(c(n1)c3cccc4c3cccc4)c(ncn2)N,BRD-K29542628-001-04-7,1-naphthyl-PP1,Tocris,3063,1-Naphthyl PP1,-9.314613,x0830,0.686518,active-covalent
C[C@@H](c1ccccc1)N/C(=N\C#N)/Nc2cccc3c2cccn3,BRD-K76894955-001-02-1,A-804598,Tocris,4473,A 804598,-9.313267,x0104,0.993471,active-noncovalent
C[C@]1(C(=O)N(C(=O)N1C)c2cc(cc(c2)Cl)Cl)Cc3ccc(cc3)Br,BRD-K64880136-001-02-6,BIRT-377,Tocris,4776,BIRT 377,-9.311330,x0195,1.943503,active-noncovalent
c1cc(ccc1c2cc(c(s2)NC(=O)N)C(=O)N)F,BRD-K51575138-001-13-2,TPCA-1,Tocris,2559,TPCA-1,-9.310594,x0749,1.17762,active-covalent
c1cc(ccc1c2cc(c(s2)NC(=O)N)C(=O)N)F,BRD-K51575138-001-12-4,TPCA-1,Selleck,S2824,TPCA-1,-9.310594,x0749,1.17762,active-covalent
c1cc(ccc1c2cc(c(s2)NC(=O)N)C(=O)N)F,BRD-K51575138-001-15-7,TPCA-1,Tocris,2559,TPCA-1,-9.310594,x0749,1.17762,active-covalent
CC1([C@H]2CC[C@@H]([C@@H]1C2)CCOCC[N+]3(CCOCC3)Cc4cc(c(cc4Br)OC)OC)C,BRD-A70998768-004-01-1,pinaverium,Prestwick,Prestw-1601,Pinaverium bromide,-9.310009,x0161,6.106539,active-noncovalent
CCCCOc1c2c[nH]nc2ncc1C(=O)c3c(cc(cc3F)C)F,BRD-K62814476-001-03-3,BMS-265246,Selleck,S2014,BMS-265246,-9.309546,x0107,4.016253,active-noncovalent
CCCCOc1c2c[nH]nc2ncc1C(=O)c3c(cc(cc3F)C)F,BRD-K62814476-001-04-1,BMS-265246,MedChemEx,HY-15275,BMS-265246,-9.309546,x0107,4.016253,active-noncovalent
Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc2ccccc2N,BRD-K02389548-001-04-1,RG2833,MedChemEx,HY-16425,RG2833,-9.308838,x0874,2.680561,active-noncovalent
Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc2ccccc2N,BRD-K02389548-001-02-5,RG2833,Selleck,S7292,RG2833 (RGFP109),-9.308838,x0874,2.680561,active-noncovalent
COc1cc(cc(c1OC)OC)C[C@@H]2c3cc(c(cc3CC[NH2+]2)O)O,BRD-A56241705-003-01-2,trimethoquinol,Sigma,PH013924,"1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol hydrochloride",-9.308619,x1077,1.361146,active-noncovalent
c1ccc2c(c1)ccc3c2ccc(c3)c4cc(nn4c5ccc(cc5)NC(=O)C[NH3+])C(F)(F)F,BRD-K90497590-001-07-5,AR-12,Adooq,A10681,2-amino-N-{4-[5-(2-phenanthryl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}acetamide,-9.305825,x0072,7.257397,active-noncovalent
c1ccc2c(c1)ccc3c2ccc(c3)c4cc(nn4c5ccc(cc5)NC(=O)C[NH3+])C(F)(F)F,BRD-K90497590-001-05-9,AR-12,Selleck,S1106,OSU-03012 (AR-12),-9.305825,x0072,7.257397,active-noncovalent
c1ccc2c(c1)ccc3c2ccc(c3)c4cc(nn4c5ccc(cc5)NC(=O)C[NH3+])C(F)(F)F,BRD-K90497590-001-08-3,AR-12,Tocris,5682,OSU 03012,-9.305825,x0072,7.257397,active-noncovalent
c1ccc2c(c1)ccc3c2ccc(c3)c4cc(nn4c5ccc(cc5)NC(=O)C[NH3+])C(F)(F)F,BRD-K90497590-001-04-2,AR-12,Selleck,S1106,OSU-03012 (AR-12),-9.305825,x0072,7.257397,active-noncovalent
c1ccc2c(c1)C(=O)OC23c4ccc(cc4Oc5c3ccc(c5)O)O,BRD-K21913543-001-02-4,fluorescein,MicroSource,1505396,FLUORESCEIN,-9.304455,x0831,0.399858,active-covalent
c1ccc(cc1)/N=N/c2ccc(nc2N)N,BRD-K76304753-003-21-1,phenazopyridine,Selleck,S4235,Phenazopyridine HCl,-9.304213,x0749,1.381834,active-covalent
c1ccc(cc1)/N=N/c2ccc(nc2N)N,BRD-K76304753-003-19-5,phenazopyridine,Selleck,S4235,Phenazopyridine HCl,-9.304213,x0749,1.381834,active-covalent
c1ccc(cc1)/N=N/c2ccc(nc2N)N,BRD-K76304753-003-20-3,phenazopyridine,MicroSource,1500473,PHENAZOPYRIDINE HYDROCHLORIDE,-9.304213,x0749,1.381834,active-covalent
Cc1cc(c(c(c1/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)C)C)OC,BRD-K62012036-001-13-6,acitretin,Selleck,S1368,Acitretin,-9.304125,x0104,6.295088,active-noncovalent
Cc1cc(c(c(c1/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)C)C)OC,BRD-K62012036-001-14-4,acitretin,Selleck,S1368,Acitretin,-9.304125,x0104,6.295088,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2cccc3c2cccc3N(C)C)C,BRD-K56509348-003-02-1,BMS-182874,Tocris,1441,BMS 182874 hydrochloride,-9.303789,x0107,2.407321,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2cccc3c2cccc3N(C)C)C,BRD-K56509348-003-03-9,BMS-182874,Tocris,1441,BMS 182874 hydrochloride,-9.303789,x0107,2.407321,active-noncovalent
c1ccc(cc1)CNC(=O)N2CCC(=O)N3[C@@H]2CN(C(=O)[C@H]3Cc4ccc(cc4)O)Cc5cccc6c5cccc6,BRD-K94455792-001-01-8,ICG-001,Selleck,S2662,ICG-001,-9.300878,x0161,10.147171,active-noncovalent
C[NH2+][C@H](CC(=O)[O-])C(=O)[O-],BRD-K62414032-001-13-8,NMDA,Tocris,114,NMDA,-9.300823,x0397,-0.277207,active-noncovalent
C[NH2+][C@H](CC(=O)[O-])C(=O)[O-],BRD-K62414032-001-12-0,NMDA,Selleck,S7072,NMDA (N-Methyl-D-aspartic acid),-9.300823,x0397,-0.277207,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cccc(c2)OC(=O)NC3CCCCC3,BRD-K92169341-001-12-0,URB597,Tocris,4612,URB 597,-9.300161,x0434,4.197375,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cccc(c2)OC(=O)NC3CCCCC3,BRD-K92169341-001-11-2,URB597,Selleck,S2631,URB597,-9.300161,x0434,4.197375,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cccc(c2)OC(=O)NC3CCCCC3,BRD-K92169341-001-10-4,URB597,Selleck,S2631,URB597,-9.300161,x0434,4.197375,active-noncovalent
c1ccc(cc1)C(CC[NH2+]CC(=O)N)c2ccccc2,BRD-K41143549-003-02-4,N20C,Tocris,2213,N20C hydrochloride,-9.300006,x0678,-0.220127,active-noncovalent
COc1ccc(cc1)c2cc(=S)ss2,BRD-K92490248-001-06-6,anethole-trithione,MedChemEx,HY-B1223,Anethole (trithione),-9.299651,x0749,-0.10582,active-covalent
COc1ccc(cc1)c2cc(=S)ss2,BRD-K92490248-001-04-1,anethole-trithione,Enzo,DL151,Anethole-trithione (anetholtrithion),-9.299651,x0749,-0.10582,active-covalent
C[C@H](C(C)(C)C)/N=C(/NC#N)\Nc1cc[nH+]cc1,BRD-A43882281-001-14-8,pinacidil,Selleck,S4366,Pinacidil,-9.298676,x0434,0.166477,active-noncovalent
C[C@H](C(C)(C)C)/N=C(/NC#N)\Nc1cc[nH+]cc1,BRD-A43882281-001-15-5,pinacidil,MicroSource,2300270,PINACIDIL,-9.298676,x0434,0.166477,active-noncovalent
Cc1cc(ccn1)c2ccc(cc2)CC(=O)Nc3ccc(cc3)c4cccnc4,BRD-K78455053-001-01-2,wnt-c59,Selleck,S7037,Wnt-C59 (C59),-9.297937,x0161,10.530983,active-noncovalent
Cc1cc(ccn1)c2ccc(cc2)CC(=O)Nc3ccc(cc3)c4cccnc4,BRD-K78455053-001-02-0,wnt-c59,Tocris,5148,Wnt-C59,-9.297937,x0161,10.530983,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1)N,BRD-K24616672-003-19-3,procaine,Selleck,S4023,Procaine HCl,-9.296793,x0104,-0.131834,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1)N,BRD-K24616672-003-20-1,procaine,MicroSource,1500504,PROCAINE HYDROCHLORIDE,-9.296793,x0104,-0.131834,active-noncovalent
CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCc4c3ccc(c4)O)C,BRD-K66766661-001-19-2,estradiol-valerate,MicroSource,1500284,ESTRADIOL VALERATE,-9.296108,x0161,4.174718,active-noncovalent
CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCc4c3ccc(c4)O)C,BRD-K66766661-001-20-0,estradiol-valerate,Selleck,S3149,Estradiol valerate,-9.296108,x0161,4.174718,active-noncovalent
c1ccc(cc1)CC[C@@H](C(=O)[O-])[NH2+][C@@H](CCCC[NH3+])C(=O)N2CCC[C@H]2C(=O)[O-],BRD-K67966701-001-10-8,lisinopril,Selleck,S2076,Lisinopril (Zestril),-9.295654,x0967,3.510908,active-noncovalent
c1ccc(cc1)CC[C@@H](C(=O)[O-])[NH2+][C@@H](CCCC[NH3+])C(=O)N2CCC[C@H]2C(=O)[O-],BRD-K67966701-001-12-4,lisinopril,Selleck,S2076,Lisinopril (Zestril),-9.295654,x0967,3.510908,active-noncovalent
c1ccc(cc1)CC[C@@H](C(=O)[O-])[NH2+][C@@H](CCCC[NH3+])C(=O)N2CCC[C@H]2C(=O)[O-],BRD-K67966701-001-11-6,lisinopril,MicroSource,1501217,LISINOPRIL,-9.295654,x0967,3.510908,active-noncovalent
Cc1cccc(n1)/C=C/c2ccccc2,BRD-K14561059-001-05-9,SIB-1893,Tocris,1214,SIB 1893,-9.295340,x0749,1.189825,active-covalent
C[NH2+][C@@H]1CCc2c(c3cc(ccc3[nH]2)C(=O)N)C1,BRD-K08255599-365-01-1,frovatriptan,Sigma,SML1291,"(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate hydrate",-9.294839,x0749,-1.356077,active-covalent
Cc1ccccc1CN2C3=C(C[N@@H+](CC3)Cc4ccccc4)C(=O)N5C2=[NH+]CC5,BRD-K19939891-001-05-4,TIC10,Selleck,S7127,TIC10,-9.294329,x0104,3.559674,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@@H](COP(=O)([O-])[O-])O)O)O,BRD-K09229706-236-02-6,riboflavin-5-phosphate-sodium,MedChemEx,HY-B0964,Riboflavin (phosphate sodium),-9.291402,x0195,3.461445,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@@H](COP(=O)([O-])[O-])O)O)O,BRD-K09229706-236-01-8,riboflavin-5-phosphate-sodium,Sigma,MFCD00065362,"sodium 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-5-O-(hydroxyphosphinato)-D-ribitol",-9.291402,x0195,3.461445,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)c2ccc(cc2)CCNS(=O)(=O)C,BRD-K42981054-001-01-9,mibampator,MedChemEx,HY-10934,LY451395,-9.289641,x0104,9.322625,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,BRD-K25650355-065-02-0,physostigmine,MicroSource,2300067,PHYSOSTIGMINE SULFATE,-9.288752,x0104,0.686922,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,BRD-K25650355-059-18-9,physostigmine-salicylate,Selleck,S4346,physostigmine salicylate,-9.288752,x0104,0.686922,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,BRD-K25650355-059-19-7,physostigmine-salicylate,Selleck,S4346,Physostigmine Salicylate,-9.288752,x0104,0.686922,active-noncovalent
CCn1c(c(c(=O)c2c1nc(cc2)C#C[C@](C)(COC)O)C(=O)NC)N,BRD-K38904395-001-02-3,SAR131675,Selleck,S2842,SAR131675,-9.288326,x0104,4.191048,active-noncovalent
C[C@@H]1COCCN1c2cc(=O)n3c(n2)N([C@@H](CC3)C(F)(F)F)Cc4cc(cnc4)Cl,BRD-K72868067-001-02-4,SAR405,MedChemEx,HY-12481,SAR405,-9.288322,x0195,4.687108,active-noncovalent
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4c5cccnc5)C)O,BRD-K50071428-001-03-3,abiraterone,Selleck,S1123,Abiraterone (CB-7598),-9.287674,x1077,4.386326,active-noncovalent
CNC(=O)c1ccc2c(c1)S(=O)(=O)c3ccccc3C2=O,BRD-K07061232-001-01-8,BW-616U,Enamine,Z30272279,"N-methyl-10-oxo-10H-dibenzo[b,e]thiopyran-3-carboxamide 5,5-dioxide",-9.285107,x0749,0.592256,active-covalent
c1ccc2c(c1)cccc2Nc3cc(c(c4c3C(=O)c5ccccc5C4=O)N)S(=O)(=O)[O-],BRD-K71266197-236-02-7,PSB-06126,Tocris,2574,PSB 06126,-9.282421,x0831,3.416429,active-covalent
C#CC1(CCCCC1)OC[C@H](C[NH+]2CCN(CC2)c3cccc(c3)C(F)(F)F)O,BRD-A11725667-001-01-8,terciprazine,PrincetonBio,OSSK_922544,1-[(1-ethynylcyclohexyl)oxy]-3-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}-2-propanol,-9.282175,x0161,4.823802,active-noncovalent
C[C@@H](c1ccc(cc1)N2Cc3ccccc3C2=O)C(=O)[O-],BRD-A44090213-001-25-6,indoprofen,MicroSource,1500351,INDOPROFEN,-9.282115,x0678,3.549881,active-noncovalent
C[C@@H](C(=O)N[C@H]1c2ccccc2-c3ccccc3N(C1=O)C)NC(=O)Cc4cc(cc(c4)F)F,BRD-K04622161-001-02-3,YO-01027,Selleck,S2711,YO-01027,-9.281399,x0195,4.730817,active-noncovalent
C[C@@H](C(=O)N[C@H]1c2ccccc2-c3ccccc3N(C1=O)C)NC(=O)Cc4cc(cc(c4)F)F,BRD-K04622161-001-03-1,YO-01027,Tocris,4489,DBZ,-9.281399,x0195,4.730817,active-noncovalent
c1ccc2c(c1)COc3ccc(cc3C2=O)CC(=O)[O-],BRD-K92116564-001-01-4,isoxepac,Ark,AK-35631,,-9.281301,x0678,3.012861,active-noncovalent
CC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)[NH3+],BRD-K22127577-001-02-9,crenolanib,Selleck,S2730,Crenolanib (CP-868596),-9.280574,x0104,5.165656,active-noncovalent
CC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)[NH3+],BRD-K22127577-001-03-7,crenolanib,Selleck,S2730,Crenolanib (CP-868596),-9.280574,x0104,5.165656,active-noncovalent
c1cc(cc(c1)Br)C(=O)N2CCC(CC2)[NH+]3CCCC3,BRD-K22229656-003-01-5,UNC-926,Tocris,4516,UNC 926 hydrochloride,-9.279716,x0104,0.753607,active-noncovalent
CC(C)[N@H+](CCC(=O)c1ccc2ccccc2c1)Cc3ccccc3,BRD-K40624912-003-13-0,ZM-39923,Tocris,1367,ZM 39923 hydrochloride,-9.279579,x0195,3.210639,active-noncovalent
CC(C)[N@H+](CCC(=O)c1ccc2ccccc2c1)Cc3ccccc3,BRD-K40624912-003-15-5,ZM-39923,Tocris,1367,ZM 39923 hydrochloride,-9.279579,x0195,3.210639,active-noncovalent
CC(C)[N@H+](CCC(=O)c1ccc2ccccc2c1)Cc3ccccc3,BRD-K40624912-003-14-8,ZM-39923,Selleck,S8004,ZM 39923 HCl,-9.279579,x0195,3.210639,active-noncovalent
CC(C)[N@H+](CCC(=O)c1ccc2ccccc2c1)Cc3ccccc3,BRD-K40624912-003-12-2,ZM-39923,Selleck,S8004,ZM 39923 HCl,-9.279579,x0195,3.210639,active-noncovalent
C[C@@]12CC[C@H]([C@@]([C@H]1CCC(=C)[C@H]2C/C=C/3\[C@@H](COC3=O)O)(C)CO)O,BRD-A86619021-001-04-8,andrographolide,Selleck,S2261,Andrographolide,-9.277561,x0161,1.281429,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C(=O)OC3C[C@H]4CC5C[C@@H](C3)[NH+]4CC5=O,BRD-K28029915-001-02-2,dolasetron,Enzo,DL199,Dolasetron,-9.275893,x0072,0.57638,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C(=O)OC3C[C@H]4CC5C[C@@H](C3)[NH+]4CC5=O,BRD-K28029915-066-03-3,dolasetron,Tocris,5629,Dolasetron mesylate,-9.275893,x0072,0.57638,active-noncovalent
Cc1cc(c(c(c1OC(=O)C)C)C)OC[C@H](C[NH2+]C(C)C)O,BRD-A99388803-001-01-5,metipranolol,Aronis,BBC/654,"4-[2-hydroxy-3-(isopropylamino)propoxy]-2,3,6-trimethylphenyl acetate",-9.275808,x0104,0.945306,active-noncovalent
C[C@H]1COc2c(c(cc3c2n1cc(c3=O)C(=O)[O-])F)C4(CC4)[NH3+],BRD-K66412701-066-01-6,pazufloxacin,MicroSource,1502319,PAZUFLOXACIN MESYLATE,-9.275057,x1334,1.20522,active-covalent
c1c(o[nH]c1=O)[C@H](C(=O)[O-])[NH3+],BRD-A04628621-001-02-6,ibotenic-acid,Tocris,285,Ibotenic acid,-9.273909,x0397,-1.305612,active-noncovalent
c1ccc(cc1)[C@@H](C(=O)c2ccccc2)O,BRD-A55748233-001-08-7,benzoin,Enamine,Z57160197,,-9.273787,x0749,-0.999631,active-covalent
CC#CCOC(=O)C1=CCC[N@@H+](C1)C,BRD-K63792901-075-02-1,arecaidine-but-2-ynyl-ester,Tocris,382,Arecaidine but-2-ynyl ester tosylate,-9.273554,x0161,-0.703077,active-noncovalent
CC(C)(C)c1ccc(cc1)C[N@H+](C)Cc2cccc3c2cccc3,BRD-K90630139-003-05-9,butenafine,Selleck,S3154,Butenafine HCl,-9.271509,x0072,1.752671,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CC[NH+]3CCN(CC3)c4cccc(c4)C(F)(F)F,BRD-K33637378-001-01-7,flibanserin,MedChemEx,HY-A0095,Flibanserin,-9.269520,x0107,5.055392,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]Cc3c2cccc3,BRD-M10474530-001-03-1,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",Tocris,730,"4-Phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride",-9.268827,x0195,-1.339484,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)Oc2c(=O)c3c(cc(cc3oc2c4cc(c(c(c4)O)O)O)O)[O-])O)O)O,BRD-K29834313-001-01-4,myricitrin,Selleck,S2327,Myricitrin,-9.268699,x0874,2.987607,active-noncovalent
c1cc(ccc1NC2C3CC4CC(C3)CC2C4)Br,BRD-K86358349-001-01-2,bromantan,Enamine,Z440843598,,-9.268532,x0749,-0.219258,active-covalent
c1cc(ccc1NC2C3CC4CC(C3)CC2C4)Br,BRD-K86358349-001-02-0,bromantan,Enamine,Z1736662073,"(1R,3S,5r,7r)-N-(4-bromophenyl)adamantan-2-amine",-9.268532,x0749,-0.219258,active-covalent
Cc1ccc(c(c1)N)NCCCc2ccccc2,BRD-K83354763-001-06-0,NFKB-activation-inhibitor-II,Selleck,S7351,JSH-23,-9.268364,x0161,-1.019111,active-noncovalent
Cc1ccc(c(c1)N)NCCCc2ccccc2,BRD-K83354763-001-03-7,NFKB-activation-inhibitor-II,Selleck,S7351,JSH-23,-9.268364,x0161,-1.019111,active-noncovalent
CCCc1c(n2c(nc3ccc(cc3n2c1=O)C)N(C)C)[O-],BRD-A70182876-001-10-8,azapropazone,Prestwick,Prestw-1003,Azapropazone,-9.268265,x0749,1.561586,active-covalent
c1cc(ccc1CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)O,BRD-K81613478-001-01-8,gastrodin,Selleck,S2383,Gastrodin,-9.266933,x0678,0.897517,active-noncovalent
c1ccc(cc1)c2nc(c3c(n2)[nH]cc3)N[C@H]4CC[C@@H](CC4)O,BRD-K34445261-001-01-4,SLV-320,Tocris,3344,SLV 320,-9.266621,x0759,1.384037,active-covalent
c1ccc(cc1)c2nc(c3c(n2)[nH]cc3)N[C@H]4CC[C@@H](CC4)O,BRD-K34445261-001-02-2,SLV-320,Tocris,3344,"4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexanol",-9.266621,x0759,1.384037,active-covalent
Cc1ccc(c(c1)Br)OCCSc2ncccn2,BRD-K64103579-003-01-5,ZLN-024,Tocris,5285,ZLN 024 hydrochloride,-9.265226,x0678,0.214349,active-noncovalent
Cc1cc(c(c(c1)C)NC(=O)N(Cc2ccc-3c(c2)Cc4c3cccc4)C5CCCCCC5)C,BRD-K91716465-001-01-2,YM-750,Tocris,3039,N-cycloheptyl-N-(9H-fluoren-2-ylmethyl)-N'-mesitylurea,-9.264599,x1077,3.739556,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C,BRD-K32891457-001-16-3,cortodoxone,MedChemEx,HY-77839,Cortodoxone,-9.263071,x0749,2.949569,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C,BRD-K32891457-001-15-5,cortodoxone,Sigma,MFCD00003662,"17,21-dihydroxypregn-4-ene-3,20-dione",-9.263071,x0749,2.949569,active-covalent
c1ccc(cc1)COCC[N+]23CCC(CC2)(CC3)C(c4ccccc4)(c5ccccc5)O,BRD-K46692793-004-01-8,umeclidinium,MedChemEx,HY-12100,Umeclidinium (bromide),-9.261590,x0161,4.078769,active-noncovalent
c1cc(=O)[nH]c2c1[nH]cc2C3=CC[NH2+]CC3,BRD-K81876028-300-02-0,CP-93129,Tocris,1032,CP 93129 dihydrochloride,-9.261219,x1334,-2.162515,active-covalent
c1cc2c(cc1F)CC[C@@H](O2)[C@@H](C[NH2+]C[C@H]([C@@H]3CCc4cc(ccc4O3)F)O)O,BRD-K04956647-003-03-3,nebivolol,Tocris,3517,Nebivolol hydrochloride,-9.259331,x0161,3.889146,active-noncovalent
c1cc2c(cc1F)CC[C@@H](O2)[C@@H](C[NH2+]C[C@H]([C@@H]3CCc4cc(ccc4O3)F)O)O,BRD-K04956647-003-04-1,nebivolol,Tocris,3517,Nebivolol hydrochloride,-9.259331,x0161,3.889146,active-noncovalent
c1cc2c(cc1F)CC[C@@H](O2)[C@@H](C[NH2+]C[C@H]([C@@H]3CCc4cc(ccc4O3)F)O)O,BRD-K04956647-003-02-5,nebivolol,Selleck,S1549,Nebivolol,-9.259331,x0161,3.889146,active-noncovalent
c1cc(c(cc1I)Cl)Nc2c(ccc(c2F)F)C(=O)NOCC3CC3,BRD-K05104363-001-10-0,PD-184352,Selleck,S1020,PD184352 (CI-1040),-9.259220,x0678,1.457861,active-noncovalent
CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C,BRD-K96006502-001-02-6,deflazacort,Selleck,S1888,Deflazacort,-9.258884,x0874,4.177077,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,BRD-K43880410-001-15-1,pregnenolone,MicroSource,1500645,PREGNENOLONE,-9.257950,x1077,4.401974,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,BRD-K43880410-001-14-4,pregnenolone,Selleck,S1914,Pregnenolone,-9.257950,x1077,4.401974,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3cscn3,BRD-K77695569-001-29-2,tiabendazole,Selleck,S1739,Thiabendazole,-9.257359,x0749,-1.544825,active-covalent
c1ccc2c(c1)[nH]c(n2)c3cscn3,BRD-K77695569-001-30-0,tiabendazole,MicroSource,1500570,THIABENDAZOLE,-9.257359,x0749,-1.544825,active-covalent
Cc1ccccc1C(=O)Nc2ccc(c(c2)C)C(=O)N3CCC[C@H](c4c3ccc(c4)Cl)O,BRD-A82035391-001-03-5,tolvaptan,Tocris,5181,Tolvaptan,-9.257117,x0874,6.66913,active-noncovalent
Cc1ccccc1C(=O)Nc2ccc(c(c2)C)C(=O)N3CCC[C@H](c4c3ccc(c4)Cl)O,BRD-A82035391-001-02-7,tolvaptan,Selleck,S2593,Tolvaptan,-9.257117,x0874,6.66913,active-noncovalent
c1ccc2c(c1)c(nn(c2=O)Cc3nc4cc(ccc4s3)C(F)(F)F)CC(=O)[O-],BRD-K84459715-001-01-6,zopolrestat,Sigma,MFCD00865476,"(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydro-1-phthalazinyl)acetic acid",-9.256023,x0161,3.610642,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cnc(c(n2)C(=O)Nc3ccccc3)N,BRD-K26756394-001-02-2,VE-821,Selleck,S8007,VE-821,-9.255527,x0104,4.891308,active-noncovalent
CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K89657519-001-01-8,testosterone-enanthate,Enzo,AC3263,TESTOSTERONE ENANTHATE (DEA license),-9.254783,x0104,6.657184,active-noncovalent
c1ccc2c(c1)[nH]c(n2)C[N@@H+](CCCC[NH3+])[C@H]3CCCc4c3nccc4,BRD-K42948882-305-01-1,AMD11070,MedChemEx,HY-50101A,AMD-070 (hydrochloride),-9.253605,x0678,1.54656,active-noncovalent
c1ccc2c(c1)c3cc(nn3c(=O)[nH]2)CO,BRD-K63651590-001-01-3,pirquinozol,Enamine,Z2467129407,"2-(hydroxymethyl)pyrazolo[1,5-c]quinazolin-5(6H)-one",-9.251904,x0195,-1.890248,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CNc3ccc(cc3)CCC(=O)[O-],BRD-K71534238-001-10-0,GW-9508,Selleck,S8014,GW9508,-9.251542,x0072,2.499699,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CNc3ccc(cc3)CCC(=O)[O-],BRD-K71534238-001-11-8,GW-9508,Tocris,2649,GW 9508,-9.251542,x0072,2.499699,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CNc3ccc(cc3)CCC(=O)[O-],BRD-K71534238-001-12-6,GW-9508,Tocris,2649,GW 9508,-9.251542,x0072,2.499699,active-noncovalent
CCN(CC)c1ccc(cc1)C(=C2C=CC(=[N+](CC)CC)C=C2)c3ccccc3,BRD-K60348325-065-09-9,brilliant-green,Acros,22960,"Brilliant Green, pure, high purity biological stain",-9.250998,x0161,4.755741,active-noncovalent
c1ccc(cc1)c2ccccc2OC[C@@H](CC(=[NH2+])N3CCCCC3)O,BRD-A64808605-003-02-7,AH11110,Tocris,998,AH 11110 hydrochloride,-9.250823,x0104,0.48086,active-noncovalent
CCc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,BRD-A04252265-003-01-4,eperisone,CombiBlocks,OR-1313,,-9.250213,x0104,0.536108,active-noncovalent
C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)c5ccccc5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O,BRD-K83631119-001-03-9,paeoniflorin,Selleck,S2410,Paeoniflorin,-9.249541,x0195,4.373141,active-noncovalent
C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)c5ccccc5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O,BRD-K83631119-001-02-1,paeoniflorin,Selleck,S2410,Paeoniflorin,-9.249541,x0195,4.373141,active-noncovalent
c1cc(c(cc1Cl)C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)O,BRD-K74305673-001-06-2,IKK-2-inhibitor-V,Selleck,S2864,IMD 0354,-9.247657,x0195,2.010386,active-noncovalent
c1cc(c(cc1Cl)C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)O,BRD-K74305673-001-07-0,IKK-2-inhibitor-V,Tocris,2611,IMD 0354,-9.247657,x0195,2.010386,active-noncovalent
c1ccc(cc1)CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-],BRD-K70592483-001-01-0,phenylacetylglutamine,Cayman,16724,,-9.244794,x0678,0.738362,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO,BRD-K46908090-001-01-4,GDC-0623,MedChemEx,HY-15610,GDC-0623,-9.244441,x0107,-0.131052,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO,BRD-K46908090-001-02-2,GDC-0623,Selleck,S7553,GDC-0623,-9.244441,x0107,-0.131052,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO,BRD-K46908090-001-03-0,GDC-0623,MedChemEx,HY-15610,"5-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide",-9.244441,x0107,-0.131052,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO,BRD-K46908090-001-04-8,GDC-0623,MedChemEx,HY-15610,GDC-0623,-9.244441,x0107,-0.131052,active-noncovalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)NCCO,BRD-A93683007-001-01-9,mabuprofen,Enamine,Z1537048897,N-(2-hydroxyethyl)-2-(4-isobutylphenyl)propanamide,-9.242089,x0946,0.037162,active-noncovalent
Cc1c([nH]c(=O)[nH]1)C(=O)c2ccc(cc2)SC,BRD-K21152241-001-07-3,enoximone,Sigma,MFCD00867130,"4-methyl-5-[4-(methylsulfanyl)benzoyl]-1,3-dihydro-2H-imidazol-2-one",-9.241360,x0104,-1.353838,active-noncovalent
c1ccc(cc1)c2cc(c3ccccc3n2)C(=O)[O-],BRD-K72915123-001-18-1,cinchophen,MicroSource,1504508,CINCHOPHEN,-9.241156,x0434,0.010749,active-noncovalent
c1ccc(cc1)c2cc(c3ccccc3n2)C(=O)[O-],BRD-K72915123-001-17-3,cinchophen,Selleck,S4190,Cinchophen,-9.241156,x0434,0.010749,active-noncovalent
c1cc(ccc1NC(=O)C[C@@H](C(=O)[O-])[NH3+])Oc2cc(c(cc2Br)F)F,BRD-K96758128-001-01-8,WAY-213613,Tocris,2652,WAY 213613,-9.239523,x0072,3.587619,active-noncovalent
c1cc(ccc1NC(=O)C[C@@H](C(=O)[O-])[NH3+])Oc2cc(c(cc2Br)F)F,BRD-K96758128-001-02-6,WAY-213613,Tocris,2652,WAY 213613,-9.239523,x0072,3.587619,active-noncovalent
c1ccc(cc1)c2ccc(cc2)C(=O)CN3c4ccccc4N5C3=[NH+]CC5,BRD-K90999434-004-01-7,CCT-031374,Tocris,4675,CCT 031374 hydrobromide,-9.237420,x0434,2.569254,active-noncovalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)F)NC4CC[NH2+]CC4,BRD-K48195801-001-01-6,tecastemizole,ChemPacific,58024,1-(4-fluorobenzyl)-N-(piperidin-4-yl)-1H-benzo[d]imidazol-2-amine,-9.233396,x0195,0.456806,active-noncovalent
CN(C(=O)N1[C@](SC(=N1)c2cc(ccc2F)F)(CCC[NH3+])c3ccccc3)OC,BRD-K37379014-001-01-2,filanesib,MedChemEx,HY-15187,ARRY-520,-9.232491,x1093,2.62286,active-noncovalent
CN(C(=O)N1[C@](SC(=N1)c2cc(ccc2F)F)(CCC[NH3+])c3ccccc3)OC,BRD-K37379014-001-02-0,filanesib,MedChemEx,HY-15187,ARRY-520,-9.232491,x1093,2.62286,active-noncovalent
Cn1c(c(c2c1nccc2)/C=C/C(=O)N3CCc4cc(c(cc4C3)OC)OC)c5ccccc5,BRD-K38905597-003-01-4,SIS3,Tocris,5291,SIS3,-9.230306,x0161,7.731919,active-noncovalent
c1cc(oc1/C=N/N2CCOC2=O)N(=O)=O,BRD-K11756522-001-09-9,furazolidone,MicroSource,1500309,FURAZOLIDONE,-9.228660,x0749,0.80851,active-covalent
c1cc(c(c(c1)Cl)S[C@@H](CCc2ccc(cc2)Cl)Cn3ccnc3)Cl,BRD-A16665823-008-12-4,butoconazole,Selleck,S1833,Butoconazole nitrate,-9.227482,x0678,1.806656,active-noncovalent
c1cc(c(c(c1)Cl)S[C@@H](CCc2ccc(cc2)Cl)Cn3ccnc3)Cl,BRD-A16665823-001-02-0,butoconazole,MicroSource,1504140,BUTOCONAZOLE,-9.227482,x0678,1.806656,active-noncovalent
c1cc(c(cc1c2ccc(cc2F)F)C(=O)[O-])O,BRD-K22031190-001-23-6,diflunisal,MicroSource,1500245,DIFLUNISAL,-9.227050,x0749,-0.183348,active-covalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,BRD-A39791822-001-05-1,hydroxyprogesterone,MicroSource,1701060,HYDROXYPROGESTERONE,-9.225187,x0749,3.397248,active-covalent
Cc1ccccc1CN2C(=O)C3=C(CC[N@H+](C3)Cc4ccccc4)N5C2=[NH+]CC5,BRD-K58529924-001-01-5,ONC201,Cayman,16109,"7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one",-9.224460,x0161,2.587135,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-],BRD-K47192521-001-05-4,icosapent,Enzo,FA001,Eicosapentaenoic acid (20:5 n-3),-9.224005,x0107,2.027741,active-noncovalent
CNC(=O)c1cc2c3ccccc3[nH]c2cn1,BRD-K61951118-001-07-9,FG-7142,Tocris,554,FG 7142,-9.223627,x0195,-1.006197,active-noncovalent
CNC(=O)c1cc2c3ccccc3[nH]c2cn1,BRD-K61951118-001-08-7,FG-7142,Tocris,554,FG 7142,-9.223627,x0195,-1.006197,active-noncovalent
C[C@@H](c1cccc(c1)C(=O)c2ccccc2)C(=O)[O-],BRD-A97739905-001-26-5,ketoprofen,MicroSource,1501215,KETOPROFEN,-9.223348,x0830,0.093835,active-covalent
C[C@@H](c1cccc(c1)C(=O)c2ccccc2)C(=O)[O-],BRD-A97739905-001-25-7,ketoprofen,Selleck,S1645,Ketoprofen,-9.223348,x0830,0.093835,active-covalent
C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,BRD-K92988025-001-01-9,perflubron,Oakwood,2311,,-9.221680,x0749,1.987324,active-covalent
C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,BRD-K92988025-001-02-7,perflubron,Sigma,MFCD00042082,"1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane",-9.221680,x0749,1.987324,active-covalent
Cc1cccc(c1)C(=O)Nc2cccc(c2)NC(=O)c3ccccc3OC,BRD-K02160913-001-02-7,ML-365,Tocris,5337,ML 365,-9.220985,x0104,7.146313,active-noncovalent
CC(C)c1cccc2c1O[C@H](C(=S)N2CC(=O)[O-])C(C)C,BRD-A80280426-001-02-0,AD-5467,Maybridge,KM06746,,-9.219696,x0830,0.609913,active-covalent
CC(C)c1cccc2c1O[C@H](C(=S)N2CC(=O)[O-])C(C)C,BRD-A80280426-001-03-8,AD-5467,Maybridge,KM06746,"(2,8-diisopropyl-3-thioxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetic acid",-9.219696,x0830,0.609913,active-covalent
C[C@@H](Cc1ccccc1)[NH2+]CCC(c2ccccc2)c3ccccc3,BRD-A10662413-043-11-2,prenylamine,Prestwick,Prestw-560,Prenylamine lactate,-9.219307,x1093,1.473732,active-noncovalent
Cc1cc(cc(c1Nc2ccnc(n2)Nc3ccc(cc3)C#N)C)/C=C/C#N,BRD-K06240250-001-01-6,rilpivirine,Selleck,S7303,Rilpivirine,-9.219070,x0831,3.973278,active-covalent
C[C@@H]1c2cc(c(cc2CC[NH2+]1)OC)OC,BRD-A75140635-003-10-9,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",Prestwick,Prestw-532,"Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride",-9.219020,x0195,0.943522,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc5c(c4)OCO5,BRD-K14796088-003-26-8,berberine,MicroSource,1500811,BERBERINE CHLORIDE,-9.217529,x0161,2.490379,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc5c(c4)OCO5,BRD-K14796088-003-25-0,berberine,Selleck,S2271,Berberine HCl,-9.217529,x0161,2.490379,active-noncovalent
c1ccc2c(c1)c(c([nH]2)c3c4ccc(cc4[nH]c3O)Br)N=O,BRD-K04923131-001-14-7,GSK-3-inhibitor-IX,Selleck,S7198,BIO,-9.216043,x0678,-0.055318,active-noncovalent
c1ccc2c(c1)c(c([nH]2)c3c4ccc(cc4[nH]c3O)Br)N=O,BRD-K04923131-001-15-4,GSK-3-inhibitor-IX,Tocris,3194,BIO,-9.216043,x0678,-0.055318,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)CCCn3c(=O)c4ccccc4[nH]c3=O,BRD-K96436774-001-01-8,pelanserin,Enamine,Z379486794,,-9.215606,x0946,3.138996,active-noncovalent
CC(=O)Oc1ccc(cc1)C(c2ccc(cc2)OC(=O)C)c3ccccn3,BRD-K39987650-001-23-3,bisacodyl,Selleck,S4047,Bisacodyl,-9.214246,x1077,3.057936,active-noncovalent
CC(=O)Oc1ccc(cc1)C(c2ccc(cc2)OC(=O)C)c3ccccn3,BRD-K39987650-001-24-1,bisacodyl,MicroSource,1500147,BISACODYL,-9.214246,x1077,3.057936,active-noncovalent
Cc1cccc(c1/[NH+]=C\2/NCCCS2)C,BRD-K21565985-003-02-3,xylazine,Selleck,S2516,Xylazine HCl,-9.213903,x0434,-2.015138,active-noncovalent
Cc1cccc(c1/[NH+]=C\2/NCCCS2)C,BRD-K21565985-001-22-5,xylazine,MicroSource,1501200,XYLAZINE,-9.213903,x0434,-2.015138,active-noncovalent
C[C@H]/1CC[C@@H]2C[C@H](C[C@@](O2)([C@@H]3CSC(=O)N3)O)OC(=O)/C=C(\CC/C=C1)/C,BRD-K61292460-001-02-3,latrunculin-b,EMDBio,428020-1MG,"LATRUNCULIN B, LATRUNCULIA MAGNIFICA",-9.213891,x0104,1.572248,active-noncovalent
CN(C)c1ccc(cc1)/C=C\2/c3ccccc3NC2=O,BRD-K20287671-001-06-9,SU-4312,Tocris,1459,SU 4312,-9.213451,x0749,0.622759,active-covalent
C[C@H]([C@H](c1ccc(cc1)O)O)[NH2+]CCc2ccc(cc2)O,BRD-K14003026-003-09-0,ritodrine,Selleck,S2533,Ritodrine hydrochloride (Yutopar),-9.212725,x0678,1.086286,active-noncovalent
C[C@H]([C@H](c1ccc(cc1)O)O)[NH2+]CCc2ccc(cc2)O,BRD-K14003026-003-08-2,ritodrine,Selleck,S2533,Ritodrine HCl,-9.212725,x0678,1.086286,active-noncovalent
COC(=O)CN1CN(C2(C1=O)CC[NH+](CC2)Cc3cccc4c3cccc4)c5ccccc5,BRD-K72904818-001-02-9,NNC-63-0532,Tocris,1780,NNC 63-0532,-9.212130,x1077,4.90229,active-noncovalent
COC(=O)CN1CN(C2(C1=O)CC[NH+](CC2)Cc3cccc4c3cccc4)c5ccccc5,BRD-K72904818-001-01-1,NNC-63-0532,Tocris,1780,NNC 63-0532,-9.212130,x1077,4.90229,active-noncovalent
CCC[N@H+](C/C=C/I)[C@H]1CCc2cccc(c2C1)O,BRD-A60594020-034-01-1,8-hydroxy-PIPAT,Tocris,797,8-Hydroxy-PIPAT,-9.210985,x0104,-0.479895,active-noncovalent
C[C@H](c1ccccc1)[NH2+]CCC(c2ccccc2)c3ccccc3,BRD-A71033472-003-23-9,fendiline,MicroSource,1501026,FENDILINE HYDROCHLORIDE,-9.210018,x0195,1.255857,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC(=O)C(=O)[O-],BRD-K09109825-001-07-3,indole-3-pyrubate,Sigma,57300,3-(1H-indol-3-yl)-2-oxopropanoic acid,-9.208225,x0072,0.549448,active-noncovalent
c1ccc(cc1)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(c(c4)C(=O)[O-])Cl)C(F)(F)F,BRD-K86063171-001-02-9,EN460,MedChemEx,HY-12837,EN460,-9.207842,x0161,6.90665,active-noncovalent
c1ccc(cc1)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(c(c4)C(=O)[O-])Cl)C(F)(F)F,BRD-K86063171-001-03-7,EN460,MedChemEx,HY-12837,EN460,-9.207842,x0161,6.90665,active-noncovalent
c1ccc(cc1)[C@@H](CO)NC(=O)Nc2ccc(cc2)c3ccncc3,BRD-K27051047-001-01-0,AS-1892802,Tocris,4927,AS 1892802,-9.207526,x0161,4.926693,active-noncovalent
COCCOc1ccc2c(c1)ncn2c3ccc4cccc(c4n3)N5CCC(CC5)[NH3+],BRD-K43621685-001-03-3,CP-673451,Selleck,S1536,CP 673451,-9.206402,x0161,6.035836,active-noncovalent
COCCOc1ccc2c(c1)ncn2c3ccc4cccc(c4n3)N5CCC(CC5)[NH3+],BRD-K43621685-001-02-5,CP-673451,Selleck,S1536,CP-673451,-9.206402,x0161,6.035836,active-noncovalent
c1ccc2c(c1)Cc3ccccc3N4[C@H]2C[NH+]=C4N,BRD-A98990573-003-01-3,epinastine,Selleck,S4253,Epinastine HCl,-9.204981,x0072,-0.221905,active-noncovalent
C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H]([C@H](C=C(C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C,BRD-K93779381-001-01-9,ingenol-mebutate,MedChemEx,HY-B0719,Ingenol Mebutate,-9.204975,x0678,3.287214,active-noncovalent
c1ccc(c(c1)[C@@H]2[C@@H](CO[C@@H](O2)c3ccccc3Cl)C/C=C\CCC(=O)[O-])O,BRD-K59433843-001-02-5,ICI-192605,Tocris,837,"ICI 192,605",-9.204534,x0434,2.469356,active-noncovalent
c1ccc(c(c1)[C@@H]2[C@@H](CO[C@@H](O2)c3ccccc3Cl)C/C=C\CCC(=O)[O-])O,BRD-K59433843-001-01-7,ICI-192605,Tocris,837,"ICI 192,605",-9.204534,x0434,2.469356,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2C(=O)C[C@@H]4[C@@]3(CCC(=O)C4)C)C,BRD-A64125466-236-04-6,dehydrocholate,MicroSource,1500225,DEHYDROCHOLATE SODIUM,-9.204472,x0874,4.249667,active-noncovalent
c1cscc1c2cc(c(s2)C(=O)N)N,BRD-K26373640-001-05-1,IKK-2-inhibitor,Selleck,S4907,SC-514,-9.202543,x0195,-0.088437,active-noncovalent
c1cscc1c2cc(c(s2)C(=O)N)N,BRD-K26373640-001-06-9,IKK-2-inhibitor,Tocris,3318,SC 514,-9.202543,x0195,-0.088437,active-noncovalent
c1cscc1c2cc(c(s2)C(=O)N)N,BRD-K26373640-001-07-7,IKK-2-inhibitor,Selleck,S4907,SC-514,-9.202543,x0195,-0.088437,active-noncovalent
COc1c2c(cc(c1N3C[C@@H]4CCC[NH2+][C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)[O-],BRD-K66615216-003-14-8,moxifloxacin,MicroSource,1504303,MOXIFLOXACIN HYDROCHLORIDE,-9.202506,x0195,6.181362,active-noncovalent
COc1c2c(cc(c1N3C[C@@H]4CCC[NH2+][C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)[O-],BRD-K66615216-003-13-0,moxifloxacin,Selleck,S1465,Moxifloxacin HCl,-9.202506,x0195,6.181362,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,BRD-A42883684-001-04-1,cholesterol,MicroSource,1500847,CHOLESTEROL,-9.201381,x1077,6.322793,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)OC3=CC(=O)CC3)O)C,BRD-K52721684-001-03-0,PCO-400,Enzo,KC131,PCO-400,-9.199242,x0195,0.241088,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)[O-],BRD-K20152659-001-10-3,dihomo-gamma-linolenic-acid,Sigma,MFCD00065721,"(8Z,11Z,14Z)-8,11,14-icosatrienoic acid",-9.198960,x0874,2.434173,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)[O-],BRD-K20152659-001-07-9,dihomo-gamma-linolenic-acid,Sigma,MFCD00065721,"(8Z,11Z,14Z)-8,11,14-icosatrienoic acid",-9.198960,x0874,2.434173,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)[O-],BRD-K20152659-001-04-6,dihomo-gamma-linolenic-acid,Enzo,FA009,"8(Z),11(Z),14(Z)-Eicosatrienoic acid",-9.198960,x0874,2.434173,active-noncovalent
c1ccc2c(c1)ccc3c2CCC(=O)O3,BRD-K27710560-001-07-5,splitomycin,Tocris,1542,Splitomicin,-9.198786,x0749,-0.988194,active-covalent
CCn1/c(=C\c2cccc[n+]2CC)/s/c(=C/3\N(c4ccccc4S3)C)/c1=O,BRD-K61695967-003-02-1,MKT-077,Tocris,4621,MKT 077,-9.196421,x1077,6.962711,active-noncovalent
CCn1/c(=C\c2cccc[n+]2CC)/s/c(=C/3\N(c4ccccc4S3)C)/c1=O,BRD-K61695967-003-01-3,MKT-077,Cayman,14395,"1-ethyl-2-{(E)-[(5E)-3-ethyl-5-(3-methyl-1,3-benzothiazol-2(3H)-ylidene)-4-oxo-1,3-thiazolidin-2-ylidene]methyl}pyridinium chloride",-9.196421,x1077,6.962711,active-noncovalent
c1cc(oc1C(=O)N2C[C@H]3C[NH2+]C[C@H]3C2)Cl,BRD-A44188509-001-01-2,AZD1446,Key,KG-0039,"2-(5-chloro-2-furoyl)octahydropyrrolo[3,4-c]pyrrole",-9.195782,x0161,-0.933812,active-noncovalent
CC(C)(C)c1ccc(cc1)c2[nH]c3ccccc3n2,BRD-K73073971-001-01-7,ZLN005,Selleck,S7447,ZLN005,-9.195212,x0195,0.935632,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)Cc3cccs3)/C(=O)N2[C@H]1C(=O)[O-],BRD-K28210218-236-08-1,cephalothin,MicroSource,1500166,CEPHALOTHIN SODIUM,-9.194923,x0830,3.928377,active-covalent
c1ccc2c(c1)c3c4c(c5c6ccccc6n7c5c3n2[C@H]8CC[C@@H]7O8)C(=O)NC4=O,BRD-A06352508-001-03-7,SB-218078,Tocris,2560,SB 218078,-9.194160,x0195,4.648302,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6n7c5c3n2[C@H]8CC[C@@H]7O8)C(=O)NC4=O,BRD-A06352508-001-05-2,SB-218078,Tocris,2560,SB 218078,-9.194160,x0195,4.648302,active-noncovalent
c1ccc2c(c1)-c3c(c4cc(ccc4[nH]3)Br)CC(=O)N2,BRD-K37312348-001-17-6,kenpaullone,Tocris,1398,Kenpaullone,-9.193865,x0678,-1.282803,active-noncovalent
c1ccc2c(c1)-c3c(c4cc(ccc4[nH]3)Br)CC(=O)N2,BRD-K37312348-001-15-0,kenpaullone,Tocris,1398,Kenpaullone,-9.193865,x0678,-1.282803,active-noncovalent
c1ccc(cc1)C(=O)O[C@H]2C[NH+]3CCC2CC3,BRD-A45929034-001-09-5,benzoclidine,MicroSource,1506155,BENZOCLIDINE,-9.192346,x0072,0.310536,active-noncovalent
CC(C)(C)[C@]1(CC[N@@H+]2C[C@@H]3c4ccccc4CCc5c3c(ccc5)[C@H]2C1)O,BRD-K23082237-003-01-5,butaclamol,Enzo,AC747,Butaclamol (+),-9.191461,x0104,1.912367,active-noncovalent
C1CCC(CC1)n2c(c(c(=O)n(c2=O)C3CCCCC3)C(=O)NCC(=O)[O-])[O-],BRD-K06455935-001-01-3,daprodustat,MedChemEx,HY-17608,Daprodustat,-9.189902,x0434,3.509507,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,BRD-K47278471-003-25-5,diphenhydramine,Selleck,S1866,Diphenhydramine HCl,-9.189106,x1093,-0.350637,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,BRD-K47278471-003-26-3,diphenhydramine,MicroSource,1500256,DIPHENHYDRAMINE HYDROCHLORIDE,-9.189106,x1093,-0.350637,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,BRD-M98649031-001-10-2,dimenhydrinate,MedChemEx,HY-B1215,Dimenhydrinate,-9.189106,x1093,-0.350637,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,BRD-M98649031-001-09-4,dimenhydrinate,MedChemEx,HY-B1215,Dimenhydrinate,-9.189106,x1093,-0.350637,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,BRD-M98649031-001-08-6,dimenhydrinate,MicroSource,1500251,DIMENHYDRINATE,-9.189106,x1093,-0.350637,active-noncovalent
c1cc(c(cc1Cl)c2nc3c(c(n2)Nc4ccncc4)nccn3)F,BRD-K24566386-001-03-5,SD-208,Tocris,3269,SD 208,-9.188960,x0678,2.758128,active-noncovalent
c1cc(c(cc1Cl)c2nc3c(c(n2)Nc4ccncc4)nccn3)F,BRD-K24566386-001-01-9,SD-208,Tocris,3269,SD 208,-9.188960,x0678,2.758128,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1[C@H]3[C@@H]([C@@H]([C@@H](O3)CO)O)O)N,BRD-K92976206-001-01-5,guanosine,Selleck,S2439,Guanosine,-9.188747,x0397,0.950626,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)O)C,BRD-K28428262-001-04-1,brivanib,Selleck,S1084,Brivanib (BMS-540215),-9.187219,x0434,5.242549,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3ccccc3S2)N4CC[NH+](CC4)CCOCCO,BRD-K68867920-051-12-3,quetiapine,Tocris,4735,Quetiapine hemifumarate,-9.185753,x0161,4.111299,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3ccccc3S2)N4CC[NH+](CC4)CCOCCO,BRD-K68867920-001-11-0,quetiapine,MicroSource,1505187,QUETIAPINE,-9.185753,x0161,4.111299,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3ccccc3S2)N4CC[NH+](CC4)CCOCCO,BRD-K68867920-051-11-5,quetiapine,Selleck,S1763,Quetiapine Fumarate,-9.185753,x0161,4.111299,active-noncovalent
CCc1c(c(nn1c2ccccc2c3cccc(c3)OCC(=O)[O-])c4ccccc4)c5ccccc5,BRD-K87956243-001-01-9,BMS-309403,Tocris,5258,BMS 309403,-9.183868,x0195,6.452486,active-noncovalent
C[C@]12CC/C(=N\OCC[NH3+])/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,BRD-K95412502-003-01-5,istaroxime,MedChemEx,HY-15718A,Istaroxime (hydrochloride),-9.181981,x0161,2.928677,active-noncovalent
c1ccc(c(c1)C2CC2)OCC3=[NH+]CCN3,BRD-K54142781-003-11-8,cirazoline,Tocris,888,Cirazoline hydrochloride,-9.181396,x0104,-0.511565,active-noncovalent
c1ccc(c(c1)C2CC2)OCC3=[NH+]CCN3,BRD-K54142781-003-13-4,cirazoline,Tocris,888,Cirazoline hydrochloride,-9.181396,x0104,-0.511565,active-noncovalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@@H](CC#N)C4CCCC4,BRD-K19601669-001-03-5,ruxolitinib-(S),Selleck,S2902,S-Ruxolitinib (INCB018424),-9.179305,x0749,1.441731,active-covalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)O,BRD-K52459643-001-17-7,alprostadil,Selleck,S1508,Alprostadil,-9.179181,x0678,2.659923,active-noncovalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)O,BRD-K52459643-001-15-1,alprostadil,Tocris,1620,Alprostadil,-9.179181,x0678,2.659923,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CCNc3c4cc(ccc4ncn3)N,BRD-K68395654-001-03-1,EVP4593,Selleck,S4902,QNZ (EVP4593),-9.177666,x0104,3.123472,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CCNc3c4cc(ccc4ncn3)N,BRD-K68395654-001-06-4,EVP4593,MedChemEx,HY-13812,QNZ,-9.177666,x0104,3.123472,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CCNc3c4cc(ccc4ncn3)N,BRD-K68395654-001-05-6,EVP4593,Selleck,S4902,QNZ (EVP4593),-9.177666,x0104,3.123472,active-noncovalent
CSc1ccc(cc1)[C@H]2C[N@H+]3CCC[C@H]3c4c2cccc4,BRD-K31168993-001-02-8,McN-5652-(+/-),Tocris,2148,(?)-McN 5652,-9.177475,x0161,-0.722501,active-noncovalent
Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)/[NH+]=C\6/NC(CO6)(C)C,BRD-K26026438-001-01-0,tucatinib,MedChemEx,HY-16069,Irbinitinib,-9.176535,x0072,9.398567,active-noncovalent
COc1ccccc1CN[C@H]2CCC[NH2+][C@H]2c3ccccc3,BRD-K09946180-300-01-6,CP-99994,Tocris,3417,CP 99994 dihydrochloride,-9.176131,x0072,1.006649,active-noncovalent
CC[NH+](CC)CCCN(c1ccccc1)C2Cc3ccccc3C2,BRD-K53236343-003-03-7,aprindine,Sigma,A7606,"N~1~-(2,3-dihydro-1H-inden-2-yl)-N~3~,N~3~-diethyl-N~1~-phenyl-1,3-propanediamine hydrochloride",-9.176032,x0195,1.350337,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCCN4CC[NH+](CC4)CCO,BRD-K42938903-332-01-1,acetophenazine,MicroSource,1503860,ACETOPHENAZINE MALEATE,-9.175442,x0104,3.809004,active-noncovalent
Cc1c(sc(n1)N)c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4,BRD-K64866502-001-04-7,CYC116,Selleck,S1171,CYC116,-9.174115,x0195,3.40044,active-noncovalent
Cc1c(sc(n1)N)c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4,BRD-K64866502-001-03-9,CYC116,Selleck,S1171,CYC116,-9.174115,x0195,3.40044,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@H](C(=O)[O-])[NH3+])I)I)O,BRD-K46428823-001-02-5,liothyronine-(isomer),MicroSource,1500778,LIOTHYRONINE,-9.173932,x0678,1.122254,active-noncovalent
CC(=CCC[C@@](C)(C=C)/C=C/c1ccc(cc1)O)C,BRD-K09785578-001-02-0,bakuchiol,MedChemEx,HY-N0235,Bakuchiol,-9.173650,x0195,-0.128976,active-noncovalent
CC(=CCC[C@@](C)(C=C)/C=C/c1ccc(cc1)O)C,BRD-K09785578-001-01-2,bakuchiol,Enzo,350-144,Bakuchiol,-9.173650,x0195,-0.128976,active-noncovalent
CCCCOC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F,BRD-K84173274-001-01-6,ufenamate,AvaChem,3123,butyl 2-[3-(trifluoromethyl)anilino]benzoate,-9.172576,x0434,1.564872,active-noncovalent
c1ccc2c(c1)[C@H]3C=CC[C@H]3[C@H](N2)c4cc5c(cc4Br)OCO5,BRD-M30288325-001-01-4,G-15,Tocris,3678,G-15,-9.172030,x0195,0.222528,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H]2CCCC[N@H+]2C)C,BRD-A03216249-003-23-5,mepivacaine,Selleck,S3155,Mepivacaine HCl,-9.171832,x0195,-0.635384,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H]2CCCC[N@H+]2C)C,BRD-A03216249-003-24-3,mepivacaine,MicroSource,1504148,MEPIVACAINE HYDROCHLORIDE,-9.171832,x0195,-0.635384,active-noncovalent
c1ccc(cc1)N/C(=[NH+]\C(=[NH2+])N)/N,BRD-K31491153-003-05-9,1-phenylbiguanide,Tocris,969,1-Phenylbiguanide hydrochloride,-9.171133,x0195,-2.739912,active-noncovalent
C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K26674531-001-02-1,GR-235,Tocris,2013,Guggulsterone,-9.170068,x0749,2.622615,active-covalent
Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)[O-])C(CCC2(C)C)(C)C,BRD-K92441787-001-04-1,bexarotene,Selleck,S2098,Bexarotene,-9.169219,x0161,3.204566,active-noncovalent
CCOC(=O)c1c(n(c2c1c(c(c(c2)Br)O)C[NH+](C)C)C)CSc3ccccc3,BRD-K73881242-003-03-8,arbidol,Selleck,S2120,Arbidol HCl,-9.169143,x0874,1.671439,active-noncovalent
CCOC(=O)c1c(n(c2c1c(c(c(c2)Br)O)C[NH+](C)C)C)CSc3ccccc3,BRD-K73881242-003-04-6,arbidol,MedChemEx,HY-14904A,Arbidol (hydrochloride),-9.169143,x0874,1.671439,active-noncovalent
CCOC(=O)c1c(n(c2c1c(c(c(c2)Br)O)C[NH+](C)C)C)CSc3ccccc3,BRD-K73881242-003-06-1,arbidol,MedChemEx,HY-14904A,Arbidol (hydrochloride),-9.169143,x0874,1.671439,active-noncovalent
CCOC(=O)c1c(n(c2c1c(c(c(c2)Br)O)C[NH+](C)C)C)CSc3ccccc3,BRD-K73881242-003-02-0,arbidol,Selleck,S2120,Arbidol HCl,-9.169143,x0874,1.671439,active-noncovalent
COc1ccc2c(c1)c(c3cc(ccc3n2)Cl)SCCC[NH3+],BRD-K61795638-300-01-0,LDN-209929,Tocris,4828,LDN 209929 dihydrochloride,-9.169050,x0104,1.810182,active-noncovalent
c1c(ccc(c1)Cl)S(=O)(=O)[C@]2(CC[C@H](CC2)NS(=O)(=O)C(F)(F)F)c3c(ccc(c3)F)F,BRD-K68795758-001-01-1,MRK-560,Tocris,4000,MRK 560,-9.167199,x0072,4.188907,active-noncovalent
C[C@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)[NH2+]C)O)[NH3+])[NH3+])[NH3+])[NH2+]C,BRD-M10279501-065-05-9,gentamycin,Sigma,MFCD00270181,"sulfuric acid compound with (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,6S)-3-amino-6-((R)-1-(met hylamino)ethyl)tetrahydro-2H-pyran-2-yloxy)-2-h",-9.166148,x0874,4.717065,active-noncovalent
CCCCC/[NH+]=C(\N)/N=N/Cc1c[nH]c2c1cc(cc2)OC,BRD-K88743730-050-04-1,tegaserod,MedChemEx,HY-14153A,Tegaserod (maleate),-9.165915,x1385,2.230646,active-covalent
CCCCC/[NH+]=C(\N)/N=N/Cc1c[nH]c2c1cc(cc2)OC,BRD-K88743730-050-05-8,tegaserod,Tocris,4613,Tegaserod maleate,-9.165915,x1385,2.230646,active-covalent
CCCCC/[NH+]=C(\N)/N=N/Cc1c[nH]c2c1cc(cc2)OC,BRD-K88743730-050-03-3,tegaserod,MicroSource,1505215,TEGASEROD MALEATE,-9.165915,x1385,2.230646,active-covalent
CNc1cc2c(cn1)ncnc2Nc3cccc(c3)Br,BRD-K48735772-001-04-8,PD-158780,Tocris,2615,PD 158780,-9.165236,x0749,0.555305,active-covalent
CNc1cc2c(cn1)ncnc2Nc3cccc(c3)Br,BRD-K48735772-001-03-0,PD-158780,Tocris,2615,PD 158780,-9.165236,x0749,0.555305,active-covalent
C[C@H](C1=[NH+]CCN1)Oc2c(cccc2Cl)Cl,BRD-A02990301-003-06-6,lofexidine,MicroSource,1502357,LOFEXIDINE  HYDROCHLORIDE,-9.164065,x0678,-0.594261,active-noncovalent
C[C@H](C1=[NH+]CCN1)Oc2c(cccc2Cl)Cl,BRD-A02990301-003-05-8,lofexidine,Selleck,S4400,Lofexidine  HCl,-9.164065,x0678,-0.594261,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccc3nccn3c2,BRD-K20745393-003-01-0,olprinone,MedChemEx,HY-14254,Olprinone (Hydrochloride),-9.161945,x0678,-0.589834,active-noncovalent
c1ccc(cc1)C(=O)c2ccc3n2CC[C@@H]3C(=O)[O-],BRD-A40639672-234-17-2,ketorolac,Selleck,S1646,Ketorolac,-9.161427,x0749,-0.620138,active-covalent
c1ccc(cc1)C(=O)c2ccc3n2CC[C@@H]3C(=O)[O-],BRD-A40639672-001-01-9,ketorolac,Selleck,S1646,Ketorolac,-9.161427,x0749,-0.620138,active-covalent
c1ccc(cc1)C(=O)c2ccc3n2CC[C@@H]3C(=O)[O-],BRD-A40639672-234-18-0,ketorolac,MicroSource,1503925,KETOROLAC TROMETHAMINE,-9.161427,x0749,-0.620138,active-covalent
CC1=NC(=O)C[C@@H]([C@H]1C(=O)Nc2cc3c[nH]nc3cc2F)c4ccc(cc4)C(F)(F)F,BRD-A10523515-001-11-1,GSK429286A,MedChemEx,HY-11000,GSK429286A,-9.161307,x0107,3.338223,active-noncovalent
CC1=NC(=O)C[C@@H]([C@H]1C(=O)Nc2cc3c[nH]nc3cc2F)c4ccc(cc4)C(F)(F)F,BRD-A10523515-001-07-9,GSK429286A,Selleck,S1474,GSK429286A,-9.161307,x0107,3.338223,active-noncovalent
CC1=NC(=O)C[C@@H]([C@H]1C(=O)Nc2cc3c[nH]nc3cc2F)c4ccc(cc4)C(F)(F)F,BRD-A10523515-001-10-3,GSK429286A,Tocris,3726,GSK 429286,-9.161307,x0107,3.338223,active-noncovalent
CC#CC[C@H](C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/C2)O)O,BRD-A45664787-001-04-8,iloprost,MedChemEx,HY-A0096,Iloprost,-9.159988,x0195,3.186644,active-noncovalent
c1cc(ccc1[C@H]2[C@H]3CC=C[C@H]3c4cc(ccc4N2)S(=O)(=O)N)Br,BRD-A18598741-001-01-2,4BP-TQS,Tocris,4234,4BP-TQS,-9.159706,x0161,2.180446,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])/C=C\c2cc(c(c(c2)OC)OC)OC,BRD-K06814349-304-02-7,fosbretabulin,MedChemEx,HY-17449,Fosbretabulin (disodium),-9.159322,x0195,4.810676,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])/C=C\c2cc(c(c(c2)OC)OC)OC,BRD-K06814349-304-01-9,fosbretabulin,MedChemEx,HY-17449,Fosbretabulin (disodium),-9.159322,x0195,4.810676,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccccc2OC,BRD-A95696066-003-13-8,nisoxetine,Tocris,1025,Nisoxetine hydrochloride,-9.158139,x0434,-0.629745,active-noncovalent
c1ccc2c(c1)c(cc(=O)[nH]2)C[C@H](C(=O)[O-])NC(=O)c3ccc(cc3)Cl,BRD-A15909516-001-06-6,rebamipide,Selleck,S2032,Rebamipide,-9.158004,x0967,2.731936,active-noncovalent
c1ccc2c(c1)c(cc(=O)[nH]2)C[C@H](C(=O)[O-])NC(=O)c3ccc(cc3)Cl,BRD-A15909516-001-07-4,rebamipide,MicroSource,1505310,REBAMIPIDE,-9.158004,x0967,2.731936,active-noncovalent
Cc1cc(sc1)c2c3ccccc3c(nn2)Nc4ccc(cc4)Oc5c(cccn5)c6ccnc(n6)N,BRD-K21728777-001-02-3,AMG900,Selleck,S2719,AMG-900,-9.154729,x0104,15.280477,active-noncovalent
CCCC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(c3ccccc3c2OC)C#N,BRD-A71262238-001-08-4,nafadotride,Tocris,1347,Nafadotride,-9.154069,x0195,2.496325,active-noncovalent
Cc1c(c2ccc(cc2n1c3ccc(cc3)OC)O)N(=O)=O,BRD-K39166528-001-01-0,ID-8,Selleck,S7327,ID-8,-9.153130,x0195,0.220504,active-noncovalent
Cc1c(c2ccc(cc2n1c3ccc(cc3)OC)O)N(=O)=O,BRD-K39166528-001-02-8,ID-8,Tocris,3853,ID 8,-9.153130,x0195,0.220504,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCn3c(=O)c4c(c5ccccc5[nH]4)[nH]c3=O,BRD-K62581435-001-03-8,3-MPPI,Tocris,581,3-MPPI,-9.152433,x0874,4.724298,active-noncovalent
CC[NH+](CC)[C@@H](C)CN1c2ccccc2Sc3c1cccc3,BRD-A16311756-003-08-5,profenamine,MicroSource,1500293,ETHOPROPAZINE HYDROCHLORIDE,-9.151715,x0195,1.118938,active-noncovalent
CC[NH+](CC)[C@@H](C)CN1c2ccccc2Sc3c1cccc3,BRD-A16311756-003-09-3,profenamine,Sigma,MFCD00012653,"N,N-diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine hydrochloride",-9.151715,x0195,1.118938,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C,BRD-K98521173-001-19-4,desoxycortone,Prestwick,Prestw-957,Deoxycorticosterone,-9.151583,x1077,0.993768,active-noncovalent
c1cc(ccc1c2c(n(cn2)C3CCCCC3)c4ccnc(n4)N)F,BRD-K96295391-300-02-5,PF-670462,Tocris,3316,PF 670462,-9.150079,x0678,1.171367,active-noncovalent
c1cc(ccc1c2c(n(cn2)C3CCCCC3)c4ccnc(n4)N)F,BRD-K96295391-300-01-7,PF-670462,MedChemEx,HY-15490,PF-670462,-9.150079,x0678,1.171367,active-noncovalent
Cc1ccc(cc1)/C(=C\C[NH+]2CCCC2)/c3cccc(n3)/C=C/C(=O)[O-],BRD-K50163129-001-01-4,acrivastine,Enzo,AC3005,ACRIVASTINE,-9.149762,x1077,1.427277,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3ccccc3n2,BRD-K62056274-332-01-8,N-methylquipazine,Tocris,566,N-Methylquipazine dimaleate,-9.148675,x0749,0.853968,active-covalent
C1C=C([C@@H]2[C@H]1C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)[O-])CO,BRD-K73771095-001-02-5,geniposidic-acid,Selleck,S2413,Geniposidic acid,-9.147568,x0107,1.919415,active-noncovalent
C1C=C([C@@H]2[C@H]1C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)[O-])CO,BRD-K73771095-001-03-3,geniposidic-acid,Selleck,S2413,Geniposidic acid,-9.147568,x0107,1.919415,active-noncovalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3)NC(=O)c4cccc(c4)C#N,BRD-K02213468-001-02-3,CDPPB,Tocris,3235,CDPPB,-9.147143,x0874,4.181287,active-noncovalent
c1cc(ccc1C(=O)Nc2ccc(nc2)Cl)Cl,BRD-K71686520-001-01-4,ICA-110381,Tocris,4950,ICA 110381,-9.147057,x0678,0.42401,active-noncovalent
CCOC(=O)c1cc2ccc(cc2oc1=O)O,BRD-K53438416-001-01-9,YZ9,Tocris,5048,YZ9,-9.146110,x0749,0.168302,active-covalent
C[C@H]([C@@](Cn1cncn1)(c2ccc(cc2F)F)O)[NH+]3CCC(=C)CC3,BRD-A30774155-001-01-2,efinaconazole,MedChemEx,HY-15660,Efinaconazole,-9.144269,x0831,1.035619,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,BRD-K68620903-001-09-8,dydrogesterone,Selleck,S4097,Dydrogesterone,-9.143844,x0749,2.688443,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,BRD-K68620903-001-10-6,dydrogesterone,Selleck,S4097,Dydrogesterone,-9.143844,x0749,2.688443,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,BRD-K68620903-001-11-4,dydrogesterone,MicroSource,1505535,DYDROGESTERONE,-9.143844,x0749,2.688443,active-covalent
Cc1ccc2c(=O)c3cccc(c3oc2c1C)CC(=O)[O-],BRD-K27938825-001-02-4,ASA-404,Selleck,S1537,DMXAA (Vadimezan),-9.143008,x0195,-0.002792,active-noncovalent
CC(C)Oc1ccc(cc1)c2cnc3c(cnn3c2)c4ccnc5c4cccc5,BRD-K39381259-001-01-0,DMH1,Selleck,S7146,DMH1,-9.141401,x0104,8.081429,active-noncovalent
CC(C)Oc1ccc(cc1)c2cnc3c(cnn3c2)c4ccnc5c4cccc5,BRD-K39381259-001-02-8,DMH1,Tocris,4126,DMH-1,-9.141401,x0104,8.081429,active-noncovalent
C[C@@H]1Cc2cc3c(cc2C(=NN1C(=O)C)c4ccc(cc4)N)OCO3,BRD-K80359953-001-02-1,talampanel,Tocris,5032,Talampanel,-9.141388,x0161,2.092256,active-noncovalent
C[C@@H]1Cc2cc3c(cc2C(=NN1C(=O)C)c4ccc(cc4)N)OCO3,BRD-K80359953-001-01-3,talampanel,MedChemEx,HY-15079,Talampanel,-9.141388,x0161,2.092256,active-noncovalent
c1ccc(cc1)c2cn3c([nH+]2)sc(n3)S(=O)(=O)N,BRD-K77634909-001-05-0,AEG3482,Tocris,2651,AEG 3482,-9.141166,x0678,1.754891,active-noncovalent
c1ccc(cc1)c2cn3c([nH+]2)sc(n3)S(=O)(=O)N,BRD-K77634909-001-03-5,AEG3482,Tocris,2651,AEG 3482,-9.141166,x0678,1.754891,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)F)c3[nH]c4c5cccnc5c6c(c4n3)cccn6,BRD-K68003372-001-01-6,APTO-253,MedChemEx,HY-16291,APTO-253,-9.140422,x1077,1.553064,active-noncovalent
CC(C)(C)OC(=O)N1CCC(CC1)COC(=O)Nc2ccccc2OC,BRD-K36485341-001-01-2,GW-542573X,Tocris,4311,GW 542573X,-9.138774,x0104,4.103321,active-noncovalent
c1ccc2c(c1)c(=O)c(c(o2)[O-])Cc3c(=O)c4ccccc4oc3[O-],BRD-K82236179-213-01-0,dicoumarol,MicroSource,1500239,DICUMAROL,-9.137878,x1093,1.178759,active-noncovalent
Cc1ccsc1/C=C/C2=[NH+]CCCN2C,BRD-K71454870-048-06-3,morantel,MicroSource,1503931,MORANTEL CITRATE,-9.137700,x0678,-1.042483,active-noncovalent
C[NH2+][C@@H]1Cc2cccc3c2n(c(=O)[nH]3)C1,BRD-K30485548-050-01-6,sumanirole,Sigma,MFCD09832637,"(2Z)-2-butenedioic acid compound with (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (1:1)",-9.137506,x0195,-0.116874,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cc(sc2c3ccc(cc3)F)Br,BRD-K06221026-001-06-8,DUP-697,Tocris,1430,DuP 697,-9.136870,x0072,1.514318,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cc(sc2c3ccc(cc3)F)Br,BRD-K06221026-001-07-6,DUP-697,Tocris,1430,DuP 697,-9.136870,x0072,1.514318,active-noncovalent
c1ccc(cc1)c2c(c3nc(cc(n3n2)C(F)(F)F)C(F)(F)F)c4ccc(cc4)O,BRD-K76568384-001-03-0,PHTPP,Tocris,2662,PHTPP,-9.136705,x0161,3.319861,active-noncovalent
c1ccc(cc1)c2c(c3nc(cc(n3n2)C(F)(F)F)C(F)(F)F)c4ccc(cc4)O,BRD-K76568384-001-02-2,PHTPP,Tocris,2662,PHTPP,-9.136705,x0161,3.319861,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)[O-])[O-])C(=O)OC2,BRD-K63750851-001-22-3,mycophenolic-acid,Tocris,1505,Mycophenolic acid,-9.135977,x0830,1.402228,active-covalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)[O-])[O-])C(=O)OC2,BRD-K63750851-001-20-7,mycophenolic-acid,MicroSource,1500674,MYCOPHENOLIC ACID,-9.135977,x0830,1.402228,active-covalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)[O-])[O-])C(=O)OC2,BRD-K63750851-001-19-9,mycophenolic-acid,Tocris,1505,Mycophenolic acid,-9.135977,x0830,1.402228,active-covalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)[O-])[O-])C(=O)OC2,BRD-K63750851-001-18-1,mycophenolic-acid,Selleck,S2487,Mycophenolic acid,-9.135977,x0830,1.402228,active-covalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=[NH2+])N2,BRD-K07954936-001-01-3,2-iminobiotin,BroadPharm,BP-20532,,-9.135775,x0678,-1.890872,active-noncovalent
Cc1cn(c(=O)n(c1=O)Cc2ccsc2C(=O)[O-])C[C@@H](C(=O)[O-])[NH3+],BRD-K09597601-001-01-2,UBP-310,Tocris,3621,UBP 310,-9.133450,x0678,1.509425,active-noncovalent
c1ccc(cc1)CN(CC2=[NH+]CCN2)c3ccccc3,BRD-K99300445-003-20-8,antazoline,Selleck,S4199,Antazoline HCl,-9.133289,x0749,-0.210421,active-covalent
c1ccc(cc1)CN(CC2=[NH+]CCN2)c3ccccc3,BRD-K99300445-003-21-6,antazoline,Tocris,791,Antazoline hydrochloride,-9.133289,x0749,-0.210421,active-covalent
c1ccc(cc1)CN(CC2=[NH+]CCN2)c3ccccc3,BRD-K99300445-001-01-2,antazoline,MicroSource,1500126,ANTAZOLINE,-9.133289,x0749,-0.210421,active-covalent
CC1=C([C@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OCCOC,BRD-A02743701-001-03-6,cilnidipine,Tocris,2629,Cilnidipine,-9.132248,x0161,8.267716,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OCCOC,BRD-A02743701-001-04-4,cilnidipine,Selleck,S1293,Cilnidipine,-9.132248,x0161,8.267716,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OCCOC,BRD-A02743701-001-02-8,cilnidipine,Selleck,S1293,Cilnidipine,-9.132248,x0161,8.267716,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OCCOC,BRD-A02743701-001-06-9,cilnidipine,Tocris,2629,Cilnidipine,-9.132248,x0161,8.267716,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)C(=O)[O-])Cl,BRD-K51324732-001-01-0,meglitinide,Enamine,Z224216672,,-9.131931,x0678,1.988334,active-noncovalent
Cc1c(ccc2c1c3ccccc3n2C(C)C)NC(=O)N4CCOCC4,BRD-K95600043-001-02-3,NPY-5RA972,Tocris,3677,NPY 5RA972,-9.131223,x0161,3.983954,active-noncovalent
Cc1c(ccc2c1c3ccccc3n2C(C)C)NC(=O)N4CCOCC4,BRD-K95600043-001-01-5,NPY-5RA972,Tocris,3677,NPY 5RA972,-9.131223,x0161,3.983954,active-noncovalent
CCn1c2ccccc2c3c1ccc(c3)C[NH2+]Cc4ccccc4OC,BRD-K73746696-003-01-8,HLCL-61,MedChemEx,HY-100025A,HLCL-61 (hydrochloride),-9.129971,x0161,1.758933,active-noncovalent
C[C@@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-A24228527-001-31-5,ofloxacin,Selleck,S1463,Ofloxacin (Floxin),-9.128493,x0195,6.188839,active-noncovalent
C[C@@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],BRD-A24228527-213-01-9,ofloxacin,MicroSource,1502044,OFLOXACIN,-9.128493,x0195,6.188839,active-noncovalent
C[N+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,BRD-A62421304-004-17-1,mepenzolate,Selleck,S4375,Mepenzolate Bromide,-9.126459,x0678,1.230275,active-noncovalent
C[N+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,BRD-A62421304-004-18-9,mepenzolate,MicroSource,1500383,MEPENZOLATE BROMIDE,-9.126459,x0678,1.230275,active-noncovalent
c1cc(c(cc1c2ccc(cc2F)C3(CC3)C(=O)[O-])Cl)Cl,BRD-K34508702-001-02-4,CHF5074,MedChemEx,HY-14399,CHF5074,-9.126347,x0749,4.926517,active-covalent
C[C@H]1C[C@H]2[C@H]3CC[C@H]([C@]3(C[C@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C,BRD-A59014912-001-01-3,medrysone,Selleck,S4332,Medrysone,-9.125561,x1077,2.385173,active-noncovalent
CC/C(=C(/c1ccc(cc1)OCC[NH+](C)C)\c2cccc(c2)O)/c3ccccc3,BRD-K38477637-001-01-0,droloxifene,LKT,D6957,3-((1E)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenyl-1-butenyl)phenol,-9.123614,x0874,2.874984,active-noncovalent
CC[C@]12CC(=C)[C@H]3[C@@H]([C@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@@H]34,BRD-A08302182-001-01-7,etonogestrel,Enzo,AC3120,ETONOGESTREL,-9.121600,x0749,2.895837,active-covalent
c1ccc(cc1)C(=O)OOC(=O)c2ccccc2,BRD-K59986511-001-04-9,benzoyl-peroxide,MicroSource,1503004,BENZOYL PEROXIDE,-9.121383,x0749,0.02242,active-covalent
c1ccc(cc1)C(=O)OOC(=O)c2ccccc2,BRD-K59986511-001-06-4,benzoyl-peroxide,Sigma,MFCD00003071,diphenylperoxyanhydride,-9.121383,x0749,0.02242,active-covalent
Cc1c(c(on1)C)c2cc(cc(c2)O)[C@H](c3ccccc3)O,BRD-A73891132-001-01-0,OXF-BD-02,Tocris,4928,OXF BD 02,-9.120838,x0161,-0.161841,active-noncovalent
c1cc(cc(c1)c2nc(no2)c3cccnc3)C#N,BRD-K40176866-001-01-6,NS-9283,Tocris,5112,NS 9283,-9.119989,x0678,4.546293,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)C(F)(F)F)C(=O)[O-],BRD-K99506538-001-03-8,xenalipin,Enamine,Z56854445,"4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxylic acid",-9.118729,x0678,0.206568,active-noncovalent
c1cc2c(c(c1)Cl)CN(C2)C3=[NH+]CCN3,BRD-K26160755-003-02-6,RS-45041-190,Tocris,889,RS 45041-190 hydrochloride,-9.116029,x0195,-1.395364,active-noncovalent
CN(C)c1ccc(cc1)c2cccc(c2)NC(=O)N(C)C,BRD-K43363084-001-02-1,atglistatin,Selleck,S7364,Atglistatin,-9.115718,x0195,1.578996,active-noncovalent
CN(C)c1ccc(cc1)c2cccc(c2)NC(=O)N(C)C,BRD-K43363084-001-01-3,atglistatin,Selleck,S7364,Atglistatin,-9.115718,x0195,1.578996,active-noncovalent
Cc1ccc2c(c1)C3(CC[NH+](CC3)CCc4c(oc(n4)c5ccccc5)C)OC(=O)N2,BRD-K87510569-001-02-8,RS-504393,Tocris,2517,RS 504393,-9.115561,x0161,6.37229,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)N,BRD-A16332958-001-09-9,modafinil,MicroSource,1505361,MODAFINIL,-9.114628,x0678,1.162295,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)N,BRD-K87278688-001-01-0,armodafinil,MicroSource,1504283,ARMODAFINIL,-9.114628,x0678,1.162295,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cn3ccccc3[nH+]2,BRD-K45125084-001-01-4,zolimidine,Enamine,Z82177056,"2-[4-(methylsulfonyl)phenyl]imidazo[1,2-a]pyridine",-9.113914,x0749,4.182984,active-covalent
COc1cc(ccc1C(=O)N2CCC(CC2)Cc3ccccc3)SC,BRD-K05464208-001-05-7,JX-401,Tocris,2657,JX 401,-9.111429,x0946,2.21751,active-noncovalent
COc1cc(ccc1C(=O)N2CCC(CC2)Cc3ccccc3)SC,BRD-K05464208-001-08-1,JX-401,Tocris,2657,JX 401,-9.111429,x0946,2.21751,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OCC#C,BRD-K23922020-075-03-7,arecaidine-propargyl-ester,Tocris,383,"2-propynyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate 4-methylbenzenesulfonate",-9.111406,x0195,-0.957181,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OCC#C,BRD-K23922020-075-02-9,arecaidine-propargyl-ester,Tocris,383,Arecaidine propargyl ester tosylate,-9.111406,x0195,-0.957181,active-noncovalent
C1CSC(=O)[C@H]1NC(=O)CSCC(=O)[O-],BRD-A05515753-001-03-2,erdosteine,MicroSource,1502383,ERDOSTEINE,-9.110259,x0678,-0.156232,active-noncovalent
C1CSC(=O)[C@H]1NC(=O)CSCC(=O)[O-],BRD-A05515753-001-04-0,erdosteine,Selleck,S1825,Erdosteine,-9.110259,x0678,-0.156232,active-noncovalent
C1CSC(=O)[C@H]1NC(=O)CSCC(=O)[O-],BRD-A05515753-001-02-4,erdosteine,Selleck,S1825,Erdosteine,-9.110259,x0678,-0.156232,active-noncovalent
C[C@@H](/C=C/c1cccc(c1)Oc2ccc(cc2)F)N(C(=O)N)O,BRD-A55946879-001-03-7,BW-B70C,Tocris,1304,BW-B 70C,-9.110114,x0195,1.687165,active-noncovalent
c1ccc(cc1)C(=O)NCCC(=O)[O-],BRD-K82142815-001-19-1,betamipron,MicroSource,1504244,BETAMIPRON,-9.109447,x0678,-1.395966,active-noncovalent
c1ccc(cc1)C(=O)NCCC(=O)[O-],BRD-K82142815-001-18-3,betamipron,Selleck,S4191,Betamipron,-9.109447,x0678,-1.395966,active-noncovalent
CCCC(=O)Nc1cccc(c1)NC(=O)c2ccccc2Br,BRD-K59036917-001-16-7,ML161,Selleck,S2916,ML161,-9.109258,x0195,4.372876,active-noncovalent
CCCC(=O)Nc1cccc(c1)NC(=O)c2ccccc2Br,BRD-K59036917-001-17-5,ML161,Tocris,4570,ML 161,-9.109258,x0195,4.372876,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N/N=N/c2ccc(cc2)C(=[NH2+])N,BRD-K92848252-001-01-9,diminazene-aceturate,MicroSource,1502349,DIMINAZENE ACETURATE,-9.109124,x0395,2.663393,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N/N=N/c2ccc(cc2)C(=[NH2+])N,BRD-K92848252-001-03-5,diminazene-aceturate,Selleck,S4104,Diminazene Aceturate,-9.109124,x0395,2.663393,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N/N=N/c2ccc(cc2)C(=[NH2+])N,BRD-K92848252-001-02-7,diminazene-aceturate,Selleck,S4104,Diminazene Aceturate,-9.109124,x0395,2.663393,active-noncovalent
Cc1cc(ccc1Oc2ccc(cc2)SC(F)(F)F)n3c(=O)[nH]c(=O)n(c3=O)C,BRD-K64514229-001-04-5,toltrazuril,Selleck,S4044,Toltrazuril,-9.108834,x0161,7.79333,active-noncovalent
Cc1cc(ccc1Oc2ccc(cc2)SC(F)(F)F)n3c(=O)[nH]c(=O)n(c3=O)C,BRD-K64514229-001-05-2,toltrazuril,MicroSource,1505681,TOLTRAZURIL,-9.108834,x0161,7.79333,active-noncovalent
C[NH+](C)CCC[C@@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-K70301876-034-13-7,escitalopram,MicroSource,1505216,ESCITALOPRAM OXALATE,-9.108678,x0678,0.097087,active-noncovalent
C[NH+](C)CCC[C@@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-K70301876-034-14-5,escitalopram,Tocris,4796,Escitalopram oxalate,-9.108678,x0678,0.097087,active-noncovalent
C[N@@H+](Cc1cc(cc(c1N)Br)Br)C2CCCCC2,BRD-K47631482-003-07-0,bromhexine,MicroSource,1503107,BROMHEXINE HYDROCHLORIDE,-9.108104,x0678,-0.298891,active-noncovalent
C[N@@H+](Cc1cc(cc(c1N)Br)Br)C2CCCCC2,BRD-K47631482-003-06-2,bromhexine,Selleck,S2060,Bromhexine HCl,-9.108104,x0678,-0.298891,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CC[C@]34C,BRD-K26024145-001-01-9,desoxycorticosterone-pivalate,InterBioScreen,STOCK1N-55228,"3,20-dioxopregn-4-en-21-yl pivalate",-9.106156,x0161,4.081986,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CC(=O)[O-],BRD-K35498378-001-06-1,alrestatin,Tocris,485,Alrestatin,-9.106066,x0195,0.988238,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CC(=O)[O-],BRD-K35498378-001-07-9,alrestatin,MicroSource,1502053,ALRESTATIN,-9.106066,x0195,0.988238,active-noncovalent
c1cc(c2ccncc2c1S(=O)(=O)NCC[NH3+])Cl,BRD-K34303607-300-02-2,CKI-7,Tocris,5329,CKI 7 dihydrochloride,-9.104425,x0678,-1.545321,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(C[C@@H]([C@@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O,BRD-A01643550-001-04-9,prednisolone-acetate,MicroSource,1500497,PREDNISOLONE ACETATE,-9.103774,x0692,2.920918,active-covalent
c1cc(c(cc1Cl)Cl)CO/N=C(\Cn2ccnc2)/c3ccc(cc3Cl)Cl,BRD-K56104152-008-04-1,oxiconazole,MicroSource,1505330,OXICONAZOLE NITRATE,-9.102717,x0107,1.985059,active-noncovalent
Cc1cc(ccc1SC)OP(=S)(OC)OC,BRD-K67217586-001-08-0,fenthion,MicroSource,330064,FENTHION,-9.102233,x0749,-0.543623,active-covalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K40853697-001-20-5,STAT3-inhibitor-VI,MedChemEx,HY-15146,NSC 74859,-9.102181,x0072,2.120873,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K40853697-001-17-1,STAT3-inhibitor-VI,Selleck,S1155,NSC 74859 (S3I-201),-9.102181,x0072,2.120873,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K40853697-001-18-9,STAT3-inhibitor-VI,MedChemEx,HY-15146,NSC 74859,-9.102181,x0072,2.120873,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K40853697-001-12-2,STAT3-inhibitor-VI,Selleck,S1155,S3I-201,-9.102181,x0072,2.120873,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K40853697-001-19-7,STAT3-inhibitor-VI,Tocris,4655,NSC 74859,-9.102181,x0072,2.120873,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH+](C)C,BRD-K82236108-001-04-9,"N-methyl-(-)ephedrine-[1r,2s]",MicroSource,2300220,"N-METHYL (-)EPHEDRINE [1R,2S]",-9.101809,x0195,-1.273494,active-noncovalent
CC(C)c1ccc(cc1)C(=O)NCCOc2ccc(cc2)C(=O)[O-],BRD-K22097830-001-01-9,OCO-1112,Enamine,Z1149820700,,-9.101601,x0678,1.39777,active-noncovalent
CCNC(=O)c1c(c([nH]n1)c2cc(c(cc2O)O)Cl)c3ccc(cc3)OC,BRD-K38548312-001-01-0,VER-49009,Selleck,S7458,VER-49009,-9.101141,x1392,0.717512,active-covalent
C[C@H]1C[C@H]2[C@H](CC[C@]3([C@@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,BRD-A61221616-001-04-3,medroxyprogesterone-acetate,MicroSource,1500379,MEDROXYPROGESTERONE ACETATE,-9.100740,x1077,2.074643,active-noncovalent
C[C@H]1C[C@H]2[C@H](CC[C@]3([C@@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,BRD-A61221616-001-05-0,medroxyprogesterone-acetate,Selleck,S2567,Medroxyprogesterone acetate,-9.100740,x1077,2.074643,active-noncovalent
Cc1cccc(c1)C(=O)NC[NH+]2CCN(CC2)c3ccccc3C#N,BRD-K47761761-050-07-8,PD-168077,Tocris,1065,PD 168077 maleate,-9.100672,x0161,4.770345,active-noncovalent
c1ccc2c(c1)C3(CC[NH+](CC3)CCc4ccc(cc4)C(F)(F)F)OC(=O)N2,BRD-K83063356-003-02-5,RS-102895,Tocris,2089,RS 102895 hydrochloride,-9.099960,x0161,4.072184,active-noncovalent
c1ccc2c(c1)C3(CC[NH+](CC3)CCc4ccc(cc4)C(F)(F)F)OC(=O)N2,BRD-K83063356-003-03-3,RS-102895,Tocris,2089,RS 102895 hydrochloride,-9.099960,x0161,4.072184,active-noncovalent
CC(C)OC(=O)/C=C\n1cnc(n1)c2cc(cc(c2)OC)C(F)(F)F,BRD-K71467466-001-02-3,KPT-185,Selleck,S7125,KPT-185,-9.099607,x0195,2.270521,active-noncovalent
C[C@H](CCC(=O)N=O)/C=C(\C)/C(=O)c1ccc(cc1)N(C)C,BRD-K68202742-001-13-2,trichostatin-a,Selleck,S1045,Trichostatin A (TSA),-9.099092,x0749,0.55163,active-covalent
C[C@H](CCC(=O)N=O)/C=C(\C)/C(=O)c1ccc(cc1)N(C)C,BRD-K68202742-001-16-5,trichostatin-a,Selleck,S1045,Trichostatin A (TSA),-9.099092,x0749,0.55163,active-covalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC4CCCC4,BRD-K60150510-001-15-6,N6-cyclopentyladenosine,Tocris,1702,N6-Cyclopentyladenosine,-9.099028,x0946,3.058001,active-noncovalent
CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3,BRD-K55166090-001-09-0,efloxate,MicroSource,1504518,EFLOXATE,-9.098845,x0195,1.884922,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCC[NH+]4CCC(CC4)CCO,BRD-K16277217-001-10-9,piperacetazine,MicroSource,1503874,PIPERACETAZINE,-9.098739,x0104,3.198788,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,BRD-A31204924-001-16-7,mitotane,Selleck,S1732,Mitotane,-9.097783,x0072,-0.463157,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,BRD-A31204924-001-17-5,mitotane,MedChemEx,HY-13690,Mitotane,-9.097783,x0072,-0.463157,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,BRD-A31204924-001-14-2,mitotane,MicroSource,330082,MITOTANE,-9.097783,x0072,-0.463157,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,BRD-A31204924-001-18-3,mitotane,MedChemEx,HY-13690,Mitotane,-9.097783,x0072,-0.463157,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,BRD-A31204924-001-13-4,mitotane,Selleck,S1732,Mitotane,-9.097783,x0072,-0.463157,active-noncovalent
c1cnn(c1)c2ccc(cc2)[C@@](Cc3[nH]cc([nH+]3)CC4(CC4)C(F)(F)F)(C(F)(F)F)O,BRD-K03886848-001-01-8,MK-5046,MedChemEx,HY-14342,MK-5046,-9.097631,x0678,2.723313,active-noncovalent
CC[NH+](CC)CCCC[C@H](c1ccccc1)NC(=O)c2ccc(cc2)N(=O)=O,BRD-A85876464-001-01-5,nibentan,Vitas-M,STL069536,,-9.097618,x0161,3.561873,active-noncovalent
CC(C)NC(=O)COc1cccc(c1)c2nc3ccccc3c(n2)Nc4ccc5c(c4)cn[nH]5,BRD-K88506063-001-01-8,KD025,MedChemEx,HY-15307,SLx-2119,-9.097225,x0161,6.937487,active-noncovalent
CC(C)c1cc(c(cc1O)O)c2n[nH]c(=O)n2c3ccc4c(c3)ccn4C,BRD-K38852836-001-02-1,ganetespib,Selleck,S1159,Ganetespib (STA-9090),-9.095671,x0195,1.295388,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Sc4c2cc(cc4)Cl,BRD-K10990317-001-04-5,clotiapine,Enzo,D108,Clothiapine,-9.093609,x0678,1.052837,active-noncovalent
C[N+]1(CCC(=C(c2ccccc2)c3ccccc3)CC1)C,BRD-K93441486-067-12-8,diphemanil,Selleck,S4034,Diphemanil Methylsulfate,-9.092729,x0831,1.36866,active-covalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCC(=O)[O-],BRD-K60241851-001-11-9,isodibut,Sigma,MFCD00181400,"4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoic acid",-9.092201,x0831,-0.666921,active-covalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCC(=O)[O-],BRD-K60241851-001-10-1,isodibut,Enamine,Z56891243,,-9.092201,x0831,-0.666921,active-covalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)[O-],BRD-K57222227-001-28-5,indomethacin,Selleck,S1723,Indomethacin,-9.092182,x0831,1.511321,active-covalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)[O-],BRD-K57222227-001-29-3,indomethacin,Tocris,1708,Indomethacin,-9.092182,x0831,1.511321,active-covalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)[O-],BRD-K57222227-001-30-1,indomethacin,MicroSource,1500350,INDOMETHACIN,-9.092182,x0831,1.511321,active-covalent
CCC[NH2+]C(C)(C)COC(=O)c1ccccc1,BRD-K65417056-003-10-1,meprylcaine,MicroSource,1505553,MEPRYLCAINE HYDROCHLORIDE,-9.091915,x0161,0.506736,active-noncovalent
Cn1c2ccccc2c(c1O)C3=c4ccccc4=NC3=O,BRD-K14529030-001-01-9,meisoindigo,MedChemEx,HY-13680,Meisoindigo,-9.091804,x0072,-0.905742,active-noncovalent
COc1ccc(cc1O)/C=C\c2cc(c(c(c2)OC)OC)OC,BRD-K61195623-001-01-4,combretastatin-A-4,ChemDiv,8020-3786,,-9.089901,x0195,2.694555,active-noncovalent
CN(C)c1ccc(cc1)c2ccc(cc2)CN(c3cccc(c3)/C=C/C(=O)OC)C(=O)C4CCCCC4,BRD-K08864679-001-02-2,fexaramine,Tocris,2563,Fexaramine,-9.089888,x1077,7.37816,active-noncovalent
CN(C)c1ccc(cc1)c2ccc(cc2)CN(c3cccc(c3)/C=C/C(=O)OC)C(=O)C4CCCCC4,BRD-K08864679-001-03-0,fexaramine,Tocris,2563,Fexaramine,-9.089888,x1077,7.37816,active-noncovalent
CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OC[C@H](C[NH2+]C(C)(C)C)O,BRD-A95602221-003-02-1,celiprolol,Prestwick,Prestw-1132,Celiprolol hydrochloride,-9.089760,x0104,4.571354,active-noncovalent
C[C@H](CN1c2ccccc2CCc3c1cccc3)C[NH+](C)C,BRD-A19195498-050-13-3,trimipramine,Selleck,S4416,Trimipramine Maleate,-9.088980,x0072,0.50917,active-noncovalent
C[C@H](CN1c2ccccc2CCc3c1cccc3)C[NH+](C)C,BRD-A19195498-050-14-1,trimipramine,MicroSource,1503117,TRIMIPRAMINE MALEATE,-9.088980,x0072,0.50917,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](Cc3c(cc(c(c3O2)[C@H]4c5c(cc(cc5O[C@@H]([C@@H]4O)c6ccc(c(c6)O)O)O)O)O)O)O)O)O,BRD-K72093555-001-01-0,procyanidin-b-2,SantaCruz,sc-228996,,-9.088621,x0161,6.702456,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](Cc3c(cc(c(c3O2)[C@H]4c5c(cc(cc5O[C@@H]([C@@H]4O)c6ccc(c(c6)O)O)O)O)O)O)O)O)O,BRD-K72093555-001-02-8,procyanidin-b-2,SantaCruz,SC-228996,Procyanidin B1,-9.088621,x0161,6.702456,active-noncovalent
CCN(CC)C(=O)[C@@]1(C[C@@H]1C[NH3+])c2ccccc2,BRD-A15202882-003-02-7,milnacipran,MicroSource,1504815,MILNACIPRAN HYDROCHLORIDE,-9.086010,x0678,-0.910534,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)Nc3ncc4c(n3)-c5c(c(nn5CCO)C(=O)N)CC4)OC(F)(F)F,BRD-K83699324-001-01-1,NMS-1286937,MedChemEx,HY-15828,NMS-1286937,-9.085902,x1093,7.874296,active-noncovalent
C/C(=C\c1ccccc1F)/CN(CC[C@H]2CCC[N@@H+]2C)C(=O)c3cc(c(c(c3)OC)OC)OC,BRD-A93717708-051-01-2,VUF11207,Tocris,4780,VUF 11207 fumarate,-9.084807,x0874,6.912045,active-noncovalent
COc1ccc(cc1OC)Cc2cnc(nc2N)N,BRD-K97464279-001-03-5,diaveridine,MicroSource,1502300,DIAVERIDINE,-9.084249,x0678,1.1437,active-noncovalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)C34C[C@@H]5C[C@H](C3)CC4C5,BRD-A95683721-001-03-8,KW-3902,Tocris,4167,KW 3902,-9.082354,x0678,1.605219,active-noncovalent
C[N@@H+]1CCC[C@H]1c2cccnc2,BRD-K05395900-322-05-4,nicotine,MicroSource,2300259,NICOTINE BITARTRATE,-9.081602,x0678,-2.32529,active-noncovalent
c1ccc(cc1)C(=O)c2cccc(c2N)CC(=O)N,BRD-K04112579-001-07-0,nepafenac,Selleck,S1255,Nepafenac,-9.081283,x0749,-0.91242,active-covalent
C[C@]12CC[C@H]3[C@@]4(CCC[C@@]([C@H]4CC[C@@]3(C1)CC2=O)(C)C(=O)[O-])C,BRD-A96529864-001-01-3,isosteviol,ChemDiv,N062-0006,,-9.080267,x0749,1.851004,active-covalent
CCCC[C@@H](CC)COC(=O)c1ccccc1O,BRD-K95161686-001-02-8,octisalate,MicroSource,1505760,OCTISALATE,-9.079791,x0195,0.014875,active-noncovalent
CN1CC(=O)N2[C@@H](C1=O)Cc3c4ccccc4[nH]c3[C@H]2c5ccc6c(c5)OCO6,BRD-K93645900-001-12-1,tadalafil,MicroSource,1505639,TADALAFIL,-9.077617,x0678,1.342667,active-noncovalent
CN1CC(=O)N2[C@@H](C1=O)Cc3c4ccccc4[nH]c3[C@H]2c5ccc6c(c5)OCO6,BRD-K93645900-001-11-3,tadalafil,Selleck,S1512,Tadalafil,-9.077617,x0678,1.342667,active-noncovalent
CCc1cc2c(c(n1)CC)CCC(=O)N2Cc3ccc(cc3)c4ccccc4c5[n-]nnn5,BRD-K11373525-003-02-1,ZD-7155,Tocris,1211,ZD 7155 hydrochloride,-9.076797,x0161,6.564856,active-noncovalent
C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@H]1[C@H]4CC[C@]([C@]4(CC3)C)(C#C)O,BRD-A82522119-001-01-7,tibolone,MicroSource,1502343,TIBOLONE,-9.076203,x0749,0.684015,active-covalent
c1ccc(cc1)c2[nH]c3cc(ccc3n2)S(=O)(=O)[O-],BRD-K02729857-001-01-9,phenylbenzimidazole-sulfonic-acid,Vitas-M,STK034479,,-9.076019,x0678,0.755846,active-noncovalent
c1cnccc1c2cc3c([nH]2)CCNC3=O,BRD-K50000283-001-04-4,PHA-767491,Selleck,S2742,PHA-767491,-9.075813,x0678,-0.859159,active-noncovalent
c1cnccc1c2cc3c([nH]2)CCNC3=O,BRD-K50000283-003-02-4,PHA-767491,Tocris,3140,PHA 767491 hydrochloride,-9.075813,x0678,-0.859159,active-noncovalent
c1ccc2c(c1)cc(o2)C3=[NH+]CCN3,BRD-K22745370-003-02-3,2-BFI,Tocris,348,2-BFI hydrochloride,-9.075667,x0749,-1.656267,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])C(=O)[O-])C2=O,BRD-K27335680-001-10-0,rhein,Selleck,S2400,Rheic Acid,-9.074903,x0749,-0.265572,active-covalent
Cc1cc(c(n1Cc2ccccc2)C)C(=O)Cn3cc(ccc3=O)C#N,BRD-K29151923-001-01-5,CYM-5520,Tocris,5418,CYM 5520,-9.072673,x0749,3.088812,active-covalent
c1ccc2c(c1)nc(s2)SN3CCOCC3,BRD-K97360717-001-09-2,N-oxydiethylenebenzothiazole-2-sulfenamide,Enamine,Z56821717,,-9.072179,x0749,-0.904295,active-covalent
c1cc(ccc1N)S(=O)(=O)c2ccc(cc2)N,BRD-K62363391-001-24-9,dapsone,MicroSource,1500222,DAPSONE,-9.071971,x0072,-0.638065,active-noncovalent
CC[N@@H+]1CCC[C@H](C1)OC(=O)C(c2ccccc2)c3ccccc3,BRD-A97479839-003-13-3,piperidolate,MicroSource,1502197,PIPERIDOLATE HYDROCHLORIDE,-9.071856,x0195,2.231065,active-noncovalent
COc1ccc(cc1OC)CCN2CC[NH+](CC2)CCCc3ccccc3,BRD-K90777969-300-02-0,cutamesine,Tocris,4951,SA 4503 dihydrochloride,-9.071821,x0161,6.857593,active-noncovalent
COc1ccc(cc1OC)CCN2CC[NH+](CC2)CCCc3ccccc3,BRD-K90777969-300-01-2,cutamesine,MedChemEx,HY-13510,SA4503 (dihydrochloride),-9.071821,x0161,6.857593,active-noncovalent
C[NH+](C)CCO[C@@H](c1ccc(cc1)Cl)c2ccccn2,BRD-A29426959-050-13-2,carbinoxamine,MicroSource,1500161,CARBINOXAMINE MALEATE,-9.071591,x0678,1.33982,active-noncovalent
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO,BRD-K41779183-001-01-2,CB-03-01,MedChemEx,HY-13331,17 alpha-propionate,-9.071207,x0749,3.079271,active-covalent
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO,BRD-K41779183-001-02-0,CB-03-01,MedChemEx,HY-13331,Cortexolone 17 alpha-propionate,-9.071207,x0749,3.079271,active-covalent
c1ccc2c(c1)ccc(c2/C=N/S(=O)(=O)c3cccs3)O,BRD-K13049524-001-04-6,STF-083010,MedChemEx,HY-15845,STF-083010,-9.070529,x0195,0.6898,active-noncovalent
c1ccc2c(c1)ccc(c2/C=N/S(=O)(=O)c3cccs3)O,BRD-K13049524-001-03-8,STF-083010,MedChemEx,HY-15845,STF-083010,-9.070529,x0195,0.6898,active-noncovalent
c1ccc(c(c1)[C@H]2CS/C(=C(/C#N)\n3ccnc3)/S2)Cl,BRD-A54275602-001-01-0,lanoconazole,AKSci,71613,,-9.069508,x0072,0.798873,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSc1ccccc1C(=O)[O-])/C)/C)C,BRD-K98453471-001-01-7,salirasib,MedChemEx,HY-14754,Salirasib,-9.068083,x0749,2.175961,active-covalent
c1ccc2c(c1)c(c[nH]2)C(=O)OCC[NH+]3CCCCC3,BRD-K27141178-003-07-3,SB-203186,Tocris,785,SB 203186 hydrochloride,-9.067726,x0831,1.401641,active-covalent
Cn1c(c([nH]c1=O)Cc2c[nH]c3c2cccc3Cl)[O-],BRD-K68851986-001-01-6,necrostatin-2,MedChemEx,HY-14622,Necrostatin 2,-9.066577,x0749,-1.181374,active-covalent
c1cc(ccc1c2ccc(o2)/C=N/N3CC(=O)NC3=O)N(=O)=O,BRD-K81272440-236-12-7,dantrolene,Tocris,507,"Dantrolene, sodium salt",-9.066478,x1077,3.837356,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=N/N3CC(=O)NC3=O)N(=O)=O,BRD-K81272440-236-13-5,dantrolene,MicroSource,1503209,DANTROLENE SODIUM,-9.066478,x1077,3.837356,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=C/3\C(=O)[N-]C(=O)S3)F,BRD-K40366680-001-04-1,CAY10505,Selleck,S2682,CAY10505,-9.066477,x0195,0.489621,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=C/3\C(=O)[N-]C(=O)S3)F,BRD-K40366680-001-03-3,CAY10505,Selleck,S2682,CAY10505,-9.066477,x0195,0.489621,active-noncovalent
Cc1nc2ccccc2n1Cc3ccc(cc3)Cl,BRD-K60443845-001-08-6,chlormidazole,MicroSource,1503733,CHLORMIDAZOLE,-9.066476,x1093,-0.843665,active-noncovalent
C[N@H+]1CCC[C@@H]1CCSc2ccc(cc2)O,BRD-A79052425-003-01-5,SIB-1553A,Tocris,4764,4-((2-(1-methylpyrrolidin-2-yl)ethyl)thio)phenol hydrochloride,-9.063419,x0161,-0.784798,active-noncovalent
c1cc(ccc1CO[C@H]2Cn3cc([nH+]c3OC2)N(=O)=O)OC(F)(F)F,BRD-K96671969-001-03-1,PA-824,Selleck,S1162,PA-824,-9.063246,x0161,2.710795,active-noncovalent
CO[C@H]1CC=C2CC[N@H+]3[C@]2(C1)C4=CC(=O)OC[C@H]4CC3,BRD-K49811169-004-06-6,NSC-9965,Enzo,AC738,Dihydro-beta-erythroidine HBr,-9.062446,x0072,-0.210685,active-noncovalent
CC(C)C[C@H](C(=O)[O-])NC(=O)OCC1c2ccccc2-c3c1cccc3,BRD-K65275554-001-04-7,NPC-15199,Tocris,675,NPC 15199,-9.061985,x0678,2.594416,active-noncovalent
CCC1(C(=O)N(C(=O)N(C1=O)COC)COC)c2ccccc2,BRD-K64834129-001-19-6,eterobarb,Vitas-M,STK091981,"5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",-9.061070,x0678,0.711674,active-noncovalent
c1ccc(cc1)/C(=C(/c2ccccc2)\c3ccc(cc3)OCCO)/CCCl,BRD-K44184170-001-01-7,ospemifene,Selleck,S4285,"2-{4-[(1Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy}ethanol",-9.060997,x0434,2.354861,active-noncovalent
c1c(onc1C(=O)N(C2CCCCC2)C3CCCCC3)C4CC4,BRD-K75940276-001-03-3,CYM-5541,Tocris,4897,CYM 5541,-9.060060,x1093,1.768906,active-noncovalent
CCN(Cc1ccncc1)C(=O)[C@@H](CO)c2ccccc2,BRD-A79672927-001-22-3,tropicamide,Tocris,909,Tropicamide,-9.059565,x0749,-1.013193,active-covalent
CCN(Cc1ccncc1)C(=O)[C@@H](CO)c2ccccc2,BRD-A79672927-001-18-1,tropicamide,Selleck,S1913,Tropicamide,-9.059565,x0749,-1.013193,active-covalent
CCN(Cc1ccncc1)C(=O)[C@@H](CO)c2ccccc2,BRD-A79672927-001-19-9,tropicamide,Tocris,909,Tropicamide,-9.059565,x0749,-1.013193,active-covalent
CCN(Cc1ccncc1)C(=O)[C@@H](CO)c2ccccc2,BRD-A79672927-001-20-7,tropicamide,MicroSource,1500599,TROPICAMIDE,-9.059565,x0749,-1.013193,active-covalent
c1[nH]c2c(n1)c(nc(n2)N)OCC3CCCCC3,BRD-K20976221-001-12-0,NU-2058,Tocris,3135,NU 2058,-9.059414,x0831,-0.995293,active-covalent
CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@@H]5O)[N@H+]3[C@@H]1O)c6ccccc6[N@@]4C,BRD-A48300215-001-04-8,ajmaline,MicroSource,1500656,AJMALINE,-9.059394,x0749,-0.3914,active-covalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,BRD-K59256312-066-15-7,gabexate,Selleck,S2101,Gabexate mesylate,-9.058656,x0104,2.142149,active-noncovalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,BRD-K59256312-066-16-5,gabexate,MedChemEx,HY-B0385,Gabexate (mesylate),-9.058656,x0104,2.142149,active-noncovalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,BRD-K59256312-066-17-3,gabexate,MedChemEx,HY-B0385,Gabexate (mesylate),-9.058656,x0104,2.142149,active-noncovalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,BRD-K59256312-066-13-2,gabexate,Selleck,S2101,Gabexate Mesylate,-9.058656,x0104,2.142149,active-noncovalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,BRD-K59256312-066-14-0,gabexate,Tocris,1798,Gabexate mesylate,-9.058656,x0104,2.142149,active-noncovalent
CCC(CC)n1c2c([nH]c1=O)ncc(n2)C#C,BRD-K51087630-001-01-6,tirasemtiv,MedChemEx,HY-15964,Tirasemtiv,-9.057319,x0195,-1.420651,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1OCC=C)O,BRD-A43671941-003-11-9,oxprenolol,Selleck,S4344,Oxprenolol HCl,-9.056771,x0874,1.661734,active-noncovalent
C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,BRD-A52460047-001-01-3,methylatropine-nitrate,MicroSource,1505445,METHYLATROPINE NITRATE,-9.056665,x0749,0.937055,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@H](C(=O)[O-])NC(=O)c3ccc(cc3)Cl,BRD-A87983072-001-01-1,benzotript,Enamine,Z85881728,,-9.056155,x0678,1.663707,active-noncovalent
c1cc(ccc1Oc2ccc(cc2)Cl)S(=O)(=O)CC3(CCOCC3)C(=O)NO,BRD-K53508936-001-01-0,CTS-1027,MedChemEx,HY-10398,CTS-1027,-9.055531,x0161,4.177226,active-noncovalent
c1cc(ccc1Oc2ccc(cc2)Cl)S(=O)(=O)CC3(CCOCC3)C(=O)NO,BRD-K53508936-001-02-8,CTS-1027,MedChemEx,HY-10398,CTS-1027,-9.055531,x0161,4.177226,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)c2ccccc2/N=C/c3c4ccccc4ccc3O,BRD-A23747351-001-05-0,sirtinol,Selleck,S2804,Sirtinol,-9.055193,x0831,4.103311,active-covalent
C[C@@H](c1ccccc1)NC(=O)c2ccccc2/N=C/c3c4ccccc4ccc3O,BRD-A23747351-001-06-8,sirtinol,Tocris,3521,Sirtinol,-9.055193,x0831,4.103311,active-covalent
C[C@@H](c1ccccc1)NC(=O)c2ccccc2/N=C/c3c4ccccc4ccc3O,BRD-A23747351-001-07-6,sirtinol,Selleck,S2804,Sirtinol,-9.055193,x0831,4.103311,active-covalent
c1ccnc(c1)C(=O)c2cnn3c2nccc3c4ccncc4,BRD-K92581468-001-01-6,ocinaplon,Tocris,4410,"2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]methanone",-9.055147,x0195,3.859484,active-noncovalent
C[C@@H](c1ccc(cc1)C(=O)c2cccs2)C(=O)[O-],BRD-A34006693-001-14-7,suprofen,Selleck,S1761,Suprofen,-9.055114,x0749,-0.553672,active-covalent
C[C@@H](c1ccc(cc1)C(=O)c2cccs2)C(=O)[O-],BRD-A34006693-001-15-4,suprofen,MicroSource,1501161,SUPROFEN,-9.055114,x0749,-0.553672,active-covalent
CC[NH+](CC)Cc1cc(ccc1O)Nc2ccnc3c2ccc(c3)Cl,BRD-K91290917-300-01-8,amodiaquine,MicroSource,1500119,AMODIAQUINE DIHYDROCHLORIDE,-9.054550,x1077,0.935603,active-noncovalent
CC[NH+](CC)Cc1cc(ccc1O)Nc2ccnc3c2ccc(c3)Cl,BRD-K91290917-336-05-3,amodiaquine,Prestwick,Prestw-309,Amodiaquin dihydrochloride dihydrate,-9.054550,x1077,0.935603,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,BRD-K63504947-001-14-7,semaxanib,Selleck,S2845,Semaxanib (SU5416),-9.054338,x0195,-1.239871,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,BRD-K63504947-001-16-2,semaxanib,Selleck,S2845,Semaxanib (SU5416),-9.054338,x0195,-1.239871,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,BRD-K63504947-001-15-4,semaxanib,Tocris,3037,SU 5416,-9.054338,x0195,-1.239871,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,BRD-K63504947-001-17-0,semaxanib,Tocris,3037,SU 5416,-9.054338,x0195,-1.239871,active-noncovalent
c1cc(cc(c1)C(F)(F)F)[C@H]2C[NH2+]CCO2,BRD-A43518428-001-01-9,flumexadol,Enamine,Z397586650,,-9.054163,x0195,-0.781817,active-noncovalent
c1cc(cc(c1)C(F)(F)F)[C@H]2C[NH2+]CCO2,BRD-A43518428-001-02-7,flumexadol,Enamine,Z1318513963,2-[3-(trifluoromethyl)phenyl]morpholine,-9.054163,x0195,-0.781817,active-noncovalent
Cn1c2c(cn1)c(nc(n2)c3cccc(c3)O)N4CCOCC4,BRD-K15858023-001-01-0,ETP-45658,Tocris,4702,ETP 45658,-9.053819,x1392,1.135841,active-covalent
CC(=O)NCCc1c2cc(ccc2[nH]c1c3ccccc3)OC,BRD-K41869275-001-03-6,2-phenylmelatonin,Tocris,680,2-Phenylmelatonin,-9.053698,x0678,0.303139,active-noncovalent
CC(=O)NCCc1c2cc(ccc2[nH]c1c3ccccc3)OC,BRD-K41869275-001-02-8,2-phenylmelatonin,Tocris,680,2-Phenylmelatonin,-9.053698,x0678,0.303139,active-noncovalent
c1cc(sc1)C(=O)Oc2ccc3cc(sc3c2)C(=[NH2+])N,BRD-K90472149-066-01-0,BCX-1470,MedChemEx,HY-50875,BCX 1470 (methanesulfonate),-9.053535,x0107,0.644422,active-noncovalent
Cc1ncc(c(n1)N)CN(C=O)/C(=C(/CCOP(=O)([O-])[O-])\SC(=O)c2ccccc2)/C,BRD-K05319475-001-04-2,benfotiamine,Selleck,S4300,Benfotiamine,-9.052117,x0678,2.254717,active-noncovalent
C1C[C@H]([C@H](O[C@@H]1C[NH3+])O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+])[NH3+])[NH3+],BRD-K48427910-001-01-1,dibekacin,MicroSource,1503114,DIBEKACIN,-9.051243,x0678,2.920093,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@H]2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K02074536-001-03-5,aloin,Selleck,S2375,Aloin,-9.050865,x1093,2.33357,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@H]2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K02074536-001-02-7,aloin,Selleck,S2375,Aloin (Barbaloin),-9.050865,x1093,2.33357,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@H]2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K02074536-001-01-9,aloin,MicroSource,1503427,ALOIN,-9.050865,x1093,2.33357,active-noncovalent
c1cc(cc(c1)Cl)c2ccc(o2)C(=O)Nc3ccc(cc3)C[NH+]4CCOCC4,BRD-K92781136-001-08-9,CID-2011756,Tocris,4644,CID 2011756,-9.050509,x0104,10.70813,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(C)C,BRD-K85333151-003-13-4,ramifenazone,MicroSource,1503822,RAMIFENAZONE,-9.050013,x0104,0.071486,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(C)C,BRD-K85333151-001-01-3,ramifenazone,Key,KS-5044,"4-(isopropylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one",-9.050013,x0104,0.071486,active-noncovalent
Cc1cc(c(n1c2ccc(cc2)F)C)C(=O)C[NH+]3CCCC3,BRD-K45841694-001-10-9,IU1,Selleck,S7134,IU1,-9.049490,x0195,0.54961,active-noncovalent
Cc1cc(c(n1c2ccc(cc2)F)C)C(=O)C[NH+]3CCCC3,BRD-K45841694-001-11-7,IU1,Selleck,S7134,IU1,-9.049490,x0195,0.54961,active-noncovalent
Cc1cc(c(n1c2ccc(cc2)F)C)C(=O)C[NH+]3CCCC3,BRD-K45841694-001-12-5,IU1,Tocris,4088,IU1,-9.049490,x0195,0.54961,active-noncovalent
CC1(CN(C1)C(=O)c2ccc(cc2)c3cccc4n3nc(n4)NC(=O)C5CC5)C,BRD-K69215269-001-01-1,solcitinib,MedChemEx,HY-16755,Solcitinib,-9.048704,x0161,4.895287,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,BRD-K18895904-001-16-1,olanzapine,MicroSource,1505024,OLANZAPINE,-9.048552,x0195,0.733564,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,BRD-K18895904-001-15-3,olanzapine,Selleck,S2493,Olanzapine,-9.048552,x0195,0.733564,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,BRD-K18895904-001-17-9,olanzapine,Selleck,S2493,Olanzapine (Zyprexa),-9.048552,x0195,0.733564,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,BRD-K18895904-001-19-5,olanzapine,Tocris,4349,Olanzapine,-9.048552,x0195,0.733564,active-noncovalent
Cc1cc(n(c1C(=O)c2ccc(cc2)Cl)C)CC(=O)[O-],BRD-K81326768-236-12-5,zomepirac,MedChemEx,HY-B0890,Zomepirac (sodium salt),-9.047338,x0830,0.158896,active-covalent
Cc1cc(n(c1C(=O)c2ccc(cc2)Cl)C)CC(=O)[O-],BRD-K81326768-001-04-0,zomepirac,MicroSource,1500615,ZOMEPIRAC SODIUM,-9.047338,x0830,0.158896,active-covalent
Cc1cc(n(c1C(=O)c2ccc(cc2)Cl)C)CC(=O)[O-],BRD-K81326768-236-11-7,zomepirac,Sigma,MFCD00057223,"sodium [5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrol-2-yl]acetate",-9.047338,x0830,0.158896,active-covalent
Cc1c2c(c3cc(ccc3[nH+]c2n[nH]1)OC)NCCOCCO,BRD-K02460719-001-01-9,SCH-51344,Tocris,5280,SCH 51344,-9.047336,x0107,0.860983,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],BRD-K30685142-001-15-4,levothyroxine,MicroSource,1500774,LEVOTHYROXINE,-9.045209,x0678,1.568864,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],BRD-K30685142-001-16-2,levothyroxine,Selleck,S2599,L-Thyroxine,-9.045209,x0678,1.568864,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],BRD-K30685142-001-17-0,levothyroxine,Sigma,MFCD00002595,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid",-9.045209,x0678,1.568864,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],BRD-K30685142-001-14-7,levothyroxine,Selleck,S2599,L-Thyroxine,-9.045209,x0678,1.568864,active-noncovalent
COc1cc(ccc1O)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)O)/O,BRD-K07572174-001-38-6,curcumin,Selleck,S1848,Curcumin,-9.044683,x0104,7.282636,active-noncovalent
COc1cc(ccc1O)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)O)/O,BRD-K07572174-001-39-4,curcumin,Selleck,S1848,Curcumin,-9.044683,x0104,7.282636,active-noncovalent
COc1cc(ccc1O)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)O)/O,BRD-K07572174-001-43-6,curcumin,Enzo,EI135,Curcumin,-9.044683,x0104,7.282636,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)Cl)c2ccccn2,BRD-K83257731-003-23-5,chloropyramine,MicroSource,1506064,CHLOROPYRAMINE HYDROCHLORIDE,-9.043710,x0195,0.87393,active-noncovalent
CCCCn1ccc(c(c1=O)Cl)N2CCC(CC2)c3ccccc3,BRD-K55029398-001-01-6,JNJ-40411813,MedChemEx,HY-15748,JNJ-40411813,-9.043389,x0104,7.351227,active-noncovalent
c1ccc2c(c1)c3c(o2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,BRD-A19102171-066-01-4,naltriben,Tocris,892,Naltriben mesylate,-9.043026,x0072,2.480544,active-noncovalent
c1ccc2c(c1)c3c(o2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,BRD-A19102171-066-02-2,naltriben,Tocris,892,Naltriben mesylate,-9.043026,x0072,2.480544,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)/C=C(\C#N)/C(=S)N,BRD-K59469039-001-09-8,tyrphostin-AG-879,Selleck,S2816,Tyrphostin AG 879 (AG 879),-9.042148,x0195,0.638424,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)/C=C(\C#N)/C(=S)N,BRD-K59469039-001-08-0,tyrphostin-AG-879,Selleck,S2816,Tyrphostin AG 879,-9.042148,x0195,0.638424,active-noncovalent
Cc1cc(=O)oc2c1cc3cc(oc3c2C)C,BRD-K54790157-001-15-5,trioxsalen,MicroSource,1500596,TRIOXSALEN,-9.041206,x0749,-0.064224,active-covalent
C[C@@]12C[C@@H]([C@@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,BRD-A65449987-001-10-4,flunisolide,MicroSource,1501187,FLUNISOLIDE,-9.040825,x0830,2.679218,active-covalent
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)[NH+](C)C,BRD-K10706131-046-05-1,rivastigmine,Tocris,4440,Rivastigmine tartrate,-9.040291,x0107,-0.384863,active-noncovalent
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)[NH+](C)C,BRD-K10706131-046-02-8,rivastigmine,Selleck,S2087,Rivastigmine Tartrate,-9.040291,x0107,-0.384863,active-noncovalent
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)[NH+](C)C,BRD-K10706131-046-03-6,rivastigmine,Tocris,4440,Rivastigmine tartrate,-9.040291,x0107,-0.384863,active-noncovalent
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)[NH+](C)C,BRD-K10706131-046-04-4,rivastigmine,MicroSource,1505388,RIVASTIGMINE TARTRATE,-9.040291,x0107,-0.384863,active-noncovalent
c1cc(oc1)CNc2c3c([nH]cn3)ncn2,BRD-K65667145-001-14-0,kinetin,Selleck,S2316,Kinetin,-9.040161,x0749,-1.998601,active-covalent
c1c[nH]c2c1c(c(c[nH+]2)C(=O)N)NC3[C@@H]4CC5C[C@H]3CC(C4)(C5)O,BRD-K21225231-001-01-2,peficitinib,MedChemEx,HY-19568,Peficitinib,-9.039919,x0072,0.372397,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)([C@H]3C[C@@H]4C[C@H]3C=C4)O,BRD-A00546892-003-05-5,biperiden,Selleck,S1285,Biperiden HCl,-9.039534,x0195,0.202995,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)([C@H]3C[C@@H]4C[C@H]3C=C4)O,BRD-A00546892-001-02-6,biperiden,MicroSource,1505514,BIPERIDEN,-9.039534,x0195,0.202995,active-noncovalent
COc1c(cc2c(c1O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC2=O)O,BRD-K04176066-001-09-1,bergenin,MicroSource,1500819,BERGENIN,-9.039062,x0195,1.192339,active-noncovalent
COc1c(cc2c(c1O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC2=O)O,BRD-K04176066-001-08-3,bergenin,Selleck,S2270,Bergenin,-9.039062,x0195,1.192339,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@@H]3CC[C@]4([C@@H]([C@H]3CC=C2C1)CCC4=O)C)C,BRD-A20758144-001-04-5,prasterone-acetate,MicroSource,270029,PRASTERONE ACETATE,-9.039054,x1077,2.892107,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)c3ccccc3,BRD-K78061844-050-02-7,4-PPBP,Tocris,620,4-PPBP maleate,-9.038963,x0161,1.907398,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)c3ccccc3,BRD-K78061844-050-01-9,4-PPBP,Tocris,620,4-PPBP maleate,-9.038963,x0161,1.907398,active-noncovalent
CCCCCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,BRD-K07625016-001-01-2,norethisterone-enanthate,AvaChem,2817,(17beta)-17-ethynyl-3-oxoestr-4-en-17-yl heptanoate,-9.037788,x0161,6.598264,active-noncovalent
c1ccc(cc1)[C@@H](c2ccc(cc2)Cl)OCC[NH+]3CCCCC3,BRD-A80908310-003-13-8,cloperastine,MicroSource,1503920,CLOPERASTINE HYDROCHLORIDE,-9.037077,x0195,0.242149,active-noncovalent
Cc1c(sc(n1)N(C)C(=O)Cc2ccc(cc2)c3ccccn3)S(=O)(=O)N,BRD-K25204779-001-01-1,pritelivir,MedChemEx,HY-15303,BAY 57-1293,-9.035913,x0161,6.004964,active-noncovalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N2CC[NH+](CC2)CC(=O)N3CCCC3,BRD-K46839850-050-04-2,cinepazide,Selleck,S3045,Cinepazide maleate,-9.034895,x0104,9.003478,active-noncovalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N2CC[NH+](CC2)CC(=O)N3CCCC3,BRD-K46839850-050-05-9,cinepazide,Selleck,S3045,Cinepazide maleate,-9.034895,x0104,9.003478,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3,BRD-K66876909-001-11-8,linezolid,Selleck,S1408,Linezolid,-9.034732,x0104,1.526061,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3,BRD-K66876909-001-12-6,linezolid,MicroSource,1502385,LINEZOLID,-9.034732,x0104,1.526061,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3,BRD-K66876909-001-15-9,linezolid,Tocris,3765,Linezolid,-9.034732,x0104,1.526061,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O,BRD-K18619710-001-14-4,digoxigenin,Selleck,S4396,Digoxigenin,-9.034569,x0395,3.434926,active-noncovalent
c1cc2c(cc1Nc3nccc(n3)Nc4cc([nH]n4)C5CC5)[nH]cn2,BRD-K17511755-001-01-7,APY-29,Tocris,4865,APY 29,-9.032714,x0946,1.706653,active-noncovalent
Cc1c(c2ccccc2o1)CNC(=O)NCc3cccs3,BRD-K37635256-001-01-4,S-07662,Tocris,5188,S 07662,-9.032615,x0104,1.164893,active-noncovalent
C=CC[N@H+]1CC[C@]23CCCC[C@H]2[C@H]1Cc4c3cc(cc4)O,BRD-K30634073-046-01-0,levallorphan,Enzo,AC891,Levallorphan tartrate,-9.031611,x0072,-0.841812,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,BRD-K33425534-001-10-9,exemestane,Tocris,3759,Exemestane,-9.030524,x0749,0.12386,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,BRD-K33425534-001-12-5,exemestane,MicroSource,1505012,EXEMESTANE,-9.030524,x0749,0.12386,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,BRD-K33425534-001-11-7,exemestane,Selleck,S1196,Exemestane,-9.030524,x0749,0.12386,active-covalent
C[C@@H](c1cc2ccc(cc2nc1c3ccccn3)F)Nc4c5c([nH]cn5)ncn4,BRD-K21077415-001-01-5,AMG-319,MedChemEx,HY-12948,,-9.029361,x0678,1.264782,active-noncovalent
C[C@@H](c1cc2ccc(cc2nc1c3ccccn3)F)Nc4c5c([nH]cn5)ncn4,BRD-A58947127-001-01-6,AMG319,Selleck,S7813,AMG319,-9.029361,x0678,1.264782,active-noncovalent
CC1(CCC(c2c1ccc(c2)C3(SCCS3)c4ccc5cc(ccc5c4)C(=O)[O-])(C)C)C,BRD-K98353094-001-01-6,MM-11253,Tocris,3822,MM 11253,-9.029353,x1077,4.73365,active-noncovalent
c1cnc2cc3c(cc2n1)[C@@H]4C[C@H]3C[NH2+]C4,BRD-A86216746-046-02-6,varenicline,Selleck,S1440,Varenicline Tartrate,-9.029347,x0195,-0.771462,active-noncovalent
Cc1c2c(nc(n1)N)C[C@@H](NC2=O)c3ccc(cc3c4cccc(n4)OC)F,BRD-K67915505-001-01-2,NVP-HSP990,MedChemEx,HY-15190,NVP-HSP990,-9.027154,x0678,2.43118,active-noncovalent
C[C@H](CC[C@H](C(C)C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K73237276-001-01-0,tacalcitol,MedChemEx,HY-32337,Tacalcitol,-9.025872,x0104,6.385508,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,BRD-K28061410-001-09-0,beta-lapachone,MedChemEx,HY-13555,?-Lapachone,-9.025756,x0195,-0.025669,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,BRD-K28061410-001-06-6,beta-lapachone,Selleck,S7261,Beta-Lapachone,-9.025756,x0195,-0.025669,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,BRD-K28061410-001-07-4,beta-lapachone,MedChemEx,HY-13555,?-Lapachone,-9.025756,x0195,-0.025669,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,BRD-K28061410-001-05-8,beta-lapachone,Selleck,S7261,Beta-Lapachone,-9.025756,x0195,-0.025669,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCCCC(=O)NO,BRD-K22503835-001-11-0,scriptaid,Selleck,S8043,Scriptaid,-9.025402,x0195,1.126429,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCCCC(=O)NO,BRD-K22503835-001-12-8,scriptaid,Tocris,2421,Scriptaid,-9.025402,x0195,1.126429,active-noncovalent
CC[C@@](C/C=C/c1ccccc1)(c2ccccc2)[N@@H+](C)CC3CC3,BRD-A48376327-003-01-5,igmesine,Tocris,2332,"(E)-N-(cyclopropylmethyl)-N-methyl-3,6-diphenylhex-5-en-3-amine hydrochloride",-9.025148,x0072,1.540341,active-noncovalent
C[C@@H](c1ccccn1)/N=N/C(=S)N2CCC2,BRD-K99170882-001-06-8,NSC-319726,Tocris,5065,NSC 319726,-9.023738,x1418,-0.454364,active-covalent
C[C@@H](c1ccccn1)/N=N/C(=S)N2CCC2,BRD-K99170882-001-04-3,NSC-319726,Selleck,S7149,NSC 319726,-9.023738,x1418,-0.454364,active-covalent
C[C@@H](c1ccccn1)/N=N/C(=S)N2CCC2,BRD-K99170882-001-05-0,NSC-319726,Selleck,S7149,NSC319726,-9.023738,x1418,-0.454364,active-covalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(=O)(CCCl)CCCl,BRD-K36394566-300-01-0,melphalan-n-oxide,Adooq,A14319,"(S)-4-(2-amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline oxide dihydrochloride",-9.023522,x0107,1.33123,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(=O)(CCCl)CCCl,BRD-A26835809-300-01-3,PX-478,Selleck,S7612,PX-478 2HCl,-9.023522,x0107,1.33123,active-noncovalent
c1cc2c(cc1C#N)c(c([nH]2)O)c3ccc(cn3)C[NH+]4CCOCC4,BRD-K61041538-001-05-5,AZD1080,MedChemEx,HY-13862,AZD1080,-9.022916,x0195,2.832623,active-noncovalent
c1cc2c(cc1C#N)c(c([nH]2)O)c3ccc(cn3)C[NH+]4CCOCC4,BRD-K61041538-001-03-0,AZD1080,Selleck,S7145,AZD1080,-9.022916,x0195,2.832623,active-noncovalent
c1cc2c(cc1C#N)c(c([nH]2)O)c3ccc(cn3)C[NH+]4CCOCC4,BRD-K61041538-001-01-4,AZD1080,Selleck,S7145,AZD1080,-9.022916,x0195,2.832623,active-noncovalent
c1cc2c(cc1C#N)c(c([nH]2)O)c3ccc(cn3)C[NH+]4CCOCC4,BRD-K61041538-001-04-8,AZD1080,MedChemEx,HY-13862,AZD1080,-9.022916,x0195,2.832623,active-noncovalent
Cc1cc(c(c2c1[nH]c(=O)c3c2ccs3)c4ccc(cc4)[C@@H](C)C[NH3+])O,BRD-K38018935-001-01-1,OTS514,MedChemEx,HY-18621,OTS514,-9.022333,x0708,4.013444,active-covalent
c1ccc2c(c1)c3ccccc3s2,BRD-K46863940-001-05-4,dibenzothiophene,MicroSource,1500235,DIBENZOTHIOPHENE,-9.022096,x0749,-1.329142,active-covalent
c1ccc2c(c1)c3ccccc3s2,BRD-K46863940-001-06-2,dibenzothiophene,Selleck,S4205,Dibenzothiophene,-9.022096,x0749,-1.329142,active-covalent
c1ccc2c(c1)c3ccccc3s2,BRD-K46863940-001-04-7,dibenzothiophene,Selleck,S4205,Dibenzothiophene,-9.022096,x0749,-1.329142,active-covalent
C[NH+](C)C/C=C/C(=O)Nc1cccc(c1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,BRD-K95902121-001-01-0,THZ2,MedChemEx,HY-12280,THZ2,-9.021342,x0161,11.910746,active-noncovalent
C[C@H](CCc1ccccc1)[NH2+][C@@H](C)[C@H](c2ccc(cc2)O)O,BRD-A36267905-003-19-2,buphenine,MedChemEx,HY-B1404,Nylidrin (hydrochloride),-9.020359,x0434,0.093537,active-noncovalent
C[C@H](CCc1ccccc1)[NH2+][C@@H](C)[C@H](c2ccc(cc2)O)O,BRD-A36267905-003-18-4,buphenine,MicroSource,1500445,NYLIDRIN HYDROCHLORIDE,-9.020359,x0434,0.093537,active-noncovalent
Cc1ccccc1N2CC[NH+](CC2)CCc3nnc4n3CCCC4,BRD-K33133047-001-01-8,dapiprazole,AvaChem,3081B,"3-{2-[4-(2-methylphenyl)-1-piperazinyl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine",-9.019834,x0107,3.022653,active-noncovalent
c1ccc(cc1)CCNc2c3c4ccccc4c(=O)c5cccc(nc2=O)[C@H]53,BRD-K15107389-001-03-6,BRD-7389,Tocris,4037,BRD 7389,-9.018826,x0195,2.806258,active-noncovalent
c1cc(ccc1c2nn(c(=O)o2)Cc3cc(ccc3O)Cl)C(F)(F)F,BRD-K95609758-001-04-5,BMS-191011,Tocris,2665,BMS 191011,-9.018175,x0946,2.783825,active-noncovalent
c1cc(ccc1c2nn(c(=O)o2)Cc3cc(ccc3O)Cl)C(F)(F)F,BRD-K95609758-001-03-7,BMS-191011,Tocris,2665,BMS 191011,-9.018175,x0946,2.783825,active-noncovalent
c1ccc2c(c1)[nH]c(n2)CCC(=O)[O-],BRD-K54824716-001-03-2,procodazole,Selleck,S4408,Procodazole,-9.017670,x0749,-2.467213,active-covalent
c1ccc2c(c1)[nH]c(n2)CCC(=O)[O-],BRD-K54824716-001-04-0,procodazole,MicroSource,1506175,PROCODAZOLE,-9.017670,x0749,-2.467213,active-covalent
Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C,BRD-K74514084-001-03-9,pazopanib,Selleck,S3012,Pazopanib,-9.017019,x0678,6.462049,active-noncovalent
Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C,BRD-K74514084-003-09-2,pazopanib,Selleck,S1035,Pazopanib HCl (GW786034 HCl),-9.017019,x0678,6.462049,active-noncovalent
CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F,BRD-K89917372-001-01-2,retigabine,MedChemEx,HY-15471,Retigabine,-9.013970,x1093,0.989133,active-noncovalent
C[C@@H]([NH3+])[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2,BRD-K44084986-300-07-6,Y-27632,Selleck,S1049,Y-27632 2HCl,-9.013731,x0749,-0.155804,active-covalent
C[C@@H]([NH3+])[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2,BRD-K44084986-300-08-4,Y-27632,Tocris,1254,Y-27632 dihydrochloride,-9.013731,x0749,-0.155804,active-covalent
C[C@@H]([NH3+])[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2,BRD-K44084986-300-09-2,Y-27632,Selleck,S1049,Y-27632 2HCl,-9.013731,x0749,-0.155804,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1cc([nH]2)C#N)O,BRD-A47884604-051-01-2,cyanopindolol,Tocris,993,Cyanopindolol hemifumarate,-9.013508,x0104,0.992998,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH2+]CCc2ccc(cc2)O,BRD-A59174698-003-18-5,ritodrine,MicroSource,1501149,RITODRINE HYDROCHLORIDE,-9.010501,x0678,0.922016,active-noncovalent
c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,BRD-K42191735-001-08-7,buparlisib,Selleck,S2247,BKM120 (NVP-BKM120),-9.009110,x0678,3.896204,active-noncovalent
c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,BRD-K42191735-001-05-3,buparlisib,Selleck,S2247,"BKM120 (NVP-BKM120, Buparlisib)",-9.009110,x0678,3.896204,active-noncovalent
CC(C)(C=C)c1cc(c(cc1O)OC)/C=C/C(=O)c2ccc(cc2)O,BRD-K26011976-001-01-0,licochalcone-a,Enzo,430-124,Licochalcone A,-9.008456,x0195,2.556264,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)C(F)(F)F)[O-])O)C,BRD-K75016267-001-01-7,SNG-1153,MedChemEx,HY-19968,SNG-1153,-9.008386,x0161,4.332038,active-noncovalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4,BRD-K89923877-004-16-2,scopolamine,Tocris,1414,Scopolamine hydrobromide,-9.007812,x0749,0.899689,active-covalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4,BRD-K89923877-004-15-4,scopolamine,Selleck,S2508,Scopolamine HBr,-9.007812,x0749,0.899689,active-covalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCC[NH+](C)C,BRD-K37814297-050-09-6,acepromazine,MicroSource,1505498,ACEPROMAZINE MALEATE,-9.007215,x0161,1.07472,active-noncovalent
COc1ccc2c(c1)cc([nH]2)C(=O)c3ccccc3,BRD-K26997899-001-02-2,D-64131,Tocris,1643,D-64131,-9.004910,x0749,0.335752,active-covalent
c1ccc2c(c1)CN3CCCC3=[NH+]2,BRD-K13819402-003-10-2,desoxypeganine,Enzo,NP073,Desoxypeganine HCl,-9.004529,x0749,-1.522814,active-covalent
Cc1cc(no1)c2nncc3n2nc(c3C(C)(C)C)OCc4ncnn4C,BRD-K44022883-001-01-7,MRK-016,Tocris,3817,"3-tert-butyl-7-(5-methyl-3-isoxazolyl)-2-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]pyrazolo[1,5-d][1,2,4]triazine",-9.003543,x1418,3.056289,active-covalent
Cc1cc(no1)c2nncc3n2nc(c3C(C)(C)C)OCc4ncnn4C,BRD-K44022883-001-02-5,MRK-016,Tocris,3817,MRK 016,-9.003543,x1418,3.056289,active-covalent
C[NH+](C)CC[C@](c1ccccc1)(c2ccccc2Cl)O,BRD-A15687940-001-05-6,clofedanol,Sigma,PH010350,1-(2-chlorophenyl)-3-(dimethylamino)-1-phenyl-1-propanol,-9.003261,x0072,-1.070159,active-noncovalent
Cc1ccc2c(cc(c(c2n1)OC(=O)c3ccccc3)Br)Br,BRD-K36222532-001-01-8,broxaldine,MicroSource,1503742,BROXALDINE,-9.002949,x0830,2.048984,active-covalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)c4ccccn4,BRD-K25486274-300-02-8,DRF053-(R),Tocris,3610,(R)-DRF053 dihydrochloride,-9.002911,x0161,5.03335,active-noncovalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)c4ccccn4,BRD-K25486274-300-01-0,DRF053-(R),Tocris,3610,(R)-DRF053 dihydrochloride,-9.002911,x0161,5.03335,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCn4c2[nH+]cc4C=O)CC1,BRD-K55991142-001-01-6,alcaftadine,MedChemEx,HY-17039,"11-(1-methyl-4-piperidinylidene)-6,11-dihydro-5H-imidazo[2,1-b][3]benzazepine-3-carbaldehyde",-9.002264,x0195,0.633199,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,BRD-K37289225-001-35-6,clozapine,Tocris,444,Clozapine,-9.001734,x0195,0.999887,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,BRD-K37289225-001-34-9,clozapine,Selleck,S2459,Clozapine,-9.001734,x0195,0.999887,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,BRD-K37289225-001-37-2,clozapine,Selleck,S2459,Clozapine (Clozaril),-9.001734,x0195,0.999887,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,BRD-K37289225-001-36-4,clozapine,MicroSource,1500685,CLOZAPINE,-9.001734,x0195,0.999887,active-noncovalent
CC(C)Oc1ccc2c(c1)occ(c2=O)c3ccccc3,BRD-K93618743-001-20-2,ipriflavone,Selleck,S2422,Ipriflavone (Osteofix),-8.999832,x0749,4.105817,active-covalent
CC(C)Oc1ccc2c(c1)occ(c2=O)c3ccccc3,BRD-K93618743-001-21-0,ipriflavone,MicroSource,1400010,IPRIFLAVONE,-8.999832,x0749,4.105817,active-covalent
CC[C@@H](c1nc2cccc(c2c(=O)n1c3ccccc3)F)Nc4c5c(nc[nH]5)ncn4,BRD-K60866521-001-07-1,idelalisib,Selleck,S2226,"CAL-101 (Idelalisib, GS-1101)",-8.999259,x0678,2.401052,active-noncovalent
Cc1cc2c(n1C)nc(nc2N3CCCC3)N4CCCC4,BRD-K84507776-003-01-4,PNU-89843,Tocris,2734,"6,7-dimethyl-2,4-di(1-pyrrolidinyl)-7H-pyrrolo[2,3-d]pyrimidine hydrochloride",-8.999031,x0195,1.428913,active-noncovalent
c1csc(c1)/C=C\2/C(=O)/C(=C/c3sccc3)/CCC2,BRD-K91298281-001-01-3,tenylidone,MicroSource,1506108,TENYLIDONE,-8.998743,x0161,4.473185,active-noncovalent
CC[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3cn(c4c3c(ccc4)C2=C1)C)C,BRD-K35941380-050-27-9,methysergide,Tocris,1064,Methysergide maleate,-8.998618,x0104,1.732964,active-noncovalent
c1ccc(cc1)NC[C@@H](Cn2c3ccc(cc3c4c2ccc(c4)Br)Br)O,BRD-A09487507-001-02-1,P7C3,Tocris,4076,P7C3,-8.998287,x0195,0.96621,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cc(ccc2C(=O)[O-])Cl,BRD-K55847762-304-01-7,lobenzarit,AKSci,K046,,-8.995890,x1093,-0.096254,active-noncovalent
c1cc(ccc1Nc2ncnc(n2)N)Cl,BRD-K21452876-003-01-8,chlorazanil,MicroSource,1503744,CHLORAZANIL HYDROCHLORIDE,-8.995859,x0830,-0.641911,active-covalent
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3F)Br)C(=O)NOCCO,BRD-K82244583-001-01-3,MEK162,Selleck,S7007,"MEK162 (ARRY-162, ARRY-438162)",-8.995431,x0749,1.645859,active-covalent
Cn1cc2c3c1cccc3[C@]4(C[C@H](C[N@H+]([C@@H]4C2)C)COC(=O)c5cc(cnc5)Br)OC,BRD-K76810206-001-08-1,nicergoline,Tocris,604,Nicergoline,-8.995126,x0107,6.0328,active-noncovalent
Cn1cc2c3c1cccc3[C@]4(C[C@H](C[N@H+]([C@@H]4C2)C)COC(=O)c5cc(cnc5)Br)OC,BRD-K76810206-001-07-3,nicergoline,MicroSource,1501133,NICERGOLINE,-8.995126,x0107,6.0328,active-noncovalent
c1cc(c(cc1Cl)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl,BRD-A82396632-008-28-2,miconazole,Selleck,S1956,Miconazole Nitrate,-8.993138,x0195,1.373379,active-noncovalent
c1cc(c(cc1Cl)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl,BRD-A82396632-001-16-2,miconazole,Selleck,S2536,Miconazole,-8.993138,x0195,1.373379,active-noncovalent
c1cc(c(cc1Cl)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl,BRD-A82396632-008-30-8,miconazole,Tocris,3016,Miconazole nitrate,-8.993138,x0195,1.373379,active-noncovalent
c1cc(c(cc1Cl)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl,BRD-A82396632-008-29-0,miconazole,MicroSource,1500413,MICONAZOLE NITRATE,-8.993138,x0195,1.373379,active-noncovalent
c1ccc(c(c1)Cn2c3c(cccn3)c(n2)c4ncc(c(n4)N)C5CC5)F,BRD-K32033120-001-01-1,BAY-41-2272,Tocris,4430,BAY 41-2272,-8.991726,x0195,3.182716,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1ccccc1C2CCCC2)O,BRD-K55705469-065-01-0,penbutolol,MicroSource,1505567,PENBUTOLOL SULFATE,-8.989674,x0195,1.260496,active-noncovalent
c1ccc(cc1)C(CC[NH+]2CCCCC2)(c3ccccc3)O,BRD-K17565903-066-23-1,pridinol,MicroSource,1503077,PRIDINOL METHANESULFONATE,-8.988610,x0678,0.331696,active-noncovalent
c1ccc(cc1)C(CC[NH+]2CCCCC2)(c3ccccc3)O,BRD-K17565903-066-22-3,pridinol,Selleck,S4371,Pridinol Methanesulfonate,-8.988610,x0678,0.331696,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)C[C@@H]4CCCC[C@H]4Cn5c(c6c(c5O)[C@H]7CC[C@@H]6C7)O,BRD-K51143828-003-03-1,lurasidone,Selleck,S3044,Lurasidone HCl,-8.988393,x0874,9.238729,active-noncovalent
CC(C)[NH+](CCc1c[nH]c2c1cccc2)C(C)C,BRD-K75385383-001-01-5,DIPT,Cayman,11550,N-[2-(1H-indol-3-yl)ethyl]-N-isopropyl-2-propanamine,-8.988087,x0072,0.044398,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)C(=O)c3ccc(cc3)F,BRD-K86003836-001-10-5,flubendazole,MicroSource,1505043,FLUBENDAZOLE,-8.986604,x0161,1.544392,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)C(=O)c3ccc(cc3)F,BRD-K86003836-001-09-7,flubendazole,Selleck,S1837,Flubendazole,-8.986604,x0161,1.544392,active-noncovalent
C[NH+]1CCN(CC1)c2c(cc3c(c2F)n(cc(c3=O)C(=O)[O-])CCF)F,BRD-K61717546-001-04-3,fleroxacin,Selleck,S2469,Fleroxacin (Quinodis),-8.985910,x1077,5.726747,active-noncovalent
C[NH+]1CCN(CC1)c2c(cc3c(c2F)n(cc(c3=O)C(=O)[O-])CCF)F,BRD-K61717546-001-05-0,fleroxacin,Selleck,S2469,Fleroxacin (Quinodis),-8.985910,x1077,5.726747,active-noncovalent
c1cc(ccc1Cn2ccnc2)/C=C/C(=O)[O-],BRD-K53061490-003-14-7,ozagrel,Tocris,1510,Ozagrel hydrochloride,-8.985313,x0072,0.601159,active-noncovalent
c1cc(ccc1Cn2ccnc2)/C=C/C(=O)[O-],BRD-K53061490-003-13-9,ozagrel,Selleck,S2067,Ozagrel HCl,-8.985313,x0072,0.601159,active-noncovalent
c1cc(ccc1Cn2ccnc2)/C=C/C(=O)[O-],BRD-K53061490-001-02-6,ozagrel,Selleck,S2496,Ozagrel,-8.985313,x0072,0.601159,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1n2cccc2)O,BRD-A26845397-051-01-9,isamoltane,Tocris,992,Isamoltane hemifumarate,-8.984540,x0195,-0.229005,active-noncovalent
Cc1cnc(nc1c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl)Nc4ccc(cc4Cl)F,BRD-K93725829-001-03-8,VX-11e,MedChemEx,HY-14178,VX-11e,-8.984134,x0161,13.663896,active-noncovalent
COC(=O)[C@@H](c1ccccc1)[C@H]2CCCC[NH2+]2,BRD-A19585813-003-03-3,methylphenidate,MicroSource,1505907,METHYLPHENIDATE HYDROCHLORIDE,-8.984003,x0195,-1.282667,active-noncovalent
C[C@H](c1ccc(cc1)C(=O)Nc2ccnc3c2cc[nH]3)[NH3+],BRD-K56751279-300-01-4,Y-39983,MedChemEx,HY-10069,Y-33075 (dihydrochloride),-8.983973,x0749,0.47307,active-covalent
c1cc(c(c(c1)F)C(=O)n2c(nc(n2)Nc3ccc(cc3)S(=O)(=O)N)N)F,BRD-K11636097-001-03-1,JNJ-7706621,Selleck,S1249,JNJ-7706621,-8.983945,x0161,4.595576,active-noncovalent
Cc1cnc(c(c1OC)C)Cn2cc(c3c2nc(nc3Cl)N)C#CCC(C)(C)O,BRD-K41705163-001-01-1,EC-144,Tocris,4701,EC 144,-8.982940,x0434,4.000541,active-noncovalent
CS(=O)(=O)[N@@](Cc1ccco1)C[C@@H](Cn2c3ccccc3c4c2cccc4)O,BRD-A94580299-001-10-4,KL-001,Tocris,4685,KL 001,-8.982489,x0195,1.720647,active-noncovalent
CCN(CC)C(=O)[C@@]1(C[C@@H]1C[NH3+])c2ccccc2,BRD-K02227374-003-07-1,milnacipran,Selleck,S3140,Milnacipran HCl,-8.981915,x0678,-0.745377,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccccc3)[O-],BRD-K10843433-001-21-9,phenylbutazone,Selleck,S1654,Phenylbutazone,-8.981514,x0678,1.268372,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccccc3)[O-],BRD-K10843433-001-23-5,phenylbutazone,Selleck,S1654,"Phenylbutazone (Butazolidin, Butatron)",-8.981514,x0678,1.268372,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccccc3)[O-],BRD-K10843433-001-22-7,phenylbutazone,MicroSource,1500482,PHENYLBUTAZONE,-8.981514,x0678,1.268372,active-noncovalent
Cc1c(=O)c2cccc(c2oc1c3ccccc3)C(=O)OCC[NH+]4CCCCC4,BRD-K47639036-003-06-6,flavoxate,Selleck,S4027,Flavoxate HCl,-8.981435,x0195,4.948348,active-noncovalent
CN1CC(=O)[NH+]=C1NC(=O)Nc2cccc(c2)Cl,BRD-K41160163-001-07-6,fenobam,Tocris,2386,Fenobam,-8.981092,x0678,-0.651827,active-noncovalent
CN1CC(=O)[NH+]=C1NC(=O)Nc2cccc(c2)Cl,BRD-K41160163-001-06-8,fenobam,Tocris,2386,Fenobam,-8.981092,x0678,-0.651827,active-noncovalent
C[C@@H]1c2ccc(cc2C[NH2+]1)c3ccc4c(c3OC(F)F)n(cc(c4=O)C(=O)[O-])C5CC5,BRD-K77038618-356-01-3,garenoxacin,MedChemEx,HY-17460A,Garenoxacin (Mesylate hydrate),-8.981041,x0874,4.378367,active-noncovalent
C=CCc1cccc(c1O)/C=N/NC(=O)CN2CC[NH+](CC2)Cc3ccccc3,BRD-K92991072-001-05-6,PAC-1,Tocris,2581,PAC 1,-8.979566,x0104,3.469486,active-noncovalent
C=CCc1cccc(c1O)/C=N/NC(=O)CN2CC[NH+](CC2)Cc3ccccc3,BRD-K92991072-001-06-4,PAC-1,Tocris,2581,PAC 1,-8.979566,x0104,3.469486,active-noncovalent
C=CCc1cccc(c1O)/C=N/NC(=O)CN2CC[NH+](CC2)Cc3ccccc3,BRD-K92991072-001-04-9,PAC-1,Selleck,S2738,PAC-1,-8.979566,x0104,3.469486,active-noncovalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-A47598013-004-18-6,citalopram,Enamine,Z905064078,,-8.976013,x0072,0.582524,active-noncovalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-A47598013-034-02-7,citalopram,Selleck,S4064,Escitalopram Oxalate,-8.976013,x0072,0.582524,active-noncovalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-A47598013-004-17-8,citalopram,MicroSource,1504172,CITALOPRAM HYDROBROMIDE,-8.976013,x0072,0.582524,active-noncovalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,BRD-A47598013-004-16-0,citalopram,Tocris,1427,Citalopram hydrobromide,-8.976013,x0072,0.582524,active-noncovalent
Cn1c(ncn1)[C@H]2c3c4c(cc(cc4N[C@@H]2c5ccc(cc5)F)F)c(=O)[nH]n3,BRD-K95142244-001-01-5,talazoparib,Selleck,S7048,BMN 673,-8.975266,x0195,1.620854,active-noncovalent
C[NH+](C)CC(=O)Nc1ccc2c(c1)c3ccccc3c(=O)[nH]2,BRD-K11853856-003-02-1,PJ-34,Tocris,3255,PJ 34 hydrochloride,-8.975261,x0195,0.111564,active-noncovalent
C[NH+](C)CC(=O)Nc1ccc2c(c1)c3ccccc3c(=O)[nH]2,BRD-K11853856-001-01-7,PJ-34,Selleck,S2886,PJ34,-8.975261,x0195,0.111564,active-noncovalent
C[NH+](C)CC(=O)Nc1ccc2c(c1)c3ccccc3c(=O)[nH]2,BRD-K11853856-001-02-5,PJ-34,Selleck,S2886,PJ34,-8.975261,x0195,0.111564,active-noncovalent
COc1ccc(cc1F)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)F,BRD-K68558722-001-04-0,deracoxib,MicroSource,1505222,DERACOXIB,-8.974410,x0161,3.921531,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-04-0,biapenem,Sigma,MFCD00864863,"(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-(5H,6H,7H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate",-8.974404,x0749,2.559813,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-01-6,biapenem,MedChemEx,HY-13573,Biapenem,-8.974404,x0749,2.559813,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-02-4,biapenem,Selleck,S1370,Biapenem,-8.974404,x0749,2.559813,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-06-5,biapenem,MedChemEx,HY-13573,Biapenem,-8.974404,x0749,2.559813,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-05-7,biapenem,MedChemEx,HY-13573,Biapenem,-8.974404,x0749,2.559813,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,BRD-A80321291-001-03-2,biapenem,Selleck,S1370,Biapenem,-8.974404,x0749,2.559813,active-covalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@H](CC#N)C4CCCC4,BRD-K53972329-001-07-0,ruxolitinib,Selleck,S1378,Ruxolitinib (INCB018424),-8.974321,x0831,1.75433,active-covalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N3CCCC3,BRD-K67601717-001-03-8,almotriptan,MicroSource,1505204,ALMOTRIPTAN,-8.972091,x0946,1.803151,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N3CCCC3,BRD-K67601717-037-02-4,almotriptan,Selleck,S2096,Almotriptan Malate,-8.972091,x0946,1.803151,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCSCC3,BRD-K86670086-001-02-5,sutezolid,MedChemEx,HY-10392,Sutezolid,-8.969722,x0104,1.907551,active-noncovalent
CCCCCCCCCCC[C@@H](c1cc(ccc1O)C)N=O,BRD-A37752546-001-01-9,1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,Sigma,MFCD00900589,(1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,-8.969067,x0072,0.619531,active-noncovalent
c1cc(ccc1C(=O)OC[C@@H](CO)O)N,BRD-A76533773-001-01-9,lisadimate,Sigma,MFCD00017109,"2,3-dihydroxypropyl 4-aminobenzoate",-8.968984,x0195,-1.363521,active-noncovalent
c1cc(ccc1O)Oc2c(cc(cc2I)CCC(=O)[O-])I,BRD-K36802417-001-01-7,diiodothyropropionic-acid,Sigma,MFCD00045945,"3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid",-8.968004,x0678,1.064673,active-noncovalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O,BRD-A48103086-001-04-2,cyproterone,MicroSource,1503921,CYPROTERONE,-8.967553,x0749,1.552157,active-covalent
CCn1cc(c(=O)c2c1cc(cc2)c3ccncc3)C(=O)[O-],BRD-K49841478-001-01-6,rosoxacin,Accela,SY038205,"1-ethyl-4-oxo-7-(4-pyridinyl)-1,4-dihydro-3-quinolinecarboxylic acid",-8.966793,x0195,2.108423,active-noncovalent
c1cc(ccc1Cc2cnc(s2)N)Br,BRD-K03808106-001-01-9,NS-19504,Tocris,5276,NS 19504,-8.965410,x0678,-1.052588,active-noncovalent
Cc1c(c(n[nH]1)C(F)(F)F)Cc2c(c3c(=O)n(c(=O)n(c3s2)C(C)C)C)C(=O)N4C[C@](CO4)(C)O,BRD-K25210703-001-01-9,AZD3965,MedChemEx,HY-12750,AZD3965,-8.965068,x1077,4.639235,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)C,BRD-K47079459-004-04-6,cetrimonium,Selleck,S4242,Cetrimonium Bromide (CTAB),-8.964239,x0161,2.714381,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)C,BRD-K47079459-004-05-3,cetrimonium,MicroSource,1503200,CETRIMONIUM BROMIDE,-8.964239,x0161,2.714381,active-noncovalent
CCCOc1ccc2c(n1)c(c[nH]2)C3=CC[NH2+]CC3,BRD-K33860217-003-03-2,CP-94253,Tocris,1317,CP 94253 hydrochloride,-8.963996,x0195,1.308316,active-noncovalent
CCCOc1ccc2c(n1)c(c[nH]2)C3=CC[NH2+]CC3,BRD-K33860217-003-04-0,CP-94253,Tocris,1317,CP 94253 hydrochloride,-8.963996,x0195,1.308316,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)N,BRD-K85882401-236-02-7,avibactam,MedChemEx,HY-14879A,Avibactam (sodium),-8.962753,x0397,0.375529,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)N,BRD-K85882401-236-01-9,avibactam,MedChemEx,HY-14879A,Avibactam (sodium),-8.962753,x0397,0.375529,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)N,BRD-K85882401-323-01-5,avibactam,MedChemEx,HY-14879B,Avibactam (sodium hydrate),-8.962753,x0397,0.375529,active-noncovalent
CC[C@@](C)(C[NH+](C)C)OC(=O)c1ccccc1,BRD-A09062839-003-10-0,amyleine,Prestwick,Prestw-49,Amyleine hydrochloride,-8.962002,x0161,0.200861,active-noncovalent
c1c2c(cc(c1Cl)Cl)[N@@]3CC[NH2+]C[C@@H]3C(=O)N2,BRD-A62021152-003-03-4,WAY-161503,Tocris,1801,WAY 161503 hydrochloride,-8.961515,x0195,0.498304,active-noncovalent
c1c2c(cc(c1Cl)Cl)[N@@]3CC[NH2+]C[C@@H]3C(=O)N2,BRD-A62021152-003-04-2,WAY-161503,Tocris,1801,"8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride",-8.961515,x0195,0.498304,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc(c2F)F)C(=O)N3CC(C3)([C@@H]4CCCC[NH2+]4)O,BRD-K03390685-001-01-7,cobimetinib,MedChemEx,HY-13064,Cobimetinib,-8.961427,x0161,3.034015,active-noncovalent
c1ccc(cc1)C(=CCC[N@H+]2CCC[C@@H](C2)C(=O)[O-])c3ccccc3,BRD-A49046702-003-08-3,SKF-89976A,Tocris,1081,SKF 89976A hydrochloride,-8.960825,x0678,2.273756,active-noncovalent
c1ccc(cc1)C(=CCC[N@H+]2CCC[C@@H](C2)C(=O)[O-])c3ccccc3,BRD-A49046702-003-09-1,SKF-89976A,Tocris,1081,SKF 89976A hydrochloride,-8.960825,x0678,2.273756,active-noncovalent
CN(C(=O)CCc1cc(n(n1)c2ccc(cc2)OC)c3ccc(cc3)Cl)O,BRD-K89714990-001-02-3,tepoxalin,Toronto,T103250,tepoxalin,-8.960777,x1077,3.216432,active-noncovalent
CN(C(=O)CCc1cc(n(n1)c2ccc(cc2)OC)c3ccc(cc3)Cl)O,BRD-K89714990-001-01-5,tepoxalin,MicroSource,1504107,TEPOXALIN,-8.960777,x1077,3.216432,active-noncovalent
Cc1ccc(o1)/C=N/NC(=O)c2ccccc2Oc3ccccc3,BRD-K30707190-001-05-8,PNU-74654,Tocris,3534,PNU 74654,-8.960410,x0678,1.525643,active-noncovalent
Cc1ccc(o1)/C=N/NC(=O)c2ccccc2Oc3ccccc3,BRD-K30707190-001-04-1,PNU-74654,Tocris,3534,PNU 74654,-8.960410,x0678,1.525643,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=c/3\c(=O)n4c5ccccc5nc4s3,BRD-K36515744-001-02-7,ITX3,MedChemEx,HY-16663,ITX3,-8.959538,x0161,3.054045,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=c/3\c(=O)n4c5ccccc5nc4s3,BRD-K36515744-001-03-5,ITX3,MedChemEx,HY-16663,ITX3,-8.959538,x0161,3.054045,active-noncovalent
CC[NH+](CCCc1ccccc1)CCCc2ccccc2,BRD-K89055274-048-22-7,alverine,Selleck,S3054,Alverine Citrate,-8.959128,x0104,1.114762,active-noncovalent
CC[NH+](CCCc1ccccc1)CCCc2ccccc2,BRD-K89055274-048-23-5,alverine,MicroSource,1500109,ALVERINE CITRATE,-8.959128,x0104,1.114762,active-noncovalent
Cc1ccc(c(c1)[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)O,BRD-K54316499-046-04-5,tolterodine,Selleck,S2550,Tolterodine tartrate,-8.958519,x0195,0.618252,active-noncovalent
Cc1ccc(c(c1)[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)O,BRD-K54316499-046-05-2,tolterodine,Selleck,S2550,Tolterodine tartrate (Detrol LA),-8.958519,x0195,0.618252,active-noncovalent
Cc1ccc(c(c1)[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)O,BRD-K54316499-046-06-0,tolterodine,Tocris,3761,Tolterodine L-tartrate,-8.958519,x0195,0.618252,active-noncovalent
C1C[C@H](N(C1)C(=O)C[NH2+]C23C[C@H]4C[C@@H](C2)CC(C4)(C3)O)C#N,BRD-A94993966-001-04-4,vildagliptin,Selleck,S3033,Vildagliptin (LAF-237),-8.958366,x0678,0.656751,active-noncovalent
C1C[C@H](N(C1)C(=O)C[NH2+]C23C[C@H]4C[C@@H](C2)CC(C4)(C3)O)C#N,BRD-A94993966-001-05-1,vildagliptin,Selleck,S3033,Vildagliptin (LAF-237),-8.958366,x0678,0.656751,active-noncovalent
c1ccc(cc1)C(=O)NC2CC[NH+](CC2)CCc3c[nH]c4c3cccc4,BRD-K76953762-001-08-5,indoramin,Maybridge,RH01633,,-8.957365,x0161,4.69645,active-noncovalent
CN(C)c1ccc2c(c1)Sc3cc(ccc3N2)N(C)C,BRD-K27460187-334-01-8,leucomethylene-blue,MedChemEx,HY-19948,Leucomethylene blue (Mesylate),-8.957329,x0749,1.581795,active-covalent
C[C@@H](c1ccccc1)NC(=O)c2c(ccs2)OCc3ccc(cc3)Cl,BRD-K61936403-001-02-5,AS-1949490,Tocris,3718,AS 1949490,-8.956342,x0749,1.430159,active-covalent
C[C@@H](c1ccccc1)NC(=O)c2c(ccs2)OCc3ccc(cc3)Cl,BRD-K61936403-001-01-7,AS-1949490,Tocris,3718,AS 1949490,-8.956342,x0749,1.430159,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C,BRD-K69636617-001-01-7,testolactone,MedChemEx,HY-13763,Testolactone,-8.955894,x0749,0.687729,active-covalent
c1ccc(cc1)/C=c\2/c(=C\c3ccc(o3)c4ccccc4F)/c(=O)n([nH]2)c5ccc(cc5)C(=O)[O-],BRD-K99916169-001-01-9,GS-143,Tocris,5636,GS 143,-8.955709,x0434,9.983988,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Oc2ccccc2OC,BRD-K00739965-001-01-9,guacetisal,AvaChem,2814,2-methoxyphenyl 2-(acetyloxy)benzoate,-8.955244,x1093,0.63617,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCC(=O)N2)O,BRD-A42167015-003-10-2,carteolol,MedChemEx,HY-17495A,Carteolol (hydrochloride),-8.953836,x0104,1.061865,active-noncovalent
C=CCc1ccc(c(c1)c2cc(ccc2O)CC=C)O,BRD-K26168087-001-09-7,magnolol,Selleck,S2321,Magnolol,-8.953657,x0946,-0.673439,active-noncovalent
c1cc(oc1/C=N/N2C[C@H](OC2=O)C[NH+]3CCOCC3)N(=O)=O,BRD-A67514145-003-06-6,furaltadone,Selleck,S4203,Furaltadone HCl,-8.952264,x0104,3.707516,active-noncovalent
c1cc(oc1/C=N/N2C[C@H](OC2=O)C[NH+]3CCOCC3)N(=O)=O,BRD-A67514145-003-05-8,furaltadone,Selleck,S4203,Furaltadone HCl,-8.952264,x0104,3.707516,active-noncovalent
c1cc(oc1/C=N/N2C[C@H](OC2=O)C[NH+]3CCOCC3)N(=O)=O,BRD-A67514145-001-02-9,furaltadone,MicroSource,1505770,FURALTADONE,-8.952264,x0104,3.707516,active-noncovalent
CCC[NH+](CCC)[C@H]1CCc2ccc(cc2C1)O,BRD-A18795974-004-08-1,7-hydroxy-DPAT,Tocris,706,7-Hydroxy-DPAT hydrobromide,-8.951046,x0749,-0.433261,active-covalent
CCC[NH+](CCC)[C@H]1CCc2ccc(cc2C1)O,BRD-A18795974-004-09-9,7-hydroxy-DPAT,Tocris,706,"7-(dipropylamino)-5,6,7,8-tetrahydro-2-naphthalenol hydrobromide",-8.951046,x0749,-0.433261,active-covalent
CCC[NH+](CCC)[C@H]1CCc2ccc(cc2C1)O,BRD-A18795974-004-07-3,7-hydroxy-DPAT,Tocris,706,7-Hydroxy-DPAT hydrobromide,-8.951046,x0749,-0.433261,active-covalent
c1ccc2c(c1)[nH]c(n2)c3c(c4cc(ccc4[nH]c3=O)Cl)N[C@@H]5C[NH+]6CCC5CC6,BRD-K02241333-001-02-7,CHIR-124,Selleck,S2683,CHIR-124,-8.950308,x0104,2.197493,active-noncovalent
CCCCCCCCc1ccc(cc1)CCC(CO)(CO)[NH3+],BRD-K88025533-003-03-3,fingolimod,Selleck,S5002,Fingolimod (FTY720) HCl,-8.949097,x0161,2.811347,active-noncovalent
CCCCCCCCc1ccc(cc1)CCC(CO)(CO)[NH3+],BRD-K88025533-003-04-1,fingolimod,Selleck,S5002,Fingolimod (FTY720),-8.949097,x0161,2.811347,active-noncovalent
c1ccc2c(c1)c(cs2)CNS(=O)(=O)N,BRD-K24864897-001-01-0,JNJ-26990990,Enamine,Z741322800,N-(1-benzothien-3-ylmethyl)sulfamide,-8.946698,x0678,-1.612202,active-noncovalent
CC(C)OC(=O)c1cc2c([nH]1)cccc2OC[C@H](C[NH2+]C(C)(C)C)O,BRD-A15530910-001-02-1,SDZ-21009,Tocris,1516,SDZ 21009,-8.945505,x0195,2.934546,active-noncovalent
c1cc2cc(ccc2nc1)Cn3c4c(ncc(n4)c5cnn(c5)CCO)nn3,BRD-K73319509-001-08-0,PF-04217903,Selleck,S1094,PF-04217903,-8.945086,x0072,3.973621,active-noncovalent
C=CC(=O)c1ccc2ccccc2c1,BRD-K95676198-001-05-9,JAK3-inhibitor-V,Tocris,1366,ZM 449829,-8.944732,x0195,-0.28736,active-noncovalent
C=C[C@H]1[C@@H](OC=C2C1=CCOC2=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K33131085-001-07-2,gentiopicrin,Sigma,SMB00416,"(5R,6S)-1-oxo-5-vinyl-5,6-dihydro-1H,3H-pyrano[3,4-c]pyran-6-yl beta-D-glucopyranoside",-8.943614,x0107,1.158538,active-noncovalent
c1cc2c(cc1Cl)[nH]c(c(c2=O)C(=O)C3CC3)[O-],BRD-K10176267-001-03-3,L-701252,Tocris,705,"L-701,252",-8.942568,x0749,0.161836,active-covalent
c1cc2c(cc[nH]c2=O)cc1OC3CC[NH2+]CC3,BRD-K56912469-003-02-0,SAR407899,MedChemEx,HY-15687,SAR407899 (hydrochloride),-8.942403,x0107,-0.454359,active-noncovalent
c1cc2c(cc[nH]c2=O)cc1OC3CC[NH2+]CC3,BRD-K56912469-003-01-2,SAR407899,MedChemEx,HY-15687,SAR407899 (hydrochloride),-8.942403,x0107,-0.454359,active-noncovalent
c1ccc2c(c1)C(=C(C2=O)c3ccc(cc3)Cl)[O-],BRD-K61802864-001-08-8,chlorindione,MicroSource,1504507,CHLORINDIONE,-8.942376,x0749,2.346788,active-covalent
CC(=O)Oc1cc2c(s1)CC[N@@H+](C2)[C@H](c3ccccc3F)C(=O)C4CC4,BRD-A83029242-001-05-3,prasugrel,Selleck,S1258,Prasugrel,-8.942296,x0104,3.08946,active-noncovalent
CC(=O)Oc1cc2c(s1)CC[N@@H+](C2)[C@H](c3ccccc3F)C(=O)C4CC4,BRD-A83029242-001-07-9,prasugrel,MedChemEx,HY-15284,Prasugrel,-8.942296,x0104,3.08946,active-noncovalent
CC(=O)Oc1cc2c(s1)CC[N@@H+](C2)[C@H](c3ccccc3F)C(=O)C4CC4,BRD-A83029242-001-08-7,prasugrel,MedChemEx,HY-15284,Prasugrel,-8.942296,x0104,3.08946,active-noncovalent
CC(=O)Oc1cc2c(s1)CC[N@@H+](C2)[C@H](c3ccccc3F)C(=O)C4CC4,BRD-A83029242-001-06-1,prasugrel,Selleck,S1258,Prasugrel (Effient),-8.942296,x0104,3.08946,active-noncovalent
C[N@@]1CC[N@@]2c3c1cccc3[C@H]4[C@@H]2CC[N@@H+](C4)CCCC(=O)c5ccc(cc5)F,BRD-K10031916-075-02-1,lumateperone,MedChemEx,HY-19733,lumateperone (Tosylate),-8.941424,x0072,4.64589,active-noncovalent
C[N@@]1CC[N@@]2c3c1cccc3[C@H]4[C@@H]2CC[N@@H+](C4)CCCC(=O)c5ccc(cc5)F,BRD-K10031916-075-01-3,lumateperone,MedChemEx,HY-19733,lumateperone (Tosylate),-8.941424,x0072,4.64589,active-noncovalent
Cc1ccc(cc1)c2cn3c4c(sc3[nH+]2)CCCC4,BRD-K31792052-004-02-7,pifithrin-cyclic,Tocris,3843,Cyclic Pifithrin-? hydrobromide,-8.940604,x0749,1.410812,active-covalent
Cc1nc2ccc(cc2c(=O)n1C[C@H]3CCC[N@H+](C3)C(C)C)Oc4ccc(cc4)F,BRD-K91403886-003-01-4,YIL-781,Tocris,3959,YIL 781,-8.939627,x0104,6.249576,active-noncovalent
CC(C)n1c(ccn1)c2c(cccn2)COc3cccc(c3C=O)O,BRD-K43639297-001-01-9,hemoglobin-modulators-1,MedChemEx,HY-18681,Hemoglobin Modulators-1,-8.937109,x0195,2.467705,active-noncovalent
COc1cc2c(cc1OC)nc(nc2NC3CCCCCC3)N4CCC(CC4)[NH+]5CCCCC5,BRD-K98179423-300-01-3,C-021,Tocris,3581,C 021 dihydrochloride,-8.936455,x0434,7.824552,active-noncovalent
C[C@@H]1C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1[C@H](C=O)O)C)O)F)C,BRD-A49447682-001-02-4,desoximetasone,MicroSource,1505722,DESOXYMETASONE,-8.936263,x0749,2.588563,active-covalent
C1CCc2c(c(c3c([nH+]2)CCC3)N)C1,BRD-K66896231-001-08-1,ipidacrine,ChemDiv,8003-7752,,-8.935726,x0749,0.101257,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH+]=C(N)N,BRD-K05434375-001-06-5,HA-1004,Enzo,EI184,HA-1004,-8.935545,x0540,-0.359324,active-noncovalent
CCCCOc1ccc(cc1)CC/C=C\2/C(=O)N(C(=O)S2)CC[NH3+],BRD-K12106308-003-01-9,K145,MedChemEx,HY-15779A,K145 (hydrochloride),-8.935119,x1093,2.76837,active-noncovalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O,BRD-K64054020-001-03-5,epoprostenol,Enzo,PG011,Prostaglandin I2 Na,-8.934647,x0161,2.592972,active-noncovalent
c1cc(c(c(c1)F)Cn2cc(nn2)C(=O)N)F,BRD-K20079257-001-09-6,rufinamide,Selleck,S1256,Rufinamide,-8.933000,x0678,0.326846,active-noncovalent
Cc1cc(ccc1n2c(ccc2c3ccc(cc3)n4ccnc4)CCC(=O)[O-])C(=O)N,BRD-K82522873-001-01-1,N6022,MedChemEx,HY-14984,N6022,-8.932371,x0107,4.514556,active-noncovalent
CCC[N@H+](CCc1cccs1)[C@H]2CCc3c(cccc3O)C2,BRD-K91111634-003-01-8,rotigotine,Tocris,3896,Rotigotine hydrochloride,-8.930602,x0678,1.645205,active-noncovalent
CCC[N@H+](CCc1cccs1)[C@H]2CCc3c(cccc3O)C2,BRD-K91111634-001-01-2,rotigotine,MedChemEx,HY-75502,Rotigotine,-8.930602,x0678,1.645205,active-noncovalent
Cc1cccc(c1)OC[C@H](C[NH2+]CCc2ccc(c(c2)OC)OC)O,BRD-A18233884-003-02-7,bevantolol,AKSci,69996,,-8.929432,x0104,4.13787,active-noncovalent
CC[NH+](CC)[C@H](C)C(=O)c1ccccc1,BRD-A37288617-003-02-2,amfepramone,Prestwick,Prestw-1471,Amfepramone hydrochloride,-8.929401,x0161,-0.191293,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,BRD-K93568044-001-32-0,hydrocortisone,MicroSource,300024,HYDROCORTISONE,-8.928353,x0072,2.392073,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,BRD-K93568044-001-31-2,hydrocortisone,Selleck,S1696,Hydrocortisone,-8.928353,x0072,2.392073,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,BRD-K93568044-001-30-4,hydrocortisone,Tocris,4093,Hydrocortisone,-8.928353,x0072,2.392073,active-noncovalent
c1cc(ccc1CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,BRD-K66030860-001-04-4,salidroside,Selleck,S2396,Salidroside (Rhodioloside),-8.927611,x0749,-0.489266,active-covalent
c1cc(ccc1CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,BRD-K66030860-001-03-6,salidroside,Selleck,S2396,Salidroside,-8.927611,x0749,-0.489266,active-covalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,BRD-A38675539-001-13-5,cyclothiazide,Tocris,713,Cyclothiazide,-8.927109,x0195,1.145224,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,BRD-A38675539-001-14-3,cyclothiazide,Sigma,MFCD00210192,"3-[(1S,4S)-bicyclo[2.2.1]hept-5-en-2-yl]-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",-8.927109,x0195,1.145224,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,BRD-A38675539-001-10-1,cyclothiazide,Tocris,713,Cyclothiazide,-8.927109,x0195,1.145224,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,BRD-A38675539-001-12-7,cyclothiazide,DuPont,A001186324,"3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide",-8.927109,x0195,1.145224,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,BRD-A38675539-001-11-9,cyclothiazide,MicroSource,1503263,CYCLOTHIAZIDE,-8.927109,x0195,1.145224,active-noncovalent
c1ccc(cc1)/[NH+]=C(/c2cccs2)\N,BRD-K52914072-001-01-5,LTA,Enamine,Z2372279192,N-phenyl-2-thiophenecarboximidamide,-8.926369,x1093,-0.95902,active-noncovalent
C[C@@H]1CCc2c(cc(c(c2Br)F)Br)N1C=O,BRD-A47940219-001-01-4,CE3F4,Tocris,4793,CE3F4,-8.926040,x0195,-0.182006,active-noncovalent
CCSc1ccc2c(c1)N(c3ccccc3S2)CCCN4CC[NH+](CC4)C,BRD-K69600043-328-05-5,thiethylperazine,Prestwick,Prestw-1068,Thiethylperazine dimalate,-8.925845,x0195,1.831158,active-noncovalent
CC(C)CNc1ccnc(n1)NCc2csc(n2)c3ccccc3,BRD-K78978711-003-01-3,KHS-101,Tocris,4888,KHS 101 hydrochloride,-8.925818,x0072,2.767502,active-noncovalent
C[C@@H]1CCC[C@H](/C=C\C(=O)O[C@]23[C@@H](/C=C/C1)[C@@H](C(=C)[C@H]([C@H]2[C@@H](NC3=O)Cc4ccccc4)C)O)O,BRD-K47000838-001-01-6,cytochalasin-b,Enzo,T108,Cytochalasin B,-8.924711,x0195,7.283056,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Br)O)F,BRD-K78643075-001-11-6,bromperidol,MicroSource,1505972,BROMPERIDOL,-8.924329,x0161,2.550554,active-noncovalent
CC(C)(C)c1cc2nnc(n2nc1OCc3ncnn3C)c4cc(ccc4F)F,BRD-K46647427-001-02-0,L-838417,Tocris,3250,"L-838,417",-8.924032,x0195,5.391193,active-noncovalent
C[C@@H](c1ccc2c(c1)c(=O)oc3c2cc(c(c3)OCc4ccc(cc4)OC)OC)O,BRD-A50998626-001-02-1,palomid-529,Selleck,S2238,Palomid 529 (P529),-8.923805,x1077,3.088466,active-noncovalent
CCOC(=O)C1=C(Oc2ccc(cc2[C@@H]1[C@@H](C#N)C(=O)OCC)Br)[NH3+],BRD-A13807286-001-07-0,HA-14-1,Tocris,1541,HA14-1,-8.923680,x0195,1.373991,active-noncovalent
CCOc1cc(cc(c1OCC)OCC)C(=O)Nc2ccc(c(c2)c3[nH]c4ccccc4n3)Cl,BRD-K35781423-001-01-6,SANT-2,Tocris,3617,SANT-2,-8.923345,x0104,10.479446,active-noncovalent
CCOc1cc(cc(c1OCC)OCC)C(=O)Nc2ccc(c(c2)c3[nH]c4ccccc4n3)Cl,BRD-K35781423-001-02-4,SANT-2,Tocris,3617,SANT-2,-8.923345,x0104,10.479446,active-noncovalent
c1ccc2c(c1)c3c(o2)C(=NCC(=O)N3)c4cccc(c4)Br,BRD-K33690734-001-01-5,5-BDBD,Tocris,3579,5-BDBD,-8.923232,x0195,-0.994135,active-noncovalent
c1ccc2c(c1)c3c(o2)C(=NCC(=O)N3)c4cccc(c4)Br,BRD-K33690734-001-02-3,5-BDBD,Tocris,3579,5-BDBD,-8.923232,x0195,-0.994135,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-046-05-4,pyrantel-pamoate,MedChemEx,HY-12641,Pyrantel (tartrate),-8.923189,x0678,-0.871357,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-096-05-9,pyrantel-tartrate,MedChemEx,HY-12640,Pyrantel (pamoate),-8.923189,x0678,-0.871357,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-096-03-4,pyrantel-pamoate,MicroSource,1500517,PYRANTEL PAMOATE,-8.923189,x0678,-0.871357,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-046-04-7,pyrantel-tartrate,MedChemEx,HY-12641,Pyrantel (tartrate),-8.923189,x0678,-0.871357,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-096-06-7,pyrantel-pamoate,MedChemEx,HY-12640,Pyrantel (pamoate),-8.923189,x0678,-0.871357,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,BRD-K20672254-046-03-9,pyrantel-tartrate,Prestwick,Prestw-212,Pyrantel tartrate,-8.923189,x0678,-0.871357,active-noncovalent
C[N@H+]1Cc2c(cccc2N)[C@@H](C1)c3ccccc3,BRD-A29644307-050-16-2,nomifensine,Selleck,S4380,Nomifensine Maleate,-8.923178,x0161,-0.496226,active-noncovalent
C[N@H+]1Cc2c(cccc2N)[C@@H](C1)c3ccccc3,BRD-A29644307-050-18-8,nomifensine,Selleck,S4380,nomifensine maleate,-8.923178,x0161,-0.496226,active-noncovalent
C[N@H+]1Cc2c(cccc2N)[C@@H](C1)c3ccccc3,BRD-A29644307-050-17-0,nomifensine,MicroSource,1503267,NOMIFENSINE MALEATE,-8.923178,x0161,-0.496226,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K64994968-001-32-5,progesterone,MicroSource,1500508,PROGESTERONE,-8.923118,x1077,2.903516,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K64994968-001-33-3,progesterone,Selleck,S1705,Progesterone,-8.923118,x1077,2.903516,active-noncovalent
COc1ccc(cc1)C(=O)/C(=C/C(=O)[O-])/Br,BRD-K17874929-236-02-0,bromebric-acid,Sigma,MFCD00795053,sodium (2Z)-3-bromo-4-(4-methoxyphenyl)-4-oxo-2-butenoate,-8.921595,x0749,-0.467006,active-covalent
c1ccc(c(c1)C(=O)[O-])NC(=O)C23CC4CC(C2)CC(C4)C3,BRD-K75167327-001-01-6,anthranilic-acid,Enamine,T0514-6571,2-[(1-adamantylcarbonyl)amino]benzoic acid,-8.920912,x0749,0.469773,active-covalent
c1cc(sc1)C(=O)c2ccc(c(c2Cl)Cl)OCC(=O)[O-],BRD-K34098590-001-02-1,tienilic-acid,Sigma,MFCD00867339,"[2,3-dichloro-4-(2-thienylcarbonyl)phenoxy]acetic acid",-8.919909,x0749,0.387485,active-covalent
COCCOc1cc2c(cc1OCCO)c(ncn2)Nc3cccc(c3)C#C,BRD-K73309154-003-02-8,OSI-420,Selleck,S2205,OSI-420,-8.919124,x0161,6.901499,active-noncovalent
c1ccc(cc1)C[NH+]2CCN(CC2)S(=O)(=O)c3ccc(cc3N(=O)=O)Cl,BRD-K45519571-001-02-6,RN-1747,Tocris,3745,RN 1747,-8.918812,x0946,3.047199,active-noncovalent
c1ccc(cc1)C[NH+]2CCN(CC2)S(=O)(=O)c3ccc(cc3N(=O)=O)Cl,BRD-K45519571-001-01-8,RN-1747,Tocris,3745,RN 1747,-8.918812,x0946,3.047199,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCC2)(C3CCCCC3)O,BRD-A31800922-003-24-4,procyclidine,Selleck,S4349,Procyclidine HCl,-8.917593,x1093,0.182121,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCC2)(C3CCCCC3)O,BRD-A31800922-003-25-1,procyclidine,MicroSource,1500507,PROCYCLIDINE HYDROCHLORIDE,-8.917593,x1093,0.182121,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])N3C(=O)c4ccccc4C3=O,BRD-K89391146-001-09-8,RG108,Tocris,3295,RG 108,-8.916986,x0831,1.087772,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])N3C(=O)c4ccccc4C3=O,BRD-K89391146-001-08-0,RG108,Selleck,S2821,RG108,-8.916986,x0831,1.087772,active-covalent
CC(=O)NCCc1c[nH]c2c1cc(c(c2)Cl)OC,BRD-K34663752-001-10-9,6-chloromelatonin,Tocris,443,6-Chloromelatonin,-8.915622,x0161,-0.949305,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(c(c2)Cl)OC,BRD-K34663752-001-09-1,6-chloromelatonin,Tocris,443,6-Chloromelatonin,-8.915622,x0161,-0.949305,active-noncovalent
C[NH+](C)CCn1c(=O)c2cccc3c/c(=N/C(=O)N)/cc(c1=O)[C@@H]32,BRD-K30933884-001-01-0,UNBS-5162,MedChemEx,HY-16509,UNBS5162,-8.915493,x0195,2.444741,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)OC,BRD-K97530723-001-19-1,melatonin,Selleck,S1204,Melatonin,-8.913157,x0104,-1.58685,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)OC,BRD-K97530723-001-24-1,melatonin,Tocris,3550,Melatonin,-8.913157,x0104,-1.58685,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)OC,BRD-K97530723-001-20-9,melatonin,Tocris,3550,Melatonin,-8.913157,x0104,-1.58685,active-noncovalent
COc1cc(ccc1O)C[C@@H](CO)[C@@H](Cc2ccc(c(c2)OC)O)CO,BRD-K91733562-001-05-0,secoisolariciresinol-(-),Sigma,MFCD01075136,"(2R,3R)-2,3-bis(4-hydroxy-3-methoxybenzyl)-1,4-butanediol",-8.912988,x0161,1.81068,active-noncovalent
CCc1ccc(cc1)OCc2ccccc2C(=O)Nc3ccc4c(c3)c(cc([nH+]4)C)N,BRD-K17705806-003-06-9,JTC-801,Tocris,2481,JTC 801,-8.912385,x1093,3.992051,active-noncovalent
CCc1ccc(cc1)OCc2ccccc2C(=O)Nc3ccc4c(c3)c(cc([nH+]4)C)N,BRD-K17705806-003-03-6,JTC-801,Selleck,S2722,JTC-801,-8.912385,x1093,3.992051,active-noncovalent
CCc1ccc(cc1)OCc2ccccc2C(=O)Nc3ccc4c(c3)c(cc([nH+]4)C)N,BRD-K17705806-003-04-4,JTC-801,Tocris,2481,JTC 801,-8.912385,x1093,3.992051,active-noncovalent
Cc1ccc(cc1Nc2ccc3c(c2)c(=O)n(cn3)C)NC(=O)c4cccc(c4)C(C)(C)C#N,BRD-K05804044-001-09-4,AZ-628,Selleck,S2746,AZ628,-8.911637,x0104,10.840225,active-noncovalent
Cc1ccc(cc1Nc2ccc3c(c2)c(=O)n(cn3)C)NC(=O)c4cccc(c4)C(C)(C)C#N,BRD-K05804044-001-06-0,AZ-628,Selleck,S2746,AZ 628,-8.911637,x0104,10.840225,active-noncovalent
Cc1ccc(cc1Nc2ccc3c(c2)c(=O)n(cn3)C)NC(=O)c4cccc(c4)C(C)(C)C#N,BRD-K05804044-001-14-4,AZ-628,Tocris,4836,AZ 628,-8.911637,x0104,10.840225,active-noncovalent
Cc1ccc(cc1Nc2ccc3c(c2)c(=O)n(cn3)C)NC(=O)c4cccc(c4)C(C)(C)C#N,BRD-K05804044-001-12-8,AZ-628,Selleck,S2746,AZ-628,-8.911637,x0104,10.840225,active-noncovalent
C/C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)/O,BRD-A42699921-001-03-6,teriflunomide,Selleck,S4169,Teriflunomide,-8.911253,x0749,1.659657,active-covalent
C/C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)/O,BRD-A42699921-001-02-8,teriflunomide,Selleck,S4169,Teriflunomide,-8.911253,x0749,1.659657,active-covalent
C/C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)/O,BRD-A42699921-001-04-4,teriflunomide,Tocris,5069,Teriflunomide,-8.911253,x0749,1.659657,active-covalent
c1cc(ccc1c2c(c(nc(c2C#N)SCC(=O)N)N)C#N)OCC3CC3,BRD-K32952627-001-01-0,BAY-60-6583,Tocris,4472,BAY 60-6583,-8.910889,x0195,3.204035,active-noncovalent
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c3ccc(cc3)F,BRD-K66296774-236-12-1,fluvastatin,Tocris,3309,Fluvastatin sodium,-8.910583,x0161,3.715332,active-noncovalent
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c3ccc(cc3)F,BRD-K66296774-236-10-5,fluvastatin,Selleck,S1909,Fluvastatin Sodium,-8.910583,x0161,3.715332,active-noncovalent
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c3ccc(cc3)F,BRD-K66296774-236-11-3,fluvastatin,Selleck,S1909,Fluvastatin sodium (Lescol),-8.910583,x0161,3.715332,active-noncovalent
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c3ccc(cc3)F,BRD-K66296774-001-07-9,fluvastatin,MicroSource,1504911,FLUVASTATIN,-8.910583,x0161,3.715332,active-noncovalent
c1ccc(cc1)n2c(ccn2)NS(=O)(=O)c3ccc(cc3)N,BRD-K10671814-001-14-8,sulfaphenazole,MicroSource,1501143,SULFAPHENAZOLE,-8.909131,x0749,0.533489,active-covalent
CCC[N@@+]12[C@H]3C[C@@H]([C@@H]([C@H]1O)CC)[C@H]4[C@@H]2C[C@@]5([C@H]3[N@](c6c5cccc6)C)[C@H]4O,BRD-A53539450-004-01-7,neo-gilurytmal,InterBioScreen,STOCK1N-12913,,-8.909109,x0749,1.2035,active-covalent
Cc1ccc(cc1)CC2(CC[NH+](CC2)CCOc3ccc(cc3)O)O,BRD-K55677650-003-02-9,CO-101244,Tocris,2456,Co 101244 hydrochloride,-8.908525,x0434,2.889613,active-noncovalent
Cc1ccc(cc1)CC2(CC[NH+](CC2)CCOc3ccc(cc3)O)O,BRD-K55677650-003-03-7,CO-101244,Tocris,2456,Co 101244 hydrochloride,-8.908525,x0434,2.889613,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-K41445866-001-18-8,alfaxalone,Prestwick,Prestw-1002,Alfaxalone,-8.907814,x0749,3.628612,active-covalent
Cc1cc(nc2c1c(c(s2)C(=O)NCc3ccc(cc3)OC)N)C,BRD-K87727457-001-01-5,VU-152100,Tocris,3383,VU 152100,-8.907442,x0161,4.380857,active-noncovalent
CS(=O)(=O)c1cc(cc2c1n(c3c2CC[C@@H]3CC(=O)[O-])Cc4ccc(cc4)Cl)F,BRD-K48894757-001-01-8,laropiprant,MedChemEx,HY-50175,Laropiprant,-8.907263,x0195,2.336156,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C,BRD-K03981224-001-19-3,ethisterone,Selleck,S2611,Ethisterone,-8.907250,x0749,2.636101,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C,BRD-K03981224-001-21-9,ethisterone,Selleck,S2611,Ethisterone,-8.907250,x0749,2.636101,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cc(ccc1Cl)Cl)O,BRD-A04971881-003-01-3,cloranolol,Sigma,PH014015,"1-(tert-butylamino)-3-(2,5-dichlorophenoxy)-2-propanol hydrochloride",-8.906892,x0104,0.140364,active-noncovalent
C/N=c\1/nc(n(s1)c2ccccc2)c3ccccc3,BRD-K29562203-004-08-3,SCH-202676,Tocris,1400,SCH 202676 hydrobromide,-8.906518,x0195,0.315959,active-noncovalent
C/N=c\1/nc(n(s1)c2ccccc2)c3ccccc3,BRD-K29562203-004-09-1,SCH-202676,Tocris,1400,SCH 202676 hydrobromide,-8.906518,x0195,0.315959,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5ccccc5C4=O)[O-])(C(=O)C)O)[NH3+])O,BRD-K69650333-003-14-0,idarubicin,Selleck,S1228,Idarubicin HCl,-8.905663,x0161,8.737393,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5ccccc5C4=O)[O-])(C(=O)C)O)[NH3+])O,BRD-K69650333-003-13-2,idarubicin,Selleck,S1228,Idarubicin HCl,-8.905663,x0161,8.737393,active-noncovalent
CCC[N@@H+]1CCC[C@H]2[C@H]1Cc3c[nH]nc3C2,BRD-K26548821-003-11-3,quinpirol-(-),Tocris,1061,(-)-Quinpirole hydrochloride,-8.903880,x1418,-0.695524,active-covalent
CCC[N@@H+]1CCC[C@H]2[C@H]1Cc3c[nH]nc3C2,BRD-K26548821-003-10-5,quinpirol-(-),Tocris,1061,(-)-Quinpirole hydrochloride,-8.903880,x1418,-0.695524,active-covalent
CCC[NH2+][C@H]1CCc2c(sc(n2)N)C1,BRD-K06388322-300-01-3,pramipexole,Tocris,4174,Pramipexole dihydrochloride,-8.901696,x0678,-0.970156,active-noncovalent
CCC[NH2+][C@H]1CCc2c(sc(n2)N)C1,BRD-K06388322-001-07-4,pramipexole,Selleck,S2460,Pramipexole,-8.901696,x0678,-0.970156,active-noncovalent
CCC[NH2+][C@H]1CCc2c(sc(n2)N)C1,BRD-K06388322-312-02-6,pramipexole,Selleck,S2011,Pramipexole dihydrochloride monohydrate,-8.901696,x0678,-0.970156,active-noncovalent
C[C@@H](Cc1ccccc1)[N@@H+](C)CC#C,BRD-A28545468-003-16-6,selegiline,MicroSource,1505781,SELEGILINE HYDROCHLORIDE,-8.901691,x0161,-0.983478,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K44009692-001-02-3,hyodeoxycholic-acid,Selleck,S2311,Hyodeoxycholic acid (HDCA),-8.901196,x0104,2.192106,active-noncovalent
C[C@H]1[C@H](Cc2ccccc2O1)[NH+](C)C,BRD-A20686268-001-01-4,trebenzomine,Sigma,PH007494,"N,N-dimethyl-N-(2-methyl-3,4-dihydro-2H-chromen-3-yl)amine",-8.900448,x0195,-0.875862,active-noncovalent
CCn1c(c([nH]c1=O)c2ccccc2)[O-],BRD-A30205217-001-11-2,ethotoin,MicroSource,1505428,ETHOTOIN,-8.900129,x0195,-1.143619,active-noncovalent
CCn1c(c([nH]c1=O)c2ccccc2)[O-],BRD-A30205217-001-12-0,ethotoin,AMS,A001578171,"3-ethyl-5-phenyl-2,4-imidazolidinedione",-8.900129,x0195,-1.143619,active-noncovalent
c1ccc(cc1)Sc2c3cc(ccc3n(c2C(=O)[O-])Cc4ccc(cc4)Cl)Cl,BRD-K54708045-001-02-1,nTZDpa,Tocris,2150,nTZDpa,-8.899461,x1093,3.438529,active-noncovalent
c1ccc(cc1)Sc2c3cc(ccc3n(c2C(=O)[O-])Cc4ccc(cc4)Cl)Cl,BRD-K54708045-001-03-9,nTZDpa,Tocris,2150,nTZDpa,-8.899461,x1093,3.438529,active-noncovalent
CC(C)c1ccc(cc1)c2cc(=O)c3ccccc3o2,BRD-K16183658-001-01-4,MN-64,MedChemEx,HY-19351,MN-64,-8.896603,x0104,1.20887,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CCC6)[C@@H](O2)[C@H](CC5)O)O)O,BRD-K66404838-310-01-1,nalbuphine,Enzo,AC893,Nalbuphine HCl 2H2O,-8.895498,x1077,2.240741,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CCC6)[C@@H](O2)[C@H](CC5)O)O)O,BRD-K66404838-001-02-4,nalbuphine,MicroSource,1501115,NALBUPHINE HYDROCHLORIDE,-8.895498,x1077,2.240741,active-noncovalent
c1ccc(c(c1)C2CCN(CC2)C(=O)Nc3ccccc3C(=O)[O-])C(F)(F)F,BRD-K59060513-001-02-5,A-1120,Tocris,3793,A 1120,-8.895464,x0161,5.816234,active-noncovalent
Cc1cc(no1)C(=O)NNCc2ccccc2,BRD-K93332168-001-11-5,isocarboxazid,Sigma,MFCD00865409,N'-benzyl-5-methyl-3-isoxazolecarbohydrazide,-8.895260,x0678,-0.557246,active-noncovalent
Cc1cc(no1)C(=O)NNCc2ccccc2,BRD-K93332168-001-10-7,isocarboxazid,Enzo,AC3152,ISOCARBOXAZID,-8.895260,x0678,-0.557246,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-K90758956-001-02-9,budesonide,Selleck,S1286,Budesonide,-8.894590,x1077,4.993361,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-K90758956-001-03-7,budesonide,Selleck,S1286,Budesonide,-8.894590,x1077,4.993361,active-noncovalent
c1ccc(cc1)S(=O)(=O)[N@@](CC(F)(F)F)c2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O,BRD-K23383398-001-10-7,T-0901317,Tocris,2373,T 0901317,-8.894518,x1077,3.935437,active-noncovalent
c1ccc(cc1)S(=O)(=O)[N@@](CC(F)(F)F)c2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O,BRD-K23383398-001-09-9,T-0901317,Tocris,2373,T 0901317,-8.894518,x1077,3.935437,active-noncovalent
c1ccc(cc1)S(=O)(=O)[N@@](CC(F)(F)F)c2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O,BRD-K23383398-001-08-1,T-0901317,Selleck,S7076,T0901317,-8.894518,x1077,3.935437,active-noncovalent
C[C@H](CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)[NH2+]CCc2cnc[nH]2,BRD-A66435872-332-02-6,HTMT,Tocris,646,(2Z)-2-butenedioic acid compound with 6-{[2-(1H-imidazol-4-yl)ethyl]amino}-N-[4-(trifluoromethyl)phenyl]heptanamide (2:1),-8.894108,x0161,2.331575,active-noncovalent
C[C@H](CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)[NH2+]CCc2cnc[nH]2,BRD-A66435872-332-01-8,HTMT,Tocris,646,HTMT dimaleate,-8.894108,x0161,2.331575,active-noncovalent
CCOP(=S)(OCC)Oc1ccc2c(c(c(=O)oc2c1)Cl)C,BRD-K41567533-001-08-3,coumophos,MicroSource,330012,COUMOPHOS,-8.893631,x0749,1.81002,active-covalent
Cc1ccc(c(c1)OCC2=[NH+]CCN2)C(C)C,BRD-K64414150-001-01-7,tymazoline,Sigma,MFCD00867736,"2-[(2-isopropyl-5-methylphenoxy)methyl]-4,5-dihydro-1H-imidazole",-8.893587,x0195,-0.799294,active-noncovalent
c1cc2c(cc1C#N)c(c[nH]2)CCCC[NH+]3CCN(CC3)c4ccc5c(c4)cc(o5)C(=O)N,BRD-K58010567-003-01-4,vilazodone,Selleck,S4259,Vilazodone HCl,-8.891726,x0395,10.708369,active-noncovalent
c1cc2c(cc1C#N)c(c[nH]2)CCCC[NH+]3CCN(CC3)c4ccc5c(c4)cc(o5)C(=O)N,BRD-K58010567-003-02-2,vilazodone,MicroSource,1504418,VILAZODONE HYDROCHLORIDE,-8.891726,x0395,10.708369,active-noncovalent
c1cc2c(cc1C#N)c(c[nH]2)CCCC[NH+]3CCN(CC3)c4ccc5c(c4)cc(o5)C(=O)N,BRD-K58010567-003-03-0,vilazodone,Selleck,S4259,Vilazodone Hydrochloride,-8.891726,x0395,10.708369,active-noncovalent
CCC[NH2+][C@@H]1CCc2c(cccc2OC)[C@@H]1C,BRD-K76677554-003-02-1,AJ76-(+),Tocris,678,(+)-AJ 76 hydrochloride,-8.891234,x0195,-0.872046,active-noncovalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)[O-])O)O,BRD-K26521938-001-09-8,dinoprostone,Cayman,10007211,"(5Z,11beta,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid",-8.891033,x0678,3.892479,active-noncovalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)[O-])O)O,BRD-K26521938-001-07-2,dinoprostone,Tocris,2296,Prostaglandin E2,-8.891033,x0678,3.892479,active-noncovalent
C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(=O)[nH]c2=O)(C)F)O)Oc3ccccc3,BRD-K05674516-001-01-7,PSI-7976,MedChemEx,HY-15005A,PSI-7976,-8.890982,x0195,5.996388,active-noncovalent
C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(=O)[nH]c2=O)(C)F)O)Oc3ccccc3,BRD-K05674516-001-02-5,sofosbuvir,MedChemEx,HY-15005,PSI-7977,-8.890982,x0195,5.996388,active-noncovalent
CC1(CCC(c2c1cc(c(c2)/C=C/c3ccc(cc3)C(=O)[O-])Cn4cccn4)(C)C)C,BRD-K83794243-001-01-8,palovarotene,MedChemEx,HY-14799,Palovarotene,-8.890108,x1077,5.506534,active-noncovalent
CCCCCCCCCCCCOS(=O)(=O)O,BRD-M58433298-001-01-6,sodium-dodecyl-sulfate,Enamine,Z1365432828,,-8.889218,x0072,0.684702,active-noncovalent
CCCCCCCCCCCCOS(=O)(=O)O,BRD-M58433298-001-02-4,sodium-dodecyl-sulfate,Sigma,74255,sodium dodecyl sulfate,-8.889218,x0072,0.684702,active-noncovalent
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)[NH3+])O,BRD-A35379661-001-04-6,sphingosylphosphorylcholine,EMDBio,567735-10MG,Sphingosylphosphoryl-choline,-8.889180,x0678,5.758393,active-noncovalent
CCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)Br)[O-])Br,BRD-K11717138-001-30-3,benzbromarone,MicroSource,1505971,BENZBROMARONE,-8.888633,x0831,0.614449,active-covalent
CCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)Br)[O-])Br,BRD-K11717138-001-29-5,benzbromarone,Selleck,S4221,Benzbromarone,-8.888633,x0831,0.614449,active-covalent
CC(C)c1cc(c(cc1Cc2cnc(nc2N)N)OC)OC,BRD-K00354853-001-01-2,RO-3,Tocris,3052,RO-3,-8.888500,x0678,1.676355,active-noncovalent
Cn1cc(c(=O)c2c1cc(cc2)F)[S@](=O)C,BRD-A79643124-001-01-9,flosequinan,Key,FE-0065,7-fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone,-8.887328,x0195,0.691596,active-noncovalent
c1ccc2c(c1)ccc(n2)/C=C/C(=O)c3ccncc3,BRD-K95573441-001-01-2,PFK-015,MedChemEx,HY-12204,PFK-015,-8.886244,x0946,2.806798,active-noncovalent
c1ccc2c(c1)ccc(n2)/C=C/C(=O)c3ccncc3,BRD-K95573441-001-02-0,PFK-015,MedChemEx,HY-12204,PFK-015,-8.886244,x0946,2.806798,active-noncovalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5[NH3+])C(=O)[O-],BRD-K00494077-066-02-7,trovafloxacin,Tocris,3863,Trovafloxacin mesylate,-8.885742,x0749,4.692539,active-covalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5[NH3+])C(=O)[O-],BRD-K00494077-066-01-9,trovafloxacin,Enzo,AC2304,Trovafloxacin mesylate,-8.885742,x0749,4.692539,active-covalent
C[C@@H]1COCC[N@@]1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C,BRD-K42436189-001-03-8,AZ20,Tocris,5198,AZ 20,-8.885229,x0434,5.407597,active-noncovalent
C[C@@H]1COCC[N@@]1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C,BRD-K42436189-001-01-2,AZ20,Selleck,S7050,AZ20,-8.885229,x0434,5.407597,active-noncovalent
Cc1ccc(cc1)Sc2cncc3c2cc(s3)C(=O)N,BRD-K77627880-001-03-2,A205804,Selleck,S2885,A-205804,-8.881916,x1093,-0.464326,active-noncovalent
Cc1ccc(cc1)Sc2cncc3c2cc(s3)C(=O)N,BRD-K77627880-001-05-7,A205804,Tocris,2524,A 205804,-8.881916,x1093,-0.464326,active-noncovalent
Cc1ccc(cc1)Sc2cncc3c2cc(s3)C(=O)N,BRD-K77627880-001-04-0,A205804,Tocris,2524,A 205804,-8.881916,x1093,-0.464326,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,BRD-K38003476-001-09-1,clocortolone-pivalate,Prestwick,Prestw-1119,Clocortolone pivalate,-8.881009,x0161,6.050467,active-noncovalent
CC[N+](CC)(CC)CCOc1ccc(cc1)/C=C/c2ccccc2,BRD-K03128577-005-07-0,MG-624,Tocris,1356,MG 624,-8.880240,x0104,3.574757,active-noncovalent
CC[N+](CC)(CC)CCOc1ccc(cc1)/C=C/c2ccccc2,BRD-K03128577-005-06-2,MG-624,Tocris,1356,MG 624,-8.880240,x0104,3.574757,active-noncovalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-19-9,anisindione,Selleck,S4304,anisindione,-8.880160,x0749,2.132096,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-22-3,anisindione,MedChemEx,HY-B0924,Anisindione,-8.880160,x0749,2.132096,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-21-5,anisindione,MedChemEx,HY-B0924,Anisindione,-8.880160,x0749,2.132096,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-18-1,anisindione,MicroSource,1502198,ANISINDIONE,-8.880160,x0749,2.132096,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-20-7,anisindione,Vitas-M,STK363125,"2-(4-methoxyphenyl)-1H-indene-1,3(2H)-dione",-8.880160,x0749,2.132096,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],BRD-K47458712-001-17-3,anisindione,Selleck,S4304,Anisindione,-8.880160,x0749,2.132096,active-covalent
C[C@H](CCCC(C(F)(F)F)(C(F)(F)F)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K08251020-001-02-8,falecalcitriol,MedChemEx,HY-32342,Falecalcitriol,-8.879029,x0104,11.810312,active-noncovalent
C[C@H](CCCC(C(F)(F)F)(C(F)(F)F)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,BRD-K08251020-001-01-0,falecalcitriol,MedChemEx,HY-32342,Falecalcitriol,-8.879029,x0104,11.810312,active-noncovalent
c1cc(ccc1CCCOCCC[NH+]2CCCCC2)Cl,BRD-K21673112-003-01-3,BF2.649,Tocris,3743,BF 2649,-8.877316,x0195,0.547377,active-noncovalent
c1cc(ccc1CCCOCCC[NH+]2CCCCC2)Cl,BRD-K21673112-003-02-1,BF2.649,Tocris,3743,BF 2649,-8.877316,x0195,0.547377,active-noncovalent
Cc1c(cccc1Cl)Nc2ccccc2C(=O)[O-],BRD-K50133271-001-17-9,tolfenamic-acid,Selleck,S1959,Tolfenamic Acid,-8.877217,x0749,-0.580624,active-covalent
Cc1c(cccc1Cl)Nc2ccccc2C(=O)[O-],BRD-K50133271-001-18-7,tolfenamic-acid,MicroSource,1501198,TOLFENAMIC ACID,-8.877217,x0749,-0.580624,active-covalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cc(cc3)CC(=O)[O-],BRD-K67637637-003-12-6,olopatadine,Selleck,S2494,Olopatadine HCl,-8.877043,x0072,0.772791,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cc(cc3)CC(=O)[O-],BRD-K67637637-003-11-8,olopatadine,Tocris,4241,Olopatadine hydrochloride,-8.877043,x0072,0.772791,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)NCC(=O)NCC(=O)[O-])[NH3+])O,BRD-K00926464-001-01-8,IMREG-1,ChemImpex,11256,,-8.875713,x0678,0.129767,active-noncovalent
CN1CCC[NH+]=C1COC(=O)[C@](c2ccccc2)(C3CCCCC3)O,BRD-A58193911-003-18-7,oxyphencyclimine,MicroSource,1503932,OXYPHENCYCLIMINE HYDROCHLORIDE,-8.875534,x0104,1.600737,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCCO,BRD-K66956375-001-11-3,oleoylethanolamide,Tocris,1484,Oleylethanolamide,-8.875390,x0161,4.816744,active-noncovalent
C[NH+](C)CC[C@H](c1ccccc1)c2ccccn2,BRD-A23072235-050-18-5,pheniramine,MicroSource,1500478,PHENIRAMINE MALEATE,-8.874435,x0195,0.826829,active-noncovalent
C[NH+](C)CC[C@H](c1ccccc1)c2ccccn2,BRD-A23072235-050-17-7,pheniramine,Selleck,S4045,Pheniramine Maleate,-8.874435,x0195,0.826829,active-noncovalent
c1ccc(cc1)CNC(=O)OCCO,BRD-K30360804-001-01-3,buramate,MicroSource,1505415,BURAMATE,-8.872669,x0678,-2.015971,active-noncovalent
C[C@H](CCC[NH3+])Nc1cc(cc2c1nccc2)OC,BRD-A55913614-316-08-8,primaquine,Selleck,S4237,Primaquine Diphosphate,-8.872667,x0195,0.164102,active-noncovalent
C[C@H](CCC[NH3+])Nc1cc(cc2c1nccc2)OC,BRD-A55913614-316-09-6,primaquine,MicroSource,1500500,PRIMAQUINE PHOSPHATE,-8.872667,x0195,0.164102,active-noncovalent
CCCCc1ccc(cc1O)O,BRD-K61036791-001-01-6,rucinol,TCI,B3773,,-8.871273,x0195,-1.037891,active-noncovalent
Cn1c(ncn1)COc2c(cc3nnc(n3n2)c4c(cccc4F)F)C5CCC5,BRD-K57416838-001-01-1,MRK-409,Sigma,SML0565,"7-cyclobutyl-3-(2,6-difluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl (1-methyl-1H-1,2,4-triazol-5-yl)methyl ether",-8.870874,x0195,2.753074,active-noncovalent
Cn1c(ncn1)COc2c(cc3nnc(n3n2)c4c(cccc4F)F)C5CCC5,BRD-K57416838-001-02-9,MRK-409,Tocris,4415,MK 0343,-8.870874,x0195,2.753074,active-noncovalent
c1cc(ccc1c2c(c(nc(c2C#N)SCc3[nH]ccn3)N)C#N)O,BRD-K67079690-001-01-2,LUF-5834,Tocris,4603,LUF 5834,-8.869262,x0107,0.862983,active-noncovalent
Cc1ccc(cc1C)n2c(=O)c(c([nH]2)C)/N=N/c3cccc(c3O)c4cccc(c4)C(=O)[O-],BRD-K40496271-001-02-5,eltrombopag,Selleck,S2229,Eltrombopag,-8.869245,x0072,8.963506,active-noncovalent
Cc1ccc(cc1C)n2c(=O)c(c([nH]2)C)/N=N/c3cccc(c3O)c4cccc(c4)C(=O)[O-],BRD-K40496271-001-03-3,eltrombopag,Selleck,S4502,Eltrombopag,-8.869245,x0072,8.963506,active-noncovalent
Cc1ccc(cc1C)n2c(=O)c(c([nH]2)C)/N=N/c3cccc(c3O)c4cccc(c4)C(=O)[O-],BRD-K40496271-396-01-1,eltrombopag,Selleck,S2229,Eltrombopag olamine,-8.869245,x0072,8.963506,active-noncovalent
COc1cccc(c1c2ccc(cc2)C[C@@H](C(=O)[O-])NC(=O)c3c(cccc3Cl)Cl)OC,BRD-K24968862-001-01-0,SB-683698,MedChemEx,HY-15770,TR-14035,-8.868683,x0161,4.976843,active-noncovalent
c1ccc(c(c1)C[NH3+])Sc2ccccc2CO,BRD-K47690382-001-03-0,bipenamol,Sigma,MFCD00075349,(2-{[2-(aminomethyl)phenyl]sulfanyl}phenyl)methanol,-8.867262,x0434,0.397268,active-noncovalent
CCOc1ccc(cc1OCC)Cc2c3cc(c(cc3ccn2)OCC)OCC,BRD-K36756879-003-08-7,ethaverine,MicroSource,1501000,ETHAVERINE HYDROCHLORIDE,-8.866529,x0161,4.754397,active-noncovalent
CC/C(=C(\c1ccc(cc1)O)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K04210847-001-21-9,afimoxifene,Sigma,H7904,4-((1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenyl-1-butenyl)phenol,-8.866489,x0072,2.445265,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)(c3ccccc3)O,BRD-K38158531-001-02-1,traxoprodil,EMDBio,504523-5MG,"CP-101,606",-8.865337,x0072,0.534215,active-noncovalent
Cc1c2c(oc1S(=O)(=O)[O-])-c3ccc4c(c3C(=O)C2=O)CCCC4(C)C,BRD-K84798689-236-02-9,sodium-tanshinone-ii-a-sulfonate,Ark,AK128306,,-8.865053,x0104,2.407336,active-noncovalent
Cc1cc(c(c(=O)o1)C2=NCCS[C@@H](C2)c3ccc(cc3OC)OC)[O-],BRD-A54927599-001-16-9,KF-38789,Tocris,2748,KF 38789,-8.864925,x0195,2.6998,active-noncovalent
Cc1cc(c(c(=O)o1)C2=NCCS[C@@H](C2)c3ccc(cc3OC)OC)[O-],BRD-A54927599-001-17-7,KF-38789,Tocris,2748,KF 38789,-8.864925,x0195,2.6998,active-noncovalent
c1ccnc(c1)c2c(cn[nH]2)c3ccnc(c3)c4ccc(cc4)C(=O)NC5CCOCC5,BRD-K78086729-001-02-7,GW-788388,Selleck,S2750,GW788388,-8.864747,x0104,9.206582,active-noncovalent
c1ccnc(c1)c2c(cn[nH]2)c3ccnc(c3)c4ccc(cc4)C(=O)NC5CCOCC5,BRD-K78086729-001-03-5,GW-788388,Tocris,3264,GW 788388,-8.864747,x0104,9.206582,active-noncovalent
c1ccc2c(c1)ccc3c2nc(s3)N,BRD-K67304264-001-10-1,SKA-31,Tocris,3670,SKA 31,-8.864293,x0195,-1.537737,active-noncovalent
c1ccc2c(c1)ccc3c2nc(s3)N,BRD-K67304264-001-08-5,SKA-31,Tocris,3670,SKA 31,-8.864293,x0195,-1.537737,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)O)C)C,BRD-K13629382-051-06-6,eseroline-(-),Prestwick,Prestw-1082,(-)-Eseroline fumarate salt,-8.863729,x0195,0.955276,active-noncovalent
CN(C)/C=[NH+]/c1c(cc(c(c1I)CCC(=O)[O-])I)I,BRD-K51956333-001-03-8,iopodic-acid,Vitas-M,STL069537,,-8.863449,x0195,-0.481387,active-noncovalent
[H]/N=C(/[C@H](C#N)c1ccccc1C(F)(F)F)\Sc2ccc(cc2)N,BRD-K12244279-001-05-8,MEK1-2-inhibitor,Tocris,1969,SL 327,-8.863404,x0830,2.09357,active-covalent
[H]/N=C(/[C@H](C#N)c1ccccc1C(F)(F)F)\Sc2ccc(cc2)N,BRD-K12244279-001-04-1,MEK1-2-inhibitor,Selleck,S1066,SL-327,-8.863404,x0830,2.09357,active-covalent
COc1ccc(cc1OC)c2cc3nccn3c(n2)Nc4c(cccn4)C(=O)N,BRD-K53281329-300-01-5,BAY-61-3606,MedChemEx,HY-14985,BAY 61-3606 (dihydrochloride),-8.862119,x0195,4.732318,active-noncovalent
CCCn1c(=O)c2c(nc[nH]2)n(c1=O)c3ccc(cc3)Cl,BRD-K33852358-001-09-9,arofylline,Maybridge,KM09088,,-8.861078,x0195,-0.053262,active-noncovalent
c1cc2c(c(c1)N)CN(C2=O)[C@H]3CCC(=O)NC3=O,BRD-A17883755-001-06-1,lenalidomide,Selleck,S1029,Lenalidomide (CC-5013),-8.861050,x0195,-0.977063,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K41170226-001-13-8,deoxycholic-acid,Enzo,BL052,Deoxycholic acid,-8.860939,x0072,2.941604,active-noncovalent
c1cc2c(cc1Cl)c3c([nH]2)[C@@H](CCC3)C(=O)N,BRD-A73908300-001-09-1,EX-527,Selleck,S1541,EX 527,-8.860684,x0195,-0.159686,active-noncovalent
c1cc2c(cc1Cl)c3c([nH]2)[C@@H](CCC3)C(=O)N,BRD-A73908300-001-06-7,EX-527,Selleck,S1541,EX 527 (Selisistat),-8.860684,x0195,-0.159686,active-noncovalent
Cc1cccc(c1)C#C[C@@]2(CCC[C@@H]3[C@H]2CCN3C(=O)OC)O,BRD-K07790550-001-01-6,mavoglurant,MedChemEx,HY-15257,Mavoglurant,-8.860550,x0161,1.288117,active-noncovalent
c1ccc(cc1)CCCOC(=O)N,BRD-K22009844-001-12-5,phenprobamate,Prestwick,Prestw-1776,Phenprobamate,-8.859355,x0072,-1.700154,active-noncovalent
c1ccc2c(c1)CCc3ccccc3C2[NH2+]CCCCCCC(=O)[O-],BRD-K24219278-001-01-6,amineptine,MedChemEx,HY-16044,Amineptine,-8.859223,x0072,0.864455,active-noncovalent
COc1ccn2c(c1)c(cn2)c3c(cc4c(n3)[nH]nc4NC(=O)c5ccc(cc5)F)F,BRD-K84068331-001-01-9,CW-008,Tocris,5495,CW 008,-8.857870,x0104,7.430861,active-noncovalent
c1cc(c(cc1[C@]23C[C@H]2C[NH2+]C3)Cl)Cl,BRD-A68942014-003-01-7,amitifadine,TygerSci,D40030,"1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl",-8.857072,x0749,-0.678181,active-covalent
C[NH+](C)[C@@H](CCOc1cccc2c1cccc2)c3ccccc3,BRD-K51579475-003-02-4,dapoxetine,Selleck,S1869,Dapoxetine HCl,-8.856596,x0104,-0.210228,active-noncovalent
CC[NH+](CC)CCNC(=O)c1c(/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c1=C)C,BRD-K42828737-044-12-4,sunitinib,Tocris,3768,Sunitinib malate,-8.856371,x0161,6.460259,active-noncovalent
CC[NH+](CC)CCNC(=O)c1c(/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c1=C)C,BRD-K42828737-044-09-0,sunitinib,Selleck,S1042,Sunitinib Malate,-8.856371,x0161,6.460259,active-noncovalent
CC[NH+](CC)CCNC(=O)c1c(/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c1=C)C,BRD-K42828737-001-03-3,sunitinib,MedChemEx,HY-10255A,Sunitinib,-8.856371,x0161,6.460259,active-noncovalent
CC[NH+](CC)CCNC(=O)c1c(/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c1=C)C,BRD-K42828737-044-10-8,sunitinib,Selleck,S1042,Sunitinib Malate (Sutent),-8.856371,x0161,6.460259,active-noncovalent
c1cc(cc(c1)F)c2c3c(cccn3)cc(n2)C4CCC(CC4)C(=O)[O-],BRD-K75080769-001-01-6,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",Key,EH-0718,,-8.855563,x0678,3.903285,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2([C@H](C=O)O)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,BRD-K77554836-001-13-2,triamcinolone,Selleck,S1933,Triamcinolone,-8.855529,x0749,2.859867,active-covalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2([C@H](C=O)O)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,BRD-K77554836-001-14-0,triamcinolone,MicroSource,1500586,TRIAMCINOLONE,-8.855529,x0749,2.859867,active-covalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2([C@H](C=O)O)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,BRD-K77554836-001-11-6,triamcinolone,Selleck,S1933,Triamcinolone (Aristocort),-8.855529,x0749,2.859867,active-covalent
CCCCCCc1ccc(cc1O)O,BRD-K99946902-001-07-5,hexylresorcinol,MicroSource,1500330,HEXYLRESORCINOL,-8.853708,x0749,-1.623758,active-covalent
C[C@@H]1C[N@@H+](CCN1C(=O)COc2ccc(cc2NC(=O)N)Cl)Cc3ccc(cc3)F,BRD-K91825936-001-01-2,ZK811752,MedChemEx,HY-12080,BX471,-8.853517,x0434,5.313913,active-noncovalent
C[C@@H]1C[N@@H+](CCN1C(=O)COc2ccc(cc2NC(=O)N)Cl)Cc3ccc(cc3)F,BRD-K91825936-001-02-0,ZK811752,Tocris,3496,BX 471,-8.853517,x0434,5.313913,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2ccccc2C#N)N3CCC[C@H](C3)[NH3+],BRD-K83003151-057-02-4,alogliptin,Selleck,S2868,Alogliptin??SYR-322??,-8.851970,x0830,0.791943,active-covalent
Cn1c(=O)cc(n(c1=O)Cc2ccccc2C#N)N3CCC[C@H](C3)[NH3+],BRD-K83003151-057-01-6,alogliptin,Selleck,S2868,Alogliptin,-8.851970,x0830,0.791943,active-covalent
C[C@@H]1C[C@@H](c2c1c(ncn2)N3CCN(CC3)C(=O)[C@H](C[NH2+]C(C)C)c4ccc(cc4)Cl)O,BRD-K71480163-001-01-4,GDC-0068,Selleck,S2808,GDC-0068,-8.851877,x0072,6.948008,active-noncovalent
c1c(c(c(c(c1Cl)Cl)Cc2c(c(cc(c2Cl)Cl)Cl)O)O)Cl,BRD-K99792991-001-34-9,hexachlorophene,MicroSource,1500328,HEXACHLOROPHENE,-8.850200,x0830,-0.56435,active-covalent
CC1([C@@H]([C@H](c2cc(ccc2O1)C#N)N(Cc3[nH]ccn3)c4ccc(cc4)Cl)O)C,BRD-K01231377-001-01-8,BMS-191095,MedChemEx,HY-14256,BMS-191095,-8.850122,x0678,1.407405,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCn3c(ccc3O)O,BRD-K50293352-300-02-1,MM77,Tocris,933,MM 77 dihydrochloride,-8.849784,x0195,1.639842,active-noncovalent
CC(=O)Oc1ccc2c(c1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,BRD-K53319039-001-01-8,estradiol-acetate,Sigma,MFCD00198969,"(17beta)-17-hydroxyestra-1,3,5(10)-trien-3-yl acetate",-8.849564,x0749,5.715438,active-covalent
C[C@@H](CCCC(C)(C)OC)C/C=C/C(=C/C(=O)OC(C)C)/C,BRD-K34591242-001-04-3,methoprene-(s),MicroSource,1504100,METHOPRENE (S),-8.849092,x0195,2.307668,active-noncovalent
c1ccc(cc1)C2=NO[C@H](C2)CC(=O)[O-],BRD-A32269193-001-01-5,VGX-1027,Selleck,S7515,VGX-1027,-8.847785,x0830,-0.820048,active-covalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)[S@@](=O)C,BRD-A14395271-074-18-6,mesoridazine,Selleck,S4334,mesoridazine besylate,-8.846491,x0195,1.963813,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)[S@@](=O)C,BRD-A14395271-074-17-8,mesoridazine,MicroSource,1505500,MESORIDAZINE BESYLATE,-8.846491,x0195,1.963813,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)[S@@](=O)C,BRD-A14395271-074-16-0,mesoridazine,Selleck,S4334,Mesoridazine Besylate,-8.846491,x0195,1.963813,active-noncovalent
c1cc2c(c[nH]c2nc1)C[NH+]3CCN(CC3)c4ccc(cc4)Cl,BRD-K05528470-305-02-2,L-745870,Tocris,1002,"L-745,870",-8.845886,x0161,0.611736,active-noncovalent
c1cc2c(c[nH]c2nc1)C[NH+]3CCN(CC3)c4ccc(cc4)Cl,BRD-K05528470-305-03-0,L-745870,Tocris,1002,"3-{[4-(4-chlorophenyl)-1-piperazinyl]methyl}-1H-pyrrolo[2,3-b]pyridine trihydrochloride",-8.845886,x0161,0.611736,active-noncovalent
CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,BRD-K46061689-001-01-9,desogestrel,Enzo,AC3084,DESOGESTREL,-8.845607,x0749,3.40353,active-covalent
c1ccc(cc1)C[C@@H](CN(C(=O)Cc2ccccc2)O)C(=O)[O-],BRD-A69126730-001-01-3,CPA-inhibitor,MedChemEx,HY-70005,CPA inhibitor,-8.844980,x0397,1.64194,active-noncovalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-09-5,cephalexin,Selleck,S1502,Cephalexin,-8.844219,x0830,1.592744,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-06-1,cephalexin,Sigma,MFCD00056877,"(6R,7R)-7-{[(2R)-2-amino-2-phenylethanoyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",-8.844219,x0830,1.592744,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-08-7,cephalexin,MedChemEx,HY-B0200,Cephalexin,-8.844219,x0830,1.592744,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-10-3,cephalexin,MicroSource,1502028,CEPHALEXIN,-8.844219,x0830,1.592744,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-05-3,cephalexin,Selleck,S1502,Cephalexin (Cefalexin),-8.844219,x0830,1.592744,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K90733503-001-07-9,cephalexin,MedChemEx,HY-B0200,Cephalexin,-8.844219,x0830,1.592744,active-covalent
C1CCC(CC1)C(C[C@H]2CCCC[NH2+]2)C3CCCCC3,BRD-A19633847-050-32-1,perhexiline,MicroSource,1503227,PERHEXILINE MALEATE,-8.843599,x0195,-0.394929,active-noncovalent
c1cc2cc(sc2c(c1)Cl)C(=O)N[C@H]3C[NH+]4CCC3CC4,BRD-K71603915-003-01-8,EVP-6124,MedChemEx,HY-15430A,EVP-6124 (hydrochloride),-8.843389,x0195,1.367774,active-noncovalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,BRD-K04394237-001-03-7,drospirenone,Selleck,S1377,Drospirenone,-8.842269,x0749,2.714764,active-covalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,BRD-K04394237-001-04-5,drospirenone,Selleck,S1377,Drospirenone,-8.842269,x0749,2.714764,active-covalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,BRD-K04394237-001-06-0,drospirenone,MicroSource,1503831,DROSPIRENONE,-8.842269,x0749,2.714764,active-covalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,BRD-K04394237-001-05-2,drospirenone,Selleck,S1377,Drospirenone,-8.842269,x0749,2.714764,active-covalent
Cc1nc(c(nc1c2ccc(cc2)[C@H]3CC[C@@H](CC3)CC(=O)[O-])C(=O)N)C,BRD-K31495718-001-01-1,AZD7687,MedChemEx,HY-15497,AZD7687,-8.840893,x0104,6.193023,active-noncovalent
Cn1cc(cn1)c2ccc3nnc(n3n2)C(c4ccc5c(c4)cccn5)(F)F,BRD-K02123250-001-06-7,JNJ-38877605,Selleck,S1114,JNJ-38877605,-8.840340,x0830,2.816189,active-covalent
C[N+](C)(CCOc1ccccc1)Cc2ccccc2,BRD-K47878171-086-05-2,bephenium-hydroxynaphthoate,Selleck,S4389,Bephenium Hydroxynaphthoate,-8.840194,x0678,-0.27769,active-noncovalent
C[N+](C)(CCOc1ccccc1)Cc2ccccc2,BRD-K47878171-086-07-8,bephenium-hydroxynaphthoate,Selleck,S4389,bephenium hydroxynaphthoate,-8.840194,x0678,-0.27769,active-noncovalent
C[N+](C)(CCOc1ccccc1)Cc2ccccc2,BRD-K47878171-086-06-0,bephenium-hydroxynaphthoate,MicroSource,1505778,BEPHENIUM HYDROXYNAPTHOATE,-8.840194,x0678,-0.27769,active-noncovalent
CCCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,BRD-A01636364-003-15-1,bupivacaine,MicroSource,1503818,BUPIVACAINE HYDROCHLORIDE,-8.840055,x0874,0.46808,active-noncovalent
CCCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,BRD-A01636364-003-14-4,bupivacaine,Selleck,S2454,Bupivacaine HCl,-8.840055,x0874,0.46808,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4([C@@]3([C@H](C[C@]2([C@@]1(C(=O)CO)O)C)O)Cl)C,BRD-A73385064-001-01-5,beclomethasone,AvaChem,3053,"9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one",-8.839439,x0874,4.744987,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-A03204438-001-02-0,allopregnanolone,Tocris,3653,Allopregnanolone,-8.838748,x0749,0.90839,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-A03204438-001-01-2,pregnanolone,Tocris,3652,Pregnanolone,-8.838748,x0749,0.90839,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-K18172896-001-02-5,eltanolone,Enzo,AC971,5-a-Pregnan-3-a-ol-20-one,-8.838284,x0749,2.459049,active-covalent
C=CCNC(=O)c1cc(cc2c1nc([nH]c2=O)Nc3ccc(c(c3)Cl)Cl)N(=O)=O,BRD-K36258877-001-03-1,AZ-10417808,Tocris,2172,AZ 10417808,-8.838186,x0678,4.463686,active-noncovalent
C=CCNC(=O)c1cc(cc2c1nc([nH]c2=O)Nc3ccc(c(c3)Cl)Cl)N(=O)=O,BRD-K36258877-001-04-9,AZ-10417808,Tocris,2172,AZ 10417808,-8.838186,x0678,4.463686,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1SC)O,BRD-A73566563-001-01-6,tiprenolol,Enamine,Z2301686183,1-(isopropylamino)-3-[2-(methylsulfanyl)phenoxy]-2-propanol,-8.836755,x0104,0.98096,active-noncovalent
c1cc2c(cc[nH]2)cc1C(=O)N,BRD-K91904471-001-02-4,SD-169,EMDBio,506158-10MG,"p38 MAP Kinase Inhibitor VII, SD-169",-8.835009,x0678,-1.964872,active-noncovalent
c1ccc(cc1)c2ccccc2NC(=O)CCCCCCCn3cc(nn3)c4cccnc4,BRD-K83289131-003-01-0,GPP-78,Tocris,4835,GPP 78 hydrochloride,-8.834772,x0161,6.832358,active-noncovalent
c1ccnc(c1)[C@H](c2ccc(cc2)Cl)OC3CC[NH+](CC3)CCCC(=O)[O-],BRD-K98624455-074-02-8,bepotastine,Selleck,S3037,Bepotastine Besilate,-8.834699,x0072,4.494926,active-noncovalent
Cc1c(c2cc(ccc2nc1c3ccc(cc3)c4ccccc4F)F)C(=O)[O-],BRD-K96123349-236-02-8,brequinar,EMDBio,508321-10MG,"Dihydroorotate Dehydrogenase Inhibitor, Brequinar",-8.833302,x0104,5.067075,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](c3ccccc3)O,BRD-A74975734-004-10-7,homatropine,MicroSource,1500332,HOMATROPINE HYDROBROMIDE,-8.832844,x0072,-0.029262,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](c3ccccc3)O,BRD-A74975734-004-09-9,homatropine,Selleck,S4025,Homatropine Bromide,-8.832844,x0072,-0.029262,active-noncovalent
C(CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])C[NH3+],BRD-K75527158-360-06-4,alendronate,Selleck,S1624,Alendronate (Fosamax),-8.832735,x0397,1.272709,active-noncovalent
C(CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])C[NH3+],BRD-K75527158-360-05-6,alendronate,MicroSource,1505166,ALENDRONATE SODIUM,-8.832735,x0397,1.272709,active-noncovalent
C(CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])C[NH3+],BRD-K75527158-360-04-9,alendronate,Selleck,S1624,Alendronate (Fosamax),-8.832735,x0397,1.272709,active-noncovalent
C[C@]12C[C@@H]([C@@H]3[C@H]([C@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C)O,BRD-A27887842-001-05-7,prednisolone,Selleck,S1737,Prednisolone,-8.831224,x0967,0.98472,active-noncovalent
C[C@]12C[C@@H]([C@@H]3[C@H]([C@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C)O,BRD-A27887842-001-04-0,prednisolone,MicroSource,1500496,PREDNISOLONE,-8.831224,x0967,0.98472,active-noncovalent
C[N+]1(CCC(CC1)OC(=O)C(c2ccccc2)c3ccccc3)C,BRD-K29313239-005-09-4,4-DAMP,Tocris,482,4-DAMP,-8.830452,x1093,2.355644,active-noncovalent
c1cc(sc1)CCOC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K89072800-001-01-8,2-TEDC,Tocris,645,2-TEDC,-8.830167,x0107,0.865614,active-noncovalent
c1ccc(cc1)C(=O)Oc2cccc3c2nccc3,BRD-K70327191-001-02-2,benzoxiquine,MicroSource,1505411,BENZOXIQUINE,-8.829908,x0195,0.424778,active-noncovalent
c1ccc2c(c1)-c3ccccc3C2NC(=O)NC(=O)c4c(cccc4Cl)F,BRD-K24527118-001-01-6,TMN-355,Tocris,4152,TMN 355,-8.828473,x0107,1.934091,active-noncovalent
C=C[C@H]1C[N@@H+]2CC[C@H]1C[C@@H]2[C@@H](c3ccnc4c3cccc4)O,BRD-K14693417-001-04-0,cinchonine,MicroSource,1500841,CINCHONINE,-8.828203,x0749,-0.902494,active-covalent
CCCCCCCC[N+](C)(C)Cc1ccccc1,BRD-K11576103-003-01-1,benzyldimethyloctylammonium,Sigma,689599,"N-benzyl-N,N-dimethyl-1-octanaminium chloride",-8.828173,x0161,0.241394,active-noncovalent
c1cc(c(cc1[C@H]([C@@H](C(=O)[O-])[NH3+])O)O)O,BRD-K20372197-001-03-1,droxidopa,Selleck,S3041,Droxidopa (L-DOPS),-8.827576,x0107,-1.674519,active-noncovalent
c1cc(c(cc1[C@H]([C@@H](C(=O)[O-])[NH3+])O)O)O,BRD-K20372197-001-02-3,droxidopa,Selleck,S3041,Droxidopa (L-DOPS),-8.827576,x0107,-1.674519,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,BRD-K62736196-015-13-6,guanaben-acetate,MicroSource,1500322,GUANABENZ ACETATE,-8.827070,x0195,1.445382,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,BRD-K62736196-015-10-2,guanaben-acetate,Tocris,885,Guanabenz acetate,-8.827070,x0195,1.445382,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,BRD-K62736196-015-09-4,guanaben-acetate,Selleck,S4065,Guanabenz Acetate,-8.827070,x0195,1.445382,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,BRD-K62736196-015-11-0,guanaben-acetate,Selleck,S4065,Guanabenz (WY-8678) Acetate,-8.827070,x0195,1.445382,active-noncovalent
CC(C)[NH2+][C@H]1CCn2c3c(cccc3[nH]c2=O)[C@@H]1O,BRD-K42816473-001-01-0,zilpaterol,Cayman,16484,"(6S,7S)-7-(isopropylamino)-6,7,8,9-tetrahydro-2,9a-diazabenzo[cd]azulene-1,6-diol",-8.827005,x0195,-0.261756,active-noncovalent
CCn1c2ccccc2c3c1ccc(c3)Nc4ccnc(n4)NCCC[NH+]5CCOCC5,BRD-K32289541-001-01-0,EHop-016,Selleck,S7319,EHop-016,-8.826856,x0161,4.568067,active-noncovalent
CC(=O)N1CCC(CC1)NC(=O)c2ccc(cc2)F,BRD-K80607346-001-01-1,FK-962,Enamine,Z90645000,N-(1-acetyl-4-piperidinyl)-4-fluorobenzamide,-8.826716,x0749,0.837053,active-covalent
C[NH+]1CCN(CC1)CC/C=C/2\c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,BRD-K97309399-001-09-4,thiothixene,MicroSource,1500576,THIOTHIXENE,-8.825116,x1077,4.598996,active-noncovalent
CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)[C@H](C=O)O,BRD-K99199077-001-17-9,hydrocortisone-butyrate,MicroSource,1503273,HYDROCORTISONE BUTYRATE,-8.824898,x0967,4.237735,active-noncovalent
CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)[C@H](C=O)O,BRD-K99199077-001-16-1,hydrocortisone-butyrate,Sigma,MFCD00083364,"(11beta)-11,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butyrate",-8.824898,x0967,4.237735,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)Cl)F,BRD-K16478699-001-09-2,PLX-4720,Selleck,S1152,PLX-4720,-8.823878,x1077,1.797285,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cccc(c2)O)[N@]3C[C@H]([N@@H+](C[C@@H]3C)CC=C)C,BRD-K74990253-001-02-8,BW-373U86,Tocris,1663,BW 373U86,-8.823284,x0104,4.729312,active-noncovalent
c1ccc(cc1)[C@H]2c3cc(ccc3N(C(=O)C=N2)CC(=O)NN)Br,BRD-K22588750-001-07-0,gidazepam,Enamine,Z56817662,"2-(7-bromo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl)acetohydrazide",-8.822670,x1077,0.571694,active-noncovalent
c1ccc(cc1)Oc2c(cc(cc2S(=O)(=O)N)C(=O)[O-])N3CCCC3,BRD-K87990216-001-10-2,piretanide,Prestwick,Prestw-1047,Piretanide,-8.822509,x1418,1.501692,active-covalent
CCn1cc[nH+]c1C[C@H]2COc3ccccc3O2,BRD-A10903566-003-07-7,imiloxan,Tocris,986,Imiloxan hydrochloride,-8.821628,x0749,0.855789,active-covalent
CC[C@@]1(Cc2ccccc2O1)C3=[NH+]CCN3,BRD-A10739734-003-10-6,efaroxan,MicroSource,2300218,EFAROXAN HYDROCHLORIDE,-8.821620,x0434,-0.460145,active-noncovalent
CC[C@@]1(Cc2ccccc2O1)C3=[NH+]CCN3,BRD-A10739734-003-09-8,efaroxan,Tocris,792,Efaroxan hydrochloride,-8.821620,x0434,-0.460145,active-noncovalent
CC(=[NH2+])NCCCC[C@@H](C(=O)[O-])[NH3+],BRD-K60036103-003-01-6,L-NIL,Tocris,1139,L-NIL hydrochloride,-8.821280,x1334,-2.653212,active-covalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],BRD-K48578705-001-14-3,methyldopa,Selleck,S1642,Methyldopa (Aldomet),-8.820736,x1374,-1.239203,active-covalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],BRD-K48578705-001-17-6,methyldopa,Selleck,S1642,Methyldopa (Aldomet),-8.820736,x1374,-1.239203,active-covalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],BRD-K48578705-001-16-8,methyldopa,MicroSource,1500403,METHYLDOPA,-8.820736,x1374,-1.239203,active-covalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],BRD-K48578705-001-15-0,methyldopa,Tocris,584,L-(-)-?-Methyldopa,-8.820736,x1374,-1.239203,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,BRD-K30213273-001-01-6,fenofibric-acid,MicroSource,1504414,FENOFIBRIC ACID,-8.820396,x0072,1.20917,active-noncovalent
c1cc2cccc3c2c(c1)[N@](S3(=O)=O)CCC[NH+]4CCN(CC4)c5ccc(cc5)F,BRD-K08998509-001-02-4,fananserin,Tocris,2645,Fananserin,-8.819551,x0104,5.985413,active-noncovalent
c1cc2cccc3c2c(c1)[N@](S3(=O)=O)CCC[NH+]4CCN(CC4)c5ccc(cc5)F,BRD-K08998509-001-03-2,fananserin,Tocris,2645,"2-{3-[4-(4-fluorophenyl)-1-piperazinyl]propyl}-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide",-8.819551,x0104,5.985413,active-noncovalent
c1cc(ccc1CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,BRD-A51820102-008-27-1,econazole,Selleck,S2535,Econazole nitrate,-8.819098,x0195,1.653327,active-noncovalent
c1cc(ccc1CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,BRD-A51820102-008-28-9,econazole,MicroSource,1501185,ECONAZOLE NITRATE,-8.819098,x0195,1.653327,active-noncovalent
COc1ccc(cc1)CC[NH+]2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(cc5)F,BRD-K37249724-001-24-0,astemizole,Tocris,3489,Astemizole,-8.818944,x0161,7.094078,active-noncovalent
COc1ccc(cc1)CC[NH+]2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(cc5)F,BRD-K37249724-001-28-1,astemizole,Tocris,3489,Astemizole,-8.818944,x0161,7.094078,active-noncovalent
COc1ccc(cc1)CC[NH+]2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(cc5)F,BRD-K37249724-001-25-7,astemizole,MicroSource,2300094,ASTEMIZOLE,-8.818944,x0161,7.094078,active-noncovalent
c1ccc2c(c1)nc(s2)SNC3CCCCC3,BRD-K64191834-001-03-1,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",AKSci,P933,"CBS, N-Cyclohexyl-2-benzothiazolesulfenamide",-8.818037,x1093,-0.812472,active-noncovalent
CC(C)(C(=O)N1CSC[C@@H]1C(=O)[O-])Oc2ccc(cc2)Cl,BRD-A64406146-001-01-2,timofibrate,Enamine,Z398944758,,-8.817378,x0749,0.075087,active-covalent
C[NH+]1CCN(CC1)CC(=O)N(C)c2ccc(cc2)/N=C(/c3ccccc3)\c4c5ccc(cc5[nH]c4O)C(=O)OC,BRD-K49075727-001-08-5,nintedanib,Selleck,S1010,Nintedanib (BIBF 1120),-8.815075,x0434,10.158189,active-noncovalent
C[NH+]1CCN(CC1)CC(=O)N(C)c2ccc(cc2)/N=C(/c3ccccc3)\c4c5ccc(cc5[nH]c4O)C(=O)OC,BRD-K49075727-001-09-3,nintedanib,Selleck,S1010,BIBF1120 (Vargatef),-8.815075,x0434,10.158189,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccccc1Cl)O,BRD-A29281099-003-03-2,clorprenaline,Selleck,S4135,Clorprenaline HCl,-8.815065,x0678,-1.074602,active-noncovalent
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,BRD-K50853363-001-02-3,dienogest,Selleck,S1251,Dienogest,-8.813466,x0749,2.532467,active-covalent
Cc1cccc(c1NC(=O)c2ccc(cc2)N)C,BRD-K48173020-001-01-8,ameltolide,Vitas-M,STK360030,,-8.813285,x0749,0.093103,active-covalent
CN1CC[NH+](CC1)CCc2ccc(c(c2)Cl)Cl,BRD-K29668683-300-02-2,BD-1063,Tocris,883,BD 1063 dihydrochloride,-8.813173,x1077,0.691202,active-noncovalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3F)NC(=O)c4ccc(cc4)N(=O)=O,BRD-K48371964-001-06-5,VU1545,Tocris,3325,VU 1545,-8.811732,x0104,5.754209,active-noncovalent
c1cc(nc(c1)Cl)N2CCC(CC2)[NH3+],BRD-K09397065-003-06-1,SR-57227A,Tocris,1205,SR 57227 hydrochloride,-8.811656,x0195,-1.056215,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@@H]([C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,BRD-K59632282-052-03-1,quinidine,MicroSource,1500523,QUINIDINE GLUCONATE,-8.810711,x0104,-0.022309,active-noncovalent
CCc1c(c(on1)C)c2c(c3ccccc3[nH]2)[C@H](C[NH+](C)C)O,BRD-A92448440-001-01-3,sari-59-801,Sigma,MFCD00159831,2-(dimethylamino)-1-[2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indol-3-yl]ethanol,-8.809806,x0708,-0.99439,active-covalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,BRD-K38775274-001-22-1,dexamethasone,Tocris,1126,Dexamethasone,-8.809409,x0749,3.39401,active-covalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,BRD-K38775274-001-23-9,dexamethasone,Selleck,S1322,Dexamethasone (DHAP),-8.809409,x0749,3.39401,active-covalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,BRD-K38775274-001-24-7,dexamethasone,Tocris,1126,Dexamethasone,-8.809409,x0749,3.39401,active-covalent
c1cc(nc(c1)Cl)SC2CC[NH2+]CC2,BRD-K55424922-003-03-6,anpirtoline,Tocris,703,Anpirtoline hydrochloride,-8.809197,x0195,-1.262077,active-noncovalent
c1cc(nc(c1)Cl)SC2CC[NH2+]CC2,BRD-K55424922-003-02-8,anpirtoline,Tocris,703,Anpirtoline hydrochloride,-8.809197,x0195,-1.262077,active-noncovalent
C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3cccc(c3)Br,BRD-K17702546-001-03-2,PD-168393,Selleck,S7039,PD168393,-8.808498,x0874,0.970707,active-noncovalent
CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,BRD-K41422683-001-02-2,stigmasterol,Selleck,S2361,Stigmasterol (Stigmasterin),-8.808438,x0161,6.551038,active-noncovalent
CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,BRD-K41422683-001-05-5,stigmasterol,Selleck,S2361,Stigmasterol,-8.808438,x0161,6.551038,active-noncovalent
c1ccc(cc1)CNc2c3ccccc3nc(n2)NCc4ccccc4,BRD-K59204667-001-05-6,DBeQ,Tocris,4417,DBeQ,-8.808304,x0434,2.133524,active-noncovalent
c1ccc(cc1)CNc2c3ccccc3nc(n2)NCc4ccccc4,BRD-K59204667-001-03-1,DBeQ,Selleck,S7199,DBeQ,-8.808304,x0434,2.133524,active-noncovalent
c1c(ccc(c1)NC(=O)c2oc(nn2)Nc3cc(c(cc3)F)F)[C@H]4CC[C@@H](CC4)CC(=O)[O-],BRD-K73984371-001-01-1,AZD3988,Tocris,4837,AZD 3988,-8.806720,x0104,13.372189,active-noncovalent
Cc1ccc(cc-2c(cc(c12)S(=O)(=O)[O-])C)C(C)C,BRD-K80043866-236-01-1,sodium-gualenate,AKSci,R239,,-8.805702,x0749,0.998694,active-covalent
CCCOC(c1ccccc1)(c2ccccc2)C(=O)OC3CC[NH+](CC3)C,BRD-K91244729-003-01-3,propiverine,Sigma,MFCD01672343,1-methyl-4-piperidinyl diphenyl(propoxy)acetate hydrochloride,-8.805073,x0678,2.430808,active-noncovalent
Cc1cc(cc(c1)OC[C@H]2CNC(=O)O2)C,BRD-A94709349-001-08-3,metaxalone,MicroSource,1504229,METAXALONE,-8.804835,x0749,-0.964583,active-covalent
c1ccc2c(c1)CCN([C@H]2c3ccc(cc3)C(F)(F)F)C(=O)Nc4ccc(cc4)F,BRD-A83792282-001-01-6,TC-I-2000,Tocris,4632,TC-I 2000,-8.804070,x0434,2.134635,active-noncovalent
c1cc(ccc1C(=O)c2c(cc(cc2Cl)Cn3c(c(nn3)C(=O)N)N)Cl)Cl,BRD-K68408772-001-05-4,carboxyamidotriazole,Sigma,MFCD00866325,"5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1H-1,2,3-triazole-4-carboxamide",-8.802904,x0195,3.923925,active-noncovalent
c1cc(ccc1C(=O)NCCS(=O)(=O)c2ccc(cn2)C(F)(F)F)Cl,BRD-K03155172-001-03-0,GSK3787,Tocris,3961,GSK 3787,-8.802741,x0195,2.075543,active-noncovalent
c1cc(ccc1C(=O)NCCS(=O)(=O)c2ccc(cn2)C(F)(F)F)Cl,BRD-K03155172-001-02-2,GSK3787,Selleck,S8025,GSK3787,-8.802741,x0195,2.075543,active-noncovalent
CC[NH+](CC)CC(=O)Nc1c(cccc1C)C,BRD-K52662033-003-21-2,lidocaine,MicroSource,1500689,LIDOCAINE HYDROCHLORIDE,-8.802265,x0195,-0.088574,active-noncovalent
CC[NH+](CC)CC(=O)Nc1c(cccc1C)C,BRD-K52662033-001-19-0,lidocaine,Selleck,S1357,Lidocaine,-8.802265,x0195,-0.088574,active-noncovalent
c1cc(ccc1OC[C@H](COC(=O)N)O)Cl,BRD-A39230911-001-10-2,chlorphensin-carbamate,Prestwick,Prestw-234,Chlorphensin carbamate,-8.801995,x0678,-1.240427,active-noncovalent
c1ccc2c(c1)c3c(cn2)c(=O)n([nH]3)c4ccc(cc4)Cl,BRD-K54093161-001-01-8,CGS-9896,ChemDiv,M436-0007,"2-(4-chlorophenyl)-1H-pyrazolo[4,3-c]quinolin-3(2H)-one",-8.801147,x0678,1.097131,active-noncovalent
c1cc(c(cc1Cl)Cc2cc(ccc2O)Cl)O,BRD-K62326629-001-19-0,dichlorophen,MicroSource,1500626,DICHLOROPHEN,-8.800409,x0749,-0.776575,active-covalent
c1cc(c(cc1Cl)Cc2cc(ccc2O)Cl)O,BRD-K62326629-001-20-8,dichlorophen,Sigma,MFCD00002322,"2,2'-methylenebis(4-chlorophenol)",-8.800409,x0749,-0.776575,active-covalent
Cc1ccc(cc1C)N2CC[NH+](CC2)CC[C@H]3c4ccccc4C(=O)N3,BRD-A82013137-300-01-1,PD-168568,Tocris,3529,PD 168568 dihydrochloride,-8.800306,x0161,3.475559,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K57275767-001-02-4,geniposide,Selleck,S2411,Geniposide,-8.799407,x0678,1.23134,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,BRD-K57275767-001-03-2,geniposide,Selleck,S2411,Geniposide,-8.799407,x0678,1.23134,active-noncovalent
CCC[NH+](CCC)C1Cc2cc(c(cc2C1)OC)OC,BRD-K70281171-050-08-9,U-99194,Tocris,1357,U 99194 maleate,-8.798027,x0104,-0.113541,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2,BRD-K04725460-001-11-3,anthralin,MedChemEx,HY-B0738,Dithranol,-8.798023,x0749,0.55111,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2,BRD-K04725460-001-12-1,anthralin,MedChemEx,HY-B0738,Dithranol,-8.798023,x0749,0.55111,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2,BRD-K04725460-001-10-5,anthralin,MicroSource,1500127,ANTHRALIN,-8.798023,x0749,0.55111,active-covalent
Cc1ccc(cc1)S(=O)(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)OC,BRD-K72231366-001-02-3,TAME,Selleck,S2225,TAME,-8.797956,x0195,1.219227,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F,BRD-K24255045-001-05-3,fluoxymesterone,Enzo,AC2315,Fluoxymesterone,-8.796730,x1077,3.533959,active-noncovalent
Cc1cccc(c1)COc2cccc(c2)/C=C/3\C(=O)NN(C3=O)c4ccccc4,BRD-K81865756-001-01-7,Y16,MedChemEx,HY-12649,Y16,-8.796130,x0161,3.727686,active-noncovalent
Cc1cccc(c1)COc2cccc(c2)/C=C/3\C(=O)NN(C3=O)c4ccccc4,BRD-K81865756-001-02-5,Y16,MedChemEx,HY-12649,Y16,-8.796130,x0161,3.727686,active-noncovalent
CCOC(=O)Nc1[nH]c2ccccc2n1,BRD-K15834839-001-02-3,lobendazole,MicroSource,1505440,LOBENDAZOLE,-8.795105,x0678,0.036746,active-noncovalent
CSc1[nH]c2cc(c(cc2n1)Oc3cccc(c3Cl)Cl)Cl,BRD-K81916719-001-14-7,triclabendazole,MicroSource,1505786,TRICLABENDAZOLE,-8.794949,x0195,-0.556406,active-noncovalent
CSc1[nH]c2cc(c(cc2n1)Oc3cccc(c3Cl)Cl)Cl,BRD-K81916719-001-13-9,triclabendazole,Selleck,S4114,Triclabendazole,-8.794949,x0195,-0.556406,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCC(=O)OC)O,BRD-A07395371-003-10-0,esmolol,Selleck,S4100,Esmolol HCl,-8.792412,x0104,0.966848,active-noncovalent
c1cc2c(cc1F)CC[C@H](O2)[C@@H](C[NH2+]C[C@H]([C@@H]3CCc4cc(ccc4O3)F)O)O,BRD-A53597562-003-01-2,nebivolol,MicroSource,1505493,NEBIVOLOL HYDROCHLORIDE,-8.791855,x0946,2.687593,active-noncovalent
Cc1cc(nn1c2ccc3ccccc3c2)OCC[NH+]4CCOCC4,BRD-K26325692-003-01-3,API-001,MedChemEx,HY-18099A,S1RA (hydrochloride),-8.789864,x0161,2.704603,active-noncovalent
CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)N(=O)=O)C,BRD-K23566484-001-14-4,nilutamide,Tocris,1759,Nilutamide,-8.789750,x0195,1.597108,active-noncovalent
CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)N(=O)=O)C,BRD-K23566484-001-15-1,nilutamide,MicroSource,1504152,NILUTAMIDE,-8.789750,x0195,1.597108,active-noncovalent
c1ccc(cc1)C[N@H+]2CN(C(=S)SC2)Cc3ccccc3,BRD-K72384124-001-08-0,sulbentine,MicroSource,1506106,SULBENTINE,-8.788582,x0749,0.405377,active-covalent
CC[NH+](CC)CCCCN1c2ccccc2Oc3c1cc(cc3)Cl,BRD-K70792160-003-06-1,10-DEBC,Tocris,2558,10-DEBC hydrochloride,-8.788382,x0946,1.545047,active-noncovalent
CC[NH+](CC)CCCCN1c2ccccc2Oc3c1cc(cc3)Cl,BRD-K70792160-003-04-6,10-DEBC,Tocris,2558,10-DEBC hydrochloride,-8.788382,x0946,1.545047,active-noncovalent
c1c(c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C#N,BRD-K26420709-001-01-7,toyocamycin,Sigma,T3580,"4-amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile",-8.788263,x0195,1.362155,active-noncovalent
c1ccc(cc1)/C(=[NH+]/Nc2ccccc2)/N,BRD-K91874254-001-01-4,CBS-1114,Vitas-M,STL483463,N'-phenylbenzimidohydrazide,-8.788101,x0749,0.002299,active-covalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,BRD-K90027355-001-20-8,spironolactone,Selleck,S4054,Spironolactone,-8.788033,x1077,2.959986,active-noncovalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,BRD-K90027355-001-19-0,spironolactone,MicroSource,1500539,SPIRONOLACTONE,-8.788033,x1077,2.959986,active-noncovalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,BRD-K90027355-001-16-6,spironolactone,Tocris,2968,Spironolactone,-8.788033,x1077,2.959986,active-noncovalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,BRD-K90027355-001-13-3,spironolactone,Selleck,S4054,spironolactone,-8.788033,x1077,2.959986,active-noncovalent
Cc1cc(ccc1NC(=O)[C@H](CCCC[NH3+])[NH3+])c2nc3cc(ccc3s2)F,BRD-K74558903-300-01-5,phortress,Key,GS-1302,"(S)-2,6-diamino-N-(4-(5-fluorobenzo[d]thiazol-2-yl)-2-methylphenyl)hexanamide dihydrochloride",-8.787956,x0104,6.846365,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2nc(c(s2)c3ccc(cc3)OC)c4ccc(cc4)OC,BRD-K30990140-003-02-4,FR-122047,Tocris,1507,FR 122047 hydrochloride,-8.787952,x1093,6.299199,active-noncovalent
Cc1c(c([nH]c1c2ccccc2F)N)C#N,BRD-K22667752-001-01-3,NS-8,Enamine,Z2306534448,2-amino-5-(2-fluorophenyl)-4-methyl-1H-pyrrole-3-carbonitrile,-8.787875,x0195,-1.729226,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])NC(=O)c2c(c3ccc(cc3s2)F)Cl,BRD-K58234744-001-01-0,CU-CPT-4a,Tocris,4883,CU CPT 4a,-8.787411,x0749,1.813917,active-covalent
CN([C@H](C[NH+]1CCCC1)c2ccccc2)C(=O)Cc3ccccc3,BRD-K93806173-003-01-8,N-MPPP,Tocris,783,N-MPPP Hydrochloride,-8.785964,x0967,1.602606,active-noncovalent
COc1cc(cc(c1OC)OC)c2cc(cnc2N)c3cccc(c3)O,BRD-K58568447-001-03-7,K02288,MedChemEx,HY-12278,K02288,-8.785391,x0104,2.694626,active-noncovalent
COc1cc(cc(c1OC)OC)c2cc(cnc2N)c3cccc(c3)O,BRD-K58568447-001-01-1,K02288,Selleck,S7359,K02288,-8.785391,x0104,2.694626,active-noncovalent
COc1cc(cc(c1OC)OC)c2cc(cnc2N)c3cccc(c3)O,BRD-K58568447-001-02-9,K02288,Tocris,4986,K 02288,-8.785391,x0104,2.694626,active-noncovalent
C[NH+](C)CCCSc1ccccc1NC(=O)/C=C/c2ccccc2,BRD-K40901640-003-01-6,cinanserin,Tocris,460,Cinanserin hydrochloride,-8.784956,x0161,2.539949,active-noncovalent
CC(C)[NH+](CC[C@H](c1ccccc1)c2cc(ccc2O)CO)C(C)C,BRD-K24603946-001-03-9,5-hydroxymethyl-tolterodine,Selleck,S2659,5-hydroxymethyl tolterodine (PNU 200577),-8.784799,x0195,0.705244,active-noncovalent
CC(C)[NH+](CC[C@H](c1ccccc1)c2cc(ccc2O)CO)C(C)C,BRD-K24603946-001-02-1,5-hydroxymethyl-tolterodine,Selleck,S2659,"5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)",-8.784799,x0195,0.705244,active-noncovalent
c1ccc2c(c1)CCC[C@H]2C3=[NH+]CCN3,BRD-A28856712-003-26-0,tetrahydrozoline,MicroSource,1500567,TETRAHYDROZOLINE HYDROCHLORIDE,-8.784272,x0678,0.000347,active-noncovalent
c1ccc2c(c1)CCC[C@H]2C3=[NH+]CCN3,BRD-A28856712-003-25-2,tetrahydrozoline,Selleck,S4043,Tetrahydrozoline HCl,-8.784272,x0678,0.000347,active-noncovalent
COc1cc(ccc1OCc2ccccc2)CN(CC[NH3+])C(=O)c3cccs3,BRD-K90410034-003-01-1,M8-B,Tocris,5324,M8 B hydrochloride,-8.782948,x0104,3.239523,active-noncovalent
CCCc1ncc(c(n1)N)C[n+]2ccccc2C,BRD-K90027121-003-01-7,amprolium,MicroSource,1500124,AMPROLIUM,-8.782370,x1093,-0.590561,active-noncovalent
CCCc1ncc(c(n1)N)C[n+]2ccccc2C,BRD-K90027121-300-13-2,amprolium,Selleck,S4144,Amprolium HCl,-8.782370,x1093,-0.590561,active-noncovalent
c1c2c([nH]c(=O)[nH]c2=O)n[nH]1,BRD-K31841515-001-07-8,oxypurinol,AlfaAesar,L07160,,-8.781333,x0678,-1.67569,active-noncovalent
c1ccc(cc1)[C@@H]2CC(=O)N(C2)CC(=O)N,BRD-A65683612-001-07-7,phenylpiracetam,MedChemEx,HY-14840,Phenylpiracetam,-8.780479,x0749,-1.067305,active-covalent
c1ccc2c(c1)C(=O)C(=C(C2=O)SCCO)SCCO,BRD-K68143200-001-11-7,NSC-95397,Tocris,1547,NSC 95397,-8.780443,x0749,-0.227705,active-covalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cccc3,BRD-K06980535-003-25-9,promazine,MicroSource,1500509,PROMAZINE HYDROCHLORIDE,-8.780368,x0874,0.204028,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cccc3,BRD-K06980535-003-26-7,promazine,MedChemEx,HY-B1225,Promazine (hydrochloride),-8.780368,x0874,0.204028,active-noncovalent
c1c(cc(c(c1)Cl)Cl)/C=C/c2c(cc(c(c2)/C=C/c3cc(c(cc3)Cl)Cl)N(=O)=O)N(=O)=O,BRD-K61120504-001-01-6,NSC636819,Tocris,5287,NSC636819,-8.780025,x0104,11.183039,active-noncovalent
CC(C)(C)c1cc(no1)C(=O)[C@H](C#N)/N=N/c2cccc(c2)Cl,BRD-K77139516-001-01-4,ESI-09,MedChemEx,HY-16704,ESI-09,-8.779360,x0195,2.072122,active-noncovalent
CC(C)(C)c1cc(no1)C(=O)[C@H](C#N)/N=N/c2cccc(c2)Cl,BRD-K77139516-001-02-2,ESI-09,Tocris,4773,ESI 09,-8.779360,x0195,2.072122,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1CC=C)O,BRD-A00993607-003-24-6,alprenolol,MicroSource,2300166,ALPRENOLOL,-8.778784,x0678,0.559812,active-noncovalent
Cn1cc(c2c1ncnc2N)c3ccc4c(c3)CCN4C(=O)Cc5cccc(c5)C(F)(F)F,BRD-K81689258-001-04-8,GSK2606414,MedChemEx,HY-18072,GSK2606414,-8.778352,x0104,8.782625,active-noncovalent
Cn1cc(c2c1ncnc2N)c3ccc4c(c3)CCN4C(=O)Cc5cccc(c5)C(F)(F)F,BRD-K81689258-001-03-0,GSK2606414,Tocris,5107,GSK 2606414,-8.778352,x0104,8.782625,active-noncovalent
Cn1cc(c2c1ncnc2N)c3ccc4c(c3)CCN4C(=O)Cc5cccc(c5)C(F)(F)F,BRD-K81689258-001-02-2,GSK2606414,MedChemEx,HY-18072,GSK2606414,-8.778352,x0104,8.782625,active-noncovalent
COc1c(ccc(c1)/C=C\2/C(=O)/C(=C/c3cc(c(cc3)O)OC)/CCC2)O,BRD-K59866480-001-08-1,cyclovalone,Enamine,Z46041679,,-8.778154,x1077,5.354759,active-noncovalent
COc1c(ccc(c1)/C=C\2/C(=O)/C(=C/c3cc(c(cc3)O)OC)/CCC2)O,BRD-K59866480-001-07-3,cyclovalone,Sigma,MFCD00019515,"(2E,6E)-2,6-bis(4-hydroxy-3-methoxybenzylidene)cyclohexanone",-8.778154,x1077,5.354759,active-noncovalent
Cc1ccc(cc1)c2ccc(cc2COc3ccc(cc3)CCC(=O)[O-])F,BRD-K24282351-001-01-4,TUG-891,Tocris,4601,TUG 891,-8.776892,x0072,3.81651,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)Cc2ccccc2,BRD-K80315159-051-02-0,DPPE,Tocris,743,DPPE fumarate,-8.776731,x1077,2.34347,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2ccc(cc2)Cl)c3cccc(n3)N4CCCC4,BRD-K33502629-001-01-0,PSNCBAM-1,Tocris,5321,PSNCBAM-1,-8.776020,x0161,5.691302,active-noncovalent
Cc1ccc(c(c1)OC[C@H](C[NH2+]C(C)(C)C)O)Cl,BRD-A48420483-001-02-3,bupranolol,Enamine,Z1650184751,1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)-2-propanol,-8.774725,x0195,0.098814,active-noncovalent
Cc1ccc(c(c1)OC[C@H](C[NH2+]C(C)(C)C)O)Cl,BRD-A48420483-001-01-5,bupranolol,Enamine,Z1497043450,,-8.774725,x0195,0.098814,active-noncovalent
CC/C(=C(\c1ccc(cc1)O)/c2ccc(cc2)OCC[NH2+]C)/c3ccccc3,BRD-K62752296-003-02-1,endoxifen,Selleck,S7839,Endoxifen HCl,-8.774714,x0072,2.713279,active-noncovalent
CC/C(=C(\c1ccc(cc1)O)/c2ccc(cc2)OCC[NH2+]C)/c3ccccc3,BRD-K62752296-003-01-3,endoxifen,MedChemEx,HY-18719A,Endoxifen (hydrochloride),-8.774714,x0072,2.713279,active-noncovalent
C#Cc1cccc(c1)Nc2c3cc4c(cc3ncn2)OCCOCCOCCO4,BRD-K31698212-001-02-9,icotinib,Selleck,S2922,Icotinib,-8.774289,x0946,7.89668,active-noncovalent
C[C@@]12c3ccccc3C[C@@H]([NH2+]1)c4c2cccc4,BRD-K58930050-050-16-6,dizocilpine-(+),Tocris,924,(+)-MK 801 maleate,-8.773538,x0072,-0.583416,active-noncovalent
C[C@@]12c3ccccc3C[C@@H]([NH2+]1)c4c2cccc4,BRD-K58930050-001-05-2,dizocilpine-(+),Selleck,S2857,MK-801 (Dizocilpine),-8.773538,x0072,-0.583416,active-noncovalent
C[C@@]12c3ccccc3C[C@@H]([NH2+]1)c4c2cccc4,BRD-K58930050-050-15-8,dizocilpine-(+),Tocris,924,(+)-MK 801 maleate,-8.773538,x0072,-0.583416,active-noncovalent
c1cc2c(cc1C(=O)N3CCCCC3)nccn2,BRD-K24771047-001-01-6,ampalex,MedChemEx,HY-10933,Ampalex,-8.773388,x0072,-0.371522,active-noncovalent
C(CCCCC(=O)[O-])CCCC(=O)[O-],BRD-K66672047-304-01-3,disodium sebacate,Sigma,MFCD00070501,disodium sebacate,-8.772362,x0678,-0.456675,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2=O,BRD-K59284035-001-07-9,chrysophanic-acid,Selleck,S2406,Chrysophanic Acid,-8.770328,x0195,-0.285665,active-noncovalent
c1ccc(cc1)NC(=O)c2ccccc2O,BRD-K83036479-001-09-2,salicylanilide,MicroSource,300618,SALICYLANILIDE,-8.769087,x0749,-1.152854,active-covalent
c1ccc(cc1)NC(=O)c2ccccc2O,BRD-K83036479-001-08-4,salicylanilide,Selleck,S4187,Salicylanilide,-8.769087,x0749,-1.152854,active-covalent
CCC(=O)N[C@@H]1CCc2cccc(c2C1)OC,BRD-A07232941-001-03-5,8-M-PDOT,Tocris,1035,8-M-PDOT,-8.766774,x0195,-0.666067,active-noncovalent
CCC(=O)N[C@@H]1CCc2cccc(c2C1)OC,BRD-A07232941-001-02-7,8-M-PDOT,Tocris,1035,8-M-PDOT,-8.766774,x0195,-0.666067,active-noncovalent
Cc1ccc(cc1)c2csc3c2c(ncn3)SCCC(=O)[O-],BRD-K64852730-001-01-7,TTP-22,Tocris,4432,TTP 22,-8.766476,x1077,1.07723,active-noncovalent
[H]/N=C\1/[C@H]([C@@H](c2c(n[nH]c2O1)c3ccc4ccccc4c3)c5cc(ccc5OC)OC)C#N,BRD-A67036568-001-01-3,RBC8,MedChemEx,HY-12873,RBC8,-8.766175,x0749,3.325971,active-covalent
[H]/N=C\1/[C@H]([C@@H](c2c(n[nH]c2O1)c3ccc4ccccc4c3)c5cc(ccc5OC)OC)C#N,BRD-A67036568-001-03-9,RBC8,MedChemEx,HY-12873,RBC8,-8.766175,x0749,3.325971,active-covalent
[H]/N=C\1/[C@H]([C@@H](c2c(n[nH]c2O1)c3ccc4ccccc4c3)c5cc(ccc5OC)OC)C#N,BRD-A67036568-001-02-1,RBC8,Tocris,5411,RBC8,-8.766175,x0749,3.325971,active-covalent
Cc1c(oc(=O)o1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4,BRD-K59045783-001-01-1,faropenem-medoxomil,MedChemEx,HY-10004,Faropenem daloxate,-8.765807,x0195,2.487131,active-noncovalent
Cc1c(oc(=O)o1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4,BRD-K59045783-001-02-9,faropenem-medoxomil,MedChemEx,HY-10004,Faropenem daloxate,-8.765807,x0195,2.487131,active-noncovalent
Cc1c(oc(=O)o1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4,BRD-K59045783-001-03-7,faropenem-medoxomil,MedChemEx,HY-10004,Faropenem daloxate,-8.765807,x0195,2.487131,active-noncovalent
C=C1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,BRD-A72767275-003-01-6,nalmefene,Selleck,S4341,Nalmefene HCl,-8.765310,x1077,1.596405,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,BRD-K82795137-001-25-4,loratadine,Tocris,1944,Loratidine,-8.764781,x0195,1.791384,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,BRD-K82795137-001-26-2,loratadine,MicroSource,1503712,LORATADINE,-8.764781,x0195,1.791384,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,BRD-K82795137-001-28-8,loratadine,Tocris,1944,Loratidine,-8.764781,x0195,1.791384,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,BRD-K82795137-001-24-7,loratadine,Selleck,S1358,Loratadine,-8.764781,x0195,1.791384,active-noncovalent
c1ccc2c(c1)C(=C(C2=O)c3ccc(cc3)Br)[O-],BRD-K50490982-001-08-2,bromindione,MicroSource,1505414,BROMINDIONE,-8.763946,x0195,2.334862,active-noncovalent
c1ccc(cc1)CNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K47105409-001-15-2,AG-490,Selleck,S1143,AG-490,-8.763856,x0678,1.367,active-noncovalent
c1ccc(cc1)CNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K47105409-001-14-5,AG-490,Tocris,414,AG 490,-8.763856,x0678,1.367,active-noncovalent
c1ccc(cc1)CNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K47105409-001-13-7,AG-490,Selleck,S1143,AG-490 (Tyrphostin B42),-8.763856,x0678,1.367,active-noncovalent
Cc1c(c(on1)C)c2ccc(c(c2)O[C@H]3CC[NH2+]C3)c4cc(c(s4)NC(=O)N)C(=O)N,BRD-K14287049-001-01-3,AZD3264,MedChemEx,HY-19362,AZD3264,-8.763084,x1077,4.858588,active-noncovalent
C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(=O)[O-],BRD-K26341917-001-01-3,L-ergothioneine,Enzo,FR111,Ergothioneine,-8.761266,x0678,-1.49538,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO,BRD-K64874225-001-04-7,NSC-4644,Enzo,NP030,Betulin,-8.761217,x0104,3.601765,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(c5ccoc5)O)O)C)O,BRD-K11672787-001-01-5,rostafuroxine,MedChemEx,HY-12283,Rostafuroxin,-8.760906,x0678,1.965369,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(c5ccoc5)O)O)C)O,BRD-K11672787-001-02-3,rostafuroxine,Tocris,5315,Rostafuroxin,-8.760906,x0678,1.965369,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC=C(C4)N=O)C)C,BRD-K18210059-001-02-6,olesoxime,MedChemEx,HY-14796,TRO 19622,-8.759113,x0161,3.46135,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC=C(C4)N=O)C)C,BRD-K18210059-001-01-8,olesoxime,MedChemEx,HY-14796,TRO 19622,-8.759113,x0161,3.46135,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC=C(C4)N=O)C)C,BRD-A33931310-001-02-5,olesoxime,MedChemEx,HY-14796,TRO 19622,-8.759113,x0161,3.46135,active-noncovalent
C1CCC(CC1)COc2c(c(nc(n2)N)N)N=O,BRD-K03294269-001-08-0,NU6027,Selleck,S7114,NU6027,-8.758625,x0749,-0.64228,active-covalent
COc1ccc2cc(ccc2c1)OCC3(CN(C3)C(=O)c4ccc(cc4)F)C(=O)[O-],BRD-K54871792-001-01-4,PF-04418948,Selleck,S7211,PF-04418948,-8.758461,x0678,4.816051,active-noncovalent
COc1ccc2cc(ccc2c1)OCC3(CN(C3)C(=O)c4ccc(cc4)F)C(=O)[O-],BRD-K54871792-001-02-2,PF-04418948,Tocris,4818,PF 04418948,-8.758461,x0678,4.816051,active-noncovalent
c1cc(cc(c1)S(=O)(=O)N2CCCCCC2)C(=O)Nc3cccc(c3)Br,BRD-K09143580-001-01-0,AK-7,Tocris,4754,AK 7,-8.757119,x0195,3.867389,active-noncovalent
CCC[N@@H+]1C[C@H](C[C@H]2[C@H]1Cc3cccc(c3C2)O)NS(=O)(=O)N(CC)CC,BRD-K02995728-003-01-9,quinagolide,MedChemEx,HY-13736A,Quinagolide (hydrochloride),-8.756313,x0104,2.326713,active-noncovalent
C[N@@]1c2cc(c(cc2C[C@H]1S(=O)(=O)[O-])/N=N/C(=O)N)O,BRD-A11070335-236-02-1,carbazochrome,Selleck,S3000,Carbazochrome sodium sulfonate (AC-17),-8.756147,x0749,1.939627,active-covalent
C[C@@H]([C@@H](Cc1ccc(cc1)Cl)c2cccc(c2)C#N)NC(=O)C(C)(C)Oc3ccc(cn3)C(F)(F)F,BRD-K35169477-001-01-9,taranabant,MedChemEx,HY-10013,Taranabant,-8.755572,x0434,6.273441,active-noncovalent
Cc1ccc(cc1)n2c(=O)n(c(=O)s2)Cc3ccc(cc3)F,BRD-K08893438-001-06-4,CCG-50014,Tocris,4567,CCG 50014,-8.755327,x0195,1.606938,active-noncovalent
Cc1ccc(cc1)n2c(=O)n(c(=O)s2)Cc3ccc(cc3)F,BRD-K08893438-001-04-9,CCG-50014,Selleck,S2901,CCG 50014,-8.755327,x0195,1.606938,active-noncovalent
Cc1ccc(cc1)n2c(=O)n(c(=O)s2)Cc3ccc(cc3)F,BRD-K08893438-001-03-1,CCG-50014,Selleck,S2901,CCG 50014,-8.755327,x0195,1.606938,active-noncovalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@H](c3ccc(cc3)O)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-A56858165-001-04-4,cefadroxil,MicroSource,1500163,CEFADROXIL,-8.755247,x0830,1.117408,active-covalent
c1cc(cc2c1cc3ccc(cc3n2)N)N,BRD-K68408467-065-01-8,proflavine-hemisulfate,MicroSource,1504305,PROFLAVINE HEMISULFATE,-8.755239,x0749,-0.479703,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c3c(c(=O)c(cn3C4CC4)C(=O)[O-])c(c2F)F)F,BRD-K63001556-001-09-6,orbifloxacin,Selleck,S4150,Orbifloxacin,-8.754795,x0195,5.179079,active-noncovalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c3c(c(=O)c(cn3C4CC4)C(=O)[O-])c(c2F)F)F,BRD-K63001556-001-10-4,orbifloxacin,Selleck,S4150,Orbifloxacin,-8.754795,x0195,5.179079,active-noncovalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c3c(c(=O)c(cn3C4CC4)C(=O)[O-])c(c2F)F)F,BRD-K63001556-001-08-8,orbifloxacin,MicroSource,1503711,ORBIFLOXACIN,-8.754795,x0195,5.179079,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N,BRD-K71799949-001-38-0,carbamazepine,Tocris,4098,Carbamazepine,-8.754364,x0072,-0.327043,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N,BRD-K71799949-001-35-6,carbamazepine,Selleck,S1693,Carbamazepine,-8.754364,x0072,-0.327043,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N,BRD-K71799949-001-36-4,carbamazepine,MicroSource,1500159,CARBAMAZEPINE,-8.754364,x0072,-0.327043,active-noncovalent
CCC[N@@H+]1CCC[C@H]2[C@H]1Cc3cnc(nc3C2)N,BRD-K13261168-300-01-0,quinelorane,Enzo,AC756,"LY-163,502",-8.753889,x0195,-0.497286,active-noncovalent
CC[NH+]1CCC(CC1)n2cc(nn2)CNc3cc4c(c(c3)Cl)ncc(c4Nc5ccc(c(c5)Cl)F)C#N,BRD-K49468759-001-05-9,cot-inhibitor-2,MedChemEx,HY-32018,Cot inhibitor-2,-8.752113,x0161,7.957746,active-noncovalent
CC[NH+]1CCC(CC1)n2cc(nn2)CNc3cc4c(c(c3)Cl)ncc(c4Nc5ccc(c(c5)Cl)F)C#N,BRD-K49468759-001-04-2,cot-inhibitor-2,MedChemEx,HY-32018,Cot inhibitor-2,-8.752113,x0161,7.957746,active-noncovalent
c1cnccc1c2cc(c(=O)[nH]c2)N,BRD-K45924332-001-16-8,amrinone,MicroSource,1503084,INAMRINONE,-8.751423,x1077,-1.831202,active-noncovalent
C[C@@H](C(=O)N)[NH2+]Cc1ccc(cc1)OCc2cccc(c2)F,BRD-K92613113-066-02-7,safinamide,Selleck,S1472,Safinamide Mesylate,-8.751310,x0104,3.939887,active-noncovalent
CN(c1c(nc(nc1N)c2c3cccnc3n(n2)Cc4ccccc4F)N)C(=O)OC,BRD-K84783599-001-01-0,riociguat,MedChemEx,HY-14779,Riociguat,-8.751081,x0195,5.730753,active-noncovalent
Cc1cc(nnc1NCC[NH+]2CCOCC2)c3ccccc3,BRD-K02867583-300-08-9,minaprine,MicroSource,1501120,MINAPRINE HYDROCHLORIDE,-8.750826,x0195,2.277347,active-noncovalent
CN(C)c1ccc2c(c1)sc-3cc(=[N+](C)C)ccc3n2,BRD-K54770538-003-14-6,methylene-blue,MedChemEx,HY-14536,Methylene Blue,-8.749982,x0749,3.068823,active-covalent
CC(C)C[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2CC1=O)OC)OC,BRD-K95739795-001-04-5,tetrabenazine,Tocris,2175,Tetrabenazine,-8.749743,x0104,1.310349,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])Cl,BRD-A81615860-003-01-7,fenclonine-(+/-),MicroSource,1502162,FENCLONINE (+/-),-8.749743,x0107,-1.760327,active-noncovalent
CC(C)C[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2CC1=O)OC)OC,BRD-K95739795-001-03-7,tetrabenazine,Tocris,2175,Tetrabenazine,-8.749743,x0104,1.310349,active-noncovalent
C1C[C@H]([NH2+]C1)C(=O)N[C@@H]2CCN(C2=O)CC(=O)N,BRD-K18573821-001-02-4,PAOPA,Tocris,5041,PAOPA,-8.749611,x0678,0.082509,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4([C@H]3C(=O)C[C@@]2([C@]1(C(=O)CO)O)C)C,BRD-K81190290-001-01-3,meprednisone,Selleck,S1689,Meprednisone,-8.749498,x0749,2.228997,active-covalent
CCN(C[C@@H](C)O)c1ccc(nn1)NNC(=O)OCC,BRD-A78134170-001-01-3,cadralazine,Key,KS-1435,ethyl 2-{6-[ethyl(2-hydroxypropyl)amino]-3-pyridazinyl}hydrazinecarboxylate,-8.749064,x0195,1.688944,active-noncovalent
C[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3,BRD-K98028353-001-01-0,savolitinib,MedChemEx,HY-15959,Savolitinib,-8.748552,x0678,2.571055,active-noncovalent
C[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3,BRD-K98028353-001-02-8,savolitinib,MedChemEx,HY-15959,Savolitinib,-8.748552,x0678,2.571055,active-noncovalent
c1c(c(=O)c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N,BRD-K97840621-001-01-5,API-1,Tocris,3897,API-1,-8.748464,x1334,2.470145,active-covalent
c1ccc2c(c1)[nH]c(=S)s2,BRD-K55160477-001-04-7,benzo[d]thiazole-2(3h)-thione,Ark,AK-47877,Benzo[d]thiazole-2(3H)-thione,-8.748226,x0678,-0.630897,active-noncovalent
c1cc(ccc1[NH+]=C(N)N)Cl,BRD-K39160765-003-02-9,4-chlorophenylguanidine,Tocris,442,4-Chlorophenylguanidine hydrochloride,-8.747316,x0195,-1.972678,active-noncovalent
CN1CC[NH+](CC1)C(c2ccccc2)c3ccccc3,BRD-K79501723-001-04-6,cyclizine,MicroSource,1500211,CYCLIZINE,-8.747169,x0831,-1.074764,active-covalent
CN1CC[NH+](CC1)C(c2ccccc2)c3ccccc3,BRD-K79501723-300-01-8,cyclizine,Selleck,S4139,Cyclizine 2HCl,-8.747169,x0831,-1.074764,active-covalent
CCc1cccc(c1)N(C)C(=[NH2+])Nc2cccc3c2cccc3,BRD-K63919159-003-08-8,aptiganel,Tocris,4492,Cerestat,-8.746843,x0195,-0.292062,active-noncovalent
CCc1cccc(c1)N(C)C(=[NH2+])Nc2cccc3c2cccc3,BRD-K63919159-003-07-0,aptiganel,EMDBio,504522-10MG,CNS-1102,-8.746843,x0195,-0.292062,active-noncovalent
[H]/N=C/[C@H](C#N)c1c2ccc(c(c2n(c1C(=O)OCC)C)Cl)Cl,BRD-K01673854-001-02-1,KH-CB19,MedChemEx,HY-12828,KH-CB19,-8.746327,x0749,0.339615,active-covalent
C[C@@]12CCC(=O)C=C1CC[C@H]3[C@H]2[C@H](C[C@@]4([C@H]3CC[C@@]4(C(=O)COP(=O)([O-])[O-])O)C)O,BRD-A46186775-369-02-0,hydrocortisone-phosphate,MicroSource,1500340,HYDROCORTISONE PHOSPHATE TRIETHYLAMINE,-8.746157,x0072,4.688531,active-noncovalent
CC1=C([C@H](C2=C(N1)CC(CC2=O)(C)C)c3ccc(cc3)N(=O)=O)C(=O)OC4CCCCC4,BRD-A44500574-001-02-6,FLI-06,Selleck,S7399,FLI-06,-8.745344,x0195,4.265436,active-noncovalent
CC1=C([C@H](C2=C(N1)CC(CC2=O)(C)C)c3ccc(cc3)N(=O)=O)C(=O)OC4CCCCC4,BRD-A44500574-001-03-4,FLI-06,Tocris,5172,FLI 06,-8.745344,x0195,4.265436,active-noncovalent
CC1=C([C@H](C2=C(N1)CC(CC2=O)(C)C)c3ccc(cc3)N(=O)=O)C(=O)OC4CCCCC4,BRD-A44500574-001-01-8,FLI-06,Selleck,S7399,FLI-06,-8.745344,x0195,4.265436,active-noncovalent
CCn1c2c(cc(c1=O)c3ccn[nH]3)c(nc(n2)N)C,BRD-K56291712-001-01-0,voxtalisib,MedChemEx,HY-15900,SAR245409,-8.745018,x0678,1.512442,active-noncovalent
COc1cccc(c1)Nc2c3c(ccn3ncn2)C[N@@H+]4CC[C@H]([C@@H](C4)O)[NH3+],BRD-K76239644-001-01-8,BMS-690514,MedChemEx,HY-10333,BMS-690514,-8.744752,x0161,3.741124,active-noncovalent
COc1cccc(c1)Nc2c3c(ccn3ncn2)C[N@@H+]4CC[C@H]([C@@H](C4)O)[NH3+],BRD-K76239644-001-02-6,BMS-690514,MedChemEx,HY-10333,BMS-690514,-8.744752,x0161,3.741124,active-noncovalent
c1cc(c(cc1C=C(C#N)C#N)O)O,BRD-K49657628-001-15-5,tyrphostin-AG-18,Selleck,S8009,AG 18 (Tyrphostin 23),-8.744196,x0161,-1.370338,active-noncovalent
c1cc(c(cc1C=C(C#N)C#N)O)O,BRD-K49657628-001-14-8,tyrphostin-AG-18,Tocris,493,AG 18,-8.744196,x0161,-1.370338,active-noncovalent
c1cc(c(cc1C=C(C#N)C#N)O)O,BRD-K49657628-001-13-0,tyrphostin-AG-18,Selleck,S8009,AG-18,-8.744196,x0161,-1.370338,active-noncovalent
CCCC[S@@](=N)(=O)CC[C@@H](C(=O)[O-])[NH3+],BRD-A47706533-001-02-6,buthionine-sulfoximine,Enzo,FR117,Buthionine sulfoximine,-8.744094,x0107,-0.647278,active-noncovalent
c1ccc(cc1)CC2=[NH+]CCN2,BRD-K46211610-003-25-9,tolazoline,Selleck,S4124,Tolazoline HCl,-8.743675,x0195,-1.206595,active-noncovalent
c1ccc(cc1)CC2=[NH+]CCN2,BRD-K46211610-003-26-7,tolazoline,MicroSource,1500580,TOLAZOLINE HYDROCHLORIDE,-8.743675,x0195,-1.206595,active-noncovalent
c1ccc(cc1)c2c3c(ncnc3oc2c4ccccc4)NC[C@@H]5CCCO5,BRD-K85139301-001-01-3,AIM-100,Tocris,4946,AIM 100,-8.743301,x0161,4.020223,active-noncovalent
C/C=C/[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccc(cc3)O)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K24871708-001-01-4,cefprozil,MicroSource,1505364,CEFPROZIL,-8.739992,x0830,1.379146,active-covalent
C/C=C/[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccc(cc3)O)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K24871708-002-03-8,cefprozil,Selleck,S2544,Cefprozil hydrate (Cefzil),-8.739992,x0830,1.379146,active-covalent
C/C=C/[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccc(cc3)O)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K24871708-002-02-0,cefprozil,Selleck,S2544,Cefprozil hydrate (Cefzil),-8.739992,x0830,1.379146,active-covalent
C/C=C/[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccc(cc3)O)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K24871708-002-04-6,cefprozil,MedChemEx,HY-B0458,Cefprozil (monohydrate),-8.739992,x0830,1.379146,active-covalent
c1ccc2c(c1)C(=O)C(=N2=O)c3ccccn3,BRD-K43978949-075-02-5,PIT,Tocris,1682,PIT,-8.738877,x0195,2.009977,active-noncovalent
c1ccc2c(c1)C[C@@H](c3ccccc3N2C(=O)N)O,BRD-A22642447-001-01-9,licarbazepine,Tocris,3865,Licarbazepine,-8.738460,x0072,-0.40209,active-noncovalent
c1ccc2c(c1)C[C@@H](c3ccccc3N2C(=O)N)O,BRD-A22642447-001-02-7,licarbazepine,Tocris,3865,Licarbazepine,-8.738460,x0072,-0.40209,active-noncovalent
CCOC(=O)C[NH+]1CCN(CC1)C(=O)/C=C/c2cc(c(c(c2)OC)OC)OC,BRD-K00531707-001-01-3,cinepazet,Sigma,MFCD00864685,"ethyl {4-[(2E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl]-1-piperazinyl}acetate",-8.738347,x0104,6.355675,active-noncovalent
C[N+]1(CCc2cc3c(cc2[C@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3)C,BRD-A57798559-003-02-5,bicuculline-methochloride-(-),Tocris,131,(-)-Bicuculline methochloride,-8.736514,x0195,2.966963,active-noncovalent
C[N+]1(CCc2cc3c(cc2[C@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3)C,BRD-A57798559-005-02-0,bicuculline-methochloride-(-),Tocris,2503,(-)-Bicuculline methiodide,-8.736514,x0195,2.966963,active-noncovalent
C[N+]1(CCc2cc3c(cc2[C@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3)C,BRD-A57798559-004-02-3,bicuculline-methochloride-(-),Tocris,109,(-)-Bicuculline methobromide,-8.736514,x0195,2.966963,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)N,BRD-K41406082-001-15-4,sulfapyridine,Selleck,S1617,Sulfapyridine,-8.735435,x0678,-0.617048,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)N,BRD-K41406082-001-16-2,sulfapyridine,MicroSource,1500551,SULFAPYRIDINE,-8.735435,x0678,-0.617048,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)[O-])C(C)(C)O,BRD-K83144676-001-06-1,olmesartan,MicroSource,1505206,OLMESARTAN,-8.735399,x0874,9.035728,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)[O-])C(C)(C)O,BRD-K83144676-001-07-9,olmesartan,MedChemEx,HY-17004,Olmesartan,-8.735399,x0874,9.035728,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)[O-])C(C)(C)O,BRD-K83144676-001-09-5,olmesartan,Tocris,4616,Olmesartan,-8.735399,x0874,9.035728,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)[O-])C(C)(C)O,BRD-K83144676-001-08-7,olmesartan,MedChemEx,HY-17004,Olmesartan,-8.735399,x0874,9.035728,active-noncovalent
c1ccc2c(c1)N(c3ccccc3S2)C[C@H]4C[NH+]5CCC4CC5,BRD-A67616246-001-07-9,levomequitazine,Vitas-M,STK324459,,-8.734183,x0072,0.766219,active-noncovalent
c1cc(ccc1CC2(CCN(CC2)c3c4cc[nH]c4ncn3)[NH3+])Cl,BRD-K76406695-001-02-9,CCT128930,Selleck,S2635,CCT128930,-8.732200,x0072,1.336289,active-noncovalent
CC[N@@H+](CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl)CCO,BRD-A99117172-065-05-7,hydroxychloroquine,Sigma,MFCD00078203,sulfuric acid compound with 2-[{4-[(7-chloro-4-quinolinyl)amino]pentyl}(ethyl)amino]ethanol (1:1),-8.730425,x0874,0.717831,active-noncovalent
CC[N@@H+](CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl)CCO,BRD-A99117172-065-04-0,hydroxychloroquine,MicroSource,1503978,HYDROXYCHLOROQUINE SULFATE,-8.730425,x0874,0.717831,active-noncovalent
c1cc(c(cc1/C=C(\C#N)/C(=O)N)O)O,BRD-K60184833-001-05-6,tyrphostin-AG-99,Tocris,497,AG 99,-8.730337,x0678,0.309901,active-noncovalent
Cc1c2c(ccn1)c3ccccc3[nH]2,BRD-K12630395-001-14-9,harmane,Tocris,1132,Harmane hydrochloride,-8.729801,x0195,-3.023064,active-noncovalent
Cc1cccc(c1NC(=O)c2ccccc2C(=O)[O-])C,BRD-K05724540-001-08-5,ftaxilide,MicroSource,1504523,FTAXILIDE,-8.728564,x0678,0.017777,active-noncovalent
C/C/1=C\CC/C(=C/[C@@H]2[C@@H](CC1)C(=C)C(=O)O2)/C,BRD-K26833429-001-04-4,costunolide,Selleck,S1319,Costunolide,-8.727715,x0195,0.126018,active-noncovalent
C/C/1=C\CC/C(=C/[C@@H]2[C@@H](CC1)C(=C)C(=O)O2)/C,BRD-K26833429-001-02-8,costunolide,Selleck,S1319,Costunolide,-8.727715,x0195,0.126018,active-noncovalent
C/C/1=C\CC/C(=C/[C@@H]2[C@@H](CC1)C(=C)C(=O)O2)/C,BRD-K26833429-001-03-6,costunolide,Tocris,2483,Costunolide,-8.727715,x0195,0.126018,active-noncovalent
C[C@@H]1CC[C@H]([C@H](C1)P(=O)(c2ccccc2)c3ccccc3)C(C)C,BRD-K99922388-001-02-0,DPO-1,Tocris,2533,DPO-1,-8.727564,x0692,1.273816,active-covalent
c1cc(c(cc1C[NH+]2CCC(CC2)Nc3ccc(nn3)C(F)(F)F)F)F,BRD-K31802667-001-01-9,JNJ-37822681,Enamine,Z1558691527,"N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine",-8.727447,x0434,3.791713,active-noncovalent
Cc1c(c(c2c(c1O)[C@@]3(C(=CC(=O)/C(=C(/C)\[O-])/C3=O)O2)C)C(=O)C)O,BRD-A12417644-001-06-8,usniacin-(+),Selleck,S2252,(+)-Usniacin,-8.726668,x0749,-0.318375,active-covalent
Cc1c(c(c2c(c1O)[C@@]3(C(=CC(=O)/C(=C(/C)\[O-])/C3=O)O2)C)C(=O)C)O,BRD-A12417644-001-07-6,usniacin-(+),Selleck,S2252,(+)-Usniacin (D-Usnic acid),-8.726668,x0749,-0.318375,active-covalent
B([C@@H]1CCCN1C(=O)[C@H](C(C)C)[NH3+])(O)O,BRD-K37419961-066-01-2,talabostat,MedChemEx,HY-13233A,Talabostat (mesylate),-8.725707,x0104,-0.521591,active-noncovalent
B([C@@H]1CCCN1C(=O)[C@H](C(C)C)[NH3+])(O)O,BRD-K37419961-066-02-0,talabostat,MedChemEx,HY-13233A,Talabostat (mesylate),-8.725707,x0104,-0.521591,active-noncovalent
B([C@@H]1CCCN1C(=O)[C@H](C(C)C)[NH3+])(O)O,BRD-K37419961-066-03-8,talabostat,MedChemEx,HY-13233A,Talabostat (mesylate),-8.725707,x0104,-0.521591,active-noncovalent
C[N@@H+]1CCc2cc3c(cc2[C@H]1O)OCO3,BRD-A57900429-003-05-8,hydrastinine,Selleck,S4369,Hydrastinine HCl,-8.725490,x0195,0.412002,active-noncovalent
C[N@@H+]1CCc2cc3c(cc2[C@H]1O)OCO3,BRD-A57900429-003-06-6,hydrastinine,MicroSource,310006,HYDRASTININE HYDROCHLORIDE,-8.725490,x0195,0.412002,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)NC(=O)[C@@H]5CCC[NH2+]5,BRD-K04266228-001-04-6,XL019,MedChemEx,HY-13775,XL019,-8.724927,x0678,13.704362,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)NC(=O)[C@@H]5CCC[NH2+]5,BRD-K04266228-001-02-0,XL019,Selleck,S7036,XL019,-8.724927,x0678,13.704362,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)NC(=O)[C@@H]5CCC[NH2+]5,BRD-K04266228-001-03-8,XL019,Selleck,S7036,XL019,-8.724927,x0678,13.704362,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)NC(=O)[C@@H]5CCC[NH2+]5,BRD-K04266228-001-05-3,XL019,MedChemEx,HY-13775,XL019,-8.724927,x0678,13.704362,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-A02759312-003-25-2,betaxolol,MicroSource,1505512,BETAXALOL HYDROCHLORIDE,-8.723422,x0104,1.943833,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-A02759312-003-23-7,betaxolol,Selleck,S1827,Betaxolol hydrochloride (Betoptic),-8.723422,x0104,1.943833,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-A02759312-003-24-5,betaxolol,Tocris,906,Betaxolol hydrochloride,-8.723422,x0104,1.943833,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-A02759312-001-03-3,betaxolol,Selleck,S2091,Betaxolol (Betoptic),-8.723422,x0104,1.943833,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-A02759312-001-02-5,betaxolol,Selleck,S2091,Betaxolol,-8.723422,x0104,1.943833,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,BRD-K43883465-003-01-5,levobetaxolol,Selleck,S4085,Levobetaxolol HCl,-8.723422,x0104,1.943833,active-noncovalent
CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC[NH+](C)C,BRD-K50938287-036-13-8,sumatriptan,Tocris,3586,Sumatriptan succinate,-8.722964,x0072,-0.018803,active-noncovalent
CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC[NH+](C)C,BRD-K50938287-036-16-1,sumatriptan,Tocris,3586,Sumatriptan succinate,-8.722964,x0072,-0.018803,active-noncovalent
CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC[NH+](C)C,BRD-K50938287-036-12-0,sumatriptan,Selleck,S1432,Sumatriptan Succinate,-8.722964,x0072,-0.018803,active-noncovalent
CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC[NH+](C)C,BRD-K50938287-001-09-0,sumatriptan,MicroSource,1505372,SUMATRIPTAN,-8.722964,x0072,-0.018803,active-noncovalent
c1ccnc(c1)CCNC(=S)Nc2ccc(cn2)Br,BRD-K00989047-001-01-2,trovirdine,MedChemEx,HY-15349,Trovirdine,-8.722900,x0397,0.531433,active-noncovalent
c1cc(cc(c1)C(F)(F)F)/C=C/2\C(=O)[N-]C(=O)S2,BRD-K70159787-001-01-1,SMI-4a,Selleck,S8005,SMI-4a,-8.722842,x0395,-0.553109,active-noncovalent
c1cc(cc(c1)F)c2cc(c(s2)C(=O)N[C@H]3CCC[NH2+]C3)NC(=O)N,BRD-K86525559-001-07-8,AZD7762,Selleck,S1532,AZD7762,-8.721803,x0161,3.476772,active-noncovalent
c1cc(cc(c1)F)c2cc(c(s2)C(=O)N[C@H]3CCC[NH2+]C3)NC(=O)N,BRD-K86525559-003-01-7,AZD7762,Tocris,5199,AZD 7762 hydrochloride,-8.721803,x0161,3.476772,active-noncovalent
c1cc(cc(c1)F)c2cc(c(s2)C(=O)N[C@H]3CCC[NH2+]C3)NC(=O)N,BRD-K86525559-001-04-5,AZD7762,Selleck,S1532,AZD7762,-8.721803,x0161,3.476772,active-noncovalent
CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,BRD-A47449001-004-12-9,ipratropium,Tocris,692,Ipratropium bromide,-8.721560,x1392,1.653072,active-covalent
CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,BRD-A47449001-004-13-7,ipratropium,MicroSource,1500354,IPRATROPIUM BROMIDE,-8.721560,x1392,1.653072,active-covalent
CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,BRD-A47449001-004-14-5,ipratropium,Selleck,S1683,Ipratropium Bromide,-8.721560,x1392,1.653072,active-covalent
c1ccc(cc1)c2csc3c2c(=O)n(c(n3)SCC(=O)NN)c4ccccc4,BRD-K51485109-001-01-4,LDN-27219,Tocris,4602,LDN 27219,-8.721227,x0195,1.276507,active-noncovalent
CNC(=O)Oc1cccc2c1cccc2,BRD-K54208592-001-09-4,carbaril,MicroSource,1504347,CARBARIL,-8.720993,x0195,-1.351455,active-noncovalent
CC(CC(=O)[O-])(CC(=O)[O-])O,BRD-K00495673-001-05-2,meglutol,MicroSource,1506183,MEGLUTOL,-8.720585,x0397,0.008515,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl,BRD-K36927236-001-30-0,glyburide,Selleck,S1716,Glyburide,-8.720565,x0161,6.57689,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl,BRD-K36927236-001-36-7,glyburide,Tocris,911,Glibenclamide,-8.720565,x0161,6.57689,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl,BRD-K36927236-001-31-8,glyburide,Tocris,911,Glibenclamide,-8.720565,x0161,6.57689,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl,BRD-K36927236-001-32-6,glyburide,MicroSource,2300229,GLYBURIDE,-8.720565,x0161,6.57689,active-noncovalent
c1cc(cc(c1)c2c[nH]c3c2c(ncn3)N4CCOCC4)C#N,BRD-K83114366-001-02-8,PF-06447475,Tocris,5716,PF 06447475,-8.720521,x0387,0.36274,active-noncovalent
c1cc(cc(c1)c2c[nH]c3c2c(ncn3)N4CCOCC4)C#N,BRD-K83114366-001-01-0,PF-06447475,MedChemEx,HY-12477,PF-06447475,-8.720521,x0387,0.36274,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3ccccc3,BRD-K77987382-001-13-2,mebendazole,MicroSource,1501110,MEBENDAZOLE,-8.720441,x0195,1.441916,active-noncovalent
c1ccnc(c1)CN(c2ccc(cc2)N3CC[NH2+]CC3)C(=O)c4ccc(o4)c5ccc(cc5)Cl,BRD-K90316462-003-01-1,MK2-IN-1,MedChemEx,HY-12834A,MK2-IN-1 (hydrochloride),-8.719788,x0874,5.376626,active-noncovalent
Cc1cc2c(cccc2n1c3nc4c(c(n3)NCc5ccccc5)COCC4)C(=O)N,BRD-K49048664-001-01-2,CB-5083,ApexBio,B6032,CB-5083,-8.719719,x0161,4.502107,active-noncovalent
Cc1cc2c(cccc2n1c3nc4c(c(n3)NCc5ccccc5)COCC4)C(=O)N,BRD-K49048664-001-02-0,CB-5083,MedChemEx,HY-12861,CB-5083,-8.719719,x0161,4.502107,active-noncovalent
c1cc2c(cc1Cl)C(=O)N3[C@@H](O2)CCO3,BRD-A53472930-001-01-7,seclazone,Enamine,Z2306534576,"7-chloro-3,3a-dihydro-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one",-8.719603,x0749,-0.03944,active-covalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,BRD-K39479472-096-04-7,pyrvinium-pamoate,MicroSource,1500521,PYRVINIUM PAMOATE,-8.719566,x0104,10.57359,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,BRD-M55114534-096-01-9,pyrvinium,Enamine,Z2216208621,"(E)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl)-6-(dimethylamino)-1-methylquinolin-1-ium 4,4'-methylenebis(3-hydroxy-2-naphthoate)",-8.719566,x0104,10.57359,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,BRD-M55114534-373-01-2,pyrvinium-pamoate,Sigma,S______P0027,,-8.719566,x0104,10.57359,active-noncovalent
CCCC[C@@H](CC)C[N@@]1CC(C[N@@](C1)C[C@H](CC)CCCC)(C)[NH3+],BRD-A18605525-001-14-0,hexetidine,MedChemEx,HY-B0996,Hexetidine,-8.719007,x1093,3.467151,active-noncovalent
CCCC[C@@H](CC)C[N@@]1CC(C[N@@](C1)C[C@H](CC)CCCC)(C)[NH3+],BRD-A18605525-001-12-4,hexetidine,MicroSource,1500633,HEXETIDINE,-8.719007,x1093,3.467151,active-noncovalent
CCCC[C@@H](CC)C[N@@]1CC(C[N@@](C1)C[C@H](CC)CCCC)(C)[NH3+],BRD-A18605525-001-13-2,hexetidine,MedChemEx,HY-B0996,Hexetidine,-8.719007,x1093,3.467151,active-noncovalent
CO[C@]1(COc2ccccc2O1)C3=[NH+]CCN3,BRD-A65597028-003-08-1,RX-821002,Tocris,1324,RX 821002 hydrochloride,-8.718850,x0678,-1.277648,active-noncovalent
CO[C@]1(COc2ccccc2O1)C3=[NH+]CCN3,BRD-A65597028-003-07-3,RX-821002,Tocris,1324,RX 821002 hydrochloride,-8.718850,x0678,-1.277648,active-noncovalent
c1cc(cc(c1)Cl)N2CC[NH2+]CC2,BRD-K75844781-003-08-0,mCPP,Enzo,AC547,1-(3-Chlorophenyl)piperazine,-8.718540,x0195,-1.599706,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C,BRD-K97091514-001-11-4,vitamin-E,CombiBlocks,QE-9484,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol",-8.718136,x0161,5.355564,active-noncovalent
COc1cc(c(cc1Cl)Cl)n2c(=O)c3ccccc3[nH]c2=S,BRD-K61128465-001-09-9,mdivi-1,Selleck,S7162,Mdivi-1,-8.717098,x0195,-0.03096,active-noncovalent
COc1cc(c(cc1Cl)Cl)n2c(=O)c3ccccc3[nH]c2=S,BRD-K61128465-001-10-7,mdivi-1,Selleck,S7162,Mdivi-1,-8.717098,x0195,-0.03096,active-noncovalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](C3=CCC=CC3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K13797099-001-02-9,cefradine,MedChemEx,HY-B1156,Cefradine,-8.717001,x0830,1.107011,active-covalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](C3=CCC=CC3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],BRD-K13797099-001-01-1,cefradine,MedChemEx,HY-B1156,Cefradine,-8.717001,x0830,1.107011,active-covalent
c1ccc2c(c1)cccc2C(=O)N3CCc4c(c5cc(ccc5n4CC(=O)[O-])F)C3,BRD-K24497734-001-01-6,setipiprant,MedChemEx,HY-16635,Setipiprant,-8.716733,x0107,3.597375,active-noncovalent
Cn1cc(cn1)c2ccc3nnc(n3n2)Sc4ccc5c(c4)cccn5,BRD-K19477839-001-07-6,SGX523,Selleck,S1112,SGX-523,-8.716206,x0072,2.480711,active-noncovalent
CN1c2cc(cc(c2OCC1=O)C(=O)N[C@H]3C[NH+]4CCC3CC4)Cl,BRD-A44133049-003-07-8,azasetron,Selleck,S2106,Azasetron HCl (Y-25130),-8.715544,x0195,1.561231,active-noncovalent
C=C(c1ccccc1OCc2cccc(c2)Cl)n3ccnc3,BRD-K73701464-003-01-3,croconazole,AKSci,K341,,-8.715119,x0967,0.987366,active-noncovalent
CCOC(=O)Nc1cc2c(c([nH+]1)N)N=C([C@H](N2)C)c3ccccc3,BRD-K39576764-071-01-6,mivobulin,Sigma,PH014089,"ethyl 5-amino-2-methyl-3-phenyl-1,4-dihydropyrido[4,3-b]pyrazin-7-ylcarbamate 2-hydroxyethanesulfonate",-8.714993,x0104,2.142501,active-noncovalent
C[C@H]\1CC[C@H](C/C1=C\C=C\2/CCC[C@@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](C)C(C)C)C)O,BRD-A34455052-001-01-8,dihydrotachysterol,Sigma,MFCD00867069,"(5E,7E,22E)-9,10-secoergosta-5,7,22-trien-3-ol",-8.714808,x0104,6.951339,active-noncovalent
c1cc(ccc1c2c(n3ccsc3n2)/C=N/OCc4ccc(c(c4)Cl)Cl)Cl,BRD-K53263234-001-05-2,CITCO,Tocris,3683,CITCO,-8.714808,x0161,3.322887,active-noncovalent
c1cc(ccc1c2c(n3ccsc3n2)/C=N/OCc4ccc(c(c4)Cl)Cl)Cl,BRD-K53263234-001-06-0,CITCO,Tocris,3683,CITCO,-8.714808,x0161,3.322887,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCn3c(c4c(c3O)[C@H]5CC[C@@H]4C5)O,BRD-K65904673-003-01-0,tandospirone,Tocris,2854,Tandospirone hydrochloride,-8.714194,x0161,5.48223,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCn3c(c4c(c3O)[C@H]5CC[C@@H]4C5)O,BRD-K65904673-001-01-4,tandospirone,MedChemEx,HY-14558,Tandospirone,-8.714194,x0161,5.48223,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3c(nns3)c4ccccc4)[NH2+]C,BRD-K68938568-001-01-7,GDC-0152,Selleck,S7010,GDC-0152,-8.713861,x0678,7.139026,active-noncovalent
C[C@@H](C(=O)N)[NH2+]Cc1ccc(cc1)OCc2ccccc2F,BRD-K01662324-066-01-1,priralfinamide,Tocris,4029,Ralfinamide mesylate,-8.713419,x0104,3.943301,active-noncovalent
C[C@@H](C(=O)N)[NH2+]Cc1ccc(cc1)OCc2ccccc2F,BRD-K01662324-001-01-8,priralfinamide,AMS,A002801679,(2S)-2-({4-[(2-fluorobenzyl)oxy]benzyl}amino)propanamide,-8.713419,x0104,3.943301,active-noncovalent
c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCC[NH+]5CCCC5,BRD-K19034817-001-04-8,pacritinib,MedChemEx,HY-16379,Pacritinib,-8.712273,x0104,11.007037,active-noncovalent
c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCC[NH+]5CCCC5,BRD-K19034817-001-01-4,pacritinib,Selleck,S8057,Pacritinib (SB1518),-8.712273,x0104,11.007037,active-noncovalent
c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCC[NH+]5CCCC5,BRD-K19034817-001-02-2,pacritinib,Selleck,S8057,Pacritinib (SB1518),-8.712273,x0104,11.007037,active-noncovalent
c1cc(ccc1NC(=O)C2(CC2)C(=O)Nc3cc(c(cc3F)Oc4ccnc(c4)NC(=O)C5CC5)F)F,BRD-K78627070-001-01-5,altiratinib,MedChemEx,HY-B0791,Altiratinib,-8.712025,x0104,12.994946,active-noncovalent
CC1(Cc2ccccc2C1)C[NH3+],BRD-K41434598-003-01-9,org-9768,Enamine,EN300-124569,,-8.711792,x0195,0.568788,active-noncovalent
CCOCc1nc2c(n1CC(C)(C)O)c3ccccc3nc2N,BRD-K76210423-001-02-4,resiquimod,Tocris,4536,Resiquimod,-8.711615,x1334,1.164754,active-covalent
CCOCc1nc2c(n1CC(C)(C)O)c3ccccc3nc2N,BRD-K76210423-001-01-6,resiquimod,MedChemEx,HY-13740,Resiquimod,-8.711615,x1334,1.164754,active-covalent
CCC1=C[C@H]2C[C@]3([C@@H]1[N@@H+](C2)CCc4c3[nH]c5c4cccc5)C(=O)OC,BRD-K92377961-001-02-9,catharanthine,Selleck,S3202,Catharanthine,-8.710958,x0749,1.347567,active-covalent
CCC1=C[C@H]2C[C@]3([C@@H]1[N@@H+](C2)CCc4c3[nH]c5c4cccc5)C(=O)OC,BRD-K92377961-001-03-7,catharanthine,Selleck,S3202,Catharanthine,-8.710958,x0749,1.347567,active-covalent
CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O,BRD-K62751771-001-01-3,levomenol,Sigma,MFCD03412455,(2S)-6-methyl-2-[(1S)-4-methyl-3-cyclohexen-1-yl]-5-hepten-2-ol,-8.710808,x0161,-0.725673,active-noncovalent
Cc1cc(no1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K28494619-001-28-2,sulfamethoxazole,MicroSource,1500550,SULFAMETHOXAZOLE,-8.710352,x0072,-0.780821,active-noncovalent
Cc1cc(no1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K28494619-001-27-4,sulfamethoxazole,Selleck,S1915,Sulfamethoxazole,-8.710352,x0072,-0.780821,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(c(c2)Cl)Cl)Cl,BRD-K25029121-001-05-8,triclocarban,ChemDiv,8003-0506,,-8.708251,x0678,2.243643,active-noncovalent
Cc1cccc(c1)N(C)C(=S)Oc2ccc3ccccc3c2,BRD-K44273375-001-25-0,tolnaftate,MicroSource,1500583,TOLNAFTATE,-8.708003,x0072,0.715893,active-noncovalent
Cc1cccc(c1)N(C)C(=S)Oc2ccc3ccccc3c2,BRD-K44273375-001-24-3,tolnaftate,Selleck,S2058,Tolnaftate,-8.708003,x0072,0.715893,active-noncovalent
CC(C)(c1[nH]c(c[nH+]1)c2ccc(cc2)OC(F)(F)F)N,BRD-K92435527-001-01-4,PF-04885614,Tocris,4916,PF 04885614,-8.707911,x0161,1.034554,active-noncovalent
Cc1ccsc1C(=CCC[N@@H+]2CCC[C@H](C2)C(=O)[O-])c3c(ccs3)C,BRD-K60160658-003-11-2,tiagabine,Enzo,AC3267,TIAGABINE HYDROCHLORIDE,-8.707520,x1334,2.64686,active-covalent
Cc1ccsc1C(=CCC[N@@H+]2CCC[C@H](C2)C(=O)[O-])c3c(ccs3)C,BRD-K60160658-003-12-0,tiagabine,Tocris,4256,Tiagabine hydrochloride,-8.707520,x1334,2.64686,active-covalent
C1CC[C@H]2[C@@H](C1)C3=C(O2)CCc4c3nc(nc4N5CC[NH2+]CC5)N,BRD-K68982262-001-01-4,A-987306,Tocris,3640,A 987306,-8.706692,x0749,0.656275,active-covalent
CCOC(=O)[C@H](Cc1ccc(c(c1)O)O)[NH3+],BRD-K90982969-003-01-8,etilevodopa,Enamine,Z756916070,,-8.706562,x0749,-1.187377,active-covalent
CCOC(=O)[C@H](Cc1ccc(c(c1)O)O)[NH3+],BRD-K90982969-001-01-2,etilevodopa,Sigma,SML0091,"ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate",-8.706562,x0749,-1.187377,active-covalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)O)[NH3+],BRD-A17745711-050-05-4,alpha-methylserotonin,Tocris,557,?-Methyl-5-hydroxytryptamine maleate,-8.705218,x1385,-1.056174,active-covalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)O)[NH3+],BRD-A17745711-050-06-2,alpha-methylserotonin,Tocris,557,?-Methyl-5-hydroxytryptamine maleate,-8.705218,x1385,-1.056174,active-covalent
c1ccc2c(c1)ccc(n2)C3=[NH+]CCN3,BRD-K55344148-003-02-6,BU-224,Tocris,725,BU 224 hydrochloride,-8.705074,x0195,-1.241735,active-noncovalent
c1cc(c(c(c1)Cl)Cl)c2cc(nc(n2)N)NC3CC3,BRD-K01054709-001-01-3,TH588,MedChemEx,HY-12814,TH588,-8.705000,x1093,0.129045,active-noncovalent
CC(C)[C@](c1ccc2cc(c(cc2c1)OC(F)F)OC(F)F)(c3cn[nH]n3)O,BRD-K72005722-001-01-2,VT-464,MedChemEx,HY-15996,VT-464,-8.704799,x0678,3.193347,active-noncovalent
COC(=O)Nc1[nH]c2ccccc2n1,BRD-K12906202-001-06-2,carbendazim,Sigma,MFCD00055390,methyl 1H-benzimidazol-2-ylcarbamate,-8.704404,x0678,-0.583603,active-noncovalent
Cc1c(c2ccc(cc2n1CC[NH+]3CCOCC3)I)C(=O)c4ccc(cc4)OC,BRD-K63533170-001-02-9,AM-630,Tocris,1120,AM 630,-8.704353,x0161,5.237054,active-noncovalent
Cc1c(c2ccc(cc2n1CC[NH+]3CCOCC3)I)C(=O)c4ccc(cc4)OC,BRD-K63533170-001-03-7,AM-630,Tocris,1120,{6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl}(4-methoxyphenyl)methanone,-8.704353,x0161,5.237054,active-noncovalent
C[NH+](C)CCOC(=O)COc1ccc(cc1)Cl,BRD-K10314788-003-12-7,meclofenoxate,MicroSource,1503226,MECLOFENOXATE HYDROCHLORIDE,-8.703523,x0161,0.270413,active-noncovalent
CN([C@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)Cc3ccc(c(c3)Cl)Cl,BRD-K53532120-003-10-3,U-50488-(-),Tocris,496,(-)-U-50488 hydrochloride,-8.703189,x0434,1.83687,active-noncovalent
CN([C@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)Cc3ccc(c(c3)Cl)Cl,BRD-K53532120-003-09-5,U-50488-(-),Tocris,496,(-)-U-50488 hydrochloride,-8.703189,x0434,1.83687,active-noncovalent
CN([C@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)Cc3ccc(c(c3)Cl)Cl,BRD-K53532120-003-11-1,U-50488-(-),Tocris,495,(?)-U-50488 hydrochloride,-8.703189,x0434,1.83687,active-noncovalent
CCOC(=O)c1c([nH]c2c1c3c(cc2)O[C@@H]4c5ccc(cc5CC[N@H+]4C3)OC)C,BRD-A89337244-001-02-9,PD-102807,Tocris,1671,PD 102807,-8.702961,x0678,5.360473,active-noncovalent
CCOC(=O)c1c([nH]c2c1c3c(cc2)O[C@@H]4c5ccc(cc5CC[N@H+]4C3)OC)C,BRD-A89337244-001-03-7,PD-102807,Tocris,1671,PD 102807,-8.702961,x0678,5.360473,active-noncovalent
c1ccc(c(c1)Cc2ccc3c(c2)nc(s3)c4ccc(cc4F)C[NH+]5CC(C5)C(=O)[O-])F,BRD-K87461578-001-01-5,TC-SP-14,Tocris,4363,TC-SP 14,-8.702904,x0104,12.692585,active-noncovalent
CC(C)/C=C/CCCCC(=O)NCc1ccc(c(c1)OC)O,BRD-K50590187-001-20-7,capsaicin,MicroSource,1501128,CAPSAICIN,-8.702892,x0161,2.816803,active-noncovalent
CC(C)/C=C/CCCCC(=O)NCc1ccc(c(c1)OC)O,BRD-K50590187-001-19-9,capsaicin,Tocris,462,(E)-Capsaicin,-8.702892,x0161,2.816803,active-noncovalent
c1ccc2c(c1)[nH]c(n2)C[NH+]3CCN(CC3)c4ccccn4,BRD-K37714784-305-02-1,ABT-724,Tocris,2214,ABT 724 trihydrochloride,-8.702614,x0946,1.645068,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)CCCOc3ccc4c(c3)OCO4,BRD-K45479396-050-01-5,BP-554,Tocris,556,BP 554 maleate,-8.701449,x0874,3.297703,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)CCCOc3ccc4c(c3)OCO4,BRD-K45479396-050-02-3,BP-554,Tocris,556,BP 554 maleate,-8.701449,x0874,3.297703,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3cc(ccc3N2)Cl)N4CC[NH2+]CC4,BRD-K10042277-001-05-0,desmethylclozapine,Tocris,1007,N-Desmethylclozapine,-8.701330,x0195,0.764507,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3ccc(cc3)Cl)c(ncn2)N,BRD-K95785537-001-24-9,PP-2,Tocris,1407,PP 2,-8.700075,x0678,0.597031,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3ccc(cc3)Cl)c(ncn2)N,BRD-K95785537-001-22-3,PP-2,Selleck,S7008,PP2,-8.700075,x0678,0.597031,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3ccc(cc3)Cl)c(ncn2)N,BRD-K95785537-001-23-1,PP-2,Tocris,1407,PP 2,-8.700075,x0678,0.597031,active-noncovalent
CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCC/C=C/C(=O)[O-])O)O,BRD-K25015158-001-02-0,limaprost-alfadex,MedChemEx,HY-B0683,Limaprost,-8.697995,x0104,3.131921,active-noncovalent
CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCC/C=C/C(=O)[O-])O)O,BRD-K25015158-001-01-2,limaprost-alfadex,MedChemEx,HY-B0683,Limaprost,-8.697995,x0104,3.131921,active-noncovalent
c1cc2c(nc3cc(ccc3n2c1)F)NNC(=O)c4cnccn4,BRD-K55305701-001-02-0,SC-144,Selleck,S7124,SC144,-8.697574,x0397,0.976988,active-noncovalent
c1cc2c(nc3cc(ccc3n2c1)F)NNC(=O)c4cnccn4,BRD-K55305701-003-01-8,SC-144,Tocris,4963,SC 144 hydrochloride,-8.697574,x0397,0.976988,active-noncovalent
c1cc2c(nc3cc(ccc3n2c1)F)NNC(=O)c4cnccn4,BRD-K55305701-001-01-2,SC-144,Selleck,S7124,SC144,-8.697574,x0397,0.976988,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2C(=O)c3ccn(=O)cc3)Cl,BRD-K47929404-001-01-0,vercirnon,MedChemEx,HY-15724,Vercirnon,-8.697428,x0434,3.962274,active-noncovalent
c1cc(ccc1N)S(=O)(=O)Nc2nccs2,BRD-K14705039-001-15-6,sulfathiazole,Selleck,S3116,Sulfathiazole,-8.697274,x0678,-0.873916,active-noncovalent
c1cc(ccc1N)S(=O)(=O)Nc2nccs2,BRD-K14705039-001-16-4,sulfathiazole,MicroSource,1500553,SULFATHIAZOLE,-8.697274,x0678,-0.873916,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,BRD-K92760278-001-07-3,riboflavin,Selleck,S2540,Riboflavin (Vitamin B2),-8.696718,x0708,1.620509,active-covalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,BRD-K92760278-001-06-5,riboflavin,Selleck,S2540,Riboflavin (Vitamin B2),-8.696718,x0708,1.620509,active-covalent
CCCC[C@@H](CC)COC(=O)/C=C/c1ccc(cc1)OC,BRD-K19972289-001-01-4,octinoxate,MicroSource,1504916,OCTINOXATE,-8.695915,x0072,3.282982,active-noncovalent
COc1cc(cc(c1)OC)/C=C/c2ccc(cc2)O,BRD-K53097745-001-01-5,pterostilbene,Enzo,385-034,Pterostilbene,-8.695619,x0749,0.538971,active-covalent
c1ccc(cc1)CNC(=O)CCCl,BRD-K44824027-001-02-1,beclamide,MicroSource,1505827,BECLAMIDE,-8.695555,x0678,-1.45003,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@](O2)(C)COc3ccc(cc3)C[C@H]4C(=O)[N-]C(=O)S4)C,BRD-A13084692-001-17-3,troglitazone,Enzo,GR210,Troglitazone,-8.695098,x1077,5.282494,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@](O2)(C)COc3ccc(cc3)C[C@H]4C(=O)[N-]C(=O)S4)C,BRD-A13084692-001-20-7,troglitazone,Tocris,3114,Troglitazone,-8.695098,x1077,5.282494,active-noncovalent
C[C@@H](c1cc2ccccc2s1)N(C(=O)N)O,BRD-A56359832-001-11-1,zileuton,Selleck,S1443,Zileuton,-8.694283,x0749,-1.016599,active-covalent
C[C@@H](c1cc2ccccc2s1)N(C(=O)N)O,BRD-A56359832-001-13-7,zileuton,Selleck,S1443,Zileuton,-8.694283,x0749,-1.016599,active-covalent
C[C@@H](c1cc2ccccc2s1)N(C(=O)N)O,BRD-A56359832-001-15-2,zileuton,Tocris,3308,Zileuton,-8.694283,x0749,-1.016599,active-covalent
C[C@@H](c1cc2ccccc2s1)N(C(=O)N)O,BRD-A56359832-001-12-9,zileuton,MicroSource,1505906,ZILEUTON,-8.694283,x0749,-1.016599,active-covalent
Cc1cc(cc(c1Cc2ccc(c(c2)C(C)C)O)C)OCC(=O)[O-],BRD-K85406984-001-01-0,sobetirome,MedChemEx,HY-14823,Sobetirome,-8.693005,x0678,1.381971,active-noncovalent
Cc1cc(cc(c1Cc2ccc(c(c2)C(C)C)O)C)OCC(=O)[O-],BRD-K85406984-001-02-8,sobetirome,Tocris,4554,GC 1,-8.693005,x0678,1.381971,active-noncovalent
c1ccc(cc1)CCCNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K34428485-001-18-4,AG-555,Tocris,618,AG 555,-8.692240,x0434,1.625377,active-noncovalent
CC1=C(C(C(=C(N1C)C)C(=O)OC)c2ccc(cc2)C(F)(F)F)C(=O)OC,BRD-K44471774-001-01-8,bay-w-9798,Vitas-M,STK060545,"dimethyl 1,2,6-trimethyl-4-[4-(trifluoromethyl)phenyl]-1,4-dihydro-3,5-pyridinedicarboxylate",-8.691492,x0161,2.593214,active-noncovalent
Cc1nnc2n1-c3ccccc3[C@H](C=C2Cc4nnc(o4)C)c5ccc(cc5)Cl,BRD-K72735080-001-01-0,BET-BAY-002,MedChemEx,HY-12421,BET-BAY 002,-8.691198,x0678,2.021384,active-noncovalent
C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O)O,BRD-K92758126-001-18-8,MD-920,Enzo,NP113,"Gibberellic acid, (+)-",-8.689821,x0749,2.862688,active-covalent
CCC(=O)O[C@@](Cc1ccccc1)(c2ccccc2)[C@@H](C)C[NH+](C)C,BRD-A54635441-078-09-1,levopropoxyphene,Prestwick,Prestw-1054,Levopropoxyphene napsylate,-8.689008,x0678,2.21976,active-noncovalent
Cc1cc(n[nH]1)Nc2cc(nc(n2)/C=C/c3ccccc3)N4CC[NH+](CC4)C,BRD-K68488863-001-04-9,ENMD-2076,Selleck,S1181,ENMD-2076,-8.688255,x1077,3.084478,active-noncovalent
COc1ccc(c(c1)O)C(=O)c2ccccc2O,BRD-K22193694-001-13-6,dioxybenzone,MicroSource,1500255,DIOXYBENZONE,-8.687089,x0678,-0.878149,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O)CCC(=O)[O-],BRD-K55966568-001-05-4,orantinib,Selleck,S1470,"TSU-68 (SU6668, Orantinib)",-8.684568,x0678,0.374559,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O)CCC(=O)[O-],BRD-K55966568-001-06-2,orantinib,Tocris,3335,SU 6668,-8.684568,x0678,0.374559,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O)CCC(=O)[O-],BRD-K55966568-001-10-4,orantinib,Tocris,3335,SU 6668,-8.684568,x0678,0.374559,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O)CCC(=O)[O-],BRD-K55966568-001-09-6,orantinib,Selleck,S1470,TSU-68,-8.684568,x0678,0.374559,active-noncovalent
Cc1cccc(n1)NC(=O)c2ccc(cc2C(=O)[O-])C(F)(F)F,BRD-K47816470-001-01-8,AF38469,MedChemEx,HY-12802,AF38469,-8.683684,x0195,1.20762,active-noncovalent
CN(CC(=O)[O-])C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC,BRD-K85693895-001-03-7,tolrestat,MedChemEx,HY-16500,Tolrestat,-8.682558,x0749,1.567495,active-covalent
CN(CC(=O)[O-])C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC,BRD-K85693895-001-01-1,tolrestat,MedChemEx,HY-16500,Tolrestat,-8.682558,x0749,1.567495,active-covalent
CN(CC(=O)[O-])C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC,BRD-K85693895-001-02-9,tolrestat,MedChemEx,HY-16500,Tolrestat,-8.682558,x0749,1.567495,active-covalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@@H](CO)c4ccccc4)C,BRD-A03932035-004-04-3,methscopolamine,MicroSource,1500401,METHSCOPOLAMINE BROMIDE,-8.682234,x0072,0.760491,active-noncovalent
Cc1cc(ccn1)C(=O)Nc2nc3cccc(c3n2[C@@H]4CCCCN(C4)C(=O)/C=C/C[NH+](C)C)Cl,BRD-K22514639-001-05-7,EGF816,MedChemEx,HY-12872,EGF816,-8.681888,x0104,6.431657,active-noncovalent
Cc1cc(ccn1)C(=O)Nc2nc3cccc(c3n2[C@@H]4CCCCN(C4)C(=O)/C=C/C[NH+](C)C)Cl,BRD-K22514639-001-04-0,EGF816,MedChemEx,HY-12872,EGF816,-8.681888,x0104,6.431657,active-noncovalent
C[C@@H](CC(c1ccccc1)c2ccccc2)[NH2+]C(C)(C)C,BRD-A33479817-003-03-7,terodiline,Sigma,MFCD00941402,"N-(tert-butyl)-4,4-diphenyl-2-butanamine hydrochloride",-8.681395,x1093,-0.248063,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(C(=O)OC3C[C@H]4CC[C@@H](C3)[N+]45CCCC5)O,BRD-K69469734-003-02-5,trospium,Selleck,S2549,Trospium chloride,-8.681177,x0874,3.198626,active-noncovalent
C[NH+](C)C/C=C(/c1ccc(cc1)Br)\c2cccnc2,BRD-K46914825-300-01-0,zimelidine,Tocris,1767,Zimelidine dihydrochloride,-8.680770,x0107,-0.109737,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c2ccccc2)(O)O,BRD-K59325863-001-04-4,delanzomib,MedChemEx,HY-10454,Delanzomib,-8.679836,x0161,5.314429,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c2ccccc2)(O)O,BRD-K59325863-001-01-0,delanzomib,MedChemEx,HY-10454,Delanzomib,-8.679836,x0161,5.314429,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c2ccccc2)(O)O,BRD-K59325863-001-02-8,delanzomib,Selleck,S1157,CEP-18770 (Delanzomib),-8.679836,x0161,5.314429,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c2ccccc2)(O)O,BRD-K59325863-001-03-6,delanzomib,Selleck,S1157,Delanzomib (CEP-18770),-8.679836,x0161,5.314429,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,BRD-K40530731-001-10-8,hyoscyamine,Selleck,S4014,Hyoscyamine,-8.679650,x0072,0.238333,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,BRD-A27290375-330-01-1,atropine,MicroSource,1500131,ATROPINE SULFATE,-8.679650,x0072,0.238333,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,BRD-A27290375-330-02-9,atropine,Selleck,S2130,Atropine,-8.679650,x0072,0.238333,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,BRD-K40530731-001-11-6,hyoscyamine,MicroSource,1500346,HYOSCYAMINE,-8.679650,x0072,0.238333,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NCC[NH+]4CCCC4,BRD-K62040061-001-01-0,toceranib,MedChemEx,HY-10330,Toceranib,-8.679184,x1077,6.377026,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NCC[NH+]4CCCC4,BRD-K62040061-011-02-7,toceranib,MedChemEx,HY-10330A,Toceranib (phosphate),-8.679184,x1077,6.377026,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NCC[NH+]4CCCC4,BRD-K62040061-011-01-9,toceranib,MedChemEx,HY-10330A,Toceranib (phosphate),-8.679184,x1077,6.377026,active-noncovalent
CCC[NH+](CCC)CCc1cccc2c1CC(=O)N2,BRD-K15933101-003-07-9,ropinirole,MicroSource,1505178,ROPINIROLE HYDROCHLORIDE,-8.679131,x0195,0.824056,active-noncovalent
CCC[NH+](CCC)CCc1cccc2c1CC(=O)N2,BRD-K15933101-003-06-1,ropinirole,Selleck,S3189,Ropinirole HCl,-8.679131,x0195,0.824056,active-noncovalent
Cc1cc(ccc1C[C@H](C)[NH3+])N(C)C,BRD-A19401019-001-01-3,amiflamine,Enamine,Z2327040082,"N-[4-(2-aminopropyl)-3-methylphenyl]-N,N-dimethylamine",-8.678908,x0749,-0.865627,active-covalent
Cc1ccc(c(c1)C)Oc2ccccc2c3csc(n3)[NH+]=C4NCCCN4,BRD-K77432251-001-01-2,abafungin,ChemImpex,28441,"4-[2-(2,4-dimethylphenoxy)phenyl]-N-tetrahydro-2(1H)-pyrimidinylidene-1,3-thiazol-2-amine",-8.678720,x0874,2.809686,active-noncovalent
C1CCC(CC1)NC(=O)CN2CC[NH2+]CC2,BRD-K92426617-001-06-3,esaprazole,Enamine,Z234896745,N-cyclohexyl-2-(1-piperazinyl)acetamide,-8.676890,x0678,-0.231951,active-noncovalent
C1CCC(CC1)NC(=O)CN2CC[NH2+]CC2,BRD-K92426617-001-05-5,esaprazole,Enamine,Z234896745,,-8.676890,x0678,-0.231951,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)N3CC[NH2+]CC3,BRD-K72462751-001-02-7,C-1,Tocris,543,C-1,-8.676439,x0749,-0.737968,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)N3CC[NH2+]CC3,BRD-K72462751-001-03-5,C-1,Tocris,543,C-1,-8.676439,x0749,-0.737968,active-covalent
CC1([C@@H]2C(=NC1=O)c3ccccc3C(=O)C2=O)C,BRD-A22713669-001-04-3,BVT-948,Tocris,2176,BVT 948,-8.675575,x0195,-0.308283,active-noncovalent
CC1([C@@H]2C(=NC1=O)c3ccccc3C(=O)C2=O)C,BRD-K68567222-001-01-2,BVT-948,Tocris,2176,BVT 948,-8.675575,x0195,-0.308283,active-noncovalent
CCc1ccc2c(nc(=O)n(c2n1)CC)c3cccc(c3)Cl,BRD-K12932420-001-03-1,YM-976,Tocris,1821,YM 976,-8.674878,x0434,0.858395,active-noncovalent
CCc1ccc2c(nc(=O)n(c2n1)CC)c3cccc(c3)Cl,BRD-K12932420-001-02-3,YM-976,Tocris,1821,YM 976,-8.674878,x0434,0.858395,active-noncovalent
C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]2CC[C@H](CC2)O)c3c(sc(c3)C#CC(C)(C)C)C(=O)[O-],BRD-K70610771-001-02-9,VX-222,Selleck,S1480,"VX-222 (VCH-222, Lomibuvir)",-8.673647,x1093,3.853147,active-noncovalent
Cn1cncc1[C@@](c2ccc(cc2)Cl)(c3ccc4c(c3)c(cc(=O)n4C)c5cccc(c5)Cl)[NH3+],BRD-K62965247-001-04-9,tipifarnib,Selleck,S1453,Tipifarnib,-8.673372,x0195,4.150408,active-noncovalent
CC1=CCC23[C@H]1[C@@H]4[C@@H](CC[C@@]2(O3)C)C(=C)C(=O)O4,BRD-K62734952-001-01-0,arglabin,MedChemEx,HY-16059,Arglabin,-8.672435,x0195,-0.090265,active-noncovalent
c1ccc2c(c1)cnnc2NN,BRD-K82103381-003-09-4,hydralazine,MedChemEx,HY-B0464,Hydralazine (hydrochloride),-8.671159,x0195,-1.971348,active-noncovalent
c1ccc2c(c1)cnnc2NN,BRD-K82103381-003-08-6,hydralazine,Selleck,S2562,Hydralazine hydrochloride,-8.671159,x0195,-1.971348,active-noncovalent
c1ccc2c(c1)cnnc2NN,BRD-K82103381-003-06-0,hydralazine,Selleck,S2562,Hydralazine HCl,-8.671159,x0195,-1.971348,active-noncovalent
c1ccc2c(c1)cnnc2NN,BRD-K82103381-003-07-8,hydralazine,MicroSource,1500334,HYDRALAZINE HYDROCHLORIDE,-8.671159,x0195,-1.971348,active-noncovalent
CCS(=O)(=O)N1CC(C1)(CC#N)n2cc(cn2)c3c4cc[nH]c4ncn3,BRD-K53581288-001-02-9,baricitinib,Selleck,S2851,"Baricitinib (LY3009104, INCB028050)",-8.669307,x0072,3.123212,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)C[C@H]4COc5ccccc5O4,BRD-A72483914-001-03-7,spiroxatrine,Tocris,631,Spiroxatrine,-8.668324,x0161,3.648764,active-noncovalent
c1ccc2c(c1)c(=O)c3ccccc3n2CC(=O)[O-],BRD-K97939847-001-12-0,cridanimod,Sigma,17927,(9-oxo-10(9H)-acridinyl)acetic acid,-8.667603,x0195,1.464592,active-noncovalent
c1ccc2c(c1)c(=O)c3ccccc3n2CC(=O)[O-],BRD-K97939847-001-11-2,cridanimod,ChemDiv,0099-0157,,-8.667603,x0195,1.464592,active-noncovalent
c1cnc(cn1)C(=O)N,BRD-K28667793-001-27-3,pyrazinamide,Selleck,S1762,Pyrazinamide,-8.667175,x0397,-0.77245,active-noncovalent
c1cnc(cn1)C(=O)N,BRD-K28667793-001-28-1,pyrazinamide,MicroSource,1500518,PYRAZINAMIDE,-8.667175,x0397,-0.77245,active-noncovalent
C[C@H](c1cccc2c1cccc2)[NH2+][C@H]3CCCC[C@@H]3NC(=O)c4ccc(cc4)Cl,BRD-K19811997-003-01-3,Calhex-231,Tocris,4387,Calhex 231 hydrochloride,-8.666510,x0195,5.018037,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K82036761-003-17-9,sertraline,MicroSource,1505262,SERTRALINE HYDROCHLORIDE,-8.666471,x0195,0.211995,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K82036761-003-16-1,sertraline,Tocris,2395,Sertraline hydrochloride,-8.666471,x0195,0.211995,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K82036761-003-19-5,sertraline,Tocris,2395,Sertraline hydrochloride,-8.666471,x0195,0.211995,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K82036761-003-20-3,sertraline,Selleck,S4053,Sertraline HCl,-8.666471,x0195,0.211995,active-noncovalent
Cn1c(c(cn1)Cl)c2cc(oc2Cl)C(=O)N[C@@H](Cc3ccc(c(c3)F)F)C[NH3+],BRD-K38332599-001-01-3,uprosertib,MedChemEx,HY-15965,GSK2141795,-8.665205,x0161,3.372025,active-noncovalent
c1ccc2c(c1)c(cn2Cc3ccc(cc3)Cl)C=O,BRD-K43449605-001-01-0,oncrasin-1,Tocris,3427,Oncrasin 1,-8.664866,x0072,-0.845748,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3cccs3,BRD-K12539581-001-21-1,nocodazole,Selleck,S2775,Nocodazole,-8.662644,x0195,1.676803,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3cccs3,BRD-K12539581-001-22-9,nocodazole,Tocris,1228,Nocodazole,-8.662644,x0195,1.676803,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3cccs3,BRD-K12539581-001-23-7,nocodazole,MicroSource,1503266,NOCODAZOLE,-8.662644,x0195,1.676803,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3cccs3,BRD-K12539581-001-25-2,nocodazole,Tocris,1228,Nocodazole,-8.662644,x0195,1.676803,active-noncovalent
C=CC[N@H+]1CCc2c(sc(n2)N)CC1,BRD-K75615183-300-06-2,talipexole,MedChemEx,HY-A0008,B-HT 920,-8.662112,x1077,-1.382778,active-noncovalent
C=CC[N@H+]1CCc2c(sc(n2)N)CC1,BRD-K75615183-300-05-4,talipexole,MedChemEx,HY-A0008,B-HT 920,-8.662112,x1077,-1.382778,active-noncovalent
C=CC[N@H+]1CCc2c(sc(n2)N)CC1,BRD-K75615183-300-03-9,talipexole,Enzo,AC253,B-HT 920 2HCl,-8.662112,x1077,-1.382778,active-noncovalent
C=CC[N@H+]1CCc2c(sc(n2)N)CC1,BRD-K75615183-300-04-7,talipexole,MedChemEx,HY-A0008,"6-allyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[4,5-d]azepin-2-ylamine dihydrochloride",-8.662112,x1077,-1.382778,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,BRD-K50720187-051-02-3,flupirtine,Selleck,S1334,Flupirtine maleate,-8.661087,x1093,1.827749,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,BRD-K50720187-050-08-2,flupirtine,MedChemEx,HY-17001,Flupirtine (Maleate),-8.661087,x1093,1.827749,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,BRD-K50720187-050-09-0,flupirtine,MedChemEx,HY-17001,Flupirtine (Maleate),-8.661087,x1093,1.827749,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,BRD-K50720187-001-02-8,flupirtine,Tocris,2867,Flupirtine maleate,-8.661087,x1093,1.827749,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,BRD-K50720187-051-03-1,flupirtine,Selleck,S1334,Flupirtine maleate,-8.661087,x1093,1.827749,active-noncovalent
CC(C)(C)[NH+]1CCC(CC1)(c2ccccc2)c3ccccc3,BRD-K18324993-001-01-6,budipine,AQBioPharma,ABP10516,BUDIPINE,-8.660541,x0678,-0.094431,active-noncovalent
CCc1cc2c(cc1CC)CC(C2)[NH2+]C[C@@H](c3ccc(c4c3ccc(=O)[nH]4)O)O,BRD-K89208535-051-01-5,indacaterol,Selleck,S3083,Indacaterol Maleate,-8.660088,x0678,2.677234,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(c(c3)F)C(F)(F)F)C,BRD-K82983861-001-06-8,GW-0742,Tocris,2229,GW 0742,-8.659649,x0195,6.030945,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(c(c3)F)C(F)(F)F)C,BRD-K82983861-001-04-3,GW-0742,Selleck,S8020,GW0742,-8.659649,x0195,6.030945,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(c(c3)F)C(F)(F)F)C,BRD-K82983861-001-05-0,GW-0742,Tocris,2229,GW 0742,-8.659649,x0195,6.030945,active-noncovalent
Cc1c(c2ccc(cc2o1)Oc3c4cc(c(cc4ncn3)OC)OC)C(=O)NC,BRD-K70504253-001-01-3,fruquintinib,MedChemEx,HY-19912,Fruquintinib,-8.659506,x0072,3.598175,active-noncovalent
CC(=O)c1ccc2c(c1)[C@@H]3C=CC[C@@H]3[C@@H](N2)c4cc5c(cc4Br)OCO5,BRD-K62696033-001-01-4,G-1,Tocris,3577,G-1,-8.659350,x0195,2.732833,active-noncovalent
COC(=O)[C@H](Cc1ccc(c(c1)O)O)[NH3+],BRD-K18749874-003-08-9,melevodopa,Sigma,MFCD00038958,"methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate hydrochloride",-8.659086,x0678,-1.654193,active-noncovalent
c1cc(ccc1C#N)c2csc(n2)/N=N/C3CCCC3,BRD-K75349868-001-01-5,remodelin,Tocris,5193,Remodelin,-8.657978,x0195,1.994579,active-noncovalent
C1CCc2c(c3c(=O)[nH]c(nc3s2)CCl)C1,BRD-K46989997-001-01-8,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",Enamine,EN300-01894,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",-8.656167,x0195,-0.413545,active-noncovalent
Cc1ccc(cc1)C(=O)c2cc(c(c(c2)O)[O-])N(=O)=O,BRD-K10852020-001-04-5,tolcapone,Selleck,S4021,Tolcapone,-8.655296,x1418,-0.425744,active-covalent
Cc1ccc(cc1)C(=O)c2cc(c(c(c2)O)[O-])N(=O)=O,BRD-K10852020-001-05-2,tolcapone,Selleck,S4021,Tolcapone,-8.655296,x1418,-0.425744,active-covalent
CC(C)Cn1cnc2c1c3ccccc3nc2N,BRD-K26657438-003-01-8,imiquimod,MicroSource,1502351,IMIQUIMOD HYDROCHLORIDE,-8.654057,x0195,-0.157234,active-noncovalent
CC(C)Cn1cnc2c1c3ccccc3nc2N,BRD-K26657438-001-17-8,imiquimod,Selleck,S1211,Imiquimod,-8.654057,x0195,-0.157234,active-noncovalent
CC(C)Cn1cnc2c1c3ccccc3nc2N,BRD-K26657438-001-15-2,imiquimod,Selleck,S1211,Imiquimod,-8.654057,x0195,-0.157234,active-noncovalent
CC(C)n1cnc2c1cc(cc2C(=O)N[C@H]3C[NH+]4CCC3CC4)Cl,BRD-K80725821-300-02-9,RS-16566,Tocris,1015,RS 16566 dihydrochloride,-8.653202,x0195,1.697903,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cccc3)[NH+](C)C,BRD-A46335897-003-26-0,promethazine,MicroSource,1500510,PROMETHAZINE HYDROCHLORIDE,-8.653181,x0195,-0.267103,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cccc3)[NH+](C)C,BRD-A46335897-003-27-8,promethazine,MedChemEx,HY-B0781,Promethazine (hydrochloride),-8.653181,x0195,-0.267103,active-noncovalent
CC(C)(C)C(=O)[C@H](n1ccnc1)Oc2ccc(cc2)Cl,BRD-A61676498-001-06-6,climbazole,MicroSource,1504833,CLIMBAZOLE,-8.652415,x0107,0.004222,active-noncovalent
CC(C)(C)C(=O)[C@H](n1ccnc1)Oc2ccc(cc2)Cl,BRD-A61676498-001-05-8,climbazole,Selleck,S4178,Climbazole,-8.652415,x0107,0.004222,active-noncovalent
c1cc(ncc1Cc2c[nH]c3c2cc(cn3)Cl)NCc4ccc(nc4)C(F)(F)F,BRD-K54519451-001-02-9,pexidartinib,MedChemEx,HY-16749,Pexidartinib,-8.651358,x1077,5.944975,active-noncovalent
CCOC(=O)c1ccc(c(c1)N)NC2CCCCC2,BRD-K97375133-001-03-9,ferrostatin-1,Tocris,5180,Ferrostatin 1,-8.651142,x0749,0.528134,active-covalent
CCOC(=O)c1ccc(c(c1)N)NC2CCCCC2,BRD-K97375133-001-01-3,ferrostatin-1,Selleck,S7243,Ferrostatin-1 (Fer-1),-8.651142,x0749,0.528134,active-covalent
CCOC(=O)c1ccc(c(c1)N)NC2CCCCC2,BRD-K97375133-001-02-1,ferrostatin-1,Selleck,S7243,Ferrostatin-1 (Fer-1),-8.651142,x0749,0.528134,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2=O,BRD-K10065684-001-07-4,dantron,MicroSource,211468,DANTHRON,-8.650962,x0749,0.285623,active-covalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,BRD-K08252256-224-02-9,diclofenac,Selleck,S3063,Diclofenac Diethylamine,-8.650775,x0107,0.487708,active-noncovalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,BRD-K08252256-236-33-8,diclofenac,MicroSource,1500237,DICLOFENAC SODIUM,-8.650775,x0107,0.487708,active-noncovalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,BRD-K08252256-236-32-0,diclofenac,Selleck,S1903,Diclofenac Sodium,-8.650775,x0107,0.487708,active-noncovalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,BRD-K08252256-237-02-1,diclofenac,Selleck,S3062,Diclofenac Potassium,-8.650775,x0107,0.487708,active-noncovalent
CCCCOc1ccc(cc1)CC(=O)NO,BRD-K36660044-001-23-4,bufexamac,Selleck,S3023,Bufexamac,-8.650715,x0104,-0.449744,active-noncovalent
CCCCOc1ccc(cc1)CC(=O)NO,BRD-K36660044-001-24-2,bufexamac,MicroSource,1502003,BUFEXAMAC,-8.650715,x0104,-0.449744,active-noncovalent
C[C@@]1(c2cccn2-c3ccccc3CO1)C[NH+]4CCC(CC4)n5c6ccccc6[nH]c5=O,BRD-A26032986-050-03-9,zaldaride,Tocris,2255,CGS 9343B,-8.650642,x1077,3.567627,active-noncovalent
C[C@@]1(c2cccn2-c3ccccc3CO1)C[NH+]4CCC(CC4)n5c6ccccc6[nH]c5=O,BRD-A26032986-050-02-1,zaldaride,Tocris,2255,CGS 9343B,-8.650642,x1077,3.567627,active-noncovalent
CC(=O)O[C@H]1Cc2ccccc2N(c3c1cccc3)C(=O)N,BRD-K61237927-001-01-7,eslicarbazepine-acetate,MedChemEx,HY-B0703,Eslicarbazepine (acetate),-8.649990,x0072,-0.353323,active-noncovalent
Cc1ccccc1N/C(=[NH+]\c2ccccc2C)/N,BRD-K33459542-001-07-4,ditolylguanidine,Tocris,841,DTG,-8.648587,x0072,-0.66387,active-noncovalent
c1cc(c(c(c1)C(=O)c2ccc(cc2)Br)N)CC(=O)[O-],BRD-K47679368-236-01-7,bromfenac,Selleck,S4248,Bromfenac Sodium,-8.648551,x0678,-0.436687,active-noncovalent
CC(C)c1cc(nc(n1)N)c2ccc(c3c2cccc3)F,BRD-K90825648-001-02-0,RS-127445,Selleck,S2698,RS-127445,-8.648408,x0195,-0.32084,active-noncovalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],BRD-K59197931-236-20-3,naproxen,Selleck,S1626,Naproxen,-8.648243,x0749,0.655443,active-covalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],BRD-K59197931-236-22-9,naproxen,Selleck,S1626,Naproxen Sodium,-8.648243,x0749,0.655443,active-covalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],BRD-K59197931-001-04-5,naproxen,MicroSource,1500425,NAPROXEN(+),-8.648243,x0749,0.655443,active-covalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],BRD-K59197931-236-21-1,naproxen,Tocris,2655,Naproxen sodium,-8.648243,x0749,0.655443,active-covalent
c1cc(c(cc1N[C@@H](c2c(non2)N)N=O)Cl)F,BRD-K22356203-001-01-8,IDO5L,MedChemEx,HY-15683,INCB024360,-8.647515,x0678,-0.290982,active-noncovalent
CCCCC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,BRD-K06014311-001-02-0,DH-97,Tocris,1218,DH 97,-8.647331,x0161,2.297367,active-noncovalent
CCCCC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,BRD-K06014311-001-03-8,DH-97,Tocris,1218,DH 97,-8.647331,x0161,2.297367,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CO,BRD-K01815685-001-15-5,indole-3-carbinol,Selleck,S2313,Indole-3-carbinol,-8.646740,x0195,2.011879,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3c(n[nH]n3)C[NH+](C)C)c4ccc(cc4)F,BRD-K30425481-003-01-0,L-760735,Tocris,4013,L 760735,-8.646544,x1077,10.44959,active-noncovalent
CCCCc1ccc(cc1)NS(=O)(=O)c2ccc(cc2)F,BRD-K10596918-001-01-9,DC-260126,Tocris,5357,DC 260126,-8.644873,x0195,0.242595,active-noncovalent
c1ccc(cc1)Oc2cccnc2,BRD-K83022601-001-01-0,CI-844,ChemImpex,26115,,-8.643821,x0678,-1.926609,active-noncovalent
CCOC(=O)c1cncn1[C@H](C)c2ccccc2,BRD-K55055802-001-10-2,etomidate,Selleck,S1329,Etomidate,-8.642980,x0161,-0.084901,active-noncovalent
CCOC(=O)c1cncn1[C@H](C)c2ccccc2,BRD-K55055802-001-09-4,etomidate,MicroSource,1505599,ETOMIDATE,-8.642980,x0161,-0.084901,active-noncovalent
CCOC(=O)c1cncn1[C@H](C)c2ccccc2,BRD-K55055802-001-08-6,etomidate,Tocris,1471,Etomidate,-8.642980,x0161,-0.084901,active-noncovalent
Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3,BRD-K77677632-003-03-4,SB-200646,Tocris,1371,SB 200646 hydrochloride,-8.642319,x0678,2.583626,active-noncovalent
Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3,BRD-K77677632-003-02-6,SB-200646,Tocris,1371,SB 200646 hydrochloride,-8.642319,x0678,2.583626,active-noncovalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,BRD-K58114536-001-01-6,rasagiline,MicroSource,1502333,RASAGILINE,-8.641811,x0104,-0.845549,active-noncovalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,BRD-K58114536-066-02-7,rasagiline,Selleck,S2102,Rasagiline mesylate,-8.641811,x0104,-0.845549,active-noncovalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,BRD-K58114536-066-03-5,rasagiline,Tocris,4308,Rasagiline mesylate,-8.641811,x0104,-0.845549,active-noncovalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,BRD-K58114536-066-04-3,rasagiline,Selleck,S2102,Rasagiline Mesylate,-8.641811,x0104,-0.845549,active-noncovalent
CC[C@@](C)(C(=O)[O-])Oc1ccc(cc1)C2(CCCCC2)c3ccc(cc3)O[C@@](C)(CC)C(=O)[O-],BRD-A90625545-001-02-0,clinofibrate,Selleck,S2664,Clinofibrate,-8.641696,x0874,7.94253,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O)O)O,BRD-K49962337-001-02-9,baicalin,Selleck,S2269,Baicalin,-8.640272,x0195,4.334407,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O)O)O,BRD-K49962337-001-01-1,baicalin,Selleck,S2269,Baicalin,-8.640272,x0195,4.334407,active-noncovalent
c1cc(ccc1CCNS(=O)(=O)c2ccc(cc2)Cl)CC(=O)[O-],BRD-K26813177-001-03-2,daltroban,Sigma,D7441,[4-(2-{[(4-chlorophenyl)sulfonyl]amino}ethyl)phenyl]acetic acid,-8.638590,x0831,1.251782,active-covalent
c1ccc2c(c1)ncc(n2)C3=[NH+]CCN3,BRD-K11696279-003-02-3,BU-239,Tocris,726,BU 239 hydrochloride,-8.636136,x0107,-1.282668,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,BRD-K68264559-001-13-4,brimonidine,Tocris,425,"UK 14,304",-8.636107,x0874,-1.220469,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,BRD-K68264559-045-04-0,brimonidine,Selleck,S4266,Brimonidine Tartrate,-8.636107,x0874,-1.220469,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,BRD-K68264559-001-14-2,brimonidine,Tocris,425,"UK 14,304",-8.636107,x0874,-1.220469,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,BRD-K68264559-045-02-4,brimonidine,Tocris,2466,"UK 14,304 tartrate",-8.636107,x0874,-1.220469,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,BRD-K68264559-045-03-2,brimonidine,Selleck,S4266,Brimonidine Tartrate,-8.636107,x0874,-1.220469,active-noncovalent
c1ccc2c(c1)c(ccc2n3c(nnc3Br)SCC(=O)[O-])C4CC4,BRD-K75024268-001-01-0,lesinurad,MedChemEx,HY-15258,Lesinurad,-8.635230,x0678,1.6531,active-noncovalent
Cc1cccc(c1)N2C[C@@H](OC2=O)CO,BRD-A67182178-001-01-7,toloxatone,Sigma,MFCD00865391,"5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one",-8.634964,x0195,-0.990133,active-noncovalent
c1ccc2c(c1)C3c4ccccc4C2C5=C3C(=O)C=CC5=O,BRD-K33308633-001-03-2,INCA-6,Tocris,2162,INCA-6,-8.634747,x0830,0.625407,active-covalent
c1ccc2c(c1)C3c4ccccc4C2C5=C3C(=O)C=CC5=O,BRD-K33308633-001-02-4,INCA-6,Tocris,2162,INCA-6,-8.634747,x0830,0.625407,active-covalent
CCOC(=O)c1ccc(cc1)N2C(=O)/C(=C\c3ccc(o3)N(=O)=O)/C(=O)N2,BRD-K66101666-001-01-5,PYR-41,Selleck,S7129,PYR-41,-8.634676,x0161,5.691107,active-noncovalent
CCOC(=O)c1ccc(cc1)N2C(=O)/C(=C\c3ccc(o3)N(=O)=O)/C(=O)N2,BRD-K66101666-001-02-3,PYR-41,Selleck,S7129,PYR-41,-8.634676,x0161,5.691107,active-noncovalent
c1cc(c(cc1O)[C@H](C(=O)[O-])[NH3+])Cl,BRD-A19381518-001-02-1,CHPG,Tocris,1049,CHPG,-8.634126,x1392,0.231413,active-covalent
Cc1cc(ccc1Nc2c(cc(c(c2F)F)F)C(=O)NOCC3CC3)I,BRD-K88677950-001-03-9,PD-198306,Tocris,2605,PD 198306,-8.633976,x0678,2.610973,active-noncovalent
CN1c2ccc(cc2N(C(=O)CC1=O)c3ccccc3)Cl,BRD-K52408781-001-02-8,clobazam,Enzo,AC3068,CLOBAZAM (DEA license),-8.632013,x0195,1.214595,active-noncovalent
c1cc(c(cc1C[NH+]2CCC(CC2)Nc3c4cc(sc4ncn3)Cl)C#N)F,BRD-K16757695-050-02-5,PRX-08066,Selleck,S8010,PRX-08066 Maleic acid,-8.630962,x0161,2.078351,active-noncovalent
CS(=O)(=O)c1ccc(c(c1)Cl)C(=O)Nc2ccc(c(c2)c3ccccn3)Cl,BRD-K44827188-001-06-0,vismodegib,Selleck,S1082,Vismodegib (GDC-0449),-8.629482,x0104,6.398676,active-noncovalent
Cn1c(c(cn1)Cl)c2cc(sc2Cl)C(=O)N[C@@H](Cc3cccc(c3)F)C[NH3+],BRD-K25412176-001-01-9,GSK2110183,MedChemEx,HY-15727,Afuresertib,-8.629450,x0874,2.702946,active-noncovalent
c1c(n(cn1)CC[NH+]2CCOCC2)N(=O)=O,BRD-K79145628-001-05-5,nimorazole,MedChemEx,HY-16349,Nimorazole,-8.626919,x0104,-0.558211,active-noncovalent
Cc1cc(cnc1)C[NH+]2CCC(=C3c4ccc(cc4CCc5c3nccc5)Cl)CC2,BRD-K98004573-051-02-8,rupatadine,Selleck,S3052,Rupatadine Fumarate,-8.626873,x0678,3.205655,active-noncovalent
Cc1c(sc[n+]1CC(=O)c2ccccc2)C,BRD-K96029467-003-01-9,alagebrium,OxChem,AX8020322,,-8.626831,x0749,-0.781083,active-covalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)NC(=O)C)O,BRD-A41304429-001-17-1,practolol,Sigma,SML1462,N-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide,-8.626266,x0104,1.664029,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)NC(=O)C)O,BRD-A41304429-001-14-8,practolol,Prestwick,Prestw-332,Practolol,-8.626266,x0104,1.664029,active-noncovalent
CC(=O)N[C@H](Cc1c[nH]c2c1cccc2)C(=O)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,BRD-K37952347-001-02-2,"L-732,138",Tocris,868,"L-732,138",-8.626165,x1077,5.235257,active-noncovalent
CC(=O)N[C@H](Cc1c[nH]c2c1cccc2)C(=O)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,BRD-K37952347-001-01-4,"L-732,138",Tocris,868,"L-732,138",-8.626165,x1077,5.235257,active-noncovalent
c1cc(ccc1n2cc(c3c2ccc(c3)Cl)C4CC[NH+](CC4)CCN5CCNC5=O)F,BRD-K69116396-001-04-1,sertindole,Prestwick,Prestw-1341,Sertindole,-8.625791,x1077,6.309246,active-noncovalent
Cc1ccc(c(c1)C)c2csc(n2)NC(=O)c3ccccc3,BRD-K70177501-003-01-4,INH1,Tocris,3551,INH1,-8.625279,x0749,1.128519,active-covalent
c1cc(ccc1C2=CC[N@H+](CC2)CCCC[C@@]34CCCc5c3c(ccc5Cl)NC4=O)Cl,BRD-A39794701-003-01-6,DR-4485,Tocris,5005,DR 4485 hydrochloride,-8.624872,x0161,6.257133,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(c(c1)Cc2ccc(cc2Cl)Cl)O,BRD-K02900412-001-11-3,clofoctol,Selleck,S4394,Clofoctol,-8.624871,x0161,1.449557,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(c(c1)Cc2ccc(cc2Cl)Cl)O,BRD-K02900412-001-12-1,clofoctol,MicroSource,1503206,CLOFOCTOL,-8.624871,x0161,1.449557,active-noncovalent
c1ccc(cc1)c2cc(n3c(n2)c(cn3)C(=O)NCCC[NH+]4CCOCC4)c5ccccc5,BRD-K79700588-001-09-7,reversan,Tocris,3722,Reversan,-8.624632,x0161,6.07509,active-noncovalent
CC[NH2+]C[C@@H](c1cccc(c1)O)O,BRD-A09925278-003-05-6,etilefrine,Prestwick,Prestw-1017,Etilefrine hydrochloride,-8.624472,x0434,-0.562904,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K76617868-003-14-3,fasudil,Tocris,541,Fasudil hydrochloride,-8.623689,x0072,-0.223502,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K76617868-003-11-9,fasudil,Tocris,541,Fasudil hydrochloride,-8.623689,x0072,-0.223502,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K76617868-001-05-5,fasudil,MicroSource,1502366,FASUDIL HYDROCHLORIDE,-8.623689,x0072,-0.223502,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K76617868-003-10-1,fasudil,Selleck,S1573,Fasudil (HA-1077) HCl,-8.623689,x0072,-0.223502,active-noncovalent
c1ccc2c(c1)c(=O)n3c(n2)CCCCC3,BRD-K77756533-001-01-4,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",Vitas-M,STL281810,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",-8.623666,x0749,-0.589382,active-covalent
c1ccc2c(c1)c(=O)n3c(n2)CCCCC3,BRD-K28773847-001-07-7,RLX,Vitas-M,STL281810,,-8.623666,x0749,-0.589382,active-covalent
Cc1ccccc1[C@H](c2ccccc2)OCC[NH+](C)C,BRD-A53576514-048-13-5,orphenadrine,Selleck,S2054,Orphenadrine Citrate,-8.622473,x0195,-0.482945,active-noncovalent
Cc1ccccc1[C@H](c2ccccc2)OCC[NH+](C)C,BRD-A53576514-048-14-3,orphenadrine,MicroSource,1500447,ORPHENADRINE CITRATE,-8.622473,x0195,-0.482945,active-noncovalent
c1ccc2c(c1)cc(s2)C(=O)Nc3ccccc3C(=O)N[C@@H]4CCCCNC4=O,BRD-A19609491-001-01-8,ANA-12,Tocris,4781,ANA 12,-8.621393,x0692,4.783695,active-covalent
c1ccc(cc1)CNC(=O)CCNNC(=O)c2ccncc2,BRD-K12102668-001-24-8,nialamide,Selleck,S4342,Nialamide,-8.621371,x0107,0.795495,active-noncovalent
c1ccc(cc1)CNC(=O)CCNNC(=O)c2ccncc2,BRD-K12102668-001-25-5,nialamide,MicroSource,1505986,NIALAMIDE,-8.621371,x0107,0.795495,active-noncovalent
COc1ccc(cc1)Nc2ccn(n2)c3ccccc3,BRD-K59875992-001-01-8,FPL-62064,Astatech,FD7168,N-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-3-AMINE,-8.621202,x0946,1.70691,active-noncovalent
c1cc2c(csc2c(c1)Cl)CO[C@H](Cn3ccnc3)c4ccc(cc4Cl)Cl,BRD-A95939040-001-01-2,sertaconazole,Selleck,S3161,Sertaconazole nitrate,-8.621009,x0195,2.545939,active-noncovalent
C=CCOc1ccc(cc1Cl)CC(=O)[O-],BRD-K47492008-001-02-7,alclofenac,Sigma,MFCD00071612,[4-(allyloxy)-3-chlorophenyl]acetic acid,-8.619066,x0749,-0.030984,active-covalent
COc1ccc(cc1OC)C[C@H]2COC(=O)[C@@H]2Cc3ccc(c(c3)OC)O,BRD-K53523901-001-04-4,arctigenin,Tocris,1777,Arctigenin,-8.618246,x0195,3.794466,active-noncovalent
COc1ccc(cc1OC)C[C@H]2COC(=O)[C@@H]2Cc3ccc(c(c3)OC)O,BRD-K53523901-001-05-1,arctigenin,Tocris,1777,Arctigenin,-8.618246,x0195,3.794466,active-noncovalent
Cc1cccc(c1NC(=O)NC(=[NH2+])NC)C,BRD-K68693535-001-03-4,lidamidine,ChemDiv,8009-0514,,-8.617196,x0104,-1.190103,active-noncovalent
c1cc(ccc1N2CCOCC2=O)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl,BRD-K37130656-001-03-8,rivaroxaban,MicroSource,1504372,RIVAROXABAN,-8.616564,x0104,3.288961,active-noncovalent
c1cc(ccc1N2CCOCC2=O)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl,BRD-K37130656-001-04-6,rivaroxaban,Selleck,S3002,Rivaroxaban,-8.616564,x0104,3.288961,active-noncovalent
CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N,BRD-K59317601-001-05-5,MLN0128,Selleck,S2811,INK 128 (MLN0128),-8.616176,x0107,0.928758,active-noncovalent
C[C@]1(CCC[NH2+]1)c2[nH]c3c(cccc3n2)C(=O)N,BRD-K12737986-001-01-4,veliparib,Selleck,S1004,Veliparib (ABT-888),-8.615685,x0104,-0.157862,active-noncovalent
CC(c1n(nc2c1cc(cc2)c3nc(ncc3)N[C@H]4CC[C@@H](CC4)[NH2+]C5CCOCC5)C)C,BRD-K15382985-001-01-7,LY2857785,MedChemEx,HY-12293,LY2857785,-8.615601,x0161,10.647203,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)CC3CCCC3,BRD-A41250306-001-11-7,cyclopenthiazide,Prestwick,Prestw-994,Cyclopenthiazide,-8.614271,x1093,2.302065,active-noncovalent
C[NH+](C)CCN(Cc1cccs1)c2ccccn2,BRD-K47323024-003-24-4,methapyrilene,Selleck,S4337,Methapyrilene HCl,-8.614017,x0434,0.954022,active-noncovalent
C[NH+](C)CCN(Cc1cccs1)c2ccccn2,BRD-K47323024-003-25-1,methapyrilene,MicroSource,1503229,METHAPYRILENE HYDROCHLORIDE,-8.614017,x0434,0.954022,active-noncovalent
c1ccc(c(c1)c2cn3c(csc3[nH+]2)CN4CC[NH2+]CC4)NC(=O)c5cnc6ccccc6n5,BRD-K95926480-003-03-6,SRT1720,Selleck,S1129,SRT1720,-8.613928,x0874,7.887377,active-noncovalent
CC1(CCC(c2c1ccc(c2)C#Cc3ccc(cc3)C(=O)[O-])(C)C)C,BRD-K81004638-001-02-5,EC-23,Tocris,4011,EC 23,-8.613768,x0104,4.151303,active-noncovalent
CC1(CCC(c2c1ccc(c2)C#Cc3ccc(cc3)C(=O)[O-])(C)C)C,BRD-K81004638-001-01-7,EC-23,Sigma,MFCD18086921,"4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)ethynyl]benzoic acid",-8.613768,x0104,4.151303,active-noncovalent
CC1CC[NH+](CC1)[C@H](c2ccc(cc2)F)c3ccc(cc3c4ccc(cc4)C(F)(F)F)[C@H](C)C(=O)[O-],BRD-A66521565-001-01-8,TC-E-5006,Tocris,4898,TC-E 5006,-8.613317,x0161,5.099864,active-noncovalent
c1ccc(c(c1)CC(=O)OCC(=O)[O-])Nc2c(cccc2Cl)Cl,BRD-K68538666-001-12-3,aceclofenac,MicroSource,1502375,ACECLOFENAC,-8.611413,x0678,0.722893,active-noncovalent
c1ccc(cc1)c2c(oc(n2)c3c(ocn3)c4cccc(c4)OCC(=O)[O-])c5ccccc5,BRD-K84895041-001-02-4,BMY-45778,Tocris,1442,BMY 45778,-8.611387,x0195,7.303289,active-noncovalent
CC1CC[NH+](CC1)CC[C@H]2CCC[N@@]2S(=O)(=O)c3cccc(c3)O,BRD-K24201553-003-12-3,SB-269970,Tocris,1612,SB 269970 hydrochloride,-8.611213,x0072,1.746502,active-noncovalent
CC1CC[NH+](CC1)CC[C@H]2CCC[N@@]2S(=O)(=O)c3cccc(c3)O,BRD-K24201553-003-11-5,SB-269970,Tocris,1612,SB 269970 hydrochloride,-8.611213,x0072,1.746502,active-noncovalent
CC1CC[NH+](CC1)CC[C@H]2CCC[N@@]2S(=O)(=O)c3cccc(c3)O,BRD-K24201553-003-10-7,SB-269970,Selleck,S2849,SB269970 HCl,-8.611213,x0072,1.746502,active-noncovalent
CC[C@@H](C)N(C)C(=O)c1cc2ccccc2c(n1)c3ccccc3Cl,BRD-A41451487-001-12-0,PK-11195,Tocris,670,PK 11195,-8.610704,x0195,1.343668,active-noncovalent
CC[C@@H](C)N(C)C(=O)c1cc2ccccc2c(n1)c3ccccc3Cl,BRD-A41451487-001-11-2,PK-11195,Tocris,670,PK 11195,-8.610704,x0195,1.343668,active-noncovalent
C[C@@H](c1ccccc1)Nc2cc(ccn2)c3c(nc([nH]3)SC)c4ccc(cc4)F,BRD-A29014990-001-02-3,ML-3403,Tocris,4586,ML 3403,-8.609939,x0831,1.396078,active-covalent
c1ccc(cc1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])c3ccccc3,BRD-K53809807-304-02-4,fosphenytoin,CombiBlocks,QA-8988,"sodium (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate",-8.609596,x0678,1.758236,active-noncovalent
c1ccc(cc1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])c3ccccc3,BRD-K53809807-304-01-6,fosphenytoin,AKSci,K681,,-8.609596,x0678,1.758236,active-noncovalent
Cc1c[nH+]c2n1-c3ccc(cc3[C@H](N=C2CCC(=O)OC)c4ccccn4)Br,BRD-K89413285-074-01-5,remimazolam,MedChemEx,HY-14867A,Remimazolam (benzenesulfonate),-8.609148,x0195,4.693167,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4([C@H](C=O)O)O)C,BRD-K43736954-001-22-3,cortodoxone,Vitas-M,STK764479,"17,21-dihydroxypregn-4-ene-3,20-dione",-8.608715,x0195,2.457387,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K01577834-001-16-9,adenosine,Selleck,S1647,Adenosine,-8.608617,x0195,-0.541328,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K01577834-001-15-1,adenosine,MicroSource,1500107,ADENOSINE,-8.608617,x0195,-0.541328,active-noncovalent
CC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C)O[C@@](O2)(C)c6ccccc6,BRD-A41774846-001-01-4,algestone-acetophenide,Prestwick,Prestw-1715,Algestone acetophenide,-8.607859,x1077,4.840492,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)C#N)N)O,BRD-A65440446-001-04-1,cimaterol,Tocris,435,Cimaterol,-8.607735,x0104,-0.982401,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-001-02-0,tianeptine,MedChemEx,HY-90003,Tianeptine,-8.607548,x1077,2.321794,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-236-07-1,tianeptine,Selleck,S1436,Tianeptine sodium,-8.607548,x1077,2.321794,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-236-06-3,tianeptine,Tocris,1972,Tianeptine sodium salt,-8.607548,x1077,2.321794,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-236-09-7,tianeptine,MedChemEx,HY-90003A,Tianeptine (sodium salt),-8.607548,x1077,2.321794,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-236-05-5,tianeptine,Selleck,S1436,Tianeptine sodium,-8.607548,x1077,2.321794,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],BRD-A53077924-001-01-2,tianeptine,MedChemEx,HY-90003,Tianeptine,-8.607548,x1077,2.321794,active-noncovalent
c1cc(ccc1C(=O)NCCC[NH+]2CCOCC2)Cl,BRD-K17979676-001-01-2,eprobemide,MicroSource,1503886,EPROBEMIDE,-8.606370,x0946,0.439233,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@H](CF)NC(=O)C(Cl)Cl)O,BRD-A30886737-001-02-9,florfenicol,MicroSource,1505978,FLORFENICOL,-8.606236,x1077,0.427112,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NCc2ccccc2,BRD-K64178227-001-09-0,BTS,Tocris,1870,BTS,-8.606181,x1093,-1.236166,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NCc2ccccc2,BRD-K64178227-001-10-8,BTS,Tocris,1870,BTS,-8.606181,x1093,-1.236166,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@@]2CCC[C@H]2c3ccc(cc3)F,BRD-K91333421-001-01-9,Ro-67-7476,Tocris,4346,Ro 67-7476,-8.605594,x1093,0.258748,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)I,BRD-K69216798-001-01-9,iodoantipyrine,AlfaAesar,L14009,"Iodoantipyrine, 99%",-8.603910,x0195,-1.056804,active-noncovalent
c1ccc(cc1)c2cc(sc2C(F)(F)F)c3nc(no3)c4cccc(c4)C(F)(F)F,BRD-K15601958-001-03-9,SEW-2871,Tocris,2284,SEW 2871,-8.603834,x0161,6.219273,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)c3c[nH]c4c3cccc4)Cl)N5CCC(CC5)[NH3+],BRD-K24593301-001-01-5,AZD3463,Selleck,S7106,AZD3463,-8.602140,x0161,7.617363,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)c3c[nH]c4c3cccc4)Cl)N5CCC(CC5)[NH3+],BRD-K24593301-001-02-3,AZD3463,Selleck,S7106,AZD3463,-8.602140,x0161,7.617363,active-noncovalent
COc1cccc(c1)C[NH+]2C[Si](O[Si](C2)(C)C)(C)C,BRD-K76139886-003-01-3,compound-58112,Sigma,MFCD10465434,"4-(3-methoxybenzyl)-2,2,6,6-tetramethyl-1,4,2,6-oxazadisilinane hydrochloride",-8.602086,x0434,1.516559,active-noncovalent
c1ccc(cc1)Sc2ccc(cc2)CO[C@H](Cn3ccnc3)c4ccc(cc4Cl)Cl,BRD-A33697453-008-02-4,fenticonazole,Selleck,S2031,Fenticonazole Nitrate,-8.600594,x0107,4.54265,active-noncovalent
CC(=O)O[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,BRD-A09349126-001-10-7,norethindrone-acetate,MicroSource,1500438,NORETHINDRONE ACETATE,-8.599212,x0749,2.416832,active-covalent
CC(C)(C(=O)N1CCN(CC1)c2ccc(c(c2)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5)C(F)(F)F)O,BRD-K49461364-001-02-8,TCS-21311,Tocris,4221,TCS 21311,-8.599113,x0434,6.817516,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-27-3,budesonide,Tocris,2671,Budesonide,-8.598451,x1077,4.963143,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-29-9,budesonide,MicroSource,1500813,BUDESONIDE,-8.598451,x1077,4.963143,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-22-4,budesonide,Tocris,2671,Budesonide,-8.598451,x1077,4.963143,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-28-1,budesonide,MedChemEx,HY-13580,Budesonide,-8.598451,x1077,4.963143,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-26-5,budesonide,MedChemEx,HY-13580,Budesonide,-8.598451,x1077,4.963143,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,BRD-A34299591-001-25-7,budesonide,Sigma,MFCD00083259,"(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one",-8.598451,x1077,4.963143,active-noncovalent
Cc1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)F,BRD-K26901728-001-05-4,lumiracoxib,Selleck,S2903,Lumiracoxib,-8.598218,x0195,0.082543,active-noncovalent
Cc1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)F,BRD-K26901728-001-06-2,lumiracoxib,MicroSource,1502387,LUMIRACOXIB,-8.598218,x0195,0.082543,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C,BRD-A79380603-304-02-4,dexamethasone-sodium-phosphate,MicroSource,1505725,BETAMETHASONE SODIUM PHOSPHATE,-8.597748,x0072,4.465572,active-noncovalent
c1cc(cc(c1)O)c2c(nc3c(n2)c(nc(n3)N)N)c4cccc(c4)O,BRD-K64785675-001-04-0,TG100-115,Selleck,S1352,TG100-115,-8.597368,x0161,1.427267,active-noncovalent
c1cc2c(cc1c3ccc4[nH+]cc(n4c3)C(=O)N5CCOCC5)nc(o2)N,BRD-K73877023-001-01-9,MLN1117,MedChemEx,HY-12285,MLN1117,-8.596728,x0107,3.34799,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCC(=O)[O-],BRD-K21071223-001-02-8,VP-20629,ChemDiv,5830-0516,,-8.596369,x0749,-2.112264,active-covalent
CCN(CC)C(=O)N[C@@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,BRD-K67943528-050-01-4,lisuride,Enzo,AC1560,Lisuride Maleate,-8.596147,x1392,1.306347,active-covalent
C[C@@H]1C[N@](CC[NH2+]1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,BRD-A74980173-213-01-1,gatifloxacin,MicroSource,1504272,GATIFLOXACIN,-8.595735,x0195,4.071667,active-noncovalent
C[C@@H]1C[N@](CC[NH2+]1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,BRD-A74980173-001-11-9,gatifloxacin,Selleck,S1340,Gatifloxacin,-8.595735,x0195,4.071667,active-noncovalent
C[C@H]1CO[C@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)[O-],BRD-K76819217-001-01-4,cabotegravir,Selleck,S7766,"Cabotegravir (GSK744, GSK1265744)",-8.595482,x0161,5.751708,active-noncovalent
C[C@H]1CO[C@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)[O-],BRD-K76819217-001-02-2,cabotegravir,MedChemEx,HY-15592,"(3S,11aR)-N-(2,4-difluorobenzyl)-3-methyl-5,6,7-trioxo-2,3,5,5a,6,7,11,11a-octahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide",-8.595482,x0161,5.751708,active-noncovalent
c1cn(c(n1)N(=O)=O)C[C@H](C[NH+]2CCCCC2)O,BRD-A67521319-001-01-6,pimonidazole,Cayman,89130,,-8.595352,x0104,0.250661,active-noncovalent
C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O,BRD-K77841042-001-15-8,brefeldin-a,Tocris,1231,Brefeldin A,-8.594706,x0946,1.759578,active-noncovalent
C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O,BRD-K77841042-001-14-1,brefeldin-a,Tocris,1231,Brefeldin A,-8.594706,x0946,1.759578,active-noncovalent
C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O,BRD-K77841042-001-11-7,brefeldin-a,Selleck,S7046,Brefeldin A,-8.594706,x0946,1.759578,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)N/C(=N\C)/NC#N,BRD-A62071884-001-06-1,siguazodan,Tocris,1148,Siguazodan,-8.593851,x0678,1.301207,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)N/C(=N\C)/NC#N,BRD-A62071884-001-04-6,siguazodan,Tocris,1148,Siguazodan,-8.593851,x0678,1.301207,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)O)CC[NH3+],BRD-K64137799-003-03-3,2-methyl-5-hydroxytryptamine,Tocris,558,3-(2-aminoethyl)-2-methyl-1H-indol-5-ol hydrochloride,-8.592785,x0305,-1.403961,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)O)CC[NH3+],BRD-K64137799-003-02-5,2-methyl-5-hydroxytryptamine,Tocris,558,2-Methyl-5-hydroxytryptamine hydrochloride,-8.592785,x0305,-1.403961,active-noncovalent
CCN(CC)c1ccc(cc1)C/N=N/C(=O)c2ccc(cc2)O,BRD-K58343622-001-02-4,DY131,Tocris,2266,DY131,-8.592434,x0946,1.050292,active-noncovalent
CCN(CC)c1ccc(cc1)C/N=N/C(=O)c2ccc(cc2)O,BRD-K58343622-001-01-6,DY131,Tocris,2266,DY131,-8.592434,x0946,1.050292,active-noncovalent
c1cc(c(cc1Br)c2[n-]nnn2)NC(=S)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F,BRD-K94342292-001-01-3,NS-11021,Tocris,4788,NS 11021,-8.592110,x0161,3.961824,active-noncovalent
COc1ccc(cc1)n2c(=O)c3cnc4c(c3[nH]2)CCCCC4,BRD-K68103045-001-02-9,CGS-20625,Tocris,2467,CGS 20625,-8.591517,x0107,1.956227,active-noncovalent
COc1ccc(cc1)n2c(=O)c3cnc4c(c3[nH]2)CCCCC4,BRD-K68103045-001-03-7,CGS-20625,Tocris,2467,CGS 20625,-8.591517,x0107,1.956227,active-noncovalent
CCCCCCCCCCCC1=C(C(=CC(=O)C1=O)[O-])[O-],BRD-K86727142-001-11-6,embelin,Selleck,S7025,Embelin,-8.591164,x0107,1.025011,active-noncovalent
CCCCCCCCCCCC1=C(C(=CC(=O)C1=O)[O-])[O-],BRD-K86727142-001-13-2,embelin,Selleck,S7025,Embelin,-8.591164,x0107,1.025011,active-noncovalent
CCCCCCCCCCCC1=C(C(=CC(=O)C1=O)[O-])[O-],BRD-K86727142-001-12-4,embelin,Tocris,2156,Embelin,-8.591164,x0107,1.025011,active-noncovalent
CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(nc2=O)N)(C)F)OC(=O)C(C)C,BRD-K69726595-001-01-2,mericitabine,MedChemEx,HY-10240,R-7128,-8.591146,x0678,3.815764,active-noncovalent
c1cc(ccc1[C@H](C#N)c2c(cc(cc2Cl)n3c(=O)[nH]c(=O)cn3)Cl)Cl,BRD-A06426627-001-04-3,diclazuril,MicroSource,1502348,DICLAZURIL,-8.590385,x0161,4.348168,active-noncovalent
c1cc(ccc1[C@H](C#N)c2c(cc(cc2Cl)n3c(=O)[nH]c(=O)cn3)Cl)Cl,BRD-A06426627-001-03-5,diclazuril,Selleck,S2028,Diclazuril,-8.590385,x0161,4.348168,active-noncovalent
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(CC=C)O,BRD-K14619660-001-01-5,altrenogest,Selleck,S3167,Altrenogest,-8.590300,x0104,1.94704,active-noncovalent
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(CC=C)O,BRD-K14619660-001-02-3,altrenogest,MicroSource,1505703,ALTRENOGEST,-8.590300,x0104,1.94704,active-noncovalent
c1cc(ccc1c2ccc(cn2)CO[C@H]3Cn4cc([nH+]c4OC3)N(=O)=O)OC(F)(F)F,BRD-K56405978-001-01-5,TBA-354,MedChemEx,HY-12485,TBA-354,-8.589870,x0104,12.034889,active-noncovalent
COC(=O)[C@@H](Cc1ccc(c(c1)O)O)[NH3+],BRD-A25827085-001-01-0,melevodopa,Vitas-M,STK874011,,-8.589643,x0387,-1.669444,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],BRD-K83776863-001-05-5,tryptophan,MicroSource,1500600,TRYPTOPHAN (L),-8.588454,x0195,-1.896073,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],BRD-K83776863-001-08-9,tryptophan,Sigma,T4196,L-tryptophan,-8.588454,x0195,-1.896073,active-noncovalent
CCC[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(CCC(=O)[O-])O)C,BRD-K37687387-237-01-7,RU-28318,Tocris,1672,"RU 28318, potassium salt",-8.588359,x0830,6.18369,active-covalent
c1ccc2c(c1)c3c([nH]2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,BRD-A47342814-003-02-6,naltrindole,Tocris,740,Naltrindole hydrochloride,-8.588151,x0072,2.740358,active-noncovalent
c1ccc2c(c1)c3c([nH]2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,BRD-A47342814-003-01-8,naltrindole,Tocris,740,Naltrindole hydrochloride,-8.588151,x0072,2.740358,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)OC(=O)c3ccc(cc3)Cl)N(=O)=O,BRD-K37933329-001-01-6,BTB06584,Selleck,S7460,BTB06584,-8.587694,x1077,2.619054,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)OC(=O)c3ccc(cc3)Cl)N(=O)=O,BRD-K37933329-001-02-4,BTB06584,Selleck,S7460,BTB06584,-8.587694,x1077,2.619054,active-noncovalent
CCOc1ccccc1O[C@H](c2ccccc2)[C@H]3C[NH2+]CCO3,BRD-M39350793-334-01-1,reboxetine,Tocris,1982,Reboxetine mesylate,-8.587440,x0678,-0.152651,active-noncovalent
CCOc1ccccc1O[C@H](c2ccccc2)[C@H]3C[NH2+]CCO3,BRD-M39350793-334-02-9,reboxetine,Tocris,1982,Reboxetine mesylate,-8.587440,x0678,-0.152651,active-noncovalent
CCOc1ccccc1O[C@H](c2ccccc2)[C@H]3C[NH2+]CCO3,BRD-K77224738-066-02-7,reboxetine,Selleck,S3199,Reboxetine mesylate,-8.587440,x0678,-0.152651,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cc(cc3)Cl,BRD-K52989797-003-28-0,clomipramine,MicroSource,2300061,CLOMIPRAMINE HYDROCHLORIDE,-8.586631,x0072,0.390731,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cc(cc3)Cl,BRD-K52989797-003-27-2,clomipramine,Tocris,457,Clomipramine hydrochloride,-8.586631,x0072,0.390731,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cc(cc3)Cl,BRD-K52989797-003-26-4,clomipramine,Selleck,S2541,Clomipramine HCl,-8.586631,x0072,0.390731,active-noncovalent
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,BRD-K46331928-001-08-2,ethynodiol-diacetate,Selleck,S3160,Ethynodiol diacetate,-8.586174,x0104,3.568216,active-noncovalent
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,BRD-K46331928-001-05-8,ethynodiol-diacetate,MicroSource,1505979,ETHYNODIOL DIACETATE,-8.586174,x0104,3.568216,active-noncovalent
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,BRD-K46331928-001-06-6,ethynodiol-diacetate,Selleck,S3160,Ethynodiol diacetate,-8.586174,x0104,3.568216,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)OC[C@H](c4ccccc4)C(=O)[O-],BRD-A34603619-001-01-9,tropesin,Sigma,MFCD00896425,3-({[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}oxy)-2-phenylpropanoic acid,-8.585983,x0161,7.039073,active-noncovalent
Cc1ccc(cc1Nc2c3cnn(c3nc(n2)c4cccnc4)C)C(=O)Nc5cccc(c5)C(F)(F)F,BRD-K79259477-001-04-9,NVP-BHG712,Selleck,S2202,NVP-BHG712,-8.585416,x0161,9.690691,active-noncovalent
c1c2c(cc(c1Cl)Br)ncn(c2=O)CC(=O)C[C@@H]3[C@H](CCC[NH2+]3)O,BRD-K54247840-004-01-3,halofuginone,EMDBio,505763-10MG,"ProRS Inhibitor, Halofuginone",-8.585073,x0161,1.133683,active-noncovalent
c1cc2cn(nc2c(c1)C(=O)N)c3ccc(cc3)[C@@H]4CCC[NH2+]C4,BRD-K54955827-001-01-4,niraparib,MedChemEx,HY-10619,MK-4827,-8.584419,x0104,2.354867,active-noncovalent
c1cc2cn(nc2c(c1)C(=O)N)c3ccc(cc3)[C@@H]4CCC[NH2+]C4,BRD-K54955827-001-02-2,niraparib,MedChemEx,HY-10619,MK-4827,-8.584419,x0104,2.354867,active-noncovalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K68402494-003-04-3,ML-9,Tocris,431,ML 9 hydrochloride,-8.583404,x0946,1.390376,active-noncovalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K68402494-003-03-5,ML-9,Tocris,431,ML 9 hydrochloride,-8.583404,x0946,1.390376,active-noncovalent
Cc1cccc(c1C)Cc2c[nH]cn2,BRD-K77597856-003-02-5,detomidine,Selleck,S2092,Detomidine HCl,-8.583353,x0678,-2.493786,active-noncovalent
CC(C)(C#N)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2,BRD-K52172416-001-11-4,anastrozole,MicroSource,1502278,ANASTROZOLE,-8.583186,x0107,1.665414,active-noncovalent
CC(C)(C#N)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2,BRD-K52172416-001-10-6,anastrozole,Selleck,S1188,Anastrozole,-8.583186,x0107,1.665414,active-noncovalent
CC(C)(C#N)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2,BRD-K52172416-001-14-8,anastrozole,Tocris,3388,Anastrozole,-8.583186,x0107,1.665414,active-noncovalent
Cc1cc2c(cc1C=O)n(c-3nc(=O)[nH]c(=O)c3n2)C,BRD-K00486786-001-02-2,Ro-08-2750,Tocris,2272,Ro 08-2750,-8.583075,x0967,-0.030166,active-noncovalent
CCCCCCCCCCCC(=O)OC[C@@H](CO)O,BRD-A10773072-001-03-4,glycerol-monolaurate,Sigma,MFCD00037815,"2,3-dihydroxypropyl laurate",-8.582887,x0104,0.461972,active-noncovalent
CC[C@@H](C)[C@H](c1ccccc1)C(=O)OCC[N+](C)(CC)CC,BRD-A56613951-004-01-1,valethamate,Sigma,MFCD00031617,"N,N-diethyl-N-methyl-2-[(3-methyl-2-phenylpentanoyl)oxy]ethanaminium bromide",-8.582633,x1093,1.079539,active-noncovalent
c1c[n+](ccc1CN=O)COC[n+]2ccc(cc2)CN=O,BRD-K33588785-001-01-9,obidoxime,Vitas-M,STL371145,,-8.582040,x0195,2.187441,active-noncovalent
COc1cc(cc(c1)OC)c2ccc3c(n[nH]c3n2)c4ccc(cc4)F,BRD-K72748448-001-01-0,APcK-110,Tocris,3704,APcK 110,-8.582015,x0104,4.588225,active-noncovalent
c1cc2c(cc1C(=O)[O-])oc(n2)c3cc(cc(c3)Cl)Cl,BRD-K23728141-001-01-2,tafamidis-meglumine,MedChemEx,HY-14852,Tafamidis,-8.581557,x0749,3.237506,active-covalent
c1ccc(cc1)C2=CC[N@H+](CC2)CCCCc3c[nH]c4c3cc(cc4)C(=O)[O-],BRD-K82484965-003-03-5,carmoxirole,Tocris,2193,Carmoxirole hydrochloride,-8.581454,x0195,3.078774,active-noncovalent
c1ccc(cc1)C2=CC[N@H+](CC2)CCCCc3c[nH]c4c3cc(cc4)C(=O)[O-],BRD-K82484965-003-04-3,carmoxirole,Tocris,2193,"3-[4-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)butyl]-1H-indole-5-carboxylic acid hydrochloride",-8.581454,x0195,3.078774,active-noncovalent
CCCCCCNC(=O)n1cc(c(=O)[nH]c1=O)F,BRD-K11630072-001-11-6,carmofur,Selleck,S1289,Carmofur,-8.581223,x0195,-0.387295,active-noncovalent
CCCCCCNC(=O)n1cc(c(=O)[nH]c1=O)F,BRD-K11630072-001-12-4,carmofur,MicroSource,1505317,CARMOFUR,-8.581223,x0195,-0.387295,active-noncovalent
CCCCCCNC(=O)n1cc(c(=O)[nH]c1=O)F,BRD-K11630072-001-13-2,carmofur,Selleck,S1289,Carmofur,-8.581223,x0195,-0.387295,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1OC)O,BRD-A51747092-003-03-0,moprolol,LifeChem,F3314-0163,,-8.581197,x0104,0.247142,active-noncovalent
CC(C)C(=O)c1ccc(c(c1)O)O,BRD-K08953028-001-09-6,U-0521,SantaCruz,sc-200745,,-8.581099,x0195,0.140887,active-noncovalent
c1ccc(cc1)OCCCCOc2c3ccc(=O)oc3cc4c2cco4,BRD-K62427771-001-01-0,AS-77,MedChemEx,HY-10015,PAP-1,-8.580244,x0195,2.397995,active-noncovalent
C[NH+](C)Cc1ccc(cc1)S(=O)(=O)n2ccc(c2)CCC(=O)N=O,BRD-K28822270-001-01-1,resminostat,Selleck,S2693,Resminostat,-8.579951,x0072,2.78676,active-noncovalent
C[NH+](C)Cc1ccc(cc1)S(=O)(=O)n2ccc(c2)CCC(=O)N=O,BRD-K28822270-001-03-7,resminostat,Selleck,S2693,Resminostat (RAS2410),-8.579951,x0072,2.78676,active-noncovalent
CC1(CC1)/N=C\2/Nc3cc(sc3S(=O)(=O)N2)Cl,BRD-K20568871-001-01-1,tifenazoxide,Sigma,SML0553,"6-chloro-N-(1-methylcyclopropyl)-4H-thieno[3,2-e][1,2,4]thiadiazin-3-amine 1,1-dioxide",-8.579398,x0749,-0.984991,active-covalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)[NH3+])[NH3+],BRD-K73425385-001-01-9,bekanamycin,Selleck,S4383,Bekanamycin,-8.579332,x0678,4.055169,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)[NH3+])[NH3+],BRD-K73425385-065-04-8,bekanamycin,MicroSource,1500812,BEKANAMYCIN SULFATE,-8.579332,x0678,4.055169,active-noncovalent
CCCOc1ccc(cc1c2cc([nH]c2c3ccncc3)c4ccc(cc4)Cl)Br,BRD-K18036262-001-03-6,L-168049,Tocris,2311,"L-168,049",-8.579216,x0678,4.926638,active-noncovalent
CCCOc1ccc(cc1c2cc([nH]c2c3ccncc3)c4ccc(cc4)Cl)Br,BRD-K18036262-001-02-8,L-168049,Tocris,2311,"L-168,049",-8.579216,x0678,4.926638,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F,BRD-K79425933-001-09-3,benperidol,Prestwick,Prestw-484,Benperidol,-8.578989,x0874,4.324753,active-noncovalent
CCOC(=O)c1c2c3ccccc3c(=O)c4cccc(nc1=O)[C@@H]42,BRD-K61918008-001-07-1,NQDI-1,MedChemEx,HY-19566,NQDI-1,-8.577385,x0195,2.494888,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)Nc4ccc(cc4)O)c5ccc(cc5)Cl)C,BRD-K43471985-001-05-5,OTX015,Selleck,S7360,OTX015,-8.576809,x0678,5.256604,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)Nc4ccc(cc4)O)c5ccc(cc5)Cl)C,BRD-K43471985-001-03-0,OTX015,Selleck,S7360,OTX015,-8.576809,x0678,5.256604,active-noncovalent
Cc1ccc2c(c1Sc3ccncc3)c(=O)[nH]c(n2)N,BRD-K36636143-001-01-0,nolatrexed,AvaChem,2072,2-amino-6-methyl-5-(4-pyridinylsulfanyl)-4(3H)-quinazolinone,-8.576667,x1077,-0.470494,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@H]3Cn4c(c5ccccc5nc4=O)N3,BRD-A04661934-001-02-9,2-PMDQ,Tocris,627,2-PMDQ,-8.576015,x0104,3.161504,active-noncovalent
Cc1[nH]c2c(n1)-c3ccccc3N(CC2)C(=O)c4ccc(cc4)NC(=O)c5ccccc5c6ccccc6,BRD-K37385792-003-02-1,conivaptan,Selleck,S2116,Conivaptan HCl,-8.575799,x0104,9.307357,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(c(c(c1)Cl)N)C(F)(F)F)O,BRD-A13116749-003-01-6,mabuterol,Sigma,32573,1-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-2-(tert-butylamino)ethanol hydrochloride,-8.575526,x0104,1.133172,active-noncovalent
COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C,BRD-K70401845-003-09-6,erlotinib,Selleck,S1023,Erlotinib HCl (OSI-744),-8.575371,x0161,7.373699,active-noncovalent
COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C,BRD-K70401845-001-15-7,erlotinib,Selleck,S1023,Erlotinib,-8.575371,x0161,7.373699,active-noncovalent
C[C@](Cc1ccc(cc1)O)(C(=O)[O-])[NH3+],BRD-K83766205-001-03-8,metirosine,Enamine,Z1255434943,,-8.574902,x0678,-1.662198,active-noncovalent
Cn1c(cc(c1O)c2ccccc2)O,BRD-A18043272-001-09-9,phensuximide,MicroSource,1505458,PHENSUCCIMIDE,-8.574121,x0161,-0.840842,active-noncovalent
CC(C)[C@@H](C(=O)OC[C@@H](CO)OCn1cnc2c1nc([nH]c2=O)N)[NH3+],BRD-A50922295-003-05-0,valganciclovir,MicroSource,1503870,VALGANCICLOVIR HYDROCHLORIDE,-8.573707,x0397,2.349597,active-noncovalent
CC(C)[C@@H](C(=O)OC[C@@H](CO)OCn1cnc2c1nc([nH]c2=O)N)[NH3+],BRD-A50922295-001-01-3,valganciclovir,Selleck,S4050,Valganciclovir HCl,-8.573707,x0397,2.349597,active-noncovalent
c1ccc2c(c1)c(=O)cc(o2)C(=O)[O-],BRD-K94720315-001-10-4,chromocarb,MicroSource,1503044,CHROMOCARB,-8.573547,x0195,-1.396586,active-noncovalent
c1ccc2c(c1)c(=O)cc(o2)C(=O)[O-],BRD-K94720315-001-09-6,chromocarb,Selleck,S4208,Chromocarb,-8.573547,x0195,-1.396586,active-noncovalent
C[NH+](C)CC[C@@H](c1ccc(cc1)Cl)c2ccccn2,BRD-K39462424-050-09-8,dexchlorpheniramine,MicroSource,1500183,DEXCHLORPHENIRAMINE MALEATE,-8.572924,x0072,0.486592,active-noncovalent
c1ccc(cc1)C(c2ccc(cc2)F)(c3ccc(cc3)F)C(=O)N,BRD-K21295289-001-01-6,senicapoc,MedChemEx,HY-50694,Senicapoc,-8.571761,x0195,-0.699505,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A04322457-003-15-3,isoprenaline,Selleck,S2566,Isoprenaline HCl,-8.569675,x0104,-0.503121,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A04322457-003-17-9,isoprenaline,MicroSource,1500357,ISOPROTERENOL HYDROCHLORIDE,-8.569675,x0104,-0.503121,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A04322457-003-16-1,isoprenaline,Tocris,1747,Isoproterenol hydrochloride,-8.569675,x0104,-0.503121,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A04322457-003-18-7,isoprenaline,Selleck,S2566,Isoprenaline hydrochloride,-8.569675,x0104,-0.503121,active-noncovalent
c1ccc(cc1)CCn2c3ccccc3nc2NC(=O)c4ccccc4,BRD-K13039700-066-01-2,GW-438014A,Tocris,4669,GW 438014A,-8.569530,x0195,1.399827,active-noncovalent
C[NH+](C)CCCCSC(=[NH2+])N,BRD-K49776472-300-03-2,SKF-91488,Tocris,512,SKF 91488 dihydrochloride,-8.569202,x0195,-0.929764,active-noncovalent
C[NH+](C)CCCCSC(=[NH2+])N,BRD-K49776472-300-02-4,SKF-91488,Tocris,512,SKF 91488 dihydrochloride,-8.569202,x0195,-0.929764,active-noncovalent
c1cc(cc(c1)C(F)(F)F)c2c(c(sn2)C(=O)[O-])N,BRD-K50813454-001-01-9,amflutizole,Enamine,Z2327605029,4-amino-3-[3-(trifluoromethyl)phenyl]-5-isothiazolecarboxylic acid,-8.568046,x0678,-0.512941,active-noncovalent
Cc1cc(no1)NC(=O)[C@@H](c2ccccc2)N3CCCc4c3cccc4,BRD-A75514485-001-01-9,CIM-0216,Tocris,5521,CIM 0216,-8.567966,x0195,1.016316,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,BRD-K49111258-003-28-9,prazosin,Tocris,623,Prazosin hydrochloride,-8.567277,x0161,6.979172,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,BRD-K49111258-003-27-1,prazosin,Selleck,S1424,Prazosin HCl,-8.567277,x0161,6.979172,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,BRD-K49111258-003-30-5,prazosin,Tocris,623,Prazosin hydrochloride,-8.567277,x0161,6.979172,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,BRD-K49111258-003-29-7,prazosin,MicroSource,1500495,PRAZOSIN HYDROCHLORIDE,-8.567277,x0161,6.979172,active-noncovalent
C[C@@H]1C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C,BRD-A10188456-001-04-9,dexamethasone,MicroSource,1500230,DEXAMETHASONE,-8.566739,x1077,3.331846,active-noncovalent
CC(=O)Nc1ccc(cc1)Cc2ccc(cc2)NC(=O)C,BRD-K44777625-001-03-5,FH1,Selleck,S7450,FH1(BRD-K4477),-8.566679,x0874,1.068891,active-noncovalent
CC(=O)Nc1ccc(cc1)Cc2ccc(cc2)NC(=O)C,BRD-K44777625-001-05-0,FH1,Tocris,5254,FH 1,-8.566679,x0874,1.068891,active-noncovalent
Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)[NH2+]CC(=O)N3CCC[C@H]3C#N,BRD-K05355328-001-01-1,anagliptin,MedChemEx,HY-14877,Anagliptin,-8.566365,x0831,5.9877,active-covalent
Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)[NH2+]CC(=O)N3CCC[C@H]3C#N,BRD-K05355328-001-02-9,anagliptin,MedChemEx,HY-14877,Anagliptin,-8.566365,x0831,5.9877,active-covalent
C/C=C\1/CS[C@@H]2/C(=N\C(=O)/C(=N\OCC(=O)[O-])/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K71059170-001-11-6,cefixime,Enzo,AC3047,CEFIXIME,-8.565940,x1077,4.696182,active-noncovalent
C/C=C\1/CS[C@@H]2/C(=N\C(=O)/C(=N\OCC(=O)[O-])/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K71059170-001-12-4,cefixime,MedChemEx,HY-B1381,Cefixime,-8.565940,x1077,4.696182,active-noncovalent
C/C=C\1/CS[C@@H]2/C(=N\C(=O)/C(=N\OCC(=O)[O-])/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K71059170-341-02-5,cefixime,Sigma,MFCD03788802,"(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]ethanoyl}amino)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trihydrate",-8.565940,x1077,4.696182,active-noncovalent
Cc1ccc(cc1)/C(=C\C=C\C(=C\C(=O)[O-])\C)/C=C/C2=C(CCCC2(C)C)C,BRD-K16229414-001-01-0,SR-11302,Tocris,2476,SR 11302,-8.565340,x0072,3.285957,active-noncovalent
c1ccc(c(c1)C(F)(F)F)n2ccnc2,BRD-K36851334-001-12-1,TRIM,Tocris,919,TRIM,-8.563854,x0195,-0.722277,active-noncovalent
c1c(c(cnc1N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,BRD-K62374002-001-01-5,PI3K-IN-2,MedChemEx,HY-12868,PQR309,-8.563664,x0107,4.948036,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCc4cc5c(cc4Cl)NC(=O)C5,BRD-K29582115-003-03-1,ziprasidone,Selleck,S1444,Ziprasidone HCl,-8.563255,x1077,4.461093,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCc4cc5c(cc4Cl)NC(=O)C5,BRD-K29582115-066-01-2,ziprasidone,MicroSource,1503850,ZIPRASIDONE MESYLATE,-8.563255,x1077,4.461093,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,BRD-K22429181-001-14-2,retinol,MicroSource,1501203,RETINOL,-8.562407,x1077,2.152281,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,BRD-K22429181-001-15-9,retinol,Sigma,MFCD00001552,retinol,-8.562407,x1077,2.152281,active-noncovalent
C[C@H]1C(=NNC(=O)S1)c2ccc3c(c2)CCCN3C(=O)c4ccc(c(c4)OC)OC,BRD-A65248799-001-01-7,EMD-53998,EMDBio,530657-10MG,"Myosin ATPase Activator, EMD57003",-8.562326,x0161,4.003616,active-noncovalent
C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,BRD-K28690501-001-02-1,diosgenin,Selleck,S2291,Diosgenin,-8.562021,x0104,6.160098,active-noncovalent
CCCCCCCC/C=C/C(=O)[O-],BRD-K42959922-001-01-5,trans-2-Undecenoic-acid,AlfaAesar,L11579,"trans-2-Undecenoic acid, tech. 80%",-8.561722,x0749,-0.208368,active-covalent
CC1(c2cc(ccc2NC(=S)O1)c3ccc(n3C)C#N)C,BRD-K99604664-001-02-9,tanaproget,MedChemEx,HY-15606,Tanaproget,-8.561598,x0195,0.740694,active-noncovalent
CC1(c2cc(ccc2NC(=S)O1)c3ccc(n3C)C#N)C,BRD-K99604664-001-01-1,tanaproget,MedChemEx,HY-15606,Tanaproget,-8.561598,x0195,0.740694,active-noncovalent
CN(C)/C(=[NH+]\CCC[C@@H](C(=O)[O-])[NH3+])/N,BRD-K36269323-300-02-6,asymmetrical-dimethylarginine,EMDBio,311203-25MG,"NG,NG-Dimethyl-L-arginine, Dihydrochloride",-8.561573,x1385,-2.559926,active-covalent
CC(=O)c1ccc2c(c1)C(=O)C3(O2)CC3,BRD-K94934625-001-01-5,spizofurone,Sigma,PH011174,"5-acetyl-3H-spiro[benzofuran-2,1'-cyclopropan]-3-one",-8.561432,x0749,-0.034877,active-covalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-K18423410-003-03-3,dexmedetomidine,Tocris,2749,Dexmedetomidine hydrochloride,-8.560138,x0946,-2.225178,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-A21607826-003-06-9,medetomidine,Tocris,5160,Medetomidine hydrochloride,-8.560138,x0946,-2.225178,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-A21607826-003-04-4,medetomidine,Selleck,S3060,Medetomidine HCl,-8.560138,x0946,-2.225178,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-A21607826-003-05-1,medetomidine,Tocris,5160,Medetomidine hydrochloride,-8.560138,x0946,-2.225178,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-K18423410-003-02-5,dexmedetomidine,Selleck,S2090,Dexmedetomidine HCl (Precedex),-8.560138,x0946,-2.225178,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,BRD-K18423410-001-02-9,dexmedetomidine,Selleck,S3075,Dexmedetomidine,-8.560138,x0946,-2.225178,active-noncovalent
Cc1nccn1CCC(c2ccccc2)(c3ccccc3)C(=O)N,BRD-K29626940-001-01-5,imidafenacin,MedChemEx,HY-B0662,"4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide",-8.559649,x0678,0.950505,active-noncovalent
Cc1nccn1CCC(c2ccccc2)(c3ccccc3)C(=O)N,BRD-K29626940-001-02-3,imidafenacin,MedChemEx,HY-B0662,Imidafenacin,-8.559649,x0678,0.950505,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])O,BRD-A20781140-001-01-7,plovamer-acetate,EMDBio,6570-100GM,"L-Tyrosine, Free Base",-8.559490,x0107,-1.447133,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])O,BRD-A20781140-001-02-5,plovamer-acetate,Sigma,MFCD00063074,tyrosine,-8.559490,x0107,-1.447133,active-noncovalent
Cc1cc(c(nc1)c2cc(ncc2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C,BRD-K40302533-001-02-9,PF-5274857,Selleck,S2777,PF-5274857,-8.559119,x0161,6.392424,active-noncovalent
Cc1cc(c(nc1)c2cc(ncc2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C,BRD-K40302533-003-01-7,PF-5274857,Tocris,5262,PF 5274857 hydrochloride,-8.559119,x0161,6.392424,active-noncovalent
c1c(c(cc(c1F)F)F)C[C@H](CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)[NH3+],BRD-K19416115-366-02-7,sitagliptin,MicroSource,1505831,SITAGLIPTIN MONOPHOSPHATE MONOHYDRATE,-8.558857,x0072,3.791487,active-noncovalent
c1c(c(cc(c1F)F)F)C[C@H](CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)[NH3+],BRD-K19416115-001-05-3,sitagliptin,Selleck,S4002,Sitagliptin phosphate monohydrate,-8.558857,x0072,3.791487,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCCNC(=O)c4cccs4)I,BRD-K47983010-001-15-3,BX-795,MedChemEx,HY-10514,BX795,-8.558571,x0161,7.881552,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCCNC(=O)c4cccs4)I,BRD-K47983010-001-12-0,BX-795,Selleck,S1274,BX-795,-8.558571,x0161,7.881552,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCCNC(=O)c4cccs4)I,BRD-K47983010-001-14-6,BX-795,MedChemEx,HY-10514,BX795,-8.558571,x0161,7.881552,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCCNC(=O)c4cccs4)I,BRD-K47983010-001-09-6,BX-795,Selleck,S1274,BX-795,-8.558571,x0161,7.881552,active-noncovalent
Cc1ccc(=O)n(c1)c2ccccc2,BRD-K96862998-001-14-8,pirfenidone,Selleck,S2907,Pirfenidone,-8.558218,x0195,-1.440449,active-noncovalent
Cc1ccc(=O)n(c1)c2ccccc2,BRD-K96862998-001-15-5,pirfenidone,Tocris,1093,Pirfenidone,-8.558218,x0195,-1.440449,active-noncovalent
C[NH2+]CCCCOc1ccccc1Cc2ccccc2,BRD-K18779551-003-08-6,bifemelane,Tocris,767,Bifemelane hydrochloride,-8.556965,x0678,1.10643,active-noncovalent
C[NH2+]CCCCOc1ccccc1Cc2ccccc2,BRD-K18779551-003-07-8,bifemelane,Tocris,767,Bifemelane,-8.556965,x0678,1.10643,active-noncovalent
C=C1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,BRD-K68407436-003-02-7,nalmefene,Tocris,4085,Nalmefene hydrochloride,-8.556619,x1077,1.121049,active-noncovalent
Cc1cccc(c1C)Nc2ccccc2C(=O)[O-],BRD-K92778217-001-31-9,mefenamic-acid,Selleck,S4078,Mefenamic Acid,-8.555771,x1093,-1.059095,active-noncovalent
Cc1cccc(c1C)Nc2ccccc2C(=O)[O-],BRD-K92778217-001-32-7,mefenamic-acid,MicroSource,1501103,MEFENAMIC ACID,-8.555771,x1093,-1.059095,active-noncovalent
c1cc(ccc1[C@H](C(=O)[O-])[NH3+])O,BRD-K30373577-001-01-1,oxfenicine,Enamine,Z1198149764,,-8.555549,x0678,-1.726665,active-noncovalent
c1cc(ccc1[C@H](C(=O)[O-])[NH3+])O,BRD-A86525947-001-01-4,oxfenicine,Vitas-M,STK391435,amino(4-hydroxyphenyl)acetic acid,-8.555549,x0678,-1.726665,active-noncovalent
C1C=CCc2c1c(n(c2O)SC(Cl)(Cl)Cl)O,BRD-A79857384-001-03-6,captan,AKSci,S329,Captan,-8.555026,x0749,-0.103503,active-covalent
c1cc(cc(c1)N2Cc3cccc(c3C2=O)Cl)C(=O)N4CCC5(CCN(CC5)c6cc[nH+]cc6)CC4,BRD-K50699835-001-01-2,ELN-441958,MedChemEx,HY-15043,ELN-441958,-8.554745,x0161,11.187769,active-noncovalent
Cc1cccc2c1[nH]c3c2nnc(n3)/N=N/[C@@H](C)c4ccccn4,BRD-K26122255-001-01-7,VLX-600,Enamine,EN300-395210,"(1Z)-1-(2-pyridinyl)ethanone (6-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazone",-8.553681,x0397,4.640306,active-noncovalent
Cc1cccc2c1[nH]c3c2nnc(n3)/N=N/[C@@H](C)c4ccccn4,BRD-K89053832-001-01-0,VLX600,ChemDiv,1927-8053,,-8.553681,x0397,4.640306,active-noncovalent
CC1(c2ccccc2[C@](O1)(CCC[NH2+]C)c3ccccc3)C,BRD-A02532772-003-01-7,talopram,Tocris,3145,Talopram hydrochloride,-8.552657,x1392,0.612293,active-covalent
C[C@H](C(=O)N1CCN(CC1)c2nc3cc(c(cc3c(n2)N)OC)OC)OC,BRD-A78277353-001-01-9,metazosin,Sigma,MFCD00891638,"6,7-dimethoxy-2-[4-(2-methoxypropanoyl)-1-piperazinyl]-4-quinazolinamine",-8.552432,x0161,5.632464,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@]34[C@@H]([C@H]([C@@H]([C@](O3)(CO4)CO)O)O)O,BRD-K10071630-001-01-0,ertugliflozin,MedChemEx,HY-15461,PF-04971729,-8.552430,x0161,4.781738,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F,BRD-A31159102-003-30-4,fluoxetine,MicroSource,1504173,FLUOXETINE HYDROCHLORIDE,-8.552185,x0874,0.623058,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F,BRD-A31159102-003-28-8,fluoxetine,Selleck,S1333,Fluoxetine HCl,-8.552185,x0874,0.623058,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F,BRD-A31159102-003-29-6,fluoxetine,Tocris,927,Fluoxetine hydrochloride,-8.552185,x0874,0.623058,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F,BRD-A31159102-003-31-2,fluoxetine,Tocris,927,Fluoxetine hydrochloride,-8.552185,x0874,0.623058,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-046-02-3,epinephrine,Selleck,S2521,Epinephrine Bitartrate,-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-001-03-6,epinephrine,Selleck,S2522,L-Adrenaline,-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-046-03-1,epinephrine,Selleck,S2521,Epinephrine bitartrate (Adrenalinium),-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-001-04-4,epinephrine,MicroSource,1500274,EPINEPHRINE BITARTRATE,-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-003-01-6,epinephrine,Selleck,S3061,Epinephrine HCl,-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-K63126190-001-05-1,epinephrine,Selleck,S2522,L-Adrenaline (Epinephrine),-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A07765530-001-05-6,epinephrine-(racemic),Selleck,S2523,DL-Adrenaline,-8.552002,x1077,-0.177613,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,BRD-A07765530-001-06-4,epinephrine-(racemic),Selleck,S2523,DL-Adrenaline,-8.552002,x1077,-0.177613,active-noncovalent
CCCN(CCC)C(=O)Cc1c(nc2n1cc(cc2)Cl)c3ccc(cc3)Cl,BRD-K66896751-001-02-4,alpidem,Sigma,A1862,"2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide",-8.551392,x0874,1.685854,active-noncovalent
c1ccc2c(c1)c(ccn2)c3c[nH]nc3c4ccccn4,BRD-K06234293-001-05-9,LY364947,Tocris,2718,LY 364947,-8.550219,x1077,-1.302115,active-noncovalent
c1ccc2c(c1)c(ccn2)c3c[nH]nc3c4ccccn4,BRD-K06234293-001-04-2,LY364947,Tocris,2718,LY 364947,-8.550219,x1077,-1.302115,active-noncovalent
c1ccc2c(c1)c(ccn2)c3c[nH]nc3c4ccccn4,BRD-K06234293-001-03-4,LY364947,Selleck,S2805,LY364947,-8.550219,x1077,-1.302115,active-noncovalent
Cc1c(c2c(cc1OCc3cccc(c3)c4ccc(cc4)C(=O)[O-])C[C@@H](C2=O)C5CCCC5)C,BRD-A13293292-001-02-6,BINA,Tocris,4048,BINA,-8.549683,x0161,7.998812,active-noncovalent
C[N@H+](CCCCCCOc1ccc(c(c1)F)C(=O)c2ccc(cc2)Br)CC=C,BRD-K55192287-051-02-9,Ro-48-8071,Tocris,5389,Ro 48-8071 fumarate,-8.549349,x0104,7.810373,active-noncovalent
C[N@H+](CCCCCCOc1ccc(c(c1)F)C(=O)c2ccc(cc2)Br)CC=C,BRD-K55192287-051-01-1,Ro-48-8071,MedChemEx,HY-18630A,Ro 48-8071 (fumarate),-8.549349,x0104,7.810373,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,BRD-K21733600-001-23-2,rofecoxib,Sigma,MFCD00935806,4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone,-8.548874,x0195,0.904695,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,BRD-K21733600-001-24-0,rofecoxib,MedChemEx,HY-17372,Rofecoxib,-8.548874,x0195,0.904695,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,BRD-K21733600-001-15-8,rofecoxib,MicroSource,1504235,ROFECOXIB,-8.548874,x0195,0.904695,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,BRD-K21733600-001-19-0,rofecoxib,Selleck,S3043,Rofecoxib (Vioxx),-8.548874,x0195,0.904695,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,BRD-K21733600-001-14-1,rofecoxib,Selleck,S3043,Rofecoxib,-8.548874,x0195,0.904695,active-noncovalent
c1cc(ccc1[C@@H]2CC[NH2+]C[C@H]2COc3ccc4c(c3)OCO4)F,BRD-K37991163-003-13-4,paroxetine,Selleck,S3005,Paroxetine HCl,-8.547364,x0434,1.711848,active-noncovalent
c1cc(ccc1[C@@H]2CC[NH2+]C[C@H]2COc3ccc4c(c3)OCO4)F,BRD-K37991163-050-18-4,paroxetine,Tocris,2141,Paroxetine maleate,-8.547364,x0434,1.711848,active-noncovalent
c1cc(ccc1[C@@H]2CC[NH2+]C[C@H]2COc3ccc4c(c3)OCO4)F,BRD-K37991163-003-14-2,paroxetine,MicroSource,1504085,PAROXETINE HYDROCHLORIDE,-8.547364,x0434,1.711848,active-noncovalent
c1cc2c(nc1)C(=C3CC[NH2+]CC3)c4ccc(cc4CC2)Cl,BRD-K82357231-001-17-5,desloratadine,Selleck,S4012,Desloratadine,-8.546451,x0195,0.90835,active-noncovalent
c1cc2c(nc1)C(=C3CC[NH2+]CC3)c4ccc(cc4CC2)Cl,BRD-K82357231-001-19-1,desloratadine,Selleck,S4012,Desloratadine,-8.546451,x0195,0.90835,active-noncovalent
c1cc2c(nc1)C(=C3CC[NH2+]CC3)c4ccc(cc4CC2)Cl,BRD-K82357231-001-18-3,desloratadine,MicroSource,1505393,DESLORATIDINE,-8.546451,x0195,0.90835,active-noncovalent
CN/C(=[NH+]\CCC[C@@H](C(=O)[O-])[NH3+])/N,BRD-K59506194-015-04-9,targinine,Cayman,10005031,,-8.545168,x0678,-2.414675,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@@H]3CC[C@@]45CCC(=O)O5)C,BRD-A20644369-001-08-6,canrenone,MicroSource,1505248,CANRENONE,-8.545122,x0072,1.714514,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K93754473-048-18-6,tamoxifen,Selleck,S1972,Tamoxifen Citrate,-8.545040,x0874,3.022174,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K93754473-048-20-2,tamoxifen,MicroSource,1500557,TAMOXIFEN CITRATE,-8.545040,x0874,3.022174,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K93754473-048-19-4,tamoxifen,Tocris,999,Tamoxifen citrate,-8.545040,x0874,3.022174,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K93754473-048-23-6,tamoxifen,Tocris,999,Tamoxifen citrate,-8.545040,x0874,3.022174,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,BRD-K93754473-048-21-0,tamoxifen,Selleck,S1972,Tamoxifen Citrate (Nolvadex),-8.545040,x0874,3.022174,active-noncovalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c(c3c(c2F)n(cc(c3=O)C(=O)[O-])C4CC4)N)F,BRD-K07612980-001-05-3,sparfloxacin,Selleck,S1884,Sparfloxacin,-8.544739,x0749,5.792213,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c(c3c(c2F)n(cc(c3=O)C(=O)[O-])C4CC4)N)F,BRD-K07612980-001-04-6,sparfloxacin,Selleck,S1884,Sparfloxacin,-8.544739,x0749,5.792213,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c(c3c(c2F)n(cc(c3=O)C(=O)[O-])C4CC4)N)F,BRD-K07612980-001-07-9,sparfloxacin,MicroSource,1502338,SPARFLOXACIN,-8.544739,x0749,5.792213,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-M64062803-001-03-9,ibuprofen-lysine,Selleck,S1518,Ibuprofen Lysine (NeoProfen),-8.543620,x0830,-0.927739,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-K14965640-001-13-2,ibuprofen-(s),Tocris,2796,(S)-(+)-Ibuprofen,-8.543620,x0830,-0.927739,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-A17655518-001-24-4,ibuprofen,MicroSource,1500347,IBUPROFEN,-8.543620,x0830,-0.927739,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-M64062803-001-02-1,ibuprofen-lysine,Selleck,S1518,Ibuprofen Lysine (NeoProfen),-8.543620,x0830,-0.927739,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-K14965640-001-12-4,ibuprofen-(s),MicroSource,1502363,DEXIBUPROFEN,-8.543620,x0830,-0.927739,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],BRD-A17655518-001-23-6,ibuprofen,Selleck,S1638,Ibuprofen,-8.543620,x0830,-0.927739,active-covalent
Cc1c(cccn1)OC[C@@H]2CCC[NH2+]2,BRD-K79803033-300-01-3,pozanicline,Sigma,SML1487,,-8.543612,x0104,-1.725536,active-noncovalent
Cc1cc2c([nH]1)cccc2OC[C@H](C[NH2+]C(C)(C)C)OC(=O)c3ccccc3,BRD-A07563059-035-01-3,bopindolol,Enzo,AR100,Bopindolol  malonate,-8.543556,x1093,3.185006,active-noncovalent
Cc1c(c(no1)c2ccccc2)c3ccc(cc3)S(=O)(=O)N,BRD-K12994359-001-19-2,valdecoxib,Tocris,4206,Valdecoxib,-8.543512,x0161,1.487798,active-noncovalent
Cc1c(c(no1)c2ccccc2)c3ccc(cc3)S(=O)(=O)N,BRD-K12994359-001-18-4,valdecoxib,Selleck,S4049,Valdecoxib,-8.543512,x0161,1.487798,active-noncovalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C,BRD-A01593789-001-03-1,chlormadinone-acetate,MicroSource,1505327,CHLORMADINONE ACETATE,-8.543476,x0874,2.087911,active-noncovalent
c1c(sc(n1)Sc2nnc(s2)N)N(=O)=O,BRD-K32730239-001-02-8,SU3327,Tocris,3607,SU 3327,-8.543318,x0678,-0.371453,active-noncovalent
c1c(sc(n1)Sc2nnc(s2)N)N(=O)=O,BRD-K32730239-001-01-0,SU3327,Tocris,3607,SU 3327,-8.543318,x0678,-0.371453,active-noncovalent
COc1cccc(c1OC)[C@@H](C2CC[NH+](CC2)CCc3ccc(cc3)F)O,BRD-K23647661-001-02-2,volinanserin,Cayman,15936,,-8.542051,x0161,3.931645,active-noncovalent
COc1cccc(c1OC)[C@@H](C2CC[NH+](CC2)CCc3ccc(cc3)F)O,BRD-K23647661-001-03-0,volinanserin,Tocris,4173,MDL 100907,-8.542051,x0161,3.931645,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCC(CC2)n3c4ccc(cc4[nH]c3=O)Cl)F,BRD-K50055394-001-03-6,halopemide,Sigma,H3041,"N-{2-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl}-4-fluorobenzamide",-8.542047,x0104,4.936451,active-noncovalent
Cc1c(c(c([nH]1)C)C(=O)OC)C(=O)c2ccccc2Cc3ccccc3,BRD-K78959463-001-13-2,FPL-64176,Tocris,1403,FPL 64176,-8.540714,x1093,1.801436,active-noncovalent
Cc1c(c(c([nH]1)C)C(=O)OC)C(=O)c2ccccc2Cc3ccccc3,BRD-K78959463-001-15-7,FPL-64176,Tocris,1403,FPL 64176,-8.540714,x1093,1.801436,active-noncovalent
Cc1c(c(c(s1)C)C(=O)NC2(CC2)c3ccc(cc3)C(=O)[O-])Cc4ccc(cc4)C(F)(F)F,BRD-K27983781-001-01-4,MK-2894,MedChemEx,HY-10413,MK-2894,-8.538946,x0831,5.744611,active-covalent
C[C@@H](c1ccccc1)Nc2cc3c(cn2)onc3c4ccc5c(c4)OCO5,BRD-K89584803-001-01-9,TC-S-7005,Tocris,4459,TC-S 7005,-8.538513,x0195,3.288938,active-noncovalent
C[NH+]1CCC(CC1)OC(c2ccccc2)c3ccccc3,BRD-K22936972-003-23-6,diphenylpyraline,MicroSource,1500258,DIPHENYLPYRALINE HYDROCHLORIDE,-8.538111,x0195,0.798633,active-noncovalent
C[NH+]1CCC(CC1)OC(c2ccccc2)c3ccccc3,BRD-K22936972-003-22-8,diphenylpyraline,Selleck,S4321,Diphenylpyraline HCl,-8.538111,x0195,0.798633,active-noncovalent
CC(C)/N=c/1\cc-2n(c3ccccc3nc2cc1Nc4ccc(cc4)Cl)c5ccc(cc5)Cl,BRD-K56614220-001-21-6,clofazimine,Selleck,S4107,Clofazimine,-8.537830,x0161,7.398273,active-noncovalent
CC(C)/N=c/1\cc-2n(c3ccccc3nc2cc1Nc4ccc(cc4)Cl)c5ccc(cc5)Cl,BRD-K56614220-001-19-0,clofazimine,MicroSource,1505974,CLOFAZIMINE,-8.537830,x0161,7.398273,active-noncovalent
CC(C)/N=c/1\cc-2n(c3ccccc3nc2cc1Nc4ccc(cc4)Cl)c5ccc(cc5)Cl,BRD-K56614220-001-18-2,clofazimine,Selleck,S4107,Clofazimine,-8.537830,x0161,7.398273,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(cc3)C(F)(F)F)C,BRD-K14880289-001-02-2,GW-501516,MedChemEx,HY-10838,GW 501516,-8.537596,x0195,6.913459,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(cc3)C(F)(F)F)C,BRD-K14880289-001-03-0,GW-501516,MedChemEx,HY-10838,GW 501516,-8.537596,x0195,6.913459,active-noncovalent
C1CSS[C@@H]1CCCCC(=O)N,BRD-A14440173-001-03-4,lipoamide,MicroSource,1505740,LIPOAMIDE,-8.537354,x0749,0.487421,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C,BRD-A62731508-001-05-8,cortisone,MicroSource,1701028,CORTISONE,-8.536163,x0749,1.78156,active-covalent
c1ccc2c(c1)[C@H](OC2=O)OC(=O)c3cccnc3Nc4cccc(c4)C(F)(F)F,BRD-A98378129-001-02-2,talniflumate,Tocris,2510,Talniflumate,-8.536000,x0107,4.692719,active-noncovalent
c1ccc2c(c1)[C@H](OC2=O)OC(=O)c3cccnc3Nc4cccc(c4)C(F)(F)F,BRD-A98378129-001-03-0,talniflumate,Tocris,2510,Talniflumate,-8.536000,x0107,4.692719,active-noncovalent
Cn1c2c(c(c(c1=O)F)Nc3ccc(cc3F)I)c(=O)n(cn2)C[C@H](CO)O,BRD-K26667523-001-03-3,TAK-733,Selleck,S2617,TAK-733,-8.535986,x0195,1.716922,active-noncovalent
Cn1c2c(c(c(c1=O)F)Nc3ccc(cc3F)I)c(=O)n(cn2)C[C@H](CO)O,BRD-K26667523-001-02-5,TAK-733,Selleck,S2617,TAK-733,-8.535986,x0195,1.716922,active-noncovalent
c1cc2c(cc[nH]c2=O)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,BRD-K77793136-003-03-0,hydroxyfasudil,Tocris,2415,HA 1100 hydrochloride,-8.535339,x1077,0.610434,active-noncovalent
C[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)Cl,BRD-K45435259-003-11-1,SCH-23390,Tocris,925,SCH 23390 hydrochloride,-8.534025,x0195,-0.098709,active-noncovalent
c1cc(ccc1O)OC[C@H](C[NH2+]CCNC(=O)N2CCOCC2)O,BRD-A59337442-051-06-1,xamoterol,Tocris,950,(2E)-2-butenedioic acid compound with N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)-4-morpholinecarboxamide (1:2),-8.532875,x0678,1.189005,active-noncovalent
c1cc(ccc1O)OC[C@H](C[NH2+]CCNC(=O)N2CCOCC2)O,BRD-A59337442-051-05-3,xamoterol,Tocris,950,Xamoterol hemifumarate,-8.532875,x0678,1.189005,active-noncovalent
c1cc(ccc1O)OC[C@H](C[NH2+]CCNC(=O)N2CCOCC2)O,BRD-A59337442-051-07-9,xamoterol,Tocris,950,Xamoterol hemifumarate,-8.532875,x0678,1.189005,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O,BRD-K18518344-001-15-9,digitoxigenin,Prestwick,Prestw-436,Digitoxigenin,-8.532637,x0678,5.116717,active-noncovalent
CC[C@H]1C[N@H+]2CC[C@@H]1C[C@@H]2[C@H](c3ccnc4c3cc(cc4)OC)O,BRD-A06390036-001-04-6,hydroquinidine,MicroSource,1500657,HYDROQUINIDINE,-8.532633,x0678,1.072872,active-noncovalent
C/C(=C\CNc1c2c([nH]cn2)ncn1)/CO,BRD-K90033078-001-08-7,zeatin,TimTec,ST057583,(2E)-2-methyl-4-(7H-purin-6-ylamino)-2-buten-1-ol,-8.532605,x0072,-1.650454,active-noncovalent
c1ccc(c(c1)CC#N)C#Cc2ccc(c(c2)F)CCC(=O)[O-],BRD-K56086081-001-01-7,TUG-770,MedChemEx,HY-15697,TUG-770,-8.532125,x0195,3.684803,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C,BRD-K76661572-001-08-4,phytonadione,Sigma,MFCD00214063,"2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone",-8.531766,x0161,5.696994,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C,BRD-K76661572-001-07-6,phytonadione,MicroSource,1505485,PHYTONADIONE [5mM],-8.531766,x0161,5.696994,active-noncovalent
CC(=O)N[C@@H]1C(=O)Nc2ccccc2C(=N1)c3ccccc3,BRD-A40302156-001-01-9,A-33903,Maybridge,RJC01921,"N-(2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide",-8.531731,x0161,0.316287,active-noncovalent
C[C@@](c1ccc(cc1)c2[n-]nnn2)(C(=O)[O-])[NH3+],BRD-A28329383-001-02-1,MTPG,Tocris,855,MTPG,-8.530491,x1077,-0.54942,active-noncovalent
c1cc(ncc1C2=CCC[C@@H]3CC[C@H]2[NH2+]3)Cl,BRD-A14574269-051-02-2,UB-165,Tocris,1348,UB 165 fumarate,-8.528747,x0678,-0.974284,active-noncovalent
c1cc(ncc1C2=CCC[C@@H]3CC[C@H]2[NH2+]3)Cl,BRD-A14574269-051-03-0,UB-165,Tocris,1348,2-(6-chloropyridin-3-yl)-9-azabicyclo[4.2.1]non-2-ene fumarate,-8.528747,x0678,-0.974284,active-noncovalent
CC[C@]1(Cc2ccccc2O1)c3[nH]ccn3,BRD-A38747044-001-02-3,KU14R,Tocris,1131,KU14R,-8.528065,x0434,-1.823596,active-noncovalent
CC[C@]1(Cc2ccccc2O1)c3[nH]ccn3,BRD-A38747044-001-03-1,KU14R,Tocris,1131,KU14R,-8.528065,x0434,-1.823596,active-noncovalent
C/C(=C\C(=O)Nc1ccccc1C(=O)[O-])/c2ccc3ccccc3c2,BRD-K04623885-001-07-5,BIBR-1532,Selleck,S1186,BIBR 1532,-8.527380,x1334,6.168351,active-covalent
C/C(=C\C(=O)Nc1ccccc1C(=O)[O-])/c2ccc3ccccc3c2,BRD-K04623885-001-10-9,BIBR-1532,Tocris,2981,BIBR 1532,-8.527380,x1334,6.168351,active-covalent
C[C@@H](c1nc2ccc(cc2c(=O)n1c3ccccc3)F)Nc4c5c([nH]cn5)ncn4,BRD-K92517771-001-01-2,acalisib,MedChemEx,HY-12644,Acalisib,-8.527308,x0104,1.167356,active-noncovalent
c1cc(c(c(c1)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,BRD-A93353767-008-02-2,isoconazole,Selleck,S2534,Isoconazole nitrate,-8.527010,x0678,1.06286,active-noncovalent
c1cc(c(c(c1)F)N(c2ccc(c(n2)c3ccc(cc3F)F)C(=O)N)C(=O)N)F,BRD-K07736136-001-03-8,VX-702,Selleck,S6005,VX-702,-8.525656,x0195,4.437309,active-noncovalent
c1cc(c(c(c1)F)N(c2ccc(c(n2)c3ccc(cc3F)F)C(=O)N)C(=O)N)F,BRD-K07736136-001-04-6,VX-702,Selleck,S6005,VX-702,-8.525656,x0195,4.437309,active-noncovalent
COc1ccc(c(c1)[C@H](CNC(=O)C[NH3+])O)OC,BRD-A79981887-003-16-4,midodrine,MicroSource,1503257,MIDODRINE HYDROCHLORIDE,-8.525501,x0678,-0.728241,active-noncovalent
Cc1c(sc(n1)c2ccc(c(c2)C#N)OCC(C)C)C(=O)[O-],BRD-K48367671-001-07-5,febuxostat,Tocris,4427,Febuxostat,-8.524560,x0749,3.160388,active-covalent
Cc1c(sc(n1)c2ccc(c(c2)C#N)OCC(C)C)C(=O)[O-],BRD-K48367671-001-06-7,febuxostat,MicroSource,1504286,FEBUXOSTAT,-8.524560,x0749,3.160388,active-covalent
Cc1c(sc(n1)c2ccc(c(c2)C#N)OCC(C)C)C(=O)[O-],BRD-K48367671-001-05-9,febuxostat,Selleck,S1547,Febuxostat,-8.524560,x0749,3.160388,active-covalent
CCCC[C@](C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O,BRD-A72351335-001-04-5,misoprostol,Sigma,M6807,"methyl (11beta,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate",-8.524277,x0161,5.049676,active-noncovalent
Cc1cc(cc(c1)NC(=O)[C@@H]2CCC[N@]2S(=O)(=O)c3ccc(cc3)OC)C,BRD-K19781342-001-02-2,ACT-462206,Tocris,5319,ACT 462206,-8.523252,x0161,3.885491,active-noncovalent
Cc1cc(cc(c1)NC(=O)[C@@H]2CCC[N@]2S(=O)(=O)c3ccc(cc3)OC)C,BRD-K19781342-001-01-4,ACT-462206,Sigma,MFCD28502270,"(S)-N-(3,5-dimethylphenyl)-1-((4-methoxyphenyl)sulfonyl)pyrrolidine-2-carboxamide",-8.523252,x0161,3.885491,active-noncovalent
C[C@@H]1Cc2c3ccccc3[nH]c2[C@H]([N@@H+]1CC(C)(C)F)c4c(cc(cc4F)/C=C/C(=O)[O-])F,BRD-K73235735-001-02-7,AZD9496,MedChemEx,HY-12870,AZD9496,-8.523156,x0678,4.575614,active-noncovalent
C[C@@H]1Cc2c3ccccc3[nH]c2[C@H]([N@@H+]1CC(C)(C)F)c4c(cc(cc4F)/C=C/C(=O)[O-])F,BRD-K73235735-050-01-6,AZD9496,MedChemEx,HY-12870A,AZD9496 (maleate),-8.523156,x0678,4.575614,active-noncovalent
CC(=O)N(Cc1cc(ccc1OC)OC)c2cc(ccc2Oc3ccccc3)F,BRD-K01080633-001-01-9,DAA-1106,MedChemEx,HY-19945,DAA-1106,-8.522312,x0678,5.074851,active-noncovalent
CS(=O)(=O)Oc1ccc2c(c1)oc(c2NC(=O)N)C(=O)c3ccc(cc3Cl)Cl,BRD-K31339321-001-03-6,lirimilast,Enamine,Z1629752566,,-8.521487,x0104,3.51492,active-noncovalent
c1cc(oc1)c2nc3c4cc(ccc4nc(n3n2)N)Cl,BRD-K49049886-001-08-7,CGS-15943,Tocris,1699,CGS 15943,-8.520206,x0161,0.591906,active-noncovalent
CC1=CC(=O)c2ccccc2C1=O,BRD-K78126613-001-27-7,menadione,Selleck,S1949,Menadione,-8.520124,x0195,1.340329,active-noncovalent
CC1=CC(=O)c2ccccc2C1=O,BRD-K78126613-001-28-5,menadione,MicroSource,1502254,MENADIONE,-8.520124,x0195,1.340329,active-noncovalent
CC1=CC(=O)c2ccccc2C1=O,BRD-K78126613-001-29-3,menadione,Selleck,S1949,Menadione,-8.520124,x0195,1.340329,active-noncovalent
C[C@H](c1cccc(c1)OC)[NH2+]CCCc2ccccc2Cl,BRD-K41662846-003-01-5,tecalcet,Cayman,17415,(R)-3-(2-chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine hydrochloride,-8.520090,x0072,1.674964,active-noncovalent
C[C@H](c1cccc(c1)OC)[NH2+]CCCc2ccccc2Cl,BRD-K41662846-003-02-3,tecalcet,Tocris,3815,R 568 hydrochloride,-8.520090,x0072,1.674964,active-noncovalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4CC[C@H](C4)[NH3+])C(=O)[O-],BRD-A41450521-075-10-8,tosufloxacin,TCI,T2506,,-8.519370,x0434,4.09372,active-noncovalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4CC[C@H](C4)[NH3+])C(=O)[O-],BRD-A41450521-003-02-7,tosufloxacin,Prestwick,Prestw-1464,Tosufloxacin hydrochloride,-8.519370,x0434,4.09372,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@@H]3[C@H]1CC[C@]2(C#C)O)OC5CCCC5,BRD-A16439188-001-01-1,quinestrol,MicroSource,1502330,QUINESTROL,-8.518817,x1077,7.427772,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)O)C(F)(F)F)C,BRD-K71281111-001-04-3,SNX-2112,Selleck,S2639,SNX-2112 (PF-04928473),-8.518524,x0161,4.37538,active-noncovalent
C=C[C@H]1C[N@@H+]2CC[C@H]1C[C@H]2[C@@H](c3ccnc4c3cccc4)O,BRD-K39079086-001-07-6,cinchonidine,Selleck,S2282,Cinchonidine,-8.518247,x0678,0.383147,active-noncovalent
C=C[C@H]1C[N@@H+]2CC[C@H]1C[C@H]2[C@@H](c3ccnc4c3cccc4)O,BRD-K39079086-001-06-8,cinchonidine,MicroSource,1500839,CINCHONIDINE,-8.518247,x0678,0.383147,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)c3ccc(cc3)CC(=O)[O-])NC(=O)O[C@H](C)c4ccccc4,BRD-K23952234-236-03-4,BMS-986020,MedChemEx,HY-16039,AM095,-8.517549,x0104,9.674446,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)c3ccc(cc3)CC(=O)[O-])NC(=O)O[C@H](C)c4ccccc4,BRD-K23952234-236-02-6,BMS-986020,MedChemEx,HY-16039,AM095,-8.517549,x0104,9.674446,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)c3ccc(cc3)CC(=O)[O-])NC(=O)O[C@H](C)c4ccccc4,BRD-K23952234-236-01-8,BMS-986020,MedChemEx,HY-16039,AM095,-8.517549,x0104,9.674446,active-noncovalent
Cc1c(sc[n+]1Cc2cnc(nc2N)C)CCO[P@@](=O)([O-])OP(=O)([O-])[O-],BRD-A09994331-003-02-4,thiamine-pyrophosphate,ChemImpex,461,Thiamine pyrophosphate,-8.516066,x0072,4.594586,active-noncovalent
c1ccc2c(c1)C(=O)C(=O)N2Cc3ccc(c(c3)Cl)Cl,BRD-K15164005-001-04-9,apoptosis-activator-II,Selleck,S2927,Apoptosis Activator 2,-8.515951,x0104,-0.466036,active-noncovalent
c1ccc2c(c1)C(=O)C(=O)N2Cc3ccc(c(c3)Cl)Cl,BRD-K15164005-001-05-6,apoptosis-activator-II,Tocris,2098,Apoptosis Activator 2,-8.515951,x0104,-0.466036,active-noncovalent
c1ccc2c(c1)C(=O)C(=O)N2Cc3ccc(c(c3)Cl)Cl,BRD-K15164005-001-06-4,apoptosis-activator-II,Tocris,2098,Apoptosis Activator 2,-8.515951,x0104,-0.466036,active-noncovalent
c1ccc(c(c1)C2=C(C(=O)NC2=O)Nc3ccc(c(c3)Cl)O)N(=O)=O,BRD-K76805682-001-15-9,SB-415286,Selleck,S2729,SB415286,-8.515545,x0678,0.988693,active-noncovalent
c1ccc(c(c1)C2=C(C(=O)NC2=O)Nc3ccc(c(c3)Cl)O)N(=O)=O,BRD-K76805682-001-16-7,SB-415286,Tocris,1617,SB 415286,-8.515545,x0678,0.988693,active-noncovalent
c1ccc(c(c1)C2=C(C(=O)NC2=O)Nc3ccc(c(c3)Cl)O)N(=O)=O,BRD-K76805682-001-17-5,SB-415286,Selleck,S2729,SB 415286,-8.515545,x0678,0.988693,active-noncovalent
C[NH2+]Cc1ccc(cc1)c2c3c4c(cc(cc4[nH]2)F)C(=O)NCC3,BRD-K88560311-011-07-1,rucaparib,Selleck,S1098,"Rucaparib (AG-014699 , PF-01367338)",-8.514799,x0104,3.110369,active-noncovalent
C[NH2+]Cc1ccc(cc1)c2c3c4c(cc(cc4[nH]2)F)C(=O)NCC3,BRD-K88560311-011-06-3,rucaparib,Selleck,S1098,"Rucaparib (AG-014699,PF-01367338)",-8.514799,x0104,3.110369,active-noncovalent
C[N+](C)(C)CCCCC[NH2+]CC12CC3CC(C1)CC(C3)C2,BRD-K13829090-303-02-9,IEM1460,Tocris,1636,IEM 1460,-8.512132,x0946,2.852551,active-noncovalent
C[N+](C)(C)CCCCC[NH2+]CC12CC3CC(C1)CC(C3)C2,BRD-K13829090-303-03-7,IEM1460,Tocris,1636,IEM 1460,-8.512132,x0946,2.852551,active-noncovalent
Cc1cc(nc(c1C#N)N[C@@H](C)CCCC(C)(C)O)Nc2cc([nH]n2)C,BRD-A12147465-003-01-4,TC-A-2317,Tocris,4066,TC-A 2317 hydrochloride,-8.511038,x0678,1.801496,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH3+],BRD-A68304895-003-03-0,BTS-54505,Tocris,2322,BTS 54-505 hydrochloride,-8.511034,x0161,-1.342386,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH3+],BRD-A68304895-003-02-2,BTS-54505,Tocris,2322,BTS 54-505 hydrochloride,-8.511034,x0161,-1.342386,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)OC(C)(C)C)c4ccc(cc4)Cl)C,BRD-K54606188-001-16-4,JQ1-(+),Tocris,4499,(+)-JQ1,-8.510890,x0195,2.4944,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)OC(C)(C)C)c4ccc(cc4)Cl)C,BRD-K54606188-001-13-1,JQ1-(+),Selleck,S7110,(+)-JQ1,-8.510890,x0195,2.4944,active-noncovalent
CC(C)(C)c1ccc(c(c1)C[NH2+][C@@H]2[C@@H](N3CCC2CC3)C(c4ccccc4)c5ccccc5)OC,BRD-K76594255-001-01-6,maropitant,MedChemEx,HY-10053,Maropitant,-8.510076,x0161,5.56902,active-noncovalent
CN(C)C(=O)n1c(nnn1)Cc2ccc(cc2)c3ccccc3,BRD-K37865504-001-04-1,LY2183240,Tocris,2452,LY 2183240,-8.509767,x0072,2.304114,active-noncovalent
CN(C)C(=O)n1c(nnn1)Cc2ccc(cc2)c3ccccc3,BRD-K37865504-001-05-8,LY2183240,Tocris,2452,LY 2183240,-8.509767,x0072,2.304114,active-noncovalent
C[C@@H](c1c(cncn1)F)[C@](Cn2cncn2)(c3ccc(cc3F)F)O,BRD-K06557128-001-08-8,voriconazole,Selleck,S1442,Voriconazole,-8.509540,x0749,1.841805,active-covalent
C[C@@H](c1c(cncn1)F)[C@](Cn2cncn2)(c3ccc(cc3F)F)O,BRD-K06557128-001-07-0,voriconazole,MicroSource,1502346,VORICONAZOLE,-8.509540,x0749,1.841805,active-covalent
C[C@@H](c1c(cncn1)F)[C@](Cn2cncn2)(c3ccc(cc3F)F)O,BRD-K06557128-001-06-2,voriconazole,Selleck,S1442,Voriconazole,-8.509540,x0749,1.841805,active-covalent
c1ccnc(c1)CNC(=O)Nc2nnc(o2)c3ccco3,BRD-K47441935-001-01-4,NK-252,Tocris,5293,NK 252,-8.509131,x0397,2.212142,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCC(=O)[O-])O)CCC4=CC(=O)C=C[C@]34C)O,BRD-A78391468-001-02-8,prednisolone-hemisuccinate,MicroSource,1505450,PREDNISOLONE HEMISUCCINATE,-8.508732,x1077,5.805588,active-noncovalent
c1cc(ccc1NNC(=[NH2+])N)/N=N/C(=S)N,BRD-K11244467-002-01-8,ambazone,Kemprotec,TC861,"(E)-2-((E)-4-(2-carbamimidoylhydrazono)cyclohexa-2,5-dien-1-ylidene)hydrazine-1-carbothioamide hydrate",-8.507830,x0161,0.087769,active-noncovalent
c1cc(ccc1NNC(=[NH2+])N)/N=N/C(=S)N,BRD-K11244467-001-08-5,ambazone,Vitas-M,STL200147,,-8.507830,x0161,0.087769,active-noncovalent
c1cc(ccc1NNC(=[NH2+])N)/N=N/C(=S)N,BRD-K11244467-001-09-3,ambazone,Vitas-M,STL200147,"2-{4-[(aminocarbothioyl)hydrazono]-2,5-cyclohexadien-1-ylidene}hydrazinecarboximidamide",-8.507830,x0161,0.087769,active-noncovalent
c1cc(ccc1/C=C(\C#N)/C(=O)[O-])O,BRD-K60302405-001-08-6,CHC,Tocris,5029,CHC,-8.507710,x0678,-0.96295,active-noncovalent
c1cc(=O)oc2c1cc3ccoc3c2,BRD-K47264279-001-08-9,psoralen,Specs,AA-504/20833002,,-8.506760,x0749,-0.342117,active-covalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,BRD-K96471533-001-10-8,nitazoxanide,MedChemEx,HY-B0217,Nitazoxanide,-8.506630,x0678,-0.041742,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,BRD-K96471533-001-07-4,nitazoxanide,Selleck,S1627,Nitazoxanide,-8.506630,x0678,-0.041742,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,BRD-K96471533-001-09-0,nitazoxanide,Selleck,S1627,"Nitazoxanide (Alinia, Annita)",-8.506630,x0678,-0.041742,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,BRD-K96471533-001-08-2,nitazoxanide,MicroSource,1503843,NITAZOXANIDE,-8.506630,x0678,-0.041742,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,BRD-K96471533-001-11-6,nitazoxanide,MedChemEx,HY-B0217,Nitazoxanide,-8.506630,x0678,-0.041742,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H]2C[C@H](N(C2)C(=O)C[NH3+])C(=O)[O-],BRD-K35589454-003-01-1,danegaptide,MedChemEx,HY-10913A,GAP-134 (Hydrochloride),-8.506472,x0678,0.227264,active-noncovalent
Cc1cc(c(n1c2cccnc2)C)/C=C\3/C(=O)N(C(=O)S3)c4ccccc4,BRD-K18634484-001-01-4,iCRT-14,Tocris,4299,iCRT 14,-8.506467,x0161,5.759191,active-noncovalent
Cc1ccc(=O)n(c1)c2ccc(cc2)O,BRD-K41267922-001-01-4,F351,Carbosynth,FH24467,1-(4-hydroxyphenyl)-5-methyl-2(1H)-pyridinone,-8.506185,x0195,-1.585394,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCCCOC,BRD-A39390670-236-12-3,rabeprazole,Sigma,SML0476,sodium 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide,-8.506046,x0161,2.974072,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCCCOC,BRD-A39390670-236-10-7,rabeprazole,MedChemEx,HY-B0656A,Rabeprazole (sodium),-8.506046,x0161,2.974072,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCCCOC,BRD-A39390670-236-09-9,rabeprazole,MicroSource,1505943,RABEPRAZOLE SODIUM,-8.506046,x0161,2.974072,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCCCOC,BRD-A39390670-236-11-5,rabeprazole,Sigma,MFCD02092688,sodium 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide,-8.506046,x0161,2.974072,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)O[C@@H](c3ccccc3)c4ccc(cc4)Cl,BRD-A51713165-003-02-6,3-CPMT,Tocris,917,3-CPMT,-8.505960,x1077,1.125363,active-noncovalent
CCCCC/C=C\C/C=C\CCCCCCCC(=O)[O-],BRD-K08973992-001-06-2,linoleic-acid,Sigma,62230,"(9Z,12Z)-9,12-octadecadienoic acid",-8.505945,x0967,1.933431,active-noncovalent
C[C@@H](Cc1ccccc1)[N@@H+](C)Cc2c(c(=O)n(n2C)c3ccccc3)C(C)C,BRD-A08255417-001-14-7,famprofazone,MicroSource,1505773,FAMPROFAZONE,-8.505906,x0749,4.680539,active-covalent
C[C@@H](Cc1ccccc1)[N@@H+](C)Cc2c(c(=O)n(n2C)c3ccccc3)C(C)C,BRD-A08255417-001-13-9,famprofazone,Selleck,S4327,Famprofazone,-8.505906,x0749,4.680539,active-covalent
c1cnc(c2c1n(cn2)[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O)N,BRD-A79431551-001-01-1,3-deazaadenosine,Enzo,AC992,3-Deazaadenosine,-8.505610,x0195,0.213296,active-noncovalent
c1ccc2c(c1)C(=O)N(S2(=O)=O)CC(=O)Nc3ccc(cc3)O,BRD-K20548681-001-01-3,SCP-1,Vitas-M,STK134741,,-8.505518,x1093,2.965523,active-noncovalent
Cc1c(cccc1N)Cn2ccc(cc2=O)OCCc3cccs3,BRD-K48888725-001-02-7,CG-400549,Astatech,52038,1-(3-amino-2-methylbenzyl)-4-[2-(2-thienyl)ethoxy]-2(1H)-pyridinone,-8.504813,x0104,2.585969,active-noncovalent
Cc1c(cccc1N)Cn2ccc(cc2=O)OCCc3cccs3,BRD-K48888725-001-01-9,CG-400549,Astatech,52038,1-(3-AMINO-2-METHYL-BENZYL)-4-(2-THIOPHEN-2-YL-ETHOXY)-2-PYRIDONE,-8.504813,x0104,2.585969,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,BRD-K19352500-332-09-4,prochlorperazine,Tocris,3287,Prochlorperazine dimaleate,-8.504507,x0195,1.567156,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,BRD-K19352500-070-12-4,prochlorperazine,MicroSource,1500505,PROCHLORPERAZINE EDISYLATE,-8.504507,x0195,1.567156,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,BRD-K19352500-332-08-6,prochlorperazine,Selleck,S4407,prochlorperazine dimaleate,-8.504507,x0195,1.567156,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,BRD-K19352500-332-07-8,prochlorperazine,Selleck,S4407,Prochlorperazine Dimaleate,-8.504507,x0195,1.567156,active-noncovalent
Cc1[nH+]cc(n1C(C)C)c2ccnc(n2)Nc3ccc(cc3)S(=O)(=O)C,BRD-K72414522-001-06-7,AZD5438,Selleck,S2621,AZD5438,-8.503536,x0195,3.149346,active-noncovalent
Cc1[nH+]cc(n1C(C)C)c2ccnc(n2)Nc3ccc(cc3)S(=O)(=O)C,BRD-K72414522-001-08-3,AZD5438,Selleck,S2621,AZD5438,-8.503536,x0195,3.149346,active-noncovalent
Cc1[nH+]cc(n1C(C)C)c2ccnc(n2)Nc3ccc(cc3)S(=O)(=O)C,BRD-K72414522-001-10-9,AZD5438,Tocris,3968,AZD 5438,-8.503536,x0195,3.149346,active-noncovalent
CCn1cc(c(n1)c2ccc(cc2)NC(=O)N(C)C)c3ccnc4c3cc([nH]4)c5cccc(c5)C[NH+](C)C,BRD-K36740062-001-06-6,GSK1070916,Selleck,S2740,GSK1070916,-8.503252,x0967,9.257502,active-noncovalent
Cc1c(cno1)C(=O)Nc2ccc(cc2)C(F)(F)F,BRD-K78692225-001-22-9,leflunomide,Selleck,S1247,Leflunomide,-8.502852,x0195,0.948139,active-noncovalent
Cc1c(cno1)C(=O)Nc2ccc(cc2)C(F)(F)F,BRD-K78692225-001-23-7,leflunomide,Tocris,2228,Leflunomide,-8.502852,x0195,0.948139,active-noncovalent
Cc1c(cno1)C(=O)Nc2ccc(cc2)C(F)(F)F,BRD-K78692225-001-24-5,leflunomide,MicroSource,1503927,LEFLUNOMIDE,-8.502852,x0195,0.948139,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(=O)c3cccnc3,BRD-K47407372-001-16-3,nifenazone,Selleck,S4401,Nifenazone,-8.502316,x0107,1.917296,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(=O)c3cccnc3,BRD-K47407372-001-17-1,nifenazone,MicroSource,1503230,NIFENAZONE,-8.502316,x0107,1.917296,active-noncovalent
CN1/C(=C/C(=O)[O-])/S[C@H](C1=O)[NH+]2CCCCC2,BRD-A72297358-001-01-8,ozolinone,Sigma,PH005634,"(2Z)-[3-methyl-4-oxo-5-(1-piperidinyl)-1,3-thiazolidin-2-ylidene]ethanoic acid",-8.501673,x0678,-0.985997,active-noncovalent
c1ccnc(c1)C(c2ccc(cc2)OS(=O)(=O)[O-])c3ccc(cc3)OS(=O)(=O)[O-],BRD-K77251551-304-02-9,sodium-picosulfate,Selleck,S4020,Sodium Picosulfate,-8.500985,x1077,4.412073,active-noncovalent
CCCCCCCCCC[C@H](CCCCCCCC)CO,BRD-A51407134-001-01-9,2-octyldodecan-1-ol,Bepharm,B77854,2-Octyldodecan-1-ol,-8.500395,x0161,3.015586,active-noncovalent
CCCCCCCCCC[C@H](CCCCCCCC)CO,BRD-A51407134-001-02-7,2-octyldodecan-1-ol,Sigma,MFCD01310428,2-octyl-1-dodecanol,-8.500395,x0161,3.015586,active-noncovalent
CC(C)(C)[NH2+]C[C@H](COc1c(nsn1)N2CCOCC2)O,BRD-K30421593-050-04-9,timolol,MicroSource,1500578,TIMOLOL MALEATE,-8.497485,x0195,0.534078,active-noncovalent
c1ccc(cc1)c2ccc3c(n2)n(c(n3)c4cccnc4N)c5ccc(cc5)C6(CCC6)[NH3+],BRD-K60171656-001-01-6,ARQ-092,MedChemEx,HY-19719,ARQ-092,-8.496807,x0397,5.850563,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)C(=O)N[C@H]3C[NH+]4CCC3CC4,BRD-K20714604-003-02-9,RS-56812,Tocris,988,RS 56812 hydrochloride,-8.496381,x1093,-0.050322,active-noncovalent
c1cc(ccc1C(=O)c2c3c(sc2N)CCCC3)Cl,BRD-K09001147-001-02-4,T-62,Enamine,Z57052872,"(2-amino-4,5,6,7-tetrahydro-1-benzothien-3-yl)(4-chlorophenyl)methanone",-8.496325,x0749,-0.977325,active-covalent
c1cc(ccc1C(=O)c2c3c(sc2N)CCCC3)Cl,BRD-K09001147-001-01-6,T-62,Enamine,Z57052872,,-8.496325,x0749,-0.977325,active-covalent
COc1ccccc1CC(=[NH2+])N2C[C@H]3[C@@H](C2)C(CCC3=O)(c4ccccc4)c5ccccc5,BRD-K40767677-001-01-1,RP67580,Tocris,1635,"(3aR,7aR)-2-[2-(2-methoxyphenyl)ethanimidoyl]-7,7-diphenyloctahydro-4H-isoindol-4-one",-8.495847,x1077,6.096984,active-noncovalent
C1Cc2c([nH]nc2c3[n-]nnn3)C1,BRD-K91405252-001-01-9,MK-0354,MedChemEx,HY-13008,MK-0354,-8.495288,x0195,-1.365407,active-noncovalent
c1cc(ccc1CCSC(=[NH2+])N)OCc2ccc(cc2)N(=O)=O,BRD-K17743697-066-03-6,KB-R7943,Tocris,1244,KB-R7943 mesylate,-8.494431,x0678,2.48113,active-noncovalent
c1cc(ccc1CCSC(=[NH2+])N)OCc2ccc(cc2)N(=O)=O,BRD-K17743697-066-04-4,KB-R7943,Tocris,1244,KB-R7943 mesylate,-8.494431,x0678,2.48113,active-noncovalent
c1cc(c(c(c1)Cl)[NH+]=C2NCCN2)Cl,BRD-K98530306-003-18-3,clonidine,MicroSource,1500198,CLONIDINE HYDROCHLORIDE,-8.493985,x1385,-2.146065,active-covalent
c1cc(c(c(c1)Cl)[NH+]=C2NCCN2)Cl,BRD-K98530306-003-16-7,clonidine,Selleck,S2458,Clonidine HCl,-8.493985,x1385,-2.146065,active-covalent
c1cc(c(c(c1)Cl)[NH+]=C2NCCN2)Cl,BRD-K98530306-003-17-5,clonidine,Tocris,690,Clonidine hydrochloride,-8.493985,x1385,-2.146065,active-covalent
Cc1c2cc(ccc2sc1S(=O)(=O)Nc3ccc(c(c3)N4CC[NH2+]CC4)OC)Cl,BRD-K82467063-001-02-7,SB-271046,Selleck,S2856,SB271046,-8.493848,x0195,3.822264,active-noncovalent
Cc1c2cc(ccc2sc1S(=O)(=O)Nc3ccc(c(c3)N4CC[NH2+]CC4)OC)Cl,BRD-K82467063-003-01-5,SB-271046,Tocris,3368,SB 271046 hydrochloride,-8.493848,x0195,3.822264,active-noncovalent
COc1ccc(cc1)COc2ccc(cc2OC)Cc3cnc(nc3N)N,BRD-K24242599-001-02-8,GW-2580,Selleck,S8042,GW2580,-8.493644,x0107,3.517439,active-noncovalent
CC(=O)NCCc1cccc2c1cc(cc2)OC,BRD-K84698278-001-03-4,agomelatine,Selleck,S1243,Agomelatine,-8.492036,x0195,-0.528973,active-noncovalent
Cc1ccc(cc1)/C(=C\C[NH+]2CCCC2)/c3ccccn3,BRD-K11742128-003-22-6,triprolidine,Tocris,662,trans-Triprolidine hydrochloride,-8.491549,x0678,-0.182607,active-noncovalent
Cc1ccc(cc1)/C(=C\C[NH+]2CCCC2)/c3ccccn3,BRD-K11742128-003-23-4,triprolidine,MicroSource,1500598,TRIPROLIDINE HYDROCHLORIDE,-8.491549,x0678,-0.182607,active-noncovalent
C[NH2+]CC/C=C/c1cccnc1,BRD-K79966802-034-01-2,rivanicline,Enzo,AC228,RJR 2403 fumarate,-8.491385,x0397,-1.165651,active-noncovalent
c1cc(ccc1COC[C@@H]2[C@H]([C@H]([C@@H](O2)n3c4c(c(ncn4)N)nc3NCc5ccc(c(c5)Cl)Cl)O)O)C#N,BRD-K32330832-001-02-8,VER-155008,Tocris,3803,VER 155008,-8.491158,x0104,10.412152,active-noncovalent
C[NH2+][C@@H](C[C@H]1CCCOC1)CNC(=O)N2CCC[C@H](C2)[C@H](c3cccc(c3)Cl)OCCNC(=O)OC,BRD-K81694556-003-01-9,VTP-27999,MedChemEx,HY-76652,VTP-27999 (Hydrochloride),-8.490170,x0678,8.027166,active-noncovalent
CCOC(=O)c1c(n(c2c1cc(cc2)O)C)C,BRD-K28405228-001-06-7,mecarbinate,Selleck,S2074,Mecarbinate,-8.489913,x0195,-0.233432,active-noncovalent
CCCCn1c(=O)c2c([nH]c(n2)C34C[C@@H]5C[C@H](C3)CC4C5)n(c1=O)CCCO,BRD-A70407468-001-02-0,PSB-36,Tocris,2019,PSB 36,-8.489496,x0749,2.508094,active-covalent
CCCCn1c(=O)c2c([nH]c(n2)C34C[C@@H]5C[C@H](C3)CC4C5)n(c1=O)CCCO,BRD-A70407468-001-03-8,PSB-36,Tocris,2019,PSB 36,-8.489496,x0749,2.508094,active-covalent
COc1c(nccn1)NS(=O)(=O)c2ccc(cc2)N,BRD-K17205817-001-06-1,sulfametopyrazine,Enamine,Z277559098,,-8.488911,x0749,-1.273688,active-covalent
c1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)NC[NH2+]CC2=O,BRD-A17154931-001-01-5,pentostatin,Enzo,AC2019,PENTOSTATIN,-8.488460,x0195,0.700901,active-noncovalent
c1ccc(cc1)C[N@H+]2CCC[C@@H]2C(=O)NCCC[NH+]3CCC4(CC3)c5ccccc5CO4,BRD-K47049295-300-02-3,BAN-ORL-24,Tocris,3661,BAN ORL 24,-8.488327,x0678,7.765002,active-noncovalent
c1ccc(cc1)C[N@H+]2CCC[C@@H]2C(=O)NCCC[NH+]3CCC4(CC3)c5ccccc5CO4,BRD-K47049295-300-03-1,BAN-ORL-24,MedChemEx,HY-13222,BAN ORL 24,-8.488327,x0678,7.765002,active-noncovalent
c1ccc(cc1)C[N@H+]2CCC[C@@H]2C(=O)NCCC[NH+]3CCC4(CC3)c5ccccc5CO4,BRD-K47049295-300-01-5,BAN-ORL-24,Tocris,3661,BAN ORL 24,-8.488327,x0678,7.765002,active-noncovalent
c1cc(c(cc1Cl)Cl)c2c(cnc(n2)NCCNc3ccc(c(n3)N)N(=O)=O)n4ccnc4,BRD-K42973005-001-04-0,CHIR-98014,Selleck,S2745,CHIR-98014,-8.488226,x0161,4.854284,active-noncovalent
c1ccc(cc1)CSCC[C@H](CCCCC(=O)[O-])SCc2ccccc2,BRD-A06916187-001-02-9,CPI-613,Selleck,S2776,CPI-613,-8.488104,x1077,2.87431,active-noncovalent
C[C@H](CC[C@H](C(C)(C)O)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,BRD-K02965577-001-03-4,secalciferol,Enzo,DM300,"24,25-Dihydroxyvitamin D3",-8.487970,x0104,5.926696,active-noncovalent
c1cc(ccc1C(c2ccc(cc2)Cl)C(Cl)(Cl)Cl)Cl,BRD-K51799616-001-05-5,"4,4'-DDT",SantaCruz,sc-238975,"4,4'-DDT",-8.487745,x0072,-0.350522,active-noncovalent
CCC[N@H+](C/C=C/I)[C@H]1CCc2ccc(cc2C1)O,BRD-A01295252-050-01-2,7-hydroxy-PIPAT,Tocris,719,7-Hydroxy-PIPAT maleate,-8.487253,x0072,-0.517415,active-noncovalent
c1ccc(cc1)c2nc(c(s2)CC(=O)[O-])c3ccc(cc3)Cl,BRD-K16077845-001-06-1,fentiazac,Prestwick,Prestw-1254,Fentiazac,-8.486486,x0195,0.439889,active-noncovalent
c1ccc(cc1)CN2C[C@@H](CC2=O)C[NH3+],BRD-A51355958-003-01-9,nebracetam,Enamine,EN300-119912,,-8.485782,x0072,-1.096927,active-noncovalent
c1cc(c(c(c1)Cl)C(=O)Nc2c[nH]nc2C(=O)NC3CC[NH2+]CC3)Cl,BRD-K13390322-001-06-3,AT-7519,Selleck,S1524,AT7519,-8.484839,x1392,2.685675,active-covalent
c1ccc(cc1)[C@H]2[C@H](CCC[NH2+]2)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,BRD-K15791587-003-02-5,L-733060,Tocris,1145,"L-733,060 hydrochloride",-8.484735,x0195,3.358076,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3cccc(c3)Br,BRD-K26603252-003-04-9,PD-153035,MedChemEx,HY-12013,PD153035 (Hydrochloride),-8.484567,x0195,0.743733,active-noncovalent
c1c(c(cc(c1O)O)O)CC[NH3+],BRD-K41809988-003-09-3,oxidopamine,MicroSource,1500450,OXIDOPAMINE HYDROCHLORIDE,-8.484477,x1077,-1.354583,active-noncovalent
c1cc(c(cc1Cl)Cl)Nc2ncc(c(n2)C(F)(F)F)C(=O)NCC3CCOCC3,BRD-K26823213-001-02-9,GW-842166,Selleck,S2778,GW842166X,-8.483861,x0161,8.172852,active-noncovalent
CCC(=O)NC[C@@H]1C[C@H]1c2cccc3c2CCO3,BRD-K62971431-001-01-9,tasimelteon,Synnovator,PBLJ6300,"N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide",-8.483717,x0195,-0.476678,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3C(=O)C[C@@]2([C@]1(C(=O)CO)O)C)C,BRD-K18207669-001-02-4,meprednisone,Selleck,S1689,Betapar (Meprednisone),-8.483637,x0072,2.479832,active-noncovalent
c1ccc2c(c1)ccc(n2)COc3cccc(c3)Nc4ccccc4C(=O)[O-],BRD-K62562723-003-02-7,SR-2640,Tocris,1804,SR 2640 hydrochloride,-8.483300,x0161,5.874979,active-noncovalent
c1ccc2c(c1)ccc(n2)COc3cccc(c3)Nc4ccccc4C(=O)[O-],BRD-K62562723-003-03-5,SR-2640,Tocris,1804,SR 2640 hydrochloride,-8.483300,x0161,5.874979,active-noncovalent
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCc2ccccc2)O)O)O,BRD-K10961822-001-05-1,latanoprost,Enzo,DL281,Latanoprost,-8.483068,x0195,5.222409,active-noncovalent
COc1ccc(cc1OC)CCC(=O)Nc2nc3ccc(cc3s2)Cl,BRD-K13302470-001-03-5,KY02111,Tocris,4731,KY 02111,-8.481296,x0397,1.933579,active-noncovalent
COc1ccc(cc1OC)CCC(=O)Nc2nc3ccc(cc3s2)Cl,BRD-K13302470-001-02-7,KY02111,Selleck,S7096,KY02111,-8.481296,x0397,1.933579,active-noncovalent
CC(=O)C[C@H](c1ccccc1)c2c(c3ccccc3oc2=O)[O-],BRD-A24514565-001-09-7,warfarin,MicroSource,1500613,WARFARIN,-8.481207,x1093,0.266227,active-noncovalent
Cc1c([nH]cn1)CSCC/N=C(\NC)/NC#N,BRD-K34157611-001-21-0,cimetidine,Tocris,902,Cimetidine,-8.480738,x0678,-1.065742,active-noncovalent
Cc1c([nH]cn1)CSCC/N=C(\NC)/NC#N,BRD-K34157611-001-16-0,cimetidine,MicroSource,1500684,CIMETIDINE,-8.480738,x0678,-1.065742,active-noncovalent
Cc1c([nH]cn1)CSCC/N=C(\NC)/NC#N,BRD-K34157611-001-14-5,cimetidine,Selleck,S1845,Cimetidine,-8.480738,x0678,-1.065742,active-noncovalent
Cc1c([nH]cn1)CSCC/N=C(\NC)/NC#N,BRD-K34157611-001-15-2,cimetidine,Tocris,902,Cimetidine,-8.480738,x0678,-1.065742,active-noncovalent
C/C(=C\c1ccccc1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)[O-],BRD-K98054437-001-11-5,epalrestat,MedChemEx,HY-66009,Epalrestat,-8.480448,x0161,3.044369,active-noncovalent
C/C(=C\c1ccccc1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)[O-],BRD-K98054437-001-12-3,epalrestat,MedChemEx,HY-66009,Epalrestat,-8.480448,x0161,3.044369,active-noncovalent
C/C(=C\c1ccccc1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)[O-],BRD-K98054437-001-09-9,epalrestat,Selleck,S2035,Epalrestat,-8.480448,x0161,3.044369,active-noncovalent
C/C(=C\c1ccccc1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)[O-],BRD-K98054437-001-08-1,epalrestat,Selleck,S2035,Epalrestat,-8.480448,x0161,3.044369,active-noncovalent
Cc1cccc(n1)c2c(c3n(n2)CCC3)c4ccnc5c4cc(cc5)C(=O)N,BRD-K78118466-001-03-3,LY2157299,Selleck,S2230,LY2157299,-8.479886,x0195,3.411653,active-noncovalent
C[N@H+](CCCOc1ccc(cc1Cl)Cl)CC#C,BRD-K73251053-003-21-4,clorgiline,Selleck,S4317,Clorgyline HCl,-8.478968,x0104,0.366475,active-noncovalent
C[N@H+](CCCOc1ccc(cc1Cl)Cl)CC#C,BRD-K73251053-003-22-2,clorgiline,MicroSource,1506065,CLORGILINE HYDROCHLORIDE,-8.478968,x0104,0.366475,active-noncovalent
c1ccc(cc1)C2(C[C@H]2C3=[NH+]CCN3)c4ccccc4,BRD-K34251960-036-01-6,cibenzoline,Sigma,C1618,"2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate",-8.477521,x0678,-0.958385,active-noncovalent
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)[O-],BRD-K91456750-001-01-9,sacubitril,MedChemEx,HY-15407,AHU-377,-8.477490,x0107,6.046391,active-noncovalent
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)[O-],BRD-K91456750-238-01-7,sacubitril,MedChemEx,HY-15407A,AHU-377 (hemicalcium salt),-8.477490,x0107,6.046391,active-noncovalent
Cc1c2cc(ccc2c(c(n1)C(=O)NCC(=O)[O-])O)Oc3ccccc3,BRD-K14385366-001-04-4,FG-4592,Selleck,S1007,Roxadustat (FG-4592),-8.476649,x0104,6.077161,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],BRD-A73930134-001-02-2,5-hydroxytryptophan,Selleck,S2374,5-hydroxytryptophan (5-HTP),-8.476649,x0678,-1.517291,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],BRD-A73930134-001-03-0,5-hydroxytryptophan,Selleck,S2374,5-hydroxytryptophan (5-HTP),-8.476649,x0678,-1.517291,active-noncovalent
Cc1c2cc(ccc2c(c(n1)C(=O)NCC(=O)[O-])O)Oc3ccccc3,BRD-K14385366-001-02-8,FG-4592,Selleck,S1007,FG-4592,-8.476649,x0104,6.077161,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C,BRD-K46556543-237-10-5,potassium-canrenoate,Selleck,S4392,Potassium Canrenoate,-8.475823,x0678,3.879283,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C,BRD-K46556543-237-09-7,potassium-canrenoate,Selleck,S4392,Potassium Canrenoate,-8.475823,x0678,3.879283,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C,BRD-K46556543-001-01-4,potassium-canrenoate,MicroSource,1500828,"CANRENOIC ACID, POTASSIUM SALT",-8.475823,x0678,3.879283,active-noncovalent
c1cc(sc1S(=O)(=O)N[C@H](CO)C(C(F)(F)F)C(F)(F)F)Cl,BRD-K58319700-001-02-9,begacestat,Tocris,4283,Begacestat,-8.474996,x0678,1.636864,active-noncovalent
c1cc(sc1S(=O)(=O)N[C@H](CO)C(C(F)(F)F)C(F)(F)F)Cl,BRD-K58319700-001-01-1,begacestat,Sigma,PZ0187,"5-chloro-N-[(1S)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]-2-thiophenesulfonamide",-8.474996,x0678,1.636864,active-noncovalent
C[NH+]1CCN(CC1)c2cccc3c2oc(=O)[nH]3,BRD-K11851476-003-01-7,pardoprunox,MedChemEx,HY-14958A,Pardoprunox (hydrochloride),-8.474820,x0107,-0.985,active-noncovalent
c1c(c(cc(c1Cl)Cl)Cl)OCC#CI,BRD-K13238168-001-02-0,haloprogin,Prestwick,Prestw-1269,Haloprogin,-8.474243,x0195,-0.800051,active-noncovalent
c1c(nc(s1)N)/C(=C/CC(=O)[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K11124378-335-01-4,ceftibuten,MedChemEx,HY-B0698A,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxy-2-butenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrate",-8.473699,x1077,2.69455,active-noncovalent
c1c(nc(s1)N)/C(=C/CC(=O)[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K11124378-002-01-0,ceftibuten,Sigma,MFCD20488049,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxy-2-butenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate",-8.473699,x1077,2.69455,active-noncovalent
c1c(nc(s1)N)/C(=C/CC(=O)[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K11124378-001-04-6,ceftibuten,MicroSource,1505207,CEFTIBUTEN,-8.473699,x1077,2.69455,active-noncovalent
c1c(nc(s1)N)/C(=C/CC(=O)[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K11124378-335-03-0,ceftibuten,MedChemEx,HY-B0698A,Ceftibuten (dihydrate),-8.473699,x1077,2.69455,active-noncovalent
c1c(nc(s1)N)/C(=C/CC(=O)[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K11124378-335-02-2,ceftibuten,MedChemEx,HY-B0698A,Ceftibuten (dihydrate),-8.473699,x1077,2.69455,active-noncovalent
CC(C)(CC12CC3CC(C1)CC(C3)C2)[NH3+],BRD-K85764479-003-01-0,somantadine,ChemBridge,4102463,"1-((3r,5r,7r)-adamantan-1-yl)-2-methylpropan-2-amine hydrochloride",-8.473557,x0161,0.530606,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4c5cccnc5)C)C,BRD-K24048528-001-01-7,abiraterone-acetate,Selleck,S2246,Abiraterone Acetate,-8.472668,x0161,6.556775,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4c5cccnc5)C)C,BRD-K24048528-001-02-5,abiraterone-acetate,Selleck,S2246,Abiraterone Acetate,-8.472668,x0161,6.556775,active-noncovalent
C[C@@]12CC3C[C@@](C1)(CC(C3)(C2)[NH3+])C,BRD-A79803969-003-16-1,memantine,Selleck,S2043,Memantine HCl,-8.472478,x1077,2.192045,active-noncovalent
C[C@@]12CC3C[C@@](C1)(CC(C3)(C2)[NH3+])C,BRD-A79803969-003-18-7,memantine,MicroSource,1501121,MEMANTINE HYDROCHLORIDE,-8.472478,x1077,2.192045,active-noncovalent
C[C@@]12CC3C[C@@](C1)(CC(C3)(C2)[NH3+])C,BRD-A79803969-003-17-9,memantine,Tocris,773,Memantine hydrochloride,-8.472478,x1077,2.192045,active-noncovalent
COC(=O)c1ccccc1NC(=O)c2ccc(cc2)F,BRD-K78633253-001-10-3,EXO-1,Tocris,1850,Exo1,-8.471998,x0195,1.631799,active-noncovalent
COC(=O)c1ccccc1NC(=O)c2ccc(cc2)F,BRD-K78633253-001-11-1,EXO-1,Tocris,1850,Exo1,-8.471998,x0195,1.631799,active-noncovalent
Cc1c(c2c(c(c1O)C)CCC(O2)(C)C)C,BRD-K07449869-001-01-5,APC-100,Sigma,MFCD00210347,"2,2,5,7,8-pentamethyl-6-chromanol",-8.471735,x0195,0.586094,active-noncovalent
c1ccc(cc1)CCC[NH+]2CCN(CC2)CCOC(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K32501161-300-07-0,vanoxerine,Tocris,421,GBR 12909 dihydrochloride,-8.471379,x0395,7.055895,active-noncovalent
c1ccc(cc1)CCC[NH+]2CCN(CC2)CCOC(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K32501161-300-06-2,vanoxerine,Tocris,421,GBR 12909 dihydrochloride,-8.471379,x0395,7.055895,active-noncovalent
Cc1ccc(cc1)c2c(n3cc(ccc3n2)C)CC(=O)N(C)C,BRD-K44876623-001-03-7,zolpidem,MicroSource,1505369,ZOLPIDEM,-8.470912,x0434,0.675408,active-noncovalent
C[NH2+][C@@H]1C[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K01649396-003-08-9,indatraline,Tocris,1588,Indatraline hydrochloride,-8.470644,x0749,-0.683995,active-covalent
C[NH2+][C@@H]1C[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,BRD-K01649396-003-07-1,indatraline,Tocris,1588,Indatraline hydrochloride,-8.470644,x0749,-0.683995,active-covalent
c1ccc-2c(c1)Cc3c2ccc(c3)C(=O)NCCCC[NH+]4CCN(CC4)c5cccc(c5Cl)Cl,BRD-K05181084-003-04-5,NGB-2904,Tocris,2635,NGB 2904,-8.470403,x0104,13.510985,active-noncovalent
c1ccc-2c(c1)Cc3c2ccc(c3)C(=O)NCCCC[NH+]4CCN(CC4)c5cccc(c5Cl)Cl,BRD-K05181084-003-03-7,NGB-2904,Tocris,2635,NGB 2904,-8.470403,x0104,13.510985,active-noncovalent
CC1=C[C@H]2[C@@H](CC[C@]3([C@@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@]4(C1=CC(=O)CC4)C,BRD-A35989968-001-04-2,megestrol-acetate,MicroSource,1500381,MEGESTROL ACETATE,-8.468674,x0749,4.991328,active-covalent
Cc1c(c(c(cn1)CO)C[NH3+])O,BRD-K96669468-300-01-1,pyridoxamine,Sigma,MFCD00012808,4-(aminomethyl)-5-(hydroxymethyl)-2-methyl-3-pyridinol dihydrochloride,-8.467906,x0540,-1.9316,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)O)CO,BRD-K48830578-001-01-9,OMDM-2,Tocris,1797,OMDM-2,-8.466260,x0161,5.266785,active-noncovalent
c1ccc2c(c1)c(=O)cc([nH]2)C(=O)[O-],BRD-K85872723-001-17-5,kynurenic-acid,Tocris,223,Kynurenic acid,-8.466244,x0678,-1.99671,active-noncovalent
c1ccc2c(c1)c(=O)cc([nH]2)C(=O)[O-],BRD-K85872723-001-15-9,kynurenic-acid,Tocris,223,Kynurenic acid,-8.466244,x0678,-1.99671,active-noncovalent
[H]/N=c\1/n(c2c(s1)CCCC2)CC(=O)c3ccc(cc3)C,BRD-K66874953-004-07-0,pifithrin-alpha,Selleck,S2929,Pifithrin-? (PFT?),-8.464807,x1093,0.038888,active-noncovalent
[H]/N=c\1/n(c2c(s1)CCCC2)CC(=O)c3ccc(cc3)C,BRD-K66874953-004-09-6,pifithrin-alpha,Selleck,S2929,Pifithrin-??,-8.464807,x1093,0.038888,active-noncovalent
[H]/N=c\1/n(c2c(s1)CCCC2)CC(=O)c3ccc(cc3)C,BRD-K66874953-004-08-8,pifithrin-alpha,Tocris,1267,Pifithrin-? hydrobromide,-8.464807,x1093,0.038888,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O,BRD-A50049929-001-01-9,oxazepam,Enzo,AC3208,OXAZEPAM,-8.463932,x0434,0.113429,active-noncovalent
Cc1cc(n[nH]1)Nc2cc(c3nc(c(n3n2)Cc4ccc(cc4F)Cl)C)C[NH+]5CCOCC5,BRD-K25630527-001-03-8,LY2784544,Selleck,S2179,LY2784544,-8.463860,x0434,4.095911,active-noncovalent
c1ccn2c(c1)nc(c2NC(=O)c3ccc(cc3)Cl)c4cccs4,BRD-K09619578-001-01-3,DS2-(806622),Tocris,3679,DS2,-8.463784,x0708,2.357302,active-covalent
c1ccn2c(c1)nc(c2NC(=O)c3ccc(cc3)Cl)c4cccs4,BRD-K09619578-001-02-1,DS2-(806622),Tocris,3679,DS2,-8.463784,x0708,2.357302,active-covalent
CC(C)(C)c1cc2c(c(c1)C(C)(C)C)OC(=O)[C@@]2(C(F)(F)F)O,BRD-A11069678-001-01-8,rac-BHFF,Tocris,3313,rac BHFF,-8.463651,x0195,1.890246,active-noncovalent
C[N@H+]1CC[C@H](C1)Oc2cc(ccc2Cl)NS(=O)(=O)c3cc(c(cc3Br)OC)OC,BRD-K95292280-001-01-3,SB-657510,Tocris,3571,SB 657510,-8.462646,x0195,4.687226,active-noncovalent
C[N@H+]1CC[C@H](C1)Oc2cc(ccc2Cl)NS(=O)(=O)c3cc(c(cc3Br)OC)OC,BRD-K95292280-001-02-1,SB-657510,Tocris,3571,SB 657510,-8.462646,x0195,4.687226,active-noncovalent
C[NH+]1CCC(CC1)c2c3ccccc3cc(=O)c4c2ccs4,BRD-K28936863-051-31-4,ketotifen,Selleck,S2024,Ketotifen Fumarate,-8.461905,x0161,1.116223,active-noncovalent
C[NH+]1CCC(CC1)c2c3ccccc3cc(=O)c4c2ccs4,BRD-K28936863-051-32-2,ketotifen,Tocris,784,Ketotifen fumarate,-8.461905,x0161,1.116223,active-noncovalent
C[NH+]1CCC(CC1)c2c3ccccc3cc(=O)c4c2ccs4,BRD-K28936863-051-33-0,ketotifen,MicroSource,1500668,KETOTIFEN FUMARATE,-8.461905,x0161,1.116223,active-noncovalent
C[N@@H+]1CCC[C@H]1c2cc(cnc2)C#C,BRD-K52681925-050-01-6,altinicline,Tocris,4766,(S)-3-ethynyl-5-(1-methylpyrrolidin-2-yl)pyridine maleate,-8.461845,x0678,-1.201048,active-noncovalent
CC[NH2+][C@@H](C)C[N@@]1CCc2c3ccccc3oc(=O)c2C1,BRD-A50016482-001-01-7,CI-923,Sigma,PH001437,"3-[2-(ethylamino)propyl]-1,2,3,4-tetrahydro-5H-chromeno[3,4-c]pyridin-5-one",-8.461320,x0195,1.952128,active-noncovalent
CC(=O)c1c(c2nc(ccc2[nH+]c1)c3cc(c(c(c3)Cl)[O-])Cl)N[C@H]4CC[C@@H](CC4)C[NH+](C)C,BRD-K53417444-003-03-1,OTS167,MedChemEx,HY-15512A,OTSSP167 (hydrochloride),-8.461239,x1077,6.644535,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cc(cc3)OC)C[NH+](C)C,BRD-K35559145-001-01-3,levomepromazine,Sigma,MFCD00083418,"(2R)-3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethyl-1-propanamine",-8.460957,x0104,1.354493,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cc(cc3)OC)C[NH+](C)C,BRD-K35559145-050-08-5,levomepromazine,Prestwick,Prestw-797,Methotrimeprazine maleat salt,-8.460957,x0104,1.354493,active-noncovalent
CC(C)c1c(c2ccccn2n1)C(=O)C(C)C,BRD-K16444452-001-09-1,ibudilast,Tocris,1694,Ibudilast,-8.460682,x0678,-0.749705,active-noncovalent
CC(C)c1c(c2ccccn2n1)C(=O)C(C)C,BRD-K16444452-001-11-7,ibudilast,Tocris,1694,Ibudilast,-8.460682,x0678,-0.749705,active-noncovalent
CC[NH+](CC)CCNC(=O)COc1ccc(cc1)OC,BRD-K20655524-003-12-0,mefexamide,MicroSource,1501108,MEFEXAMIDE HYDROCHLORIDE,-8.460430,x0195,1.386094,active-noncovalent
CC1(CC(CC([NH2+]1)(C)C)Oc2ccc(nn2)c3ccc(cc3O)c4c[nH]nc4)C,BRD-K08532119-001-01-5,LMI070,MedChemEx,HY-19620,LMI070,-8.460411,x0161,8.744926,active-noncovalent
C=CC(=O)N1CCC[C@H](C1)n2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N,BRD-K70301465-001-05-9,ibrutinib,Selleck,S2680,Ibrutinib,-8.460383,x0161,5.822034,active-noncovalent
C=CC(=O)N1CCC[C@H](C1)n2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N,BRD-K70301465-001-02-6,ibrutinib,Selleck,S2680,Ibrutinib (PCI-32765),-8.460383,x0161,5.822034,active-noncovalent
COc1ccc(cc1)c2ccc(=[NH2+])n(n2)CCCC(=O)[O-],BRD-K79905821-004-03-6,gabazine,Tocris,1262,SR 95531 hydrobromide,-8.459710,x0749,0.970943,active-covalent
COc1ccc(cc1)c2ccc(=[NH2+])n(n2)CCCC(=O)[O-],BRD-K79905821-004-04-4,gabazine,Tocris,1262,SR 95531 hydrobromide,-8.459710,x0749,0.970943,active-covalent
c1ccc(cc1)[C@H](CC[NH3+])Oc2ccc(cc2)C(F)(F)F,BRD-A79769222-001-01-3,norfluoxetine,Cayman,15900,3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine,-8.459107,x0072,0.139022,active-noncovalent
c1cc(ccc1c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F)Cl,BRD-K76365178-001-01-5,SC-236,Tocris,3919,SC 236,-8.458914,x0161,2.343424,active-noncovalent
c1ccc(cc1)C(CCC[NH+]2CCCCC2)(c3ccccc3)O,BRD-K01663662-003-20-2,diphenidol,Enamine,Z57257314,,-8.458512,x0195,0.683459,active-noncovalent
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O,BRD-K28307902-001-20-9,flutamide,Selleck,S1908,Flutamide,-8.456950,x0195,0.4676,active-noncovalent
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O,BRD-K28307902-001-23-3,flutamide,Tocris,4094,Flutamide,-8.456950,x0195,0.4676,active-noncovalent
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O,BRD-K28307902-001-21-7,flutamide,MicroSource,1500995,FLUTAMIDE,-8.456950,x0195,0.4676,active-noncovalent
CCn1cnc2c1nc(nc2Nc3cccc(c3)Cl)N[C@@H]4CCCC[C@@H]4[NH3+],BRD-K56239177-300-01-3,CGP-74514,Tocris,5472,CGP 74514 dihydrochloride,-8.455705,x0195,4.374947,active-noncovalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)[C@@H]2CC2(Cl)Cl,BRD-A49358627-001-13-8,ciprofibrate,Selleck,S2665,Ciprofibrate,-8.455509,x0749,-0.984108,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)[C@@H]2CC2(Cl)Cl,BRD-A49358627-001-14-6,ciprofibrate,MicroSource,1502008,CIPROFIBRATE,-8.455509,x0749,-0.984108,active-covalent
c1cc2c(ccc(c2nc1)[O-])N(=O)=O,BRD-K97534525-001-23-5,nitroxoline,MicroSource,1506173,NITROXOLINE,-8.454420,x0195,-0.509403,active-noncovalent
c1cc2c(ccc(c2nc1)[O-])N(=O)=O,BRD-K97534525-001-24-3,nitroxoline,MedChemEx,HY-B1159,Nitroxoline,-8.454420,x0195,-0.509403,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CCl)O)O)N[C@@H]4C[C@@H]5CC[C@H]4C5,BRD-A13598753-001-01-2,5'-Chloro-5'-deoxy-ENBA-(+/-),Tocris,3576,(?)-5'-Chloro-5'-deoxy-ENBA,-8.452888,x0195,5.075738,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CCl)O)O)N[C@@H]4C[C@@H]5CC[C@H]4C5,BRD-A13598753-001-02-0,5'-Chloro-5'-deoxy-ENBA-(+/-),Tocris,3576,(+/-)-5'-Chloro-5'-deoxy-ENBA,-8.452888,x0195,5.075738,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)C)OC(=O)C,BRD-K48329353-001-01-3,"6,_7-dehydro-17-acetoxy-progesterone",InterBioScreen,STOCK1N-54662,,-8.451935,x0161,3.535066,active-noncovalent
Cc1nc(on1)COc2ccccc2OC[C@H](C[NH2+]C(C)(C)C)O,BRD-A29944538-003-08-3,proxodolol,InterBioScreen,STOCK3S-35298,,-8.451578,x0195,1.613461,active-noncovalent
Cc1ccc(cc1n2c(cc(c(c2=O)Br)OCc3ccc(cc3F)F)C)C(=O)NC,BRD-K95880107-001-02-4,PH-797804,Selleck,S2726,PH-797804,-8.450583,x0874,5.714786,active-noncovalent
c1ccc2c(c1)N(c3cc(ccc3S2)Cl)CCC[NH+]4CCN(CC4)CCO,BRD-K10995081-001-27-9,perphenazine,Sigma,Y0001045,2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl}ethanol,-8.449662,x0195,3.556635,active-noncovalent
c1ccc2c(c1)N(c3cc(ccc3S2)Cl)CCC[NH+]4CCN(CC4)CCO,BRD-K10995081-001-28-7,perphenazine,MedChemEx,HY-A0077,Perphenazine,-8.449662,x0195,3.556635,active-noncovalent
c1ccc2c(c1)N(c3cc(ccc3S2)Cl)CCC[NH+]4CCN(CC4)CCO,BRD-K10995081-001-26-1,perphenazine,MicroSource,1503934,PERPHENAZINE,-8.449662,x0195,3.556635,active-noncovalent
C[C@@H]([C@H](c1ccccc1)O)[NH2+]C,BRD-A54236247-003-04-3,ephedrine-(racemic),MicroSource,1500525,RACEPHEDRINE HYDROCHLORIDE,-8.449311,x0195,-1.027178,active-noncovalent
C/C/1=C/CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,BRD-K34851558-001-02-3,parthenolide-(-),Selleck,S2341,(-)-Parthenolide,-8.448843,x0195,-0.121231,active-noncovalent
Cc1c(n2cccc(c2n1)OCc3ccccc3)CC#N,BRD-K55748775-001-02-2,SCH-28080,Tocris,1690,SCH 28080,-8.448485,x0195,0.380432,active-noncovalent
c1ccc(cc1)CCNC(=O)CCCl,BRD-K08791496-001-01-0,fenaclon,MicroSource,1503901,FENACLON,-8.448026,x0161,-1.65125,active-noncovalent
CCC/C=C\1/C2=C(C=CCC2)C(=O)O1,BRD-K48875051-001-01-0,ligustilide,MedChemEx,HY-N0401,Ligustilide,-8.447991,x0195,-1.26091,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)C[NH+]3CCN(CC3)C(=O)OC(C(F)(F)F)C(F)(F)F,BRD-K48424871-001-03-1,JW-642,Tocris,4906,JW 642,-8.447926,x0104,7.685696,active-noncovalent
CC(C)[C@H](C(=O)[O-])[NH3+],BRD-K59424860-001-01-4,val,Enzo,AC1026,D-Valine,-8.447546,x0397,-0.709729,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)CSCCC(=O)[O-])NC(=O)O[C@@H](C)c3ccccc3Cl,BRD-A25569250-001-03-3,KI-16425,Selleck,S1315,Ki16425,-8.447453,x0161,7.102325,active-noncovalent
c1ccc(cc1)CO[C@@H]([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-M77041484-001-03-4,TBOA-(DL),Tocris,1223,"(2R,3R)-2-amino-3-(benzyloxy)succinic acid compound with (2S,3S)-2-amino-3-(benzyloxy)succinic acid (1:1)",-8.447106,x1418,-1.020867,active-covalent
c1ccc(cc1)CO[C@@H]([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-M77041484-001-01-8,TBOA-(DL),Tocris,1223,DL-TBOA,-8.447106,x1418,-1.020867,active-covalent
c1ccc(cc1)CO[C@@H]([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-M77041484-001-02-6,TBOA-(DL),Tocris,1223,DL-TBOA,-8.447106,x1418,-1.020867,active-covalent
Cc1ccccc1c2ccc(cc2)C(=O)N3C/C(=N\OC)/C[C@H]3C(=O)NC[C@H](c4ccccc4)O,BRD-K42009284-001-01-1,OT-R-antagonist-1,MedChemEx,HY-15015,OT-R antagonist 1,-8.446954,x0107,7.151957,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)Cc3ccccc3,BRD-A24191444-045-10-6,ifenprodil,Tocris,545,Ifenprodil hemitartrate,-8.446609,x0104,3.434539,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)Cc3ccccc3,BRD-A24191444-046-03-9,ifenprodil,Selleck,S4091,Ifenprodil Tartrate,-8.446609,x0104,3.434539,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)Cc3ccccc3,BRD-A24191444-046-02-1,ifenprodil,Selleck,S4091,Ifenprodil Tartrate,-8.446609,x0104,3.434539,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)Cc3ccccc3,BRD-A24191444-046-01-3,ifenprodil,MicroSource,1506000,IFENPRODIL TARTRATE,-8.446609,x0104,3.434539,active-noncovalent
Cn1cc(c2c1cc(c(c2)C(=O)N3CCC(CC3)Cc4ccc(cc4)F)Cl)C(=O)C(=O)N(C)C,BRD-K45385835-001-02-4,SX-011,Tocris,3639,SX 011,-8.446242,x0161,5.115178,active-noncovalent
Cn1cc(c2c1cc(c(c2)C(=O)N3CCC(CC3)Cc4ccc(cc4)F)Cl)C(=O)C(=O)N(C)C,BRD-K45385835-001-03-2,SX-011,Tocris,3639,"2-(6-chloro-5-{[4-(4-fluorobenzyl)-1-piperidinyl]carbonyl}-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide",-8.446242,x0161,5.115178,active-noncovalent
Cc1c(sc2n1c3cc(ccc3n2)N)C(=O)NC4CCCCC4,BRD-K48059230-003-02-9,YM-298198-desmethyl,Tocris,2447,Desmethyl-YM 298198,-8.445809,x0072,2.656394,active-noncovalent
C[NH+]1CCC(CC1)CNc2ccc3[nH+]cc(n3n2)c4cccc(c4)OC(F)(F)F,BRD-K80700417-001-04-2,SGI-1776,Selleck,S2198,SGI-1776 free base,-8.445366,x0434,5.262997,active-noncovalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N(C)C,BRD-K73368362-001-08-3,BIX-02189,Tocris,4842,BIX 02189,-8.444479,x1077,3.131696,active-noncovalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N(C)C,BRD-K73368362-001-07-5,BIX-02189,Selleck,S1531,BIX 02189,-8.444479,x1077,3.131696,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH2+]C(C)C,BRD-A24587114-066-21-7,isoetharine,Selleck,S4330,Isoetharine Mesylate,-8.443722,x0749,-1.189583,active-covalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH2+]C(C)C,BRD-A24587114-066-22-5,isoetharine,MicroSource,1505977,ISOETHARINE MESYLATE,-8.443722,x0749,-1.189583,active-covalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH2+]C(C)C,BRD-A24587114-066-23-3,isoetharine,Selleck,S4330,isoetharine mesylate,-8.443722,x0749,-1.189583,active-covalent
C1CCC[NH+](CCC1)CCNC(=[NH2+])N,BRD-K62676709-065-05-5,guanethidine,Selleck,S4328,Guanethidine Sulfate,-8.443386,x1334,-1.525316,active-covalent
C1CCC[NH+](CCC1)CCNC(=[NH2+])N,BRD-K62676709-001-01-9,guanethidine,MicroSource,1500323,GUANETHIDINE,-8.443386,x1334,-1.525316,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O)C,BRD-K15231341-001-01-5,hemomex-s,MedChemEx,HY-N0835,(20S)-Protopanaxatriol,-8.442374,x0104,4.792748,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C(=O)C=C2C1)CCC4=O)C)C,BRD-K07785030-001-01-6,7-keto-DHEA,ChemImpex,24167,"(3beta)-7,17-dioxoandrost-5-en-3-yl acetate",-8.440795,x0749,4.316175,active-covalent
c1cc(cc(c1)O)c2cnc3c(n2)c(nc(n3)N)N,BRD-K46392623-001-02-5,TG-100713,Selleck,S2870,TG100713,-8.440187,x0678,0.825408,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)c2ccc(cc2)C#N,BRD-A50062753-001-01-3,LY-404187,Tocris,5297,LY 404187,-8.439507,x0104,2.308454,active-noncovalent
C[N@H+]1CCC[C@H](C1)CC2c3ccccc3Sc4c2cccc4,BRD-A33711280-003-03-1,metixene,Prestwick,Prestw-491,Metixene hydrochloride,-8.438705,x0678,1.399432,active-noncovalent
COc1ccc(cc1)CN2c3ccc(cc3C(=O)C2=O)OC(F)(F)F,BRD-K24187789-001-01-7,VU0238429,Tocris,3634,VU 0238429,-8.438686,x0195,2.347591,active-noncovalent
COc1ccc(cc1)CN2c3ccc(cc3C(=O)C2=O)OC(F)(F)F,BRD-K24187789-001-02-5,VU0238429,Tocris,3634,VU 0238429,-8.438686,x0195,2.347591,active-noncovalent
CCCOc1ccc(cc1N)C(=O)OCC[NH+](CC)CC,BRD-K79116891-003-15-1,proxymetacaine,MicroSource,1505688,PROPARACAINE HYDROCHLORIDE,-8.438590,x0946,1.921319,active-noncovalent
CCCOc1ccc(cc1N)C(=O)OCC[NH+](CC)CC,BRD-K79116891-003-14-4,proxymetacaine,Selleck,S1828,Proparacaine HCl,-8.438590,x0946,1.921319,active-noncovalent
C1CCC(CC1)CCC[C@H](CC(=O)NO)c2nc(no2)C(=O)N,BRD-K06294530-001-03-1,UK-383367,Tocris,4188,UK 383367,-8.437532,x0107,1.872203,active-noncovalent
C1CCC(CC1)CCC[C@H](CC(=O)NO)c2nc(no2)C(=O)N,BRD-K06294530-001-01-5,UK-383367,Selleck,S2224,UK 383367,-8.437532,x0107,1.872203,active-noncovalent
C1CCC(CC1)CCC[C@H](CC(=O)NO)c2nc(no2)C(=O)N,BRD-K06294530-001-02-3,UK-383367,Selleck,S2224,UK 383367,-8.437532,x0107,1.872203,active-noncovalent
C[C@]12CC[C@@H]3[C@@H]([C@]1(CC[C@@H]2C4=CC(=O)OC4)O)CC[C@]5([C@@]3(CC[C@@H](C5)O)C=O)O,BRD-A55312468-001-04-7,k-strophanthidin,Enzo,NP306,Strophanthidin acetate,-8.437345,x1077,3.11867,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)Sc4cccc(c4)NC(=O)C=C)Cl,BRD-K81728688-001-04-4,WZ8040,Selleck,S1179,WZ8040,-8.436563,x1077,6.535563,active-noncovalent
c1ccc(cc1)c2cc(=O)c3cccc(c3o2)CC(=O)[O-],BRD-K35882976-001-04-7,mitoflaxone,Specs,AN-308/15495081,2-(4-oxo-2-phenyl-4H-chromen-8-yl)acetic acid,-8.436230,x0678,1.071672,active-noncovalent
c1c(nc[nH]1)C[C@@H](C(=O)N2CCC[C@@H]2C(=O)N)NC(=O)[C@@H]3CCC(=O)N3,BRD-A16997652-001-02-3,protirelin,MicroSource,1506101,PROTIRELIN,-8.435274,x0678,2.158676,active-noncovalent
CCCCCCCCCCCC(=O)N(CCO)CCO,BRD-K11548689-001-01-6,lauric-diethanolamide,Enamine,Z1262465391,,-8.434810,x0161,2.596414,active-noncovalent
CCCC(c1ccccc1)(c2ccccc2)C(=O)OCC[NH+](CC)CC,BRD-K46317332-003-17-8,proadifen,MicroSource,1502084,PROADIFEN HYDROCHLORIDE,-8.434317,x0678,3.289539,active-noncovalent
CCCC(c1ccccc1)(c2ccccc2)C(=O)OCC[NH+](CC)CC,BRD-K46317332-003-16-0,proadifen,Selleck,S4381,Proadifen HCl,-8.434317,x0678,3.289539,active-noncovalent
CCCC(c1ccccc1)(c2ccccc2)C(=O)OCC[NH+](CC)CC,BRD-K46317332-003-18-6,proadifen,Selleck,S4381,proadifen hydrochloride,-8.434317,x0678,3.289539,active-noncovalent
Cc1cnc(nc1NCc2ccc(cc2)n3ccnn3)c4ccccc4C(C)C,BRD-K93942811-001-01-3,ML-323,MedChemEx,HY-17543,ML-323,-8.432630,x0072,4.841766,active-noncovalent
CCN1C[C@H](C(C1=O)(c2ccccc2)c3ccccc3)CC[NH+]4CCOCC4,BRD-A46179541-311-03-8,doxapram,MicroSource,1505534,DOXAPRAM HYDROCHLORIDE,-8.431566,x0678,3.9378,active-noncovalent
CCN1C[C@H](C(C1=O)(c2ccccc2)c3ccccc3)CC[NH+]4CCOCC4,BRD-A46179541-311-02-0,doxapram,Selleck,S4037,Doxapram HCl,-8.431566,x0678,3.9378,active-noncovalent
Cc1ccc(cc1)/C=C\2/[C@@H]3CC[C@](C2=O)(C3(C)C)C,BRD-A55464252-001-01-2,3-(4-methylbenzylidene)camphor,AlfaAesar,A16566,"3-(4-Methylbenzylidene)camphor, 99+%",-8.429641,x0749,0.320068,active-covalent
B1(c2ccc(cc2CO1)Cl)O,BRD-K21920947-001-02-1,AN2718,Enamine,Z1739256298,"5-chloro-2,1-benzoxaborol-1(3H)-ol",-8.428252,x0195,-0.122729,active-noncovalent
B1(c2ccc(cc2CO1)Cl)O,BRD-K21920947-001-01-3,AN2718,Enamine,EN300-117650,,-8.428252,x0195,-0.122729,active-noncovalent
C(C[C@@](C(F)F)(C(=O)[O-])[NH3+])C[NH3+],BRD-A96292436-003-16-1,eflornithine,Enzo,AC3107,EFLORNITHINE HYDROCHLORIDE,-8.426789,x0397,-0.58513,active-noncovalent
Cc1cccc(n1)c2c([nH]c(n2)C(C)(C)C)c3ccc4c(c3)nccn4,BRD-K37720887-001-07-8,SB-525334,Selleck,S1476,SB525334,-8.426558,x0678,3.126976,active-noncovalent
Cc1cccc(n1)c2c([nH]c(n2)C(C)(C)C)c3ccc4c(c3)nccn4,BRD-K37720887-001-08-6,SB-525334,Tocris,3211,SB 525334,-8.426558,x0678,3.126976,active-noncovalent
CCCn1cnc2c1c(=O)n(c(=O)n2C)CCCCC(=O)C,BRD-K59273480-001-10-6,propentofylline,Enzo,AC648,Propentofylline,-8.425456,x0195,2.001665,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c(cc([nH]2)c3cc4ccccc4[nH]3)OC,BRD-K15600710-066-05-8,obatoclax,Selleck,S1057,Obatoclax mesylate (GX15-070),-8.424305,x1093,3.339286,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c(cc([nH]2)c3cc4ccccc4[nH]3)OC,BRD-K15600710-066-04-1,obatoclax,Selleck,S1057,Obatoclax Mesylate (GX15-070),-8.424305,x1093,3.339286,active-noncovalent
c1ccc(cc1)NC(=O)/C=C/c2c3c(cc(cc3Cl)Cl)[nH]c2C(=O)[O-],BRD-K81981783-236-03-7,gavestinel,Tocris,2348,Gavestinel,-8.424241,x1093,2.619192,active-noncovalent
c1ccc(cc1)NC(=O)/C=C/c2c3c(cc(cc3Cl)Cl)[nH]c2C(=O)[O-],BRD-K81981783-236-01-1,gavestinel,Tocris,2348,Gavestinel,-8.424241,x1093,2.619192,active-noncovalent
c1ccc(cc1)NC(=O)/C=C/c2c3c(cc(cc3Cl)Cl)[nH]c2C(=O)[O-],BRD-K81981783-236-02-9,gavestinel,Tocris,2348,"sodium 3-[(1E)-3-anilino-3-oxo-1-propenyl]-4,6-dichloro-1H-indole-2-carboxylate",-8.424241,x1093,2.619192,active-noncovalent
CCOC(=O)Nc1ccc(cc1N)NCc2c(cc(cc2C)C)C,BRD-K13944729-001-01-7,AA-29504,Tocris,3972,AA 29504,-8.423727,x1093,2.290653,active-noncovalent
CCCC[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K32892871-003-01-7,JHW-007,Tocris,4351,JHW 007 hydrochloride,-8.423425,x0072,2.97024,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N4[C@H]2CCC4)OC,BRD-K13474508-001-02-0,"L-655,708",Tocris,1327,"L-655,708",-8.423057,x1334,1.965286,active-covalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N4[C@H]2CCC4)OC,BRD-K13474508-001-01-2,"L-655,708",Tocris,1327,"L-655,708",-8.423057,x1334,1.965286,active-covalent
c1cc(cc(c1)O)Nc2ccc(nn2)Nc3cccc(c3)O,BRD-K38687824-001-02-5,beta-amyloid-synthesis-inhibitor,Maybridge,MO08553,,-8.422981,x0946,3.475116,active-noncovalent
CCOC(=O)C(C)(C)Oc1ccc(cc1)Cl,BRD-K45252063-001-12-8,clofibrate,Selleck,S1820,Clofibrate (Atromid-S),-8.421970,x0195,-0.330876,active-noncovalent
CCOC(=O)C(C)(C)Oc1ccc(cc1)Cl,BRD-K45252063-001-13-6,clofibrate,MicroSource,1503429,CLOFIBRATE,-8.421970,x0195,-0.330876,active-noncovalent
CCOC(=O)C(C)(C)Oc1ccc(cc1)Cl,BRD-K45252063-001-14-4,clofibrate,Selleck,S1820,Clofibrate,-8.421970,x0195,-0.330876,active-noncovalent
C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C,BRD-K85883481-001-22-4,prednisone,Selleck,S1622,Prednisone (Adasone),-8.420488,x0072,1.809015,active-noncovalent
C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C,BRD-K85883481-001-24-0,prednisone,Selleck,S1622,Prednisone,-8.420488,x0072,1.809015,active-noncovalent
C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C,BRD-K85883481-001-25-7,prednisone,MicroSource,1500499,PREDNISONE,-8.420488,x0072,1.809015,active-noncovalent
c1cc(cc(c1)F)/C=C/C(=O)NC2CC2,BRD-K25154476-001-01-4,cinflumide,Enamine,Z32368088,(2E)-N-cyclopropyl-3-(3-fluorophenyl)-2-propenamide,-8.419362,x0195,-0.742532,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,BRD-K74186897-001-10-8,cytisine,Selleck,S2287,Cytisine,-8.417797,x0195,0.201234,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,BRD-K74186897-001-12-4,cytisine,Selleck,S2287,"Cytisine (Baphitoxine, Sophorine)",-8.417797,x0195,0.201234,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,BRD-K74186897-001-13-2,cytisine,MicroSource,1504027,CYTISINE,-8.417797,x0195,0.201234,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,BRD-K74186897-001-11-6,cytisine,Tocris,1390,(-)-Cytisine,-8.417797,x0195,0.201234,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOC)O,BRD-A03623303-045-09-5,metoprolol,MicroSource,1500411,METOPROLOL TARTRATE,-8.417479,x0104,0.51493,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOC)O,BRD-A03623303-046-15-0,metoprolol,Tocris,3256,Metoprolol tartrate,-8.417479,x0104,0.51493,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOC)O,BRD-A03623303-046-14-3,metoprolol,Selleck,S1856,Metoprolol Tartrate,-8.417479,x0104,0.51493,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)C(=O)NCC#N,BRD-K87737963-001-06-0,cyt387,Selleck,S2219,CYT387,-8.417415,x0161,10.326409,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)C(=O)NCC#N,BRD-K87737963-001-07-8,cyt387,Selleck,S2219,Momelotinib (CYT387),-8.417415,x0161,10.326409,active-noncovalent
c1cc(ccc1OC(=O)N2CC[NH+]3CCC2CC3)Br,BRD-K02782351-003-01-5,SSR-180711,Tocris,5559,SSR 180711 hydrochloride,-8.416765,x0749,0.499,active-covalent
c1cc(c(c2c1[NH+]=C3NC(=O)CN3C2)Cl)Cl,BRD-K62200014-001-02-6,anagrelide,Selleck,S3172,Anagrelide,-8.416256,x0749,-1.436996,active-covalent
c1cc(c(c2c1[NH+]=C3NC(=O)CN3C2)Cl)Cl,BRD-K62200014-003-11-3,anagrelide,MicroSource,1505590,ANAGRELIDE HYDROCHLORIDE,-8.416256,x0749,-1.436996,active-covalent
c1cc(c(c2c1[NH+]=C3NC(=O)CN3C2)Cl)Cl,BRD-K62200014-003-10-5,anagrelide,Selleck,S3172,Anagrelide HCl,-8.416256,x0749,-1.436996,active-covalent
c1ccc(cc1)C(c2ccccc2)[NH+]3CCN(CC3)CCCn4c5ccccc5[nH]c4=O,BRD-K02079473-001-01-3,oxatomide,Vitas-M,STL147112,,-8.415870,x0967,3.038671,active-noncovalent
C[C@H](CCc1ccccc1)[NH2+]C[C@@H](c2ccc(c(c2)C(=O)N)O)O,BRD-A07440155-003-25-4,labetalol,MicroSource,1503243,LABETALOL HYDROCHLORIDE,-8.415393,x0107,1.273903,active-noncovalent
COC(=O)[N-]C(=S)Nc1ccccc1NC(=S)[N-]C(=O)OC,BRD-K90168339-001-09-4,thiophanate,Sigma,MFCD00055294,methyl [2-({[(methoxycarbonyl)amino]carbothioyl}amino)anilino]carbothioylcarbamate,-8.414536,x0749,0.662868,active-covalent
COC(=O)[N-]C(=S)Nc1ccccc1NC(=S)[N-]C(=O)OC,BRD-K90168339-001-08-6,thiophanate,MicroSource,1503974,THIOPHANATE,-8.414536,x0749,0.662868,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4[C@H](C=O)O)C)O,BRD-K73589401-001-23-6,corticosterone,Prestwick,Prestw-432,Corticosterone,-8.412957,x0967,1.206327,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4[C@H](C=O)O)C)O,BRD-K73589401-001-25-1,corticosterone,Tocris,3685,Corticosterone,-8.412957,x0967,1.206327,active-noncovalent
c1cc(c(c(c1)Cl)CC(=O)NC(=[NH2+])N)Cl,BRD-K32830106-001-02-6,guanfacine,MicroSource,1505435,GUANFACINE,-8.412230,x1334,-0.723087,active-covalent
c1cc(c(c(c1)Cl)CC(=O)NC(=[NH2+])N)Cl,BRD-K32830106-003-21-2,guanfacine,MicroSource,1505435,GUANFACINE HYDROCHLORIDE,-8.412230,x1334,-0.723087,active-covalent
c1cc(c(c(c1)Cl)CC(=O)NC(=[NH2+])N)Cl,BRD-K32830106-003-20-4,guanfacine,Tocris,1030,Guanfacine hydrochloride,-8.412230,x1334,-0.723087,active-covalent
Cn1c2cnc3ccc(cc3c2n(c1=O)c4ccc(c(c4)C(F)(F)F)N5CC[NH2+]CC5)c6ccc(nc6)OC,BRD-K29415052-050-05-5,BGT226,Selleck,S2749,NVP-BGT226,-8.411229,x0161,8.923715,active-noncovalent
Cn1c2cnc3ccc(cc3c2n(c1=O)c4ccc(c(c4)C(F)(F)F)N5CC[NH2+]CC5)c6ccc(nc6)OC,BRD-K29415052-050-04-8,BGT226,Selleck,S2749,BGT226 (NVP-BGT226),-8.411229,x0161,8.923715,active-noncovalent
CSc1nc(cc(n1)Oc2ccc(cc2)c3nc([nH]n3)Nc4cccc(c4)C(F)(F)F)N,BRD-K90747162-001-01-4,KG-5,Tocris,5260,KG 5,-8.410840,x0104,11.741092,active-noncovalent
C[C@H]1C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C,BRD-A02180903-001-04-5,betamethasone,MicroSource,1500144,BETAMETHASONE,-8.410234,x0749,3.452157,active-covalent
c1cc(c(cc1C(F)(F)F)NC(=O)c2ccncc2)N3CCCCC3,BRD-K62621335-001-01-7,SRPIN340,Selleck,S7270,SRPIN340,-8.409800,x0195,1.167427,active-noncovalent
c1cc(c(cc1C(F)(F)F)NC(=O)c2ccncc2)N3CCCCC3,BRD-K62621335-001-02-5,SRPIN340,Tocris,5063,SRPIN340,-8.409800,x0195,1.167427,active-noncovalent
C[N@@H+]1CCO[C@@H](c2ccccc2C1)c3ccccc3,BRD-A78877355-001-03-0,nefopam,MicroSource,1501137,NEFOPAM,-8.408761,x1392,-0.042866,active-covalent
C[N@@H+]1CCO[C@@H](c2ccccc2C1)c3ccccc3,BRD-A78877355-003-11-9,nefopam,Selleck,S4180,Nefopam HCl,-8.408761,x1392,-0.042866,active-covalent
c1cc(sc1CO)c2ccc(o2)c3ccc(s3)CO,BRD-K00317371-001-06-1,RITA,Selleck,S2781,RITA (NSC 652287),-8.408442,x1093,3.028058,active-noncovalent
c1cc(sc1CO)c2ccc(o2)c3ccc(s3)CO,BRD-K00317371-001-05-3,RITA,Selleck,S2781,RITA (NSC 652287),-8.408442,x1093,3.028058,active-noncovalent
c1ccc(cc1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-],BRD-K52959329-238-01-9,mitiglinide,Selleck,S2073,Mitiglinide calcium,-8.408325,x1093,1.279354,active-noncovalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3cccc(c3C(=O)N4[C@H]2CCC4)Br,BRD-K96936751-001-01-4,bretazenil,Tocris,3568,Bretazenil,-8.408072,x0874,1.416242,active-noncovalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3cccc(c3C(=O)N4[C@H]2CCC4)Br,BRD-K96936751-001-02-2,bretazenil,Tocris,3568,Bretazenil,-8.408072,x0874,1.416242,active-noncovalent
c1ccc(cc1)NS(=O)(=O)c2cccc(c2)CCC(=O)N=O,BRD-K17743125-001-08-4,belinostat,Selleck,S1085,Belinostat (PXD101),-8.407567,x0072,1.824816,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@H]4CCCO4,BRD-A22256192-310-02-8,terazosin,Selleck,S2059,Terazosin HCl,-8.407208,x0161,4.943123,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@H]4CCCO4,BRD-A22256192-003-22-7,terazosin,Tocris,1506,Terazosin hydrochloride,-8.407208,x0161,4.943123,active-noncovalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,BRD-K62353271-001-04-7,baclofen-(R),Selleck,S3072,(R)-baclofen,-8.406635,x0759,-0.781243,active-covalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,BRD-K62353271-001-02-1,baclofen-(R),Selleck,S3072,(R)-baclofen,-8.406635,x0759,-0.781243,active-covalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,BRD-A84174873-003-07-4,baclofen,MicroSource,1500135,BACLOFEN HYDROCHLORIDE (+/-),-8.406635,x0759,-0.781243,active-covalent
CC1(c2ccccc2C(=O)N(C1=O)CC[NH+]3CCN(CC3)c4ccccc4OC)C,BRD-K93188295-300-02-2,ARC-239,Tocris,928,ARC 239 dihydrochloride,-8.406599,x0161,4.64398,active-noncovalent
CC(C)Oc1ccc2c(c1)oc3ccc(cc3c2=O)C(=O)[O-],BRD-K59339270-001-03-4,AH6809,Tocris,671,AH 6809,-8.406567,x0749,2.337259,active-covalent
CC(C)Oc1ccc2c(c1)oc3ccc(cc3c2=O)C(=O)[O-],BRD-K59339270-001-02-6,AH6809,Tocris,671,AH 6809,-8.406567,x0749,2.337259,active-covalent
c1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)NC[NH2+]CC2=O,BRD-K91543828-001-02-0,pentostatin,MedChemEx,HY-A0006,Pentostatin,-8.405374,x0749,-0.140595,active-covalent
C[C@]12CCC(=O)C=C1[C@H](C[C@H]3[C@@H]2[C@H](C[C@]4([C@@H]3C[C@@H]5[C@]4(OC(O5)(C)C)[C@H](C=O)O)C)O)F,BRD-A49765801-001-04-1,fludroxycortide,MicroSource,1501175,FLURANDRENOLIDE,-8.405338,x0874,2.038433,active-noncovalent
c1ccc(cc1)NC(=O)CCCCCCC(=O)NO,BRD-K81418486-001-51-7,vorinostat,Tocris,4652,SAHA,-8.405173,x0678,0.987174,active-noncovalent
c1ccc(cc1)NC(=O)CCCCCCC(=O)NO,BRD-K81418486-001-47-5,vorinostat,Selleck,S1047,Vorinostat (SAHA),-8.405173,x0678,0.987174,active-noncovalent
c1ccc(cc1)NC(=O)CCCCCCC(=O)NO,BRD-K81418486-001-44-2,vorinostat,Selleck,S1047,"Vorinostat (SAHA, MK0683)",-8.405173,x0678,0.987174,active-noncovalent
C[NH+](C)CCOC1=Cc2ccccc2Sc3c1cc(cc3)Cl,BRD-K64557645-001-02-4,zotepine,Prestwick,Prestw-1368,Zotepine,-8.403874,x0104,-0.059576,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,BRD-K61314889-001-05-1,endo-IWR-1,Tocris,3532,endo-IWR 1,-8.403872,x0104,12.469067,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,BRD-K61314889-001-06-9,endo-IWR-1,Tocris,3532,endo-IWR 1,-8.403872,x0104,12.469067,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,BRD-K61314889-001-04-4,endo-IWR-1,Selleck,S7086,IWR-1-endo,-8.403872,x0104,12.469067,active-noncovalent
Cc1ccc(c(c1Cl)Nc2ccccc2C(=O)[O-])Cl,BRD-K50398167-236-22-7,meclofenamic-acid,MicroSource,1500377,MECLOFENAMATE SODIUM,-8.403840,x1093,-0.446186,active-noncovalent
c1cc(ccc1c2nc(on2)[C@H]3CCCN(C3)C(=O)c4ccc(cc4)F)F,BRD-K56543881-001-02-7,ADX-47273,Selleck,S2690,ADX-47273,-8.403830,x0195,2.692955,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(cc2N(=O)=O)Cl,BRD-K89000287-001-01-1,BTB1,Tocris,5399,BTB1,-8.402944,x0072,0.430956,active-noncovalent
CC1(c2ccccc2N(C1=O)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F)C,BRD-K41194171-003-09-7,LY310762,MedChemEx,HY-13527,LY310762,-8.402941,x0072,2.411981,active-noncovalent
Cc1c[nH+]c([nH]1)c2cnc(nc2c3ccc(cc3Cl)Cl)NCCNc4ccc(cn4)C#N,BRD-K16189898-001-21-9,CHIR-99021,Tocris,4423,CHIR 99021,-8.402782,x0161,4.11693,active-noncovalent
Cc1c[nH+]c([nH]1)c2cnc(nc2c3ccc(cc3Cl)Cl)NCCNc4ccc(cn4)C#N,BRD-K16189898-003-03-3,CHIR-99021,Selleck,S2924,CHIR-99021 (CT99021) HCl,-8.402782,x0161,4.11693,active-noncovalent
c1cc(ccc1C(CCC[NH+]2CCC(CC2)(c3ccc(c(c3)C(F)(F)F)Cl)O)c4ccc(cc4)F)F,BRD-K15409150-001-05-8,penfluridol,Selleck,S4151,Penfluridol,-8.401995,x0104,8.987319,active-noncovalent
c1cc(ccc1C(CCC[NH+]2CCC(CC2)(c3ccc(c(c3)C(F)(F)F)Cl)O)c4ccc(cc4)F)F,BRD-K15409150-001-07-4,penfluridol,MicroSource,1505691,PENFLURIDOL,-8.401995,x0104,8.987319,active-noncovalent
CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO,BRD-K34032314-001-02-5,betamethasone-valerate,Selleck,S1690,Betamethasone valerate (Betnovate),-8.401898,x1077,5.475881,active-noncovalent
CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO,BRD-K34032314-001-03-3,betamethasone-valerate,Selleck,S1690,Betamethasone valerate (Betnovate),-8.401898,x1077,5.475881,active-noncovalent
CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO,BRD-K34032314-001-04-1,betamethasone-valerate,MicroSource,1500145,BETAMETHASONE VALERATE,-8.401898,x1077,5.475881,active-noncovalent
CC(C)[C@@H](C(=O)OCCOCn1cnc2c1nc([nH]c2=O)N)[NH3+],BRD-K46435977-003-11-1,valaciclovir,Selleck,S1876,Valaciclovir HCl,-8.401814,x1093,1.61239,active-noncovalent
CC(C)[C@@H](C(=O)OCCOCn1cnc2c1nc([nH]c2=O)N)[NH3+],BRD-K46435977-003-12-9,valaciclovir,MicroSource,1505368,VALACYCLOVIR HYDROCHLORIDE,-8.401814,x1093,1.61239,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)CSCCC(=O)OC)NC(=O)O[C@@H](C)c3ccccc3Cl,BRD-A94323479-001-02-8,ki16198,Selleck,S2906,Ki16198,-8.401700,x0161,8.297773,active-noncovalent
C[C@H]1[C@@H]2Cc3ccc(cc3[C@]1(CC[N@H+]2CC=C)C)O,BRD-A47364545-003-02-6,SK&F-10047-(+),Tocris,1079,(+)-SK&F 10047 hydrochloride,-8.401029,x0678,-1.067959,active-noncovalent
CCCOc1ccc2c(c1)[nH]c(n2)NC(=O)OC,BRD-K52075715-001-07-5,oxibendazole,MicroSource,1503373,OXIBENDAZOLE,-8.400433,x0195,0.686804,active-noncovalent
CCCOc1ccc2c(c1)[nH]c(n2)NC(=O)OC,BRD-K52075715-001-06-7,oxibendazole,Selleck,S1851,Oxibendazole,-8.400433,x0195,0.686804,active-noncovalent
c1ccc(cc1)C[C@@H]2Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)C(F)(F)F,BRD-A80017228-001-25-7,bendroflumethiazide,MicroSource,1503104,BENDROFLUMETHIAZIDE,-8.397747,x0195,2.873947,active-noncovalent
c1ccc(cc1)C[C@@H]2Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)C(F)(F)F,BRD-A80017228-001-24-0,bendroflumethiazide,Selleck,S4387,Bendroflumethiazide,-8.397747,x0195,2.873947,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)I,BRD-K75855670-001-14-2,iodoquinol,MicroSource,1500353,IODOQUINOL,-8.397536,x0195,-0.601292,active-noncovalent
c1c(c(c(cc1F)F)Nc2n(c3nc(ncc3n2)N[C@H]4CC[C@@H](CC4)O)[C@@H]5COCC5)F,BRD-K48213016-001-01-8,CC-930,MedChemEx,HY-15495,CC-930,-8.397164,x0161,6.461361,active-noncovalent
C[N@@H+]1[C@@H]2CC[C@H]1C=C(C2)c3c(ccs3)Br,BRD-A23155040-051-01-7,NS-3861,Tocris,4831,NS 3861,-8.397058,x0104,-0.019743,active-noncovalent
c1cc(cc(c1)O)Nc2c(cnc(n2)Nc3cccc(c3)O)F,BRD-K23902832-001-01-7,R112,MedChemEx,HY-16420,R112,-8.395176,x1392,1.820266,active-covalent
CC(=O)O[C@@H]1[C@H](C[NH2+][C@@H]1Cc2ccc(cc2)OC)O,BRD-K91370081-001-25-1,anisomycin,Tocris,1290,Anisomycin,-8.394763,x1385,-0.055347,active-covalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,BRD-K97181089-003-22-1,amiloride,Selleck,S1811,Amiloride HCl,-8.394518,x0397,-1.261454,active-noncovalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,BRD-K97181089-310-06-3,amiloride,Selleck,S2560,Amiloride hydrochloride dihydrate,-8.394518,x0397,-1.261454,active-noncovalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,BRD-K97181089-003-23-9,amiloride,Tocris,890,Amiloride hydrochloride,-8.394518,x0397,-1.261454,active-noncovalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,BRD-K97181089-003-24-7,amiloride,MicroSource,1500112,AMILORIDE HYDROCHLORIDE,-8.394518,x0397,-1.261454,active-noncovalent
c1ccc2cc(ccc2c1)O,BRD-K21164796-001-02-8,beta-naphthol,MicroSource,1504501,beta-NAPHTHOL,-8.394147,x0195,1.179228,active-noncovalent
c1cc2c(cc1n3c(nnc3Sc4ncc(s4)N(=O)=O)O)OCCO2,BRD-K73982490-001-02-9,BI-78D3,Tocris,3314,BI 78D3,-8.393758,x0107,1.681865,active-noncovalent
c1cc2c(cc1n3c(nnc3Sc4ncc(s4)N(=O)=O)O)OCCO2,BRD-K73982490-001-03-7,BI-78D3,Tocris,3314,BI 78D3,-8.393758,x0107,1.681865,active-noncovalent
C[N@@H+]1CCC[C@H](CC1)n2c(=O)c3ccccc3c(n2)Cc4ccc(cc4)Cl,BRD-A68888262-003-15-1,azelastine,Selleck,S2552,Azelastine HCl,-8.393094,x0195,2.964064,active-noncovalent
C[N@@H+]1CCC[C@H](CC1)n2c(=O)c3ccccc3c(n2)Cc4ccc(cc4)Cl,BRD-A68888262-003-16-9,azelastine,MicroSource,1505340,AZELASTINE HYDROCHLORIDE,-8.393094,x0195,2.964064,active-noncovalent
c1cc(ccc1CCCCCCCCCCCCCCC(=O)[O-])I,BRD-K53156781-001-01-4,omega-(4-Iodophenyl)pentadecanoic acid,Sigma,MFCD00040778,15-(4-iodophenyl)pentadecanoic acid,-8.392443,x0104,6.312736,active-noncovalent
Cn1cc(cn1)[C@H]2c3cnnc(=O)c4c3c(cc(c4)NC(=O)[C@@H](C5CCCCC5)[NH3+])N2,BRD-K03063480-001-05-8,PF-477736,Selleck,S2904,PF-477736,-8.392074,x0104,5.17499,active-noncovalent
Cn1cc(cn1)[C@H]2c3cnnc(=O)c4c3c(cc(c4)NC(=O)[C@@H](C5CCCCC5)[NH3+])N2,BRD-K03063480-001-06-6,PF-477736,Selleck,S2904,PF 477736,-8.392074,x0104,5.17499,active-noncovalent
Cn1cc(cn1)[C@H]2c3cnnc(=O)c4c3c(cc(c4)NC(=O)[C@@H](C5CCCCC5)[NH3+])N2,BRD-K03063480-001-07-4,PF-477736,Tocris,4277,PF 477736,-8.392074,x0104,5.17499,active-noncovalent
CC[N@@H+](Cc1ccc(nc1)Cl)/C(=C/N(=O)=O)/NC,BRD-K47887731-001-01-4,nitenpyram,Selleck,S4422,Nitenpyram,-8.391289,x0678,-0.443444,active-noncovalent
c1cc(c(c(c1)Cl)C(=O)NCc2ccc3c(c2)OCO3)Cl,BRD-K06890060-001-09-1,alda-1,Tocris,4005,Alda 1,-8.390648,x0749,0.499879,active-covalent
C[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)Br,BRD-A52588987-004-08-2,SKF-83566,Tocris,1586,SKF 83566 hydrobromide,-8.390101,x1386,-0.816821,active-covalent
C[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)Br,BRD-A52588987-004-09-0,SKF-83566,Tocris,1586,SKF 83566 hydrobromide,-8.390101,x1386,-0.816821,active-covalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@@]3([C@@H](C[C@@]2([C@@]1(C(=O)CO)O)C)O)F)C,BRD-K12955147-001-01-8,betamethasone,Selleck,S1500,Betamethasone,-8.389809,x0874,1.977613,active-noncovalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)C)N,BRD-K47598052-001-15-8,PP-1,Tocris,1397,PP 1,-8.388062,x0678,0.351325,active-noncovalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)C)N,BRD-K47598052-001-14-1,PP-1,Selleck,S7060,PP1,-8.388062,x0678,0.351325,active-noncovalent
Cc1c(sc(c1C(=O)c2cccc(c2)C(F)(F)F)N)C,BRD-K77951111-001-04-5,PD-81723,Tocris,1363,PD 81723,-8.388001,x0749,-0.4975,active-covalent
COc1c2ccc(=O)oc2cc3c1cco3,BRD-K12968785-001-13-3,bergapten,MicroSource,300546,BERGAPTEN,-8.387637,x0195,-0.13881,active-noncovalent
COc1c2ccc(=O)oc2cc3c1cco3,BRD-K12968785-001-12-5,bergapten,Selleck,S4239,Bergapten,-8.387637,x0195,-0.13881,active-noncovalent
Cc1cc(=O)oc2c1ccc(c2C=O)O,BRD-K81316007-001-01-8,4-mu-8C,Selleck,S7272,4?8C,-8.387300,x0195,-0.444912,active-noncovalent
Cc1cc(n[nH]1)Nc2c(cc(c(n2)N[C@@H](C)c3ccc(cc3)F)C#N)F,BRD-K64888243-001-03-7,AZ960,Selleck,S2214,AZ 960,-8.386241,x0759,1.463382,active-covalent
Cc1cc(n[nH]1)Nc2c(cc(c(n2)N[C@@H](C)c3ccc(cc3)F)C#N)F,BRD-K64888243-001-04-5,AZ960,Selleck,S2214,AZ 960,-8.386241,x0759,1.463382,active-covalent
C[N@H+](C/C=C/c1ccccc1)Cc2cccc3c2cccc3,BRD-K74141488-003-10-4,naftifine,Selleck,S3156,Naftifine HCl,-8.383686,x0104,0.391958,active-noncovalent
C[N@H+](C/C=C/c1ccccc1)Cc2cccc3c2cccc3,BRD-K74141488-003-11-2,naftifine,MicroSource,1505446,NAFTIFINE HYDROCHLORIDE,-8.383686,x0104,0.391958,active-noncovalent
Cc1cc(c(c(c1)C)/N=c/2\cc-3n(c(=O)n2C)CCc4c3cc(c(c4)OC)OC)C,BRD-K84663978-003-03-7,trequinsin,Tocris,2337,Trequinsin hydrochloride,-8.383359,x0195,5.325616,active-noncovalent
Cc1cc(c(c(c1)C)/N=c/2\cc-3n(c(=O)n2C)CCc4c3cc(c(c4)OC)OC)C,BRD-K84663978-003-02-9,trequinsin,Tocris,2337,Trequinsin hydrochloride,-8.383359,x0195,5.325616,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)(C3CCCCC3)O,BRD-A48180038-003-24-3,trihexyphenidyl,MicroSource,1500592,TRIHEXYPHENIDYL HYDROCHLORIDE,-8.383334,x0195,0.108433,active-noncovalent
CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K70650177-001-01-7,testosterone-undecanoate,MedChemEx,HY-B0626,Testosterone (undecanoate),-8.383152,x0161,8.186523,active-noncovalent
CN(C)c1cccc(c1)Oc2cnc(nc2)Nc3cccc(c3)O,BRD-K70614402-001-01-0,SEN-1269,Tocris,4699,SEN 1269,-8.382158,x0161,3.797624,active-noncovalent
CN1(=O)[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,BRD-A70067498-001-01-8,atropine-oxide,MicroSource,1505407,ATROPINE OXIDE,-8.381306,x0749,0.278869,active-covalent
COc1cc(cc(c1OC)OC)Cc2cnc(nc2N)N,BRD-K07208025-001-29-7,trimethoprim,Selleck,S3129,Trimethoprim,-8.381269,x0678,0.929803,active-noncovalent
COc1cc(cc(c1OC)OC)Cc2cnc(nc2N)N,BRD-K07208025-001-31-3,trimethoprim,MicroSource,1500595,TRIMETHOPRIM,-8.381269,x0678,0.929803,active-noncovalent
c1cnccc1C(=O)NN,BRD-K87202646-061-05-6,pasiniazid,MicroSource,1503381,PASINIAZID,-8.380651,x0540,-1.577832,active-noncovalent
c1cnccc1C(=O)NN,BRD-K87202646-001-32-6,isoniazid,Selleck,S1937,Isoniazid,-8.380651,x0540,-1.577832,active-noncovalent
c1cnccc1C(=O)NN,BRD-K87202646-001-33-4,isoniazid,MicroSource,1500355,ISONIAZID,-8.380651,x0540,-1.577832,active-noncovalent
c1cnccc1C(=O)NN,BRD-K87202646-061-04-9,pasiniazid,Selleck,S4404,Pasiniazid,-8.380651,x0540,-1.577832,active-noncovalent
CC(=O)N(C)c1cccc(c1)c2ccnc3n2ncc3C(=O)c4cccs4,BRD-K90948141-001-02-2,indiplon,Tocris,3597,Indiplon,-8.380480,x0195,3.667733,active-noncovalent
CC(=O)N(C)c1cccc(c1)c2ccnc3n2ncc3C(=O)c4cccs4,BRD-K90948141-001-01-4,indiplon,Tocris,3597,Indiplon,-8.380480,x0195,3.667733,active-noncovalent
CCc1c(/c/2c/c3c(c(/c(/n3)c/c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)O)CCC(=O)O)C)C)C=C)C,BRD-M75036822-003-01-7,hemin,InterBioScreen,STOCK1N-03493,,-8.380009,x0161,13.179747,active-noncovalent
C[C@H](Cc1ccc(cc1)OCC(=O)[O-])[NH2+]C[C@@H](c2cccc(c2)Cl)O,BRD-K07507905-236-03-4,BRL-37344,Tocris,948,sodium [4-((2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)phenoxy]acetate,-8.379393,x0874,4.208467,active-noncovalent
C[C@H](Cc1ccc(cc1)OCC(=O)[O-])[NH2+]C[C@@H](c2cccc(c2)Cl)O,BRD-K07507905-236-02-6,BRL-37344,Tocris,948,"BRL 37344, sodium salt",-8.379393,x0874,4.208467,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2ccccc2C(F)(F)F)C,BRD-K46384212-001-03-7,o-3M3FBS,Tocris,1942,o-3M3FBS,-8.378460,x0678,1.309712,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2ccccc2C(F)(F)F)C,BRD-K46384212-001-02-9,o-3M3FBS,Tocris,1942,o-3M3FBS,-8.378460,x0678,1.309712,active-noncovalent
Cc1csc(n1)NC(=O)CSc2ccc(nn2)c3ccccc3,BRD-K27074404-001-08-4,VU-0240551,MedChemEx,HY-16689,VU 0240551,-8.378383,x0161,2.806194,active-noncovalent
CCC(C)(C)c1ccc(cc1)C[C@@H](C)C[NH+]2C[C@H](O[C@H](C2)C)C,BRD-A37390343-003-03-5,amorolfine,MicroSource,1502371,AMOROLFINE HYDROCHLORIDE,-8.377674,x0195,3.290105,active-noncovalent
CCC(C)(C)c1ccc(cc1)C[C@@H](C)C[NH+]2C[C@H](O[C@H](C2)C)C,BRD-A37390343-003-02-7,amorolfine,Selleck,S1676,Amorolfine HCl,-8.377674,x0195,3.290105,active-noncovalent
CCCOc1cc(ccc1C(=O)OCC[NH+](CC)CC)N,BRD-K18250272-003-11-0,propoxycaine,MicroSource,1505572,PROPOXYCAINE HYDROCHLORIDE,-8.376968,x0104,1.194543,active-noncovalent
c1c2c(=O)[nH]cnc2n[nH]1,BRD-K86307448-001-17-5,allopurinol,MicroSource,1500108,ALLOPURINOL,-8.376930,x0678,-2.053843,active-noncovalent
c1c2c(=O)[nH]cnc2n[nH]1,BRD-K86307448-001-16-7,allopurinol,Selleck,S1630,Allopurinol,-8.376930,x0678,-2.053843,active-noncovalent
c1c2c(=O)[nH]cnc2n[nH]1,BRD-K86307448-001-19-1,allopurinol,Selleck,S1630,Allopurinol (Zyloprim),-8.376930,x0678,-2.053843,active-noncovalent
CCCCCC/C=C\CCCCCCCC(=O)[O-],BRD-K91356052-001-04-0,palmitoleic-acid,Sigma,MFCD00004437,(9Z)-9-hexadecenoic acid,-8.376905,x0107,1.025842,active-noncovalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCN3C(=O)CC4(CCCC4)CC3=O,BRD-A50764878-003-02-8,MDL-73005EF,Tocris,411,MDL 73005EF hydrochloride,-8.376335,x0104,2.025415,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)CC[C@@]43C)C)O,BRD-A53566267-001-01-9,anecortave-acetate,InterBioScreen,STOCK1N-04044,,-8.374510,x0874,3.103683,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)[O-])C,BRD-K55191674-237-18-3,benzylpenicillin,MicroSource,1500465,PENICILLIN G POTASSIUM,-8.374472,x0831,2.095767,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)[O-])C,BRD-K55191674-236-06-0,benzylpenicillin,Selleck,S4160,Penicillin G Sodium,-8.374472,x0831,2.095767,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)[O-])C,BRD-K55191674-236-07-8,benzylpenicillin,Selleck,S4160,Benzylpenicillin sodium,-8.374472,x0831,2.095767,active-covalent
C[NH+](C)CCOc1ccc(cc1)/C(=C(/CCCl)\c2ccccc2)/c3ccccc3,BRD-K51350053-048-15-7,toremifene,Selleck,S1776,Toremifene Citrate,-8.373688,x0434,3.606279,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)/C(=C(/CCCl)\c2ccccc2)/c3ccccc3,BRD-K51350053-048-17-3,toremifene,Selleck,S1776,"Toremifene Citrate (Fareston, Acapodene)",-8.373688,x0434,3.606279,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)/C(=C(/CCCl)\c2ccccc2)/c3ccccc3,BRD-K51350053-048-16-5,toremifene,MicroSource,1505682,TOREMIFENE CITRATE,-8.373688,x0434,3.606279,active-noncovalent
c1cc(c(cc1C(F)(F)F)N(=O)=O)C(=O)C2C(=O)CCCC2=O,BRD-K01109406-001-04-5,nitisinone,MedChemEx,HY-B0607,Nitisinone,-8.373479,x0749,1.026721,active-covalent
c1cc(c(cc1C(F)(F)F)N(=O)=O)C(=O)C2C(=O)CCCC2=O,BRD-K01109406-001-03-7,nitisinone,Enzo,AC3204,NITISINONE,-8.373479,x0749,1.026721,active-covalent
CC(C)(C(=O)OCCOC(=O)c1cccnc1)Oc2ccc(cc2)Cl,BRD-K49338325-001-03-4,etofibrate,Selleck,S4264,Etofibrate,-8.372146,x0107,2.788949,active-noncovalent
CC[C@@H](CO)[NH2+]CCN[C@@H](CC)CO,BRD-K93231391-300-05-6,ethambutol,Selleck,S4004,Ethambutol HCl,-8.371911,x1093,0.213792,active-noncovalent
CC[C@@H](CO)[NH2+]CCN[C@@H](CC)CO,BRD-K93231391-300-06-4,ethambutol,MicroSource,1500288,ETHAMBUTOL HYDROCHLORIDE,-8.371911,x1093,0.213792,active-noncovalent
c1cc2c(cc1Br)c3cc(ccc3n2C[C@H](CN4CC[NH2+]CC4)O)Br,BRD-A18763547-300-06-3,BAX-channel-blocker,Tocris,2160,Bax channel blocker,-8.371155,x0195,0.681509,active-noncovalent
c1cc2c(cc1Br)c3cc(ccc3n2C[C@H](CN4CC[NH2+]CC4)O)Br,BRD-A18763547-300-05-5,BAX-channel-blocker,Tocris,2160,Bax channel blocker,-8.371155,x0195,0.681509,active-noncovalent
CCn1c2ccccc2[nH]c1=O,BRD-K70586315-001-02-4,1-EBIO,Tocris,1041,1-EBIO,-8.369204,x0678,-1.635887,active-noncovalent
CCn1c2ccccc2[nH]c1=O,BRD-K70586315-001-03-2,1-EBIO,Tocris,1041,1-EBIO,-8.369204,x0678,-1.635887,active-noncovalent
Cc1ccc(cn1)NC(=O)Nc2cccc(c2F)C[NH+]3CCN(CC3)C(=O)OC,BRD-K36680103-001-01-6,omecamtiv-mecarbil,Selleck,S2623,Omecamtiv mecarbil (CK-1827452),-8.368703,x0161,5.884,active-noncovalent
CNC(=O)c1c2cc(c(cc2oc1c3ccc(cc3)F)[N@@](CCO)S(=O)(=O)C)C4CC4,BRD-K79989959-001-01-4,nesbuvir,MedChemEx,HY-14775,Nesbuvir,-8.368328,x0104,4.859359,active-noncovalent
c1cc(oc1)C(=O)N2CC[NH+](CC2)CC(=O)Nc3cc(ccc3Cl)C(F)(F)F,BRD-K81044214-001-06-4,ML-348,Tocris,5345,ML 348,-8.368025,x0104,3.485729,active-noncovalent
c1cc(c(cc1CC(=O)N2CCCC[C@@H]2C[NH+]3CCCC3)Cl)Cl,BRD-A37347161-003-02-6,BRL-52537,Tocris,699,BRL 52537 hydrochloride,-8.366723,x0678,1.075299,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNc3nccc(n3)c4cccnc4,BRD-K16485616-001-12-1,mocetinostat,Selleck,S1122,Mocetinostat (MGCD0103),-8.365228,x0104,6.008764,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNc3nccc(n3)c4cccnc4,BRD-K16485616-001-08-9,mocetinostat,Selleck,S1122,Mocetinostat (MGCD0103),-8.365228,x0104,6.008764,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNc3nccc(n3)c4cccnc4,BRD-K16485616-001-13-9,mocetinostat,MedChemEx,HY-12164,mocetinostat,-8.365228,x0104,6.008764,active-noncovalent
c1ccc(cc1)/C=C/Cn2cc(cn2)/C=C/C(=O)Nc3ccc(cc3N)F,BRD-K61688984-001-02-9,RGFP966,Selleck,S7229,RGFP966,-8.364725,x0104,7.315005,active-noncovalent
Cc1cc(c(c(c1)C)NC(=O)[C@H]2C[C@@H]3CC[C@H]2C3)C,BRD-A12633378-001-07-0,ML-213,Tocris,4519,ML 213,-8.363173,x0161,0.322113,active-noncovalent
c1ccc(c(c1)C2=NCC(=O)Nc3c2cc(cc3)N(=O)=O)Cl,BRD-K38183498-001-02-0,clonazepam,MicroSource,1505958,CLONAZEPAM,-8.362827,x0072,0.768441,active-noncovalent
CCCCCCCCCCCCCCC[C@H]([C@H](CO)[NH3+])O,BRD-K93944989-001-08-0,safingol,Enzo,SL125,Dihydrosphingosine,-8.362826,x0161,2.853089,active-noncovalent
c1cc(cnc1)/C=C/C(=O)NCc2ccc(cc2)C(=O)Nc3cc(ccc3N)F,BRD-K28537285-001-01-8,chidamide,MedChemEx,HY-13592,Chidamide,-8.361370,x0104,9.004685,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH2+]CC3,BRD-K86171477-001-01-3,eltoprazine,MedChemEx,HY-16687,"1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine",-8.358266,x0195,0.082391,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH2+]CC3,BRD-K86171477-001-02-1,eltoprazine,MedChemEx,HY-16687,Eltoprazine,-8.358266,x0195,0.082391,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH2+]CC3,BRD-K86171477-001-03-9,eltoprazine,MedChemEx,HY-16687,Eltoprazine,-8.358266,x0195,0.082391,active-noncovalent
C[N@+]12CCCC[C@@H]1CCC(=C(c3cccs3)c4cccs4)C2,BRD-K77552740-004-01-0,tiquizium,AKSci,R610,,-8.357582,x0749,1.241138,active-covalent
CCCCOC(=O)c1ccc(cc1)O,BRD-K08287586-001-14-3,butyl-paraben,MicroSource,1505995,BUTYL PARABEN,-8.355982,x0749,-0.16415,active-covalent
Cc1ccc(c(c1)NCc2ccc3c(c2)n(c(n3)NCCC[NH+]4CCOCC4)Cc5c(ccc(n5)C)O)CCCO,BRD-K66097663-001-01-8,TMC-353121,MedChemEx,HY-11097,TMC353121,-8.355792,x0395,11.343549,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH2+]C[C@H](c2ccc(c(c2)NC=O)O)O,BRD-K54006094-051-06-6,formoterol,Tocris,1448,Formoterol hemifumarate,-8.355700,x0107,3.064521,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH2+]C[C@H](c2ccc(c(c2)NC=O)O)O,BRD-K54006094-051-01-7,formoterol,Selleck,S2020,Formoterol Hemifumarate,-8.355700,x0107,3.064521,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH2+]C[C@H](c2ccc(c(c2)NC=O)O)O,BRD-K54006094-051-02-5,formoterol,Tocris,1448,Formoterol hemifumarate,-8.355700,x0107,3.064521,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH2+]C[C@H](c2ccc(c(c2)NC=O)O)O,BRD-K54006094-051-03-3,formoterol,Selleck,S2020,Formoterol hemifumarate,-8.355700,x0107,3.064521,active-noncovalent
CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@@]4(c5c(coc5C3=O)C(=O)O[C@@H]4COC)C)C,BRD-K87343924-001-12-3,wortmannin,Selleck,S2758,Wortmannin,-8.354596,x0195,3.98995,active-noncovalent
CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@@]4(c5c(coc5C3=O)C(=O)O[C@@H]4COC)C)C,BRD-K87343924-001-15-6,wortmannin,Selleck,S2758,Wortmannin,-8.354596,x0195,3.98995,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O)[NH2+]C(C)C,BRD-K78666826-003-02-4,procaterol,Tocris,1102,Procaterol hydrochloride,-8.353899,x0107,-0.185854,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O)[NH2+]C(C)C,BRD-K78666826-003-01-6,procaterol,Tocris,1102,Procaterol hydrochloride,-8.353899,x0107,-0.185854,active-noncovalent
C[C@@H](c1ccc(cc1)C(=O)NCCC(=O)[O-])n2c(cc(n2)c3cc(cc(c3)Cl)Cl)c4ccc5cc(ccc5c4)OC,BRD-K16732600-001-01-7,MK-0893,MedChemEx,HY-50663,MK 0893,-8.353322,x0072,11.633482,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Oc4c2cc(cc4)Cl,BRD-K39915878-036-24-4,loxapine,Selleck,S4086,Loxapine Succinate,-8.351931,x0678,2.063933,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Oc4c2cc(cc4)Cl,BRD-K39915878-036-25-1,loxapine,MicroSource,2300242,LOXAPINE SUCCINATE,-8.351931,x0678,2.063933,active-noncovalent
c1cc(cnc1)C[NH3+],BRD-K68653965-001-01-1,picolamine,MicroSource,1506167,PICOLAMINE,-8.351899,x0426,-2.054507,active-noncovalent
c1cc(cc(c1)Cl)Nc2nccc(n2)c3ccnc(c3)NCCCO,BRD-K79090631-001-22-3,CGP-60474,Tocris,5471,CGP 60474,-8.351830,x0946,3.433026,active-noncovalent
COc1ccc(cc1)[C@H]2CC(=NN2c3ccc(cc3)S(=O)(=O)N)c4ccccc4,BRD-A28422330-001-10-1,ML-141,Tocris,4266,ML 141,-8.351234,x0161,3.933494,active-noncovalent
c1ccc(c(c1)[C@@H]2c3cc(ccc3NC(=O)CS2)Cl)Cl,BRD-A35623999-001-06-5,CGP-37157,Tocris,1114,CGP 37157,-8.351077,x0072,-0.191742,active-noncovalent
c1ccc(c(c1)[C@@H]2c3cc(ccc3NC(=O)CS2)Cl)Cl,BRD-A35623999-001-05-7,CGP-37157,Tocris,1114,CGP 37157,-8.351077,x0072,-0.191742,active-noncovalent
c1ccc(c(c1)C(=O)OCCOCCO)Nc2cccc(c2)C(F)(F)F,BRD-K73541271-001-03-6,etofenamate,MedChemEx,HY-17361,Etofenamate,-8.350521,x0434,3.417844,active-noncovalent
Cc1cc(ccc1OCCCC(=O)NO)Cl,BRD-K11558771-001-13-9,droxinostat,Selleck,S1422,Droxinostat,-8.350462,x0678,-1.551235,active-noncovalent
Cc1cccc(c1NC(=O)CC23CCC[NH+]2CCC3)C,BRD-K83245588-001-01-4,pilsicainide,AKSci,H671,,-8.349420,x0434,0.644463,active-noncovalent
Cc1cc(cnc1c2ccnc(c2)C)CC(=O)Nc3ccc(cn3)c4cnccn4,BRD-K16810791-001-01-0,LGK-974,Selleck,S7143,LGK-974,-8.349251,x0161,12.425439,active-noncovalent
Cc1cc(cc(c1CC2=[NH+]CCN2)C)C(C)(C)C,BRD-K08356259-003-24-7,xylometazoline,MicroSource,1500614,XYLOMETAZOLINE HYDROCHLORIDE,-8.348288,x0161,-0.781708,active-noncovalent
Cc1cc(cc(c1CC2=[NH+]CCN2)C)C(C)(C)C,BRD-K08356259-003-23-9,xylometazoline,Selleck,S2576,Xylometazoline HCl,-8.348288,x0161,-0.781708,active-noncovalent
CCNC(=O)CC1=N[C@@H](c2cc(ccc2-n3c1nnc3C)OC)c4ccc(cc4)Cl,BRD-K08109215-001-06-4,I-BET-762,Selleck,S7189,I-BET-762,-8.347149,x1077,3.230984,active-noncovalent
CCC[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,BRD-K43644456-001-04-0,WP1130,Selleck,S2243,WP1130,-8.347046,x1077,2.688839,active-noncovalent
CCC[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,BRD-K43644456-001-03-2,WP1130,Selleck,S2243,Degrasyn (WP1130),-8.347046,x1077,2.688839,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,BRD-K94441233-001-17-1,mevastatin,MicroSource,1601000,MEVASTATIN,-8.346699,x0195,4.260885,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,BRD-K94441233-001-15-5,mevastatin,Tocris,1526,Mevastatin,-8.346699,x0195,4.260885,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,BRD-K94441233-001-12-2,mevastatin,Tocris,1526,Mevastatin,-8.346699,x0195,4.260885,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,BRD-K94441233-001-16-3,mevastatin,Selleck,S4223,Mevastatin,-8.346699,x0195,4.260885,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,BRD-K94441233-001-13-0,mevastatin,Selleck,S4223,Mevastatin,-8.346699,x0195,4.260885,active-noncovalent
Cc1cccc(c1NC(=O)c2cc(c(cc2[O-])Cl)S(=O)(=O)N)C,BRD-K27393415-001-01-0,xipamide,OxChem,AX8031911,,-8.346377,x0678,2.506342,active-noncovalent
Cc1cnc(c(c1OC)C)CSc2[nH]c3ccc(cc3n2)OC,BRD-K69035426-001-01-3,omeprazole-sulfide,AKSci,V1823,,-8.345440,x0434,0.772268,active-noncovalent
C[NH+](C)C[C@@H]1CCCC[C@]1(c2cccc(c2)OC)O,BRD-K51033547-003-02-6,tramadol,MicroSource,1505389,TRAMADOL HYDROCHLORIDE,-8.345022,x0678,0.787263,active-noncovalent
Cn1c2cc(c(cc2n(c1=O)C)N3CCCC3)NC(=O)c4ccccc4OC,BRD-K13106865-001-01-7,PFI-4,Tocris,5576,PFI 4,-8.344585,x0195,3.470444,active-noncovalent
COc1c2c(ccc(=O)o2)cc3c1occ3,BRD-K63430059-001-16-4,methoxsalen,Selleck,S1952,Methoxsalen,-8.344160,x0749,-0.459771,active-covalent
COc1c2c(ccc(=O)o2)cc3c1occ3,BRD-K63430059-001-17-2,methoxsalen,MicroSource,1500400,METHOXSALEN,-8.344160,x0749,-0.459771,active-covalent
Cc1cc(ccc1OCC(=O)[O-])OCc2nc(cs2)c3ccccc3Cl,BRD-K19409553-001-01-6,GPR120-modulator-1,MedChemEx,HY-50162,GPR120 modulator 1,-8.344146,x0161,7.108516,active-noncovalent
CCOC(=O)[C@@]12C[C@@H]1[C@@H](c3ccccc3O2)N=O,BRD-A05729358-001-03-8,CPCCOEt,Tocris,1028,CPCCOEt,-8.343886,x0072,-0.827991,active-noncovalent
CCOC(=O)[C@@]12C[C@@H]1[C@@H](c3ccccc3O2)N=O,BRD-A05729358-001-02-0,CPCCOEt,Tocris,1028,CPCCOEt,-8.343886,x0072,-0.827991,active-noncovalent
c1cc2c(nc1)C(=O)/C(=N/CC[NH+]3CCOCC3)/[C@@H](C2=O)Cl,BRD-K03109492-001-03-0,NSC-663284,Tocris,1867,NSC 663284,-8.343728,x0195,0.948169,active-noncovalent
c1cc2c(nc1)C(=O)/C(=N/CC[NH+]3CCOCC3)/[C@@H](C2=O)Cl,BRD-K03109492-001-02-2,NSC-663284,Tocris,1867,NSC 663284,-8.343728,x0195,0.948169,active-noncovalent
C1CC[NH+](C1)CC#CCN2CCCC2=O,BRD-K21936341-051-04-0,oxotremorine-sesquifumarate,Tocris,843,Oxotremorine sesquifumarate,-8.343220,x0749,-1.445747,active-covalent
C1CC[NH+](C1)CC#CCN2CCCC2=O,BRD-K21936341-051-03-2,oxotremorine-sesquifumarate,Tocris,843,Oxotremorine sesquifumarate,-8.343220,x0749,-1.445747,active-covalent
C[C@@H](COc1ccccc1Cc2ccccc2)[NH+]3CCCCC3,BRD-A42423104-001-01-4,benproperine,AvaChem,1567,1-[2-(2-benzylphenoxy)-1-methylethyl]piperidine,-8.342884,x0104,1.182902,active-noncovalent
CCCCCCOc1ccccc1C(=O)N,BRD-K12609457-001-03-1,exalamide,MicroSource,1503403,EXALAMIDE,-8.340953,x1093,0.096903,active-noncovalent
CN1C(=O)N(C(=O)[C@]12CN(C[C@H]2c3ccc(cc3)C#N)c4ccc(cn4)C(=O)[O-])c5cc(cc(c5)Cl)Cl,BRD-K85649978-001-02-1,BMS-688521,Key,KE-0042,"6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]nicotinic acid",-8.340836,x0072,7.625041,active-noncovalent
CCc1cc(c(c(c1O)C(=O)NC[C@@H]2CCC[N@H+]2CC)OC)Cl,BRD-K50417881-003-17-4,eticlopride,Tocris,1847,Eticlopride hydrochloride,-8.340616,x0195,0.381606,active-noncovalent
c1cc(c(c(c1)Cl)Cl)c2c(nc(nn2)N)N,BRD-K93460210-001-23-7,lamotrigine,MicroSource,1505610,LAMOTRIGINE,-8.340552,x0678,-0.026422,active-noncovalent
c1cc(c(c(c1)Cl)Cl)c2c(nc(nn2)N)N,BRD-K93460210-001-22-9,lamotrigine,Selleck,S3024,Lamotrigine,-8.340552,x0678,-0.026422,active-noncovalent
Cc1ccc(cc1)/C=C\2/C(=O)/C(=C/c3ccc(cc3)C)/C[NH2+]C2,BRD-K81197548-003-02-2,NSC-632839,Tocris,2647,NSC 632839 hydrochloride,-8.339958,x0104,4.604075,active-noncovalent
Cc1ccc(cc1)/C=C\2/C(=O)/C(=C/c3ccc(cc3)C)/C[NH2+]C2,BRD-K81197548-003-01-4,NSC-632839,Tocris,2647,NSC 632839 hydrochloride,-8.339958,x0104,4.604075,active-noncovalent
Cc1cccc(c1Nc2ncc3cc(ccc3n2)c4c(c(cc(c4Cl)OC)OC)Cl)NC(=O)C=C,BRD-K72898849-001-01-8,BLU9931,MedChemEx,HY-12823,BLU9931,-8.339640,x0104,7.890209,active-noncovalent
CCC[NH2+]CCc1ccc(cc1)NS(=O)(=O)c2ccc(cc2)OC(F)(F)F,BRD-K04635846-003-01-6,PNU-177864,Tocris,3355,PNU 177864 hydrochloride,-8.339514,x0161,3.585941,active-noncovalent
c1cc(c(cc1Cl)Cl)[C@@H](Cn2ccnc2)OCc3ccsc3Cl,BRD-A33084557-001-06-6,tioconazole,Selleck,S1910,Tioconazole,-8.339412,x0195,0.847988,active-noncovalent
c1cc(c(cc1Cl)Cl)[C@@H](Cn2ccnc2)OCc3ccsc3Cl,BRD-A33084557-001-07-4,tioconazole,MicroSource,1505581,TIOCONAZOLE,-8.339412,x0195,0.847988,active-noncovalent
COc1ccc(c(c1)O)C(=O)c2ccccc2,BRD-K59037100-001-14-7,oxybenzone,MicroSource,1500451,OXYBENZONE,-8.339141,x0749,-1.085215,active-covalent
CC(C)(C)c1ccc(cc1)NC(=O)N2CCN(CC2)c3c(cccn3)Cl,BRD-K66541497-001-01-7,BCTC,Tocris,3875,BCTC,-8.338799,x0161,6.37802,active-noncovalent
CCC(=O)N[C@@H]1Cc2ccccc2[C@H](C1)c3ccccc3,BRD-A67482312-001-02-6,4-P-PDOT,Tocris,1034,4-P-PDOT,-8.337657,x0678,-0.534029,active-noncovalent
CCC(=O)N[C@@H]1Cc2ccccc2[C@H](C1)c3ccccc3,BRD-A67482312-001-03-4,4-P-PDOT,Tocris,1034,4-P-PDOT,-8.337657,x0678,-0.534029,active-noncovalent
C(CC[NH2+]CCC[NH3+])C[NH2+]CCC[NH3+],BRD-K18375018-376-02-3,spermine,Enzo,AC412,Spermine 4HCl,-8.337255,x0104,-0.009859,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)[O-],BRD-K81074237-001-02-3,azilsartan,Selleck,S3046,Azilsartan,-8.336603,x0104,6.428352,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)[O-],BRD-K81074237-001-03-1,azilsartan,Tocris,4553,Azilsartan,-8.336603,x0104,6.428352,active-noncovalent
CCC(=O)O[C@]1([C@H](C[C@@H]2[C@@]1(C[C@H]([C@@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl,BRD-K65877271-001-01-8,halobetasol-propionate,Selleck,S4089,Halobetasol Propionate,-8.336428,x1077,4.90197,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(c(c1)CO)O)O,BRD-A88254928-001-07-9,albuterol,MicroSource,1500677,ALBUTEROL,-8.336200,x0104,-0.652408,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(c(c1)CO)O)O,BRD-A88254928-065-04-1,albuterol,Selleck,S2507,Salbutamol sulfate (Albuterol),-8.336200,x0104,-0.652408,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(c(c1)CO)O)O,BRD-K34469523-003-03-0,levalbuterol,MicroSource,1505811,LEVALBUTEROL HYDROCHLORIDE,-8.336200,x0104,-0.652408,active-noncovalent
C(C[C@H](CCC(=O)[O-])C(=O)[O-])CS,BRD-A66788520-001-01-7,2-(3-mercaptopropyl)pentanedioic acid,Tocris,5033,2-(3-mercaptopropyl)pentanedioic acid,-8.335565,x0397,-1.061044,active-noncovalent
c1c[nH]c2c1cc(cn2)c3c4c(ncnc4n(n3)C5CCCC5)N,BRD-K81801188-001-05-1,PP-121,Tocris,3894,PP 121,-8.334117,x0678,2.145313,active-noncovalent
c1c[nH]c2c1cc(cn2)c3c4c(ncnc4n(n3)C5CCCC5)N,BRD-K81801188-001-02-8,PP-121,Selleck,S2622,PP121,-8.334117,x0678,2.145313,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,BRD-K23403298-003-01-9,benzyldimethylhexadecylammonium,Acros,40207,"Benzyldimethylhexadecylammonium chloride, hydrate, 97%",-8.333984,x0161,4.750135,active-noncovalent
CS(=O)(=O)N1CC[NH+](CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4c[nH]n5)N6CCOCC6,BRD-K52911425-001-09-8,GDC-0941,Selleck,S1065,GDC-0941,-8.333515,x0434,7.562601,active-noncovalent
Cc1ccnc(c1)NC(=O)[C@@H](C)c2cccc(c2)C(=O)c3ccccc3,BRD-A85548292-001-01-8,piketoprofen,Enamine,Z1537384907,,-8.333107,x0678,4.597998,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N(=O)=O)O,BRD-K79821389-001-03-5,rubitecan,Sigma,MFCD06656294,"(4S)-4-ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",-8.332558,x0104,4.321136,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H]([C@@H](Cc1ccccc1)[NH3+])O,BRD-K59574735-001-12-6,ubenimex,Tocris,1956,Bestatin,-8.332558,x0104,0.354993,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H]([C@@H](Cc1ccccc1)[NH3+])O,BRD-K59574735-001-11-8,ubenimex,Selleck,S1591,Ubenimex (Bestatin),-8.332558,x0104,0.354993,active-noncovalent
CC(C)(C#N)c1ccc(cc1)N2c3c4cc(ccc4ncc3COC2=O)c5cc6ccccc6nc5,BRD-K24556407-001-02-3,ETP-46464,Selleck,S8050,ETP-46464,-8.331543,x0195,7.858925,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],BRD-K35079116-001-02-5,asiatic-acid,Selleck,S2266,Asiatic acid,-8.331235,x1077,6.586283,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],BRD-K35079116-001-03-3,asiatic-acid,Selleck,S2266,Asiatic Acid,-8.331235,x1077,6.586283,active-noncovalent
CC(C)c1ccccc1Cc2cc(c(c(c2O)O)O)C(=O)Nc3ccc(cc3)S(=O)(=O)c4ccccc4C(C)(C)C,BRD-K28360340-001-08-3,TW-37,Selleck,S1121,TW-37,-8.329865,x0104,16.233519,active-noncovalent
CC(C)c1ccccc1Cc2cc(c(c(c2O)O)O)C(=O)Nc3ccc(cc3)S(=O)(=O)c4ccccc4C(C)(C)C,BRD-K28360340-001-05-9,TW-37,Selleck,S1121,TW-37,-8.329865,x0104,16.233519,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CC[C@@]([C@]3(C[C@@H]([C@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O,BRD-A45044890-236-02-3,methylprednisolone-sodium-succinate,MicroSource,1503255,METHYLPREDNISOLONE SODIUM SUCCINATE,-8.329448,x1077,4.950315,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,BRD-A28940325-001-25-7,trichlormethiazide,Selleck,S1667,Trichlormethiazide (Achletin),-8.328909,x0195,0.958409,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,BRD-A28940325-001-23-2,trichlormethiazide,Selleck,S1667,Trichlormethiazide,-8.328909,x0195,0.958409,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,BRD-A28940325-001-24-0,trichlormethiazide,MicroSource,1500590,TRICHLORMETHIAZIDE,-8.328909,x0195,0.958409,active-noncovalent
c1cc(ccc1O)O[C@@H]2CCCCO2,BRD-A62562325-001-02-5,deoxyarbutin,Selleck,S4132,Deoxyarbutin,-8.328835,x0678,-1.032727,active-noncovalent
c1cc(ccc1O)O[C@@H]2CCCCO2,BRD-A62562325-001-03-3,deoxyarbutin,Selleck,S4132,Deoxyarbutin,-8.328835,x0678,-1.032727,active-noncovalent
C[C@@H]([C@H](c1cc(ccc1OC)OC)O)[NH3+],BRD-A39189014-003-22-7,methoxamine,MicroSource,1500399,METHOXAMINE HYDROCHLORIDE,-8.327927,x1077,-1.868046,active-noncovalent
C[C@@H]([C@H](c1cc(ccc1OC)OC)O)[NH3+],BRD-A39189014-003-21-9,methoxamine,Selleck,S4338,Methoxamine HCl,-8.327927,x1077,-1.868046,active-noncovalent
CC(=O)N(c1ccccc1/C=C/c2ccn(=O)cc2)S(=O)(=O)c3ccc(cc3)OC,BRD-K70511574-001-06-9,HMN-214,Selleck,S1485,HMN-214,-8.327533,x1077,4.496236,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cc(ncn2)Nc3ccc(cc3)OC(F)(F)F,BRD-K97056771-001-13-1,GNF-2,Selleck,S2899,GNF-2,-8.326980,x0107,4.470155,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cc(ncn2)Nc3ccc(cc3)OC(F)(F)F,BRD-K97056771-001-14-9,GNF-2,Tocris,4399,GNF 2,-8.326980,x0107,4.470155,active-noncovalent
COc1ccc(cc1O[C@H]2C[C@@H]3CC[C@H]2C3)C4CNC(=O)NC4,BRD-K76614248-001-01-2,atizoram,Cayman,13183,"5-{3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl}tetrahydro-2(1H)-pyrimidinone",-8.325622,x0749,0.428175,active-covalent
c1cc(c(cc1F)[C@H]2CCCN2c3ccn4c(n3)c(cn4)NC(=O)N5CC[C@@H](C5)O)F,BRD-K36574127-001-01-3,LOXO-101,MedChemEx,HY-12866,LOXO-101,-8.325197,x0195,6.333929,active-noncovalent
COc1cc(ccc1NS(=O)(=O)c2ccsc2C(=O)OC)Nc3ccccc3,BRD-K98684188-001-03-7,GSK-0660,Tocris,3433,GSK 0660,-8.324645,x0161,4.335835,active-noncovalent
COc1cc(ccc1NS(=O)(=O)c2ccsc2C(=O)OC)Nc3ccccc3,BRD-K98684188-001-02-9,GSK-0660,Tocris,3433,GSK 0660,-8.324645,x0161,4.335835,active-noncovalent
Cc1nnc2n1-c3c(cc(s3)CCC(=O)N4CCOCC4)[C@@H](N=C2)c5ccccc5Cl,BRD-K28115081-001-03-5,apafant,Tocris,2339,WEB 2086,-8.324315,x0774,4.116947,active-covalent
Cc1nnc2n1-c3c(cc(s3)CCC(=O)N4CCOCC4)[C@@H](N=C2)c5ccccc5Cl,BRD-K28115081-001-02-7,apafant,Tocris,2339,WEB 2086,-8.324315,x0774,4.116947,active-covalent
C1CSS[C@@H]1CCCCC(=O)[O-],BRD-A16347691-001-13-1,thioctic-acid,MicroSource,1503941,THIOCTIC ACID,-8.323378,x0749,-1.931952,active-covalent
C[C@H]([C@H](c1ccccc1)O)[NH3+],BRD-K27853494-003-04-7,"1s,2r-phenylpropanolamine",MicroSource,1500484,"1S,2R-PHENYLPROPANOLAMINE HYDROCHLORIDE",-8.323056,x0678,-0.54607,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CC[C@@H]4[C@@H]3CC=C(C4)N=O,BRD-K38041788-001-02-9,norgestimate,MicroSource,1505562,NORGESTIMATE,-8.322652,x0749,4.94438,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CC[C@@H]4[C@@H]3CC=C(C4)N=O,BRD-K38041788-001-01-1,norgestimate,Sigma,MFCD00867874,"(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-nitroso-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate",-8.322652,x0749,4.94438,active-covalent
CC(=CCC/C(=C/CC/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)/C)C,BRD-K99431849-001-01-7,peretinoin,MedChemEx,HY-100008,Peretinoin,-8.322544,x0072,3.18731,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)/C)C,BRD-K99431849-001-02-5,peretinoin,MedChemEx,HY-100008,Peretinoin,-8.322544,x0072,3.18731,active-noncovalent
c1cc(c(c2c1c([nH]n2)C[C@H](CC(=O)N3CCn4c(nnc4C(F)(F)F)C3)[NH3+])F)F,BRD-K04035716-011-01-9,PK-44,Tocris,4145,PK 44 phosphate,-8.322359,x0195,2.999208,active-noncovalent
c1cc2c(c(ccc2)S(=O)(=O)NC[C@H]3CC[C@@H](CC3)CNc4nc(c5c(n4)cccc5)N)cc1,BRD-K34321528-003-01-2,CGP-71683,Tocris,2199,CGP 71683 hydrochloride,-8.321639,x0104,9.569212,active-noncovalent
c1cc2c(c(ccc2)S(=O)(=O)NC[C@H]3CC[C@@H](CC3)CNc4nc(c5c(n4)cccc5)N)cc1,BRD-K34321528-003-02-0,CGP-71683,Tocris,2199,CGP 71683 hydrochloride,-8.321639,x0104,9.569212,active-noncovalent
Cc1cc(c(cc1NC(=O)c2cc(cc(c2O)I)I)Cl)[C@@H](C#N)c3ccc(cc3)Cl,BRD-A19952358-001-11-3,closantel,MicroSource,1504835,CLOSANTEL,-8.321163,x0104,7.771939,active-noncovalent
Cc1cc(c(cc1NC(=O)c2cc(cc(c2O)I)I)Cl)[C@@H](C#N)c3ccc(cc3)Cl,BRD-A19952358-001-12-1,closantel,Selleck,S4106,Closantel,-8.321163,x0104,7.771939,active-noncovalent
Cc1cc(c(cc1NC(=O)c2cc(cc(c2O)I)I)Cl)[C@@H](C#N)c3ccc(cc3)Cl,BRD-A19952358-236-01-6,closantel,Selleck,S4105,Closantel Sodium,-8.321163,x0104,7.771939,active-noncovalent
Cc1cc(c(cc1NC(=O)c2cc(cc(c2O)I)I)Cl)[C@@H](C#N)c3ccc(cc3)Cl,BRD-A19952358-001-10-5,closantel,Selleck,S4106,Closantel,-8.321163,x0104,7.771939,active-noncovalent
Cc1ccc(cc1S(=O)(=O)[N@](C)/N=C/c2c[nH+]c3n2cc(cc3)Br)N(=O)=O,BRD-K49371609-003-03-8,PIK-75,Selleck,S1205,PIK-75,-8.321043,x0195,3.011107,active-noncovalent
CCOc1ccn(c(=O)c1C(=O)Nc2ccc(c(c2)F)Oc3ccnc(c3Cl)N)c4ccc(cc4)F,BRD-K40738845-001-05-0,BMS-777607,Selleck,S1561,BMS-777607,-8.320773,x0104,14.430702,active-noncovalent
Cc1ccc(c(c1)[C@H](C[NH2+]C(C)C)O)C,BRD-A98083480-001-01-3,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",Enamine,Z1020681722,,-8.320657,x0195,-0.578098,active-noncovalent
c1ccc(cc1)C(c2ccccc2)([C@@H]3CC[N@@H+](C3)CCc4ccc5c(c4)CCO5)C(=O)N,BRD-K95773607-004-03-8,darifenacin,Selleck,S3144,Darifenacin HBr,-8.320539,x0104,5.789972,active-noncovalent
c1ccc(cc1)C(c2ccccc2)([C@@H]3CC[N@@H+](C3)CCc4ccc5c(c4)CCO5)C(=O)N,BRD-K95773607-004-04-6,darifenacin,MicroSource,1505714,DARIFENACIN HYDROBROMIDE,-8.320539,x0104,5.789972,active-noncovalent
CC(C)COC(=O)c1ccc(cc1)N,BRD-K96714749-001-01-0,isobutamben,MicroSource,1506196,ISOBUTAMBEN,-8.320525,x0678,-0.014044,active-noncovalent
C[N@@H+]1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4c3cc(cc4)OC,BRD-K33211335-004-01-7,dextromethorphan,MicroSource,1500233,DEXTROMETHORPHAN HYDROBROMIDE,-8.320422,x0874,1.740038,active-noncovalent
c1ccc2c(c1)C(=O)N[C@]2(c3ccc(c(c3)S(=O)(=O)N)Cl)O,BRD-A26384407-001-25-1,chlorthalidone,MicroSource,1500187,CHLORTHALIDONE,-8.319755,x0830,0.762131,active-covalent
Cn1c(=O)c-2nc(nn(c2nc1=O)C)c3ccc(cc3)C(F)(F)F,BRD-K01129913-001-01-5,walrycin-b,MedChemEx,HY-18219,Walrycin B,-8.318973,x0397,3.416106,active-noncovalent
C[N@H+](CCCN1c2ccccc2CCc3c1cccc3)CC(=O)c4ccc(cc4)Cl,BRD-K82147103-001-02-7,lofepramine,Tocris,2545,Lofepramine,-8.318087,x0946,1.906679,active-noncovalent
C[N@H+](CCCN1c2ccccc2CCc3c1cccc3)CC(=O)c4ccc(cc4)Cl,BRD-K82147103-003-05-6,lofepramine,Key,KS-1301,"1-(4-chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl](methyl)amino]ethanone hydrochloride",-8.318087,x0946,1.906679,active-noncovalent
Cc1c(c2ccc(c(c2o1)O)OC)C(=O)c3cc(c(c(c3)OC)OC)OC,BRD-K20468903-001-02-4,BNC105,MedChemEx,HY-16114,BNC105,-8.318060,x0195,3.608096,active-noncovalent
Cc1c(c2ccc(c(c2o1)O)OC)C(=O)c3cc(c(c(c3)OC)OC)OC,BRD-K20468903-001-01-6,BNC105,MedChemEx,HY-16114,BNC105,-8.318060,x0195,3.608096,active-noncovalent
Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC,BRD-K42673188-001-01-1,verubulin,Key,EE-0048,"N-(4-methoxyphenyl)-N,2-dimethyl-4-quinazolinamine",-8.315365,x1093,0.263634,active-noncovalent
Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC,BRD-K42673188-003-01-7,verubulin,Tocris,5231,MPC 6827 hydrochloride,-8.315365,x1093,0.263634,active-noncovalent
c1cc(cnc1)N2CC[C@H](C2)[NH3+],BRD-A29844814-300-01-5,ABT-202,Enamine,EN300-69225,,-8.314229,x0195,-2.161838,active-noncovalent
Cc1c(oc2c1c(c3c(n2)CCCC3)NC(=O)CN4CCCC4=O)C,BRD-K23672206-001-01-4,BCI-540,MedChemEx,HY-17553,Coluracetam,-8.313836,x0749,2.991383,active-covalent
c1ccc(cc1)C(=O)N2CCC(CC2)CCCCNC(=O)/C=C/c3cccnc3,BRD-K58550667-001-08-7,FK-866,Enzo,270-501,FK-866,-8.313380,x0434,5.877028,active-noncovalent
c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)N(=O)=O,BRD-K08111712-001-14-2,chloramphenicol,Selleck,S1677,Chloramphenicol,-8.312917,x0161,0.654513,active-noncovalent
c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)N(=O)=O,BRD-K08111712-001-16-7,chloramphenicol,MicroSource,1500174,CHLORAMPHENICOL,-8.312917,x0161,0.654513,active-noncovalent
Cc1cc(on1)[C@@H](/C=N/c2ccc(cc2)Cl)C(=O)Nc3ccc(cc3)Cl,BRD-K16338837-001-02-6,CCMI,Tocris,3837,CCMI,-8.312459,x0107,3.145009,active-noncovalent
Cc1cc(on1)[C@@H](/C=N/c2ccc(cc2)Cl)C(=O)Nc3ccc(cc3)Cl,BRD-K16338837-001-01-8,CCMI,Tocris,3837,CCMI,-8.312459,x0107,3.145009,active-noncovalent
C[N@@H+]1C[C@@H]2c3ccccc3Oc4ccc(cc4[C@H]2C1)Cl,BRD-M82363962-001-02-8,asenapine,Tocris,3737,Asenapine maleate,-8.312070,x0072,-0.121926,active-noncovalent
C[N@@H+]1C[C@@H]2c3ccccc3Oc4ccc(cc4[C@H]2C1)Cl,BRD-K95260951-050-02-3,asenapine,Selleck,S1283,Asenapine,-8.312070,x0072,-0.121926,active-noncovalent
C[N@@H+]1C[C@@H]2c3ccccc3Oc4ccc(cc4[C@H]2C1)Cl,BRD-K95260951-050-03-1,asenapine,Tocris,3737,Asenapine maleate,-8.312070,x0072,-0.121926,active-noncovalent
CCc1cccc(c1[NH+]=C2NCCN2)CC,BRD-K18905250-003-02-4,ST-91,Tocris,2638,ST 91,-8.311742,x1385,-2.391271,active-covalent
CCc1cccc(c1[NH+]=C2NCCN2)CC,BRD-K18905250-003-03-2,ST-91,Tocris,2638,ST 91,-8.311742,x1385,-2.391271,active-covalent
CCCC[C@@H]1c2ccccc2C(=O)O1,BRD-A59378440-001-01-3,butylphthalide,MedChemEx,HY-B0647,Butylphthalide,-8.311562,x0195,-0.971396,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,BRD-K51751936-001-09-1,alfadolone-acetate,Prestwick,Prestw-1001,Alfadolone acetate,-8.309730,x0104,4.928648,active-noncovalent
C[C@H](C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K72106461-001-02-1,SYM-2081,Enzo,AC428,SYM 2081,-8.308601,x0397,-0.57228,active-noncovalent
CC(C)Oc1ccccc1OC(=O)NC,BRD-K08231299-001-08-1,propoxur,MicroSource,330066,PROPOXUR,-8.308443,x0195,-0.950349,active-noncovalent
c1ccc(cc1)NC(=O)N2CCC(CC2)Cc3cc4ccccc4nc3,BRD-K83213911-001-07-7,PF-750,Tocris,3307,PF 750,-8.308383,x0161,3.222784,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@](C4)(C)O)C)C,BRD-K28217197-001-01-4,ganaxolone,Tocris,2531,Ganaxolone,-8.307878,x0749,3.752216,active-covalent
Cc1ccc(c(c1)Cl)NC2=[NH+]CCN2,BRD-K82687598-001-01-6,tolonidine,Enamine,Z2412196366,"N-(2-chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine",-8.307787,x0195,-2.502121,active-noncovalent
C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,BRD-K28120222-001-08-4,parthenolide-(alternate-stereo),Prestwick,Prestw-550,Parthenolide,-8.307545,x0195,1.461672,active-noncovalent
C[NH+](C)CCCn1cc(c2c1ccc(c2)OC)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,BRD-K36984403-001-02-7,go-6983,Selleck,S2911,Go 6983,-8.305967,x0195,3.675151,active-noncovalent
C[NH+](C)CCCn1cc(c2c1ccc(c2)OC)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,BRD-K36984403-001-03-5,go-6983,Selleck,S2911,Go 6983,-8.305967,x0195,3.675151,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(cc2O)OC,BRD-K18613660-001-05-5,mexeneone,MicroSource,1506199,MEXENEONE,-8.305769,x1093,0.153322,active-noncovalent
CCCCOc1ccc(cc1Cl)c2cc(cnc2)C(=O)NCc3cccnc3N4CCOCC4,BRD-K20239555-001-01-2,A-887826,Tocris,4249,A 887826,-8.304589,x0161,9.571317,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC2c3ccccc3Oc4c2cccc4,BRD-K10852420-001-02-5,AH-7614,Tocris,5256,AH 7614,-8.304498,x0692,0.668183,active-covalent
C[NH+]1CCC(=C2c3ccccc3Sc4c2cccc4)CC1,BRD-K88090157-050-10-8,pimethixene,MicroSource,1501114,PIMETHIXENE MALEATE,-8.302923,x0195,-0.613068,active-noncovalent
COc1cccc(c1)n2c(cc(n2)C(=O)[O-])c3ccc(c(c3)Cl)C4CCCCC4,BRD-K32031961-001-01-7,TC-LPA5-4,Tocris,4708,TC LPA5 4,-8.302910,x0072,5.143402,active-noncovalent
CCn1c2c(cn1)c(c(cn2)C(=O)OCC)/N=N/C(C)C,BRD-K64755930-003-03-2,etazolate,Tocris,438,Etazolate hydrochloride,-8.302033,x0195,1.254539,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O,BRD-K93201765-001-01-0,sodium-gluconate,MicroSource,1300035,SODIUM GLUCONATE,-8.301626,x0397,0.047513,active-noncovalent
Cc1cc(c(c(c1)C)Nc2ccnc(n2)Nc3ccc(cc3)C#N)C,BRD-K12885236-001-02-7,dapivirine,Selleck,S2914,Dapivirine (TMC120),-8.301179,x0434,2.303166,active-noncovalent
c1cc2c(ccc(c2nc1)O)Cl,BRD-K46982791-001-09-4,cloxyquin,MicroSource,1500202,CLOXYQUIN,-8.300875,x0195,-1.412699,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(cc5c4)O)O,BRD-K63784565-001-06-2,10-hydroxycamptothecin,Selleck,S2423,10-Hydroxycamptothecin,-8.300719,x0161,1.726565,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(cc5c4)O)O,BRD-K63784565-001-05-4,10-hydroxycamptothecin,Selleck,S2423,(S)-10-Hydroxycamptothecin,-8.300719,x0161,1.726565,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)OCC[NH+]3CCOCC3)[O-])C(=O)OC2,BRD-K92428153-001-07-7,mycophenolate-mofetil,Tocris,4102,Mycophenolate mofetil,-8.300500,x0195,4.109415,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)OCC[NH+]3CCOCC3)[O-])C(=O)OC2,BRD-K92428153-001-05-1,mycophenolate-mofetil,MicroSource,1504567,MYCOPHENOLATE MOFETIL,-8.300500,x0195,4.109415,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)OCC[NH+]3CCOCC3)[O-])C(=O)OC2,BRD-K92428153-001-04-4,mycophenolate-mofetil,Selleck,S1501,Mycophenolate Mofetil,-8.300500,x0195,4.109415,active-noncovalent
c1c([nH]cn1)C[C@H](C(=O)[O-])NC(=O)CC[NH3+],BRD-A96051074-001-02-2,carnosine,SantaCruz,sc-202521A,,-8.300128,x1093,-0.274429,active-noncovalent
CC(=O)Nc1ccc(cc1)OC[C@@](C)(C(=O)Nc2ccc(c(c2)C(F)(F)F)N(=O)=O)O,BRD-K82164249-001-03-5,andarine,Selleck,S1140,Andarine,-8.299338,x0104,4.410064,active-noncovalent
CCCCn1c(c(nc1c2ccccc2)c3ccccc3)C[NH+](Cc4ccc5c(c4)OCO5)Cc6ccc7c(c6)OCO7,BRD-K17539220-001-01-5,NDT-9513727,Tocris,3333,NDT 9513727,-8.299243,x1077,10.183081,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2OC(=O)CCC5CCCC5)O,BRD-A91452556-001-04-0,estradiol-cypionate,MicroSource,1500283,ESTRADIOL CYPIONATE,-8.299145,x0874,5.524435,active-noncovalent
Cc1ccc2c(c1)[C@]34CCCC[C@@H]3[C@H](C2)[N@@H+](CC4)C,BRD-K29812331-011-01-7,dimemorfan,Key,KS-1259,"phosphoric acid compound with (9alpha,13alpha,14alpha)-3,17-dimethylmorphinan (1:1)",-8.298336,x1077,3.184784,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-],BRD-K02152879-414-01-3,sivelestat,MedChemEx,HY-17443B,Sivelestat (sodium tetrahydrate),-8.297880,x0195,5.378425,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-],BRD-K02152879-414-02-1,sivelestat,MedChemEx,HY-17443B,Sivelestat (sodium tetrahydrate),-8.297880,x0195,5.378425,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-],BRD-K02152879-236-01-0,sivelestat,Tocris,3535,Sivelestat sodium salt,-8.297880,x0195,5.378425,active-noncovalent
CCN(c1ccccc1C)C(=O)/C=C/C,BRD-K57179821-001-15-4,crotamiton,MicroSource,1505271,CROTAMITON,-8.297319,x0678,-0.202038,active-noncovalent
CN(c1[nH]c(=O)ccn1)C2CCN(CC2)c3nc4ccccc4n3Cc5ccc(cc5)F,BRD-K21884483-001-03-7,mizolastine,Selleck,S2107,Mizolastine (Mizollen),-8.296378,x0104,5.780606,active-noncovalent
c1cc2c(ccc(c2nc1)O)N=O,BRD-K13169950-001-14-4,NSC-3852,Tocris,2521,NSC 3852,-8.295759,x0195,-1.806737,active-noncovalent
CCCCCn1cc(c(=O)c2c1ccc(c2)c3ccccc3)C(=O)NC45CC6CC(C4)CC(C6)C5,BRD-K74965187-001-01-3,COR-170,Tocris,4756,COR 170,-8.295734,x0161,7.256584,active-noncovalent
Cc1cc(nc2c1c(c(s2)C(=O)NCc3ccc(cc3)Cl)N)C,BRD-K12483104-001-01-2,VU10010,Tocris,3141,VU 10010,-8.295556,x0104,3.540952,active-noncovalent
C[NH+](C)CCOC(=O)[C@@H](c1ccccc1)C2(CCCC2)O,BRD-A77291778-003-22-0,cyclopentolate,MicroSource,1500212,CYCLOPENTOLATE HYDROCHLORIDE,-8.295277,x1093,0.196755,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)N(=O)=O)O,BRD-A21280314-001-06-8,nifenalol,Enamine,Z56755859,2-(isopropylamino)-1-(4-nitrophenyl)ethanol,-8.294984,x0749,-0.432345,active-covalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K24556098-001-19-1,deoxycorticosterone-acetate,MicroSource,300029,DESOXYCORTICOSTERONE ACETATE,-8.294564,x0946,1.880829,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K24556098-001-16-7,deoxycorticosterone-acetate,Selleck,S4243,Deoxycorticosterone acetate,-8.294564,x0946,1.880829,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K24556098-001-18-3,deoxycorticosterone-acetate,Selleck,S4243,Deoxycorticosterone acetate,-8.294564,x0946,1.880829,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-K24556098-001-17-5,deoxycorticosterone-acetate,Selleck,S4243,Deoxycorticosterone acetate,-8.294564,x0946,1.880829,active-noncovalent
c1ccc(cc1)/C=C/C(=O)NCCO,BRD-K76021681-001-02-2,brolitene,Vitas-M,STK429148,(2E)-N-(2-hydroxyethyl)-3-phenyl-2-propenamide,-8.294021,x0161,-1.199315,active-noncovalent
c1ccc(cc1)/C=C/C(=O)NCCO,BRD-K76021681-001-01-4,brolitene,ChemBridge,5334325,,-8.294021,x0161,-1.199315,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)C,BRD-K12568846-001-14-6,amidopyrine,Selleck,S3209,Amidopyrine,-8.293386,x0749,-0.356114,active-covalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)C,BRD-K12568846-001-15-3,amidopyrine,MicroSource,1500621,AMINOPYRINE,-8.293386,x0749,-0.356114,active-covalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)C,BRD-K12568846-001-16-1,amidopyrine,Selleck,S3209,Amidopyrine,-8.293386,x0749,-0.356114,active-covalent
c1cc2c(cc1C(=O)N)c(c[nH]2)CC[NH3+],BRD-K92382976-050-01-1,5-carboxamidotryptamine,Tocris,458,5-Carboxamidotryptamine maleate,-8.293371,x0195,-2.371067,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1ccccc1C,BRD-A53952395-003-25-1,prilocaine,MicroSource,1503270,PRILOCAINE HYDROCHLORIDE,-8.293068,x0195,-0.540839,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1ccccc1C,BRD-A53952395-001-02-4,prilocaine,Selleck,S1619,Prilocaine,-8.293068,x0195,-0.540839,active-noncovalent
C[NH2+]C[C@@H](c1cccc(c1)O)O,BRD-K73381542-003-22-6,phenylephrine,Selleck,S2569,Phenylephrine HCl,-8.292872,x0434,-0.449871,active-noncovalent
C[NH2+]C[C@@H](c1cccc(c1)O)O,BRD-K73381542-003-23-4,phenylephrine,MicroSource,1500483,PHENYLEPHRINE HYDROCHLORIDE,-8.292872,x0434,-0.449871,active-noncovalent
C[NH2+]C[C@@H](c1cccc(c1)O)O,BRD-K73381542-003-24-2,phenylephrine,Selleck,S2569,Phenylephrine hydrochloride,-8.292872,x0434,-0.449871,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCOCC2)Cl,BRD-K07237224-001-20-4,moclobemide,Tocris,4395,Moclobemide,-8.292768,x0161,0.131119,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCOCC2)Cl,BRD-K07237224-001-19-6,moclobemide,Selleck,S3212,Moclobemide (Ro 111163),-8.292768,x0161,0.131119,active-noncovalent
CSc1nc(c(c(n1)NC2CCCC2)N(=O)=O)NC3CCCC3,BRD-K75478907-001-02-3,GS-39783,Tocris,2001,GS 39783,-8.292576,x0195,2.408158,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)S(=O)(=O)C)F)CC(=O)[O-],BRD-K37708699-001-01-4,exisulind,LKT,S8146,(Z)-2-(5-fluoro-2-methyl-1-(4-(methylsulfonyl)benzylidene)-1H-inden-3-yl)acetic acid,-8.292515,x0831,3.133467,active-covalent
c1cc(cc(c1)OCC(C(F)F)(F)F)C[NH2+]CCc2c[nH]c3c2ccc(c3)F,BRD-K79102359-003-01-6,idalopirdine,MedChemEx,HY-14338A,Lu AE58054 (Hydrochloride),-8.291562,x0161,4.292994,active-noncovalent
c1[nH]c2c(n1)c(=S)[nH]cn2,BRD-K91601245-001-12-0,mercaptopurine,Selleck,S1305,Mercaptopurine (6-MP),-8.290368,x0678,-1.782668,active-noncovalent
c1[nH]c2c(n1)c(=S)[nH]cn2,BRD-K91601245-001-13-8,mercaptopurine,MicroSource,1500387,MERCAPTOPURINE,-8.290368,x0678,-1.782668,active-noncovalent
CCCCCCCCCCCCCCSCC(=O)[O-],BRD-K47539947-001-03-7,tetradecylthioacetic-acid,Enzo,GR236,Tetradecylthioacetic acid,-8.289843,x0104,4.648468,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cccc3)C[NH+](C)C,BRD-A49225603-045-10-0,alimemazine,MicroSource,1500593,TRIMEPRAZINE TARTRATE,-8.288328,x0195,0.438504,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cccc3)C[NH+](C)C,BRD-M58473998-046-01-0,trimeprazine,Sigma,MFCD00242594,"(2R,3R)-2,3-dihydroxybutanedioic acid compound with N,N,2-trimethyl-3-(10H-phenothiazin-10-yl)-1-propanamine (1:2)",-8.288328,x0195,0.438504,active-noncovalent
c1cnc(cn1)C(=O)NC(=[NH2+])N,BRD-K61693562-300-01-7,pyrazinoylguanidine,Enamine,Z1198155666,,-8.288226,x0678,-1.963946,active-noncovalent
COc1ccc(cc1)Nc2c3cc(ccc3ncn2)OC,BRD-K87696786-003-05-1,LY456236,Tocris,2390,LY 456236 hydrochloride,-8.288116,x0072,-0.626352,active-noncovalent
COc1ccc(cc1)Nc2c3cc(ccc3ncn2)OC,BRD-K87696786-003-04-4,LY456236,Tocris,2390,LY 456236 hydrochloride,-8.288116,x0072,-0.626352,active-noncovalent
Cc1cn2c(cc(n2)[C@@H]3CCCCN3C(=O)c4cc(ccc4NS(=O)(=O)C)Cl)nc1N5CC[C@@H](C5)[NH3+],BRD-K45906612-001-01-8,presatovir,MedChemEx,HY-16727,Presatovir,-8.286894,x0874,7.476789,active-noncovalent
CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,BRD-K34234316-003-04-7,benzalkonium,MicroSource,1503610,BENZALKONIUM CHLORIDE,-8.286427,x0195,1.896843,active-noncovalent
CCCCCCCCCCCCCCCCCCO,BRD-K20501889-001-02-0,octadecan-1-ol,Ark,AK114210,Octadecan-1-ol,-8.286419,x0161,3.504264,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,BRD-A13133631-001-04-0,fluorometholone,MicroSource,1500304,FLUOROMETHOLONE,-8.286389,x0749,3.345319,active-covalent
c1ccc(cc1)C[C@@H](C(=O)[O-])[NH2+]Cc2ccc(cc2)Cl,BRD-A57806482-001-01-4,BRL-26314,Sigma,PH000560,N-(4-chlorobenzyl)phenylalanine,-8.286190,x0397,0.336504,active-noncovalent
c1ccc(cc1)CCCCNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K81048131-001-02-4,AG-556,Tocris,616,AG 556,-8.285829,x0678,2.257239,active-noncovalent
c1cc(cc(c1)N2C(=O)/C(=C\c3ccc(cc3)C(=O)[O-])/SC2=S)C(F)(F)F,BRD-K72004355-001-01-9,CFTRinh-172,Selleck,S7139,CFTRinh-172,-8.285606,x0072,3.671097,active-noncovalent
c1cc(cc(c1)N2C(=O)/C(=C\c3ccc(cc3)C(=O)[O-])/SC2=S)C(F)(F)F,BRD-K72004355-001-02-7,CFTRinh-172,Tocris,3430,CFTRinh 172,-8.285606,x0072,3.671097,active-noncovalent
c1cc(cc(c1)N2C(=O)/C(=C\c3ccc(cc3)C(=O)[O-])/SC2=S)C(F)(F)F,BRD-K72004355-001-03-5,CFTRinh-172,Tocris,3430,CFTRinh 172,-8.285606,x0072,3.671097,active-noncovalent
CC(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,BRD-A07780951-065-09-2,metaproterenol,Selleck,S4335,Metaproterenol Sulfate,-8.285376,x0434,-1.514423,active-noncovalent
CC(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,BRD-A07780951-065-10-0,metaproterenol,Selleck,S4335,metaproterenol sulfate,-8.285376,x0434,-1.514423,active-noncovalent
CC(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,BRD-A07780951-001-08-9,metaproterenol,MicroSource,1500390,METAPROTERENOL,-8.285376,x0434,-1.514423,active-noncovalent
C1COCCN1C(=[NH2+])NC(=[NH2+])N,BRD-K57291914-003-10-2,moroxydine,MicroSource,1506078,MOROXYDINE HYDROCHLORIDE,-8.284554,x0195,-1.368725,active-noncovalent
C1COCCN1C(=[NH2+])NC(=[NH2+])N,BRD-K57291914-003-09-4,moroxydine,Selleck,S2486,Moroxydine HCl,-8.284554,x0195,-1.368725,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4[C@@](C2)(C(=O)OC)O)CC3,BRD-K89704198-001-12-3,vincamine,MicroSource,1500647,VINCAMINE,-8.284317,x0195,2.088748,active-noncovalent
c1cc(ccc1C(=O)[O-])NC(=O)CCn2cnc3c2nc[nH]c3=O,BRD-K21612934-001-01-1,leteprinim,Sigma,MFCD00925649,"4-{[3-(6-oxo-1,6-dihydro-9H-purin-9-yl)propanoyl]amino}benzoic acid",-8.284295,x0831,1.031088,active-covalent
Cn1c2ccc(cc2nc1CCCC(=O)[O-])N(CCCl)CCCl,BRD-K17068645-003-05-9,bendamustine,Selleck,S1212,Bendamustine HCL,-8.284176,x0104,1.246928,active-noncovalent
Cn1c2ccc(cc2nc1CCCC(=O)[O-])N(CCCl)CCCl,BRD-K17068645-003-04-2,bendamustine,Selleck,S1212,Bendamustine HCl,-8.284176,x0104,1.246928,active-noncovalent
Cc1c(nc[nH]1)c2ccc(cc2)Cl,BRD-K06388517-001-01-2,lofemizole,AMS,A001365113,5-(4-chlorophenyl)-4-methyl-1H-imidazole,-8.284163,x0749,-3.04293,active-covalent
CN1(=O)[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4,BRD-A49906757-004-09-8,scopolamine-n-oxide,Prestwick,Prestw-232,Scopolamin-N-oxide hydrobromide,-8.284106,x0072,0.857821,active-noncovalent
c1c(cc(c2c1[nH]c(cc2=O)C(=O)[O-])Cl)Cl,BRD-K60287130-001-05-7,"5,7-dichlorokynurenic-acid",Tocris,286,"5,7-Dichlorokynurenic acid",-8.283470,x0678,0.57522,active-noncovalent
c1c(cc(c2c1[nH]c(cc2=O)C(=O)[O-])Cl)Cl,BRD-K60287130-001-06-5,"5,7-dichlorokynurenic-acid",Tocris,286,"5,7-Dichlorokynurenic acid",-8.283470,x0678,0.57522,active-noncovalent
C/C(=C\c1ccc(cc1)C(=O)[O-])/c2ccc3c(c2)C(CCC3(C)C)(C)C,BRD-K49685476-001-16-7,TTNPB,Selleck,S4627,TTNPB,-8.283151,x0104,4.727339,active-noncovalent
C/C(=C\c1ccc(cc1)C(=O)[O-])/c2ccc3c(c2)C(CCC3(C)C)(C)C,BRD-K49685476-001-15-9,TTNPB,Tocris,761,TTNPB,-8.283151,x0104,4.727339,active-noncovalent
C/C(=C\c1ccc(cc1)C(=O)[O-])/c2ccc3c(c2)C(CCC3(C)C)(C)C,BRD-K49685476-001-14-2,TTNPB,Selleck,S4627,TTNPB (Arotinoid Acid),-8.283151,x0104,4.727339,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,BRD-K17415526-001-03-5,tyrphostin-AG-835,Tocris,579,"Tyrphostin B44, (+) enantiomer",-8.282710,x0678,1.457686,active-noncovalent
CCCCCCCCc1ccc(cc1)c2ccc(cc2)C(=O)[O-],BRD-K93176058-001-04-4,AC-55649,Tocris,2436,AC 55649,-8.281613,x0161,4.909442,active-noncovalent
CCCCCCCCc1ccc(cc1)c2ccc(cc2)C(=O)[O-],BRD-K93176058-001-03-6,AC-55649,Tocris,2436,AC 55649,-8.281613,x0161,4.909442,active-noncovalent
c1cc(ccc1CN(c2ccc(cc2)C#N)n3cnnc3)Br,BRD-K38398115-001-01-9,YM-511,Tocris,3278,"4-[(4-bromobenzyl)(4H-1,2,4-triazol-4-yl)amino]benzonitrile",-8.280618,x0678,0.081421,active-noncovalent
CC(C)c1cc2c(cc1S(=O)(=O)[O-])[C@]3(CCC[C@@]([C@@H]3CC2)(C)C(=O)[O-])C,BRD-K03353589-236-01-4,ecabet,OxChem,AX8127117,,-8.280455,x0749,1.264003,active-covalent
c1cc(c(cc1Cl)O)Oc2ccc(cc2Cl)Cl,BRD-K41731458-001-15-1,triclosan,MicroSource,1505465,TRICLOSAN,-8.280219,x0749,-0.281838,active-covalent
Cc1nnc(n1C2C[C@H]3CC[C@@H](C2)[NH+]3CC[C@@H](c4ccccc4)NC(=O)C5CCC(CC5)(F)F)C(C)C,BRD-A04352665-001-05-3,maraviroc,Selleck,S2003,Maraviroc,-8.279219,x0874,6.374802,active-noncovalent
Cc1nnc(n1C2C[C@H]3CC[C@@H](C2)[NH+]3CC[C@@H](c4ccccc4)NC(=O)C5CCC(CC5)(F)F)C(C)C,BRD-A04352665-001-06-1,maraviroc,Tocris,3756,Maraviroc,-8.279219,x0874,6.374802,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=S)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K00610438-003-03-3,altanserin,Tocris,1809,Altanserin hydrochloride,-8.278597,x0107,4.036002,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=S)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K00610438-003-02-5,altanserin,Tocris,1809,Altanserin hydrochloride,-8.278597,x0107,4.036002,active-noncovalent
c1ccc2c(c1)cc(c(n2)C(=O)[O-])CC(=O)[O-],BRD-K06159959-001-02-0,CCMQ,Tocris,1238,CCMQ,-8.278330,x0678,-1.335129,active-noncovalent
c1cc(cnc1)C(=O)NO,BRD-K28030264-001-02-7,N-hydroxynicotinamide,Sigma,MFCD00033801,N-hydroxynicotinamide,-8.277518,x0397,-1.802069,active-noncovalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,BRD-A64092382-003-19-1,mexiletine,Tocris,2596,Mexiletine hydrochloride,-8.276011,x0195,0.887797,active-noncovalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,BRD-A64092382-003-16-7,mexiletine,Selleck,S4225,Mexiletine HCl,-8.276011,x0195,0.887797,active-noncovalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,BRD-A64092382-003-17-5,mexiletine,Tocris,2596,Mexiletine hydrochloride,-8.276011,x0195,0.887797,active-noncovalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,BRD-A64092382-003-18-3,mexiletine,MicroSource,1503929,MEXILETINE HYDROCHLORIDE,-8.276011,x0195,0.887797,active-noncovalent
c1c(cc(c(c1Cl)[NH+]=C2NCCN2)Cl)N,BRD-K38911213-003-01-6,apraclonidine,Ark,AK143283,,-8.275959,x1385,-0.382955,active-covalent
CC[C@@]1(CCC(=O)NC1=O)c2ccc(cc2)N,BRD-A25234499-001-17-5,aminoglutethimide,Selleck,S1672,Aminoglutethimide,-8.275949,x1385,-0.427152,active-covalent
CC[C@@]1(CCC(=O)NC1=O)c2ccc(cc2)N,BRD-A25234499-001-19-1,aminoglutethimide,Selleck,S1672,Aminoglutethimide (Cytadren),-8.275949,x1385,-0.427152,active-covalent
CC[C@@]1(CCC(=O)NC1=O)c2ccc(cc2)N,BRD-A25234499-001-18-3,aminoglutethimide,MicroSource,1500115,AMINOGLUTETHIMIDE,-8.275949,x1385,-0.427152,active-covalent
CCCCCCCC/C=C\CCCCCCCC(=O)[O-],BRD-M75061779-001-01-2,ethanolamine-oleate,MicroSource,1506170,ETHANOLAMINE OLEATE,-8.275096,x0678,3.052744,active-noncovalent
c1cc(ccc1CS[C@@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,BRD-A70649075-008-29-0,sulconazole,Selleck,S4120,Sulconazole Nitrate,-8.274795,x0678,2.633976,active-noncovalent
c1cc(ccc1CS[C@@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,BRD-A70649075-008-30-8,sulconazole,MicroSource,1501148,SULCONAZOLE NITRATE,-8.274795,x0678,2.633976,active-noncovalent
c1cc(ccc1C(=O)[O-])N[C@@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,BRD-A74648924-001-02-3,K-247,ChemBridge,5493356,,-8.274609,x0749,-0.81791,active-covalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(c(c3)Br)O,BRD-K07487750-001-03-3,WHI-P154,Selleck,S2867,WHI-P154,-8.273545,x0195,0.809634,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(c(c3)Br)O,BRD-K07487750-001-05-8,WHI-P154,Tocris,3115,WHI-P 154,-8.273545,x0195,0.809634,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(c(c3)Br)O,BRD-K07487750-001-04-1,WHI-P154,Selleck,S2867,WHI-P154,-8.273545,x0195,0.809634,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@@](O2)(C)C(=O)[O-])C,BRD-A17846016-001-13-9,trolox,Enzo,FR105,Trolox,-8.273417,x0749,-0.047243,active-covalent
Cc1cc(c(n(c1=O)C)Nc2ccc(cc2F)I)C(=O)NOCCO,BRD-K37687095-001-06-9,AZD8330,Selleck,S2134,AZD8330,-8.273303,x1392,0.480895,active-covalent
Cc1cc(c(n(c1=O)C)Nc2ccc(cc2F)I)C(=O)NOCCO,BRD-K37687095-001-07-7,AZD8330,Selleck,S2134,AZD8330,-8.273303,x1392,0.480895,active-covalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K38903228-001-11-9,hesperidin,Selleck,S2323,Methyl-Hesperidin,-8.271994,x0161,12.222178,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K38903228-001-12-7,hesperidin,Selleck,S2323,Methyl-Hesperidin,-8.271994,x0161,12.222178,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,BRD-K38903228-001-13-5,hesperidin,Selleck,S2309,Hesperidin,-8.271994,x0161,12.222178,active-noncovalent
CC[C@H](c1ccccc1)c2c(=O)c3ccccc3oc2[O-],BRD-A49838158-001-01-1,phenprocoumon,Abblis,AB2000540,,-8.271743,x0678,-0.453923,active-noncovalent
c1ccc(cc1)CCCn2c(nc(c2c3ccncc3)c4ccc(cc4)F)C#CCCO,BRD-K07074923-001-02-3,RWJ-67657,Tocris,2999,RWJ 67657,-8.271724,x0161,4.003207,active-noncovalent
c1ccc(cc1)CCCn2c(nc(c2c3ccncc3)c4ccc(cc4)F)C#CCCO,BRD-K07074923-001-01-5,RWJ-67657,Cayman,18718,4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol,-8.271724,x0161,4.003207,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F,BRD-K61496577-001-19-4,flumethasone,Selleck,S4088,Flumethasone,-8.271636,x0749,3.445065,active-covalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F,BRD-K61496577-001-20-2,flumethasone,MicroSource,1501196,FLUMETHASONE,-8.271636,x0749,3.445065,active-covalent
c1csc2c1[nH]cc(c2=O)C(=O)N[C@H]3C[NH+]4CCC3CC4,BRD-K44164034-003-01-1,pumosetrag,Sigma,SML1038,"(R)-7-hydroxy-N-(quinuclidin-3-yl)thieno[3,2-b]pyridine-6-carboxamide hydrochloride",-8.271628,x0749,1.092836,active-covalent
C[NH2+][C@@H](CCC[NH+]=C(N)N)C(=O)[O-],BRD-K20946707-001-01-9,L-monomethylarginine,Tocris,3513,(2S)-5-{[amino(imino)methyl]amino}-2-(methylamino)pentanoic acid,-8.270660,x0678,-0.977888,active-noncovalent
CCn1c2cc(c(cc2[nH]c1=O)Cl)Cl,BRD-K89299012-001-08-6,DCEBIO,Tocris,1422,DCEBIO,-8.270514,x0195,-1.668149,active-noncovalent
CCn1c2cc(c(cc2[nH]c1=O)Cl)Cl,BRD-K89299012-001-07-8,DCEBIO,Tocris,1422,DCEBIO,-8.270514,x0195,-1.668149,active-noncovalent
CCn1c2cc(c(cc2[nH]c1=O)Cl)Cl,BRD-K89299012-001-06-0,DCEBIO,Tocris,1422,DCEBIO,-8.270514,x0195,-1.668149,active-noncovalent
COc1ccc(cc1OC)C(=O)N2CCN(CC2)c3ccc4c(c3)CCC(=O)N4,BRD-K13414800-001-01-3,vesnarinone,MedChemEx,HY-15297,Vesnarinone,-8.270296,x0104,7.503967,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)OCC(=O)[O-],BRD-K67563174-001-16-8,acemetacin,Selleck,S2602,Acemetacin,-8.270082,x0678,4.670188,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)OCC(=O)[O-],BRD-K67563174-001-17-6,acemetacin,MicroSource,1500666,ACEMETACIN,-8.270082,x0678,4.670188,active-noncovalent
CC(C)(C)C(=O)[C@@H](Nc1ccc(cc1)Cl)/N=N/c2ccc(cc2)Cl,BRD-K66584608-001-01-3,TY-52156,MedChemEx,HY-19736,TY-52156,-8.269421,x0195,1.562114,active-noncovalent
CC(C)(C)C(=O)[C@@H](Nc1ccc(cc1)Cl)/N=N/c2ccc(cc2)Cl,BRD-K66584608-001-03-9,TY-52156,MedChemEx,HY-19736,TY-52156,-8.269421,x0195,1.562114,active-noncovalent
CC(C)(C)C(=O)[C@@H](Nc1ccc(cc1)Cl)/N=N/c2ccc(cc2)Cl,BRD-K66584608-001-02-1,TY-52156,Tocris,5328,TY 52156,-8.269421,x0195,1.562114,active-noncovalent
CCCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CO)Cl,BRD-K76205745-237-16-5,losartan,Selleck,S1359,Losartan Potassium (DuP 753),-8.268547,x0161,4.026978,active-noncovalent
CCCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CO)Cl,BRD-K76205745-001-06-6,losartan,MicroSource,1504268,LOSARTAN,-8.268547,x0161,4.026978,active-noncovalent
CCCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CO)Cl,BRD-K76205745-237-19-9,losartan,Tocris,3798,Losartan potassium,-8.268547,x0161,4.026978,active-noncovalent
CCCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CO)Cl,BRD-K76205745-237-18-1,losartan,Pharmeks,PHBB_SC-09765.obs1160624,potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)biphenyl-2-yl)tetrazol-1-ide,-8.268547,x0161,4.026978,active-noncovalent
C[C@H](Cc1ccc(cc1)OC)[NH2+]C[C@@H](c2ccc(c3c2ccc(=O)[nH]3)O)O,BRD-K25095405-001-01-5,carmoterol,BidePharm,BD239285,,-8.268541,x0434,3.731831,active-noncovalent
CCOCCOC(=O)/C=C/c1ccc(cc1)OC,BRD-K17828029-001-01-5,cinoxate,Enamine,Z53833825,,-8.268268,x0749,1.106538,active-covalent
c1cc2c(cc1Cl)[nH]c(cc2=O)C(=O)[O-],BRD-K84214706-001-06-5,7-chlorokynurenic-acid,Tocris,237,7-Chlorokynurenic acid,-8.267561,x0749,-1.617187,active-covalent
c1cc2c(cc1Cl)[nH]c(cc2=O)C(=O)[O-],BRD-K84214706-001-05-7,7-chlorokynurenic-acid,Tocris,237,7-Chlorokynurenic acid,-8.267561,x0749,-1.617187,active-covalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,BRD-K19507340-001-22-1,megestrol-acetate,Selleck,S1304,Megestrol Acetate,-8.267296,x1077,1.939831,active-noncovalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,BRD-K19507340-001-25-4,megestrol-acetate,Selleck,S1304,Megestrol Acetate,-8.267296,x1077,1.939831,active-noncovalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K11196887-001-21-2,norfloxacin,MicroSource,1500440,NORFLOXACIN,-8.265566,x0749,3.932214,active-covalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K11196887-001-20-4,norfloxacin,Selleck,S1509,Norfloxacin (Norxacin),-8.265566,x0749,3.932214,active-covalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K11196887-001-22-0,norfloxacin,Selleck,S1509,Norfloxacin (Norxacin),-8.265566,x0749,3.932214,active-covalent
c1cc(c(c(c1)Cl)Cl)OCCC[NH2+]CCO,BRD-K61734568-003-02-1,"2,3-DCPE",Tocris,2137,"2,3-DCPE hydrochloride",-8.264155,x0104,0.071261,active-noncovalent
c1c([nH]cn1)CCSC(=[NH2+])N,BRD-K33183200-303-02-4,imetit,Tocris,729,Imetit dihydrobromide,-8.263945,x0195,-2.24946,active-noncovalent
CS(=O)(=O)c1ccc(c2c1[C@@H](C(C2)(F)F)O)Oc3cc(cc(c3)F)C#N,BRD-K20850787-001-01-6,PT-2385,MedChemEx,HY-12867,PT-2385,-8.263245,x0104,1.890592,active-noncovalent
C[C@H](CSC(=O)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2ccccc2)C(=O)[O-],BRD-K51784806-001-01-6,alacepril,Key,KS-1321,(2S)-2-[({(2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]-2-pyrrolidinyl}carbonyl)amino]-3-phenylpropanoic acid,-8.263102,x0830,4.164509,active-covalent
c1ccc(cc1)Cn2c3ccccc3nc2N4CC[NH2+]CC4,BRD-K62398570-300-01-2,lerisetron,LifeChem,F2145-0456,,-8.262736,x0072,-0.214873,active-noncovalent
CC1(CCC(c2c1ccc(c2)C(=O)Nc3ccc(cc3)C(=O)[O-])(C)C)C,BRD-K06854232-001-19-9,AM-580,Tocris,760,AM 580,-8.262286,x0104,5.044396,active-noncovalent
CC1(CCC(c2c1ccc(c2)C(=O)Nc3ccc(cc3)C(=O)[O-])(C)C)C,BRD-K06854232-001-22-3,AM-580,Tocris,760,AM 580,-8.262286,x0104,5.044396,active-noncovalent
c1cc2c(cc1I)/C(=C/c3cc(c(c(c3)Br)[O-])Br)/C(=O)N2,BRD-K39520573-001-04-6,GW-5074,Tocris,1381,GW 5074,-8.262082,x0749,1.240342,active-covalent
c1cc2c(cc1I)/C(=C/c3cc(c(c(c3)Br)[O-])Br)/C(=O)N2,BRD-K39520573-001-03-8,GW-5074,Selleck,S2872,GW5074,-8.262082,x0749,1.240342,active-covalent
c1cc2c(cc1I)/C(=C/c3cc(c(c(c3)Br)[O-])Br)/C(=O)N2,BRD-K39520573-001-02-0,GW-5074,Selleck,S2872,GW5074,-8.262082,x0749,1.240342,active-covalent
c1ccc2c(c1)CN(C(=O)O2)CC(=O)N,BRD-K92129045-001-01-6,caroxazone,Enamine,Z2327531727,"2-(2-oxo-2H-1,3-benzoxazin-3(4H)-yl)acetamide",-8.262027,x0195,-1.595566,active-noncovalent
CC1(CCC(c2c1ccc(c2)NC(=O)c3ccc(cc3)C(=O)[O-])(C)C)C,BRD-K36627727-001-05-4,tamibarotene,Selleck,S4260,Tamibarotene,-8.261535,x1077,5.553789,active-noncovalent
c1cnccc1Cc2cnc[nH]2,BRD-K49519092-303-02-2,immethridine,Tocris,2315,Immethridine dihydrobromide,-8.261357,x0749,-2.572648,active-covalent
c1cnccc1Cc2cnc[nH]2,BRD-K49519092-303-03-0,immethridine,Tocris,2315,4-(1H-imidazol-5-ylmethyl)pyridine dihydrobromide,-8.261357,x0749,-2.572648,active-covalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)N)c4ccc(cc4)Cl)C,BRD-K15811707-001-01-2,CPI-203,MedChemEx,HY-15846,CPI-203,-8.261066,x0831,0.560912,active-covalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)N)c4ccc(cc4)Cl)C,BRD-K15811707-001-02-0,CPI-203,Tocris,5331,CPI 203,-8.261066,x0831,0.560912,active-covalent
CC[C@@H](c1ccccc1)NC(=O)c2c(c(nc3c2cccc3)c4ccccc4)C,BRD-K04414442-001-08-3,SB-222200,Tocris,1393,SB 222200,-8.260946,x1077,4.278363,active-noncovalent
CC[C@@H](c1ccccc1)NC(=O)c2c(c(nc3c2cccc3)c4ccccc4)C,BRD-K04414442-001-09-1,SB-222200,Tocris,1393,SB 222200,-8.260946,x1077,4.278363,active-noncovalent
C[C@H]1C[C@H](CC([N@@H+]1C)(C)C)OC(=O)[C@H](c2ccccc2)O,BRD-A37942872-003-20-6,eucatropine,Prestwick,Prestw-794,Eucatropine hydrochloride,-8.260940,x0195,0.779758,active-noncovalent
c1ccc2c(c1)CC[C@@H]2Nc3c4ccn(c4ncn3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N,BRD-K67844266-003-01-9,pevonedistat,MedChemEx,HY-10484,MLN4924 (hydrochloride),-8.260508,x0161,6.739411,active-noncovalent
c1ccc(c(c1)C/C(=N\Nc2nc(cs2)c3ccc(c(c3)Cl)Cl)/C(=O)[O-])N(=O)=O,BRD-K52366702-001-02-4,4EGI-1,Selleck,S7369,4EGI-1,-8.260505,x0678,3.775691,active-noncovalent
c1ccc(c(c1)C/C(=N\Nc2nc(cs2)c3ccc(c(c3)Cl)Cl)/C(=O)[O-])N(=O)=O,BRD-K52366702-001-01-6,4EGI-1,Selleck,S7369,4EGI-1,-8.260505,x0678,3.775691,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K04301924-236-03-2,ceftizoxim,MedChemEx,HY-B1596A,Ceftizoxime (sodium),-8.260223,x1077,2.853966,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K04301924-236-02-4,ceftizoxim,MedChemEx,HY-B1596A,Ceftizoxime (sodium),-8.260223,x1077,2.853966,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H](CCS3)C(=O)[O-],BRD-K04301924-236-01-6,ceftizoxim,Enzo,AC3053,CEFTIZOXIM SODIUM,-8.260223,x1077,2.853966,active-noncovalent
C[C@]12CC[C@@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)[C@@]1(CC[C@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O,BRD-K28343777-001-01-6,20-hydroxyecdysone,Selleck,S2417,20-Hydroxyecdysone,-8.260140,x0161,7.096393,active-noncovalent
c1cc2c(cc1F)[C@]3(CCO2)C(=O)NC(=O)N3,BRD-A89164055-001-03-3,sorbinil,Key,FS-1063,,-8.259608,x0161,-0.020272,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC[N@@H+](CCO)Cc3ccc(cc3)CCC(=O)N=O,BRD-K56957086-001-06-3,dacinostat,Selleck,S1095,LAQ824 (Dacinostat),-8.259498,x0749,4.750712,active-covalent
c1ccc2c(c1)c(c[nH]2)CC[N@@H+](CCO)Cc3ccc(cc3)CCC(=O)N=O,BRD-K56957086-001-09-7,dacinostat,Selleck,S1095,"LAQ824 (NVP-LAQ824, Dacinostat)",-8.259498,x0749,4.750712,active-covalent
c1cc(ccc1C[C@H](C(=O)[O-])[NH3+])I,BRD-K66664625-001-01-2,4-iodo-L-phenylalanine,Key,PS-6219,,-8.258878,x1077,-2.252246,active-noncovalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)NO,BRD-A40940854-001-01-1,ibuproxam,Enzo,EI375,Ibuproxam,-8.258434,x0749,-0.91065,active-covalent
c1cc(cc(c1)n2nccn2)Nc3c(cnc(n3)N[C@@H]4CCCC[C@@H]4[NH3+])C(=O)N,BRD-K53734668-003-04-6,PRT062607,Selleck,S8032,"PRT062607 (P505-15, BIIB057) HCl",-8.258021,x0161,4.484923,active-noncovalent
c1cc(cc(c1)n2nccn2)Nc3c(cnc(n3)N[C@@H]4CCCC[C@@H]4[NH3+])C(=O)N,BRD-K53734668-003-02-0,PRT062607,Selleck,S8032,"PRT062607 (P505-15, PRT2607, BIIB057) HCl",-8.258021,x0161,4.484923,active-noncovalent
CC(S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc2ncc(cc2)C(F)(F)F)(C)C,BRD-K06357403-001-02-2,velneperit,MedChemEx,HY-14423,Velneperit,-8.258002,x0104,5.847058,active-noncovalent
CC(S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc2ncc(cc2)C(F)(F)F)(C)C,BRD-K06357403-001-01-4,velneperit,MedChemEx,HY-14423,Velneperit,-8.258002,x0104,5.847058,active-noncovalent
Cn1cc(c2c1cncc2)c3ccnc(n3)Nc4ccc(cc4OC)N5CC[NH+](CC5)C,BRD-K80935598-001-02-9,AZ191,Tocris,5232,AZ 191,-8.257649,x0104,6.547439,active-noncovalent
Cn1cc(c2c1cncc2)c3ccnc(n3)Nc4ccc(cc4OC)N5CC[NH+](CC5)C,BRD-K80935598-001-01-1,AZ191,Selleck,S7338,AZ191,-8.257649,x0104,6.547439,active-noncovalent
CC[NH+](CC)CC(=O)Oc1ccc(cc1)NC(=O)C,BRD-K54496168-003-01-2,propacetamol,AKSci,K088,,-8.257581,x0104,0.562393,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])O,BRD-K71822263-001-03-2,D-Serine,Enzo,AC392,D-Serine,-8.256297,x0397,-0.581897,active-noncovalent
C[C@@H](c1ccc(cc1)F)Nc2cc(cc(n2)Nc3cnccn3)c4cnn(c4)C,BRD-K21865955-003-01-5,NS-018,MedChemEx,HY-19631B,NS-018 (hydrochloride),-8.255767,x0678,2.973858,active-noncovalent
CCOC(=O)[C@H]1[C@@H]([C@@H]2C(=NC1=C)CC(CC2=O)(C)C)c3ccc(cc3)c4ccccc4,BRD-A56690687-001-01-6,ITD-1,Tocris,5068,ITD 1,-8.255048,x1077,2.540393,active-noncovalent
c1cc(oc1)c2nnc3n2nc(s3)C4CCCCC4,BRD-K50905564-001-07-7,cardionogen-1,Tocris,4475,Cardionogen 1,-8.254781,x0708,0.848869,active-covalent
c1[nH]c2c(n1)c(=O)[nH]cn2,BRD-K03739921-001-06-8,hypoxanthine,Selleck,S2424,Hypoxanthine,-8.254661,x0678,-1.367245,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1nc(cc(n1)Nc2ccc3c(c2)c(cc([nH+]3)C)N)C,BRD-A80213327-305-08-3,NSC-23766,Tocris,2161,NSC 23766,-8.253355,x0104,6.209444,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1nc(cc(n1)Nc2ccc3c(c2)c(cc([nH+]3)C)N)C,BRD-A80213327-305-07-5,NSC-23766,Selleck,S8031,NSC 23766,-8.253355,x0104,6.209444,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1nc(cc(n1)Nc2ccc3c(c2)c(cc([nH+]3)C)N)C,BRD-A80213327-305-13-3,NSC-23766,Tocris,2161,NSC 23766,-8.253355,x0104,6.209444,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1nc(cc(n1)Nc2ccc3c(c2)c(cc([nH+]3)C)N)C,BRD-A80213327-305-11-7,NSC-23766,Selleck,S8031,NSC 23766,-8.253355,x0104,6.209444,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2[nH]c3ccc(cc3n2)Cl,BRD-K15086322-050-02-1,JNJ-10191584,Tocris,2441,JNJ 10191584 maleate,-8.253301,x0195,-0.58804,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2[nH]c3ccc(cc3n2)Cl,BRD-K15086322-050-01-3,JNJ-10191584,Tocris,2441,JNJ 10191584 maleate,-8.253301,x0195,-0.58804,active-noncovalent
CC(=O)N(C)c1cc(ccc1F)c2ccnc3n2ncc3C(=O)c4cccs4,BRD-K42066335-001-01-0,lorediplon,MedChemEx,HY-19371,Lorediplon,-8.253090,x0104,2.502088,active-noncovalent
CCOc1ccccc1OC[C@@H]2C[NH2+]CCO2,BRD-A59198242-003-02-9,viloxazine,Prestwick,Prestw-1361,Viloxazine hydrochloride,-8.250784,x0678,-0.039324,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCCC[NH+]2CCN(CC2)c3ccccc3OC,BRD-K73196317-003-14-8,urapidil,Tocris,1772,Urapidil hydrochloride,-8.250312,x0161,4.502961,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCCC[NH+]2CCN(CC2)c3ccccc3OC,BRD-K73196317-003-15-5,urapidil,MicroSource,1503100,URAPIDIL HYDROCHLORIDE,-8.250312,x0161,4.502961,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCCC[NH+]2CCN(CC2)c3ccccc3OC,BRD-K73196317-003-13-0,urapidil,Selleck,S2025,Urapidil HCl,-8.250312,x0161,4.502961,active-noncovalent
C[C@H](Cc1ccc2c(c1)OCO2)[C@@H](C)Cc3ccc(c(c3)OC)O,BRD-K94948151-001-07-4,macelignan,MedChemEx,HY-N0064,Macelignan,-8.249751,x0072,1.973871,active-noncovalent
c1cc2cc([nH]c2c(c1)N(=O)=O)C(=O)[O-],BRD-K02816415-001-01-9,CRT0044876,Selleck,S7449,CRT0044876,-8.249027,x0195,0.06662,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,BRD-A04327189-001-16-9,synephrine,Selleck,S2362,Synephrine (Oxedrine),-8.247826,x0434,-0.080787,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,BRD-A04327189-003-02-5,synephrine,Selleck,S2438,Synephrine HCl,-8.247826,x0434,-0.080787,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,BRD-A04327189-003-03-3,synephrine,Selleck,S2438,Synephrine HCl,-8.247826,x0434,-0.080787,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,BRD-A04327189-001-14-4,synephrine,Selleck,S2362,Synephrine,-8.247826,x0434,-0.080787,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,BRD-A04327189-001-15-1,synephrine,MicroSource,1506085,OXEDRINE,-8.247826,x0434,-0.080787,active-noncovalent
Cc1ccccc1C(=O)c2ccc(cc2Cl)Nc3ccc(cc3N)Br,BRD-K42452249-001-02-5,EO-1428,Tocris,2908,EO 1428,-8.247787,x0161,2.754115,active-noncovalent
Cc1ccccc1C(=O)c2ccc(cc2Cl)Nc3ccc(cc3N)Br,BRD-K42452249-001-03-3,EO-1428,Tocris,2908,EO 1428,-8.247787,x0161,2.754115,active-noncovalent
Cc1ccc(cc1)NC(=O)CCCCCC(=O)Nc2ccccc2N,BRD-K45044657-001-02-2,TC-H-106,Tocris,4270,TC-H 106,-8.246964,x1385,2.295516,active-covalent
COC1(CC[NH+](CC1)CCc2c[nH]c3c2cc(cc3)F)C[S@](=O)c4ccccc4,BRD-K52394958-001-02-7,GR-159897,Tocris,1274,GR 159897,-8.246887,x1077,6.037807,active-noncovalent
COC1(CC[NH+](CC1)CCc2c[nH]c3c2cc(cc3)F)C[S@](=O)c4ccccc4,BRD-K52394958-001-03-5,GR-159897,Tocris,1274,GR 159897,-8.246887,x1077,6.037807,active-noncovalent
CC[N+](C)(C)c1cccc(c1)O,BRD-K81128206-003-24-4,edrophonium,MicroSource,2300219,EDROPHONIUM CHLORIDE,-8.246325,x0161,0.311664,active-noncovalent
C[C@@H](Cn1ccc2c1cc(c(c2)F)Cl)[NH3+],BRD-K28007504-051-02-0,Ro-60-0175,Tocris,1854,Ro 60-0175 fumarate,-8.245057,x0161,-0.9094,active-noncovalent
C[C@@H](Cn1ccc2c1cc(c(c2)F)Cl)[NH3+],BRD-K28007504-051-01-2,Ro-60-0175,Tocris,1854,Ro 60-0175 fumarate,-8.245057,x0161,-0.9094,active-noncovalent
CC[NH2+][C@@H](C)Cc1cccc(c1)C(F)(F)F,BRD-K58626373-003-07-8,dexfenfluramine,Prestwick,Prestw-1392,Dexfenfluramine hydrochloride,-8.244839,x0678,-0.227659,active-noncovalent
COc1ccc(cc1)c2c(c3ccc(cc3o2)OC)C(=O)c4ccc(cc4)C#N,BRD-K78637815-001-02-2,LY320135,Tocris,2387,LY 320135,-8.244498,x1392,2.705491,active-covalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1C)C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C,BRD-K43586850-001-02-9,lacidipine,Selleck,S1994,Lacidipine,-8.243956,x0195,5.528185,active-noncovalent
C1CCC2(CC1)CC[NH2+]CC2,BRD-K49545903-003-01-4,"4,4-pentamethylenepiperidine",Tocris,3692,"4,4-Pentamethylenepiperidine hydrochloride",-8.243912,x0678,0.878476,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C,BRD-K15360631-325-01-4,dehydroepiandrosterone-sulfate,Sigma,MFCD11045975,sodium (3beta)-17-oxoandrost-5-en-3-yl sulfate dihydrate,-8.243103,x1077,3.122132,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)NC4CCCC4,BRD-K70088346-001-01-6,2-chloro-N6-cyclopentyladenosine,Tocris,1705,2-Chloro-N6-cyclopentyladenosine,-8.243065,x0946,2.807674,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)NC4CCCC4,BRD-K70088346-001-02-4,2-chloro-N6-cyclopentyladenosine,Tocris,1705,2-Chloro-N6-cyclopentyladenosine,-8.243065,x0946,2.807674,active-noncovalent
c1cc(cc(c1)Cl)N2CC[N@@H+](CC2=O)Cc3cncn3Cc4ccc(cc4)C#N,BRD-K10958118-003-01-5,L-778123,MedChemEx,HY-16273A,L-778123 (hydrochloride),-8.240721,x0161,3.176154,active-noncovalent
C=CCO[C@H](Cn1ccnc1)c2ccc(cc2Cl)Cl,BRD-A11776908-065-01-5,enilconazole,MicroSource,1506067,ENILCONAZOLE SULFATE,-8.240651,x0749,0.585238,active-covalent
CCOC(=O)c1ccccc1OC(=O)N,BRD-K21892374-001-01-6,ethyl-2-(carbamoyloxy)benzoate,Enamine,Z2306534743,ethyl 2-[(aminocarbonyl)oxy]benzoate,-8.240365,x1418,1.655224,active-covalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,BRD-K85090592-003-20-2,pilocarpine,Tocris,694,Pilocarpine hydrochloride,-8.239864,x0107,-0.633509,active-noncovalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,BRD-K85090592-003-18-6,pilocarpine,Selleck,S4231,Pilocarpine HCl,-8.239864,x0107,-0.633509,active-noncovalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,BRD-K85090592-008-22-7,pilocarpine,MicroSource,1500487,PILOCARPINE NITRATE,-8.239864,x0107,-0.633509,active-noncovalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,BRD-K85090592-003-19-4,pilocarpine,Tocris,694,Pilocarpine hydrochloride,-8.239864,x0107,-0.633509,active-noncovalent
CC[C@@H](C)[C@@H](C(=O)NCC[NH+]1CCOCC1)[NH3+],BRD-A04649065-001-01-7,LM11A-31,Enamine,Z393627376,2-amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide,-8.239474,x0434,-0.928098,active-noncovalent
COc1cc(nc(n1)OC)NS(=O)(=O)c2ccc(cc2)N,BRD-K71125014-001-27-1,sulphadimethoxine,MicroSource,1501144,SULFADIMETHOXINE,-8.239340,x1334,1.84898,active-covalent
COc1cc(nc(n1)OC)NS(=O)(=O)c2ccc(cc2)N,BRD-K71125014-001-26-3,sulphadimethoxine,Selleck,S1962,Sulphadimethoxine,-8.239340,x1334,1.84898,active-covalent
CC(C)[NH+](CC[C@](c1ccccc1)(c2ccccn2)C(=O)N)C(C)C,BRD-A29734509-011-12-8,disopyramide,Selleck,S4322,Disopyramide Phosphate,-8.237773,x0874,4.299673,active-noncovalent
CC(C)[NH+](CC[C@](c1ccccc1)(c2ccccn2)C(=O)N)C(C)C,BRD-A29734509-011-13-6,disopyramide,MicroSource,1500261,DISOPYRAMIDE PHOSPHATE,-8.237773,x0874,4.299673,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4)O,BRD-K37890730-001-15-1,camptothecin,Selleck,S1288,Camptothecin,-8.237311,x0161,1.186231,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4)O,BRD-K37890730-001-16-9,camptothecin,Tocris,1100,Camptothecin,-8.237311,x0161,1.186231,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4)O,BRD-K37890730-001-17-7,camptothecin,Selleck,S1288,Camptothecin,-8.237311,x0161,1.186231,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=O)C2)CC3,BRD-K40227168-001-12-9,vinburnine,Enzo,NP088,"Eburnamonine, (-)-",-8.237022,x0195,0.5901,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCC1)c2ccccc2,BRD-K59895502-001-01-9,caramiphen,ChemDiv,4435-0092,,-8.236529,x0195,1.426931,active-noncovalent
c1ccnc(c1)C(=O)Nc2cccc(c2)Cl,BRD-K66527818-001-02-6,VU0364770,Selleck,S2862,VU 0364770,-8.236387,x1093,-0.014686,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@H]([C@@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,BRD-K07940445-310-02-9,quinine,Selleck,S2502,Quinine HCl Dihydrate,-8.236301,x0678,2.337399,active-noncovalent
C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,BRD-K13112821-001-14-1,artemisinin,Tocris,2668,Artemisinin,-8.236082,x0195,1.88803,active-noncovalent
C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,BRD-K13112821-001-17-4,artemisinin,Selleck,S1282,Artemisinin,-8.236082,x0195,1.88803,active-noncovalent
C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,BRD-K13112821-001-18-2,artemisinin,MicroSource,1503042,ARTEMISININ,-8.236082,x0195,1.88803,active-noncovalent
C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,BRD-K13112821-001-16-6,artemisinin,Tocris,2668,Artemisinin,-8.236082,x0195,1.88803,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)([C@H](C=O)O)O,BRD-K35240538-001-26-2,methylprednisolone,MicroSource,1500406,METHYLPREDNISOLONE,-8.234892,x0749,3.335369,active-covalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)([C@H](C=O)O)O,BRD-K35240538-001-25-4,methylprednisolone,Selleck,S1733,Methylprednisolone,-8.234892,x0749,3.335369,active-covalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)([C@H](C=O)O)O,BRD-K35240538-001-24-7,methylprednisolone,Tocris,4819,Methylprednisolone,-8.234892,x0749,3.335369,active-covalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,BRD-A68997559-065-04-5,sisomicin-sulfate,MicroSource,1500536,SISOMICIN SULFATE,-8.234397,x0434,4.924045,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)C[NH2+]C)[NH3+])[NH3+])[NH3+])O,BRD-K18552138-001-01-8,micronomicin,AvaChem,1979,"(1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-D-erythro-hexopyranoside",-8.234350,x0874,4.732576,active-noncovalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)c3ccccc3,BRD-K41853443-001-02-9,"1,3-dipropyl-8-phenylxanthine",Tocris,486,"1,3-Dipropyl-8-phenylxanthine",-8.233935,x0678,0.894229,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(c3ccc(cc3)F)c4ccc(cc4)F,BRD-A85216385-003-02-4,3-alpha-bis-(4-fluorophenyl)-methoxytropane,Tocris,918,3?-Bis-(4-fluorophenyl) methoxytropane hydrochloride,-8.233776,x1077,2.678867,active-noncovalent
c1ccc(c(c1)F)S(=O)(=O)[N@@]2CCOc3c2cccc3N4CC[NH2+]CC4,BRD-K96418224-300-01-8,R-1485,Tocris,4964,R 1485 dihydrochloride,-8.232874,x0072,3.238175,active-noncovalent
CCOc1ccc(cc1)NC(=S)N2CCC(CC2)C(c3ccccc3)(c4ccccc4)O,BRD-K42629487-001-08-6,SF-11,Tocris,3898,SF 11,-8.232600,x1093,4.254228,active-noncovalent
Cc1cccc(c1)Oc2c[nH]c(=O)nc2,BRD-K41772907-001-02-0,tolimidone,Tocris,4582,MLR 1023,-8.230483,x0195,-0.765736,active-noncovalent
Cc1cccc(c1)Oc2c[nH]c(=O)nc2,BRD-K41772907-001-01-2,tolimidone,Axon,1941,,-8.230483,x0195,-0.765736,active-noncovalent
CCOC(=O)C1=C(NC(=C([C@@H]1C#Cc2ccccc2)C(=O)OCc3ccc(cc3)N(=O)=O)c4ccccc4)C,BRD-A06784547-001-02-6,MRS1334,Tocris,1385,MRS 1334,-8.230335,x0161,8.676752,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F,BRD-K55468218-003-02-8,spiperone,Tocris,995,Spiperone hydrochloride,-8.230008,x0434,4.273938,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F,BRD-K55468218-001-26-1,spiperone,MicroSource,1501152,SPIPERONE,-8.230008,x0434,4.273938,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,BRD-A18696154-003-21-8,idazoxan,Tocris,793,Idazoxan hydrochloride,-8.228940,x0195,-1.446433,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,BRD-K70759443-001-01-4,idazoxane,AMS,A001595684,"2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole",-8.228940,x0195,-1.446433,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,BRD-A18696154-003-22-6,idazoxan,MicroSource,1506073,IDAZOXAN HYDROCHLORIDE,-8.228940,x0195,-1.446433,active-noncovalent
C[C@@H](CCCCn1c(=O)c2c(ncn2C)n(c1=O)C)O,BRD-A05334458-001-02-8,lisofylline,Enzo,LP102,Lisofylline,-8.228798,x0195,0.511054,active-noncovalent
C[NH+](C)CCc1ccc(cc1)O,BRD-K93631643-001-03-2,hordenine,Selleck,S2385,Hordenine,-8.228170,x0161,-0.81358,active-noncovalent
C[NH+](C)CCc1ccc(cc1)O,BRD-K93631643-001-02-4,hordenine,Selleck,S2385,Hordenine,-8.228170,x0161,-0.81358,active-noncovalent
c1ccc2c(c1)c3c(o2)c(ncn3)N4CCN(CC4)C(=S)NCc5ccc6c(c5)OCO6,BRD-K66538826-001-07-2,amuvatinib,Selleck,S1244,Amuvatinib (MP-470),-8.228062,x0161,10.121054,active-noncovalent
C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C,BRD-K73201113-001-01-3,octamethyltrisiloxane,Sigma,MFCD00008264,"1,1,1,3,3,5,5,5-octamethyltrisiloxane",-8.226797,x0749,-0.445096,active-covalent
CC(C)(CC(=O)NCCn1ccc2c1c(ncn2)Nc3ccc(c(c3)Cl)Oc4cccc(c4)C(F)(F)F)O,BRD-K80343549-001-02-6,TAK-285,Selleck,S2784,TAK-285,-8.226374,x0161,10.355312,active-noncovalent
C[C@H](C(=O)OC(C)(C)Cc1ccc(cc1)Cl)[NH3+],BRD-A14966924-003-07-7,alaproclate,AlfaAesar,J62741,,-8.226223,x1418,-0.233565,active-covalent
CCOc1ccc2c(c1)C(=CC(N2)(C)C)C,BRD-K56792340-001-13-2,ethoxyquin,Prestwick,Prestw-765,Ethoxyquin,-8.226137,x0195,-0.154035,active-noncovalent
CC(=CCc1c(ccc2c1oc(=O)cc2)OC)C,BRD-K78294846-001-12-4,osthol,Selleck,S2337,Osthole,-8.226069,x0195,-0.379364,active-noncovalent
Cc1c(nc(o1)c2ccccc2)CCC(=O)c3ccc(cc3)Cc4c([nH]c(=O)s4)[O-],BRD-K82908348-001-01-9,darglitazone,Cayman,17681,"5-{4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]benzyl}-1,3-thiazolidine-2,4-dione",-8.225974,x0072,3.44964,active-noncovalent
CC(C)n1cnc2c1nc(nc2NCCc3ccc(cc3)O)c4csc5c4cccc5,BRD-K36739687-001-03-0,stemregenin-1,Selleck,S2858,StemRegenin 1 (SR1),-8.224808,x0831,3.824781,active-covalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]CC3CC[NH+](CC3)Cc4ccc(cc4)C(=O)[O-],BRD-K09223495-001-01-4,GSK2879552,MedChemEx,HY-18632,GSK2879552,-8.224319,x0749,2.698341,active-covalent
C[N@@H+]1C[C@@H](C[C@H]1CCOc2ccccc2CCc3cccc(c3)OC)O,BRD-K15588452-003-02-7,R-96544,Tocris,1742,R-96544 hydrochloride,-8.224092,x0195,3.977313,active-noncovalent
C[N@@H+]1C[C@@H](C[C@H]1CCOc2ccccc2CCc3cccc(c3)OC)O,BRD-K15588452-003-03-5,R-96544,Tocris,1742,R-96544 hydrochloride,-8.224092,x0195,3.977313,active-noncovalent
CCCCCCC(=O)OC1CC([NH2+]C(C1)(C)C)(C)C,BRD-K49119234-003-03-4,TMPH,Tocris,2438,TMPH hydrochloride,-8.223905,x0161,1.288973,active-noncovalent
CCCCCCC(=O)OC1CC([NH2+]C(C1)(C)C)(C)C,BRD-K49119234-003-02-6,TMPH,Tocris,2438,TMPH hydrochloride,-8.223905,x0161,1.288973,active-noncovalent
COc1ccc(cc1)CNC(=O)Nc2ncc(s2)N(=O)=O,BRD-K67860401-001-05-6,AR-A014418,Selleck,S7435,AR-A014418,-8.223884,x0678,1.077857,active-noncovalent
COc1ccc(cc1)CNC(=O)Nc2ncc(s2)N(=O)=O,BRD-K67860401-001-07-2,AR-A014418,Tocris,3966,AR-A 014418,-8.223884,x0678,1.077857,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1c(csc1C(=O)OC)C,BRD-A70514680-003-11-2,articaine,Selleck,S3150,Articaine HCl,-8.223339,x0195,1.082176,active-noncovalent
c1ccc(c(c1)N2CC=C(NC2=O)c3cccc(c3)N(=O)=O)O,BRD-K48869804-001-09-6,icilin,Tocris,1531,Icilin,-8.223249,x0161,2.316718,active-noncovalent
C[C@@H](C(F)(F)F)Oc1ccc(cc1C(=O)N2CCN(CC2)c3c(cc(cn3)C(F)(F)F)F)S(=O)(=O)C,BRD-K13756951-001-01-4,bitopertin,MedChemEx,HY-10809,Bitopertin,-8.223043,x1077,7.232036,active-noncovalent
C[N@H+]1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4,BRD-K30652337-001-01-9,eletriptan,MicroSource,1505819,ELETRIPTAN HYDROBROMIDE,-8.222871,x0874,2.481781,active-noncovalent
C[N@H+]1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4,BRD-K30652337-004-03-9,eletriptan,Tocris,3862,Eletriptan hydrobromide,-8.222871,x0874,2.481781,active-noncovalent
C[N@H+]1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4,BRD-K30652337-004-02-1,eletriptan,Tocris,3862,Eletriptan hydrobromide,-8.222871,x0874,2.481781,active-noncovalent
C[N@H+]1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4,BRD-K30652337-004-01-3,eletriptan,Selleck,S3180,Eletriptan HBr,-8.222871,x0874,2.481781,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCCO5,BRD-K09132007-001-11-7,D-4476,Tocris,2902,D 4476,-8.222851,x0434,6.436473,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCCO5,BRD-K09132007-001-07-5,D-4476,Tocris,2902,D 4476,-8.222851,x0434,6.436473,active-noncovalent
CCO[C@@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)c3ccc(c(c3)Cl)N,BRD-K26712974-001-01-5,VX-765,Selleck,S2228,VX-765,-8.220553,x0967,6.342767,active-noncovalent
CCCCCCCCCCCC(=O)[O-],BRD-K67375056-001-07-9,lauric-acid,Enzo,BL137,Dodecanoic acid (Lauric acid),-8.219894,x0678,-0.009171,active-noncovalent
C[C@H](Cc1ccc(c(c1)OC)OC)[C@@H](C)Cc2ccc(c(c2)OC)OC,BRD-K76788410-001-01-6,terameprocol,Sigma,MFCD11113155,"4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene",-8.218856,x0195,3.542558,active-noncovalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,BRD-A97437073-001-09-8,rosiglitazone,Tocris,5325,Rosiglitazone,-8.218854,x0749,4.618966,active-covalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,BRD-A97437073-050-14-5,rosiglitazone,MicroSource,1504263,ROSIGLITAZONE MALEATE,-8.218854,x0749,4.618966,active-covalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,BRD-A97437073-003-14-4,rosiglitazone,Selleck,S2075,Rosiglitazone HCl,-8.218854,x0749,4.618966,active-covalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,BRD-A97437073-001-08-0,rosiglitazone,Selleck,S2556,Rosiglitazone,-8.218854,x0749,4.618966,active-covalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,BRD-A97437073-050-13-7,rosiglitazone,Selleck,S2505,Rosiglitazone maleate,-8.218854,x0749,4.618966,active-covalent
c1cc2c(cc1OCCCCc3nnnn3C4CCCCC4)CCC(=O)N2,BRD-K67017579-001-26-5,cilostazol,Selleck,S1294,Cilostazol,-8.217163,x1334,6.080779,active-covalent
c1cc2c(cc1OCCCCc3nnnn3C4CCCCC4)CCC(=O)N2,BRD-K67017579-001-28-1,cilostazol,MicroSource,1505230,CILOSTAZOL,-8.217163,x1334,6.080779,active-covalent
c1cc2c(cc1OCCCCc3nnnn3C4CCCCC4)CCC(=O)N2,BRD-K67017579-001-29-9,cilostazol,Tocris,1692,Cilostazol,-8.217163,x1334,6.080779,active-covalent
c1cc2c(cc1OCCCCc3nnnn3C4CCCCC4)CCC(=O)N2,BRD-K67017579-001-27-3,cilostazol,Tocris,1692,Cilostazol,-8.217163,x1334,6.080779,active-covalent
CC[C@H](c1cccc(c1)O)[C@@H](C)C[NH+](C)C,BRD-K25699529-003-01-1,tapentadol,MicroSource,1900050,TAPENTADOL HYDROCHLORIDE,-8.216426,x0749,-1.066239,active-covalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K51768138-001-09-1,lomustine,MedChemEx,HY-13669,Lomustine,-8.215820,x0195,-0.065398,active-noncovalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K51768138-001-07-5,lomustine,Selleck,S1840,Lomustine (CeeNU),-8.215820,x0195,-0.065398,active-noncovalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K51768138-001-10-9,lomustine,MedChemEx,HY-13669,Lomustine,-8.215820,x0195,-0.065398,active-noncovalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K51768138-001-04-2,lomustine,Selleck,S1840,Lomustine,-8.215820,x0195,-0.065398,active-noncovalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K51768138-001-05-9,lomustine,MicroSource,1502301,LOMUSTINE,-8.215820,x0195,-0.065398,active-noncovalent
Cc1cccc(n1)c2c(nc([nH]2)C(C)(C)C)c3ccc4c(c3)OCO4,BRD-K40109029-001-02-9,SB-505124,Selleck,S2186,SB505124,-8.215747,x0678,2.748106,active-noncovalent
CC[NH+](CC)CCOC(=O)[C@@H](c1ccccc1)C2CCCCC2,BRD-A22267103-003-13-1,drofenine,MicroSource,1500999,DROFENINE HYDROCHLORIDE,-8.215308,x1093,1.41107,active-noncovalent
Cc1ccc(o1)CNc2c3cc(ccc3ncn2)c4ccc(o4)CO,BRD-K64835161-001-02-8,ML167,Selleck,S7509,ML167,-8.215120,x0104,2.23357,active-noncovalent
C(CC(=O)[O-])C(=O)C(=O)[O-],BRD-K89712525-001-02-1,2-oxoglutaric-acid,Enamine,Z57127547,,-8.215040,x0397,-0.466179,active-noncovalent
CCCCOc1nc(c2c(n1)[N@](CC(=O)N2)Cc3cccc(c3)C[NH+]4CCCC4)N,BRD-K73585091-001-01-5,GS-9620,MedChemEx,HY-15601,GS-9620,-8.214684,x0874,3.670897,active-noncovalent
CCCCOc1nc(c2c(n1)[N@](CC(=O)N2)Cc3cccc(c3)C[NH+]4CCCC4)N,BRD-K73585091-001-02-3,GS-9620,MedChemEx,HY-15601,GS-9620,-8.214684,x0874,3.670897,active-noncovalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])C(=O)[O-])O,BRD-K61585876-001-01-0,3-carboxy-4-hydroxyphenylglycine-(S),Tocris,329,(S)-3-Carboxy-4-hydroxyphenylglycine,-8.213431,x1412,0.208363,active-covalent
Cc1c(cno1)C(=O)N2CCCCC2,BRD-K43647122-001-01-3,nerbacadol,Enamine,Z228841354,1-[(5-methyl-4-isoxazolyl)carbonyl]piperidine,-8.213220,x0195,-1.249621,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C,BRD-K50265942-001-01-2,mometasone,Sigma,MFCD02683426,"(11beta,16alpha)-9,21-dichloro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione",-8.212431,x0874,4.162085,active-noncovalent
CCN(CCNC(=O)Nc1ccccc1Br)c2cccc(c2)C,BRD-K03665769-001-01-1,SB-452533,Tocris,3265,SB 452533,-8.212340,x0104,1.619724,active-noncovalent
c1ccc2c(c1)CCC/C(=C\C(=O)[O-])/[C@@H]2O,BRD-A85025557-001-02-5,NCS-382,Tocris,780,NCS-382,-8.211833,x0749,-1.300124,active-covalent
CC(C)(C)[C@H](/C=C/c1ccc2c(c1)OCO2)O,BRD-A72441487-001-05-7,stiripentol,Sigma,S6826,"(1E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol",-8.211080,x0749,1.487662,active-covalent
CC[C@]1(CCCC[N@@H+](C1)C)c2cccc(c2)O,BRD-A02710418-003-11-8,meptazinol,Selleck,S3204,Meptazinol HCl,-8.210585,x0161,0.69831,active-noncovalent
CC[C@]1(CCCC[N@@H+](C1)C)c2cccc(c2)O,BRD-A02710418-003-12-6,meptazinol,Selleck,S3204,Meptazinol HCl,-8.210585,x0161,0.69831,active-noncovalent
CC[C@]1(CCCC[N@@H+](C1)C)c2cccc(c2)O,BRD-A02710418-003-13-4,meptazinol,Tocris,3636,Meptazinol hydrochloride,-8.210585,x0161,0.69831,active-noncovalent
CCOc1cc(c(cc1OCC)OCC)C(=O)CCC(=O)[O-],BRD-K37543758-001-01-3,trepibutone,AvaChem,1611,"4-oxo-4-(2,4,5-triethoxyphenyl)butanoic acid",-8.210217,x0678,1.678268,active-noncovalent
COc1cc(cc(c1O)C(=O)NCCO)CC=C,BRD-K60102752-001-02-2,alibendol,Selleck,S1928,Alibendol,-8.210127,x0678,-1.000929,active-noncovalent
C[NH+]1[C@@H]2CC[C@@H]1CC(C2)OC(c3ccccc3)c4ccccc4,BRD-K48061146-066-01-7,benztropine-mesylate,Selleck,S3163,Benztropine mesylate,-8.210074,x0072,0.539846,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N,BRD-K52313696-001-12-3,tacedinaline,Selleck,S2818,CI994 (Tacedinaline),-8.209475,x1093,5.084809,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N,BRD-K52313696-001-14-9,tacedinaline,Tocris,2952,CI 994,-8.209475,x1093,5.084809,active-noncovalent
CC1(Cc2cc(c(cc2-c3n1c4c(c3)nc5ccccc5n4)OC)OC)C,BRD-K06712146-001-02-0,YM-90709,Tocris,1675,YM 90709,-8.208828,x0161,4.904428,active-noncovalent
CC1(Cc2cc(c(cc2-c3n1c4c(c3)nc5ccccc5n4)OC)OC)C,BRD-K06712146-001-03-8,YM-90709,MedChemEx,HY-19969,YM-90709,-8.208828,x0161,4.904428,active-noncovalent
c1ccc(cc1)[C@@H](c2ccccn2)/N=N/c3ccc(cn3)Cl,BRD-K76180386-001-03-2,JIB04,Tocris,4972,JIB 04,-8.208703,x0749,1.674938,active-covalent
c1ccc(cc1)[C@@H](c2ccccn2)/N=N/c3ccc(cn3)Cl,BRD-K76180386-001-02-4,JIB04,Selleck,S7281,JIB04 (NSC693627),-8.208703,x0749,1.674938,active-covalent
c1ccc(cc1)[C@@H](c2ccccn2)/N=N/c3ccc(cn3)Cl,BRD-K76180386-001-01-6,JIB04,Selleck,S7281,JIB-04,-8.208703,x0749,1.674938,active-covalent
Cc1cc(=O)c2c(o1)c(c3c(c2OC)cco3)OC,BRD-K80353807-001-25-3,khellin,Sigma,60730,"4,9-dimethoxy-7-methyl-5H-furo[3,2-g]chromen-5-one",-8.208635,x0195,1.815673,active-noncovalent
Cc1cc(=O)c2c(o1)c(c3c(c2OC)cco3)OC,BRD-K80353807-001-24-6,khellin,MicroSource,210866,KHELLIN,-8.208635,x0195,1.815673,active-noncovalent
c1cc(c(cc1C(F)(F)F)NC(=O)Nc2cc(ccc2[O-])C(F)(F)F)[O-],BRD-K73738482-001-02-5,NS-1643,Tocris,3062,NS 1643,-8.208409,x0874,6.375517,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=C2)C(=O)OCC)CC3,BRD-K53318339-001-24-9,vinpocetine,MicroSource,1503115,VINPOCETINE,-8.208232,x0195,3.441494,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=C2)C(=O)OCC)CC3,BRD-K53318339-001-23-1,vinpocetine,Tocris,757,Vinpocetine,-8.208232,x0195,3.441494,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=C2)C(=O)OCC)CC3,BRD-K53318339-001-26-4,vinpocetine,Selleck,S2110,Vinpocetine (Cavinton),-8.208232,x0195,3.441494,active-noncovalent
CCc1c([nH]c(=O)[nH]1)C(=O)c2ccncc2,BRD-K71977764-001-01-2,piroximone,Enamine,Z2306534716,"4-ethyl-5-isonicotinoyl-1,3-dihydro-2H-imidazol-2-one",-8.207845,x1382,-1.622733,active-covalent
Cc1nc2cnccc2n1Cc3ccc(cc3F)C(=O)c4cn(c5c4c(ccc5)C#C)C(=O)N(C)C,BRD-K97233161-003-01-5,ABT-491,EMDBio,511071-2MG,"PAF Receptor Antagonist, ABT-491",-8.207167,x1077,6.756321,active-noncovalent
CCC(=O)O[C@@H]1CC[C@H]2[C@@]1(CC[C@@H]3[C@@H]2CC[C@@H]4[C@]3(C[C@@H](C(=O)C4)C)C)C,BRD-A38706605-001-01-2,dromostanolone-propionate,ANpharma,AN-45527,2-methyl-3-oxoandrostan-17-yl propionate,-8.206539,x0072,3.029767,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCC1)c2ccc(cc2)N(=O)=O,BRD-K28453807-003-11-2,nitrocaramiphen,Tocris,469,Nitrocaramiphen hydrochloride,-8.206180,x0195,1.680877,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC(C)(C)CO,BRD-K65786282-001-08-3,CGP-7930,Tocris,1513,CGP 7930,-8.206158,x0195,0.816551,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC(C)(C)CO,BRD-K65786282-001-07-5,CGP-7930,Tocris,1513,CGP 7930,-8.206158,x0195,0.816551,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ncccn2,BRD-K88405679-003-03-1,thonzylamine,MicroSource,1503135,THONZYLAMINE HYDROCHLORIDE,-8.206113,x0874,1.598924,active-noncovalent
C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,BRD-K62277907-001-01-6,PYM50028,Enzo,NP272,Sarsasapogenin,-8.205397,x0678,4.952915,active-noncovalent
CCCCN(CC)c1c2c(c(n(c2nc(n1)C)c3c(cc(cc3C)C)C)C)C,BRD-K01363385-003-01-5,antalarmin,Tocris,2778,Antalarmin hydrochloride,-8.204543,x0104,8.0587,active-noncovalent
c1cc(sc1)c2cc(no2)C(=O)NC3CC3,BRD-K53903639-001-04-7,ISX-9,Tocris,4439,ISX 9,-8.204162,x0161,-0.192758,active-noncovalent
c1ccc2c(c1)cc(s2)C(=O)[O-],BRD-K75282704-001-02-4,BL-5583,Enamine,Z89265777,,-8.203632,x0195,-1.283081,active-noncovalent
COC(=O)/C=C/C(=O)OCCn1c(ccc1O)O,BRD-K87386013-001-01-7,diroximel-fumarate,WuXi,WXC04774,,-8.203455,x0195,0.722878,active-noncovalent
CCCCCCCC/C=C\CCCCCC[C@H](C(=O)[O-])O,BRD-A74347210-001-01-7,minerval,Sigma,SML0256,(9Z)-2-hydroxy-9-octadecenoic acid,-8.203146,x0831,1.388611,active-covalent
C[C@@H](c1ccccc1)NC(=O)[C@@H]2CSCN2C(=O)c3ccccc3,BRD-A00055058-001-01-0,RS-0481,Enamine,Z102844102,3-benzoyl-N-(1-phenylethyl)thiazolidine-4-carboxamide,-8.202857,x0104,1.867791,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-015-12-7,gossypol,Selleck,S2812,AT101,-8.201283,x1077,6.186256,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-015-14-3,gossypol,Selleck,S2303,Gossypol Acetate,-8.201283,x1077,6.186256,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-001-17-6,gossypol,Tocris,3367,AT 101,-8.201283,x1077,6.186256,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-001-16-8,gossypol,Tocris,3367,AT 101,-8.201283,x1077,6.186256,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-015-13-5,gossypol,Selleck,S2812,AT101,-8.201283,x1077,6.186256,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,BRD-K19295594-001-15-0,gossypol,Selleck,S2303,Gossypol,-8.201283,x1077,6.186256,active-noncovalent
CCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,BRD-K50938786-003-11-8,ropivacaine,Selleck,S4058,Ropivacaine HCl,-8.200874,x0434,0.253987,active-noncovalent
CC(C)(C)c1ccc(cc1)/C(=C/C(=O)c2ccc(cc2)OC)/O,BRD-K14401183-001-11-5,avobenzone,MicroSource,1504190,AVOBENZONE,-8.198940,x0161,2.582972,active-noncovalent
CC(C)(C)c1ccc(cc1)/C(=C/C(=O)c2ccc(cc2)OC)/O,BRD-K14401183-001-10-7,avobenzone,Selleck,S1904,Avobenzone,-8.198940,x0161,2.582972,active-noncovalent
Cc1cccc(n1)c2c([nH]c(n2)CNc3ccccc3F)c4ccc5ncnn5c4,BRD-K74396648-001-01-4,EW-7197,Selleck,S7530,EW-7197,-8.198914,x0874,3.937001,active-noncovalent
COc1ccc(cc1OC2CCCC2)C3(CCC(CC3)C(=O)[O-])C#N,BRD-K38473998-001-02-0,cilomilast,Selleck,S1455,Cilomilast,-8.198668,x0749,3.096292,active-covalent
Cc1nc2ccsc2c(n1)Nc3c4c(n[nH]3)C(N(C4)C(=O)N[C@H](C[NH+](C)C)c5ccccc5)(C)C,BRD-K37764012-001-04-1,PF-03758309,MedChemEx,HY-13007,PF-3758309,-8.198112,x0161,10.268263,active-noncovalent
[2H]C([2H])([2H])C(CCO[C@@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)(C([2H])([2H])[2H])O,BRD-K81332461-001-01-4,maxacalcitol,MedChemEx,HY-15329,Maxacalcitol-D6,-8.197425,x0874,6.074526,active-noncovalent
CC[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[C@@H]4c5cc(c(cc5CC[NH2+]4)OC)OC)OC)OC,BRD-K03067624-001-02-3,emetine,Selleck,S4323,Emetine,-8.197369,x0434,9.285647,active-noncovalent
c1ccc(cc1)CCCc2c(=O)[nH]c3ccc(cc3n2)C(=O)NO,BRD-K19958299-001-01-1,TCS-2210,Tocris,3877,TCS 2210,-8.197081,x0195,0.789852,active-noncovalent
Cc1c(c2ccccc2n1CC[NH+]3CCOCC3)C(=O)c4ccc(cc4)OC,BRD-K46209126-001-06-4,pravadoline,Cayman,10006973,(4-methoxyphenyl){2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl}methanone,-8.196087,x0072,4.85544,active-noncovalent
Cc1cc(sc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-A87125127-001-02-2,3-MATIDA,Tocris,2196,3-MATIDA,-8.195889,x1418,-1.912475,active-covalent
C(CSSCCNC(=[NH2+])N)NC(=[NH2+])N,BRD-K69191882-065-01-6,guanidinoethyldisulfide-bicarbonate,TygerSci,G67400,N-[2-(2-Guanidino-ethyldisulfanyl)-ethyl]guanidine H2SO4,-8.194515,x1334,-0.183869,active-covalent
c1ccc2c(c1)cc(s2)C3(CCCCC3)[NH+]4CCCCC4,BRD-K15519488-050-02-1,CS-110266,Tocris,702,BTCP maleate,-8.194106,x0434,1.416575,active-noncovalent
c1ccc2c(c1)cc(s2)C3(CCCCC3)[NH+]4CCCCC4,BRD-K15519488-050-01-3,CS-110266,Tocris,702,BTCP maleate,-8.194106,x0434,1.416575,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)N3CCCC3=O)O)C,BRD-K24526313-001-18-5,levcromakalim,Sigma,MFCD00133201,"(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-3,4-dihydro-2H-chromene-6-carbonitrile",-8.192831,x0195,0.408461,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)N3CCCC3=O)O)C,BRD-K24526313-001-17-7,levcromakalim,Tocris,1378,Levcromakalim,-8.192831,x0195,0.408461,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)N3CCCC3=O)O)C,BRD-M89827113-001-01-5,cromakalim,Tocris,1377,Cromakalim,-8.192831,x0195,0.408461,active-noncovalent
CCC1(C(=O)NCNC1=O)c2ccccc2,BRD-K32247306-001-27-8,primidone,Selleck,S1965,Primidone,-8.191757,x0678,0.406458,active-noncovalent
CCC1(C(=O)NCNC1=O)c2ccccc2,BRD-K32247306-001-28-6,primidone,Tocris,830,Primidone,-8.191757,x0678,0.406458,active-noncovalent
CCC1(C(=O)NCNC1=O)c2ccccc2,BRD-K32247306-001-29-4,primidone,MicroSource,1500501,PRIMIDONE,-8.191757,x0678,0.406458,active-noncovalent
CCNC(=O)c1c(c(on1)c2cc(c(cc2O)O)C(C)C)c3ccc(cc3)C[NH+]4CCOCC4,BRD-K41859756-001-09-2,NVP-AUY922,MedChemEx,HY-10215,NVP-AUY922,-8.191033,x1077,6.007355,active-noncovalent
CCNC(=O)c1c(c(on1)c2cc(c(cc2O)O)C(C)C)c3ccc(cc3)C[NH+]4CCOCC4,BRD-K41859756-001-06-8,NVP-AUY922,Selleck,S1069,AUY922 (NVP-AUY922),-8.191033,x1077,6.007355,active-noncovalent
CCNC(=O)c1c(c(on1)c2cc(c(cc2O)O)C(C)C)c3ccc(cc3)C[NH+]4CCOCC4,BRD-K41859756-001-08-4,NVP-AUY922,Selleck,S1069,"Luminespib (AUY-922, NVP-AUY922)",-8.191033,x1077,6.007355,active-noncovalent
c1cc(c(c2c1c(c([nH]2)O)N=O)Cl)Cl,BRD-K37602296-001-01-6,NS-309,Tocris,3895,NS 309,-8.190699,x1385,-1.012595,active-covalent
c1cc(c(cc1NC(=O)c2ccc(cn2)F)[C@]34COC[C@@H]3CSC(=[NH+]4)N)F,BRD-K17953908-001-01-7,LY2886721,Selleck,S2156,LY2886721,-8.190559,x0678,4.464283,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O,BRD-K05850076-001-01-5,sotagliflozin,MedChemEx,HY-15516,LX-4211,-8.190347,x0161,2.749021,active-noncovalent
CCn1c2c(cncc2nc1c3c(non3)N)C[NH2+]C4CC[NH2+]CC4,BRD-K49597925-300-01-9,SB-747651A,Tocris,4630,SB 747651A dihydrochloride,-8.190108,x0678,2.935771,active-noncovalent
CCC[C@@H](C(=O)[O-])[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-],BRD-K00768353-001-01-8,perindoprilat,MicroSource,1504316,PERINDOPRILAT,-8.189720,x0830,1.833617,active-covalent
CC(C)Cn1c2c(c(=O)n(c1=O)C)[nH]c(n2)COC,BRD-K56077740-001-09-2,MMPX,Tocris,552,MMPX,-8.189321,x0678,-0.644452,active-noncovalent
CCCCOC(=O)c1ccc(cc1)N,BRD-K27217864-001-22-3,butamben,MicroSource,1500767,BUTAMBEN,-8.188950,x0678,-0.401835,active-noncovalent
c1cn(cc(c1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],BRD-K67642028-001-03-6,mimosine,Enzo,CC102,"Mimosine, L-",-8.187805,x0107,-1.885106,active-noncovalent
c1cn(cc(c1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],BRD-K98151021-001-01-2,L-mimosine,Sigma,MFCD00075909,(2S)-2-amino-3-(3-hydroxy-4-oxo-1(4H)-pyridinyl)propanoic acid,-8.187805,x0107,-1.885106,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)CNC(=O)c2ccc(c(c2)OC)OC,BRD-K96740444-001-02-1,itopride,MicroSource,1502353,ITOPRIDE  HYDROCHLORIDE,-8.187288,x0161,5.82036,active-noncovalent
Cc1ccc(cc1O)C(C)C,BRD-K15541734-001-02-0,antioxine,Sigma,42632,5-isopropyl-2-methylphenol,-8.187159,x0195,0.604017,active-noncovalent
Cc1ccc(cc1O)C(C)C,BRD-K15541734-001-01-2,antioxine,Enamine,Z104496566,,-8.187159,x0195,0.604017,active-noncovalent
COc1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K87492696-001-16-5,sulfameter,MicroSource,1501155,SULFAMETER,-8.186386,x0072,0.138375,active-noncovalent
COc1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,BRD-K87492696-001-15-7,sulfameter,Selleck,S1618,Sulfameter,-8.186386,x0072,0.138375,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CC(=O)N)O,BRD-K44993696-001-13-1,atenolol-(-),Sigma,MFCD00074918,2-(4-{[(2S)-2-hydroxy-3-(isopropylamino)propyl]oxy}phenyl)acetamide,-8.186227,x0104,0.411835,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CC(=O)N)O,BRD-A20239487-001-25-6,atenolol-(+/-),MicroSource,1501127,ATENOLOL,-8.186227,x0104,0.411835,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CC(=O)N)O,BRD-K44993696-001-12-3,atenolol-(-),Tocris,393,(S)-(-)-Atenolol,-8.186227,x0104,0.411835,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CC(=O)N)O,BRD-A20239487-001-24-9,atenolol-(+/-),Tocris,387,(RS)-Atenolol,-8.186227,x0104,0.411835,active-noncovalent
c1cc2c(cc1OS(=O)(=O)N)oc(=O)c3c2CCCCC3,BRD-K87777313-001-02-2,irosustat,Sigma,S1950,"6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate",-8.184781,x0072,2.629883,active-noncovalent
c1ccc(cc1)C2=NCC(=O)Nc3c2c4c(s3)CCCC4,BRD-K89490285-001-08-1,bentazepam,Asinex,ASN 03222017,"5-phenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e][1,4]diazepin-2-one",-8.184340,x0072,0.731878,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)SC)OC)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K26619122-001-02-1,thiocolchicoside,Prestwick,Prestw-539,Thiocolchicoside,-8.184196,x1077,10.367887,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Cl)Cl,BRD-K17075857-001-17-6,chloroxine,MicroSource,1503202,CHLOROXINE,-8.184093,x0195,-1.56939,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Cl)Cl,BRD-K17075857-001-18-4,chloroxine,Selleck,S1839,Chloroxine,-8.184093,x0195,-1.56939,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Cl)Cl,BRD-K17075857-001-16-8,chloroxine,Selleck,S1839,Chloroxine,-8.184093,x0195,-1.56939,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)[O-])C)C(=O)[O-],BRD-K16898998-001-01-6,bevirimat-dimeglumine,MedChemEx,HY-N0842,Bevirimat,-8.183790,x0104,14.073778,active-noncovalent
CC(=O)N[C@H](Cc1ccc(cc1)O)C(=O)[O-],BRD-A24857382-001-03-4,N-acetyl-tyrosine,Enamine,Z239130480,,-8.182658,x0161,-0.897919,active-noncovalent
Cc1cc2c(cc1Cl)nc(s2)NC(=O)Cc3ccccc3,BRD-K47409078-001-01-8,LH846,MedChemEx,HY-15704,LH846,-8.182569,x0161,2.048667,active-noncovalent
Cc1cc2c(cc1Cl)nc(s2)NC(=O)Cc3ccccc3,BRD-K47409078-001-02-6,LH846,Tocris,4896,LH 846,-8.182569,x0161,2.048667,active-noncovalent
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K45245728-335-01-4,ursodeoxycholyltaurine,Enzo,AC2330,Tauroursodeoxy cholic acid dihydrate,-8.182104,x0104,7.961321,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2CCC[NH+]4CCN(CC4)CCO,BRD-K43786866-300-02-3,opipramol,Prestwick,Prestw-1456,Opipramol dihydrochloride,-8.182003,x0434,1.247712,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-065-05-3,neomycin-sulfate,Selleck,S2568,Neomycin sulfate,-8.181787,x0395,11.683975,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-326-01-8,neomycin,MedChemEx,HY-B0470,Neomycin (sulfate),-8.181787,x0395,11.683975,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-326-02-6,neomycin,MedChemEx,HY-B0470,Neomycin (sulfate),-8.181787,x0395,11.683975,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-065-04-6,neomycin,Selleck,S2568,Neomycin sulfate,-8.181787,x0395,11.683975,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-326-03-4,neomycin-sulfate,MicroSource,1500427,NEOMYCIN TRISULFATE,-8.181787,x0395,11.683975,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K71013094-001-02-5,neomycin,Sigma,MFCD00242602,"(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside",-8.181787,x0395,11.683975,active-noncovalent
CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C,BRD-A29731977-001-04-5,17-hydroxyprogesterone-caproate,MicroSource,1500343,HYDROXYPROGESTERONE CAPROATE,-8.181354,x0874,4.185933,active-noncovalent
CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC,BRD-A93963402-001-01-6,prednicarbate,MicroSource,1503876,PREDNICARBATE,-8.180903,x0104,7.244973,active-noncovalent
CC(C)(C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O)O,BRD-K82027074-001-08-3,2-hydroxyflutamide,Sigma,MFCD00563126,2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,-8.178343,x0195,0.648114,active-noncovalent
CC(C)(C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O)O,BRD-K82027074-001-07-5,2-hydroxyflutamide,Enamine,Z1603855929,,-8.178343,x0195,0.648114,active-noncovalent
c1cc(c(cc1N)O)C(=O)[O-],BRD-K80267133-001-18-5,aminosalicylate,Selleck,S4073,Sodium 4-Aminosalicylate,-8.178270,x0678,1.585292,active-noncovalent
c1cc(c(cc1N)O)C(=O)[O-],BRD-K80267133-001-17-7,aminosalicylate,MicroSource,1500116,AMINOSALICYLATE SODIUM,-8.178270,x0678,1.585292,active-noncovalent
c1cc(c(cc1N)O)C(=O)[O-],BRD-K80267133-001-19-3,aminosalicylate,Selleck,S4073,Aminosalicylate Sodium,-8.178270,x0678,1.585292,active-noncovalent
CC(C)(Cc1ccc2ccccc2c1)[NH2+]C[C@H](COc3cccc(c3C#N)Cl)O,BRD-K75506300-003-01-2,NPS-2143,Tocris,3626,NPS 2143 hydrochloride,-8.176714,x0161,2.954873,active-noncovalent
CC(C)(Cc1ccc2ccccc2c1)[NH2+]C[C@H](COc3cccc(c3C#N)Cl)O,BRD-K75506300-001-01-6,NPS-2143,Selleck,S2633,NPS-2143,-8.176714,x0161,2.954873,active-noncovalent
C1CCC2(CC1)OC[C@H](O2)C[NH+]=C(N)N,BRD-A14262390-065-01-8,guanadrel,MicroSource,1505544,GUANADREL SULFATE,-8.176382,x1334,-0.197923,active-covalent
CNC(=O)c1cccc(c1)NCC(=O)NCCc2ccc(c(c2)OC)OC,BRD-K47371940-001-01-6,ecabapide,Enamine,Z52799962,,-8.176240,x0104,3.697738,active-noncovalent
CC(=CCC/C(=C/CNCC[NH2+]C1C2CC3CC(C2)CC1C3)/C)C,BRD-A08772153-001-02-4,SQ-109,MedChemEx,HY-14989,SQ109,-8.176208,x0104,2.241235,active-noncovalent
CC(=CCC/C(=C/CNCC[NH2+]C1C2CC3CC(C2)CC1C3)/C)C,BRD-A08772153-001-01-6,SQ-109,MedChemEx,HY-14989,SQ109,-8.176208,x0104,2.241235,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,BRD-A10977446-001-13-9,carvedilol,Tocris,2685,Carvedilol,-8.175734,x0195,3.439154,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,BRD-A10977446-001-12-1,carvedilol,Selleck,S1831,Carvedilol,-8.175734,x0195,3.439154,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,BRD-A10977446-001-17-0,carvedilol,Tocris,2685,Carvedilol,-8.175734,x0195,3.439154,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,BRD-A10977446-011-01-3,carvedilol,MicroSource,1504417,CARVEDILOL PHOSPHATE,-8.175734,x0195,3.439154,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,BRD-A10977446-001-14-7,carvedilol,MicroSource,1504257,CARVEDILOL,-8.175734,x0195,3.439154,active-noncovalent
B1(c2ccc(cc2CO1)F)O,BRD-K76713213-001-02-1,tavaborole,MedChemEx,HY-10980,AN-2690,-8.175386,x0195,1.199646,active-noncovalent
B1(c2ccc(cc2CO1)F)O,BRD-K76713213-001-01-3,tavaborole,MedChemEx,HY-10980,AN-2690,-8.175386,x0195,1.199646,active-noncovalent
COc1cc(c(c(c1)OC)C(=O)CCC[NH+]2CCCC2)OC,BRD-K19462402-003-24-6,buflomedil,MicroSource,1505992,BUFLOMEDIL HYDROCHLORIDE,-8.175121,x0946,1.132615,active-noncovalent
COc1cc(c(c(c1)OC)C(=O)CCC[NH+]2CCCC2)OC,BRD-K19462402-003-23-8,buflomedil,Selleck,S2607,Buflomedil HCl,-8.175121,x0946,1.132615,active-noncovalent
c1c(c(cc(c1N2CC2)N(=O)=O)N(=O)=O)C(=O)N,BRD-K08748705-001-08-2,tretazicar,Sigma,MFCD00869490,"5-(1-aziridinyl)-2,4-dinitrobenzamide",-8.174968,x0195,1.051433,active-noncovalent
c1cc2c(cc1[C@@H]3[C@H]4CO[C@@H]([C@H]4CO3)c5ccc6c(c5)OCO6)OCO2,BRD-K11631773-001-11-6,sesamin,Selleck,S2392,Sesamin,-8.174314,x0195,3.392811,active-noncovalent
c1cc2c(cc1[C@@H]3[C@H]4CO[C@@H]([C@H]4CO3)c5ccc6c(c5)OCO6)OCO2,BRD-K11631773-001-10-8,sesamin,Selleck,S2392,Sesamin (Fagarol),-8.174314,x0195,3.392811,active-noncovalent
CCCSc1ccc2c(c1)nc([nH]2)NC(=O)OC,BRD-K79131256-001-18-7,albendazole,MicroSource,1503903,ALBENDAZOLE,-8.174183,x0195,0.855212,active-noncovalent
CCCSc1ccc2c(c1)nc([nH]2)NC(=O)OC,BRD-K79131256-001-17-9,albendazole,Selleck,S1640,Albendazole,-8.174183,x0195,0.855212,active-noncovalent
c1ccc(cc1)C(=NOCC[N@H+]2CCC=C(C2)C(=O)[O-])c3ccccc3,BRD-K42221274-003-08-5,NNC-711,Tocris,1779,NNC 711,-8.173513,x0072,2.371169,active-noncovalent
c1ccc(cc1)C(=NOCC[N@H+]2CCC=C(C2)C(=O)[O-])c3ccccc3,BRD-K42221274-003-07-7,NNC-711,Tocris,1779,NNC 711,-8.173513,x0072,2.371169,active-noncovalent
c1cc(ncc1C(=O)[O-])SSc2ccc(cn2)C(=O)[O-],BRD-K26530649-001-01-6,carboxypyridine-disulfide,Sigma,MFCD00006454,"6,6'-disulfanediyldinicotinic acid",-8.172651,x0678,0.201645,active-noncovalent
COc1cc(c(c(c1)OC)/C=C/2\c3ccccc3NC2=O)OC,BRD-K09638361-001-03-0,IC261,MedChemEx,HY-12774,IC261,-8.171141,x0195,3.727551,active-noncovalent
COc1cc(c(c(c1)OC)/C=C/2\c3ccccc3NC2=O)OC,BRD-K09638361-001-02-2,IC261,MedChemEx,HY-12774,IC261,-8.171141,x0195,3.727551,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@](O2)(CO)CCl)O)F,BRD-K21415491-001-01-4,ALS-8176,MedChemEx,HY-12983,ALS-8176 (active form),-8.170980,x0195,1.102131,active-noncovalent
CC[C@@H]1Cn2c(c-3nc(nc3n(c2=O)C)c4ccccc4)N1,BRD-K10177585-003-02-4,PSB-11,Tocris,2012,PSB 11 hydrochloride,-8.170166,x0195,1.430011,active-noncovalent
CC[C@@H]1Cn2c(c-3nc(nc3n(c2=O)C)c4ccccc4)N1,BRD-K10177585-003-03-2,PSB-11,Tocris,2012,PSB 11 hydrochloride,-8.170166,x0195,1.430011,active-noncovalent
c1c(cc(c(c1Sc2cc(cc(c2O)Cl)Cl)O)Cl)Cl,BRD-K39120595-304-04-7,bithionol,MicroSource,1500148,BITHIONATE SODIUM,-8.169826,x0161,-0.568085,active-noncovalent
C[C@@H](C(=O)N1CCC[C@H]1C(=O)[O-])[NH2+][C@@H](CCc2ccccc2)C(=O)[O-],BRD-K99447003-335-04-1,enalaprilat,Selleck,S1657,Enalaprilat dihydrate,-8.169508,x1392,2.496611,active-covalent
C[C@@H](C(=O)N1CCC[C@H]1C(=O)[O-])[NH2+][C@@H](CCc2ccccc2)C(=O)[O-],BRD-K99447003-335-06-6,enalaprilat,MedChemEx,HY-B0231,Enalaprilat (dihydrate),-8.169508,x1392,2.496611,active-covalent
C[C@@H](C(=O)N1CCC[C@H]1C(=O)[O-])[NH2+][C@@H](CCc2ccccc2)C(=O)[O-],BRD-K99447003-335-05-8,enalaprilat,MedChemEx,HY-B0231,Enalaprilat (dihydrate),-8.169508,x1392,2.496611,active-covalent
C[C@@H](C(=O)N1CCC[C@H]1C(=O)[O-])[NH2+][C@@H](CCc2ccccc2)C(=O)[O-],BRD-K99447003-335-03-3,enalaprilat,MicroSource,1503833,ENALAPRILAT,-8.169508,x1392,2.496611,active-covalent
C[C@@H](C(=O)N1CCC[C@H]1C(=O)[O-])[NH2+][C@@H](CCc2ccccc2)C(=O)[O-],BRD-K99447003-335-02-5,enalaprilat,Selleck,S1657,Enalaprilat Dihydrate,-8.169508,x1392,2.496611,active-covalent
Cc1cc(nc(n1)c2ccc(cc2)Br)NCCO,BRD-K07656463-001-01-5,AS-1269574,Tocris,4177,AS 1269574,-8.169496,x0434,0.515834,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Cl)O)F,BRD-K67783091-001-26-1,haloperidol,MicroSource,1500325,HALOPERIDOL,-8.169347,x0874,2.848721,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Cl)O)F,BRD-K67783091-003-07-7,haloperidol,Tocris,931,Haloperidol hydrochloride,-8.169347,x0874,2.848721,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Cl)O)F,BRD-K67783091-001-25-3,haloperidol,Selleck,S1920,Haloperidol,-8.169347,x0874,2.848721,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,BRD-K68507560-003-25-3,dicycloverine,MicroSource,1500240,DICYCLOMINE HYDROCHLORIDE,-8.167810,x0195,0.652623,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,BRD-K68507560-003-24-6,dicycloverine,Selleck,S4373,Dicyclomine HCl,-8.167810,x0195,0.652623,active-noncovalent
C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C,BRD-K44942604-346-04-7,pentolinium,Prestwick,Prestw-188,Pentolinium bitartrate,-8.166785,x0749,-0.226975,active-covalent
C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C,BRD-K44942604-346-05-4,pentolinium,Acros,38802,,-8.166785,x0749,-0.226975,active-covalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(cc1Cl)O)O,BRD-A07164067-001-01-2,meluadrine,MedChemEx,HY-50291,HOKU-81,-8.166273,x0678,-1.519167,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc3ccc(c(c3)N(=O)=O)F,BRD-A50737080-001-05-5,CGK-733,Selleck,S7136,CGK 733,-8.166167,x0195,8.25348,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc3ccc(c(c3)N(=O)=O)F,BRD-A50737080-001-02-2,CGK-733,Selleck,S7136,CGK 733,-8.166167,x0195,8.25348,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc3ccc(c(c3)N(=O)=O)F,BRD-A50737080-001-03-0,CGK-733,Tocris,2639,CGK 733,-8.166167,x0195,8.25348,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc3ccc(c(c3)N(=O)=O)F,BRD-A50737080-001-06-3,CGK-733,Tocris,2639,CGK 733,-8.166167,x0195,8.25348,active-noncovalent
CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCc2cccc(c2)Oc3ccccc3)C,BRD-A22106989-001-06-8,phenothrin,MicroSource,1504098,PHENOTHRIN,-8.165730,x0072,3.463867,active-noncovalent
CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCc2cccc(c2)Oc3ccccc3)C,BRD-A22106989-001-05-0,phenothrin,Selleck,S4364,Phenothrin,-8.165730,x0072,3.463867,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,BRD-K71772032-315-01-7,sisomicin,AvaChem,3048,"4,6-diamino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)pentopyranoside",-8.165520,x1077,3.807878,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,BRD-K71772032-315-02-5,sisomicin,MedChemEx,HY-B1222,Sisomicin (sulfate),-8.165520,x1077,3.807878,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,BRD-K71772032-001-01-3,sisomicin,MedChemEx,HY-B1222,Sisomicin (sulfate),-8.165520,x1077,3.807878,active-noncovalent
CN(Cc1cccc(c1)c2ccccc2)C(=O)Oc3ccc(cc3)c4ccc(cc4)C(=O)N,BRD-K83176916-001-01-4,WWL-123,Tocris,5317,WWL 123,-8.165477,x0161,9.182288,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO)N,BRD-K84794093-001-07-5,dideoxyadenosine,Berry,PR 3495,,-8.165439,x1334,-0.410805,active-covalent
CC(C)(C)[NH2+]C[C@@H](c1ccccc1Cl)O,BRD-A37441042-003-04-8,tulobuterol,MicroSource,1503954,TULOBUTEROL HYDROCHLORIDE,-8.163395,x0195,-1.238242,active-noncovalent
CCc1cnn2c1nc(cc2NCc3cccn(=O)c3)N4CCCC[C@H]4CCO,BRD-K13662825-001-07-5,dinaciclib,Selleck,S2768,Dinaciclib (SCH727965),-8.163247,x1077,3.285891,active-noncovalent
COc1cc(ccc1O)C(=S)N2CCOCC2,BRD-K26502378-001-07-9,vanitiolide,MicroSource,1504348,VANITIOLIDE,-8.162444,x0749,0.329497,active-covalent
[H]/N=C(/N)\Nc1nc(cs1)c2c[nH+]c([nH]2)C,BRD-K12261274-001-01-6,zaltidine,MedChemEx,HY-15541,Zaltidine,-8.161084,x1093,-0.459382,active-noncovalent
[H]/N=C(/N)\Nc1nc(cs1)c2c[nH+]c([nH]2)C,BRD-K12261274-001-02-4,zaltidine,MedChemEx,HY-15541,Zaltidine,-8.161084,x1093,-0.459382,active-noncovalent
C[NH2+]CC[N@@](Cc1c([nH]nc1)c2ccc(cc2)O[C@H]3C[C@@H](C3)OCCC4CCOCC4)C,BRD-K33586289-003-02-8,EPZ020411,MedChemEx,HY-12970A,EPZ020411 (hydrochloride),-8.160522,x0161,8.781646,active-noncovalent
C[NH2+]CC[N@@](Cc1c([nH]nc1)c2ccc(cc2)O[C@H]3C[C@@H](C3)OCCC4CCOCC4)C,BRD-K33586289-003-01-0,EPZ020411,MedChemEx,HY-12970A,EPZ020411 (hydrochloride),-8.160522,x0161,8.781646,active-noncovalent
CN1C(=O)N(C(=O)[C@]1(CO)c2ccccc2)c3ccc(c(c3)C(F)(F)F)C#N,BRD-K04643927-001-01-6,GLPG0492-R-enantiomer,MedChemEx,HY-18102A,GLPG0492 (R enantiomer),-8.160019,x0161,2.360845,active-noncovalent
c1ccc(cc1)[C@H]2c3ccccc3CCN2C(=O)O[C@H]4C[NH+]5CCC4CC5,BRD-K24723746-036-02-5,solifenacin-succinate,Selleck,S3048,Solifenacin succinate,-8.159551,x0195,2.389067,active-noncovalent
c1ccc(cc1)[C@H]2c3ccccc3CCN2C(=O)O[C@H]4C[NH+]5CCC4CC5,BRD-K24723746-001-01-1,solifenacin-succinate,MicroSource,1505497,SOLIFENACIN SUCCINATE,-8.159551,x0195,2.389067,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)c2ccc(o2)N(=O)=O,BRD-K20605374-001-05-4,NSC-697923,Selleck,S7142,NSC697923,-8.158440,x0678,-0.104934,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)c2ccc(o2)N(=O)=O,BRD-K20605374-001-06-2,NSC-697923,Tocris,4858,NSC 697923,-8.158440,x0678,-0.104934,active-noncovalent
COCCNC(=O)COc1ccc(cc1)OCC[NH2+]C[C@@H](COc2ccccc2)O,BRD-K28971625-003-01-4,ZD-7114,Tocris,930,ZD 7114 hydrochloride,-8.157308,x0104,7.057059,active-noncovalent
CN(C)/N=N/c1ccc(cc1)C(=O)[O-],BRD-K59929863-001-01-9,CB-10-277,Vitas-M,STK021840,,-8.156445,x0749,0.554835,active-covalent
Cc1cc(c(cc1OC(=O)C)C(C)C)OCC[NH+](C)C,BRD-K81144366-003-19-7,moxisylyte,MicroSource,1506079,MOXISYLYTE HYDROCHLORIDE,-8.155870,x0195,-0.1289,active-noncovalent
CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)N[C@H]1c2ccccc2-c3ccccc3NC1=O,BRD-K22024824-001-03-7,RG4733,MedChemEx,HY-11102,RO4929097,-8.155630,x0874,6.162867,active-noncovalent
c1cc2c(nc1)OC[C@@H]3CCCN3C2=O,BRD-K40002998-001-01-5,org-26576,AMS,A000267767,"(9aS)-8,9,9a,10-tetrahydro-5H,7H-pyrido[3,2-f]pyrrolo[2,1-c][1,4]oxazepin-5-one",-8.155533,x0195,-1.1194,active-noncovalent
C[NH+]1C[C@@H]2CN(C[C@@H]2C1)c3ccc(nn3)c4ccccc4,BRD-K79743788-001-01-2,A-582941,Tocris,4341,A 582941,-8.154700,x0749,5.138059,active-covalent
CCn1cc(c(=O)c2c1cc3c(c2)OCO3)C(=O)[O-],BRD-K73394555-237-01-1,oxolinic-acid,MicroSource,1502030,OXOLINIC ACID,-8.154512,x0749,0.540497,active-covalent
c1ccc2cc(ccc2c1)C(=O)NCC[NH+]3CCC4(CC3)C(=O)NCN4c5cccc(c5)F,BRD-K93317811-003-02-2,VU-0364739,Tocris,4171,VU 0364739 hydrochloride,-8.153996,x0195,7.703426,active-noncovalent
C(CCCC(=O)NO)CCC(=O)NO,BRD-K54729176-001-02-8,SBHA,Tocris,3810,SBHA,-8.153867,x0161,-1.112478,active-noncovalent
c1ccc2c(c1)CC(=O)c3ccccc3N2C(=O)N,BRD-K04196797-001-23-6,oxcarbazepine,Selleck,S1391,Oxcarbazepine,-8.153791,x0161,-0.719204,active-noncovalent
c1ccc2c(c1)CC(=O)c3ccccc3N2C(=O)N,BRD-K04196797-001-24-4,oxcarbazepine,MicroSource,1504243,OXCARBAZEPINE,-8.153791,x0161,-0.719204,active-noncovalent
c1ccc2c(c1)CC(=O)c3ccccc3N2C(=O)N,BRD-K04196797-001-25-1,oxcarbazepine,Selleck,S1391,Oxcarbazepine,-8.153791,x0161,-0.719204,active-noncovalent
C1CC(=[NH2+])N(C1)Cc2c(c(=O)[nH]c(=O)[nH]2)Cl,BRD-K11973162-003-01-8,tipiracil,MedChemEx,HY-A0063,Tipiracil (hydrochloride),-8.153749,x0692,-0.3192,active-covalent
CC(C)NC(=O)c1ccc(cc1)CNNC,BRD-K13032584-003-21-9,procarbazine,MedChemEx,HY-13733,Procarbazine (Hydrochloride),-8.153365,x0195,0.038095,active-noncovalent
CC(C)NC(=O)c1ccc(cc1)CNNC,BRD-K13032584-003-19-3,procarbazine,Selleck,S1995,Procarbazine hydrochloride (Matulane),-8.153365,x0195,0.038095,active-noncovalent
CC(C)NC(=O)c1ccc(cc1)CNNC,BRD-K13032584-003-18-5,procarbazine,Selleck,S1995,Procarbazine HCl (Matulane),-8.153365,x0195,0.038095,active-noncovalent
CC(C)NC(=O)c1ccc(cc1)CNNC,BRD-K13032584-001-01-5,procarbazine,MicroSource,1502326,PROCARBAZINE HYDROCHLORIDE,-8.153365,x0195,0.038095,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1OC(=O)C(C)(C)C)[C@H](C[NH2+]C)O,BRD-A47494775-003-11-3,dipivefrine,Prestwick,Prestw-632,Dipivefrin hydrochloride,-8.152368,x0195,4.053575,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)NO,BRD-K82178523-001-01-6,L-asparagine-n-hydroxy,Sigma,A6508,(2S)-2-amino-4-(hydroxyamino)-4-oxobutanoic acid,-8.151939,x0397,-1.404679,active-noncovalent
CCOc1ccc(cc1OCC)c2nc(no2)c3cccc4c3CC[C@H]4[NH2+]CCO,BRD-A43005764-003-01-5,CYM-5442,Tocris,3601,CYM 5442 hydrochloride,-8.151823,x1077,8.552122,active-noncovalent
C[N+](C)(C)CC#CCN1CCCC1=O,BRD-K01942991-005-08-2,oxotremorine-m,Tocris,1067,Oxotremorine M,-8.151625,x0749,-0.181603,active-covalent
C[N+](C)(C)CC#CCN1CCCC1=O,BRD-K01942991-005-09-0,oxotremorine-m,Tocris,1067,"N,N,N-trimethyl-4-(2-oxo-1-pyrrolidinyl)-2-butyn-1-aminium iodide",-8.151625,x0749,-0.181603,active-covalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@@H]3[C@H]2O3)OC(=O)[C@H](CO)c4ccccc4,BRD-K64990126-004-01-1,scopolamine,MicroSource,1500534,SCOPOLAMINE HYDROBROMIDE,-8.151495,x1392,-0.169356,active-covalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccc(cc3)c4ccccn4,BRD-K40331046-305-01-5,CR8-(R),Tocris,3605,(R)-CR8,-8.151196,x0874,6.877199,active-noncovalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccc(cc3)c4ccccn4,BRD-K40331046-305-02-3,CR8-(R),Tocris,3605,(R)-CR8,-8.151196,x0874,6.877199,active-noncovalent
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COc2cccc(c2)C(F)(F)F)O)O)O,BRD-K23976833-001-01-0,travoprost,Enzo,AC3276,TRAVOPROST,-8.151101,x1077,7.159332,active-noncovalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3ccsc3C(=O)N(C2)C,BRD-K80778372-001-03-3,Ro-19-4605,Tocris,1995,Ro 19-4603,-8.150911,x0749,0.73328,active-covalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3ccsc3C(=O)N(C2)C,BRD-K80778372-001-02-5,Ro-19-4605,Tocris,1995,Ro 19-4603,-8.150911,x0749,0.73328,active-covalent
CC(=O)C(=Cc1cc(c(c(c1)O)[O-])N(=O)=O)C(=O)C,BRD-K75551531-001-01-3,nitecapone,Cayman,18656,"3-(3,4-dihydroxy-5-nitrobenzylidene)-2,4-pentanedione",-8.150795,x0195,-0.447542,active-noncovalent
CCCCc1ccc(nc1)C(=O)N,BRD-K51700582-001-01-2,bupicomide,Enamine,Z2408581540,5-butyl-2-pyridinecarboxamide,-8.150414,x0749,-1.357078,active-covalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,BRD-K37270826-001-26-8,mifepristone,Tocris,1479,Mifepristone,-8.149806,x1093,3.189302,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,BRD-K37270826-001-29-2,mifepristone,Tocris,1479,Mifepristone,-8.149806,x1093,3.189302,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,BRD-K37270826-001-31-8,mifepristone,MicroSource,1505615,MIFEPRISTONE,-8.149806,x1093,3.189302,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,BRD-K37270826-001-27-6,mifepristone,Selleck,S2606,Mifepristone (Mifeprex),-8.149806,x1093,3.189302,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,BRD-K37270826-001-30-0,mifepristone,Selleck,S2606,Mifepristone,-8.149806,x1093,3.189302,active-noncovalent
C1[C@H]([C@H](O[C@H]1N2C[NH+]=C(NC2=O)N)CO)O,BRD-K46690591-001-01-2,KP-1212,Berry,PY 7106,,-8.149708,x0397,-0.091006,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,BRD-K94353609-001-20-8,fluocinolone-acetonide,Selleck,S2470,Fluocinolone Acetonide,-8.149630,x0874,5.450798,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,BRD-K94353609-001-21-6,fluocinolone-acetonide,MicroSource,1500302,FLUOCINOLONE ACETONIDE,-8.149630,x0874,5.450798,active-noncovalent
CC(=O)CCc1ccc2cc(ccc2c1)OC,BRD-K65146499-001-26-1,nabumetone,Selleck,S4051,Nabumetone,-8.149064,x0195,0.016594,active-noncovalent
CC(=O)CCc1ccc2cc(ccc2c1)OC,BRD-K65146499-001-27-9,nabumetone,MicroSource,1503650,NABUMETONE,-8.149064,x0195,0.016594,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,BRD-K76723084-001-23-2,isotretinoin,MicroSource,1502013,ISOTRETINON,-8.148855,x0830,2.36252,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,BRD-K76723084-001-24-0,isotretinoin,MedChemEx,HY-15127,Isotretinoin,-8.148855,x0830,2.36252,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,BRD-K76723084-001-22-4,isotretinoin,Selleck,S1379,Isotretinoin,-8.148855,x0830,2.36252,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,BRD-K76723084-001-25-7,isotretinoin,Selleck,S1379,Isotretinoin,-8.148855,x0830,2.36252,active-covalent
c1cc(ccc1c2c(n3c(n2)SCC3)c4ccncc4)F,BRD-K96809896-300-02-3,SKF-86002,Tocris,2008,SKF 86002 dihydrochloride,-8.148355,x0195,0.129375,active-noncovalent
c1cnccc1C/N=N/C(=S)N,BRD-K86435560-001-01-0,perchlozone,Vitas-M,STK060728,,-8.145007,x0426,-1.256819,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])OC)C2=O,BRD-K67772619-001-05-1,rheochrysidin,Selleck,S2395,Rheochrysidin,-8.144560,x0195,2.123625,active-noncovalent
Cc1cc(c(c(c1NC(=O)C[NH+](CC(=O)[O-])CC(=O)[O-])C)Br)C,BRD-K96691275-001-01-2,mebrofenin,Sigma,MFCD00216974,"2,2'-(2-(3-bromo-2,4,6-trimethylphenylamino)-2-oxoethylazanediyl)diacetic acid",-8.144441,x0830,1.019662,active-covalent
Cc1cc(ccc1N)Cn2c3c(c(nc(n3)N)c4ccco4)nn2,BRD-K56565215-001-01-9,vipadenant,MedChemEx,HY-10857,Vipadenant,-8.144427,x1093,3.694048,active-noncovalent
c1cc2c(cc1Cl)[C@@](OC(=O)N2)(C#CC3CC3)C(F)(F)F,BRD-K40758068-001-08-2,efavirenz,Enzo,DL535,Efavirenz,-8.143311,x0195,0.283896,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C,BRD-K56515112-001-21-6,medrysone,MicroSource,1500380,MEDRYSONE,-8.141653,x1077,3.629516,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)NCC[NH+]3CCC(CC3)(Cc4ccccc4)O,BRD-K07682953-001-01-8,palosuran,MedChemEx,HY-10655,Palosuran,-8.140141,x0104,3.904709,active-noncovalent
C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)NC(=[NH2+])N)O)[NH+]=C(N)N)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)[NH2+]C)(CO)O,BRD-A67363467-001-01-3,dihydrostreptomycin,MicroSource,1500249,DIHYDROSTREPTOMYCIN [5mM],-8.140064,x0161,8.100967,active-noncovalent
Cn1cnc2c1nc(nc2NCc3ccccc3)NCCO,BRD-K82731415-001-07-0,olomoucine,Tocris,1284,Olomoucine,-8.139955,x0708,0.553819,active-covalent
c1cc(ccc1C(=O)N/N=C/c2ccc(o2)N(=O)=O)O,BRD-K68188368-001-08-6,nifuroxazide,Selleck,S4182,Nifuroxazide,-8.139940,x1093,1.94884,active-noncovalent
c1cc(ccc1C(=O)N/N=C/c2ccc(o2)N(=O)=O)O,BRD-K68188368-001-09-4,nifuroxazide,MicroSource,1505788,NIFUROXAZIDE,-8.139940,x1093,1.94884,active-noncovalent
c1cc(ccc1C(=O)N/N=C/c2ccc(o2)N(=O)=O)O,BRD-K68188368-001-11-0,nifuroxazide,Selleck,S4182,Nifuroxazide,-8.139940,x1093,1.94884,active-noncovalent
COc1ccc(c2c1c(=S)c3ccccc3[nH]2)OC,BRD-K62949423-001-03-1,NSC-625987,Tocris,2152,NSC 625987,-8.139662,x0195,1.307298,active-noncovalent
CC[C@@H](c1ccccc1)NC(=O)c2c3ccccc3nc(c2O)c4ccccc4,BRD-K47095176-001-01-6,talnetant,MedChemEx,HY-14552,Talnetant,-8.138851,x0195,2.599826,active-noncovalent
C[C@H](CSC(=O)c1ccccc1)C(=O)N2C[C@H](C[C@H]2C(=O)[O-])Sc3ccccc3,BRD-K46654563-238-01-0,zofenopril-calcium,MedChemEx,HY-B0655,Zofenopril (calcium),-8.138183,x0397,4.112679,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@@H](CF)NC(=O)C(Cl)Cl)O,BRD-K11298197-001-12-0,florfenicol,Selleck,S4201,Florfenicol,-8.138136,x0104,0.578093,active-noncovalent
CCc1c([nH]c2c1C(=O)[C@@H](CC2)C[NH+]3CCOCC3)C,BRD-A65280694-003-13-7,molindone,MicroSource,1506018,MOLINDONE HYDROCHLORIDE,-8.137992,x0195,0.194772,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2c(c(=O)c3ccc(cc3o2)Cl)Cc4ccccc4)C(C)C,BRD-K68532323-003-05-1,SB-743921,Tocris,5109,SB 743921 Hydrochloride,-8.137464,x1077,7.618764,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2c(c(=O)c3ccc(cc3o2)Cl)Cc4ccccc4)C(C)C,BRD-K68532323-003-02-8,SB-743921,Selleck,S2182,SB743921,-8.137464,x1077,7.618764,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCNc3ccc(cc3)Nc4ccncc4,BRD-K65924316-001-07-2,serdemetan,Selleck,S1172,JNJ 26854165 (Serdemetan),-8.136547,x0195,0.316,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCNc3ccc(cc3)Nc4ccncc4,BRD-K65924316-001-03-1,serdemetan,Selleck,S1172,JNJ-26854165 (Serdemetan),-8.136547,x0195,0.316,active-noncovalent
C[NH2+]CCn1c2c3cc4c(cc3ncc2c5cc(c(cc5c1=O)OC)OC)OCO4,BRD-K99475619-001-01-2,genz-644282,MedChemEx,HY-16228,Genz-644282,-8.135910,x0104,3.796107,active-noncovalent
C[C@@H](Cc1ccc(cc1)O)[NH3+],BRD-A80871782-004-06-9,hydroxyamphetamine,MicroSource,211425,HYDROXYAMPHETAMINE HYDROBROMIDE,-8.135716,x1077,-0.657226,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)NC(=O)c2cc(cc(c2)F)F,BRD-K54538117-001-01-7,LY450108,MedChemEx,HY-10935,LY450108,-8.135439,x0104,6.337623,active-noncovalent
CC(C)OC(=O)Nc1cccc(c1)Cl,BRD-K59590127-001-04-5,chlorpropham,Sigma,MFCD00037108,isopropyl 3-chlorophenylcarbamate,-8.134335,x0195,-0.537085,active-noncovalent
c1cc(ncc1F)c2nc(on2)c3cc(cc(c3)F)C#N,BRD-K61043483-001-01-5,AZD9272,Tocris,5613,AZD 9272,-8.134156,x1093,3.119286,active-noncovalent
CC[NH+](CC)Cc1nccn1c2ccc(cc2C(=O)c3ccccc3Cl)N(=O)=O,BRD-K84011460-051-01-7,nizofenone,AKSci,67653,,-8.134041,x0678,2.432424,active-noncovalent
C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],BRD-K69346723-001-04-8,glutathione,MicroSource,1502248,GLUTATHIONE,-8.133867,x0678,2.101231,active-noncovalent
CC[S@](=O)c1nc(cc(n1)C(F)(F)F)c2cccc(c2)OCc3ccccc3,BRD-A60153876-001-01-0,BETP,Tocris,4778,BETP,-8.133290,x0161,4.478679,active-noncovalent
C1C[C@H]2C[NH2+][C@@H](C[C@H]2C[C@H]1CCc3[n-]nnn3)C(=O)[O-],BRD-K34313798-001-01-6,LY215490,MedChemEx,HY-75704,Tezampanel,-8.132271,x0107,0.344603,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)[O-])I)I)O,BRD-K61236135-001-09-0,tiratricol,MicroSource,1506047,TIRATRICOL,-8.131705,x0830,2.802558,active-covalent
c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)[O-])I)I)O,BRD-K61236135-001-08-2,tiratricol,Selleck,s4185,Tiratricol,-8.131705,x0830,2.802558,active-covalent
C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)[O-])C,BRD-K54634444-001-04-2,artesunate,Selleck,S2265,Artesunate,-8.131416,x0678,5.134055,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)[O-])C,BRD-K54634444-001-05-9,artesunate,MicroSource,1504829,ARTESUNATE,-8.131416,x0678,5.134055,active-noncovalent
c1cn(nc1NC(=[NH2+])NCC(F)(F)F)CCCCC(=O)N,BRD-K11071038-001-01-7,ICI-162846,Tocris,833,"ICI 162,846",-8.131327,x1334,0.454533,active-covalent
CCOC(=O)[C@H](Cc1ccc(cc1)N(=O)=O)NC(=O)c2ccccc2,BRD-K16107558-001-01-4,SB-297006,Tocris,4213,SB 297006,-8.130223,x0434,2.163389,active-noncovalent
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,BRD-K02637541-001-18-0,celecoxib,MicroSource,1503678,CELECOXIB,-8.128628,x0161,2.484577,active-noncovalent
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,BRD-K02637541-001-17-2,celecoxib,Selleck,S1261,Celecoxib,-8.128628,x0161,2.484577,active-noncovalent
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,BRD-K02637541-001-22-2,celecoxib,Tocris,3786,Celecoxib,-8.128628,x0161,2.484577,active-noncovalent
C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)[O-])SCC/[NH+]=C/N)O,BRD-K23200955-002-01-5,imipenem,MicroSource,1506001,IMIPENEM,-8.128130,x0161,-0.193875,active-noncovalent
C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)[O-])SCC/[NH+]=C/N)O,BRD-K23200955-002-02-3,imipenem,Sigma,MFCD09753321,"(5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate",-8.128130,x0161,-0.193875,active-noncovalent
Cc1ccc(cc1)/N=C/2\CC(=O)c3c(nc(s3)C)C2=O,BRD-K06426971-001-03-5,ryuvidine,Tocris,2609,Ryuvidine,-8.127855,x0749,1.390133,active-covalent
Cc1ccc(cc1)/N=C/2\CC(=O)c3c(nc(s3)C)C2=O,BRD-K06426971-001-02-7,ryuvidine,Tocris,2609,Ryuvidine,-8.127855,x0749,1.390133,active-covalent
C[N@+]1(CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@@]3([C@H]1C5)O)O)CC6CC6,BRD-K33732501-004-01-0,methylnaltrexone,MedChemEx,HY-75766,Methylnaltrexone (Bromide),-8.127031,x0678,0.428653,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)C(=O)CC5)O)O,BRD-K88172511-003-21-1,naltrexone,MicroSource,1503262,NALTREXONE HYDROCHLORIDE,-8.126569,x0072,1.961475,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)C(=O)CC5)O)O,BRD-K88172511-003-19-5,naltrexone,Selleck,S2103,Naltrexone HCl,-8.126569,x0072,1.961475,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)C(=O)CC5)O)O,BRD-K88172511-003-20-3,naltrexone,Selleck,S2103,Naltrexone HCl,-8.126569,x0072,1.961475,active-noncovalent
c1ccc(cc1)c2cc(ncn2)I,BRD-K25690923-001-02-4,4-iodo-6-phenylpyrimidine,Tocris,3429,4-IPP,-8.125819,x0195,-1.544307,active-noncovalent
c1cc(ccc1NC(=O)c2cc(cc(c2O)Br)Br)Br,BRD-K09118247-001-03-3,tribomsalan,Vitas-M,STK301503,,-8.125379,x0749,1.081122,active-covalent
C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,BRD-K78431006-001-11-0,crizotinib,Selleck,S1068,Crizotinib (PF-02341066),-8.124951,x0104,4.692201,active-noncovalent
C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,BRD-K78431006-001-15-1,crizotinib,MedChemEx,HY-50878,Crizotinib,-8.124951,x0104,4.692201,active-noncovalent
C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,BRD-K78431006-001-10-2,crizotinib,Selleck,S1068,Crizotinib (PF-02341066),-8.124951,x0104,4.692201,active-noncovalent
Cn1c(nnc1S(=O)(=O)C)c2ccccc2,BRD-K50888640-001-01-6,MDL-27531,Otava,2630816,"4-methyl-3-(methylsulfonyl)-5-phenyl-4H-1,2,4-triazole",-8.124414,x0195,1.275952,active-noncovalent
C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N@@H+](C1)CCC4,BRD-K66845263-001-04-8,sophocarpine,Selleck,S2405,Sophocarpine,-8.124063,x0195,1.897273,active-noncovalent
C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N@@H+](C1)CCC4,BRD-K66845263-001-03-0,sophocarpine,Vitas-M,STK801894,"13,14-didehydromatridin-15-one",-8.124063,x0195,1.897273,active-noncovalent
C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N@@H+](C1)CCC4,BRD-K66845263-001-02-2,sophocarpine,Selleck,S2405,Sophocarpine,-8.124063,x0195,1.897273,active-noncovalent
Cc1cc(c(cc1C2CC[NH2+]CC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl,BRD-K22149900-001-05-4,ceritinib,MedChemEx,HY-15656,LDK378,-8.123479,x0161,7.554864,active-noncovalent
Cc1cc(c(cc1C2CC[NH2+]CC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl,BRD-K22149900-001-01-3,ceritinib,Selleck,S7083,LDK378,-8.123479,x0161,7.554864,active-noncovalent
Cc1cc(c(cc1C2CC[NH2+]CC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl,BRD-K22149900-001-03-9,ceritinib,Selleck,S7083,Ceritinib (LDK378),-8.123479,x0161,7.554864,active-noncovalent
Cc1cc(c(cc1C2CC[NH2+]CC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl,BRD-K22149900-001-06-2,ceritinib,MedChemEx,HY-15656,LDK378,-8.123479,x0161,7.554864,active-noncovalent
c1ccc(c(c1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O)Cl,BRD-A11990600-001-03-4,lorazepam,Enzo,AC3164,LORAZEPAM,-8.123451,x0434,0.43332,active-noncovalent
c1ccc(cc1)C(COC(=O)N)COC(=O)N,BRD-K99107520-001-23-3,felbamate,Selleck,S1330,Felbamate,-8.122873,x0161,0.097529,active-noncovalent
c1ccc(cc1)C(COC(=O)N)COC(=O)N,BRD-K99107520-001-25-8,felbamate,Selleck,S1330,Felbamate,-8.122873,x0161,0.097529,active-noncovalent
c1ccc(cc1)C(COC(=O)N)COC(=O)N,BRD-K99107520-001-24-1,felbamate,Tocris,869,Felbamate,-8.122873,x0161,0.097529,active-noncovalent
c1ccc(cc1)C(COC(=O)N)COC(=O)N,BRD-K99107520-001-27-4,felbamate,Tocris,869,Felbamate,-8.122873,x0161,0.097529,active-noncovalent
C[C@@H]1Nc2ccc(cc2S(=O)(=O)N1)Cl,BRD-A14344385-001-03-2,IDRA-21,Tocris,1219,IDRA 21,-8.122155,x0195,0.240607,active-noncovalent
C[C@@H]1Nc2ccc(cc2S(=O)(=O)N1)Cl,BRD-A14344385-001-04-0,IDRA-21,Tocris,1219,IDRA 21,-8.122155,x0195,0.240607,active-noncovalent
c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)[C@H]([C@H]3CCCC[NH2+]3)O,BRD-A89585551-003-16-6,mefloquine,MicroSource,1503070,MEFLOQUINE,-8.121846,x0195,2.134004,active-noncovalent
C[NH+]1CCN(CC1)c2cc(ccc2OC)NS(=O)(=O)c3ccc(cc3)I,BRD-K80639402-003-02-9,SB-258585,Tocris,1961,SB 258585 hydrochloride,-8.121441,x0161,1.896967,active-noncovalent
CN(c1cccc(n1)OC)C(=S)Oc2ccc3c(c2)CCCC3,BRD-K35775715-001-03-1,liranaftate,Selleck,S1997,Liranaftate,-8.121175,x0072,2.015744,active-noncovalent
c1cc(ccc1C[N@@]2CCCNCC[NH2+]CCC[NH2+]CC2)C[N@]3CCCNCC[NH2+]CCC[NH2+]CC3,BRD-K33240821-001-05-4,plerixafor,Selleck,S8030,Plerixafor,-8.121090,x1077,8.039696,active-noncovalent
c1cc(ccc1C[N@@]2CCCNCC[NH2+]CCC[NH2+]CC2)C[N@]3CCCNCC[NH2+]CCC[NH2+]CC3,BRD-K33240821-001-06-2,plerixafor,MedChemEx,HY-10046,Plerixafor,-8.121090,x1077,8.039696,active-noncovalent
c1cc(ccc1C[N@@]2CCCNCC[NH2+]CCC[NH2+]CC2)C[N@]3CCCNCC[NH2+]CCC[NH2+]CC3,BRD-K33240821-001-03-9,plerixafor,Selleck,S8030,Plerixafor (AMD3100),-8.121090,x1077,8.039696,active-noncovalent
c1cc(ccc1C[N@@]2CCCNCC[NH2+]CCC[NH2+]CC2)C[N@]3CCCNCC[NH2+]CCC[NH2+]CC3,BRD-K33240821-400-02-5,plerixafor,MedChemEx,HY-50912,Plerixafor (octahydrochloride),-8.121090,x1077,8.039696,active-noncovalent
COc1cccc(c1)N2CCN(CC2)C3=[NH+]c4c(cccc4F)[C@@H](N3c5cc(ccc5OC)C(F)(F)F)CC(=O)[O-],BRD-K94288301-001-01-7,letermovir,MedChemEx,HY-15233,Letermovir,-8.120955,x0874,8.993427,active-noncovalent
c1ccc(cc1)NC(=O)[C@@]23C[C@@H]2[C@@H](c4ccccc4O3)N=O,BRD-A59709458-001-02-6,PHCCC,Tocris,1027,PHCCC,-8.120083,x0195,-0.172981,active-noncovalent
c1ccc(cc1)NC(=O)[C@@]23C[C@@H]2[C@@H](c4ccccc4O3)N=O,BRD-A59709458-001-01-8,PHCCC,Tocris,1027,PHCCC,-8.120083,x0195,-0.172981,active-noncovalent
CCOC(=O)CSCC[C@H]1[NH2+][C@H](CS1)C(=O)[O-],BRD-A32597168-001-03-6,letosteine,AKSci,R082,,-8.119851,x0830,-0.721208,active-covalent
Cc1cc(cc(c1)NC(=O)Cc2ccc(cc2)OC(C)(C)C(=O)[O-])C,BRD-K37355418-236-01-6,efaproxiral,Selleck,S4263,Efaproxiral Sodium,-8.119609,x0104,2.417236,active-noncovalent
c1cc(nc(c1)NS(=O)(=O)c2ccc(cc2)c3ccc(cc3)C#N)N,BRD-K18289362-001-01-4,PF-915275,MedChemEx,HY-18056,PF-915275,-8.119098,x0104,3.561376,active-noncovalent
c1cc(nc(c1)NS(=O)(=O)c2ccc(cc2)c3ccc(cc3)C#N)N,BRD-K18289362-001-02-2,PF-915275,Tocris,3291,PF 915275,-8.119098,x0104,3.561376,active-noncovalent
COc1ccc(cc1)Oc2c(cnn(c2=O)C3c4ccccc4-c5c3cccc5)Cl,BRD-K27732927-001-03-6,CYM-50769,Tocris,4948,CYM 50769,-8.119084,x0946,3.358585,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)OC(=O)C[NH3+])C(F)(F)F)C,BRD-K73197500-001-02-2,SNX-5422,Selleck,S2656,PF-04929113 (SNX-5422),-8.118729,x0161,7.788061,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)OC(=O)C[NH3+])C(F)(F)F)C,BRD-K73197500-001-04-8,SNX-5422,MedChemEx,HY-10213,PF-04929113,-8.118729,x0161,7.788061,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)OC(=O)C[NH3+])C(F)(F)F)C,BRD-K73197500-001-03-0,SNX-5422,Selleck,S2656,PF-04929113 (SNX-5422),-8.118729,x0161,7.788061,active-noncovalent
CC[NH+](CC)CC(=O)N1c2ccccc2CCc3c1cc(cc3)NC(=O)OCC,BRD-K24570280-001-01-8,CINPA-1,Tocris,5605,CINPA 1,-8.118647,x0946,2.503768,active-noncovalent
COC(=O)c1ccc2c(c1)nc(n2CCCc3ccccc3)NC(=O)c4ccccc4,BRD-K72264770-001-03-2,BRD4770,MedChemEx,HY-16705,BRD4770,-8.117898,x0434,4.448519,active-noncovalent
COC(=O)c1ccc2c(c1)nc(n2CCCc3ccccc3)NC(=O)c4ccccc4,BRD-K72264770-001-04-0,BRD4770,MedChemEx,HY-16705,BRD4770,-8.117898,x0434,4.448519,active-noncovalent
c1cc(oc1)CNc2cc(c(cc2C(=O)[O-])S(=O)(=O)N)Cl,BRD-K78010432-001-24-9,furosemide,Tocris,3109,Furosemide,-8.116973,x0072,0.490749,active-noncovalent
c1cc(oc1)CNc2cc(c(cc2C(=O)[O-])S(=O)(=O)N)Cl,BRD-K78010432-001-20-7,furosemide,Selleck,S1603,Furosemide,-8.116973,x0072,0.490749,active-noncovalent
c1cc(oc1)CNc2cc(c(cc2C(=O)[O-])S(=O)(=O)N)Cl,BRD-K78010432-001-21-5,furosemide,MicroSource,1500310,FUROSEMIDE,-8.116973,x0072,0.490749,active-noncovalent
CCCCc1ccc2c(c1)[nH]c(n2)NC(=O)OC,BRD-K02407574-001-09-7,parbendazole,Prestwick,Prestw-1110,Parbendazole,-8.116457,x1077,0.402377,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2NC(=O)c3c[nH]c(=O)cc3C(F)(F)F)c4cccc(c4)C[NH+]5CCOCC5,BRD-K94083718-001-01-9,OICR-9429,Tocris,5267,OICR 9429,-8.115351,x0104,12.631888,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1CCC(CO)CO)N,BRD-K47780086-001-07-9,penciclovir,MicroSource,1502320,PENCICLOVIR,-8.114223,x0397,-0.369864,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1CCC(CO)CO)N,BRD-K47780086-001-06-1,penciclovir,Selleck,S4184,Penciclovir,-8.114223,x0397,-0.369864,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1CCC(CO)CO)N,BRD-K47780086-001-08-7,penciclovir,Selleck,S4184,Penciclovir,-8.114223,x0397,-0.369864,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ccccn2,BRD-K97564742-050-32-7,mepyramine,MicroSource,1500519,PYRILAMINE MALEATE,-8.113931,x0434,1.229648,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ccccn2,BRD-K97564742-050-31-9,mepyramine,Tocris,660,Mepyramine maleate,-8.113931,x0434,1.229648,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ccccn2,BRD-K97564742-051-02-8,mepyramine,Selleck,S4382,Pyrilamine Maleate,-8.113931,x0434,1.229648,active-noncovalent
C[N+]1(CC[C@@H](C1)OC(=O)[C@](c2ccccc2)(C3CCCC3)O)C,BRD-A81233518-004-16-1,glycopyrrolate,MicroSource,1505753,GLYCOPYRROLATE,-8.113657,x1093,0.994371,active-noncovalent
CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,BRD-K39484304-001-16-5,triptolide,Selleck,S3604,Triptolide (PG490),-8.112088,x0749,2.879341,active-covalent
CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,BRD-K39484304-001-14-0,triptolide,Tocris,3253,Triptolide,-8.112088,x0749,2.879341,active-covalent
Cc1cc(=O)oc2c1ccc(c2)O,BRD-K46424862-001-14-1,hymecromone,Selleck,S2256,4-Methylumbelliferone (4-MU),-8.111824,x0195,0.220993,active-noncovalent
Cc1cc(=O)oc2c1ccc(c2)O,BRD-K46424862-001-15-8,hymecromone,MicroSource,1506174,HYMECHROME,-8.111824,x0195,0.220993,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc(c(c4)OC)OC,BRD-K58466253-003-14-0,palmatine-chloride,Selleck,S2397,Palmatine chloride,-8.111174,x0749,5.22114,active-covalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,BRD-K30240666-051-13-4,clemastine,Selleck,S1847,Clemastine Fumarate,-8.110670,x0678,0.756534,active-noncovalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,BRD-K30240666-051-15-9,clemastine,MicroSource,1500191,CLEMASTINE FUMARATE,-8.110670,x0678,0.756534,active-noncovalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,BRD-K30240666-051-14-2,clemastine,Tocris,1453,Clemastine fumarate,-8.110670,x0678,0.756534,active-noncovalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,BRD-K30240666-051-16-7,clemastine,Tocris,1453,Clemastine fumarate,-8.110670,x0678,0.756534,active-noncovalent
Cc1ccccc1OC[C@@H](CO)O,BRD-A55469827-001-07-4,mephenesin,MicroSource,1501140,MEPHENESIN,-8.110322,x0195,-1.252566,active-noncovalent
COc1ccc(cc1)OC[C@@H]2c3cc(c(cc3CCN2C(=O)c4cccc(c4)Cl)OC)OC,BRD-A35425966-001-02-3,CIQ,Tocris,4105,CIQ,-8.109567,x0161,3.980991,active-noncovalent
c1cc(c(cc1[C@H](C[NH2+]CCCCCC[NH2+]C[C@@H](c2ccc(c(c2)O)O)O)O)O)O,BRD-A33894669-065-01-9,hexoprenaline,Carbosynth,HEXOPRENALINE SULPHATE,"sulfuric acid compound with 4-{2-[(6-{[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino}hexyl)amino]-1-hydroxyethyl}-1,2-benzenediol (1:1)",-8.109411,x0678,4.168571,active-noncovalent
CNC(=O)c1ccc(cc1F)c2cnc3[nH+]cc(n3n2)Cc4ccc5c(c4)cccn5,BRD-K81016934-001-02-0,INC-280,Selleck,S2788,INCB28060,-8.109189,x0678,5.220325,active-noncovalent
Cn1c2ccccc2c(n1)C(=O)NC3C[C@H]4CCC[C@@H](C3)[NH+]4C,BRD-A10967948-003-06-3,granisetron,MicroSource,1502365,GRANISETRON HYDROCHLORIDE,-8.108163,x0749,1.977584,active-covalent
Cn1c2ccccc2c(n1)C(=O)NC3C[C@H]4CCC[C@@H](C3)[NH+]4C,BRD-A10967948-003-05-5,granisetron,Selleck,S1345,Granisetron HCl,-8.108163,x0749,1.977584,active-covalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,BRD-K57886322-001-16-6,fluocinonide,Selleck,S2608,Fluocinonide,-8.105221,x1077,3.974033,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@@H]2O[C@H]4[C@@H]([C@@H]([C@H]([C@H](O4)CO)O)O)O,BRD-K12413266-001-01-3,casanthranol-variant,MicroSource,1506179,CASANTHRANOL [cascaroside A shown],-8.104877,x0161,3.557292,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(c(c3)F)NC(=O)Nc4ccc(cc4F)F,BRD-K47150025-001-05-3,KI-8751,Selleck,S1363,Ki8751,-8.103120,x0104,7.515146,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(c(c3)F)NC(=O)Nc4ccc(cc4F)F,BRD-K47150025-001-06-1,KI-8751,Tocris,2542,Ki 8751,-8.103120,x0104,7.515146,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(c(c3)F)NC(=O)Nc4ccc(cc4F)F,BRD-K47150025-001-09-5,KI-8751,Tocris,2542,Ki 8751,-8.103120,x0104,7.515146,active-noncovalent
c1cnccc1c2c(c(sc2c3ccncc3)c4ccncc4)c5ccncc5,BRD-K64451768-001-05-4,GANT-58,Tocris,3889,GANT 58,-8.102582,x0195,4.556455,active-noncovalent
c1cc(nc(c1)Nc2nccs2)C[NH+]3CCN(CC3)C(=O)c4cccc(c4F)Cl,BRD-K25279140-001-01-5,MK-8745,Selleck,S7065,MK-8745,-8.102244,x1077,4.808391,active-noncovalent
CCCCCC[C@@H](CCC)C(=O)[O-],BRD-K49223707-001-01-0,arundic-acid,Tocris,4530,(2R)-2-propyloctanoic acid,-8.101088,x0397,-0.378283,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC,BRD-K69144501-001-01-1,E-2012,Sigma,MFCD02259226,"methyl (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoate",-8.100369,x0195,1.719844,active-noncovalent
CCC(CC)n1ccc2c1cc(cc2C(=O)NCc3c(cc([nH]c3=O)C)C)C#N,BRD-K91535048-001-01-2,EI1,MedChemEx,HY-15573,EI1,-8.100223,x0104,3.831552,active-noncovalent
C[NH+](C)Cc1c[nH]c2c1cccc2,BRD-K26005076-001-12-8,gramine,Selleck,S2304,Gramine,-8.099701,x0072,-0.759802,active-noncovalent
CCc1c(c([nH]c1C(=O)Nc2cc(ccc2[O-])S(=O)(=O)N(CC)CC)C)C(=O)C,BRD-K69211575-001-01-9,XD-14,Tocris,5489,XD 14,-8.099055,x0678,6.49512,active-noncovalent
C1CC1C(C2CC2)NC3=[NH+]CCO3,BRD-K01638814-011-01-4,rilmenidine,Selleck,S7548,"phosphoric acid compound with N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine (1:1)",-8.098516,x0678,-0.589017,active-noncovalent
C1CC1C(C2CC2)NC3=[NH+]CCO3,BRD-K01638814-051-16-8,rilmenidine,Tocris,790,Rilmenidine hemifumarate,-8.098516,x0678,-0.589017,active-noncovalent
C[N@]1[C@H](Nc2cc(c(cc2S1(=O)=O)S(=O)(=O)N)Cl)CCl,BRD-A95340155-001-09-7,methyclothiazide,Selleck,S4057,Methyclothiazide,-8.097831,x0749,0.43257,active-covalent
c1cc2c(cc(c(c2nc1)O)I)Cl,BRD-K09255212-001-16-6,clioquinol,MicroSource,1505114,CLIOQUINOL,-8.097764,x0195,-1.289215,active-noncovalent
Cc1ccc-2c(c1)Cc3c2n(nc3C(=O)NN4CCCCC4)c5ccc(cc5Cl)Cl,BRD-K65285700-001-02-3,GP1a,Tocris,2764,GP 1a,-8.097659,x0161,4.813636,active-noncovalent
Cc1c(cccc1Cl)Nc2c(cccn2)C(=O)[O-],BRD-M63173034-001-03-6,clonixin-lysinate,Sigma,MFCD07364029,"(2S)-2,6-diaminohexanoic acid compound with 2-(3-chloro-2-methylanilino)nicotinic acid (1:1)",-8.096487,x0749,-0.475775,active-covalent
Cc1c(cccc1Cl)Nc2c(cccn2)C(=O)[O-],BRD-M63173034-001-02-8,clonixin-lysinate,Prestwick,Prestw-1104,Clonixin Lysinate,-8.096487,x0749,-0.475775,active-covalent
C1CC[NH+](C1)CC#CC[NH+]2CCCC2,BRD-K08619838-300-05-7,tremorine,Prestwick,Prestw-331,Tremorine dihydrochloride,-8.095699,x0104,-0.318592,active-noncovalent
Cc1c(c(c2c(c1O)O2)O)O,BRD-A64228451-001-08-4,terreic-acid-(-),Tocris,1405,(-)-Terreic acid,-8.095338,x0678,2.169094,active-noncovalent
CC(=O)N([C@@H]1c2cc(ccc2OC([C@H]1O)(C)C)C#N)OCc3ccccc3,BRD-K42679050-001-02-1,Y-27152,Tocris,2077,Y-27152,-8.094987,x0195,1.910041,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)[NH3+],BRD-K81136890-003-01-6,leucylleucine-methyl-ester,ChemImpex,4578,,-8.094801,x0195,0.244613,active-noncovalent
CCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(C[C@H]([C@@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C(=O)COC(=O)C,BRD-K33720171-001-01-0,difluprednate,Selleck,S4095,Difluprednate,-8.094021,x1077,6.232285,active-noncovalent
c1cc(ccc1C(=O)N[C@H]2C[NH+]3CCC2CC3)Cl,BRD-K28863208-001-02-0,PNU-282987,Tocris,2303,PNU 282987,-8.093317,x0749,-0.20947,active-covalent
c1cc(ccc1C(=O)N[C@H]2C[NH+]3CCC2CC3)Cl,BRD-K28863208-001-03-8,PNU-282987,Tocris,2303,PNU 282987,-8.093317,x0749,-0.20947,active-covalent
C[NH+]1CCN(CC1)C(=O)Oc2c3c(c(n2c4ccc(cn4)Cl)O)nccn3,BRD-K29220403-001-10-8,eszopiclone,MicroSource,1503425,ESZOPICLONE,-8.093206,x0195,1.68632,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)OCC,BRD-K76011241-001-02-6,oseltamivir-phosphate,Selleck,S2597,Oseltamivir phosphate,-8.092500,x0387,0.606775,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)OCC,BRD-K76011241-011-02-5,oseltamivir-phosphate,Selleck,S2597,Oseltamivir Phosphate,-8.092500,x0387,0.606775,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)OCC,BRD-K76011241-001-01-8,oseltamivir-phosphate,MicroSource,1504912,OSELTAMIVIR PHOSPHATE,-8.092500,x0387,0.606775,active-noncovalent
CC([C@H]1CC[C@@H](CC1)C(=O)N[C@H](C(=O)[O-])Cc2ccccc2)C,BRD-K84658672-001-04-8,nateglinide,MicroSource,1504258,NATEGLINIDE,-8.091651,x1093,1.7277,active-noncovalent
CCC[NH+](CCC)[C@@H]1CCc2c(cccc2OC)[C@@H]1C,BRD-K66715657-050-01-0,UH-232-(+),Tocris,775,(+)-UH 232 maleate,-8.091217,x0104,-0.248981,active-noncovalent
CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)C[NH2+]C)N,BRD-K04701033-001-03-9,VE-822,Selleck,S7102,VE-822,-8.091070,x0104,14.149117,active-noncovalent
CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)C[NH2+]C)N,BRD-K04701033-001-01-3,VE-822,Selleck,S7102,VE-822,-8.091070,x0104,14.149117,active-noncovalent
CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)C[NH2+]C)N,BRD-K04701033-001-04-7,VE-822,MedChemEx,HY-13902,VE-822,-8.091070,x0104,14.149117,active-noncovalent
Cc1ccc(nc1)c2ccc(cn2)C,BRD-K65498798-001-01-7,abametapir,Sigma,MFCD01740554,"5,5'-dimethyl-2,2'-bipyridine",-8.090454,x0749,-0.951375,active-covalent
C[C@@H](c1ccc(c2c1cccc2)F)C(=O)Nc3cc(ccc3CCCC(=O)[O-])C#N,BRD-A80567330-001-01-7,ONO-AE3-208,Tocris,3565,ONO AE3 208,-8.090360,x0161,2.467426,active-noncovalent
c1ccc(cc1)[C@@H](CC(=O)[O-])C[NH3+],BRD-A66920069-001-01-3,fenigam,Enamine,Z1255487817,,-8.090292,x1374,0.131936,active-covalent
CC1(C(=C(C(=O)O1)OCC2CC2)c3ccc(cc3)S(=O)(=O)C)C,BRD-K09090523-001-02-1,firocoxib,MicroSource,1504526,FIROCOXIB,-8.090115,x0749,2.1476,active-covalent
COc1cc2c(cc1OC)nc(cn2)c3ccccc3,BRD-K76064317-001-08-1,tyrphostin-AG-1296,Selleck,S8024,Tyrphostin AG 1296,-8.089603,x0195,4.330508,active-noncovalent
COc1cc2c(cc1OC)nc(cn2)c3ccccc3,BRD-K76064317-001-07-3,tyrphostin-AG-1296,Selleck,S8024,Tyrphostin AG 1296,-8.089603,x0195,4.330508,active-noncovalent
Cc1cc2c(o1)cc(cc2Oc3cnc(nc3)C(=O)N(C)C)C(=O)Nc4cnc(cn4)C,BRD-K27755542-001-01-6,PF-04937319,Sigma,PZ0320,,-8.089417,x0161,9.079286,active-noncovalent
Cc1ccccc1[C@H](C(=O)NC2CCCCC2)N(c3cccc(c3)F)C(=O)Cn4ccnc4C,BRD-A56371469-001-03-3,AGI-5198,Selleck,S7185,AGI-5198,-8.088991,x0434,6.199118,active-noncovalent
C[C@@H](c1cc2cccc(c2c(=O)n1c3ccccc3)Cl)Nc4c5c([nH]cn5)ncn4,BRD-K93468883-001-02-0,IPI-145,Selleck,S7028,IPI-145 (INK1197),-8.086636,x0678,1.492673,active-noncovalent
c1ccc(cc1)C(C#N)(c2ccccc2)c3ccccc3Cl,BRD-K81341251-001-01-9,TRAM-39,Tocris,4952,TRAM 39,-8.086554,x0831,1.611564,active-covalent
CC(C)c1ccc(cc1S(=O)(=O)C)C(=O)NC(=[NH2+])N,BRD-K21670884-001-01-9,cariporide,SantaCruz,sc-337619A,,-8.086206,x0874,-0.508025,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cc(cc3)C#N)C[NH+](C)C,BRD-A42881122-001-01-1,cyamemazine,Sigma,MFCD00868180,10-[3-(dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile,-8.086164,x0195,1.344982,active-noncovalent
Cc1c(cc(n1CCC[NH+]2CCOCC2)c3ccccc3)C(=O)Nc4cccc(c4)C(F)(F)F,BRD-K03391209-001-02-0,HC-067047,Tocris,4100,HC 067047,-8.085832,x0678,7.082258,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NCl,BRD-K93546328-236-02-8,chloramine-t,MicroSource,1504506,CHLORAMINE-T,-8.084645,x0195,-0.099806,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3cccc(c3)Cl,BRD-K68336408-001-10-9,tyrphostin-AG-1478,Selleck,S2728,AG-1478 (Tyrphostin AG-1478),-8.084390,x0195,0.698656,active-noncovalent
Cc1cc(cc(c1OCCCc2cc(no2)C)C)c3nc(on3)C(F)(F)F,BRD-K27625831-001-02-9,pleconaril,MedChemEx,HY-19952,Pleconaril,-8.083837,x0104,4.480647,active-noncovalent
Cc1cc(cc(c1OCCCc2cc(no2)C)C)c3nc(on3)C(F)(F)F,BRD-K27625831-001-01-1,pleconaril,SantaCruz,sc-391701,,-8.083837,x0104,4.480647,active-noncovalent
COc1ccc(cc1OC)c2cc(=O)c3c(o2)cc(c(c3[O-])OC)O,BRD-K47031502-001-02-4,eupatilin,MedChemEx,HY-N0783,Eupatilin,-8.083821,x0749,4.983503,active-covalent
COc1ccc(cc1OC)c2cc(=O)c3c(o2)cc(c(c3[O-])OC)O,BRD-K47031502-001-01-6,eupatilin,Astatech,SC3971,,-8.083821,x0749,4.983503,active-covalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OC(=O)C,BRD-K92902018-001-01-9,hydroxyprogesterone-acetate,Sigma,MFCD00021156,"3,20-dioxopregn-4-en-17-yl acetate",-8.082519,x0161,5.115191,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO,BRD-K99063460-001-13-1,didanosine,Selleck,S1702,Didanosine (Videx),-8.082516,x0874,-0.656635,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO,BRD-K99063460-001-12-3,didanosine,Selleck,S1702,Didanosine,-8.082516,x0874,-0.656635,active-noncovalent
COc1ccc(cc1[C@]2(c3ccc(cc3NC2=O)C(F)(F)F)F)Cl,BRD-K56740996-001-02-1,flindokalner,Tocris,4949,MaxiPost,-8.082101,x0072,0.736968,active-noncovalent
COc1ccc(cc1[C@]2(c3ccc(cc3NC2=O)C(F)(F)F)F)Cl,BRD-K56740996-001-01-3,flindokalner,Sigma,SML1313,"(3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one",-8.082101,x0072,0.736968,active-noncovalent
CC[NH2+]Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C,BRD-K85804405-003-01-3,LY231617,Otava,4920201,"2,6-ditert-butyl-4-[(ethylamino)methyl]phenol hydrochloride",-8.080976,x0195,-0.989855,active-noncovalent
c1cc(c(cc1[C@H](C[NH3+])O)O)O,BRD-K87349682-001-04-9,norepinephrine,MicroSource,1500436,NOREPINEPHRINE,-8.080631,x1077,0.641569,active-noncovalent
c1cc(c(cc1[C@H](C[NH3+])O)O)O,BRD-K87349682-347-03-8,norepinephrine,Selleck,S2615,Noradrenaline bitartrate monohydrate (Levoph,-8.080631,x1077,0.641569,active-noncovalent
c1cc(c(cc1[C@H](C[NH3+])O)O)O,BRD-K87349682-347-02-0,norepinephrine,Selleck,S2615,Noradrenaline bitartrate monohydrate,-8.080631,x1077,0.641569,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CCC2=O)OS(=O)(=O)[O-],BRD-A22143024-231-03-8,estropipate,MicroSource,1505116,ESTROPIPATE,-8.079415,x0749,6.142692,active-covalent
C[n+]1ccc(cc1)C(=O)NCc2ccccc2,BRD-K10029415-005-06-9,enisamium-iodide,Vitas-M,STL194198,,-8.078783,x0072,-0.229624,active-noncovalent
C[C@@H]1C[N@H+](CCN1C(=O)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl)C,BRD-K41626799-001-01-1,AZD3759,MedChemEx,HY-18750,AZD3759,-8.078625,x0195,7.929772,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCCCCC2)C,BRD-K90727284-001-05-0,pincainide,Enamine,Z46160202,"2-(1-azepanyl)-N-(2,6-dimethylphenyl)acetamide",-8.077922,x0104,0.427889,active-noncovalent
C[C@H]1C[N@@H+](CC[C@@]1(C)c2cccc(c2)O)C[C@H](C(C)C)NC(=O)[C@H]3Cc4ccc(cc4C[NH2+]3)O,BRD-K95837862-300-01-7,JDTic,MedChemEx,HY-10487,JDTic (dihydrochloride),-8.077757,x1077,6.057244,active-noncovalent
CC[NH+](CC)Cc1ccc(cc1)C(=O)N(CCc2ccccc2OC)[C@@H]3CC[NH2+]C3,BRD-K11821338-300-01-8,PF-429242,Tocris,3354,PF 429242,-8.077729,x0161,2.82457,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)CCN(C)C,BRD-K36864847-303-02-5,BD-1047,Tocris,956,BD 1047 dihydrobromide,-8.077511,x0161,1.166687,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)CCN(C)C,BRD-K36864847-303-03-3,BD-1047,Tocris,956,BD 1047 dihydrobromide,-8.077511,x0161,1.166687,active-noncovalent
c1cc2c(cc1Nc3ccc(cc3F)F)CCc4ccc(cc4C2=O)OC[C@@H](CO)O,BRD-K83607951-001-02-2,skepinone-l,Selleck,S7214,Skepinone-L,-8.077421,x0104,7.290931,active-noncovalent
Cn1cc(cn1)CCn2cnc(c2c3ccc(cc3)C#N)c4cnn(c4)C,BRD-K66830666-001-01-9,BAZ2-ICR,Tocris,5266,BAZ2-ICR,-8.077212,x0678,2.80728,active-noncovalent
c1cc2c(cc1)C[C@@H](CC2)C[NH2+]C[C@H]3CC[C@@H](CC3)CNS(=O)(=O)c4c(cccc4)N(=O)=O,BRD-A40413915-003-01-2,NTNCB,Tocris,2155,NTNCB hydrochloride,-8.076832,x0104,10.263242,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)OC)[O-])O)C,BRD-A61299447-001-01-0,"5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione",Sigma,MFCD22422519,"5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)chromane-3,4-dione",-8.076475,x0195,3.257965,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)OC)[O-])O)C,BRD-K24476327-001-01-3,icaritin,MedChemEx,HY-N0678,Icaritin,-8.076475,x0195,3.257965,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)OC)[O-])O)C,BRD-K24476327-001-02-1,icaritin,MedChemEx,HY-N0678,Icaritin,-8.076475,x0195,3.257965,active-noncovalent
CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)/C=C/C[NH+]3CCCCC3)N(C1=O)S(=O)(=O)C,BRD-K37864785-001-01-0,GW-311616,MedChemEx,HY-15891,GW311616,-8.075225,x0195,3.464208,active-noncovalent
Cc1cc(=O)n(n1C)c2ccccc2,BRD-K46937689-001-15-0,phenazone,MicroSource,1500128,ANTIPYRINE,-8.075042,x0195,-0.890955,active-noncovalent
Cc1cc(=O)n(n1C)c2ccccc2,BRD-K46937689-001-14-3,phenazone,Selleck,S3173,Antipyrine,-8.075042,x0195,-0.890955,active-noncovalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2cccc3c2non3)C(=O)OC(C)C,BRD-A90799790-001-20-7,isradipine,Tocris,2004,Isradipine,-8.074436,x0831,1.434487,active-covalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2cccc3c2non3)C(=O)OC(C)C,BRD-A90799790-001-17-3,isradipine,Tocris,2004,Isradipine,-8.074436,x0831,1.434487,active-covalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2cccc3c2non3)C(=O)OC(C)C,BRD-A90799790-001-16-5,isradipine,Selleck,S1662,Isradipine,-8.074436,x0831,1.434487,active-covalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2cccc3c2non3)C(=O)OC(C)C,BRD-A90799790-001-19-9,isradipine,MicroSource,2300234,ISRADIPINE,-8.074436,x0831,1.434487,active-covalent
C[C@H]1C(=O)N(c2cnc(nc2[N@@]1CCC(C)C)Nc3cc(c(c(c3)F)[O-])F)C,BRD-A81370665-001-06-9,BI-D1870,MedChemEx,HY-10510,BI-D1870,-8.074274,x0104,3.95777,active-noncovalent
C[C@H]1C(=O)N(c2cnc(nc2[N@@]1CCC(C)C)Nc3cc(c(c(c3)F)[O-])F)C,BRD-A81370665-001-04-4,BI-D1870,Selleck,S2843,BI-D1870,-8.074274,x0104,3.95777,active-noncovalent
C[C@H]1C(=O)N(c2cnc(nc2[N@@]1CCC(C)C)Nc3cc(c(c(c3)F)[O-])F)C,BRD-A81370665-001-03-6,BI-D1870,Selleck,S2843,BI-D1870,-8.074274,x0104,3.95777,active-noncovalent
C[NH+](C)CCN(C)c1cc(c(cc1NC(=O)C=C)Nc2nccc(n2)c3c[nH]c4c3cccc4)OC,BRD-K81958169-001-01-1,AZ5104,Selleck,S7298,AZ5104,-8.074039,x0104,12.638021,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4ccc5c(c4)[nH]c(n5)c6ccc(cc6)O,BRD-K17026858-001-01-2,pibenzimol,MedChemEx,HY-15558,Hoechst 33258,-8.073908,x0104,13.436482,active-noncovalent
CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C23CCC3)c4cc(c(nc4)C#N)C(F)(F)F,BRD-K91308639-001-02-7,apalutamide,Selleck,S2840,ARN-509,-8.073809,x0161,11.685003,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,BRD-K01095011-001-14-2,finasteride,Selleck,S1197,Finasteride,-8.073549,x0104,4.317053,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,BRD-K01095011-001-15-9,finasteride,MicroSource,1506069,FINASTERIDE,-8.073549,x0104,4.317053,active-noncovalent
Cc1c-2c(on1)[C@@H](N=C(c3c2cccc3)c4ccc(cc4)Cl)CC(=O)N,BRD-K19871656-001-01-3,CPI-0610,MedChemEx,HY-12863,CPI-0610,-8.072785,x0195,0.528279,active-noncovalent
CCC[S@](=O)c1ccc2c(c1)[nH]c(n2)NC(=O)OC,BRD-A67060370-001-02-9,albendazole-oxide,Selleck,S1836,Albendazole Oxide,-8.072536,x0195,0.700318,active-noncovalent
C[C@]12CC[C@H]([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(CO)O)(C)CO)O,BRD-K85140930-001-12-7,aphidicolin,Enzo,CC101,Aphidicolin,-8.072189,x0749,1.015151,active-covalent
COc1c(ccc2c1n/c(=[NH+]/C(=O)c3cnc(nc3)N)/n4c2NCC4)OCCC[NH+]5CCOCC5,BRD-K24666289-001-04-9,copanlisib,MedChemEx,HY-15346,BAY 80-6946,-8.071752,x0104,9.738357,active-noncovalent
COc1c(ccc2c1n/c(=[NH+]/C(=O)c3cnc(nc3)N)/n4c2NCC4)OCCC[NH+]5CCOCC5,BRD-K24666289-001-02-3,copanlisib,MedChemEx,HY-15346,BAY 80-6946,-8.071752,x0104,9.738357,active-noncovalent
COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c2ccccc2Cc3ccc4ccccc4c3)Br,BRD-K43905307-001-01-2,"L-798,106",Tocris,3342,"L-798,106",-8.071481,x0967,4.704815,active-noncovalent
COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c2ccccc2Cc3ccc4ccccc4c3)Br,BRD-K43905307-001-02-0,"L-798,106",Tocris,3342,"L-798,106",-8.071481,x0967,4.704815,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)[O-],BRD-K49759007-001-11-9,4-hydroxy-phenazone,Prestwick,Prestw-30,"Antipyrine, 4-hydroxy",-8.070366,x0195,-1.795038,active-noncovalent
CC(C)Sc1ccc2c(c1)[nH]c(n2)NC(=O)OC,BRD-K02764365-001-13-6,methiazole,Prestwick,Prestw-1080,Methiazole,-8.070083,x0195,0.73791,active-noncovalent
CC[C@H]1c2cc(c(cc2C(=NN=C1C)c3ccc(c(c3)OC)OC)OC)OC,BRD-K94830213-001-01-3,tofisopam,Sigma,MFCD00823171,"1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine d_1_",-8.069748,x0434,3.212898,active-noncovalent
Cc1cc(nc(n1)SCC(=O)Nc2ncc(s2)Cc3cccc4c3cccc4)C,BRD-K16472653-001-01-6,SirReal-2,Tocris,5457,SirReal 2,-8.067632,x0161,4.580142,active-noncovalent
C1C[C@@H]2[C@@H]3CCCN4(=O)[C@H]3[C@H](CCC4)CN2C(=O)C1,BRD-A57833392-001-01-7,oxymatrine,Selleck,S2338,Oxymatrine,-8.066957,x0195,-0.177332,active-noncovalent
CCOc1ccccc1O[C@H](c2ccccc2)[C@@H]3C[NH2+]CCO3,BRD-A43974499-066-02-9,reboxetine,Cayman,15038,2-((2-ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate,-8.066821,x1392,1.151294,active-covalent
CCS(=O)(=O)[N@@](Cc1cccnc1)c2cccc(c2)c3ccc(cc3)C#N,BRD-K34675210-003-01-4,CBiPES,Tocris,3949,CBiPES hydrochloride,-8.065010,x0107,4.101642,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,BRD-K47635719-001-20-3,dexamethasone-acetate,Selleck,S3124,Dexamethasone acetate,-8.064781,x1077,4.002753,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,BRD-K47635719-001-21-1,dexamethasone-acetate,MicroSource,1500231,DEXAMETHASONE ACETATE,-8.064781,x1077,4.002753,active-noncovalent
c1ccc(cc1)C2(CCCCC2)C(=O)OCC[NH+]3CCOCC3,BRD-K57304726-003-07-7,PRE-084,Tocris,589,PRE-084 hydrochloride,-8.063684,x0678,1.737202,active-noncovalent
c1ccc(cc1)C2(CCCCC2)C(=O)OCC[NH+]3CCOCC3,BRD-K57304726-003-06-9,PRE-084,Tocris,589,PRE-084 hydrochloride,-8.063684,x0678,1.737202,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])[NH3+],BRD-K00911807-003-01-2,D-Phenylalanine,MicroSource,1503391,D-PHENYLALANINE,-8.063537,x0195,-0.219731,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])[NH3+],BRD-K00911807-001-04-0,D-Phenylalanine,Selleck,S4153,D-Phenylalanine,-8.063537,x0195,-0.219731,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])[NH3+],BRD-K00911807-001-03-2,D-Phenylalanine,Selleck,S4153,D-Phenylalanine,-8.063537,x0195,-0.219731,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)CC[NH3+],BRD-K38580127-003-15-4,serotonin,Selleck,S4244,Serotonin HCl,-8.063527,x0678,-2.660199,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)CC[NH3+],BRD-K38580127-003-17-0,serotonin,Selleck,S4244,Serotonin HCl,-8.063527,x0678,-2.660199,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)CC[NH3+],BRD-K38580127-003-16-2,serotonin,Tocris,3547,Serotonin hydrochloride,-8.063527,x0678,-2.660199,active-noncovalent
CS(=O)(=O)c1ccc(cc1)Cn2c3c(cc(cc3F)F)c4c2[C@H](CCC4)CC(=O)[O-],BRD-A85472596-001-02-2,L-670596,Tocris,1949,"L-670,596",-8.063210,x0195,3.369994,active-noncovalent
Cc1cc(c(cc1Br)NC(=O)Nc2cnc(cn2)C)OC[C@@H]3C[NH2+]CCO3,BRD-K14109347-001-05-9,LY2603618,Selleck,S2626,LY2603618 (IC-83),-8.061742,x0678,3.695373,active-noncovalent
Cc1cc(c(cc1Br)NC(=O)Nc2cnc(cn2)C)OC[C@@H]3C[NH2+]CCO3,BRD-K14109347-001-03-4,LY2603618,Selleck,S2626,LY2603618,-8.061742,x0678,3.695373,active-noncovalent
CCc1ccc(nc1)CCOc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,BRD-A48430263-003-19-8,pioglitazone,Tocris,4124,Pioglitazone hydrochloride,-8.061571,x0161,3.622119,active-noncovalent
CCc1ccc(nc1)CCOc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,BRD-A48430263-003-17-2,pioglitazone,MicroSource,1504401,PIOGLITAZONE HYDROCHLORIDE,-8.061571,x0161,3.622119,active-noncovalent
CCc1ccc(nc1)CCOc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,BRD-A48430263-003-16-4,pioglitazone,Selleck,S2046,Pioglitazone HCl,-8.061571,x0161,3.622119,active-noncovalent
CCc1ccc(nc1)CCOc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,BRD-A48430263-001-07-7,pioglitazone,Selleck,S2590,Pioglitazone,-8.061571,x0161,3.622119,active-noncovalent
CC1([C@@H](N2[C@H](S1)/C(=N\C[NH+]3CCCCCC3)/C2=O)C(=O)OCOC(=O)C(C)(C)C)C,BRD-K67100011-001-01-8,pivmecillinam,Sigma,SML0817,"[(2,2-dimethylpropanoyl)oxy]methyl (2S,5R,6R)-6-{[(E)-1-azepanylmethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-8.060032,x0161,4.655313,active-noncovalent
CC1([C@@H](N2[C@H](S1)/C(=N\C[NH+]3CCCCCC3)/C2=O)C(=O)OCOC(=O)C(C)(C)C)C,BRD-K67100011-003-07-1,pivmecillinam,MedChemEx,HY-B0810A,Pivmecillinam (hydrochloride),-8.060032,x0161,4.655313,active-noncovalent
CC1([C@@H](N2[C@H](S1)/C(=N\C[NH+]3CCCCCC3)/C2=O)C(=O)OCOC(=O)C(C)(C)C)C,BRD-K67100011-003-06-3,pivmecillinam,Prestwick,Prestw-1053,Pivmecillinam hydrochloride,-8.060032,x0161,4.655313,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCc3ccccc3N(C2=O)CC(=O)[O-],BRD-K49807096-003-14-8,benazepril,Selleck,S1284,Benazepril HCl,-8.059981,x1077,2.697432,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCc3ccccc3N(C2=O)CC(=O)[O-],BRD-K49807096-003-16-3,benazepril,MicroSource,1505200,BENAZEPRIL HYDROCHLORIDE,-8.059981,x1077,2.697432,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCc3ccccc3N(C2=O)CC(=O)[O-],BRD-K49807096-003-17-1,benazepril,Tocris,2578,Benazepril hydrochloride,-8.059981,x1077,2.697432,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCc3ccccc3N(C2=O)CC(=O)[O-],BRD-K49807096-003-15-5,benazepril,Tocris,2578,Benazepril hydrochloride,-8.059981,x1077,2.697432,active-noncovalent
COc1cc(c(c(c1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)Nc3ccc(cc3F)I)F)F,BRD-K85751432-001-03-3,refametinib,MedChemEx,HY-14691,Refametinib,-8.058771,x0874,4.262965,active-noncovalent
CC1(CCCCC1)COc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,BRD-A93000692-001-08-1,ciglitazone,Tocris,1307,Ciglitazone,-8.058140,x0072,2.13171,active-noncovalent
CC(C)(C(=O)NO)NS(=O)(=O)c1ccc(cc1)Oc2ccc(cc2)F,BRD-K33234937-001-01-7,CP-471474,Tocris,3780,CP 471474,-8.056687,x0161,3.189416,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)O)O)O)[O-])O)O)O)O)O)O,BRD-K20482099-001-10-2,rutin,Selleck,S2350,Rutin,-8.056040,x0161,10.051561,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)O)O)O)[O-])O)O)O)O)O)O,BRD-K20482099-001-11-0,rutin,MicroSource,300607,RUTIN,-8.056040,x0161,10.051561,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)O)O)O)[O-])O)O)O)O)O)O,BRD-K20482099-001-09-4,rutin,Selleck,S2350,Rutin (Rutoside),-8.056040,x0161,10.051561,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc4c(n3)N(c5ccccc5C(=O)N4C)C,BRD-K64857848-001-06-4,ERK5-IN-1,MedChemEx,HY-14403,ERK5-IN-1,-8.056010,x0161,9.520687,active-noncovalent
CCC[NH+](CCC)CCc1ccc(c(c1)OCCc2ccccc2)OC,BRD-K11443721-003-01-6,NE-100,Tocris,3133,N-{2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethyl}-N-propyl-1-propanamine hydrochloride,-8.055286,x0946,3.897025,active-noncovalent
CCC[NH+](CCC)CCc1ccc(c(c1)OCCc2ccccc2)OC,BRD-K11443721-003-02-4,NE-100,Tocris,3133,NE 100 hydrochloride,-8.055286,x0946,3.897025,active-noncovalent
CC(C)C[C@H]1c2c(c3ccc(cc3[nH]2)OC)C[C@@H]4N1C(=O)[C@@H](NC4=O)CCC(=O)OC(C)(C)C,BRD-K64642496-001-03-2,Ko143,MedChemEx,HY-10010,Ko 143,-8.055276,x0161,6.2082,active-noncovalent
CC(C)C[C@H]1c2c(c3ccc(cc3[nH]2)OC)C[C@@H]4N1C(=O)[C@@H](NC4=O)CCC(=O)OC(C)(C)C,BRD-K64642496-001-04-0,Ko143,Tocris,3241,Ko 143,-8.055276,x0161,6.2082,active-noncovalent
C[NH+]1CCC(CC1)NC(=O)c2cc(c(cc2F)Nc3ncc4c(n3)[N@@](CC(C(=O)N4C)(F)F)C5CCCC5)OC,BRD-K48059512-003-01-0,TAK-960,Tocris,5403,TAK 960 hydrochloride,-8.053601,x0104,12.81145,active-noncovalent
C[NH+]1CCC(CC1)NC(=O)c2cc(c(cc2F)Nc3ncc4c(n3)[N@@](CC(C(=O)N4C)(F)F)C5CCCC5)OC,BRD-K48059512-001-01-4,TAK-960,MedChemEx,HY-15160,TAK-960,-8.053601,x0104,12.81145,active-noncovalent
CCNC(=O)/C=C/c1cccc(c1)Br,BRD-K66241279-001-01-8,cinromide,MicroSource,1502552,CINROMIDE,-8.053030,x0104,-1.147967,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,BRD-K62213621-001-01-6,dihydroartemisinin,Selleck,S2290,Dihydroartemisinin (DHA),-8.052610,x0195,0.511201,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,BRD-K62213621-001-02-4,dihydroartemisinin,MicroSource,1504143,ARTENIMOL,-8.052610,x0195,0.511201,active-noncovalent
Cc1cc(c(cc1)/[NH+]=C/N(/C=[NH+]/c2c(cc(cc2)C)C)C)C,BRD-K33335792-001-04-0,amitraz,MicroSource,1505299,AMITRAZ,-8.051087,x0104,2.728761,active-noncovalent
Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl,BRD-K86309810-001-01-5,ravoxertinib,Adooq,A13420,(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one,-8.050423,x0161,9.257073,active-noncovalent
Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl,BRD-A20830788-001-01-9,GDC-0994,Selleck,S7554,GDC-0994,-8.050423,x0161,9.257073,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N,BRD-K20484910-001-14-7,ampyrone,Prestwick,Prestw-181,Ampyrone,-8.050354,x0195,-0.715918,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)N,BRD-K06644925-001-03-0,oleamide,Tocris,878,Oleamide,-8.049994,x0072,2.465363,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Br)Br,BRD-K23301018-001-10-9,broxyquinoline,MicroSource,1500623,BROXYQUINOLINE,-8.049944,x0195,-1.239858,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Br)Br,BRD-K23301018-001-09-1,broxyquinoline,Selleck,S4195,Broxyquinoline,-8.049944,x0195,-1.239858,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Br)Br,BRD-K23301018-001-11-7,broxyquinoline,Selleck,S4195,Broxyquinoline,-8.049944,x0195,-1.239858,active-noncovalent
CCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C)C,BRD-K31627533-001-09-5,rimexolone,Prestwick,Prestw-1020,Rimexolone,-8.049366,x0104,4.36096,active-noncovalent
CC(C)(CC(=O)N1CCCC1)[NH2+]CC(=O)N2C[C@H](C[C@H]2C#N)F,BRD-K83020231-001-01-2,DBPR108,MedChemEx,HY-12528,DBPR108,-8.048960,x0195,0.946783,active-noncovalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4)CC5CC5,BRD-A99899486-004-01-9,cimetropium,Sigma,MFCD00869708,"(1R,2R,4S,5S)-9-(cyclopropylmethyl)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide",-8.048899,x0072,3.328525,active-noncovalent
CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=[NH+]1)N,BRD-K80431395-001-04-0,triciribine,Tocris,2151,API-2,-8.048512,x0104,0.653029,active-noncovalent
CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=[NH+]1)N,BRD-K80431395-001-07-3,triciribine,Selleck,S1117,Triciribine (Triciribine phosphate),-8.048512,x0104,0.653029,active-noncovalent
CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=[NH+]1)N,BRD-K80431395-001-09-9,triciribine,Selleck,S1117,Triciribine,-8.048512,x0104,0.653029,active-noncovalent
CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=[NH+]1)N,BRD-K80431395-001-08-1,triciribine,Tocris,2151,API-2,-8.048512,x0104,0.653029,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=O)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K49671696-001-05-4,ketanserin,Selleck,S2232,Ketanserin,-8.048051,x0107,3.866022,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=O)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K49671696-046-01-8,ketanserin,MicroSource,1505346,KETANSERIN TARTRATE,-8.048051,x0107,3.866022,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=O)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K49671696-045-08-5,ketanserin,Tocris,908,Ketanserin tartrate,-8.048051,x0107,3.866022,active-noncovalent
c1cc(ccc1SC(P(=O)([O-])[O-])P(=O)([O-])[O-])Cl,BRD-K10845183-304-01-6,tiludronate,Enzo,AC3269,TILUDRONATE DISODIUM,-8.047916,x0831,0.11147,active-covalent
CCCCCCC[n+]1ccc(cc1)c2cc[n+](cc2)CCCCCCC,BRD-K41262162-303-02-2,DHBP,Tocris,839,DHBP dibromide,-8.047262,x0161,6.685586,active-noncovalent
Cc1c(c(c(c2c1O[C@@](CC2)(C)CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)C)C,BRD-A61850409-001-10-7,alpha-tochopheryl-acetate,MicroSource,310040,alpha-TOCHOPHERYL ACETATE [4mM],-8.047083,x0161,6.857991,active-noncovalent
COc1cc(c(cc1C(=O)CCC2CC[NH+](CC2)CCNS(=O)(=O)C)Cl)N,BRD-K50018155-003-02-1,RS-67506,Tocris,990,RS 67506 hydrochloride,-8.047054,x0104,3.360257,active-noncovalent
CCCOc1ccc2c(c1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC)C,BRD-K75097983-001-01-0,promestriene,Carbosynth,PROMESTRIENE,"(17beta)-17-methoxy-3-propoxyestra-1,3,5(10)-triene",-8.046851,x0104,5.437048,active-noncovalent
CCOc1ccc(cc1)N/C(=[NH+]\c2ccc(cc2)OCC)/C,BRD-K81092066-311-01-6,phenacaine,MPBio,5201349,PHENACAINE HCl MONOHYDRATE,-8.046440,x0678,2.827523,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)OP(=O)([O-])[O-],BRD-A73427433-240-01-3,adaprev,TCI,G0052,,-8.045837,x0397,1.649929,active-noncovalent
CCc1c(c(n(n1)CCO)CC)Oc2cc(cc(c2)C#N)C#N,BRD-K03289534-001-01-4,lersivirine,MedChemEx,HY-14267,Lersivirine,-8.045688,x0749,0.774915,active-covalent
C[C@]12CCCC([C@@H]1CC[C@@]3([C@@H]2CC(=O)O3)C)(C)C,BRD-K72925150-001-11-1,sclareolide,Selleck,S2355,Sclareolide,-8.045598,x1311,1.21164,active-covalent
C[C@]12CCCC([C@@H]1CC[C@@]3([C@@H]2CC(=O)O3)C)(C)C,BRD-K72925150-001-10-3,sclareolide,Selleck,S2355,Sclareolide (Norambreinolide),-8.045598,x1311,1.21164,active-covalent
CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)[O-],BRD-K38197229-001-29-9,bumetanide,MicroSource,1502004,BUMETANIDE,-8.045586,x1418,2.489038,active-covalent
CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)[O-],BRD-K38197229-001-28-1,bumetanide,Selleck,S1287,Bumetanide,-8.045586,x1418,2.489038,active-covalent
CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)[O-],BRD-K38197229-001-31-5,bumetanide,Tocris,3108,Bumetanide,-8.045586,x1418,2.489038,active-covalent
CCCCOC(=O)c1ccccc1C(=O)OCCCC,BRD-K73477617-001-08-5,dibutyl-phthalate,MicroSource,330086,DIBUTYL PHTHALATE,-8.044425,x0678,0.713128,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@]35[C@H](O5)C[C@@H]4c6ccc(=O)oc6)C)O,BRD-K25970317-001-01-6,resibufogenin,MedChemEx,HY-N0815,Resibufogenin,-8.043370,x1077,5.679932,active-noncovalent
c1ccc2c(c1)ncc3n2c(=O)on3,BRD-K26015241-001-03-6,ODQ,Tocris,880,ODQ,-8.043167,x0195,-1.002345,active-noncovalent
c1ccc2c(c1)ncc3n2c(=O)on3,BRD-K26015241-001-04-4,ODQ,Tocris,880,ODQ,-8.043167,x0195,-1.002345,active-noncovalent
C1CC[N@H+]2C[C@H]3C[C@@H]([C@H]2C1)C=C4[C@H]3[NH2+]CCC4,BRD-K96391852-001-02-8,aloperine,Selleck,S2420,Aloperine,-8.043051,x0831,0.518654,active-covalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)/C=C/C(=O)NCc3ccc(cc3)OC,BRD-K98155362-001-07-7,GR46611,Tocris,864,GR 46611,-8.042381,x0161,5.883855,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)/C=C/C(=O)NCc3ccc(cc3)OC,BRD-K98155362-001-08-5,GR46611,Tocris,864,GR 46611,-8.042381,x0161,5.883855,active-noncovalent
COC(=O)/C=C/c1cc(ccc1O)O,BRD-K35573744-001-06-8,erbstatin-analog,Tocris,577,"Methyl 2,5-dihydroxycinnamate",-8.041966,x0749,-1.39393,active-covalent
COc1cc(c(cc1C(=O)OCCC[NH+]2CCCCC2)Cl)N,BRD-K01868942-003-02-7,RS-23597-190,Tocris,728,RS 23597-190 hydrochloride,-8.041738,x1311,3.526006,active-covalent
CC(C)(C)c1cc(cc(c1O)Br)C=C(C#N)C#N,BRD-K08310154-001-03-8,AG-1024,Selleck,S1234,AG-1024,-8.041611,x0161,-0.443243,active-noncovalent
CCOC(=O)C(=O)Nc1cccc(c1C(=O)N)OC,BRD-K43419711-001-01-4,Wy-16922,Sigma,PH006760,ethyl [2-(aminocarbonyl)-3-methoxyanilino](oxo)acetate,-8.041411,x0195,0.395076,active-noncovalent
Cc1cccc(c1)NC(=O)/N=c\2/c(=O)n(c3ccccc3c(n2)c4ccccc4)C[C@@H](c5ccccc5C)O,BRD-K09436144-001-01-7,YM022,Sigma,MFCD00917023,"N-(3-methylphenyl)-N'-{(3R)-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl}urea",-8.041023,x0967,6.241793,active-noncovalent
CC1(CN2C(=CSC2=[NH+]1)CS/C(=[NH+]/C3CCCCC3)/NC4CCCCC4)C,BRD-K73499906-300-01-0,IT1t,Tocris,4596,IT1t,-8.040545,x0967,2.085173,active-noncovalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-14-4,tetracycline,MedChemEx,HY-B0474,Tetracycline (hydrochloride),-8.039650,x0831,1.352145,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-10-2,tetracycline,Selleck,S2574,Tetracycline hydrochloride,-8.039650,x0831,1.352145,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-09-4,tetracycline,MicroSource,1500566,TETRACYCLINE HYDROCHLORIDE,-8.039650,x0831,1.352145,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-13-6,tetracycline,MedChemEx,HY-B0474,Tetracycline (hydrochloride),-8.039650,x0831,1.352145,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-08-6,tetracycline,Selleck,S2574,Tetracycline HCl,-8.039650,x0831,1.352145,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,BRD-A34788695-003-12-8,tetracycline,Sigma,T3383,"(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide hydrochloride",-8.039650,x0831,1.352145,active-covalent
CC(=O)NCCc1c2cc(ccc2[nH]c1I)OC,BRD-K25649279-001-02-0,2-iodomelatonin,Tocris,737,2-Iodomelatonin,-8.039362,x0967,-0.590816,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(c(c3)Oc4ccc5c(c4)CC(=O)N5)C,BRD-K61845293-300-01-9,DDR1-IN-1,Tocris,5077,DDR1-IN-1,-8.039228,x0395,15.935494,active-noncovalent
CCOC(=O)CCNc1cc(nc(n1)c2cccnc2)N3CCc4ccccc4CC3,BRD-K55438324-001-01-8,GSK-J5,Tocris,4689,GSK J5,-8.038395,x0678,7.362231,active-noncovalent
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],BRD-K95237249-001-26-5,probenecid,MicroSource,1500502,PROBENECID,-8.038395,x0678,-0.896455,active-noncovalent
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],BRD-K95237249-001-25-7,probenecid,Selleck,S4022,Probenecid,-8.038395,x0678,-0.896455,active-noncovalent
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],BRD-K95237249-001-27-3,probenecid,Tocris,4107,Probenecid,-8.038395,x0678,-0.896455,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N(CCCl)CCCl,BRD-K10180294-001-07-3,uracil-mustard,MedChemEx,HY-13544,Uramustine,-8.036856,x1077,-0.049812,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N(CCCl)CCCl,BRD-K10180294-001-04-0,uracil-mustard,Sigma,MFCD00085645,"5-[bis(2-chloroethyl)amino]-2,4(1H,3H)-pyrimidinedione",-8.036856,x1077,-0.049812,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N(CCCl)CCCl,BRD-K10180294-001-06-5,uracil-mustard,MedChemEx,HY-13544,Uramustine,-8.036856,x1077,-0.049812,active-noncovalent
C[N@@H+](CC#C)Cc1ccccc1,BRD-K83597974-003-22-2,pargyline,MicroSource,1500462,PARGYLINE HYDROCHLORIDE,-8.036759,x0678,-0.773641,active-noncovalent
C[C@H](c1cccc2c1cccc2)[NH2+]CCCc3cccc(c3)C(F)(F)F,BRD-K73838513-003-05-5,cinacalcet,Selleck,S1260,Cinacalcet HCl,-8.036066,x1093,0.82883,active-noncovalent
CC(C)CCOC(=O)/C=C/c1ccc(cc1)OC,BRD-K37851352-001-01-0,isopentyl-4-methoxycinnamate,Enamine,Z212714982,,-8.035893,x0104,0.911788,active-noncovalent
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO,BRD-K57080016-001-15-9,selumetinib,Selleck,S1008,Selumetinib (AZD6244),-8.035765,x1392,1.964057,active-covalent
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO,BRD-K57080016-001-19-1,selumetinib,Selleck,S1008,selumetinib,-8.035765,x1392,1.964057,active-covalent
c1cc(sc1)CNc2cc(c(cc2c3n[n-]nn3)S(=O)(=O)N)Cl,BRD-K68770713-001-01-8,azosemide,AKSci,69592,,-8.035453,x0678,1.804828,active-noncovalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4,BRD-K27351809-001-09-5,nomegestrol-acetate,Prestwick,Prestw-1033,Nomegestrol acetate,-8.035282,x0749,3.400102,active-covalent
CCn1c2cc3c(cc2c(=O)c(n1)C(=O)[O-])OCO3,BRD-K14704277-001-22-6,cinoxacin,Selleck,S4361,Cinoxacin,-8.035224,x0749,0.17175,active-covalent
CCn1c2cc3c(cc2c(=O)c(n1)C(=O)[O-])OCO3,BRD-K14704277-001-23-4,cinoxacin,MicroSource,1500190,CINOXACIN,-8.035224,x0749,0.17175,active-covalent
CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)/C=C/c2ccc(cc2)C(=O)[O-],BRD-K71487808-001-02-8,CH55,Tocris,2020,Ch 55,-8.035036,x0072,3.906791,active-noncovalent
CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)/C=C/c2ccc(cc2)C(=O)[O-],BRD-K71487808-001-03-6,CH55,Tocris,2020,Ch 55,-8.035036,x0072,3.906791,active-noncovalent
c1cc2c(cc1COc3ccc(cc3CCC(=O)[O-])C(=O)c4ccc(cc4O)OC5CCCC5)o[nH]c2=O,BRD-K84925803-001-01-9,T-5224,MedChemEx,HY-12270,T-5224,-8.034080,x0104,11.11045,active-noncovalent
CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c3c2ccc(c3)Nc4ncc(c(n4)NC5CCC5)C(F)(F)F,BRD-K68747584-001-03-8,PF-03814735,Tocris,4821,PF 03814735,-8.033995,x0195,10.396976,active-noncovalent
CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c3c2ccc(c3)Nc4ncc(c(n4)NC5CCC5)C(F)(F)F,BRD-K68747584-001-02-0,PF-03814735,MedChemEx,HY-14574,PF-03814735,-8.033995,x0195,10.396976,active-noncovalent
CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc2cccnc2,BRD-K44869961-001-01-6,GPI-1046,Key,ES-0040,"(S)-3-(pyridin-3-yl)propyl 1-(3,3-dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylate",-8.033459,x0678,3.436929,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCO5,BRD-K67298865-001-08-2,SB-431542,Selleck,S1067,SB431542,-8.032700,x0072,5.902494,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCO5,BRD-K67298865-001-10-8,SB-431542,Tocris,1614,SB 431542,-8.032700,x0072,5.902494,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCO5,BRD-K67298865-001-09-0,SB-431542,Tocris,1614,SB 431542,-8.032700,x0072,5.902494,active-noncovalent
COc1ccc(cc1)C(=C(c2ccc(cc2)OC)Cl)c3ccc(cc3)OC,BRD-K27062708-001-23-1,chlorotrianisene,Prestwick,Prestw-757,Chlorotrianisene,-8.030936,x1077,2.726352,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@H]3CC[C@H]([C@@H](N3C2=O)C(=O)[O-])Cl)[NH3+],BRD-K28935038-001-02-2,loracarbef,Prestwick,Prestw-1431,Loracarbef,-8.030867,x0830,1.570871,active-covalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,BRD-A15297126-001-04-3,fluocinolone-acetonide,MicroSource,1500303,FLUOCINONIDE,-8.030271,x1077,6.173573,active-noncovalent
CC(=O)O[C@H]1C[C@H]([C@@]2(CC[C@H]3C(=O)O[C@@H](C[C@@]3([C@H]2C1=O)C)c4ccoc4)C)C(=O)OC,BRD-K19284129-001-02-6,salvinorin-a,Enzo,NO109,Salvinorin A,-8.030253,x0678,3.610631,active-noncovalent
CCN(c1cccc(c1)c2ccnc3n2ncc3C#N)C(=O)C,BRD-K92657060-001-05-7,zaleplon,MicroSource,1505925,ZALEPLON,-8.029950,x0195,1.60787,active-noncovalent
C[NH2+]CCc1ccccn1,BRD-K91315211-300-06-5,betahistine,MicroSource,1500670,BETAHISTINE HYDROCHLORIDE,-8.029685,x0195,-1.500758,active-noncovalent
C[NH2+]CCc1ccccn1,BRD-K91315211-300-05-7,betahistine,Selleck,S3176,Betahistine 2HCl,-8.029685,x0195,-1.500758,active-noncovalent
C[C@@H](C(=O)N[C@]1(C[C@H]([C@@H]2[C@H]1[C@H]2C(=O)[O-])Sc3nc[nH]n3)C(=O)[O-])[NH3+],BRD-K68220839-413-02-8,LY2979165,MedChemEx,HY-13239,LY2979165,-8.028719,x0678,0.858591,active-noncovalent
C[C@@H](C(=O)N[C@]1(C[C@H]([C@@H]2[C@H]1[C@H]2C(=O)[O-])Sc3nc[nH]n3)C(=O)[O-])[NH3+],BRD-K68220839-413-01-0,LY2979165,MedChemEx,HY-13239,LY2979165,-8.028719,x0678,0.858591,active-noncovalent
CC(C)(Cc1ccccc1)[NH3+],BRD-K96319534-003-03-9,phentermine,Prestwick,Prestw-1308,Phentermine hydrochloride,-8.028697,x0195,-0.204447,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCNC(=O)c3ccc4ccccc4c3,BRD-K17378184-300-05-9,BP-897,Prestwick,Prestw-559,DO 897/99,-8.028259,x0161,9.950016,active-noncovalent
CCN(CC)C(=O)N[C@H]1C[C@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@H+](C1)C,BRD-A89207210-001-01-6,terguride,Kemprotec,37686-84-3,"1,1-diethyl-3-((9S)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)urea",-8.027876,x0104,1.97941,active-noncovalent
c1ccc2c(c1)[C@@H]3[C@@H](C3(F)F)c4ccccc4C2[NH+]5CCN(CC5)C[C@H](COc6cccc7c6cccn7)O,BRD-K70557564-305-03-6,zosuquidar,Selleck,S1481,Zosuquidar (LY335979) 3HCl,-8.027611,x0072,10.377995,active-noncovalent
c1ccc2c(c1)[C@@H]3[C@@H](C3(F)F)c4ccccc4C2[NH+]5CCN(CC5)C[C@H](COc6cccc7c6cccn7)O,BRD-K70557564-305-04-4,zosuquidar,Tocris,5456,Zosuquidar trihydrochloride,-8.027611,x0072,10.377995,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)CCO)NC(=O)c3ccc(cc3)N(=O)=O,BRD-K81053848-001-01-0,KS-176,Tocris,4169,KS 176,-8.026518,x0708,6.363857,active-covalent
Cc1ccc(cc1)S(=O)(=O)n2c3ccccc3nc2N,BRD-K89306950-001-12-5,ML130,Selleck,S2863,ML130 (Nodinitib-1),-8.024640,x1093,-0.389575,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)n2c3ccccc3nc2N,BRD-K89306950-001-13-3,ML130,Tocris,4354,ML 130,-8.024640,x1093,-0.389575,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2cccc3c2nccc3,BRD-A45107007-001-03-4,salubrinal,Tocris,2347,Salubrinal,-8.024623,x0874,6.738516,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2cccc3c2nccc3,BRD-A45107007-001-06-7,salubrinal,Tocris,2347,Salubrinal,-8.024623,x0874,6.738516,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2cccc3c2nccc3,BRD-A45107007-001-02-6,salubrinal,Selleck,S2923,Salubrinal,-8.024623,x0874,6.738516,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2cccc3c2nccc3,BRD-A45107007-001-05-9,salubrinal,Selleck,S2923,Salubrinal,-8.024623,x0874,6.738516,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH2+]CCC(=O)c2cccc(c2)OC,BRD-K73027814-003-01-0,oxyfedrine,Kemprotec,16777-42-7,"3-{[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino}-1-(3-methoxyphenyl)-1-propanone hydrochloride",-8.023825,x0749,1.425935,active-covalent
C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3OC(=S)S,BRD-A77118605-237-07-9,D609,Enzo,ST330,D609,-8.023685,x0195,1.340989,active-noncovalent
C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3OC(=S)S,BRD-A77118605-237-06-1,D609,Tocris,1437,D609,-8.023685,x0195,1.340989,active-noncovalent
C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3OC(=S)S,BRD-A77118605-237-09-5,D609,MedChemEx,HY-70072,D609,-8.023685,x0195,1.340989,active-noncovalent
C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3OC(=S)S,BRD-A77118605-237-08-7,D609,MedChemEx,HY-70072,D609,-8.023685,x0195,1.340989,active-noncovalent
CC(C)[C@@H](C(=O)[O-])NS(=O)(=O)c1ccc(cc1)c2ccc(cc2)Br,BRD-K60984070-001-02-8,PD-166793,Tocris,2520,PD 166793,-8.023660,x0104,1.640961,active-noncovalent
CC(C)[C@@H](C(=O)[O-])NS(=O)(=O)c1ccc(cc1)c2ccc(cc2)Br,BRD-K60984070-001-01-0,PD-166793,Tocris,2520,PD 166793,-8.023660,x0104,1.640961,active-noncovalent
CC(C)Oc1ccc(cc1C#N)c2nc(no2)c3cccc4c3CC[C@@H]4[NH2+]CCO,BRD-K46625559-001-01-8,ozanimod,MedChemEx,HY-12288,Ozanimod,-8.022897,x0104,10.887599,active-noncovalent
c1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)nc[nH]3)N5CCOCC5,BRD-K77286328-001-03-7,reversine,MedChemEx,HY-14711,Reversine,-8.022801,x0161,3.682743,active-noncovalent
c1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)nc[nH]3)N5CCOCC5,BRD-K77286328-001-06-0,reversine,MedChemEx,HY-14711,Reversine,-8.022801,x0161,3.682743,active-noncovalent
CC(C)[C@@H](CO)n1cc(c(=O)c2c1cc(c(c2)Cc3cccc(c3F)Cl)OC)C(=O)[O-],BRD-K54472332-001-03-4,elvitegravir,Selleck,S2001,"Elvitegravir (GS-9137, JTK-303)",-8.022557,x0195,5.224998,active-noncovalent
c1cc(ccc1C(=O)[O-])N[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,BRD-A45906415-001-01-9,K-MAP,ChemBridge,5728441,,-8.022279,x0749,-0.095909,active-covalent
CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2,BRD-K52960356-001-13-0,acetohexamide,MicroSource,1505425,ACETOHEXAMIDE,-8.021811,x0434,0.268216,active-noncovalent
CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2,BRD-K52960356-001-15-5,acetohexamide,MedChemEx,HY-B0881,Acetohexamide,-8.021811,x0434,0.268216,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[C@@H](C[NH+]3CCN(CC3)c4cccc(c4)Cl)O,BRD-A51829654-300-02-8,BRL-15572,Selleck,S2677,BRL-15572,-8.021626,x1077,5.204999,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[C@@H](C[NH+]3CCN(CC3)c4cccc(c4)Cl)O,BRD-A51829654-003-07-7,BRL-15572,Tocris,1207,BRL 15572 hydrochloride,-8.021626,x1077,5.204999,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[C@@H](C[NH+]3CCN(CC3)c4cccc(c4)Cl)O,BRD-A51829654-300-03-6,BRL-15572,Selleck,S2677,BRL-15572,-8.021626,x1077,5.204999,active-noncovalent
c1cc2c(cc1/C=C/C(=O)N3CCCCC3)OCO2,BRD-K43873574-001-01-8,ilepcimide,Enamine,Z31424455,,-8.019592,x0072,0.716502,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C)F,BRD-A50064262-001-04-7,flumethasone-pivalate,MicroSource,1500300,FLUMETHAZONE PIVALATE,-8.016963,x0104,6.379371,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)NC(=O)c2ccccc2C(=O)[O-],BRD-K77115421-001-05-9,phthalylsulfacetamide,MedChemEx,HY-B0967,Phthalylsulfacetamide,-8.015586,x0104,2.743187,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)NC(=O)c2ccccc2C(=O)[O-],BRD-K77115421-001-02-6,phthalylsulfacetamide,Selleck,S4365,Phthalylsulfacetamide,-8.015586,x0104,2.743187,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)NC(=O)c2ccccc2C(=O)[O-],BRD-K77115421-001-03-4,phthalylsulfacetamide,MicroSource,1505728,PHTHALYLSULFACETAMIDE,-8.015586,x0104,2.743187,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)NC(=O)c2ccccc2C(=O)[O-],BRD-K77115421-001-04-2,phthalylsulfacetamide,Selleck,S4365,phthalylsulfacetamide,-8.015586,x0104,2.743187,active-noncovalent
CCOC(=O)O[C@@H](C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](c3ccccc3)[NH3+])(C)C,BRD-A41698174-003-11-2,bacampicillin,Sigma,S______B1885,"1-[(ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride",-8.015089,x0161,5.939056,active-noncovalent
CCOC(=O)O[C@@H](C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](c3ccccc3)[NH3+])(C)C,BRD-A41698174-003-12-0,bacampicillin,MedChemEx,HY-B1149A,Bacampicillin (hydrochloride),-8.015089,x0161,5.939056,active-noncovalent
CCOC(=O)O[C@@H](C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](c3ccccc3)[NH3+])(C)C,BRD-A41698174-003-13-8,bacampicillin,MicroSource,1503102,BACAMPICILLIN HYDROCHLORIDE,-8.015089,x0161,5.939056,active-noncovalent
c1cc(cnc1)C(=O)N,BRD-K28912512-001-23-2,nicotinamide,Selleck,S1899,Nicotinamide (Vitamin B3),-8.013707,x0397,-1.441368,active-noncovalent
c1cc(cnc1)C(=O)N,BRD-K28912512-001-24-0,nicotinamide,MicroSource,1505397,NIACINAMIDE,-8.013707,x0397,-1.441368,active-noncovalent
c1cc(cnc1)C(=O)N,BRD-K28912512-001-25-7,nicotinamide,Selleck,S1899,Nicotinamide (Niacinamide),-8.013707,x0397,-1.441368,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4ccnc4,BRD-K15916496-001-26-1,clotrimazole,Selleck,S1606,Clotrimazole,-8.013454,x0678,1.963459,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4ccnc4,BRD-K15916496-001-29-5,clotrimazole,Tocris,4096,Clotrimazole,-8.013454,x0678,1.963459,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4ccnc4,BRD-K15916496-001-27-9,clotrimazole,MicroSource,1500200,CLOTRIMAZOLE,-8.013454,x0678,1.963459,active-noncovalent
c1cc(ccc1C[NH2+]CC[C@@H](C(=O)N2CCCCC2)[NH3+])Cl,BRD-K38966689-300-01-5,UAMC-00039,Tocris,4954,UAMC 00039 dihydrochloride,-8.012881,x0104,-0.162795,active-noncovalent
CC[C@@H](C)C[NH2+]CC(=O)N1CCc2c(ccs2)[C@H]1COc3cccc(c3)C,BRD-A33603104-003-01-8,RU-SKI-43,Tocris,4886,RU-SKI 43 hydrochloride,-8.011550,x0708,2.249989,active-covalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)Cl)C)O,BRD-K54187111-001-09-2,dichlorisone-acetate,MicroSource,1505779,DICHLORISONE ACETATE,-8.011309,x0195,3.466781,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)Cl)C)O,BRD-K54187111-001-08-4,dichlorisone-acetate,Selleck,S4395,dichlorisone acetate,-8.011309,x0195,3.466781,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)Cl)C)O,BRD-K54187111-001-07-6,dichlorisone-acetate,Selleck,S4395,Dichlorisone Acetate,-8.011309,x0195,3.466781,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)Cl)C3=CC[NH2+]CC3,BRD-K47659338-003-02-8,EMD-386088,Tocris,2382,EMD 386088 hydrochloride,-8.011148,x0161,-1.854587,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)Cl)C3=CC[NH2+]CC3,BRD-K47659338-003-03-6,EMD-386088,Tocris,2382,EMD 386088 hydrochloride,-8.011148,x0161,-1.854587,active-noncovalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)CNC(=O)c4c(cccn4)C)N,BRD-K55487946-001-01-3,WEHI-345-analog,MedChemEx,HY-100112,WEHI-345 (analog),-8.011008,x0434,4.066232,active-noncovalent
C[C@H]1[C@@](OCC([NH2+]1)(C)C)(c2cccc(c2)Cl)O,BRD-K13394247-003-01-4,radafaxine,MedChemEx,HY-17590,Radafaxine (hydrochloride),-8.010698,x0195,-0.843013,active-noncovalent
Cc1c(ccc(c1Cl)C#N)n2c(c3n(c2=O)CC[C@H]3O)[O-],BRD-K99092662-001-01-1,PS178990,MedChemEx,HY-12111,BMS-564929,-8.010637,x0749,3.444252,active-covalent
c1ccc(cc1)OC[C@H](C[NH2+]CCOc2ccc(cc2)OCC(=O)[O-])O,BRD-K52487250-003-01-2,"ICI-215,001",Tocris,929,"ICI 215,001 hydrochloride",-8.010162,x0072,3.764595,active-noncovalent
C[C@H](c1cc(cc2c1oc(cc2=O)N3CCOCC3)C(=O)N(C)C)Nc4cc(cc(c4)F)F,BRD-K47289408-001-01-5,AZD8186,Adooq,A14164,,-8.009823,x0161,4.552712,active-noncovalent
C[C@H](c1cc(cc2c1oc(cc2=O)N3CCOCC3)C(=O)N(C)C)Nc4cc(cc(c4)F)F,BRD-K47289408-001-02-3,AZD8186,Selleck,S7694,AZD8186,-8.009823,x0161,4.552712,active-noncovalent
c1cc(c(c2c1ccc(=O)o2)O)O,BRD-K61269089-001-05-5,daphnetin,Selleck,S2554,Daphnetin,-8.008783,x0195,-0.15803,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@H]5C[N@H+]([C@@H]6Cc7c[nH]c8c7c(ccc8)C6=C5)C,BRD-A43227343-046-01-4,ergotamine,MicroSource,1505584,ERGOTAMINE TARTRATE,-8.008703,x0161,10.371037,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)Nc4cc(ccc4C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,BRD-K30373883-001-02-8,dutasteride,Selleck,S1202,Dutasteride,-8.006441,x0104,11.186233,active-noncovalent
COc1nccc(n1)c2c(ncn2C3CC[NH2+]CC3)c4ccc(cc4)F,BRD-K19412355-001-01-0,SB-242235,MedChemEx,HY-18306,SB 242235,-8.006007,x0678,5.123811,active-noncovalent
CC(C)(C)c1nc(c(s1)c2ccnc(n2)N)c3cccc(c3F)NS(=O)(=O)c4c(cccc4F)F,BRD-K09951645-001-11-8,dabrafenib,Selleck,S2807,Dabrafenib,-8.005080,x0161,5.678475,active-noncovalent
CC(C)(C)c1nc(c(s1)c2ccnc(n2)N)c3cccc(c3F)NS(=O)(=O)c4c(cccc4F)F,BRD-K09951645-001-06-8,dabrafenib,Selleck,S2807,Dabrafenib (GSK2118436),-8.005080,x0161,5.678475,active-noncovalent
CC(C)(C)c1nc(c(s1)c2ccnc(n2)N)c3cccc(c3F)NS(=O)(=O)c4c(cccc4F)F,BRD-K09951645-001-08-4,dabrafenib,MedChemEx,HY-14660,dabrafenib,-8.005080,x0161,5.678475,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)C[C@@H](CO)O,BRD-A00827783-001-24-6,dyphylline,MicroSource,1500269,DYPHYLLINE,-8.004972,x0195,0.487407,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)C[C@@H](CO)O,BRD-A00827783-001-23-8,dyphylline,Selleck,S1504,Dyphylline,-8.004972,x0195,0.487407,active-noncovalent
Cc1[nH]c(=O)c2cccc(c2n1)O,BRD-K48692744-001-02-0,NU-1025,Tocris,1401,NU 1025,-8.004765,x0397,-1.842941,active-noncovalent
Cc1[nH]c(=O)c2cccc(c2n1)O,BRD-K48692744-001-03-8,NU-1025,Tocris,1401,NU 1025,-8.004765,x0397,-1.842941,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)OCC3CC[NH+](CC3)CCNS(=O)(=O)C,BRD-K49945136-001-10-0,GR-113808,Tocris,1322,GR 113808,-8.003805,x0946,3.636848,active-noncovalent
C[C@H]1CCC[C@]2(C1=C[C@H]3[C@@H](C2)OC(=O)C3=C)C,BRD-K53731810-001-04-3,alantolactone,Tocris,4490,Alantolactone,-8.003726,x0161,-0.052951,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],BRD-K67102207-236-10-1,phenylbutyrate,Tocris,2682,Sodium 4-Phenylbutyrate,-8.003681,x0678,0.928271,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],BRD-K67102207-236-07-7,phenylbutyrate,Tocris,2682,Sodium 4-Phenylbutyrate,-8.003681,x0678,0.928271,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],BRD-K67102207-236-06-9,phenylbutyrate,Selleck,S4125,Sodium Phenylbutyrate,-8.003681,x0678,0.928271,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],BRD-K67102207-236-08-5,phenylbutyrate,MicroSource,1300040,SODIUM PHENYLBUTYRATE,-8.003681,x0678,0.928271,active-noncovalent
Cc1cccc(n1)CC(=O)N2CCc3c2ccc(c3F)c4cn(c5c4c(ncn5)N)C,BRD-K41104902-001-01-3,GSK2656157,Selleck,S7033,GSK2656157,-8.003498,x0104,5.624688,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4cccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)O,BRD-A49035384-003-29-7,methacycline,MedChemEx,HY-B0449,Methacycline (hydrochloride),-8.003436,x0831,0.843497,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4cccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)O,BRD-A49035384-003-30-5,methacycline,Selleck,S2527,Methacycline HCl,-8.003436,x0831,0.843497,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4cccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)O,BRD-A49035384-003-28-9,methacycline,Selleck,S2527,Methacycline hydrochloride (Physiomycine),-8.003436,x0831,0.843497,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4cccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)O,BRD-A49035384-003-27-1,methacycline,MicroSource,1501104,METHACYCLINE HYDROCHLORIDE,-8.003436,x0831,0.843497,active-covalent
C[NH2+]CCc1ccc(c(c1)O)O,BRD-K33151569-003-09-7,deoxyepinephrine,Enzo,AC835,N-Methyldopamine HCl,-8.003169,x1077,0.659803,active-noncovalent
C[C@H]1CCO[C@@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)[O-],BRD-K36386086-001-01-1,dolutegravir,Selleck,S2667,Dolutegravir (GSK1349572),-8.003065,x0161,5.928443,active-noncovalent
c1ccc2c(c1)nc(s2)N3CC[NH+](CC3)Cc4ccc5c(c4)OCO5,BRD-K91868854-001-03-6,2-[1-(4-piperonyl)piperazinyl]benzothiazole,Tocris,736,2-[1-(4-Piperonyl)piperazinyl]benzothiazole,-8.002810,x0946,2.985574,active-noncovalent
CCCNC(=O)NS(=O)(=O)c1ccc(cc1)Cl,BRD-K97746869-001-27-0,chlorpropamide,MicroSource,1500185,CHLORPROPAMIDE,-8.002065,x0678,-1.004033,active-noncovalent
CCCNC(=O)NS(=O)(=O)c1ccc(cc1)Cl,BRD-K97746869-001-26-2,chlorpropamide,Selleck,S4166,Chlorpropamide,-8.002065,x0678,-1.004033,active-noncovalent
CC(C)[NH2+][C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O,BRD-K85285268-003-01-1,RU-42173,Enzo,AR113,Zilpaterol,-8.001442,x0107,0.477327,active-noncovalent
C[C@H]1C[NH2+]CCc2c1cc(cc2)Cl,BRD-K55013654-003-02-3,lorcaserin,Selleck,S4109,Lorcaserin HCl,-8.000593,x1077,1.547026,active-noncovalent
c1cc2n(c1)[C@@]3(CC(=O)NC3=O)C(=O)N(C2=O)Cc4ccc(cc4F)Br,BRD-K50489389-001-01-8,ranirestat,MedChemEx,HY-15314,Ranirestat,-8.000050,x0434,1.666834,active-noncovalent
COc1ccc(cc1)c2cc(=O)c3c(o2)c(c(c(c3OC)OC)OC)OC,BRD-K25186396-001-09-6,tangeritin,Selleck,S2363,Tangeretin,-7.999967,x0104,4.693087,active-noncovalent
CN1CC[NH+](CC1)C2=Cc3ccccc3Oc4c2cc(cc4)Cl,BRD-K92588747-051-02-7,2-CMDO,Tocris,782,2-CMDO,-7.999454,x0195,2.355893,active-noncovalent
c1cn2c(nc1=[NH2+])O[C@@H]3[C@H]2O[C@@H]([C@H]3O)CO,BRD-K67536197-003-11-4,cyclocytidine,MicroSource,1504137,ANCITABINE HYDROCHLORIDE,-7.998925,x0397,-1.052817,active-noncovalent
c1cn2c(nc1=[NH2+])O[C@@H]3[C@H]2O[C@@H]([C@H]3O)CO,BRD-K67536197-003-10-6,cyclocytidine,Selleck,S1973,Cyclocytidine HCl,-7.998925,x0397,-1.052817,active-noncovalent
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl,BRD-K39983086-001-07-9,loteprednol,Selleck,S1669,Loteprednol etabonate,-7.998891,x1077,5.133439,active-noncovalent
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl,BRD-K39983086-001-06-1,loteprednol,Selleck,S1669,Loteprednol etabonate,-7.998891,x1077,5.133439,active-noncovalent
c1cc(cc(c1)NC(=O)C(=O)[O-])c2n[n-]nn2,BRD-K74236708-001-01-9,acitazanolast,LifeChem,F2119-0003,,-7.997951,x0195,1.006023,active-noncovalent
c1cc(cc(c1)NC(=O)C(=O)[O-])c2n[n-]nn2,BRD-K74236708-001-02-7,acitazanolast,LifeChem,F2119-0003,oxo[3-(1H-tetraazol-5-yl)anilino]acetic acid,-7.997951,x0195,1.006023,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,BRD-K77947974-001-16-3,fluspirilene,Enzo,AC116,Fluspirilene,-7.997648,x0161,8.2142,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)CCC5=CC(=O)C=C[C@@]53C)F)O,BRD-A92439610-001-05-7,triamcinolone-acetonide,Selleck,S1628,Triamcinolone Acetonide,-7.995887,x0874,2.544178,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)CCC5=CC(=O)C=C[C@@]53C)F)O,BRD-A92439610-001-04-0,triamcinolone-acetonide,MicroSource,1500587,TRIAMCINOLONE ACETONIDE,-7.995887,x0874,2.544178,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC(=O)[O-],BRD-K44004064-001-07-3,acefylline,Prestwick,Prestw-1507,Acefylline,-7.995131,x1418,0.790358,active-covalent
COc1cc(ccc1O)[C@H]2[C@@H](Oc3cc(ccc3O2)[C@H]4[C@@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,BRD-A06629414-001-02-3,silymarin,Selleck,S2358,Silymarin,-7.992285,x1077,6.519494,active-noncovalent
COc1cc(ccc1O)[C@H]2[C@@H](Oc3cc(ccc3O2)[C@H]4[C@@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,BRD-A06629414-001-03-1,silymarin,Selleck,S2358,Silymarin (Silybin B),-7.992285,x1077,6.519494,active-noncovalent
c1cc(c(nc1)C/N=N/C(=S)N)N,BRD-K01669786-001-03-0,triapine,MedChemEx,HY-10082,Triapine,-7.992079,x1093,-1.233786,active-noncovalent
c1cc(c(nc1)C/N=N/C(=S)N)N,BRD-K01669786-001-01-4,triapine,Selleck,S7470,Triapine,-7.992079,x1093,-1.233786,active-noncovalent
c1cc(c(nc1)C/N=N/C(=S)N)N,BRD-K01669786-001-02-2,triapine,Selleck,S7470,Triapine,-7.992079,x1093,-1.233786,active-noncovalent
c1ccnc(c1)c2c(c3n(n2)CCC3)c4ccnc5c4ccc(c5)OCC[NH+]6CCOCC6,BRD-K47557313-001-02-7,LY2109761,Selleck,S2704,LY2109761,-7.991952,x0161,5.34052,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C)N5CCC(CC5)O,BRD-K50387473-001-09-4,XMD8-92,MedChemEx,HY-14443,XMD8-92,-7.990553,x0161,9.084008,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C)N5CCC(CC5)O,BRD-K50387473-001-11-0,XMD8-92,MedChemEx,HY-14443,XMD8-92,-7.990553,x0161,9.084008,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C)N5CCC(CC5)O,BRD-K50387473-001-10-2,XMD8-92,Tocris,4132,XMD 8-92,-7.990553,x0161,9.084008,active-noncovalent
c1ccc2c(c1)CN(c3cc(ccc3O2)Cl)C(=O)NNC(=O)CCc4ccncc4,BRD-K62715847-003-01-4,SC-51089,Tocris,3758,SC 51089,-7.988515,x0678,2.675278,active-noncovalent
c1cc(c(nc1)c2ccc3c(c2)ncnc3Nc4ccc(cc4)C(F)(F)F)C(F)(F)F,BRD-K43316319-001-01-8,MK-2295,DuPont,A002859262,N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)-2-pyridinyl]-4-quinazolinamine,-7.988082,x1077,5.414619,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1)OCC,BRD-K54799382-003-08-4,parethoxycaine,ChemBridge,6771521,,-7.987778,x0195,1.130812,active-noncovalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,BRD-K56558538-003-11-9,ambroxol,Selleck,S3064,Ambroxol HCl,-7.987587,x0749,-1.057344,active-covalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,BRD-K56558538-003-14-3,ambroxol,MicroSource,1503080,AMBROXOL HYDROCHLORIDE,-7.987587,x0749,-1.057344,active-covalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,BRD-K56558538-003-12-7,ambroxol,Tocris,2404,Ambroxol hydrochloride,-7.987587,x0749,-1.057344,active-covalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,BRD-K56558538-003-13-5,ambroxol,Tocris,2404,Ambroxol hydrochloride,-7.987587,x0749,-1.057344,active-covalent
c1cc(ccc1C(=O)Nc2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O)C(F)(F)F,BRD-K26501486-001-01-3,SR-1078,Tocris,4874,SR 1078,-7.986461,x0104,7.615238,active-noncovalent
c1cc(c(cc1F)F)C(Cn2cncn2)(Cn3cncn3)O,BRD-K05977355-001-18-2,fluconazole,Selleck,S1331,Fluconazole,-7.986347,x0678,0.316013,active-noncovalent
c1cc(c(cc1F)F)C(Cn2cncn2)(Cn3cncn3)O,BRD-K05977355-001-23-2,fluconazole,Sigma,Y0000557,"2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-2-propanol",-7.986347,x0678,0.316013,active-noncovalent
c1cc(c(cc1F)F)C(Cn2cncn2)(Cn3cncn3)O,BRD-K05977355-001-19-0,fluconazole,MicroSource,1503975,FLUCONAZOLE,-7.986347,x0678,0.316013,active-noncovalent
CC(C)C[C@@H](C(=O)OC)NC(=O)c1ccc(cc1c2cccc3c2cccc3)NC[C@H](CS)[NH3+],BRD-K19669037-001-01-1,GGTI-298,EMDBio,345883-250UG,GGTI-298,-7.985645,x0434,5.78465,active-noncovalent
Cc1cc(ccc1OCCOCC[N+](C)(C)Cc2ccccc2)C(C)(C)CC(C)(C)C,BRD-K46531780-003-18-9,methylbenzethonium-chloride,MicroSource,1503253,METHYLBENZETHONIUM CHLORIDE,-7.985348,x0104,7.049484,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,BRD-A67799922-003-28-6,phenoxybenzamine,MedChemEx,HY-B0431A,Phenoxybenzamine (hydrochloride),-7.985278,x0678,1.391693,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,BRD-A67799922-003-27-8,phenoxybenzamine,Selleck,S2499,Phenoxybenzamine HCl,-7.985278,x0678,1.391693,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,BRD-A67799922-003-29-4,phenoxybenzamine,MedChemEx,HY-B0431A,Phenoxybenzamine (hydrochloride),-7.985278,x0678,1.391693,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,BRD-A67799922-003-26-0,phenoxybenzamine,Selleck,S2499,Phenoxybenzamine HCl,-7.985278,x0678,1.391693,active-noncovalent
Cc1ccc(cc1[N@](CC(=O)Nc2c(cccc2F)F)S(=O)(=O)C)Cl,BRD-K61250484-001-02-3,FPH1-(BRD-6125),Selleck,S7451,FPH1 (BRD-6125),-7.984847,x1093,1.614615,active-noncovalent
Cc1ncc(c(n1)N)CNC(=O)N(CCCl)N=O,BRD-K13240081-003-06-7,nimustine,Sigma,MFCD01676942,5-[({[1-(2-chloroethyl)-2-oxohydrazino]carbonyl}amino)methyl]-2-methyl-4-pyrimidinamine hydrochloride,-7.984723,x0678,-0.550256,active-noncovalent
Cc1ncc(c(n1)N)CNC(=O)N(CCCl)N=O,BRD-K13240081-001-06-1,nimustine,MicroSource,1504151,NIMUSTINE,-7.984723,x0678,-0.550256,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)Cl,BRD-K50836978-001-03-3,purvalanol-a,Tocris,1580,Purvalanol A,-7.984373,x0195,3.24041,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)Cl,BRD-K50836978-001-02-5,purvalanol-a,Tocris,1580,Purvalanol A,-7.984373,x0195,3.24041,active-noncovalent
c1ccc(cc1)Nc2nc(c3c(n2)n(cn3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,BRD-K49197823-001-09-8,CV-1808,Tocris,1710,CV 1808,-7.983310,x0161,2.289168,active-noncovalent
CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc2ccc(cc2Cl)F,BRD-K61567297-001-02-7,resatorvid,MedChemEx,HY-11109,TAK-242,-7.982865,x0946,1.17995,active-noncovalent
CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc2ccc(cc2Cl)F,BRD-K61567297-001-01-9,resatorvid,MedChemEx,HY-11109,TAK-242,-7.982865,x0946,1.17995,active-noncovalent
c1c(c(cc2c1NCNS2(=O)=O)S(=O)(=O)N)C(F)(F)F,BRD-K36862742-001-25-6,hydroflumethiazide,MicroSource,1500341,HYDROFLUMETHIAZIDE,-7.981071,x0749,1.153847,active-covalent
CC(C)n1c2ccccc2n(c1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)[NH+]4C,BRD-A62743154-003-01-5,BIMU-8,Tocris,4374,BIMU 8,-7.980006,x0104,2.933909,active-noncovalent
CC(C)c1ccc(c(n1)SCCCCCCCC[NH+](C)C)C(=O)c2cccs2,BRD-K48449073-034-02-7,Y-29794,Tocris,1634,Y-29794 oxalate,-7.979596,x0104,5.462403,active-noncovalent
Cn1c2ccccc2c(=O)c(c1[O-])C(=O)N(C)c3ccccc3,BRD-K03384561-001-02-7,roquinimex,Tocris,1461,Linomide,-7.979484,x0161,0.241284,active-noncovalent
c1cc(c(cc1F)OC2CCN(CC2)c3cc(on3)c4nnn(n4)CC(=O)[O-])Br,BRD-K29656036-001-02-5,MK-8245,Selleck,S1158,MK-8245,-7.978674,x0104,7.592761,active-noncovalent
c1cc(ccc1n2cc([nH]c2=O)N3CCOCC3)Cl,BRD-K43055376-001-01-2,ADD-233089,MedChemEx,HY-14953,AWD 131-138,-7.977933,x0874,0.204196,active-noncovalent
CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K18574842-323-11-6,nafcillin,Selleck,S4042,Nafcillin Sodium,-7.977597,x0874,4.073454,active-noncovalent
CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K18574842-236-17-7,nafcillin,MicroSource,1500420,NAFCILLIN SODIUM,-7.977597,x0874,4.073454,active-noncovalent
CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K18574842-323-10-8,nafcillin,Selleck,S4042,Nafcillin Sodium,-7.977597,x0874,4.073454,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1Cl)N,BRD-K86864073-001-01-1,chloroprocaine,Enamine,Z1724408123,2-(diethylamino)ethyl 4-amino-2-chlorobenzoate,-7.975324,x0104,0.71637,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)Nc3cc(ccc3OC)Cl,BRD-K67537649-001-03-7,PQ-401,Selleck,S8003,PQ 401,-7.974754,x0104,2.883629,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)Nc3cc(ccc3OC)Cl,BRD-K67537649-001-05-2,PQ-401,Tocris,2768,PQ 401,-7.974754,x0104,2.883629,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)Nc3cc(ccc3OC)Cl,BRD-K67537649-001-04-5,PQ-401,Tocris,2768,PQ 401,-7.974754,x0104,2.883629,active-noncovalent
COc1cccc(c1OCC[NH2+]C[C@H]2COc3ccccc3O2)OC,BRD-A01493904-003-12-1,WB-4101,Tocris,946,WB 4101 hydrochloride,-7.974638,x1093,2.237276,active-noncovalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)N[C@H]8O)[NH2+]C)OC,BRD-K45293975-001-02-0,7-hydroxystaurosporine,EMDBio,539644-500UG,UCN-01,-7.973598,x0195,7.249223,active-noncovalent
COc1ccsc1C[NH2+]CC[C@]2(CCOC3(C2)CCCC3)c4ccccn4,BRD-K35626314-003-01-1,TRV130,MedChemEx,HY-16655A,TRV130 (hydrochloride),-7.973586,x1077,4.300395,active-noncovalent
c1ccc(c(c1)c2ccnc3c2CN(C(=O)CO3)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)F,BRD-K67397687-001-01-3,GPBAR-A,Tocris,4478,GPBAR-A,-7.972985,x0830,4.302186,active-covalent
Cc1ccccc1OC[C@H](C[NH2+]CCOc2ccc(cc2)C(=O)N)O,BRD-A60498477-001-01-2,tolamolol,Sigma,MFCD00864712,4-(2-{[2-hydroxy-3-(2-methylphenoxy)propyl]amino}ethoxy)benzamide,-7.972984,x0749,3.198057,active-covalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,BRD-K10670311-001-15-5,sulfasalazine,MicroSource,1500552,SULFASALAZINE,-7.972161,x1077,6.204938,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,BRD-K10670311-001-14-8,sulfasalazine,Selleck,S1576,Sulfasalazine,-7.972161,x1077,6.204938,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,BRD-K10670311-001-17-1,sulfasalazine,Tocris,4935,Sulfasalazine,-7.972161,x1077,6.204938,active-noncovalent
c1ccc2c(c1)c(no2)CS(=O)(=O)N,BRD-K48300629-001-14-5,zonisamide,Tocris,2625,Zonisamide,-7.972009,x1311,-0.769935,active-covalent
c1ccc2c(c1)c(no2)CS(=O)(=O)N,BRD-K48300629-001-17-8,zonisamide,Tocris,2625,Zonisamide,-7.972009,x1311,-0.769935,active-covalent
c1ccc2c(c1)c(no2)CS(=O)(=O)N,BRD-K48300629-001-13-7,zonisamide,Selleck,S1445,Zonisamide,-7.972009,x1311,-0.769935,active-covalent
c1cc(c(c2c1non2)N(=O)=O)Nc3cc(cc(c3)Cl)F,BRD-K21894922-001-01-9,TC-S-7009,Tocris,5243,TC-S 7009,-7.971840,x0830,0.893205,active-covalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,BRD-K03243820-001-23-8,trifluridine,Selleck,S1778,Trifluridine (Viroptic),-7.971839,x0195,-0.075157,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,BRD-K03243820-001-22-0,trifluridine,Selleck,S1778,Trifluridine,-7.971839,x0195,-0.075157,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,BRD-K03243820-001-25-3,trifluridine,MicroSource,1504183,TRIFLURIDINE,-7.971839,x0195,-0.075157,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,BRD-K03243820-001-24-6,trifluridine,Tocris,4460,Trifluorothymidine,-7.971839,x0195,-0.075157,active-noncovalent
CC(C)OC(=O)N[C@H]1Cc2c3cc(ccc3n(c2C1)Cc4ccccn4)C#N,BRD-K90171280-001-01-4,LY2452473,Sigma,MFCD14666518,"isopropyl (2S)-7-cyano-4-(2-pyridinylmethyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-2-ylcarbamate",-7.969918,x0161,2.887365,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCC[NH+](C)C,BRD-K77428767-001-01-7,UNC0224,Tocris,3861,UNC0224,-7.969607,x0434,7.160881,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCC[NH+](C)C,BRD-K77428767-001-02-5,UNC0224,Tocris,3861,UNC 0224,-7.969607,x0434,7.160881,active-noncovalent
c1ccc(cc1)OCC[NH+]2CCC(CC2)n3c4ccccc4[nH]c3=O,BRD-K78096648-001-05-7,oxiperomide,Enamine,Z130192198,,-7.969455,x0749,2.368571,active-covalent
c1ccc(cc1)C(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K20431737-001-09-9,benzoylpas,Vitas-M,STL062186,4-(benzoylamino)-2-hydroxybenzoic acid,-7.969001,x1093,1.384869,active-noncovalent
c1ccc(cc1)C(=O)Nc2ccc(c(c2)O)C(=O)[O-],BRD-K20431737-001-08-1,benzoylpas,MicroSource,1505413,BENZOYLPAS,-7.969001,x1093,1.384869,active-noncovalent
Cc1c(sc(n1)NC(=O)C(C)(C)C)c2ccc(c(c2)S(=O)(=O)Nc3ccc(cc3)O)OC,BRD-K75528696-001-01-2,PI4KIII-beta-inhibitor-1,MedChemEx,HY-100198,PI4KIIIbeta-IN-10,-7.968918,x0161,6.41481,active-noncovalent
CC(=O)OCC(CCn1cnc2c1nc(nc2)N)COC(=O)C,BRD-K45033733-001-11-4,famciclovir,Selleck,S2467,Famciclovir,-7.968711,x0678,1.751061,active-noncovalent
CC(=O)OCC(CCn1cnc2c1nc(nc2)N)COC(=O)C,BRD-K45033733-001-12-2,famciclovir,MicroSource,1505201,FAMCICLOVIR,-7.968711,x0678,1.751061,active-noncovalent
c1cc(c(cc1c2c(sc(n2)N)c3ccncc3)Cl)Cl,BRD-K82028950-300-02-9,CGH2466,Tocris,2344,CGH 2466 dihydrochloride,-7.967635,x0195,0.508492,active-noncovalent
c1cc(c(cc1c2c(sc(n2)N)c3ccncc3)Cl)Cl,BRD-K82028950-300-03-7,CGH2466,Tocris,2344,"4-(3,4-dichlorophenyl)-5-(4-pyridinyl)-1,3-thiazol-2-amine dihydrochloride",-7.967635,x0195,0.508492,active-noncovalent
C[C@@H](CC(c1ccccc1)(c2ccccc2)C(=O)N)[NH+](C)C,BRD-A69917777-065-02-2,aminopentamide,MicroSource,1505650,AMINOPENTAMIDE SULFATE,-7.967306,x0195,-0.336748,active-noncovalent
CC(=O)N(C/C=C/c1cccc(c1)Oc2ccccc2)O,BRD-K80194255-001-01-9,BW-A4C,Sigma,B7559,N-hydroxy-N-[(2E)-3-(3-phenoxyphenyl)-2-propenyl]acetamide,-7.967043,x0195,1.149873,active-noncovalent
CCN\1c2cc(ccc2S/C1=C\C(=O)C)OC,BRD-K97072811-001-11-4,TG-003,Selleck,S7320,TG003,-7.966709,x1077,-0.415389,active-noncovalent
CC[C@@H]1Nc2cc(c(cc2C(=O)N1)S(=O)(=O)N)Cl,BRD-A59303141-001-10-4,quinethazone,MicroSource,1503877,QUINETHAZONE,-7.966033,x0749,-0.226702,active-covalent
c1c([nH]cn1)CC2CC[NH2+]CC2,BRD-K25906698-303-02-7,immepip,Tocris,932,Immepip dihydrobromide,-7.965981,x0387,-2.830835,active-noncovalent
C[C@@H](C[NH2+]C1CCCCC1)OC(=O)c2ccccc2,BRD-A97730597-003-11-5,hexylcaine,Prestwick,Prestw-788,Hexylcaine hydrochloride,-7.965596,x0104,0.205799,active-noncovalent
c1cc(cc(c1)/C=N/N=C/c2cc(ccc2)F)F,BRD-K82002057-001-01-2,DFB,Tocris,1625,DFB,-7.965388,x0678,4.396173,active-noncovalent
C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]2CC[C@@H](CC2)OC)c3c(sc(c3)C4=CCCCC4)C(=O)[O-],BRD-K75956464-237-01-5,VCH-916,MedChemEx,HY-13465,VCH-916,-7.965369,x0678,4.546048,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)C2=CC3(CC[NH2+]CC3)Oc4c2c(ccc4)O,BRD-K39624409-003-03-4,ADL5859,Selleck,S1139,ADL5859 HCl,-7.965066,x0161,2.988739,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)C2=CC3(CC[NH2+]CC3)Oc4c2c(ccc4)O,BRD-K39624409-003-02-6,ADL5859,Selleck,S1139,ADL5859 HCl,-7.965066,x0161,2.988739,active-noncovalent
CNc1ccc(cc1n2cc(nc2)c3ccc(cc3)C(F)(F)F)N(=O)=O,BRD-K89462779-001-01-8,CU-T12-9,Tocris,5414,CU-T12-9,-7.964957,x0104,2.99274,active-noncovalent
CC(C)(CCCCCCC(C)(C)CO)CO,BRD-K43890836-001-01-6,gemcadiol,Sigma,PH000291,"2,2,9,9-tetramethyl-1,10-decanediol",-7.964784,x0161,-0.315771,active-noncovalent
c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)CN5CCS(=O)(=O)CC5,BRD-K16803204-001-01-6,filgotinib,MedChemEx,HY-18300,GLPG0634,-7.964261,x0831,5.27006,active-covalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])C(=O)[O-])C(=O)[O-],BRD-K86305586-001-02-3,"3,4-DCPG-(S)",Tocris,1302,"(S)-3,4-DCPG",-7.963343,x0195,1.289927,active-noncovalent
CC1=NN=C(c2cc3c(cc2C1)OCO3)c4ccc(cc4)N,BRD-K24240364-003-09-6,GYKI-52466,Tocris,1454,GYKI 52466 dihydrochloride,-7.962801,x0195,0.581698,active-noncovalent
CC1=NN=C(c2cc3c(cc2C1)OCO3)c4ccc(cc4)N,BRD-K24240364-003-08-8,GYKI-52466,Tocris,1454,GYKI 52466 hydrochloride,-7.962801,x0195,0.581698,active-noncovalent
Cc1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)[nH]cn3)N5CCOCC5,BRD-K45551181-001-03-9,MPI-0479605,MedChemEx,HY-12660,MPI-0479605,-7.962461,x1077,3.835703,active-noncovalent
Cc1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)[nH]cn3)N5CCOCC5,BRD-K45551181-001-01-3,MPI-0479605,Selleck,S7488,MPI-0479605,-7.962461,x1077,3.835703,active-noncovalent
Cc1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)[nH]cn3)N5CCOCC5,BRD-K45551181-001-04-7,MPI-0479605,MedChemEx,HY-12660,MPI-0479605,-7.962461,x1077,3.835703,active-noncovalent
Cc1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)[nH]cn3)N5CCOCC5,BRD-K45551181-001-02-1,MPI-0479605,Selleck,S7488,MPI-0479605,-7.962461,x1077,3.835703,active-noncovalent
CCCC(CCC)C(=O)OC1C[C@H]2CC[C@@H](C1)[N+]2(C)C,BRD-A06771424-004-01-7,anisotropine,Selleck,S4305,Anisotropine Methylbromide,-7.960395,x0749,1.331631,active-covalent
Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)[O-])Cl,BRD-K01902415-001-11-7,pirinixic-acid,Tocris,1312,WY 14643,-7.960026,x0678,1.365359,active-noncovalent
Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)[O-])Cl,BRD-K01902415-001-13-3,pirinixic-acid,Tocris,1312,WY 14643,-7.960026,x0678,1.365359,active-noncovalent
Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)[O-])Cl,BRD-K01902415-001-10-9,pirinixic-acid,Selleck,S8029,WY-14643 (Pirinixic Acid),-7.960026,x0678,1.365359,active-noncovalent
Cc1ccccc1N2[C@H](Nc3cc(c(cc3C2=O)S(=O)(=O)N)Cl)C,BRD-A61793559-001-14-9,metolazone,Selleck,S1610,Metolazone,-7.959642,x0104,2.436327,active-noncovalent
Cc1ccccc1N2[C@H](Nc3cc(c(cc3C2=O)S(=O)(=O)N)Cl)C,BRD-A61793559-001-16-4,metolazone,Selleck,S1610,Metolazone (Zaroxolyn),-7.959642,x0104,2.436327,active-noncovalent
Cc1ccccc1N2[C@H](Nc3cc(c(cc3C2=O)S(=O)(=O)N)Cl)C,BRD-A61793559-001-15-6,metolazone,MicroSource,2300325,METOLAZONE,-7.959642,x0104,2.436327,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)CS(=O)(=O)[O-],BRD-K76812510-236-14-8,metamizole,MicroSource,1503298,DIPYRONE,-7.959010,x0072,0.253315,active-noncovalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@@H]2CC(=C)[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,BRD-A42746051-001-02-9,melengestrol-acetate,MicroSource,1505727,MELENGESTROL ACETATE,-7.957759,x1392,3.783334,active-covalent
C[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,BRD-K05445342-001-02-0,WP1066,Selleck,S2796,WP1066,-7.953921,x0195,1.256752,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,BRD-K05445342-001-05-3,WP1066,Selleck,S2796,WP1066,-7.953921,x0195,1.256752,active-noncovalent
CC[N+](C)(CC)CC(=O)Nc1c(cccc1C)C,BRD-K60060639-005-02-2,N-methyllidocaine-iodide,Tocris,1042,N-Methyllidocaine iodide,-7.953074,x0434,0.3343,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,BRD-K39621635-001-06-3,artemether,Selleck,S2264,Artemether,-7.952964,x0195,0.968964,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,BRD-K39621635-001-09-7,artemether,MicroSource,1505032,ARTEMETHER,-7.952964,x0195,0.968964,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,BRD-K39621635-001-08-9,artemether,Selleck,S2264,Artemether,-7.952964,x0195,0.968964,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,BRD-K39621635-001-07-1,artemether,MedChemEx,HY-N0402,Artemether,-7.952964,x0195,0.968964,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,BRD-K39621635-001-05-5,artemether,MedChemEx,HY-N0402,Artemether,-7.952964,x0195,0.968964,active-noncovalent
CC/C(=C(/CC)\c1ccc(cc1)OP(=O)([O-])[O-])/c2ccc(cc2)OP(=O)([O-])[O-],BRD-K20801936-001-01-9,fosfestrol,MatrixSci,59774,,-7.952000,x1077,8.159372,active-noncovalent
C1CN(C(=O)N[C@@H]1O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-A86248581-001-01-4,tetrahydrouridine,EMDBio,584222-10MG,Tetrahydrouridine,-7.951298,x0397,0.11674,active-noncovalent
c1cc(cc(c1)Oc2ccc(cc2)N(=O)=O)N3C(=O)c4ccc(cc4C3=O)C(=O)[O-],BRD-K26439554-001-01-3,H2L-5765834,Tocris,4870,H2L 5765834,-7.950715,x0195,5.265572,active-noncovalent
C1CN(CCN1C(=O)CCBr)C(=O)CCBr,BRD-K15656090-001-07-3,pipobroman,MedChemEx,HY-16398,Pipobroman,-7.950488,x0195,0.978048,active-noncovalent
C1CN(CCN1C(=O)CCBr)C(=O)CCBr,BRD-K15656090-001-04-0,pipobroman,MicroSource,1503393,PIPOBROMAN,-7.950488,x0195,0.978048,active-noncovalent
C1CN(CCN1C(=O)CCBr)C(=O)CCBr,BRD-K15656090-001-06-5,pipobroman,MedChemEx,HY-16398,Pipobroman,-7.950488,x0195,0.978048,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,BRD-A50157456-065-20-6,terbutaline,MicroSource,1500558,TERBUTALINE HEMISULFATE,-7.949095,x0749,-1.237693,active-covalent
CC(C)(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,BRD-A50157456-065-21-4,terbutaline,MedChemEx,HY-B0802,Terbutaline (sulfate),-7.949095,x0749,-1.237693,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1[nH]c(=O)[nH]2)O,BRD-A40084411-003-07-7,CGP-12177,Tocris,1134,CGP 12177 hydrochloride,-7.948481,x0830,0.374014,active-covalent
c1cc(ccc1C(=O)[O-])N[C@@H]2[C@H]([C@@H]([C@H](CO2)O)O)O,BRD-A90642009-001-03-2,benaxibine,Vitas-M,STK026946,N-(4-carboxyphenyl)pentopyranosylamine,-7.947579,x0749,-0.210799,active-covalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N2CCCCCCC2,BRD-K08699567-001-01-9,cinoctramide,MicroSource,1506186,CINOCTRAMIDE,-7.947321,x0161,2.977239,active-noncovalent
Cn1c(nn(c1=S)C)c2cccc(c2)F,BRD-K98557884-001-01-6,suritozole,Enamine,Z2306534679,"5-(3-fluorophenyl)-2,4-dimethyl-2,4-dihydro-3H-1,2,4-triazole-3-thione",-7.945951,x0161,0.089679,active-noncovalent
C=CC(=O)Nc1cc2c(cc1OCCC[NH+]3CCOCC3)ncnc2Nc4ccc(c(c4)Cl)F,BRD-K50168500-001-07-9,canertinib,Selleck,S1019,Canertinib (CI-1033),-7.945840,x0104,10.279604,active-noncovalent
c1ccc2c(c1)N3CCC[C@@H]3NS2(=O)=O,BRD-K02501528-001-01-1,S18986,EMDBio,504983-5MG,S18986,-7.944489,x0195,-0.271669,active-noncovalent
C[C@@H](COc1ccccc1)[NH2+][C@@H](C)[C@@H](c2ccc(cc2)O)O,BRD-A16700644-003-04-4,isoxsuprine,MicroSource,1500359,ISOXSUPRINE HYDROCHLORIDE,-7.944475,x0195,-0.413306,active-noncovalent
c1cc2c(cc1OC(F)(F)F)sc(n2)N,BRD-K21283037-001-21-5,riluzole,MicroSource,1505348,RILUZOLE,-7.944470,x0749,0.287348,active-covalent
c1cc2c(cc1OC(F)(F)F)sc(n2)N,BRD-K21283037-001-20-7,riluzole,Selleck,S1614,Riluzole,-7.944470,x0749,0.287348,active-covalent
c1cc2c(cc1OC(F)(F)F)sc(n2)N,BRD-K21283037-003-11-2,riluzole,Tocris,768,Riluzole,-7.944470,x0749,0.287348,active-covalent
Cc1ccc2c(c1)c3c([nH]2)[C@@H]([NH2+]CC3)Cc4ccc(c(c4Cl)OC)OC,BRD-A64004759-003-01-9,LY266097,Tocris,4081,LY 266097 hydrochloride,-7.943959,x0072,2.382556,active-noncovalent
CCCCCOC(=O)c1ccc(cc1)N(C)C,BRD-K42336459-001-01-7,p-dimethylinamyl-benzoate,Enamine,Z791135158,,-7.943680,x0104,0.163116,active-noncovalent
CN(C)/N=N/c1c([nH]cn1)C(=O)N,BRD-K35520305-001-16-9,dacarbazine,Selleck,S1221,Dacarbazine,-7.943605,x0161,-1.542457,active-noncovalent
CN(C)/N=N/c1c([nH]cn1)C(=O)N,BRD-K35520305-001-17-7,dacarbazine,MicroSource,1500218,DACARBAZINE,-7.943605,x0161,-1.542457,active-noncovalent
COc1cc(c(cc1C(=O)N[C@H]2C[NH+]3CCC2CC3)Cl)N,BRD-A65615053-003-03-0,zacopride,Tocris,1795,Zacopride hydrochloride,-7.942384,x0749,0.979687,active-covalent
COc1cc(c(cc1C(=O)N[C@H]2C[NH+]3CCC2CC3)Cl)N,BRD-A65615053-003-02-2,zacopride,Tocris,1795,Zacopride hydrochloride,-7.942384,x0749,0.979687,active-covalent
c1cc(ccc1C(=[NH2+])N)OCCCCCOc2ccc(cc2)C(=[NH2+])N,BRD-K13183738-317-10-2,pentamidine,MicroSource,1500641,PENTAMIDINE ISETHIONATE,-7.942265,x0946,2.717852,active-noncovalent
c1cc(ccc1C(=[NH2+])N)OCCCCCOc2ccc(cc2)C(=[NH2+])N,BRD-K13183738-300-02-5,pentamidine,Selleck,S4007,Pentamidine,-7.942265,x0946,2.717852,active-noncovalent
CCCn1c(=O)c(cn2c1nc(n2)N)C,BRD-K52219182-001-02-4,ICI-63197,Tocris,1816,ICI 63197,-7.941606,x0195,-0.74308,active-noncovalent
CCCn1c(=O)c(cn2c1nc(n2)N)C,BRD-K52219182-001-03-2,ICI-63197,Tocris,1816,ICI 63197,-7.941606,x0195,-0.74308,active-noncovalent
C=CCSC[C@@H]1Nc2cc(c(cc2S(=O)(=O)N1)S(=O)(=O)N)Cl,BRD-A56675431-001-12-3,althiazide,MicroSource,1500804,ALTHIAZIDE,-7.939148,x0195,2.518134,active-noncovalent
CC(=O)N([C@@H]1c2cc(ccc2OC([C@H]1O)(C)C)C#N)O,BRD-K45117373-001-02-9,Y-26763,Tocris,2076,Y-26763,-7.938430,x0195,0.521843,active-noncovalent
c1ccc(cc1)CCCCCCNS(=O)(=O)c2cccc3c2cccc3Cl,BRD-K25875056-001-02-0,SC-9,Tocris,433,SC-9,-7.938409,x0946,2.436299,active-noncovalent
c1ccc(cc1)CCCCCCNS(=O)(=O)c2cccc3c2cccc3Cl,BRD-K25875056-001-03-8,SC-9,Tocris,433,SC-9,-7.938409,x0946,2.436299,active-noncovalent
C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](Cn3cncn3)(c4cc(ccc4F)F)O,BRD-A17009129-001-01-3,isavuconazole,MedChemEx,HY-14273,Isavuconazole,-7.937481,x0161,4.926529,active-noncovalent
C[N@H+](CC[C@H](c1ccc(cc1)F)Oc2ccc(cc2)c3ccccc3)CC(=O)[O-],BRD-K53979406-003-02-8,ALX-5407,Tocris,1757,ALX 5407 hydrochloride,-7.937108,x0759,4.891068,active-covalent
C[N@H+](CC[C@H](c1ccc(cc1)F)Oc2ccc(cc2)c3ccccc3)CC(=O)[O-],BRD-K53979406-003-03-6,ALX-5407,Tocris,1757,ALX 5407 hydrochloride,-7.937108,x0759,4.891068,active-covalent
C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F,BRD-A66869276-001-02-9,diflorasone-diacetate,MicroSource,1505880,DIFLORASONE DIACETATE,-7.935430,x0749,5.18815,active-covalent
CC(=O)OCC(=O)NCCCOc1cccc(c1)C[NH+]2CCCCC2,BRD-K81855038-003-13-9,roxatidine-acetate,MicroSource,1502334,ROXATIDINE ACETATE HYDROCHLORIDE,-7.934253,x0104,2.750396,active-noncovalent
CC(=O)OCC(=O)NCCCOc1cccc(c1)C[NH+]2CCCCC2,BRD-K81855038-003-12-1,roxatidine-acetate,Selleck,S1880,Roxatidine Acetate HCl,-7.934253,x0104,2.750396,active-noncovalent
CC(=O)OCC(=O)NCCCOc1cccc(c1)C[NH+]2CCCCC2,BRD-K81855038-003-14-7,roxatidine-acetate,MedChemEx,HY-B0305A,2-oxo-2-({3-[3-(1-piperidinylmethyl)phenoxy]propyl}amino)ethyl acetate hydrochloride,-7.934253,x0104,2.750396,active-noncovalent
CC(C)c1cccc(c1OS(=O)(=O)[N-]C(=O)Cc2c(cc(cc2C(C)C)C(C)C)C(C)C)C(C)C,BRD-K67901620-001-02-0,avasimibe,Selleck,S2187,Avasimibe,-7.933449,x0161,7.009776,active-noncovalent
CC(C)c1cccc(c1OS(=O)(=O)[N-]C(=O)Cc2c(cc(cc2C(C)C)C(C)C)C(C)C)C(C)C,BRD-K67901620-001-03-8,avasimibe,Selleck,S2187,Avasimibe (CI-1011),-7.933449,x0161,7.009776,active-noncovalent
C[C@H](CC1CCCCC1)[NH2+]C,BRD-A35667010-001-01-8,propylhexedrine,PrincetonBio,OSSL_312908,1-cyclohexyl-N-methyl-2-propanamine,-7.932984,x0195,-0.478747,active-noncovalent
CC[NH+](CC)CCOC(=O)C(c1ccccc1)c2ccccc2,BRD-K60907894-003-22-7,adiphenine,Selleck,S2082,Adiphenine HCl,-7.931138,x0678,2.419209,active-noncovalent
CC[NH+](CC)CCOC(=O)C(c1ccccc1)c2ccccc2,BRD-K60907894-003-23-5,adiphenine,MicroSource,1503073,ADIPHENINE HYDROCHLORIDE,-7.931138,x0678,2.419209,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K05185389-236-05-1,risedronate,Selleck,S1428,Risedronate sodium,-7.930654,x0397,-0.296937,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K05185389-001-02-6,risedronate,Selleck,S1874,Risedronic acid (Actonel),-7.930654,x0397,-0.296937,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K05185389-001-03-4,risedronate,Selleck,S1874,Risedronic acid (Actonel),-7.930654,x0397,-0.296937,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K05185389-236-03-6,risedronate,Selleck,S1428,Risedronate sodium,-7.930654,x0397,-0.296937,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K05185389-236-04-4,risedronate,MicroSource,1505944,RISEDRONATE SODIUM,-7.930654,x0397,-0.296937,active-noncovalent
Cc1cc2c(cc1CC(=O)c3c(ccs3)S(=O)(=O)Nc4c(c(no4)C)Cl)OCO2,BRD-K63806092-236-03-4,sitaxentan,MedChemEx,HY-11103,Sitaxsentan (sodium),-7.928009,x0749,3.480048,active-covalent
Cc1cc2c(cc1CC(=O)c3c(ccs3)S(=O)(=O)Nc4c(c(no4)C)Cl)OCO2,BRD-K63806092-236-02-6,sitaxentan,Selleck,S3034,Sitaxentan sodium,-7.928009,x0749,3.480048,active-covalent
Cc1cc2c(cc1CC(=O)c3c(ccs3)S(=O)(=O)Nc4c(c(no4)C)Cl)OCO2,BRD-K63806092-236-04-2,sitaxentan,Selleck,S3034,Sitaxentan sodium (TBC-11251),-7.928009,x0749,3.480048,active-covalent
Cc1cc2c(cc1CC(=O)c3c(ccs3)S(=O)(=O)Nc4c(c(no4)C)Cl)OCO2,BRD-K63806092-236-05-9,sitaxentan,MedChemEx,HY-11103,Sitaxsentan (sodium),-7.928009,x0749,3.480048,active-covalent
C[C@H](C(=O)Nc1ccc(cc1)Cl)ONC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F,BRD-A79726147-001-01-5,CCG-1423,Tocris,5233,CCG 1423,-7.927452,x0161,3.349465,active-noncovalent
C[C@@H](Cn1ccc(n1)c2ccc(c(c2)Cl)C#N)NC(=O)c3cc(n[nH]3)[C@H](C)O,BRD-A44971162-001-02-7,ODM-201,Selleck,S7559,ODM-201,-7.927373,x0104,3.22976,active-noncovalent
C[C@@H](Cn1ccc(n1)c2ccc(c(c2)Cl)C#N)NC(=O)c3cc(n[nH]3)[C@H](C)O,BRD-A44971162-001-01-9,ODM-201,MedChemEx,HY-16985,,-7.927373,x0104,3.22976,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(cc(c1)OC(=O)N(C)C)OC(=O)N(C)C)O,BRD-A17462676-003-11-6,bambuterol,MicroSource,1505173,BAMBUTEROL HYDROCHLORIDE,-7.925732,x1077,3.234667,active-noncovalent
C[N+]1(Cc2c(c(c(c(c2Cl)Cl)Cl)Cl)C1)CC[N+](C)(C)C,BRD-K18030938-302-02-7,chlorisondamine-diiodide,Tocris,1001,Chlorisondamine diiodide,-7.925576,x0195,0.482886,active-noncovalent
CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,BRD-K18131774-001-17-6,ethoxzolamide,Selleck,S4326,Ethoxzolamide,-7.925233,x0749,1.462418,active-covalent
CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,BRD-K18131774-001-18-4,ethoxzolamide,MicroSource,1505426,ETHOXZOLAMIDE,-7.925233,x0749,1.462418,active-covalent
C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,BRD-K19761926-001-02-8,eplerenone,Tocris,2397,Eplerenone,-7.925105,x1077,3.060764,active-noncovalent
C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,BRD-K19761926-001-03-6,eplerenone,Selleck,S1707,Eplerenone,-7.925105,x1077,3.060764,active-noncovalent
C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,BRD-K19761926-001-04-4,eplerenone,Selleck,S1707,Eplerenone,-7.925105,x1077,3.060764,active-noncovalent
c1cc(c(cc1C[C@H](C(=O)[O-])O)O)O,BRD-A93699261-236-02-6,sodium-danshensu,Selleck,S2401,Sodium Danshensu,-7.924992,x0397,0.457213,active-noncovalent
c1cc(c(cc1C[C@H](C(=O)[O-])O)O)O,BRD-A93699261-236-03-4,sodium-danshensu,Selleck,S2401,Sodium Danshensu,-7.924992,x0397,0.457213,active-noncovalent
C1C[NH+]2CCC1C(=O)C2(CO)CO,BRD-K15318909-001-10-5,PRIMA1,Tocris,1862,PRIMA-1,-7.923908,x0354,2.277416,active-noncovalent
C1C[NH+]2CCC1C(=O)C2(CO)CO,BRD-K15318909-001-12-1,PRIMA1,Tocris,1862,"2,2-bis(hydroxymethyl)quinuclidin-3-one",-7.923908,x0354,2.277416,active-noncovalent
c1cc(cc(c1)S(=O)(=O)n2cccc2/C=C(\C#N)/S(=O)(=O)c3ccc(cc3)F)N(=O)=O,BRD-K00256256-001-06-1,AMZ30,MedChemEx,HY-12833,AMZ30,-7.923602,x0107,4.635574,active-noncovalent
CCCCC[C@H](CCCC(=O)[O-])O,BRD-A96977263-001-03-7,M-14157,Enzo,KC141,5-Hydroxydecanoate,-7.923564,x0678,-1.18734,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,BRD-A23124853-001-01-4,PF-06463922,Selleck,S7536,PF-06463922,-7.922224,x0195,4.096615,active-noncovalent
Cc1cc(cc2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O,BRD-K04657451-001-01-0,D-delta-Tocopherol,Acros,42105,"D-delta-Tocopherol, 93%",-7.922076,x1077,4.388152,active-noncovalent
C[NH+](C)Cc1c2ccccc2oc1C(=O)NCCOc3ccc(cc3)C(=O)NO,BRD-K12867552-001-04-7,PCI-24781,Selleck,S1090,PCI-24781 (Abexinostat),-7.921602,x0104,5.033025,active-noncovalent
c1cnc(=O)n(c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K87714311-001-02-7,zebularine,Tocris,2293,Zebularine,-7.921249,x0195,-1.461043,active-noncovalent
c1cnc(=O)n(c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K87714311-001-03-5,zebularine,Selleck,S7113,Zebularine,-7.921249,x0195,-1.461043,active-noncovalent
c1cnc(=O)n(c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K87714311-001-04-3,zebularine,Selleck,S7113,Zebularine,-7.921249,x0195,-1.461043,active-noncovalent
CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,BRD-K97884852-001-05-4,malotilate,Selleck,S1137,Malotilate,-7.919761,x0195,0.346156,active-noncovalent
CCO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,BRD-K96006160-001-02-9,artemotil,MedChemEx,HY-B0770,Artemotil,-7.919469,x0195,0.948459,active-noncovalent
CCO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,BRD-K96006160-001-01-1,artemotil,AKSci,N732,,-7.919469,x0195,0.948459,active-noncovalent
CCO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,BRD-K96006160-001-03-7,artemotil,MedChemEx,HY-B0770,Artemotil,-7.919469,x0195,0.948459,active-noncovalent
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)[NH+]5C)C,BRD-K33082088-001-03-3,retapamulin,Selleck,S4056,Retapamulin,-7.919022,x1077,5.733658,active-noncovalent
Cc1c(c(on1)C)c2cc3c(cc2OC)c4c(cn3)[nH]c(=O)n4[C@H](C)c5ccccn5,BRD-K36363294-300-01-4,I-BET151,Tocris,4650,I-BET 151 dihydrochloride,-7.918883,x0195,4.625948,active-noncovalent
Cc1c(c(on1)C)c2cc3c(cc2OC)c4c(cn3)[nH]c(=O)n4[C@H](C)c5ccccn5,BRD-K36363294-001-04-2,I-BET151,Selleck,S2780,I-BET151 (GSK1210151A),-7.918883,x0195,4.625948,active-noncovalent
c1ccc2c(c1)cc(n2CC(=O)[O-])C(=O)Nc3nc(cs3)c4ccccc4Cl,BRD-K35629949-001-02-0,SR-27897,Tocris,2190,SR 27897,-7.918825,x1392,3.422351,active-covalent
c1ccc2c(c1)cc(n2CC(=O)[O-])C(=O)Nc3nc(cs3)c4ccccc4Cl,BRD-K35629949-001-03-8,SR-27897,Tocris,2190,SR 27897,-7.918825,x1392,3.422351,active-covalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O,BRD-K21528677-001-03-6,desonide,Selleck,S1701,Desonide,-7.918822,x0161,3.797793,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O,BRD-K21528677-001-02-8,desonide,Selleck,S1701,Desonide,-7.918822,x0161,3.797793,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O,BRD-K21528677-001-04-4,desonide,MicroSource,1505726,DESONIDE,-7.918822,x0161,3.797793,active-noncovalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])O)C(=O)[O-],BRD-K74133873-001-01-7,4-carboxy-3-hydroxyphenylglycine-(S),Tocris,320,(S)-4-Carboxy-3-hydroxyphenylglycine,-7.916189,x1334,-1.042533,active-covalent
CC[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,BRD-K34685430-050-11-7,methylergometrine,Tocris,549,Methylergometrine maleate,-7.915889,x0874,2.319227,active-noncovalent
CC[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,BRD-K34685430-050-12-5,methylergometrine,MicroSource,1500404,METHYLERGONOVINE MALEATE,-7.915889,x0874,2.319227,active-noncovalent
Cc1ccc2c(cc(c(c2n1)O)Cl)Cl,BRD-K90374350-001-09-2,chlorquinaldol,Selleck,S4192,Chlorquinaldol,-7.915258,x0195,-0.916835,active-noncovalent
Cc1ccc2c(cc(c(c2n1)O)Cl)Cl,BRD-K90374350-001-10-0,chlorquinaldol,MicroSource,212151,CHLORQUINALDOL,-7.915258,x0195,-0.916835,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)OCOC(=O)C(C)(C)C)C,BRD-K32791151-001-04-0,pivampicillin,Prestwick,Prestw-1009,Pivampicillin,-7.914359,x0874,6.979208,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC,BRD-K61937613-001-01-1,doconexent-ethyl-ester,Cayman,9090310,,-7.913710,x0967,3.097547,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)F,BRD-K47337578-034-02-5,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,Tocris,523,4F 4PP oxalate,-7.913655,x0946,2.515383,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)F,BRD-K47337578-034-03-3,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,Tocris,523,4F 4PP oxalate,-7.913655,x0946,2.515383,active-noncovalent
Cc1c(oc(=O)o1)C[NH+]2CCN(CC2)c3cc4c(cc3F)c(=O)c(c5n4[C@H](S5)C)C(=O)[O-],BRD-A92341659-001-03-2,prulifloxacin,MicroSource,1502328,PRULIFLOXACIN,-7.913574,x0195,5.501433,active-noncovalent
Cc1c(oc(=O)o1)C[NH+]2CCN(CC2)c3cc4c(cc3F)c(=O)c(c5n4[C@H](S5)C)C(=O)[O-],BRD-A92341659-001-04-0,prulifloxacin,MedChemEx,HY-B0024,Prulifloxacin,-7.913574,x0195,5.501433,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)[S@](=O)c3ccccc3,BRD-A33447119-001-11-6,oxfendazole,MicroSource,1505296,OXFENDAZOLE,-7.913330,x0749,1.696627,active-covalent
COC(=O)Nc1[nH]c2ccc(cc2n1)[S@](=O)c3ccccc3,BRD-A33447119-001-10-8,oxfendazole,Selleck,S1830,Oxfendazole,-7.913330,x0749,1.696627,active-covalent
c1c(cncc1F)CO,BRD-K73381198-001-01-1,5-fluoro-3-pyridyl-methanol,Manchester,B12130,,-7.912810,x0397,-1.404928,active-noncovalent
COc1ccc(cc1)COc2ccc(cc2)CC#N,BRD-K53849769-001-01-0,O4I1,Tocris,5639,O4I1,-7.912587,x0678,0.694672,active-noncovalent
c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O,BRD-K76927775-001-11-8,nitrofurantoin,MedChemEx,HY-A0090,Nitrofurantoin,-7.912397,x0749,2.122373,active-covalent
c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O,BRD-K76927775-001-13-4,nitrofurantoin,MedChemEx,HY-A0090,Nitrofurantoin,-7.912397,x0749,2.122373,active-covalent
c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O,BRD-K76927775-001-10-0,nitrofurantoin,MicroSource,1500433,NITROFURANTOIN,-7.912397,x0749,2.122373,active-covalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCCCN3C(=O)CC4(CCCC4)CC3=O,BRD-A17453586-003-02-3,MDL-72832,Tocris,412,MDL 72832 hydrochloride,-7.912358,x0195,4.532029,active-noncovalent
COc1ccc(cc1)C(=O)C[C@]2(c3c(ccc(c3NC2=O)Cl)Cl)O,BRD-A62182663-001-04-8,YK-4-279,Tocris,4067,YK 4-279,-7.910984,x0195,1.84168,active-noncovalent
COc1ccc(cc1)C(=O)C[C@]2(c3c(ccc(c3NC2=O)Cl)Cl)O,BRD-A62182663-001-03-0,YK-4-279,MedChemEx,HY-14507,YK-4-279,-7.910984,x0195,1.84168,active-noncovalent
c1ccc(c(c1)C(=O)OCCO)O,BRD-K41866823-001-01-3,2-hydroxyethyl-salicylate,Acros,17410,2-Hydroxyethyl salicylate,-7.910770,x0195,-1.99787,active-noncovalent
C[C@H]1CS(=O)(=O)CC[N@]1/N=C/c2ccc(o2)N(=O)=O,BRD-A00100033-001-08-9,nifurtimox,Prestwick,Prestw-1024,Nifurtimox,-7.910373,x0749,2.135944,active-covalent
c12c(=O)[nH]c(nc1n[nH]n2)N,BRD-K53114651-001-11-9,azaguanine-8,Selleck,S4194,Azaguanine-8,-7.909998,x0305,-1.037859,active-noncovalent
c12c(=O)[nH]c(nc1n[nH]n2)N,BRD-K53114651-001-12-7,azaguanine-8,Selleck,S4194,Azaguanine-8,-7.909998,x0305,-1.037859,active-noncovalent
CCOc1ccc(cc1)NC(=O)C[C@H](C)O,BRD-A88684804-001-04-3,bucetin,MicroSource,1505772,BUCETIN,-7.908566,x0161,0.012859,active-noncovalent
CCO[C@@H](Cc1ccc(cc1)OCCc2ccc(cc2)OS(=O)(=O)C)C(=O)[O-],BRD-K15507868-001-04-5,tesaglitazar,Tocris,3965,Tesaglitazar,-7.907948,x0874,6.53737,active-noncovalent
CCO[C@@H](Cc1ccc(cc1)OCCc2ccc(cc2)OS(=O)(=O)C)C(=O)[O-],BRD-K15507868-001-03-7,tesaglitazar,Cayman,16791,,-7.907948,x0874,6.53737,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2ccc(cc2c3[n-]nnn3)Br)C(F)(F)F,BRD-K24434292-001-02-1,NS-3623,Tocris,4462,NS 3623,-7.906827,x0749,3.843603,active-covalent
c1cc2c(cc1N(=O)=O)S(=O)(=O)C=C2,BRD-K17061841-001-03-5,stattic,Selleck,S7024,Stattic,-7.906605,x0195,0.721266,active-noncovalent
CN(C(=O)[C@@H]([C@H](Cc1ccccc1)NC(=O)c2cc3cc(ccc3[nH]2)Cl)O)OC,BRD-K53913008-001-01-5,CP-316819,Tocris,3542,CP 316819,-7.906336,x0434,6.186084,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N[C@H]4CCC[C@@H]4O,BRD-K40578143-001-02-6,GR-79236,Tocris,1957,GR 79236,-7.906315,x0195,3.270088,active-noncovalent
C[C@@H](Cc1cccc(c1)C(F)(F)F)[NH2+]CCOC(=O)c2ccccc2,BRD-A22305049-003-13-6,benfluorex,MicroSource,1500669,BENFLUOREX HYDROCHLORIDE,-7.906297,x0397,3.150327,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC,BRD-K58148589-001-02-8,betamethasone-dipropionate,Selleck,S1688,Betamethasone Dipropionate (Diprolene),-7.905554,x1077,5.476507,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC,BRD-K58148589-001-03-6,betamethasone-dipropionate,MicroSource,1503210,"BETAMETHASONE 17,21-DIPROPIONATE",-7.905554,x1077,5.476507,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@H]([C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,BRD-K48278478-001-01-2,quinine,MicroSource,1500524,QUININE,-7.904837,x0195,0.540994,active-noncovalent
c12c(c(c(c(c1Br)Br)Br)Br)n[nH]n2,BRD-K97118047-001-04-6,"4,5,6,7-tetrabromobenzotriazole",Tocris,2275,TBB,-7.904695,x0195,-0.734434,active-noncovalent
c12c(c(c(c(c1Br)Br)Br)Br)n[nH]n2,BRD-K97118047-001-03-8,"4,5,6,7-tetrabromobenzotriazole",Tocris,2275,TBB,-7.904695,x0195,-0.734434,active-noncovalent
CN1Cc2cc(ccc2NC1=O)NS(=O)(=O)c3ccccc3OC,BRD-K13094524-001-04-2,PFI-1,Selleck,S1216,PFI-1 (PF-6405761),-7.904339,x1077,1.861057,active-noncovalent
CN1Cc2cc(ccc2NC1=O)NS(=O)(=O)c3ccccc3OC,BRD-K13094524-001-07-5,PFI-1,Selleck,S1216,PFI-1(PF-6405761),-7.904339,x1077,1.861057,active-noncovalent
CN1Cc2cc(ccc2NC1=O)NS(=O)(=O)c3ccccc3OC,BRD-K13094524-001-09-1,PFI-1,Tocris,4445,PFI 1,-7.904339,x1077,1.861057,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)O,BRD-K08033334-003-04-3,lincomycin,MicroSource,1500368,LINCOMYCIN HYDROCHLORIDE,-7.903935,x0678,3.08526,active-noncovalent
CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc2ccccc2,BRD-K70402238-001-02-8,nexturastat-a,Selleck,S7473,Nexturastat A,-7.903157,x0678,1.838628,active-noncovalent
Cc1cc(nc(n1)O[C@H](C(=O)[O-])C(c2ccccc2)(c3ccccc3)OC)C,BRD-K41185545-001-02-3,ambrisentan,Selleck,S2097,Ambrisentan,-7.902950,x0678,4.349689,active-noncovalent
Cn1c2c(c(nc(=O)c1=O)c3ccccc3)CC(=CC2)Cl,BRD-A93093700-001-02-9,temazepam,MicroSource,1900034,TEMAZEPAM,-7.902535,x0161,-0.062323,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCC(=O)[O-],BRD-K91495480-001-02-2,AGP-103,Enzo,BL147,Docosanoic acid,-7.902370,x0967,3.953199,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K27871792-236-01-0,flucloxacillin,Sigma,MFCD01682108,"sodium (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-7.901321,x0072,4.703441,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K27871792-001-01-8,flucloxacillin,Prestwick,Prestw-1011,Flucloxacillin sodium,-7.901321,x0072,4.703441,active-noncovalent
Cc1ccccc1N(C)C(=O)c2ccc(c(c2)N(=O)=O)[S@@](=O)c3nccs3,BRD-A91031770-001-01-8,SB-268262,Tocris,4314,SB 268262,-7.900994,x0072,3.304822,active-noncovalent
c1cc(c(cc1/C=C/C(=O)O[C@@H]2C[C@@](C[C@H]([C@H]2O)O)(C(=O)[O-])OC(=O)/C=C/c3ccc(c(c3)O)O)O)O,BRD-K53083666-001-01-0,"1,5-dicaffeoylquinic-acid",AnalytiCon,NP-000244,,-7.900674,x0305,12.405254,active-noncovalent
COc1ccc(c2c1cccc2)C(=O)CCC(=O)[O-],BRD-K53852914-001-01-8,menbutone,MicroSource,1506198,MENBUTONE,-7.900501,x0195,-0.215614,active-noncovalent
CCOC(=O)C1=C(N=C([C@@H]([C@H]1c2cccc(c2Cl)Cl)C(=O)OC)C)C,BRD-A30815329-001-10-5,felodipine,MicroSource,1505887,FELODIPINE,-7.900434,x1077,1.392454,active-noncovalent
CCOC(=O)C1=C(N=C([C@@H]([C@H]1c2cccc(c2Cl)Cl)C(=O)OC)C)C,BRD-A30815329-001-12-1,felodipine,Tocris,2960,Felodipine,-7.900434,x1077,1.392454,active-noncovalent
CCOC(=O)C1=C(N=C([C@@H]([C@H]1c2cccc(c2Cl)Cl)C(=O)OC)C)C,BRD-A30815329-001-08-9,felodipine,Selleck,S1885,Felodipine,-7.900434,x1077,1.392454,active-noncovalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=O)N2,BRD-K89210380-001-13-7,biotin,Selleck,S3130,Biotin (Vitamin B7),-7.900241,x0678,-1.446178,active-noncovalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=O)N2,BRD-K89210380-001-14-5,biotin,MicroSource,1503009,BIOTIN,-7.900241,x0678,-1.446178,active-noncovalent
Cc1ccc-2c(c1)Cc3c2n(nc3C(=O)NC4CCCCC4)c5ccc(cc5Cl)Cl,BRD-K34608650-001-02-4,GP2a,Tocris,2678,GP 2a,-7.900201,x0161,3.664043,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccncc2,BRD-K67080878-001-15-4,milrinone,Selleck,S2484,Milrinone,-7.899122,x1077,-1.632242,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccncc2,BRD-K67080878-001-16-2,milrinone,MicroSource,1505489,MILRINONE,-7.899122,x1077,-1.632242,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)I,BRD-K92000912-001-12-6,AM-251,Tocris,1117,AM 251,-7.897401,x0161,5.512533,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)I,BRD-K92000912-001-11-8,AM-251,Selleck,S2819,AM251,-7.897401,x0161,5.512533,active-noncovalent
c1ccc(cc1)C(=O)NS(=O)(=O)c2ccc(cc2)N,BRD-K59983611-001-21-9,sulfabenzamide,MicroSource,1500544,SULFABENZAMIDE,-7.897392,x1093,0.309767,active-noncovalent
CC(=C[C@@H]1[C@H](C1(C)C)C(=O)O[C@H]2CC(=O)C(=C2)C/C=C\C=C)C,BRD-K79856453-001-01-6,pyrethrins,MicroSource,330068,PYRETHRINS,-7.897375,x0104,2.218969,active-noncovalent
CC(C)C[C@H](C(=O)NCC(=O)N)NC(=O)[C@H]1CCC[NH2+]1,BRD-A09911125-001-01-4,prolylleucylglycinamide,Pharmeks,PHAR208436,N-(1-{[(2-amino-2-oxoethyl)amino]carbonyl}-3-methylbutyl)-2-pyrrolidinecarboxamide,-7.896436,x0678,0.994309,active-noncovalent
c1c(cc(c2c1[nH]c(c2CCC(=O)[O-])C(=O)[O-])Cl)Cl,BRD-K59753853-001-02-3,MDL-29951,MedChemEx,HY-16312,MDL-29951,-7.895853,x0749,-0.446735,active-covalent
c1cc(c(cc1N(=O)=O)C(=O)Nc2ccncc2)Cl,BRD-K31843556-001-03-3,T-0070907,Selleck,S2871,T0070907,-7.895780,x1093,0.717132,active-noncovalent
c1cc(c(cc1N(=O)=O)C(=O)Nc2ccncc2)Cl,BRD-K31843556-001-04-1,T-0070907,Tocris,2301,T 0070907,-7.895780,x1093,0.717132,active-noncovalent
c1cc(c(cc1N(=O)=O)C(=O)Nc2ccncc2)Cl,BRD-K31843556-001-05-8,T-0070907,Tocris,2301,T 0070907,-7.895780,x1093,0.717132,active-noncovalent
c1ccc(cc1)NC(=O)c2cc(ccc2Cl)N(=O)=O,BRD-K93258693-001-17-3,GW-9662,Tocris,1508,GW 9662,-7.895027,x0678,-0.183277,active-noncovalent
c1ccc(cc1)NC(=O)c2cc(ccc2Cl)N(=O)=O,BRD-K93258693-001-16-5,GW-9662,Selleck,S2915,GW9662,-7.895027,x0678,-0.183277,active-noncovalent
Cc1nc2cnc3ccc(cc3c2n1c4ccc(cc4)C(C)(C)C#N)C#Cc5cccnc5,BRD-K00652956-001-01-5,BAG-956,Tocris,3606,BAG 956,-7.894453,x0161,8.653147,active-noncovalent
CC(C)(C)c1ccc(cc1)O,BRD-K06338106-001-01-4,4-tert-butylphenol,Enamine,Z57127886,,-7.894217,x0195,0.615873,active-noncovalent
C[C@H]1C[NH2+]CCC[N@@]1S(=O)(=O)c2cccc3c2c(cnc3)F,BRD-K53814070-310-01-3,ripasudil,MedChemEx,HY-15685,K-115,-7.893481,x0072,1.119164,active-noncovalent
C[NH+]1CCC(CC1)Nc2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BRD-K70914287-300-02-8,BIBX-1382,Tocris,2416,BIBX 1382 dihydrochloride,-7.893158,x0195,2.403205,active-noncovalent
C[NH+]1CCC(CC1)Nc2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BRD-K70914287-300-03-6,BIBX-1382,Tocris,2416,BIBX 1382 dihydrochloride,-7.893158,x0195,2.403205,active-noncovalent
CNC(=S)[C@]1(CCCS1)c2ccccn2,BRD-A71765060-001-01-4,picartamide,Enamine,Z2327673151,N-methyl-2-(2-pyridinyl)tetrahydro-2-thiophenecarbothioamide,-7.892972,x1093,0.13465,active-noncovalent
c1cc(ccc1[C@H](CCC[NH+]2CCN(CC2)c3ncc(cn3)F)O)F,BRD-A15435692-003-02-3,BMY-14802,Tocris,1440,BMY 14802 hydrochloride,-7.892874,x0397,2.665689,active-noncovalent
CCCCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)OCC[NH+](CC)CC)I,BRD-K17561142-003-35-8,amiodarone,Selleck,S1979,Amiodarone HCl,-7.892573,x0104,6.526455,active-noncovalent
CCCCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)OCC[NH+](CC)CC)I,BRD-K17561142-003-33-3,amiodarone,MicroSource,2300165,AMIODARONE HYDROCHLORIDE,-7.892573,x0104,6.526455,active-noncovalent
CCCCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)OCC[NH+](CC)CC)I,BRD-K17561142-003-32-5,amiodarone,Selleck,S1979,Amiodarone HCl,-7.892573,x0104,6.526455,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F,BRD-K81709173-001-09-5,halcinonide,Selleck,S4098,Halcinonide,-7.892338,x0161,4.950805,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3c(n2)ccc(n3)OC,BRD-A42270467-001-04-4,tenatoprazole,MicroSource,1502342,TENATOPRAZOLE,-7.892107,x0107,1.486317,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cccc(c2)OC)[N@]3C[C@H]([N@@H+](C[C@@H]3C)CC=C)C,BRD-K29546239-001-02-3,SNC-80,Tocris,764,SNC 80,-7.892004,x0161,5.956344,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cccc(c2)OC)[N@]3C[C@H]([N@@H+](C[C@@H]3C)CC=C)C,BRD-K29546239-001-04-9,SNC-80,Tocris,764,SNC 80,-7.892004,x0161,5.956344,active-noncovalent
Cc1c2ccc(=O)[nH]c2ccn1,BRD-K40715924-001-01-1,medorinone,Key,3N-012,,-7.891969,x0195,-1.428318,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,BRD-A45538101-001-01-9,fluticasone-propionate,MicroSource,1505603,FLUTICASONE PROPIONATE,-7.890997,x1077,5.208011,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-28-1,edaravone,Tocris,786,Edaravone,-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K84517077-001-01-3,N-demethylantipyrine,Sigma,Y0001138,"5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one",-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-27-3,edaravone,Selleck,S1326,Edaravone,-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-33-1,edaravone,MedChemEx,HY-B0099,Edaravone,-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-34-9,edaravone,MedChemEx,HY-B0099,Edaravone,-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-29-9,edaravone,MicroSource,1503635,EDARAVONE,-7.889587,x0195,-2.068452,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,BRD-K35458079-001-31-5,edaravone,Selleck,S1326,Edaravone (MCI-186),-7.889587,x0195,-2.068452,active-noncovalent
Cn1cnc2c1c(=O)n(c(=O)[nH]2)C,BRD-K24084088-001-11-3,paraxanthine,Enzo,AC633,Paraxanthine,-7.888196,x0195,-1.600651,active-noncovalent
c1cc(c(cc1OCC(F)(F)F)C(=O)NC[C@H]2CCCC[NH2+]2)OCC(F)(F)F,BRD-A09472452-015-23-4,flecainide,MicroSource,1505540,FLECAINIDE ACETATE,-7.887606,x0195,5.631233,active-noncovalent
c1cc(c(cc1OCC(F)(F)F)C(=O)NC[C@H]2CCCC[NH2+]2)OCC(F)(F)F,BRD-A09472452-015-26-7,flecainide,Tocris,1470,Flecainide acetate,-7.887606,x0195,5.631233,active-noncovalent
c1cc(c(cc1OCC(F)(F)F)C(=O)NC[C@H]2CCCC[NH2+]2)OCC(F)(F)F,BRD-A09472452-015-22-6,flecainide,Tocris,1470,Flecainide acetate,-7.887606,x0195,5.631233,active-noncovalent
CC[NH+](CC)Cc1ccc2cc(ccc2c1)COC(=O)Nc3ccc(cc3)C(=O)NO,BRD-K13810148-311-03-2,givinostat,Selleck,S2170,Givinostat (ITF2357),-7.887281,x0104,10.39607,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)F,BRD-K47832606-001-30-1,floxuridine,Selleck,S1299,Floxuridine,-7.886731,x0195,-0.218815,active-noncovalent
CCCCCCOc1cc2c(cc1N(C)c3ncc(cn3)C(=O)[O-])C(CCC2(C)C)(C)C,BRD-K11428250-001-01-0,PA-452,Tocris,5086,PA 452,-7.885966,x1077,6.531063,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C=C(C#N)C#N,BRD-K40255344-001-17-6,tyrphostin-A9,Selleck,S2895,Tyrphostin 9,-7.885646,x1418,1.009787,active-covalent
c1cc(ccc1[C@H](C[NH3+])O)O,BRD-A14240607-003-24-6,octopamine,Selleck,S3188,"(+,-)-Octopamine HCl",-7.885104,x0434,-0.16886,active-noncovalent
c1cc(ccc1[C@H](C[NH3+])O)O,BRD-A14240607-003-26-1,octopamine,MicroSource,1500639,OCTOPAMINE HYDROCHLORIDE,-7.885104,x0434,-0.16886,active-noncovalent
c1cc(ccc1[C@H](C[NH3+])O)O,BRD-A14240607-003-25-3,octopamine,Tocris,2242,Octopamine hydrochloride,-7.885104,x0434,-0.16886,active-noncovalent
c1cc(ccc1[C@H](C[NH3+])O)O,BRD-A14240607-003-27-9,octopamine,Selleck,S3188,"(+,-)-Octopamine HCl",-7.885104,x0434,-0.16886,active-noncovalent
c1ccc(cc1)C/[NH+]=C(/N)\NC(=O)c2c(nc(c(n2)Cl)N)N,BRD-K87158025-001-01-6,benzamil,Enzo,NA103,Benzamil HCl,-7.885048,x0104,3.315492,active-noncovalent
c1ccc(cc1)C/[NH+]=C(/N)\NC(=O)c2c(nc(c(n2)Cl)N)N,BRD-K87158025-003-08-7,benzamil,Tocris,3380,Benzamil,-7.885048,x0104,3.315492,active-noncovalent
COc1ccc(cc1)/C=C/C(=O)[O-],BRD-K26273521-001-07-3,trans-4-Methoxycinnamic-acid,Vitas-M,STK005095,,-7.884934,x0749,-0.137578,active-covalent
C1CC[N@@H+]2C[C@@H]3C[C@@H]([C@H]2C1)C[N@@H+]4[C@H]3CCCC4,BRD-K32847234-065-04-6,sparteine-sulfate,MicroSource,300548,SPARTEINE SULFATE,-7.884753,x0072,-0.943451,active-noncovalent
c1cc(c(cc1F)F)C2=NO[C@H](C2)CC(=O)N3CCOCC3,BRD-A81603255-001-01-0,CPSI-1306-(+/-),Tocris,4400,(+/-)-CPSI,-7.884601,x0749,0.225679,active-covalent
CC(C)(C)c1ccc(cc1)c2[nH]c3cccc(c3n2)N4CC[NH+](CC4)Cc5ccc6c(c5)nccn6,BRD-K08657056-300-01-1,WAY-207024,Tocris,3890,WAY 207024 dihydrochloride,-7.883661,x0395,11.304897,active-noncovalent
c1cc(ccc1OC[C@@H](CO)O)Cl,BRD-A92262698-001-02-5,chlorphenesin,Sigma,MFCD00021990,"3-(4-chlorophenoxy)-1,2-propanediol",-7.883345,x0749,-1.586887,active-covalent
c1cc(ccc1OC[C@@H](CO)O)Cl,BRD-A92262698-001-01-7,chlorphenesin,Enamine,Z995094004,,-7.883345,x0749,-1.586887,active-covalent
CC(C)c1cc(on1)CNc2nc(cc(n2)N3CC[NH+](CC3)C)Nc4cc([nH]n4)C5CC5,BRD-K14274271-001-02-8,XL228,MedChemEx,HY-15749,XL228,-7.883111,x0397,6.360263,active-noncovalent
CC(C)c1cc(on1)CNc2nc(cc(n2)N3CC[NH+](CC3)C)Nc4cc([nH]n4)C5CC5,BRD-K14274271-001-01-0,XL228,MedChemEx,HY-15749,XL228,-7.883111,x0397,6.360263,active-noncovalent
CC[NH+](CC)CCOC(=O)[C@@H](Cc1cccc2c1cccc2)C[C@@H]3CCCO3,BRD-A67862938-034-14-9,naftidrofuryl,MicroSource,1503419,NAFRONYL OXALATE,-7.882974,x0072,3.669286,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc3c(c2)[nH]c(n3)c4ccc(cc4)OC,BRD-A84575140-001-02-4,pimobendan,Selleck,S1550,Pimobendan,-7.882498,x1077,1.896057,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)[O-],BRD-K39965020-001-09-1,doconexent,MicroSource,1503885,DOCONEXENT,-7.881674,x0830,2.414224,active-covalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)[O-],BRD-K39965020-001-12-5,doconexent,Sigma,D2534,"(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoic acid",-7.881674,x0830,2.414224,active-covalent
C[C@@H]1Cc2ccccc2[N@@]1NC(=O)c3ccc(c(c3)S(=O)(=O)N)Cl,BRD-A95869247-001-25-1,indapamide,Selleck,S1730,Indapamide,-7.880660,x0104,1.802119,active-noncovalent
C[C@@H]1Cc2ccccc2[N@@]1NC(=O)c3ccc(c(c3)S(=O)(=O)N)Cl,BRD-A95869247-001-26-9,indapamide,MicroSource,1500349,INDAPAMIDE,-7.880660,x0104,1.802119,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](CSc1nc(cs1)c2ccc(s2)C(=O)N)O,BRD-A28044053-001-01-7,arotinolol,AKSci,K136,,-7.880533,x0104,1.404525,active-noncovalent
CC(C)c1ccc(cc1)CC(=O)N2CCC[C@H](C2)c3cccc(c3)OC(C)(C)C(=O)[O-],BRD-K96843359-001-02-6,CP-775146,Tocris,4190,CP 775146,-7.878687,x0874,5.837505,active-noncovalent
CC(C)c1c(c(=O)n(n1C)c2ccccc2)NC(=O)Nc3ccc(cc3)Cl,BRD-K16497916-001-01-6,TC-FPR-43,Tocris,4624,TC-FPR 43,-7.877841,x0161,3.747969,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNC(=O)OCc3cccnc3,BRD-K77908580-001-09-6,entinostat,Selleck,S1053,Entinostat (MS-275),-7.877308,x0104,7.27787,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNC(=O)OCc3cccnc3,BRD-K77908580-001-10-4,entinostat,Selleck,S1053,"Entinostat (MS-275, SNDX-275)",-7.877308,x0104,7.27787,active-noncovalent
c1ccc2c(c1)nc(n2c3nc(nc(n3)N4CCOCC4)N5CCOCC5)C(F)F,BRD-K63068307-001-08-9,ZSTK-474,Selleck,S1072,ZSTK474,-7.875796,x0195,5.244563,active-noncovalent
c1cc(c(c(c1)Cl)Cl)N2CC[NH+](CC2)CCCCOc3ccc4c(c3)NC(=O)CC4,BRD-K70358946-001-14-0,aripiprazole,Selleck,S1975,Aripiprazole,-7.875067,x0161,5.269394,active-noncovalent
c1cc(c(c(c1)Cl)Cl)N2CC[NH+](CC2)CCCCOc3ccc4c(c3)NC(=O)CC4,BRD-K70358946-001-15-7,aripiprazole,MicroSource,1505851,ARIPIPRAZOLE,-7.875067,x0161,5.269394,active-noncovalent
c1cc(c(c(c1)Cl)Cl)N2CC[NH+](CC2)CCCCOc3ccc4c(c3)NC(=O)CC4,BRD-K70358946-001-17-3,aripiprazole,Tocris,5584,Aripiprazole,-7.875067,x0161,5.269394,active-noncovalent
c1cc(cc(c1)Cl)NC(=O)Nc2ncc(s2)CCNc3c4c(ccs4)ncn3,BRD-K71512533-066-03-6,SNS-314,Tocris,4584,SNS 314 mesylate,-7.874863,x0104,6.753718,active-noncovalent
c1cc(cc(c1)Cl)NC(=O)Nc2ncc(s2)CCNc3c4c(ccs4)ncn3,BRD-K71512533-066-02-8,SNS-314,Selleck,S1154,SNS-314 Mesylate,-7.874863,x0104,6.753718,active-noncovalent
CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)[O-],BRD-K52523550-001-01-5,N-acetylcarnosine,AKSci,R096,,-7.874116,x0107,0.259622,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-001-13-1,SB-203580,Selleck,SB203580,,-7.873383,x0161,4.136209,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-003-02-0,SB-203580,Tocris,1402,SB 203580 hydrochloride,-7.873383,x0161,4.136209,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-001-09-9,SB-203580,Selleck,S1076,SB203580,-7.873383,x0161,4.136209,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-001-12-3,SB-203580,Selleck,S1076,SB 203580,-7.873383,x0161,4.136209,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-001-10-7,SB-203580,Tocris,1202,SB 203580,-7.873383,x0161,4.136209,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,BRD-A37704979-001-15-6,SB-203580,Tocris,1202,SB 203580,-7.873383,x0161,4.136209,active-noncovalent
CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,BRD-K36788280-001-04-6,ribociclib,MedChemEx,HY-15777,LEE011,-7.872331,x0161,7.775085,active-noncovalent
CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,BRD-K36788280-001-01-2,ribociclib,Selleck,S7440,LEE011,-7.872331,x0161,7.775085,active-noncovalent
CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,BRD-K36788280-001-03-8,ribociclib,Selleck,S7440,Ribociclib (LEE011),-7.872331,x0161,7.775085,active-noncovalent
CC[NH+](CC)CCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C,BRD-K22025381-003-01-9,U-18666A,Tocris,1638,U 18666A,-7.870731,x0104,6.191417,active-noncovalent
CC([C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)[O-])Cc2ccccc2)C,BRD-K44353683-001-10-9,nateglinide,Tocris,4231,Nateglinide,-7.870385,x0107,2.384827,active-noncovalent
CC([C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)[O-])Cc2ccccc2)C,BRD-K44353683-001-07-5,nateglinide,Selleck,S2489,Nateglinide,-7.870385,x0107,2.384827,active-noncovalent
CC([C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)[O-])Cc2ccccc2)C,BRD-K44353683-001-08-3,nateglinide,Tocris,4231,Nateglinide,-7.870385,x0107,2.384827,active-noncovalent
Cc1c(sc(n1)NC(=O)C)c2ccc(c(c2)S(=O)(=O)NCCO)Cl,BRD-K29395450-001-06-8,PIK-93,Selleck,S1489,PIK-93,-7.870296,x0072,1.366463,active-noncovalent
Cc1cc(cc(c1OC(C)(C)C(=O)[O-])C)/C=C/C(=O)c2ccc(cc2)SC,BRD-K03165895-001-01-9,elafibranor,MedChemEx,HY-16737,Elafibranor,-7.870007,x0161,7.092819,active-noncovalent
c1ccc2c(c1)c(ccn2)CNc3ccsc3C(=O)Nc4ccc(cc4)OC(F)(F)F,BRD-K25340465-001-07-9,OSI-930,Selleck,S1220,OSI-930,-7.869781,x0770,6.127423,active-covalent
c1ccc2c(c1)c(ccn2)CNc3ccsc3C(=O)Nc4ccc(cc4)OC(F)(F)F,BRD-K25340465-001-11-1,OSI-930,Selleck,S1220,OSI-930,-7.869781,x0770,6.127423,active-covalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4)C,BRD-K48619321-004-17-6,methscopolamine,Selleck,S1978,Methscopolamine,-7.869523,x0072,0.701153,active-noncovalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4)C,BRD-K48619321-004-16-8,methscopolamine,Selleck,S1978,Methscopolamine (Pamine),-7.869523,x0072,0.701153,active-noncovalent
c1c(cc(cc1O)O)[C@H](C(=O)[O-])[NH3+],BRD-A20589515-001-02-9,dihydroxyphenylglycine,Tocris,342,"(RS)-3,5-DHPG",-7.868940,x0830,0.234233,active-covalent
C[NH+](C)C[C@@H](c1ccc(cc1)OC)C2(CCCCC2)O,BRD-A51714012-003-13-6,venlafaxine,MicroSource,1504171,VENLAFAXINE HYDROCHLORIDE,-7.868102,x0678,-0.205259,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)OC)C2(CCCCC2)O,BRD-A51714012-003-14-4,venlafaxine,Tocris,2917,Venlafaxine hydrochloride,-7.868102,x0678,-0.205259,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)OC)C2(CCCCC2)O,BRD-A51714012-003-12-8,venlafaxine,Selleck,S1441,Venlafaxine,-7.868102,x0678,-0.205259,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C3(CCOCC3)CNC(=O)c4cccnc4Sc5ccccc5,BRD-K83547600-001-01-7,JNJ-47965567,Tocris,5299,JNJ 47965567,-7.867516,x1077,7.461389,active-noncovalent
COc1cc2c(cc1OC)C[N@@H+](CC2)CCc3ccc(cc3)NC(=O)c4cc(c(cc4NC(=O)c5cc6ccccc6nc5)OC)OC,BRD-K09353376-001-02-1,tariquidar,Selleck,S8028,Tariquidar,-7.867481,x0395,18.326916,active-noncovalent
COc1cc2c(cc1OC)C[N@@H+](CC2)CCc3ccc(cc3)NC(=O)c4cc(c(cc4NC(=O)c5cc6ccccc6nc5)OC)OC,BRD-K09353376-001-03-9,tariquidar,Selleck,S8028,Tariquidar,-7.867481,x0395,18.326916,active-noncovalent
CC(=O)Oc1cccc(c1)O,BRD-K85603128-001-03-5,resorcinol-monoacetate,MicroSource,1503500,RESORCINOL MONOACETATE,-7.866498,x0195,-1.682726,active-noncovalent
CC(=O)Oc1cccc(c1)O,BRD-K85603128-001-04-3,resorcinol-monoacetate,MedChemEx,HY-B0894,Resorcinol (monoacetate),-7.866498,x0195,-1.682726,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O,BRD-A71816415-236-04-3,pravastatin,MicroSource,1505803,PRAVASTATIN SODIUM,-7.865650,x0678,5.54506,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,BRD-K96155658-001-01-5,exo-IWR-1,Tocris,3947,exo-IWR 1,-7.865381,x0104,11.732782,active-noncovalent
CCc1nc(c(s1)c2ccnc(c2)NC(=O)c3ccccc3)c4cccc(c4)C,BRD-K52751261-001-08-7,TAK-715,Tocris,4254,TAK 715,-7.864714,x0161,3.575182,active-noncovalent
CCc1nc(c(s1)c2ccnc(c2)NC(=O)c3ccccc3)c4cccc(c4)C,BRD-K52751261-001-06-1,TAK-715,Selleck,S2928,TAK-715,-7.864714,x0161,3.575182,active-noncovalent
CCCCNc1c2cnn(c2[nH+]c(c1C(=O)OCC)C)CC,BRD-K34154330-003-06-4,tracazolate,Tocris,1558,Tracazolate hydrochloride,-7.864121,x0195,0.782205,active-noncovalent
CCCC[C@@]1(Cc2cc(c(c(c2C1=O)Cl)Cl)OCCCC(=O)[O-])C3CCCC3,BRD-A39255369-001-03-1,DCPIB,Tocris,1540,DCPIB,-7.863991,x0104,2.570428,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,BRD-K86161929-001-11-7,cortisone-acetate,Selleck,S2559,Cortisone acetate (Cortone),-7.863702,x0161,4.469667,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,BRD-K86161929-001-13-3,cortisone-acetate,MicroSource,1500207,CORTISONE ACETATE,-7.863702,x0161,4.469667,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,BRD-K86161929-001-12-5,cortisone-acetate,Selleck,S2559,Cortisone acetate,-7.863702,x0161,4.469667,active-noncovalent
c1ccc(cc1)c2[nH]c(c[nH+]2)C[NH+]3CCN(CC3)c4ncccn4,BRD-K28639661-001-01-6,NGD-94-1,Tocris,3298,2-{4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl}pyrimidine,-7.863264,x0104,3.234155,active-noncovalent
CC(C)COc1ccc(cc1)CNC(=O)N(Cc2ccc(cc2)F)C3CC[NH+](CC3)C,BRD-K83405785-001-01-5,pimavanserin,MedChemEx,HY-14557,Pimavanserin,-7.862399,x0161,4.327637,active-noncovalent
CCc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,BRD-K86892782-001-17-0,edoxudine,MicroSource,1503214,EDOXUDINE,-7.860795,x0195,-0.59574,active-noncovalent
CC[N+](CC)(CC)CC[C@@](c1ccccc1)(C2CCCCC2)O,BRD-A22152765-003-10-0,tridihexethyl,Prestwick,Prestw-1042,Tridihexethyl chloride,-7.859320,x0195,0.509748,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)OCc2ccccn2,BRD-A75224450-001-01-6,ibuprofen-piconol,Enamine,Z1537603096,,-7.859004,x0749,1.790224,active-covalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)OCc2ccccn2,BRD-A75224450-001-02-4,ibuprofen-piconol,Enamine,Z1537603096,2-pyridinylmethyl 2-(4-isobutylphenyl)propanoate,-7.859004,x0749,1.790224,active-covalent
CCn1c2c(c(n1)C)NC(=O)CN=C2c3ccccc3,BRD-K57427145-001-01-6,ripazepam,Sigma,PH000306,"1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e][1,4]diazepin-5(1H)-one",-7.858985,x0161,0.731127,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)NC3CC[NH2+]CC3,BRD-K63018010-001-01-7,relebactam,MedChemEx,HY-16752,Relebactam,-7.858875,x0678,2.199068,active-noncovalent
CC(=C)[C@@H]1CC[C@@]([C@@H](C1)C(=C)C)(C)C=C,BRD-K21045639-001-01-2,beta-elemene,Sigma,63965,"(1S,2S,4R)-2,4-diisopropenyl-1-methyl-1-vinylcyclohexane",-7.858797,x0195,0.74765,active-noncovalent
CS(=O)(=O)Nc1ccc2c(c1)c3c(ccc(c3o2)OC(F)F)C(=O)Nc4c(cncc4Cl)Cl,BRD-K92303087-001-01-6,oglemilast,MedChemEx,HY-15178,Oglemilast,-7.858404,x0434,7.724797,active-noncovalent
c1cn(nn1)c2c[nH]n(c2=O)c3cc(ncn3)N4CCOCC4,BRD-K01291782-001-01-1,molidustat,MedChemEx,HY-12654,Molidustat,-7.858057,x0195,3.962774,active-noncovalent
c1cn(nn1)c2c[nH]n(c2=O)c3cc(ncn3)N4CCOCC4,BRD-K01291782-001-02-9,molidustat,MedChemEx,HY-12654,Molidustat,-7.858057,x0195,3.962774,active-noncovalent
CCOP(=S)(OCC)Oc1c(cc(c(n1)Cl)Cl)Cl,BRD-K08303368-001-10-0,chlorpyrifos,MicroSource,330058,CHLORPYRIFOS,-7.857464,x0749,0.146182,active-covalent
C[N@H+]1[C@@H](CCC[C@H]1CC(=O)c2ccccc2)C[C@H](c3ccccc3)O,BRD-A65243462-003-04-4,lobeline,MicroSource,1500758,LOBELINE HYDROCHLORIDE,-7.856845,x0678,3.529644,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,BRD-K67511046-001-02-3,naloxone,MicroSource,1500422,NALOXONE HYDROCHLORIDE,-7.856458,x0831,1.214326,active-covalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,BRD-K67511046-003-14-4,naloxone,Selleck,S3066,Naloxone HCl,-7.856458,x0831,1.214326,active-covalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,BRD-K67511046-003-16-9,naloxone,Selleck,S3066,Naloxone HCl,-7.856458,x0831,1.214326,active-covalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,BRD-K67511046-003-15-1,naloxone,Tocris,599,Naloxone hydrochloride,-7.856458,x0831,1.214326,active-covalent
C[N@@](CCc1ccc(c(c1)Cl)Cl)CC[NH+]2CCCC2,BRD-K17008822-303-02-1,BD-1008,Tocris,511,BD 1008 dihydrobromide,-7.855129,x0195,1.337615,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,BRD-K41141507-001-17-0,cyproterone-acetate,MicroSource,1500216,CYPROTERONE ACETATE,-7.855025,x1077,2.12258,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,BRD-K41141507-001-15-4,cyproterone-acetate,Sigma,MFCD00864671,"(2aR,3aS,3bS,3cS,5aS,6R,8aS,8bR)-6-acetyl-10-chloro-3b,5a-dimethyl-2-oxo-2,2a,3,3a,3b,3c,4,5,5a,6,7,8,8a,8b-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-6-yl acetate",-7.855025,x1077,2.12258,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,BRD-K41141507-001-16-2,cyproterone-acetate,Selleck,S2042,Cyproterone Acetate,-7.855025,x1077,2.12258,active-noncovalent
C[NH+](C)CCn1cc(c2c1nccc2)S(=O)(=O)c3cccc(c3)F,BRD-K63483542-300-01-6,WAY-208466,Tocris,3904,WAY 208466 dihydrochloride,-7.851625,x0072,2.412639,active-noncovalent
C1C2CC3CC1CC(C2)(C3)[NH3+],BRD-K70330367-003-08-7,amantadine,MicroSource,1500110,AMANTADINE HYDROCHLORIDE,-7.850710,x0354,1.495489,active-noncovalent
C1C2CC3CC1CC(C2)(C3)[NH3+],BRD-K70330367-003-07-9,amantadine,Selleck,S2451,Amantadine HCl,-7.850710,x0354,1.495489,active-noncovalent
CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,BRD-K60230970-001-17-5,MG-132,Selleck,S2619,MG-132,-7.849687,x0678,11.281413,active-noncovalent
CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,BRD-K60230970-001-13-4,MG-132,Selleck,S2619,MG-132,-7.849687,x0678,11.281413,active-noncovalent
CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,BRD-K60230970-001-16-7,MG-132,Selleck,S2619,MG-132,-7.849687,x0678,11.281413,active-noncovalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(CC2CCCCC2)[O-])O,BRD-A74208568-003-02-3,CGP-54626,Tocris,1088,CGP 54626 hydrochloride,-7.849515,x0104,5.214393,active-noncovalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(CC2CCCCC2)[O-])O,BRD-A74208568-003-01-5,CGP-54626,Tocris,1088,CGP 54626 hydrochloride,-7.849515,x0104,5.214393,active-noncovalent
c1cc(ccc1Cc2c(nc3n(c2=O)CCS3)[O-])Cl,BRD-A96466199-001-01-4,nuclomedone,InterBioScreen,STOCK6S-24941,"6-(4-chlorobenzyl)-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-5,7(6H)-dione",-7.849031,x0161,-0.481305,active-noncovalent
c1cc(c2c(c1NCC[NH2+]CCO)C(=O)c3c(ccc(c3C2=O)[O-])[O-])NCC[NH2+]CCO,BRD-K21680192-300-16-9,mitoxantrone,Selleck,S2485,Mitoxantrone Hydrochloride,-7.848516,x1077,5.516359,active-noncovalent
c1cc(c2c(c1NCC[NH2+]CCO)C(=O)c3c(ccc(c3C2=O)[O-])[O-])NCC[NH2+]CCO,BRD-K21680192-300-15-1,mitoxantrone,MicroSource,1503278,MITOXANTRONE HYDROCHLORIDE,-7.848516,x1077,5.516359,active-noncovalent
c1cc(c2c(c1NCC[NH2+]CCO)C(=O)c3c(ccc(c3C2=O)[O-])[O-])NCC[NH2+]CCO,BRD-K21680192-300-14-4,mitoxantrone,Selleck,S2485,Mitoxantrone HCl,-7.848516,x1077,5.516359,active-noncovalent
CO[C@H]1CC[C@H](CC1)C(=O)c2cc3c(nc4c(c3)CCCO4)cc2,BRD-K25596805-001-02-6,JNJ-16259685,Tocris,2333,JNJ 16259685,-7.848005,x0195,1.532543,active-noncovalent
CO[C@H]1CC[C@H](CC1)C(=O)c2cc3c(nc4c(c3)CCCO4)cc2,BRD-K25596805-001-01-8,JNJ-16259685,Tocris,2333,JNJ 16259685,-7.848005,x0195,1.532543,active-noncovalent
CC1(C(=O)N(C(=S)N1c2ccc(c(c2)F)C(=O)NC)c3ccc(c(c3)C(F)(F)F)C#N)C,BRD-K56851771-001-06-8,enzalutamide,Selleck,S1250,Enzalutamide (MDV3100),-7.847151,x0161,9.964658,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSc1ccccc1C(=O)N)/C)/C)C,BRD-K14590126-001-01-6,farnesyl-thiosalicylic-acid-amide,Cayman,13175,"2-{[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]sulfanyl}benzamide",-7.845528,x0072,2.355908,active-noncovalent
c1cc2c(cc1C(=O)N[C@H]3C[NH+]4CCC3CC4)OCCO2,BRD-K48053228-051-01-7,PHA-568487,Tocris,3134,PHA 568487,-7.845007,x0749,1.415914,active-covalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,BRD-K66788707-001-15-0,fludarabine,Tocris,3495,Fludarabine,-7.844747,x0195,-0.060676,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,BRD-K66788707-001-17-6,fludarabine,Selleck,S1491,Fludarabine (Fludara),-7.844747,x0195,-0.060676,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,BRD-K66788707-001-14-3,fludarabine,Tocris,3495,Fludarabine,-7.844747,x0195,-0.060676,active-noncovalent
CCCCCCCCCCCCCCCC(=O)NCCO,BRD-K68095457-001-10-1,palmitoylethanolamide,Tocris,879,Palmitoylethanolamide,-7.844695,x0161,3.02086,active-noncovalent
CCCCCCCCCCCCCCCC(=O)NCCO,BRD-K68095457-001-11-9,palmitoylethanolamide,MicroSource,1506156,PALMIDROL [5mM],-7.844695,x0161,3.02086,active-noncovalent
COc1cn(nc(c1=O)c2ccnn2c3ccccc3)c4ccc(cc4F)n5cccn5,BRD-K57155378-001-01-1,TAK-063,MedChemEx,HY-12472,TAK-063,-7.844015,x0104,4.673433,active-noncovalent
C[C@]1([C@@H]([C@H](O[C@H]1n2cnc3c2nc(nc3NC4CCCC4)Cl)CO)O)O,BRD-K63932022-001-02-3,2'-MeCCPA,Tocris,2281,2'-MeCCPA,-7.843780,x0195,3.812112,active-noncovalent
C[C@]1([C@@H]([C@H](O[C@H]1n2cnc3c2nc(nc3NC4CCCC4)Cl)CO)O)O,BRD-K63932022-001-01-5,2'-MeCCPA,Tocris,2281,2'-MeCCPA,-7.843780,x0195,3.812112,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)NC(=O)OC,BRD-K83023055-001-02-7,GR-135531,Tocris,896,GR 135531,-7.842125,x0195,-0.322875,active-noncovalent
c1cc(ccc1c2[nH]c3cc(ccc3n2)c4[nH]c5ccc(cc5n4)N)N,BRD-K58299615-001-03-5,Ro-90-7501,Tocris,2408,Ro 90-7501,-7.841928,x0104,8.157389,active-noncovalent
c1cc(ccc1c2[nH]c3cc(ccc3n2)c4[nH]c5ccc(cc5n4)N)N,BRD-K58299615-001-04-3,Ro-90-7501,Tocris,2408,Ro 90-7501,-7.841928,x0104,8.157389,active-noncovalent
CC1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K13281575-001-13-4,semustine,MicroSource,1503422,SEMUSTINE,-7.841726,x0678,0.239533,active-noncovalent
CC1CCC(CC1)NC(=O)N(CCCl)N=O,BRD-K13281575-001-14-2,semustine,Sigma,MFCD00133811,1-(2-chloroethyl)-1-{[(4-methylcyclohexyl)amino]carbonyl}-2-oxohydrazine,-7.841726,x0678,0.239533,active-noncovalent
CC(=O)c1cc(c(s1)Sc2cccc(c2Cl)Cl)N(=O)=O,BRD-K13606314-001-01-3,P5091,Selleck,S7132,P5091 (P005091),-7.841539,x0831,0.242826,active-covalent
c1ccc(cc1)N2c3ccccc3C(C2=O)(Cc4ccncc4)Cc5ccncc5,BRD-K59332007-300-02-7,linopirdine,Tocris,1999,Linopirdine dihydrochloride,-7.841304,x0678,2.885648,active-noncovalent
c1ccc(cc1)N2c3ccccc3C(C2=O)(Cc4ccncc4)Cc5ccncc5,BRD-K59332007-300-03-5,linopirdine,Tocris,1999,Linopirdine dihydrochloride,-7.841304,x0678,2.885648,active-noncovalent
CCOC(=O)[C@@H]1[C@H](NC(=S)N=C1C)c2cccc(c2)O,BRD-A78377521-001-05-5,monastrol,Tocris,1305,Monastrol,-7.839993,x1392,0.663849,active-covalent
CCOC(=O)[C@@H]1[C@H](NC(=S)N=C1C)c2cccc(c2)O,BRD-A78377521-001-06-3,monastrol,Tocris,1305,Monastrol,-7.839993,x1392,0.663849,active-covalent
CC(C)(C)C1CCC(CC1)CC2=C(c3ccccc3C(=O)C2=O)[O-],BRD-A07947329-001-01-4,buparvaquone,MedChemEx,HY-17581,Buparvaquone,-7.839726,x0161,0.803331,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)N,BRD-K21520694-236-02-6,sulfacetamide,Selleck,S4081,Sulfacetamide Sodium,-7.839550,x0678,-1.415762,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)N,BRD-K21520694-001-21-4,sulfacetamide,MicroSource,1500545,SULFACETAMIDE,-7.839550,x0678,-1.415762,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCN(CC2)C[C@H](COc3ccccc3OC)O)C,BRD-A97674275-300-04-9,ranolazine,Tocris,3118,Ranolazine dihydrochloride,-7.839061,x0161,7.388915,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCN(CC2)C[C@H](COc3ccccc3OC)O)C,BRD-A97674275-001-11-8,ranolazine,MicroSource,1505366,RANOLAZINE,-7.839061,x0161,7.388915,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCN(CC2)C[C@H](COc3ccccc3OC)O)C,BRD-A97674275-001-10-0,ranolazine,Selleck,S1799,Ranolazine,-7.839061,x0161,7.388915,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCN(CC2)C[C@H](COc3ccccc3OC)O)C,BRD-A97674275-300-03-1,ranolazine,Selleck,S1425,Ranolazine 2HCl,-7.839061,x0161,7.388915,active-noncovalent
c1ccc(cc1)NCCCO,BRD-K49721826-001-02-7,3-anilinopropan-1-ol,Enamine,Z104584292,,-7.838931,x0678,-0.344585,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O,BRD-K45664306-001-19-6,prednisolone-acetate,Selleck,S2570,Prednisolone acetate (Omnipred),-7.838795,x1077,3.921675,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O,BRD-K45664306-001-20-4,prednisolone-acetate,Selleck,S2570,Prednisolone acetate (Omnipred),-7.838795,x1077,3.921675,active-noncovalent
CCOc1ccc(cc1OCC)CC2=NCCc3c2cc(c(c3)OCC)OCC,BRD-K14658796-003-01-6,drotaverine,Enamine,EN300-260709,"(1E)-1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride",-7.838648,x0434,3.942897,active-noncovalent
CCOc1ccc(cc1OCC)CC2=NCCc3c2cc(c(c3)OCC)OCC,BRD-K14658796-001-01-0,drotaverine,Vitas-M,STK301594,,-7.838648,x0434,3.942897,active-noncovalent
CCCOC(=O)c1ccc(cc1)O,BRD-K60783397-001-09-5,propylparaben,ChemDiv,0099-0143,,-7.837325,x0678,-0.771328,active-noncovalent
CC(=O)[C@@]1(Cc2c(c(c3c(c2[O-])C(=O)c4ccccc4C3=O)[O-])[C@H](C1)O[C@H]5C[C@@H]([C@@H](CO5)O)O)[NH3+],BRD-K13843533-001-02-5,amrubicin,MedChemEx,HY-B0067,Amrubicin,-7.836733,x0161,7.338374,active-noncovalent
CC(=O)[C@@]1(Cc2c(c(c3c(c2[O-])C(=O)c4ccccc4C3=O)[O-])[C@H](C1)O[C@H]5C[C@@H]([C@@H](CO5)O)O)[NH3+],BRD-K13843533-001-01-7,amrubicin,MedChemEx,HY-B0067,Amrubicin,-7.836733,x0161,7.338374,active-noncovalent
C[C@]12CCCC([C@@H]1CC[C@@]([C@@H]2CC[C@](C)(C=C)O)(C)O)(C)C,BRD-A23127772-001-02-3,sclareol,Selleck,S2354,Sclareol,-7.836132,x0195,0.450733,active-noncovalent
c1cc(ncc1Cl)C(=O)NCC[NH3+],BRD-K51486818-003-03-6,lazabemide,Tocris,2460,Lazabemide hydrochloride,-7.835135,x0678,-1.118979,active-noncovalent
c1cc(ncc1Cl)C(=O)NCC[NH3+],BRD-K51486818-003-02-8,lazabemide,Tocris,2460,Lazabemide hydrochloride,-7.835135,x0678,-1.118979,active-noncovalent
C1CC[N@@H+]2[C@H](C1)[C@]34C[C@H]2C=CC3=CC(=O)O4,BRD-K49071277-001-04-7,securinine,MicroSource,1505334,SECURININE,-7.834994,x0104,3.111532,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc(cc1)O,BRD-K55462201-001-07-3,AM-404,Tocris,1116,AM 404,-7.834989,x0967,3.784786,active-noncovalent
c1ccc(c(c1)NC(=O)Nc2ccc(cc2O)N(=O)=O)Br,BRD-K61323504-001-04-0,SB-225002,Tocris,2725,SB 225002,-7.834857,x0749,2.044956,active-covalent
c1ccc(c(c1)NC(=O)Nc2ccc(cc2O)N(=O)=O)Br,BRD-K61323504-001-06-5,SB-225002,Tocris,2725,SB 225002,-7.834857,x0749,2.044956,active-covalent
CC(=O)O/N=C/1\c2cc(ccc2N(C1=O)Cc3cc(ccc3Cl)Cl)Cl,BRD-K94485812-001-03-7,LDN-57444,MedChemEx,HY-18637,LDN-57444,-7.834804,x0195,1.5332,active-noncovalent
CC(=O)O/N=C/1\c2cc(ccc2N(C1=O)Cc3cc(ccc3Cl)Cl)Cl,BRD-K94485812-001-01-1,LDN-57444,Selleck,S7135,LDN-57444,-7.834804,x0195,1.5332,active-noncovalent
CC(=O)O/N=C/1\c2cc(ccc2N(C1=O)Cc3cc(ccc3Cl)Cl)Cl,BRD-K94485812-001-02-9,LDN-57444,Selleck,S7135,LDN-57444,-7.834804,x0195,1.5332,active-noncovalent
c1cc2cccnc2c(c1)O,BRD-K66808046-065-03-7,oxyquinoline,MicroSource,1500456,OXYQUINOLINE HEMISULFATE,-7.834648,x0195,-1.752149,active-noncovalent
CCc1cccc(c1NC(=O)C[NH+](CC(=O)[O-])CC(=O)[O-])CC,BRD-K63979671-001-10-1,etifenin,Prestwick,Prestw-504,Etifenin,-7.834459,x0830,1.940287,active-covalent
CCC(=O)O[C@H]1CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,BRD-A48720949-001-04-0,testosterone-propionate,MicroSource,300034,TESTOSTERONE PROPIONATE,-7.833282,x0678,3.942052,active-noncovalent
COc1cc(ccc1Cl)NC(=O)c2ccccn2,BRD-K45462423-001-04-5,VU0361737,Tocris,3707,VU 0361737,-7.832375,x0195,0.754179,active-noncovalent
COc1cc(ccc1Cl)NC(=O)c2ccccn2,BRD-K45462423-001-03-7,VU0361737,Tocris,3707,VU 0361737,-7.832375,x0195,0.754179,active-noncovalent
COc1cc(ccc1Cl)NC(=O)c2ccccn2,BRD-K45462423-001-02-9,VU0361737,Selleck,S2892,VU 0361737,-7.832375,x0195,0.754179,active-noncovalent
COc1cc(cc(c1OC)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O)OCO4,BRD-K47869605-001-32-0,podophyllotoxin,MicroSource,2300332,PODOFILOX,-7.832320,x0161,2.622307,active-noncovalent
CN1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,BRD-K89375097-300-08-8,pirenzepine,MicroSource,1501138,PIRENZEPINE HYDROCHLORIDE,-7.829867,x0104,1.65991,active-noncovalent
C/C(=C(/C#N)\C(=O)Nc1cc(ccc1Br)Br)/O,BRD-A30655177-001-14-0,LFM-A13,Tocris,1300,LFM-A13,-7.829633,x0195,-0.204488,active-noncovalent
CC[N+](CC)(CC)CC(=O)Nc1c(cccc1C)C,BRD-K56596464-004-10-7,QX-314,Tocris,1014,QX 314 bromide,-7.829500,x0434,-0.472772,active-noncovalent
CC[N+](CC)(CC)CC(=O)Nc1c(cccc1C)C,BRD-K56596464-003-02-6,QX-314,Tocris,2313,QX 314 chloride,-7.829500,x0434,-0.472772,active-noncovalent
CCOCCn1c2ccccc2nc1N3CCC[N@H+](CC3)C,BRD-K15010214-364-02-7,emedastine,TCI,E0936,,-7.829353,x0434,1.50186,active-noncovalent
CCOCCn1c2ccccc2nc1N3CCC[N@H+](CC3)C,BRD-K15010214-364-01-9,emedastine,Prestwick,Prestw-1274,Emedastine,-7.829353,x0434,1.50186,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCNC(=O)C34CC5CC(C3)CC(C5)C4,BRD-K67789209-001-01-0,adatanserin,Enamine,Z749259376,,-7.828271,x0104,3.875784,active-noncovalent
c1ccc(cc1)NC(=O)C2C(=O)NC(=S)NC2=O,BRD-K45152786-001-08-4,merbarone,EMDBio,445800-25MG,Merbarone,-7.828114,x0678,0.959082,active-noncovalent
Cc1c2c(cs1)C(=O)Nc3ccccc3N2C(=O)C[NH+]4CCN(CC4)C,BRD-K06147391-300-06-8,telenzepine,Tocris,1122,Telenzepine dihydrochloride,-7.828099,x0195,1.569919,active-noncovalent
Cc1c2c(cs1)C(=O)Nc3ccccc3N2C(=O)C[NH+]4CCN(CC4)C,BRD-K06147391-003-03-5,telenzepine,MicroSource,1504187,TELENZEPINE HYDROCHLORIDE,-7.828099,x0195,1.569919,active-noncovalent
CCC(=O)c1c(cc(cc1O)O)O,BRD-K43383936-001-05-2,flopropione,MicroSource,1500629,FLOPROPIONE,-7.827406,x0195,-0.33485,active-noncovalent
CCC(=O)c1c(cc(cc1O)O)O,BRD-K43383936-001-04-5,flopropione,Selleck,S4249,Flopropione,-7.827406,x0195,-0.33485,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC(C)C,BRD-K30758549-001-01-8,isopropyl-palmitate,TCI,P0005,,-7.827374,x0161,1.492651,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC(C)C,BRD-K30758549-001-02-6,isopropyl-palmitate,Sigma,MFCD00008993,isopropyl palmitate,-7.827374,x0161,1.492651,active-noncovalent
Cc1c(nccn1)N2CCCCC2,BRD-K25317177-065-01-4,modaline,MicroSource,1506123,MODALINE SULFATE,-7.827106,x0387,-0.930844,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)[O-],BRD-K18059238-001-10-4,gamma-linolenic-acid,Enzo,FA006,gamma-Linolenic acid (18:3 n-6),-7.826504,x0967,1.139612,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)[O-],BRD-K18059238-001-11-2,gamma-linolenic-acid,Cayman,90220,,-7.826504,x0967,1.139612,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)[O-],BRD-K18059238-001-13-8,gamma-linolenic-acid,Sigma,MFCD00065718,"(6Z,9Z,12Z)-6,9,12-octadecatrienoic acid",-7.826504,x0967,1.139612,active-noncovalent
c1cc2c(c(c1)N)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,BRD-A12994259-001-02-1,pomalidomide,Selleck,S1567,Pomalidomide,-7.825874,x0195,0.222414,active-noncovalent
CCn1cc(c2c(c1=O)cc(s2)C(=[NH2+])NC3CCS(=O)(=O)CC3)c4cccc(c4)C(F)(F)F,BRD-K04972057-001-01-1,I-BRD9,MedChemEx,HY-18975,I-BRD9,-7.825500,x0104,6.200523,active-noncovalent
CCn1cc(c2c(c1=O)cc(s2)C(=[NH2+])NC3CCS(=O)(=O)CC3)c4cccc(c4)C(F)(F)F,BRD-K04972057-001-02-9,I-BRD9,Tocris,5591,I-BRD9,-7.825500,x0104,6.200523,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)O)(C)C)OC,BRD-K99621550-300-01-8,tubocurarine,MicroSource,1500602,TUBOCURARINE CHLORIDE,-7.823708,x0104,11.02999,active-noncovalent
CC(=O)c1ccc(c(c1)Oc2ccc(cc2F)F)NS(=O)(=O)C,BRD-K38350380-001-01-8,FK-3311,MedChemEx,HY-14445,FK 3311,-7.822788,x0434,1.110251,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cc(cc(c3)Cl)N,BRD-K07762753-001-05-1,aminopurvalanol-a,Tocris,2072,Aminopurvalanol A,-7.822013,x0678,3.823563,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cc(cc(c3)Cl)N,BRD-K07762753-001-04-4,aminopurvalanol-a,Tocris,2072,Aminopurvalanol A,-7.822013,x0678,3.823563,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,BRD-K72259270-003-23-1,dyclonine,Selleck,S2041,Dyclonine HCl,-7.821922,x0104,1.798369,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,BRD-K72259270-003-25-6,dyclonine,Selleck,S2041,Dyclonine hydrochloride,-7.821922,x0104,1.798369,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,BRD-K72259270-003-24-9,dyclonine,MicroSource,1500268,DYCLONINE HYDROCHLORIDE,-7.821922,x0104,1.798369,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,BRD-K72259270-003-26-4,dyclonine,MedChemEx,HY-B0364A,Dyclonine (hydrochloride),-7.821922,x0104,1.798369,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,BRD-K72259270-003-27-2,dyclonine,MedChemEx,HY-B0364A,Dyclonine (hydrochloride),-7.821922,x0104,1.798369,active-noncovalent
CN(c1ccc(cc1)OC(=O)c2ccco2)C(=O)C(Cl)Cl,BRD-K10974103-001-21-1,diloxanide,MicroSource,1505532,DILOXANIDE FUROATE,-7.821535,x0749,4.296216,active-covalent
C[C@@H](c1ccccc1)NC(=O)CNC(=O)c2cccc(c2)Cl,BRD-K19482962-001-01-8,JNJ-63533054,MedChemEx,HY-19838,JNJ-63533054,-7.821272,x0104,1.28927,active-noncovalent
CC(C)(Cc1c[nH]c2c1cc(cc2)Cl)[NH2+]CCOc3ccccc3OCC4CC4,BRD-K76840893-003-03-3,RS-17053,Tocris,985,RS 17053 hydrochloride,-7.820681,x1077,3.918497,active-noncovalent
CC(C)(Cc1c[nH]c2c1cc(cc2)Cl)[NH2+]CCOc3ccccc3OCC4CC4,BRD-K76840893-003-02-5,RS-17053,Tocris,985,RS 17053 hydrochloride,-7.820681,x1077,3.918497,active-noncovalent
c1cc2c(cc1Br)C=CC(=O)C2=O,BRD-K34149328-001-02-1,bonaphthone,AMS,A000684624,"6-bromo-1,2-naphthalenedione",-7.819712,x0195,0.675792,active-noncovalent
c1cc2c(cc1Br)C=CC(=O)C2=O,BRD-K34149328-001-01-3,bonaphthone,Vitas-M,STK028617,,-7.819712,x0195,0.675792,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=O)/C)/C,BRD-K79884267-001-01-4,retinaldehyde,SantaCruz,sc-210778A,,-7.819566,x0104,2.170285,active-noncovalent
c1ccc2c(c1)ccc(=O)o2,BRD-K23913458-001-20-7,coumarin,MicroSource,1400208,COUMARIN,-7.819531,x0195,-0.164728,active-noncovalent
c1ccc2c(c1)ccc(=O)o2,BRD-K23913458-001-19-9,coumarin,Selleck,S4170,Coumarin,-7.819531,x0195,-0.164728,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N,BRD-K26060080-065-05-6,adenine,Selleck,S1982,Adenine sulfate,-7.817648,x0678,-0.946514,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N,BRD-K26060080-001-10-1,adenine,Selleck,S1981,Adenine,-7.817648,x0678,-0.946514,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N,BRD-K26060080-001-11-9,adenine,MicroSource,1500807,ADENINE,-7.817648,x0678,-0.946514,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N,BRD-K26060080-003-07-3,adenine,Selleck,S1983,Adenine HCl,-7.817648,x0678,-0.946514,active-noncovalent
Cc1ccnc2c1NC(=O)c3cccnc3N2C4CC4,BRD-K15502390-001-20-9,nevirapine,MicroSource,1503842,NEVIRAPINE,-7.817565,x0195,0.078637,active-noncovalent
Cc1ccnc2c1NC(=O)c3cccnc3N2C4CC4,BRD-K15502390-001-19-1,nevirapine,Selleck,S1742,Nevirapine,-7.817565,x0195,0.078637,active-noncovalent
c1ccc(cc1)[S@](=O)c2ccc3nnnn3n2,BRD-A53134341-001-03-2,Ro-106-9920,Tocris,1778,Ro 106-9920,-7.817238,x0678,-0.379731,active-noncovalent
c1ccc(cc1)[S@](=O)c2ccc3nnnn3n2,BRD-A53134341-001-04-0,Ro-106-9920,Tocris,1778,Ro 106-9920,-7.817238,x0678,-0.379731,active-noncovalent
CCOC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3,BRD-K98203492-003-04-1,GSK-J4,Selleck,S7070,GSK J4 HCl,-7.815744,x1077,5.195135,active-noncovalent
CCOC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3,BRD-K98203492-001-02-9,GSK-J4,Tocris,4594,GSK J4,-7.815744,x1077,5.195135,active-noncovalent
CCOC(=O)O[C@@H](c1ccnc2c1cc(cc2)OC)[C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C,BRD-K97028990-001-04-4,quinine-ethyl-carbonate,MicroSource,310050,QUININE ETHYL CARBONATE,-7.815491,x0107,1.905864,active-noncovalent
CCn1c2c(cncc2nc1c3c(non3)N)C(=O)N4CC[C@@H](C4)[NH3+],BRD-K49110935-300-01-9,SB-772077B,Tocris,4118,SB 772077B dihydrochloride,-7.815361,x0195,1.492855,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)[O-],BRD-K93767137-001-01-1,oseltamivir-carboxylate,MedChemEx,HY-13318,Oseltamivir (acid),-7.814522,x0678,-1.938359,active-noncovalent
CCCC[NH+](CCCC)CCCOC(=O)c1ccc(cc1)N,BRD-K99622919-001-23-0,butacaine,MicroSource,1503914,BUTACAINE,-7.813479,x0104,3.035688,active-noncovalent
CCCC[NH+](CCCC)CCCOC(=O)c1ccc(cc1)N,BRD-K99622919-001-22-2,butacaine,Selleck,S4310,Butacaine,-7.813479,x0104,3.035688,active-noncovalent
Cc1cc(c(c(c1CC2=[NH+]CCN2)C)O)C(C)(C)C,BRD-K16195444-003-25-2,oxymetazoline,Tocris,1142,Oxymetazoline hydrochloride,-7.813391,x0104,-0.904101,active-noncovalent
Cc1cc(c(c(c1CC2=[NH+]CCN2)C)O)C(C)(C)C,BRD-K16195444-003-24-5,oxymetazoline,Selleck,S2495,Oxymetazoline HCl,-7.813391,x0104,-0.904101,active-noncovalent
Cc1cc(c(c(c1CC2=[NH+]CCN2)C)O)C(C)(C)C,BRD-K16195444-003-26-0,oxymetazoline,MicroSource,1500453,OXYMETAZOLINE HYDROCHLORIDE,-7.813391,x0104,-0.904101,active-noncovalent
CC(=O)c1cc(c(s1)Sc2ccc(cc2F)F)N(=O)=O,BRD-K97714174-001-02-1,P22077,Tocris,4485,P 22077,-7.811275,x1386,-0.037968,active-covalent
CC(=O)c1cc(c(s1)Sc2ccc(cc2F)F)N(=O)=O,BRD-K97714174-001-01-3,P22077,Selleck,S7133,P22077,-7.811275,x1386,-0.037968,active-covalent
COCCCC/C(=N\OCC[NH3+])/c1ccc(cc1)C(F)(F)F,BRD-K53517854-050-21-4,fluvoxamine,MicroSource,1505604,FLUVOXAMINE MALEATE,-7.810683,x0072,2.003484,active-noncovalent
COCCCC/C(=N\OCC[NH3+])/c1ccc(cc1)C(F)(F)F,BRD-K53517854-050-20-6,fluvoxamine,Tocris,1033,Fluvoxamine maleate,-7.810683,x0072,2.003484,active-noncovalent
COCCCC/C(=N\OCC[NH3+])/c1ccc(cc1)C(F)(F)F,BRD-K53517854-051-01-4,fluvoxamine,Selleck,S1336,Fluvoxamine maleate,-7.810683,x0072,2.003484,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H](C[C@H](O3)CO)O)N,BRD-K65428967-001-08-4,cordycepin,Tocris,2294,Cordycepin,-7.810182,x0107,-0.5952,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H](C[C@H](O3)CO)O)N,BRD-K65428967-001-09-2,cordycepin,Tocris,2294,Cordycepin,-7.810182,x0107,-0.5952,active-noncovalent
CCCCOCCOc1c(sc(n1)c2ccc(c(c2)F)C(=O)[O-])C,BRD-K31144453-001-02-2,AC-261066,Tocris,4046,AC 261066,-7.810064,x0749,1.759861,active-covalent
CC[NH+](CC)CCc1nc(no1)c2ccccc2,BRD-K42596464-048-11-9,oxolamine,MicroSource,1506027,OXOLAMINE CITRATE,-7.810038,x0161,1.097381,active-noncovalent
c1ccnc(c1)CO,BRD-K28492574-001-01-6,piconol,MicroSource,1506166,PICONOL,-7.810037,x0397,-1.521887,active-noncovalent
CC(C)NNC(=O)c1ccncc1,BRD-K88568253-011-19-9,iproniazid,MicroSource,1500634,IPRONIAZID PHOSPHATE,-7.809742,x0749,-0.588052,active-covalent
c1cc(ccc1OCC(=O)N2CC[NH+](CC2)Cc3ccc4c(c3)OCO4)Cl,BRD-K37688416-003-13-1,fipexide,MicroSource,1503222,FIPEXIDE HYDROCHLORIDE,-7.809350,x0195,5.740016,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,BRD-K01292756-001-24-3,pimozide,Tocris,937,Pimozide,-7.808833,x0678,4.267696,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,BRD-K01292756-001-25-0,pimozide,MicroSource,1501134,PIMOZIDE,-7.808833,x0678,4.267696,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,BRD-K01292756-001-27-6,pimozide,Tocris,937,Pimozide,-7.808833,x0678,4.267696,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,BRD-K01292756-001-23-5,pimozide,Selleck,S4358,Pimozide,-7.808833,x0678,4.267696,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)Oc2ccccc2OC,BRD-A71725768-001-01-3,metoxibutropate,Specs,AN-652/42191159,,-7.807845,x0072,1.210593,active-noncovalent
c1cnc(cn1)Cl,BRD-K84075000-001-05-5,2-Chloropyrazine,Prestwick,Prestw-1087,2-Chloropyrazine,-7.807575,x0397,-1.311359,active-noncovalent
c1cc(c(cc1Cl)Cl)/C(=C/n2cncn2)/Cl,BRD-K09659835-003-01-4,loreclezole,Tocris,1295,Loreclezole hydrochloride,-7.807415,x0678,0.291094,active-noncovalent
c1c(cc(c(c1NC(=O)c2c(c(cc(c2Cl)Cl)Cl)O)O)Cl)Cl,BRD-K07283971-001-01-3,oxyclozanide,MicroSource,1504940,OXYCLOZANIDE,-7.806450,x0104,0.859844,active-noncovalent
CCn1c(n[nH]c1=O)c2ccc(cc2)Cl,BRD-K58146797-001-01-2,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",AMS,A002683787,"5-(4-chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",-7.805787,x0397,0.552453,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC(CC2)[C@@H](c3ccccc3)O,BRD-A62057054-001-04-9,MDL-11939,Tocris,870,"MDL 11,939",-7.804554,x1093,3.078626,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC(CC2)[C@@H](c3ccccc3)O,BRD-A62057054-001-03-1,MDL-11939,Tocris,870,"MDL 11,939",-7.804554,x1093,3.078626,active-noncovalent
CCOc1cccc(c1)NC(=O)c2ccc(c(c2)C(F)(F)F)N3CCCC3,BRD-K42536037-001-01-3,EPPTB,Tocris,4518,EPPTB,-7.804005,x0104,4.921219,active-noncovalent
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,BRD-K55930204-236-23-5,phenytoin,Selleck,S2524,Phenytoin sodium,-7.802949,x1077,-1.393601,active-noncovalent
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,BRD-K55930204-236-24-3,phenytoin,MicroSource,1500485,PHENYTOIN SODIUM,-7.802949,x1077,-1.393601,active-noncovalent
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,BRD-K55930204-001-20-9,phenytoin,Selleck,S2525,Phenytoin,-7.802949,x1077,-1.393601,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K18135438-001-14-2,chenodeoxycholic-acid,MicroSource,1500837,CHENODIOL,-7.801655,x0104,2.559822,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K18135438-001-16-7,chenodeoxycholic-acid,Selleck,S1843,Chenodeoxycholic Acid,-7.801655,x0104,2.559822,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])C[NH3+],BRD-A13561534-003-02-0,ornithine,MicroSource,1504524,ORNITHINE HYDROCHLORIDE,-7.800433,x0107,-1.393746,active-noncovalent
Cc1ccc(cn1)c2c(cc(cn2)Cl)c3ccc(cc3)S(=O)(=O)C,BRD-K54770957-001-04-3,etoricoxib,MedChemEx,HY-15321,Etoricoxib,-7.799803,x0678,2.447868,active-noncovalent
c1cc2c(c(c1)S(=O)(=O)N)c(cc3c2[nH]c(=O)c(=O)[nH]3)N(=O)=O,BRD-K11796549-001-05-2,NBQX,Tocris,373,NBQX,-7.798525,x0749,1.100792,active-covalent
c1cc2c(c(c1)S(=O)(=O)N)c(cc3c2[nH]c(=O)c(=O)[nH]3)N(=O)=O,BRD-K11796549-001-04-5,NBQX,Tocris,373,NBQX,-7.798525,x0749,1.100792,active-covalent
c1cc2c(c(c1)S(=O)(=O)N)c(cc3c2[nH]c(=O)c(=O)[nH]3)N(=O)=O,BRD-K11796549-304-01-9,NBQX,Tocris,1044,NBQX disodium salt,-7.798525,x0749,1.100792,active-covalent
CCCCCCC[N@H+](CC)CCC[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A74391928-051-03-9,ibutilide,Tocris,3908,Ibutilide hemifumarate,-7.798430,x0072,4.777071,active-noncovalent
CCCCCCC[N@H+](CC)CCC[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A74391928-051-01-3,ibutilide,Selleck,S2118,Ibutilide Fumarate,-7.798430,x0072,4.777071,active-noncovalent
CCCCCCC[N@H+](CC)CCC[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A74391928-051-02-1,ibutilide,Selleck,S2118,Ibutilide fumarate,-7.798430,x0072,4.777071,active-noncovalent
CC[C@](CO)(c1ccccc1)C(=O)OC2C[C@H]3CC[C@@H](C2)[N+]3(C)C,BRD-A35868371-005-01-6,troventol,MatrixSci,59775,,-7.798120,x0161,0.886779,active-noncovalent
C/C=C/C/C=C/CCC(=O)[C@@H]1[C@@H](O1)C(=O)N,BRD-K52075040-001-09-7,cerulenin,Enzo,G237,Cerulenin,-7.794919,x0749,1.097536,active-covalent
CCCOC(=O)c1ccccc1,BRD-K15329706-001-01-6,propyl-benzoate,Enamine,Z53835171,,-7.794863,x0195,-1.471616,active-noncovalent
CCOC(=O)C1=C(C(=O)N(C1)Cc2ccccc2)O,BRD-A96485169-001-14-3,EBPC,Tocris,518,EBPC,-7.793982,x1386,-0.413983,active-covalent
Cc1cc(no1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@@]2C)O,BRD-A75552914-001-15-0,isoxicam,Selleck,S4398,Isoxicam,-7.793593,x0678,1.09446,active-noncovalent
Cc1cc(no1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@@]2C)O,BRD-A75552914-001-16-8,isoxicam,MicroSource,1503242,ISOXICAM,-7.793593,x0678,1.09446,active-noncovalent
CCC(CC)Nc1cc([nH+]c(c1C)Oc2c(cc(cc2C)C)C)C,BRD-K31394475-003-01-5,CP-376395,Tocris,3212,CP 376395 hydrochloride,-7.793513,x0104,4.216809,active-noncovalent
CCC(CC)Nc1cc([nH+]c(c1C)Oc2c(cc(cc2C)C)C)C,BRD-K31394475-001-01-9,CP-376395,Key,GD-0065,"N-(1-ethylpropyl)-2-(mesityloxy)-3,6-dimethyl-4-pyridinamine",-7.793513,x0104,4.216809,active-noncovalent
CCOCCOc1ccccc1C(=O)N,BRD-K60914966-001-01-4,etosalamide,MicroSource,1503888,ETOSALAMIDE,-7.792745,x0195,-0.747661,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,BRD-K62310379-001-13-9,fluticasone-propionate,Selleck,S1992,Fluticasone propionate,-7.792624,x1077,6.352453,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,BRD-K62310379-001-10-5,fluticasone-propionate,Tocris,2007,Fluticasone propionate,-7.792624,x1077,6.352453,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,BRD-K62310379-001-12-1,fluticasone-propionate,Tocris,2007,Fluticasone propionate,-7.792624,x1077,6.352453,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)OCCOCC[N+](C)(C)Cc2ccccc2,BRD-K72723676-003-16-0,benzethonium,Selleck,S4162,Benzethonium Chloride,-7.791896,x0104,7.832701,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)OCCOCC[N+](C)(C)Cc2ccccc2,BRD-K72723676-003-17-8,benzethonium,MicroSource,1500138,BENZETHONIUM CHLORIDE,-7.791896,x0104,7.832701,active-noncovalent
C[NH+]1C[C@H]2CCC[C@@H](C1)C2OC(=O)[C@](c3ccccc3)(C4CCCC4)O,BRD-A64698388-003-01-7,levo-phencynonate,ChemPacific,36081,Bencynoate hydrochloride,-7.791839,x0072,1.058365,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])O)Cl)O,BRD-A34145622-003-23-6,demeclocycline,MedChemEx,HY-17560,Demeclocycline (hydrochloride),-7.791792,x0749,2.68408,active-covalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])O)Cl)O,BRD-A34145622-003-24-4,demeclocycline,MedChemEx,HY-17560,Demeclocycline (hydrochloride),-7.791792,x0749,2.68408,active-covalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])O)Cl)O,BRD-A34145622-003-25-1,demeclocycline,Selleck,S4279,Demeclocycline HCl,-7.791792,x0749,2.68408,active-covalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])O)Cl)O,BRD-A34145622-003-22-8,demeclocycline,MicroSource,1500226,DEMECLOCYCLINE HYDROCHLORIDE,-7.791792,x0749,2.68408,active-covalent
c1cc(oc1)c2nc3nc(nc(n3n2)N)NCCc4ccc(cc4)O,BRD-K19605405-001-02-7,ZM-241385,Tocris,1036,ZM 241385,-7.791051,x1093,2.303543,active-noncovalent
c1cc(oc1)c2nc3nc(nc(n3n2)N)NCCc4ccc(cc4)O,BRD-K19605405-001-03-5,ZM-241385,Tocris,1036,ZM 241385,-7.791051,x1093,2.303543,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)N,BRD-K75089421-003-24-5,procainamide,MicroSource,1500503,PROCAINAMIDE HYDROCHLORIDE,-7.791017,x0678,0.04755,active-noncovalent
CCCCCCCCCCCCCCCC=O,BRD-K35114608-001-01-7,1-hexadecanal,DuPont,A001212276,palmitaldehyde,-7.790753,x0104,1.653852,active-noncovalent
CC(C)Oc1cccc(c1)n2c(nc3ccccc3c2=O)CCc4c[nH]c5c4cc(cc5)Br,BRD-K33864865-001-02-5,LY225910,Tocris,1018,LY 225910,-7.790017,x0104,4.921688,active-noncovalent
CC(C)Oc1cccc(c1)n2c(nc3ccccc3c2=O)CCc4c[nH]c5c4cc(cc5)Br,BRD-K33864865-001-03-3,LY225910,Tocris,1018,LY 225910,-7.790017,x0104,4.921688,active-noncovalent
CN(C)C(=O)[C@@H]([C@H](Cc1ccccc1)NC(=O)c2cc3cc(ccc3[nH]2)Cl)O,BRD-K19171642-001-02-3,CP-91149,Selleck,S2717,CP-91149,-7.788883,x0749,3.814968,active-covalent
CCc1ccc(cc1)/C=C/2\C(=O)[N-]C(=S)S2,BRD-K49460120-001-05-8,10058-F4,Selleck,S7153,10058-F4,-7.788473,x1418,0.12184,active-covalent
CCc1ccc(cc1)/C=C/2\C(=O)[N-]C(=S)S2,BRD-K49460120-001-02-5,10058-F4,Selleck,S7153,10058-F4,-7.788473,x1418,0.12184,active-covalent
CCc1ccc(cc1)/C=C/2\C(=O)[N-]C(=S)S2,BRD-K49460120-001-06-6,10058-F4,Tocris,4406,10058-F4,-7.788473,x1418,0.12184,active-covalent
CCCC[C@H](CC)CC[C@H](CC(C)C)OS(=O)(=O)[O-],BRD-A55664972-236-02-6,sodium-tetradecyl-sulfate,MicroSource,1300042,SODIUM TETRADECYL SULFATE,-7.787877,x1418,1.016324,active-covalent
COc1cc(c(cc1S(=O)(=O)[O-])C(=O)c2ccccc2)O,BRD-K38602774-001-03-2,sulisobenzone,MicroSource,1505462,SULISOBENZONE,-7.787257,x0749,0.429579,active-covalent
COc1cc(c(cc1S(=O)(=O)[O-])C(=O)c2ccccc2)O,BRD-K38602774-002-01-4,sulisobenzone,ChemBridge,5304975,,-7.787257,x0749,0.429579,active-covalent
CC(C)(C)c1cc(ccc1OCC[N@@H+](C)CC(=O)[O-])c2ccc3c(c2)OCO3,BRD-K13888115-003-02-2,LY2365109,Tocris,3397,LY 2365109 hydrochloride,-7.786794,x0104,4.675703,active-noncovalent
CC(C)(C)c1cc(ccc1OCC[N@@H+](C)CC(=O)[O-])c2ccc3c(c2)OCO3,BRD-K13888115-003-03-0,LY2365109,Tocris,3397,LY 2365109 hydrochloride,-7.786794,x0104,4.675703,active-noncovalent
c1cc(ccc1C#N)C(c2ccc(cc2)C#N)n3cncn3,BRD-K88789588-001-16-4,letrozole,Tocris,4382,Letrozole,-7.784835,x0072,0.408835,active-noncovalent
c1cc(ccc1C#N)C(c2ccc(cc2)C#N)n3cncn3,BRD-K88789588-001-14-9,letrozole,Selleck,S1235,Letrozole,-7.784835,x0072,0.408835,active-noncovalent
CC(C)(C)C#C/C=C/C[N@@H+](C)Cc1cccc2c1cccc2,BRD-K68132782-001-03-3,terbinafine,Selleck,S1725,Terbinafine,-7.784606,x0195,0.857633,active-noncovalent
CC(C)(C)C#C/C=C/C[N@@H+](C)Cc1cccc2c1cccc2,BRD-K68132782-003-13-8,terbinafine,Selleck,S2557,Terbinafine HCl,-7.784606,x0195,0.857633,active-noncovalent
CC(C)(C)C#C/C=C/C[N@@H+](C)Cc1cccc2c1cccc2,BRD-K68132782-003-14-6,terbinafine,MicroSource,1505392,TERBINAFINE HYDROCHLORIDE,-7.784606,x0195,0.857633,active-noncovalent
c1cc(c2c(c1O)CCC2)Cl,BRD-K01653460-001-01-1,chlorindanol,MicroSource,1503743,CHLORINDANOL,-7.783982,x0195,2.22846,active-noncovalent
c1ccc2c(c1)C(=O)c3ccccc3C2(Cc4ccncc4)Cc5ccncc5,BRD-K42748308-300-02-0,XE-991,Tocris,2000,XE 991 dihydrochloride,-7.783828,x1077,2.771159,active-noncovalent
CC(C)(CS(=O)(=O)Nc1ccc2c(c1)CCN(C2)C(=O)COc3cccnc3)O,BRD-K18280217-001-01-0,Nampt-IN-1,MedChemEx,HY-12971,Nampt-IN-1,-7.783819,x0161,4.885235,active-noncovalent
CC(=O)NNC(=O)N1Cc2ccccc2Oc3c1cc(cc3)Cl,BRD-K52512893-001-09-7,SC-19220,Tocris,1206,SC 19220,-7.783723,x0678,1.188279,active-noncovalent
CC(=O)NNC(=O)N1Cc2ccccc2Oc3c1cc(cc3)Cl,BRD-K52512893-001-08-9,SC-19220,Tocris,1206,SC 19220,-7.783723,x0678,1.188279,active-noncovalent
C[C@@H](Cc1ccccc1OC)[NH2+]C,BRD-A21474126-001-01-6,methoxyphenamine,Sigma,PH011732,1-(2-methoxyphenyl)-N-methyl-2-propanamine,-7.783570,x0678,-0.90503,active-noncovalent
C[C@@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,BRD-K40308497-001-01-2,crizotinib-(S),Selleck,S7505,(S)-crizotinib,-7.783271,x0946,4.224203,active-noncovalent
C[C@@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,BRD-K40308497-001-02-0,crizotinib-(S),Selleck,S7505,(S)-crizotinib,-7.783271,x0946,4.224203,active-noncovalent
c1cc(c(nc1)NCc2ccncc2)C(=O)Nc3ccc(cc3)C4(CCCC4)C#N,BRD-K25244359-066-02-6,apatinib,Selleck,S2221,Apatinib,-7.783111,x0678,5.918957,active-noncovalent
c1cc(c(nc1)NCc2ccncc2)C(=O)Nc3ccc(cc3)C4(CCCC4)C#N,BRD-K25244359-066-03-4,apatinib,Selleck,S2221,Apatinib (YN968D1),-7.783111,x0678,5.918957,active-noncovalent
C[C@H](Cc1c[nH]cn1)[NH3+],BRD-K80028314-303-02-6,alpha-methylhistamine-dihydrobromide-(R)-(-),Tocris,569,(R)-(-)-?-Methylhistamine dihydrobromide,-7.782684,x0397,-1.925054,active-noncovalent
CCCCOc1cc(ccc1N)C(=O)OCC[NH+](CC)CC,BRD-K04185004-003-11-9,oxybuprocaine,Selleck,S4229,Oxybuprocaine HCl,-7.781488,x0104,2.94968,active-noncovalent
CCCCOc1cc(ccc1N)C(=O)OCC[NH+](CC)CC,BRD-K04185004-003-12-7,oxybuprocaine,MicroSource,1505502,BENOXINATE HYDROCHLORIDE,-7.781488,x0104,2.94968,active-noncovalent
CCCCOc1cc(ccc1N)C(=O)OCC[NH+](CC)CC,BRD-K04185004-003-13-5,oxybuprocaine,Selleck,S4229,Oxybuprocaine HCl,-7.781488,x0104,2.94968,active-noncovalent
CCOc1cc(c(cc1C(=O)NC[C@@H]2C[N@@H+](CCO2)Cc3ccc(cc3)F)Cl)N,BRD-A39052811-048-11-0,mosapride,Selleck,S1385,Mosapride Citrate,-7.781440,x0946,4.532256,active-noncovalent
CCOc1cc(c(cc1C(=O)NC[C@@H]2C[N@@H+](CCO2)Cc3ccc(cc3)F)Cl)N,BRD-A39052811-048-12-8,mosapride,Tocris,2844,Mosapride citrate,-7.781440,x0946,4.532256,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O,BRD-K06408664-001-03-5,fludrocortisone-acetate,MicroSource,1500299,FLUDROCORTISONE ACETATE,-7.780887,x1077,3.314455,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O,BRD-K06408664-001-02-7,fludrocortisone-acetate,Sigma,MFCD00864160,"(11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate",-7.780887,x1077,3.314455,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-])O,BRD-K76592088-001-02-1,3-carboxy-4-hydroxyphenylglycine-(R),Tocris,328,(R)-3-Carboxy-4-hydroxyphenylglycine,-7.779323,x1334,0.953402,active-covalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,BRD-A69651145-003-09-8,minocycline,Selleck,S4226,Minocycline HCl,-7.777530,x0161,2.84184,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,BRD-A69651145-003-11-4,minocycline,MedChemEx,HY-17412,Minocycline (hydrochloride),-7.777530,x0161,2.84184,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,BRD-A69651145-003-07-2,minocycline,MicroSource,1500414,MINOCYCLINE HYDROCHLORIDE,-7.777530,x0161,2.84184,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,BRD-A69651145-003-10-6,minocycline,Sigma,MFCD00083669,"(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide hydrochloride",-7.777530,x0161,2.84184,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,BRD-A69651145-003-08-0,minocycline,Selleck,S4226,Minocycline HCl,-7.777530,x0161,2.84184,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH2+]C,BRD-K45014108-003-01-8,ephedrine,MicroSource,1500273,"EPHEDRINE (1R,2S) HYDROCHLORIDE",-7.777114,x0195,-0.508458,active-noncovalent
c1cc(ccc1S(=O)(=O)[N@@](Cc2ccc(cc2F)c3ncon3)[C@H](CCC(F)(F)F)C(=O)N)Cl,BRD-K83720053-001-03-8,avagacestat,Selleck,S1262,Avagacestat (BMS-708163),-7.776841,x1077,6.620564,active-noncovalent
c1ccc(cc1)CCn2c3c(cn2)c4nc(nn4c(n3)N)c5ccco5,BRD-K81225797-001-03-1,SCH-58261,Tocris,2270,SCH 58261,-7.773768,x0195,4.305171,active-noncovalent
c1ccc(cc1)CCn2c3c(cn2)c4nc(nn4c(n3)N)c5ccco5,BRD-K81225797-001-02-3,SCH-58261,Tocris,2270,SCH 58261,-7.773768,x0195,4.305171,active-noncovalent
CC(C)(CCCCCCCCCCC(C)(C)CC(=O)[O-])CC(=O)[O-],BRD-K92908289-001-01-8,medica-16,Cayman,90290,"3,3,14,14-tetramethylhexadecanedioic acid",-7.773540,x0072,6.387487,active-noncovalent
Cc1ccccc1C(c2ccccc2C)[NH+]3[C@@H]4CC[C@H]3CC(C4)(c5ccccc5)O,BRD-A06700447-001-01-5,SCH-221510,Tocris,3240,SCH 221510,-7.772344,x0874,2.106154,active-noncovalent
C=C1[C@H](C[C@@H]([C@H]1CO)O)n2cnc3c2nc([nH]c3=O)N,BRD-K08206212-002-01-0,entecavir,Selleck,S1252,Entecavir Hydrate,-7.771270,x0874,0.632539,active-noncovalent
Cc1c(c2c(cccc2n1CC(=O)[O-])NC(=O)C)Sc3ccc(cc3)Cl,BRD-K83186168-001-01-8,AZD1981,Selleck,S7263,AZD1981,-7.771173,x1077,1.771205,active-noncovalent
C[N@@H+]1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1Cc4c3c(c(cc4)OC)O)OC,BRD-K83459933-001-05-4,sinomenine,Selleck,S2359,Sinomenine,-7.769701,x0072,3.826462,active-noncovalent
CCC1=C(CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@@H](CC3)C)C,BRD-K34776109-001-15-8,glimepiride,Tocris,2396,Glimepiride,-7.768931,x0434,9.749931,active-noncovalent
CCC1=C(CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@@H](CC3)C)C,BRD-K34776109-001-16-6,glimepiride,MicroSource,1504915,GLIMEPIRIDE,-7.768931,x0434,9.749931,active-noncovalent
CCC1=C(CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@@H](CC3)C)C,BRD-K34776109-001-14-1,glimepiride,Selleck,S1344,Glimepiride,-7.768931,x0434,9.749931,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-001-03-1,desvenlafaxine,Selleck,S4113,Desvenlafaxine,-7.768776,x0434,-0.688119,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-036-04-5,desvenlafaxine,Selleck,S4112,Desvenlafaxine Succinate,-7.768776,x0434,-0.688119,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-036-05-2,desvenlafaxine,Tocris,4194,WY 45233 succinate,-7.768776,x0434,-0.688119,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-001-02-3,desvenlafaxine,Selleck,S4113,Desvenlafaxine,-7.768776,x0434,-0.688119,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-036-03-7,desvenlafaxine,MicroSource,1504280,DESVENLAFAXINE SUCCINATE,-7.768776,x0434,-0.688119,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,BRD-A98845662-036-02-9,desvenlafaxine,Selleck,S4112,Desvenlafaxine Succinate,-7.768776,x0434,-0.688119,active-noncovalent
CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)[O-])O,BRD-K41234004-001-03-1,icomucret,Enzo,H015,15(S)-HETE,-7.767545,x0749,1.23662,active-covalent
C=C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3csc(n3)N)N=O)/C(=O)N2[C@H]1C(=O)[O-],BRD-K15766189-001-08-0,cefdinir,Selleck,S1605,Cefdinir,-7.766286,x0678,3.219015,active-noncovalent
C=C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3csc(n3)N)N=O)/C(=O)N2[C@H]1C(=O)[O-],BRD-K15766189-001-10-6,cefdinir,Selleck,S1605,Cefdinir (Omnicef),-7.766286,x0678,3.219015,active-noncovalent
C=C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3csc(n3)N)N=O)/C(=O)N2[C@H]1C(=O)[O-],BRD-K15766189-001-09-8,cefdinir,MicroSource,1505208,CEFDINIR,-7.766286,x0678,3.219015,active-noncovalent
CC(C)[C@@H](c1ccccc1)C(=O)Nc2ccc(cc2)C(=O)NO,BRD-K13167095-001-02-9,AR-42,Selleck,S2244,AR-42,-7.766232,x0072,1.484874,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-K78712176-001-15-8,carbidopa,MedChemEx,HY-B0311,Carbidopa,-7.766119,x0678,-1.530595,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-K78712176-001-13-3,carbidopa,MicroSource,1502150,CARBIDOPA,-7.766119,x0678,-1.530595,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-K78712176-001-12-5,carbidopa,Tocris,455,(S)-(-)-Carbidopa,-7.766119,x0678,-1.530595,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-K78712176-001-14-1,carbidopa,Selleck,S1891,Carbidopa,-7.766119,x0678,-1.530595,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-K78712176-001-11-7,carbidopa,Selleck,S1891,Carbidopa,-7.766119,x0678,-1.530595,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,BRD-A69512159-001-07-3,carbidopa,MedChemEx,HY-B0311,Carbidopa,-7.766119,x0678,-1.530595,active-noncovalent
Cc1cc(c(cc1Cl)C(C)C)O,BRD-K04358951-001-01-0,chlorothymol,Enamine,Z104485030,,-7.765419,x1418,-0.06896,active-covalent
C[C@@H](C[NH+]1CCC(CC1)Cc2ccccc2)[C@H](c3ccc(cc3)O)O,BRD-K51541829-050-01-0,Ro-25-6981,Tocris,1594,Ro 25-6981 hydrochloride,-7.764874,x0874,2.185169,active-noncovalent
C[C@@H](C[NH+]1CCC(CC1)Cc2ccccc2)[C@H](c3ccc(cc3)O)O,BRD-K51541829-050-02-8,Ro-25-6981,Tocris,1594,Ro 25-6981 maleate,-7.764874,x0874,2.185169,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2cccc(c2)C(F)(F)F)C,BRD-K09635314-001-04-2,m-3M3FBS,Tocris,1941,m-3M3FBS,-7.764846,x1093,0.755471,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2cccc(c2)C(F)(F)F)C,BRD-K09635314-001-03-4,m-3M3FBS,Tocris,1941,m-3M3FBS,-7.764846,x1093,0.755471,active-noncovalent
Cc1cc(c(cc1c2cc(c(cc2C)OI)C(C)C)C(C)C)OI,BRD-K36617478-001-01-5,thymol-iodide,SantaCruz,sc-215985,Thymol iodide,-7.764456,x0874,4.283166,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],BRD-K62309135-001-05-2,L-glutamic-acid,Sigma,MFCD00012619,(2S)-2-aminopentanedioic acid hydrochloride,-7.764096,x0397,-0.682901,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K29582677-300-09-8,flunarizine,Tocris,522,Flunarizine dihydrochloride,-7.763595,x1077,4.686754,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K29582677-300-11-4,flunarizine,Tocris,522,Flunarizine dihydrochloride,-7.763595,x1077,4.686754,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K29582677-300-10-6,flunarizine,MicroSource,1500993,FLUNARIZINE HYDROCHLORIDE,-7.763595,x1077,4.686754,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K29582677-300-08-0,flunarizine,Selleck,S2030,Flunarizine 2HCl,-7.763595,x1077,4.686754,active-noncovalent
c1cc2c(c[nH]c2nc1)Cc3ccc(nc3)NCc4ccc(cc4)C(F)(F)F,BRD-K79294107-300-01-6,PLX-647,Tocris,5102,PLX 647 dihydrochloride,-7.763232,x1077,4.834178,active-noncovalent
C1=C(c2c(c(c(c(c2Cl)Cl)Cl)Cl)C1=O)[O-],BRD-K27536248-001-01-7,TCID,Selleck,S7140,TCID,-7.762191,x0195,1.09763,active-noncovalent
C1=C(c2c(c(c(c(c2Cl)Cl)Cl)Cl)C1=O)[O-],BRD-K27536248-001-02-5,TCID,Selleck,S7140,TCID,-7.762191,x0195,1.09763,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,BRD-K06902185-001-21-9,minoxidil,Tocris,583,Minoxidil,-7.761233,x0104,-0.950074,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,BRD-K06902185-003-01-7,minoxidil,MicroSource,1500415,MINOXIDIL HYDROCHLORIDE,-7.761233,x0104,-0.950074,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,BRD-K06902185-001-22-7,minoxidil,Sigma,MFCD00063409,6-amino-2-imino-4-(1-piperidinyl)-1(2H)-pyrimidinol,-7.761233,x0104,-0.950074,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,BRD-K06902185-001-17-7,minoxidil,Tocris,583,Minoxidil,-7.761233,x0104,-0.950074,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,BRD-K06902185-001-16-9,minoxidil,Selleck,S1383,Minoxidil,-7.761233,x0104,-0.950074,active-noncovalent
c1cc(ccc1CCCC(=O)[O-])N(CCCl)CCCl,BRD-K29458283-001-29-9,chlorambucil,MicroSource,1500171,CHLORAMBUCIL,-7.760257,x0678,-0.116368,active-noncovalent
c1cc(ccc1[C@@H](C[NH3+])CS(=O)(=O)[O-])Cl,BRD-A24122750-001-03-7,saclofen,Tocris,246,Saclofen,-7.759218,x1077,-1.129721,active-noncovalent
CN1CC[NH+](CC1)[C@H](c2ccccc2)c3ccc(cc3)Cl,BRD-A57133233-003-11-0,chlorcyclizine,Enzo,AC2340,Chlorcyclizine hydrochloride,-7.758842,x0831,-0.445655,active-covalent
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C,BRD-K34068325-066-01-1,delavirdine,Enzo,GR314,Delavirdine mesylate,-7.758618,x0104,10.716485,active-noncovalent
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C,BRD-K34068325-066-04-5,delavirdine,Tocris,4149,Delavirdine mesylate,-7.758618,x0104,10.716485,active-noncovalent
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C,BRD-K34068325-066-03-7,delavirdine,MedChemEx,HY-10571A,Delavirdine (mesylate),-7.758618,x0104,10.716485,active-noncovalent
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C,BRD-K34068325-066-02-9,delavirdine,Sigma,MFCD00866948,N-[2-({4-[3-(isopropylamino)-2-pyridinyl]-1-piperazinyl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate,-7.758618,x0104,10.716485,active-noncovalent
CC1([C@@H]([C@H]1C(=O)O[C@H](C#N)c2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,BRD-A62798249-001-04-4,cypermethrin,MicroSource,1503606,CYPERMETHRIN,-7.758310,x0161,4.277112,active-noncovalent
CCn1cc(c(=O)c2c1nc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K78113049-001-17-0,enoxacin,Selleck,S1756,Enoxacin (Penetrex),-7.758130,x0749,4.001971,active-covalent
CCn1cc(c(=O)c2c1nc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K78113049-001-15-4,enoxacin,Selleck,S1756,Enoxacin,-7.758130,x0749,4.001971,active-covalent
CCn1cc(c(=O)c2c1nc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],BRD-K78113049-001-16-2,enoxacin,MicroSource,1503215,ENOXACIN,-7.758130,x0749,4.001971,active-covalent
CC[N+](C)(CC)CCC[n+]1c2cc(ccc2c3ccc(cc3c1c4ccccc4)N)N,BRD-K14821965-302-05-2,propidium-iodide,Prestwick,Prestw-792,Propidium iodide,-7.757973,x1385,3.633862,active-covalent
CCCCCCCC[NH2+][C@@H](C)[C@H](c1ccc(cc1)SC(C)C)O,BRD-A34205397-001-04-5,suloctidil,MicroSource,1501153,SULOCTIDIL,-7.757906,x0195,3.150908,active-noncovalent
COc1ccc(cc1)S(=O)(=O)Nc2cccnc2Nc3ccc(cc3)O,BRD-K91623615-001-06-8,ABT-751,Tocris,4138,ABT 751,-7.754601,x0678,3.921333,active-noncovalent
COc1ccc(cc1)S(=O)(=O)Nc2cccnc2Nc3ccc(cc3)O,BRD-K91623615-001-05-0,ABT-751,Selleck,S1165,ABT-751,-7.754601,x0678,3.921333,active-noncovalent
COc1ccc(cc1)S(=O)(=O)Nc2cccnc2Nc3ccc(cc3)O,BRD-K91623615-001-04-3,ABT-751,Selleck,S1165,ABT-751 (E7010),-7.754601,x0678,3.921333,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],BRD-K68185022-001-14-8,ursolic-acid,Selleck,S2370,Ursolic Acid,-7.754503,x0874,5.112388,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],BRD-K68185022-001-12-2,ursolic-acid,Sigma,Y0001523,"(3beta,9alpha)-3-hydroxyurs-12-en-28-oic acid",-7.754503,x0874,5.112388,active-noncovalent
c1[nH]c2c(=S)[nH]c(nc2n1)N,BRD-K49350383-001-14-5,thioguanine,MicroSource,1500573,THIOGUANINE,-7.753992,x0540,-1.370223,active-noncovalent
c1[nH]c2c(=S)[nH]c(nc2n1)N,BRD-K49350383-001-13-7,thioguanine,Selleck,S1774,Thioguanine,-7.753992,x0540,-1.370223,active-noncovalent
c1[nH]c2c(=S)[nH]c(nc2n1)N,BRD-K49350383-001-15-2,thioguanine,MicroSource,1504530,TIOGUANINE,-7.753992,x0540,-1.370223,active-noncovalent
CC(=O)N[C@@H](Cc1ccccc1)C(=O)[O-],BRD-K53205568-001-02-6,afalanine,MicroSource,1506105,AFALANINE,-7.753862,x0161,-1.088239,active-noncovalent
c1ccc2c(c1)c(=O)[n-]c(=O)o2,BRD-K13238618-001-05-9,carsalam,MicroSource,1504504,CARSALAM,-7.753559,x0195,-0.748014,active-noncovalent
CCC(=O)c1ccc(cc1)O,BRD-K07441213-001-18-9,paroxypropione,MicroSource,1506169,PAROXYPROPIONE,-7.752612,x0195,0.079775,active-noncovalent
CCN(CC)C(=O)c1cccnc1,BRD-K91544578-001-03-8,nikethamide,MicroSource,1506157,NIKETHAMIDE,-7.751633,x0107,-1.160873,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])[C@@H](C(=O)[O-])F,BRD-A11731518-001-01-7,BAY-85-8050,AlfaAesar,L10517,,-7.750725,x0397,-0.938094,active-noncovalent
CCCC[N@@H+]1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,BRD-K33251802-001-01-3,miglustat,Enzo,SL230,N-Butyldeoxynojirmycin HCL,-7.750454,x0195,1.301476,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)N4CCOCC4,BRD-K94379058-001-06-8,BML-190,Tocris,1383,BML-190,-7.749722,x0161,4.571539,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)N4CCOCC4,BRD-K94379058-001-05-0,BML-190,Selleck,S2854,BML-190,-7.749722,x0161,4.571539,active-noncovalent
CC(=O)c1ccc2c(c1)[C@@H]([C@@H](C(O2)(C)C)O)NC(=O)c3ccc(c(c3)Cl)F,BRD-K36970462-001-01-6,tonabersat,MedChemEx,HY-15204,Tonabersat,-7.749680,x0195,3.172472,active-noncovalent
c1ccc(cc1)[C@H](C[NH2+]CCOc2ccc(cc2)CC(=O)[O-])O,BRD-K64157027-003-02-7,ZD-2079,Tocris,2154,ZD 2079,-7.749617,x0874,2.328329,active-noncovalent
CCCCNc1ccc(cc1)C(=O)OCC[NH+](C)C,BRD-K45071273-003-24-9,tetracaine,Selleck,S2573,Tetracaine HCl,-7.748345,x0946,1.51398,active-noncovalent
CCCCNc1ccc(cc1)C(=O)OCC[NH+](C)C,BRD-K45071273-003-25-6,tetracaine,MicroSource,1500564,TETRACAINE HYDROCHLORIDE,-7.748345,x0946,1.51398,active-noncovalent
c1ccc(c(c1)C(=O)NCC(=O)[O-])I,BRD-K56634222-001-03-0,2-iodohippuric-acid,Enamine,Z85887266,,-7.746661,x1418,0.462153,active-covalent
CC1(CCCCCCC1)[NH+]2CCC(CC2)n3c4ccccc4nc3[C@@H]5CCC[NH2+]C5,BRD-K73276278-305-01-1,MCOPPB,Tocris,3763,MCOPPB trihydrochloride,-7.746440,x0195,5.154736,active-noncovalent
CN([C@@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)c3ccc(c(c3)Cl)Cl,BRD-K20995441-001-02-5,U-54494A,Tocris,498,U-54494A hydrochloride,-7.744275,x0195,2.095278,active-noncovalent
CCCN(CCC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccccc1,BRD-A44863528-001-13-2,proglumide,MicroSource,1501119,PROGLUMIDE,-7.744035,x0749,1.948983,active-covalent
CCCCCCCCCCCCCCCCO,BRD-K37203094-001-02-5,1-hexadecanol,Selleck,S4173,1-Hexadecanol,-7.743927,x0104,1.698458,active-noncovalent
CCCCCCCCCCCCCCCCO,BRD-K37203094-001-03-3,1-hexadecanol,Selleck,S4173,1-Hexadecanol,-7.743927,x0104,1.698458,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)S(=O)(=O)NC3CC[NH2+]CC3)C(F)(F)F,BRD-K61871885-001-01-3,WAY-316606,MedChemEx,HY-10858,WAY 316606,-7.743923,x0107,5.716702,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)S(=O)(=O)NC3CC[NH2+]CC3)C(F)(F)F,BRD-K61871885-003-01-9,WAY-316606,Tocris,4767,WAY 316606 hydrochloride,-7.743923,x0107,5.716702,active-noncovalent
COc1cc(ncn1)NS(=O)(=O)c2ccc(cc2)N,BRD-K14116214-001-09-6,sulfamonomethoxine,MicroSource,1501147,SULFAMONOMETHOXINE,-7.742991,x0678,0.71189,active-noncovalent
c1cc2c(cc1Cl)nc(o2)N,BRD-K66353228-001-13-8,zoxazolamine,Selleck,S4233,Zoxazolamine,-7.742792,x0195,-1.562301,active-noncovalent
c1cc2c(cc1Cl)nc(o2)N,BRD-K66353228-001-14-6,zoxazolamine,MicroSource,1504216,ZOXAZOLAMINE,-7.742792,x0195,-1.562301,active-noncovalent
c1cc(ccc1c2cnc3c(cnn3c2)c4ccncc4)OCC[NH+]5CCCCC5,BRD-K54233340-300-05-1,dorsomorphin,Tocris,3093,Dorsomorphin dihydrochloride,-7.740695,x0104,8.920537,active-noncovalent
Cc1c(scn1)CCCl,BRD-K50422030-003-02-6,clomethiazole,Tocris,881,Chlormethiazole hydrochloride,-7.740016,x0195,-1.031952,active-noncovalent
Cc1c(scn1)CCCl,BRD-K50422030-001-05-3,clomethiazole,Enamine,EN300-60459,,-7.740016,x0195,-1.031952,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)NCC(=O)Oc3ccccc3OC,BRD-K70924353-001-01-2,amtolmetin-guacil,OxChem,AX8076550,,-7.739934,x0434,5.427167,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,BRD-K65331431-001-08-8,retinyl-acetate,Sigma,95140,O~15~-acetylretinol,-7.739920,x0104,5.738379,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,BRD-K65331431-001-06-2,retinyl-acetate,MicroSource,1503051,RETINYL ACETATE,-7.739920,x0104,5.738379,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-213-21-5,ciclopirox,MicroSource,1500189,CICLOPIROX OLAMINE,-7.739372,x0678,-0.739681,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-213-25-6,ciclopirox,Sigma,MFCD00078997,6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone compound with 2-aminoethanol (1:1),-7.739372,x0678,-0.739681,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-213-24-9,ciclopirox,Selleck,S3019,Ciclopirox ethanolamine,-7.739372,x0678,-0.739681,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-213-20-7,ciclopirox,Selleck,S3019,Ciclopirox ethanolamine,-7.739372,x0678,-0.739681,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-001-03-2,ciclopirox,Selleck,S2528,Ciclopirox (Penlac),-7.739372,x0678,-0.739681,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,BRD-K13044802-001-02-4,ciclopirox,Selleck,S2528,Ciclopirox,-7.739372,x0678,-0.739681,active-noncovalent
c1ccc(cc1)CC(=O)Nc2nc3ccc(cc3c4n2nc(n4)c5ccco5)Cl,BRD-K37618799-001-04-8,MRS-1220,Tocris,1217,MRS 1220,-7.739103,x0161,5.575661,active-noncovalent
c1ccc(cc1)CC(=O)Nc2nc3ccc(cc3c4n2nc(n4)c5ccco5)Cl,BRD-K37618799-001-03-0,MRS-1220,Tocris,1217,MRS 1220,-7.739103,x0161,5.575661,active-noncovalent
CCCCC1=[NH+]C2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[n-]nnn5,BRD-K60038276-001-08-2,irbesartan,Selleck,S1507,Irbesartan,-7.739009,x0874,5.487609,active-noncovalent
CCCCC1=[NH+]C2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[n-]nnn5,BRD-K60038276-001-09-0,irbesartan,MicroSource,1504259,IRBESARTAN,-7.739009,x0874,5.487609,active-noncovalent
c1c(c(cc2c1[nH]c(=O)c(=O)n2CP(=O)([O-])[O-])N3CCOCC3)C(F)(F)F,BRD-K67525671-001-03-3,ZK-200775,Tocris,2345,ZK 200775,-7.738261,x0195,2.592191,active-noncovalent
c1c(c(cc2c1[nH]c(=O)c(=O)n2CP(=O)([O-])[O-])N3CCOCC3)C(F)(F)F,BRD-K67525671-001-02-5,ZK-200775,Tocris,2345,ZK 200775,-7.738261,x0195,2.592191,active-noncovalent
c1cc(cnc1)CNc2cc3c(cn2)ncc(c3Nc4ccc(c(c4)Cl)F)C#N,BRD-K51776215-001-02-5,TC-S-7006,Tocris,5240,TC-S 7006,-7.737694,x0678,3.016347,active-noncovalent
CCN(CC)C(=O)/C(=C/c1cc(c(c(c1)O)[O-])N(=O)=O)/C#N,BRD-K83636919-001-05-5,entacapone,Selleck,S3147,Entacapone,-7.737253,x1418,1.796353,active-covalent
CCN(CC)C(=O)/C(=C/c1cc(c(c(c1)O)[O-])N(=O)=O)/C#N,BRD-K83636919-001-03-0,entacapone,Selleck,S3147,Entacapone,-7.737253,x1418,1.796353,active-covalent
CCN(CC)C(=O)/C(=C/c1cc(c(c(c1)O)[O-])N(=O)=O)/C#N,BRD-K83636919-001-04-8,entacapone,MicroSource,1502381,ENTACAPONE,-7.737253,x1418,1.796353,active-covalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-],BRD-K03070961-001-08-5,arachidonic-acid,Enzo,FA003,"5(Z),8(Z),11(Z),14(Z)-Eicosatetraenoic acid",-7.736992,x0967,2.3398,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-],BRD-K03070961-001-10-1,arachidonic-acid,Sigma,MFCD00004417,"(5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid",-7.736992,x0967,2.3398,active-noncovalent
CCCCN(CC)c1c(cc(cc1N(=O)=O)C(F)(F)F)N(=O)=O,BRD-K33903083-001-03-5,benfluralin,Sigma,MFCD00078630,"N-butyl-N-[2,6-dinitro-4-(trifluoromethyl)phenyl]-N-ethylamine",-7.736940,x0195,1.448954,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccccc1I,BRD-K71698503-003-01-6,I-BZA2,ChemBridge,7531337,,-7.736885,x0161,-0.292011,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCCO,BRD-A62428732-300-06-3,hydroxyzine,Selleck,S4026,Hydroxyzine 2HCl,-7.736731,x1093,3.078856,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCCO,BRD-A62428732-096-10-9,hydroxyzine,MicroSource,1500345,HYDROXYZINE PAMOATE,-7.736731,x1093,3.078856,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K72093121-001-16-3,vidarabine,Selleck,S1784,Vidarabine,-7.736373,x0195,-0.076774,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K72093121-001-17-1,vidarabine,MicroSource,1500609,VIDARABINE,-7.736373,x0195,-0.076774,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,BRD-K88429204-001-35-1,pyrimethamine,MicroSource,1500520,PYRIMETHAMINE,-7.735847,x0678,1.725594,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,BRD-K88429204-001-33-6,pyrimethamine,Selleck,S2006,Pyrimethamine,-7.735847,x0678,1.725594,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,BRD-K88429204-001-34-4,pyrimethamine,Tocris,3918,Pyrimethamine,-7.735847,x0678,1.725594,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,BRD-K88429204-001-38-5,pyrimethamine,Tocris,3918,Pyrimethamine,-7.735847,x0678,1.725594,active-noncovalent
c1cc(ccc1CC2CC[NH+](CC2)C[C@@H](c3ccc(cc3)Cl)O)F,BRD-A61392169-001-02-7,eliprodil,Tocris,2195,Eliprodil,-7.735111,x0161,2.410087,active-noncovalent
c1c[nH]nc1CC[NH3+],BRD-K20075662-300-04-0,betazole,Prestwick,Prestw-43,Betazole hydrochloride,-7.734958,x0397,-1.685102,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3CC[C@@H]([C@H](N3C2=O)C(=O)[O-])Cl)[NH3+],BRD-A04915500-002-01-3,loracarbef,Kemprotec,121961-22-6,7-((R)-2-amino-2-phenylacetamido)-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate,-7.734709,x1077,0.675864,active-noncovalent
CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](c2ccc(cc2)c3ccc(cc3)S(=O)(=O)C)C(F)(F)F)F,BRD-K22822991-001-02-3,odanacatib,Selleck,S1115,Odanacatib (MK-0822),-7.734351,x0072,8.947259,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)C[C@@H](COc2ccc(cc2)NS(=O)(=O)C)O,BRD-A11813248-003-02-4,AM-92016,Tocris,876,AM 92016 hydrochloride,-7.733725,x0161,4.707982,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)C[C@@H](COc2ccc(cc2)NS(=O)(=O)C)O,BRD-A11813248-003-03-2,AM-92016,Tocris,876,AM 92016 hydrochloride,-7.733725,x0161,4.707982,active-noncovalent
CCc1cc2cc(c(cc2c(n1)Cc3ccccc3)OC)OC,BRD-K12742203-003-01-7,moxaverine,Innovapharm,BBS-00028240,"1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride",-7.733162,x0195,0.516838,active-noncovalent
C[C@](COc1ccc(cc1)C#N)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,BRD-K29735307-001-02-9,ostarine,Selleck,S1174,MK-2866 (GTx-024),-7.732401,x0161,3.910649,active-noncovalent
Cc1cc([nH]n1)Nc2c(cnc(n2)N[C@@H](C)c3ncc(cn3)F)Cl,BRD-K65928735-001-06-8,AZD1480,Tocris,5617,AZD 1480,-7.732144,x0397,1.497418,active-noncovalent
Cc1cc([nH]n1)Nc2c(cnc(n2)N[C@@H](C)c3ncc(cn3)F)Cl,BRD-K65928735-001-04-3,AZD1480,MedChemEx,HY-10193,AZD-1480,-7.732144,x0397,1.497418,active-noncovalent
c1ccc(cc1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,BRD-K03504028-001-07-6,amygdalin,Selleck,S2260,Amygdalin,-7.731322,x0161,5.19909,active-noncovalent
c1ccc(cc1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,BRD-K03504028-001-08-4,amygdalin,Selleck,S2260,Laetrile,-7.731322,x0161,5.19909,active-noncovalent
Cc1cc2c(cc1S(=O)(=O)N)S(=O)(=O)CCC2,BRD-K58265391-001-12-7,meticrane,MicroSource,1506077,METICRANE,-7.730537,x0749,1.120684,active-covalent
Cc1cc2c(cc1S(=O)(=O)N)S(=O)(=O)CCC2,BRD-K58265391-001-11-9,meticrane,Selleck,S4339,Meticrane,-7.730537,x0749,1.120684,active-covalent
C[N+](C)(C)CCCCCC[N+](C)(C)C,BRD-K10598093-303-06-1,hexamethonium,MicroSource,1503297,HEXAMETHONIUM BROMIDE,-7.730157,x0749,-0.367363,active-covalent
C[N+](C)(C)CCCCCC[N+](C)(C)C,BRD-K10598093-303-05-3,hexamethonium,Selleck,S4069,Hexamethonium bromide,-7.730157,x0749,-0.367363,active-covalent
C[N+](C)(C)CCCCCC[N+](C)(C)C,BRD-K10598093-303-07-9,hexamethonium,Selleck,S4069,Hexamethonium Bromide,-7.730157,x0749,-0.367363,active-covalent
c1ccc2c(c1)c3c(n2CCC(=O)[O-])CC[C@H](C3)NS(=O)(=O)c4ccc(cc4)F,BRD-K08586861-001-01-1,ramatroban,MedChemEx,HY-B0745,Ramatroban,-7.729426,x0874,2.219549,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[NH+]3CCN(CC3)C[C@H](COc4cccc5c4cc([nH]5)C#N)O,BRD-A64553394-001-04-4,DPI-201106,Enzo,NA116,SDZ-201106,-7.729252,x0104,6.367249,active-noncovalent
CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N,BRD-K25835157-001-02-2,PRT062070,MedChemEx,HY-15999,Cerdulatinib,-7.727309,x0161,9.031203,active-noncovalent
CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N,BRD-K25835157-001-01-4,PRT062070,MedChemEx,HY-15999,Cerdulatinib,-7.727309,x0161,9.031203,active-noncovalent
CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N,BRD-K25835157-001-04-8,PRT062070,MedChemEx,HY-15999,Cerdulatinib,-7.727309,x0161,9.031203,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCCCC2)I,BRD-K78844995-001-02-6,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,Tocris,763,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,-7.727271,x0195,0.715666,active-noncovalent
COc1ccc(cc1)c2c(onc2c3ccc(cc3)OC)CC(=O)[O-],BRD-K49372556-001-04-1,mofezolac,Sigma,MFCD00712149,"[3,4-bis(4-methoxyphenyl)-5-isoxazolyl]acetic acid",-7.726921,x0678,1.984264,active-noncovalent
Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@@]34CC[C@@H](C3(C)C)C[C@@H]4NC(=O)[C@H](CCS(=O)(=O)C)[NH3+],BRD-A43930669-003-03-6,L-368899,Tocris,2641,"L-368,899 hydrochloride",-7.725110,x0104,9.475391,active-noncovalent
Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@@]34CC[C@@H](C3(C)C)C[C@@H]4NC(=O)[C@H](CCS(=O)(=O)C)[NH3+],BRD-A43930669-003-02-8,L-368899,Tocris,2641,"L-368,899 hydrochloride",-7.725110,x0104,9.475391,active-noncovalent
[H]/N=C(/N)\Nc1nc(cs1)CSCC/N=C(\NC)/NC#N,BRD-K15071410-001-03-7,tiotidine,Tocris,826,Tiotidine,-7.724619,x0678,-0.193608,active-noncovalent
[H]/N=C(/N)\Nc1nc(cs1)CSCC/N=C(\NC)/NC#N,BRD-K15071410-001-01-1,tiotidine,Tocris,826,Tiotidine,-7.724619,x0678,-0.193608,active-noncovalent
c1cc2c(cc1/C=C/C=C/C(=O)N3CCCCC3)OCO2,BRD-K59522102-001-14-6,piperine,MicroSource,1500873,PIPERINE,-7.724535,x0946,4.643145,active-noncovalent
c1cc2c(cc1/C=C/C=C/C(=O)N3CCCCC3)OCO2,BRD-K59522102-001-15-3,piperine,Selleck,S2344,Piperine (1-Piperoylpiperidine),-7.724535,x0946,4.643145,active-noncovalent
c1cc2c(cc1/C=C/C=C/C(=O)N3CCCCC3)OCO2,BRD-K59522102-001-13-8,piperine,Selleck,S2344,Piperine,-7.724535,x0946,4.643145,active-noncovalent
c1cc2c(=O)cc[nH]c2cc1Cl,BRD-K83335125-001-07-0,chloroxoquinoline,Alinda,ALBB-024683,7-chloroquinolin-4(1H)-one,-7.723324,x1382,-1.794918,active-covalent
c1ccc(cc1)/C=C/2\C[C@]3([C@H]4Cc5ccc(c6c5[C@@]3(CC[N@@H+]4CC7CC7)[C@H](C2=O)O6)O)O,BRD-A55484088-050-03-3,BNTX,Tocris,899,BNTX maleate,-7.722379,x1077,3.104246,active-noncovalent
c1ccc(cc1)/C=C/2\C[C@]3([C@H]4Cc5ccc(c6c5[C@@]3(CC[N@@H+]4CC7CC7)[C@H](C2=O)O6)O)O,BRD-A55484088-050-04-1,BNTX,Tocris,899,"(4aS,7aR,12bS)-6-((E)-benzylidene)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]i",-7.722379,x1077,3.104246,active-noncovalent
c1ccc(cc1)/C=C/2\C[C@]3([C@H]4Cc5ccc(c6c5[C@@]3(CC[N@@H+]4CC7CC7)[C@H](C2=O)O6)O)O,BRD-A55484088-050-02-5,BNTX,Tocris,899,BNTX maleate,-7.722379,x1077,3.104246,active-noncovalent
CC(=C)C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2c6c(c7ccccc7[nH]6)C[C@]3([C@H]1C5)O)O,BRD-A75769826-003-04-7,SDM25N,Tocris,1410,"(4bS,8aS,14bR)-7-(2-methylallyl)-5,6,7,8,14,14b-hexahydro-4,8-methanobenzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol hydro",-7.722163,x0434,2.344419,active-noncovalent
CC(=C)C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2c6c(c7ccccc7[nH]6)C[C@]3([C@H]1C5)O)O,BRD-A75769826-003-02-1,SDM25N,Tocris,1410,SDM25N hydrochloride,-7.722163,x0434,2.344419,active-noncovalent
CC(=C)C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2c6c(c7ccccc7[nH]6)C[C@]3([C@H]1C5)O)O,BRD-A75769826-003-03-9,SDM25N,Tocris,1410,SDM25N hydrochloride,-7.722163,x0434,2.344419,active-noncovalent
CCCc1c2c(c(=O)[nH]c(n2)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)C)n(n1)C,BRD-K79759585-048-04-8,sildenafil,MicroSource,1504099,SILDENAFIL CITRATE,-7.720498,x1077,6.739037,active-noncovalent
CCCc1c2c(c(=O)[nH]c(n2)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)C)n(n1)C,BRD-K79759585-048-07-1,sildenafil,Tocris,3784,Sildenafil citrate,-7.720498,x1077,6.739037,active-noncovalent
CCCc1c2c(c(=O)[nH]c(n2)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)C)n(n1)C,BRD-K79759585-048-03-0,sildenafil,Selleck,S1431,Sildenafil Citrate,-7.720498,x1077,6.739037,active-noncovalent
COc1ccc2c(c1)sc(n2)NC(=O)Nc3ccccc3,BRD-K07202345-001-19-4,frentizole,MedChemEx,HY-15374,Frentizole,-7.719878,x0161,2.717683,active-noncovalent
C[C@@H](Cc1cccc(c1)O)[NH3+],BRD-A04447196-001-01-8,gepefrine,Sigma,MFCD00047912,3-(2-aminopropyl)phenol,-7.719238,x0195,-0.384771,active-noncovalent
Cc1ccc2c(c1CCC(=O)[O-])CC[C@H](C2)NS(=O)(=O)c3ccc(cc3)Cl,BRD-K43975632-001-01-1,terutroban,MedChemEx,HY-16991,Terutroban,-7.718481,x0104,1.550164,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@@H]2C[C@H]([C@H](O2)CO)O)F,BRD-A03757454-001-03-4,floxuridine,MicroSource,1503059,FLOXURIDINE,-7.718280,x0749,-0.663745,active-covalent
CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCCC(=O)[O-],BRD-K46254452-001-01-5,GABA-linoleamide,Enzo,EL131,Linoleoyl GABA,-7.717864,x0830,4.857137,active-covalent
Cn1c(c[nH+]c1COc2ccc(cc2)SC)N(=O)=O,BRD-K37069697-001-01-3,fexinidazole,Ark,AK116408,,-7.717305,x0678,-0.197433,active-noncovalent
CC1([C@@H]([C@H]1C(=O)OCc2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,BRD-A25366096-001-07-3,permethrin,MicroSource,1504932,PERMETHRIN,-7.716930,x0072,3.655137,active-noncovalent
CC1([C@@H]([C@H]1C(=O)OCc2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,BRD-A25366096-001-08-1,permethrin,Sigma,MFCD00041809,"3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",-7.716930,x0072,3.655137,active-noncovalent
CC1([C@@H]([C@H]1C(=O)OCc2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,BRD-A25366096-001-09-9,permethrin,MedChemEx,HY-B0887,Permethrin,-7.716930,x0072,3.655137,active-noncovalent
Cc1cc(nn2c1nnc2)N3CCCCC3,BRD-K26598477-001-01-0,zindotrine,Labotest,LT00032874,"8-methyl-6-(1-piperidinyl)[1,2,4]triazolo[4,3-b]pyridazine",-7.715386,x1418,-0.76045,active-covalent
c1c([nH]cn1)CCCCC[NH3+],BRD-K20049318-303-02-1,impentamine,Tocris,1858,Impentamine dihydrobromide,-7.714113,x0161,-2.136858,active-noncovalent
COc1ccc(cc1)c2c(nc([nH]2)c3ccc(o3)c4cccc(c4)Cl)c5ccc(cc5)OC,BRD-K22631935-001-02-7,neurodazine,Tocris,3656,Neurodazine,-7.713920,x0434,10.014067,active-noncovalent
COc1ccc(cc1)c2c(nc([nH]2)c3ccc(o3)c4cccc(c4)Cl)c5ccc(cc5)OC,BRD-K22631935-001-03-5,neurodazine,Tocris,3656,Neurodazine,-7.713920,x0434,10.014067,active-noncovalent
Cc1cc(ccc1Cl)O,BRD-K89056082-001-06-9,chlorocresol,Selleck,S4209,Chlorocresol,-7.713615,x0678,1.320104,active-noncovalent
Cc1cc(ccc1Cl)O,BRD-K89056082-001-08-5,chlorocresol,Selleck,S4209,Chlorocresol,-7.713615,x0678,1.320104,active-noncovalent
Cc1cc(ccc1Cl)O,BRD-K89056082-001-07-7,chlorocresol,MicroSource,1500178,CHLOROCRESOL,-7.713615,x0678,1.320104,active-noncovalent
c1cn(c(n1)N(=O)=O)CC(=O)NCCO,BRD-K96042922-001-09-8,etanidazole,Prestwick,Prestw-649,Etanidazole,-7.710000,x0195,-0.832875,active-noncovalent
CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)([O-])[O-])C,BRD-K85178109-001-02-3,fostamatinib,Selleck,S2625,Fostamatinib (R788),-7.709750,x0161,8.166006,active-noncovalent
CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)([O-])[O-])C,BRD-K85178109-001-03-1,fostamatinib,Selleck,S2625,R788 (Fostamatinib),-7.709750,x0161,8.166006,active-noncovalent
Cc1c(snn1)C(=O)Nc2ccc(cc2)n3c(cc(n3)C(F)(F)F)C(F)(F)F,BRD-K42563464-001-02-7,YM-58483,Tocris,3939,YM 58483,-7.708714,x0874,5.368865,active-noncovalent
Cc1c(snn1)C(=O)Nc2ccc(cc2)n3c(cc(n3)C(F)(F)F)C(F)(F)F,BRD-K42563464-001-01-9,YM-58483,EMDBio,203890-5MG,"CRAC Channel Inhibitor, BTP2",-7.708714,x0874,5.368865,active-noncovalent
COc1ccc(c(c1C(=O)c2cnc(nc2N)NC3CCN(CC3)S(=O)(=O)C)F)F,BRD-K52233191-001-02-4,R547,Selleck,S2688,R547,-7.708702,x0104,6.498393,active-noncovalent
CCOc1c(cnn(c1=O)C)N2CCOCC2,BRD-K90629600-001-01-4,emorfazone,Sigma,PH011085,4-ethoxy-2-methyl-5-(4-morpholinyl)-3(2H)-pyridazinone,-7.708623,x0195,0.977809,active-noncovalent
c1cnccc1C[C@H](C(Cl)(Cl)Cl)O,BRD-A93477898-001-04-2,PETCM,Tocris,1758,PETCM,-7.708463,x0195,-1.717108,active-noncovalent
C[C@H]1C[N@](CC[NH2+]1)Cc2ccc(cc2)CC(=O)N3CCC(CC3)Nc4cccc(c4)F,BRD-K23248433-001-01-8,camicinal,MedChemEx,HY-10922,GSK962040,-7.708221,x0161,9.638716,active-noncovalent
Cc1cc(cc(c1OCCO)C)c2[nH]c(=O)c3c(n2)cc(cc3OC)OC,BRD-K20001883-001-02-7,apabetalone,Selleck,S7295,RVX-208,-7.707962,x0678,5.666363,active-noncovalent
CCC(=O)N1CCOc2c(cc(cc2OC[C@H]3CCC[N@H+](C3)C)c4ccc(c(c4)OC)OC)C1,BRD-K57090026-001-02-4,I-CBP-112,Tocris,4891,I-CBP 112,-7.707639,x0678,9.233074,active-noncovalent
CC1=NS(=O)(=O)c2cc(ccc2N1)Cl,BRD-K73109821-001-20-1,diazoxide,MicroSource,2300206,DIAZOXIDE,-7.707629,x0678,-1.530224,active-noncovalent
CC1=NS(=O)(=O)c2cc(ccc2N1)Cl,BRD-K73109821-001-19-3,diazoxide,Tocris,964,Diazoxide,-7.707629,x0678,-1.530224,active-noncovalent
CC1=NS(=O)(=O)c2cc(ccc2N1)Cl,BRD-K73109821-001-22-7,diazoxide,Tocris,964,Diazoxide,-7.707629,x0678,-1.530224,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K09416995-001-38-1,lovastatin,Tocris,1530,Lovastatin,-7.706153,x0678,4.213886,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K09416995-001-43-1,lovastatin,Tocris,1530,Lovastatin,-7.706153,x0678,4.213886,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K09416995-001-44-9,lovastatin,Selleck,S2061,Lovastatin,-7.706153,x0678,4.213886,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K09416995-001-40-7,lovastatin,Selleck,S2061,Lovastatin (Mevacor),-7.706153,x0678,4.213886,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K09416995-001-39-9,lovastatin,MicroSource,1503977,LOVASTATIN,-7.706153,x0678,4.213886,active-noncovalent
CCCCCCOC(=O)CCC(=O)C[NH3+],BRD-K73753850-003-01-6,hexaminolevulinate,MedChemEx,HY-16045,Hexaminolevulinate (hydrochloride),-7.705358,x0195,-0.13197,active-noncovalent
COc1ccc(cc1)CCCO[C@H](Cn2ccnc2)c3ccc(cc3)OC,BRD-A72703248-003-04-9,SKF-96365,Tocris,1147,SKF 96365 hydrochloride,-7.705253,x0434,4.473018,active-noncovalent
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(c1=O)C,BRD-K57569181-001-27-5,pentoxifylline,MicroSource,1503611,PENTOXIFYLLINE,-7.704874,x0195,0.348407,active-noncovalent
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(c1=O)C,BRD-K57569181-001-26-7,pentoxifylline,Selleck,S4345,Pentoxifylline,-7.704874,x0195,0.348407,active-noncovalent
c1ccc2c(c1)nc(s2)[C@@H](C#N)c3ccnc(n3)OCc4ccc(cc4)C[NH+]5CCOCC5,BRD-A53813595-001-01-8,PGL5001,MedChemEx,HY-14761,AS 602801,-7.703079,x0434,5.522473,active-noncovalent
c1ccc2c(c1)nc(s2)[C@@H](C#N)c3ccnc(n3)OCc4ccc(cc4)C[NH+]5CCOCC5,BRD-A53813595-001-03-4,PGL5001,MedChemEx,HY-14761,AS 602801,-7.703079,x0434,5.522473,active-noncovalent
c1ccc2c(c1)nc(s2)[C@@H](C#N)c3ccnc(n3)OCc4ccc(cc4)C[NH+]5CCOCC5,BRD-A53813595-001-02-6,PGL5001,MedChemEx,HY-14761,AS 602801,-7.703079,x0434,5.522473,active-noncovalent
CCn1c(nc(n1)C2CCN(CC2)C(=O)CCO)c3cnc(c(n3)c4nnc(o4)C(C)(C)C)N,BRD-K82894950-001-01-0,AZD8835,MedChemEx,HY-12869,AZD-8835,-7.700245,x0104,11.604568,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O,BRD-K74377520-001-01-7,D-(+)-maltose,MicroSource,1301024,D-(+)-MALTOSE,-7.700126,x0678,1.910256,active-noncovalent
C(CC[NH3+])C[C@@H](C(=O)[O-])[NH3+],BRD-K86016185-001-01-3,L-lysine,Sigma,23128,L-lysine,-7.699625,x0426,-1.982931,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(cc3)Oc4ccccc4,BRD-K50495309-001-03-8,SRC-kinase-inhibitor-I,Tocris,3642,Src I1,-7.699623,x0161,5.787766,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(cc3)Oc4ccccc4,BRD-K50495309-001-02-0,SRC-kinase-inhibitor-I,Tocris,3642,Src I1,-7.699623,x0161,5.787766,active-noncovalent
COC(=O)[C@@H](c1ccccc1)NC(=O)c2cc(nc3c2cccc3)c4ccccc4,BRD-K61097567-001-08-5,SB-218795,Tocris,1376,SB 218795,-7.697436,x0104,4.571591,active-noncovalent
COC(=O)[C@@H](c1ccccc1)NC(=O)c2cc(nc3c2cccc3)c4ccccc4,BRD-K61097567-001-09-3,SB-218795,Tocris,1376,SB 218795,-7.697436,x0104,4.571591,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CNc3c(nnc(n3)c4ccccn4)c5ccccc5,BRD-K44432556-001-05-5,ML-228,Tocris,4565,ML 228,-7.695485,x0161,7.169086,active-noncovalent
CCCCC(C(=O)CC[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)(F)F,BRD-K33814251-001-01-4,lubiprostone,Selleck,S1675,Lubiprostone,-7.695035,x0195,4.678328,active-noncovalent
CCCCC(C(=O)CC[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)(F)F,BRD-K33814251-001-02-2,lubiprostone,Selleck,S1675,Lubiprostone,-7.695035,x0195,4.678328,active-noncovalent
c1ccc(cc1)CC(=O)NC(=O)N,BRD-K40905133-001-04-9,phenacemide,MicroSource,1500472,PHENACEMIDE,-7.692772,x1382,-1.980903,active-covalent
CNC(=O)c1cccc(c1)NC(=O)N2CCC(CC2)Oc3ccccc3Cl,BRD-K99308908-001-01-5,A-939572,Tocris,4845,A 939572,-7.692274,x0161,6.002271,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)C[NH3+])O)[NH3+])[NH3+],BRD-K05619559-001-10-1,tobramycin,MicroSource,1500579,TOBRAMYCIN,-7.691922,x0161,2.493421,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)C[NH3+])O)[NH3+])[NH3+],BRD-K05619559-001-12-7,tobramycin,Selleck,S2514,Tobramycin,-7.691922,x0161,2.493421,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCNC4=O)C(=O)[O-])C,BRD-A46717658-236-02-5,azlocillin,Selleck,S3195,Azlocillin sodium salt,-7.691888,x0874,6.234234,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K22134346-001-22-3,simvastatin,MicroSource,1504236,SIMVASTATIN,-7.690138,x0678,4.199494,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K22134346-001-28-0,simvastatin,Tocris,1965,Simvastatin,-7.690138,x0678,4.199494,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K22134346-001-21-5,simvastatin,Tocris,1965,Simvastatin,-7.690138,x0678,4.199494,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K22134346-001-24-9,simvastatin,Selleck,S1792,Simvastatin (Zocor),-7.690138,x0678,4.199494,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,BRD-K22134346-001-30-6,simvastatin,Selleck,S1792,Simvastatin,-7.690138,x0678,4.199494,active-noncovalent
Cn1c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cc4OC)OC5CC[NH+](CC5)C,BRD-K59146805-001-03-7,AZ3146,Selleck,S2731,AZ 3146,-7.688654,x0107,7.114388,active-noncovalent
Cn1c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cc4OC)OC5CC[NH+](CC5)C,BRD-K59146805-001-04-5,AZ3146,Selleck,S2731,AZ 3146,-7.688654,x0107,7.114388,active-noncovalent
Cn1c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cc4OC)OC5CC[NH+](CC5)C,BRD-K59146805-001-05-2,AZ3146,Tocris,3994,AZ 3146,-7.688654,x0107,7.114388,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C[NH+]2CCOCC2)O)N(=O)=O,BRD-A40546373-001-01-8,morinidazole,MedChemEx,HY-15781,Morinidazole,-7.688618,x0678,0.055268,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,BRD-K37516142-001-11-3,idebenone,Selleck,S2605,Idebenone,-7.688451,x0161,2.984118,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,BRD-K37516142-001-09-7,idebenone,Selleck,S2605,Idebenone,-7.688451,x0161,2.984118,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,BRD-K37516142-001-10-5,idebenone,MicroSource,1505755,IDEBENONE,-7.688451,x0161,2.984118,active-noncovalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)[NH3+],BRD-K62240499-001-04-2,huperzine-a,Selleck,S2251,(-)-Huperzine A,-7.687847,x0072,-0.56659,active-noncovalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)[NH3+],BRD-K62240499-001-06-7,huperzine-a,Selleck,S2251,(-)-Huperzine A (HupA),-7.687847,x0072,-0.56659,active-noncovalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)[NH3+],BRD-K62240499-001-05-9,huperzine-a,MedChemEx,HY-17387,(-)-Huperzine A,-7.687847,x0072,-0.56659,active-noncovalent
Cc1cnc(cn1=O)C(=O)[O-],BRD-K63736853-001-03-0,acipimox,Selleck,S1806,Acipimox,-7.687257,x0397,-1.668829,active-noncovalent
Cc1cnc(cn1=O)C(=O)[O-],BRD-K63736853-001-04-8,acipimox,MicroSource,1504831,ACIPIMOX,-7.687257,x0397,-1.668829,active-noncovalent
Cc1cnc(cn1=O)C(=O)[O-],BRD-K63736853-001-06-3,acipimox,Tocris,2784,Acipimox,-7.687257,x0397,-1.668829,active-noncovalent
C[C@H](c1c(cncc1Cl)Cl)Oc2ccc3c(c2)c([nH]n3)/C=C/c4cnn(c4)CCO,BRD-K17203476-001-01-9,LY2874455,MedChemEx,HY-13304,LY2874455,-7.687100,x0104,5.523982,active-noncovalent
c1ccc2c(c1)c(=O)[nH]cn2,BRD-K91758890-001-10-0,4-HQN,Tocris,2192,4-HQN,-7.686851,x0195,-1.494357,active-noncovalent
Cc1c(nc(n1c2ccc(cc2)F)C)C#Cc3ccnc(c3)Cl,BRD-K62387885-001-01-9,basimglurant,MedChemEx,HY-15446,RG7090,-7.685889,x0161,4.517709,active-noncovalent
Cc1nc2ccc(cc2o1)NC(=O)Nc3ccnc4c3nccc4,BRD-K41567364-001-04-6,SB-334867,Tocris,1960,SB 334867,-7.683864,x0104,4.714297,active-noncovalent
Cc1nc2ccc(cc2o1)NC(=O)Nc3ccnc4c3nccc4,BRD-K41567364-001-05-3,SB-334867,Tocris,1960,SB 334867,-7.683864,x0104,4.714297,active-noncovalent
c1c(c(nc(=O)n1[C@H]2C[C@H]([C@H](O2)CO)O)N)Cl,BRD-K48988407-001-01-2,cytochlor,Berry,PY 7114,,-7.683834,x0749,-0.492026,active-covalent
Cc1ccc(cn1)c2ncn(n2)c3ccc(cc3)Nc4nccc(n4)c5cccc(c5)N6CCOCC6,BRD-K60952143-001-01-0,SR-3306,MedChemEx,HY-12829,SR-3306,-7.683475,x0104,14.313149,active-noncovalent
CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@@H](CCc2ccccc2)O)O)O,BRD-A45153512-001-01-0,bimatoprost,Selleck,S1407,Bimatoprost,-7.683450,x0161,3.315766,active-noncovalent
C(CC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],BRD-K94780074-001-07-5,S-Nitrosoglutathione,Cayman,82240,(2S)-2-amino-5-({(1R)-2-[(carboxymethyl)amino]-1-[(nitrososulfanyl)methyl]-2-oxoethyl}amino)-5-oxopentanoic acid,-7.682157,x0678,1.819848,active-noncovalent
C(CC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],BRD-K94780074-001-06-7,S-Nitrosoglutathione,Cayman,82240,,-7.682157,x0678,1.819848,active-noncovalent
Cc1cc(ccc1[N-]S(=O)(=O)c2cc(ccc2Cl)Cl)N(=O)=O,BRD-K48112880-001-02-3,FH-535,Tocris,4344,FH 535,-7.681582,x0072,0.310043,active-noncovalent
CCCCc1cc2ccccc2c(n1)OCC[NH+](C)C,BRD-K73391359-003-10-2,dimethisoquin,Prestwick,Prestw-630,Dimethisoquin hydrochloride,-7.679631,x0195,0.543875,active-noncovalent
c1c(cncc1I)OC[C@@H]2CC[NH2+]2,BRD-K90065682-300-02-6,5-iodo-A-85380,Tocris,1518,5-Iodo-A-85380 dihydrochloride,-7.677116,x0107,-2.143496,active-noncovalent
c1c(cncc1I)OC[C@@H]2CC[NH2+]2,BRD-K90065682-300-03-4,5-iodo-A-85380,Tocris,1518,3-[(2S)-2-azetidinylmethoxy]-5-iodopyridine dihydrochloride,-7.677116,x0107,-2.143496,active-noncovalent
c1cc2c(cc1Cl)[nH]c(=O)o2,BRD-K98174813-001-17-2,chlorzoxazone,Selleck,S4155,Chlorzoxazone,-7.677007,x0678,-0.605363,active-noncovalent
c1cc2c(cc1Cl)[nH]c(=O)o2,BRD-K98174813-001-18-0,chlorzoxazone,MicroSource,1500188,CHLORZOXAZONE,-7.677007,x0678,-0.605363,active-noncovalent
CCCCCCCCCCCCCCCC(=O)C(F)(F)F,BRD-K05677083-001-05-4,PACOCF3,Tocris,1460,PACOCF3,-7.675981,x0161,2.447101,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SCC(=O)[O-],BRD-K33809398-001-01-8,SCMC-Lys,ChemImpex,629,,-7.675538,x0397,-1.011245,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SCC(=O)[O-],BRD-K33809398-001-02-6,SCMC-Lys,ChemImpex,629,(2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid,-7.675538,x0397,-1.011245,active-noncovalent
c1c(c(cc2c1[nH]c(=O)c(=O)[nH]2)N(=O)=O)C#N,BRD-K19438463-001-05-5,CNQX,Tocris,190,CNQX,-7.675429,x0195,-1.168271,active-noncovalent
c1c(c(cc2c1[nH]c(=O)c(=O)[nH]2)N(=O)=O)C#N,BRD-K19438463-304-01-2,CNQX,Tocris,1045,CNQX disodium salt,-7.675429,x0195,-1.168271,active-noncovalent
c1ccn2c(c1)nn(c2=O)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,BRD-K70778732-003-27-5,trazodone,MicroSource,1503121,TRAZODONE HYDROCHLORIDE,-7.675406,x0195,3.803604,active-noncovalent
c1ccn2c(c1)nn(c2=O)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,BRD-K70778732-003-26-7,trazodone,Selleck,S2582,Trazodone HCl,-7.675406,x0195,3.803604,active-noncovalent
C[C@H](CCC=C(C)C)[NH2+]C,BRD-A64743628-001-01-5,isometheptene-mucate,Prestwick,Prestw-1023,Isometheptene mucate,-7.675300,x0195,-0.368529,active-noncovalent
CCCCOc1ccc(cc1)C(=O)Nc2ccc(cc2F)F,BRD-K86109159-001-02-6,VU0357121,Selleck,S2795,VU 0357121,-7.675128,x0161,4.284451,active-noncovalent
C[NH2+]CC(=O)c1ccc(c(c1)O)O,BRD-K82343404-003-03-2,adrenalone,MicroSource,1506124,ADRENALONE HYDROCHLORIDE,-7.675081,x0195,-0.150242,active-noncovalent
C[NH2+]CC(=O)c1ccc(c(c1)O)O,BRD-K82343404-003-02-4,adrenalone,Selleck,S3185,Adrenalone HCl,-7.675081,x0195,-0.150242,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)Cl,BRD-K13296708-001-05-8,rimonabant,Selleck,S3021,Rimonabant,-7.674757,x0161,4.753968,active-noncovalent
CC(=C)[C@@H]1CC[C@@]([C@H](C1)C(=C)C)(C)C=C,BRD-K79565391-001-01-8,elemene,Enamine,EN300-179368,,-7.674039,x0195,1.898342,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-K61443506-237-01-0,esomeprazole,MicroSource,1502361,ESOMEPRAZOLE POTASSIUM,-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-K61443506-236-02-0,esomeprazole,Selleck,S2233,Esomeprazole Sodium,-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-K61443506-239-01-6,esomeprazole,Selleck,S1743,Esomeprazole magnesium (Nexium),-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-A55962179-001-21-3,omeprazole,Selleck,S1389,Omeprazole,-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-A55962179-001-22-1,omeprazole,Tocris,2583,Omeprazole,-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-A55962179-001-24-7,omeprazole,Selleck,S1389,Omeprazole (Prilosec),-7.673481,x0161,0.524879,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,BRD-A55962179-001-23-9,omeprazole,MicroSource,1505693,OMEPRAZOLE,-7.673481,x0161,0.524879,active-noncovalent
CCCCCCC[N+](CC)(CC)CCCCc1ccc(cc1)Cl,BRD-K02680176-075-12-9,clofilium,Sigma,C2365,"N-[4-(4-chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium 4-methylbenzenesulfonate",-7.673071,x0434,4.065622,active-noncovalent
CCCCCCC[N+](CC)(CC)CCCCc1ccc(cc1)Cl,BRD-K02680176-075-11-1,clofilium,Prestwick,Prestw-319,Clofilium tosylate,-7.673071,x0434,4.065622,active-noncovalent
Cc1cn(cn1)c2ccc(cc2OC)/C=C/3\CCCN(C3=O)[C@@H](C)c4ccc(cc4)F,BRD-K50564936-001-01-6,E-2012,MedChemEx,HY-10016,E 2012,-7.672136,x0104,9.462562,active-noncovalent
c1cc(cnc1)[C@H]2CCC[NH2+]2,BRD-A24543851-001-05-7,nornicotine,Enzo,AC1067,"D,L-Nornicotine",-7.671556,x1418,-2.549044,active-covalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],BRD-A34716233-004-03-5,AMPA-(RS),Tocris,1074,(RS)-AMPA hydrobromide,-7.671542,x0678,-2.111543,active-noncovalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],BRD-K92493880-001-03-0,AMPA-(S),Tocris,254,(S)-AMPA,-7.671542,x0678,-2.111543,active-noncovalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],BRD-A34716233-001-02-3,AMPA-(RS),Tocris,169,(RS)-AMPA,-7.671542,x0678,-2.111543,active-noncovalent
CCOC(=O)[C@@H](C)Oc1ccc(cc1)Oc2nc3ccc(cc3o2)Cl,BRD-K44777569-001-01-7,fenoxaprop-p-ethyl,MedChemEx,HY-B2013,Fenoxaprop-P-ethyl,-7.670126,x0161,3.870901,active-noncovalent
c1cc(ccc1CC[C@@H]2Cc3c(=O)[nH]c(nc3NC2)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K66036108-001-01-9,lometrexol,Cayman,18049,"(2S)-2-[(4-{2-[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl}benzoyl)amino]pentanedioic acid",-7.668202,x0104,10.54583,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C,BRD-K11510141-001-04-2,teprenone,MedChemEx,HY-B0779,Teprenone,-7.666862,x1077,2.479311,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C,BRD-K11510141-001-02-6,teprenone,SantaCruz,sc-252851,,-7.666862,x1077,2.479311,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C,BRD-K11510141-001-01-8,teprenone,SantaCruz,sc-252851,,-7.666862,x1077,2.479311,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C,BRD-K11510141-001-03-4,teprenone,MedChemEx,HY-B0779,Teprenone,-7.666862,x1077,2.479311,active-noncovalent
C[NH+]1CCN(CC1)CCCN2c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,BRD-K08619574-334-05-4,thioproperazine,Prestwick,Prestw-149,Thioproperazine dimesylate,-7.666005,x0195,2.764021,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(c(c1)O)O,BRD-K95523387-001-09-6,OLDA,Tocris,1641,OLDA,-7.665141,x0104,3.031698,active-noncovalent
CCNCCS(=O)(=O)NC[C@@]1(N([NH+]=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)c2ccccc2,BRD-K83029223-001-01-3,litronesib,MedChemEx,HY-14846,Litronesib,-7.664155,x0678,6.975262,active-noncovalent
C1C[NH2+]Cc2c1c(=O)[nH]o2,BRD-K89104321-003-14-8,gaboxadol,Tocris,807,THIP hydrochloride,-7.662099,x0678,-0.946189,active-noncovalent
C1C[NH2+]Cc2c1c(=O)[nH]o2,BRD-K89104321-003-16-3,gaboxadol,Tocris,807,THIP hydrochloride,-7.662099,x0678,-0.946189,active-noncovalent
C1C[NH2+]Cc2c1c(=O)[nH]o2,BRD-K89104321-003-15-5,gaboxadol,MicroSource,1503648,GABOXADOL HYDROCHLORIDE,-7.662099,x0678,-0.946189,active-noncovalent
c1ccc(cc1)n2c(c(c(=O)n2c3ccccc3)CC[S@](=O)c4ccccc4)[O-],BRD-A36217750-001-16-3,sulfinpyrazone,MicroSource,1500554,SULFINPYRAZONE,-7.660124,x0946,1.934472,active-noncovalent
C(CO)CSC[C@@H](C(=O)[O-])[NH3+],BRD-K54838207-001-02-0,fudosteine,Selleck,S2129,Fudosteine,-7.658846,x0397,-1.124211,active-noncovalent
C(CO)CSC[C@@H](C(=O)[O-])[NH3+],BRD-K54838207-001-03-8,fudosteine,Selleck,S2129,Fudosteine,-7.658846,x0397,-1.124211,active-noncovalent
C[N@@]1CCC[N@@H+](CC1)[C@H](c2ccccc2)c3ccc(cc3)Cl,BRD-A22769835-300-05-7,homochlorcyclizine,Enzo,AC927,Homochlorcyclizine 2HCl,-7.658725,x0072,0.411703,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)NC(=O)c2cc(ccc2O)Cl,BRD-K35960502-001-19-2,niclosamide,Selleck,S3030,Niclosamide (Niclocide),-7.658549,x0678,0.550615,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)NC(=O)c2cc(ccc2O)Cl,BRD-K35960502-001-20-0,niclosamide,MicroSource,1503265,NICLOSAMIDE,-7.658549,x0678,0.550615,active-noncovalent
c1c(cc(cc1O)O)[C@@H](C(=O)[O-])[NH3+],BRD-K57796080-001-03-7,"3,5-DHPG-(S)",Tocris,805,"(S)-3,5-DHPG",-7.657719,x1093,-0.762413,active-noncovalent
CCOC(=O)[C@H]1CS[C@H]([NH2+]1)Cc2ccc(cc2)OCc3ccc(cc3)N(=O)=O,BRD-A14316475-001-03-1,SN-6,Tocris,2184,SN-6,-7.655899,x0104,5.704345,active-noncovalent
CCOC(=O)[C@H]1CS[C@H]([NH2+]1)Cc2ccc(cc2)OCc3ccc(cc3)N(=O)=O,BRD-A14316475-001-02-3,SN-6,Tocris,2184,SN-6,-7.655899,x0104,5.704345,active-noncovalent
c1nc(nc(=O)n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,BRD-K03406345-001-27-8,azacitidine,Selleck,S1782,Azacitidine,-7.654997,x0967,-0.072791,active-noncovalent
c1nc(nc(=O)n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,BRD-K03406345-001-21-1,azacitidine,MicroSource,1502111,AZACITIDINE,-7.654997,x0967,-0.072791,active-noncovalent
c1nc(nc(=O)n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,BRD-K03406345-001-24-5,azacitidine,Tocris,3842,5-Azacytidine,-7.654997,x0967,-0.072791,active-noncovalent
c1cc(c(c(c1)F)C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(cc5)C(=O)[O-])F,BRD-K83963101-001-06-9,MLN-8054,Selleck,S1100,MLN8054,-7.653778,x0161,5.465325,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,BRD-A01320529-104-11-9,salmeterol,Sigma,MFCD00897708,1-hydroxy-2-naphthoic acid compound with 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1:1),-7.652020,x0678,5.178392,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,BRD-A01320529-104-13-5,salmeterol,Tocris,4712,Salmeterol xinafoate,-7.652020,x0678,5.178392,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,BRD-A01320529-104-14-3,salmeterol,MedChemEx,HY-17453,Salmeterol (xinafoate),-7.652020,x0678,5.178392,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,BRD-A01320529-104-12-7,salmeterol,MedChemEx,HY-17453,Salmeterol (xinafoate),-7.652020,x0678,5.178392,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,BRD-A01320529-104-10-1,salmeterol,Tocris,4712,Salmeterol xinafoate,-7.652020,x0678,5.178392,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)NS(=O)(=O)C,BRD-K58486055-001-02-7,reparixin,MedChemEx,HY-15251,Reparixin,-7.651780,x0104,0.281511,active-noncovalent
c1cc(ccc1OS(=O)(=O)c2ccc(cc2)Cl)Cl,BRD-K89409436-001-01-4,chlorfenson,Sigma,MFCD00055266,4-chlorophenyl 4-chlorobenzenesulfonate,-7.651767,x0195,-0.022547,active-noncovalent
c1cc(c(cc1C(=O)NO)O)O,BRD-K94146583-001-01-6,didox,MedChemEx,HY-19387,Didox,-7.651239,x0678,-1.967388,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C[C@@H](C)CC(C)(C)C,BRD-A96510685-213-03-7,piroctone-olamine,MicroSource,1503875,PIROCTONE OLAMINE,-7.650666,x1385,-0.751252,active-covalent
B([C@H](CC(C)C)NC(=O)CNC(=O)c1cc(ccc1Cl)Cl)(O)O,BRD-K78659596-001-03-9,ixazomib,Selleck,S2180,MLN2238,-7.650191,x1093,1.594776,active-noncovalent
CCCCCCCCCCCCCCCC[n+]1ccccc1,BRD-K87700323-003-04-4,cetylpyridinium,Selleck,S4172,Cetylpyridinium Chloride,-7.649395,x0161,1.679896,active-noncovalent
CCCCCCCCCCCCCCCC[n+]1ccccc1,BRD-K87700323-003-05-1,cetylpyridinium,MicroSource,1500169,CETYLPYRIDINIUM CHLORIDE,-7.649395,x0161,1.679896,active-noncovalent
CCCCCCCCCCCCCCCC[n+]1ccccc1,BRD-K87700323-003-06-9,cetylpyridinium,Selleck,S4172,Cetylpyridinium Chloride,-7.649395,x0161,1.679896,active-noncovalent
c1cc(ncc1C#N)NCC[NH2+]CC(=O)N2CCC[C@H]2C#N,BRD-K77396579-300-01-0,NVP-DPP728,Tocris,3506,NVP DPP 728 dihydrochloride,-7.649087,x0749,2.194446,active-covalent
CC[NH+](CC)CC#CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,BRD-A65013509-003-24-4,oxybutynin,MicroSource,1505399,OXYBUTYNIN CHLORIDE,-7.648388,x1093,1.728189,active-noncovalent
CC[NH+](CC)CC#CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,BRD-A65013509-003-23-6,oxybutynin,Selleck,S3117,Oxybutynin chloride,-7.648388,x1093,1.728189,active-noncovalent
CC[NH+](CC)CC#CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,BRD-A65013509-001-02-4,oxybutynin,Selleck,S1754,Oxybutynin (Ditropan),-7.648388,x1093,1.728189,active-noncovalent
COc1c(c2ccc(cc2c(=O)o1)N)Cl,BRD-K22010301-001-04-6,JLK-6,Tocris,2677,JLK 6,-7.648152,x0195,1.116039,active-noncovalent
C[N@@H+]1CC[C@@]23C=C[C@@H](C[C@@H]2Oc4c3c(ccc4OC)C1)O,BRD-K49481516-004-18-3,galantamine,Tocris,686,Galanthamine hydrobromide,-7.647754,x1418,-0.289139,active-covalent
C[N@@H+]1CC[C@@]23C=C[C@@H](C[C@@H]2Oc4c3c(ccc4OC)C1)O,BRD-K49481516-001-01-5,galantamine,MicroSource,1501202,GALANTAMINE,-7.647754,x1418,-0.289139,active-covalent
CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)[C@@H](CO)O)OCCC[NH+](C)C)C,BRD-K97643133-003-09-3,amiprilose,Prestwick,Prestw-845,Amiprilose hydrochloride,-7.647443,x1093,0.873544,active-noncovalent
COc1cc(c(cc1C(=O)OCC[NH+]2CCCCC2)Cl)N,BRD-K69343602-003-01-3,ML-10302,Tocris,3499,ML 10302 hydrochloride,-7.647382,x0195,2.051589,active-noncovalent
CCCCOC(=O)c1cc2c3ccccc3[nH]c2cn1,BRD-K87349602-001-03-8,beta-CCB,Tocris,405,?-CCB,-7.647235,x0161,0.117404,active-noncovalent
CS(=O)(=O)c1cccc(c1)CNc2c(cnc(n2)Nc3ccc4c(c3)CCC(=O)N4)C(F)(F)F,BRD-K79239947-001-07-6,PF-573228,Tocris,3239,PF 573228,-7.647145,x0678,5.777452,active-noncovalent
CS(=O)(=O)c1cccc(c1)CNc2c(cnc(n2)Nc3ccc4c(c3)CCC(=O)N4)C(F)(F)F,BRD-K79239947-001-06-8,PF-573228,Selleck,S2013,PF-573228,-7.647145,x0678,5.777452,active-noncovalent
C[C@](c1ccccc1)(c2ccccn2)OCC[NH+](C)C,BRD-A44008656-036-25-8,doxylamine,MicroSource,1500267,DOXYLAMINE SUCCINATE,-7.647050,x0678,1.486874,active-noncovalent
C[C@](c1ccccc1)(c2ccccn2)OCC[NH+](C)C,BRD-A44008656-036-24-1,doxylamine,Selleck,S4240,Doxylamine Succinate,-7.647050,x0678,1.486874,active-noncovalent
c1cc2c(cc1C(=O)N3CCCCC3)OCO2,BRD-K25140590-001-03-0,CX-516,Tocris,1048,1-BCP,-7.647049,x0749,-0.806157,active-covalent
Cc1cc(c(c(c1)OC)[C@@H]2C=C(CC[C@H]2C(=C)C)C)OC,BRD-K18316707-001-02-7,O-1918,Tocris,2288,O-1918,-7.646493,x0195,0.637737,active-noncovalent
Cc1cc(c(c(c1)OC)[C@@H]2C=C(CC[C@H]2C(=C)C)C)OC,BRD-K18316707-001-03-5,O-1918,Tocris,2288,O-1918,-7.646493,x0195,0.637737,active-noncovalent
CC[C@](COC(=O)c1cc(c(c(c1)OC)OC)OC)(c2ccccc2)[NH+](C)C,BRD-A92630576-001-02-0,trimebutine,Selleck,S2085,Trimebutine,-7.646284,x0104,4.878076,active-noncovalent
CC[C@](COC(=O)c1cc(c(c(c1)OC)OC)OC)(c2ccccc2)[NH+](C)C,BRD-A92630576-050-24-1,trimebutine,MicroSource,1505011,TRIMEBUTINE MALEATE,-7.646284,x0104,4.878076,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CCC(=O)OC/C=C(\C)/CCC=C(C)C)/C)/C)C,BRD-K02780233-001-02-5,geranyl-farnesylacetate,Adooq,A13666,"(2E)-3,7-dimethyl-2,6-octadienyl (4E,8E)-5,9,13-trimethyl-4,8,12-tetradecatrienoate",-7.644895,x0161,4.548738,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CCC(=O)OC/C=C(\C)/CCC=C(C)C)/C)/C)C,BRD-K02780233-001-01-7,geranyl-farnesylacetate,AKSci,R260,,-7.644895,x0161,4.548738,active-noncovalent
CCn1cc(c(=O)c2c1nc(cc2)C)C(=O)[O-],BRD-K47886988-001-22-2,nalidixic-acid,MicroSource,1500756,NALIDIXIC ACID,-7.643285,x0195,-0.072307,active-noncovalent
CCn1cc(c(=O)c2c1nc(cc2)C)C(=O)[O-],BRD-K47886988-001-21-4,nalidixic-acid,Selleck,S2328,Nalidixic acid,-7.643285,x0195,-0.072307,active-noncovalent
C[C@@H]1COC2(O1)CCN(CC2)c3nc(=O)c4cc(cc(c4s3)N(=O)=O)C(F)(F)F,BRD-A53037217-001-02-0,BTZ043-racemate,Selleck,S1097,BTZ043 Racemate,-7.643061,x0104,5.030409,active-noncovalent
c1cnc(cn1)/N=N/C(=O)CCn2cnc(n2)c3cc(cc(c3)C(F)(F)F)C(F)(F)F,BRD-K21361524-001-01-1,selinexor,Selleck,S7252,KPT-330,-7.642896,x0874,6.750192,active-noncovalent
COc1cc2c(cc1OCCCCCCC(=O)NO)c(ncn2)Nc3cccc(c3)C#C,BRD-K41278234-001-03-0,CUDC-101,Selleck,S1194,CUDC-101,-7.642329,x0874,8.948504,active-noncovalent
COC(=O)c1cccnc1,BRD-K10132944-001-01-1,methyl-nicotinate,Vitas-M,STK803258,,-7.641403,x0397,-1.427759,active-noncovalent
COC(=O)c1cccnc1,BRD-K10132944-001-02-9,methyl-nicotinate,Sigma,Y0000398,methyl nicotinate,-7.641403,x0397,-1.427759,active-noncovalent
CCN(Cc1ccccc1)C(=O)Cn2c3c(cnc(n3)c4ccccc4)n(c2=O)C,BRD-K45875383-001-02-0,XBD173,Tocris,5281,AC 5216,-7.640609,x0161,4.783602,active-noncovalent
CCN(Cc1ccccc1)C(=O)Cn2c3c(cnc(n3)c4ccccc4)n(c2=O)C,BRD-K45875383-001-01-2,XBD173,MedChemEx,HY-15527,Emapunil,-7.640609,x0161,4.783602,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)I,BRD-K14762862-001-01-9,I-BZA,Enamine,Z27720938,,-7.639282,x0104,0.537733,active-noncovalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4C(=C(C(=C([C@]4(C3=O)O)O)C(=O)N)O)[NH+](C)C)O)[O-])O,BRD-M28128163-003-01-7,doxycycline-hyclate,MedChemEx,HY-N0565B,Doxycycline (hyclate),-7.638790,x0831,0.980915,active-covalent
C[NH+]1CCN(CC1)C(=O)[C@@H]2[C@H]3CC[C@@H]([C@H]2C(=O)[O-])O3,BRD-A73709786-001-02-1,LB-100,MedChemEx,HY-18597,LB-100,-7.638383,x0104,0.374189,active-noncovalent
C[NH+]1CCN(CC1)C(=O)[C@@H]2[C@H]3CC[C@@H]([C@H]2C(=O)[O-])O3,BRD-A73709786-001-01-3,LB-100,MedChemEx,HY-18597,LB-100,-7.638383,x0104,0.374189,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NC[C@@H](C[NH+]4CCOCC4)O,BRD-K75911534-001-01-6,SU014813,MedChemEx,HY-10501,SU14813,-7.636889,x0161,7.322211,active-noncovalent
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc2nncs2,BRD-K59745944-001-03-8,PHT-427,Selleck,S1556,PHT-427,-7.636552,x0161,3.515656,active-noncovalent
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc2nncs2,BRD-K59745944-001-02-0,PHT-427,Selleck,S1556,PHT-427,-7.636552,x0161,3.515656,active-noncovalent
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc2nncs2,BRD-K59745944-001-04-6,PHT-427,Tocris,4598,PHT 427,-7.636552,x0161,3.515656,active-noncovalent
COc1ccnc(c1OC)C[S@](=O)c2[nH]c3ccc(cc3n2)OC(F)F,BRD-A22380646-236-06-6,pantoprazole,MedChemEx,HY-17507A,Pantoprazole (sodium),-7.636497,x0195,2.130254,active-noncovalent
COc1ccnc(c1OC)C[S@](=O)c2[nH]c3ccc(cc3n2)OC(F)F,BRD-A22380646-001-05-6,pantoprazole,MicroSource,1505818,PANTOPRAZOLE,-7.636497,x0195,2.130254,active-noncovalent
COc1ccnc(c1OC)C[S@](=O)c2[nH]c3ccc(cc3n2)OC(F)F,BRD-A22380646-236-05-8,pantoprazole,SantaCruz,sc-204831,Pantoprazole Sodium,-7.636497,x0195,2.130254,active-noncovalent
CC(C)(C)c1c([nH]cn1)/C=c\2/c(=O)[nH]/c(=C\c3ccccc3)/c(=O)[nH]2,BRD-K99498722-001-02-6,plinabulin,MedChemEx,HY-14444,Plinabulin,-7.636461,x1334,1.788566,active-covalent
CC(C)(C)c1c([nH]cn1)/C=c\2/c(=O)[nH]/c(=C\c3ccccc3)/c(=O)[nH]2,BRD-K99498722-001-03-4,plinabulin,Adooq,A10654,"(3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylene]-2,5-piperazinedione",-7.636461,x1334,1.788566,active-covalent
CC(C)(C)c1c([nH]cn1)/C=c\2/c(=O)[nH]/c(=C\c3ccccc3)/c(=O)[nH]2,BRD-K99498722-001-04-2,plinabulin,MedChemEx,HY-14444,Plinabulin,-7.636461,x1334,1.788566,active-covalent
CC(C)(c1cc(oc1)S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)O,BRD-K55418700-001-03-0,MCC950,MedChemEx,HY-12815,MCC950,-7.635713,x0678,2.615707,active-noncovalent
CC(C)(c1cc(oc1)S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)O,BRD-K55418700-001-02-2,MCC950,MedChemEx,HY-12815,MCC950,-7.635713,x0678,2.615707,active-noncovalent
c1ccc(cc1)CSCC2=Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)Cl,BRD-K21450440-001-13-8,benzthiazide,Selleck,S4308,Benzthiazide,-7.635537,x0874,2.202485,active-noncovalent
c1ccc(cc1)CSCC2=Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)Cl,BRD-K21450440-001-14-6,benzthiazide,MicroSource,1500141,BENZTHIAZIDE,-7.635537,x0874,2.202485,active-noncovalent
COc1ccncc1C(=O)NC(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccccc3,BRD-K12745498-001-02-6,S1P1-agonist-III,Tocris,4747,TC-G 1006,-7.634964,x0104,8.382128,active-noncovalent
COc1ccncc1C(=O)NC(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccccc3,BRD-K12745498-001-03-4,S1P1-agonist-III,MedChemEx,HY-12835,S1P1 Agonist III,-7.634964,x0104,8.382128,active-noncovalent
COc1ccncc1C(=O)NC(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccccc3,BRD-K12745498-001-01-8,S1P1-agonist-III,MedChemEx,HY-12835,S1P1 Agonist III,-7.634964,x0104,8.382128,active-noncovalent
C1C[N+]2(CCN1C(=O)CCBr)CC[N+]3(CCN(CC3)C(=O)CCBr)CC2,BRD-K96684644-300-01-7,spirobromin,MatrixSci,59769,,-7.634099,x1077,3.561585,active-noncovalent
c1ccc(cc1)C#CS(=O)(=O)N,BRD-K96799727-001-06-6,pifithrin-mu,Tocris,2653,Pifithrin-?,-7.633925,x0195,-1.411928,active-noncovalent
c1ccc(cc1)C#CS(=O)(=O)N,BRD-K96799727-001-05-8,pifithrin-mu,Selleck,S2930,Pifithrin-?,-7.633925,x0195,-1.411928,active-noncovalent
c1ccc(cc1)C#CS(=O)(=O)N,BRD-K96799727-001-07-4,pifithrin-mu,Selleck,S2930,Pifithrin-??,-7.633925,x0195,-1.411928,active-noncovalent
CCC[C@@H](C)NC(=O)c1ccc(c(c1)Cl)Cl,BRD-A67975844-001-01-8,NSC-405020,Selleck,S8072,NSC 405020,-7.632828,x0749,-0.174465,active-covalent
CCC[C@@H](C)NC(=O)c1ccc(c(c1)Cl)Cl,BRD-A67975844-001-02-6,NSC-405020,Tocris,4902,NSC 405020,-7.632828,x0749,-0.174465,active-covalent
CS(=O)(=O)Nc1cc2c(cc1Oc3ccccc3)c(=O)c(co2)NC=O,BRD-K15426076-001-01-2,iguratimod,MedChemEx,HY-17009,Iguratimod,-7.631998,x0072,2.177427,active-noncovalent
c1ccc(cc1)[C@@](c2ccc(cc2)F)(c3ccccc3F)n4ccnc4,BRD-A00218260-001-03-4,flutrimazole,SantaCruz,sc-358236,,-7.630484,x0830,2.31106,active-covalent
Cc1ccc2c(n1)cccc2N3CC[NH+](CC3)CCc4cccc(c4)N5CCNC5=O,BRD-K69669039-001-01-8,GSK163090,MedChemEx,HY-14348,GSK163090,-7.630254,x0161,8.196003,active-noncovalent
Cc1ncc(c(n1)N)CN(C=O)/C(=C(\CCOP(=O)([O-])[O-])/SC(=O)c2ccccc2)/C,BRD-K07359318-001-03-9,benfotiamine,Selleck,S4300,benfotiamine,-7.629818,x0072,5.243099,active-noncovalent
Cc1ncc(c(n1)N)CN(C=O)/C(=C(\CCOP(=O)([O-])[O-])/SC(=O)c2ccccc2)/C,BRD-K07359318-396-01-7,benfotiamine,MicroSource,1503105,BENFOTIAMINE,-7.629818,x0072,5.243099,active-noncovalent
CCOP(=S)(OCC)Oc1cc(nc(n1)C(C)C)C,BRD-K60567437-001-10-2,dimpylate,MicroSource,330017,DIMPYLATE,-7.629673,x0195,0.688753,active-noncovalent
C[C@H]1O[C@@]2(C[NH+]3CCC2CC3)CS1,BRD-M98279124-300-01-1,cevimeline,Tocris,3689,Cevimeline hydrochloride,-7.629404,x0195,1.784779,active-noncovalent
Cc1nc(nc(n1)N[C@H]2CCC[C@H](C2)C(=O)NCc3ccc(cc3C(F)(F)F)C#N)NC,BRD-K62738477-001-01-7,GSK2256294A,MedChemEx,HY-19644,GSK2256294A,-7.628737,x0195,5.093792,active-noncovalent
c1cn(c(cc1=O)[O-])[C@@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,BRD-A26105646-001-06-1,3-deazauridine,AMS,A001578548,"1-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione",-7.628164,x0195,-0.575315,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)COc3ccc(cc3)C(=O)c4ccccc4,BRD-K68810443-001-01-9,adiporon,Selleck,S7365,AdipoRon,-7.628057,x0161,6.689488,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)COc3ccc(cc3)C(=O)c4ccccc4,BRD-K68810443-003-01-5,adiporon,Tocris,5096,AdipoRon hydrochloride,-7.628057,x0161,6.689488,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)COc3ccc(cc3)C(=O)c4ccccc4,BRD-K68810443-001-02-7,adiporon,Selleck,S7365,Adiporon,-7.628057,x0161,6.689488,active-noncovalent
CC1=C([C@@H](C(=C(N1)C#N)C(=O)OC)c2cccc(c2)N(=O)=O)C(=O)OC(C)C,BRD-A84687895-001-04-0,nilvadipine,Selleck,S2721,Nilvadipine (ARC029),-7.626749,x0946,3.54608,active-noncovalent
CC1=C([C@@H](C(=C(N1)C#N)C(=O)OC)c2cccc(c2)N(=O)=O)C(=O)OC(C)C,BRD-A84687895-001-03-2,nilvadipine,Selleck,S2721,Nilvadipine,-7.626749,x0946,3.54608,active-noncovalent
CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@@H](CO)c4ccccc4)C,BRD-A53951045-004-01-6,butylscopolamine-bromide,Selleck,S2378,Butylscopolamine Bromide,-7.626504,x0104,3.649127,active-noncovalent
CCn1c2c(cnc(c2nc1c3c(non3)N)C#CC(C)(C)O)OC[C@H]4CCC[NH2+]C4,BRD-K25325018-001-06-4,GSK690693,Tocris,4144,GSK 690693,-7.626368,x0107,5.965072,active-noncovalent
CCn1c2c(cnc(c2nc1c3c(non3)N)C#CC(C)(C)O)OC[C@H]4CCC[NH2+]C4,BRD-K25325018-001-02-3,GSK690693,Selleck,S1113,GSK690693,-7.626368,x0107,5.965072,active-noncovalent
CCn1c2c(cnc(c2nc1c3c(non3)N)C#CC(C)(C)O)OC[C@H]4CCC[NH2+]C4,BRD-K25325018-001-05-6,GSK690693,Selleck,S1113,GSK690693,-7.626368,x0107,5.965072,active-noncovalent
CCC(=O)Nc1cccc(c1)Oc2c(cnc(n2)Nc3ccc(cc3OC)N4CC[NH+](CC4)C)Cl,BRD-K45909031-001-01-5,WZ4003,Selleck,S7317,WZ4003,-7.625815,x0161,7.012189,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)[nH]2,BRD-K41592905-001-01-6,7-methylxanthine,Sigma,MFCD00037979,"7-methyl-3,7-dihydro-1H-purine-2,6-dione",-7.625719,x0678,-1.1415,active-noncovalent
CC(C)c1cccc(c1O)C(C)C,BRD-K82255054-001-15-9,propofol,MicroSource,1505022,PROPOFOL,-7.624539,x0749,-0.133274,active-covalent
CC(C)c1cccc(c1O)C(C)C,BRD-K82255054-001-17-5,propofol,Enamine,Z1245735300,"2,6-diisopropylphenol",-7.624539,x0749,-0.133274,active-covalent
c1cn(c(=O)nc1N)[C@@H]2CS[C@@H](O2)CO,BRD-K02992638-001-11-8,lamivudine,Selleck,S1706,Lamivudine,-7.623175,x0195,0.176206,active-noncovalent
Cc1ccc(cc1)c2c(cnn2C)c3c4c(ncnc4N5CC[C@@H](C5)[NH+]6CCCCC6)n(n3)C,BRD-K78318619-001-02-7,PF-4981517,Selleck,S2921,PF-4981517,-7.622152,x0161,3.926917,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[NH+]4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,BRD-K20168442-004-07-1,vecuronium,MicroSource,1505709,VECURONIUM BROMIDE,-7.619817,x0305,11.844361,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[NH+]4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,BRD-K20168442-004-06-3,vecuronium,Selleck,S1405,Vecuronium Bromide,-7.619817,x0305,11.844361,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,BRD-K42352790-001-05-3,anandamide,Enzo,FA017,Anandamide,-7.619699,x0195,1.811116,active-noncovalent
c1cc(ccc1O)O,BRD-K11227669-001-07-8,hydroquinone,MicroSource,1504237,HYDROQUINONE,-7.618016,x0678,1.485014,active-noncovalent
c1cc(ccc1O)O,BRD-K11227669-001-08-6,hydroquinone,MedChemEx,HY-B0951,Hydroquinone,-7.618016,x0678,1.485014,active-noncovalent
CCCCNNC(=O)c1ccc(cc1)Br,BRD-K20480395-001-01-6,UF-010,Tocris,5588,UF 010,-7.616483,x0195,-0.734894,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-])C(=O)[O-],BRD-K06204668-001-02-6,"3,4-DCPG-(R)",Tocris,1395,"(R)-3,4-DCPG",-7.615626,x1412,1.382748,active-covalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-])C(=O)[O-],BRD-A49947412-001-02-0,"3,4-DCPG-(+/-)",Tocris,1394,"(RS)-3,4-DCPG",-7.615626,x1412,1.382748,active-covalent
Cc1[nH]c(=O)c2c(n1)CCSC2,BRD-K94920105-001-03-9,DR-2313,Tocris,2496,DR 2313,-7.615080,x0195,-1.687355,active-noncovalent
CC(C)c1c(c(nc(n1)[N@@](C)S(=O)(=O)C)c2ccc(cc2)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O,BRD-K82941592-238-04-5,rosuvastatin,Selleck,S2169,Rosuvastatin Calcium,-7.613783,x1077,6.1126,active-noncovalent
CC(C)c1c(c(nc(n1)[N@@](C)S(=O)(=O)C)c2ccc(cc2)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O,BRD-K82941592-238-03-7,rosuvastatin,MicroSource,1505213,ROSUVASTATIN CALCIUM,-7.613783,x1077,6.1126,active-noncovalent
CC(O)(c1ncc(cc1)C2=Nc3n(c(=O)cnc3NC2)[C@H]4CC[C@@H](CC4)OC)C,BRD-K88737571-001-01-4,CC-223,MedChemEx,HY-16956,CC-223,-7.612970,x0434,4.359593,active-noncovalent
CC(O)(c1ncc(cc1)C2=Nc3n(c(=O)cnc3NC2)[C@H]4CC[C@@H](CC4)OC)C,BRD-K88737571-001-02-2,CC-223,MedChemEx,HY-16956,CC-223,-7.612970,x0434,4.359593,active-noncovalent
CC(C)(C)c1ccc(cc1)C[N@](Cc2cccc(c2)OCC(=O)[O-])S(=O)(=O)c3cccnc3,BRD-K11452913-001-01-9,evatanepag,MedChemEx,HY-14839,Evatanepag,-7.612241,x0678,6.064514,active-noncovalent
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BRD-K45497762-336-01-6,succinylcholine-chloride,Selleck,S4121,Succinylcholine Chloride Dihydrate,-7.610557,x0195,2.147089,active-noncovalent
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BRD-K45497762-336-03-2,succinylcholine-chloride,Sigma,MFCD00150564,trimethyl[2-({4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl}oxy)ethyl]ammonium dichloride dihydrate,-7.610557,x0195,2.147089,active-noncovalent
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BRD-K45497762-336-02-4,succinylcholine-chloride,Selleck,S4121,Succinylcholine Chloride Dihydrate,-7.610557,x0195,2.147089,active-noncovalent
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BRD-K45497762-300-01-2,succinylcholine-chloride,DuPont,A000521780,trimethyl[2-({4-oxo-4-[2-(trimethylammonio)ethoxy]butanoyl}oxy)ethyl]ammonium dichloride,-7.610557,x0195,2.147089,active-noncovalent
C/C/1=C\CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,BRD-K98548675-001-05-9,parthenolide,Tocris,610,Parthenolide,-7.610229,x0195,2.589629,active-noncovalent
C/C/1=C\CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,BRD-K98548675-001-06-7,parthenolide,Tocris,610,Parthenolide,-7.610229,x0195,2.589629,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH3+],BRD-K47029922-003-10-9,tranylcypromine,Tocris,3852,Tranylcypromine hydrochloride,-7.610173,x0195,-0.136462,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH3+],BRD-K47029922-003-11-7,tranylcypromine,Selleck,S4246,Tranylcypromine (2-PCPA) HCl,-7.610173,x0195,-0.136462,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH3+],BRD-K47029922-003-12-5,tranylcypromine,Tocris,3852,Tranylcypromine hydrochloride,-7.610173,x0195,-0.136462,active-noncovalent
CCCCc1nc2cc(ccc2n1CC[NH+](CC)CC)CCC(=O)N=O,BRD-K86797399-001-05-1,SB-939,Selleck,S1515,SB939 (Pracinostat),-7.608974,x0107,2.91698,active-noncovalent
CCCCc1nc2cc(ccc2n1CC[NH+](CC)CC)CCC(=O)N=O,BRD-K86797399-001-04-4,SB-939,Selleck,S1515,Pracinostat (SB939),-7.608974,x0107,2.91698,active-noncovalent
CCOC(=O)Nc1ccc2c(c1)N(c3ccccc3CC2)C(=O)C[NH+](C)C,BRD-K75250001-001-01-3,tiracizine,ChemDiv,4119-0057,,-7.608211,x0678,1.174379,active-noncovalent
CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)[O-])[NH3+],BRD-K58937086-001-01-4,glutathione-monoisopropyl-ester,ChemImpex,8169,,-7.608127,x0072,1.351963,active-noncovalent
CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)[O-])[NH3+],BRD-K58937086-001-02-2,glutathione-monoisopropyl-ester,Sigma,MFCD00237073,(2S)-2-amino-5-{[(1R)-2-[(2-isopropoxy-2-oxoethyl)amino]-2-oxo-1-(sulfanylmethyl)ethyl]amino}-5-oxopentanoic acid,-7.608127,x0072,1.351963,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])SSC[C@H](C(=O)[O-])[NH3+],BRD-A15397381-001-03-3,L-Cystine,Enamine,Z56346947,"3,3'-disulfanediylbis(2-aminopropanoic acid)",-7.606093,x0759,-2.049349,active-covalent
C([C@H](C(=O)[O-])[NH3+])SSC[C@H](C(=O)[O-])[NH3+],BRD-A15397381-001-02-5,L-Cystine,Enamine,Z56346947,,-7.606093,x0759,-2.049349,active-covalent
CCN(CC)c1ccc(cc1)n2nc3cc(c(cc3n2)N)C,BRD-K25570267-001-01-4,ezutromid,Vitas-M,STK101977,"N-[4-(5-amino-6-methyl-2H-1,2,3-benzotriazol-2-yl)phenyl]-N,N-diethylamine",-7.605188,x1077,6.715784,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)[O-],BRD-K45401373-001-20-9,betulinic-acid,Selleck,S3603,Betulinic acid,-7.604858,x0305,4.301952,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)[O-],BRD-K45401373-001-21-7,betulinic-acid,Tocris,3906,Betulinic acid,-7.604858,x0305,4.301952,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)[O-],BRD-K45401373-001-22-5,betulinic-acid,Selleck,S3603,Betulinic acid,-7.604858,x0305,4.301952,active-noncovalent
C[C@@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O)O,BRD-A56621826-001-02-1,oxytetracycline,MedChemEx,HY-B0275,Oxytetracycline,-7.604815,x0749,2.651987,active-covalent
COc1ccccc1N2CC[NH+](CC2)CCN3C(=O)CC4(CCCC4)CC3=O,BRD-K31054881-300-04-7,BMY-7378,Tocris,1006,BMY 7378 dihydrochloride,-7.603386,x0874,4.136384,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCN3C(=O)CC4(CCCC4)CC3=O,BRD-K31054881-300-03-9,BMY-7378,Selleck,S2691,BMY 7378,-7.603386,x0874,4.136384,active-noncovalent
CCCCNc1nc(c2c(n1)n(c(=O)[nH]2)Cc3ccc(nc3)OCC[NH+](C)C)N,BRD-K46384285-001-01-3,DSR-6434,Tocris,4809,DSR 6434,-7.603218,x1077,5.086026,active-noncovalent
CCn1cc(c(=O)c2c1nc(nc2)N3CC[NH2+]CC3)C(=O)[O-],BRD-K08999871-213-01-5,pipemidic-acid,MicroSource,1502024,PIPEMIDIC ACID,-7.601439,x0749,4.761625,active-covalent
Cc1cccc(n1)N2CCC(CC2)CCNC(=O)OCC(=O)NC,BRD-K99819791-001-01-1,SA-47,Tocris,4785,SA 47,-7.601103,x0161,3.47265,active-noncovalent
COc1ccc2c(c1OC)C[N@H+]3CCc4cc(c(cc4[C@@H]3C2)OC)OC,BRD-K35719256-001-02-6,rotundine,Selleck,S2437,Rotundine,-7.599979,x0104,2.613185,active-noncovalent
c1ccc(cc1)[C@H]2[C@@H](N(NC2=O)C(=O)Nc3ccc(cc3)Br)c4ccccc4,BRD-K24675965-001-04-1,LY288513,Tocris,1524,LY 288513,-7.596226,x0072,3.006929,active-noncovalent
C(CCCC(=O)[O-])CCCC(=O)[O-],BRD-K08976401-001-18-5,azelaic-acid,MicroSource,1500648,AZELAIC ACID,-7.595922,x1077,-0.553735,active-noncovalent
c1cc(cc(c1)/C=N/N=C/c2cc(ccc2)Cl)Cl,BRD-K82903013-001-01-4,"3,3'-dichlorobenzaldazine",Tocris,1952,DCB,-7.595606,x0161,4.382931,active-noncovalent
C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N)[NH3+])O,BRD-K02206208-001-01-4,rapastinel,MedChemEx,HY-16728,Rapastinel,-7.594476,x0195,4.925363,active-noncovalent
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c(n1)c2ccccc2)c3ccccc3,BRD-K21191422-001-02-3,selexipag,Tocris,3351,NS 304,-7.594406,x0161,7.113093,active-noncovalent
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c(n1)c2ccccc2)c3ccccc3,BRD-K21191422-001-01-5,selexipag,MedChemEx,HY-14870,NS-304,-7.594406,x0161,7.113093,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,BRD-K98769987-001-22-9,flumazenil,Tocris,1328,Flumazenil,-7.594099,x0161,3.635421,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,BRD-K98769987-001-21-1,flumazenil,Selleck,S1332,Flumazenil,-7.594099,x0161,3.635421,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,BRD-K98769987-001-25-2,flumazenil,Tocris,1328,Flumazenil,-7.594099,x0161,3.635421,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,BRD-K98769987-001-23-7,flumazenil,MicroSource,1505701,FlUMAZENIL,-7.594099,x0161,3.635421,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4ccccn4,BRD-K85606544-001-09-1,neratinib,Selleck,S2150,Neratinib (HKI-272),-7.593379,x0072,15.365936,active-noncovalent
Cc1cc(cc(c1)C(=O)NOCCCCCC(=O)NO)C,BRD-K49921286-001-02-6,LMK-235,Tocris,4830,LMK 235,-7.592885,x0104,1.558027,active-noncovalent
C[C@@H]([C@@H](c1cccc(c1)O)O)[NH3+],BRD-K96253961-046-04-9,metaraminol,MicroSource,1503251,METARAMINOL BITARTRATE,-7.592824,x0195,-0.323258,active-noncovalent
C[C@@H]([C@@H](c1cccc(c1)O)O)[NH3+],BRD-K96253961-046-05-6,metaraminol,Selleck,S4336,metaraminol bitartrate,-7.592824,x0195,-0.323258,active-noncovalent
C[C@@H]([C@@H](c1cccc(c1)O)O)[NH3+],BRD-K96253961-046-03-1,metaraminol,Selleck,S4336,Metaraminol Bitartrate,-7.592824,x0195,-0.323258,active-noncovalent
C12(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(C(C(C(C2(F)F)(F)F)(F)F)(F)F)F)F,BRD-K55401595-001-01-8,perfluorodecalin,Sigma,MFCD00010626,"1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecahydronaphthalene",-7.591651,x0195,5.973361,active-noncovalent
c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4,BRD-K17443395-065-01-4,abacavir,Selleck,S3165,Abacavir sulfate,-7.591563,x0161,0.959488,active-noncovalent
c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4,BRD-K17443395-065-03-0,abacavir,Tocris,4148,Abacavir hemisulfate,-7.591563,x0161,0.959488,active-noncovalent
c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4,BRD-K17443395-065-02-2,abacavir,MicroSource,1502410,ABACAVIR SULFATE,-7.591563,x0161,0.959488,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C)O)N(=O)=O,BRD-A70083328-001-24-3,secnidazole,Selleck,S2537,Secnidazole (Flagentyl),-7.591474,x0195,1.994949,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C)O)N(=O)=O,BRD-A70083328-001-22-7,secnidazole,Selleck,S2537,Secnidazole,-7.591474,x0195,1.994949,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C)O)N(=O)=O,BRD-A70083328-001-23-5,secnidazole,MicroSource,1505304,SECNIDAZOLE,-7.591474,x0195,1.994949,active-noncovalent
COCCOc1ccc(cc1)Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)F,BRD-K87782578-001-01-4,AVL-292,Selleck,S7173,AVL-292,-7.591451,x0678,7.743527,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])O,BRD-K87122641-001-08-1,naringeninic-acid,Vitas-M,STL163567,,-7.590920,x0678,-0.848564,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])O,BRD-K87122641-001-10-7,naringeninic-acid,Sigma,55823,(2E)-3-(4-hydroxyphenyl)-2-propenoic acid,-7.590920,x0678,-0.848564,active-noncovalent
c1cc2cc(ccc2nc1)/C=C\3/C(=O)N/C(=[NH+]/Cc4cccs4)/S3,BRD-K78373679-001-03-7,Ro-3306,Tocris,4181,Ro 3306,-7.589867,x0104,1.507663,active-noncovalent
CC(C)(C)NC(=S)/N=N/Cc1c(cnn1c2ccc(cc2F)F)C(=O)OC,BRD-K06405316-001-03-3,CID-2745687,Tocris,4293,CID 2745687,-7.589744,x0874,2.690178,active-noncovalent
CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O,BRD-K05907307-001-07-1,nonivamide,MicroSource,1506172,NONIVAMIDE,-7.589106,x0104,2.83133,active-noncovalent
CC[NH+](CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2,BRD-K06181161-048-15-1,carbetapentane,Tocris,454,Carbetapentane citrate,-7.588834,x0161,2.801282,active-noncovalent
CC[NH+](CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2,BRD-K06181161-048-16-9,carbetapentane,MicroSource,1501129,CARBETAPENTANE CITRATE,-7.588834,x0161,2.801282,active-noncovalent
c1ccc(cc1)c2c(nc3c(n2)c(nc(n3)N)N)N,BRD-K92049597-001-19-0,triamterene,Selleck,S4080,Triamterene,-7.588733,x1385,1.377171,active-covalent
c1ccc(cc1)c2c(nc3c(n2)c(nc(n3)N)N)N,BRD-K92049597-001-20-8,triamterene,MicroSource,1500589,TRIAMTERENE,-7.588733,x1385,1.377171,active-covalent
CC(C)c1nnc(n1c2cccc3c2non3)c4ccc(nc4)c5ccccc5,BRD-K07150325-001-02-5,ASP-2535,Tocris,5308,ASP 2535,-7.588682,x0161,3.51267,active-noncovalent
CC(C)c1nnc(n1c2cccc3c2non3)c4ccc(nc4)c5ccccc5,BRD-K07150325-001-01-7,ASP-2535,Tocris,5308,"4-(3-isopropyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl)benzo[c][1,2,5]oxadiazole",-7.588682,x0161,3.51267,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)OC(CO)CO,BRD-K77087341-001-02-4,2-Oleoylglycerol,Cayman,16537,2-hydroxy-1-(hydroxymethyl)ethyl (9Z)-9-octadecenoate,-7.587991,x0397,4.220522,active-noncovalent
Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C,BRD-K53153417-001-10-4,butylated-hydroxytoluene,MicroSource,1600716,BUTYLATED HYDROXYTOLUENE,-7.587984,x0749,0.425382,active-covalent
CCCC[C@H](c1ccccc1)O,BRD-A66284731-001-02-0,fenipentol,MicroSource,1503890,FENIPENTOL,-7.586759,x0072,-1.724383,active-noncovalent
CC[N+](CC)(CC)CCOc1cccc(c1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC,BRD-K43106192-320-09-2,gallamine-triethiodide,Selleck,S2471,Gallamine Triethiodide,-7.586231,x0161,8.58553,active-noncovalent
CC[N+](CC)(CC)CCOc1cccc(c1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC,BRD-K43106192-320-10-0,gallamine-triethiodide,MicroSource,1500312,GALLAMINE TRIETHIODIDE,-7.586231,x0161,8.58553,active-noncovalent
COc1ccc(cc1C(=O)NCc2cccnc2)C(=O)NCc3cccnc3,BRD-K67277431-002-10-5,picotamide,Prestwick,Prestw-119,Picotamide monohydrate,-7.585968,x0434,5.229572,active-noncovalent
c1ccc(cc1)C2([C@H]3CN(CCN3C(=O)O2)C(=O)NCc4ccc(cc4)F)c5ccccc5,BRD-A63344375-001-01-8,SHA-68,Tocris,4510,SHA 68,-7.585949,x1077,5.479857,active-noncovalent
CCOC(=O)c1ccc(cc1)N,BRD-K75466013-001-14-4,benzocaine,MicroSource,1500139,BENZOCAINE,-7.585262,x0678,-0.492863,active-noncovalent
CCOC(=O)c1ccc(cc1)N,BRD-K75466013-001-13-6,benzocaine,Selleck,S4210,Benzocaine,-7.585262,x0678,-0.492863,active-noncovalent
CCCn1c(=O)c2c(nc([nH]2)c3cnn(c3)Cc4cccc(c4)C(F)(F)F)n(c1=O)CC,BRD-K68453341-001-01-1,GS-6201,Tocris,4727,"3-ethyl-1-propyl-8-{1-[3-(trifluoromethyl)benzyl]-1H-pyrazol-4-yl}-3,7-dihydro-1H-purine-2,6-dione",-7.584797,x0104,9.50558,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],BRD-A42571354-300-13-8,cetirizine,MicroSource,1505371,CETIRIZINE HYDROCHLORIDE,-7.584497,x1093,4.190551,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],BRD-K27184429-300-01-3,levocetirizine,MicroSource,1504914,LEVOCETIRIZINE DIHYDROCHLORIDE,-7.584497,x1093,4.190551,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],BRD-A42571354-300-12-0,cetirizine,Tocris,2577,Cetirizine dihydrochloride,-7.584497,x1093,4.190551,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],BRD-A42571354-300-11-2,cetirizine,Selleck,S1291,Cetirizine DiHCl,-7.584497,x1093,4.190551,active-noncovalent
C[C@@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)O,BRD-K96362839-001-01-9,cedrol-(+),Sigma,MFCD00077619,"(7beta,8alpha)-cedran-8-ol",-7.583910,x0195,3.029954,active-noncovalent
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,BRD-K18922609-004-24-9,neostigmine,Selleck,S2490,Neostigmine bromide (Prostigmin),-7.583836,x0161,-0.441862,active-noncovalent
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,BRD-K18922609-004-22-3,neostigmine,Selleck,S2490,Neostigmine bromide (Prostigmin),-7.583836,x0161,-0.441862,active-noncovalent
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,BRD-K18922609-004-23-1,neostigmine,MicroSource,1500428,NEOSTIGMINE BROMIDE,-7.583836,x0161,-0.441862,active-noncovalent
CCO[C@@H](CN1CC[NH+](CC1)C[C@H](C)C(=O)c2ccccc2)c3ccccc3,BRD-A72212290-300-02-2,eprazinone,Selleck,S4137,Eprazinone 2HCl,-7.583731,x0161,6.249402,active-noncovalent
CCO[C@@H](CN1CC[NH+](CC1)C[C@H](C)C(=O)c2ccccc2)c3ccccc3,BRD-A72212290-300-01-4,eprazinone,Selleck,S4137,Eprazinone 2HCl,-7.583731,x0161,6.249402,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH3+],BRD-A43974575-065-05-1,tranylcypromine,MicroSource,1500584,TRANYLCYPROMINE SULFATE,-7.582352,x0678,0.198163,active-noncovalent
Cc1c(nc(c(n1)C)C)C,BRD-K25691735-001-09-5,chuanxiongzine,Enzo,RD123,Tetramethylpyrazine,-7.582305,x0397,-1.290597,active-noncovalent
C[C@@H](C12CC3CC(C1)CC(C3)C2)[NH3+],BRD-A75479906-003-11-1,rimantadine,MicroSource,1505460,RIMANTADINE HYDROCHLORIDE,-7.582181,x0354,1.421023,active-noncovalent
C[C@@H](C12CC3CC(C1)CC(C3)C2)[NH3+],BRD-A75479906-001-02-4,rimantadine,Selleck,S1964,Rimantadine,-7.582181,x0354,1.421023,active-noncovalent
C([C@@H](C(=O)[O-])O)C(=O)[O-],BRD-A18396475-001-15-3,malic-acid,Enamine,Z104473230,,-7.582117,x0397,0.143209,active-noncovalent
C([C@@H](C(=O)[O-])O)C(=O)[O-],BRD-A18396475-001-16-1,malic-acid,Enamine,Z104473230,malic acid,-7.582117,x0397,0.143209,active-noncovalent
Cc1cc(n(n1)c2ccccc2)N3CCN(CC3)[C@H]4C[C@H]([NH2+]C4)C(=O)N5CCSC5,BRD-K48068743-001-01-6,teneligliptin,MedChemEx,HY-14806,Teneligliptin,-7.581713,x0161,5.863654,active-noncovalent
C[N@H+]1CCc2cc(c(cc2[C@@H]1CCc3ccc(cc3)Cl)O)OC,BRD-A63546914-003-02-0,Ro-04-5595,Tocris,2005,Ro 04-5595 hydrochloride,-7.579240,x0749,-0.140979,active-covalent
C[N@H+]1CCc2cc(c(cc2[C@@H]1CCc3ccc(cc3)Cl)O)OC,BRD-A63546914-003-03-8,Ro-04-5595,Tocris,2005,Ro 04-5595 hydrochloride,-7.579240,x0749,-0.140979,active-covalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC3OCCO3,BRD-K70507123-001-08-9,doxofylline,Selleck,S4164,Doxofylline,-7.578553,x0749,0.372341,active-covalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC3OCCO3,BRD-K70507123-001-09-7,doxofylline,MicroSource,1502358,DOXOFYLLINE,-7.578553,x0749,0.372341,active-covalent
c1cc2cn[nH]c2c(c1)N(=O)=O,BRD-K04430056-001-17-7,7-nitroindazole,Tocris,602,7-Nitroindazole,-7.578208,x0195,-1.127789,active-noncovalent
c1cc2cn[nH]c2c(c1)N(=O)=O,BRD-K04430056-001-18-5,7-nitroindazole,Tocris,602,7-Nitroindazole,-7.578208,x0195,-1.127789,active-noncovalent
c1cc2cn[nH]c2c(c1)N(=O)=O,BRD-K04430056-236-02-1,7-nitroindazole,Tocris,800,7-NINA,-7.578208,x0195,-1.127789,active-noncovalent
c1c(c2c([nH]1)c(=O)[nH]cn2)[C@H]3[C@@H]([C@@H]([C@H]([NH2+]3)CO)O)O,BRD-K16505263-003-01-1,forodesine,MedChemEx,HY-16209,Forodesine (hydrochloride),-7.577288,x0195,-0.34125,active-noncovalent
c1c(c2c([nH]1)c(=O)[nH]cn2)[C@H]3[C@@H]([C@@H]([C@H]([NH2+]3)CO)O)O,BRD-K16505263-003-02-9,forodesine,MedChemEx,HY-16209,Forodesine (hydrochloride),-7.577288,x0195,-0.34125,active-noncovalent
CC1(CC(=C(C(=O)C1)[C@H]2c3ccccc3OC4=C2C(=O)CC(C4)(C)C)[O-])C,BRD-A42553870-001-14-3,L-152804,Tocris,1382,"L-152,804",-7.576981,x0195,2.159363,active-noncovalent
CC1(CC(=C(C(=O)C1)[C@H]2c3ccccc3OC4=C2C(=O)CC(C4)(C)C)[O-])C,BRD-A42553870-001-15-0,L-152804,Tocris,1382,"L-152,804",-7.576981,x0195,2.159363,active-noncovalent
Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)C[NH+]5CCN(CC5)C(=O)[C@H](C)O,BRD-K23228615-001-03-6,GDC-0980,Selleck,S2696,"Apitolisib (GDC-0980, RG7422)",-7.576761,x0434,9.982135,active-noncovalent
Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)C[NH+]5CCN(CC5)C(=O)[C@H](C)O,BRD-K23228615-001-02-8,GDC-0980,Selleck,S2696,GDC-0980 (RG7422),-7.576761,x0434,9.982135,active-noncovalent
CC(=O)C[C@H](c1ccc(cc1)N(=O)=O)c2c(c3ccccc3oc2=O)[O-],BRD-A65051990-001-12-9,acenocoumarol,MicroSource,1502411,ACENOCOUMAROL,-7.575912,x1093,1.881826,active-noncovalent
Cc1c(c(n(=O)c(c1Cl)C)Cl)c2nc(on2)c3cc(c(c(c3)O)[O-])N(=O)=O,BRD-K66192203-001-01-4,opicapone,MedChemEx,HY-14896,Opicapone,-7.575891,x0161,4.071661,active-noncovalent
Cc1c(c(n(=O)c(c1Cl)C)Cl)c2nc(on2)c3cc(c(c(c3)O)[O-])N(=O)=O,BRD-K66192203-001-02-2,opicapone,MedChemEx,HY-14896,Opicapone,-7.575891,x0161,4.071661,active-noncovalent
c1ccc(cc1)C(c2ccccc2)O[C@@H]3CCC[N@H+](C3)CCc4ccc5c(c4)OCO5,BRD-K80451230-051-02-6,zamifenacin,Tocris,2579,Zamifenacin fumarate,-7.575010,x1077,4.993143,active-noncovalent
c1ccc(cc1)C(c2ccccc2)O[C@@H]3CCC[N@H+](C3)CCc4ccc5c(c4)OCO5,BRD-K80451230-051-03-4,zamifenacin,Tocris,2579,Zamifenacin fumarate,-7.575010,x1077,4.993143,active-noncovalent
c1cc(c(cc1Cl)Cl)OCCOc2ccc(nc2Cl)CF,BRD-K69877120-001-01-7,CYM-50260,Tocris,4677,CYM 50260,-7.574833,x0104,0.715165,active-noncovalent
C[C@@H]1CS[C@H]2/C(=N\C(=O)[C@@H](C3=CCC=CC3)[NH3+])/C(=O)N2[C@@H]1C(=O)[O-],BRD-A90807417-001-04-5,cephradine,MicroSource,1500168,CEPHRADINE,-7.574284,x0107,0.767056,active-noncovalent
CCCC[NH+]1CCC(CC1)CNC(=O)c2c3ccccc3n4c2OCCC4,BRD-K02750403-001-01-4,piboserod,MedChemEx,HY-15574,Piboserod,-7.574043,x0195,2.844138,active-noncovalent
CCCC[NH+]1CCC(CC1)CNC(=O)c2c3ccccc3n4c2OCCC4,BRD-K02750403-001-02-2,piboserod,MedChemEx,HY-15574,Piboserod,-7.574043,x0195,2.844138,active-noncovalent
CC1([C@@H]([N@@](CCS1)S(=O)(=O)c2ccc(cc2)OCC#CCO)C(=O)NO)C,BRD-K06883221-001-01-9,apratastat,Sigma,SML1543,"(3S)-N-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholinecarboxamide",-7.573582,x0072,3.252765,active-noncovalent
CC(=O)N[C@@H](CSSC[C@@H](C(=O)[O-])NC(=O)C)C(=O)[O-],BRD-K32372024-001-01-0,D-7193,ChemImpex,4347,,-7.573561,x0830,1.18866,active-covalent
CC(C)[C@@H](c1ccc(cc1)Cl)C(=O)Nc2nccs2,BRD-A54139254-001-09-2,4-CMTB,Tocris,4642,4-CMTB,-7.572751,x0072,-0.102143,active-noncovalent
C[C@@H]1CC(=O)C=C([C@]12C(=O)c3c(cc(c(c3O2)Cl)OC)OC)OC,BRD-K08273968-001-19-0,griseofulvin,Selleck,S4071,Griseofulvin,-7.572611,x0161,1.868664,active-noncovalent
C[C@@H]1CC(=O)C=C([C@]12C(=O)c3c(cc(c(c3O2)Cl)OC)OC)OC,BRD-K08273968-001-16-6,griseofulvin,MicroSource,200046,GRISEOFULVIN,-7.572611,x0161,1.868664,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)NO)Cl,BRD-K88553858-001-02-7,benurestat,MicroSource,1505410,BENURESTAT,-7.571667,x0946,-0.348254,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cc(c(c(c3)OC)OC)OC)O,BRD-A62197763-001-01-1,enciprazine,Key,KE-0221,"1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(3,4,5-trimethoxyphenoxy)-2-propanol",-7.571525,x0161,4.602426,active-noncovalent
CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)[O-])Cc3c[nH]c4c3cccc4,BRD-A59961917-001-01-0,BQ-123,Selleck,S7883,BQ-123,-7.570893,x0678,15.715569,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])[NH2+][C@@H](Cc1cncn1Cc2cc(cc(c2)Cl)Cl)C(=O)[O-],BRD-K67068943-001-01-0,ORE1001,EMDBio,530616-2MG,"ACE2 Inhibitor, MLN-4760",-7.570468,x0967,3.639286,active-noncovalent
Cc1ccc(c(c1)O)C(C)C,BRD-K17458574-001-07-7,thymol,Enamine,Z57127464,,-7.570327,x0749,0.135256,active-covalent
C[C@]1(c2cc(c(cc2CC[NH2+]1)O)O)C(=O)[O-],BRD-A49952467-001-02-4,salsolinol-1-carboxylic-acid,Tocris,636,Salsolinol-1-carboxylic acid,-7.570035,x0830,0.248994,active-covalent
C[NH2+][C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)[NH3+])[NH3+])[NH3+])O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)[NH3+])O)O)O,BRD-K36062294-001-04-0,apramycin,MicroSource,1505249,APRAMYCIN SULFATE,-7.569222,x1077,11.818742,active-noncovalent
Cc1cccc(c1)OC(=O)C,BRD-K33442414-001-02-6,meta-cresyl-acetate,MicroSource,1506049,meta-CRESYL ACETATE,-7.568030,x0195,0.967415,active-noncovalent
CC1([C@H]([N@@](CS1)S(=O)(=O)c2ccccc2)C(=O)N[C@@H](CNC(=O)NCc3ccccc3)C(=O)[O-])C,BRD-K17621556-001-01-5,TC-I-15,Tocris,4527,TC-I 15,-7.567400,x0107,7.882239,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)[O-])O,BRD-K29392254-001-02-2,pantothenic-acid,Selleck,S2498,D-Pantothenic acid,-7.567369,x0678,-0.668688,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)[O-])O,BRD-K29392254-001-03-0,pantothenic-acid,Selleck,S2498,D-Pantothenic acid,-7.567369,x0678,-0.668688,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)[O-])O,BRD-K29392254-236-01-6,pantothenic-acid,MicroSource,1505715,PANTOTHENIC ACID(d) Na salt,-7.567369,x0678,-0.668688,active-noncovalent
COc1ccc(nn1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,BRD-K15045219-001-01-8,salazodine,Aronis,BBC/534,2-hydroxy-5-[(4-{[(6-methoxy-3-pyridazinyl)amino]sulfonyl}phenyl)diazenyl]benzoic acid,-7.567366,x0104,6.861734,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-304-03-9,pemetrexed,MicroSource,1502390,PEMETREXED,-7.566911,x0072,5.676728,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-434-01-8,pemetrexed,Key,KS-1185,"disodium (2S)-2-({4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}amino)pentanedioate heptahydrate",-7.566911,x0072,5.676728,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-380-01-3,pemetrexed,MedChemEx,HY-13781,Pemetrexed (disodium hemipenta hydrate) (1:2:2.5),-7.566911,x0072,5.676728,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-304-05-4,pemetrexed,MedChemEx,HY-13781,Pemetrexed (disodium hemipenta hydrate),-7.566911,x0072,5.676728,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-304-04-7,pemetrexed,Selleck,S1135,Pemetrexed,-7.566911,x0072,5.676728,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K32842773-304-06-2,pemetrexed,Selleck,S1135,Pemetrexed,-7.566911,x0072,5.676728,active-noncovalent
COc1ccc(cc1OC)CC[NH3+],BRD-K59570838-003-01-9,homoveratrylamine,Prestwick,Prestw-1787,Homoveratrylamine,-7.565498,x1385,-0.297474,active-covalent
C[C@H](C(F)(F)F)Nc1c(c(nc2n1ncn2)Cl)c3c(cc(cc3F)OCCC[NH2+]C)F,BRD-A02473266-001-01-1,cevipabulin,MedChemEx,HY-14949,Cevipabulin,-7.565431,x0395,5.15668,active-noncovalent
C[C@@H]1CCC[C@@H](N1C(=O)CCSC(=O)C)C(=O)[O-],BRD-A32172948-001-07-6,methiopril,ChemDiv,3228-0039,,-7.564294,x0749,0.924087,active-covalent
CC(C)Oc1ccc(cc1C#N)c2nc(no2)c3cccc4c3CC[C@H]4[NH2+]CCC(=O)[O-],BRD-A29148886-003-01-4,RP-001,Tocris,4289,RP 001 hydrochloride,-7.560754,x1077,12.57836,active-noncovalent
CC(=C)[C@H]1CCC(=CC1)CO,BRD-A13323580-001-04-8,perillyl-alcohol,Enamine,EN300-97783,,-7.558175,x0195,0.218919,active-noncovalent
CC(=C)[C@H]1CCC(=CC1)CO,BRD-A13323580-001-05-5,perillyl-alcohol,Enamine,EN300-97783,(4-isopropenyl-1-cyclohexen-1-yl)methanol,-7.558175,x0195,0.218919,active-noncovalent
C/C=C/c1ccc(cc1)OC,BRD-K49060658-001-05-6,anethole,MicroSource,1503705,ANETHOLE,-7.557606,x0749,-1.496922,active-covalent
C/C=C/c1ccc(cc1)OC,BRD-K49060658-001-08-0,anethole,MedChemEx,HY-B0900,Anethole,-7.557606,x0749,-1.496922,active-covalent
C/C=C/c1ccc(cc1)OC,BRD-K49060658-001-07-2,anethole,MedChemEx,HY-B0900,Anethole,-7.557606,x0749,-1.496922,active-covalent
C[C@@H](C(=O)N[C@@H]1c2ccccc2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O,BRD-K81957469-001-01-0,semagacestat,Selleck,S1594,Semagacestat (LY450139),-7.557137,x0195,2.748354,active-noncovalent
CCCCOc1ccc(cc1)OCCC[NH+]2CCOCC2,BRD-K46523383-003-21-1,pramoxine,Selleck,S4092,Pramoxine HCl,-7.554747,x1077,4.201209,active-noncovalent
CCCCOc1ccc(cc1)OCCC[NH+]2CCOCC2,BRD-K46523383-003-22-9,pramoxine,MicroSource,1501139,PRAMOXINE HYDROCHLORIDE,-7.554747,x1077,4.201209,active-noncovalent
C#CC[C@H](c1nc2cc(ccc2c(=O)n1Nc3ccccc3)Cl)N(CCC[NH3+])C(=O)c4cccc(c4F)Cl,BRD-K43436647-001-01-7,ARQ-621,Selleck,S7355,ARQ 621,-7.553823,x1077,6.540272,active-noncovalent
Cc1nc(c(c(n1)Cl)[NH+]=C2NCCN2)OC,BRD-K77771411-001-12-7,moxonidine,Selleck,S2066,Moxonidine,-7.553299,x1412,-0.928597,active-covalent
Cc1nc(c(c(n1)Cl)[NH+]=C2NCCN2)OC,BRD-K77771411-003-12-3,moxonidine,Tocris,2282,Moxonidine hydrochloride,-7.553299,x1412,-0.928597,active-covalent
Cc1nc(c(c(n1)Cl)[NH+]=C2NCCN2)OC,BRD-K77771411-003-10-7,moxonidine,Tocris,2282,Moxonidine hydrochloride,-7.553299,x1412,-0.928597,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1ccc(cc1)NC(=O)NC2CCCCC2)O,BRD-A94276798-001-01-4,talinolol,Cayman,16116,,-7.553074,x0104,5.678339,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,BRD-A92177080-001-02-1,betamethasone-acetate,MicroSource,1505723,BETAMETHASONE ACETATE,-7.552953,x0749,3.446673,active-covalent
CC(C)(C)c1ccc(cc1)/C=C/C(=O)Nc2ccc3c(c2)OCCO3,BRD-K01995783-001-01-6,AMG-9810,Tocris,2316,AMG 9810,-7.551974,x0104,7.760746,active-noncovalent
CC(C)(C)c1ccc(cc1)/C=C/C(=O)Nc2ccc3c(c2)OCCO3,BRD-K01995783-001-02-4,AMG-9810,Tocris,2316,AMG 9810,-7.551974,x0104,7.760746,active-noncovalent
CC1(CC[C@@H]([C@]23[C@@H]1C[C@]([C@]45[C@@H]2CC[C@H]([C@H]4O)C(=C)C5=O)(OC3)O)O)C,BRD-K23925186-001-02-8,oridonin,Selleck,S2335,Oridonin (Isodonol),-7.550424,x0874,1.168055,active-noncovalent
CC1(CC[C@@H]([C@]23[C@@H]1C[C@]([C@]45[C@@H]2CC[C@H]([C@H]4O)C(=C)C5=O)(OC3)O)O)C,BRD-K23925186-001-01-0,oridonin,Selleck,S2335,Oridonin,-7.550424,x0874,1.168055,active-noncovalent
C[N@H+]1CCc2cc3c(cc2[C@@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3,BRD-A07870296-001-06-6,bicuculline-(+),Selleck,S7071,(+)-Bicuculline,-7.549971,x0161,1.201591,active-noncovalent
C[N@H+]1CCc2cc3c(cc2[C@@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3,BRD-A07870296-001-07-4,bicuculline-(+),Tocris,130,(+)-Bicuculline,-7.549971,x0161,1.201591,active-noncovalent
c1cc(ccc1C(=O)NP(=O)(N)N)F,BRD-K67445247-001-02-1,flurofamide,Tocris,478,Flurofamide,-7.549950,x0749,-1.196422,active-covalent
c1cc(ccc1C(=O)NP(=O)(N)N)F,BRD-K67445247-001-03-9,flurofamide,Tocris,478,N-(4-fluorobenzoyl)phosphoric triamide,-7.549950,x0749,-1.196422,active-covalent
c1cc(ccc1C(=O)NP(=O)(N)N)F,BRD-K67445247-001-04-7,flurofamide,Tocris,478,Flurofamide,-7.549950,x0749,-1.196422,active-covalent
c1nc2c(=O)[nH]c(nc2n1COC(CO)CO)N,BRD-K22662435-001-19-1,ganciclovir,Selleck,S1878,Ganciclovir,-7.549510,x0397,-0.631122,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COC(CO)CO)N,BRD-K22662435-001-17-5,ganciclovir,Selleck,S1878,Ganciclovir,-7.549510,x0397,-0.631122,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COC(CO)CO)N,BRD-K22662435-001-18-3,ganciclovir,MicroSource,1502362,GANCICLOVIR,-7.549510,x0397,-0.631122,active-noncovalent
CCOC(=O)c1c[nH]cn1,BRD-K15337272-001-01-3,C-751,Key,PS-5461,,-7.548897,x0397,-2.403877,active-noncovalent
COc1ccc(cc1OC2CCCC2)C(=O)Nc3c(cncc3Cl)Cl,BRD-K47642186-001-01-3,piclamilast,Enamine,Z1629094848,,-7.547668,x0195,2.434424,active-noncovalent
COc1ccc(cc1OC2CCCC2)C(=O)Nc3c(cncc3Cl)Cl,BRD-K47642186-001-02-1,piclamilast,Tocris,4525,Piclamilast,-7.547668,x0195,2.434424,active-noncovalent
c1cc(c2ccsc2c1)N3CC[NH+](CC3)CCCCOc4ccc5ccc(=O)[nH]c5c4,BRD-K00911143-001-01-9,brexpiprazole,MedChemEx,HY-15780,Brexpiprazole,-7.547366,x0195,4.439841,active-noncovalent
CCCC[C@@H](CC)COC(=O)C(=C(c1ccccc1)c2ccccc2)C#N,BRD-K39023557-001-01-7,octocrylene,MicroSource,1506187,OCTOCRYLENE,-7.546808,x0195,3.53265,active-noncovalent
C[NH+]1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4cc(ccc4Cl)OC,BRD-K51329597-001-01-3,AZM-475271,Tocris,3963,AZM 475271,-7.545916,x0104,7.108506,active-noncovalent
C[C@H]1COCC[N@@]1c2c3ccc(nc3nc(n2)[N@@]4CCOC[C@@H]4C)c5ccc(c(c5)CO)OC,BRD-K69932463-001-10-6,AZD8055,Selleck,S1555,AZD8055,-7.545352,x0434,9.883545,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,BRD-K50817623-303-06-5,pancuronium,Selleck,S2497,Pancuronium dibromide,-7.545088,x0104,12.492639,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,BRD-K50817623-303-05-7,pancuronium,Selleck,S2497,Pancuronium (Pavulon),-7.545088,x0104,12.492639,active-noncovalent
c1cc2c(cc1)C(=O)C(=C(C2=O)[C@H]3CC[C@@H](CC3)c4ccc(cc4)Cl)[O-],BRD-A19795905-001-07-2,atovaquone,Selleck,S3079,Atovaquone,-7.545006,x0104,4.504325,active-noncovalent
c1cc2c(cc1)C(=O)C(=C(C2=O)[C@H]3CC[C@@H](CC3)c4ccc(cc4)Cl)[O-],BRD-A19795905-001-08-0,atovaquone,MicroSource,1504210,ATOVAQUONE,-7.545006,x0104,4.504325,active-noncovalent
c1c2c(=O)[nH]cnc2n(n1)[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O,BRD-A93407926-001-01-1,allopurinol-riboside,Berry,PRA 10011,,-7.544447,x0104,-0.929789,active-noncovalent
COC(=O)c1ccccc1O,BRD-K10103010-001-01-1,methyl-salicylate,Enamine,Z19703590,,-7.543220,x0195,0.723,active-noncovalent
c1ccc(cc1)Nc2nc(c(s2)NC(=O)C3CCCCC3)C(=O)N,BRD-K46344388-001-01-3,UNC-3230,Tocris,5271,UNC 3230,-7.542748,x0195,2.776312,active-noncovalent
C[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],BRD-K02976377-001-08-2,levonordefrin,Sigma,MFCD00134415,"4-[(1R,2S)-2-amino-1-hydroxypropyl]-1,2-benzenediol",-7.542301,x0678,0.114039,active-noncovalent
C[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],BRD-K02976377-001-07-4,levonordefrin,MicroSource,1500365,LEVONORDEFRIN,-7.542301,x0678,0.114039,active-noncovalent
c1cc(cc(c1)Cl)OCc2c3c(ncnc3n(n2)C4CCOCC4)N,BRD-K43428468-003-04-0,PF-4800567,Tocris,4281,PF 4800567 hydrochloride,-7.540519,x0195,2.191015,active-noncovalent
Cc1nnc(s1)Sc2c3cc(c(cc3ncn2)OC)OC,BRD-K29895144-001-01-0,SKLB1002,Selleck,S7258,SKLB1002,-7.540480,x0195,1.811193,active-noncovalent
C1C[C@](C[C@H]1C(=O)[O-])(C(=O)[O-])[NH3+],BRD-M29936662-001-02-0,cis-ACPD,Tocris,186,cis-ACPD,-7.539293,x0397,-0.016384,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=C[C@]34C)O,BRD-A94523291-304-02-7,prednisolone-sodium-phosphate,MicroSource,1505712,PREDNISOLONE SODIUM PHOSPHATE,-7.539170,x0072,5.913172,active-noncovalent
CC(C)[NH2+]CCCn1c2c(c(ncn2)N)nc1Sc3cc4c(cc3I)OCO4,BRD-K36529613-001-02-6,PU-H71,MedChemEx,HY-11038,PU-H71,-7.538965,x0830,2.095583,active-covalent
c1ccn2c(c1)[nH+]cc2CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K89337853-001-02-9,minodronic-acid,AvaChem,2663H,"1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyldiphosphonic acid",-7.538495,x0831,1.053046,active-covalent
c1ccn2c(c1)[nH+]cc2CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K89337853-001-01-1,minodronic-acid,AKSci,Y0229,,-7.538495,x0831,1.053046,active-covalent
c1ccc2c(c1)ccc(n2)COc3ccc(cc3)[C@@H](C4CCCC4)C(=O)[O-],BRD-K12852738-001-01-2,veliflapon,Sigma,SML0411,(2R)-cyclopentyl[4-(2-quinolinylmethoxy)phenyl]ethanoic acid,-7.538077,x0107,3.346542,active-noncovalent
c1ccc(cc1)Nc2cc(ccc2C(=O)N3CCC(CC3)[NH+]4CCCC4)C(=O)N5CCC(CC5)[NH+]6CCCC6,BRD-K83189926-001-03-1,UNC1215,Selleck,S7088,UNC1215,-7.536646,x0104,9.938217,active-noncovalent
c1ccc(cc1)Nc2cc(ccc2C(=O)N3CCC(CC3)[NH+]4CCCC4)C(=O)N5CCC(CC5)[NH+]6CCCC6,BRD-K83189926-001-04-9,UNC1215,Selleck,S7088,UNC1215,-7.536646,x0104,9.938217,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)Br,BRD-K79095980-001-09-6,broxuridine,MedChemEx,HY-15910,5-BrdU,-7.535619,x0195,-0.660028,active-noncovalent
CN1CC[NH+](CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)Cl,BRD-A19053834-050-09-5,clorotepine,Sigma,MFCD00153855,"(2Z)-2-butenedioic acid compound with 1-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-methylpiperazine (1:1)",-7.535008,x1418,0.970428,active-covalent
c1ccc(cc1)C2=C/C(=C\c3ccc(o3)c4ccc(cc4)N(=O)=O)/C(=O)N2c5ccc(cc5)C(=O)[O-],BRD-K67173685-001-07-7,4E1RCat,Tocris,4215,4E1RCat,-7.534995,x0104,8.555868,active-noncovalent
c1ccc(cc1)C2=C/C(=C\c3ccc(o3)c4ccc(cc4)N(=O)=O)/C(=O)N2c5ccc(cc5)C(=O)[O-],BRD-K67173685-001-06-9,4E1RCat,Selleck,S7370,4E1RCat,-7.534995,x0104,8.555868,active-noncovalent
c1ccc(cc1)C2=C/C(=C\c3ccc(o3)c4ccc(cc4)N(=O)=O)/C(=O)N2c5ccc(cc5)C(=O)[O-],BRD-K67173685-001-08-5,4E1RCat,Selleck,S7370,4E1RCat,-7.534995,x0104,8.555868,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])/N=C\2/[C@@H](C(=O)C23CCCCC3)Br)Nc4c5cnccc5ccn4,BRD-K40870905-001-01-7,CT-7758,MedChemEx,HY-70073,Zaurategrast,-7.534440,x1077,8.210489,active-noncovalent
c1c(c(nc(c1SC#N)N)N)SC#N,BRD-K54395039-001-02-5,PR-619,Selleck,S7130,PR-619,-7.533534,x0195,-1.195087,active-noncovalent
c1c(c(nc(c1SC#N)N)N)SC#N,BRD-K54395039-001-01-7,PR-619,Selleck,S7130,PR-619,-7.533534,x0195,-1.195087,active-noncovalent
COC(=O)c1ccc(cc1)O,BRD-K78321730-001-10-8,methylparaben,Enamine,Z19674820,,-7.533010,x0678,-0.091205,active-noncovalent
Cc1cc(cc(c1Cl)C)O,BRD-K17223896-001-10-0,chloroxylenol,MicroSource,1500182,CHLOROXYLENOL,-7.532886,x0195,1.809145,active-noncovalent
C[C@@]1(CC(=O)N(C1=O)C)c2ccccc2,BRD-A57592049-001-01-6,methsuximide,MicroSource,1505443,METHSUXIMIDE,-7.531943,x0749,-0.91108,active-covalent
C[C@@H](CC(=O)[O-])C[NH3+],BRD-A62890442-077-01-0,3-methyl-GABA,Tocris,386,3-Methyl-GABA,-7.530840,x0397,0.252076,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)c5ccco5)C)O)Cl)C,BRD-K60640630-001-10-2,mometasone-furoate,Selleck,S1987,Mometasone furoate,-7.530324,x0874,6.04536,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)c5ccco5)C)O)Cl)C,BRD-K60640630-001-11-0,mometasone-furoate,MicroSource,1505367,MOMETASONE FUROATE,-7.530324,x0874,6.04536,active-noncovalent
Cc1ccnc2c1CCC[C@H]2C(=S)N,BRD-A02933148-001-01-8,isotiquimide,Enamine,Z2380439294,"4-methyl-5,6,7,8-tetrahydro-8-quinolinecarbothioamide",-7.529212,x1077,-0.201179,active-noncovalent
c1cc(c(cc1C(=O)Nc2c(cncc2Cl)Cl)OCC3CC3)OC(F)F,BRD-K03194791-001-04-8,roflumilast,Selleck,S2131,Roflumilast,-7.528419,x0104,3.756761,active-noncovalent
C[NH+](C)C1(CCCC1)CNC(=O)c2cc(c(c(c2)OC)OCc3ccccc3)OC,BRD-K32853922-003-01-8,Org-25543,Tocris,4782,Org 25543 hydrochloride,-7.528271,x0161,6.452113,active-noncovalent
COc1ccc(c(c1)OC)/C=C/c2cc(cc(c2)OC)OC,BRD-K96233303-001-02-7,TMS,Tocris,1509,TMS,-7.526848,x0749,3.712268,active-covalent
COc1ccc(c(c1)OC)/C=C/c2cc(cc(c2)OC)OC,BRD-K96233303-001-01-9,TMS,Tocris,1509,TMS,-7.526848,x0749,3.712268,active-covalent
C[C@@H](Cc1ccccc1)[NH3+],BRD-K21160401-065-01-0,dextroamphetamine,MicroSource,1900001,DEXTROAMPHETAMINE SULFATE,-7.525565,x0195,-0.837161,active-noncovalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(c4cccs4)(c5cccs5)O)C,BRD-K62782754-337-02-5,tiotropium,Selleck,S2547,Tiotropium Bromide hydrate,-7.525481,x0874,1.803602,active-noncovalent
Cc1cc(ccc1S(=O)(=O)Nc2cc3c(cc2OC)n(c(=O)n3C)C)Br,BRD-K92658264-001-01-8,OF-1,Tocris,5289,OF 1,-7.524962,x0104,1.895034,active-noncovalent
Cn1c(nc2ccccc2c1=O)COc3ccc(cc3)C[C@H]4C(=O)[N-]C(=O)S4,BRD-A00147595-001-01-5,balaglitazone,MedChemEx,HY-16086,Balaglitazone,-7.524362,x0161,2.621367,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1ccc(o1)C[NH+](C)C,BRD-K70505054-003-14-0,ranitidine,Tocris,1967,Ranitidine hydrochloride,-7.523872,x0104,1.932747,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1ccc(o1)C[NH+](C)C,BRD-K70505054-003-11-6,ranitidine,Selleck,S1801,Ranitidine,-7.523872,x0104,1.932747,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1ccc(o1)C[NH+](C)C,BRD-K70505054-003-13-2,ranitidine,Selleck,S1801,Ranitidine (Zantac),-7.523872,x0104,1.932747,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1ccc(o1)C[NH+](C)C,BRD-K70505054-003-12-4,ranitidine,MicroSource,1501151,RANITIDINE HYDROCHLORIDE,-7.523872,x0104,1.932747,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O,BRD-A67531813-001-01-6,polyinosine,Sigma,MFCD00066754,"(3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl dihydrogen phosphate",-7.523212,x0397,1.437476,active-noncovalent
C[N@]1c2c(oc(=O)n(c2=O)c3ccccn3)-c4ccccc4S1(=O)=O,BRD-K17219082-001-02-9,droxicam,Sigma,MFCD00866032,"5-methyl-3-(2-pyridinyl)-2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide",-7.522986,x0195,3.064661,active-noncovalent
C[N@]1c2c(oc(=O)n(c2=O)c3ccccn3)-c4ccccc4S1(=O)=O,BRD-K17219082-001-01-1,droxicam,Ark,AK129765,,-7.522986,x0195,3.064661,active-noncovalent
Cc1c(c(sn1)NC(=O)c2ccccc2)C(=O)Nc3ccc(cc3)Cl,BRD-K01773083-001-01-4,denotivir,Vitas-M,STL450987,5-(benzoylamino)-N-(4-chlorophenyl)-3-methyl-4-isothiazolecarboxamide,-7.522829,x0831,3.093921,active-covalent
COc1ccc2cc(ccc2c1)c3c(nc([nH]3)c4ccc(cc4)[S@@](=O)C)c5ccncc5,BRD-A92800748-001-05-5,tie2-kinase-inhibitor,Selleck,S1577,Tie2 kinase inhibitor,-7.522776,x0104,6.908889,active-noncovalent
c1ccc(c(c1)c2c3cc(c(c(c3oc-4c(c(=O)c(cc24)I)I)I)[O-])I)C(=O)[O-],BRD-K14920963-304-02-7,erythrosine,MicroSource,1505751,ERYTHROSINE SODIUM,-7.522429,x1385,4.204712,active-covalent
c1cc2c(c(c1)N(=O)=O)[nH]nc2Br,BRD-K24689407-001-07-1,3-bromo-7-nitroindazole,Tocris,735,3-Bromo-7-nitroindazole,-7.522428,x0195,-2.129492,active-noncovalent
c1cc2c(c(c1)N(=O)=O)[nH]nc2Br,BRD-K24689407-001-06-3,3-bromo-7-nitroindazole,Tocris,735,3-Bromo-7-nitroindazole,-7.522428,x0195,-2.129492,active-noncovalent
Cc1cccc(c1NC(=O)C[N+](C)(C)C)C,BRD-K40782193-003-02-9,QX-222,Tocris,1043,QX 222,-7.522398,x0678,-0.423458,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3C2=C4CC[NH+](CC4)CCNC(=O)C5CCN(CC5)C=O,BRD-K06496777-003-01-4,AT-1015,Tocris,4468,AT 1015,-7.522274,x0874,4.479126,active-noncovalent
c1nc2c(=S)[nH]c(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K75649340-001-13-1,tioguanine,Prestwick,Prestw-347,Thioguanosine,-7.522156,x0397,-0.619994,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,BRD-K75864342-001-14-2,menatetrenone,Sigma,MFCD00079646,"2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]naphthoquinone",-7.521097,x0967,7.18693,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH+](C)C,BRD-A23359898-003-10-0,sibutramine,MicroSource,1505210,SIBUTRAMINE HYDROCHLORIDE,-7.520057,x0678,0.525127,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH+](C)C,BRD-A23359898-003-11-8,sibutramine,MedChemEx,HY-14469,Sibutramine (hydrochloride),-7.520057,x0678,0.525127,active-noncovalent
C[C@@H]1[C@@H](CC[N@H+]1Cc2ccccc2)NC(=O)c3cc(c(cc3OC)NC)Cl,BRD-M80207679-001-01-5,nemonapride,Tocris,1746,Nemonapride,-7.518836,x0195,4.171217,active-noncovalent
C[C@@H]1[C@@H](CC[N@H+]1Cc2ccccc2)NC(=O)c3cc(c(cc3OC)NC)Cl,BRD-M80207679-001-02-3,nemonapride,Tocris,1746,Nemonapride,-7.518836,x0195,4.171217,active-noncovalent
COc1ccc(c(c1OC)OC)CN2CC[NH2+]CC2,BRD-K88366685-300-06-0,trimetazidine,MicroSource,1506088,TRIMETAZIDINE DIHYDROCHLORIDE,-7.518697,x0195,1.683291,active-noncovalent
COc1cc2c(cc1OC3CCN(CC3)C(=O)C=C)c(ncn2)Nc4ccc(c(c4F)Cl)Cl,BRD-K50010139-001-02-3,poziotinib,Adooq,A13044,"1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one",-7.518446,x0161,7.990705,active-noncovalent
COc1cc2c(cc1OC3CCN(CC3)C(=O)C=C)c(ncn2)Nc4ccc(c(c4F)Cl)Cl,BRD-K50010139-001-01-5,poziotinib,Selleck,S7358,Poziotinib (HM781-36B),-7.518446,x0161,7.990705,active-noncovalent
C[NH+](C)C[C@@H](COc1ccccc1CCc2cccc(c2)OC)OC(=O)CCC(=O)[O-],BRD-A34358106-003-01-6,sarpogrelate,MedChemEx,HY-10564,Sarpogrelate (hydrochloride),-7.517602,x0195,3.743083,active-noncovalent
C[NH+](C)C[C@@H](COc1ccccc1CCc2cccc(c2)OC)OC(=O)CCC(=O)[O-],BRD-A34358106-003-02-4,sarpogrelate,Tocris,3739,Sarpogrelate hydrochloride,-7.517602,x0195,3.743083,active-noncovalent
CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OC(C)C)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)C,BRD-K36611520-001-01-6,CP-532623,Sigma,PZ0225,"isopropyl (2R,4S)-4-(N-(3,5-bis(trifluoromethyl)benzyl)acetamido)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate",-7.515710,x0434,6.696,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(C[C@@H]([C@H]3[C@@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,BRD-A65767837-001-04-4,hydrocortisone-acetate,MicroSource,1500338,HYDROCORTISONE ACETATE,-7.515005,x0874,4.070052,active-noncovalent
c1cc(c(cc1/C=C/C(=O)[O-])O)O,BRD-K09900591-001-26-7,caffeic-acid,Selleck,S2277,Caffeic acid,-7.514489,x0678,-1.141097,active-noncovalent
c1cc(c(cc1/C=C/C(=O)[O-])O)O,BRD-K09900591-001-25-9,caffeic-acid,Selleck,S2277,Caffeic Acid,-7.514489,x0678,-1.141097,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K05673000-236-12-1,dicloxacillin,MicroSource,1500238,DICLOXACILLIN SODIUM,-7.514229,x0072,3.879964,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K05673000-323-12-7,dicloxacillin,Selleck,S4111,Dicloxacillin Sodium,-7.514229,x0072,3.879964,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K05673000-323-13-5,dicloxacillin,Selleck,S4111,Dicloxacillin Sodium,-7.514229,x0072,3.879964,active-noncovalent
C[N@H+]1CCc2cc3c(c(c2[C@@H]1[C@H]4c5ccc(c(c5C(=O)O4)OC)OC)OC)OCO3,BRD-K91301684-003-05-5,noscapine,MicroSource,1500443,NOSCAPINE HYDROCHLORIDE,-7.513397,x0195,2.674571,active-noncovalent
Cc1c2ccccc2oc1CN(C)C(=O)/C=C/c3cc4c(nc3)NC(=O)CC4,BRD-K23791635-001-01-3,AFN-1252,MedChemEx,HY-16911,AFN-1252,-7.513005,x0678,4.757421,active-noncovalent
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,BRD-K76792669-001-08-1,citric-acid,Sigma,MFCD00150031,"trisodium 2-hydroxy-1,2,3-propanetricarboxylate dihydrate",-7.512378,x0397,0.827459,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-47-3,tretinoin,Sigma,T1850000,retinoic acid,-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-48-1,tretinoin,MedChemEx,HY-14649,Retinoic acid,-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-44-0,tretinoin,Selleck,S1653,All-trans Retinoic Acid (Tretinoin),-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-51-5,tretinoin,MedChemEx,HY-14649,Retinoic acid,-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-39-0,tretinoin,MicroSource,1502016,TRETINOIN,-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-37-4,tretinoin,Selleck,S1653,Tretinoin,-7.511844,x0104,2.907273,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,BRD-K71879491-001-38-2,tretinoin,Tocris,695,Retinoic acid,-7.511844,x0104,2.907273,active-noncovalent
CC1(C(=O)N(C(=O)N1C)C[C@@H]([C@@H](CC2CCCC2)C(=O)N3CCCCC3)C(=O)NO)C,BRD-K95362002-001-01-1,cipemastat,Tocris,2916,"(2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-(1-piperidinyl)-2-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]butanamide",-7.511179,x1077,3.542305,active-noncovalent
Cc1cnc(c(c1OC)C)Cn2cnc3c2nc(nc3Cl)N,BRD-K51967704-001-03-6,BIIB021,Selleck,S1175,BIIB021,-7.510887,x0104,0.295313,active-noncovalent
Cc1cnc(c(c1OC)C)Cn2cnc3c2nc(nc3Cl)N,BRD-K51967704-001-04-4,BIIB021,Tocris,4608,BIIB 021,-7.510887,x0104,0.295313,active-noncovalent
c1ccc2c(c1)cccc2c3cn(cc3C(=O)N4CCOCC4)Cc5cncn5Cc6ccc(cc6)Br,BRD-K18834913-001-03-7,LB42708,Tocris,4294,LB 42708,-7.510770,x0678,5.900898,active-noncovalent
c1ccc2c(c1)cccc2c3cn(cc3C(=O)N4CCOCC4)Cc5cncn5Cc6ccc(cc6)Br,BRD-K18834913-001-01-1,LB42708,Selleck,S7467,LB42708,-7.510770,x0678,5.900898,active-noncovalent
c1ccc2c(c1)cccc2c3cn(cc3C(=O)N4CCOCC4)Cc5cncn5Cc6ccc(cc6)Br,BRD-K18834913-001-02-9,LB42708,Selleck,S7467,LB42708,-7.510770,x0678,5.900898,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(cc2)S(=O)(=O)N)F,BRD-K77867004-001-02-7,U-104,Selleck,S2866,U-104,-7.510766,x0678,3.265928,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(cc2)S(=O)(=O)N)F,BRD-K77867004-001-03-5,U-104,Tocris,4540,U 104,-7.510766,x0678,3.265928,active-noncovalent
Cn1cnc(c1Sc2nncn2C)N(=O)=O,BRD-K63151507-001-02-4,MNITMT,Tocris,2492,MNITMT,-7.509956,x0195,-0.081011,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O,BRD-K79711234-001-18-3,thiamphenicol,MicroSource,1503136,THIAMPHENICOL,-7.508799,x0104,0.801947,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O,BRD-K79711234-001-17-5,thiamphenicol,Selleck,S2583,Thiamphenicol,-7.508799,x0104,0.801947,active-noncovalent
Cn1c2cccc(c2c(=O)c(c1[O-])C(=O)N(C)c3ccc(cc3)C(F)(F)F)OC,BRD-K14653796-001-01-1,tasquinimod,MedChemEx,HY-10528,Tasquinimod,-7.507373,x0830,3.169958,active-covalent
C[C@H]1CC[C@@H]2[C@]13C[C@H]([C@](O3)(CC2=C)O)C(C)C,BRD-K41933240-001-03-2,curcumol,Selleck,S2407,Curcumol,-7.506904,x0678,0.568843,active-noncovalent
C[C@H]1CC[C@@H]2[C@]13C[C@H]([C@](O3)(CC2=C)O)C(C)C,BRD-K41933240-001-02-4,curcumol,Selleck,S2407,Curcumol,-7.506904,x0678,0.568843,active-noncovalent
c1cc(c(cc1Cl)c2nc(nc(n2)N)N)Cl,BRD-K74195153-050-12-1,irsogladine,Tocris,2504,Irsogladine maleate,-7.506547,x0831,-0.609001,active-covalent
c1cc(c(cc1Cl)c2nc(nc(n2)N)N)Cl,BRD-K74195153-050-13-9,irsogladine,Tocris,2504,Irsogladine maleate,-7.506547,x0831,-0.609001,active-covalent
c1cc(c(cc1Cl)c2nc(nc(n2)N)N)Cl,BRD-K74195153-001-04-1,irsogladine,Selleck,S1929,Irsogladine,-7.506547,x0831,-0.609001,active-covalent
C(CC[NH2+]CCC[NH3+])C[NH3+],BRD-K40438880-305-06-6,spermidine,Tocris,959,Spermidine trihydrochloride,-7.505499,x1334,-1.346699,active-covalent
c1c(c(nc(=O)n1[C@@H]2CS[C@@H](O2)CO)N)F,BRD-K61452026-001-04-6,emtricitabine,Selleck,S1704,Emtricitabine,-7.502925,x0967,0.016762,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc4cc(c(=O)n(c4n3)C5CCCC5)C#N,BRD-K88554883-001-01-6,ON123300,MedChemEx,HY-12624,ON123300,-7.502903,x0161,9.723948,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc4cc(c(=O)n(c4n3)C5CCCC5)C#N,BRD-K88554883-001-03-2,ON123300,MedChemEx,HY-12624,ON123300,-7.502903,x0161,9.723948,active-noncovalent
COc1cc(c(cc1C(=O)NC2CC[NH+](CC2)Cc3ccccc3)Cl)N,BRD-K17294426-050-12-3,clebopride,Prestwick,Prestw-380,Clebopride maleate,-7.502891,x0107,3.691851,active-noncovalent
c1c2c(c(c(c1F)N3C[C@H]4[C@H](C3)OCC[NH2+]4)C#N)n(cc(c2=O)C(=O)[O-])C5CC5,BRD-K98384930-003-01-5,finafloxacin,SantaCruz,sc-211507,,-7.502719,x1385,4.27647,active-covalent
Cc1c(nc(o1)c2ccccc2)CCOc3ccc(c4c3ccs4)C[C@H]5C(=O)[N-]C(=O)S5,BRD-A25182582-001-01-8,edaglitazone,Tocris,4784,Edaglitazone,-7.502297,x1077,5.769472,active-noncovalent
CC(=O)Oc1cccc(c1OC(=O)C)C(=O)[O-],BRD-K47608922-001-04-7,dipyrocetyl,MicroSource,1503032,DIPYROCETYL,-7.501822,x1334,2.620432,active-covalent
CC(C)(C)c1cc(ccc1O)OC,BRD-K93035859-001-07-6,butylated-hydroxyanisole,MicroSource,1503740,BUTYLATED HYDROXYANISOLE,-7.501354,x0195,0.985634,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@@H](CC2CCCC2)C(=O)Nc3nccs3,BRD-K21672174-001-03-0,Ro-28-1675,MedChemEx,HY-10595,Ro 28-1675,-7.501330,x0072,2.396574,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl,BRD-K29113274-001-26-7,ketoconazole,Selleck,S1353,Ketoconazole,-7.500534,x0104,10.605803,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl,BRD-K29113274-001-27-5,ketoconazole,Tocris,1103,Ketoconazole,-7.500534,x0104,10.605803,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl,BRD-K29113274-001-28-3,ketoconazole,Selleck,S1353,Ketoconazole,-7.500534,x0104,10.605803,active-noncovalent
COc1ccc2cccc(c2c1)N3CC[NH+](CC3)CCNC(=O)c4ccc(cc4)F,BRD-K46766488-003-02-0,S-14506,Tocris,1771,S 14506 hydrochloride,-7.500387,x0161,5.997057,active-noncovalent
COc1ccc2cccc(c2c1)N3CC[NH+](CC3)CCNC(=O)c4ccc(cc4)F,BRD-K46766488-003-03-8,S-14506,Tocris,1771,S 14506 hydrochloride,-7.500387,x0161,5.997057,active-noncovalent
C[C@@H](Cn1cnc2c1c(=O)n(c(=O)n2C)C)O,BRD-A28887267-001-19-3,proxyphylline,MicroSource,1505915,PROXYPHYLLINE,-7.499759,x0195,-0.626274,active-noncovalent
CNC(=O)c1cnn(c1)c2nc(c3c(n2)n(cn3)[C@H]4[C@@H]([C@H]([C@H](O4)CO)O)O)N,BRD-A78341343-001-01-6,regadenoson,Enzo,AC3239,REGADENOSON,-7.499290,x0161,3.349013,active-noncovalent
CC(C)c1cc(c(c(c1)C(C)C)c2csc(n2)N(CC[NH+](C)C)Cc3cccnc3)C(C)C,BRD-K57774929-001-01-3,foropafant,Sigma,SML0542,"N~1~,N~1~-dimethyl-N~2~-(3-pyridinylmethyl)-N~2~-[4-(2,4,6-triisopropylphenyl)-1,3-thiazol-2-yl]-1,2-ethanediamine",-7.498280,x0874,4.726926,active-noncovalent
Cc1c(c(c(cn1)CO)CO)O,BRD-K14349461-003-13-1,pyridoxine,Selleck,S3113,Pyridoxine HCl,-7.498221,x0540,-1.208706,active-noncovalent
Cc1c(c(c(cn1)CO)CO)O,BRD-K14349461-001-04-4,pyridoxine,MicroSource,1505453,PYRIDOXINE,-7.498221,x0540,-1.208706,active-noncovalent
Cc1cc(no1)NC(=O)Nc2ccc(cc2Cl)Oc3ccnc4c3cc(c(c4)OC)OC,BRD-K53414658-001-08-2,tivozanib,Selleck,S1207,Tivozanib (AV-951),-7.497941,x0104,6.034445,active-noncovalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,BRD-A39172021-001-10-3,ampiroxicam,MicroSource,1504830,AMPIROXICAM,-7.497814,x1392,4.126433,active-covalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,BRD-A39172021-001-09-5,ampiroxicam,Selleck,S4011,Ampiroxicam,-7.497814,x1392,4.126433,active-covalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,BRD-A39172021-001-14-5,ampiroxicam,MedChemEx,HY-17484,Ampiroxicam,-7.497814,x1392,4.126433,active-covalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,BRD-A39172021-001-11-1,ampiroxicam,Selleck,S4011,Ampiroxicam,-7.497814,x1392,4.126433,active-covalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,BRD-A39172021-001-13-7,ampiroxicam,MedChemEx,HY-17484,Ampiroxicam,-7.497814,x1392,4.126433,active-covalent
CCCCC(C)(C)[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)[O-])O)O,BRD-K92301463-001-05-5,"16,16-dimethylprostaglandin-e2",Enzo,PG021,"16,16-Dimethyl-prostaglandin E2",-7.497766,x0195,3.160221,active-noncovalent
Cc1c(sc(n1)N)CC[NH3+],BRD-K39670393-303-02-1,amthamine,Tocris,668,Amthamine dihydrobromide,-7.496300,x0678,-1.038985,active-noncovalent
c1c2c(cc(c1N(=O)=O)N(=O)=O)[nH]c(=O)c(=O)[nH]2,BRD-K64400208-001-08-3,DNQX,Tocris,189,DNQX,-7.496219,x0749,-0.149636,active-covalent
c1c2c(cc(c1N(=O)=O)N(=O)=O)[nH]c(=O)c(=O)[nH]2,BRD-K64400208-304-01-6,DNQX,Tocris,2312,DNQX disodium salt,-7.496219,x0749,-0.149636,active-covalent
c1c2c(cc(c1N(=O)=O)N(=O)=O)[nH]c(=O)c(=O)[nH]2,BRD-K64400208-001-09-1,DNQX,Tocris,189,DNQX,-7.496219,x0749,-0.149636,active-covalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N,BRD-K34022604-001-09-0,clofarabine,Tocris,2600,Clofarabine,-7.496195,x1334,1.547925,active-covalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N,BRD-K34022604-001-05-8,clofarabine,Selleck,S1218,Clofarabine,-7.496195,x1334,1.547925,active-covalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N,BRD-K34022604-001-06-6,clofarabine,Tocris,2600,Clofarabine,-7.496195,x1334,1.547925,active-covalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C[C@H]3[C@H](O3)CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)O2)O)(C)C)C)O)C,BRD-K71823332-001-03-7,epothilone-a,Selleck,S1297,Epothilone A,-7.496130,x0874,6.530704,active-noncovalent
CCCCCCCCC(=O)NCc1cc(c(cc1I)O)OC,BRD-K49236613-001-02-3,6-iodo-nordihydrocapsaicin,Tocris,1975,6-Iodonordihydrocapsaicin,-7.494491,x0830,0.46447,active-covalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(Cc2ccccc2)[O-])O,BRD-A89672324-001-04-8,CGP-55845,Tocris,1248,CGP 55845 hydrochloride,-7.494284,x0195,3.55612,active-noncovalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(Cc2ccccc2)[O-])O,BRD-A89672324-001-03-0,CGP-55845,Tocris,1248,CGP 55845 hydrochloride,-7.494284,x0195,3.55612,active-noncovalent
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)C)O)C)C(=O)COC(=O)C,BRD-K24452555-001-01-7,methylprednisolone-aceponate,Alinda,IVK/0069385,"(6alpha,11beta)-21-(acetyloxy)-11-hydroxy-6-methyl-3,20-dioxopregna-1,4-dien-17-yl propionate",-7.493558,x1077,5.171679,active-noncovalent
Cc1c2c(nc(n1)Nc3cnn(c3)C4CC[NH2+]CC4)N(c5cc6ccccc6cc5C(=O)N2C)C,BRD-K58726989-001-01-9,HTH-01-015,Tocris,5622,HTH 01-015,-7.493075,x0395,9.966136,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)N[C@H]2CCC[NH2+]C2,BRD-A68589262-001-04-3,troxipide,Selleck,S4128,Troxipide,-7.492558,x0946,0.997745,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)N[C@H]2CCC[NH2+]C2,BRD-A68589262-001-05-0,troxipide,Selleck,S4128,Troxipide,-7.492558,x0946,0.997745,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4cccn4,BRD-K30071764-001-03-0,TRAM-34,MedChemEx,HY-13519,TRAM-34,-7.491485,x0678,2.288652,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4cccn4,BRD-K30071764-001-02-2,TRAM-34,MedChemEx,HY-13519,TRAM-34,-7.491485,x0678,2.288652,active-noncovalent
CCCC(CCC)C(=O)NCC(=O)N,BRD-K32804101-001-01-8,valrocemide,Enamine,Z1505862723,N-(2-amino-2-oxoethyl)-2-propylpentanamide,-7.488742,x0749,-1.388959,active-covalent
CCCCNc1nc2n(cc(c2cn1)c3ccc(cc3)CN4CC[NH+](CC4)C)[C@H]5CC[C@@H](CC5)O,BRD-K91283740-003-01-6,UNC2025,MedChemEx,HY-12344A,UNC2025 (hydrochloride),-7.488516,x0104,10.527816,active-noncovalent
Cc1ccccc1c2cc(ncc2N(C)C(=O)C(C)(C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)N4CC[NH+](CC4)C,BRD-K97428065-001-01-2,netupitant,MedChemEx,HY-16346,Netupitant,-7.488314,x0967,8.879102,active-noncovalent
CC(=O)Nc1nc2c(cccc2s1)Oc3cc(ncn3)c4ccc(cc4)C(F)(F)F,BRD-K34185671-001-02-8,AMG-517,Selleck,S7115,AMG-517,-7.487254,x0072,4.850291,active-noncovalent
CC(C)(C(=O)OCCn1cnc2c1c(=O)n(c(=O)n2C)C)Oc3ccc(cc3)Cl,BRD-K49840922-001-05-1,etofylline-clofibrate,Enamine,Z51093246,,-7.487112,x0072,4.848745,active-noncovalent
CC(C)(C(=O)Nc1cccc(c1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4cc(ccc4Cl)OC)[NH3+],BRD-K49456274-001-01-9,pilaralisib,MedChemEx,HY-16526,XL-147,-7.486388,x0161,8.021278,active-noncovalent
COc1cc(c(cc1OC)N(=O)=O)C=O,BRD-K03564313-001-03-3,DMNB,Tocris,2088,DMNB,-7.485889,x0195,1.662257,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2CCC[C@H]2C(=O)[O-],BRD-K57545991-050-23-1,enalapril,Selleck,S1941,Enalapril Maleate,-7.485037,x0874,2.133281,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2CCC[C@H]2C(=O)[O-],BRD-K57545991-050-24-9,enalapril,MicroSource,1501214,ENALAPRIL MALEATE,-7.485037,x0874,2.133281,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC,BRD-K97810537-001-14-4,beclomethasone-dipropionate,Selleck,S3078,Beclomethasone dipropionate,-7.484417,x1077,6.281798,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC,BRD-K97810537-001-12-8,beclomethasone-dipropionate,Selleck,S3078,Beclomethasone dipropionate,-7.484417,x1077,6.281798,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC,BRD-K97810537-001-13-6,beclomethasone-dipropionate,MicroSource,1500136,BECLOMETHASONE DIPROPIONATE,-7.484417,x1077,6.281798,active-noncovalent
c1ccc(cc1)NC(=O)NCC[NH2+]C[C@@H](COc2ccccc2C#N)O,BRD-A03359064-001-02-3,ICI-89406,Tocris,832,ICI 89406,-7.483131,x0946,4.871194,active-noncovalent
CCCCCCCCCCCCCC[C@H]([C@H]([C@H](CO)[NH3+])O)O,BRD-K05048137-001-03-9,phytosphingosine,Enzo,SL150,Phytosphingosine,-7.482892,x0104,2.374791,active-noncovalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,BRD-A08545410-311-03-4,doxycycline,Selleck,S4163,Doxycycline hyclate,-7.482436,x0831,1.251877,active-covalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,BRD-A08545410-003-07-8,doxycycline,Selleck,S4005,Doxycycline HCl,-7.482436,x0831,1.251877,active-covalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,BRD-A08545410-311-01-8,doxycycline,Selleck,S4163,Doxycycline Hyclate,-7.482436,x0831,1.251877,active-covalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,BRD-A08545410-003-08-6,doxycycline,Selleck,S4005,Doxycycline HCl,-7.482436,x0831,1.251877,active-covalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,BRD-A08545410-003-06-0,doxycycline,MicroSource,1500266,DOXYCYCLINE HYDROCHLORIDE,-7.482436,x0831,1.251877,active-covalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC(C)(C)C=O,BRD-K95851186-001-07-8,CGP-13501,Tocris,1514,CGP 13501,-7.481975,x0195,0.194679,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)OC(=O)[C@H](C)[NH3+])C,BRD-K57187269-001-02-4,brivanib-alaninate,Selleck,S1138,Brivanib Alaninate (BMS-582664),-7.480270,x0104,10.16998,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)OC(=O)[C@H](C)[NH3+])C,BRD-K57187269-001-04-0,brivanib-alaninate,MedChemEx,HY-10336,Brivanib (alaninate),-7.480270,x0104,10.16998,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)OC(=O)[C@H](C)[NH3+])C,BRD-K57187269-001-03-2,brivanib-alaninate,Selleck,S1138,Brivanib alaninate (BMS-582664),-7.480270,x0104,10.16998,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3C[C@@H]([C@H](O3)CO)O)Cl)N,BRD-K93034159-001-25-8,cladribine,Selleck,S1199,Cladribine,-7.479826,x1334,0.492139,active-covalent
C1CC[N@H+]2C[C@H]3C[C@@H]([C@@H]2C1)CN4[C@H]3CCCC4=O,BRD-A92826379-001-01-5,lupanine,ChemDiv,N010-0020,,-7.478840,x0678,1.666286,active-noncovalent
c1ccc(cc1)[C@H]2C[C@@H]2[NH3+],BRD-K88809146-003-04-7,tranylcypromine,Selleck,S4246,Tranylcypromine (2-PCPA) HCl,-7.476551,x0195,-0.179183,active-noncovalent
CCOC(=O)c1ccc(cc1)O,BRD-K02464583-001-02-2,ethyl-paraben,MicroSource,1400151,ETHYL PARABEN,-7.475868,x0749,-0.740133,active-covalent
C[C@]12CC[C@H](C1(C)C)[C@@H]([C@@H]2O)O,BRD-K41962502-001-01-8,"cis-exo-camphanediol-2,3",Sigma,MFCD07784411,"(1S,2R,3S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-diol",-7.475666,x0354,2.34941,active-noncovalent
CC(C)(C(=O)N[C@H](Cc1c[nH]c2c1cccc2)C(=O)N3CCC[C@](C3)(Cc4ccccc4)C(=O)N(C)N(C)C)[NH3+],BRD-K01174345-001-01-9,anamorelin,MedChemEx,HY-14734,Anamorelin,-7.475605,x0161,9.246417,active-noncovalent
CC[C@@H](c1cccc(c1)O)[C@@H](C)C[NH+](C)C,BRD-K04283354-003-02-7,tapentadol,MedChemEx,HY-70042A,Tapentadol (hydrochloride),-7.474434,x0678,-1.180815,active-noncovalent
CC[C@@H](c1cccc(c1)O)[C@@H](C)C[NH+](C)C,BRD-K04283354-003-01-9,tapentadol,MedChemEx,HY-70042A,Tapentadol (hydrochloride),-7.474434,x0678,-1.180815,active-noncovalent
C1C[N@@](C[C@@H]([NH2+]1)C(=O)[O-])CCCP(=O)([O-])[O-],BRD-K66094457-001-01-5,CPP,EMDBio,504839-10MG,(R)-CPP,-7.473998,x0749,-0.216944,active-covalent
C1C[N@@](C[C@@H]([NH2+]1)C(=O)[O-])CCCP(=O)([O-])[O-],BRD-K66094457-001-02-3,CPP,Tocris,247,(2R)-4-(3-phosphonopropyl)-2-piperazinecarboxylic acid,-7.473998,x0749,-0.216944,active-covalent
Cc1c(c(=O)c(c([nH]1)C)Cl)Cl,BRD-K80036624-001-04-0,clopidol,MicroSource,1505319,CLOPIDOL,-7.473747,x0678,2.1083,active-noncovalent
C=CCNc1c2cc(ccc2ncn1)Br,BRD-K08478539-001-13-8,SMER-28,Tocris,4297,SMER 28,-7.473435,x0104,-1.031748,active-noncovalent
C1CCCCCCCOC(=O)CCCCCC1,BRD-K36982194-001-01-6,oxacyclohexadecan-2-one,Sigma,MFCD00039667,oxacyclohexadecan-2-one,-7.473433,x1311,1.921597,active-covalent
c1cc2c(cc1O)oc(=O)s2,BRD-K41876534-001-12-9,tioxolone,Selleck,S2603,Tioxolone,-7.473081,x0678,-1.69347,active-noncovalent
c1cc2c(cc1O)oc(=O)s2,BRD-K41876534-001-13-7,tioxolone,MicroSource,1503094,TIOXOLONE,-7.473081,x0678,-1.69347,active-noncovalent
C=CCn1c2c(=O)[nH]c(nc2n(c1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K00091711-001-02-0,RWJ-21757,Sigma,MFCD00867591,"7-allyl-2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-hydroxy-7,9-dihydro-8H-purin-8-one",-7.471807,x0104,1.944731,active-noncovalent
C=CCn1c2c(=O)[nH]c(nc2n(c1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K00091711-001-01-2,RWJ-21757,Tocris,2719,RWJ 21757,-7.471807,x0104,1.944731,active-noncovalent
C=CCn1c2c(=O)[nH]c(nc2n(c1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,BRD-K00091711-001-03-8,RWJ-21757,Tocris,2719,RWJ 21757,-7.471807,x0104,1.944731,active-noncovalent
C[C@H]1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)/C(=N\OC(C)(C)C(=O)[O-])/c2csc(n2)N,BRD-K62607865-236-01-6,aztreonam,Selleck,S1505,Aztreonam,-7.470818,x1077,4.532209,active-noncovalent
C[C@H]1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)/C(=N\OC(C)(C)C(=O)[O-])/c2csc(n2)N,BRD-K62607865-236-02-4,aztreonam,MicroSource,1505122,AZTREONAM,-7.470818,x1077,4.532209,active-noncovalent
C[C@H]1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)/C(=N\OC(C)(C)C(=O)[O-])/c2csc(n2)N,BRD-K62607865-001-09-7,aztreonam,Selleck,S1505,"Aztreonam (Azactam, Cayston)",-7.470818,x1077,4.532209,active-noncovalent
Cc1[nH+]cc(n1C[C@H](CCl)O)N(=O)=O,BRD-A42759514-001-19-7,ornidazole,Selleck,S3121,Ornidazole,-7.469433,x0195,1.311598,active-noncovalent
Cc1[nH+]cc(n1C[C@H](CCl)O)N(=O)=O,BRD-A42759514-001-20-5,ornidazole,MicroSource,1505981,ORNIDAZOLE,-7.469433,x0195,1.311598,active-noncovalent
Cc1[nH+]cc(n1C[C@H](CCl)O)N(=O)=O,BRD-A42759514-001-21-3,ornidazole,Selleck,S3121,Ornidazole,-7.469433,x0195,1.311598,active-noncovalent
CCC(CC)(/C=C/C=C/[C@@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)O,BRD-K28456624-001-01-1,seocalcitol,MedChemEx,HY-32341,Seocalcitol,-7.466984,x0104,10.176199,active-noncovalent
CCC(CC)(/C=C/C=C/[C@@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)O,BRD-K28456624-001-02-9,seocalcitol,MedChemEx,HY-32341,Seocalcitol,-7.466984,x0104,10.176199,active-noncovalent
C[C@@H](CN(c1c(cc(c(c1I)N)I)I)C(=O)C)C(=O)[O-],BRD-A37492983-001-10-3,iocetamic-acid,Prestwick,Prestw-838,Iocetamic acid,-7.465908,x0749,0.65873,active-covalent
C[C@H](C(=O)c1cccc(c1)Cl)[NH2+]C(C)(C)C,BRD-A05186015-003-20-6,bupropion,MicroSource,1504174,BUPROPION,-7.465584,x0195,0.174907,active-noncovalent
C[C@H](C(=O)c1cccc(c1)Cl)[NH2+]C(C)(C)C,BRD-A05186015-003-19-8,bupropion,Selleck,S2452,Amfebutamone HCl,-7.465584,x0195,0.174907,active-noncovalent
C[C@H](C(=O)c1cccc(c1)Cl)[NH2+]C(C)(C)C,BRD-A05186015-003-21-4,bupropion,Tocris,2831,Bupropion hydrochloride,-7.465584,x0195,0.174907,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)c3ccc(cc3)I,BRD-K62537556-001-02-5,4-IBP,Tocris,748,4-IBP,-7.465173,x1093,2.1859,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(no1)Br)O,BRD-A08316590-001-01-3,broxaterol,Enamine,Z2417826612,1-(3-bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol,-7.464785,x0161,-0.760454,active-noncovalent
Cc1cc(ccn1)c2nc(co2)C(=O)Nc3cn(nc3C(=O)N)C4CCOCC4,BRD-K73565918-003-01-4,AS-2444697,Tocris,5430,AS 2444697,-7.464242,x0104,10.151232,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4cncn4)c5ccc(cc5Cl)Cl,BRD-K86204871-001-16-2,terconazole,MicroSource,1503847,TERCONAZOLE,-7.463266,x0104,9.7589,active-noncovalent
c1cc(cc(c1)N2CCN(CC2)c3cc(=O)n(c(=O)[nH]3)C4CCCCC4)C(F)(F)F,BRD-K77547509-001-03-3,ML-179,Tocris,4957,ML 179,-7.462735,x0104,9.876748,active-noncovalent
c1cc(c(cc1N2C(=O)C(=C(C2=O)Cl)[NH+]3CCOCC3)Cl)Cl,BRD-K79555887-001-01-0,RI-1,Selleck,S8077,RI-1,-7.462540,x0161,1.733916,active-noncovalent
CCN(CC)CC[NH2+][C@H](c1ccccc1)C(=O)OCCC(C)C,BRD-A91733352-300-03-7,camylofine-chlorhydrate,Selleck,S4391,Camylofin Chlorhydrate,-7.462274,x0434,2.628938,active-noncovalent
CCN(CC)CC[NH2+][C@H](c1ccccc1)C(=O)OCCC(C)C,BRD-A91733352-300-04-5,camylofine-chlorhydrate,MicroSource,1505785,CAMYLOFINE DIHYDROCHLORIDE,-7.462274,x0434,2.628938,active-noncovalent
CCN(CC)CC[NH2+][C@H](c1ccccc1)C(=O)OCCC(C)C,BRD-A91733352-300-05-2,camylofine-chlorhydrate,Selleck,S4391,camylofine chlorhydrate,-7.462274,x0434,2.628938,active-noncovalent
CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,BRD-K45528773-001-06-4,M-344,Selleck,S2779,M344,-7.459508,x0967,1.083137,active-noncovalent
CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,BRD-K45528773-001-08-0,M-344,Tocris,2771,M 344,-7.459508,x0967,1.083137,active-noncovalent
CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,BRD-K45528773-001-07-2,M-344,Selleck,S2779,M344,-7.459508,x0967,1.083137,active-noncovalent
CC(=O)O[C@H]1C[NH+]2CCC1CC2,BRD-A32673558-003-03-9,aceclidine,Selleck,S4376,Aceclidine HCl,-7.459302,x0195,1.2765,active-noncovalent
CC(=O)O[C@H]1C[NH+]2CCC1CC2,BRD-A32673558-001-02-5,aceclidine,MicroSource,1501124,ACECLIDINE,-7.459302,x0195,1.2765,active-noncovalent
CC(=O)O[C@H]1C[NH+]2CCC1CC2,BRD-A32673558-003-04-7,aceclidine,Selleck,S4301,Aceclidine Hydrochloride,-7.459302,x0195,1.2765,active-noncovalent
CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)[O-])O)O,BRD-K53124401-001-03-8,LTB4,Enzo,LB004,Leukotriene B4,-7.458946,x0749,3.401797,active-covalent
CCCCOc1cc(c2ccccc2n1)C(=O)NCC[NH+](CC)CC,BRD-K99121711-003-20-5,cinchocaine,MicroSource,1500236,DIBUCAINE HYDROCHLORIDE,-7.458789,x0195,2.864946,active-noncovalent
CCCCOc1cc(c2ccccc2n1)C(=O)NCC[NH+](CC)CC,BRD-K99121711-003-19-7,cinchocaine,Selleck,S4038,Dibucaine HCl,-7.458789,x0195,2.864946,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)F)N,BRD-K71106091-001-06-1,fludarabine-phosphate,MicroSource,1505705,FLUDARABINE PHOSPHATE,-7.458449,x0104,2.227975,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)F)N,BRD-K71106091-001-05-3,fludarabine-phosphate,Selleck,S1229,Fludarabine Phosphate,-7.458449,x0104,2.227975,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)F)N,BRD-K71106091-001-09-5,fludarabine-phosphate,Selleck,S1229,Fludarabine Phosphate (Fludara),-7.458449,x0104,2.227975,active-noncovalent
COc1c(c2cc(ccc2[nH]1)F)C(=O)OCC3CC[NH+](CC3)CCNS(=O)(=O)C,BRD-K62594868-082-08-6,GR125487,Tocris,1658,GR 125487 sulfamate,-7.458382,x0104,4.404208,active-noncovalent
C[N@](c1ccccc1CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,BRD-K93788137-001-04-1,PF-431396,Tocris,4278,PF 431396,-7.458097,x0195,5.785334,active-noncovalent
CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c3ccc(cc3)F)N4CC[NH+](CC4)C5COC5,BRD-K21070437-001-01-4,LY3000328,MedChemEx,HY-15533,Cathepsin S inhibitor,-7.456302,x0161,7.545227,active-noncovalent
COc1c(ncnc1OC)NS(=O)(=O)c2ccc(cc2)N,BRD-K55250441-001-12-2,sulfadoxine,Selleck,S2511,Sulfadoxine (Sulphadoxine),-7.455932,x0678,-0.388746,active-noncovalent
COc1c(ncnc1OC)NS(=O)(=O)c2ccc(cc2)N,BRD-K55250441-001-13-0,sulfadoxine,MicroSource,1506086,SULFADOXINE,-7.455932,x0678,-0.388746,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K97163964-001-04-1,L-Aspartic-Acid,Sigma,A1330000,(2S)-2-aminobutanedioic acid,-7.455688,x0426,-0.393357,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],BRD-K97163964-001-03-3,L-Aspartic-Acid,Enzo,AC367,L-Aspartic acid,-7.455688,x0426,-0.393357,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,BRD-K88682005-001-16-6,chlorothiazide,MicroSource,1500180,CHLOROTHIAZIDE,-7.455159,x0749,-1.03307,active-covalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,BRD-K88682005-001-15-8,chlorothiazide,Selleck,S1641,Chlorothiazide,-7.455159,x0749,-1.03307,active-covalent
CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2c3cc4c(cc3CC[N@@H+]5[C@@]2(CCC5)C=C1OC)OCO4)O)O,BRD-K76674262-001-03-3,homoharringtonine,Tocris,1416,Homoharringtonine,-7.453186,x0161,8.404169,active-noncovalent
C[n+]1ccccc1CN=O,BRD-K24221957-003-01-6,pralidoxime-chloride,Sigma,MFCD00011981,2-[(E)-(hydroxyimino)methyl]-1-methylpyridinium chloride,-7.453171,x0678,1.700232,active-noncovalent
C[n+]1ccccc1CN=O,BRD-K84281997-003-09-2,pralidoxime,MicroSource,1505449,PRALIDOXIME CHLORIDE,-7.453171,x0678,1.700232,active-noncovalent
C[n+]1ccccc1CN=O,BRD-K84281997-003-08-4,pralidoxime,MedChemEx,HY-B1200,Pralidoxime (chloride),-7.453171,x0678,1.700232,active-noncovalent
C[n+]1ccccc1CN=O,BRD-K84281997-066-03-2,pralidoxime,MicroSource,1502043,PRALIDOXIME MESYLATE,-7.453171,x0678,1.700232,active-noncovalent
Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,BRD-K12219985-001-26-1,glipizide,MicroSource,1505433,GLIPIZIDE,-7.451027,x0161,7.580122,active-noncovalent
Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,BRD-K12219985-001-25-3,glipizide,Selleck,S1715,Glipizide,-7.451027,x0161,7.580122,active-noncovalent
CC(=O)Nc1ccc(cc1)OC(=O)C,BRD-K93611241-001-02-2,diacetamate,MicroSource,1504515,DIACETAMATE,-7.450303,x0195,-1.069632,active-noncovalent
C[C@@]1([C@@H]2C[C@@H](C2(C)C)C[C@H]1O)O,BRD-A75263867-001-01-1,"2,3-cis/exo-pinanediol",Maybridge,JFD01247,,-7.449685,x0678,1.240745,active-noncovalent
C[n+]1cccc(c1)OC(=O)N(C)C,BRD-K69688083-004-22-3,mestinon,Selleck,S1608,Pyridostigmine Bromide,-7.448599,x0195,-1.193319,active-noncovalent
C[n+]1cccc(c1)OC(=O)N(C)C,BRD-K69688083-004-23-1,mestinon,MicroSource,1503240,PYRIDOSTIGMINE BROMIDE,-7.448599,x0195,-1.193319,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2[C@H]([C@H]([C@@H](O2)CO)O)F,BRD-K18948558-001-01-9,clevudine,Selleck,S3001,Clevudine,-7.448004,x0749,0.465895,active-covalent
c1cc(ccc1N)S(=O)(=O)N=C(N)N,BRD-K45086103-001-14-8,sulfaguanidine,Selleck,S4175,Sulfaguanidine,-7.447862,x0678,-0.900342,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N=C(N)N,BRD-K45086103-001-16-3,sulfaguanidine,Selleck,S4175,Sulfaguanidine,-7.447862,x0678,-0.900342,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N=C(N)N,BRD-K45086103-001-15-5,sulfaguanidine,MicroSource,1501146,SULFAGUANIDINE,-7.447862,x0678,-0.900342,active-noncovalent
c1c2c(c(c(c1I)[O-])I)Oc3c(cc(c(c3I)[O-])I)C24c5c(c(c(c(c5Cl)Cl)Cl)Cl)C(=O)O4,BRD-K36163066-304-02-4,rose-bengal-lactone,CombiBlocks,QF-7123,"disodium 2,3,4,5-tetrachloro-6-(2,4,5,7-tetraiodo-6-oxido-3-oxo-3H-xanthen-9-yl)benzoate",-7.447324,x0830,4.10359,active-covalent
COc1cc(cn[n+]1c2ccccc2)N,BRD-K51387999-067-01-6,amezinium,CombiBlocks,QH-7299,4-amino-6-methoxy-1-phenylpyridazin-1-ium methyl sulfate,-7.445935,x0678,-0.313519,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cnc(n3c2nnc3)NCc4ccco4,BRD-K19002914-001-01-3,EED226,MedChemEx,HY-101117,EED226,-7.445227,x0104,3.888935,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)[N-]C(=O)CCl)OC)C,BRD-A78111609-001-01-2,AGM-1470,Enzo,WN111,TNP-470,-7.445002,x0749,3.57063,active-covalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)OCC[NH+]3CCOCC3)C(F)(F)F,BRD-K38938675-001-01-4,morniflumate,AKSci,O651,,-7.444160,x0434,3.56863,active-noncovalent
C[N@@]1C(=C(c2c(cc(s2)Cl)S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A90551241-001-09-0,lornoxicam,Selleck,S2047,Lornoxicam,-7.441769,x0195,0.959629,active-noncovalent
C[N@@]1C(=C(c2c(cc(s2)Cl)S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A90551241-001-10-8,lornoxicam,MicroSource,1502302,LORNOXICAM,-7.441769,x0195,0.959629,active-noncovalent
CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)[O-])NC(=[NH2+])N)NC(=O)C,BRD-K00519864-341-02-5,peramivir,Selleck,S2716,Peramivir Trihydrate,-7.441146,x1418,1.977924,active-covalent
CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)[O-])NC(=[NH2+])N)NC(=O)C,BRD-K00519864-341-03-3,peramivir,Selleck,S2716,Peramivir Trihydrate,-7.441146,x1418,1.977924,active-covalent
CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1,BRD-K30431096-004-01-3,domiphen,Selleck,S4186,Domiphen Bromide,-7.440799,x0161,3.70603,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)OCc3ccccn3)c4[nH]ccn4,BRD-K05973499-300-01-0,AZ-12080282,Tocris,4838,AZ 12080282 dihydrochloride,-7.440422,x0104,8.976297,active-noncovalent
COc1cc(cc(c1)OC)COc2cc(c(cc2C(=O)CCC3CC[NH+](CC3)CCNS(=O)(=O)C)Cl)N,BRD-K20742498-003-02-9,RS-39604,Tocris,991,RS 39604 hydrochloride,-7.439988,x1077,8.718392,active-noncovalent
c1ccc(cc1)[C@H](C2CCCCC2)C(=O)NCCC[NH+]3CCCCCC3,BRD-A30590053-003-02-9,MR-16728,Tocris,537,MR 16728 hydrochloride,-7.439721,x1077,2.662759,active-noncovalent
C[Se]C[C@@H](C(=O)[O-])[NH3+],BRD-K74227499-001-02-9,se-methylselenocysteine,Sigma,MFCD00800565,(2R)-2-amino-3-(methylselanyl)propanoic acid,-7.439632,x1077,-0.881034,active-noncovalent
C[Se]C[C@@H](C(=O)[O-])[NH3+],BRD-K74227499-001-01-1,se-methylselenocysteine,Acros,30064,,-7.439632,x1077,-0.881034,active-noncovalent
CCOC(=O)C1=C(Oc2ccc(cc2[C@H]1[C@H](C#N)C(=O)OCC)Br)[NH3+],BRD-K18163608-001-02-3,HA14-1,Selleck,S1071,HA14-1,-7.438788,x0395,1.674971,active-noncovalent
CCOC(=O)C1=C(Oc2ccc(cc2[C@H]1[C@H](C#N)C(=O)OCC)Br)[NH3+],BRD-K18163608-001-05-6,HA14-1,Selleck,S1071,HA14-1,-7.438788,x0395,1.674971,active-noncovalent
CCC(=O)c1ccc(cc1)OC[C@H](C[NH+]2CCN(CC2)c3ccccc3)O,BRD-A28958257-001-01-2,centpropazine,Enamine,Z31370920,,-7.438686,x0161,3.67054,active-noncovalent
CCC(=O)c1ccc(cc1)OC[C@H](C[NH+]2CCN(CC2)c3ccccc3)O,BRD-A28958257-001-02-0,centpropazine,Enamine,Z31370920,1-{4-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propoxy]phenyl}-1-propanone,-7.438686,x0161,3.67054,active-noncovalent
CCOC(=O)[C@]1(CO1)CCCCCCOc2ccc(cc2)Cl,BRD-K32405725-001-02-8,etomoxir,MedChemEx,HY-50202,Etomoxir,-7.438437,x0874,2.171562,active-noncovalent
c1cc(c(cc1C(=O)N)N(=O)=O)I,BRD-K11153516-001-05-5,iniparib,Selleck,S1087,Iniparib (BSI-201),-7.437030,x0195,-0.8906,active-noncovalent
c1ccc(cc1)/C=C/C=O,BRD-K38088841-001-01-7,cinnamaldehyde,Otava,1778825,,-7.436707,x0195,-0.23931,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,BRD-K99879819-001-03-9,lorlatinib,Tocris,5640,PF 06463922,-7.435363,x0161,3.190225,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,BRD-K99879819-001-02-1,lorlatinib,MedChemEx,HY-12215,"(R)-2(6)-amino-5(5)-fluoro-1(1),4,7-trimethyl-6-oxo-1(1)H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-1(5)-carbonitrile",-7.435363,x0161,3.190225,active-noncovalent
COc1c2c(nc(n1)N)n(cn2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,BRD-K84466663-001-05-4,nelarabine,Selleck,S1213,Nelarabine,-7.435084,x0104,0.443265,active-noncovalent
c1c(cc(cc1C(F)(F)F)NC(=O)c2cnc(nc2C(F)(F)F)Cl)C(F)(F)F,BRD-K71900389-001-01-9,SP-100030,Tocris,5309,SP 100030,-7.434964,x0104,1.884705,active-noncovalent
c1cc2c(ccc(c2nc1)O)C(=O)[O-],BRD-K70751730-001-10-4,IOX1,MedChemEx,HY-12304,IOX1,-7.434624,x0195,-0.381775,active-noncovalent
c1cc2c(ccc(c2nc1)O)C(=O)[O-],BRD-K70751730-001-11-2,IOX1,Tocris,4464,IOX 1,-7.434624,x0195,-0.381775,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,BRD-M54096567-001-01-9,sodium-gluconate,Selleck,S4174,Sodium Gluconate,-7.433662,x0397,0.355475,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,BRD-M54096567-001-03-5,sodium-gluconate,Selleck,S4174,Sodium Gluconate,-7.433662,x0397,0.355475,active-noncovalent
CCC[C@@](C)(COC(=O)N)COC(=O)NC(C)C,BRD-A99939097-001-24-2,carisoprodol,MicroSource,1500162,CARISOPRODOL,-7.432961,x0434,0.30329,active-noncovalent
CC(C)OC(=O)C1=CN(CC(c2c1[nH]c3c2cccc3)(C)C)C(=O)c4ccc(c(c4)F)F,BRD-K54640016-001-04-7,WAY-362450,Selleck,S2694,XL335,-7.432894,x0161,5.483747,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)[C@H]([C@H]2O)O,BRD-K44602126-001-01-3,"2,3-cis/exo-camphanediol",BroadPharm,BP-30021,,-7.432168,x0354,2.325516,active-noncovalent
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)[O-])C)C)O,BRD-K30968378-001-01-9,INT-747,MedChemEx,HY-12222,INT-747,-7.431846,x0104,3.558746,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4c5cc(ccc5[nH]n4)Cc6cc(cc(c6)F)F,BRD-K39009484-001-01-4,entrectinib,Selleck,S7998,Entrectinib (RXDX-101),-7.431131,x0104,9.837744,active-noncovalent
CN1C2C(N(C1=O)C)N(C(=O)N2C)C,BRD-K76606751-001-01-7,mebicar,ChemDiv,8645-0066,,-7.431121,x0195,-0.109554,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C,BRD-K02528732-001-02-4,fluorometholone-acetate,Selleck,S4228,Fluorometholone Acetate,-7.428937,x0161,4.521892,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C,BRD-K02528732-001-01-6,fluorometholone-acetate,Selleck,S4228,Fluorometholone Acetate,-7.428937,x0161,4.521892,active-noncovalent
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3ccnc(c3)C(C)(C)C(F)(F)F,BRD-K54997624-001-06-0,alpelisib,Selleck,S2814,BYL719,-7.428156,x1077,6.693727,active-noncovalent
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)N4CC[NH+](CC4)C,BRD-K39841531-001-02-1,TG-101209,Selleck,S2692,TG101209,-7.427381,x0161,6.587752,active-noncovalent
C[C@H]1[C@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=[NH+]CCS4)C(=O)OCOC(=O)C(C)(C)C)[C@@H](C)O,BRD-K06900071-001-01-2,tebipenem,Selleck,S2159,Tebipenem Pivoxil,-7.426876,x1077,6.034785,active-noncovalent
Cc1c(c(no1)c2ccccc2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K01244426-323-07-7,cloxacillin,Selleck,S2564,Cloxacillin sodium,-7.425532,x0072,4.167361,active-noncovalent
Cc1c(c(no1)c2ccccc2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K01244426-323-08-5,cloxacillin,Selleck,S2564,Cloxacillin Sodium,-7.425532,x0072,4.167361,active-noncovalent
Cc1c(c(no1)c2ccccc2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K01244426-236-12-1,cloxacillin,MicroSource,1500201,CLOXACILLIN SODIUM,-7.425532,x0072,4.167361,active-noncovalent
C[C@@H]1[C@H](C(=NC(=C)[C@@H]1C(=O)OCCSc2ccccc2)C)C(=O)OC,BRD-A29289453-001-04-7,PCA-4248,Tocris,571,PCA 4248,-7.425279,x0104,1.546191,active-noncovalent
C[C@@H]1[C@H](C(=NC(=C)[C@@H]1C(=O)OCCSc2ccccc2)C)C(=O)OC,BRD-A29289453-001-05-4,PCA-4248,Tocris,571,PCA 4248,-7.425279,x0104,1.546191,active-noncovalent
C1CCC(CC1)(CC(=O)[O-])C[NH3+],BRD-K62737565-003-02-6,gabapentin,Selleck,S1338,Gabapentin Hydrochloride,-7.425027,x0678,0.414708,active-noncovalent
C1CCC(CC1)(CC(=O)[O-])C[NH3+],BRD-K62737565-001-09-5,gabapentin,Selleck,S2133,Gabapentin (Neurontin),-7.425027,x0678,0.414708,active-noncovalent
C1CCC(CC1)(CC(=O)[O-])C[NH3+],BRD-K62737565-001-10-3,gabapentin,MicroSource,1505805,GABAPENTIN,-7.425027,x0678,0.414708,active-noncovalent
c1ccc(cc1)[C@H](C[NH2+]CCc2ccc(cc2)NC(=O)Cc3csc(n3)N)O,BRD-K47949423-001-03-1,mirabegron,Selleck,S4009,Mirabegron (YM178),-7.424723,x0678,5.798409,active-noncovalent
c1ccc(cc1)[C@H](C[NH2+]CCc2ccc(cc2)NC(=O)Cc3csc(n3)N)O,BRD-K47949423-001-02-3,mirabegron,Selleck,S4009,Mirabegron,-7.424723,x0678,5.798409,active-noncovalent
CC[C@](C)(C(=O)NCC(F)(F)F)Nc1ccnc(n1)c2c[nH]c3c2cccn3,BRD-A95300432-001-01-3,decernotinib,MedChemEx,HY-12469,Decernotinib,-7.424261,x0946,3.271701,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CS[C@H](O2)CO,BRD-A02309928-001-04-1,lamivudine,MicroSource,1503839,LAMIVUDINE,-7.423395,x0195,0.343134,active-noncovalent
CCOc1cc(ccc1C(=O)OC)NC(=O)C,BRD-K02475039-001-01-0,ethopabate,MicroSource,1505424,ETHOPABATE,-7.422160,x0195,0.948018,active-noncovalent
CCCn1c(=O)c2c([nH]c1=O)nc([nH]2)c3ccc(cc3)S(=O)(=O)[O-],BRD-K49027941-001-01-1,PSB-1115,Tocris,2009,PSB 1115,-7.422032,x0104,2.940826,active-noncovalent
CCCn1c(=O)c2c([nH]c1=O)nc([nH]2)c3ccc(cc3)S(=O)(=O)[O-],BRD-K49027941-001-02-9,PSB-1115,Tocris,2009,PSB 1115,-7.422032,x0104,2.940826,active-noncovalent
COc1ccc(cc1OC)Cc2c3cc(c(cc3ccn2)OC)OC,BRD-K15567136-003-27-2,papaverine,MicroSource,1500459,PAPAVERINE HYDROCHLORIDE,-7.421810,x0072,2.018422,active-noncovalent
CC(=O)Nc1ccc(cc1)O,BRD-K41524689-001-22-7,paracetamol,Tocris,1706,Acetaminophen,-7.421527,x0678,-1.858383,active-noncovalent
CC(=O)Nc1ccc(cc1)O,BRD-K41524689-001-25-0,paracetamol,Tocris,1706,Acetaminophen,-7.421527,x0678,-1.858383,active-noncovalent
CC(=O)Nc1ccc(cc1)O,BRD-K41524689-001-23-5,paracetamol,MicroSource,1500101,ACETAMINOPHEN,-7.421527,x0678,-1.858383,active-noncovalent
c1ccc(c(c1)CNc2nnnn2c3cccc(c3Cl)Cl)Oc4ccccn4,BRD-K60427831-001-01-0,A-839977,Tocris,4232,A 839977,-7.421249,x0678,3.731865,active-noncovalent
c1cc(c(cc1CC[NH3+])O)O,BRD-K43887077-003-27-1,dopamine,Selleck,S2529,Dopamine hydrochloride (Inotropin),-7.420176,x0678,0.252695,active-noncovalent
c1cc(c(cc1CC[NH3+])O)O,BRD-K43887077-003-25-5,dopamine,Selleck,S2529,Dopamine HCl,-7.420176,x0678,0.252695,active-noncovalent
c1cc(c(cc1CC[NH3+])O)O,BRD-K43887077-003-26-3,dopamine,MicroSource,1500263,DOPAMINE HYDROCHLORIDE,-7.420176,x0678,0.252695,active-noncovalent
COc1ccc(cc1)C(=O)N2CCCC2=O,BRD-K88611939-001-25-7,aniracetam,Tocris,867,Aniracetam,-7.419021,x0161,-0.799464,active-noncovalent
COc1ccc(cc1)C(=O)N2CCCC2=O,BRD-K88611939-001-23-2,aniracetam,Tocris,867,Aniracetam,-7.419021,x0161,-0.799464,active-noncovalent
COc1ccc(cc1)C(=O)N2CCCC2=O,BRD-K88611939-001-22-4,aniracetam,Selleck,S1281,Aniracetam,-7.419021,x0161,-0.799464,active-noncovalent
c1nc(c2c(n1)n(c(n2)Br)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])O)N,BRD-A09554849-236-07-6,8-bromo-cAMP,Tocris,1140,"8-Bromo-cAMP, sodium salt",-7.418727,x0967,1.10324,active-noncovalent
c1c(c(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N)F,BRD-K18157228-001-01-7,fdcyd,SantaCruz,sc-252267,,-7.418592,x0195,-0.860631,active-noncovalent
CC(=O)Oc1ccccc1C(=O)[O-],BRD-K11433652-001-18-8,aspirin,Selleck,S3017,Aspirin (Acetylsalicylic acid),-7.418229,x0678,1.265237,active-noncovalent
CC(=O)Oc1ccccc1C(=O)[O-],BRD-K11433652-001-23-8,aspirin,Tocris,4092,Aspirin,-7.418229,x0678,1.265237,active-noncovalent
CC(=O)Oc1ccccc1C(=O)[O-],BRD-K11433652-001-17-0,aspirin,MicroSource,1500130,ASPIRIN,-7.418229,x0678,1.265237,active-noncovalent
CC(=O)Oc1ccccc1C(=O)[O-],BRD-K11433652-001-16-2,aspirin,Selleck,S3017,Aspirin,-7.418229,x0678,1.265237,active-noncovalent
CCOc1ccccc1C(=O)[O-],BRD-K04843302-001-02-5,2-ethoxybenzoic-acid,Enamine,Z111665440,2-ethoxybenzoic acid,-7.418130,x0195,1.312595,active-noncovalent
C#Cc1c[nH]c(=O)[nH]c1=O,BRD-K26425819-001-01-3,eniluracil,Sigma,MFCD19160708,"5-ethynyl-2,4(1H,3H)-pyrimidinedione",-7.416646,x0678,-1.472335,active-noncovalent
COc1cc(cc(c1OC)OC)C[NH+]2CCN(CC2)c3ccc(cc3)F,BRD-K75052463-001-01-4,V-51,ChemBridge,5259117,"1-(4-fluorophenyl)-4-(3,4,5-trimethoxybenzyl)piperazine",-7.416143,x0161,2.425855,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)OC(=O)C,BRD-K64381438-001-03-8,ulipristal,Selleck,S3081,Ulipristal,-7.415710,x1077,4.554104,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)OC(=O)C,BRD-K64381438-001-02-0,ulipristal,Selleck,S3081,Ulipristal,-7.415710,x1077,4.554104,active-noncovalent
CCOC(=O)CC(=O)N1CCS[C@H]1COc2ccccc2OC,BRD-A87673115-001-04-1,moguisteine,Selleck,S3104,Moguisteine,-7.414721,x0072,2.218696,active-noncovalent
C1[C@@H]2[C@H]([C@H]([C@@H](O2)n3c4c(c(=O)[nH]c(n4)N)nc3Br)O)O[P@@](=O)(O1)[O-],BRD-A00077618-236-07-6,8-bromo-cGMP,Tocris,1089,"8-Bromo-cGMP, sodium salt",-7.413481,x1077,1.907962,active-noncovalent
c1ccc2c(c1)N(c3ccccc3S2)C(=O)CN4CC[NH+](CC4)Cc5ccc6c(c5)OCO6,BRD-K77564118-001-03-1,fenoverine,Vitas-M,STK210707,"10-{[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]acetyl}-10H-phenothiazine",-7.412993,x0874,8.64907,active-noncovalent
Cc1c([nH]cn1)CC[NH3+],BRD-K70821460-300-02-4,4-methylhistamine,Tocris,2342,4-Methylhistamine dihydrochloride,-7.412735,x1093,-2.016881,active-noncovalent
CC(C)C(=O)Nc1ncc(s1)c2cc(nn2c3c(cccc3Cl)Cl)C(F)F,BRD-K75373031-001-01-7,LIMKi-3,Tocris,4745,LIMKi 3,-7.411934,x0678,3.649282,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A33168282-003-16-4,sotalol,Selleck,S2509,Sotalol,-7.411757,x0830,0.957513,active-covalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A33168282-003-17-2,sotalol,Tocris,952,Sotalol hydrochloride,-7.411757,x0830,0.957513,active-covalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,BRD-A33168282-003-18-0,sotalol,MicroSource,1506043,SOTALOL HYDROCHLORIDE,-7.411757,x0830,0.957513,active-covalent
CCCCCCCCCCCCCC(=O)OC(C)C,BRD-K13409143-001-02-7,isopropyl-myristate,Sigma,MFCD00008982,isopropyl myristate,-7.411432,x0161,1.771505,active-noncovalent
CCCCCCCCCCCCCC(=O)OC(C)C,BRD-K13409143-001-01-9,isopropyl-myristate,Acros,41285,,-7.411432,x0161,1.771505,active-noncovalent
CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1[C@H](O1)C(=O)[O-],BRD-K21937671-001-09-2,loxistatin-acid,Selleck,S7392,Loxistatin Acid (E-64C),-7.409754,x0397,1.171182,active-noncovalent
CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1[C@H](O1)C(=O)[O-],BRD-K21937671-001-10-0,loxistatin-acid,Selleck,S7392,Loxistatin Acid (E-64C),-7.409754,x0397,1.171182,active-noncovalent
C[C@@H]([NH+]1[C@@H]2CC(C[C@H]1CC2)C(=O)[O-])c3cc4c(c(ccc4cc3)O[C@H]5CC[C@H](CC5)C(F)(F)F)C(F)(F)F,BRD-A94640958-001-01-7,autotaxin-modulator-1,MedChemEx,HY-12812,Autotaxin modulator 1,-7.408940,x0072,11.687784,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)CO,BRD-K76204040-001-03-8,pyridoxal,Vitas-M,STL137770,3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde,-7.408602,x0678,-1.626119,active-noncovalent
c1ccc(cc1)C(=O)CC#N,BRD-K87573013-001-01-0,CL-225385,Enamine,EN300-17202,3-oxo-3-phenylpropanenitrile,-7.408493,x0161,-1.618272,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCO,BRD-K83064458-001-23-0,etofylline,Enzo,AC627,7-(b-Hydroxyethyl)theophylline,-7.408077,x0195,-0.171797,active-noncovalent
C[C@@H](Cc1cnc[nH]1)[NH3+],BRD-K28308851-303-01-8,alpha-methylhistamine-dihydrobromide-(S)-(+),Tocris,572,(S)-(+)-?-Methylhistamine dihydrobromide,-7.407391,x0540,-1.621851,active-noncovalent
C(C[C@H](C(=O)[O-])[NH3+])C[NH+]=C(N)N,BRD-K76811153-003-01-3,L-Arginine,Selleck,S3174,L-Arginine HCl,-7.406691,x0749,-2.379351,active-covalent
CC[NH+](CC)CCOC(=O)c1cc(c(cc1OC)N)Cl,BRD-K15868788-003-07-7,SDZ-205-557,Tocris,2037,SDZ 205-557 hydrochloride,-7.406668,x0678,1.202557,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O,BRD-K60511616-236-06-3,pravastatin,Tocris,2318,Pravastatin sodium salt,-7.403814,x0195,5.364272,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O,BRD-K60511616-236-08-9,pravastatin,Selleck,S3036,Pravastatin sodium,-7.403814,x0195,5.364272,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O,BRD-K60511616-236-07-1,pravastatin,Tocris,2318,Pravastatin sodium salt,-7.403814,x0195,5.364272,active-noncovalent
CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2ccc(=O)[nH]c2=O)OC(=O)C)OC(=O)C,BRD-K18323388-001-01-1,uridine-triacetate,Bepharm,B7900,,-7.403125,x0831,2.202373,active-covalent
CN1C(=O)N(C(=O)[C@@]1(CO)c2ccccc2)c3ccc(c(c3)C(F)(F)F)C#N,BRD-K15893360-001-01-8,GLPG0492,MedChemEx,HY-18102,GLPG0492,-7.401314,x0161,2.451721,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,BRD-K71696703-001-11-1,triflusal,MedChemEx,HY-B0531,Triflusal,-7.399758,x0161,-0.816285,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,BRD-K71696703-001-08-7,triflusal,MedChemEx,HY-B0531,2-(acetyloxy)-4-(trifluoromethyl)benzoic acid,-7.399758,x0161,-0.816285,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,BRD-K71696703-001-09-5,triflusal,MedChemEx,HY-B0531,Triflusal,-7.399758,x0161,-0.816285,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,BRD-K71696703-001-07-9,triflusal,Selleck,S3200,Triflusal,-7.399758,x0161,-0.816285,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,BRD-K71696703-001-06-1,triflusal,Selleck,S3200,Triflusal,-7.399758,x0161,-0.816285,active-noncovalent
CC(=O)c1ccc(c(c1)OC)OCCC[NH+]2CCC(CC2)c3c4ccc(cc4on3)F,BRD-K48722833-001-07-6,iloperidone,Selleck,S1483,Iloperidone,-7.399706,x0104,10.400541,active-noncovalent
CC(C)(C)Nc1c(c(cc([nH+]1)Nc2ccc(cc2)C(=O)N)N)C#N,BRD-K76792630-001-01-2,TC-Mps1-12,Tocris,4750,TC Mps1 12,-7.398635,x0434,0.903012,active-noncovalent
CC(C)Cn1cnc2c1c(=O)n(c(=O)n2C)C,BRD-K06762493-001-08-1,isbufylline,Vitas-M,STK868787,,-7.397810,x0195,0.491059,active-noncovalent
CSCC[C@H](C(=O)[O-])[NH3+],BRD-A39515206-001-01-9,methionine,Sigma,M0950000,methionine,-7.397245,x0397,-1.044356,active-noncovalent
CNC(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc(cc3OC)N4CCOCC4)Cl,BRD-K21025364-001-04-9,NVP-TAE226,Selleck,S2820,TAE226 (NVP-TAE226),-7.396210,x0161,5.556483,active-noncovalent
CNC(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc(cc3OC)N4CCOCC4)Cl,BRD-K21025364-001-05-6,NVP-TAE226,Selleck,S2820,NVP-TAE226,-7.396210,x0161,5.556483,active-noncovalent
CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)[O-])c5nc6ccccc6n5C)C,BRD-K73999723-001-11-3,telmisartan,MicroSource,1505261,TELMISARTAN,-7.395685,x0434,10.149735,active-noncovalent
CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)[O-])c5nc6ccccc6n5C)C,BRD-K73999723-001-13-9,telmisartan,Tocris,5139,Telmisartan,-7.395685,x0434,10.149735,active-noncovalent
CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)[O-])c5nc6ccccc6n5C)C,BRD-K73999723-001-10-5,telmisartan,Selleck,S1738,Telmisartan,-7.395685,x0434,10.149735,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)N(=O)=O,BRD-K76775527-001-29-4,nimesulide,Tocris,2470,Nimesulide,-7.393459,x0678,0.186667,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)N(=O)=O,BRD-K76775527-001-28-6,nimesulide,Selleck,S2040,Nimesulide,-7.393459,x0678,0.186667,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)N(=O)=O,BRD-K76775527-001-30-2,nimesulide,MicroSource,1503231,NIMESULIDE,-7.393459,x0678,0.186667,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1csc(n1)C[NH+](C)C,BRD-K73589491-001-12-0,nizatidine,Selleck,S1890,Nizatidine,-7.392585,x0104,1.463995,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1csc(n1)C[NH+](C)C,BRD-K73589491-001-11-2,nizatidine,MicroSource,1505985,NIZATIDINE,-7.392585,x0104,1.463995,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)/C=C/C#N,BRD-K48684885-001-04-2,BAY-11-7085,Tocris,1743,Bay 11-7085,-7.392424,x0749,-0.235556,active-covalent
C(CCC(=O)[O-])CC(=O)[O-],BRD-K10656395-001-02-1,adipic-acid,Enamine,Z57127533,,-7.392212,x0397,-1.25537,active-noncovalent
Cc1cc(c(c(=O)[nH]1)CNC(=O)c2c(n(c3c2cccc3)[C@H](C)C4CCOCC4)C)OC,BRD-K18319422-001-01-7,CPI-360,MedChemEx,HY-15955,CPI-360,-7.391708,x0104,6.232828,active-noncovalent
C[C@@H]([C@H](C)O)[C@@H](C(=O)[O-])[NH3+],BRD-K90305467-001-01-3,ID-1101,Sigma,50118,"2-amino-2,3,5-trideoxy-3-methyl-L-ribonic acid",-7.390915,x1077,0.00275,active-noncovalent
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,BRD-K10799896-001-25-4,clobetasol-propionate,Selleck,S2584,Clobetasol propionate,-7.389101,x0072,4.959024,active-noncovalent
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,BRD-K10799896-001-26-2,clobetasol-propionate,MicroSource,1503918,CLOBETASOL PROPIONATE,-7.389101,x0072,4.959024,active-noncovalent
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,BRD-K10799896-001-24-7,clobetasol-propionate,Sigma,C8037,"(11beta,16beta)-21-chloro-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propionate",-7.389101,x0072,4.959024,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)[N-]C(=O)CCl)OC)C,BRD-K53597484-001-02-7,TNP-470,Sigma,MFCD00870281,"(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl chloroacetylcarbamate",-7.387981,x0749,5.112265,active-covalent
C1CCC(CC1)[NH2+]C2CCCCC2,BRD-K57091285-001-07-7,dicyclohexylamine,Vitas-M,STK379549,,-7.387631,x0678,-1.659221,active-noncovalent
COc1ccc(cc1OC)C[C@@H]2c3cc(c(cc3CC[NH2+]2)OC)OC,BRD-A91831168-003-02-5,tetrahydropapaverine,Selleck,S2367,Tetrahydropapaverine HCl,-7.386902,x0195,2.411545,active-noncovalent
Cc1c2cnc(nc2n(c(=O)c1C(=O)C)C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,BRD-K51313569-003-03-3,palbociclib,Selleck,S1116,Palbociclib (PD-0332991) HCl,-7.386431,x0161,8.371318,active-noncovalent
Cc1c2cnc(nc2n(c(=O)c1C(=O)C)C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,BRD-K51313569-001-07-8,palbociclib,Selleck,S1116,Palbociclib,-7.386431,x0161,8.371318,active-noncovalent
c1cc2cnccc2cc1NC(=O)NCC(=O)N3CCCC3,BRD-K86718786-001-01-7,SGC-707,Tocris,5367,SGC 707,-7.385285,x0946,1.106375,active-noncovalent
C(CCC(=O)[O-])CC[NH3+],BRD-K64931368-003-01-4,aminocaproic-acid,MicroSource,1500114,AMINOCAPROIC ACID HYDROCHLORIDE,-7.383017,x0734,-0.023601,active-covalent
C(CCC(=O)[O-])CC[NH3+],BRD-K64931368-001-13-3,aminocaproic-acid,Selleck,S1671,?6-??-?Aminocaproic acid,-7.383017,x0734,-0.023601,active-covalent
C(CCC(=O)[O-])CC[NH3+],BRD-K64931368-001-14-1,aminocaproic-acid,Selleck,S1671,??6-????-Aminocaproic acid,-7.383017,x0734,-0.023601,active-covalent
CC[NH2+]C1(CCN(CC1)c2c3c(ncn2)n(c(n3)c4ccccc4Cl)c5ccc(cc5)Cl)C(=O)N,BRD-K09090949-001-01-9,"CP-945,598",MedChemEx,HY-10871,Otenabant,-7.382950,x1392,8.426431,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)Cl,BRD-K19111024-001-20-9,clofibric-acid,MicroSource,1500195,CLOFIBRIC ACID,-7.382083,x0692,-0.684806,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)Cl,BRD-K19111024-001-19-1,clofibric-acid,Tocris,825,Clofibric acid,-7.382083,x0692,-0.684806,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)Cl,BRD-K19111024-001-18-3,clofibric-acid,Selleck,S4207,Clofibric Acid,-7.382083,x0692,-0.684806,active-covalent
c1cc(c(cc1Cl)Cl)OCC(=O)N2CCC(CC2)NC(=O)CCCS,BRD-K26305185-001-01-3,K-Ras(G12C)-inhibitor-6,Selleck,S7333,K-Ras(G12C) inhibitor 6,-7.380242,x0161,5.459369,active-noncovalent
c1cc(c(cc1Cl)Cl)OCC(=O)N2CCC(CC2)NC(=O)CCCS,BRD-K26305185-001-02-1,K-Ras(G12C)-inhibitor-6,Selleck,S7333,K-Ras(G12C) inhibitor 6,-7.380242,x0161,5.459369,active-noncovalent
CC(=O)NC1=[NH+]N([C@](S1)(C)c2ccccc2)C(=O)C,BRD-A67748489-001-10-0,K-858,Tocris,3703,K 858,-7.379666,x0831,-0.591683,active-covalent
CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C,BRD-K11073688-001-01-6,CPI-1189,ChemDiv,Y030-2548,,-7.379025,x0749,0.375319,active-covalent
c1ccc(cc1)c2ccc(cc2)NC(=O)c3ccccc3C(=O)[O-],BRD-K27584835-001-01-6,kartogenin,Tocris,4513,Kartogenin,-7.377553,x0967,2.312629,active-noncovalent
C[C@H](Cc1cc2c(c(c1)C(=O)N)[N@@](CC2)CCCO)[NH2+]CCOc3ccccc3OCC(F)(F)F,BRD-K10906636-001-02-9,silodosin,Selleck,S1613,Silodosin,-7.377306,x1093,7.782474,active-noncovalent
C[C@H](Cc1cc2c(c(c1)C(=O)N)[N@@](CC2)CCCO)[NH2+]CCOc3ccccc3OCC(F)(F)F,BRD-K10906636-001-01-1,silodosin,Selleck,S1613,Silodosin,-7.377306,x1093,7.782474,active-noncovalent
CCCCC1(C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)COC(=O)CCC(=O)[O-],BRD-K78815826-001-13-8,suxibuzone,Selleck,S4367,Suxibuzone,-7.377217,x0678,5.338089,active-noncovalent
CCCCC1(C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)COC(=O)CCC(=O)[O-],BRD-K78815826-001-14-6,suxibuzone,MicroSource,1501157,SUXIBUZONE,-7.377217,x0678,5.338089,active-noncovalent
C[Se]CC[C@H](C(=O)[O-])[NH3+],BRD-A18774709-001-01-9,selenomethionine,Sigma,S3875,2-amino-4-(methylselanyl)butanoic acid,-7.374523,x0397,-1.155312,active-noncovalent
COc1cc(ccc1O)CC=C,BRD-K32977963-001-05-0,eugenol,MicroSource,1500296,EUGENOL,-7.374389,x0161,0.894403,active-noncovalent
CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc2ccccc2,BRD-K22520627-001-01-7,DVD-111,MedChemEx,HY-17456,Noopept,-7.374214,x0072,1.72493,active-noncovalent
CC[C@@H]1[C@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@@]4([C@H]([C@@H]3[C@H]1O)CC[C@@H]4[C@H](C)CCC(=O)[O-])C)C)O,BRD-A75838038-001-01-4,obeticholic-acid,Selleck,S7660,Obeticholic Acid,-7.373323,x1077,2.369372,active-noncovalent
CCOC(=O)C1=C(N(C(=C([C@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)CC#C)C,BRD-A78093359-001-06-3,MRS1845,Tocris,1866,MRS 1845,-7.373179,x0678,3.62817,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K15697815-001-15-4,ursodiol,MicroSource,1500605,URSODIOL,-7.370848,x0072,3.562704,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BRD-K15697815-001-16-2,ursodiol,Selleck,S1643,Ursodiol,-7.370848,x0072,3.562704,active-noncovalent
CC(C)[NH+](CCNC(=O)CN1CCCC1=O)C(C)C,BRD-K21123171-001-02-9,pramiracetam,Selleck,S2594,Pramiracetam,-7.370676,x0831,0.105341,active-covalent
CN(C)c1c(nc(c(n1)N)C(=O)Nc2cccnc2)Cl,BRD-K68633617-003-02-9,ACDPP,Tocris,2254,ACDPP hydrochloride,-7.370589,x0397,1.871722,active-noncovalent
c1cc(c(cc1Cl)Cl)C(=O)NS(=O)(=O)c2ccc(s2)Br,BRD-K42495768-001-01-7,tasisulam,Selleck,S7326,Tasisulam,-7.369979,x0195,0.744812,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H](C)[NH3+])C,BRD-A92670106-003-05-4,tocainide,MicroSource,1506048,TOCAINIDE HYDROCHLORIDE,-7.368019,x0195,-1.729886,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)[N@@](C)c4cccc(c4)Cl)/[nH]c(=C)c1C(=O)N5CC[NH+](CC5)C,BRD-K02965346-001-06-7,SU-11274,Tocris,4101,SU 11274,-7.367474,x0161,9.97196,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)[N@@](C)c4cccc(c4)Cl)/[nH]c(=C)c1C(=O)N5CC[NH+](CC5)C,BRD-K02965346-001-07-5,SU-11274,Selleck,S1080,SU11274,-7.367474,x0161,9.97196,active-noncovalent
CCCCCCCCCCCCOS(=O)(=O)[O-],BRD-K05680146-001-01-2,dodecyl-sulfate,Sigma,MFCD00067711,dodecyl hydrogen sulfate,-7.366870,x0161,1.73196,active-noncovalent
c1ccc(cc1)C(=O)NCC(=O)[O-],BRD-K62914667-001-13-9,hippuric-acid,CombiBlocks,QE-9843,(benzoylamino)acetic acid,-7.366289,x0107,-0.728143,active-noncovalent
c1ccc(cc1)Cn2cc(c3c2ccc(c3)c4ccc(cc4)OC(F)(F)F)C(=O)C(=O)[O-],BRD-K30882994-001-02-4,tiplaxtinin,Tocris,5565,Tiplaxtinin,-7.365982,x0161,7.576361,active-noncovalent
c1ccc(cc1)Cn2cc(c3c2ccc(c3)c4ccc(cc4)OC(F)(F)F)C(=O)C(=O)[O-],BRD-K30882994-001-01-6,tiplaxtinin,MedChemEx,HY-15253,Tiplaxtinin,-7.365982,x0161,7.576361,active-noncovalent
Cc1ccc(cc1)c2nc(on2)CSc3nnc(n3c4ccc(cc4)OC)c5ccncc5,BRD-K75664313-001-03-4,JW-74,Tocris,5653,JW 74,-7.365215,x0946,4.536261,active-noncovalent
Cc1ccc(cc1)c2nc(on2)CSc3nnc(n3c4ccc(cc4)OC)c5ccncc5,BRD-K75664313-001-02-6,JW-74,PrincetonBio,OSSL_897842,JW-74,-7.365215,x0946,4.536261,active-noncovalent
CN1[C@H](S(=O)(=O)CCC1=O)c2ccc(cc2)Cl,BRD-A20348246-001-15-8,chlormezanone,MicroSource,2300062,CHLORMEZANONE,-7.365206,x0072,-0.180584,active-noncovalent
CN1[C@H](S(=O)(=O)CCC1=O)c2ccc(cc2)Cl,BRD-A20348246-001-14-1,chlormezanone,Tocris,456,Chlormezanone,-7.365206,x0072,-0.180584,active-noncovalent
CN1[C@H](S(=O)(=O)CCC1=O)c2ccc(cc2)Cl,BRD-A20348246-001-13-3,chlormezanone,Selleck,S2021,Chlormezanone,-7.365206,x0072,-0.180584,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)[nH]c(n2)Br,BRD-M67659203-001-01-9,pamabrom,MicroSource,1505951,PAMABROM,-7.364717,x0678,-2.153057,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O,BRD-K28824103-001-04-4,genipin,Selleck,S2412,Genipin,-7.364646,x0161,0.264784,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O,BRD-K28824103-001-03-6,genipin,MedChemEx,HY-17389,Genipin,-7.364646,x0161,0.264784,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O,BRD-K28824103-001-02-8,genipin,Selleck,S2412,Genipin,-7.364646,x0161,0.264784,active-noncovalent
C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](Cn3cncn3)(c4ccc(cc4F)F)O,BRD-K03503561-001-01-4,ravuconazole,Cayman,18750,"4-{2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-1,3-thiazol-4-yl}benzonitrile",-7.363572,x0874,3.993403,active-noncovalent
CC[NH+](CC)CCOc1ccc-2c(c1)C(=O)c3c2ccc(c3)OCC[NH+](CC)CC,BRD-K34568562-001-04-3,tilorone,MicroSource,2300009,TILORONE,-7.363031,x0434,10.171506,active-noncovalent
Cc1c2c(n(n1)C)NCCN=C2c3cccc(c3)Cl,BRD-K14571191-001-01-6,zometapine,Sigma,PH000288,"4-(3-chlorophenyl)-1,3-dimethyl-1,6,7,8-tetrahydropyrazolo[3,4-e][1,4]diazepine",-7.361910,x1385,0.72685,active-covalent
CC(C)(c1cccc(n1)n2c3c(cnc(n3)Nc4ccc(cc4)N5CC[NH+](CC5)C)c(=O)n2CC=C)O,BRD-K54256913-001-08-7,MK-1775,Selleck,S1525,MK-1775,-7.361495,x0104,9.374803,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@H](CC[C@@H](C(=O)[O-])[NH3+])[NH3+])O)O)N,BRD-K91100918-001-03-8,sinefungin,Sigma,S8559,Sinefungin,-7.360650,x1093,1.820152,active-noncovalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-001-08-9,oxytetracycline,Selleck,S1773,Oxytetracycline (Terramycin),-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-001-11-3,oxytetracycline,MedChemEx,HY-B0275,Oxytetracycline,-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-335-06-5,oxytetracycline,Selleck,S2052,Oxytetracycline dihydrate,-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-003-06-9,oxytetracycline,MicroSource,1500457,OXYTETRACYCLINE,-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-001-10-5,oxytetracycline,Selleck,S2052,Oxytetracycline dihydrate,-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-002-07-9,oxytetracycline,Sigma,MFCD00151234,"(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-5,6,10,12a-tetrahydroxy-6-methyl-1,3,11,12-tetraoxo-1,2,3,4,4a,5,5a,6,11,11a,12,12a-dodecahydro-2-naphthacenecarboxamide hydrate",-7.360538,x0831,1.60487,active-covalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,BRD-A22740840-001-09-7,oxytetracycline,Selleck,S1773,Oxytetracycline (Terramycin),-7.360538,x0831,1.60487,active-covalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H](C(=C2F)CO)O)O,BRD-K66213167-001-01-2,RX-3117,MedChemEx,HY-15228,RX-3117,-7.358811,x0678,0.990404,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H](C(=C2F)CO)O)O,BRD-K66213167-001-02-0,RX-3117,MedChemEx,HY-15228,RX-3117,-7.358811,x0678,0.990404,active-noncovalent
C[C@@](CS(=O)(=O)c1ccc(cc1)F)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,BRD-A29485665-001-11-0,bicalutamide,Selleck,S1190,Bicalutamide,-7.358737,x0434,2.337765,active-noncovalent
C[C@@](CS(=O)(=O)c1ccc(cc1)F)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,BRD-A29485665-001-14-4,bicalutamide,Tocris,3389,Bicalutamide,-7.358737,x0434,2.337765,active-noncovalent
C[C@@](CS(=O)(=O)c1ccc(cc1)F)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,BRD-A29485665-001-12-8,bicalutamide,MicroSource,1504827,BICALUTAMIDE,-7.358737,x0434,2.337765,active-noncovalent
CC/[NH+]=C\1/N[C@@H]2[C@H]([C@@H]([C@H](O[C@@H]2S1)CO)O)O,BRD-K38380126-001-02-2,thiamet-g,Tocris,4390,Thiamet G,-7.357924,x0195,-0.81117,active-noncovalent
CC/[NH+]=C\1/N[C@@H]2[C@H]([C@@H]([C@H](O[C@@H]2S1)CO)O)O,BRD-K38380126-001-01-4,thiamet-g,Selleck,S7213,Thiamet G,-7.357924,x0195,-0.81117,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)O,BRD-K29173907-001-09-2,isoflupredone-acetate,Prestwick,Prestw-6,Isoflupredone acetate,-7.357622,x0967,3.226404,active-noncovalent
CCN1C[C@@H](n2c3c(c(c2C1=O)[O-])c(=O)n(nc3C(=O)NC)Cc4ccc(c(c4)Cl)F)C,BRD-K03128512-001-02-8,MK-2048,Selleck,S2765,MK-2048,-7.356881,x0161,6.791452,active-noncovalent
CCN1C[C@@H](n2c3c(c(c2C1=O)[O-])c(=O)n(nc3C(=O)NC)Cc4ccc(c(c4)Cl)F)C,BRD-K03128512-001-03-6,MK-2048,Selleck,S2765,MK-2048,-7.356881,x0161,6.791452,active-noncovalent
CCN(c1ccccc1)C(=O)c2c(c3c(cccc3Cl)n(c2=O)C)[O-],BRD-K60918217-001-03-8,laquinimod,Selleck,S2787,Laquinimod (ABR-215062),-7.356830,x0161,1.216524,active-noncovalent
CCN(c1ccccc1)C(=O)c2c(c3c(cccc3Cl)n(c2=O)C)[O-],BRD-K60918217-001-02-0,laquinimod,Selleck,S2787,Laquinimod,-7.356830,x0161,1.216524,active-noncovalent
CSC[C@@H]1CN(C(=O)O1)/N=C/c2ccc(o2)N(=O)=O,BRD-A71407503-001-02-6,inimur,MedChemEx,HY-A0059,Nifuratel,-7.356424,x0749,0.269778,active-covalent
CSC[C@@H]1CN(C(=O)O1)/N=C/c2ccc(o2)N(=O)=O,BRD-A71407503-001-01-8,inimur,MedChemEx,HY-A0059,Nifuratel,-7.356424,x0749,0.269778,active-covalent
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],BRD-K54529596-001-25-5,captopril,MicroSource,1500682,CAPTOPRIL,-7.356261,x0397,-0.52103,active-noncovalent
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],BRD-K54529596-001-28-9,captopril,Selleck,S2051,Captopril,-7.356261,x0397,-0.52103,active-noncovalent
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],BRD-K54529596-001-26-3,captopril,Selleck,S2051,Captopril (Capoten),-7.356261,x0397,-0.52103,active-noncovalent
c1cc(ccc1N)S(=O)(=O)[N-]C(=O)N,BRD-K13486660-001-01-0,sulfacarbamide,MicroSource,1506107,SULFACARBAMIDE,-7.356099,x0395,-0.73005,active-noncovalent
[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O,BRD-K36474365-001-06-6,tartaric-acid,MicroSource,1300044,TARTARIC ACID (L),-7.354960,x0397,0.411672,active-noncovalent
CC(=O)O[C@@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,BRD-K24023109-003-26-0,diltiazem,Tocris,685,Diltiazem hydrochloride,-7.354584,x0874,3.357933,active-noncovalent
CC(=O)O[C@@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,BRD-K24023109-003-25-2,diltiazem,Selleck,S1865,Diltiazem HCl,-7.354584,x0874,3.357933,active-noncovalent
CC(=O)O[C@@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,BRD-K24023109-003-28-6,diltiazem,Tocris,685,Diltiazem hydrochloride,-7.354584,x0874,3.357933,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c4c2[C@H]5[C@@]67CC[N@@H+]([C@@H]([C@@]6(C4)O)Cc8c7c(c(cc8)O)O5)CC9CC9,BRD-A33514596-003-01-2,N-benzylnaltrindole,Tocris,754,N-Benzylnaltrindole hydrochloride,-7.354385,x0434,4.262975,active-noncovalent
CC[NH2+][C@]1(CCCCC1=O)c2cccs2,BRD-A30582499-003-05-1,tiletamine,MicroSource,1503879,TILETAMINE HYDROCHLORIDE,-7.354254,x0195,-0.552156,active-noncovalent
Cc1cc(nc(n1)n2c(cc(n2)C)OC)OC,BRD-K39339537-001-21-0,epirizole,Prestwick,Prestw-32,Epirizole,-7.353932,x0434,0.269679,active-noncovalent
C[C@H]1Cc2cc3c(c(c2-c4c(cc(c(c4OC)OC)OC)C[C@@H]1C)OC)OCO3,BRD-K86294588-001-01-9,schisandrin-b,Selleck,S3600,Schisandrin B (Sch B),-7.353252,x0195,4.96182,active-noncovalent
C[C@]1([C@@H]([C@H](O[C@H]1n2cnc3c2nc([nH]c3=O)N)CO)O)O,BRD-K78092779-001-01-6,2'-c-methylguanosine,Sigma,MFCD13194756,"(2R,3R,4R,5R)-2-(2-amino-6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol",-7.353133,x0874,0.890805,active-noncovalent
C[NH+]1CCN(CC1)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)N(C)C)Cl,BRD-K84034737-001-01-1,TP-0903,MedChemEx,HY-12963,TP-0903,-7.350684,x0161,10.48704,active-noncovalent
C[NH2+][C@H]1C[C@H]([C@@H]([C@H]([C@@H]1O)O[C@H]2[C@H]([C@@H]3[C@H]([C@H](O2)CO)O[C@]4(O3)[C@@H]([C@H]([C@H]([C@H](O4)[C@@H](CO)[NH3+])O)O)O)O)O)[NH3+],BRD-A67101513-001-03-7,hygromycin-b,Selleck,S2908,Hygromycin B,-7.349528,x1093,4.965153,active-noncovalent
CCN(CC)C(=S)SSC(=S)N(CC)CC,BRD-K32744045-001-30-4,disulfiram,Selleck,S1680,Disulfiram,-7.349272,x0195,0.066822,active-noncovalent
CCN(CC)C(=S)SSC(=S)N(CC)CC,BRD-K32744045-001-31-2,disulfiram,MicroSource,1500262,DISULFIRAM,-7.349272,x0195,0.066822,active-noncovalent
CCN(CC)C(=S)SSC(=S)N(CC)CC,BRD-K32744045-001-34-6,disulfiram,Selleck,S1680,disulfiram,-7.349272,x0195,0.066822,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-20-2,topotecan,Selleck,S1231,Topotecan HCl,-7.348374,x0678,6.730656,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-24-4,topotecan,MedChemEx,HY-13768A,Topotecan (Hydrochloride),-7.348374,x0678,6.730656,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-21-0,topotecan,MicroSource,1505820,TOPOTECAN HYDROCHLORIDE,-7.348374,x0678,6.730656,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-23-6,topotecan,Key,KS-1410,"(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride",-7.348374,x0678,6.730656,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-22-8,topotecan,Selleck,S1231,Topotecan HCl,-7.348374,x0678,6.730656,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,BRD-K55696337-003-25-1,topotecan,MedChemEx,HY-13768A,Topotecan (Hydrochloride),-7.348374,x0678,6.730656,active-noncovalent
CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2,BRD-A08187463-001-12-9,racecadotril,MicroSource,1502331,RACECADOTRIL,-7.347688,x0946,3.161538,active-noncovalent
CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2,BRD-A08187463-001-11-1,racecadotril,Selleck,S2503,Racecadotril,-7.347688,x0946,3.161538,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,BRD-A08430411-001-01-9,ginkgolide-b,Tocris,1657,Ginkgolide B,-7.347661,x0946,2.692613,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)[O-],BRD-K96137854-001-18-9,enoxolone,MicroSource,1500990,ENOXOLONE,-7.343379,x0104,5.651156,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)[O-],BRD-K96137854-001-17-1,enoxolone,Selleck,S2296,Enoxolone,-7.343379,x0104,5.651156,active-noncovalent
CCCCOc1cc(ccc1OC)C[C@H]2CNC(=O)N2,BRD-A07207424-001-14-0,Ro-20-1724,Tocris,415,Ro 20-1724,-7.343188,x0678,-0.145818,active-noncovalent
CCCCOc1cc(ccc1OC)C[C@H]2CNC(=O)N2,BRD-A07207424-001-13-2,Ro-20-1724,Tocris,415,Ro 20-1724,-7.343188,x0678,-0.145818,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2,BRD-A36978621-001-01-9,tetrahydrofolic-acid,Sigma,MFCD00135583,"(2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl)methyl]amino}benzoyl)amino]pentanedioic acid",-7.342076,x0104,11.585022,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)[NH3+],BRD-A03826781-065-03-6,ribostamycin-sulfate,MicroSource,1503939,RIBOSTAMYCIN SULFATE,-7.340278,x0195,3.25213,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O)O,BRD-K35952844-238-02-0,calcium-gluceptate,MicroSource,1300012,CALCIUM GLUCEPTATE,-7.338240,x0397,-0.292078,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O)O,BRD-K35952844-236-01-6,sodium-glucoheptonate,TCI,G0214,,-7.338240,x0397,-0.292078,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O)O,BRD-K35952844-238-01-2,calcium-gluceptate,Selleck,S4311,Calcium Gluceptate,-7.338240,x0397,-0.292078,active-noncovalent
CCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,BRD-K86410485-046-01-0,eliglustat,MedChemEx,HY-14885A,Eliglustat (hemitartrate),-7.336362,x0161,5.404441,active-noncovalent
CCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,BRD-K86410485-001-01-5,eliglustat,MedChemEx,HY-14885,Eliglustat,-7.336362,x0161,5.404441,active-noncovalent
C[C@]1(C(=O)C=C(O1)C(=O)[O-])c2ccccc2,BRD-A29520968-001-03-5,acifran,Tocris,1762,Acifran,-7.335707,x0072,-0.270744,active-noncovalent
C[C@]1(C(=O)C=C(O1)C(=O)[O-])c2ccccc2,BRD-A29520968-001-02-7,acifran,Tocris,1762,Acifran,-7.335707,x0072,-0.270744,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCOCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)I,BRD-K59419204-001-02-7,AM-281,Tocris,1115,AM 281,-7.334095,x0161,4.338239,active-noncovalent
C[N+](C)(C)C[C@@H](CC(=O)[O-])O,BRD-K59647213-001-10-5,levocarnitine,MicroSource,1505437,LEVOCARNITINE,-7.333771,x0830,-0.876813,active-covalent
C[N+](C)(C)C[C@@H](CC(=O)[O-])O,BRD-K59647213-001-09-7,levocarnitine,Selleck,S2388,L-carnitine,-7.333771,x0830,-0.876813,active-covalent
[H]/N=C(/NCCC[C@@H](C(=O)[O-])[NH3+])\NN(=O)=O,BRD-K89223384-001-05-2,NG-nitro-arginine,Sigma,72750,(2S)-2-amino-5-{[imino(2-oxido-2-oxohydrazino)methyl]amino}pentanoic acid,-7.333673,x0678,0.257637,active-noncovalent
[H]/N=C(/NCCC[C@@H](C(=O)[O-])[NH3+])\NN(=O)=O,BRD-K89223384-001-04-5,NG-nitro-arginine,ChemDiv,Y041-4623,,-7.333673,x0678,0.257637,active-noncovalent
Cc1c(c(=O)n(c(=O)n1Cc2c(cccc2F)C(F)(F)F)C[C@@H](c3ccccc3)[NH2+]CCCC(=O)[O-])c4cccc(c4F)OC,BRD-K55808645-001-01-4,elagolix,MedChemEx,HY-14789,Elagolix,-7.333425,x0072,9.584294,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C/C=C(\CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)O2)O)(C)C)C)O)C)/C,BRD-K52762805-001-01-2,epothilone-d,MedChemEx,HY-15278,Epothilone D,-7.333379,x1077,7.434181,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCC[N@H+](C2)Cc3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,BRD-K97181463-003-02-9,benidipine,Selleck,S2017,Benidipine hydrochloride,-7.331946,x0161,7.230065,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCC[N@H+](C2)Cc3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,BRD-K97181463-003-01-1,benidipine,Selleck,S2017,Benidipine HCl,-7.331946,x0161,7.230065,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)OC)OC)OC)OC,BRD-K00259736-001-18-0,colchicine,Tocris,1364,Colchicine,-7.331703,x0874,4.886572,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)OC)OC)OC)OC,BRD-K00259736-001-16-4,colchicine,MicroSource,1500205,COLCHICINE,-7.331703,x0874,4.886572,active-noncovalent
C1[C@H]([C@H]([C@H]([C@@H]([N@H+]1CCO)CO)O)O)O,BRD-A63310107-001-04-8,miglitol,MicroSource,1504273,MIGLITOL,-7.331421,x0946,1.745795,active-noncovalent
Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@]2C)O,BRD-A84174393-001-34-3,meloxicam,Selleck,S1734,Meloxicam,-7.331417,x0195,0.732254,active-noncovalent
Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@]2C)O,BRD-A84174393-236-07-1,meloxicam,MicroSource,1504150,MELOXICAM SODIUM,-7.331417,x0195,0.732254,active-noncovalent
Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@]2C)O,BRD-A84174393-323-07-7,meloxicam,Sigma,MFCD11046047,"sodium 2-methyl-3-{[(5-methyl-1,3-thiazol-2-yl)amino]carbonyl}-2H-1,2-benzothiazin-4-olate 1,1-dioxide hydrate",-7.331417,x0195,0.732254,active-noncovalent
c1ccc(c(c1)C(=O)[O-])[S-],BRD-K36998189-001-03-5,o-mercapto-benzoic-acid,Enamine,Z1270312072,"6-thioxo-1,3-cyclohexadiene-1-carboxylic acid",-7.330590,x0195,-1.309285,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)COP(=O)([O-])[O-],BRD-K50712474-002-02-5,MC-1,Sigma,MFCD00149414,(4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl dihydrogen phosphate hydrate,-7.330033,x0397,-1.138488,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)COP(=O)([O-])[O-],BRD-K50712474-001-02-7,MC-1,Vitas-M,STL185213,,-7.330033,x0397,-1.138488,active-noncovalent
CC1=CC[C@@H](CC1)C(=C)C,BRD-K20879694-001-02-5,D-limonene,MicroSource,307080,d-LIMONENE,-7.329607,x0678,0.007376,active-noncovalent
CC1=CC[C@@H](CC1)C(=C)C,BRD-K20879694-001-01-7,D-limonene,Sigma,MFCD00062991,(4R)-4-isopropenyl-1-methyl-1-cyclohexene,-7.329607,x0678,0.007376,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC(=O)Nc3ccc(nn3)c4ccccc4,BRD-K54264768-001-01-2,ETC-159,MedChemEx,HY-18988,ETC-159,-7.329115,x0104,3.362389,active-noncovalent
Cc1cc(cc(c1Oc2c(c(nc(n2)Nc3ccc(cc3)C#N)N)Br)C)C#N,BRD-K74717603-001-02-2,etravirine,Selleck,S3080,Etravirine (TMC125),-7.328958,x0195,2.556853,active-noncovalent
Cc1cc(c2cc(cc(c2n1)F)F)NC(=O)Nc3ccc(cc3)N(C)C,BRD-K53913732-001-05-9,SB-408124,Tocris,1963,SB 408124,-7.324407,x0967,3.002191,active-noncovalent
Cc1cc(c2cc(cc(c2n1)F)F)NC(=O)Nc3ccc(cc3)N(C)C,BRD-K53913732-001-07-5,SB-408124,Tocris,1963,SB 408124,-7.324407,x0967,3.002191,active-noncovalent
Cc1cc(c2cc(cc(c2n1)F)F)NC(=O)Nc3ccc(cc3)N(C)C,BRD-K53913732-001-06-7,SB-408124,Selleck,S1545,SB-408124,-7.324407,x0967,3.002191,active-noncovalent
Cc1cc(c2cc(cc(c2n1)F)F)NC(=O)Nc3ccc(cc3)N(C)C,BRD-K53913732-001-04-2,SB-408124,Selleck,S1545,SB408124,-7.324407,x0967,3.002191,active-noncovalent
c1ccc2c(c1)COC23CC[NH+](CC3)CCCCc4cn(c5c4cccc5)c6ccc(cc6)F,BRD-K51333959-003-01-3,siramesine,MedChemEx,HY-14221A,Siramesine (hydrochloride),-7.323810,x0161,6.740878,active-noncovalent
Cc1cn2c(c(cc(c2[nH+]1)C(=O)NCC3CC[NH+](CC3)CC(C)C)Cl)N,BRD-K21306330-001-01-0,CJ-033466,Tocris,3089,CJ 033466,-7.322286,x0967,2.790133,active-noncovalent
C1C[N@@](C[C@H]([NH2+]1)C(=O)[O-])CCCP(=O)([O-])[O-],BRD-A60832661-001-01-8,CPP,AMS,A001591521,4-(3-phosphonopropyl)-2-piperazinecarboxylic acid,-7.321845,x0759,-0.518677,active-covalent
CC(=O)CCc1ccc(c(c1)OC)O,BRD-K33510429-001-02-3,vanillylacetone,Selleck,S2371,Vanillylacetone,-7.321841,x0161,-1.091357,active-noncovalent
CC(=O)CCc1ccc(c(c1)OC)O,BRD-K33510429-001-03-1,vanillylacetone,Selleck,S2371,Vanillylacetone,-7.321841,x0161,-1.091357,active-noncovalent
C[C@H](C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)[O-])Oc3ccccc3,BRD-A66025870-237-06-9,phenethicillin,Prestwick,Prestw-723,Phenethicillin potassium salt,-7.321492,x0072,2.194026,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)OCOC(=O)C(C)(C)C)C,BRD-A63431791-001-01-9,sulbactam-pivoxil,AvaChem,3125,"(pivaloyloxy)methyl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide",-7.319220,x0749,2.382709,active-covalent
CC(C)CCNc1c(cccn1)C(=O)N2CC[NH+](CC2)Cc3ccccc3,BRD-K74371986-001-01-7,NSI-189,MedChemEx,HY-13999,NSI-189,-7.319119,x0874,3.690094,active-noncovalent
CC(=O)c1ccc(c(c1)OC)O,BRD-K64990520-001-08-4,apocynin,Selleck,S2425,Apocynin,-7.318929,x0195,1.124141,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(cc3F)Cl,BRD-K41337261-003-02-8,ZM-306416,Tocris,2499,ZM 306416 hydrochloride,-7.318065,x0195,0.858332,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(cc3F)Cl,BRD-K41337261-001-03-0,ZM-306416,Selleck,S2897,ZM 306416,-7.318065,x0195,0.858332,active-noncovalent
COC[C@H](Cn1ccnc1N(=O)=O)O,BRD-A16263897-001-06-6,misonidazole,Cayman,15606,1-methoxy-3-(2-nitro-1H-imidazol-1-yl)-2-propanol,-7.317417,x0195,-0.675832,active-noncovalent
CCn1c2ccccc2n(c1=O)C3=C(C[N@@H+](CC3)CC4CCCCCCC4)CO,BRD-K69837166-003-02-0,trap-101,Tocris,2508,Trap 101,-7.315215,x0161,4.660111,active-noncovalent
CCn1c2ccccc2n(c1=O)C3=C(C[N@@H+](CC3)CC4CCCCCCC4)CO,BRD-K69837166-003-03-8,trap-101,Tocris,2508,Trap 101,-7.315215,x0161,4.660111,active-noncovalent
Cc1ccc(c(=O)n1c2ccc(cc2)F)C(=O)Nc3ccc(c(c3)F)Oc4cc5cnn(c5cc4c6c[nH]nc6)C,BRD-K18961567-001-01-1,LY2801653,MedChemEx,HY-15514,LY2801653,-7.314072,x0104,15.204038,active-noncovalent
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)OCC[NH+]4CCCC4,BRD-K12502280-001-08-0,TG-101348,Selleck,S2736,TG101348 (SAR302503),-7.313903,x0874,7.375597,active-noncovalent
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)OCC[NH+]4CCCC4,BRD-K12502280-001-11-4,TG-101348,Selleck,S2736,"Fedratinib (SAR302503, TG101348)",-7.313903,x0874,7.375597,active-noncovalent
CCN(CC)c1cc(nc2n1ncn2)C,BRD-K95763993-001-19-3,trapidil,Prestwick,Prestw-1012,Trapidil,-7.313612,x0195,-0.349126,active-noncovalent
Cc1cc(c(c(c1)C)NS(=O)(=O)c2ccc(cc2)OC)C,BRD-K26514105-001-01-7,GSK-37647,Tocris,5257,GSK 137647,-7.313596,x0749,0.123737,active-covalent
COc1ccc(cc1N2CC[NH2+]CC2)S(=O)(=O)Nc3cc(cc(c3OC)Cl)Cl,BRD-K03988082-001-01-7,SB-399885,Tocris,3189,SB 399885 hydrochloride,-7.311103,x0678,3.965573,active-noncovalent
c1nc(nn1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,BRD-K60369935-001-17-5,ribavirin,Tocris,4501,Ribavirin,-7.309648,x0708,0.522702,active-covalent
c1nc(nn1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,BRD-K60369935-001-15-9,ribavirin,MicroSource,1503938,RIBAVIRIN,-7.309648,x0708,0.522702,active-covalent
c1nc(nn1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,BRD-K60369935-001-18-3,ribavirin,Selleck,S2504,Ribavirin,-7.309648,x0708,0.522702,active-covalent
C([C@@H](C(=O)[O-])[NH3+])SSC[C@@H](C(=O)[O-])[NH3+],BRD-K99679910-001-02-3,L-Cystine,Sigma,30199,"(2R,2'R)-3,3'-disulfanediylbis(2-aminopropanoic acid)",-7.309270,x1418,-1.604699,active-covalent
CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)[O-])O)C(=O)[O-],BRD-K63177377-001-01-8,ETC-1002,MedChemEx,HY-12357,ETC-1002,-7.309196,x0874,3.349734,active-noncovalent
c1cc2c(c(c1)N)c(=O)[nH][nH]c2=O,BRD-K52559566-001-02-9,monosodium-alpha-luminol,MedChemEx,HY-15922,Luminol,-7.308018,x0195,-0.111482,active-noncovalent
c1cc2c(c(c1)N)c(=O)[nH][nH]c2=O,BRD-K52559566-001-01-1,monosodium-alpha-luminol,Enamine,Z56813244,,-7.308018,x0195,-0.111482,active-noncovalent
CC(C)[N+](C)(CCC(c1ccccc1)(c2ccccc2)C(=O)N)C(C)C,BRD-K14127446-005-22-7,isopropamide-iodide,MicroSource,1500356,ISOPROPAMIDE IODIDE,-7.307547,x0195,1.934325,active-noncovalent
C1[C@@H]2CC3(C[C@@H](C2=O)CC1C3)O,BRD-A57877027-001-01-7,idramantone,MicroSource,1506164,IDRAMANTONE,-7.306119,x0354,2.839947,active-noncovalent
C1CCC(CC1)NS(=O)(=O)[O-],BRD-K50785021-001-03-9,cyclamic-acid,MicroSource,1301015,CYCLAMIC ACID,-7.305093,x0678,-0.061369,active-noncovalent
C1CCC(CC1)NS(=O)(=O)[O-],BRD-K50785021-001-02-1,cyclamic-acid,Selleck,S4015,Cyclamic  acid,-7.305093,x0678,-0.061369,active-noncovalent
C1CCC(CC1)NS(=O)(=O)[O-],BRD-K50785021-001-04-7,cyclamic-acid,MicroSource,1502367,SODIUM CYCLAMATE,-7.305093,x0678,-0.061369,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3cccc(c3Cl)Cl)OC)CC[NH+]4CCOCC4,BRD-K10705233-001-02-2,GW-405833,Tocris,2374,GW 405833,-7.304730,x0195,5.053479,active-noncovalent
CCc1cccc(c1NC(=O)N2Cc3c([nH]nc3NC(=O)c4ccc(cc4)N5CC[NH+](CC5)C)C2)CC,BRD-K09443272-001-03-3,PHA-680632,Selleck,S1454,PHA-680632,-7.304335,x0104,16.863283,active-noncovalent
Cc1ccc(nc1c2cccc(c2)C(=O)[O-])NC(=O)C3(CC3)c4ccc5c(c4)OC(O5)(F)F,BRD-K69236721-001-02-7,lumacaftor,Selleck,S1565,VX-809 (Lumacaftor),-7.303419,x0104,11.059223,active-noncovalent
c1c(ccc(c1)N2C(=O)c3c(ncnc3N)OCC2)[C@H]4CC[C@@H](CC4)CC(=O)[O-],BRD-K30550578-001-01-3,PF-04620110,MedChemEx,HY-13009,PF-04620110,-7.302903,x1077,7.7715,active-noncovalent
CCn1cnc(c1C(=O)NC)C(=O)NC,BRD-K19672466-001-02-3,ethimizol,MedChemEx,HY-13918,Etimizol,-7.301723,x0195,-0.091048,active-noncovalent
CCCN(CC1CC1)c2c(c(nc(n2)C)Nc3c(cc(cc3Cl)Cl)Cl)Cl,BRD-K61177364-003-02-9,NBI-27914,Tocris,1591,NBI 27914 hydrochloride,-7.301192,x0874,2.732496,active-noncovalent
CCCN(CC1CC1)c2c(c(nc(n2)C)Nc3c(cc(cc3Cl)Cl)Cl)Cl,BRD-K61177364-003-03-7,NBI-27914,Tocris,1591,NBI 27914 hydrochloride,-7.301192,x0874,2.732496,active-noncovalent
CO[P@](=O)(CC[C@H](C(=O)[O-])[NH3+])Oc1cccc(c1)CC(=O)[O-],BRD-A25625670-001-01-9,GGsTop,Tocris,4452,GGsTop,-7.300609,x0830,2.297394,active-covalent
C(CCCC(=O)NCCO)CCCC(=O)NCCO,BRD-K78097265-001-01-6,adelmidrol,MicroSource,1301013,ADELMIDROL,-7.298946,x0946,0.661907,active-noncovalent
c1ccc2c(c1)C(=O)NS2(=O)=O,BRD-K46493214-001-06-7,saccharin,MicroSource,1501171,SACCHARIN,-7.298658,x0678,1.041963,active-noncovalent
CC1(c2ccc(cc2C(=O)N(C1=O)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4)OC)C,BRD-K80396088-001-12-0,gliquidone,Selleck,S3151,Gliquidone,-7.298075,x0161,8.161846,active-noncovalent
COC[C@@]1(C(=O)C2CC[NH+]1CC2)CO,BRD-A09004963-001-01-3,APR-246,Adooq,A13636,2-(hydroxymethyl)-2-(methoxymethyl)quinuclidin-3-one,-7.297840,x0354,2.456188,active-noncovalent
CC[C@@H](C)SSc1[nH]ccn1,BRD-A56592690-001-04-3,PX-12,MedChemEx,HY-13734,PX-12,-7.296520,x1093,-1.530191,active-noncovalent
c1ccc2c(c1)C(=O)c3ccccc3C2(Cc4ccnc(c4)F)Cc5ccnc(c5)F,BRD-K89274813-001-02-3,DMP-543,Tocris,2330,DMP 543,-7.296119,x1077,4.262038,active-noncovalent
c1ccc2c(c1)C(=O)c3ccccc3C2(Cc4ccnc(c4)F)Cc5ccnc(c5)F,BRD-K89274813-001-03-1,DMP-543,Tocris,2330,DMP 543,-7.296119,x1077,4.262038,active-noncovalent
CC(C)Nc1nc2cc(c(cc2n1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl,BRD-K59524082-001-01-3,maribavir,MedChemEx,HY-16305,Maribavir,-7.295496,x0749,1.876386,active-covalent
C[C@@H]1COCC[N@@]1c2cc(nc(n2)c3ccnc4c3cc[nH]4)C5(CC5)[S@@](=N)(=O)C,BRD-A36013532-001-01-3,AZD6738,Selleck,S7693,AZD6738,-7.294543,x1412,4.45619,active-covalent
CCOc1cc(ccc1OC)[C@@H](CS(=O)(=O)C)N2C(=O)c3cccc(c3C2=O)NC(=O)C,BRD-K93208532-001-02-5,apremilast,Selleck,S8034,Apremilast (CC-10004),-7.293816,x0874,3.787838,active-noncovalent
CC(C)Nc1ncccn1,BRD-K95957366-001-02-6,isaxonine,MicroSource,1504617,ISAXONINE,-7.293537,x1093,-1.466703,active-noncovalent
c1cc2c(cc1NC(=O)NCC(=O)N3CCCCC3)snn2,BRD-K60635008-001-01-5,UNC-2327,Tocris,5057,UNC 2327,-7.293296,x0434,1.462844,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,BRD-K97799481-001-16-0,theophylline,MicroSource,1500568,THEOPHYLLINE,-7.292322,x0678,-2.135367,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,BRD-K97799481-230-01-7,aminophylline,Selleck,S1673,Aminophylline,-7.292322,x0678,-2.135367,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,BRD-K97799481-205-02-7,aminophylline,Key,KS-1426,"2-hydroxy-N,N,N-trimethylethanaminium 1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide",-7.292322,x0678,-2.135367,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,BRD-K97799481-205-01-9,oxtriphylline,MicroSource,1505759,OXTRIPHYLLINE,-7.292322,x0678,-2.135367,active-noncovalent
Cc1cccc(c1)Oc2c(c(=O)n3cccc(c3n2)C)/C=C(\C#N)/c4nc5ccccc5s4,BRD-K26970495-001-01-9,CCG-63802,MedChemEx,HY-70074,CCG-63802,-7.292311,x0161,6.144271,active-noncovalent
Cc1cccc(c1)Oc2c(c(=O)n3cccc(c3n2)C)/C=C(\C#N)/c4nc5ccccc5s4,BRD-K26970495-001-02-7,CCG-63802,MedChemEx,HY-70074,CCG-63802,-7.292311,x0161,6.144271,active-noncovalent
c1cc(ccc1C(=O)NCCC(=O)[O-])/N=N/c2ccc(c(c2)C(=O)[O-])O,BRD-K41410256-304-02-2,balsalazide,MicroSource,1502414,BALSALAZIDE DISODIUM,-7.292026,x0874,4.639498,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-300-07-1,histamine,Tocris,3545,Histamine dihydrochloride,-7.291480,x0397,-2.017792,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-001-19-0,histamine,Selleck,S4117,Histamine Phosphate,-7.291480,x0397,-2.017792,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-300-10-5,histamine,Tocris,3545,Histamine dihydrochloride,-7.291480,x0397,-2.017792,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-300-06-3,histamine,Selleck,S4118,Histamine 2HCl,-7.291480,x0397,-2.017792,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-316-01-0,histamine,Selleck,S4117,Histamine Phosphate,-7.291480,x0397,-2.017792,active-noncovalent
c1c([nH]cn1)CC[NH3+],BRD-K01674964-300-08-9,histamine,MicroSource,1500331,HISTAMINE DIHYDROCHLORIDE,-7.291480,x0397,-2.017792,active-noncovalent
C[C@@H](CCCC(C)(C)O)[NH3+],BRD-A32988684-003-08-7,heptaminol,MicroSource,1503218,HEPTAMINOL HYDROCHLORIDE,-7.290907,x0195,-0.08389,active-noncovalent
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)[NH+]5CCOCC5)C)C)[N+]6(CCCC6)CC=C,BRD-K43305603-004-02-8,rocuronium,Selleck,S1397,Rocuronium Bromide,-7.289984,x0104,10.160816,active-noncovalent
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)[NH+]5CCOCC5)C)C)[N+]6(CCCC6)CC=C,BRD-K43305603-004-03-6,rocuronium,MicroSource,1503846,ROCURONIUM BROMIDE,-7.289984,x0104,10.160816,active-noncovalent
CCn1c2c(cc(c1=O)c3ccc(cc3Cl)Cl)cnc(n2)Nc4ccc(c(c4)F)N5CC[NH2+]CC5,BRD-K57243773-001-02-4,FRAX486,Tocris,5190,FRAX 486,-7.289445,x0104,13.490346,active-noncovalent
CCn1c2c(cc(c1=O)c3ccc(cc3Cl)Cl)cnc(n2)Nc4ccc(c(c4)F)N5CC[NH2+]CC5,BRD-K57243773-001-01-6,FRAX486,MedChemEx,HY-15542B,FRAX486,-7.289445,x0104,13.490346,active-noncovalent
C1CS(=O)(=O)NC[N@@]1C[N@]2CCS(=O)(=O)NC2,BRD-K98765504-001-01-5,taurolidine,Sigma,T7329,"4-[(1,1-dioxido-1,2,4-thiadiazinan-4-yl)methyl]-1,2,4-thiadiazinane 1,1-dioxide",-7.289390,x1077,0.547316,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)n2cc(cc2C)C)C,BRD-K34411045-001-01-9,HJC-0350,Tocris,4844,HJC 0350,-7.288846,x1311,-0.127421,active-covalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,BRD-K60025295-003-05-8,crystal-violet,Selleck,S1917,Crystal Violet,-7.288476,x0072,4.048831,active-noncovalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,BRD-K60025295-003-07-4,crystal-violet,Selleck,S1917,Crystal violet,-7.288476,x0072,4.048831,active-noncovalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,BRD-K60025295-003-06-6,crystal-violet,MicroSource,1500315,GENTIAN VIOLET,-7.288476,x0072,4.048831,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)[O-],BRD-K20545304-001-01-6,bardoxolone,MedChemEx,HY-14909,Bardoxolone,-7.287426,x0072,6.542771,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,BRD-K15976406-001-03-3,telbivudine,Selleck,S1651,Telbivudine,-7.287242,x1077,-0.189432,active-noncovalent
Cc1c(cc(cc1N(=O)=O)N(=O)=O)C(=O)N,BRD-K93240442-001-08-4,dinitolmide,MicroSource,1503036,DINITOLMIDE,-7.283859,x0195,2.822728,active-noncovalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccccc3,BRD-K07691486-001-15-5,roscovitine,Selleck,S1153,"Roscovitine (Seliciclib,CYC202)",-7.283674,x0195,1.934532,active-noncovalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccccc3,BRD-K07691486-001-19-7,roscovitine,Selleck,S1153,seliciclib,-7.283674,x0195,1.934532,active-noncovalent
c12c([nH]c(=O)[nH]1)[nH]c(=O)[nH]c2=O,BRD-K01295354-001-02-8,uric-acid,Enamine,Z104473370,,-7.283333,x0678,-0.831158,active-noncovalent
c1ccc-2c(c1)CCCc3c2nnc(c3)NCC[NH+]4CCOCC4,BRD-K19309090-300-05-5,SR-95639A,Prestwick,Prestw-406,"Morpholinoethylamino-3-benzocyclohepta-(5,6-c)-pyridazine dihydrochloride",-7.282874,x1077,2.478735,active-noncovalent
c1cc(ccc1[C@H](CCO)NC(=O)C2(CCN(CC2)c3c4cc[nH]c4ncn3)[NH3+])Cl,BRD-K99023089-001-03-7,AZD5363,Selleck,S8019,AZD5363,-7.282774,x0678,3.469905,active-noncovalent
CCCCC#Cc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC,BRD-K34672903-001-02-5,HEMADO,Tocris,1579,HEMADO,-7.281894,x0161,3.641852,active-noncovalent
CCCCC#Cc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC,BRD-K34672903-001-01-7,HEMADO,Tocris,1579,HEMADO,-7.281894,x0161,3.641852,active-noncovalent
CC[N+](C)(CC)CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,BRD-A14208071-004-19-8,oxyphenonium,MicroSource,1505783,OXYPHENONIUM BROMIDE,-7.281858,x0195,1.615906,active-noncovalent
CC1(CCC(c2c1cc(c(c2Cl)O)C(=O)Nc3cc(c(c(c3)F)C(=O)[O-])F)(C)C)C,BRD-K32533226-001-01-3,AGN-195183,MedChemEx,HY-16684,AGN 195183,-7.281340,x0104,6.680884,active-noncovalent
CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C,BRD-K85119730-001-27-1,tolbutamide,Selleck,S2443,Tolbutamide,-7.279900,x0434,-0.660936,active-noncovalent
CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C,BRD-K85119730-001-28-9,tolbutamide,MicroSource,1500581,TOLBUTAMIDE,-7.279900,x0434,-0.660936,active-noncovalent
C[NH+]1CCN(CC1)C(=O)C[NH2+][C@@H]2C[C@H]2c3ccc(cc3)OCc4ccccc4,BRD-K41415459-300-01-6,RN-1,Tocris,4977,RN 1 dihydrochloride,-7.279611,x0104,5.123285,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)O,BRD-M08959712-001-01-9,tyloxapol,MedChemEx,HY-B1068,Tyloxapol,-7.277876,x0195,-0.62146,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)O,BRD-M08959712-001-02-7,tyloxapol,MedChemEx,HY-B1068,Tyloxapol,-7.277876,x0195,-0.62146,active-noncovalent
C/C=C/c1cc(c(cc1OC)OC)OC,BRD-K72536715-001-01-5,alpha-Asarone,Cayman,11681,alpha-Asarone,-7.277765,x0195,0.384876,active-noncovalent
c1cncnc1C#N,BRD-K04552268-001-02-4,4-pyrimidinecarbonitrile,Enamine,Z1116387809,4-pyrimidinecarbonitrile,-7.277214,x0540,-0.857503,active-noncovalent
c1c(nc(c(=O)[nH]1)C(=O)N)F,BRD-K04264130-001-01-4,favipiravir,AdvChemBlocks,F-4501,6-fluoro-3-hydroxypyrazine-2-carboxamide,-7.276232,x0397,-2.089181,active-noncovalent
c1nc(c2c(n1)n(cn2)CCOCP(=O)([O-])[O-])N,BRD-K77484724-001-02-0,adefovir,AKSci,H714,,-7.275754,x0072,0.608602,active-noncovalent
c1nc(c2c(n1)n(cn2)CCOCP(=O)([O-])[O-])N,BRD-K77484724-001-03-8,adefovir,Sigma,MFCD00866943,[2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid,-7.275754,x0072,0.608602,active-noncovalent
CCn1cc(c(=O)c2c1nc(nc2)N3CCCC3)C(=O)[O-],BRD-K37682401-213-01-1,piromidic-acid,MicroSource,1502045,PIROMIDIC ACID,-7.275673,x0749,2.582258,active-covalent
CCn1cc(c(=O)c2c1nc(nc2)N3CCCC3)C(=O)[O-],BRD-K37682401-001-08-5,piromidic-acid,Selleck,S4348,Piromidic Acid,-7.275673,x0749,2.582258,active-covalent
CCn1cc(c(=O)c2c1nc(nc2)N3CCCC3)C(=O)[O-],BRD-K37682401-001-09-3,piromidic-acid,Selleck,S4348,piromidic acid,-7.275673,x0749,2.582258,active-covalent
CCNC(=O)N(CCC[NH+](C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@@H+](C1)CC=C,BRD-K86882815-001-03-2,cabergoline,Enzo,DL219,Cabergoline,-7.275115,x1077,4.712576,active-noncovalent
CCNC(=O)N(CCC[NH+](C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@@H+](C1)CC=C,BRD-K86882815-001-05-7,cabergoline,Tocris,2664,Cabergoline,-7.275115,x1077,4.712576,active-noncovalent
CCOCCn1c2ccccc2nc1C3CC[NH+](CC3)CCc4ccc(cc4)C(C)(C)C(=O)[O-],BRD-K51937257-001-01-4,bilastine,MedChemEx,HY-14447,Bilastine,-7.274716,x0161,9.82631,active-noncovalent
Cc1cc(n(n1)c2ccccc2)NC(=O)Nc3ccc(c(c3)F)F,BRD-K51137250-001-02-6,ML-297,Tocris,5380,ML 297,-7.271844,x0967,2.798281,active-noncovalent
c1ccc2c(c1)[C@@H](N(C2=O)C3CCOCC3)C(=O)NCc4ccc(cc4)OC(F)(F)F,BRD-A84202322-001-01-7,NAV-26,Tocris,4691,NAV 26,-7.271275,x0831,6.635731,active-covalent
CC[N+](C)(C)Cc1ccccc1Br,BRD-K49669424-075-19-2,bretylium,Sigma,MFCD00038731,"N-(2-bromobenzyl)-N,N-dimethylethanaminium 4-methylbenzenesulfonate",-7.271035,x0161,-0.506485,active-noncovalent
CC[N+](C)(C)Cc1ccccc1Br,BRD-K49669424-001-01-6,bretylium,MicroSource,1502018,BRETYLIUM TOSYLATE,-7.271035,x0161,-0.506485,active-noncovalent
c1c(nc[nH]1)/C=C/C(=O)[O-],BRD-K52670952-003-01-4,cis-urocanic-acid,Enamine,Z607808534,,-7.270299,x0678,-2.342592,active-noncovalent
c1c(nc[nH]1)/C=C/C(=O)[O-],BRD-K52670952-003-02-2,cis-urocanic-acid,Enamine,Z607808534,,-7.270299,x0678,-2.342592,active-noncovalent
COc1cccc(c1c2cc([nH]n2)Nc3cnc(cn3)C#N)OCCC[NH3+],BRD-K20463415-001-01-8,LY2606368,MedChemEx,HY-18174,LY2606368,-7.269921,x0874,2.859998,active-noncovalent
COc1cccc(c1c2cc([nH]n2)Nc3cnc(cn3)C#N)OCCC[NH3+],BRD-K20463415-300-01-4,LY2606368,MedChemEx,HY-18174A,LY2606368 (dihydrochloride),-7.269921,x0874,2.859998,active-noncovalent
CCC/[NH+]=C\1/N(C(=O)/C(=C/c2ccc(c(c2)Cl)OC[C@@H](CO)O)/S1)c3ccccc3C,BRD-K44030614-001-01-6,ponesimod,MedChemEx,HY-10569,Ponesimod,-7.269185,x1077,6.91159,active-noncovalent
Cc1cnc(c(n1)OC)NS(=O)(=O)c2cccnc2c3ccc(cc3)c4nnco4,BRD-K31553034-001-03-0,zibotentan,Selleck,S1456,Zibotentan (ZD4054),-7.268618,x0305,3.939615,active-noncovalent
[C@@H]1(C(=O)C(=C(C(=O)C1=O)[O-])[O-])O,BRD-K90177246-001-05-5,tetroquinone,MicroSource,1503330,TETROQUINONE,-7.266967,x0397,1.315667,active-noncovalent
CCC(=O)c1cc(n(c1C)c2ccc(cc2)S(=O)(=O)N)c3ccc(cc3)Cl,BRD-K33059059-001-01-0,A-867744,Tocris,4571,A 867744,-7.266709,x0305,3.354073,active-noncovalent
Cn1cc[nH]c1=S,BRD-K54416256-001-18-1,methimazole,Selleck,S1609,Methimazole,-7.266704,x0678,-1.423629,active-noncovalent
Cn1cc[nH]c1=S,BRD-K54416256-001-19-9,methimazole,MicroSource,1500396,METHIMAZOLE,-7.266704,x0678,-1.423629,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,BRD-A13078313-304-07-3,carbenicillin,Selleck,S3179,Carbenicillin disodium,-7.266460,x1077,2.473617,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,BRD-A13078313-304-06-5,carbenicillin,MicroSource,1500160,CARBENICILLIN DISODIUM,-7.266460,x1077,2.473617,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,BRD-A13078313-304-08-1,carbenicillin,MedChemEx,HY-B0525A,"disodium (2S,5R,6R)-3,3-dimethyl-6-[(3-oxido-3-oxo-2-phenylpropanoyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-7.266460,x1077,2.473617,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,BRD-A13078313-304-09-9,carbenicillin,MedChemEx,HY-B0525A,Carbenicillin (disodium),-7.266460,x1077,2.473617,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,BRD-A13078313-304-05-7,carbenicillin,Selleck,S3179,Carbenicillin disodium,-7.266460,x1077,2.473617,active-noncovalent
C[C@]1(c2c(ccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)[O-])O)Cl)O,BRD-A25492003-003-13-3,chlortetracycline,MicroSource,1500186,CHLORTETRACYCLINE HYDROCHLORIDE,-7.265966,x0831,1.576631,active-covalent
C[C@]1(c2c(ccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)[O-])O)Cl)O,BRD-A25492003-003-14-1,chlortetracycline,Selleck,S4156,Chlortetracycline HCl,-7.265966,x0831,1.576631,active-covalent
C[C@]1(c2c(ccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)[O-])O)Cl)O,BRD-A25492003-003-15-8,chlortetracycline,Selleck,S4156,Chlortetracycline HCl,-7.265966,x0831,1.576631,active-covalent
c1cc(cnc1)C(=O)[O-],BRD-K60237333-001-28-9,niacin,Selleck,S1744,Niacin (Nicotinic acid),-7.265731,x0397,-1.45106,active-noncovalent
c1cc(cnc1)C(=O)[O-],BRD-K60237333-001-26-3,niacin,Selleck,S1744,Nicotinic Acid,-7.265731,x0397,-1.45106,active-noncovalent
c1cc(cnc1)C(=O)[O-],BRD-K60237333-001-27-1,niacin,MicroSource,1500430,NIACIN,-7.265731,x0397,-1.45106,active-noncovalent
C[C@H](c1ncc(s1)C(=O)Nc2cc(c(cn2)Cl)C(F)(F)F)NC(=O)c3c(c(ncn3)N)Cl,BRD-K43410529-001-02-3,MLN2480,MedChemEx,HY-15246,MLN 2480,-7.265237,x0104,12.259191,active-noncovalent
C[NH+](C)CCCOc1cc(n(n1)Cc2ccccc2)C(=O)Nc3ccc(cc3)OC,BRD-K64341947-003-03-2,CFM-1571,Tocris,2586,CFM 1571 hydrochloride,-7.264049,x1077,5.689401,active-noncovalent
C[NH+](C)CCCOc1cc(n(n1)Cc2ccccc2)C(=O)Nc3ccc(cc3)OC,BRD-K64341947-003-02-4,CFM-1571,Tocris,2586,CFM 1571 hydrochloride,-7.264049,x1077,5.689401,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2O)OC(=O)N(CCCl)CCCl,BRD-A70858459-001-01-7,estramustine,MicroSource,1502384,ESTRAMUSTINE,-7.263798,x0104,9.939362,active-noncovalent
Cc1ccc(cc1Nc2ccc\3c(c2)NC(=O)/C3=C\c4ccc[nH]4)NC(=O)Nc5cc(ccc5F)C(F)(F)F,BRD-K19975102-001-01-2,GNF-5837,Tocris,4559,GNF 5837,-7.263728,x0072,16.849657,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)[O-],BRD-K44442813-001-11-1,pidotimod,Selleck,S3106,Pidotimod,-7.263474,x0678,-0.555523,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)[O-],BRD-K44442813-001-12-9,pidotimod,MicroSource,1502322,PIDOTIMOD,-7.263474,x0678,-0.555523,active-noncovalent
c1ccnc(c1)C(=O)Nc2ccc(c(c2)Cl)Oc3ccc(cn3)Cl,BRD-K68674163-001-01-7,VU-0422288,Tocris,5378,VU 0422288,-7.260602,x0072,3.624881,active-noncovalent
CCCCC[NH2+]CC(=O)N,BRD-K64338723-001-01-6,milacemide,Enamine,Z104536260,,-7.258897,x0678,-1.598048,active-noncovalent
CC1=C(C(CC=C1)(C)C)C=O,BRD-K90582192-001-01-9,safranal,Sigma,MFCD00209531,"2,6,6-trimethyl-1,3-cyclohexadiene-1-carbaldehyde",-7.258222,x0678,2.794579,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)O[C@H]5[C@@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,BRD-A59001851-001-01-3,ginkgolide-b,Tocris,1657,Ginkgolide B,-7.257959,x0874,2.554263,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)O[C@H]5[C@@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,BRD-A59001851-001-02-1,ginkgolide-b,Selleck,S1343,Ginkgolide B,-7.257959,x0874,2.554263,active-noncovalent
CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,BRD-K00634421-001-02-8,brivaracetam,MedChemEx,HY-14449,Brivaracetam,-7.257905,x0749,-0.643114,active-covalent
CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,BRD-K00634421-001-01-0,brivaracetam,MedChemEx,HY-14449,Brivaracetam,-7.257905,x0749,-0.643114,active-covalent
Cc1csc2c1ncnc2N[C@@H](C)C[NH+]3CCN(CC3)S(=O)(=O)c4ccc(c(c4)Cl)Cl,BRD-K32322923-001-01-7,LPA2-antagonist-1,MedChemEx,HY-18075,LPA2 antagonist 1,-7.257020,x0107,8.185106,active-noncovalent
CC(C)[NH2+]CC[N@](C(C)C)S(=O)(=O)c1ccc(cc1Cl)Cl,BRD-K95581532-001-01-5,RN-1734,Tocris,3746,RN 1734,-7.256175,x0678,0.93142,active-noncovalent
CC(C)[NH2+]CC[N@](C(C)C)S(=O)(=O)c1ccc(cc1Cl)Cl,BRD-K95581532-001-02-3,RN-1734,Tocris,3746,RN 1734,-7.256175,x0678,0.93142,active-noncovalent
c1coc2c1[nH]c(c2)C(=O)[O-],BRD-K49504902-001-01-6,SEP-227900,Enamine,Z1198172211,,-7.255233,x0195,-1.341274,active-noncovalent
C[C@]12CC[C@H](C1(C)C)[C@H](C2=O)Br,BRD-A62841832-001-01-1,3-bromocamphor,Vitas-M,STK121291,,-7.253036,x0354,2.539126,active-noncovalent
c1cc2c(cc1/C=C/N(=O)=O)OCO2,BRD-K42205652-001-05-0,"MNS-(3,4-Methylenedioxy-nitrostyrene)",Selleck,S4921,"MNS (3,4-Methylenedioxy-??-nitrostyrene)",-7.252650,x0749,-0.119083,active-covalent
c1cc2c(cc1/C=C/N(=O)=O)OCO2,BRD-K42205652-001-02-7,"MNS-(3,4-Methylenedioxy-nitrostyrene)",Selleck,S4921,"MNS (3,4-Methylenedioxy-?-nitrostyrene, MDBN)",-7.252650,x0749,-0.119083,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)CCNC(=O)c2ccc(cc2)Cl,BRD-K46018455-001-26-8,bezafibrate,Selleck,S4159,Bezafibrate,-7.252120,x0195,3.482476,active-noncovalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)CCNC(=O)c2ccc(cc2)Cl,BRD-K46018455-001-27-6,bezafibrate,MicroSource,1502046,BEZAFIBRATE,-7.252120,x0195,3.482476,active-noncovalent
CS(=O)(=O)[N@@]1CCc2c1nc(nc2c3cnc(nc3)N)N4CCOCC4,BRD-K28352084-001-03-1,CH5132799,Selleck,S2699,CH5132799,-7.252045,x0678,2.030961,active-noncovalent
CS(=O)(=O)[N@@]1CCc2c1nc(nc2c3cnc(nc3)N)N4CCOCC4,BRD-K28352084-001-02-3,CH5132799,Selleck,S2699,CH5132799,-7.252045,x0678,2.030961,active-noncovalent
C[C@H]1CCNC(=[NH2+])S1,BRD-A28318179-003-08-5,aminomethyltransferase,Tocris,871,AMT hydrochloride,-7.251394,x1077,-0.067574,active-noncovalent
Cc1c(sc2n1c3cc(ccc3n2)N)C(=O)N(C)C4CCCCC4,BRD-K59650319-003-03-3,YM-298198,Tocris,2448,YM 298198 hydrochloride,-7.251255,x0874,3.01785,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)CCOC(c3ccccc3)c4ccccc4,BRD-K92015269-300-01-2,GBR-12783,Tocris,513,GBR 12783 dihydrochloride,-7.250877,x0195,5.230481,active-noncovalent
C[C@@H]1C[N@@H+](C[C@H]1c2[nH]c(=O)c3cnn(c3n2)C4CCOCC4)Cc5ncccn5,BRD-K50031829-001-01-6,PF-04447943,MedChemEx,HY-15441,PF-04447943,-7.250768,x0107,3.736224,active-noncovalent
c1cc(ccc1[C@](C[NH3+])(CS(=O)(=O)[O-])O)Cl,BRD-A27924917-001-03-3,2-hydroxysaclofen,Tocris,245,2-Hydroxysaclofen,-7.250540,x0161,-1.626622,active-noncovalent
CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,BRD-K50388907-001-30-4,fenofibrate,MicroSource,1501010,FENOFIBRATE,-7.249400,x1077,2.698469,active-noncovalent
CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,BRD-K50388907-001-32-0,fenofibrate,Tocris,4113,Fenofibrate,-7.249400,x1077,2.698469,active-noncovalent
CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,BRD-K50388907-001-29-6,fenofibrate,Selleck,S1794,Fenofibrate,-7.249400,x1077,2.698469,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)N,BRD-K79511609-001-20-0,2-chloroadenosine,Tocris,3136,2-Chloroadenosine,-7.249277,x1412,0.385911,active-covalent
Cn1cc(c2c1cccc2)C[NH2+]CC3CCN(CC3)c4ncc(cn4)C(=O)NO,BRD-K83837640-001-04-8,JNJ-26481585,Selleck,S1096,Quisinostat (JNJ-26481585),-7.249227,x0161,6.351513,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[NH2+]CCNC(c3ccccc3)c4ccccc4,BRD-K23335153-300-02-5,AMN-082,Tocris,2385,AMN 082 dihydrochloride,-7.249079,x1077,3.198946,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[NH2+]CCNC(c3ccccc3)c4ccccc4,BRD-K23335153-300-03-3,AMN-082,Tocris,2385,AMN 082 dihydrochloride,-7.249079,x1077,3.198946,active-noncovalent
c1cc(cnc1)CO,BRD-K76600340-045-04-9,nicotinyl-alcohol-tartrate,MicroSource,1503038,NICOTINYL ALCOHOL TARTRATE,-7.247877,x0397,-1.604825,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,BRD-K97009491-238-03-8,calcium-levofolinate,Selleck,S2588,Calcium levofolinate (Calcium Folinate),-7.247639,x0395,10.040487,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,BRD-K97009491-238-02-0,calcium-levofolinate,Selleck,S2588,Calcium levofolinate (Calcium Folinate),-7.247639,x0395,10.040487,active-noncovalent
c1c2c(cc(c1Cl)OC(F)(F)F)nc([nH]2)n3cc(cn3)C(=O)[O-],BRD-K01036220-001-01-0,JNJ-42041935,MedChemEx,HY-12832,JNJ-42041935,-7.247526,x0678,3.237191,active-noncovalent
CC(C)(Cc1ccccc1)[NH2+]C,BRD-K18194590-065-08-0,mephentermine,MicroSource,1503250,MEPHENTERMINE SULFATE,-7.247328,x0678,-0.550731,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COc3ccccc3)C(=O)[O-])C,BRD-K43966364-237-04-8,penicillin-v-potassium,MicroSource,1500467,PENICILLIN V POTASSIUM,-7.247251,x0831,2.001694,active-covalent
CCOc1cc(ccc1C(=O)[O-])CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3,BRD-K82846253-001-15-4,repaglinide,Tocris,3805,Repaglinide,-7.246802,x1077,4.68751,active-noncovalent
CCOc1cc(ccc1C(=O)[O-])CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3,BRD-K82846253-001-16-2,repaglinide,MicroSource,1506035,REPAGLINIDE,-7.246802,x1077,4.68751,active-noncovalent
CCOc1cc(ccc1C(=O)[O-])CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3,BRD-K82846253-001-14-7,repaglinide,Selleck,S1426,Repaglinide,-7.246802,x1077,4.68751,active-noncovalent
CCOc1cc(ccc1C(=O)[O-])CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3,BRD-K82846253-001-17-0,repaglinide,Tocris,3805,Repaglinide,-7.246802,x1077,4.68751,active-noncovalent
C(C[C@H](C(=O)[O-])[NH3+])CNC(=O)N,BRD-A12237696-001-04-2,L-Citrulline,Vitas-M,STK802460,,-7.245191,x0830,-1.584727,active-covalent
CCCCCCOc1c(nsn1)C2=CCC[N@@H+](C2)C,BRD-K72815923-034-02-0,xanomeline,Tocris,3569,Xanomeline oxalate,-7.245153,x0104,0.504934,active-noncovalent
CCCCCCOc1c(nsn1)C2=CCC[N@@H+](C2)C,BRD-K72815923-034-01-2,xanomeline,MedChemEx,HY-13410,Xanomeline (oxalate),-7.245153,x0104,0.504934,active-noncovalent
C=CC[NH+]1CCN(CC1)c2c(nc3ccccc3n2)C#N,BRD-K38370968-050-01-3,3-AQC,Tocris,666,3-AQC,-7.244846,x0874,1.00276,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cccc3)NC(=O)Nc4ccccc4F,BRD-K30159788-001-01-9,RSV604,MedChemEx,HY-12993,RSV604,-7.244839,x0874,2.802741,active-noncovalent
CC[C@]1(C(=O)N(C(=O)N1)C)c2ccccc2,BRD-A83937277-001-10-5,mephenytoin,MicroSource,1503709,MEPHENYTOIN,-7.243958,x0434,-0.398338,active-noncovalent
CCOC(=O)n1ccn(c1=S)C,BRD-K87156652-001-11-9,carbimazole,Selleck,S4048,Carbimazole,-7.243903,x0195,-1.268667,active-noncovalent
CCOC(=O)n1ccn(c1=S)C,BRD-K87156652-001-13-5,carbimazole,Selleck,S4048,Carbimazole,-7.243903,x0195,-1.268667,active-noncovalent
CCOC(=O)n1ccn(c1=S)C,BRD-K87156652-001-12-7,carbimazole,MicroSource,1505323,CARBIMAZOLE,-7.243903,x0195,-1.268667,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])O)C(=O)[O-],BRD-A80383043-001-03-3,4-carboxy-3-hydroxyphenylglycine-(RS),Tocris,310,(RS)-4-Carboxy-3-hydroxyphenylglycine,-7.242720,x0749,-1.151227,active-covalent
c1ccc(c(c1)C(=O)[O-])O,BRD-K93632104-001-17-2,salicylic-acid,MicroSource,1500535,SALICYLIC ACID,-7.241326,x1093,-1.360959,active-noncovalent
c1ccc(c(c1)C(=O)[O-])O,BRD-K93632104-001-18-0,sodium-salicylate,MicroSource,1500533,SODIUM SALICYLATE,-7.241326,x1093,-1.360959,active-noncovalent
c1ccc(c(c1)C(=O)[O-])O,BRD-K93632104-001-19-8,sodium-salicylate,Selleck,S3137,Sodium salicylate,-7.241326,x1093,-1.360959,active-noncovalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)NCCCCCCCCCC[NH3+],BRD-K03301001-003-03-3,A-7,Tocris,378,A-7 hydrochloride,-7.240339,x0749,2.457125,active-covalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)NCCCCCCCCCC[NH3+],BRD-K03301001-003-02-5,A-7,Tocris,378,A-7 hydrochloride,-7.240339,x0749,2.457125,active-covalent
CS(=O)(=O)n1cc2c(n1)C[N@@H+](C2)[C@@H]3C[C@@H]([C@H](OC3)c4cc(ccc4F)F)[NH3+],BRD-K14171291-001-01-4,omarigliptin,MedChemEx,HY-15981,Omarigliptin,-7.240102,x0072,5.884093,active-noncovalent
CS(=O)(=O)n1cc2c(n1)C[N@@H+](C2)[C@@H]3C[C@@H]([C@H](OC3)c4cc(ccc4F)F)[NH3+],BRD-K14171291-001-02-2,omarigliptin,MedChemEx,HY-15981,Omarigliptin,-7.240102,x0072,5.884093,active-noncovalent
CCc1cc(ccn1)C(=S)N,BRD-K51207550-001-22-2,ethionamide,Selleck,S1777,Ethionamide,-7.240012,x0749,-1.75029,active-covalent
CCc1cc(ccn1)C(=S)N,BRD-K51207550-001-23-0,ethionamide,MicroSource,1500292,ETHIONAMIDE,-7.240012,x0749,-1.75029,active-covalent
COc1cc(ccc1O)/C=C/C(=O)[O-],BRD-K66295376-001-12-3,ferulic-acid,Selleck,S2300,Ferulic Acid,-7.238907,x0195,-0.874705,active-noncovalent
COc1cc(ccc1O)/C=C/C(=O)[O-],BRD-K66295376-236-01-8,ferulic-acid,MedChemEx,HY-N0060A,Ferulic acid (sodium),-7.238907,x0195,-0.874705,active-noncovalent
COc1cc(ccc1O)/C=C/C(=O)[O-],BRD-K66295376-001-13-1,ferulic-acid,Selleck,S2300,Fumalic acid (Ferulic acid),-7.238907,x0195,-0.874705,active-noncovalent
COc1cc(ccc1O)/C=C/C(=O)[O-],BRD-K66295376-236-02-6,ferulic-acid,MedChemEx,HY-N0060A,Ferulic acid (sodium),-7.238907,x0195,-0.874705,active-noncovalent
c1ccc2c(c1)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,BRD-A93255169-001-28-3,thalidomide,Tocris,652,Thalidomide,-7.238844,x0195,-0.370109,active-noncovalent
c1ccc2c(c1)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,BRD-A93255169-001-27-5,thalidomide,Selleck,S1193,Thalidomide,-7.238844,x0195,-0.370109,active-noncovalent
CCCc1cc(ccn1)C(=S)N,BRD-K75360161-001-17-2,protionamide,Selleck,S1881,Protionamide,-7.238395,x1077,-1.408317,active-noncovalent
CCCc1cc(ccn1)C(=S)N,BRD-K75360161-001-18-0,protionamide,MicroSource,1505316,PROTIONAMIDE,-7.238395,x1077,-1.408317,active-noncovalent
CCC(CC)[C@@H](c1ccc(cc1)Nc2nc3ccccc3s2)n4cncn4,BRD-A95755460-001-01-3,talarozole,MedChemEx,HY-14531,Talarozole,-7.238343,x0104,6.204222,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)N,BRD-K06665116-001-02-6,L-asparagine,Sigma,MFCD00064401,L-asparagine,-7.237053,x0426,-1.04612,active-noncovalent
CCCCCC/C=C/C=C\CCCCCCCC(=O)[O-],BRD-K80025777-001-01-4,"cis-9,trans-11-Conjugated-linoleic-acid",Enzo,BL119,"9(E),11(Z)-Octadecadienoic acid",-7.236617,x0161,1.79788,active-noncovalent
CC1(CCN(CC1)C(=O)Nc2nc3c(ccc(c3s2)N4CCOCC4)OC)O,BRD-K93045741-001-01-0,tozadenant,MedChemEx,HY-10995,Tozadenant,-7.235772,x0161,4.535137,active-noncovalent
C1CN(C(=[NH+]1)N)CC(=O)[O-],BRD-K14379200-001-04-7,cyclocreatine,Sigma,MFCD00134455,(2-imino-1-imidazolidinyl)acetic acid,-7.235110,x1077,-0.252595,active-noncovalent
CN1[C@@H](CCC1=O)c2cccnc2,BRD-K94144010-001-13-9,cotinine,MicroSource,1500208,COTININE,-7.234568,x0195,-1.13741,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)F,BRD-K08799216-001-05-3,pelitinib,Selleck,S1392,Pelitinib (EKB-569),-7.233969,x0736,8.311902,active-covalent
CCC(CC)CC1(CCCCC1)C(=O)Nc2ccccc2SC(=O)C(C)C,BRD-K18849474-001-04-4,dalcetrapib,Selleck,S2772,Dalcetrapib??JTT-705??,-7.233555,x0874,4.727252,active-noncovalent
CCC(CC)CC1(CCCCC1)C(=O)Nc2ccccc2SC(=O)C(C)C,BRD-K18849474-001-03-6,dalcetrapib,Selleck,S2772,"Dalcetrapib (JTT-705, RO4607381)",-7.233555,x0874,4.727252,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OC,BRD-K88646909-004-15-4,arecoline,Selleck,S2614,Arecoline,-7.232696,x0104,1.30768,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OC,BRD-K88646909-004-16-2,arecoline,MicroSource,1500680,ARECOLINE HYDROBROMIDE,-7.232696,x0104,1.30768,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)[O-])O)O)O)O)O)O,BRD-K01624185-001-05-7,maltobionic-acid,CombiBlocks,QA-2870,,-7.232462,x0749,1.839697,active-covalent
COCCC[NH+]1CCC(CC1)NC(=O)c2cc(c(c3c2OCC3)N)Cl,BRD-K33681278-036-01-2,prucalopride,Selleck,S4247,Prucalopride Succinat,-7.232248,x1077,4.365895,active-noncovalent
COCCC[NH+]1CCC(CC1)NC(=O)c2cc(c(c3c2OCC3)N)Cl,BRD-K33681278-001-02-4,prucalopride,Selleck,S2875,Prucalopride,-7.232248,x1077,4.365895,active-noncovalent
Cc1cccc(c1)C/N=N/c2cc(n3c(n2)cc(n3)c4ccncc4)N5CCOCC5,BRD-K38627885-001-01-9,APY0201,MedChemEx,HY-15982,APY0201,-7.231820,x0161,7.630601,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)Cl)O,BRD-A07600638-060-05-2,meclocycline-sulfosalicylate,MicroSource,1501118,MECLOCYCLINE SULFOSALICYLATE,-7.229702,x0831,1.363286,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)Cl)O,BRD-A07600638-060-04-5,meclocycline-sulfosalicylate,Selleck,S4331,Meclocycline Sulfosalicylate,-7.229702,x0831,1.363286,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)Cl)O,BRD-A07600638-060-06-0,meclocycline-sulfosalicylate,DuPont,A001593196,"(4S,4aR,5S,5aS,12aS)-7-chloro-4-(dimethylamino)-5,10,12a-trihydroxy-6-methylene-1,3,11,12-tetraoxo-1,2,3,4,4a,5,5a,6,11,11a,12,12a-dodecahydrotetracene-2-carboxamide 2-hydroxy-5-sulfobenzoate",-7.229702,x0831,1.363286,active-covalent
C[C@@H](CCCC(C)C)[NH3+],BRD-A37873789-001-01-9,octodrine,MicroSource,1505447,OCTODRINE,-7.227858,x0195,-1.047991,active-noncovalent
CCCCCCCCCCCCCCCc1cccc(c1)OCC(=O)NCCO,BRD-K26358347-001-01-7,PDP-EA,Tocris,5210,PDP-EA,-7.227537,x0104,5.716921,active-noncovalent
CC(=O)Nc1ccccc1,BRD-K11094367-001-10-1,acetanilide,MicroSource,1501173,ACETANILIDE,-7.226410,x0195,-2.094514,active-noncovalent
CC(=O)Nc1ccccc1,BRD-K11094367-001-09-3,acetanilide,Selleck,S2538,Acetanilide,-7.226410,x0195,-2.094514,active-noncovalent
CCC(=O)N(c1ccccc1)C2(CC[NH+](CC2)CCc3cccs3)COC,BRD-K21547160-001-01-4,sufentanil,MedChemEx,HY-13754,Sufentanil,-7.224805,x0072,4.362268,active-noncovalent
CN(C)c1ccccc1C[N@H+]2CCC[N@]([C@@H]2c3ccncc3)Cc4ccccc4N(C)C,BRD-K09485525-001-03-9,GANT-61,Tocris,3191,GANT 61,-7.224788,x0874,6.163834,active-noncovalent
CC(C)C[C@@H](C(=O)NCCCCNC(=[NH2+])N)NC(=O)[C@H]1[C@@H](O1)C(=O)[O-],BRD-K06273313-001-07-9,E-64,Selleck,S7379,E-64,-7.224435,x0107,2.500952,active-noncovalent
CC(C)C[C@@H](C(=O)NCCCCNC(=[NH2+])N)NC(=O)[C@H]1[C@@H](O1)C(=O)[O-],BRD-K06273313-001-08-7,E-64,Selleck,S7379,E-64,-7.224435,x0107,2.500952,active-noncovalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3)NC(=O)c4ccc(cc4)N(=O)=O,BRD-K54783522-001-01-8,VU29,Tocris,4458,VU 29,-7.222107,x0104,5.132686,active-noncovalent
Cc1cc(cc(c1N)C)Oc2ccc3c(c2)n(c(n3)COc4ccc(cc4)C[C@H]5C(=O)[N-]C(=O)S5)C,BRD-A24560335-300-01-2,efatutazone,MedChemEx,HY-14792B,Inolitazone (dihydrochloride),-7.221126,x0104,17.826218,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@@H]3CCCO3)N,BRD-A56987319-001-12-9,SQ-22536,Tocris,1435,SQ 22536,-7.220680,x0195,-0.029406,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@@H]3CCCO3)N,BRD-A56987319-001-13-7,SQ-22536,Tocris,1435,SQ 22536,-7.220680,x0195,-0.029406,active-noncovalent
COc1ccc(cc1OC)CC[NH2+]Cc2ccc(c(c2)OC)OCc3ccc(nc3)Cl,BRD-K71667152-003-09-8,SBE-13,Tocris,4292,SBE 13 hydrochloride,-7.220505,x0104,8.357759,active-noncovalent
Cc1c(nc(n1c2ccc(cc2)OC(F)(F)F)C)C#Cc3ccnc(c3)Cl,BRD-K30572193-001-02-0,CTEP,Selleck,S2861,CTEP (RO4956371),-7.218218,x0104,7.989308,active-noncovalent
CC(=O)NCCCCCC(=O)[O-],BRD-K72215350-001-06-5,acexamic-acid,MicroSource,1503045,ACEXAMIC ACID,-7.216861,x0749,-1.374192,active-covalent
c1cc2c(c(c1)OCC(COc3cccc4c3c(=O)cc(o4)C(=O)[O-])O)c(=O)cc(o2)C(=O)[O-],BRD-K20920669-304-09-1,cromoglicic-acid,Selleck,S1911,Disodium Cromoglycate,-7.216455,x0104,4.630596,active-noncovalent
c1cc2c(c(c1)OCC(COc3cccc4c3c(=O)cc(o4)C(=O)[O-])O)c(=O)cc(o2)C(=O)[O-],BRD-K20920669-304-10-9,cromoglicic-acid,MicroSource,1500210,CROMOLYN SODIUM,-7.216455,x0104,4.630596,active-noncovalent
C[C@@H]([C@@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,BRD-K36859431-300-02-3,sapropterin,Cayman,81880,,-7.216211,x0195,-0.539573,active-noncovalent
C[C@@H]([C@@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,BRD-K36859431-300-04-9,sapropterin,Cayman,81880,"(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-4(1H)-pteridinone dihydrochloride",-7.216211,x0195,-0.539573,active-noncovalent
C[C@@H]([C@@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,BRD-K36859431-300-03-1,sapropterin,Cayman,81880,"(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-4(1H)-pteridinone dihydrochloride",-7.216211,x0195,-0.539573,active-noncovalent
C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)[O-])C)C)(C)C)O,BRD-K90647725-001-07-3,oleanolic-acid,Selleck,S2334,Oleanolic Acid (Caryophyllin),-7.215147,x0678,5.006927,active-noncovalent
C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)[O-])C)C)(C)C)O,BRD-K90647725-001-06-5,oleanolic-acid,Selleck,S2334,Oleanolic Acid,-7.215147,x0678,5.006927,active-noncovalent
CC[C@](CC(=O)N)(c1ccccc1)O,BRD-A66143912-001-01-1,3-hydroxy-3-phenylpentanamide,Enamine,Z2327510224,3-hydroxy-3-phenylpentanamide,-7.214869,x1077,0.684328,active-noncovalent
C([C@@H](C(=O)[O-])S)C(=O)[O-],BRD-A43435802-001-02-0,mercaptosuccinic-acid,Enamine,Z104478826,,-7.214594,x0397,0.203207,active-noncovalent
C([C@@H](C(=O)[O-])S)C(=O)[O-],BRD-A43435802-001-01-2,mercaptosuccinic-acid,Enamine,Z104478826,,-7.214594,x0397,0.203207,active-noncovalent
CN(C[C@H](CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NC[C@H](CO)O)I,BRD-A72075775-001-10-4,iopromide,Prestwick,Prestw-872,Iopromide,-7.213267,x1077,5.807608,active-noncovalent
CN(C[C@H](CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NC[C@H](CO)O)I,BRD-A72075775-001-11-2,iopromide,Sigma,1344804,"N~1~,N~3~-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N~1~-methylisophthalamide",-7.213267,x1077,5.807608,active-noncovalent
Cc1c(c(=O)n2ccccc2n1)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,BRD-K25224017-001-25-0,pirenperone,Prestwick,Prestw-531,Pirenperone,-7.212084,x1077,4.884548,active-noncovalent
c1cc(c2c(c1)ncc(n2)c3cnn(c3)C4CC[NH2+]CC4)c5cc(c(c(c5)F)C[NH+]6CCOCC6)F,BRD-K02017404-300-07-0,NVP-BSK805,Selleck,S2686,NVP-BSK805 2HCl,-7.212049,x0161,8.862748,active-noncovalent
c1cc(c2c(c1)ncc(n2)c3cnn(c3)C4CC[NH2+]CC4)c5cc(c(c(c5)F)C[NH+]6CCOCC6)F,BRD-K02017404-300-06-2,NVP-BSK805,Selleck,S2686,NVP-BSK805 2HCl,-7.212049,x0161,8.862748,active-noncovalent
CN(CC(=O)[O-])C(=[NH2+])N,BRD-K19615002-001-02-3,creatine,Vitas-M,STL163516,,-7.211684,x0107,-0.986652,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)C(=O)c4ccc(cc4)F)[NH2+]C,BRD-K08248804-001-01-8,LCL-161,MedChemEx,HY-15518,LCL161,-7.211381,x1077,6.933286,active-noncovalent
CCCn1c2c(c(=O)[nH]c1=O)nc[nH]2,BRD-K35007173-001-07-5,enprofylline,Enzo,AC635,3-N-Propylxanthine,-7.211030,x0397,-2.034954,active-noncovalent
CC(C)(C)C(=O)NCCCC(=O)[O-],BRD-K62264492-001-02-3,pivagabine,Enamine,Z85888809,"4-[(2,2-dimethylpropanoyl)amino]butanoic acid",-7.209982,x0397,-1.051168,active-noncovalent
CC(C)(C)C(=O)NCCCC(=O)[O-],BRD-K62264492-001-01-5,pivagabine,Enamine,Z85888809,,-7.209982,x0397,-1.051168,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)Nc2cn3cc(ccc3[nH+]2)n4ccnc4,BRD-K29660062-300-01-2,TC-ASK-10,Tocris,4825,TC ASK 10,-7.209290,x0104,8.481403,active-noncovalent
c1nc(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N,BRD-K79254416-001-24-2,decitabine,Tocris,2624,Decitabine,-7.208980,x0397,-0.111461,active-noncovalent
c1nc(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N,BRD-K79254416-001-21-8,decitabine,Selleck,S1200,Decitabine,-7.208980,x0397,-0.111461,active-noncovalent
c1nc(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N,BRD-K79254416-001-22-6,decitabine,Tocris,2624,Decitabine,-7.208980,x0397,-0.111461,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-15-3,nifedipine,Tocris,1075,Nifedipine,-7.208480,x0946,2.116804,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-21-1,nifedipine,Selleck,S1808,Nifedipine (Adalat),-7.208480,x0946,2.116804,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-27-8,nifedipine,MedChemEx,HY-B0284,Nifedipine,-7.208480,x0946,2.116804,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-29-4,nifedipine,MedChemEx,HY-B0284,Nifedipine,-7.208480,x0946,2.116804,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-14-6,nifedipine,Selleck,S1808,Nifedipine,-7.208480,x0946,2.116804,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,BRD-K96354014-001-17-9,nifedipine,MicroSource,1500431,NIFEDIPINE,-7.208480,x0946,2.116804,active-noncovalent
C[N@H+]1CC[C@H](C[C@@H]1c2[nH]c3ccccc3n2)NC(=O)Nc4ccc(cc4)C#N,BRD-K34341643-001-01-4,glasdegib,MedChemEx,HY-16391,PF-04449913,-7.205805,x0104,7.168968,active-noncovalent
CCCC(C)(COC(=O)N)COC(=O)N,BRD-K19180152-001-02-6,meprobamate,Enzo,AC3174,MEPROBAMATE (DEA license),-7.205605,x1077,2.314628,active-noncovalent
Cc1c(ccc(c1F)S(=O)(=O)C)C(=O)N2CCOc3ccc(cc3C2)c4ccc(nc4)N,BRD-K03549949-001-01-0,XL388,Selleck,S7035,XL388,-7.205416,x0107,5.58503,active-noncovalent
CCC1(C(=O)NC(=O)N(C1=O)C)CC,BRD-K88143662-001-01-5,metharbital,Enamine,Z2205958937,"5,5-diethyl-1-methyl-2,4,6(1H,3H,5H)-pyrimidinetrione",-7.205359,x0678,1.890334,active-noncovalent
c1cn(c(=O)nc1N)C[C@@H](CO)OCP(=O)([O-])[O-],BRD-K96153583-001-05-1,cidofovir,Selleck,S1516,Cidofovir (Vistide),-7.204826,x0397,0.526044,active-noncovalent
c1cn(c(=O)nc1N)C[C@@H](CO)OCP(=O)([O-])[O-],BRD-K96153583-001-04-4,cidofovir,Selleck,S1516,Cidofovir (Vistide),-7.204826,x0397,0.526044,active-noncovalent
CCCCCCCCCCCCCC(=O)O,BRD-M78068755-001-01-2,miriplatin,MedChemEx,HY-16325A,Miriplatin,-7.203644,x0161,0.167883,active-noncovalent
CCCCCCCCCCCCCC(=O)O,BRD-M78068755-001-02-0,miriplatin,MedChemEx,HY-16325A,Miriplatin,-7.203644,x0161,0.167883,active-noncovalent
C[NH+]1CCC(CC1)NC(=O)c2cc(on2)c3c(cc(cc3Oc4ccc(cc4)N(=O)=O)O)O,BRD-K58770988-001-01-8,NMS-E973,Selleck,S7282,NMS-E973,-7.203517,x1077,5.711392,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)CNC(=O)c2cc(c(c(c2)OC)OC)OC,BRD-K34415467-003-13-0,trimethobenzamide,MicroSource,1500594,TRIMETHOBENZAMIDE HYDROCHLORIDE,-7.202495,x0161,7.244851,active-noncovalent
c1c(c(nc(=O)n1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)N)I,BRD-K07160047-001-01-3,fiacitabine,MedChemEx,HY-50735,Fiacitabine,-7.201056,x0195,-0.346686,active-noncovalent
C[C@H](c1ccccn1)[NH2+]NC(=S)/N=N/C(=S)Nc2ccccc2Cl,BRD-K57027742-001-01-1,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,Key,MS-0738,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,-7.200891,x0397,3.178131,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,BRD-K65544384-236-01-0,4-aminohippuric-acid,Selleck,S4414,Sodium 4-aminohippurate Hydrate,-7.200277,x0107,0.323321,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,BRD-K65544384-001-14-1,4-aminohippuric-acid,Selleck,S2883,4-Aminohippuric Acid,-7.200277,x0107,0.323321,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,BRD-K65544384-236-02-8,4-aminohippuric-acid,Selleck,S4414,SodiuM 4-aMinohippurate hydrate,-7.200277,x0107,0.323321,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,BRD-K65544384-236-03-6,4-aminohippuric-acid,MedChemEx,HY-A0080,Aminohippurate (sodium),-7.200277,x0107,0.323321,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,BRD-K65544384-001-15-8,4-aminohippuric-acid,MicroSource,1503069,AMINOHIPPURIC ACID,-7.200277,x0107,0.323321,active-noncovalent
C/C(=N\NC(=O)[C@@H](c1c2ccccc2c(=O)[nH]n1)NC(=O)c3ccccc3)/c4cccc(c4)Br,BRD-A27911617-001-01-7,AC-55541,MedChemEx,HY-14350,AC-55541,-7.200106,x0678,4.741849,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2NC(=O)c3cccc(c3)OC)C(=O)OC,BRD-K47726410-001-01-2,WDR5-0103,Tocris,5323,WDR5 0103,-7.199833,x0104,4.046089,active-noncovalent
CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C,BRD-K20285085-074-04-5,R406,Selleck,S2194,R406,-7.199767,x0195,7.154663,active-noncovalent
CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C,BRD-K20285085-001-07-1,R406,Selleck,S1533,R406 (free base),-7.199767,x0195,7.154663,active-noncovalent
CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C,BRD-K20285085-074-03-7,R406,Selleck,S2194,R406,-7.199767,x0195,7.154663,active-noncovalent
Cc1ncc(c(n1)N)CN(C=O)/C(=C(\CCO)/SSC[C@@H]2CCCO2)/C,BRD-A71157293-003-10-0,fursultiamine,Prestwick,Prestw-1007,Fursultiamine Hydrochloride,-7.198684,x0678,2.803697,active-noncovalent
CC(Oc1ccc(cc1)O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K28470988-001-04-6,L-690330,Tocris,681,"L-690,330",-7.198024,x0678,1.451885,active-noncovalent
c1[nH]c(c(n1)C(=O)N)O,BRD-K70053378-001-01-1,SM-108,Ark,AK-26137,,-7.196554,x0678,-0.692069,active-noncovalent
c1[nH]c(c(n1)C(=O)N)O,BRD-K70053378-001-02-9,SM-108,Ark,AK-26137,4-hydroxy-1H-imidazole-5-carboxamide,-7.196554,x0678,-0.692069,active-noncovalent
C1C=CN(C=C1C(=O)N)CC(=O)N,BRD-K90215590-001-01-4,caricotamide,Enamine,Z2306534737,"1-(2-amino-2-oxoethyl)-1,4-dihydro-3-pyridinecarboxamide",-7.195629,x0104,1.557687,active-noncovalent
C[C@@H]1CCC[C@@H](N1NC(=O)c2ccc(c(c2)S(=O)(=O)N)Cl)C,BRD-A85651701-001-19-7,clopamide,Selleck,S4316,Clopamide,-7.195360,x0678,2.022569,active-noncovalent
COc1cc2c(cc1C(=O)N)c(ccn2)Oc3ccc(c(c3)Cl)NC(=O)NC4CC4,BRD-K39974922-001-04-3,lenvatinib,Selleck,S1164,Lenvatinib (E7080),-7.194967,x0072,4.843326,active-noncovalent
Cc1c(onc1C2CC[NH+](CC2)CCc3ccccc3)c4ccc(cc4)Cl,BRD-K13211965-003-02-8,L-741742,Tocris,1004,"L-741,742 hydrochloride",-7.194885,x0161,6.747882,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)Cc3ccc4c(c3)OCO4,BRD-K47936004-003-11-4,piribedil,Tocris,1031,Piribedil hydrochloride,-7.194218,x0104,1.604658,active-noncovalent
COc1ccc(cc1N)CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,BRD-K55790047-001-01-8,ON-01500,Enamine,Z374851066,,-7.193934,x0072,5.883688,active-noncovalent
CCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,BRD-K84366268-003-01-0,levocarnitine-propionate,MedChemEx,HY-B0932,Levocarnitine propionate (hydrochloride),-7.193191,x0734,1.259349,active-covalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,BRD-K79612754-001-19-1,inosine,Selleck,S2442,Inosine,-7.192561,x1077,-0.093726,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,BRD-K79612754-001-21-7,inosine,MicroSource,3100024,INOSINE,-7.192561,x1077,-0.093726,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,BRD-K79612754-001-20-9,inosine,Selleck,S2442,Inosine,-7.192561,x1077,-0.093726,active-noncovalent
C[C@@H]1CO/C(=[NH+]\c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5nccs5)/N1,BRD-K46386702-001-02-1,ARRY-334543,Selleck,S2755,Varlitinib,-7.192212,x0395,7.255657,active-noncovalent
CC1(Cc2cnc(nc2-c3c1c(nn3C)C(=O)NC)Nc4ccc(cc4)N5CC[NH+](CC5)C)C,BRD-K60997853-001-02-3,PHA-848125,Selleck,S2751,Milciclib (PHA-848125),-7.190920,x0104,12.93278,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,BRD-K23586533-003-01-6,clindamycin,MicroSource,1500193,CLINDAMYCIN HYDROCHLORIDE,-7.190077,x0434,2.428291,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,BRD-K23586533-003-02-4,clindamycin,Selleck,S2457,Clindamycin HCl,-7.190077,x0434,2.428291,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,BRD-K23586533-001-03-6,clindamycin,Selleck,S2830,Clindamycin,-7.190077,x0434,2.428291,active-noncovalent
C[C@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)O,BRD-A61188230-001-01-6,cedrol,Vitas-M,STK066400,,-7.189905,x0678,3.307032,active-noncovalent
CC(=O)Nc1cccc(c1)O,BRD-K16474819-001-09-6,metacetamol,MicroSource,211175,METACETAMOL,-7.189803,x0195,-1.843277,active-noncovalent
CNC(=O)c1cc(ccn1)COc2c3c(cco3)c(nn2)Nc4ccc(cc4)Cl,BRD-K84564571-001-02-4,telatinib,Selleck,S2231,Telatinib,-7.187358,x0072,5.656888,active-noncovalent
COc1cc(nc(n1)O[C@H](C(=O)[O-])C(c2ccccc2)(c3ccccc3)OC)OC,BRD-K54863166-001-01-9,darusentan,Key,EE-0200,"(2S)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-3-methoxy-3,3-diphenylpropanoic acid",-7.187346,x0195,5.429739,active-noncovalent
C[NH+](C)CCCSC(=[NH2+])N,BRD-K23541596-300-07-2,dimaprit,Selleck,S4320,Dimaprit 2HCl,-7.186809,x0195,-1.098618,active-noncovalent
C[NH+](C)CCCSC(=[NH2+])N,BRD-K23541596-300-08-0,dimaprit,Tocris,506,Dimaprit dihydrochloride,-7.186809,x0195,-1.098618,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC,BRD-A44448661-001-04-8,pentobarbital,Prestwick,Prestw-1491,Pentobarbital,-7.186369,x0678,0.3255,active-noncovalent
C[N@H+]1CC[C@H](C1)Oc2cc(ccc2C(F)(F)F)NS(=O)(=O)c3cc(c(cc3Br)OC)OC,BRD-K68633027-001-01-9,SB-706375,Tocris,4667,SB 706375,-7.185539,x0161,4.512883,active-noncovalent
C(C[NH3+])C(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K58513245-304-03-5,pamidronate,Selleck,S1311,Pamidronate Disodium,-7.184543,x0397,1.096899,active-noncovalent
C(C[NH3+])C(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K58513245-304-02-7,pamidronate,Selleck,S1311,Pamidronate Disodium,-7.184543,x0397,1.096899,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2c(c(cc(c2OC)Cl)Cl)O,BRD-K04111260-001-12-6,raclopride,Tocris,1810,Raclopride,-7.183842,x0195,0.575568,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2c(c(cc(c2OC)Cl)Cl)O,BRD-K04111260-001-10-0,raclopride,Tocris,1810,Raclopride,-7.183842,x0195,0.575568,active-noncovalent
CCOc1ccccc1OCC[NH2+][C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC,BRD-K74339692-001-01-9,tamsulosin,Enzo,DL160,Tamsulosin HCl,-7.183609,x0072,4.130675,active-noncovalent
CCOc1ccccc1OCC[NH2+][C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC,BRD-K74339692-003-03-1,tamsulosin,Tocris,3050,Tamsulosin hydrochloride,-7.183609,x0072,4.130675,active-noncovalent
CCOc1ccccc1C(=O)N,BRD-K88308881-001-06-8,ethenzamide,MicroSource,1502735,ETHENZAMIDE,-7.182890,x0195,1.687286,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OCCCOc2ccc(cc2)OCC(=O)[O-],BRD-K98372770-001-09-0,L-165041,Tocris,1856,"L-165,041",-7.182696,x0104,5.024017,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OCCCOc2ccc(cc2)OCC(=O)[O-],BRD-K98372770-001-08-2,L-165041,Tocris,1856,"L-165,041",-7.182696,x0104,5.024017,active-noncovalent
CCc1ccc(cc1)C2=CC(Sc3c2cc(cc3)C#Cc4ccc(cc4)C(=O)[O-])(C)C,BRD-K70262971-001-01-9,AGN-194310,MedChemEx,HY-16681,AGN 194310,-7.182004,x0072,6.399373,active-noncovalent
CC(C)[C@@H]1[C@H]2CC[C@H](C2)[C@H]1[NH3+],BRD-A18074780-003-04-6,AGN-192403,Tocris,1072,AGN 192403 Hydrochloride,-7.181125,x1382,0.882873,active-covalent
CC(C)[C@@H]1[C@H]2CC[C@H](C2)[C@H]1[NH3+],BRD-A18074780-003-02-0,AGN-192403,Tocris,1072,AGN 192403 hydrochloride,-7.181125,x1382,0.882873,active-covalent
C[C@@H](OC(=O)C(C)C)OC(=O)NCC1(CCCCC1)CC(=O)[O-],BRD-A86665761-001-01-1,gabapentin-enacarbil,AdvChemBlocks,G-5813,{1-[({[1-(isobutyryloxy)ethoxy]carbonyl}amino)methyl]cyclohexyl}acetic acid,-7.180681,x1093,2.808141,active-noncovalent
CCOC(=O)Nc1cc(nn2c1nnc2C)c3ccc(c(c3)NS(=O)(=O)C)C,BRD-K44665581-001-02-6,bromosporine,Tocris,4758,Bromosporine,-7.179783,x0072,5.484174,active-noncovalent
CCOC(=O)Nc1cc(nn2c1nnc2C)c3ccc(c(c3)NS(=O)(=O)C)C,BRD-K44665581-001-01-8,bromosporine,Selleck,S7233,Bromosporine,-7.179783,x0072,5.484174,active-noncovalent
COc1cc(ccc1)/C=N/N=C/c2cc(ccc2)OC,BRD-K36775483-001-01-4,DMeOB,Tocris,1953,DMeOB,-7.179430,x0104,6.196317,active-noncovalent
c1ccc(cc1)CCNN,BRD-K87024524-065-17-7,phenelzine,MicroSource,1500476,PHENELZINE SULFATE,-7.177473,x0195,0.222423,active-noncovalent
c1ccc(cc1)CCNN,BRD-K87024524-065-18-5,phenelzine,Sigma,MFCD00050687,sulfuric acid compound with 1-(2-phenylethyl)hydrazine (1:1),-7.177473,x0195,0.222423,active-noncovalent
c1ccc(cc1)CCNN,BRD-K87024524-001-04-0,phenelzine,Sigma,MFCD00047825,1-(2-phenylethyl)hydrazine,-7.177473,x0195,0.222423,active-noncovalent
COc1cc(c(cc1C(=O)N[C@H]2CC[N@H+](C[C@@H]2OC)CCCOc3ccc(cc3)F)Cl)N,BRD-A12896037-001-04-3,cisapride,MicroSource,1505594,CISAPRIDE,-7.177229,x0104,8.21454,active-noncovalent
CCOC(=O)c1cc(c(nc1C)N2CCC(CC2)C(=O)NS(=O)(=O)Cc3ccccc3)C#N,BRD-K77060810-001-01-5,AZD1283,MedChemEx,HY-15799,AZD1283,-7.177125,x0104,10.825068,active-noncovalent
CC(C)(C)[C@@H]1CCc2c(sc(c2C(=O)[O-])NC(=O)c3ccco3)C1,BRD-A90751343-001-01-0,CaCCinh-A01,Tocris,4877,CaCCinh-A01,-7.177065,x0749,2.688998,active-covalent
CC(C)(C)c1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],BRD-A65145453-001-06-1,ATPA,Tocris,1107,ATPA,-7.176110,x0195,-0.068826,active-noncovalent
CC(C)(C)c1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],BRD-A65145453-001-07-9,ATPA,Tocris,1107,3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)alanine,-7.176110,x0195,-0.068826,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(c(c(c1)Cl)N)Cl)O,BRD-A75726477-003-21-3,clenbuterol,MicroSource,1503917,CLENBUTEROL HYDROCHLORIDE,-7.176079,x0749,-1.07869,active-covalent
C[C@@H](C[NH+](CCN(C[C@@H](C)O)C[C@@H](C)O)C[C@H](C)O)O,BRD-A78588743-001-03-4,editol,MicroSource,1301023,EDITOL,-7.176039,x1077,0.905676,active-noncovalent
CC(C)n1c2ccc(cc2nn1)C(=O)[O-],BRD-K15196155-001-02-3,IBC-293,Tocris,2469,IBC 293,-7.175660,x0708,-1.142823,active-covalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,BRD-K88061624-001-21-4,mizoribine,Selleck,S1384,Mizoribine (Bredinin),-7.173338,x0195,-0.23259,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,BRD-K88061624-001-22-2,mizoribine,Selleck,S1384,Mizoribine,-7.173338,x0195,-0.23259,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,BRD-K88061624-001-20-6,mizoribine,MicroSource,1503416,MIZORIBINE,-7.173338,x0195,-0.23259,active-noncovalent
C[C@@H]1C[N@@H+]([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F,BRD-K17555800-003-01-5,talmapimod,Tocris,3528,SCIO 469 hydrochloride,-7.173151,x0161,7.390558,active-noncovalent
C[C@@H]1C[N@@H+]([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F,BRD-K17555800-003-02-3,talmapimod,Tocris,3528,SCIO 469 hydrochloride,-7.173151,x0161,7.390558,active-noncovalent
C[C@@H]1C[N@@H+]([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F,BRD-K17555800-001-01-9,talmapimod,MedChemEx,HY-10406,SCIO-469,-7.173151,x0161,7.390558,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F,BRD-K58811567-001-02-7,HKI-357,Tocris,3580,HKI 357,-7.172997,x0072,15.885283,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F,BRD-K58811567-001-01-9,HKI-357,Tocris,3580,(E)-N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,-7.172997,x0072,15.885283,active-noncovalent
CCOc1cc(ccc1O)C=O,BRD-K82104468-001-05-0,ethyl-vanillin,MicroSource,1503887,ETHYL VANILLIN,-7.171193,x0195,-1.317195,active-noncovalent
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl,BRD-K23984367-001-07-5,sorafenib,Selleck,S7397,Sorafenib,-7.169781,x0104,11.043346,active-noncovalent
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl,BRD-K23984367-075-15-2,sorafenib,Selleck,S1040,Sorafenib Tosylate,-7.169781,x0104,11.043346,active-noncovalent
c1cc(c(c2c1nsn2)NC3=[NH+]CCN3)Cl,BRD-K06335600-003-20-7,tizanidine,Tocris,3609,Tizanidine hydrochloride,-7.166359,x0831,-1.736664,active-covalent
c1cc(c(c2c1nsn2)NC3=[NH+]CCN3)Cl,BRD-K06335600-003-19-9,tizanidine,Selleck,S1437,Tizanidine HCl,-7.166359,x0831,-1.736664,active-covalent
c1cc(c(c2c1nsn2)NC3=[NH+]CCN3)Cl,BRD-K06335600-003-22-3,tizanidine,Tocris,3609,Tizanidine hydrochloride,-7.166359,x0831,-1.736664,active-covalent
CCN(CC)C(=O)c1ccc(c(c1)OC)O,BRD-K38055836-001-22-9,ethamivan,Sigma,MFCD00026727,"N,N-diethyl-4-hydroxy-3-methoxybenzamide",-7.165920,x0161,-0.465419,active-noncovalent
CCN(CC)C(=O)c1ccc(c(c1)OC)O,BRD-K38055836-001-21-1,ethamivan,MicroSource,1505994,ETHAMIVAN,-7.165920,x0161,-0.465419,active-noncovalent
CC[NH+](CC)CC1CCN(CC1)c2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BRD-K49294207-300-03-8,BIBU-1361,Tocris,2417,BIBU 1361 dihydrochloride,-7.165226,x0104,11.224558,active-noncovalent
CC[NH+](CC)CC1CCN(CC1)c2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BRD-K49294207-300-04-6,BIBU-1361,Tocris,2417,BIBU 1361 dihydrochloride,-7.165226,x0104,11.224558,active-noncovalent
C[C@@H](CN1CC(=O)NC(=O)C1)[NH+]2CC(=O)NC(=O)C2,BRD-K07265709-003-05-6,dexrazoxane,Selleck,S1222,Dexrazoxane Hydrochloride,-7.161602,x0678,0.661064,active-noncovalent
C[C@@H](CN1CC(=O)NC(=O)C1)[NH+]2CC(=O)NC(=O)C2,BRD-K07265709-003-03-1,dexrazoxane,Selleck,S1222,"Dexrazoxane HCl (ICRF-187, ADR-529)",-7.161602,x0678,0.661064,active-noncovalent
C[C@@H](CN1CC(=O)NC(=O)C1)[NH+]2CC(=O)NC(=O)C2,BRD-K07265709-003-04-9,dexrazoxane,Tocris,3857,Dexrazoxane hydrochloride,-7.161602,x0678,0.661064,active-noncovalent
c1cc(ccc1C(=O)Nn2c(c3c(c2O)[C@H]4C=C[C@@H]3[C@H]5[C@@H]4C5)O)C(F)(F)F,BRD-K24312986-001-01-2,tecovirimat,MedChemEx,HY-14805,Tecovirimat,-7.160572,x1077,5.942441,active-noncovalent
Cn1cnc2c1c(=O)n(c(=O)n2C)C,BRD-K02404261-001-16-7,caffeine,MicroSource,1500155,CAFFEINE,-7.160553,x0195,-0.350667,active-noncovalent
c1ccc(cc1)/C=C/CN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4,BRD-K07220430-001-18-4,cinnarazine,ChemDiv,R033-0071,,-7.158864,x0104,4.421618,active-noncovalent
c1ccc(cc1)/C=C/CN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4,BRD-K07220430-001-19-2,cinnarazine,MicroSource,1503204,CINNARAZINE,-7.158864,x0104,4.421618,active-noncovalent
CC1=CC[C@H](C[C@@H]1O)C(C)(C)O,BRD-K58262380-001-01-0,sobrepin,TCI,S0444,,-7.158757,x0195,0.717607,active-noncovalent
c1cc(c(cc1N)C(=O)[O-])O,BRD-K28849549-001-11-8,mesalazine,Selleck,S1681,Mesalamine,-7.158207,x0397,-1.34766,active-noncovalent
c1cc(c(cc1N)C(=O)[O-])O,BRD-K28849549-001-12-6,mesalazine,MicroSource,1505993,MESALAMINE,-7.158207,x0397,-1.34766,active-noncovalent
c1cc(c(cc1N)C(=O)[O-])O,BRD-K28849549-001-13-4,mesalazine,Selleck,S1681,Mesalamine (Lialda),-7.158207,x0397,-1.34766,active-noncovalent
C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)[O-])O,BRD-A49622760-001-01-9,faropenem,Astatech,41111,,-7.157839,x0678,-0.155329,active-noncovalent
CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO)O,BRD-A31454688-001-01-6,monostearin,TCI,G0085,,-7.157495,x0072,9.285683,active-noncovalent
C/C/1=C\CCC(=C)[C@H]2CC([C@@H]2CC1)(C)C,BRD-K26878113-001-01-6,g-caryophyllene,Sigma,MFCD00075925,"(1R,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene",-7.155902,x0195,1.364232,active-noncovalent
CN(C)C(=[NH2+])c1ccc(cc1)C(=O)Nc2ccc(cc2C(=O)Nc3ccc(cn3)Cl)OC,BRD-K45275534-001-01-3,betrixaban,MedChemEx,HY-10268,Betrixaban,-7.155660,x0161,9.152383,active-noncovalent
Cc1cccc(c1O)C(=O)[O-],BRD-K75608666-001-08-3,hydroxytoluic-acid,MicroSource,212064,HYDROXYTOLUIC ACID,-7.154855,x0195,-1.819344,active-noncovalent
CCN(CC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],BRD-K24443618-001-10-2,etebenecid,MicroSource,1504349,ETEBENECID,-7.152837,x0749,-1.089426,active-covalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)I,BRD-K76634210-001-12-1,idoxuridine,Selleck,S1883,Idoxuridine,-7.152639,x0195,-1.061428,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)I,BRD-K76634210-001-14-7,idoxuridine,MicroSource,1502350,IDOXURIDINE,-7.152639,x0195,-1.061428,active-noncovalent
C[C@@]12CC[C@H]3[C@]([C@@]14[C@H](O4)C(=O)O[C@H]2c5ccoc5)(C(=O)C[C@@H]6[C@@]37COC(=O)C[C@@H]7OC6(C)C)C,BRD-K05906022-001-05-1,limonin,Selleck,S2319,Limonin,-7.152341,x0104,4.383711,active-noncovalent
C[C@](C(=O)Nc1ccc(cc1)S(=O)(=O)c2ccccc2)(C(F)(F)F)O,BRD-A62209527-001-04-5,ZM-226600,Tocris,882,ZM 226600,-7.152056,x1077,3.411685,active-noncovalent
C[C@]1([C@@H]2C[C@@H](C2(C)C)C[C@@H]1O)O,BRD-K69885552-001-01-7,pinanediol,Sigma,MFCD09955216,"(1R,2R,3S,5S)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol",-7.151390,x0678,2.141744,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C[C@@H]([C@H](O2)CO)O,BRD-K91822704-003-07-2,torcitabine,MedChemEx,HY-17564,2'-Deoxycytidine (hydrochloride),-7.150455,x0195,-0.764965,active-noncovalent
CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NCCCCCC[NH3+],BRD-K31313613-003-04-2,BS-181,Selleck,S1572,BS-181 HCl,-7.148095,x0161,5.958488,active-noncovalent
CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NCCCCCC[NH3+],BRD-K31313613-300-01-8,BS-181,Tocris,5608,BS 181 dihydrochloride,-7.148095,x0161,5.958488,active-noncovalent
CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NCCCCCC[NH3+],BRD-K31313613-003-05-9,BS-181,Selleck,S1572,BS-181 HCl,-7.148095,x0161,5.958488,active-noncovalent
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,BRD-K81062487-001-05-8,taurocholate,Enzo,BL056,Taurocholic acid sodium salt,-7.146979,x1077,9.29294,active-noncovalent
C[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)[nH]n3)c4ccc(cc4)F,BRD-K65170927-001-01-6,aprepitant,Selleck,S1189,Aprepitant,-7.146827,x0104,7.577214,active-noncovalent
CCOc1ccc(c2c1nccc2)S(=O)(=O)[O-],BRD-K08837089-236-01-6,actinoquinol,MicroSource,1505401,ACTINOQUINOL SODIUM,-7.146725,x0195,0.991122,active-noncovalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K27798832-001-01-5,cefetamet,Sigma,MFCD00864836,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",-7.146536,x0830,4.118134,active-covalent
Cc1cccn2c1ncc(c2=O)c3[n-]nnn3,BRD-K31731454-237-02-5,pemirolast,Selleck,S4008,Pemirolast (BMY 26517) potassium,-7.146090,x0195,0.536994,active-noncovalent
Cc1cccn2c1ncc(c2=O)c3[n-]nnn3,BRD-K31731454-237-03-3,pemirolast,MedChemEx,HY-B0538A,Pemirolast (potassium),-7.146090,x0195,0.536994,active-noncovalent
CO/N=C/1\CN(C[C@@H]1C[NH3+])c2c(cc3c(=O)c(cn(c3n2)C4CC4)C(=O)[O-])F,BRD-A40787240-066-04-6,gemifloxacin,MicroSource,1505802,GEMIFLOXACIN MESYLATE,-7.145956,x0874,4.798139,active-noncovalent
COc1cccc(c1C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(c(c5)OC)C(=O)[O-])F,BRD-K75295174-001-05-0,alisertib,Selleck,S1133,Alisertib (MLN8237),-7.144316,x0161,9.574923,active-noncovalent
CC(C)C(=O)Oc1ccc(cc1[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)CO,BRD-K46731503-050-01-8,fesoterodine,Selleck,S2240,Fesoterodine Fumarate,-7.142383,x0967,3.347524,active-noncovalent
CC(C)C(=O)Oc1ccc(cc1[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)CO,BRD-K46731503-051-04-0,fesoterodine,Selleck,S2240,Fesoterodine Fumarate,-7.142383,x0967,3.347524,active-noncovalent
Cc1cc(nn1Cc2ccnc(c2)N3CC[NH+](CC3)C4CC4)c5nc(no5)c6ccc(cc6)OC(F)(F)F,BRD-K70463136-001-01-5,BAY-87-2243,MedChemEx,HY-15836,BAY 87-2243,-7.141499,x0104,12.122856,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(c(cc1OC)N)Cl,BRD-K75641298-003-25-0,metoclopramide,MicroSource,1500410,METOCLOPRAMIDE HYDROCHLORIDE,-7.141313,x0830,2.379444,active-covalent
CCCCCOC(=O)Nc1c(cn(c(=O)n1)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O)F,BRD-K61192372-001-06-3,capecitabine,Tocris,4799,Capecitabine,-7.139324,x0946,3.353472,active-noncovalent
CCCCCOC(=O)Nc1c(cn(c(=O)n1)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O)F,BRD-K61192372-001-07-1,capecitabine,Selleck,S1156,Capecitabine,-7.139324,x0946,3.353472,active-noncovalent
CCCCCOC(=O)Nc1c(cn(c(=O)n1)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O)F,BRD-K61192372-001-05-5,capecitabine,Selleck,S1156,Capecitabine (Xeloda),-7.139324,x0946,3.353472,active-noncovalent
CCCCCOC(=O)Nc1c(cn(c(=O)n1)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O)F,BRD-K61192372-001-08-9,capecitabine,MicroSource,1502271,CAPECITABINE,-7.139324,x0946,3.353472,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C,BRD-A83802939-304-04-2,dexamethasone-sodium-phosphate,MicroSource,1500232,DEXAMETHASONE SODIUM PHOSPHATE,-7.138883,x0395,5.805726,active-noncovalent
c1ccc(cc1)CCO,BRD-K42371134-001-06-6,phenylethyl-alcohol,MicroSource,1505398,PHENYLETHYL ALCOHOL,-7.138820,x0678,0.957879,active-noncovalent
CCCCCCCCO,BRD-K09338665-001-07-1,1-octanol,Enamine,Z104473500,,-7.137148,x0749,-0.966088,active-covalent
CCCCCCCCO,BRD-K09338665-001-08-9,1-octanol,Enamine,Z104473500,1-octanol,-7.137148,x0749,-0.966088,active-covalent
C=CC(=O)N1CCC[C@@H](C1)n2c3c(c(ncn3)N)n(c2=O)c4ccc(cc4)Oc5ccccc5,BRD-A13689093-001-01-8,ONO-4059,Selleck,S7877,ONO-4059,-7.136615,x0104,7.808119,active-noncovalent
CCOc1ccc(cc1)NC(=O)C,BRD-K38323065-001-19-9,phenacetin,MicroSource,1500642,PHENACETIN,-7.136196,x0195,-1.216916,active-noncovalent
CCOc1ccc(cc1)NC(=O)C,BRD-K38323065-001-18-1,phenacetin,Selleck,S2577,Phenacetin,-7.136196,x0195,-1.216916,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)([O-])[O-],BRD-K15891719-213-01-1,tenofovir,MicroSource,1502393,TENOFOVIR,-7.134853,x0708,0.72362,active-covalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)([O-])[O-],BRD-K15891719-001-04-4,tenofovir,Selleck,S1401,Tenofovir,-7.134853,x0708,0.72362,active-covalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)([O-])[O-],BRD-K15891719-001-05-1,tenofovir,Selleck,S1401,Tenofovir (Viread),-7.134853,x0708,0.72362,active-covalent
C(C[NH3+])C[NH2+]CCSP(=O)([O-])[O-],BRD-K73947551-001-04-4,amifostine,MicroSource,1503081,AMIFOSTINE,-7.130889,x0708,-1.00381,active-covalent
c1ccc(cc1)c2cccc(c2)Cn3c(cnn3)c4cccc(c4)n5c6c(c(n5)c7ccc(cc7)Cl)c(ncn6)N,BRD-K88154110-001-01-0,KB-SRC-4,Tocris,4660,KB SRC 4,-7.129788,x0161,9.74993,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K71847383-001-13-3,cytarabine,MicroSource,1500217,CYTARABINE,-7.129302,x0107,-0.321712,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K71847383-001-07-5,cytarabine,Selleck,S1648,Cytarabine,-7.129302,x0107,-0.321712,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K71847383-001-12-5,cytarabine,Selleck,S2053,Cytidine,-7.129302,x0107,-0.321712,active-noncovalent
c1cc(ccc1[C@H]([C@@H](COC(=O)CCC(=O)[O-])NC(=O)C(Cl)Cl)O)N(=O)=O,BRD-K25209357-236-01-2,chloramphenicol-sodium-succinate,MicroSource,1500173,CHLORAMPHENICOL SODIUM SUCCINATE,-7.129247,x0104,3.0513,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3)C(=O)[O-],BRD-K64659768-001-12-8,phthalylsulfathiazole,MicroSource,1502021,PHTHALYLSULFATHIAZOLE,-7.128944,x0104,4.287243,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3)C(=O)[O-],BRD-K64659768-001-13-6,phthalylsulfathiazole,MedChemEx,HY-B1407,Phthalylsulfathiazole,-7.128944,x0104,4.287243,active-noncovalent
CCN(CC)C(=O)N1CC[NH+](CC1)C,BRD-K45542189-048-22-1,diethylcarbamazine,MicroSource,1500242,DIETHYLCARBAMAZINE CITRATE,-7.128884,x0195,-0.72127,active-noncovalent
Cc1cccc(c1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,BRD-A50311610-300-11-2,meclizine,Tocris,4245,Meclizine dihydrochloride,-7.127591,x0195,5.660975,active-noncovalent
Cc1cccc(c1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,BRD-A50311610-300-09-6,meclizine,Selleck,S1986,Meclizine 2HCl,-7.127591,x0195,5.660975,active-noncovalent
Cc1cccc(c1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,BRD-A50311610-300-10-4,meclizine,MicroSource,1500376,MECLIZINE HYDROCHLORIDE,-7.127591,x0195,5.660975,active-noncovalent
CCOC(=O)Nc1ccc2c(c1)N(c3ccccc3S2)C(=O)CC[NH+]4CCOCC4,BRD-K21548250-003-19-1,moracizine,Prestwick,Prestw-1051,Moricizine hydrochloride,-7.127420,x0195,3.321037,active-noncovalent
C1CN[P@](=O)(OC1)N(CCCl)CCCl,BRD-A09722536-002-17-2,cyclophosphamide,Selleck,S2057,Cyclophosphamide monohydrate,-7.126987,x0434,-0.289529,active-noncovalent
C1CN[P@](=O)(OC1)N(CCCl)CCCl,BRD-A09722536-002-19-8,cyclophosphamide,Selleck,S2057,Cyclophosphamide monohydrate,-7.126987,x0434,-0.289529,active-noncovalent
C1CN[P@](=O)(OC1)N(CCCl)CCCl,BRD-A09722536-002-18-0,cyclophosphamide,MicroSource,1500213,CYCLOPHOSPHAMIDE,-7.126987,x0434,-0.289529,active-noncovalent
c1ccnc(c1)CC[NH3+],BRD-K17874705-300-04-0,2-pyridylethylamine,Tocris,2478,2-Pyridylethylamine dihydrochloride,-7.126884,x0195,-2.020775,active-noncovalent
c1ccnc(c1)CC[NH3+],BRD-K17874705-300-03-2,2-pyridylethylamine,Tocris,2478,2-Pyridylethylamine dihydrochloride,-7.126884,x0195,-2.020775,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCN3C(=O)CC4(CCCC4)CC3=O,BRD-K93461745-003-25-0,buspirone,MicroSource,2300173,BUSPIRONE HYDROCHLORIDE,-7.126230,x0161,5.27178,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCN3C(=O)CC4(CCCC4)CC3=O,BRD-K93461745-003-24-3,buspirone,Tocris,962,Buspirone hydrochloride,-7.126230,x0161,5.27178,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCN3C(=O)CC4(CCCC4)CC3=O,BRD-K93461745-003-23-5,buspirone,Selleck,S4256,Buspirone HCl,-7.126230,x0161,5.27178,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)C5CC5)F,BRD-K78122587-300-04-3,NNC-55-0396,Tocris,2268,"(1S,2S)-2-{2-[[3-(1H-benzimidazol-2-yl)propyl](methyl)amino]ethyl}-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-2-naphthalenyl cyclo",-7.126084,x1077,7.022749,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)C5CC5)F,BRD-K78122587-300-02-7,NNC-55-0396,Tocris,2268,NNC 55-0396 dihydrochloride,-7.126084,x1077,7.022749,active-noncovalent
Cc1c(cccc1Cl)S(=O)(=O)Nc2nc(cs2)CC(=O)N3CC[NH+](CC3)C,BRD-K01742705-001-01-7,BVT-2733,MedChemEx,HY-18054,BVT 2733,-7.125951,x0678,1.598685,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)/C(=C(/c2ccccc2)\Cl)/c3ccccc3,BRD-K29950728-048-18-2,clomifene,Selleck,S2561,Clomifene citrate (Serophene),-7.125950,x1077,4.702589,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)/C(=C(/c2ccccc2)\Cl)/c3ccccc3,BRD-K29950728-048-17-4,clomifene,MicroSource,1500196,CLOMIPHENE CITRATE,-7.125950,x1077,4.702589,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)/C(=C(/c2ccccc2)\Cl)/c3ccccc3,BRD-K29950728-048-16-6,clomifene,Selleck,S2561,Clomifene citrate,-7.125950,x1077,4.702589,active-noncovalent
CCCCCCCCCC[C@H]([C@H]1C=C[C@@H]2[C@H]([N@@]1Nc3ccc(cc3)N(=O)=O)C(=O)N(C2=O)c4ccccc4)O,BRD-A30000356-001-01-9,A12B4C3,Tocris,5097,A12B4C3,-7.124813,x0104,7.600841,active-noncovalent
CCCCCCCCCCCCCCOS(=O)(=O)[O-],BRD-K84544951-236-01-0,sodium-tetradecyl-sulfate,AlfaAesar,B21941,,-7.124451,x0749,3.230445,active-covalent
CCCC(=O)OCOC(=O)C(C)(C)C,BRD-K20504455-001-01-0,pivanex,Sigma,MFCD00209896,"[(2,2-dimethylpropanoyl)oxy]methyl butyrate",-7.124444,x0161,-0.235037,active-noncovalent
C1CCC(=NOC(=O)NCCCCCCNC(=O)ON=C2CCCCC2)CC1,BRD-K56047318-001-06-3,RHC-80267,Tocris,1842,RHC 80267,-7.123348,x0874,4.2168,active-noncovalent
C1CCC(=NOC(=O)NCCCCCCNC(=O)ON=C2CCCCC2)CC1,BRD-K56047318-001-07-1,RHC-80267,Tocris,1842,RHC 80267,-7.123348,x0874,4.2168,active-noncovalent
COc1c2[nH]c(cc2ccc1)c3nc(n4c3c(ncn4)N)[C@H]5CC[C@@H](CC5)C(=O)[O-],BRD-K87124298-001-03-4,OSI-027,Selleck,S2624,OSI-027,-7.123304,x0434,5.754238,active-noncovalent
COc1c2[nH]c(cc2ccc1)c3nc(n4c3c(ncn4)N)[C@H]5CC[C@@H](CC5)C(=O)[O-],BRD-K87124298-001-04-2,OSI-027,Selleck,S2624,OSI-027,-7.123304,x0434,5.754238,active-noncovalent
C[C@H](C[NH+](C)C)[C@@](C)(Cc1ccc(cc1)Cl)O,BRD-A43809092-003-02-1,clobutinol,Prestwick,Prestw-1380,Clobutinol hydrochloride,-7.122184,x0749,-0.421063,active-covalent
CCC(CC)(c1ccccc1)C(=O)OCCOCC[NH+](CC)CC,BRD-K17977438-048-02-4,oxelaidin,MicroSource,1505774,OXELAIDIN CITRATE,-7.120561,x0161,3.112299,active-noncovalent
CCC(CC)(c1ccccc1)C(=O)OCCOCC[NH+](CC)CC,BRD-K17977438-048-03-2,oxelaidin,Selleck,S4402,Oxeladin Citrate,-7.120561,x0161,3.112299,active-noncovalent
CCC(CC)(c1ccccc1)C(=O)OCCOCC[NH+](CC)CC,BRD-K17977438-048-04-0,oxelaidin,Selleck,S4402,oxelaidin citrate,-7.120561,x0161,3.112299,active-noncovalent
c1cc2c(cc1NC(=O)Nc3ccc4c(c3)cc(cc4O)S(=O)(=O)[O-])cc(cc2O)S(=O)(=O)[O-],BRD-K75114721-304-02-6,AMI-1,ChemBridge,FT47-8059,AMI-1,-7.118473,x0104,15.3568,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],BRD-K15014948-213-01-3,tranexamic-acid,MicroSource,1502026,TRANEXAMIC ACID,-7.117168,x0426,1.933726,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],BRD-K15014948-001-09-5,tranexamic-acid,Selleck,S1875,Tranexamic acid (Transamin),-7.117168,x0426,1.933726,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],BRD-K15014948-001-11-1,tranexamic-acid,MedChemEx,HY-B0149,Tranexamic acid,-7.117168,x0426,1.933726,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],BRD-K15014948-001-10-3,tranexamic-acid,MedChemEx,HY-B0149,Tranexamic acid,-7.117168,x0426,1.933726,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],BRD-K15014948-001-12-9,tranexamic-acid,Selleck,S1875,Tranexamic Acid,-7.117168,x0426,1.933726,active-noncovalent
C[N+](C)(C)CCO[P@](=O)([O-])OC[C@@H](CO)O,BRD-A72390365-001-15-2,choline-alfoscerate,MedChemEx,HY-17552,sn-Glycero-3-phosphocholine,-7.116318,x0397,-0.272395,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)[N-]c2ccc(cc2)N(=O)=O,BRD-K76845197-001-05-4,sulfanitran,MicroSource,1503339,SULFANITRAN,-7.116084,x0195,1.326532,active-noncovalent
CCS(=O)(=O)[N@@]1CCC[C@H]2[C@@H]1C[C@H]3c4ccc(cc4CC[N@@H+]3C2)OC,BRD-K86600316-003-02-0,RS-79948,Tocris,987,RS 79948 hydrochloride,-7.115642,x0161,2.597311,active-noncovalent
C[C@@]1(CC(=O)c2ccccc2C1=O)S(=O)(=O)[O-],BRD-A19777893-236-01-9,menadione-bisulfite,Sigma,M5750,"sodium 2-methyl-1,4-dioxo-1,2,3,4-tetrahydro-2-naphthalenesulfonate",-7.114249,x0195,0.251391,active-noncovalent
c1ccc(cc1)c2c(c(=O)[nH]c(n2)N)Br,BRD-K17500877-001-02-1,bropirimine,LifeChem,F2158-0617,,-7.113606,x0195,-0.8158,active-noncovalent
CC(C)Cn1c2c(c(=O)n(c1=O)C)[nH]cn2,BRD-K94979336-001-20-0,IBMX,Tocris,2845,IBMX,-7.113242,x0195,-0.648371,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@]1(C(=O)C[C@@H]3[C@@H]2C(=O)C[C@H]4[C@@]3(CCC(=O)C4)C)C,BRD-A11551002-001-04-6,dehydrocholate-acid,MicroSource,1500907,DEHYDROCHOLIC ACID,-7.112357,x0749,5.046535,active-covalent
CCCCCCCNS(=O)(=O)c1cccc2c1cccc2Cl,BRD-K05361803-001-03-9,SC-10,Tocris,430,SC-10,-7.111990,x0072,1.56168,active-noncovalent
CO/N=C(/c1ccco1)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)COC(=O)N)C(=O)[O-],BRD-K02733959-236-05-1,cefuroxime,MedChemEx,HY-B1256,Cefuroxime (sodium),-7.110830,x0874,4.3022,active-noncovalent
CO/N=C(/c1ccco1)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)COC(=O)N)C(=O)[O-],BRD-K02733959-236-06-9,cefuroxime,MedChemEx,HY-B1256,Cefuroxime (sodium),-7.110830,x0874,4.3022,active-noncovalent
CO/N=C(/c1ccco1)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)COC(=O)N)C(=O)[O-],BRD-K02733959-236-07-7,cefuroxime,MicroSource,1502033,CEFUROXIME SODIUM,-7.110830,x0874,4.3022,active-noncovalent
CC(=O)O[C@H]1C[C@H]2CC[C@@]1(C2(C)C)C,BRD-A41385909-001-02-1,bornyl-acetate,Vitas-M,STK079562,"1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate",-7.110511,x0195,1.939854,active-noncovalent
CC(=O)O[C@H]1C[C@H]2CC[C@@]1(C2(C)C)C,BRD-A41385909-001-01-3,bornyl-acetate,MicroSource,1502510,BORNYL ACETATE,-7.110511,x0195,1.939854,active-noncovalent
CCCCC1CCC(CC1)c2nc(no2)c3ccncc3,BRD-K25524093-003-01-7,PSN-375963,Tocris,3353,PSN 375963 hydrochloride,-7.109426,x0161,3.207222,active-noncovalent
CCCCC1CCC(CC1)c2nc(no2)c3ccncc3,BRD-K25524093-003-02-5,PSN-375963,Tocris,3353,PSN 375963 hydrochloride,-7.109426,x0161,3.207222,active-noncovalent
C([C@@H]1[C@H]([C@H]([C@@H](O1)n2c3c(c(=O)[nH]c(n3)N)sc2=O)O)O)O,BRD-K87535339-001-01-6,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",Berry,PRA 10047,,-7.109203,x0104,0.562717,active-noncovalent
C[C@]12[C@@H]3[C@H]4[C@@H]([C@@H]([C@]1(C[C@H]5[C@@]2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O,BRD-A91822151-001-05-0,picrotin,SantaCruz,sc-228947,Picrotin,-7.107205,x0072,3.421275,active-noncovalent
CC(=O)N[C@@H](CS)C(=O)[O-],BRD-K59058747-001-19-1,acetylcysteine,Selleck,S1623,Acetylcysteine,-7.105511,x0397,-0.75018,active-noncovalent
CC(=O)N[C@@H](CS)C(=O)[O-],BRD-K59058747-001-20-9,acetylcysteine,MicroSource,1500105,ACETYLCYSTEINE,-7.105511,x0397,-0.75018,active-noncovalent
CC(=O)N[C@@H](CS)C(=O)[O-],BRD-K59058747-001-18-3,acetylcysteine,Selleck,S1623,Acetylcysteine,-7.105511,x0397,-0.75018,active-noncovalent
c1c(cc(c(c1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,BRD-K71499074-001-12-9,diclofenamide,Selleck,S2177,Dichlorphenamide,-7.105409,x0195,1.845236,active-noncovalent
CSC[C@@H](C(=O)[O-])[NH3+],BRD-K63123526-001-01-2,S-methylcysteine,Ark,AK-44172,,-7.103190,x1077,-1.33734,active-noncovalent
CSC[C@@H](C(=O)[O-])[NH3+],BRD-K63123526-001-02-0,S-methylcysteine,Ark,AK-44172,(2R)-2-amino-3-(methylsulfanyl)propanoic acid,-7.103190,x1077,-1.33734,active-noncovalent
CCCCCCCCCCCCN1CCCCCC1=O,BRD-K35698076-001-01-2,laurocapram,InterBioScreen,STOCK1S-00317,,-7.102621,x0104,2.51255,active-noncovalent
CC[C@@H](Cc1c(cc(c(c1I)N)I)I)C(=O)[O-],BRD-A42628519-001-12-4,iopanic-acid,MicroSource,1503923,IOPANIC ACID,-7.102503,x0749,0.526762,active-covalent
c1c(c2c(ncnc2n1[C@@H]3[C@H]([C@H]([C@H](O3)CO)O)O)N)C(=O)N,BRD-A64064900-001-02-3,sangivamycin,EMDBio,559307-1MG,Sangivamycin,-7.101930,x0195,0.453103,active-noncovalent
C1[C@H]([C@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@H]([C@H]([C@@H]([C@@H](O2)C[NH3+])O)O)[NH3+])O[C@@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)O)[NH3+],BRD-A86073102-001-01-6,ribostamycin,Bosche,R5782,"4,6-diamino-3-hydroxy-2-(pentofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxyhexopyranoside",-7.101848,x1077,3.055126,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,BRD-K31139048-001-03-2,omega-3-acid-esters,MedChemEx,HY-B0747,Eicosapentaenoic acid (ethyl ester),-7.099202,x0161,2.24343,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,BRD-K31139048-001-02-4,omega-3-acid-esters,MicroSource,1300030,OMEGA-3-ACID ESTERS (EPA shown),-7.099202,x0161,2.24343,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,BRD-K31139048-001-04-0,omega-3-acid-esters,MedChemEx,HY-B0747,Eicosapentaenoic acid (ethyl ester),-7.099202,x0161,2.24343,active-noncovalent
CC(C)N/C(=[NH+]\C(C)C)/SCC(=O)/N=C/1\[C@@H]2N(C1=O)[C@H]([C@@H](CS2)COC(=O)C)C(=O)[O-],BRD-K63835048-001-01-0,cefathiamidine,AKSci,S023,,-7.097280,x0874,4.464244,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2CCCO2)F,BRD-K99383816-001-02-7,ftorafur,Selleck,S1300,FT-207 (NSC 148958),-7.095570,x0161,-1.541123,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2CCCO2)F,BRD-K99383816-001-03-5,ftorafur,Selleck,S1300,"Tegafur (FT-207, NSC 148958)",-7.095570,x0161,-1.541123,active-noncovalent
CCNC(=O)CC[C@H](C(=O)[O-])[NH3+],BRD-A08715367-001-01-7,L-Theanine,Enzo,AC1565,L-theanine,-7.095416,x0397,-1.620254,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)N(C)Cc6ccccc6)O,BRD-K83508485-001-03-5,FK-888,Tocris,2400,FK 888,-7.094897,x0104,12.795797,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)N(C)Cc6ccccc6)O,BRD-K83508485-001-02-7,FK-888,Tocris,2400,FK 888,-7.094897,x0104,12.795797,active-noncovalent
C[C@]([C@@H](CC(=O)[O-])C(=O)[O-])(C(=O)[O-])O,BRD-M01344114-348-01-0,threo-2-methylisocitrate-(DL),MedChemEx,HY-16581A,DL-threo-2-methylisocitrate (sodium),-7.094349,x0397,1.865708,active-noncovalent
c1c(cc(cc1C(=O)NCCO)C(=O)NCCO)C(=O)NCCO,BRD-K70404782-001-01-6,LM-22A4,Tocris,4607,LM 22A4,-7.094324,x0678,1.685162,active-noncovalent
c1cc(cc(c1)O)O,BRD-K74190368-001-04-3,resorcinol,MicroSource,1500527,RESORCINOL,-7.094061,x0678,1.269469,active-noncovalent
CC(C)CNc1c2[nH+]cc(n2cc(n1)c3cccc4c3cccn4)c5ccc(cc5)C(=O)NC6CC6,BRD-K18530250-001-01-6,Mps-BAY-2a,Tocris,5562,Mps BAY 2a,-7.094054,x0104,9.174999,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,BRD-K91900765-001-08-4,VX-745,MedChemEx,HY-10328,VX-745,-7.090709,x0072,2.741809,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,BRD-K91900765-001-07-6,VX-745,MedChemEx,HY-10328,VX-745,-7.090709,x0072,2.741809,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,BRD-K91900765-001-06-8,VX-745,Selleck,S1458,VX-745,-7.090709,x0072,2.741809,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,BRD-K91900765-001-05-0,VX-745,Selleck,S1458,VX-745,-7.090709,x0072,2.741809,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)N(=O)=O)c2ccccc2C(F)(F)F)C(=O)OC,BRD-K14329163-001-03-9,BAY-K-8644-(s)-(-),Tocris,1546,(S)-(-)-Bay K 8644,-7.090485,x0195,3.326992,active-noncovalent
C[C@H]1CC[C@@H](CC1)n2c3nc(ncc3c4c2cncc4)Nc5nc6c(cc5)CN(CC6)C(=O)CO,BRD-K97452254-001-01-3,AMG-925,MedChemEx,HY-15889,AMG 925,-7.089983,x1077,8.035824,active-noncovalent
COc1cc(c(cc1OC)OC)C=O,BRD-K88219015-001-10-8,asaraldehyde,Selleck,S2531,Asaraldehyde,-7.086948,x0195,0.057104,active-noncovalent
C(CC[NH+]=C(N)N)C[NH3+],BRD-K49738308-065-04-9,agmatine,Enzo,AC162,Agmatine sulfate,-7.086675,x0195,-1.148363,active-noncovalent
c1cc(sc1)[C@H]2C(=O)NCC[NH2+]2,BRD-A41835910-001-02-2,tenilsetam,Enamine,EN300-93479,3-(2-thienyl)-2-piperazinone,-7.086032,x1382,-0.923065,active-covalent
c1cc(sc1)[C@H]2C(=O)NCC[NH2+]2,BRD-A41835910-001-01-4,tenilsetam,LifeChem,F2147-0982,,-7.086032,x1382,-0.923065,active-covalent
COc1ccc(cc1)n2c(nnc2SCCCN3C(=O)c4cccc5c4c(ccc5)C3=O)c6ccncc6,BRD-K19316653-001-02-0,WIKI4,MedChemEx,HY-16910,WIKI4,-7.085532,x0161,7.058526,active-noncovalent
CCCCCCCCCCCCCCOc1ccc(o1)C(=O)[O-],BRD-K71164191-001-01-0,KD-023,EMDBio,613450-5MG,TOFA,-7.084907,x0161,3.441221,active-noncovalent
C(=C(/C(=O)[O-])\O)\C(=O)[O-],BRD-K61279411-001-02-0,oxaloacetate,Enamine,Z271128590,,-7.083964,x0397,0.159195,active-noncovalent
C(=C(/C(=O)[O-])\O)\C(=O)[O-],BRD-K61279411-001-03-8,oxaloacetate,Sigma,MFCD00002592,2-oxosuccinic acid,-7.083964,x0397,0.159195,active-noncovalent
CC(=O)c1ccc(cc1O)OC,BRD-K94239562-001-05-5,paeonol,Selleck,S2339,Paeonol,-7.083340,x0749,0.858483,active-covalent
CC1(OC[C@H](O1)COC(=O)CCc2ccc(cc2)OC[C@H](C[NH2+]CCNC(=O)N3CCOCC3)O)C,BRD-K86436199-003-01-3,landiolol,AKSci,V1307,,-7.082905,x1077,7.774826,active-noncovalent
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCOS(=O)(=O)[O-])C)C)O,BRD-K33067152-236-01-1,INT-767,MedChemEx,HY-12434,INT-767,-7.082079,x0161,4.428645,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CC[C@H](O2)CO,BRD-K85925969-001-17-4,zalcitabine,MicroSource,1502360,ZALCITABINE,-7.082031,x0195,-0.738436,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CC[C@H](O2)CO,BRD-K85925969-001-16-6,zalcitabine,Selleck,S1719,Zalcitabine,-7.082031,x0195,-0.738436,active-noncovalent
C[C@@H](C(=O)N[C@@H](c1ccccc1)C(=O)OC(C)(C)C)NC(=O)Cc2cc(cc(c2)F)F,BRD-K47177710-001-03-1,DAPT,Tocris,2634,DAPT,-7.081965,x0397,4.015122,active-noncovalent
C[C@@H](C(=O)N[C@@H](c1ccccc1)C(=O)OC(C)(C)C)NC(=O)Cc2cc(cc(c2)F)F,BRD-K47177710-001-04-9,DAPT,Tocris,2634,DAPT,-7.081965,x0397,4.015122,active-noncovalent
C[C@@H](C(=O)N[C@@H](c1ccccc1)C(=O)OC(C)(C)C)NC(=O)Cc2cc(cc(c2)F)F,BRD-K47177710-001-02-3,DAPT,Selleck,S2215,DAPT (GSI-IX),-7.081965,x0397,4.015122,active-noncovalent
C[C@H]1[C@@H]2CC[C@]3([C@@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(\CCC=C(C)C)/C(=O)[O-])OC(=O)C)C)O)C,BRD-A06935312-001-04-3,fusidic-acid,MicroSource,1500311,FUSIDIC ACID,-7.081671,x0072,8.268873,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,BRD-K93880783-001-27-4,stavudine,Tocris,4990,Stavudine,-7.081596,x0678,-1.198525,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,BRD-K93880783-001-26-6,stavudine,MicroSource,1502339,STAVUDINE,-7.081596,x0678,-1.198525,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,BRD-K93880783-001-28-2,stavudine,Selleck,S1398,Stavudine (d4T),-7.081596,x0678,-1.198525,active-noncovalent
COc1c(cc(cn1)c2ccc3c(c2)c(ccn3)c4ccnnc4)NS(=O)(=O)c5ccc(cc5F)F,BRD-K07972848-001-02-0,GSK2126458,Selleck,S2658,GSK2126458 (GSK458),-7.078689,x0967,7.471109,active-noncovalent
c1ccc(c(c1)C(=O)N)O,BRD-K81130846-001-17-4,salicylamide,MicroSource,1500532,SALICYLAMIDE,-7.078387,x0195,-1.627761,active-noncovalent
C[NH+](C)CCOc1cc(ccc1NC(=O)[C@@H]2COc3ccccc3O2)c4c[nH]nc4,BRD-A86468475-300-01-3,SR-3677,Tocris,3667,SR 3677 dihydrochloride,-7.078302,x0874,3.950801,active-noncovalent
Cc1cc(ccc1N(C)C)Cn2cnc3c2C[C@H](N(C3)C(=O)C(c4ccccc4)c5ccccc5)C(=O)[O-],BRD-K34713073-001-01-3,PD-123319,Selleck,S7098,PD123319,-7.077927,x0072,10.200863,active-noncovalent
Cc1cc(ccc1N(C)C)Cn2cnc3c2C[C@H](N(C3)C(=O)C(c4ccccc4)c5ccccc5)C(=O)[O-],BRD-K34713073-362-01-9,PD-123319,Tocris,1361,PD 123319 ditrifluoroacetate,-7.077927,x0072,10.200863,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)OC,BRD-K17617556-001-01-3,NIDA-41020,Tocris,3921,NIDA 41020,-7.076996,x0161,5.079546,active-noncovalent
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,BRD-K49783248-303-07-6,decamethonium,Selleck,S4072,Decamethonium Bromide,-7.076600,x0749,1.509383,active-covalent
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,BRD-K49783248-303-08-4,decamethonium,MicroSource,1505991,DECAMETHONIUM BROMIDE,-7.076600,x0749,1.509383,active-covalent
C[C@]1([C@@H]([C@H](O[C@H]1n2ccc(nc2=O)N)CO)O)F,BRD-K07798980-001-01-9,PSI-6130,MedChemEx,HY-10165,PSI-6130,-7.075310,x0195,0.726987,active-noncovalent
C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])Cn3ccnn3,BRD-A18611368-001-01-5,tazobactam,MicroSource,1502341,TAZOBACTAM,-7.073960,x1418,-0.0559,active-covalent
CCOP(=O)(Cc1ccc(cc1)C(=O)Nc2ccc(cc2C#N)Br)OCC,BRD-K62490786-001-01-1,ibrolipim,Sigma,N1540,diethyl 4-[(4-bromo-2-cyanoanilino)carbonyl]benzylphosphonate,-7.073559,x0104,5.721933,active-noncovalent
c1cc(cc(c1)F)N2CNC(=O)C23CC[NH+](CC3)CCNC(=O)c4ccc(c(c4)F)F,BRD-K24600306-003-01-9,ML-298,Tocris,4895,ML 298 hydrochloride,-7.071095,x0195,7.748351,active-noncovalent
CC(C)Oc1cc(ccc1C2=[NH+][C@H]([C@@H](N2C(=O)N3CCNC(=O)C3)c4ccc(cc4)Cl)c5ccc(cc5)Cl)OC,BRD-A12230535-001-06-7,nutlin-3,Selleck,S1061,Nutlin-3,-7.070114,x0678,8.237206,active-noncovalent
CC(C)Oc1cc(ccc1C2=[NH+][C@H]([C@@H](N2C(=O)N3CCNC(=O)C3)c4ccc(cc4)Cl)c5ccc(cc5)Cl)OC,BRD-A12230535-001-11-7,nutlin-3,Selleck,S1061,Nutlin-3,-7.070114,x0678,8.237206,active-noncovalent
c1ccc-2c(c1)CCCc3c2nnc(c3)n4c(nc(n4)Nc5ccc6c(c5)CC[C@H](CC6)[NH+]7CCCC7)N,BRD-K14870255-001-02-3,R-428,MedChemEx,HY-15150,R428,-7.069294,x0104,17.33349,active-noncovalent
CC(C)c1ccccc1S(=O)(=O)c2cc(c3c(c2N(=O)=O)cccn3)N,BRD-K12079898-001-02-6,PD-160170,Tocris,2200,PD 160170,-7.068833,x0072,0.674178,active-noncovalent
CC(C)c1ccccc1S(=O)(=O)c2cc(c3c(c2N(=O)=O)cccn3)N,BRD-K12079898-001-03-4,PD-160170,Tocris,2200,PD 160170,-7.068833,x0072,0.674178,active-noncovalent
Cc1cnc(cn1)CNC(=O)c2c(=O)c3ccc(nc3n4c2sc5c4cccc5)N6CCC[N@H+](CC6)C,BRD-K12787259-001-04-3,CX-5461,MedChemEx,HY-13323,CX-5461,-7.067456,x0104,7.667005,active-noncovalent
C[C@H]1C[N@@H+](CC[C@@]1(C)c2cccc(c2)O)C[C@H](Cc3ccccc3)C(=O)NCC(=O)[O-],BRD-K07857022-002-01-1,alvimopan,MedChemEx,HY-76657,Alvimopan (monohydrate),-7.066267,x0072,6.279792,active-noncovalent
Cn1c(c[nH+]c1COC(=O)N)N(=O)=O,BRD-K94266545-001-23-3,ronidazole,Selleck,S4062,Ronidazole,-7.064361,x1412,-0.893774,active-covalent
Cn1c(c[nH+]c1COC(=O)N)N(=O)=O,BRD-K94266545-001-24-1,ronidazole,MicroSource,1501154,RONIDAZOLE,-7.064361,x1412,-0.893774,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCNC4=O)C(=O)[O-])C,BRD-K60663764-236-05-4,azlocillin,MicroSource,1503101,AZLOCILLIN SODIUM,-7.063849,x0749,5.787402,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCNC4=O)C(=O)[O-])C,BRD-K60663764-236-04-7,azlocillin,MicroSource,1503101,AZLOCILLIN SODIUM,-7.063849,x0749,5.787402,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)NC(=O)N4CCNC4=O)C(=O)[O-])C,BRD-K60663764-236-03-9,azlocillin,Selleck,S3195,Azlocillin sodium salt,-7.063849,x0749,5.787402,active-covalent
C1CN(C(=O)[C@H]1[NH3+])O,BRD-K41304947-001-03-2,HA-966-(S)-(-),Tocris,282,(S)-(-)-HA-966,-7.062572,x0678,-1.537953,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)/C=C/C#N,BRD-K15025317-001-17-7,BAY-11-7082,Selleck,S2913,BAY 11-7082 (BAY 11-7821),-7.061751,x0678,-0.933878,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)/C=C/C#N,BRD-K15025317-001-15-1,BAY-11-7082,Tocris,1744,Bay 11-7821,-7.061751,x0678,-0.933878,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)/C=C/C#N,BRD-K15025317-001-14-4,BAY-11-7082,Selleck,S2913,BAY 11-7082,-7.061751,x0678,-0.933878,active-noncovalent
CC(C)(C)c1cc(cc(c1OC)c2ccc3cc(ccc3c2)NS(=O)(=O)C)n4ccc(=O)[nH]c4=O,BRD-K02943813-001-01-9,dasabuvir,MedChemEx,HY-13998,ABT-333,-7.060244,x0749,7.865893,active-covalent
CCCc1ccc(cc1)C(=O)[O-],BRD-K42108215-001-01-5,4-propylbenzoic-acid,Maybridge,BTB09874,,-7.060189,x0749,-0.573138,active-covalent
c1cc(ccc1S(=O)(=O)N/C=N/CCSCc2csc(n2)[NH+]=C(N)N)Br,BRD-K22421059-001-01-5,ebrotidine,MedChemEx,HY-15538,Ebrotidine,-7.057098,x0195,1.384449,active-noncovalent
c1cc(ccc1S(=O)(=O)N/C=N/CCSCc2csc(n2)[NH+]=C(N)N)Br,BRD-K22421059-001-02-3,ebrotidine,MedChemEx,HY-15538,Ebrotidine,-7.057098,x0195,1.384449,active-noncovalent
c1cc(ccc1S(=O)(=O)N/C=N/CCSCc2csc(n2)[NH+]=C(N)N)Br,BRD-K22421059-001-03-1,ebrotidine,MedChemEx,HY-15538,Ebrotidine,-7.057098,x0195,1.384449,active-noncovalent
c1ccc(cc1)CS(=O)(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccc4c(c3)cnn4c5ccc(cc5)F,BRD-K29328421-001-01-6,GSK9027,Tocris,4116,GSK 9027,-7.056571,x0104,14.334852,active-noncovalent
CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)[O-])NC(=[NH2+])N,BRD-K23067689-001-03-9,zanamivir,Selleck,S3007,Zanamivir,-7.055729,x1412,0.113695,active-covalent
CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)[O-])NC(=[NH2+])N,BRD-K23067689-001-02-1,zanamivir,Selleck,S3007,Zanamivir (Relenza),-7.055729,x1412,0.113695,active-covalent
C[n+]1cccc(c1)C(=O)[O-],BRD-K69231085-003-05-7,trigonelline,Enzo,NP322,Trigonelline HCl,-7.052485,x0195,-1.598281,active-noncovalent
CC(C)([C@H](C(=O)[O-])[NH3+])S,BRD-K17518951-001-04-8,penicillamine-(D),Selleck,S1853,Penicillamine (Cuprimine),-7.051102,x0397,-0.393278,active-noncovalent
CC(C)([C@H](C(=O)[O-])[NH3+])S,BRD-K17518951-001-03-0,penicillamine-(D),Selleck,S1853,Penicillamine (Cuprimine),-7.051102,x0397,-0.393278,active-noncovalent
CC(C)(Cc1ccccc1)N(C)C(=O)C[NH+](CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2,BRD-K56940463-001-13-8,oxethazaine,Selleck,S4343,Oxethazaine,-7.049588,x0104,6.713627,active-noncovalent
CC(C)(Cc1ccccc1)N(C)C(=O)C[NH+](CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2,BRD-K56940463-001-14-6,oxethazaine,MicroSource,1503279,OXETHAZAINE,-7.049588,x0104,6.713627,active-noncovalent
CC(C)(CO)c1cc2cc(c(cc2n1C[C@H](CO)O)F)NC(=O)C3(CC3)c4ccc5c(c4)OC(O5)(F)F,BRD-K97101532-001-02-8,tezacaftor,Selleck,S7059,VX-661,-7.049496,x0104,11.604088,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])NC(=O)N,BRD-K60240222-001-01-4,carglumic-acid,MicroSource,1506153,CARGLUMIC ACID,-7.048933,x1478,-0.476215,active-covalent
CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,BRD-K38969488-001-01-6,tributyrin,Sigma,MFCD00009392,"2,3-bis(butyryloxy)propyl butyrate",-7.048782,x0195,1.207493,active-noncovalent
CCCC(CCC)C(=O)Nc1ccn(c(=O)n1)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,BRD-K04993719-001-01-7,LY2334737,MedChemEx,HY-13672,LY2334737,-7.048708,x0161,4.819611,active-noncovalent
CCc1nc2c(nc(cc2n1c3ccc(cc3)CCNC(=O)NS(=O)(=O)c4ccc(cc4)C)C)C,BRD-K62050508-001-01-0,grapiprant,MedChemEx,HY-16781,Grapiprant,-7.047754,x0104,4.833041,active-noncovalent
CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1[NH+]3CCCC3)C(=O)Cc4ccc(c(c4)Cl)Cl,BRD-K28192623-066-08-1,spiradoline,Enzo,AC771,U-62066,-7.047631,x0874,3.392584,active-noncovalent
Cc1cc(cc2c1ncc(c2Nc3cccc(c3)OC)C(=O)N)S(=O)(=O)c4cccc(c4)C(=O)N(C)C,BRD-K37590257-001-02-8,GSK256066,Selleck,S2620,GSK256066,-7.047472,x0195,9.804851,active-noncovalent
C[N@H+]1CCc2cc3c(c(c2[C@@H]1[C@@H]4c5ccc(c(c5C(=O)O4)OC)OC)OC)OCO3,BRD-K89237706-003-02-6,noscapine,Selleck,S4363,Noscapine HCl,-7.047083,x0946,3.442561,active-noncovalent
C[N@H+]1CCc2cc3c(c(c2[C@@H]1[C@@H]4c5ccc(c(c5C(=O)O4)OC)OC)OC)OCO3,BRD-K89237706-003-03-4,noscapine,Tocris,1697,Noscapine hydrochloride,-7.047083,x0946,3.442561,active-noncovalent
C[C@H](c1ccc(cc1CCCC(=O)[O-])F)[N@@](c2cc(ccc2F)F)S(=O)(=O)c3ccc(cc3)Cl,BRD-K02950022-001-02-9,BMS-299897,EMDBio,565793-5MG,"gamma-Secretase Inhibitor XXIV, BMS299897",-7.045794,x1077,5.632058,active-noncovalent
CC(=O)[C@H]1CC[C@H]2[C@@]1(CC[C@@H]3[C@@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CCC(=O)[O-])C)C,BRD-A35912562-001-02-8,pregnenolone-succinate,MicroSource,1505713,PREGNENOLONE SUCCINATE,-7.045090,x0104,4.175292,active-noncovalent
COc1ccc(cc1OC)C(=O)Nc2c(c3c(s2)CCCC3)C(=O)N,BRD-K81376179-001-05-5,TCS-359,Selleck,S8023,TCS 359,-7.043690,x0195,5.124317,active-noncovalent
COc1ccc(cc1OC)C(=O)Nc2c(c3c(s2)CCCC3)C(=O)N,BRD-K81376179-001-03-0,TCS-359,Selleck,S8023,TCS 359,-7.043690,x0195,5.124317,active-noncovalent
COc1ccc(cc1OC)C(=O)Nc2c(c3c(s2)CCCC3)C(=O)N,BRD-K81376179-001-06-3,TCS-359,Tocris,2591,TCS 359,-7.043690,x0195,5.124317,active-noncovalent
COc1ccc(cc1OC)C(=O)Nc2c(c3c(s2)CCCC3)C(=O)N,BRD-K81376179-001-04-8,TCS-359,Tocris,2591,TCS 359,-7.043690,x0195,5.124317,active-noncovalent
CNc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,BRD-K81807412-001-10-6,N6-methyladenosine,Selleck,S3190,N6-methyladenosine (m6A),-7.043509,x0749,1.551131,active-covalent
[H]/N=C(/NCCC[C@@H](C(=O)OC)[NH3+])\NN(=O)=O,BRD-K33141550-003-05-7,L-NAME,Tocris,665,L-NAME hydrochloride,-7.040486,x0678,0.517575,active-noncovalent
[H]/N=C(/NCCC[C@@H](C(=O)OC)[NH3+])\NN(=O)=O,BRD-K33141550-003-06-5,L-NAME,Tocris,665,L-NAME hydrochloride,-7.040486,x0678,0.517575,active-noncovalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6,BRD-A36010170-001-04-0,amcinonide,MicroSource,1503816,AMCINONIDE,-7.039162,x1077,6.024382,active-noncovalent
c1cc2c(cc1C(=O)CC[NH+]3CCN(CC3)C(=O)OCc4cc(cc(c4)Cl)Cl)oc(=O)[nH]2,BRD-K50865540-001-02-3,PF-8380,MedChemEx,HY-13344,PF-8380,-7.039152,x0395,10.572473,active-noncovalent
c1cc2c(cc1C(=O)CC[NH+]3CCN(CC3)C(=O)OCc4cc(cc(c4)Cl)Cl)oc(=O)[nH]2,BRD-K50865540-001-01-5,PF-8380,MedChemEx,HY-13344,PF-8380,-7.039152,x0395,10.572473,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2CCCCCC2,BRD-K32164935-001-31-6,tolazamide,Selleck,S4356,tolazamide,-7.038291,x0434,1.028551,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2CCCCCC2,BRD-K32164935-001-30-8,tolazamide,MicroSource,1501201,TOLAZAMIDE,-7.038291,x0434,1.028551,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2CCCCCC2,BRD-K32164935-001-29-0,tolazamide,Selleck,S4356,Tolazamide,-7.038291,x0434,1.028551,active-noncovalent
CCCc1c2c(cc3c1oc(cc3=O)C(=O)[O-])c(=O)cc(n2CC)C(=O)[O-],BRD-K64716392-001-02-1,nedocromil,MedChemEx,HY-13448,"9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid",-7.036067,x0749,4.193643,active-covalent
CCCc1c2c(cc3c1oc(cc3=O)C(=O)[O-])c(=O)cc(n2CC)C(=O)[O-],BRD-K64716392-001-01-3,nedocromil,MedChemEx,HY-13448,Nedocromil,-7.036067,x0749,4.193643,active-covalent
CCCc1c2c(cc3c1oc(cc3=O)C(=O)[O-])c(=O)cc(n2CC)C(=O)[O-],BRD-K64716392-001-03-9,nedocromil,MedChemEx,HY-13448,Nedocromil,-7.036067,x0749,4.193643,active-covalent
c1c(nc(s1)[NH+]=C(N)N)CSCC/C(=N\S(=O)(=O)N)/N,BRD-K00673382-001-18-9,famotidine,MicroSource,1501003,FAMOTIDINE,-7.032886,x0749,-0.144233,active-covalent
c1c(nc(s1)[NH+]=C(N)N)CSCC/C(=N\S(=O)(=O)N)/N,BRD-K00673382-001-17-1,famotidine,Selleck,S2078,Famotidine,-7.032886,x0749,-0.144233,active-covalent
c1ccc(cc1)[C@@H](C(=O)[O-])O,BRD-A91448670-001-06-4,mandelic-acid,Enamine,Z104473974,,-7.032335,x0678,0.589566,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC=C,BRD-A23970436-236-04-2,thiamylal,MicroSource,1900002,THIAMYLAL SODIUM,-7.031550,x1077,0.313263,active-noncovalent
CC[NH2+][C@@H]1C[C@@H](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)C,BRD-K71075609-003-01-0,dorzolamide,Selleck,S1375,Dorzolamide HCL,-7.031237,x0749,2.98992,active-covalent
CNC(=O)C[NH+]1CCC(CC1)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl,BRD-K98572433-001-02-9,AZD8931,Selleck,S2192,AZD8931 (Sapitinib),-7.030771,x0104,10.252519,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)C(=O)N(C2=O)CCCC[NH+]3CCN(CC3)c4ccccn4,BRD-A04203391-001-08-3,piricapiron,Vitas-M,STK012745,,-7.030288,x0161,5.61482,active-noncovalent
C(CC(=O)C=[N+]=N)[C@@H](C(=O)[O-])[NH3+],BRD-K38458514-001-01-8,diazooxonorleucine,ChemImpex,7038,,-7.030227,x0195,-0.84906,active-noncovalent
c1c(c(c[nH]c1=O)Cl)[O-],BRD-K35687421-001-02-5,gimeracil,Selleck,S2055,Gimeracil,-7.029076,x0678,-1.187959,active-noncovalent
c1c(c(c[nH]c1=O)Cl)[O-],BRD-K35687421-001-03-3,gimeracil,Selleck,S2055,Gimeracil,-7.029076,x0678,-1.187959,active-noncovalent
Cn1cc(c2c1cccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N(C)CC[NH+](C)C)NC(=O)C=C,BRD-K42805893-001-04-9,osimertinib,MedChemEx,HY-15772,AZD-9291,-7.028326,x0104,14.12647,active-noncovalent
Cc1[nH]c(=O)c2cc(ccc2n1)CN(C)c3ccc(s3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K89839824-001-05-3,raltitrexed,Selleck,S1192,Raltitrexed,-7.027585,x0072,8.02577,active-noncovalent
Cc1[nH]c(=O)c2cc(ccc2n1)CN(C)c3ccc(s3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K89839824-001-06-1,raltitrexed,Selleck,S1192,Raltitrexed (Tomudex),-7.027585,x0072,8.02577,active-noncovalent
c1cc(c(nc1)C(=O)[O-])C(=O)[O-],BRD-K51885093-001-11-2,quinolinic-acid,Tocris,225,Quinolinic acid,-7.027446,x0397,-0.514073,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,BRD-K15108141-001-08-2,gemcitabine,MedChemEx,HY-17026,gemcitabine,-7.027234,x0195,1.114584,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,BRD-K15108141-003-04-7,gemcitabine,Tocris,3259,Gemcitabine hydrochloride,-7.027234,x0195,1.114584,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,BRD-K15108141-001-06-6,gemcitabine,Selleck,S1714,Gemcitabine,-7.027234,x0195,1.114584,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,BRD-K15108141-003-05-4,gemcitabine,Selleck,S1149,Gemcitabine HCl (Gemzar),-7.027234,x0195,1.114584,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)Nc2nc(cs2)c3cccc(c3)N(=O)=O,BRD-K12639498-001-01-3,Ro-61-8048,MedChemEx,HY-12347,Ro 61-8048,-7.026592,x0434,2.338696,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)Nc2nc(cs2)c3cccc(c3)N(=O)=O,BRD-K12639498-001-02-1,Ro-61-8048,Tocris,3254,Ro 61-8048,-7.026592,x0434,2.338696,active-noncovalent
[H]/N=C/1\[C@H](C(=O)C2=C(C1=O)[C@@H]([C@]3([N@@]2C[C@@H]4[C@H]3[NH2+]4)OC)COC(=O)N)C,BRD-A48237631-001-04-8,mitomycin-c,MicroSource,330002,MITOMYCIN,-7.026125,x0195,2.412194,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]4[C@H](O3)CO[P@@](=O)(O4)[O-])O)N,BRD-A41840684-001-01-8,cyclic-AMP,ChemDiv,6048-0067,,-7.025957,x0749,0.774849,active-covalent
Cc1cccc(c1OC(=O)C)C(=O)[O-],BRD-K58648841-001-04-7,cresopirine,MicroSource,1401414,CRESOPIRINE,-7.024745,x1418,1.57155,active-covalent
C[C@@H]([NH2+]Cc1cc(cc2c1[nH]c(=O)c(=O)[nH]2)Br)P(=O)([O-])[O-],BRD-K60946979-003-01-7,CGP-78608,Tocris,1493,CGP 78608 hydrochloride,-7.024529,x1458,0.889458,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccsc3)C(=O)[O-])C(=O)[O-])C,BRD-A55051145-304-03-2,ticarcillin,MedChemEx,HY-B1175,Ticarcillin (disodium),-7.022274,x0678,2.468013,active-noncovalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2ccccc2OC(F)F)C(=O)OC,BRD-K36379990-001-01-1,riodipine,Sigma,MFCD00728312,"dimethyl 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate",-7.020562,x0749,1.709565,active-covalent
CCNC(=O)[C@@H]1[C@H]([C@@H]([C@@H](O1)n2cnc3c2nc(nc3N)NCCc4ccc(cc4)CCC(=O)[O-])O)O,BRD-K12614344-003-01-8,CGS-21680,Selleck,S2153,CGS 21680 HCl,-7.018566,x0072,5.7889,active-noncovalent
Cc1cc2cc(ccc2n(c1=O)C)NS(=O)(=O)c3ccc(cc3OC)C#N,BRD-K03042257-001-01-2,NI-57,Tocris,5546,NI 57,-7.018385,x0072,1.832331,active-noncovalent
C[C@@]1(CSC(=N1)c2ccc(cc2O)OCCOCCOC)C(=O)[O-],BRD-K23005288-001-01-8,SP-420,MedChemEx,HY-16912,SP-420,-7.017741,x0104,2.694627,active-noncovalent
c1c(cc(c(c1N(=O)=O)[O-])O)N(=O)=O,BRD-K18602506-001-08-0,OR-486,Tocris,483,OR-486,-7.017367,x0397,-1.129764,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)S(=O)(=O)[O-],BRD-K52284881-236-02-4,chiniofon,MicroSource,1504510,CHINIOFON,-7.016592,x0195,-0.529984,active-noncovalent
Cc1cnc(cn1=O)COC,BRD-K53605365-001-01-4,proacipimox,Enamine,Z2306534452,5-(methoxymethyl)-2-methylpyrazine 1-oxide,-7.016461,x0397,-1.399904,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])[NH3+],BRD-K83896451-001-06-7,glutamine-(l),Selleck,S1749,L-Glutamine,-7.016332,x0107,-0.07157,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])[NH3+],BRD-K83896451-001-07-5,glutamine-(l),Selleck,S1749,L-Glutamine,-7.016332,x0107,-0.07157,active-noncovalent
CCS(=O)(=O)N1CCC(CC1)[C@@H](C)n2c(c(c3c2cccc3)C(=O)NCc4c(cc([nH]c4=O)C)OC)C,BRD-K97181972-001-01-9,CPI-169,MedChemEx,HY-15956A,CPI-169,-7.016264,x0104,10.819799,active-noncovalent
C1[C@H](NC(=O)S1)C(=O)[O-],BRD-K92413528-001-06-9,procysteine,Sigma,MFCD00066092,"(4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid",-7.015034,x0397,0.39697,active-noncovalent
C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)[O-],BRD-K94250879-235-03-9,clavulanate,MicroSource,1505124,CLAVULANATE LITHIUM,-7.014199,x0678,-0.062309,active-noncovalent
C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)[O-],BRD-K94250879-001-01-9,clavulanate,AvaChem,1995,"(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",-7.014199,x0678,-0.062309,active-noncovalent
C[C@H]([C@@H](C(=O)[O-])[NH3+])O,BRD-K75508643-001-02-6,L-threonine,Sigma,V900466,"(2S,3R)-2-amino-3-hydroxybutanoic acid",-7.013843,x0426,-0.076663,active-noncovalent
C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)[O-])[NH2+][C@@H](CCc3ccccc3)C(=O)[O-],BRD-K42317111-001-01-7,quinaprilat,MicroSource,1505455,QUINAPRILAT,-7.010143,x1392,3.032454,active-covalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)N,BRD-A10111329-001-04-6,adenosine-phosphate,MicroSource,1500667,ADENOSINE 5-MONOPHOSPHATE,-7.009175,x0678,1.74481,active-noncovalent
Cc1ccc(c(c1c2ccc3c(c2)ccc(n3)C)N)C(=O)c4c(n(n(c4=O)c5ccccc5)C)c6ccccc6,BRD-K04374714-003-01-1,AMG-PERK-44,Tocris,5517,AMG PERK 44,-7.007693,x0107,7.596229,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-K45158365-001-12-2,valsartan,Tocris,4216,Valsartan,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-M31057929-001-01-2,LCZ696,MedChemEx,HY-18204A,LCZ696,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-M31057929-314-01-9,LCZ696,MedChemEx,HY-18204A,LCZ696,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-K45158365-001-10-6,valsartan,Selleck,S1894,Valsartan,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-M31057929-447-01-7,LCZ696,Selleck,S7678,LCZ696,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-K45158365-001-11-4,valsartan,MicroSource,1505209,VALSARTAN,-7.007352,x1077,5.021784,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],BRD-M31057929-385-01-9,LCZ696,MedChemEx,HY-18204A,LCZ696,-7.007352,x1077,5.021784,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2c(ccc(c2OC)Br)OC,BRD-K54094468-003-11-1,remoxipride,Tocris,916,Remoxipride hydrochloride,-7.007163,x0104,0.857353,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC[C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O)O)O)O)O)O)O,BRD-K67117832-001-01-9,dextran,ANpharma,AN-19460,"(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hexana;l",-7.006890,x0874,4.601258,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@]2CCCC[C@@H]2C(=O)Nc3nc(cs3)c4ccc(cc4)OC,BRD-K60020910-001-02-5,ML-277,Tocris,4777,ML 277,-7.006354,x0161,4.753538,active-noncovalent
c1cn(cn1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K84253429-001-04-4,zoledronic-acid,Selleck,S1314,Zoledronic Acid (Zoledronate),-7.005376,x0397,0.577223,active-noncovalent
c1cn(cn1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K84253429-001-03-6,zoledronic-acid,Selleck,S1314,Zoledronic Acid,-7.005376,x0397,0.577223,active-noncovalent
C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)[O-])[NH3+],BRD-K11595419-001-02-2,dipeptamin,ChemImpex,1676,(2S)-5-amino-2-{[(2S)-2-aminopropanoyl]amino}-5-oxopentanoic acid,-7.004703,x1392,-0.508823,active-covalent
C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)[O-])[NH3+],BRD-K11595419-001-01-4,dipeptamin,ChemImpex,1676,,-7.004703,x1392,-0.508823,active-covalent
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3csc(n3)C(C)(C)C,BRD-K49055432-001-07-5,A66,Tocris,5595,A66,-7.004224,x0104,7.572278,active-noncovalent
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3csc(n3)C(C)(C)C,BRD-K49055432-001-04-2,A66,Selleck,S2636,A66,-7.004224,x0104,7.572278,active-noncovalent
c1cc(sc1)CC(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-],BRD-K15514357-001-05-6,cefalonium,MicroSource,1505997,CEFALONIUM,-7.003020,x1077,5.413579,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@@H](C[C@]4([C@@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F,BRD-A88138582-001-04-8,halcinonide,MicroSource,1503237,HALCINONIDE,-7.001339,x0874,2.881391,active-noncovalent
CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-A55424491-001-19-9,methotrexate,MicroSource,1500398,METHOTREXATE(+/-),-7.000900,x0104,10.222954,active-noncovalent
CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K59456551-001-22-6,methotrexate,Selleck,S1210,Abitrexate (Methotrexate),-7.000900,x0104,10.222954,active-noncovalent
CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K59456551-001-20-0,methotrexate,Tocris,1230,Methotrexate,-7.000900,x0104,10.222954,active-noncovalent
CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K59456551-001-19-2,methotrexate,Selleck,S1210,Methotrexate,-7.000900,x0104,10.222954,active-noncovalent
CN(C)C(=[NH2+])NC(=[NH2+])N,BRD-K79602928-003-19-9,metformin,MicroSource,1505814,METFORMIN HYDROCHLORIDE,-6.999578,x0195,-1.264648,active-noncovalent
CN(C)C(=[NH2+])NC(=[NH2+])N,BRD-K79602928-003-18-1,metformin,Selleck,S1950,Metformin hydrochloride (Glucophage),-6.999578,x0195,-1.264648,active-noncovalent
CN(C)C(=[NH2+])NC(=[NH2+])N,BRD-K79602928-003-21-5,metformin,Tocris,2864,Metformin hydrochloride,-6.999578,x0195,-1.264648,active-noncovalent
CC[NH+](CC)CCC(=O)N1c2ccccc2Sc3c1cc(cc3)NC(=O)OCC,BRD-K10667240-001-01-7,ethacizin,Vitas-M,STK995917,ethyl 10-[3-(diethylamino)propanoyl]-10H-phenothiazin-2-ylcarbamate,-6.997653,x0104,2.898732,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSC(=O)c4ccco4)C(=O)[O-],BRD-K82960980-003-02-7,ceftiofur,Selleck,S2543,Ceftiofur hydrochloride,-6.996276,x0072,8.45213,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSC(=O)c4ccco4)C(=O)[O-],BRD-K82960980-003-03-5,ceftiofur,Selleck,S2543,Ceftiofur HCl,-6.996276,x0072,8.45213,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSC(=O)c4ccco4)C(=O)[O-],BRD-K82960980-003-01-9,ceftiofur,MicroSource,1504832,CEFTIOFUR HYDROCHLORIDE,-6.996276,x0072,8.45213,active-noncovalent
CCC(=O)OCN1C(=O)C=CC1=O,BRD-K39706510-001-03-9,MIRA-1,Tocris,3362,MIRA-1,-6.994695,x0195,-0.514669,active-noncovalent
CCCc1cc(=O)[nH]c(=S)[nH]1,BRD-K48168960-001-19-2,propylthiouracil,MicroSource,1500515,PROPYLTHIOURACIL,-6.994293,x1382,-0.664079,active-covalent
CCCc1cc(=O)[nH]c(=S)[nH]1,BRD-K48168960-001-18-4,propylthiouracil,Selleck,S1988,Propylthiouracil,-6.994293,x1382,-0.664079,active-covalent
CC[C@H](C)c1ccc(cc1)NC(=O)Cn2cnc3c2c(=O)n(c(=O)n3C)C,BRD-A16560607-001-02-5,TCS-5861528,Tocris,3938,TCS 5861528,-6.993474,x0104,2.075933,active-noncovalent
C1CC1CCCCCCCCC(=O)N(CCC(=O)[O-])O,BRD-K15256258-001-02-1,TC-E-5002,Tocris,5089,TC-E 5002,-6.990997,x0104,1.41982,active-noncovalent
C1CC1CCCCCCCCC(=O)N(CCC(=O)[O-])O,BRD-K15256258-001-01-3,TC-E-5002,Tocris,5089,TC-E502,-6.990997,x0104,1.41982,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],BRD-K27885593-001-06-8,corosolic-acid,MedChemEx,HY-N0280,Corosolic acid,-6.989219,x1077,4.439054,active-noncovalent
CCC[C@@H](C(=O)Nc1cn(cn1)C(C)(C)C[NH2+]CC(C)(C)C)[NH2+][C@H]2CCc3cc(cc(c3C2)F)F,BRD-K61691541-001-01-1,PF-03084014,MedChemEx,HY-15185,PF-3084014,-6.989083,x0434,7.853283,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,BRD-K43164539-001-11-5,cholic-acid,Enzo,BL051,Cholic acid,-6.989046,x0874,2.299131,active-noncovalent
CC(C)SC(=[NH2+])N,BRD-K10673031-004-02-0,S-Isopropylisothiourea,Tocris,897,S-Isopropylisothiourea hydrobromide,-6.988349,x0195,-0.851732,active-noncovalent
C[C@@H]1[C@H](OC(=O)N1Cc2cc(ccc2c3cc(c(cc3OC)F)C(C)C)C(F)(F)F)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,BRD-K44366189-001-01-9,anacetrapib,Selleck,S2748,Anacetrapib (MK-0859),-6.986848,x0107,8.883404,active-noncovalent
Cc1nc(no1)Cn2cnc3c2c(=O)n(c(=O)n3C)C,BRD-K24820488-001-01-7,CH-170,Enamine,Z164701248,,-6.985542,x0397,0.23524,active-noncovalent
CCOC(=O)Nc1c[n+](no1)N2CCOCC2,BRD-K63861289-001-19-6,molsidomine,MicroSource,1500673,MOLSIDOMINE,-6.984628,x0161,0.039102,active-noncovalent
COCCN(c1nc(cs1)c2ccccc2)C(=O)c3cc(c(c(c3)OC)OC)OC,BRD-K53030960-001-01-4,eact,Tocris,4876,Eact,-6.983391,x0195,5.71149,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NCN2,BRD-K13078532-001-27-6,hydrochlorothiazide,Selleck,S1708,Hydrochlorothiazide,-6.983059,x0749,0.931554,active-covalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NCN2,BRD-K13078532-001-28-4,hydrochlorothiazide,MicroSource,1500335,HYDROCHLOROTHIAZIDE,-6.983059,x0749,0.931554,active-covalent
CC(C)(c1cc(cc(c1)C(F)(F)F)C(=O)N[C@@H]2CCc3ccc(cc3C2)Oc4ccnc5c4CCC(=O)N5)[NH3+],BRD-K52644305-300-01-3,ML-786,Tocris,5036,ML 786 dihydrochloride,-6.982310,x0104,11.323399,active-noncovalent
CC(C)(C)C[C@H]1[C@]2(c3ccc(cc3NC2=O)Cl)[C@H]([C@@H]([NH2+]1)C(=O)NC4CCC(CC4)O)c5cccc(c5F)Cl,BRD-A16035238-001-01-7,SAR405838,Selleck,S7649,MI-773 (SAR405838),-6.981516,x0434,6.805144,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])NC(=O)C[NH3+],BRD-K85066592-001-01-6,gly-gln,Ark,AK-44843,,-6.981233,x0107,-0.937883,active-noncovalent
CCS(=O)(=O)CCn1c([nH+]cc1N(=O)=O)C,BRD-K89125793-001-26-0,tinidazole,MicroSource,1502127,TINIDAZOLE,-6.980912,x0195,0.311748,active-noncovalent
CCS(=O)(=O)CCn1c([nH+]cc1N(=O)=O)C,BRD-K89125793-001-27-8,tinidazole,Selleck,S4068,Tinidazole,-6.980912,x0195,0.311748,active-noncovalent
CCS(=O)(=O)CCn1c([nH+]cc1N(=O)=O)C,BRD-K89125793-001-25-2,tinidazole,Selleck,S4068,Tinidazole,-6.980912,x0195,0.311748,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-A55272860-001-14-6,sulpiride,Tocris,894,(RS)-(?)-Sulpiride,-6.980053,x0946,0.953545,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-A55272860-001-16-1,sulpiride,Tocris,894,(RS)-(+/-)-Sulpiride,-6.980053,x0946,0.953545,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-A55272860-001-15-3,sulpiride,MicroSource,1501150,SULPIRIDE,-6.980053,x0946,0.953545,active-noncovalent
CCCCCC[C@H](C/C=C\CCCCCCCC(=O)[O-])O,BRD-K33682646-001-02-7,ricinoleic-acid,TCI,R0027,,-6.979123,x0104,1.398992,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O,BRD-K42064204-001-01-3,tagatose,Sigma,F3510,D-fructose,-6.978385,x0397,-0.160861,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O,BRD-K51431759-001-02-9,dextrose,Selleck,S2123,Dextrose,-6.978385,x0397,0.131999,active-noncovalent
CN(C1CCCCC1)C(=O)CCCOc2ccc3c(c2)ccc(=O)[nH]3,BRD-K28578425-001-09-6,cilostamide,Tocris,915,Cilostamide,-6.977753,x0749,1.480774,active-covalent
CN(C1CCCCC1)C(=O)CCCOc2ccc3c(c2)ccc(=O)[nH]3,BRD-K28578425-001-07-0,cilostamide,Tocris,915,Cilostamide,-6.977753,x0749,1.480774,active-covalent
COc1ccc(c(c1OC)OC)CN2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K62858456-300-01-4,lomerizine,Selleck,S4084,Lomerizine HCl,-6.977340,x1077,7.332078,active-noncovalent
COc1ccc(c(c1OC)OC)CN2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K62858456-001-01-8,lomerizine,MicroSource,1502303,LOMERIZINE HYDROCHLORIDE,-6.977340,x1077,7.332078,active-noncovalent
COc1ccc(cc1)n2c3c(c(n2)C(=O)N)CCN(C3=O)c4ccc(cc4)N5CCCCC5=O,BRD-K67121414-001-02-5,apixaban,Selleck,S1593,Apixaban,-6.976688,x0104,9.310549,active-noncovalent
COc1ccc(cc1)n2c3c(c(n2)C(=O)N)CCN(C3=O)c4ccc(cc4)N5CCCCC5=O,BRD-K67121414-001-03-3,apixaban,MicroSource,1506317,APIXABAN,-6.976688,x0104,9.310549,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)[O-],BRD-K84091759-001-08-9,candesartan,MicroSource,1502288,CANDESARTAN,-6.974200,x0397,5.284816,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)[O-],BRD-K84091759-001-10-5,candesartan,Tocris,4791,Candesartan,-6.974200,x0397,5.284816,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)[O-],BRD-K84091759-001-07-1,candesartan,Selleck,S1578,Candesartan,-6.974200,x0397,5.284816,active-noncovalent
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,BRD-K97440753-066-18-1,dihydroergocristine,Tocris,474,Dihydroergocristine mesylate,-6.973650,x0434,10.950288,active-noncovalent
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,BRD-K97440753-066-19-9,dihydroergocristine,Tocris,474,Dihydroergocristine mesylate,-6.973650,x0434,10.950288,active-noncovalent
CCCCCCCC(=O)OC[C@@H](CO)O,BRD-A48938994-001-15-8,monoctanoin,Sigma,MFCD00056652,"2,3-dihydroxypropyl octanoate",-6.971525,x0749,-0.310734,active-covalent
CCCCCCCC(=O)OC[C@@H](CO)O,BRD-A48938994-001-14-1,monoctanoin,Sigma,MFCD00056652,"2,3-dihydroxypropyl octanoate",-6.971525,x0749,-0.310734,active-covalent
CCOC(=O)C1=C(NC(=C([C@@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)C,BRD-A02006392-001-15-6,nitrendipine,Selleck,S2491,Nitrendipine,-6.970303,x0946,1.847763,active-noncovalent
CCOC(=O)C1=C(NC(=C([C@@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)C,BRD-A02006392-001-17-2,nitrendipine,MicroSource,1503609,NITRENDIPINE,-6.970303,x0946,1.847763,active-noncovalent
CCOC(=O)C1=C(NC(=C([C@@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)C,BRD-A02006392-001-19-8,nitrendipine,Tocris,601,Nitrendipine,-6.970303,x0946,1.847763,active-noncovalent
CCOC(=O)C1=C(NC(=C([C@@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)C,BRD-A02006392-001-16-4,nitrendipine,Tocris,601,Nitrendipine,-6.970303,x0946,1.847763,active-noncovalent
Cn1cnc(=[NH2+])c2c1nc[nH]2,BRD-K81647657-001-04-3,3-methyladenine,Selleck,S2767,3-Methyladenine,-6.969131,x0426,-1.15363,active-noncovalent
Cn1cnc(=[NH2+])c2c1nc[nH]2,BRD-K81647657-001-05-0,3-methyladenine,Selleck,S2767,3-Methyladenine (3-MA),-6.969131,x0426,-1.15363,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(c(cc1OC)N)Br,BRD-K73642618-001-13-3,bromopride,MicroSource,1503108,BROMOPRIDE,-6.964396,x0830,1.550046,active-covalent
CCO[C@H]1[C@@H]([C@H]([C@H](O1)[C@@H](COCc2ccccc2)OCc3ccccc3)OCc4ccccc4)O,BRD-A60294240-001-03-7,tribenoside,Prestwick,Prestw-1019,Tribenoside,-6.963276,x0678,5.57873,active-noncovalent
COc1ccc2c(n1)c(c3ccc(cc3n2)Cl)Nc4cc(c(c(c4)C[NH+]5CCCC5)O)C[NH+]6CCCC6,BRD-K73132780-411-01-3,pyronaridine,MicroSource,1502329,PYRONARIDINE TETRAPHOSPHATE,-6.962176,x0161,6.272173,active-noncovalent
COc1ccc2c(n1)c(c3ccc(cc3n2)Cl)Nc4cc(c(c(c4)C[NH+]5CCCC5)O)C[NH+]6CCCC6,BRD-K73132780-001-01-2,pyronaridine,Vitas-M,STK597795,"4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(1-pyrrolidinylmethyl)phenol",-6.962176,x0161,6.272173,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])/C=C/c2cc(c(c(c2)OC)OC)OC,BRD-K68399195-304-01-1,fosbretabulin,MedChemEx,HY-17449,Fosbretabulin,-6.958936,x0072,5.418865,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])/C=C/c2cc(c(c(c2)OC)OC)OC,BRD-K68399195-304-02-9,fosbretabulin,MedChemEx,HY-17449,Fosbretabulin,-6.958936,x0072,5.418865,active-noncovalent
CCCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4[n-]nnn4)C(=O)[O-])Cl,BRD-K23533833-001-01-9,carboxylosartan,Cayman,15957,"2-butyl-4-chloro-1-{[2'-(1H-tetraazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid",-6.958681,x0678,5.697941,active-noncovalent
CNc1nc(cc(n1)NCc2ccc(cc2Cl)NS(=O)(=O)C)c3ccccn3,BRD-K87199310-001-01-4,TC-G-1008,Tocris,5355,TC-G 1008,-6.958504,x0161,4.43435,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,BRD-K80684056-001-09-3,cantharidin,MedChemEx,HY-N0209,Cantharidin,-6.957710,x0678,3.538229,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,BRD-K80684056-001-06-9,cantharidin,MedChemEx,HY-N0209,Cantharidin,-6.957710,x0678,3.538229,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,BRD-K80684056-001-05-1,cantharidin,Sigma,MFCD00134968,"(3aR,4S,7R,7aS)-3a,7a-dimethylhexahydro-4,7-epoxyisobenzofuran-1,3-dione",-6.957710,x0678,3.538229,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,BRD-K80684056-001-04-4,cantharidin,Tocris,1548,Cantharidin,-6.957710,x0678,3.538229,active-noncovalent
C[C@H]1[C@@](CC[N@@H+](C1)[C@H]2CC[C@@](CC2)(c3ccc(cc3)F)C#N)(C(=O)[O-])c4ccccc4,BRD-K33453211-003-11-5,levocabastine,Prestwick,Prestw-1039,Levocabastine hydrochloride,-6.954379,x0107,4.927478,active-noncovalent
Cn1cnc(c1Sc2c-3ncnc3nc[nH]2)N(=O)=O,BRD-K32821942-001-21-3,azathioprine,MicroSource,1500133,AZATHIOPRINE,-6.953889,x0749,-0.311938,active-covalent
Cn1cnc(c1Sc2c-3ncnc3nc[nH]2)N(=O)=O,BRD-K32821942-001-20-5,azathioprine,Selleck,S1721,Azathioprine,-6.953889,x0749,-0.311938,active-covalent
Cn1cnc(c1Sc2c-3ncnc3nc[nH]2)N(=O)=O,BRD-K32821942-001-22-1,azathioprine,Tocris,4099,Azathioprine,-6.953889,x0749,-0.311938,active-covalent
CC[N+](CC)(CC)CCOc1cccc(c1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC,BRD-K43106192-320-11-8,gallamine-triethiodide,Selleck,S2471,Gallamine triethiodide (Flaxedil),-6.953104,x0161,8.822757,active-noncovalent
CCc1cc(ccc1C[NH+]2CC(C2)C(=O)[O-])/C(=N/OCc3ccc(c(c3)C(F)(F)F)C4CCCCC4)/C,BRD-K62384160-001-02-0,siponimod,MedChemEx,HY-12355,Siponimod,-6.952504,x0104,9.807712,active-noncovalent
CCc1cc(ccc1C[NH+]2CC(C2)C(=O)[O-])/C(=N/OCc3ccc(c(c3)C(F)(F)F)C4CCCCC4)/C,BRD-K62384160-001-01-2,siponimod,Selleck,S7179,BAF312 (Siponimod),-6.952504,x0104,9.807712,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-10-7,ascorbic-acid,MedChemEx,HY-B0166,L-Ascorbic acid,-6.952201,x0397,0.976952,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-09-9,ascorbic-acid,Sigma,95209,"(5R)-5-((S)-1,2-dihydroxyethyl)-4-hydroxydihydrofuran-2,3-dione",-6.952201,x0397,0.976952,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-07-3,ascorbic-acid,Selleck,S3114,Vitamin C (Ascorbic acid),-6.952201,x0397,0.976952,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-05-7,ascorbic-acid,Selleck,S3114,Vitamin C,-6.952201,x0397,0.976952,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-12-3,ascorbic-acid,MicroSource,1502230,ASCORBIC ACID,-6.952201,x0397,0.976952,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,BRD-A85242401-001-11-5,ascorbic-acid,MedChemEx,HY-B0166,L-Ascorbic acid,-6.952201,x0397,0.976952,active-noncovalent
c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(cc(c(c2I)C(=O)[O-])I)I)I)C(=O)[O-])I,BRD-K67261995-001-11-7,iodipamide,MicroSource,1500772,IODIPAMIDE,-6.950761,x0434,9.138085,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OC[C@@H](COc2ccc3c(=O)cc(oc3c2CCC)C(=O)[O-])O,BRD-A96456596-001-02-2,FPL-55712,Tocris,2276,FPL 55712,-6.950739,x0072,4.890154,active-noncovalent
c1cc(oc1/C=N/NC(=O)N)N(=O)=O,BRD-K79092138-001-11-0,nitrofurazone,MicroSource,1500434,NITROFURAZONE,-6.950427,x0678,-1.09625,active-noncovalent
c1cc(oc1/C=N/NC(=O)N)N(=O)=O,BRD-K79092138-001-10-2,nitrofurazone,Selleck,S1644,Nitrofural,-6.950427,x0678,-1.09625,active-noncovalent
COC(=O)N/N=C/c1cn(=O)c2ccccc2n1=O,BRD-K56735750-001-09-2,carbadox,Selleck,S4312,Carbadox,-6.949158,x0678,1.106364,active-noncovalent
COC(=O)N/N=C/c1cn(=O)c2ccccc2n1=O,BRD-K56735750-001-07-6,carbadox,Selleck,S4312,carbadox,-6.949158,x0678,1.106364,active-noncovalent
COC(=O)N/N=C/c1cn(=O)c2ccccc2n1=O,BRD-K56735750-001-06-8,carbadox,MicroSource,1505294,CARBADOX,-6.949158,x0678,1.106364,active-noncovalent
c1cc2c(nc1)NC(=O)[C@@]23Cc4ccc(cc4C3)NC(=O)CN5[C@@H](C[NH2+]C6(C5=O)CCCC6)c7cc(cc(c7)F)F,BRD-K66911501-003-01-2,MK-3207,MedChemEx,HY-10302,MK-3207 (Hydrochloride),-6.947433,x0072,14.405572,active-noncovalent
COc1cc(ccc1O)C=O,BRD-K24258499-001-05-8,vanillin,Selleck,S3071,Vanillin,-6.947381,x0195,1.248685,active-noncovalent
C=C[C@@H](CCC(=O)[O-])[NH3+],BRD-A07893380-213-01-7,vigabatrin,MicroSource,1502036,VIGABATRIN,-6.946140,x0107,0.655558,active-noncovalent
c1cc(c(cc1O)S(=O)(=O)[O-])O,BRD-K71055333-224-06-6,etamsylate,Selleck,S4152,Ethamsylate,-6.946067,x0397,0.954252,active-noncovalent
c1cc(c(cc1O)S(=O)(=O)[O-])O,BRD-K71055333-224-05-8,etamsylate,Selleck,S4152,Ethamsylate,-6.946067,x0397,0.954252,active-noncovalent
Cc1nc(nc2c1cc(c(=O)n2[C@H]3CC[C@@H](CC3)OCCO)c4cnc(cc4)OC)N,BRD-K07310275-001-02-5,PF-04691502,Selleck,S2743,PF-04691502,-6.945398,x0678,6.738318,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCCO)O,BRD-K71210479-001-05-5,dexpanthenol,MicroSource,1505420,DEXPANTHENOL,-6.943398,x0104,-0.556527,active-noncovalent
CC(=O)NCCCCCCNC(=O)C,BRD-K04710043-001-17-8,hexamethylenebisacetamide,Sigma,MFCD00008684,N-[6-(acetylamino)hexyl]acetamide,-6.940607,x0161,-0.625344,active-noncovalent
CC[NH2+][C@H]1C[N@@](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)CCCOC,BRD-K74913225-001-12-4,brinzolamide,Selleck,S3178,Brinzolamide,-6.939740,x0830,1.600966,active-covalent
CC[NH2+][C@H]1C[N@@](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)CCCOC,BRD-K74913225-001-14-0,brinzolamide,MicroSource,1502418,BRINZOLAMIDE,-6.939740,x0830,1.600966,active-covalent
CC[NH2+][C@H]1C[N@@](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)CCCOC,BRD-K74913225-001-13-2,brinzolamide,Selleck,S3178,Brinzolamide,-6.939740,x0830,1.600966,active-covalent
CC(=CCC[C@@](C)(C=C)O)C,BRD-A43082461-001-06-3,linalool,InterBioScreen,STOCK1N-50425,,-6.938700,x0195,-0.723632,active-noncovalent
CCCCNc1nc(c(cn1)c2ncc(cc2)C[NH+]3CCOCC3)N[C@H]4CC[C@@H](CC4)O,BRD-K01773560-001-01-6,UNC2250,Selleck,S7342,UNC2250,-6.936693,x0161,8.857053,active-noncovalent
CCCCNc1nc(c(cn1)c2ncc(cc2)C[NH+]3CCOCC3)N[C@H]4CC[C@@H](CC4)O,BRD-K01773560-001-02-4,UNC2250,Selleck,S7342,UNC2250,-6.936693,x0161,8.857053,active-noncovalent
CCOc1cc(cc(c1OCC(=O)OC)Cl)/C=c/2\c(=C)[nH]n(c2=O)c3ccccc3,BRD-K35945299-001-04-2,SJ-172550,MedChemEx,HY-16664,SJ-172550,-6.935921,x1077,6.389097,active-noncovalent
CCOc1cc(cc(c1OCC(=O)OC)Cl)/C=c/2\c(=C)[nH]n(c2=O)c3ccccc3,BRD-K35945299-001-02-6,SJ-172550,MedChemEx,HY-16664,SJ-172550,-6.935921,x1077,6.389097,active-noncovalent
CCOc1cc(cc(c1OCC(=O)OC)Cl)/C=c/2\c(=C)[nH]n(c2=O)c3ccccc3,BRD-K35945299-001-03-4,SJ-172550,Tocris,3929,SJ 172550,-6.935921,x1077,6.389097,active-noncovalent
Cc1cccc(c1)O,BRD-K22518984-001-01-8,metacresol,MicroSource,1301055,METACRESOL,-6.935145,x0678,1.572605,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)C(F)(F)F)NC4C[NH+](C4)CCF,BRD-K24869513-001-02-1,CNX-2006,MedChemEx,HY-13897,CNX-2006,-6.934228,x0161,10.686507,active-noncovalent
c1ccnc(c1)N2CC[NH+](CC2)CCCC(=O)c3ccc(cc3)F,BRD-K45861246-001-14-2,azaperone,MicroSource,1505332,AZAPERONE,-6.933517,x0195,1.817073,active-noncovalent
c1ccnc(c1)N2CC[NH+](CC2)CCCC(=O)c3ccc(cc3)F,BRD-K45861246-001-13-4,azaperone,Selleck,S4219,Azaperone,-6.933517,x0195,1.817073,active-noncovalent
c1ccnc(c1)N2CC[NH+](CC2)CCCC(=O)c3ccc(cc3)F,BRD-K45861246-001-15-9,azaperone,Selleck,S4219,Azaperone,-6.933517,x0195,1.817073,active-noncovalent
c1ccc2c(c1)n(=O)c(nn2=O)N,BRD-K92968657-001-01-6,tirapazamine,MedChemEx,HY-13767,Tirapazamine,-6.933386,x0195,-1.612451,active-noncovalent
c1ccc2c(c1)n(=O)c(nn2=O)N,BRD-K92968657-001-02-4,tirapazamine,Adooq,A12754,"4-hydroxy-3-imino-3,4-dihydrobenzo[e][1,2,4]triazine 1-oxide",-6.933386,x0195,-1.612451,active-noncovalent
CCN(CC)C(=O)c1cccc(c1)C,BRD-K94080537-001-09-7,diethyltoluamide,MicroSource,1601020,DIETHYLTOLUAMIDE,-6.933324,x0072,-0.924081,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)/C=C/Br,BRD-A63675168-001-01-6,brivudine,TCI,B3404,,-6.932117,x0195,0.401673,active-noncovalent
C([C@@H]([C@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O,BRD-A63267145-001-01-0,hexonic-acid,Sigma,MFCD00067379,,-6.930202,x0397,1.180158,active-noncovalent
C[NH+]1CCN(CC1)S(=O)(=O)c2ccc(cc2)c3cnc(c(n3)C(=O)Nc4cccnc4)N,BRD-K85849709-001-01-5,AZD2858,Selleck,S7253,AZD2858,-6.927661,x0104,9.21698,active-noncovalent
Cc1ccc(o1)C[N+](C)(C)C,BRD-K45437867-005-04-1,5-methylfurmethiodide,Tocris,588,"N,N,N-trimethyl(5-methyl-2-furyl)methanaminium iodide",-6.927426,x0195,0.020185,active-noncovalent
Cc1ccc(o1)C[N+](C)(C)C,BRD-K45437867-005-03-3,5-methylfurmethiodide,Tocris,588,5-Methylfurmethiodide,-6.927426,x0195,0.020185,active-noncovalent
CN(C(=O)N[C@H]1[C@@H]([C@@H]([C@@H](O[C@@H]1O)CO)O)O)N=O,BRD-A94713674-001-02-3,streptozotocin,MedChemEx,HY-13753,Streptozocin,-6.926556,x0749,0.479239,active-covalent
C[NH+]1CCN(CC1)C(=O)[C@H]2[C@H]3CC[C@@H]([C@@H]2C(=O)[O-])O3,BRD-A49767491-001-01-8,LB-100,MedChemEx,HY-18597,LB-100,-6.926182,x0104,0.256371,active-noncovalent
CN1C(=O)N(C(=O)[C@]12C[N@H+](C[C@H]2c3ccc(cc3)C#N)Cc4cc(cs4)C(=O)[O-])c5cc(cc(c5)Cl)Cl,BRD-K20093108-001-02-3,BMS-587101,Key,HE-0001,"5-{[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]methyl}-3-thiophenecarboxylic acid",-6.925756,x0072,6.931083,active-noncovalent
c1cc(cc(c1)OCC(=O)[O-])C[N@@](Cc2ccc(cc2)n3cccn3)S(=O)(=O)c4cccnc4,BRD-K88854110-001-01-5,taprenepag,MedChemEx,HY-14899,Taprenepag,-6.925707,x0678,6.517551,active-noncovalent
CC1(CCC(CC1)C(C)(C)O)O,BRD-K93396439-002-01-2,terpene,MicroSource,1506188,TERPENE HYDRATE,-6.924755,x0195,0.403397,active-noncovalent
CCCCCN(CCCCC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccc(c(c1)Cl)Cl,BRD-A29854054-236-12-6,lorglumide,MicroSource,2300261,LORGLUMIDE SODIUM,-6.922289,x0967,6.524166,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F,BRD-K81528515-001-13-8,nilotinib,Selleck,S1033,Nilotinib (AMN-107),-6.921753,x0967,13.35315,active-noncovalent
c1ccc(c(c1)NS(=O)(=O)c2cc(c(cc2F)Cl)C(=O)N3CC[N@@H+]4CCC[C@@H]4C3)F,BRD-K11792081-001-01-4,ABT-639,MedChemEx,HY-19721,ABT-639,-6.921333,x0946,3.944069,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSC[C@@H](C(=O)[O-])NC(=O)C)/C)/C)C,BRD-K79437791-001-05-7,acetyl-farnesyl-cysteine,Enzo,G200,Acetyl-farnesyl-cysteine,-6.921150,x0104,4.748341,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSC[C@@H](C(=O)[O-])NC(=O)C)/C)/C)C,BRD-K79437791-001-06-5,acetyl-farnesyl-cysteine,Cayman,63270,"(2R)-2-(acetylamino)-3-{[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]sulfanyl}propanoic acid",-6.921150,x0104,4.748341,active-noncovalent
C/N=C(/NS(=O)(=O)c1ccc(cc1)Cl)\N2C[C@@H](C(=N2)c3ccc(cc3)Cl)c4ccccc4,BRD-A54228901-001-01-7,SLV-319-(+/-),Tocris,4605,(+/-)-SLV 319,-6.919682,x1077,4.689683,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,BRD-K50329370-001-09-0,levomenthol,Sigma,V900632,"(1R,2S,5R)-2-isopropyl-5-methylcyclohexanol",-6.919027,x0195,0.534768,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,BRD-K50329370-001-08-2,levomenthol,MicroSource,1503134,LEVOMENTHOL,-6.919027,x0195,0.534768,active-noncovalent
CC(C)[N@]1Cc2cc(ccc2[N@](S1(=O)=O)CC[N@H+]3CCC(=CC3)c4c[nH]c5c4ccc(c5)F)S(=O)(=O)C,BRD-K08534264-001-01-4,LY393558,Tocris,3350,LY 393558,-6.918391,x0104,8.851781,active-noncovalent
C[NH2+]CCc1cnc[nH]1,BRD-K64422603-300-02-7,N-alpha-Methylhistamine-dihydrochloride,Tocris,573,N?-Methylhistamine dihydrochloride,-6.917665,x1093,-2.212258,active-noncovalent
CCOC(=S)SSC(=S)OCC,BRD-K05919151-001-01-6,dixanthogen,MicroSource,1503891,DIXANTHOGEN,-6.916988,x0678,-1.018546,active-noncovalent
c1cc(ccc1NC(=O)CCC(=O)[O-])S(=O)(=O)Nc2nccs2,BRD-K01950558-001-14-7,succinylsulfathiazole,MicroSource,1502025,SUCCINYLSULFATHIAZOLE,-6.910339,x0104,3.080726,active-noncovalent
CCc1cc(c(cc1OCCCCCC(C)(C)c2n[n-]nn2)O)C(=O)C,BRD-K92492521-001-03-7,LY255283,Tocris,2208,LY 255283,-6.909581,x1077,4.751159,active-noncovalent
CCc1cc(c(cc1OCCCCCC(C)(C)c2n[n-]nn2)O)C(=O)C,BRD-K92492521-001-02-9,LY255283,Tocris,2208,LY 255283,-6.909581,x1077,4.751159,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,BRD-A54393207-001-03-6,levomenthol,Sigma,M2772,2-isopropyl-5-methylcyclohexanol,-6.909360,x0195,0.299971,active-noncovalent
CCCC[C@@H](CC)COC(=O)C[C@H](C(=O)OC[C@H](CC)CCCC)S(=O)(=O)[O-],BRD-A00092689-236-03-8,docusate,MicroSource,1503881,DOCUSATE SODIUM,-6.908270,x0967,3.908334,active-noncovalent
CCn1c2c(c(ncn2)N)nc1OCC,BRD-K31170746-001-01-6,ANR-94,Tocris,3937,ANR 94,-6.907362,x0540,-0.43008,active-noncovalent
CN([C@@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O)C(=O)/C=C/c7ccoc7,BRD-K89272869-003-01-8,nalfurafine,MedChemEx,HY-12745A,Nalfurafine (hydrochloride),-6.906093,x0874,6.058391,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H](C)C(=O)N2[C@@H]3CCCC[C@@H]3C[C@H]2C(=O)[O-],BRD-A32505112-001-04-4,trandolapril,MicroSource,1505264,TRANDOLAPRIL,-6.905635,x0874,3.606593,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]2[C@H](C[C@]4([C@@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)[O-])O)C)O,BRD-A07000685-001-04-4,hydrocortisone-hemisuccinate,MicroSource,1500339,HYDROCORTISONE HEMISUCCINATE,-6.905630,x0395,10.294176,active-noncovalent
Cc1cccc(n1)CC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)NS(=O)(=O)C,BRD-K41713976-300-03-4,E-4031,Tocris,1808,E-4031 dihydrochloride,-6.905343,x1077,6.956835,active-noncovalent
Cc1cccc(n1)CC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)NS(=O)(=O)C,BRD-K41713976-300-02-6,E-4031,Tocris,1808,E-4031 dihydrochloride,-6.905343,x1077,6.956835,active-noncovalent
Cc1ccc(cc1NC(=O)c2cc(nn2C)C)Oc3ccc4[nH+]c(cn4n3)NC(=O)C5CC5,BRD-K67262033-001-01-0,TAK-593,MedChemEx,HY-15506,TAK-593,-6.905018,x0072,8.574073,active-noncovalent
CCOC(=O)c1ccc(cc1)c2ccc(cc2)OC(=O)N(C)Cc3cccc(c3)c4ccncc4,BRD-K49389158-001-01-3,WWL-113,Tocris,5259,WWL 113,-6.903438,x0104,9.94834,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2cc(ccc2c3ccsc3)S(=O)(=O)NC4CC4)C(F)(F)F,BRD-K04691817-001-01-8,AGI-6780,Selleck,S7241,AGI-6780,-6.903009,x1093,6.226255,active-noncovalent
Cc1c2/cc\3/c(c(c(n3)/cc/4\nc(/cc\5/c(c(c(n5)/cc(/c1CCC(=O)[O-])\n2)CCC(=O)[O-])C)[C@H]([C@@H]4[C@@H](C)O)C)C)[C@@H](C)O,BRD-A44995766-300-03-0,hematoporphyrin,MedChemEx,HY-B0754A,Hematoporphyrin (dihydrochloride),-6.902246,x0072,12.410522,active-noncovalent
Cc1c2/cc\3/c(c(c(n3)/cc/4\nc(/cc\5/c(c(c(n5)/cc(/c1CCC(=O)[O-])\n2)CCC(=O)[O-])C)[C@H]([C@@H]4[C@@H](C)O)C)C)[C@@H](C)O,BRD-A44995766-001-02-6,hematoporphyrin,Sigma,MFCD00005077,"3,3'-(7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethylporphyrin-2,18-diyl)dipropionic acid",-6.902246,x0072,12.410522,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)Cl,BRD-K97833335-001-08-2,"2,4-dinitrochlorobenzene",Sigma,C3762,"1-chloro-2,4-dinitrobenzene",-6.898301,x0195,-0.407963,active-noncovalent
CN1c2c(=O)[nH]c(nc2NC[C@@H]1CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])N,BRD-K28580965-238-01-3,metafolin,MedChemEx,HY-17383,Levomefolate (calcium),-6.896361,x0104,11.32953,active-noncovalent
CN1c2c(=O)[nH]c(nc2NC[C@@H]1CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])N,BRD-K28580965-238-02-1,metafolin,MedChemEx,HY-17383,Levomefolate (calcium),-6.896361,x0104,11.32953,active-noncovalent
CN1c2c(=O)[nH]c(nc2NC[C@@H]1CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])N,BRD-K28580965-238-03-9,metafolin,MedChemEx,HY-17383,Levomefolate (calcium),-6.896361,x0104,11.32953,active-noncovalent
Cc1ccc(cc1C2CC[NH+](CC2)Cc3ccc(cc3)Oc4ccc(c(c4)F)F)NC(=O)C(C)C,BRD-K49702221-003-02-4,SNAP-94847,Tocris,3347,SNAP 94847 hydrochloride,-6.896015,x0104,13.041213,active-noncovalent
Cc1ccc(cc1C2CC[NH+](CC2)Cc3ccc(cc3)Oc4ccc(c(c4)F)F)NC(=O)C(C)C,BRD-K49702221-003-01-6,SNAP-94847,Tocris,3347,SNAP 94847 hydrochloride,-6.896015,x0104,13.041213,active-noncovalent
CCCNC(=O)Nc1ccc(cc1Cl)Oc2c3cc(c(cc3ncn2)OC)OC,BRD-K90993449-001-02-7,KRN-633,Selleck,S1557,KRN 633,-6.895981,x0072,4.721053,active-noncovalent
Cc1c(cc(cn1)NC(=O)c2ccc(c(c2)C(F)(F)F)C[NH+]3CCN(CC3)C)Nc4nccc(n4)c5cccnc5,BRD-K68870568-066-01-5,flumatinib,MedChemEx,HY-13905,Flumatinib (mesylate),-6.894921,x0104,16.633417,active-noncovalent
c1ccc(cc1)CS(=O)(=O)F,BRD-K33422401-001-06-4,phenylmethylsulfonyl-fluoride,Selleck,S3025,PMSF (Phenylmethylsulfonyl Fluoride),-6.893592,x0195,1.00793,active-noncovalent
c1ccc(cc1)CS(=O)(=O)F,BRD-K33422401-001-05-6,phenylmethylsulfonyl-fluoride,Selleck,S3025,PMSF,-6.893592,x0195,1.00793,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2C[C@H]3CCC[C@H]3C2,BRD-A61154809-001-16-7,gliclazide,Selleck,S2601,Gliclazide (Diamicron),-6.893043,x0161,0.721958,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2C[C@H]3CCC[C@H]3C2,BRD-A61154809-001-14-2,gliclazide,Selleck,S2601,Gliclazide,-6.893043,x0161,0.721958,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2C[C@H]3CCC[C@H]3C2,BRD-A61154809-001-15-9,gliclazide,MicroSource,1504145,GLICLAZIDE,-6.893043,x0161,0.721958,active-noncovalent
C1C[NH2+]CC(=C1)C(=O)[O-],BRD-K01980392-003-11-6,guvacine,Tocris,234,Guvacine hydrochloride,-6.892298,x0397,-1.564192,active-noncovalent
Cc1cc(c(cc1c2cc3cnc(nc3nc2C)NC)NC(=O)NCCC(C)(C)C)F,BRD-K38385169-001-03-7,LY3009120,Selleck,S7842,LY3009120,-6.891865,x0395,7.670618,active-noncovalent
Cc1cc(c(cc1c2cc3cnc(nc3nc2C)NC)NC(=O)NCCC(C)(C)C)F,BRD-K38385169-001-04-5,LY3009120,MedChemEx,HY-12558,"1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea",-6.891865,x0395,7.670618,active-noncovalent
Cc1cc(n(n1)c2nc(cc(n2)NC(=O)C)c3cccc(n3)N4CCC(CC4)OC)C,BRD-K76989898-001-01-1,TC-G-1004,Tocris,4407,TC-G 1004,-6.890007,x0161,7.249458,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)CNS(=O)(=O)N)C(=O)[O-])[C@@H](C)O,BRD-K45319714-002-04-3,doripenem,MedChemEx,HY-B0187A,Doripenem (monohydrate),-6.888804,x1392,2.557902,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)CNS(=O)(=O)N)C(=O)[O-])[C@@H](C)O,BRD-K45319714-002-03-5,doripenem,MedChemEx,HY-B0187A,Doripenem (monohydrate),-6.888804,x1392,2.557902,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)CNS(=O)(=O)N)C(=O)[O-])[C@@H](C)O,BRD-K45319714-002-02-7,doripenem,Sigma,MFCD09749887,"(4R,5S,6S)-3-[((3S,5S)-5-{[(aminosulfonyl)amino]methyl}-3-pyrrolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate",-6.888804,x1392,2.557902,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)CNS(=O)(=O)N)C(=O)[O-])[C@@H](C)O,BRD-K45319714-002-05-0,doripenem,Selleck,S1374,Doripenem Hydrate,-6.888804,x1392,2.557902,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)CNS(=O)(=O)N)C(=O)[O-])[C@@H](C)O,BRD-K45319714-002-01-9,doripenem,Selleck,S1374,Doripenem Hydrate,-6.888804,x1392,2.557902,active-covalent
c1cc(oc1)C[S@@](=O)CC(=O)NC/C=C\COc2cc(ccn2)C[NH+]3CCCCC3,BRD-A67516570-001-02-8,lafutidine,Selleck,S2065,Lafutidine,-6.885114,x0434,4.627494,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,BRD-K66035042-001-10-1,sorbitol,Selleck,S2393,Sorbitol,-6.884149,x0397,-0.200244,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,BRD-K66035042-001-11-9,mannitol-D,MicroSource,1300028,MANNITOL,-6.884149,x0397,-0.200244,active-noncovalent
CCS(=O)(=O)[N@@](C)[C@H]1c2cc(ccc2OC([C@@H]1O)(C)C)C#N,BRD-M02075109-001-01-1,chromanol-(+/-),Tocris,1412,Chromanol 293B,-6.883930,x0678,0.036249,active-noncovalent
CCS(=O)(=O)[N@@](C)[C@H]1c2cc(ccc2OC([C@@H]1O)(C)C)C#N,BRD-K27911943-001-02-8,"chromanol-293B-(-)-[3R,4S]",Tocris,1475,"(-)-[3R,4S]-Chromanol 293B",-6.883930,x0678,0.036249,active-noncovalent
C[N+](C)(C)C[C@H](CC(=O)[O-])O,BRD-A89594340-003-12-3,carnitine-(D/L),MicroSource,1500624,CARNITINE (dl) HYDROCHLORIDE,-6.883874,x0830,-0.317963,active-covalent
C[N+](C)(C)C[C@H](CC(=O)[O-])O,BRD-A89594340-003-11-5,carnitine-(D/L),Selleck,S2293,DL-Carnitine HCl,-6.883874,x0830,-0.317963,active-covalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)Nc4cccc(c4)C(=O)[O-])C(=O)[O-])[C@@H](C)O,BRD-A40472231-304-02-5,ertapenem,SantaCruz,sc-391428,,-6.883097,x0161,7.648061,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)Nc4cccc(c4)C(=O)[O-])C(=O)[O-])[C@@H](C)O,BRD-A40472231-304-01-7,ertapenem,SantaCruz,sc-391428,,-6.883097,x0161,7.648061,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4cc(c(cc4ncn3)OCCC[NH+]5CCCC5)OC,BRD-K86930074-001-05-0,cediranib,Selleck,S1017,Cediranib (AZD2171),-6.880923,x0395,9.843558,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F,BRD-K51544265-001-04-2,cabozantinib,Selleck,S1119,"Cabozantinib (XL184, BMS-907351)",-6.880868,x0104,10.938002,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F,BRD-K51544265-001-06-7,cabozantinib,Tocris,5422,XL 184,-6.880868,x0104,10.938002,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)N2CCOCC2,BRD-K53220666-001-02-6,trimetozine,MicroSource,1504214,TRIMETOZINE,-6.880165,x0946,1.376225,active-noncovalent
C1[C@H](ON=C1Cl)[C@H](C(=O)[O-])[NH3+],BRD-K13050541-001-01-9,acivicin,Enzo,EI113,Acivicin,-6.880086,x0397,-0.451904,active-noncovalent
CCc1ccc(o1)/C=C/C(=O)Nc2ccc(cc2)C(=O)C,BRD-K49788188-001-01-0,heclin,Tocris,5433,Heclin,-6.879212,x0161,5.670797,active-noncovalent
c1c(cc(cc1N(=O)=O)N(=O)=O)C(=O)N,BRD-K76381435-001-08-6,nitromide,MicroSource,1500435,NITROMIDE,-6.878201,x0195,0.182786,active-noncovalent
C[C@@]1([C@@H]2CC[C@@H](C2)C1(C)C)[NH2+]C,BRD-A20119038-003-07-8,mecamylamine,MicroSource,1500374,MECAMYLAMINE HYDROCHLORIDE,-6.875599,x0354,3.203235,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1c(nsn1)N2CCOCC2)O,BRD-K08806317-050-29-1,timolol,Tocris,649,(S)-Timolol maleate,-6.871535,x0104,1.355484,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1c(nsn1)N2CCOCC2)O,BRD-K08806317-051-01-8,timolol,Selleck,S4123,Timolol Maleate,-6.871535,x0104,1.355484,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)[O-])OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C,BRD-A44696962-001-01-4,acetyl-11-keto-beta-boswellic-acid,AnalytiCon,NP-008611,,-6.871237,x0104,9.488108,active-noncovalent
CC(C[C@H]1[NH2+][C@H]([C@@H]([C@@]12C(=O)Nc3c2ccc(c3)Cl)c4c(c(ccc4)Cl)F)C(=O)N[C@H]5CC[C@@H](CC5)O)(C)C,BRD-K86736469-001-02-1,SAR405838,MedChemEx,HY-17493,MI-773,-6.869808,x1077,8.134271,active-noncovalent
CC(C[C@H]1[NH2+][C@H]([C@@H]([C@@]12C(=O)Nc3c2ccc(c3)Cl)c4c(c(ccc4)Cl)F)C(=O)N[C@H]5CC[C@@H](CC5)O)(C)C,BRD-K86736469-001-01-3,SAR405838,MedChemEx,HY-17493,MI-773,-6.869808,x1077,8.134271,active-noncovalent
c1cc(cc(c1)Br)c2cc(nc3c2c(ncn3)N)c4ccc(nc4)N5CCOCC5,BRD-K36021395-300-02-4,ABT-702,Tocris,2372,ABT 702 dihydrochloride,-6.867449,x0161,7.133646,active-noncovalent
c1cc(cc(c1)Br)c2cc(nc3c2c(ncn3)N)c4ccc(nc4)N5CCOCC5,BRD-K36021395-300-03-2,ABT-702,Tocris,2372,"5-(3-bromophenyl)-7-[6-(4-morpholinyl)-3-pyridinyl]pyrido[2,3-d]pyrimidin-4-amine dihydrochloride",-6.867449,x0161,7.133646,active-noncovalent
CC(=O)O[C@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,BRD-A69636825-003-04-7,diltiazem,MicroSource,2300214,DILTIAZEM HYDROCHLORIDE,-6.867219,x0678,3.777793,active-noncovalent
C1C[N@@]([P@](=O)(OC1)NCCCl)CCCl,BRD-A67097164-001-17-9,ifosfamide,Selleck,S1302,Ifosfamide,-6.866999,x1093,-0.539076,active-noncovalent
C1C[N@@]([P@](=O)(OC1)NCCCl)CCCl,BRD-A67097164-001-18-7,ifosfamide,MicroSource,1505480,IFOSFAMIDE,-6.866999,x1093,-0.539076,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)C[NH+]3CCN(CC3)C(=O)Oc4ccc(cc4)N(=O)=O,BRD-K38875233-001-03-9,JZL-195,Tocris,4715,JZL 195,-6.865613,x0104,8.369266,active-noncovalent
CCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(CC(=O)[C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)C)C)C(=O)CCl,BRD-K58810291-001-16-2,clobetasone-butyrate,Sigma,MFCD00133196,"(16beta)-21-chloro-9-fluoro-16-methyl-3,11,20-trioxopregna-1,4-dien-17-yl butyrate",-6.862772,x1077,5.739863,active-noncovalent
Cc1c(c(=O)n2c(n1)CCCC2)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,BRD-K53857191-001-22-7,risperidone,MicroSource,1506038,RISPERIDONE,-6.862376,x0161,3.870242,active-noncovalent
Cc1c(c(=O)n2c(n1)CCCC2)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,BRD-K53857191-001-21-9,risperidone,Selleck,S1615,Risperidone,-6.862376,x0161,3.870242,active-noncovalent
Cc1cccc(c1OC(=O)N(c2ccc(cc2OC)OC)c3ccnc(n3)Nc4ccc(cc4)N5CC[NH+](CC5)C)C,BRD-K50199947-001-03-4,WH-4-023,Tocris,5413,WH-4-023,-6.861629,x0104,11.696636,active-noncovalent
c1c(cc(cc1O)O)O,BRD-K00405906-001-01-9,phloroglucin,Vitas-M,STL146346,,-6.860658,x0678,1.815792,active-noncovalent
c1ccc2c(c1)C(=O)N(S2(=O)=O)CCCC[NH+]3CCN(CC3)c4ncccn4,BRD-K90574421-001-03-5,ipsapirone,Tocris,1869,Ipsapirone,-6.860624,x0874,4.995875,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@H](C2=O)N3C(=O)[C@H]([NH2+]C3(C)C)c4ccccc4)C(=O)[O-])C,BRD-A27828834-237-04-4,hetacillin,MicroSource,1500327,HETACILLIN POTASSIUM,-6.860322,x0072,3.177027,active-noncovalent
CCS(=O)(=O)Nc1ccc2c(c1)c(c([nH]2)O)/C(=N\c3ccc(cc3)C[NH+]4CCCCC4)/c5ccccc5,BRD-K58122457-001-02-2,hesperadin,Selleck,S1529,Hesperadin,-6.857933,x0874,6.468416,active-noncovalent
CCS(=O)(=O)Nc1ccc2c(c1)c(c([nH]2)O)/C(=N\c3ccc(cc3)C[NH+]4CCCCC4)/c5ccccc5,BRD-K58122457-003-01-0,hesperadin,Tocris,3988,Hesperadin hydrochloride,-6.857933,x0874,6.468416,active-noncovalent
CC(C)C(=O)SCCCCC[C@@H](C(=O)NC12CC3CC(C1)CC(C3)C2)NC(=O)OC(C)(C)C,BRD-K68358632-001-01-0,TCS-HDAC6-20b,Tocris,4805,TCS HDAC6 20b,-6.855196,x0161,6.705804,active-noncovalent
CCOCc1cc(c(c(c1)OC)c2ccc(cc2)C[C@@H](C(=O)[O-])NC(=O)c3c(cccc3F)F)OC,BRD-K17513304-001-01-9,firategrast,MedChemEx,HY-14951,Firategrast,-6.853431,x0104,7.071155,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,BRD-K32107296-001-14-4,temozolomide,Selleck,S1237,Temozolomide,-6.853195,x0195,-0.429285,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,BRD-K32107296-001-16-9,temozolomide,MicroSource,1502289,TEMOZOLAMIDE,-6.853195,x0195,-0.429285,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,BRD-K32107296-001-20-1,temozolomide,Tocris,2706,Temozolomide,-6.853195,x0195,-0.429285,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,BRD-K32107296-001-15-1,temozolomide,Tocris,2706,Temozolomide,-6.853195,x0195,-0.429285,active-noncovalent
CC[C@@H]1C(=O)N(c2cnc(nc2[N@@]1C3CCCC3)Nc4ccc(cc4OC)C(=O)NC5CC[NH+](CC5)C)C,BRD-K64890080-001-13-8,BI-2536,Selleck,S1109,BI 2536,-6.850269,x0104,13.185356,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccsc3)C(=O)[O-])C(=O)[O-])C,BRD-K29229654-304-02-0,ticarcillin,Selleck,S3193,Ticarcillin sodium,-6.849438,x0678,1.466908,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccsc3)C(=O)[O-])C(=O)[O-])C,BRD-K29229654-304-03-8,ticarcillin,Selleck,S3193,Ticarcillin sodium,-6.849438,x0678,1.466908,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccsc3)C(=O)[O-])C(=O)[O-])C,BRD-K29229654-304-04-6,ticarcillin,MicroSource,1505678,TICARCILLIN DISODIUM,-6.849438,x0678,1.466908,active-noncovalent
Cn1c(c[nH+]c1N(=O)=O)COP(=O)(NCCBr)NCCBr,BRD-K20958582-001-01-4,TH-302,MedChemEx,HY-10535,TH-302,-6.848451,x0678,2.101515,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)Oc4cccc(c4)NC(=O)C=C)Cl,BRD-K73293050-001-03-1,WZ-3146,Selleck,S1170,WZ3146,-6.846328,x0161,6.278522,active-noncovalent
CC(C)C[C@@H](CC(=O)[O-])C[NH3+],BRD-K66786476-003-01-9,pregabalin,MicroSource,1505816,PREGABALIN HYDROCHLORIDE,-6.845840,x1374,-0.682424,active-covalent
CC(C)C[C@@H](CC(=O)[O-])C[NH3+],BRD-K66786476-001-01-3,pregabalin,MedChemEx,HY-17414,Pregabalin,-6.845840,x1374,-0.682424,active-covalent
C[NH+]1CCN(CC1)c2ncc(c(n2)N)c3cc(cc(c3Cl)Cl)Cl,BRD-K53195974-001-01-9,sipatrigine,Tocris,4044,"2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinylamine",-6.845108,x0874,4.914263,active-noncovalent
C[NH+]1CCN(CC1)c2ncc(c(n2)N)c3cc(cc(c3Cl)Cl)Cl,BRD-K53195974-001-02-7,sipatrigine,Tocris,4044,Sipatrigine,-6.845108,x0874,4.914263,active-noncovalent
C[C@@H](OC(=O)C)OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3ccco3)COC(=O)N,BRD-A22303829-001-02-4,cefuroxime-axetil,MicroSource,1504175,CEFUROXIME AXETIL,-6.844593,x0104,6.538997,active-noncovalent
C[C@@H](OC(=O)C)OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3ccco3)COC(=O)N,BRD-A22303829-001-01-6,cefuroxime-axetil,Sigma,A4237,"1-(acetyloxy)ethyl (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-{[(2Z)-2-(2-furyl)-2-(methoxyimino)ethanoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-6.844593,x0104,6.538997,active-noncovalent
CN(C)NC(=O)CCC(=O)[O-],BRD-K83452553-001-05-8,daminozide,Tocris,4684,Daminozide,-6.844227,x0107,-1.126765,active-noncovalent
c1cc(c(c(c1)F)C(=O)NC(=O)Nc2cc(c(cc2Cl)OC([C@@H](C(F)(F)F)F)(F)F)Cl)F,BRD-A71774530-001-05-9,lufenuron,MicroSource,1505355,LUFENURON,-6.843878,x0104,8.923728,active-noncovalent
CC[C@H](C)n1cc(c2c1cc(cc2C(=O)NCc3c(cc([nH]c3=O)C)C)c4ccc(nc4)N5CC[NH2+]CC5)C,BRD-K21867462-001-02-9,GSK2816126,MedChemEx,HY-13470,GSK126,-6.843451,x0678,10.178727,active-noncovalent
CC[C@H](C)n1cc(c2c1cc(cc2C(=O)NCc3c(cc([nH]c3=O)C)C)c4ccc(nc4)N5CC[NH2+]CC5)C,BRD-K21867462-001-03-7,GSK2816126,MedChemEx,HY-13470,GSK126,-6.843451,x0678,10.178727,active-noncovalent
C[N@H+](C/C=C/c1ccc(cc1)Cl)Cc2ccccc2[N@@](CCO)S(=O)(=O)c3ccc(cc3)OC,BRD-K93480852-001-05-5,KN-93,MedChemEx,HY-15465,KN-93,-6.842664,x0678,5.015238,active-noncovalent
C[N@H+](C/C=C/c1ccc(cc1)Cl)Cc2ccccc2[N@@](CCO)S(=O)(=O)c3ccc(cc3)OC,BRD-K93480852-001-06-3,KN-93,MedChemEx,HY-15465,KN-93,-6.842664,x0678,5.015238,active-noncovalent
C[N@H+](C/C=C/c1ccc(cc1)Cl)Cc2ccccc2[N@@](CCO)S(=O)(=O)c3ccc(cc3)OC,BRD-K93480852-003-01-0,KN-93,MedChemEx,HY-15465A,KN-93 (hydrochloride),-6.842664,x0678,5.015238,active-noncovalent
CC(C)Cc1c(nc(s1)N)c2ccc(o2)P(=O)([O-])[O-],BRD-K35601925-001-01-9,CS-917,MedChemEx,HY-16307,MB05032,-6.839567,x1385,1.15942,active-covalent
CC(C)Cc1c(nc(s1)N)c2ccc(o2)P(=O)([O-])[O-],BRD-K35601925-001-02-7,CS-917,MedChemEx,HY-16307,MB05032,-6.839567,x1385,1.15942,active-covalent
CC1(C[C@@H]1C(=O)/N=C(\CCCCCSC[C@@H](C(=O)[O-])[NH3+])/C(=O)[O-])C,BRD-K85518562-236-08-9,cilastatin,AvaChem,1721,"(2Z)-7-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-2-({[(1R)-2,2-dimethylcyclopropyl]carbonyl}amino)-2-heptenoic acid",-6.839529,x1311,2.951142,active-covalent
CC1(C[C@@H]1C(=O)/N=C(\CCCCCSC[C@@H](C(=O)[O-])[NH3+])/C(=O)[O-])C,BRD-K85518562-236-09-7,cilastatin,Tocris,2709,Cilastatin sodium,-6.839529,x1311,2.951142,active-covalent
CCC[C@@H](C(=O)OCC)[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-],BRD-K92731339-227-05-6,perindopril,Selleck,S1506,Perindopril Erbumine (Aceon),-6.837787,x0161,2.927814,active-noncovalent
CCC[C@@H](C(=O)OCC)[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-],BRD-K92731339-227-04-9,perindopril,MicroSource,1505212,PERINDOPRIL ERBUMINE,-6.837787,x0161,2.927814,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)N,BRD-A99833829-003-25-5,bethanechol,Selleck,S2455,Bethanechol chloride,-6.837536,x0195,-0.605701,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)N,BRD-A99833829-003-27-1,bethanechol,Selleck,S2455,Bethanechol chloride,-6.837536,x0195,-0.605701,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)N,BRD-A99833829-003-26-3,bethanechol,MicroSource,1500146,BETHANECHOL CHLORIDE,-6.837536,x0195,-0.605701,active-noncovalent
c1cc(c(cc1N[C@@H](c2c(non2)NCCNS(=O)(=O)N)N=O)Br)F,BRD-K79450420-001-03-4,epacadostat,MedChemEx,HY-15689,,-6.837383,x0161,2.625098,active-noncovalent
c1cc(c(cc1N[C@@H](c2c(non2)NCCNS(=O)(=O)N)N=O)Br)F,BRD-K79450420-001-01-8,INCB-024360,MedChemEx,HY-15689,INCB 024360,-6.837383,x0161,2.625098,active-noncovalent
c1cc(c(cc1N[C@@H](c2c(non2)NCCNS(=O)(=O)N)N=O)Br)F,BRD-K79450420-001-02-6,epacadostat,Selleck,S7910,Epacadostat (INCB024360),-6.837383,x0161,2.625098,active-noncovalent
Cc1ccc(cc1)O,BRD-K56940914-001-04-2,cresol,MicroSource,1500209,CRESOL,-6.833539,x0678,1.077796,active-noncovalent
COc1cc(c(c2c1OCO2)c3c(cc(c4c3OCO4)OC)C(=O)OC)CO,BRD-K16546375-001-01-4,bicyclol,Sigma,B3313,"methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-4,4'-bibenzo[d][1,3]dioxole-5-carboxylate",-6.831580,x0104,4.277013,active-noncovalent
CC1(C(=O)[N-]C(=O)O1)C,BRD-K43687498-001-09-8,dimethadione,MicroSource,1500253,DIMETHADIONE,-6.829866,x0397,1.274811,active-noncovalent
CCCC(=O)N1CCCN(CC1)c2nc3cc(c(cc3c(n2)N)OC)OC,BRD-K35034482-001-01-8,bunazosin,Enamine,Z1172912933,,-6.828152,x0195,2.297624,active-noncovalent
CC[C@]1(CC(=O)NC1=O)C,BRD-A99633051-001-08-8,ethosuximide,Sigma,MFCD00072123,"4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one",-6.826540,x0678,1.438711,active-noncovalent
CC[C@]1(CC(=O)NC1=O)C,BRD-A99633051-001-07-0,ethosuximide,MicroSource,1502196,ETHOSUXIMIDE,-6.826540,x0678,1.438711,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O,BRD-K81447180-001-01-0,lincomycin,Selleck,S2479,Lincomycin HCl,-6.826063,x0434,1.992323,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O,BRD-K81447180-003-21-4,lincomycin,Selleck,S2479,Lincomycin hydrochloride (Lincocin),-6.826063,x0434,1.992323,active-noncovalent
CC(C)(C)[C@H](NC(=O)Cc1ccc(c(c1)OC)OC)N/C(=N\c2cccc3c2cccn3)/NC#N,BRD-A78952587-001-02-3,A740003,Tocris,3701,A 740003,-6.825935,x0967,5.064668,active-noncovalent
CC(C)(C)[C@H](NC(=O)Cc1ccc(c(c1)OC)OC)N/C(=N\c2cccc3c2cccn3)/NC#N,BRD-A78952587-001-01-5,A740003,Tocris,3701,A 740003,-6.825935,x0967,5.064668,active-noncovalent
CCCCCCCC(=O)[O-],BRD-K35170555-001-09-5,caprylic-acid,Enamine,Z104495238,,-6.825423,x0759,-0.697367,active-covalent
CCCCCCCC(=O)[O-],BRD-K35170555-001-12-9,caprylic-acid,Enamine,Z104495238,octanoic acid,-6.825423,x0759,-0.697367,active-covalent
c1cc(c(nc1)C(=O)[O-])CC(=O)[O-],BRD-K30519779-001-03-1,homoquinolinic-acid,Tocris,197,Homoquinolinic acid,-6.825365,x0397,-0.491433,active-noncovalent
c1cc(nc(c1)C[C@]2(CC[C@H](CC2)Oc3c(c(ccc3)Cl)F)C(=O)[O-])Nc4sccn4,BRD-K53665955-001-03-0,MK-5108,Selleck,S2770,MK-5108 (VX-689),-6.825205,x0434,5.785969,active-noncovalent
c1cc(cc(c1)N)C(=O)N,BRD-K08703257-001-12-1,3-amino-benzamide,Selleck,S1132,INO-1001,-6.822288,x0195,-1.503326,active-noncovalent
c1cc(cc(c1)N)C(=O)N,BRD-K08703257-001-13-9,3-amino-benzamide,Tocris,788,3-Aminobenzamide,-6.822288,x0195,-1.503326,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)OP(=O)([O-])[O-],BRD-K67760597-240-01-5,barium-6-O-phosphonato-D-glucose,TCI,G0052,barium 6-O-phosphonato-D-glucose,-6.822249,x0397,-0.722114,active-noncovalent
C(CCl)NC(=O)N(CCCl)N=O,BRD-K36234266-001-09-8,carmustine,MicroSource,1503110,CARMUSTINE,-6.821645,x0397,-0.985928,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(c(c(c2)C(C)(C)C)O)C(C)(C)C,BRD-K72029282-001-22-0,probucol,Selleck,S2119,Probucol,-6.821153,x0830,6.849023,active-covalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(c(c(c2)C(C)(C)C)O)C(C)(C)C,BRD-K72029282-001-23-8,probucol,MicroSource,1501109,PROBUCOL,-6.821153,x0830,6.849023,active-covalent
c1cc(cc(c1)C(F)(F)F)C(=O)NCC(=O)N[C@@H]2CC[N@H+](C2)Cc3ccc(cc3)Cl,BRD-K51528698-003-01-4,Teijin-compound-1,Tocris,3664,Teijin compound 1,-6.818528,x0161,7.58298,active-noncovalent
C[C@@H]1[C@H]([C@H]([C@@H](O1)n2cc(c(=O)[nH]c2=O)F)O)O,BRD-K58262659-001-09-7,doxifluridine,Selleck,S2045,Doxifluridine,-6.818216,x0195,-0.991421,active-noncovalent
C[C@@H]1[C@H]([C@H]([C@@H](O1)n2cc(c(=O)[nH]c2=O)F)O)O,BRD-K58262659-001-10-5,doxifluridine,MicroSource,1501189,DOXIFLURIDINE,-6.818216,x0195,-0.991421,active-noncovalent
Cc1[nH+]cc(n1CCO)N(=O)=O,BRD-K52020312-001-26-8,metronidazole,MicroSource,1500412,METRONIDAZOLE,-6.818151,x0195,1.854535,active-noncovalent
Cc1[nH+]cc(n1CCO)N(=O)=O,BRD-K52020312-001-25-0,metronidazole,Selleck,S1907,Metronidazole,-6.818151,x0195,1.854535,active-noncovalent
COc1ccc(cc1)O,BRD-K45216060-001-11-8,mequinol,Selleck,S4077,Mequinol,-6.815259,x0678,1.344143,active-noncovalent
COc1ccc(cc1)O,BRD-K45216060-001-10-0,mequinol,MicroSource,212037,MEQUINOL,-6.815259,x0678,1.344143,active-noncovalent
COc1ccc(cc1)O,BRD-K45216060-001-09-2,mequinol,Selleck,S4077,Mequinol,-6.815259,x0678,1.344143,active-noncovalent
Cc1c(c(no1)c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K96786677-323-03-8,oxacillin,Selleck,S2563,Oxacillin sodium monohydrate,-6.815174,x0072,2.218609,active-noncovalent
Cc1c(c(no1)c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K96786677-236-02-4,oxacillin,MicroSource,1500448,OXACILLIN SODIUM,-6.815174,x0072,2.218609,active-noncovalent
Cc1c(c(no1)c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K96786677-323-02-0,oxacillin,Selleck,S2563,Oxacillin sodium monohydrate,-6.815174,x0072,2.218609,active-noncovalent
c1cc(ccc1C[NH3+])S(=O)(=O)N,BRD-K30649484-003-13-7,mafenide,MicroSource,1500372,MAFENIDE HYDROCHLORIDE,-6.814958,x0161,0.970719,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N,BRD-K53448858-001-08-8,acadesine,Tocris,2840,AICAR,-6.814649,x0195,0.72514,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N,BRD-K53448858-001-09-6,acadesine,Selleck,S1802,Acadesine,-6.814649,x0195,0.72514,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N,BRD-K53448858-001-07-0,acadesine,Selleck,S1802,AICAR (Acadesine),-6.814649,x0195,0.72514,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCN(c3ccccn3)C(=O)C4CCCCC4,BRD-K69812556-305-02-0,WAY-100635,Selleck,S2663,WAY-100635 Maleate,-6.813808,x0434,5.853747,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)OC,BRD-K69694239-001-02-2,bardoxolone-methyl,Selleck,S8078,Bardoxolone Methyl,-6.813228,x0072,6.730457,active-noncovalent
CCC1(CC(=O)NC(=O)C1)C,BRD-K14993104-001-05-9,bemegride,Selleck,S4197,Bemegride,-6.810605,x0678,1.545831,active-noncovalent
CC[C@]1(C(=O)N(C(=O)O1)C)C,BRD-A22128695-001-02-6,paramethadione,MicroSource,1505456,PARAMETHADIONE,-6.809840,x0678,-1.007773,active-noncovalent
CC[C@]1(C(=O)N(C(=O)O1)C)C,BRD-A22128695-001-03-4,paramethadione,Enamine,Z2327506990,"5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione",-6.809840,x0678,-1.007773,active-noncovalent
CCc1c(ccc(n1)C)O,BRD-K28982731-001-01-6,emoxipin,Vitas-M,STK037982,,-6.808307,x1093,-1.231166,active-noncovalent
[C@@H](C(F)(F)F)(OC(F)F)Cl,BRD-A31564021-001-02-6,isoflurane,Sigma,MFCD00066609,"2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane",-6.807446,x0195,1.587062,active-noncovalent
[C@@H](C(F)(F)F)(OC(F)F)Cl,BRD-A31564021-001-01-8,isoflurane,Enamine,EN300-123043,,-6.807446,x0195,1.587062,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,BRD-K49404994-001-09-1,levetiracetam,Selleck,S1356,Levetiracetam,-6.806917,x0678,1.121142,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,BRD-K49404994-001-11-7,levetiracetam,Selleck,S1356,Levetiracetam,-6.806917,x0678,1.121142,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,BRD-K49404994-001-13-3,levetiracetam,Tocris,2839,Levetiracetam,-6.806917,x0678,1.121142,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,BRD-K49404994-001-10-9,levetiracetam,MicroSource,1502265,LEVETIRACETAM,-6.806917,x0678,1.121142,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(c(c1)OC)O,BRD-K31560319-001-02-3,olvanil,Tocris,934,Olvanil,-6.806349,x0161,5.047533,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(c(c1)OC)O,BRD-K31560319-001-01-5,olvanil,Tocris,934,Olvanil,-6.806349,x0161,5.047533,active-noncovalent
c1cc(ccc1C(=O)[O-])S(=O)(=O)N(Cl)Cl,BRD-K68091065-001-04-7,halazone,MicroSource,1500324,HALAZONE,-6.805539,x0749,-1.166231,active-covalent
CC(=O)OCC(COC(=O)C)OC(=O)C,BRD-K92844263-001-09-8,triacetin,MicroSource,1500585,TRIACETIN,-6.805501,x0195,0.764885,active-noncovalent
C(CC#N)CSC(=[NH2+])N,BRD-K61339991-003-01-8,kevetrin,MedChemEx,HY-16271,Kevetrin (hydrochloride),-6.804411,x0195,-1.674575,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)C(=O)N,BRD-K26807903-001-04-3,aklomide,MicroSource,1503014,AKLOMIDE,-6.801215,x0195,-1.540048,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)C(=O)Nc3c4c([nH]n3)CN(C4)C(=O)[C@@H](c5ccccc5)OC,BRD-K07881437-001-03-8,danusertib,Selleck,S1107,Danusertib (PHA-739358),-6.801111,x0104,11.059961,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)C(=O)Nc3c4c([nH]n3)CN(C4)C(=O)[C@@H](c5ccccc5)OC,BRD-K07881437-001-04-6,danusertib,Selleck,S1107,Danusertib (PHA-739358),-6.801111,x0104,11.059961,active-noncovalent
Cc1csc(n1)S(=O)(=O)[N@](CC(C)C)c2cc3c(cc2OCc4ccc(cc4)C(=O)[O-])CCC3,BRD-K76725781-001-01-9,ONO-8130,Tocris,5406,ONO 8130,-6.800794,x0678,4.637889,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)C)O)[NH3+])O,BRD-K43389675-003-20-9,daunorubicin,Tocris,1467,Daunorubicin hydrochloride,-6.800050,x0161,10.656235,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)C)O)[NH3+])O,BRD-K43389675-001-02-1,daunorubicin,MicroSource,1500223,DAUNORUBICIN,-6.800050,x0161,10.656235,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)C)O)[NH3+])O,BRD-K43389675-003-19-1,daunorubicin,Selleck,S3035,Daunorubicin HCl,-6.800050,x0161,10.656235,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)C)O)[NH3+])O,BRD-K43389675-003-16-7,daunorubicin,Selleck,S3035,Daunorubicin HCl (Daunomycin HCl),-6.800050,x0161,10.656235,active-noncovalent
C([C@@H](C[NH3+])O)C(=O)[O-],BRD-A40777960-001-04-2,aminohydroxybutyric-acid,MicroSource,1503041,AMINOHYDROXYBUTYRIC ACID,-6.799708,x0397,-1.095971,active-noncovalent
c1cc(c(c(c1NS(=O)(=O)[N@@]2CC[C@H](C2)F)F)C(=O)c3c[nH]c4c3cc(cn4)c5cnc(nc5)C6CC6)F,BRD-K53723268-001-01-3,PLX8394,MedChemEx,HY-18972,PLX8394,-6.799100,x0195,6.993168,active-noncovalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N,BRD-K24507548-001-01-8,cintriamide,MicroSource,1502553,CINTRIAMIDE,-6.798541,x0195,1.799045,active-noncovalent
C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)NC[NH+]5CCCC5)[O-])[NH+](C)C)O)[O-])[O-])O,BRD-A62336573-001-03-1,rolitetracycline,MicroSource,1505684,ROLITETRACYCLINE,-6.796695,x0874,5.835131,active-noncovalent
C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)NC[NH+]5CCCC5)[O-])[NH+](C)C)O)[O-])[O-])O,BRD-A62336573-001-04-9,rolitetracycline,Selleck,S4352,rolitetracycline,-6.796695,x0874,5.835131,active-noncovalent
C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)NC[NH+]5CCCC5)[O-])[NH+](C)C)O)[O-])[O-])O,BRD-A62336573-001-02-3,rolitetracycline,Selleck,S4352,Rolitetracycline,-6.796695,x0874,5.835131,active-noncovalent
Cc1cc(nc2c1c(c(cc2N[C@H](C)CCC[NH3+])OC)Oc3cccc(c3)C(F)(F)F)OC,BRD-A78965079-036-01-8,tafenoquine,Sigma,SML0396,"N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine succinate",-6.796340,x0161,6.292658,active-noncovalent
C[NH+](C)C1(CCC2(CC1)c3c(c4cc(ccc4[nH]3)F)CCO2)c5ccccc5,BRD-K48141473-001-01-7,cebranopadol,MedChemEx,HY-15536,Cebranopadol,-6.796281,x1077,4.19727,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O)O,BRD-K52618540-001-09-9,inositol,MicroSource,1500352,INOSITOL,-6.795132,x0397,2.0733,active-noncovalent
c1cc(cc(c1)C(=O)NCCO)c2cc(ncn2)Nc3ccc(cc3)OC(F)(F)F,BRD-K87632963-001-03-0,GNF-5,Tocris,4908,GNF 5,-6.793793,x0161,9.430552,active-noncovalent
c1ccc(cc1)c2cnn3c2ncc(c3)c4ccc(cc4)OCC[NH+]5CCOCC5,BRD-K40575944-001-01-5,DMH4,Tocris,4471,DMH4,-6.793792,x0104,10.905908,active-noncovalent
COCCNC(=O)Cn1cnc(n1)N(=O)=O,BRD-K37747025-001-08-2,sanazole,Asinex,BAS 00535149,"N-(2-methoxyethyl)-2-(3-nitro-1H-1,2,4-triazol-1-yl)acetamide",-6.793581,x0397,-0.265977,active-noncovalent
CC[C@@H](C)[C@@H](C(=O)[O-])[NH3+],BRD-A02232681-001-01-8,isoleucine,Enamine,Z1270446358,isoleucine,-6.793243,x1077,-1.159926,active-noncovalent
CC1(OC[C@@H]([C@@H](O1)c2ccccc2)NC(=O)Nc3ccc(cc3Br)Br)C,BRD-K61721596-001-02-8,JNJ-10397049,Tocris,4317,JNJ 10397049,-6.792242,x0967,2.286503,active-noncovalent
c1cc(ncc1CN2CCN=C2NN(=O)=O)Cl,BRD-K76609936-001-08-4,imidacloprid,SantaCruz,sc-211632,Imidacloprid,-6.792168,x0749,-0.768668,active-covalent
Cc1c(cccc1C(=O)Nc2ccc(nc2)N3C[C@H](O[C@H](C3)C)C)c4ccc(cc4)OC(F)(F)F,BRD-K19796430-001-09-8,sonidegib,Selleck,S2151,"LDE225 (NVP-LDE225, Erismodegib)",-6.789901,x0104,14.804453,active-noncovalent
Cc1c(cccc1C(=O)Nc2ccc(nc2)N3C[C@H](O[C@H](C3)C)C)c4ccc(cc4)OC(F)(F)F,BRD-K19796430-001-05-6,sonidegib,Selleck,S2151,"LDE225 (NVP-LDE225,Erismodegib)",-6.789901,x0104,14.804453,active-noncovalent
CC(=O)OC[C@@H](C(=O)[O-])[NH3+],BRD-K63247785-001-01-5,o-acetyl-L-serine,Astatech,50434,(2S)-3-(acetyloxy)-2-aminopropanoic acid,-6.789260,x0397,-0.268353,active-noncovalent
c1c(cc(c(c1Cl)n2c(c(c(n2)C#N)[S@](=O)C(F)(F)F)N)Cl)C(F)(F)F,BRD-A50675702-001-07-1,fipronil,MicroSource,1505354,FIPRONIL,-6.789096,x0104,2.429728,active-noncovalent
C[C@@H]1NC(=[NH+]C(=[NH+]1)N(C)C)N,BRD-K55822903-003-02-6,imeglimin,MedChemEx,HY-14771A,Imeglimin (hydrochloride),-6.788079,x1077,-1.282005,active-noncovalent
C[C@@H]1NC(=[NH+]C(=[NH+]1)N(C)C)N,BRD-K55822903-003-01-8,imeglimin,MedChemEx,HY-14771A,Imeglimin (hydrochloride),-6.788079,x1077,-1.282005,active-noncovalent
c1c(on[n+]1N2CCOCC2)N,BRD-K86344238-003-03-8,linsidomine,Cayman,82220,,-6.785273,x0195,-0.821476,active-noncovalent
c1c(on[n+]1N2CCOCC2)N,BRD-K86344238-003-04-6,linsidomine,EMDBio,567028-20MG,"SIN-1, Hydrochloride",-6.785273,x0195,-0.821476,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c(c(c3)O)C(=O)CCc4ccc(cc4)O)O)CO)O)O)O)O)O,BRD-K13511380-001-01-4,naringin-dihydrochalcone,Selleck,S2389,Naringin Dihydrochalcone,-6.785189,x0395,13.195445,active-noncovalent
C1CC(=O)N2C1CCC2=O,BRD-K38564664-001-01-1,rolziracetam,Sigma,PH000303,"dihydro-1H-pyrrolo[1,2-a]pyrrole-3,5(2H,6H)-dione",-6.784109,x0195,-1.115463,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(ccc1OC)S(=O)(=O)C,BRD-K57432881-003-21-8,tiapride,MicroSource,1503086,TIAPRIDE HYDROCHLORIDE,-6.783593,x0161,2.09338,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O,BRD-K54028654-001-02-6,cabaletta,Enzo,AC1507,Trehalose,-6.783356,x0195,0.994477,active-noncovalent
C(CCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])CC[NH3+],BRD-K60212747-236-01-1,neridronic-acid,Toronto,N390025,Neridronate Sodium Salt,-6.781166,x0397,0.783106,active-noncovalent
c1cnc(nc1)C#N,BRD-K95015809-001-02-8,2-cyanopyrimidine,Enamine,Z441820390,,-6.779339,x0195,-0.753104,active-noncovalent
CCCCCCCCCCC(C)(C)C(=O)Nc1c(cc(cc1OC)OC)OC,BRD-K88544581-001-06-1,CI-976,Tocris,2227,CI 976,-6.778949,x0434,4.216387,active-noncovalent
CCCCCCCCCCC(C)(C)C(=O)Nc1c(cc(cc1OC)OC)OC,BRD-K88544581-001-08-7,CI-976,Tocris,2227,CI 976,-6.778949,x0434,4.216387,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)NCCCCCC(=O)[O-],BRD-K04282412-001-16-3,capobenic-acid,MicroSource,1505417,CAPOBENIC ACID,-6.777803,x1077,2.826342,active-noncovalent
CSc1nc2ccc3c(c2s1)sc(n3)NC(=O)C(c4ccccc4)c5ccccc5,BRD-K18745919-001-01-3,Gue-1654,Tocris,4742,Gue 1654,-6.774632,x0104,5.561836,active-noncovalent
COc1ccc(cc1OC)c2cc(=O)c3c(o2)c(c(c(c3OC)OC)OC)OC,BRD-K06753942-001-14-5,nobiletin,Selleck,S2333,Nobiletin,-6.773530,x0161,5.651453,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)n2C,BRD-K34888156-001-11-2,theobromine,Selleck,S2368,Theobromine,-6.771730,x0678,-1.538761,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)n2C,BRD-K34888156-213-01-4,theobromine,MicroSource,1500649,THEOBROMINE,-6.771730,x0678,-1.538761,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,BRD-A75919782-399-03-4,leucovorin,Selleck,S1236,Leucovorin Calcium,-6.770385,x0104,11.359306,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,BRD-A75919782-238-08-3,leucovorin,MicroSource,1500364,LEUCOVORIN CALCIUM,-6.770385,x0104,11.359306,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,BRD-A75919782-399-02-6,leucovorin,Selleck,S1236,Leucovorin Calcium,-6.770385,x0104,11.359306,active-noncovalent
CCc1cc2c(cc1N3CCC(CC3)[NH+]4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C,BRD-K11267252-001-04-4,alectinib,Selleck,S2762,Alectinib (CH5424802),-6.768570,x0104,11.803966,active-noncovalent
CCc1cc2c(cc1N3CCC(CC3)[NH+]4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C,BRD-K11267252-001-06-9,alectinib,Selleck,S2762,alectinib,-6.768570,x0104,11.803966,active-noncovalent
COc1cccc(c1)NC(=O)/C=C/c2ccc(cc2)Cl,BRD-K61536336-001-02-5,SB-366791,Tocris,1615,SB 366791,-6.767305,x0161,2.844237,active-noncovalent
COc1cccc(c1)NC(=O)/C=C/c2ccc(cc2)Cl,BRD-K61536336-001-01-7,SB-366791,Tocris,1615,SB 366791,-6.767305,x0161,2.844237,active-noncovalent
c1ccc(c(c1)CO)O,BRD-K08493205-001-04-9,salicyl-alcohol,MicroSource,1500531,SALICYL ALCOHOL,-6.765286,x0678,1.318454,active-noncovalent
CC(C)[C@@H](Cc1ccc(c(c1)OCCCOC)OC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)[NH3+],BRD-K30020243-051-03-3,aliskiren-hemifumarate,Selleck,S2199,Aliskiren Hemifumarate,-6.765131,x0434,9.837183,active-noncovalent
CC(C)[C@@H](Cc1ccc(c(c1)OCCCOC)OC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)[NH3+],BRD-K30020243-051-02-5,aliskiren-hemifumarate,MicroSource,1505710,ALISKIREN HEMIFUMARATE,-6.765131,x0434,9.837183,active-noncovalent
CC(C)[C@@H](Cc1ccc(c(c1)OCCCOC)OC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)[NH3+],BRD-K30020243-051-04-1,aliskiren-hemifumarate,Tocris,5491,Aliskiren hemifumarate,-6.765131,x0434,9.837183,active-noncovalent
C(CCl)NP(=O)(NCCCl)[O-],BRD-K12047401-001-01-5,palifosfamide,MedChemEx,HY-14798,Palifosfamide,-6.761575,x0397,-0.440269,active-noncovalent
C(CCl)NP(=O)(NCCCl)[O-],BRD-K12047401-001-02-3,palifosfamide,MedChemEx,HY-14798,Palifosfamide,-6.761575,x0397,-0.440269,active-noncovalent
CC(=O)N[C@@H](C(=O)[O-])C(C)(C)SN=O,BRD-A67006024-001-05-5,SNAP,Cayman,82250,N-acetyl-3-(nitrososulfanyl)valine,-6.761235,x0678,0.155672,active-noncovalent
CC(=O)N[C@@H](C(=O)[O-])C(C)(C)SN=O,BRD-A67006024-001-04-8,SNAP,Cayman,82250,,-6.761235,x0678,0.155672,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3(C2)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,BRD-A95121829-001-08-9,ginkgolide-a,Selleck,S2026,Ginkgolide A,-6.760429,x0874,2.575958,active-noncovalent
C1[C@H]([C@H]([C@@H]([C@H]([NH2+]1)CO)O)O)O,BRD-K89665618-003-02-5,1-deoxymannojirimycin,Tocris,1259,1-Deoxymannojirimycin hydrochloride,-6.757922,x0397,-0.058883,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)c2ccc(cc2)NC(=O)C,BRD-K97417064-001-02-4,acedapsone,MicroSource,1505376,ACEDAPSONE,-6.757399,x0874,2.739755,active-noncovalent
c1ccc2c(c1)C[C@@H](C(=O)N2C[C@H](CO)O)NC(=O)c3cc4cc(sc4[nH]3)Cl,BRD-A90201073-001-01-2,GPi-688,Tocris,3967,GPi 688,-6.756771,x0104,4.480597,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)[NH3+],BRD-K55188888-065-01-2,ribostamycin,MedChemEx,HY-B1228,Ribostamycin (sulfate),-6.756208,x0195,3.542784,active-noncovalent
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-],BRD-K33396764-001-11-1,alpha-linolenic-acid,Sigma,MFCD00065720,"(9Z,12Z,15Z)-9,12,15-octadecatrienoic acid",-6.755825,x0072,1.90815,active-noncovalent
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-],BRD-K33396764-001-08-7,alpha-linolenic-acid,Enzo,FA005,Linolenic acid (18:3 n-3),-6.755825,x0072,1.90815,active-noncovalent
C1CCc2nnnn2CC1,BRD-K57718010-001-11-9,pentylenetetrazol,MicroSource,2300347,PENTYLENETETRAZOL,-6.755241,x0195,-0.564213,active-noncovalent
C1CCc2nnnn2CC1,BRD-K57718010-001-12-7,pentylenetetrazol,MedChemEx,HY-B1242,Pentylenetetrazol,-6.755241,x0195,-0.564213,active-noncovalent
C1CCc2nnnn2CC1,BRD-K57718010-001-10-1,pentylenetetrazol,Tocris,2687,Pentylenetetrazole,-6.755241,x0195,-0.564213,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)N(=O)=O)c2ccccc2C(F)(F)F)C(=O)OC,BRD-A05457250-001-08-4,BAY-K-8644-(+/-),Tocris,1544,(?)-Bay K 8644,-6.754812,x0195,3.683764,active-noncovalent
C[N@]1C(=C(c2ccccc2S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A57382968-001-27-4,piroxicam,Selleck,S1713,Piroxicam,-6.754350,x0195,0.819305,active-noncovalent
C[N@]1C(=C(c2ccccc2S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A57382968-001-29-0,piroxicam,MicroSource,1500491,PIROXICAM,-6.754350,x0195,0.819305,active-noncovalent
C[N@]1C(=C(c2ccccc2S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A57382968-001-28-2,piroxicam,Tocris,960,Piroxicam,-6.754350,x0195,0.819305,active-noncovalent
COc1ccc(cc1NCC(=O)[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,BRD-K55187425-236-05-2,rigosertib,Selleck,S1362,Rigosertib (ON-01910),-6.754086,x1077,10.011747,active-noncovalent
COc1ccc(cc1NCC(=O)[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,BRD-K55187425-236-07-8,rigosertib,MedChemEx,HY-12037,Rigosertib (sodium),-6.754086,x1077,10.011747,active-noncovalent
COc1ccc(cc1NCC(=O)[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,BRD-K55187425-236-06-0,rigosertib,Selleck,S1362,Rigosertib (ON-01910),-6.754086,x1077,10.011747,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)CC2=O,BRD-K10034334-001-03-3,camphor-(+),MedChemEx,HY-B1173,(+)-Camphor,-6.752044,x0354,2.960401,active-noncovalent
Cc1c(n(c2c1cc(cc2)C(=O)N[C@@H](C)c3ccc(cc3)N(=O)=O)Cc4ccc(cc4)c5ccccc5C(=O)[O-])C,BRD-K62814487-001-03-0,SR-1664,Tocris,4409,SR 1664,-6.751905,x0395,16.19359,active-noncovalent
CCCC(=O)OCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1C)C(=O)OC)c2cccc(c2Cl)Cl,BRD-A01563671-001-02-7,cleviprex,Selleck,S2080,Clevidipine Butyrate,-6.749033,x0434,3.362175,active-noncovalent
c1cc2c(c(c1)NC(=O)C[NH+]3CCN(CC3)C(=O)[C@H]4[C@@H]([C@@H]([C@H](O4)n5cnc6c5ncnc6N)O)O)CNC2=O,BRD-K66998413-300-01-6,EB-47,Tocris,4140,EB 47,-6.748909,x0104,8.76412,active-noncovalent
c1cc(cc(c1)N)CNC(=O)c2ccc(nc2)Oc3ccc(cc3)OCc4cccc(c4)F,BRD-K52087522-300-01-2,YM-244769,Tocris,4544,YM 244769,-6.748499,x0104,14.866316,active-noncovalent
c1ccc2c(c1)nc(s2)NCCCOc3cccc(c3)C[NH+]4CCCCC4,BRD-K08996725-332-01-7,zolantidine,Tocris,1070,Zolantidine dimaleate,-6.746805,x0195,3.243317,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OC,BRD-A68083442-001-01-6,pranidipine,AKSci,R730,,-6.743464,x0072,4.103506,active-noncovalent
Cn1c2ccc(cc2nc1Nc3ccc(cc3)C(F)(F)F)Oc4ccnc(c4)c5[nH]cc([nH+]5)C(F)(F)F,BRD-K93123848-001-04-1,RAF265,Selleck,S2161,RAF265 (CHIR-265),-6.743401,x0104,11.823798,active-noncovalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCCOc3ccc4c(c3)OCO4,BRD-K60371362-001-01-7,osemozotan,Sigma,MFCD17012664,"N-[3-(1,3-benzodioxol-5-yloxy)propyl]-N-[(2S)-2,3-dihydro-1,4-benzodioxin-2-ylmethyl]amine",-6.742275,x0434,3.332738,active-noncovalent
Cc1ccc(cc1O)N(=O)=O,BRD-K22327730-001-01-1,2-methyl-5-nitrophenol,Enamine,Z415740552,,-6.739691,x0195,-1.264223,active-noncovalent
CCN(CC)C[C@@H]1CCCC[N@H+]1CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,BRD-A00520476-001-08-2,otenzepad,Tocris,1105,AF-DX 116,-6.737418,x0195,4.195566,active-noncovalent
CCN(CC)C[C@@H]1CCCC[N@H+]1CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,BRD-A00520476-001-07-4,otenzepad,Tocris,1105,AF-DX 116,-6.737418,x0195,4.195566,active-noncovalent
Cc1c(cccc1c2ccccc2)COc3cc(c(c(c3)OC)C[N@@H+]4CCCC[C@H]4C(=O)[O-])OC,BRD-K04032780-001-01-8,PD1-PDL-inhibitor-1,MedChemEx,HY-19991,PD1-PDL1 inhibitor 1,-6.736674,x0161,11.312593,active-noncovalent
c1cc2c(cc1C(c3ccc4c(c3)OCO4)(C5CCN(CC5)C(=O)OC(C(F)(F)F)C(F)(F)F)O)OCO2,BRD-K46734292-001-03-6,KML29,MedChemEx,HY-18977,KML29,-6.735508,x1077,6.847657,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])[NH3+],BRD-K12853841-001-02-2,L-leucine,Sigma,V900431,L-leucine,-6.734673,x0397,-1.611812,active-noncovalent
C1C[C@H](N(C1)C(=O)C[NH3+])C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K83502127-001-01-6,trofinetide,Sigma,MFCD00144405,(2S)-2-({[(2S)-1-(aminoacetyl)-2-pyrrolidinyl]carbonyl}amino)pentanedioic acid,-6.734662,x0107,0.953208,active-noncovalent
C1C[NH2+][C@@H]([C@H]([C@@H]1O)O)CO,BRD-K61536264-001-01-3,fagomine,MedChemEx,HY-13005,Fagomine,-6.732061,x0397,1.247653,active-noncovalent
Cc1cccc(c1n2c(=O)c3cnc(nc3n4c2nc5c4cccc5)Nc6ccc(cc6)N7CC[NH+](CC7)C)C,BRD-K34362291-001-01-5,TC-S-7003,Tocris,3567,TC-S 7003,-6.730227,x0104,10.679654,active-noncovalent
c1cc(ccc1C(=O)[O-])N,BRD-K58497451-237-10-7,potassium-p-aminobenzoate,MicroSource,1500113,POTASSIUM p-AMINOBENZOATE,-6.729932,x0678,-1.172653,active-noncovalent
CCCCCCCCCCCCCCCCn1cc[n+](c1C)Cc2ccccc2,BRD-K31086665-005-01-2,NH125,Tocris,3439,NH 125,-6.729867,x0104,4.912759,active-noncovalent
CCCCCCCCCCCCCCCCn1cc[n+](c1C)Cc2ccccc2,BRD-K31086665-005-04-6,NH125,Selleck,S7436,NH125,-6.729867,x0104,4.912759,active-noncovalent
CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])O)O,BRD-K36262466-001-06-3,aceneuramic-acid,OxChem,AX8013467,,-6.728955,x0830,0.077577,active-covalent
CCCCCCCCCC(=O)OCCN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,BRD-K27898013-001-01-4,fluphenazine-decanoate,AKSci,67470,,-6.728208,x0104,11.163265,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K13050303-001-18-1,uridine,Selleck,S2029,Uridine,-6.727376,x0195,-0.530491,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,BRD-K13050303-001-17-3,uridine,Selleck,S2029,Uridine,-6.727376,x0195,-0.530491,active-noncovalent
c1ccc(cc1)C(=O)[O-],BRD-K53397409-001-11-5,benzoic-acid,Selleck,S4161,Benzoic Acid,-6.727146,x0195,-1.759296,active-noncovalent
c1ccc(cc1)C(=O)[O-],BRD-K53397409-001-12-3,benzoic-acid,MicroSource,1503001,BENZOIC ACID,-6.727146,x0195,-1.759296,active-noncovalent
c1ccc(cc1)C(=O)[O-],BRD-K53397409-001-13-1,benzoic-acid,Selleck,S4161,Benzoic acid,-6.727146,x0195,-1.759296,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)NC(=O)C,BRD-K07753030-003-17-6,acecainide,MicroSource,2300154,ACECAINIDE HYDROCHLORIDE,-6.726013,x0749,1.633672,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2ccc(cc2)C(=O)Nc3cc([nH]n3)CCc4cc(cc(c4)OC)OC,BRD-K28392481-001-05-1,AZD4547,Selleck,S2801,AZD4547,-6.725709,x0104,13.255028,active-noncovalent
c1ccc(cc1)c2ccc(nc2)NC(=O)CSc3nc4c(c(=O)n3c5ccccc5)SCC4,BRD-K53234107-001-01-6,IWP-L6,Selleck,S7301,IWP-L6,-6.724668,x0397,6.010602,active-noncovalent
C1CC(=O)N(C1)CC(=O)N,BRD-K19456237-001-26-8,piracetam,Selleck,S3070,Piracetam,-6.723598,x1382,0.53925,active-covalent
C1CC(=O)N(C1)CC(=O)N,BRD-K19456237-001-27-6,piracetam,MicroSource,1502195,PIRACETAM,-6.723598,x1382,0.53925,active-covalent
c1cc(ccc1O)Cl,BRD-K40992116-001-09-7,parachlorophenol,MicroSource,1500460,PARACHLOROPHENOL,-6.721465,x0678,0.96077,active-noncovalent
c1c(sc(n1)N2CCNC2=O)N(=O)=O,BRD-K53123955-001-10-5,niridazole,Prestwick,Prestw-469,Niridazole,-6.720467,x0195,-0.175161,active-noncovalent
C(C(N(C(C(C(F)(F)F)(F)F)(F)F)C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)(F)F,BRD-K16758059-001-01-8,perfluamine,Oakwood,46164,,-6.718937,x0678,3.007843,active-noncovalent
c1cc(ccc1O)S(=O)(=O)[O-],BRD-K41024817-325-01-0,4-phenolsulfonic-acid,Acros,12398,"4-Phenolsulfonic acid, sodium salt dihydrate, 99%",-6.718559,x0678,1.42173,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,BRD-A55416093-001-06-4,colforsin,MicroSource,1503804,COLFORSIN,-6.718480,x0072,2.847127,active-noncovalent
COC(=O)C(Cc1ccc(cc1)OCCn2c3ccc(cc3sc2=O)C(=O)c4ccccc4)C(=O)OC,BRD-K48826825-001-01-8,S26948,Tocris,3690,S26948,-6.716258,x0967,7.926984,active-noncovalent
COC(=O)C(Cc1ccc(cc1)OCCn2c3ccc(cc3sc2=O)C(=O)c4ccccc4)C(=O)OC,BRD-K48826825-001-02-6,S26948,Tocris,3690,S26948,-6.716258,x0967,7.926984,active-noncovalent
C(=C\SC(=[NH2+])N)\C(=O)[O-],BRD-K44825564-065-01-4,ZAPA,Tocris,180,ZAPA sulfate,-6.713453,x0397,-0.717552,active-noncovalent
c1ccc(cc1)N2CN(C(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F)Cc5cccc(c5)F,BRD-K45662124-050-02-3,3'-fluorobenzylspiperone,Tocris,701,3'-Fluorobenzylspiperone maleate,-6.707654,x0161,8.018098,active-noncovalent
c1ccc(cc1)N2CN(C(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F)Cc5cccc(c5)F,BRD-K45662124-050-01-5,3'-fluorobenzylspiperone,Tocris,701,3'-Fluorobenzylspiperone maleate,-6.707654,x0161,8.018098,active-noncovalent
Cc1ccc(cc1C(=O)Nc2ccc(c(c2)Cl)C(=O)N3Cc4cccn4Cc5c3cccc5)F,BRD-K59391348-001-01-7,lixivaptan,Carbosynth,FL24915,"N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide",-6.704662,x0104,7.061966,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O)C,BRD-K57865272-001-01-2,A0001,Enzo,FR115,Tocopherylquinone,-6.696704,x0434,5.566412,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O)C,BRD-K57865272-001-02-0,A0001,Sigma,MFCD00135657,"2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethylbenzo-1,4-quinone",-6.696704,x0434,5.566412,active-noncovalent
C[NH+](CCc1ccc(c(c1)OC)OC)CCc2ccc(c(c2)OC)OC,BRD-K06208435-003-08-2,YS-035,Tocris,416,YS-035 hydrochloride,-6.696684,x1077,2.876891,active-noncovalent
Cc1c(c(=O)n2c(n1)[C@H](CCC2)O)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,BRD-A99888680-001-04-6,paliperidone,MicroSource,1502318,PALIPERIDONE,-6.696205,x0749,4.593727,active-covalent
Cc1c(c(=O)n2c(n1)[C@H](CCC2)O)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,BRD-A99888680-001-03-8,paliperidone,Selleck,S1724,Paliperidone,-6.696205,x0749,4.593727,active-covalent
Cc1c(c(=O)n2c(n1)[C@H](CCC2)O)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,BRD-A99888680-001-05-3,paliperidone,Selleck,S1724,Paliperidone (Invega),-6.696205,x0749,4.593727,active-covalent
c1c(cc(c(c1NC(=O)C(=O)[O-])Cl)NC(=O)C(=O)[O-])C#N,BRD-K66937583-001-01-2,lodoxamide,Prestwick,Prestw-1746,Lodoxamide,-6.696201,x0195,2.107244,active-noncovalent
C[C@@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@H]3[C@@H]([C@H]([C@@](CO3)(C)O)[NH2+]C)O)[NH3+])[NH3+])[NH3+])[NH2+]C,BRD-A89445950-001-01-6,gentamycin,MicroSource,1500314,GENTAMICIN,-6.694995,x0434,6.309504,active-noncovalent
C[C@@H](c1nccs1)NC(=O)Nc2ccc(cc2OC)Oc3ccnc4c3cc(c(c4)OC)OC,BRD-A88787317-001-01-0,KI-20227,Tocris,4481,Ki 20227,-6.693755,x0104,10.283014,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCOCC[NH+](C)C,BRD-K74236984-001-04-8,UNC0321,MedChemEx,HY-10930,UNC0321,-6.693455,x0434,9.960918,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCOCC[NH+](C)C,BRD-K74236984-001-05-5,UNC0321,MedChemEx,HY-10930,UNC0321,-6.693455,x0434,9.960918,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cccc3F)NC(=O)[C@H](CCC(F)(F)F)[C@H](CC4CC4)C(=O)N,BRD-K22316123-001-01-9,BMS-983970,MedChemEx,HY-12419,BMS-983970,-6.692356,x0967,7.827426,active-noncovalent
c1ccc(cc1)CCCN2CC[NH+](CC2)CCOC(c3ccccc3)c4ccccc4,BRD-K50135270-300-02-3,GBR-12935,Tocris,514,GBR 12935 dihydrochloride,-6.691256,x0072,6.123117,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@@H](C5)C[NH+]6CCCC6)ncnc4N,BRD-K15179513-001-03-4,NVP-ADW742,Selleck,S1088,NVP-ADW742,-6.690422,x0161,9.073007,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@@H](C5)C[NH+]6CCCC6)ncnc4N,BRD-K15179513-001-04-2,NVP-ADW742,Selleck,S1088,NVP-ADW742,-6.690422,x0161,9.073007,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@@H](C5)C[NH+]6CCCC6)ncnc4N,BRD-K15179513-001-05-9,NVP-ADW742,Tocris,5247,NVP ADW 742,-6.690422,x0161,9.073007,active-noncovalent
CC(C)[C@@]1(CC[C@H](C1)[NH2+][C@H]2CCOC[C@H]2OC)C(=O)N3CCc4c(cc(cn4)C(F)(F)F)C3,BRD-K14175878-001-01-6,MK-0812,MedChemEx,HY-50669,MK-0812,-6.690018,x0104,4.268947,active-noncovalent
Cc1cccc(c1)C/N=N/c2cc(nc(n2)OCCc3ccccn3)N4CCOCC4,BRD-K41783120-001-02-8,STA-5326,MedChemEx,HY-14644,Apilimod,-6.688016,x0161,7.005303,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(nc2)Nc3ncc(c(n3)c4cc5c(c(c4)F)nc(n5C(C)C)C)F,BRD-K33622447-066-01-9,abemaciclib,Selleck,S7158,LY2835219,-6.687015,x0161,12.960886,active-noncovalent
CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,BRD-K45724504-001-01-6,anguidine,Enzo,NP563,Diacetoxyscirpenol,-6.685803,x0678,1.846563,active-noncovalent
C(CNCC[NH2+]CCN)[NH3+],BRD-K37111771-300-02-6,trientine,MicroSource,1505675,TRIENTINE HYDROCHLORIDE,-6.685519,x0195,-1.436531,active-noncovalent
CC[N@@H+](CCCCOC(=O)c1ccc(c(c1)OC)OC)[C@@H](C)Cc2ccc(cc2)OC,BRD-A09467419-003-22-4,mebeverine,MicroSource,1501117,MEBEVERINE HYDROCHLORIDE,-6.685260,x0395,8.771286,active-noncovalent
Cc1[nH+]cc(n1C)N(=O)=O,BRD-K72728560-001-01-4,dimetridazole,MicroSource,1506152,DIMETRIDAZOLE,-6.684147,x0195,-0.362739,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3ccc(c(c3)Cl)C(=O)[O-],BRD-K41564320-001-02-0,purvalanol-b,Tocris,1581,Purvalanol B,-6.684000,x1077,4.586001,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3ccc(c(c3)Cl)C(=O)[O-],BRD-K41564320-001-03-8,purvalanol-b,Tocris,1581,Purvalanol B,-6.684000,x1077,4.586001,active-noncovalent
CC(C)(CO)[C@@H](C(=O)NCCCO)O,BRD-A59413292-001-08-2,dexpanthenol,MicroSource,1505656,PANTHENOL (dl),-6.683384,x0104,-1.013604,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Oc4cccc(c4)NC(=O)C=C)Cl,BRD-K72420232-001-13-1,WZ-4002,Selleck,S1173,WZ4002,-6.681519,x0161,7.264341,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Oc4cccc(c4)NC(=O)C=C)Cl,BRD-K72420232-001-12-3,WZ-4002,Selleck,S1173,WZ4002,-6.681519,x0161,7.264341,active-noncovalent
Cc1c(noc1N(C(=O)C)S(=O)(=O)c2ccc(cc2)N)C,BRD-K84810336-001-01-9,sulfisoxazole-acetyl,MicroSource,1505461,SULFISOXAZOLE ACETYL,-6.681178,x0678,0.869631,active-noncovalent
C1[C@H]([C@H]([C@@H](C=C1C(=O)[O-])O)O)O,BRD-A92096630-001-02-8,shikimic-acid,Selleck,S2356,Shikimic Acid,-6.680902,x0397,1.920156,active-noncovalent
CO[C@@H]1[C@@H]([C@H](O[C@H]1n2cnc3c2ncnc3NC4CCCCC4)CO)O,BRD-K39558284-001-01-2,SDZ-WAG-994,Tocris,2465,SDZ WAG 994,-6.680842,x0195,2.637644,active-noncovalent
CO[C@@H]1[C@@H]([C@H](O[C@H]1n2cnc3c2ncnc3NC4CCCCC4)CO)O,BRD-K39558284-001-02-0,SDZ-WAG-994,Tocris,2465,SDZ WAG 994,-6.680842,x0195,2.637644,active-noncovalent
C(OC(C(F)(F)F)C(F)(F)F)F,BRD-K05638300-001-02-0,sevoflurane,Enamine,EN300-123016,"1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane",-6.680532,x0195,3.625789,active-noncovalent
C(OC(C(F)(F)F)C(F)(F)F)F,BRD-K05638300-001-01-2,sevoflurane,Enamine,EN300-123016,,-6.680532,x0195,3.625789,active-noncovalent
CC(C)(CC[C@](CC(=O)OC)(C(=O)O[C@H]1[C@@H]2c3cc4c(cc3CC[N@H+]5[C@@]2(CCC5)C=C1OC)OCO4)O)O,BRD-K96358241-001-01-9,harringtonine,Enzo,NP435,Harringtonine,-6.680471,x0195,5.524935,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],BRD-K17849083-001-31-1,tranilast,MicroSource,1505333,TRANILAST,-6.676440,x0678,7.704247,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],BRD-K17849083-001-30-3,tranilast,Tocris,1098,Tranilast,-6.676440,x0678,7.704247,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],BRD-K17849083-001-29-5,tranilast,Selleck,S1439,Tranilast,-6.676440,x0678,7.704247,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],BRD-K17849083-001-32-9,tranilast,Selleck,S1439,Tranilast (SB 252218),-6.676440,x0678,7.704247,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],BRD-K17849083-001-34-5,tranilast,Tocris,1098,Tranilast,-6.676440,x0678,7.704247,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-17-6,valproic-acid,Enzo,550-304,"Valproic Acid, Sodium Salt",-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-21-8,valproic-acid,Tocris,2815,"Valproic acid, sodium salt",-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-20-0,divalproex-sodium,Selleck,S1703,Divalproex sodium,-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-15-0,valproic-acid,Selleck,S1168,Valproic acid sodium salt (Sodium valproate),-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-16-8,valproic-acid,MicroSource,1500606,VALPROATE SODIUM,-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-19-2,divalproex-sodium,Selleck,S1703,Divalproex Sodium,-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-236-18-4,valproic-acid,EMDBio,676380-5GM,"Valproic Acid, Sodium Salt",-6.672935,x0397,-1.281044,active-noncovalent
CCCC(CCC)C(=O)[O-],BRD-K41260949-001-18-2,divalproex-sodium,Sigma,MFCD00002672,2-propylpentanoic acid,-6.672935,x0397,-1.281044,active-noncovalent
CC(=O)N[C@H]1CCSC1=O,BRD-A57957888-001-08-0,citiolone,MicroSource,1503205,CITIOLONE,-6.672120,x1382,-1.347595,active-covalent
CCCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,BRD-K70693421-001-02-9,genz-123346,MedChemEx,HY-12744,Genz-123346 (free base),-6.670636,x0678,4.821352,active-noncovalent
CCCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,BRD-K70693421-001-01-1,genz-123346,MedChemEx,HY-12744,Genz-123346 (free base),-6.670636,x0678,4.821352,active-noncovalent
c1c(cnc(=O)[nH]1)F,BRD-K34437622-001-06-4,5-FP,Maybridge,JFD02014,,-6.668768,x0426,-1.462918,active-noncovalent
c1c(cnc(=O)[nH]1)F,BRD-K34437622-001-08-0,5-FP,Sigma,MFCD00223678,5-fluoro-2-pyrimidinol,-6.668768,x0426,-1.462918,active-noncovalent
C[N@@]1C(=C(c2c(ccs2)S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A22844106-001-25-2,tenoxicam,Selleck,S2512,Tenoxicam,-6.667237,x1093,0.274216,active-noncovalent
C[N@@]1C(=C(c2c(ccs2)S1(=O)=O)O)C(=O)Nc3ccccn3,BRD-A22844106-001-26-0,tenoxicam,MicroSource,1503142,TENOXICAM,-6.667237,x1093,0.274216,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(c(cc2OC)N)S(=O)(=O)CC,BRD-A60197193-001-14-6,amisulpride,Tocris,2132,Amisulpride,-6.667191,x1077,1.816472,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(c(cc2OC)N)S(=O)(=O)CC,BRD-A60197193-001-13-8,amisulpride,Selleck,S1280,Amisulpride,-6.667191,x1077,1.816472,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-K51671335-001-12-2,levosulpiride,Tocris,895,(S)-(-)-Sulpiride,-6.666968,x0678,1.094567,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-K51671335-001-10-6,levosulpiride,Tocris,895,(S)-(-)-Sulpiride,-6.666968,x0678,1.094567,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,BRD-K51671335-001-09-8,levosulpiride,Selleck,S2104,Levosulpiride,-6.666968,x0678,1.094567,active-noncovalent
C[C@H]1[C@@H]2C[C@@H]3[C@@]45CO[C@@]([C@@H]4[C@H](C(=O)O3)OC(=O)/C=C(\C)/C(C)C)([C@H]([C@@H]([C@@H]5[C@]2(CC(=O)C1=O)C)O)O)C(=O)OC,BRD-A36057565-001-01-0,bruceantin,MedChemEx,HY-N0840,Bruceantin,-6.666441,x1077,8.837848,active-noncovalent
C[C@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)OCOC(=O)C(C)(C)C,BRD-K21372554-003-01-7,cefetamet-pivoxil,AKSci,H785,,-6.665365,x0161,8.576129,active-noncovalent
C[C@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)OCOC(=O)C(C)(C)C,BRD-K21372554-001-01-1,cefetamet-pivoxil,AvaChem,2005,"[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-6.665365,x0161,8.576129,active-noncovalent
C[C@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)OCOC(=O)C(C)(C)C,BRD-K21372554-003-02-5,cefetamet-pivoxil,MedChemEx,HY-B1894A,Cefetamet pivoxil (hydrochloride),-6.665365,x0161,8.576129,active-noncovalent
CC(=O)Nc1ccc(cc1)CC(=O)[O-],BRD-K33483813-001-10-0,actarit,MicroSource,1502413,ACTARIT,-6.664743,x0195,-1.172869,active-noncovalent
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)Cc3cccs3,BRD-K70976396-236-27-8,cefoxitin,MedChemEx,HY-B1117,Cefoxitin (sodium),-6.663137,x1093,3.441852,active-noncovalent
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)Cc3cccs3,BRD-K70976396-236-25-2,cefoxitin,MicroSource,1502031,CEFOXITIN SODIUM,-6.663137,x1093,3.441852,active-noncovalent
CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)[O-])NC(=O)Cc3cccs3,BRD-K70976396-236-26-0,cefoxitin,MedChemEx,HY-B1117,Cefoxitin (sodium),-6.663137,x1093,3.441852,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)Nc2ncc3cc(c(=O)n(c3n2)C)c4c(cccc4Cl)Cl,BRD-K93217218-300-01-5,PD-166285,Tocris,3785,PD 166285 dihydrochloride,-6.661061,x0104,12.730069,active-noncovalent
c1ccc(c(c1)NS(=O)(=O)c2ccc(cc2Cl)NC(=O)c3ccccn3)Cl,BRD-K72687424-001-03-4,VU0364439,Tocris,4371,VU 0364439,-6.660601,x0104,5.495927,active-noncovalent
c1ccc(c(c1)NS(=O)(=O)c2ccc(cc2Cl)NC(=O)c3ccccn3)Cl,BRD-K72687424-001-02-6,VU0364439,Selleck,S8035,VU 0364439,-6.660601,x0104,5.495927,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2cc(nc3c2cc[nH]3)Nc4ccc(cc4OC)N5CCC(CC5)O,BRD-K94853001-300-01-7,Mps1-IN-1,Tocris,5142,Mps1-IN-1 dihydrochloride,-6.659744,x0434,9.00076,active-noncovalent
c1ccnc(c1)C(=O)[O-],BRD-K60612034-001-07-9,picolinic-acid,Enamine,Z57968195,,-6.658438,x1382,-1.691668,active-covalent
c1ccnc(c1)C(=O)[O-],BRD-K60612034-001-08-7,picolinic-acid,Enamine,EN300-18459,2-pyridinecarboxylic acid,-6.658438,x1382,-1.691668,active-covalent
CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc2ccccc2C(=O)OCC,BRD-K44590731-001-01-7,TU-2100,Vitas-M,STK379708,,-6.654632,x0104,9.85755,active-noncovalent
Cc1ccc(cc1S(=O)(=O)N(C)C)N(=O)=O,BRD-K84266862-001-04-0,BRL-50481,Tocris,2237,BRL 50481,-6.652535,x0195,-0.09624,active-noncovalent
Cc1ccc(cc1S(=O)(=O)N(C)C)N(=O)=O,BRD-K84266862-001-03-2,BRL-50481,Tocris,2237,BRL 50481,-6.652535,x0195,-0.09624,active-noncovalent
C[N+](C)(C)CCOC(=O)N,BRD-K75037734-003-14-7,carbachol,MicroSource,1500158,CARBACHOL,-6.651458,x0195,-0.222365,active-noncovalent
C[N+](C)(C)CCOC(=O)N,BRD-K75037734-003-13-9,carbachol,Selleck,S4359,Carbachol,-6.651458,x0195,-0.222365,active-noncovalent
Cn1c(=O)c(c(nc1N2CCCCS2(=O)=O)C(=O)NCc3ccc(cc3)F)[O-],BRD-K49555808-001-03-9,BMS-707035,Selleck,S1366,BMS-707035,-6.650924,x0161,3.478505,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],BRD-K30019776-001-01-9,dexfosfoserine,Sigma,MFCD00065935,(2S)-2-amino-3-(phosphonooxy)propanoic acid,-6.650231,x0397,-0.157288,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],BRD-K30019776-003-01-5,dexfosfoserine,MicroSource,1506151,DEXFOSFOSERINE HYDROCHLORIDE,-6.650231,x0397,-0.157288,active-noncovalent
CCCCOC(=O)C(=C)C#N,BRD-K66918327-001-01-3,enbucrilate,Ark,AK162172,butyl 2-cyanoacrylate,-6.649953,x0749,-1.202796,active-covalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccccc4)c5ccc(cc5)F)CC3,BRD-K54665485-001-07-9,R-59022,Tocris,2194,R 59-022,-6.649329,x1077,8.717361,active-noncovalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccccc4)c5ccc(cc5)F)CC3,BRD-K54665485-001-08-7,R-59022,Tocris,2194,R 59-022,-6.649329,x1077,8.717361,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2nc3cc(ccc3c(=O)n2Cc4ccccc4)Cl)C(C)C,BRD-K64881305-001-03-7,ispinesib,Selleck,S1452,Ispinesib (SB-715992),-6.643319,x0107,8.247526,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2nc3cc(ccc3c(=O)n2Cc4ccccc4)Cl)C(C)C,BRD-K64881305-001-05-2,ispinesib,Selleck,S1452,Ispinesib (SB-715992),-6.643319,x0107,8.247526,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2nc3cc(ccc3c(=O)n2Cc4ccccc4)Cl)C(C)C,BRD-K64881305-001-06-0,ispinesib,Tocris,5408,Ispinesib,-6.643319,x0107,8.247526,active-noncovalent
c1c(c([nH]c(=O)n1)N)F,BRD-K82143716-001-19-9,flucytosine,Selleck,S1666,Flucytosine,-6.641623,x0397,-1.275055,active-noncovalent
c1c(c([nH]c(=O)n1)N)F,BRD-K82143716-001-20-7,flucytosine,MicroSource,1505429,FLUCYTOSINE,-6.641623,x0397,-1.275055,active-noncovalent
C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F,BRD-K26838195-075-04-9,AST-1306,Selleck,S2185,AST-1306,-6.638890,x0678,9.470634,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCC[N@]3CCC[C@@H](N3C2=O)C(=O)[O-],BRD-K65518078-002-01-1,cilazapril,Selleck,S2081,Cilazapril Monohydrate,-6.635386,x0678,2.521193,active-noncovalent
CC(C)c1ccc(cc1)NC(=O)Cn2cnc3c2c(=O)n(c(=O)n3C)C,BRD-K73815512-001-02-5,HC-030031,Selleck,S2918,HC-030031,-6.633213,x0107,1.126396,active-noncovalent
COc1cc(cc(c1OC)OC)C(=S)N2CCOCC2,BRD-K29570907-001-07-3,sulmetozine,Vitas-M,STK877639,"4-(3,4,5-trimethoxybenzothioyl)morpholine",-6.629495,x0072,0.743137,active-noncovalent
c1ccc(c(c1)C(=O)[O-])OP(=O)([O-])[O-],BRD-K28687144-001-08-7,fosfosal,Sigma,MFCD00042645,2-(phosphonooxy)benzoic acid,-6.628698,x0692,-0.32062,active-covalent
c1ccc(c(c1)C(=O)[O-])OP(=O)([O-])[O-],BRD-K28687144-001-07-9,fosfosal,MicroSource,1502012,FOSFOSAL,-6.628698,x0692,-0.32062,active-covalent
Cn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)[C@@H](c4ccccc4)O)/C(=O)N3[C@H]2C(=O)[O-],BRD-K27130738-236-15-8,cefamandole,MicroSource,1502038,CEFAMANDOLE SODIUM,-6.628018,x0830,7.30245,active-covalent
Cn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)[C@@H](c4ccccc4)O)/C(=O)N3[C@H]2C(=O)[O-],BRD-K27130738-236-14-1,cefamandole,Sigma,MFCD07793339,"sodium (6R,7R)-7-{[(2R)-2-hydroxy-2-phenylethanoyl]amino}-3-{[(1-methyl-1H-tetraazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-6.628018,x0830,7.30245,active-covalent
Cc1c[nH]c2c1c(ncn2)N3CCC(CC3)(C[NH3+])C(=O)Nc4cccc(c4)OC(=O)N(C)C,BRD-K21038058-001-02-7,LX7101,MedChemEx,HY-12659,LX7101,-6.627611,x0161,8.430913,active-noncovalent
Cc1c[nH]c2c1c(ncn2)N3CCC(CC3)(C[NH3+])C(=O)Nc4cccc(c4)OC(=O)N(C)C,BRD-K21038058-001-01-9,LX7101,MedChemEx,HY-12659,LX7101,-6.627611,x0161,8.430913,active-noncovalent
C([C@@H]([C@@H]1[C@@H]([C@@H]2[C@H](O1)O[C@@H](O2)C(Cl)(Cl)Cl)O)O)O,BRD-A98174560-001-02-1,chloralose,MicroSource,1504511,CHLORALOSE,-6.626921,x1077,0.0067,active-noncovalent
c1c(cc(cc1C(F)(F)F)NC(=O)Nc2c(cc(cc2Br)Br)c3n[n-]nn3)C(F)(F)F,BRD-K93314017-001-01-7,NS-5806,Tocris,4166,NS 5806,-6.623809,x0161,3.286069,active-noncovalent
CCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,BRD-K24483849-001-01-8,trimethylolpropane-triacrylate,Sigma,MFCD00008628,"2,2-bis[(acryloyloxy)methyl]butyl acrylate",-6.623683,x0195,2.110817,active-noncovalent
Cc1c[nH]c(=O)n(c1=O)CCC[NH+]2CCN(CC2)c3ccccc3OCC(F)(F)F,BRD-K08640512-003-02-3,RS-100329,Tocris,1325,RS 100329 hydrochloride,-6.623541,x0874,4.254226,active-noncovalent
CC(=CCC[C@@]1(C=Cc2c(c3c(c(c2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)[O-])[O-])C)C,BRD-K08542803-001-02-3,gambogic-acid,MedChemEx,HY-N0087,Gambogic Acid,-6.623364,x0104,11.284286,active-noncovalent
CC(=CCC[C@@]1(C=Cc2c(c3c(c(c2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)[O-])[O-])C)C,BRD-K08542803-001-01-5,gambogic-acid,MedChemEx,HY-N0087,Gambogic Acid,-6.623364,x0104,11.284286,active-noncovalent
CC(=CCC[C@@]1(C=Cc2c(c3c(c(c2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)[O-])[O-])C)C,BRD-K08542803-001-03-1,gambogic-acid,Enzo,AP305,Gambogic acid,-6.623364,x0104,11.284286,active-noncovalent
C[C@@H](C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC[S@](=O)C)CO)NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],BRD-A01907367-001-01-7,FK-33-824,Enzo,AC906,"(D-Ala2,N-Me-Phe4, Methionin (O)-ol5)-enkephalin",-6.622825,x0072,9.968464,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-])OC(=O)N(CCCl)CCCl,BRD-K00077635-304-01-2,estramustine-phosphate,Enzo,AC1524,Estramustine phosphate sodium,-6.622704,x0104,12.238982,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[N@@H+](C3)CC[N@@]4C[C@@H]5C[C@H](C4)c6cccc(=O)n6C5,BRD-K17751100-001-01-1,CC4,Tocris,5236,CC4,-6.622642,x1077,8.758259,active-noncovalent
c1cc(cn(=O)c1)C(=O)[O-],BRD-K20417253-001-01-9,oxiniacic-acid,MicroSource,1506168,OXINIACIC ACID,-6.621933,x0397,-0.883689,active-noncovalent
c1cc(cn(=O)c1)C(=O)[O-],BRD-K20417253-001-02-7,oxiniacic-acid,Vitas-M,STK012697,nicotinic acid 1-oxide,-6.621933,x0397,-0.883689,active-noncovalent
CCC(CC)Nc1c(nc(c(n1)C)c2ccc(cc2OC)OC(F)(F)F)OC,BRD-K81779590-003-01-6,NGD-98-2,Tocris,4315,NGD 98-2 hydrochloride,-6.621778,x0161,9.11067,active-noncovalent
CC(=O)N1CC[NH+](CC1)C,BRD-K96055017-003-02-7,1-acetyl-4-methylpiperazine,Tocris,351,1-Acetyl-4-methylpiperazine hydrochloride,-6.621731,x0195,-1.593016,active-noncovalent
C[C@H](c1ccccc1C(F)(F)F)Oc2cc(sc2C(=O)N)n3cnc4c3cc(cc4)CN5CC[NH+](CC5)C,BRD-K92428232-001-10-6,GSK461364,Selleck,S2193,GSK461364,-6.621489,x0161,8.145857,active-noncovalent
CC1(C2CCC(O1)(CC2)C)C,BRD-K29996876-001-10-1,eucalyptol,MicroSource,1500294,EUCALYPTOL,-6.620468,x0354,2.960086,active-noncovalent
CC1(C2CCC(O1)(CC2)C)C,BRD-K29996876-001-09-3,eucalyptol,AMS,A001464384,"1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane",-6.620468,x0354,2.960086,active-noncovalent
CC(C)NC(=O)c1ccc(cn1)C#Cc2ccncc2,BRD-K79337272-001-01-6,LSN-2463359,Tocris,5275,LSN 2463359,-6.618568,x1348,3.097231,active-covalent
Cc1ccc(cc1)C(=O)O[C@H]([C@H](C(=O)[O-])OC(=O)c2ccc(cc2)C)C(=O)[O-],BRD-M12328004-001-01-8,C106,Enzo,C106,(+)-Nicotine di-p-toluoyl-D-tartrate,-6.617877,x0397,4.594471,active-noncovalent
CCCCCCCCCCCCCCOC(=O)c1cccnc1,BRD-K88153212-001-01-9,myristyl-nicotinate,Accela,SY025969,tetradecyl nicotinate,-6.616635,x0072,2.674796,active-noncovalent
COc1ccccc1N2CCN(CC2)c3c4cc(c(cc4nc(n3)C5CC5)OC)OC,BRD-K92606079-001-02-0,ML314,MedChemEx,HY-16639,ML314,-6.615392,x0874,6.362915,active-noncovalent
COC(=O)CCC(=O)C[NH3+],BRD-K01292611-003-17-8,methyl-aminolevulinate,Enzo,AC3187,METHYL AMINOLEVULINATE HCl,-6.614754,x0161,0.413856,active-noncovalent
c1cc2c(c[nH]c2c(c1)NS(=O)(=O)c3ccc(cc3)S(=O)(=O)N)Cl,BRD-K17610631-001-03-3,indisulam,Sigma,SML1225,"N~1~-(3-chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide",-6.613886,x0831,1.463004,active-covalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O,BRD-A89637065-001-01-0,uridine-5'-triphosphate,Sigma,MFCD00274571,"((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyltriphosphoric acid",-6.613816,x0678,4.693637,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCC[N@H+](CCCc2ccc(cc2)N(=O)=O)CCO,BRD-K32311154-001-01-0,nifekalant,Prestwick,Prestw-1774,Nifekalant,-6.612022,x0831,3.363313,active-covalent
COc1ccc(cc1)C(=O)/C(=C(/c2ccc3c(c2)OCO3)\C(=O)[O-])/Cc4cc(c(c(c4)OC)OC)OC,BRD-K13826399-236-01-7,PD-156707,Sigma,PZ0141,"sodium (2Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-(3,4,5-trimethoxybenzyl)-2-butenoate",-6.608471,x0678,6.148612,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N3CC[NH+](CC3)C[C@@H](COc4cccc5c4cccn5)O,BRD-A14941520-051-01-0,dofequidar,MedChemEx,HY-17013A,Dofequidar (fumarate),-6.605924,x0072,7.813655,active-noncovalent
CCC(=O)OCC(=O)[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2[C@@H](CC4=CC(=O)C=C[C@]34C)Cl)O)C)C)OC(=O)CC,BRD-A17407635-001-04-0,alclometasone-dipropionate,Prestwick,Prestw-771,Alclometasone dipropionate,-6.605162,x1077,7.576808,active-noncovalent
C(CCCCNC(=O)C(Cl)Cl)CCCNC(=O)C(Cl)Cl,BRD-K30930903-001-01-3,WIN-18446,DuPont,A001467449,"2,2-dichloro-N-{8-[(dichloroacetyl)amino]octyl}acetamide",-6.602551,x0104,2.15039,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)Nc3ccc(cc3)S(=O)(=O)Nc4nccs4,BRD-K03149601-001-02-6,ICA-121431,Tocris,5066,ICA 121431,-6.600619,x1093,5.676949,active-noncovalent
CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2,BRD-K76452401-001-03-6,piperonyl-butoxide,MicroSource,1504191,PIPERONYL BUTOXIDE,-6.600555,x0195,3.32341,active-noncovalent
C1[C@H]2N1C(=O)NC2=[NH2+],BRD-A78195072-001-06-2,imexon,MicroSource,1506181,IMEXON,-6.598052,x0104,-0.929676,active-noncovalent
c1c(cc(c(c1O)O)O)C(=O)[O-],BRD-K77345217-001-05-0,gallic-acid,MicroSource,210369,GALLIC ACID,-6.597979,x0195,-1.539497,active-noncovalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-17-4,streptozotocin,Tocris,1621,Streptozocin,-6.596341,x0749,1.820003,active-covalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-11-7,streptozotocin,Selleck,S1312,Streptozotocin (STZ),-6.596341,x0749,1.820003,active-covalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-12-5,streptozotocin,MicroSource,1500543,STREPTOZOSIN,-6.596341,x0749,1.820003,active-covalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-14-1,streptozotocin,Sigma,S0130,2-deoxy-2-{[(1-methyl-2-oxohydrazino)carbonyl]amino}-alpha-D-glucopyranose,-6.596341,x0749,1.820003,active-covalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-13-3,streptozotocin,Selleck,S1312,Streptozotocin (Zanosar),-6.596341,x0749,1.820003,active-covalent
CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,BRD-K34411947-001-15-8,streptozotocin,MedChemEx,HY-13753,Streptozocin,-6.596341,x0749,1.820003,active-covalent
CCC1(C(=O)CC=NC1=O)CC,BRD-K36116267-001-15-3,pyrithyldione,MicroSource,1503085,PYRITHYLDIONE,-6.593908,x0678,2.4765,active-noncovalent
CN1CC(=O)NC1=[NH2+],BRD-K13495773-001-12-2,creatinine,MicroSource,1600300,CREATININE,-6.591959,x1077,-0.826494,active-noncovalent
CN1CC(=O)NC1=[NH2+],BRD-K13495773-001-11-4,creatinine,Selleck,S3102,Creatinine,-6.591959,x1077,-0.826494,active-noncovalent
CNC(=O)c1ccc2c(c1)CCO[C@H]2CC[NH+]3CCN(CC3)c4ccc(cc4)C(=O)N,BRD-K81616657-001-01-4,PNU-142633,Tocris,1985,"(1S)-1-(2-{4-[4-(aminocarbonyl)phenyl]-1-piperazinyl}ethyl)-N-methyl-3,4-dihydro-1H-2-benzopyran-6-carboxamide",-6.588407,x0107,8.158602,active-noncovalent
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)[NH2+]C(CO)CO,BRD-K66850609-001-07-4,voglibose,Selleck,S4101,Voglibose,-6.587879,x0107,-1.090427,active-noncovalent
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)[NH2+]C(CO)CO,BRD-K66850609-001-05-8,voglibose,Tocris,3596,Voglibose,-6.587879,x0107,-1.090427,active-noncovalent
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)[NH2+]C(CO)CO,BRD-K66850609-001-06-6,voglibose,Tocris,3596,Voglibose,-6.587879,x0107,-1.090427,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])[S@](=O)[O-],BRD-A25800195-001-02-2,L-Cysteinesulfinic-acid,Tocris,216,L-Cysteinesulfinic acid,-6.587493,x0397,-0.669348,active-noncovalent
Cc1ccccc1C(=O)Nc2ccc(cc2)C(=O)N3CCC[C@H](c4c3cccc4)[NH+](C)C,BRD-A31095847-001-02-3,mozavaptan,Selleck,S2920,Mozavaptan,-6.587044,x0678,6.492266,active-noncovalent
c1cc(cnc1)C[NH+]2CCC(CC2)n3c4c(cn3)c(nc(n4)c5ccc6c(c5)cc[nH]6)N7CCOCC7,BRD-K85920262-001-02-1,WAY-600,Selleck,S2689,WAY-600,-6.585862,x0107,10.788937,active-noncovalent
CC(C)(C(=O)N[C@@H](CS)C(=O)[O-])S,BRD-K24697665-001-02-2,bucillamine,Kemprotec,TC508,(2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid,-6.585582,x0397,0.195796,active-noncovalent
CC(C)(C(=O)N[C@@H](CS)C(=O)[O-])S,BRD-K24697665-001-01-4,bucillamine,AKSci,K055,,-6.585582,x0397,0.195796,active-noncovalent
C=CCNc1nc(nc(n1)N2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F)NCC=C,BRD-K82677201-001-01-6,almitrine,AKSci,H525,,-6.584793,x0161,12.288854,active-noncovalent
Cc1cc(cc2c1nc(nn2)Nc3ccc(cc3)OCC[NH+]4CCCC4)c5cc(ccc5Cl)O,BRD-K18424115-003-01-3,TG-100572,MedChemEx,HY-10185,TG 100572 (Hydrochloride),-6.583385,x0104,14.877046,active-noncovalent
CC(C)c1c(c(c(n1CC[C@H](C[C@H](CC(=O)[O-])O)O)c2ccc(cc2)F)c3ccccc3)C(=O)Nc4ccccc4,BRD-K69726342-001-03-4,atorvastatin,MicroSource,1503722,ATORVASTATIN CALCIUM,-6.583282,x0305,7.793304,active-noncovalent
CC(C)c1c(c(c(n1CC[C@H](C[C@H](CC(=O)[O-])O)O)c2ccc(cc2)F)c3ccccc3)C(=O)Nc4ccccc4,BRD-K69726342-238-02-4,atorvastatin,Selleck,S2077,Atorvastatin Calcium,-6.583282,x0305,7.793304,active-noncovalent
CC(C)c1c(c(c(n1CC[C@H](C[C@H](CC(=O)[O-])O)O)c2ccc(cc2)F)c3ccccc3)C(=O)Nc4ccccc4,BRD-K69726342-238-03-2,atorvastatin,Tocris,3776,Atorvastatin hemicalcium salt,-6.583282,x0305,7.793304,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)c2cccc(c2)N(=O)=O)C(=O)OCCOC,BRD-A58048407-001-17-0,nimodipine,Selleck,S1747,Nimodipine,-6.582630,x0946,3.68244,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)c2cccc(c2)N(=O)=O)C(=O)OCCOC,BRD-A58048407-001-18-8,nimodipine,Tocris,600,Nimodipine,-6.582630,x0946,3.68244,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)c2cccc(c2)N(=O)=O)C(=O)OCCOC,BRD-A58048407-001-20-4,nimodipine,MicroSource,1503600,NIMODIPINE,-6.582630,x0946,3.68244,active-noncovalent
C(C(CO)OP(=O)([O-])[O-])O,BRD-K39061174-001-01-0,beta-glycerophosphoric-acid,Vitas-M,STL280247,,-6.582582,x0397,1.036254,active-noncovalent
Cc1ncn(n1)c2c3c(c(c[nH]3)C(=O)C(=O)N4CCN(CC4)C(=O)c5ccccc5)c(cn2)OC,BRD-K97883416-001-01-4,BMS-626529,MedChemEx,HY-15440,BMS-626529,-6.581596,x0161,8.64344,active-noncovalent
c1cc(c(cc1Nc2c3cc(cc(c3ncc2C#N)Cl)NCc4cn(nn4)CC[NH+]5CCCCCC5)Cl)F,BRD-K98710228-001-01-6,cot-inhibitor-1,MedChemEx,HY-32015,Cot inhibitor-1,-6.579896,x0161,7.683175,active-noncovalent
C[C@@]1([C@@H]([C@@H](O[C@H]1n2ccc(nc2=O)N)CO)O)O,BRD-A66966115-001-01-0,NM107,LifeChem,F9995-0334,,-6.579246,x0678,-0.574604,active-noncovalent
COc1ccccc1O,BRD-K96282009-001-08-8,guaiacol,MicroSource,1506165,GUAIACOL,-6.578890,x0678,1.258259,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)[O-],BRD-K47195926-001-06-6,acedoben,MicroSource,1502412,ACEDOBEN,-6.577055,x0749,-1.542238,active-covalent
c1ccc2c(c1)CC[N@H+](C2)C[C@H](CNC(=O)c3cc(ncn3)NC4COC4)O,BRD-K70446295-001-01-7,EPZ015666,MedChemEx,HY-12727,EPZ015666,-6.576731,x0874,2.887697,active-noncovalent
CCOC(=O)C[C@@H](C(=O)OCC)SP(=S)(OC)OC,BRD-A01976766-001-07-6,malathion,MedChemEx,HY-B0943,Malathion,-6.574487,x1385,0.443053,active-covalent
CCOC(=O)C[C@@H](C(=O)OCC)SP(=S)(OC)OC,BRD-A01976766-001-04-3,malathion,MicroSource,330021,MALATHION,-6.574487,x1385,0.443053,active-covalent
CCOC(=O)C[C@@H](C(=O)OCC)SP(=S)(OC)OC,BRD-A01976766-001-06-8,malathion,MedChemEx,HY-B0943,Malathion,-6.574487,x1385,0.443053,active-covalent
Cn1c(nc(=O)c(=O)[nH]1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K96734425-324-01-5,ceftriaxone,MicroSource,1503111,CEFTRIAXONE SODIUM TRIHYDRATE,-6.573850,x0749,9.095644,active-covalent
Cn1c(nc(=O)c(=O)[nH]1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K96734425-304-01-7,ceftriaxone,MedChemEx,HY-B0712B,Ceftriaxone (sodium salt),-6.573850,x0749,9.095644,active-covalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)C6CC[NH+](CC6)Cc7ccccn7,BRD-K79404599-001-09-3,enzastaurin,Selleck,S1055,Enzastaurin (LY317615),-6.573524,x0072,9.339551,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C[C@H]3C(O3)(CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)N2)O)(C)C)C)O)C)C,BRD-K03601870-001-01-2,ixabepilone,MedChemEx,HY-10222,Ixabepilone,-6.571754,x0874,6.742483,active-noncovalent
C[C@H]1COCC[N@@]1c2c3ccc(nc3nc(n2)[N@@]4CCOC[C@@H]4C)c5cccc(c5)C(=O)NC,BRD-K99113996-001-02-0,AZD2014,Selleck,S2783,AZD2014,-6.571436,x0434,8.475578,active-noncovalent
C1N2CN3CN1C[N+](C2)(C3)C/C=C\Cl,BRD-K88956297-003-01-9,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",BidePharm,BD51690,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium chloride",-6.571005,x1311,-0.151723,active-covalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,BRD-K64052750-001-16-7,gefitinib,Selleck,S1025,Gefitinib (ZD1839),-6.570576,x0104,10.462821,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,BRD-K64052750-001-23-3,gefitinib,Tocris,3000,Iressa,-6.570576,x0104,10.462821,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,BRD-K64052750-001-22-5,gefitinib,Selleck,S1025,Gefitinib,-6.570576,x0104,10.462821,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,BRD-K64052750-001-17-5,gefitinib,Tocris,3000,Iressa,-6.570576,x0104,10.462821,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K36524108-065-03-2,paromomycin,Selleck,S4183,Paromomycin Sulfate,-6.565146,x0395,10.161886,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K36524108-065-07-3,paromomycin,Sigma,S______P9297,,-6.565146,x0395,10.161886,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K36524108-065-06-5,paromomycin,MicroSource,1503228,PAROMOMYCIN SULFATE,-6.565146,x0395,10.161886,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K36524108-065-05-7,paromomycin,Selleck,S4183,Paromomycin Sulfate,-6.565146,x0395,10.161886,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],BRD-K36524108-065-04-0,paromomycin,MedChemEx,HY-B0956,Paromomycin (sulfate),-6.565146,x0395,10.161886,active-noncovalent
C1C[NH2+][C@H](C[C@H]1CP(=O)([O-])[O-])C(=O)[O-],BRD-K48738253-001-02-4,selfotel,Enzo,AC1301,CGS 19755,-6.565018,x1348,-0.034125,active-covalent
Cc1ccc(c(c1)C(=O)N2CCN(CC[C@H]2C)c3nc4cc(ccc4o3)Cl)n5nccn5,BRD-K94293891-001-01-3,suvorexant,Selleck,S7279,Suvorexant (MK-4305),-6.563778,x0107,4.557585,active-noncovalent
CN1CC[NH+](CC1)CCCCn2c(cn(c2=O)/N=C/c3ccc(o3)c4ccc(cc4)Cl)[O-],BRD-K38913877-300-01-9,azimilide,MedChemEx,HY-18600A,Azimilide (Dihydrochloride),-6.562619,x0104,7.504821,active-noncovalent
C(CC(=O)[O-])C(=O)C[NH3+],BRD-K57631554-003-07-0,5-aminolevulinic-acid,MicroSource,1504184,AMINOLEVULINIC ACID HYDROCHLORIDE,-6.562369,x0107,-0.565888,active-noncovalent
C(CC(=O)[O-])C(=O)C[NH3+],BRD-K57631554-003-06-2,5-aminolevulinic-acid,Selleck,S2553,5-Aminolevulinic acid HCl,-6.562369,x0107,-0.565888,active-noncovalent
COC(=O)/C=C/C(=O)N[C@@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,BRD-K95110148-003-02-3,beta-funaltrexamine,Tocris,926,?-Funaltrexamine hydrochloride,-6.562361,x0395,5.125313,active-noncovalent
COC(=O)/C=C/C(=O)N[C@@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,BRD-K95110148-003-01-5,beta-funaltrexamine,Tocris,926,?-Funaltrexamine hydrochloride,-6.562361,x0395,5.125313,active-noncovalent
C(CNCCNCC[NH2+]CCN)[NH3+],BRD-K41298358-395-03-4,tetraethylenepentamine,Selleck,S4410,tetraethylenepentamine pentahydrochloride,-6.560149,x1334,-0.320493,active-covalent
C(CNCCNCC[NH2+]CCN)[NH3+],BRD-K41298358-395-02-6,tetraethylenepentamine,Selleck,S4410,Tetraethylenepentamine 5HCl,-6.560149,x1334,-0.320493,active-covalent
CSCC[C@@H](C(=O)[O-])[NH3+],BRD-K06502269-001-02-6,L-methionine,Sigma,V900487,L-methionine,-6.557175,x0397,-0.952864,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O,BRD-K58968598-001-03-6,sucralose,Selleck,S4214,Sucralose,-6.557084,x1334,1.151262,active-covalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O,BRD-K58968598-001-02-8,sucralose,MicroSource,1505953,SUCRALOSE,-6.557084,x1334,1.151262,active-covalent
C[Se]CC[C@@H](C(=O)[O-])[NH3+],BRD-K74664543-001-01-1,selenomethionine,Ark,AK-81303,(2S)-2-amino-4-(methylselanyl)butanoic acid,-6.556980,x1077,-0.777233,active-noncovalent
C[Se]CC[C@@H](C(=O)[O-])[NH3+],BRD-K74664543-213-01-2,selenomethionine,MicroSource,1506163,SELENOMETHIONINE,-6.556980,x1077,-0.777233,active-noncovalent
CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c2cc(c(c(c2O)Cl)OCCN3CC[NH+](CC3)C)Cl,BRD-K81405859-300-02-2,JTE-607,Tocris,5185,JTE 607 dihydrochloride,-6.555426,x0104,9.332161,active-noncovalent
CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c2cc(c(c(c2O)Cl)OCCN3CC[NH+](CC3)C)Cl,BRD-K81405859-300-01-4,JTE-607,Tocris,5185,"ethyl (3,5-dichloro-2-hydroxy-4-(2-(4-methylpiperazin-1-yl)ethoxy)benzoyl)-L-phenylalaninate dihydrochloride",-6.555426,x0104,9.332161,active-noncovalent
COCCOc1ccc(cc1)N2CC[NH+](CC2)CCn3c4c(cn3)c5nc(nn5c(n4)N)c6ccco6,BRD-K46290096-001-01-1,preladenant,MedChemEx,HY-10889,Preladenant,-6.554716,x0305,12.406708,active-noncovalent
C1[C@@H](O1)Cn2c(=O)n(c(=O)n(c2=O)C[C@H]3CO3)C[C@H]4CO4,BRD-A39935389-001-05-9,teroxirone,ChemDiv,0168-0391,,-6.554161,x0195,1.307913,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c([nH]3)ncnc4N[C@H](C)c5ccccc5,BRD-K40718343-001-02-6,AEE788,Selleck,S1486,AEE788 (NVP-AEE788),-6.551585,x0395,11.640175,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c([nH]3)ncnc4N[C@H](C)c5ccccc5,BRD-K40718343-001-04-2,AEE788,Tocris,5318,AEE 788,-6.551585,x0395,11.640175,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c([nH]3)ncnc4N[C@H](C)c5ccccc5,BRD-K40718343-001-03-4,AEE788,Selleck,S1486,AEE788 (NVP-AEE788),-6.551585,x0395,11.640175,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)N[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O)CO)O)O)I,BRD-A45543382-001-10-0,metrizamide,Selleck,S4379,Metrizamide,-6.549838,x0072,7.024528,active-noncovalent
CC(C)(C)c1cnc(o1)CSc2cnc(s2)NC(=O)C3CC[NH2+]CC3,BRD-K43389698-001-09-9,BMS-387032,Selleck,S1145,SNS-032 (BMS-387032),-6.549581,x0195,3.554519,active-noncovalent
CC(C)(C)c1cnc(o1)CSc2cnc(s2)NC(=O)C3CC[NH2+]CC3,BRD-K43389698-001-07-3,BMS-387032,Selleck,S1145,SNS-032 (BMS-387032),-6.549581,x0195,3.554519,active-noncovalent
CN(C(=S)c1ccccc1)NC(=O)CC(=O)NN(C)C(=S)c2ccccc2,BRD-K82135108-001-04-3,elesclomol,Selleck,S1052,Elesclomol (STA-4783),-6.549118,x1077,2.757903,active-noncovalent
Cc1c(c(c(c(c1N)C)C)NCC(=O)N(C)C2CC[NH+](CC2)Cc3ccc(cc3)C(=O)N)C,BRD-K71250460-001-01-1,SUN-11602,Tocris,4826,SUN 11602,-6.548300,x0104,9.175738,active-noncovalent
c1ccc(c(c1)c2nc-3ccn(cc3n2)Cc4ccc(nn4)c5ccc(cc5C(F)(F)F)C(F)(F)F)F,BRD-K26701552-001-01-8,tegobuvir,MedChemEx,HY-10544,Tegobuvir,-6.547794,x0104,11.391927,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@@H]4COc5ccccc5O4,BRD-A13188892-066-23-1,doxazosin,Tocris,2964,Doxazosin mesylate,-6.546585,x1077,10.350284,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@@H]4COc5ccccc5O4,BRD-A13188892-066-21-5,doxazosin,Selleck,S1324,Doxazosin Mesylate,-6.546585,x1077,10.350284,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@@H]4COc5ccccc5O4,BRD-A13188892-066-22-3,doxazosin,MicroSource,1505976,DOXAZOSIN MESYLATE,-6.546585,x1077,10.350284,active-noncovalent
CC(C)([C@@H](C(=O)[O-])[NH3+])S,BRD-A16376407-213-01-1,penicillamine-(racemic),MicroSource,1500464,PENICILLAMINE,-6.545851,x0689,0.052823,active-covalent
C1C[C@H]([NH2+]C1)C(=O)[O-],BRD-K01666412-001-02-0,L-proline,Sigma,V900338,L-proline,-6.542516,x0397,-0.90584,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)N,BRD-K62412084-001-07-1,para-toluenesulfonamide,Enamine,Z45415564,,-6.541236,x0161,0.253463,active-noncovalent
C1CN1P(=S)(N2CC2)N3CC3,BRD-K09631521-001-12-3,thiotepa,MedChemEx,HY-17574,Thio-TEPA,-6.536787,x0678,1.902072,active-noncovalent
C1CN1P(=S)(N2CC2)N3CC3,BRD-K09631521-001-09-9,thiotepa,MicroSource,1503324,THIOTEPA,-6.536787,x0678,1.902072,active-noncovalent
C1CN1P(=S)(N2CC2)N3CC3,BRD-K09631521-001-11-5,thiotepa,MedChemEx,HY-17574,Thio-TEPA,-6.536787,x0678,1.902072,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)Cc4c(cccc4Cl)Cl)/[nH]c(=C)c1C(=O)N5CCC[C@@H]5C[NH+]6CCCC6,BRD-K95435023-001-08-5,PHA-665752,Selleck,S1070,PHA-665752,-6.532330,x0104,13.99505,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)Cc4c(cccc4Cl)Cl)/[nH]c(=C)c1C(=O)N5CCC[C@@H]5C[NH+]6CCCC6,BRD-K95435023-001-07-7,PHA-665752,Tocris,2693,PHA 665752,-6.532330,x0104,13.99505,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)Cc4c(cccc4Cl)Cl)/[nH]c(=C)c1C(=O)N5CCC[C@@H]5C[NH+]6CCCC6,BRD-K95435023-001-10-1,PHA-665752,Selleck,S1070,PHA-665752,-6.532330,x0104,13.99505,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)Cc4c(cccc4Cl)Cl)/[nH]c(=C)c1C(=O)N5CCC[C@@H]5C[NH+]6CCCC6,BRD-K95435023-001-09-3,PHA-665752,Tocris,2693,PHA 665752,-6.532330,x0104,13.99505,active-noncovalent
Cc1c2c(cc(nc2n(n1)C)NNC(=O)Nc3cc(nc(c3)Cl)Cl)C(C)C,BRD-K43330982-001-02-3,JTE-013,Tocris,2392,JTE 013,-6.532018,x1392,4.365682,active-covalent
Cc1c2c(cc(nc2n(n1)C)NNC(=O)Nc3cc(nc(c3)Cl)Cl)C(C)C,BRD-K43330982-001-03-1,JTE-013,Tocris,2392,JTE 013,-6.532018,x1392,4.365682,active-covalent
COc1cc(c(cc1C(=O)N[C@@H]2CC[N@H+](C[C@@H]2OC)CCCOc3ccc(cc3)F)Cl)N,BRD-K06895174-001-02-8,cisapride,Tocris,1695,Cisapride,-6.529933,x0104,8.558516,active-noncovalent
COc1cc(c(cc1C(=O)N[C@@H]2CC[N@H+](C[C@@H]2OC)CCCOc3ccc(cc3)F)Cl)N,BRD-K06895174-001-03-6,cisapride,Tocris,1695,Cisapride,-6.529933,x0104,8.558516,active-noncovalent
COP(=O)([C@H](c1ccc(cc1)Cl)OP(=O)(OC)OC)OC,BRD-A72066420-001-04-5,mifobate,Tocris,2022,SR 202,-6.527545,x0434,0.06929,active-noncovalent
[H]/N=C(\Sc1c(cccc1)N)/[C@@H]([C@H](/C(=N/[H])/Sc2c(cccc2)N)C#N)C#N,BRD-K91701654-001-03-1,U-0126,Selleck,S1102,U0126-EtOH,-6.527519,x1077,2.471756,active-noncovalent
[H]/N=C(\Sc1c(cccc1)N)/[C@@H]([C@H](/C(=N/[H])/Sc2c(cccc2)N)C#N)C#N,BRD-K91701654-001-02-3,U-0126,Selleck,S1102,U0126-EtOH,-6.527519,x1077,2.471756,active-noncovalent
[H]/N=C(\Sc1c(cccc1)N)/[C@@H]([C@H](/C(=N/[H])/Sc2c(cccc2)N)C#N)C#N,BRD-K18787491-001-08-6,U-0126,Tocris,1144,U0126,-6.527519,x1077,2.471756,active-noncovalent
CCCCS(=O)(=O)N[C@@H](Cc1ccc(cc1)OCCCCC2CC[NH2+]CC2)C(=O)[O-],BRD-K37872686-003-01-9,tirofiban,Enzo,AC3271,TIROFIBAN HYDROCHLORIDE,-6.524443,x0104,5.992146,active-noncovalent
C[N@]1CCOCCN(C(=O)C2=Cc3cc(ccc3-c4c(c5ccc(cc5n4C2)C(=O)NS1(=O)=O)C6CCCCC6)OC)C,BRD-K49659468-436-01-2,TMC647055,MedChemEx,HY-15591A,TMC647055 (Choline salt),-6.524429,x0104,11.106306,active-noncovalent
C[C@H]1Cc2cc3c(c(c2-c4c(cc(c(c4OC)OC)OC)C[C@]1(C)O)OC)OCO3,BRD-K18878288-001-07-2,schisandrol-b,MedChemEx,HY-N0692,Schisandrol B,-6.522957,x0195,2.908107,active-noncovalent
C[C@H]1Cc2cc3c(c(c2-c4c(cc(c(c4OC)OC)OC)C[C@]1(C)O)OC)OCO3,BRD-K18878288-001-06-4,schisandrol-b,MedChemEx,HY-N0692,"(6S,7S)-1,2,3,13-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",-6.522957,x0195,2.908107,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K78364995-236-19-1,cefotaxime,MicroSource,1500165,CEFOTAXIME SODIUM,-6.521293,x0874,5.337823,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K78364995-236-17-5,cefotaxime,MedChemEx,HY-A0088,Cefotaxime (sodium salt),-6.521293,x0874,5.337823,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K78364995-236-16-7,cefotaxime,Sigma,MFCD00079073,"sodium (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-6.521293,x0874,5.337823,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)[O-],BRD-K78364995-236-18-3,cefotaxime,MedChemEx,HY-A0088,Cefotaxime (sodium salt),-6.521293,x0874,5.337823,active-noncovalent
CC(C)(C)c1cc(c(cc1NC(=O)c2c[nH]c3ccccc3c2=O)O)C(C)(C)C,BRD-K52818472-001-02-2,ivacaftor,Selleck,S1144,Ivacaftor (VX-770),-6.520783,x1093,4.678478,active-noncovalent
C[NH2+][C@H]1CN(C[C@@H]1OC)c2ccc3c(=O)c(cn(c3n2)c4nccs4)C(=O)[O-],BRD-K23677682-003-01-2,voreloxin,MedChemEx,HY-16518,Voreloxin (Hydrochloride),-6.520636,x0104,5.022151,active-noncovalent
CCCC(CCC)C(=O)N,BRD-K54698528-001-01-2,valpromide,Sigma,MFCD00051534,2-propylpentanamide,-6.515154,x0874,-1.336065,active-noncovalent
Cc1c[nH]nc1,BRD-K56810756-001-03-0,fomepizole,MicroSource,1506159,FOMEPIZOLE,-6.513643,x0678,-1.889521,active-noncovalent
Cc1c[nH]nc1,BRD-K56810756-003-07-7,fomepizole,MicroSource,1505432,FOMEPIZOLE HYDROCHLORIDE,-6.513643,x0678,-1.889521,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)N(C)C)C(=O)[O-])[C@@H](C)O,BRD-K01612348-001-14-8,meropenem,MicroSource,1502310,MEROPENEM,-6.512314,x0195,1.259332,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)N(C)C)C(=O)[O-])[C@@H](C)O,BRD-K01612348-001-11-4,meropenem,Key,KS-5224,"(4R,5S,6S)-3-({(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",-6.512314,x0195,1.259332,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)N(C)C)C(=O)[O-])[C@@H](C)O,BRD-K01612348-001-13-0,meropenem,Selleck,S1381,Meropenem,-6.512314,x0195,1.259332,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)N(C)C)C(=O)[O-])[C@@H](C)O,BRD-K01612348-001-12-2,meropenem,Selleck,S1381,Meropenem,-6.512314,x0195,1.259332,active-noncovalent
C[N@@](c1c(cccn1)CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,BRD-K99545815-001-06-3,PF-562271,Selleck,S2890,PF-562271,-6.512026,x0678,5.963979,active-noncovalent
C[N@@](c1c(cccn1)CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,BRD-K99545815-003-01-0,PF-562271,Selleck,S7357,PF-562271 HCl,-6.512026,x0678,5.963979,active-noncovalent
C[N@@](c1c(cccn1)CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,BRD-K99545815-074-03-7,PF-562271,Selleck,S2672,PF-00562271,-6.512026,x0678,5.963979,active-noncovalent
C[N@@](c1c(cccn1)CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,BRD-K99545815-074-02-9,PF-562271,Selleck,S2672,PF-00562271,-6.512026,x0678,5.963979,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H]2N1C(=O)C(=O)N2)O)O)O)O,BRD-K02898090-001-02-7,kifunensine,EMDBio,422500-1MG,"Kifunensine, Kitasatosporia kifunense",-6.512012,x0397,-0.981104,active-noncovalent
C[NH+](C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O,BRD-K90817094-001-03-4,bedaquiline,MedChemEx,HY-14881,Bedaquiline,-6.509989,x0967,5.910684,active-noncovalent
C[NH+](C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O,BRD-K90817094-001-02-6,bedaquiline,MedChemEx,HY-14881,Bedaquiline,-6.509989,x0967,5.910684,active-noncovalent
C[NH+](C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O,BRD-K90817094-001-05-9,bedaquiline,MedChemEx,HY-14881,Bedaquiline,-6.509989,x0967,5.910684,active-noncovalent
c1ccc(cc1)CO,BRD-K98494274-001-05-1,benzyl-alcohol,Sigma,V800080,phenylmethanol,-6.508918,x0678,1.203218,active-noncovalent
c1ccc(cc1)CO,BRD-K98494274-001-03-6,benzyl-alcohol,MicroSource,1502555,BENZYL ALCOHOL,-6.508918,x0678,1.203218,active-noncovalent
c1c[nH+]cc(c1N)N,BRD-K80262108-001-07-0,amifampridine,MedChemEx,HY-14946,Amifampridine,-6.505768,x0354,1.084761,active-noncovalent
C[C@H](C(=O)[O-])O,BRD-M29182745-001-01-4,ammonium-lactate,MicroSource,1506202,AMMONIUM LACTATE,-6.505556,x0397,-0.928236,active-noncovalent
CC(C)OP(=O)(OC(C)C)F,BRD-K56575995-001-03-0,isoflurophate,Sigma,MFCD00008873,diisopropyl fluoridophosphate,-6.504571,x0397,-0.821991,active-noncovalent
CC(C)OP(=O)(OC(C)C)F,BRD-K56575995-001-02-2,isoflurophate,Sigma,MFCD00008873,diisopropyl fluoridophosphate,-6.504571,x0397,-0.821991,active-noncovalent
C(C[NH+]=C(N)N)C(=O)[O-],BRD-K50781608-001-02-1,guanidinopropionic-acid,Sigma,MFCD00045939,N-[amino(imino)methyl]-beta-alanine,-6.500461,x0678,-1.225132,active-noncovalent
C[N@]1[C@H](Nc2cc(c(cc2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F,BRD-A15739803-001-01-0,polythiazide,Kemprotec,346-18-9,"6-chloro-2-methyl-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",-6.498771,x0107,1.440919,active-noncovalent
CCCCC[C@@H](C)[NH3+],BRD-A19958636-065-04-4,tuaminoheptane,MicroSource,1500601,TUAMINOHEPTANE SULFATE,-6.497232,x1077,-1.431129,active-noncovalent
Cc1ccccc1/N=N/c2ccc(c(c2)C)NC(=O)c3ccnn3C,BRD-K22314899-001-02-4,CH223191,Tocris,3858,CH 223191,-6.494285,x0104,6.080789,active-noncovalent
C1C[C@H]([C@@H]2[C@@H]([C@@H](C[N@H+]2C1)O)O)O,BRD-K15170068-001-03-2,swainsonine,Enzo,S112,Swainsonine,-6.493390,x1418,1.124058,active-covalent
c1c(cc(c(c1I)[O-])I)I,BRD-K59013864-001-01-1,AM-24,Enamine,EN300-19379,,-6.493266,x0195,-1.069591,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SS(=O)(=O)[O-],BRD-K59527975-236-01-8,S-Sulfo-L-cysteine-sodium-salt,Tocris,162,S-Sulfo-L-cysteine sodium salt,-6.491928,x0397,-0.146515,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)Cc2c(oc(n2)c3ccc(cc3)C(=O)NCc4cccnc4)C,BRD-K39171998-001-04-5,STF-118804,Tocris,5207,STF 118804,-6.487862,x0395,10.065716,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)Cc2c(oc(n2)c3ccc(cc3)C(=O)NCc4cccnc4)C,BRD-K39171998-001-01-1,STF-118804,Selleck,S7316,STF-118804,-6.487862,x0395,10.065716,active-noncovalent
C([C@@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,BRD-A73556557-001-07-2,tagatose,Enamine,EN300-85889,hex-2-ulose,-6.485415,x0397,-0.169732,active-noncovalent
C([C@@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,BRD-A73556557-001-06-4,tagatose,EMDBio,567692-250GM,L(-)Sorbose,-6.485415,x0397,-0.169732,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CO[C@H](S2)CO,BRD-K55172746-001-01-3,apricitabine,Key,AS-2749,"4-amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-2(1H)-pyrimidinone",-6.480754,x1386,-0.483216,active-covalent
C/C(=C\[C@H](C(=O)[O-])[NH3+])/CP(=O)([O-])[O-],BRD-A90272038-001-01-7,CGP-37849,EMDBio,504842-10MG,CGP 37849,-6.478532,x0397,-0.300517,active-noncovalent
C/C(=C\[C@H](C(=O)[O-])[NH3+])/CP(=O)([O-])[O-],BRD-A90272038-001-02-5,CGP-37849,Tocris,1469,(3E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid,-6.478532,x0397,-0.300517,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)c3c(cccc3OC)OC)C(=O)[O-])C,BRD-K34388247-236-09-0,methicillin,Sigma,51454,"sodium (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-6.477583,x0749,2.159463,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)c3c(cccc3OC)OC)C(=O)[O-])C,BRD-K34388247-236-08-2,methicillin,MicroSource,1500395,METHICILLIN SODIUM,-6.477583,x0749,2.159463,active-covalent
C1CNc2c(c(=O)c2=O)N(C1)CCP(=O)([O-])[O-],BRD-K04643877-001-03-2,perzinfotel,Sigma,MFCD00912427,"2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethylphosphonic acid",-6.476451,x1311,0.241919,active-covalent
CC1=[NH+]CC[C@H](N1)C(=O)[O-],BRD-K60902958-001-01-9,ectoine-zwitterion,Sigma,MFCD03419286,"(4S)-2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid",-6.473692,x0678,0.574183,active-noncovalent
CC(C)[NH2+]CCN(c1ccc2c(c1)nc(cn2)c3cnn(c3)C)c4cc(cc(c4)OC)OC,BRD-K84868168-001-01-0,erdafitinib,MedChemEx,HY-18708,Erdafitinib,-6.472165,x0161,5.669953,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N-]c2ccc3c(c2)c(cn3CC(=O)N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(F)(F)F,BRD-K07788774-001-01-0,NTRC-824,Tocris,5438,NTRC 824,-6.467732,x0434,7.446362,active-noncovalent
CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C,BRD-K71350836-001-02-4,butalbital,Prestwick,Prestw-1251,Butalbital,-6.467599,x0195,1.446272,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,BRD-K11905747-300-12-1,spectinomycin,Selleck,S2510,Spectinomycin HCl,-6.465862,x0195,0.878049,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,BRD-K11905747-300-11-3,spectinomycin,MedChemEx,HY-B0438,Spectinomycin (dihydrochloride),-6.465862,x0195,0.878049,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,BRD-K11905747-300-10-5,spectinomycin,MedChemEx,HY-B0438,Spectinomycin (dihydrochloride),-6.465862,x0195,0.878049,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,BRD-K11905747-300-08-9,spectinomycin,MicroSource,1500538,SPECTINOMYCIN HYDROCHLORIDE,-6.465862,x0195,0.878049,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,BRD-K11905747-300-09-7,spectinomycin,Selleck,S2510,Spectinomycin  hydrochloride,-6.465862,x0195,0.878049,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)O[C@H]2CC[N@H+](C2)Cc3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,BRD-K78781788-003-01-9,barnidipine,AKSci,O375,,-6.464103,x0161,6.232798,active-noncovalent
C[C@H]([C@@H](Cc1cccc(c1)C(=[NH2+])N)C(=O)OC)NC(=O)c2ccc(cc2)c3ccn(=O)cc3,BRD-K80082640-001-01-0,otamixaban,MedChemEx,HY-70035,Otamixaban,-6.464006,x0678,4.935571,active-noncovalent
CC(=O)Nc1c(cc(c(c1I)C(=O)[O-])I)I,BRD-K46416130-001-07-7,acetriazoic-acid,MedChemEx,HY-B1406,Acetrizoic acid,-6.461906,x0195,-0.113845,active-noncovalent
CC(=O)Nc1c(cc(c(c1I)C(=O)[O-])I)I,BRD-K46416130-001-06-9,acetriazoic-acid,MicroSource,1504142,ACETRIAZOIC ACID,-6.461906,x0195,-0.113845,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,BRD-K44133266-236-03-7,sulbactam,Selleck,S2551,Sulbactam sodium,-6.461625,x0678,2.462934,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,BRD-K44133266-001-10-0,sulbactam,Selleck,S1958,Sulbactam,-6.461625,x0678,2.462934,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,BRD-K44133266-236-02-9,sulbactam,Selleck,S2551,Sulbactam sodium (Unasyn),-6.461625,x0678,2.462934,active-noncovalent
C1CC1(C(=O)[O-])[NH3+],BRD-K66465025-001-05-1,ACPC,Enzo,AC387,1-Aminocyclopropanecarboxylic acid,-6.460526,x1077,-1.054857,active-noncovalent
C([C@H]([C@@H]([C@H]([C@@H](CO)O)O)O)O)O,BRD-K36513555-001-02-0,sorbitol,MicroSource,1300043,SORBITOL,-6.459620,x0397,-0.318509,active-noncovalent
C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,BRD-K30374899-001-09-3,mannitol-D,Selleck,S2381,D-Mannitol,-6.458498,x0397,0.391323,active-noncovalent
c1ccc(cc1)OCCN2CCCc3c2cccc3CNc4ccc(c(c4)F)CCC(=O)[O-],BRD-K75254015-001-01-9,AS-2034178,Tocris,5035,AS 2034178,-6.456038,x0104,10.214705,active-noncovalent
CCS(=O)(=O)c1cccc(c1)c2cc(c(c3c2c4cc(cnc4[nH]3)C)C)C(=O)NC5CC[NH+](CC5)C,BRD-K01683783-001-02-6,TAK-901,Selleck,S2718,TAK-901,-6.455890,x0104,7.22732,active-noncovalent
CC(C)c1cccc2c1nc(cc2c3ccccc3)c4ccc([nH]4)c5ccc(cc5)C(=O)[O-],BRD-K18347943-001-01-8,ER-50891,Tocris,3823,ER 50891,-6.455600,x0104,6.8936,active-noncovalent
C(CCl)[NH+](CCCl)CCCl,BRD-K29888499-003-03-8,trichlormethine,MicroSource,300563,TRICHLORMETHINE HYDROCHLORIDE,-6.453944,x0434,-0.145017,active-noncovalent
CCCc1cn(c2c1nc([nH]c2=O)c3cc(ccc3OCCC)S(=O)(=O)N4CC[NH+](CC4)CCO)CC,BRD-K82967685-300-01-2,mirodenafil,MedChemEx,HY-14930A,Mirodenafil (dihydrochloride),-6.453191,x0161,6.417799,active-noncovalent
Cc1c(cccc1F)NC(=O)Nc2ccc(c(c2[O-])S(=O)(=O)[C@H]3CCCNC3)Cl,BRD-K13769342-001-01-5,danirixin,MedChemEx,HY-19768,Danirixin,-6.451350,x1077,6.026271,active-noncovalent
CCC[C@@H]([C@H](CC)CO)O,BRD-A55455283-001-02-1,"2-ethyl-1,3-hexanediol",Sigma,MFCD00004578,"2-ethyl-1,3-hexanediol",-6.450663,x0195,-0.001247,active-noncovalent
CCC[C@@H]([C@H](CC)CO)O,BRD-A55455283-001-01-3,"2-ethyl-1,3-hexanediol",TCI,E0119,,-6.450663,x0195,-0.001247,active-noncovalent
CN(C(=O)N[C@H]1CC[C@@H](CC1)CC[NH+]2CCN(CC2)c3c(c(ccc3)Cl)Cl)C,BRD-K57764956-001-02-8,cariprazine,MedChemEx,HY-14763,Cariprazine,-6.450283,x0104,8.131659,active-noncovalent
Cc1cc(c(c(=O)o1)C(=O)C)[O-],BRD-A17300716-001-01-5,dehydroacetic-acid,MicroSource,1301016,DEHYDROACETIC ACID,-6.446742,x0397,-0.640712,active-noncovalent
Cc1cc(=O)[nH]c(=S)[nH]1,BRD-K11900042-001-14-4,methylthiouracil,MicroSource,1500408,METHYLTHIOURACIL,-6.446671,x0678,0.562903,active-noncovalent
Cc1cc(=O)[nH]c(=S)[nH]1,BRD-K11900042-001-13-6,methylthiouracil,Selleck,S3138,Methylthiouracil,-6.446671,x0678,0.562903,active-noncovalent
C1C[N@@H+]2C[C@@H]([C@H]([C@@H]([C@H]2[C@H]1O)O)O)O,BRD-K20897876-001-11-8,castanospermine,Tocris,759,Castanospermine,-6.445244,x0195,1.432321,active-noncovalent
C1C[N@@H+]2C[C@@H]([C@H]([C@@H]([C@H]2[C@H]1O)O)O)O,BRD-K20897876-001-10-0,castanospermine,Tocris,759,Castanospermine,-6.445244,x0195,1.432321,active-noncovalent
c1cc(c(c(c1)F)F)[C@@H]2CC[C@H](c3c(cccn3)[C@H]2[NH3+])OC(=O)N4CCC(CC4)n5c6cccnc6[nH]c5=O,BRD-K55781385-001-01-7,BMS-927711,MedChemEx,HY-15498,BMS-927711,-6.441045,x0967,12.362933,active-noncovalent
c1ccc2c(c1)C3(C(=O)N2)OCC4(CO3)COC5(c6ccccc6NC5=O)OC4,BRD-K24554037-001-08-3,JW-67,Tocris,4651,JW 67,-6.440076,x0161,5.193632,active-noncovalent
c1ccnc(c1)C[NH2+]Cc2ccc(cc2)C[N@@]3CCCNCC[NH2+]CCC[NH2+]CC3,BRD-K03019184-439-01-0,AMD-3465,Tocris,4179,AMD 3465 hexahydrobromide,-6.437649,x1077,6.929173,active-noncovalent
C1C[NH+](CC[N@@](CCN(CC[N@]1CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],BRD-K11099631-001-08-4,gadoterate-meglumine,Sigma,86734,"2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid",-6.436503,x1385,4.543472,active-covalent
C1C[NH+](CC[N@@](CCN(CC[N@]1CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],BRD-K11099631-001-07-6,gadoterate-meglumine,TCI,T1875,,-6.436503,x1385,4.543472,active-covalent
CC1=[NH+]C[C@@H]([C@H](N1)C(=O)[O-])O,BRD-K03871161-001-01-9,5-hydroxyectoine,Sigma,MFCD01863080,"(4S,5S)-5-hydroxy-2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid",-6.435124,x0678,0.89056,active-noncovalent
CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@H](CC3CCC3)C(=O)C(=O)N)C,BRD-A09735281-001-04-1,boceprevir,MedChemEx,HY-10237,Boceprevir,-6.431930,x0161,9.295568,active-noncovalent
CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@H](CC3CCC3)C(=O)C(=O)N)C,BRD-A09735281-001-03-3,boceprevir,MedChemEx,HY-10237,Boceprevir,-6.431930,x0161,9.295568,active-noncovalent
CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@H](CC3CCC3)C(=O)C(=O)N)C,BRD-A09735281-001-02-5,boceprevir,MedChemEx,HY-10237,Boceprevir,-6.431930,x0161,9.295568,active-noncovalent
C[C@@]1(CCOC(=O)C1)O,BRD-A05674712-001-06-0,"mevalonic-d,-l-acid-lactone",Prestwick,Prestw-750,"Mevalonic-D, L acid lactone",-6.430621,x0195,1.453366,active-noncovalent
c1cc2c(c(c1)S(=O)(=O)Nc3ccsc3C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-])nsn2,BRD-K50653584-019-01-4,EG00229,MedChemEx,HY-10799,EG00229,-6.428161,x1077,5.44295,active-noncovalent
c1cc2c(c(c1)S(=O)(=O)Nc3ccsc3C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-])nsn2,BRD-K50653584-001-01-2,EG00229,Tocris,4931,EG 00229,-6.428161,x1077,5.44295,active-noncovalent
c1c(c(cc(c1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,BRD-K97521363-001-15-3,clorsulon,Selleck,S2613,Clorsulon,-6.426647,x0749,1.918982,active-covalent
c1c(c(cc(c1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,BRD-K97521363-001-16-1,clorsulon,MicroSource,1505115,CLORSULON,-6.426647,x0749,1.918982,active-covalent
C/C=C\1/[C@@H](C(=CO[C@@H]1O[C@@H]2[C@@H]([C@H]([C@H]([C@@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OCCc3ccc(c(c3)O)O,BRD-A00842753-001-01-9,oleuropein,Selleck,S7867,Oleuropein,-6.423532,x0434,8.234,active-noncovalent
CCCNS(=O)(=O)Nc1c(c(ncn1)OCCOc2ncc(cn2)Br)c3ccc(cc3)Br,BRD-K48812570-001-02-3,macitentan,Selleck,S8051,Macitentan,-6.419363,x0161,6.405572,active-noncovalent
CCCNS(=O)(=O)Nc1c(c(ncn1)OCCOc2ncc(cn2)Br)c3ccc(cc3)Br,BRD-K48812570-001-03-1,macitentan,Selleck,S8051,Macitentan,-6.419363,x0161,6.405572,active-noncovalent
C[NH2+]CC(=O)[O-],BRD-K51263939-001-08-6,sarcosine,Enamine,Z104480276,,-6.414515,x0397,-0.547569,active-noncovalent
COc1cccc(c1)c2ccc(c(c2)F)NC(=O)C3=C(CCC3)C(=O)[O-],BRD-K40797222-001-01-8,SC-12267,MedChemEx,HY-14908,Vidofludimus,-6.414360,x0104,4.353426,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N,BRD-K02594908-001-15-6,sulfanilamide,Selleck,S1685,Sulfanilamide,-6.414182,x0678,1.135623,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N,BRD-K02594908-001-16-4,sulfanilamide,MicroSource,1500646,SULFANILAMIDE,-6.414182,x0678,1.135623,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)[NH3+])O)O)O,BRD-K29918010-003-04-1,glucosamine,MicroSource,1500316,GLUCOSAMINE HYDROCHLORIDE,-6.412652,x0107,-0.226572,active-noncovalent
CC(=O)N[C@H]1[C@@H]([C@@H]([C@@H](O[C@@H]1O)CO)O)O,BRD-A92872453-001-01-8,N-acetylmannosamine,Vitas-M,STK801944,,-6.410317,x0749,-0.433607,active-covalent
CS(=O)(=O)OCCCCOS(=O)(=O)C,BRD-K23204545-001-15-6,busulfan,Selleck,S1692,Busulfan,-6.407554,x0749,0.009122,active-covalent
CS(=O)(=O)OCCCCOS(=O)(=O)C,BRD-K23204545-001-16-4,busulfan,MicroSource,1500152,BUSULFAN,-6.407554,x0749,0.009122,active-covalent
CS(=O)(=O)OCCCCOS(=O)(=O)C,BRD-K23204545-001-18-0,busulfan,Selleck,S1692,"Busulfan (Myleran, Busulfex)",-6.407554,x0749,0.009122,active-covalent
CC1(C(=O)N(C(=O)O1)C)C,BRD-K16606819-001-11-9,trimethadione,Sigma,MFCD00047084,"3,5,5-trimethyl-1,3-oxazolidine-2,4-dione",-6.405789,x0195,1.851163,active-noncovalent
CC1(C(=O)N(C(=O)O1)C)C,BRD-K16606819-001-10-1,trimethadione,MicroSource,1505466,TRIMETHADIONE,-6.405789,x0195,1.851163,active-noncovalent
CC1(C(=O)N(C(=O)O1)C)C,BRD-K16606819-001-13-5,trimethadione,MedChemEx,HY-A0092,Trimethadione,-6.405789,x0195,1.851163,active-noncovalent
CC1(C(=O)N(C(=O)O1)C)C,BRD-K16606819-001-12-7,trimethadione,MedChemEx,HY-A0092,Trimethadione,-6.405789,x0195,1.851163,active-noncovalent
Cc1c(cc(cn1)Cl)NCc2ccc(s2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4,BRD-K17472821-001-02-0,GSK2830371,Tocris,5140,GSK 2830371,-6.404488,x1077,7.73113,active-noncovalent
Cc1c(cc(cn1)Cl)NCc2ccc(s2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4,BRD-K17472821-001-01-2,GSK2830371,MedChemEx,HY-15832,GSK 2830371,-6.404488,x1077,7.73113,active-noncovalent
[C@@H]([C@@H](C(=O)[O-])S)(C(=O)[O-])S,BRD-K88701661-001-03-7,dimercaptosuccinic-acid,AlfaAesar,A17909,"(2R,3S)-2,3-disulfanylbutanedioic acid",-6.403480,x0397,0.637231,active-noncovalent
[C@@H]([C@@H](C(=O)[O-])S)(C(=O)[O-])S,BRD-K88701661-001-02-9,dimercaptosuccinic-acid,AlfaAesar,A17909,,-6.403480,x0397,0.637231,active-noncovalent
Cc1c(oc(=O)o1)CCl,BRD-K03044000-001-01-8,80841-78-7,Sigma,671975,"4-(chloromethyl)-5-methyl-1,3-dioxol-2-one",-6.402489,x0195,1.07821,active-noncovalent
C([C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)O,BRD-K18320600-001-01-9,tagatose,Sigma,MFCD00134449,D-tagatose,-6.396017,x0397,-0.288589,active-noncovalent
CCC(=O)NC[C@H](Cc1ccc(cc1)OCCc2c(oc(n2)c3ccccc3)C)/N=C(/C)\CC(=O)c4ccc(cc4)C(F)(F)F,BRD-K20828910-001-01-2,GW-6471,Tocris,4618,GW 6471,-6.394127,x0104,11.111118,active-noncovalent
CCC(=O)NC[C@H](Cc1ccc(cc1)OCCc2c(oc(n2)c3ccccc3)C)/N=C(/C)\CC(=O)c4ccc(cc4)C(F)(F)F,BRD-K20828910-001-02-0,GW-6471,Tocris,4618,GW 6471,-6.394127,x0104,11.111118,active-noncovalent
[H]/N=C(\SC)/[C@@H]([C@H](/C(=N/[H])/SC)C#N)C#N,BRD-K63169195-001-01-5,U-0124,Tocris,1868,U0124,-6.393508,x0678,-0.442328,active-noncovalent
C[C@@H](CC(=O)[O-])O,BRD-A41387824-001-06-0,beta-Hydroxybutyrate,Vitas-M,STL377875,,-6.390899,x0397,-0.853151,active-noncovalent
CC1(C2C[C@H](C(O1)([C@H](C2)O)C)O)C,BRD-A59329714-001-01-5,epomediol,TimTec,ST50983621,"1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane-6,7-diol",-6.390732,x0678,2.315909,active-noncovalent
c1c(nc(s1)N)/C(=N/OCC(=O)[O-])/C(=O)N[C@H]2[C@H](N(C2=O)S(=O)(=O)[O-])COC(=O)N,BRD-K71026158-304-01-0,carumonam,Sigma,MFCD00875847,"disodium ({[(Z)-2-[((2S,3S)-2-{[(aminocarbonyl)oxy]methyl}-4-oxo-1-sulfonato-3-azetidinyl)amino]-1-(2-amino-1,3-thiazol-4-yl)-2-oxoethylidene]amino}oxy)acetate",-6.388405,x1077,7.024623,active-noncovalent
[H]/N=C/1\[C@@H]2N(C1=O)[C@H]([C@@H](CS2)COC(=O)C)C(=O)[O-],BRD-K65377893-001-07-4,7-aminocephalosporanic-acid,Selleck,S2530,7-Aminocephalosporanic acid,-6.385460,x0678,0.144051,active-noncovalent
[H]/N=C/1\[C@@H]2N(C1=O)[C@H]([C@@H](CS2)COC(=O)C)C(=O)[O-],BRD-K65377893-001-08-2,7-aminocephalosporanic-acid,Selleck,S2530,7-Aminocephalosporanic acid,-6.385460,x0678,0.144051,active-noncovalent
CC(C)[C@@H](/C=C(\C)/C(=O)[O-])N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)c1ccccc1)[NH2+]C,BRD-K87512222-019-01-7,taltobulin,MedChemEx,HY-15584A,Taltobulin (trifluoroacetate),-6.384556,x0967,4.642055,active-noncovalent
CC[NH2+]CCC[NH2+]CCCC[NH2+]CCC[NH2+]CC,BRD-K04603573-376-01-3,"1,12-Besm",Tocris,500,"N~1~,N~4~-bis[3-(ethylamino)propyl]-1,4-butanediamine tetrahydrochloride",-6.384076,x0104,2.476927,active-noncovalent
CCCCc1nc(c(c(=O)n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CC(=S)N(C)C)C,BRD-K21586122-001-01-9,fimasartan,MedChemEx,HY-B0780,Fimasartan,-6.383174,x0161,6.659751,active-noncovalent
CCCCc1nc(c(c(=O)n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)CC(=S)N(C)C)C,BRD-K21586122-001-02-7,fimasartan,MedChemEx,HY-B0780,"2-(3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butylidene-6-methyl-4-oxo-1,2,3,4-tetrahydropyrimidin-5-yl)-N,N-dimethylethanethioamide",-6.383174,x0161,6.659751,active-noncovalent
CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c1ncnc2N)OCOC(=O)C(C)(C)C,BRD-K96159438-001-06-3,adefovir-dipivoxil,Selleck,S1718,Adefovir Dipivoxil,-6.382543,x1077,5.390455,active-noncovalent
CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c1ncnc2N)OCOC(=O)C(C)(C)C,BRD-K96159438-001-07-1,adefovir-dipivoxil,Selleck,S1718,"Adefovir Dipivoxil (Preveon, Hepsera)",-6.382543,x1077,5.390455,active-noncovalent
CNC(=O)c1ccccc1Nc2cc(ncc2C(F)(F)F)Nc3ccc(cc3OC)N4CCOCC4,BRD-K09877029-001-01-2,VS-4718,MedChemEx,HY-13917,PND-1186,-6.382465,x0161,9.072814,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])S,BRD-K00795468-001-02-1,L-cysteine,Sigma,95437,L-cysteine,-6.381304,x0397,-0.905945,active-noncovalent
c1ccc(cc1)NC(=O)OC[C@H](C[NH+]2CCCCC2)OC(=O)Nc3ccccc3,BRD-A30693873-003-11-0,diperodon,Selleck,S4397,Diperodon HCl,-6.380083,x1077,5.662772,active-noncovalent
c1ccc(cc1)NC(=O)OC[C@H](C[NH+]2CCCCC2)OC(=O)Nc3ccccc3,BRD-A30693873-003-12-8,diperodon,MicroSource,1505780,DIPERODON HYDROCHLORIDE,-6.380083,x1077,5.662772,active-noncovalent
CCOP(=O)([C@@H](C)NC(=O)N(CCCl)N=O)OCC,BRD-A62893078-001-02-3,fotemustine,MedChemEx,HY-B0733,Fotemustine,-6.379870,x0397,1.78416,active-noncovalent
CCOP(=O)([C@@H](C)NC(=O)N(CCCl)N=O)OCC,BRD-A62893078-001-01-5,fotemustine,MedChemEx,HY-B0733,Fotemustine,-6.379870,x0397,1.78416,active-noncovalent
CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)NC,BRD-K51662849-001-08-8,ilomastat,Selleck,S7157,GM6001,-6.379023,x0434,3.733557,active-noncovalent
CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)NC,BRD-K51662849-001-05-4,ilomastat,Selleck,S7157,"Ilomastat (GM6001, Galardin)",-6.379023,x0434,3.733557,active-noncovalent
Cc1nnc(o1)C(=O)NC(C)(C)c2nc(c(c(=O)n2C)[O-])C(=O)NCc3ccc(cc3)F,BRD-K05658747-001-03-7,raltegravir,Selleck,S2005,Raltegravir (MK-0518),-6.378845,x0749,6.361009,active-covalent
Cc1nnc(o1)C(=O)NC(C)(C)c2nc(c(c(=O)n2C)[O-])C(=O)NCc3ccc(cc3)F,BRD-K05658747-001-02-9,raltegravir,Selleck,S2005,Raltegravir (MK-0518),-6.378845,x0749,6.361009,active-covalent
c1cc(cc(c1)F)C#Cc2ccc(cn2)C(=O)NC3CCC3,BRD-K83649660-003-03-0,VU0360172,Tocris,4323,VU 0360172 hydrochloride,-6.378730,x1077,6.039604,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)c1cc(n(n1)c2ccnc3c2ccc(c3)Cl)c4c(cccc4OC)OC,BRD-K79608170-001-02-1,TC-NTR1-17,Tocris,5087,TC NTR1 17,-6.377967,x0395,6.333961,active-noncovalent
CCOC(=O)c1ccc(nc1)C#Cc2ccc3c(c2)C(CCS3)(C)C,BRD-K76841105-001-04-7,tazarotene,Selleck,S1569,Tazarotene,-6.377547,x0104,5.305731,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O[C@@H]6CCCCO6,BRD-K83794624-003-01-3,pirarubicin,MedChemEx,HY-13725A,"(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranoside hydrochloride",-6.376424,x0104,16.236561,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O[C@@H]6CCCCO6,BRD-K83794624-003-02-1,pirarubicin,MedChemEx,HY-13725A,Pirarubicin (Hydrochloride),-6.376424,x0104,16.236561,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O[C@@H]6CCCCO6,BRD-K83794624-001-03-3,pirarubicin,Selleck,S1393,Pirarubicin,-6.376424,x0104,16.236561,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O[C@@H]6CCCCO6,BRD-K83794624-001-02-5,pirarubicin,Selleck,S1393,Pirarubicin,-6.376424,x0104,16.236561,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)Nc3ccccc3NS(=O)(=O)C)Cl)N4CCOCC4,BRD-K87021635-003-02-2,CZC-54252,Tocris,4534,CZC 54252 hydrochloride,-6.376280,x0967,6.673436,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,BRD-A12490291-001-01-2,sulbactam,MicroSource,1502340,SULBACTAM,-6.376079,x0678,2.19464,active-noncovalent
C(C(=O)O)C(CC(=O)O)(C(=O)O)O,BRD-M41245765-001-04-2,lithium-citrate,MicroSource,1504269,LITHIUM CITRATE,-6.375349,x0397,1.513501,active-noncovalent
C(C(=O)O)C(CC(=O)O)(C(=O)O)O,BRD-M41245765-001-05-9,lithium-citrate,Selleck,S4399,lithium citrate,-6.375349,x0397,1.513501,active-noncovalent
C(C(=O)O)C(CC(=O)O)(C(=O)O)O,BRD-M41245765-001-03-4,lithium-citrate,Selleck,S4399,Lithium Citrate,-6.375349,x0397,1.513501,active-noncovalent
CC(C)(c1ccc(cc1)OC[C@H]2CO2)c3ccc(cc3)OC[C@H]4CO4,BRD-A16694057-001-06-8,BADGE,Tocris,1326,BADGE,-6.373281,x0104,3.150494,active-noncovalent
C(CC(=O)[O-])C[NH3+],BRD-K77245796-003-01-6,gamma-aminobutyric-acid,MicroSource,1500678,gamma-AMINOBUTYRIC ACID HYDROCHLORIDE,-6.370827,x0397,-1.117989,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)C,BRD-K27406233-001-07-7,acetyl-l-leucine,MicroSource,1502001,ACETYL-L-LEUCINE,-6.368969,x0397,-0.594247,active-noncovalent
c1cc(ccc1/C=C/C(=C\2/C(=O)[C@@H](C(=O)[C@](C2=O)([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)/[O-])O,BRD-A52169337-001-01-9,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",MedChemEx,HY-N0567,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-;2-yl)cyclohexane-1,3,5-trione",-6.367967,x0678,6.650409,active-noncovalent
c1cc(ccc1/C=C/C(=C\2/C(=O)[C@@H](C(=O)[C@](C2=O)([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)/[O-])O,BRD-A52169337-001-02-7,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",MedChemEx,HY-N0567,Hydroxysafflor yellow A,-6.367967,x0678,6.650409,active-noncovalent
COc1cc2c(cc1NC(=O)/C=C/C[NH+]3CCCCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,BRD-K57169635-001-04-5,dacomitinib,Selleck,S2727,"Dacomitinib (PF299804, PF299)",-6.367520,x0104,9.053497,active-noncovalent
CC(C)(C)[C@@]1(C[C@H]2[C@@]3([C@]14[C@H](C(=O)O[C@H]4OC3=O)O)CC(=O)O2)O,BRD-A41714661-001-02-0,bilobalide,Selleck,S2276,Bilobalide,-6.367469,x0678,3.539291,active-noncovalent
CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/c4ccc(cn4)c5cccc(c5)F)[C@H](OC3=O)C,BRD-K93442924-001-03-4,vorapaxar,Adooq,A12832,"ethyl (1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-ylcarbamate",-6.364000,x0072,11.598401,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)C(=O)Nc3ccc(c(c3)N4CC[NH+](CC4)C)OC)c5nc(on5)C,BRD-K11911061-003-11-9,GR-127935,Tocris,1477,GR 127935 hydrochloride,-6.361451,x0305,20.587685,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)CCOC(c3ccc(cc3)F)c4ccc(cc4)F,BRD-K92577649-300-01-2,GBR-13069,Tocris,420,GBR 13069 dihydrochloride,-6.361447,x0104,5.191729,active-noncovalent
CC1([C@H](N2[C@@H](S1)[C@H](C2=O)NC(=O)[C@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)[O-])C,BRD-K45114938-236-02-6,mezlocillin,Selleck,S4179,Mezlocillin Sodium,-6.358181,x1077,10.015395,active-noncovalent
CC1([C@H](N2[C@@H](S1)[C@H](C2=O)NC(=O)[C@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)[O-])C,BRD-K45114938-236-01-8,mezlocillin,Selleck,S4179,Mezlocillin Sodium,-6.358181,x1077,10.015395,active-noncovalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccc(cc4)F)c5ccc(cc5)F)CC3,BRD-K40887525-001-23-5,ritanserin,Tocris,1955,Ritanserin,-6.356082,x0434,9.699434,active-noncovalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccc(cc4)F)c5ccc(cc5)F)CC3,BRD-K40887525-001-22-7,ritanserin,MicroSource,1503421,RITANSERIN,-6.356082,x0434,9.699434,active-noncovalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccc(cc4)F)c5ccc(cc5)F)CC3,BRD-K40887525-001-21-9,ritanserin,Tocris,1955,Ritanserin,-6.356082,x0434,9.699434,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CNC(=O)c3nc(no3)c4cc(c(c(c4)Br)[O-])Br,BRD-K84892605-001-01-1,IOWH032,Selleck,S7329,IOWH032,-6.355387,x0434,11.308578,active-noncovalent
c1cc(oc1CO)CO,BRD-K29791386-001-01-8,"2,5-furandimethanol",Key,TS-01680,"furan-2,5-diyldimethanol",-6.355311,x0678,0.863693,active-noncovalent
c1ccc(cc1)O,BRD-K76549667-001-04-6,phenol,Sigma,V800301,phenol,-6.355002,x0678,1.339961,active-noncovalent
CN(C)C(=S)SSC(=S)N(C)C,BRD-K29254801-001-14-7,thiram,MicroSource,1503322,THIRAM,-6.352805,x0678,-0.717324,active-noncovalent
CCOC(=O)N1CSC[C@@H]1C(=O)[O-],BRD-A05523972-001-01-5,telmesteine,TCI,T1974,,-6.350442,x0749,0.401623,active-covalent
CCC1(C(=O)NC(=O)NC1=O)CC,BRD-K83359602-001-02-3,barbital,MicroSource,1900040,BARBITAL,-6.349185,x0354,2.585864,active-noncovalent
C1C[N@](C[C@@H]([NH2+]1)C(=O)[O-])C/C=C/P(=O)([O-])[O-],BRD-K45163704-001-01-5,midafotel,EMDBio,504840-10MG,(R)-CPPene,-6.348824,x0678,0.6934,active-noncovalent
C1C[N@](C[C@@H]([NH2+]1)C(=O)[O-])C/C=C/P(=O)([O-])[O-],BRD-K45163704-001-02-3,midafotel,Tocris,1265,(2R)-4-[(2E)-3-phosphono-2-propenyl]-2-piperazinecarboxylic acid,-6.348824,x0678,0.6934,active-noncovalent
CC(=O)N1CC[N+](CC1)(C)C,BRD-K97019106-005-02-9,"4-acetyl-1,1-dimethylpiperazinium",Tocris,352,"4-Acetyl-1,1-dimethylpiperazinium iodide",-6.345225,x0195,-0.816167,active-noncovalent
CC(C)(C)c1ccc(cc1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,BRD-A91444184-300-01-9,buclizine,Key,KS-1250,1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine dihydrochloride,-6.344145,x0678,8.813284,active-noncovalent
c1ccc(cc1)C(CC(=O)N2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5ccccc5,BRD-K16037980-001-01-1,Z160,MedChemEx,HY-14462,NP118809,-6.343742,x0874,6.011436,active-noncovalent
CS(=O)(=O)c1ccc(nc1)c2nnc(n2c3ccccc3Cl)/C=C/c4nnc(o4)c5ccc(cc5)C#N,BRD-K12198961-001-01-8,G007-LK,MedChemEx,HY-12438,G007-LK,-6.339536,x0104,12.752099,active-noncovalent
CC(C)C[N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)c4ccc(cc4)N,BRD-K84986517-001-01-8,darunavir,Selleck,S1620,Darunavir Ethanolate,-6.337689,x0161,7.485701,active-noncovalent
CCCC(=O)C1CCN(CC1)c2c3c(ncn2)CCN(C3)C(=O)c4ccc(cc4)c5ccccc5,BRD-K44043890-001-01-4,PK-THPP,Tocris,5338,PK-THPP,-6.337166,x0161,9.068021,active-noncovalent
Cc1c2c(=O)[nH]c(nn2c(n1)[C@@H](CCCc3ccccc3)[C@@H](C)O)Cc4ccc(c(c4)OC)OC,BRD-K86932920-001-02-9,bay-60-7550,MedChemEx,HY-14992,Bay 60-7550,-6.336129,x0107,6.491718,active-noncovalent
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)C)O,BRD-K41707108-001-05-6,ceramide,Tocris,744,Ceramide,-6.335195,x0874,3.830844,active-noncovalent
c1cc(cn(=O)c1)CO,BRD-K78299798-001-02-2,mepiroxol,Selleck,S4333,Mepiroxol,-6.335049,x0397,1.539311,active-noncovalent
c1cc(cn(=O)c1)CO,BRD-K78299798-001-03-0,mepiroxol,MicroSource,1504616,MEPIROXOL,-6.335049,x0397,1.539311,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)[NH3+])C(=O)[O-])C,BRD-K30284967-001-01-8,6-aminopenicillanic-acid,Enamine,Z1269203097,,-6.334925,x0678,1.361331,active-noncovalent
C[C@@H](C(=O)N[C@H]1c2ccccc2-c3ccccc3N(C1=O)C)NC(=O)[C@H](c4cc(cc(c4)F)F)O,BRD-K20013301-001-02-6,LY411575,Selleck,S2714,LY411575,-6.334172,x0195,4.822925,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)OC)/O,BRD-K30331124-001-01-7,ASC-J9,MedChemEx,HY-15194,ASC-J9,-6.333081,x0104,9.665345,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)OC)/O,BRD-K30331124-001-02-5,ASC-J9,Adooq,A11300,"(1E,4E,6E)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one",-6.333081,x0104,9.665345,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)OC)/O,BRD-K30331124-001-03-3,ASC-J9,MedChemEx,HY-15194,ASC-J9,-6.333081,x0104,9.665345,active-noncovalent
C1CC1Nc2nc(nc(n2)N)N,BRD-K36711084-001-02-0,cyromazine,MicroSource,1505903,CYROMAZINE,-6.331579,x0195,-0.557496,active-noncovalent
C1CC1Nc2nc(nc(n2)N)N,BRD-K36711084-001-01-2,cyromazine,Selleck,S4167,Cyromazine,-6.331579,x0195,-0.557496,active-noncovalent
CC(=O)O[C@@H]1C[C@@H]2[C@](C=CC(=O)C2(C)C)([C@@H]3[C@@]1(C45[C@H](O4)C(=O)O[C@H]([C@@]5(CC3)C)c6ccoc6)C)C,BRD-K02703275-001-07-5,gedunin,Tocris,3387,Gedunin,-6.331065,x0104,4.822803,active-noncovalent
C1C[C@]([C@H]2[C@@H]1[C@@H]2C(=O)[O-])(C(=O)[O-])[NH3+],BRD-K65359424-001-02-1,eglumetad,MedChemEx,HY-18941,LY354740,-6.328829,x0678,-1.195588,active-noncovalent
C1C[C@]([C@H]2[C@@H]1[C@@H]2C(=O)[O-])(C(=O)[O-])[NH3+],BRD-K65359424-001-01-3,eglumetad,EMDBio,504685-10MG,LY 354740,-6.328829,x0678,-1.195588,active-noncovalent
C[C@@H](C[NH+]1CCC(CC1)n2c3ccc(cc3[nH]c2=O)Cl)NC(=O)c4ccc5ccccc5c4,BRD-K48535733-003-02-0,VU0155069,Tocris,3575,VU 0155069,-6.328038,x0072,9.062818,active-noncovalent
C[C@@H](C[NH+]1CCC(CC1)n2c3ccc(cc3[nH]c2=O)Cl)NC(=O)c4ccc5ccccc5c4,BRD-K48535733-003-01-2,VU0155069,Tocris,3575,VU 0155069,-6.328038,x0072,9.062818,active-noncovalent
CN(C)C(=O)C(CC[NH+]1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4,BRD-K61250553-003-32-2,loperamide,MicroSource,2300241,LOPERAMIDE HYDROCHLORIDE,-6.326635,x0874,6.237812,active-noncovalent
CN(C)C(=O)C(CC[NH+]1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4,BRD-K61250553-003-29-8,loperamide,Selleck,S2480,Loperamide HCl,-6.326635,x0874,6.237812,active-noncovalent
CN(C)C(=O)C(CC[NH+]1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4,BRD-K61250553-003-30-6,loperamide,Tocris,840,Loperamide hydrochloride,-6.326635,x0874,6.237812,active-noncovalent
c1ccc(cc1)C(=O)NNC(=O)c2ccc(cc2)CNS(=O)(=O)c3ccc(c(c3)Cl)F,BRD-K09787262-001-02-7,TCN201,Tocris,4154,TCN 201,-6.321129,x1077,6.760864,active-noncovalent
c1ccc(cc1)C(=O)NNC(=O)c2ccc(cc2)CNS(=O)(=O)c3ccc(c(c3)Cl)F,BRD-K09787262-001-01-9,TCN201,Tocris,4154,TCN 201,-6.321129,x1077,6.760864,active-noncovalent
C#CC[C@H](Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-A74914197-001-02-9,pralatrexate,Selleck,S1497,Pralatrexate,-6.320901,x0161,9.643076,active-noncovalent
CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,BRD-K20902145-001-01-2,treosulfan,MedChemEx,HY-16503,Treosulfan,-6.314137,x0678,0.175831,active-noncovalent
CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,BRD-K20902145-001-02-0,treosulfan,MedChemEx,HY-16503,Treosulfan,-6.314137,x0678,0.175831,active-noncovalent
Cc1c(cccc1O)C(=O)N[C@@H](CSc2ccccc2)[C@@H](C[N@@H+]3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,BRD-K74117820-066-10-8,nelfinavir,Enzo,DL566,NELFINAVIR MESYLATE,-6.314024,x0678,9.362102,active-noncovalent
CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)Cc2ccccc2)CC(=O)[O-])CCCNC(=[NH2+])N,BRD-K57252450-001-02-5,cilengitide,Selleck,S7077,Cilengitide,-6.313160,x0678,12.992766,active-noncovalent
Cc1ccc(c(c1)NC(=O)Nc2ccc(cc2)c3cccc4c3c([nH]n4)N)F,BRD-K99749624-001-07-0,linifanib,Selleck,S1003,Linifanib (ABT-869),-6.308022,x1093,6.920532,active-noncovalent
CC(C)C[C@H]([C@H](CSc1cccs1)C(=O)NO)C(=O)N[C@@H](Cc2ccccc2)C(=O)NC,BRD-K82818427-001-04-8,batimastat,Selleck,S7155,Batimastat (BB-94),-6.307945,x0161,4.617013,active-noncovalent
CC(C)C[C@H]([C@H](CSc1cccs1)C(=O)NO)C(=O)N[C@@H](Cc2ccccc2)C(=O)NC,BRD-K82818427-001-02-2,batimastat,Selleck,S7155,Batimastat (BB-94),-6.307945,x0161,4.617013,active-noncovalent
CCC(=O)N1CCN(CC1)c2ccc(cc2C(F)(F)F)n3c(=O)ccc4c3c5cc(ccc5nc4)c6cc7ccccc7nc6,BRD-K40175214-001-13-2,torin-1,Selleck,S2827,Torin 1,-6.306356,x0161,9.416107,active-noncovalent
CCC(=O)N1CCN(CC1)c2ccc(cc2C(F)(F)F)n3c(=O)ccc4c3c5cc(ccc5nc4)c6cc7ccccc7nc6,BRD-K40175214-001-11-6,torin-1,Selleck,S2827,Torin 1,-6.306356,x0161,9.416107,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)[N@]2c3ccc(cc3[C@@]([C@@H]2C(=O)N4CCC[C@H]4C(=O)N)(c5ccccc5Cl)O)Cl,BRD-K96720755-001-02-6,relcovaptan,Tocris,2310,SR 49059,-6.305134,x0678,8.038572,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)[N@]2c3ccc(cc3[C@@]([C@@H]2C(=O)N4CCC[C@H]4C(=O)N)(c5ccccc5Cl)O)Cl,BRD-K96720755-001-03-4,relcovaptan,Tocris,2310,SR 49059,-6.305134,x0678,8.038572,active-noncovalent
Cc1c(n(nc1C(=O)NCc2cccnc2)c3ccc(cc3Cl)Cl)c4ccc(cc4)Cl,BRD-K71315565-001-01-6,MJ-15,Tocris,4063,MJ 15,-6.303871,x0161,6.172039,active-noncovalent
C[C@@H]1CN(C[C@@H](O1)C)c2nc3c(ccc(n3)c4ccc(c(c4)CO)OC)c(n2)N5CCOCC5,BRD-K67566344-001-08-3,ku-0063794,Selleck,S1226,Ku-0063794,-6.301973,x0104,8.929121,active-noncovalent
C[C@@H]1CN(C[C@@H](O1)C)c2nc3c(ccc(n3)c4ccc(c(c4)CO)OC)c(n2)N5CCOCC5,BRD-K67566344-001-07-5,ku-0063794,Selleck,S1226,KU-0063794,-6.301973,x0104,8.929121,active-noncovalent
CC(C)(C)c1cc(n(n1)C)C(=O)N[C@@H](Cc2cccc(c2)Cl)C(=O)NCC#N,BRD-K40269473-001-02-2,cathepsin-inhibitor-1,Selleck,S2847,Cathepsin Inhibitor 1,-6.299233,x1077,3.24539,active-noncovalent
COc1cc(cc(c1)OC)C(=O)NNC(=O)Nc2cccc3c2cccc3,BRD-K54297077-001-01-8,TC-O-9311,Tocris,4255,TC-O 9311,-6.297140,x0874,5.670385,active-noncovalent
Cc1c(c(c(c2c1O[C@@](CC2)(C)CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C,BRD-A39830855-001-01-6,tocofersolan,MedChemEx,HY-B0717,Tocofersolan,-6.295692,x0104,14.890189,active-noncovalent
Cn1cc(cn1)c2cc3c(ccc4ccc(cc4c3=O)NS(=O)(=O)[N@](C)C[C@@H]5COCCO5)nc2,BRD-K56405753-001-02-4,MK-2461,Selleck,S2774,MK-2461,-6.295341,x0161,7.971868,active-noncovalent
CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OCC)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OC,BRD-K55675242-001-02-2,torcetrapib,Tocris,4184,Torcetrapib,-6.290599,x0434,6.889785,active-noncovalent
CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OCC)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OC,BRD-K55675242-001-03-0,torcetrapib,Selleck,S2792,Torcetrapib,-6.290599,x0434,6.889785,active-noncovalent
C(C(=O)[O-])[NH3+],BRD-K72369578-001-04-1,AZD4282,Enzo,AC389,Glycine,-6.288817,x0397,-1.204358,active-noncovalent
CN(CCOP(=O)([O-])[O-])C(=[NH2+])N,BRD-K42991124-001-04-8,creatinol-phosphate,CombiBlocks,QA-2638,2-[[amino(imino)methyl](methyl)amino]ethyl dihydrogen phosphate,-6.288644,x0678,-0.761039,active-noncovalent
CN(CCOP(=O)([O-])[O-])C(=[NH2+])N,BRD-K42991124-001-03-0,creatinol-phosphate,CombiBlocks,QA-2638,,-6.288644,x0678,-0.761039,active-noncovalent
Cc1cc(n(n1)c2cccc(c2)[C@H](CC(=O)[O-])C[N@H+]3CC[C@H](C3)CCc4ccc5c(n4)NCCC5)C,BRD-K88165431-003-01-4,integrin-antagonist-1,MedChemEx,HY-19767A,Integrin Antagonist 1 (hydrochloride),-6.286559,x0195,8.532822,active-noncovalent
CCSC(=[NH2+])N,BRD-K81623406-004-08-3,EIT-hydrobromide,Tocris,873,EIT hydrobromide,-6.284570,x0195,-0.679324,active-noncovalent
CCCCc1[nH+]c(cn1c2ccc(cc2)Oc3ccc(cc3)Cl)c4ccc(cc4)OCCC[NH+](CC)CC,BRD-K51899933-001-02-6,azeliragon,MedChemEx,HY-50682,Azeliragon,-6.280085,x1249,16.313515,active-noncovalent
Cc1cc(cc(c1)NC(=O)Nc2ccc(cc2)OS(=O)(=O)N)C,BRD-K96798615-001-01-4,S4,Tocris,5577,S4,-6.274925,x0161,6.27191,active-noncovalent
CCCCCCCCNC(=O)/C(=C/c1cn(c2c1cccc2)CCC[NH+](C)C)/C#N,BRD-K23479488-001-01-3,dynole-34-2,Tocris,4222,Dynole 34-2,-6.273475,x0161,5.999307,active-noncovalent
C[C@H]1[C@H](O1)P(=O)([O-])[O-],BRD-K81101512-234-01-9,fosfomycin,Selleck,S4385,Fosfomycin Tromethamine,-6.271924,x0397,0.386062,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,BRD-K05531427-001-01-7,briciclib,MedChemEx,HY-16366,Briciclib,-6.271150,x0874,4.890191,active-noncovalent
C1[C@H]([C@H]([C@@H]([C@](O1)(CO)O)O)O)O,BRD-K89588135-001-01-9,tagatose,TCI,F0060,,-6.265881,x0397,1.492321,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([N@@H+]1CCO)CO)O)O)O,BRD-K44779798-001-11-5,miglitol,Selleck,S2589,Miglitol,-6.265810,x0104,1.967342,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([N@@H+]1CCO)CO)O)O)O,BRD-K44779798-001-10-7,miglitol,Tocris,4985,Miglitol,-6.265810,x0104,1.967342,active-noncovalent
CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,BRD-K26134695-001-03-6,calpeptin,Tocris,448,Calpeptin,-6.265189,x0195,3.109439,active-noncovalent
CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,BRD-K26134695-001-04-4,calpeptin,Tocris,448,Calpeptin,-6.265189,x0195,3.109439,active-noncovalent
C[C@@H](C(=O)[O-])[NH3+],BRD-K25125382-001-02-5,L-alanine,Sigma,5130,L-alanine,-6.264976,x0397,-1.295259,active-noncovalent
C[C@@H](C(=O)[O-])[NH3+],BRD-A33317514-001-01-3,alanine,Sigma,V900641,alanine,-6.264976,x0397,-1.295259,active-noncovalent
CC(=O)Nc1ncc(s1)N(=O)=O,BRD-K39467894-001-06-7,nithiamide,Selleck,S4232,Nithiamide,-6.264691,x0195,-0.719063,active-noncovalent
CC(=O)Nc1ncc(s1)N(=O)=O,BRD-K39467894-001-04-2,nithiamide,Selleck,S4232,Nithiamide,-6.264691,x0195,-0.719063,active-noncovalent
CC(=O)Nc1ncc(s1)N(=O)=O,BRD-K39467894-001-05-9,nithiamide,MicroSource,1505448,NITHIAMIDE,-6.264691,x0195,-0.719063,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)O)C,BRD-K95053546-001-02-7,tempol,Acros,17505,,-6.263585,x0678,1.66846,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)O)C,BRD-K95053546-001-03-5,tempol,Selleck,S2910,Tempol (4-Hydroxy-TEMPO),-6.263585,x0678,1.66846,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)O)C,BRD-K95053546-001-01-9,tempol,Selleck,S2910,Tempol,-6.263585,x0678,1.66846,active-noncovalent
Cc1c2ccc(cc2oc(=O)c1Cc3ccnc(c3F)NS(=O)(=O)NC)Oc4ncccn4,BRD-K82804538-001-02-8,Ro-5126766,MedChemEx,HY-18652,Ro 5126766,-6.262840,x0104,6.141362,active-noncovalent
Cc1c2ccc(cc2oc(=O)c1Cc3ccnc(c3F)NS(=O)(=O)NC)Oc4ncccn4,BRD-K82804538-001-03-6,Ro-5126766,MedChemEx,HY-18652,Ro 5126766,-6.262840,x0104,6.141362,active-noncovalent
Cc1c2ccc(cc2oc(=O)c1Cc3ccnc(c3F)NS(=O)(=O)NC)Oc4ncccn4,BRD-K82804538-001-01-0,Ro-5126766,Selleck,S7170,RO5126766 (CH5126766),-6.262840,x0104,6.141362,active-noncovalent
c1ccc(c(c1)[C@@H](C(=O)NC2CC(C2)(F)F)N(c3cc(cnc3)F)C(=O)[C@@H]4CCC(=O)N4c5cc(ccn5)C#N)Cl,BRD-K93073858-001-01-1,ivosidenib,MedChemEx,HY-18767,Ivosidenib,-6.262630,x0072,8.022852,active-noncovalent
C1[C@H](CN(C1=O)CC(=O)N)O,BRD-K50677762-001-01-5,oxiracetam,MedChemEx,HY-17554,(R)-Oxiracetam,-6.261655,x0678,-0.915121,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@]([C@H]2O)(CO)O)CO)O)O)O)O,BRD-K77258318-001-04-6,lactulose,MicroSource,1500363,LACTULOSE,-6.258671,x0397,0.069418,active-noncovalent
C[C@@H](Cn1cnc2c1ncnc2N)OC[P@@](=O)(N[C@H](C)C(=O)OC(C)C)Oc3ccccc3,BRD-A25988899-001-01-6,tenofovir-alafenamide,Selleck,S7856,Tenofovir Alafenamide (GS-7340),-6.257431,x0161,7.294532,active-noncovalent
CC(=O)N[C@@H]1C[C@@H]([C@H](O[C@H]1O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2C(=O)[O-])O)O)O)CO)O,BRD-K59788572-236-01-3,hyaluronic-acid,Sigma,MFCD00875848,"sodium (2S,3S,4R,5R,6R)-3-((2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4,5,6-trihydroxytetra hydro-2H-pyran-2-carboxylate",-6.257191,x0967,1.890009,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccc(cc1)CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3,BRD-K96263742-001-15-5,GW-7647,Tocris,1677,GW 7647,-6.256680,x1077,10.593776,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccc(cc1)CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3,BRD-K96263742-001-14-8,GW-7647,Tocris,1677,GW 7647,-6.256680,x1077,10.593776,active-noncovalent
CC(=O)O[C@H]1C[C@@]2([C@@H](O2)CC[C@]3([C@H](O3)C[C@H]4CC(=O)C(=C)[C@@H]1C4(C)C)C)C,BRD-A51571244-001-01-9,hypoestoxide,EMDBio,401006-1MG,"Hypoestoxide, Hypoestes rosea",-6.256434,x1077,4.43848,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)[O-])C)(C)C(=O)[O-],BRD-A29700858-304-02-6,carbenoxolone,MicroSource,1502005,CARBENOXOLONE SODIUM,-6.254039,x0104,12.567831,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)[O-])C)(C)C(=O)[O-],BRD-A29700858-304-03-4,carbenoxolone,Selleck,S4368,Carbenoxolone Sodium,-6.254039,x0104,12.567831,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)[O-])C)(C)C(=O)[O-],BRD-A29700858-304-01-8,carbenoxolone,Selleck,S4368,Carbenoxolone disodiuM,-6.254039,x0104,12.567831,active-noncovalent
COc1cccc(c1)c2cc(nc(n2)N)NCc3ccc4c(c3)OCO4,BRD-K42624714-001-04-1,BML-284,MedChemEx,HY-19987,BML-284,-6.253788,x0161,3.430127,active-noncovalent
CNC(=O)[C@@H](c1ccccc1)[N@H+]2CCc3cc(c(cc3[C@@H]2CCc4ccc(cc4)C(F)(F)F)OC)OC,BRD-K84810405-003-01-1,almorexant,MedChemEx,HY-10805A,Almorexant (hydrochloride),-6.251147,x0434,7.546526,active-noncovalent
c1(=O)[nH]c(=O)n(c(=O)n1Cl)Cl,BRD-K76375510-237-01-1,troclosene,MicroSource,1506193,TROCLOSENE POTASSIUM,-6.250667,x0678,-1.182786,active-noncovalent
C(/C(=C/C(=O)[O-])/C(=O)[O-])C(=O)[O-],BRD-K71756122-001-02-5,cis-aconitic-acid,Enamine,Z57204893,,-6.250174,x0397,0.495711,active-noncovalent
CCCC[C@@H](CC)CN/C(=[NH+]\C(=[NH2+])NCCCCCC/[NH+]=C(\N)/N/C(=[NH+]/C[C@H](CC)CCCC)/N)/N,BRD-A27883417-300-01-6,alexidine,Selleck,S4302,Alexidine HCl,-6.250127,x0072,10.228508,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,BRD-K40787673-001-02-1,lacitol,MicroSource,1505436,D-LACTITOL MONOHYDRATE,-6.247335,x0161,1.083255,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,BRD-K40787673-001-01-3,lacitol,MicroSource,1301027,LACITOL,-6.247335,x0161,1.083255,active-noncovalent
CCOc1ccccc1n2c(=O)c3ccccc3nc2[C@@H](C)[NH+]4CCN(CC4)C(=O)COc5ccc(cc5)Cl,BRD-A25004090-001-09-2,erastin,Selleck,S7242,Erastin,-6.245820,x0104,12.615198,active-noncovalent
CCOc1ccccc1n2c(=O)c3ccccc3nc2[C@@H](C)[NH+]4CCN(CC4)C(=O)COc5ccc(cc5)Cl,BRD-A25004090-001-08-4,erastin,Selleck,S7242,Erastin,-6.245820,x0104,12.615198,active-noncovalent
Cn1c(ccn1)c2c3ccccc3c(nn2)N4CCC(CC4)N(C)C(=O)c5ccc(cc5C(F)(F)F)F,BRD-K50498985-001-03-3,taladegib,MedChemEx,HY-13242,LY2940680,-6.245088,x0104,11.218395,active-noncovalent
C1CCN(C1)C(=S)S,BRD-K80970344-201-08-6,pyrrolidine-dithiocarbamate,Tocris,727,Pyrrolidinedithiocarbamate ammonium,-6.243721,x0195,-1.756637,active-noncovalent
Cc1c(cc(c(=O)n1c2cccc(c2)C(F)(F)F)C(=O)NCc3ccc(cn3)S(=O)(=O)C)c4ccnn4C,BRD-K31476763-001-01-5,AZD9668,MedChemEx,HY-15651,Alvelestat,-6.242570,x0434,8.373281,active-noncovalent
C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)ON(=O)=O)O,BRD-K82225283-001-03-1,isosorbide-mononitrate,MicroSource,1503807,ISOSORBIDE MONONITRATE,-6.241794,x0195,0.662822,active-noncovalent
CC(=O)OCC[N+](C)(C)C,BRD-K82381502-003-23-1,acetylcholine,Selleck,S1805,Acetylcholine Chloride,-6.241586,x0161,0.079057,active-noncovalent
CC(=O)OCC[N+](C)(C)C,BRD-K82381502-003-24-9,acetylcholine,MicroSource,1500104,ACETYLCHOLINE CHLORIDE,-6.241586,x0161,0.079057,active-noncovalent
CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(cc1)Oc2ccccc2,BRD-K58894520-001-01-1,ONO-4817,Sigma,MFCD09971106,"N-[(1S,3S)-1-[(ethoxymethoxy)methyl]-4-(hydroxyamino)-3-methyl-4-oxobutyl]-4-phenoxybenzamide",-6.240033,x1077,5.77245,active-noncovalent
c1ccc2c(c1)c(ccn2)C(=O)N[C@H]3CCN([C@@H](C3)Cc4ccc(cc4)Cl)C(=O)c5cc(cc(c5)C(F)(F)F)C(F)(F)F,BRD-K96615647-001-01-2,AV-608,MedChemEx,HY-18006,NKP608,-6.237064,x0434,12.339688,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)[O-],BRD-K72222507-003-17-6,quinapril,Selleck,S2581,Quinapril hydrochloride (Accupril),-6.235715,x0107,4.019722,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)[O-],BRD-K72222507-003-16-8,quinapril,MicroSource,1503076,QUINAPRIL HYDROCHLORIDE,-6.235715,x0107,4.019722,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)[O-],BRD-K72222507-003-15-0,quinapril,Selleck,S2581,Quinapril HCl,-6.235715,x0107,4.019722,active-noncovalent
CC(C)(C#Cc1cc2c(cc1NC(=O)C=C)c(ncn2)Nc3ccc(c(c3)Cl)F)[NH+]4CCN(CC4)C,BRD-K23190681-001-01-1,AV-412,MedChemEx,HY-10346A,AV-412 (free base),-6.233950,x0305,14.091053,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-003-33-2,doxorubicin,Selleck,S1208,doxorubicin,-6.232330,x0161,10.236048,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-003-30-8,doxorubicin,Tocris,2252,Doxorubicin hydrochloride,-6.232330,x0161,10.236048,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-001-05-4,doxorubicin,MicroSource,1505483,DOXORUBICIN,-6.232330,x0161,10.236048,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-003-35-7,doxorubicin,Selleck,S1208,Doxorubicin (Adriamycin),-6.232330,x0161,10.236048,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-003-31-6,doxorubicin,Selleck,S1208,Doxorubicin (Adriamycin),-6.232330,x0161,10.236048,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,BRD-K92093830-003-34-0,doxorubicin,Tocris,2252,Doxorubicin hydrochloride,-6.232330,x0161,10.236048,active-noncovalent
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)[C@@H](C(C)C)[NH3+])C,BRD-K33813875-003-01-8,valnemulin,Selleck,S4216,Valnemulin HCl,-6.231472,x1077,9.103285,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)[O-],BRD-K57313110-001-06-8,pidolic-acid,MicroSource,1506185,PIDOLIC ACID,-6.229568,x0397,-0.877371,active-noncovalent
COCc1nnc(n1c2ccc(nc2)OC)N3CC(C3)Oc4ccc(cc4Cl)F,BRD-K31417912-001-01-9,PF-3274167,MedChemEx,HY-15023,PF-3274167,-6.229277,x1077,4.791365,active-noncovalent
CCOC(=O)[C@H](C)Oc1cccc2c1ccn(c2=O)CC(=O)Nc3ccc4c(c3)OCCO4,BRD-A43885598-001-09-9,SID-7969543,Tocris,3440,SID 7969543,-6.225727,x0104,8.354181,active-noncovalent
CCOC(=O)[C@H](C)Oc1cccc2c1ccn(c2=O)CC(=O)Nc3ccc4c(c3)OCCO4,BRD-A43885598-001-08-1,SID-7969543,Tocris,3440,SID 7969543,-6.225727,x0104,8.354181,active-noncovalent
Cc1cc(nc(n1)N)Nc2ccc(cc2)NC(=O)c3ccc(cc3)Nc4ccnc5c4cccc5,BRD-K61228301-001-01-2,SGI-1027,Selleck,S7276,SGI-1027,-6.225705,x0305,18.719467,active-noncovalent
Cc1c(cc(cc1F)C(=O)NC2CC2)c3ccc(cn3)C(=O)NCC(C)(C)C,BRD-K56195681-001-01-0,losmapimod,MedChemEx,HY-10402,Losmapimod,-6.224504,x0874,6.40689,active-noncovalent
c1c(o[nH]c1=O)C[NH3+],BRD-K60441002-001-04-8,muscimol,Tocris,289,Muscimol,-6.222374,x0708,-2.105647,active-covalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)[O-])OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C,BRD-K54907283-001-01-2,AKBA,MedChemEx,HY-N0892,AKBA,-6.219287,x0072,9.241456,active-noncovalent
C[C@@H]1CCC[C@@H]([NH2+]1)C,BRD-A21276153-001-01-1,"2,6-dimethylpiperidine",MicroSource,1301019,NANOFIN,-6.217931,x0354,2.081057,active-noncovalent
Cc1c(c(=O)ccn1C)[O-],BRD-K06878038-001-17-8,deferiprone,Selleck,S4067,Deferiprone,-6.215428,x0195,1.350611,active-noncovalent
Cc1c(c(=O)ccn1C)[O-],BRD-K06878038-001-18-6,deferiprone,MicroSource,1504512,DEFERIPRONE,-6.215428,x0195,1.350611,active-noncovalent
COCC[NH+]1CCC(CC1)(C(=O)NO)S(=O)(=O)c2ccc(cc2)Oc3ccc(cc3)OC(F)(F)F,BRD-K51102532-003-01-8,SD-2590,Tocris,4775,SD 2590 hydrochloride,-6.215165,x0161,9.071182,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)CO,BRD-K59436580-001-01-7,tedizolid,MedChemEx,HY-14855,Tedizolid,-6.214591,x0104,8.43609,active-noncovalent
C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,BRD-K28595280-001-03-7,meglumine,Selleck,S1974,Meglumine,-6.214108,x0195,-0.285502,active-noncovalent
C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,BRD-K28595280-001-04-5,meglumine,MicroSource,1300029,MEGLUMINE,-6.214108,x0195,-0.285502,active-noncovalent
C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,BRD-K28595280-001-05-2,meglumine,Selleck,S1974,Meglumine,-6.214108,x0195,-0.285502,active-noncovalent
CNc1cc2c(cc1F)c(=O)n(c(=O)[nH]2)c3ccc(cc3)NC(=O)NS(=O)(=O)c4ccc(s4)Cl,BRD-K59271229-001-02-3,elinogrel,Tocris,5316,Elinogrel,-6.212714,x0104,16.393463,active-noncovalent
CNc1cc2c(cc1F)c(=O)n(c(=O)[nH]2)c3ccc(cc3)NC(=O)NS(=O)(=O)c4ccc(s4)Cl,BRD-K59271229-001-01-5,elinogrel,Tocris,5316,"3-{4-[({[(5-chloro-2-thienyl)sulfonyl]amino}carbonyl)amino]phenyl}-6-fluoro-7-(methylamino)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline",-6.212714,x0104,16.393463,active-noncovalent
COc1ccc(cc1)C2(CCOCC2)CNC(=O)c3ccc(cc3)NC(=O)c4ccco4,BRD-K53328210-001-04-4,JW-55,Tocris,4514,JW 55,-6.212562,x0104,7.016994,active-noncovalent
C1[C@H](C[NH2+][C@H]1C(=O)[O-])O,BRD-A12454076-001-01-9,L-Hydroxyproline,Enamine,Z56899020,,-6.212473,x0397,-0.98798,active-noncovalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)O,BRD-K75923785-001-02-5,scopine,Selleck,S2545,Scopine,-6.211310,x0354,2.696193,active-noncovalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)O,BRD-K75923785-003-02-1,scopine,Selleck,S2548,Scopine HCl,-6.211310,x0354,2.696193,active-noncovalent
C(CC(=O)[O-])CO,BRD-K82166906-236-02-8,sodium-oxybate,MicroSource,1300038,SODIUM OXYBATE,-6.211149,x0397,-0.759996,active-noncovalent
c1ccc2cc(ccc2c1)S(=O)(=O)N3CCN(CC3)c4ncc(cn4)C(=O)NO,BRD-K86687746-001-01-3,R306465,AdvChemBlocks,A-632,5-pyrimidinecarboxamide-n-hydroxy-2-4-2-naphthalenylsulfonyl-1-piperazinyl,-6.211020,x0831,5.098031,active-covalent
c1c[nH+]ccc1N,BRD-K22482860-001-21-4,dalfampridine,MicroSource,1501130,FAMPRIDINE,-6.206439,x0678,1.499393,active-noncovalent
c1c[nH+]ccc1N,BRD-K22482860-001-20-6,dalfampridine,Tocris,940,4-Aminopyridine,-6.206439,x0678,1.499393,active-noncovalent
c1cc(ccc1c2c(c(nc(c2C#N)SCc3csc(n3)c4ccc(cc4)Cl)N)C#N)OCCO,BRD-K97025174-001-01-4,capadenoson,MedChemEx,HY-14917,Capadenoson,-6.204699,x0967,8.639643,active-noncovalent
c1ccc(cc1)CCCC[P@@](=O)(CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3)[O-],BRD-A33506612-001-01-2,fosinoprilat,AvaChem,2813,"(2S,4S)-4-cyclohexyl-1-{[hydroxy(4-phenylbutyl)phosphoryl]acetyl}-2-pyrrolidinecarboxylic acid",-6.203476,x0195,4.51,active-noncovalent
CN(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,BRD-A55902763-001-01-3,2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose,Labotest,LT00452082,2-deoxy-2-{[(1-methyl-2-oxohydrazino)carbonyl]amino}hexose,-6.202899,x0678,0.663452,active-noncovalent
CCCCC[N@H+](C)CCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K08681769-323-03-7,ibandronate,Selleck,S3148,Ibandronate sodium,-6.202074,x1386,2.322914,active-covalent
CCCCC[N@H+](C)CCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K08681769-323-04-5,ibandronate,MicroSource,1504818,IBANDRONATE SODIUM,-6.202074,x1386,2.322914,active-covalent
CCCCC[N@H+](C)CCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K08681769-323-05-2,ibandronate,Selleck,S3148,Ibandronate sodium,-6.202074,x1386,2.322914,active-covalent
c1cc(ccc1C(=O)[O-])S(=O)(=O)N,BRD-K09295674-001-09-8,carzenide,MicroSource,1504505,CARZENIDE,-6.200413,x1493,-0.81212,active-covalent
CSc1ccccc1Nc2c3c(c(ncn3)NCC4CC4)nc(n2)N5CC[NH2+]CC5,BRD-K84605263-003-01-6,KHK-IN-1,MedChemEx,HY-12841A,KHK-IN-1 (hydrochloride),-6.200347,x0161,6.335861,active-noncovalent
C([C@H]([C@@H](C(=O)CO)O)O)O,BRD-K10759144-001-04-3,xylose,Selleck,S2124,Xylose,-6.198619,x0397,0.072082,active-noncovalent
C([C@H]([C@@H](C(=O)CO)O)O)O,BRD-K10759144-001-03-5,xylose,Selleck,S2124,Xylose,-6.198619,x0397,0.072082,active-noncovalent
C[N+](C)(C)NCCC(=O)[O-],BRD-K79392608-335-01-8,meldonium,LifeChem,F2173-0055,"3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propanoate dihydrate",-6.194065,x0759,-1.659464,active-covalent
CCOC(=O)[C@H](CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@H](c2ccccc2)C(=O)OCC)[NH3+],BRD-K98963219-001-03-8,ezatiostat,MedChemEx,HY-13634A,Ezatiostat,-6.192182,x0072,6.697016,active-noncovalent
CCOC(=O)[C@H](CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@H](c2ccccc2)C(=O)OCC)[NH3+],BRD-K98963219-001-01-2,ezatiostat,MedChemEx,HY-13634A,Ezatiostat,-6.192182,x0072,6.697016,active-noncovalent
CCOC(=O)[C@H](CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@H](c2ccccc2)C(=O)OCC)[NH3+],BRD-K98963219-001-02-0,ezatiostat,MedChemEx,HY-13634A,Ezatiostat,-6.192182,x0072,6.697016,active-noncovalent
C1(C(C(C(C(C1Br)Br)Br)Br)Br)Br,BRD-K06817181-001-02-3,"1,2,3,4,5,6-hexabromocyclohexane",Tocris,2291,"1,2,3,4,5,6-Hexabromocyclohexane",-6.188857,x0195,2.597784,active-noncovalent
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,BRD-K29653726-001-15-9,topiramate,MicroSource,1505801,TOPIRAMATE,-6.187458,x0072,1.496668,active-noncovalent
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,BRD-K29653726-001-16-7,topiramate,Tocris,3620,Topiramate,-6.187458,x0072,1.496668,active-noncovalent
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,BRD-K29653726-001-13-4,topiramate,Selleck,S1438,Topiramate,-6.187458,x0072,1.496668,active-noncovalent
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,BRD-K29653726-001-14-2,topiramate,Tocris,3620,Topiramate,-6.187458,x0072,1.496668,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-])S(=O)(=O)[O-],BRD-K03907181-236-07-6,cefsulodin,MicroSource,1502029,CEFSULODIN SODIUM,-6.186849,x0967,9.105096,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-])S(=O)(=O)[O-],BRD-K03907181-236-06-8,cefsulodin,MedChemEx,HY-13588,Cefsulodin (sodium),-6.186849,x0967,9.105096,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-])S(=O)(=O)[O-],BRD-K03907181-236-05-0,cefsulodin,MedChemEx,HY-13588,Cefsulodin (sodium),-6.186849,x0967,9.105096,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-])S(=O)(=O)[O-],BRD-K03907181-236-04-3,cefsulodin,Sigma,MFCD07793338,"sodium (6R,7R)-3-{[4-(aminocarbonyl)-1-pyridiniumyl]methyl}-8-oxo-7-{[(2R)-2-phenyl-2-sulfonatoethanoyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-6.186849,x0967,9.105096,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)[O-],BRD-K21910317-001-12-3,"2,4-dinitrophenol",MicroSource,330008,"2,4-DINITROPHENOL",-6.177756,x0195,-0.750233,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@@H]3CO[C@](O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl,BRD-A38350138-001-04-9,ketoconazole,MicroSource,1500362,KETOCONAZOLE,-6.177489,x0395,8.061793,active-noncovalent
C(=O)(N)/N=N/C(=O)N,BRD-K87036601-001-02-4,azodicarbonamide,AMS,A001025136,"(E)-1,2-diazenedicarboxamide",-6.175929,x0397,0.367971,active-noncovalent
C(=O)(N)/N=N/C(=O)N,BRD-K87036601-001-01-6,azodicarbonamide,MatrixSci,99173,,-6.175929,x0397,0.367971,active-noncovalent
CC(C)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C,BRD-K43167535-001-01-3,C34,Tocris,5373,C34,-6.174691,x0195,2.184219,active-noncovalent
CCCCc1nc2ccn(c(=O)c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)CC(=O)N(C)C,BRD-K88759641-003-03-6,EMD-66684,Tocris,1849,EMD 66684,-6.174309,x0161,10.380798,active-noncovalent
CCCCc1nc2ccn(c(=O)c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)CC(=O)N(C)C,BRD-K88759641-003-02-8,EMD-66684,Tocris,1849,EMD 66684,-6.174309,x0161,10.380798,active-noncovalent
CC1(CCCC([NH+]1C)(C)C)C,BRD-K71075093-045-14-7,pempidine,MicroSource,1503383,PEMPIDINE TARTRATE,-6.173277,x1418,2.973513,active-covalent
C1C[NH2+]CC=C1C(=O)[O-],BRD-K66480997-003-10-0,isoguvacine,Tocris,235,Isoguvacine hydrochloride,-6.172853,x0426,-1.153825,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,BRD-K01942833-001-01-8,ginsenoside-c-k,MedChemEx,HY-N0904,Ginsenoside C-K,-6.170712,x0072,10.288644,active-noncovalent
CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)c2cccc(c2)NS(=O)(=O)c3ccc(cn3)C(F)(F)F)[O-])CCc4ccccc4,BRD-A10039652-001-01-2,tipranavir,MedChemEx,HY-15148,Tipranavir,-6.170661,x0678,12.801685,active-noncovalent
CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)c2cccc(c2)NS(=O)(=O)c3ccc(cn3)C(F)(F)F)[O-])CCc4ccccc4,BRD-A10039652-001-02-0,tipranavir,MedChemEx,HY-15148,Tipranavir,-6.170661,x0678,12.801685,active-noncovalent
C1[NH+]2CN3CN1CN(C2)C3,BRD-K30114692-001-16-7,methenamine,MicroSource,1500394,METHENAMINE,-6.170158,x0354,-0.878579,active-noncovalent
C1[NH+]2CN3CN1CN(C2)C3,BRD-K30114692-001-15-9,methenamine,Selleck,S3139,Methenamine,-6.170158,x0354,-0.878579,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,BRD-K86301799-001-35-5,dipyridamole,Tocris,691,Dipyridamole,-6.167103,x0161,10.040852,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,BRD-K86301799-001-34-8,dipyridamole,Selleck,S1895,Dipyridamole,-6.167103,x0161,10.040852,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,BRD-K86301799-001-37-1,dipyridamole,Selleck,S1895,Dipyridamole (Persantine),-6.167103,x0161,10.040852,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,BRD-K86301799-001-39-7,dipyridamole,Tocris,691,Dipyridamole,-6.167103,x0161,10.040852,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,BRD-K86301799-001-36-3,dipyridamole,MicroSource,1500259,DIPYRIDAMOLE,-6.167103,x0161,10.040852,active-noncovalent
C(CC(=O)[O-])[C@H](CP(=O)([O-])[O-])C(=O)[O-],BRD-A74387232-001-02-5,PMPA,Tocris,1380,PMPA (NAALADase inhibitor),-6.163751,x1478,0.424676,active-covalent
c1c(c(c(c(c1I)[O-])I)[O-])I,BRD-K48963429-001-02-7,riodoxol,Vitas-M,STK279680,"2,4,6-triiodo-1,3-benzenediol",-6.162321,x0397,0.136751,active-noncovalent
c1c(c(c(c(c1I)[O-])I)[O-])I,BRD-K48963429-001-01-9,riodoxol,Vitas-M,STK279680,,-6.162321,x0397,0.136751,active-noncovalent
CCCCCON=O,BRD-K03326591-001-01-4,amyl-nitrite,Sigma,MFCD00036132,pentyl nitrite,-6.161128,x0195,0.159827,active-noncovalent
C(C(F)(F)F)OCC(F)(F)F,BRD-K14763542-001-03-1,flurothyl,TCI,B1293,"1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane",-6.159462,x0195,0.158772,active-noncovalent
C(C(F)(F)F)OCC(F)(F)F,BRD-K14763542-001-02-3,flurothyl,MicroSource,1505430,FLUROTHYL,-6.159462,x0195,0.158772,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)c2[nH]c(c(n2)c3ccc4c(c3)CC[C@@H]4N=O)c5ccncc5,BRD-K78809024-001-05-7,SB-590885,Selleck,S2220,SB590885,-6.157538,x0107,6.965679,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)c2[nH]c(c(n2)c3ccc4c(c3)CC[C@@H]4N=O)c5ccncc5,BRD-K78809024-001-02-4,SB-590885,Selleck,S2220,SB590885,-6.157538,x0107,6.965679,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)c2[nH]c(c(n2)c3ccc4c(c3)CC[C@@H]4N=O)c5ccncc5,BRD-K78809024-001-03-2,SB-590885,Selleck,SB590885,,-6.157538,x0107,6.965679,active-noncovalent
C([C@@H]([C@@H]1[C@H]([C@H](C(=O)O1)O)O)O)O,BRD-A67265925-236-02-6,sodium-ascorbate,Selleck,S4245,Sodium ascorbate,-6.155290,x0195,1.475943,active-noncovalent
C([C@@H]([C@@H]1[C@H]([C@H](C(=O)O1)O)O)O)O,BRD-A67265925-236-01-8,sodium-ascorbate,Selleck,S4245,Sodium ascorbate,-6.155290,x0195,1.475943,active-noncovalent
C=CCS[S@@](=O)CC=C,BRD-A60402836-001-01-0,allicin,AKSci,P489,,-6.153313,x0195,-0.975572,active-noncovalent
C1[C@H](C(=O)NO1)[NH3+],BRD-K87226815-001-17-1,cycloserine-(d),MicroSource,1500215,CYCLOSERINE (D),-6.152460,x0708,-0.682215,active-covalent
C1[C@H](C(=O)NO1)[NH3+],BRD-K87226815-001-20-5,cycloserine-(d),MedChemEx,HY-B0030,D-Cycloserine,-6.152460,x0708,-0.682215,active-covalent
C1[C@H](C(=O)NO1)[NH3+],BRD-K87226815-001-18-9,cycloserine-(d),Selleck,S1998,D-Cycloserine,-6.152460,x0708,-0.682215,active-covalent
C1[C@H](C(=O)NO1)[NH3+],BRD-K87226815-001-19-7,cycloserine-(d),Selleck,S1998,D-Cycloserine,-6.152460,x0708,-0.682215,active-covalent
C1[C@H](C(=O)NO1)[NH3+],BRD-K87226815-001-21-3,cycloserine-(d),MedChemEx,HY-B0030,D-Cycloserine,-6.152460,x0708,-0.682215,active-covalent
C[C@@H](C(=O)N[C@@H](C)P(=O)([O-])[O-])[NH3+],BRD-K80403280-001-02-1,alafosfalin,Sigma,MFCD01569244,(1R)-1-{[(2S)-2-aminopropanoyl]amino}ethylphosphonic acid,-6.152182,x0397,-0.381822,active-noncovalent
CCCCCCCCOc1ccccc1C(=O)Nc2ccc(cc2)C(=O)OCC[N+](C)(CC)CC,BRD-K85337334-004-02-6,otilonium,Selleck,S3047,Otilonium Bromide,-6.144907,x0104,9.822679,active-noncovalent
CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/c1c(cc(c(c1C)C)OC)C,BRD-K49076555-001-03-1,etretinate,MedChemEx,HY-B0797,"ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate",-6.139826,x0104,6.852928,active-noncovalent
CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/c1c(cc(c(c1C)C)OC)C,BRD-K49076555-001-05-6,etretinate,MedChemEx,HY-B0797,Etretinate,-6.139826,x0104,6.852928,active-noncovalent
CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/c1c(cc(c(c1C)C)OC)C,BRD-K49076555-001-01-5,etretinate,Prestwick,Prestw-1409,Etretinate,-6.139826,x0104,6.852928,active-noncovalent
CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/c1c(cc(c(c1C)C)OC)C,BRD-K49076555-001-04-9,etretinate,MedChemEx,HY-B0797,Etretinate,-6.139826,x0104,6.852928,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)[O-])I,BRD-K99241550-001-03-5,metrizoic-acid,TCI,M1363,,-6.134947,x0104,1.064025,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)[O-])I,BRD-K99241550-001-04-3,metrizoic-acid,Sigma,MFCD00867964,"3-(acetylamino)-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoic acid",-6.134947,x0104,1.064025,active-noncovalent
C1N2CN3CN1C[N+](C2)(C3)CCO,BRD-K09317629-004-01-7,Y-11,Tocris,4498,Y 11,-6.131771,x0734,-0.271533,active-covalent
C1[C@@H](O1)[C@@H]([C@@H]([C@@H]2CO2)O)O,BRD-K68502831-001-01-2,dianhydrogalactitol,MedChemEx,HY-16513,VAL-083,-6.129712,x0397,-0.275352,active-noncovalent
C(CC[NH3+])C[NH3+],BRD-K75282878-300-05-3,putrescine,Sigma,P6024,"1,4-butanediamine dihydrochloride",-6.129576,x0708,-0.63344,active-covalent
CC(C)c1cccc(c1OCC(=O)N2CCN(CC2)c3nc4cc(c(cc4c(n3)N)OC)OC)OC,BRD-K84924479-300-01-1,Rec-15/2615,Tocris,3284,Rec 15/2615 dihydrochloride,-6.129451,x0104,14.830603,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)F,BRD-K24844714-001-25-2,5-fluorouracil,MicroSource,1500305,FLUOROURACIL,-6.128564,x0678,-0.764327,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)F,BRD-K24844714-001-24-5,5-fluorouracil,Selleck,S1209,"Fluorouracil (5-Fluoracil, 5-FU)",-6.128564,x0678,-0.764327,active-noncovalent
c1cc(c(nc1)[N@]2CCC(=CC2)C(=O)Nc3ccc(cc3)S(=O)(=O)C(F)(F)F)C(F)(F)F,BRD-K87665527-001-01-3,A-784168,Tocris,4319,A 784168,-6.127667,x0104,9.947566,active-noncovalent
CCCCCOc1c(ccc2c1[nH]c(=O)c(c2)C(=O)NCc3ccc4c(c3)OCO4)OC,BRD-K63150726-001-03-9,JTE-907,Tocris,2479,JTE 907,-6.124097,x0104,9.327377,active-noncovalent
CCCCCOc1c(ccc2c1[nH]c(=O)c(c2)C(=O)NCc3ccc4c(c3)OCO4)OC,BRD-K63150726-001-02-1,JTE-907,Tocris,2479,JTE 907,-6.124097,x0104,9.327377,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CC[NH3+])O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],BRD-A01603276-001-02-0,amikacin,Selleck,S3122,Amikacin hydrate,-6.121760,x0434,9.889233,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CC[NH3+])O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],BRD-A01603276-001-01-2,amikacin,Selleck,S3122,Amikacin hydrate,-6.121760,x0434,9.889233,active-noncovalent
Cn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)[C@@H](c4ccccc4)OC=O)/C(=O)N3[C@H]2C(=O)[O-],BRD-K17903788-236-03-5,cefamandole-nafate,MicroSource,1502041,CEFAMANDOLE NAFATE,-6.120968,x0387,7.031049,active-noncovalent
Cn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)[C@@H](c4ccccc4)OC=O)/C(=O)N3[C@H]2C(=O)[O-],BRD-K17903788-236-02-7,cefamandole-nafate,MedChemEx,HY-B1166,Cefamandole (nafate),-6.120968,x0387,7.031049,active-noncovalent
Cn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)[C@@H](c4ccccc4)OC=O)/C(=O)N3[C@H]2C(=O)[O-],BRD-K17903788-236-01-9,cefamandole-nafate,MedChemEx,HY-B1166,Cefamandole (nafate),-6.120968,x0387,7.031049,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2ncnc(n2)Nc3ccc(cc3OC)N4CCC(CC4)N5CC[NH+](CC5)C,BRD-K06542892-001-02-7,ASP3026,Tocris,5310,ASP 3026,-6.113815,x0104,15.241507,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2ncnc(n2)Nc3ccc(cc3OC)N4CCC(CC4)N5CC[NH+](CC5)C,BRD-K06542892-001-01-9,ASP3026,MedChemEx,HY-13326,ASP3026,-6.113815,x0104,15.241507,active-noncovalent
C[Si](C)(C)O[Si](C)(C)C,BRD-K26674746-001-01-4,dimethicone,Sigma,MFCD00008265,"1,1,1,3,3,3-hexamethyldisiloxane",-6.111279,x0161,-0.651893,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)[N@@]2CCC[N@](CC2)S(=O)(=O)c3ccc(c(c3)OC)OC,BRD-K45168550-001-01-9,SB-756050,Enamine,Z223304562,,-6.111258,x1077,6.539073,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])n1c(=O)[n-]c(=O)o1,BRD-K92404805-001-07-0,L-Quisqualic-acid,Tocris,188,L-Quisqualic acid,-6.103328,x0195,-0.783679,active-noncovalent
C[C@@H]1C(=O)NC(=O)N1,BRD-K06050544-001-03-1,5-methylhydantoin-(D),Selleck,S4378,Methylhydantoin-5-(D),-6.101764,x0397,-1.113914,active-noncovalent
C[C@@H]1C(=O)NC(=O)N1,BRD-K06050544-001-04-9,5-methylhydantoin-(D),Selleck,S4378,(D)-5-methylhydantoin,-6.101764,x0397,-1.113914,active-noncovalent
c1ccc(c(c1)N)S(=O)(=O)N,BRD-K32681104-001-11-6,2-aminobenzenesulfonamide,Prestwick,Prestw-913,2-Aminobenzenesulfonamide,-6.101264,x0678,0.690118,active-noncovalent
[C@@H]1(C(=O)NC(=O)N1)NC(=O)N,BRD-A96407378-001-15-1,allantoin,MicroSource,1500801,ALLANTOIN,-6.096950,x0397,-0.264776,active-noncovalent
COP(=O)(OC)OC=C(Cl)Cl,BRD-K23779958-001-05-8,dichlorvos,MicroSource,330018,DICHLORVOS,-6.096808,x1311,-0.887044,active-covalent
Cc1c(c(c2ccccc2n1)c3ccc4c5c3nccc5CCO4)[C@@H](C(=O)[O-])OC(C)(C)C,BRD-K53422148-001-01-8,BI-224436,MedChemEx,HY-18595,BI 224436,-6.093194,x0831,3.680474,active-covalent
CNC(=O)c1cc(ccn1)Oc2ccc(c(c2)F)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl,BRD-K16730910-001-07-3,regorafenib,Selleck,S1178,Regorafenib (BAY 73-4506),-6.092853,x0104,10.589393,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cn2)C(C)(C)NC(=O)c3cc4c(cc3F)c(=O)c5ccccc5[nH]4,BRD-K56932272-001-01-1,BMS-566419,Tocris,5492,BMS 566419,-6.091782,x0104,15.297998,active-noncovalent
c1cc(cc(c1)C(F)(F)F)CC(=O)Nc2cc(ccc2F)Oc3ccc4c(c3C#N)sc(n4)NC(=O)C5CC5,BRD-K31866293-001-01-6,TAK-632,Selleck,S7291,TAK-632,-6.088855,x0434,11.370799,active-noncovalent
CC(=O)NCC(=O)N[C@H](CCC(=O)[O-])C(=O)[O-],BRD-K28121004-001-02-9,N-acetylglycyl-D-glutamic-acid,Tocris,395,(2R)-2-{[(acetylamino)acetyl]amino}pentanedioic acid,-6.088543,x0678,-0.049434,active-noncovalent
CC(=O)NCC(=O)N[C@H](CCC(=O)[O-])C(=O)[O-],BRD-K28121004-001-01-1,N-acetylglycyl-D-glutamic-acid,Tocris,395,N-Acetylglycyl-D-glutamic acid,-6.088543,x0678,-0.049434,active-noncovalent
Cc1c(cccc1Cl)S(=O)(=O)Nc2c3c(nc(n2)NCCc4ccccc4)CC[N@H+](C3)Cc5ccccc5,BRD-K35772771-001-01-3,CaMKII-IN-1,MedChemEx,HY-18271,CaMKII-IN-1,-6.087747,x1077,7.045226,active-noncovalent
Cc1c(cccc1Cl)S(=O)(=O)Nc2c3c(nc(n2)NCCc4ccccc4)CC[N@H+](C3)Cc5ccccc5,BRD-K35772771-001-02-1,CaMKII-IN-1,MedChemEx,HY-18271,CaMKII-IN-1,-6.087747,x1077,7.045226,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2ccc(cc2)Cl,BRD-A45869167-001-11-8,sal003,Tocris,3657,Sal 003,-6.086724,x0195,3.897975,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2ccc(cc2)Cl,BRD-A45869167-001-12-6,sal003,Tocris,3657,Sal 003,-6.086724,x0195,3.897975,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2ccc(cc2)Cl,BRD-A45869167-001-10-0,sal003,Selleck,S7437,Sal003,-6.086724,x0195,3.897975,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl)Cl)Cl,BRD-K93814253-001-05-0,lindane,MedChemEx,HY-A0085,Lindane,-6.085452,x0072,3.068994,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl)Cl)Cl,BRD-K93814253-001-06-8,lindane,MedChemEx,HY-A0085,Lindane,-6.085452,x0072,3.068994,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl)Cl)Cl,BRD-K93814253-001-04-3,lindane,MicroSource,330071,LINDANE,-6.085452,x0072,3.068994,active-noncovalent
c1cc(ccc1CN2CC[NH+](CC2)Cc3ccncc3)c4ccc(cc4F)C(C(F)(F)F)(C(F)(F)F)O,BRD-K11641193-001-02-6,SR-2211,Tocris,4869,SR 2211,-6.084247,x0104,12.140878,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)OCCC[NH+]2CCC(CC2)(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-K44309363-003-02-1,dexniguldipine,Tocris,1124,(R)-(-)-Niguldipine hydrochloride,-6.079570,x0104,14.945582,active-noncovalent
C([C@H]1[C@@H]([C@H]([C@@H](C(=O)O1)O)O)O)O,BRD-K04288422-001-04-4,gluconolactone,MicroSource,1503092,GLUCONOLACTONE,-6.077347,x0195,1.739199,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)[O-],BRD-K89348303-001-14-7,ramipril,MicroSource,1505214,RAMIPRIL,-6.076232,x0831,3.411259,active-covalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)[O-],BRD-K89348303-001-16-2,ramipril,Tocris,5250,Ramipril,-6.076232,x0831,3.411259,active-covalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)[O-],BRD-K89348303-001-17-0,ramipril,Selleck,S1793,Ramipril,-6.076232,x0831,3.411259,active-covalent
Cc1cc(ncn1)c2ccc3c(c2)CC[C@H]3[NH+]4CC5(C4)CCN(CC5)C(=O)Cc6cn7cc(sc7[nH+]6)C,BRD-K02554563-001-01-6,PF-05190457,Sigma,PZ0270,,-6.075219,x0395,14.740516,active-noncovalent
c1cc(cc(c1)Oc2ccc(cn2)C(F)(F)F)C=C3CCN(CC3)C(=O)Nc4cccnn4,BRD-K86816506-001-01-8,PF-04457845,MedChemEx,HY-14376,PF-04457845,-6.074865,x0967,6.241827,active-noncovalent
C1CN(C(=O)[C@@H]1[NH3+])O,BRD-K58046914-001-03-8,HA-966-(R)-(+),Tocris,281,(R)-(+)-HA-966,-6.074100,x0195,-0.426737,active-noncovalent
C(CC(=O)NCCO)CO,BRD-K51364817-001-01-4,etoxybamide,Sigma,PH008175,4-hydroxy-N-(2-hydroxyethyl)butanamide,-6.073131,x0195,-0.933686,active-noncovalent
c1cc(cnc1)C(=O)OCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)COC(=O)c4cccnc4,BRD-K11256763-001-01-5,niceritrol,Kemprotec,5/3/68,"3-[(3-pyridinylcarbonyl)oxy]-2,2-bis{[(3-pyridinylcarbonyl)oxy]methyl}propyl nicotinate",-6.072967,x0434,12.644121,active-noncovalent
Cc1cc([nH]n1)Nc2cc(nc(n2)Sc3ccc(cc3)NC(=O)C4CC4)N5CC[NH+](CC5)C,BRD-K59369769-001-20-3,tozasertib,Selleck,S1048,"VX-680 (Tozasertib, MK-0457)",-6.060990,x0072,6.25819,active-noncovalent
Cc1cc([nH]n1)Nc2cc(nc(n2)Sc3ccc(cc3)NC(=O)C4CC4)N5CC[NH+](CC5)C,BRD-K59369769-001-23-7,tozasertib,Selleck,S1048,Tozasertib,-6.060990,x0072,6.25819,active-noncovalent
CCc1nn(c(=O)n1CCOc2ccccc2)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,BRD-K90789829-003-12-4,nefazodone,Tocris,2777,Nefazodone hydrochloride,-6.057721,x0161,5.466818,active-noncovalent
CCc1nn(c(=O)n1CCOc2ccccc2)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,BRD-K90789829-001-07-8,nefazodone,MicroSource,1502314,NEFAZODONE HYDROCHLORIDE,-6.057721,x0161,5.466818,active-noncovalent
C[N@@H+]1CCc2cc(c3cc2[C@H]1Cc4ccc(c(c4)Oc5ccc(cc5)C[C@H]6c7c(cc8c(c7O3)OCO8)CC[N@H+]6C)OC)OC,BRD-K96194081-001-12-8,cepharanthine,Selleck,S4238,Cepharanthine,-6.054167,x0104,11.935081,active-noncovalent
C[N@@H+]1CCc2cc(c3cc2[C@H]1Cc4ccc(c(c4)Oc5ccc(cc5)C[C@H]6c7c(cc8c(c7O3)OCO8)CC[N@H+]6C)OC)OC,BRD-K96194081-001-11-0,cepharanthine,Selleck,S4238,Cepharanthine,-6.054167,x0104,11.935081,active-noncovalent
C[N@@H+]1CCc2cc(c3cc2[C@H]1Cc4ccc(c(c4)Oc5ccc(cc5)C[C@H]6c7c(cc8c(c7O3)OCO8)CC[N@H+]6C)OC)OC,BRD-K96194081-001-10-2,cepharanthine,MicroSource,1505322,CEPHARANTHINE,-6.054167,x0104,11.935081,active-noncovalent
CC1=CC(=O)[N-]S(=O)(=O)O1,BRD-K50850824-237-02-2,acesulfame-potassium,Selleck,S2884,Acesulfame Potassium,-6.053989,x0107,1.419963,active-noncovalent
CC1=CC(=O)[N-]S(=O)(=O)O1,BRD-K50850824-237-04-8,acesulfame-potassium,Selleck,S2884,Acesulfame Potassium,-6.053989,x0107,1.419963,active-noncovalent
CC1=CC(=O)[N-]S(=O)(=O)O1,BRD-K50850824-237-03-0,acesulfame-potassium,MicroSource,1506104,ACESULFAME POTASSIUM,-6.053989,x0107,1.419963,active-noncovalent
Cc1ccc(cc1Nc2ncc(cn2)c3cncnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)C[N@@H+]5CC[C@H](C5)N(C)C,BRD-A75975749-001-01-4,bafetinib,Selleck,S1369,Bafetinib (INNO-406),-6.053698,x0305,17.849171,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)ON(=O)=O)ON(=O)=O,BRD-K55853390-001-12-4,isosorbide-dinitrate,MicroSource,1500358,ISOSORBIDE DINITRATE,-6.053446,x0195,0.351276,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)ON(=O)=O)ON(=O)=O,BRD-K55853390-001-13-2,isosorbide-dinitrate,Enamine,Z2433066075,"(3R,3aS,6S,6aS)-hexahydrofuro[3,2-b]furan-3,6-diyl dinitrate",-6.053446,x0195,0.351276,active-noncovalent
C/C(=C/C(=O)[O-])/O,BRD-K73234506-235-02-1,lithium-acetoacetate,SantaCruz,sc-215253,,-6.053140,x0397,-0.968273,active-noncovalent
CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,BRD-K80653534-001-01-7,N-acetyl-D-glucosamine,Vitas-M,STK801800,,-6.051872,x0161,0.467369,active-noncovalent
CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-],BRD-K13619941-213-01-8,aceglutamide,MicroSource,1502368,ACEGLUTAMIDE,-6.051047,x0678,-0.4277,active-noncovalent
CCC[C@H](c1ccc2c(c1)OCO2)NC(=O)N3[C@H](C(C3=O)(CC)CC)Oc4ccc(cc4)C(=O)N5CC[NH+](CC5)C,BRD-K54936858-001-01-6,DMP-777,MedChemEx,HY-75957,DMP 777,-6.048290,x0104,12.965792,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3cc(c(cc3C[C@H]2C(=O)[O-])OC)OC,BRD-K34441861-003-05-4,moexipril,Selleck,S2079,Moexipril HCl,-6.047195,x0161,6.42961,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3cc(c(cc3C[C@H]2C(=O)[O-])OC)OC,BRD-K34441861-003-07-0,moexipril,Selleck,S2079,Moexipril HCl,-6.047195,x0161,6.42961,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3cc(c(cc3C[C@H]2C(=O)[O-])OC)OC,BRD-K34441861-003-06-2,moexipril,Tocris,2691,Moexipril hydrochloride,-6.047195,x0161,6.42961,active-noncovalent
C(CC(=O)[O-])C(=O)[O-],BRD-K45238818-001-02-6,succinic-acid,Enamine,Z57127453,,-6.045701,x0397,-0.08644,active-noncovalent
C[C@H](c1nnc2n1cc(cc2F)c3cnn(c3)C)n4ccc5c(c4=O)cc(cn5)OCCOC,BRD-K27061362-001-01-6,AMG-337,MedChemEx,HY-18696,AMG-337,-6.044123,x0161,8.062849,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCNC(=O)c4cc5cc(ccc5[nH]4)F,BRD-K61560897-003-01-4,FIPI,Tocris,3600,FIPI,-6.042112,x0434,6.237188,active-noncovalent
C[N+](C)(C)CC(=O)[O-],BRD-K12014493-001-02-2,betaine,MicroSource,1503007,BETAINE HYDROCHLORIDE,-6.036696,x0397,-1.290607,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,BRD-K74724920-001-02-4,sucrose,Sigma,84097,alpha-D-lyxo-hex-5-ulofuranosyl alpha-D-glucopyranoside,-6.036209,x0161,0.634116,active-noncovalent
CC[C@@H]1C(=O)/N=C(/C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)\C(C)C,BRD-K61397605-001-03-4,romidepsin,MedChemEx,HY-15149,Romidepsin,-6.031364,x0678,5.617712,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C,BRD-K21396683-001-04-8,marimastat,MedChemEx,HY-12169,Marimastat,-6.031151,x0195,2.193069,active-noncovalent
C[NH+](CCCl)CCCl,BRD-K12829205-003-05-1,mechlorethamine,MedChemEx,HY-B1253,Chlormethine (hydrochloride),-6.030697,x0104,0.465153,active-noncovalent
C[NH+](CCCl)CCCl,BRD-K12829205-003-02-8,mechlorethamine,Selleck,S4252,Mechlorethamine HCl,-6.030697,x0104,0.465153,active-noncovalent
C[NH+](CCCl)CCCl,BRD-K12829205-003-03-6,mechlorethamine,Selleck,S4252,Mechlorethamine HCl,-6.030697,x0104,0.465153,active-noncovalent
C[NH+](CCCl)CCCl,BRD-K12829205-001-04-8,mechlorethamine,MicroSource,1500375,MECHLORETHAMINE,-6.030697,x0104,0.465153,active-noncovalent
C[NH+](CCCl)CCCl,BRD-K12829205-003-04-4,mechlorethamine,MedChemEx,HY-B1253,Chlormethine (hydrochloride),-6.030697,x0104,0.465153,active-noncovalent
COC(=O)/C=C/C(=O)OC,BRD-K31111078-001-04-2,dimethyl-fumarate,MicroSource,1506154,DIMETHYL FUMARATE,-6.027863,x0749,-0.846561,active-covalent
COC(=O)/C=C/C(=O)OC,BRD-K31111078-001-03-4,dimethyl-fumarate,Selleck,S2586,Dimethyl Fumarate,-6.027863,x0749,-0.846561,active-covalent
COC(=O)/C=C/C(=O)OC,BRD-K31111078-001-05-9,dimethyl-fumarate,Selleck,S2586,Dimethyl Fumarate,-6.027863,x0749,-0.846561,active-covalent
CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C1=O)(C)CC(=O)[O-])c2cccc(c2)Cl)c3ccc(cc3)Cl,BRD-K64925568-001-01-8,AMG-232,MedChemEx,HY-12296,AMG 232,-6.026146,x0678,5.683777,active-noncovalent
Cn1cc(cn1)c2ccc(cc2)S(=O)(=O)n3ccc(c3)/C=C/C(=O)Nc4ccccc4N,BRD-K11773281-075-01-6,4SC-202,MedChemEx,HY-16012,4SC-202,-6.025577,x0161,7.700596,active-noncovalent
Cn1cc(cn1)c2ccc(cc2)S(=O)(=O)n3ccc(c3)/C=C/C(=O)Nc4ccccc4N,BRD-K11773281-075-02-4,4SC-202,Selleck,S7555,4SC-202,-6.025577,x0161,7.700596,active-noncovalent
Cn1cc(cn1)c2ccc(cc2)S(=O)(=O)n3ccc(c3)/C=C/C(=O)Nc4ccccc4N,BRD-K11773281-001-02-0,4SC-202,MedChemEx,HY-16012A,4SC-202 (free base),-6.025577,x0161,7.700596,active-noncovalent
Cn1cc(cn1)c2ccc(cc2)S(=O)(=O)n3ccc(c3)/C=C/C(=O)Nc4ccccc4N,BRD-K11773281-001-01-2,4SC-202,MedChemEx,HY-16012A,4SC-202 (free base),-6.025577,x0161,7.700596,active-noncovalent
CCCC(=O)[O-],BRD-K05878375-236-06-5,sodium-butyrate,Selleck,S1999,Sodium butyrate,-6.025297,x0397,-1.177732,active-noncovalent
CCCC(=O)[O-],BRD-K05878375-236-05-7,sodium-butyrate,Selleck,S1999,Sodium butyrate,-6.025297,x0397,-1.177732,active-noncovalent
CC([N@@H+]([C@H]1C[C@H](C1)CCc2nc3c([nH]2)ccc(c3)C(C)(C)C)C[C@H]4O[C@H]([C@@H]([C@@H]4O)O)n5c6ncnc(c6nc5)N)C,BRD-K26531771-001-02-2,EPZ-5676,Selleck,S7062,EPZ-5676,-6.020384,x0434,8.8292,active-noncovalent
CC([N@@H+]([C@H]1C[C@H](C1)CCc2nc3c([nH]2)ccc(c3)C(C)(C)C)C[C@H]4O[C@H]([C@@H]([C@@H]4O)O)n5c6ncnc(c6nc5)N)C,BRD-K26531771-001-01-4,EPZ-5676,Selleck,S7062,EPZ5676,-6.020384,x0434,8.8292,active-noncovalent
C(=O)([O-])P(=O)([O-])[O-],BRD-K85146014-314-05-4,foscarnet,Selleck,S3076,Foscarnet Sodium,-6.019588,x0397,1.184445,active-noncovalent
C(=O)([O-])P(=O)([O-])[O-],BRD-K85146014-314-06-2,foscarnet,MicroSource,1502019,FOSCARNET SODIUM,-6.019588,x0397,1.184445,active-noncovalent
C(=O)([O-])P(=O)([O-])[O-],BRD-K85146014-314-07-0,foscarnet,Selleck,S3076,Foscarnet Sodium,-6.019588,x0397,1.184445,active-noncovalent
CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@@H]1[C@H](C([C@@H](O1)n2ccc(nc2=O)N)(F)F)O,BRD-K09456915-001-01-2,gemcitabine-elaidate,MedChemEx,HY-13538,Gemcitabine (elaidate),-6.010929,x0305,8.631453,active-noncovalent
CC(C)(C)C[NH2+]Cc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A72591750-066-01-1,omadacycline,MedChemEx,HY-14865A,Omadacycline (mesylate),-6.010816,x0395,6.261561,active-noncovalent
C[C@@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O)O)O)O,BRD-A86354194-002-01-7,L-(+)-Rhamnose-Monohydrate,Selleck,S2317,L-(+)-Rhamnose Monohydrate,-6.010091,x0397,1.870863,active-noncovalent
CCc\1c(c2/cc\3/c(c(c(n3)/cc\4/c(c(c(n4)/cc\5/c(c(c(n5)/cc1\n2)C)C=C)C)CCC(=O)[O-])CCC(=O)[O-])C)C,BRD-K26813314-001-08-5,protoporphyrin-ix,MicroSource,1501111,PROTOPORPHYRIN IX,-6.006186,x0161,12.788814,active-noncovalent
Cc1c(c(on1)C)c2ccc3c(c2)nc(n3C[C@H](C)[NH+]4CCOCC4)CCc5ccc(c(c5)Cl)OC,BRD-K24821794-001-01-4,SGC-CBP30,Selleck,S7256,SGC-CBP30,-6.006063,x1077,6.340674,active-noncovalent
Cc1c(c(on1)C)c2ccc3c(c2)nc(n3C[C@H](C)[NH+]4CCOCC4)CCc5ccc(c(c5)Cl)OC,BRD-K24821794-001-04-8,SGC-CBP30,Tocris,4889,SGC-CBP30,-6.006063,x1077,6.340674,active-noncovalent
CN(C)C(=S)SC(=S)N(C)C,BRD-K36889451-001-01-1,tetramethylthiuram-monosulfide,AKSci,O362,Tetramethylthiuram monosulfide,-6.000518,x0397,-0.684169,active-noncovalent
c1cc(oc1CO)C=O,BRD-K86799112-001-03-8,5-HMF,Sigma,53407,5-(hydroxymethyl)-2-furaldehyde,-5.999448,x0195,0.592262,active-noncovalent
c1cc(oc1CO)C=O,BRD-K86799112-001-02-0,5-HMF,OxChem,AX8022137,,-5.999448,x0195,0.592262,active-noncovalent
c1cc(oc1CO)C=O,BRD-K86799112-001-04-6,5-HMF,Sigma,MFCD00003234,5-(hydroxymethyl)-2-furaldehyde,-5.999448,x0195,0.592262,active-noncovalent
C[C@@H](Cc1ccccc1)Oc2cc(cc(c2)O[C@@H](C)COC)C(=O)Nc3ccc(cn3)C(=O)[O-],BRD-K03827870-001-01-3,GKA-50,Tocris,5133,GKA 50,-5.998562,x1077,9.810345,active-noncovalent
C[C@@H]([C@H](CO)O)Nc1cc(nc(n1)SCc2cccc(c2F)F)NS(=O)(=O)N3CCC3,BRD-K34801930-001-01-9,AZD5069,MedChemEx,HY-13021,SRT3190,-5.998133,x0678,3.56272,active-noncovalent
CC(=C)[C@H]1C[NH2+][C@@H]([C@H]1CC(=O)[O-])C(=O)[O-],BRD-K52459018-001-09-1,kainic-acid,Tocris,222,Kainic acid,-5.996588,x0678,-0.781602,active-noncovalent
C[C@@H](c1c(c(=O)c2cc(ccc2o1)F)c3cccc(c3)F)n4c5c(c(n4)c6ccc(c(c6)F)OC(C)C)c(ncn5)N,BRD-K52579889-001-01-9,TGR-1202,MedChemEx,HY-12279,TGR-1202,-5.995760,x0161,9.675762,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,BRD-K87774949-001-05-4,istradefylline,MedChemEx,HY-10888,Istradefylline,-5.995617,x0104,8.658486,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,BRD-K87774949-001-04-7,istradefylline,Selleck,S2790,Istradefylline (KW-6002),-5.995617,x0104,8.658486,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,BRD-K87774949-001-06-2,istradefylline,MedChemEx,HY-10888,Istradefylline,-5.995617,x0104,8.658486,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,BRD-K87774949-001-03-9,istradefylline,Selleck,S2790,Istradefylline,-5.995617,x0104,8.658486,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,BRD-K87774949-001-07-0,istradefylline,MedChemEx,HY-10888,Istradefylline,-5.995617,x0104,8.658486,active-noncovalent
[C@@H](C(Cl)(Cl)Cl)(NC(=O)N[C@H](C(Cl)(Cl)Cl)O)O,BRD-A41657926-001-03-0,dicloralurea,MicroSource,1503738,DICLORALUREA,-5.995288,x0195,-0.248607,active-noncovalent
CCC[C@@H](c1cccnc1)Nc2c(cnc(n2)c3ccc(c(c3)OC)NC(=O)NCC)C,BRD-K23363278-001-02-1,CYT-997,Selleck,S2195,,-5.988197,x0161,6.714613,active-noncovalent
CCC(C)(C)C(=O)[O-],BRD-K44963273-001-06-9,HQK-1001,Enamine,Z995036360,,-5.987889,x0397,-0.067977,active-noncovalent
CCC(C)(C)C(=O)[O-],BRD-K44963273-001-07-7,HQK-1001,Enamine,Z995036360,"2,2-dimethylbutanoic acid",-5.987889,x0397,-0.067977,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O,BRD-K87424134-001-01-0,alpha-D-glucopyranose,Sigma,MFCD00081554,alpha-D-glucopyranose,-5.986013,x0397,0.890781,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)Cc5ccccc5)OC)OC,BRD-K26818574-305-07-6,BIX-01294,Selleck,S8006,BIX01294,-5.983993,x0104,8.079293,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)Cc5ccccc5)OC)OC,BRD-K26818574-305-08-4,BIX-01294,Tocris,3364,BIX 01294,-5.983993,x0104,8.079293,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)Cc5ccccc5)OC)OC,BRD-K26818574-305-04-3,BIX-01294,Selleck,S8006,BIX 01294,-5.983993,x0104,8.079293,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)Cc5ccccc5)OC)OC,BRD-K26818574-001-06-3,BIX-01294,MedChemEx,HY-10587,BIX-01294,-5.983993,x0104,8.079293,active-noncovalent
C[NH+]1CCN(CC1)CCCOc2cc3c(cc2OC)c(c(cn3)C#N)Nc4cc(c(cc4Cl)Cl)OC,BRD-K99964838-001-11-9,bosutinib,Selleck,S1014,Bosutinib (SKI-606),-5.977585,x0104,10.145185,active-noncovalent
C[NH+]1CCN(CC1)CCCOc2cc3c(cc2OC)c(c(cn3)C#N)Nc4cc(c(cc4Cl)Cl)OC,BRD-K99964838-001-12-7,bosutinib,Tocris,4361,Bosutinib,-5.977585,x0104,10.145185,active-noncovalent
CC(C)(C)N(=Cc1ccc(cc1S(=O)(=O)[O-])S(=O)(=O)[O-])=O,BRD-K46133855-304-02-0,NXY-059,Selleck,S6002,NXY-059,-5.972500,x0830,1.468631,active-covalent
CC(C)(C)N(=Cc1ccc(cc1S(=O)(=O)[O-])S(=O)(=O)[O-])=O,BRD-K46133855-304-03-8,NXY-059,Tocris,3645,NXY 059,-5.972500,x0830,1.468631,active-covalent
c1c([nH]c(=O)[nH]c1=O)C(=O)[O-],BRD-K32572029-001-05-1,orotic-acid,MicroSource,1504525,OROTIC ACID,-5.968839,x0397,-0.103497,active-noncovalent
c1c([nH]c(=O)[nH]c1=O)C(=O)[O-],BRD-K32572029-001-04-4,orotic-acid,Selleck,S2336,Orotic acid (6-Carboxyuracil),-5.968839,x0397,-0.103497,active-noncovalent
CC1([C@]2(C(=O)/C(=C\c3ccc(cc3)/C=C/4\C(=O)[C@@]5(C([C@H]4CC5)(C)C)CS(=O)(=O)[O-])/[C@@H]1CC2)CS(=O)(=O)[O-])C,BRD-A47953250-001-01-7,ecamsule-triethanolamine,MicroSource,1503832,ECAMSULE TRIETHANOLAMINE,-5.963475,x0161,10.183493,active-noncovalent
CC(C)[C@@](CCC[N@@H+](C)CCc1ccc(c(c1)OC)OC)(C#N)c2ccc(c(c2)OC)OC,BRD-A09533288-003-29-6,verapamil,Selleck,S4202,Verapamil HCl,-5.957987,x0434,5.748117,active-noncovalent
CC(C)[C@@](CCC[N@@H+](C)CCc1ccc(c(c1)OC)OC)(C#N)c2ccc(c(c2)OC)OC,BRD-A09533288-003-31-2,verapamil,MicroSource,2300307,VERAPAMIL HYDROCHLORIDE,-5.957987,x0434,5.748117,active-noncovalent
CCNC(=O)C#Cc1ccc2c(c1)[nH]c(c2/C(=N\c3ccc(cc3)C[NH+](C)C)/c4ccccc4)O,BRD-K37492701-001-01-1,BI-847325,Selleck,S7843,BI-847325,-5.956319,x0678,7.631635,active-noncovalent
CCNC(=O)C#Cc1ccc2c(c1)[nH]c(c2/C(=N\c3ccc(cc3)C[NH+](C)C)/c4ccccc4)O,BRD-K37492701-001-02-9,BI-847325,Selleck,S7843,,-5.956319,x0678,7.631635,active-noncovalent
C[C@@H]1CC[C@@H](C[N@@]1c2cc(nc(n2)NC)c3ccc4c(c3)n[nH]c4N)C(=O)NC5CCCCC5,BRD-K70642949-001-04-5,GSK2334470,Tocris,4143,GSK 2334470,-5.955046,x1077,10.819234,active-noncovalent
C[C@@H](C(=O)NCC(=O)[O-])S,BRD-A85295731-001-04-9,tiopronin,Selleck,S2062,Tiopronin (Thiola),-5.948997,x1402,-0.663369,active-covalent
C[C@@H](C(=O)NCC(=O)[O-])S,BRD-A85295731-001-03-1,tiopronin,MicroSource,1506190,TIOPRONIN,-5.948997,x1402,-0.663369,active-covalent
C[C@@H](C(=O)NCC(=O)[O-])S,BRD-A85295731-001-06-4,tiopronin,MedChemEx,HY-B0373,Tiopronin,-5.948997,x1402,-0.663369,active-covalent
C[C@@H](C(=O)NCC(=O)[O-])S,BRD-A85295731-001-05-6,tiopronin,Sigma,MFCD00004861,[(2-sulfanylpropanoyl)amino]acetic acid,-5.948997,x1402,-0.663369,active-covalent
C[C@@H](C(=O)NCC(=O)[O-])S,BRD-A85295731-001-02-3,tiopronin,Selleck,S2062,Tiopronin,-5.948997,x1402,-0.663369,active-covalent
c1c2c(c-3cc(c(=O)c(c3oc2c(c(c1I)[O-])I)I)I)c4c(c(c(c(c4Cl)Cl)Cl)Cl)C(=O)[O-],BRD-K33623053-304-02-5,rose-bengal,SantaCruz,sc-203757,,-5.948451,x0831,5.749134,active-covalent
c1c2c(c-3cc(c(=O)c(c3oc2c(c(c1I)[O-])I)I)I)c4c(c(c(c(c4Cl)Cl)Cl)Cl)C(=O)[O-],BRD-K33623053-304-01-7,rose-bengal,Acros,18945,"Rose Bengal, 85%, pure, high purity, Biological stain",-5.948451,x0831,5.749134,active-covalent
CCCCCC[C@@H]1[C@H]([C@@H](OC(=O)[C@@H]([C@H](OC1=O)C)NC(=O)c2cccc(c2O)NC=O)C)OC(=O)CC(C)C,BRD-A67709388-001-05-4,antimycin-a,Prestwick,Prestw-222,Antimycin A,-5.943910,x0434,8.564847,active-noncovalent
C1C(=O)NCC(=O)N1,BRD-K95941975-001-01-5,piperazinedione,Enamine,Z56854487,"2,5-piperazinedione",-5.934034,x0397,-0.830889,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@@H](CC[NH3+])O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],BRD-A30051119-002-01-8,amikacin,MicroSource,1500111,AMIKACIN HYDRATE,-5.928375,x0397,10.205736,active-noncovalent
c1ccc(cc1)CCCCOc2ccc(cc2)C(=O)Nc3cccc4c3oc(cc4=O)c5[n-]nnn5,BRD-K97045029-001-04-3,pranlukast,Selleck,S1829,Pranlukast,-5.921621,x0161,10.02446,active-noncovalent
c1ccc(cc1)CCCCOc2ccc(cc2)C(=O)Nc3cccc4c3oc(cc4=O)c5[n-]nnn5,BRD-K97045029-001-02-7,pranlukast,MedChemEx,HY-B0290,Pranlukast,-5.921621,x0161,10.02446,active-noncovalent
[C@H](C(OC(F)F)(F)F)(F)Cl,BRD-A51831848-001-01-7,enflurane,Apollo,PC2040,,-5.918174,x0195,1.140914,active-noncovalent
CC[C@H](C)[C@@H](CC)C(=O)N,BRD-A96644976-001-01-5,valnoctamide,Sigma,V4765,2-ethyl-3-methylpentanamide,-5.918057,x0397,0.570011,active-noncovalent
C(/C=C/C(=O)[O-])O,BRD-K91614056-001-02-2,trans-4-Hydroxycrotonic-acid,Tocris,538,trans-4-Hydroxycrotonic acid,-5.915820,x0397,-1.070218,active-noncovalent
Cn1c(=O)cnn(c1=O)CCCC[NH+]2CCN(CC2)c3ncccn3,BRD-K87948281-001-01-9,F-11440,MedChemEx,HY-19946,F 11440,-5.913647,x0967,3.568595,active-noncovalent
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O,BRD-K04548931-003-13-2,epirubicin,MicroSource,1505708,EPIRUBICIN HYDROCHLORIDE,-5.908774,x0072,9.152333,active-noncovalent
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O,BRD-K04548931-003-16-5,epirubicin,Selleck,S1223,Epirubicin HCl,-5.908774,x0072,9.152333,active-noncovalent
c1c[nH]c(=S)[nH]c1=O,BRD-K58819470-001-05-9,2-thiouracil,MicroSource,1503973,2-THIOURACIL,-5.908463,x0678,-0.847148,active-noncovalent
c1c[nH]c(=S)[nH]c1=O,BRD-K58819470-001-04-2,2-thiouracil,Selleck,S3100,2-Thiouracil,-5.908463,x0678,-0.847148,active-noncovalent
CCN(CC)C(=S)S,BRD-K40654626-236-01-5,ditiocarb-sodium-trihydrate,Enamine,Z104495648,,-5.906865,x0195,-0.746354,active-noncovalent
CCN(CC)C(=S)S,BRD-K40654626-236-02-3,ditiocarb-sodium-trihydrate,Enamine,Z104495648,sodium diethyldithiocarbamate,-5.906865,x0195,-0.746354,active-noncovalent
Cc1ccc(cc1C#Cc2c[nH+]c3n2nccc3)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[NH+]5CCN(CC5)C,BRD-K44227013-001-08-0,ponatinib,Selleck,S1490,Ponatinib (AP24534),-5.897119,x0072,15.395288,active-noncovalent
Cc1ccc(cc1C#Cc2c[nH+]c3n2nccc3)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[NH+]5CCN(CC5)C,BRD-K44227013-001-06-4,ponatinib,Selleck,S1490,Ponatinib (AP24534),-5.897119,x0072,15.395288,active-noncovalent
COP(=O)([C@H](C(Cl)(Cl)Cl)O)OC,BRD-A22101059-001-15-5,metrifonate,MedChemEx,HY-B1220,Metrifonate,-5.890461,x0678,-0.09351,active-noncovalent
COP(=O)([C@H](C(Cl)(Cl)Cl)O)OC,BRD-A22101059-001-13-0,metrifonate,MicroSource,1505765,TRICHLORFON,-5.890461,x0678,-0.09351,active-noncovalent
COP(=O)([C@H](C(Cl)(Cl)Cl)O)OC,BRD-A22101059-001-14-8,metrifonate,MedChemEx,HY-B1220,Metrifonate,-5.890461,x0678,-0.09351,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC,BRD-A72603112-236-04-0,thiopental,MicroSource,1900005,THIOPENTAL SODIUM,-5.886500,x0874,0.160966,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC,BRD-A72603112-236-05-7,thiopental,Key,KS-1432,"5-ethyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione",-5.886500,x0874,0.160966,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,BRD-K09602097-001-13-6,forskolin,Tocris,1099,Forskolin,-5.886298,x1077,3.480398,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,BRD-K09602097-001-20-1,forskolin,Tocris,1099,Forskolin,-5.886298,x1077,3.480398,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,BRD-K09602097-001-23-5,forskolin,Selleck,S2449,Forskolin,-5.886298,x1077,3.480398,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,BRD-K72166146-066-06-2,dihydroergotamine,Tocris,475,Dihydroergotamine mesylate,-5.886262,x0434,11.632869,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,BRD-K72166146-066-04-7,dihydroergotamine,Tocris,475,Dihydroergotamine mesylate,-5.886262,x0434,11.632869,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,BRD-K72166146-066-05-4,dihydroergotamine,MicroSource,1500248,DIHYDROERGOTAMINE MESYLATE,-5.886262,x0434,11.632869,active-noncovalent
CO[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2OC,BRD-A17224697-001-01-0,dimethyl-isosorbide,AMS,A000684285,"3,6-dimethoxyhexahydrofuro[3,2-b]furan",-5.885822,x0195,0.049791,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@H]2C[C@H]3[C@](O3)(CCC[C@@H]([C@@H]([C@H](C(=O)C([C@@H](CC(=O)O2)O)(C)C)C)O)C)C,BRD-K68164687-001-01-6,epothilone-b,Selleck,S1364,"Epothilone B (EPO906, Patupilone)",-5.884714,x0161,7.457699,active-noncovalent
C(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K94072573-001-09-9,medronic-acid,Sigma,MFCD00002139,methylenediphosphonic acid,-5.884517,x0397,2.292354,active-noncovalent
C=COCC(F)(F)F,BRD-K56908511-001-02-0,fluroxene,MedChemEx,HY-B1163,Fluroxene,-5.883624,x0195,1.015226,active-noncovalent
C=COCC(F)(F)F,BRD-K56908511-001-01-2,fluroxene,MicroSource,1506162,FLUROXENE,-5.883624,x0195,1.015226,active-noncovalent
CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3NCc4cccc(c4)I)O)O,BRD-K31135544-001-07-0,IB-MECA,Tocris,1066,IB-MECA,-5.881217,x0104,6.283956,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)OC(=O)CC[NH+](C)C,BRD-K19388745-003-01-7,colforsin-daproate,EMDBio,344281-5MG,"Forskolin, NKH477",-5.878110,x1077,5.536201,active-noncovalent
COc1cc(c(c2c1OCO2)c3c(cc(c4c3OCO4)OC)C(=O)OC)C(=O)OC,BRD-K26581543-001-01-6,bifendate,AKSci,H367,,-5.876218,x1093,5.397553,active-noncovalent
c1([nH]c(=O)[nH]c(=O)n1)C(=O)[O-],BRD-K31468676-237-02-6,oxonic-acid,Sigma,MFCD00010565,"potassium 4,6-dihydroxy-1,3,5-triazine-2-carboxylate",-5.875919,x0397,-0.312021,active-noncovalent
c1([nH]c(=O)[nH]c(=O)n1)C(=O)[O-],BRD-K31468676-237-01-8,oxonic-acid,AKSci,H840,,-5.875919,x0397,-0.312021,active-noncovalent
COC(=O)[C@H](CS)[NH3+],BRD-A77473570-003-04-2,mecysteine,MicroSource,1500636,MECYSTEINE HYDROCHLORIDE,-5.873409,x1077,-1.849459,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N(CC(=O)[O-])C2Cc3ccccc3C2,BRD-K00573984-003-01-5,delapril,AKSci,R741,,-5.868373,x0397,6.843447,active-noncovalent
CC[NH2+][C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@@](CO2)(C)O)[NH2+]C)O)O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+],BRD-A59825838-326-01-4,netilmicin,MedChemEx,HY-A0086,Netilmicin (sulfate),-5.867146,x0161,5.26021,active-noncovalent
CC[NH2+][C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@@](CO2)(C)O)[NH2+]C)O)O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+],BRD-A59825838-315-04-1,netilmicin,Selleck,S4052,Netilmicin Sulfate,-5.867146,x0161,5.26021,active-noncovalent
CC[NH2+][C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@@](CO2)(C)O)[NH2+]C)O)O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+],BRD-A59825838-315-02-5,netilmicin,MicroSource,1505482,NETILMICIN SULFATE,-5.867146,x0161,5.26021,active-noncovalent
CC[NH2+][C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@@](CO2)(C)O)[NH2+]C)O)O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+],BRD-A59825838-315-03-3,netilmicin,Selleck,S4052,Netilmicin Sulfate,-5.867146,x0161,5.26021,active-noncovalent
C/C=C/C=C/C(=O)[O-],BRD-K55892330-001-01-8,sorbic-acid,Enamine,Z57127888,,-5.865325,x1402,-1.805277,active-covalent
CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K37949327-001-06-3,etidronic-acid,Selleck,S1857,Etidronate (Didronel),-5.864782,x0397,2.143732,active-noncovalent
CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K37949327-001-07-1,etidronic-acid,Selleck,S1857,Etidronate (Didronel),-5.864782,x0397,2.143732,active-noncovalent
CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],BRD-K37949327-304-06-1,etidronic-acid,MicroSource,1505537,ETIDRONATE DISODIUM,-5.864782,x0397,2.143732,active-noncovalent
C[C@H]1C(=O)NC(=O)N1,BRD-K56033645-001-07-5,5-methylhydantoin-(L),Prestwick,Prestw-860,Methylhydantoin-5-(L),-5.862810,x0397,-0.772721,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,BRD-A84465106-001-08-7,nisoldipine,MedChemEx,HY-17402,Nisoldipine,-5.862644,x0195,2.675113,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,BRD-A84465106-001-06-1,nisoldipine,Selleck,S1748,Nisoldipine,-5.862644,x0195,2.675113,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,BRD-A84465106-001-03-8,nisoldipine,Selleck,S1748,Nisoldipine,-5.862644,x0195,2.675113,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,BRD-A84465106-001-09-5,nisoldipine,MedChemEx,HY-17402,Nisoldipine,-5.862644,x0195,2.675113,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,BRD-A84465106-001-05-3,nisoldipine,MicroSource,1505390,NISOLDIPINE,-5.862644,x0195,2.675113,active-noncovalent
CC(C)(C)CC(=O)Nc1c(cc(cc1F)C(=O)/N=c\2/n(ccs2)COP(=O)([O-])[O-])F,BRD-K83970940-001-01-0,Lu-AA-47070,Tocris,4783,Lu AA 47070,-5.862073,x0161,7.29557,active-noncovalent
C1[C@H]([NH2+]CS1)C(=O)[O-],BRD-A38592941-001-02-7,timonacic,MicroSource,1503320,TIMONACIC,-5.857564,x0397,-1.290276,active-noncovalent
CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](c3ccc(cc3)F)C(F)(F)F,BRD-K36338614-001-01-3,VBY-825,MedChemEx,HY-15958,VBY-825,-5.851007,x0195,8.549653,active-noncovalent
CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](c3ccc(cc3)F)C(F)(F)F,BRD-K36338614-001-02-1,VBY-825,MedChemEx,HY-15958,VBY-825,-5.851007,x0195,8.549653,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-22-3,etoposide,Selleck,S1225,Etoposide,-5.850513,x0305,8.490698,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-25-6,etoposide,MedChemEx,HY-13629,etoposide,-5.850513,x0305,8.490698,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-18-1,etoposide,Selleck,S1225,Etoposide (VP-16);Etoposide,-5.850513,x0305,8.490698,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-21-5,etoposide,Tocris,1226,Etoposide,-5.850513,x0305,8.490698,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-27-2,etoposide,MicroSource,1500903,ETOPOSIDE,-5.850513,x0305,8.490698,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,BRD-K37798499-001-24-9,etoposide,Tocris,1226,Etoposide,-5.850513,x0305,8.490698,active-noncovalent
C=CCNC(=S)N,BRD-K89634775-001-09-9,allylthiourea,MicroSource,1506125,ALLYLTHIOUREA,-5.850431,x1077,-0.796983,active-noncovalent
C=CCNC(=S)N,BRD-K89634775-001-08-1,allylthiourea,Selleck,S4017,Allylthiourea,-5.850431,x1077,-0.796983,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@@H]([C@@H](O1)O)F)O)O)O,BRD-A53037300-001-01-0,2-fluoro-2-deoxy-D-galactose,SantaCruz,sc-220725,,-5.846755,x0397,2.409425,active-noncovalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)C4(C[NH+](C4)C5CCN(CC5)C(=O)c6ccnc(c6F)C(F)(F)F)CC#N,BRD-K67482377-001-01-8,itacitinib,MedChemEx,HY-16997,Itacitinib,-5.845541,x0104,17.759993,active-noncovalent
CC(C)C[N@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)c3ccc(cc3)N,BRD-K47827687-001-02-2,amprenavir,Selleck,S1639,Amprenavir,-5.843825,x1077,7.448068,active-noncovalent
Cc1c(c(=O)n(n1CC(C)(C)O)c2ccccc2)C(=O)Nc3ccc(cn3)Oc4ccnc5c4ccc(c5)OC,BRD-K21782625-001-02-4,AMG458,Selleck,S2747,AMG-458,-5.843764,x0395,14.893829,active-noncovalent
Cc1c(c(=O)n(n1CC(C)(C)O)c2ccccc2)C(=O)Nc3ccc(cn3)Oc4ccnc5c4ccc(c5)OC,BRD-K21782625-001-03-2,AMG458,Selleck,S2747,AMG458,-5.843764,x0395,14.893829,active-noncovalent
CC(C)(CNc1nc(nc(n1)Nc2ccnc(c2)C(F)(F)F)c3cccc(n3)C(F)(F)F)O,BRD-K70601687-001-01-3,enasidenib,MedChemEx,HY-18690,Enasidenib,-5.841792,x0195,5.652153,active-noncovalent
CC[C@H]1C[N@@H+]2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[C@@H]4c5cc(c(cc5CC[NH2+]4)OC)OC)OC)OC,BRD-A25687296-300-04-3,emetine,MicroSource,1500272,EMETINE DIHYDROCHLORIDE,-5.839166,x0104,8.019431,active-noncovalent
C[N@@H+](CCc1ccc(cc1)NS(=O)(=O)C)CCOc2ccc(cc2)NS(=O)(=O)C,BRD-K86887724-001-12-2,dofetilide,Tocris,3757,Dofetilide,-5.833112,x0874,3.451874,active-noncovalent
C[N@@H+](CCc1ccc(cc1)NS(=O)(=O)C)CCOc2ccc(cc2)NS(=O)(=O)C,BRD-K86887724-001-10-6,dofetilide,Selleck,S1658,Dofetilide (Tikosyn),-5.833112,x0874,3.451874,active-noncovalent
C[N@@H+](CCc1ccc(cc1)NS(=O)(=O)C)CCOc2ccc(cc2)NS(=O)(=O)C,BRD-K86887724-001-09-8,dofetilide,Selleck,S1658,Dofetilide,-5.833112,x0874,3.451874,active-noncovalent
CC[C@@H](C)Nc1cc(c(cc1C(=O)N)C)C(=O)NC2C[C@H]3CC[C@@H](C2)N3c4ccc(cn4)C(=O)C5CC5,BRD-A03506276-001-01-5,XL888,Selleck,S7122,XL888,-5.833009,x1093,10.507541,active-noncovalent
C[C@](C(=O)Nc1ccc(cc1Cl)S(=O)(=O)c2ccc(cc2)C(=O)N(C)C)(C(F)(F)F)O,BRD-A87435144-001-01-6,AZD7545,Selleck,S7517,AZD7545,-5.831319,x0072,9.30142,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H](CN(C2=O)C)C(=O)[O-],BRD-K34332569-001-01-3,imidapril,Selleck,S2109,Imidapril HCl,-5.821062,x0749,4.460928,active-covalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)(C)C[N@@H+](C)CCC(c2ccccc2)c3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,BRD-A18992208-003-02-7,lercanidipine,Sigma,MFCD07773089,"3-{2-[(3,3-diphenylpropyl)(methyl)amino]-1,1-dimethylethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride",-5.820556,x0434,12.211259,active-noncovalent
c1csc(n1)N,BRD-K13421763-001-06-2,aminothiazole,MicroSource,1503017,AMINOTHIAZOLE,-5.819404,x0397,-1.438565,active-noncovalent
c1csc(n1)N,BRD-K13421763-001-07-0,aminothiazole,Selleck,S4198,Aminothiazole,-5.819404,x0397,-1.438565,active-noncovalent
c1csc(n1)N,BRD-K13421763-001-05-4,aminothiazole,Selleck,S4198,Aminothiazole,-5.819404,x0397,-1.438565,active-noncovalent
CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)Nc2ccc(cc2OC)C(=O)[O-])c3cccc(c3F)Cl)(C#N)c4ccc(cc4F)Cl,BRD-K62627508-001-01-5,idasanutlin,MedChemEx,HY-15676,RG7388,-5.817652,x0678,8.030433,active-noncovalent
Cc1ccc(c(c1)C(=O)N2C[C@@H](CC[C@H]2C)COc3ccc(cn3)F)c4ncccn4,BRD-K03894385-001-01-1,MK-6096,MedChemEx,HY-15653,MK-6096,-5.816286,x0678,4.364389,active-noncovalent
CCc1cnc(nc1)N2CCC(CC2)c3nc(cs3)COc4ccc(cc4)n5cnnn5,BRD-K32218650-001-01-6,MBX-2982,MedChemEx,HY-15291,MBX-2982,-5.814882,x0967,10.806892,active-noncovalent
C[N+](C)(CCO)CF,BRD-K51199656-003-01-4,fluoromethylcholine,MatrixSci,8941,,-5.814754,x0678,1.044962,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3c(nc(s3)c4ncco4)c5ccccc5)[NH2+]C,BRD-K69351586-001-01-0,CUDC-427,MedChemEx,HY-15835,CUDC-427,-5.810103,x0104,10.341121,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3c(nc(s3)c4ncco4)c5ccccc5)[NH2+]C,BRD-K69351586-001-02-8,CUDC-427,MedChemEx,HY-15835,CUDC-427,-5.810103,x0104,10.341121,active-noncovalent
C[C@@H]1C[NH+](C[C@@H](O1)C)CC(=O)Nc2ccc3c(c2)Cc4cccc(c4S3)c5cc(=O)cc(o5)N6CCOCC6,BRD-K36016295-001-05-2,KU-60019,Selleck,S1570,KU-60019,-5.808309,x0104,11.716086,active-noncovalent
C[C@@H]1C[NH+](C[C@@H](O1)C)CC(=O)Nc2ccc3c(c2)Cc4cccc(c4S3)c5cc(=O)cc(o5)N6CCOCC6,BRD-K36016295-001-04-5,KU-60019,Selleck,S1570,KU-60019,-5.808309,x0104,11.716086,active-noncovalent
C[C@@H]1C[NH+](C[C@@H](O1)C)CC(=O)Nc2ccc3c(c2)Cc4cccc(c4S3)c5cc(=O)cc(o5)N6CCOCC6,BRD-K36016295-001-06-0,KU-60019,Tocris,4176,KU 60019,-5.808309,x0104,11.716086,active-noncovalent
CC(C)C(C)(C)C,BRD-K19427720-001-01-6,triptan,Sigma,92340,"2,2,3-trimethylbutane",-5.802810,x0195,2.082346,active-noncovalent
Cc1c(scn1)CCC2=C(N3[C@@H](/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C3=O)SC2)C(=O)OCOC(=O)C(C)(C)C,BRD-K72167406-001-04-7,cefditoren-pivoxil,MicroSource,1505360,CEFDITORIN PIVOXIL,-5.802316,x0072,8.250792,active-noncovalent
Cc1c(scn1)CCC2=C(N3[C@@H](/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C3=O)SC2)C(=O)OCOC(=O)C(C)(C)C,BRD-K72167406-001-02-1,cefditoren-pivoxil,Selleck,S1768,Cefditoren pivoxil,-5.802316,x0072,8.250792,active-noncovalent
Cc1c(scn1)CCC2=C(N3[C@@H](/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C3=O)SC2)C(=O)OCOC(=O)C(C)(C)C,BRD-K72167406-001-03-9,cefditoren-pivoxil,Selleck,S1768,Cefditoren Pivoxil,-5.802316,x0072,8.250792,active-noncovalent
C1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O,BRD-K97808269-001-02-7,2-deoxyglucose,Enzo,AC1512,2-Deoxyglucose,-5.801751,x0397,1.597066,active-noncovalent
CCN1CCCC1=O,BRD-K08288352-001-03-6,1-ethyl-2-pyrrolidone,CombiBlocks,QA-6551,1-Ethyl-2-pyrrolidone,-5.793274,x0195,-0.803268,active-noncovalent
CNC(=O)c1ccc(cc1)Nc2ncc(c(n2)NCc3c(nccn3)[N@@](C)S(=O)(=O)C)C(F)(F)F,BRD-K43578482-001-01-4,defactinib,MedChemEx,HY-12289,Defactinib,-5.791530,x0161,5.985013,active-noncovalent
CNC(=O)c1ccc(cc1)Nc2ncc(c(n2)NCc3c(nccn3)[N@@](C)S(=O)(=O)C)C(F)(F)F,BRD-K43578482-001-02-2,defactinib,MedChemEx,HY-12289,Defactinib,-5.791530,x0161,5.985013,active-noncovalent
Cc1ccc(cc1OC)C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3c(nc4ccccc4n3)Nc5cc(cc(c5)OC)OC,BRD-K75308783-001-07-0,SAR-245409,Selleck,S1523,SAR245409 (XL765),-5.791416,x0104,15.0582,active-noncovalent
c1c(cc(c2c1CCc3cc(cnc3[C@@H]2C4CCN(CC4)C(=O)CC5CCN(CC5)C(=O)N)Br)Br)Cl,BRD-K41599323-001-02-3,lonafarnib,Selleck,S2797,Lonafarnib,-5.787611,x0434,5.679151,active-noncovalent
CCC[NH+]1CCN(CC1)c2ccc(cc2)C(=O)NC3(CCCCC3)C(=O)NCC#N,BRD-K27204852-001-01-9,balicatib,MedChemEx,HY-15100,Balicatib,-5.784652,x0104,5.972367,active-noncovalent
CCC[NH+]1CCN(CC1)c2ccc(cc2)C(=O)NC3(CCCCC3)C(=O)NCC#N,BRD-K27204852-001-02-7,balicatib,Tocris,5585,Balicatib,-5.784652,x0104,5.972367,active-noncovalent
C[N@H+](CCCN1CCc2cc(c(cc2CC1=O)OC)OC)CCc3ccc(c(c3)OC)OC,BRD-K92446736-003-02-2,zatebradine,Tocris,2202,Zatebradine hydrochloride,-5.770046,x0161,5.580887,active-noncovalent
C[N@H+](CCCN1CCc2cc(c(cc2CC1=O)OC)OC)CCc3ccc(c(c3)OC)OC,BRD-K92446736-001-01-8,zatebradine,MedChemEx,HY-13422A,Zatebradine,-5.770046,x0161,5.580887,active-noncovalent
C[N@H+](CCCN1CCc2cc(c(cc2CC1=O)OC)OC)CCc3ccc(c(c3)OC)OC,BRD-K92446736-003-03-0,zatebradine,MedChemEx,HY-13422,Zatebradine (hydrochloride),-5.770046,x0161,5.580887,active-noncovalent
c1cc(ccc1c2c(ncnc2OCCOc3ncc(cn3)Br)NS(=O)(=O)N)Br,BRD-K34843150-001-03-0,ACT-132577,MedChemEx,HY-15895,ACT-132577,-5.761244,x0830,3.593738,active-covalent
c1cc(ccc1c2c(ncnc2OCCOc3ncc(cn3)Br)NS(=O)(=O)N)Br,BRD-K34843150-001-01-4,ACT-132577,MedChemEx,HY-15895,ACT-132577,-5.761244,x0830,3.593738,active-covalent
c1cc(ccc1c2c(ncnc2OCCOc3ncc(cn3)Br)NS(=O)(=O)N)Br,BRD-K34843150-001-02-2,ACT-132577,MedChemEx,HY-15895,ACT-132577,-5.761244,x0830,3.593738,active-covalent
CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,BRD-K24790130-001-07-1,tricaprylin,MicroSource,1504370,CAPRYILIDENE,-5.758681,x0161,6.884688,active-noncovalent
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5,BRD-K12343256-001-08-9,trametinib,Selleck,S2673,Trametinib (GSK1120212),-5.756244,x0434,9.067148,active-noncovalent
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5,BRD-K12343256-001-18-8,trametinib,Selleck,S2673,Trametinib,-5.756244,x0434,9.067148,active-noncovalent
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5,BRD-K12343256-001-11-3,trametinib,Selleck,S2673,GSK1120212 (Trametinib),-5.756244,x0434,9.067148,active-noncovalent
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5,BRD-K12343256-001-14-7,trametinib,MedChemEx,HY-10999,trametinib,-5.756244,x0434,9.067148,active-noncovalent
C[NH+](C)CCS,BRD-K81645907-001-01-1,captamine,MicroSource,1301014,CAPTAMINE,-5.755614,x0678,0.501535,active-noncovalent
B(c1cccc(c1)COc2ccc(cc2)/C=C\3/C(=O)N(C(=O)S3)Cc4ccc(cc4)F)(O)O,BRD-K64452997-001-01-4,HA-130,Tocris,4196,HA 130,-5.754289,x0072,14.778224,active-noncovalent
c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N,BRD-A11132253-001-08-2,nadide,MicroSource,1500419,NADIDE,-5.750131,x0678,11.142702,active-noncovalent
CC(C)(C)c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O,BRD-A06352418-001-25-9,terfenadine,MicroSource,1503708,TERFENADINE,-5.745995,x0161,10.076937,active-noncovalent
CC(C)(C)c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O,BRD-A06352418-001-24-2,terfenadine,Selleck,S4353,Terfenadine,-5.745995,x0161,10.076937,active-noncovalent
CC(C)(C)c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O,BRD-A06352418-001-27-5,terfenadine,Tocris,3948,Terfenadine,-5.745995,x0161,10.076937,active-noncovalent
C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)[O-])C(=O)[O-])[NH2+]C[C@@H](c3cccc(c3)Cl)O,BRD-K06467130-304-02-7,CL316243,Tocris,1499,"disodium 5-((2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)-1,3-benzodioxole-2,2-dicarboxylate",-5.744147,x0387,5.401624,active-noncovalent
C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-],BRD-K30126819-304-02-7,dimesna,Selleck,S1201,Dimesna,-5.739307,x0749,0.246087,active-covalent
C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-],BRD-K30126819-304-03-5,dimesna,MicroSource,1502283,DIMESNA,-5.739307,x0749,0.246087,active-covalent
C[C@@]1(Cn2cc([nH+]c2O1)N(=O)=O)COc3ccc(cc3)N4CCC(CC4)Oc5ccc(cc5)OC(F)(F)F,BRD-K17480742-001-01-1,delamanid,Adooq,A12864,"(2R)-2-methyl-6-nitro-2-[(4-{4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl}phenoxy)methyl]-2,3-dihydroimidazo[2,1-b][1,3]oxazole",-5.738438,x0305,18.058842,active-noncovalent
c1c[nH]c(=O)[nH]c1=O,BRD-K80129304-001-08-1,uracil,Selleck,S4177,Uracil,-5.734784,x0678,0.52186,active-noncovalent
c1c[nH]c(=O)[nH]c1=O,BRD-K80129304-001-09-9,uracil,MicroSource,1502345,URACIL,-5.734784,x0678,0.52186,active-noncovalent
CC(C)(C)C(=O)CN1c2ccccc2[N@@](C[C@H](C1=O)NC(=O)Nc3cccc(c3)C(=O)[O-])C4CCCCC4,BRD-K17295893-001-01-0,nastorazepide,MedChemEx,HY-17617,Nastorazepide,-5.733604,x1077,8.928677,active-noncovalent
Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,BRD-K71035033-001-08-9,masitinib,Selleck,S1064,Masitinib (AB1010),-5.724760,x0104,14.521437,active-noncovalent
Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,BRD-K71035033-001-07-1,masitinib,Selleck,S1064,Masitinib (AB1010),-5.724760,x0104,14.521437,active-noncovalent
C[NH+](C)C1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4ccccc4P(=O)(C)C)Cl,BRD-K56032964-001-02-1,AP26113,Selleck,S7000,AP26113,-5.720325,x0161,11.458323,active-noncovalent
C[C@@H]1CCN([C@H](C1)C(=O)[O-])C(=O)[C@H](CCC[NH+]=C(N)N)NS(=O)(=O)c2cccc3c2NC[C@@H](C3)C,BRD-A48261811-001-08-1,argatroban,Selleck,S2069,Argatroban,-5.714763,x1093,7.397885,active-noncovalent
C[C@@H]1CCN([C@H](C1)C(=O)[O-])C(=O)[C@H](CCC[NH+]=C(N)N)NS(=O)(=O)c2cccc3c2NC[C@@H](C3)C,BRD-A48261811-001-07-3,argatroban,Tocris,1637,Argatroban,-5.714763,x1093,7.397885,active-noncovalent
C1[C@]([C@@H]2[C@H]([C@@H]2S1(=O)=O)C(=O)[O-])(C(=O)[O-])[NH3+],BRD-K49519144-001-04-6,LY2140023,Selleck,S6001,LY2140023 (LY404039),-5.714149,x1478,-1.001788,active-covalent
C1[C@]([C@@H]2[C@H]([C@@H]2S1(=O)=O)C(=O)[O-])(C(=O)[O-])[NH3+],BRD-K49519144-001-03-8,LY2140023,Selleck,S6001,LY404039,-5.714149,x1478,-1.001788,active-covalent
C([C@H](C([C@H](CO)O)O)O)O,BRD-K49313711-001-05-4,ribitol,Selleck,S2612,Ribitol,-5.703939,x0397,0.403005,active-noncovalent
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)F,BRD-K48443249-001-01-0,CNX-774,Selleck,S7257,CNX-774,-5.703188,x0104,14.203353,active-noncovalent
CC/C=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@H](CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C,BRD-K27515606-003-01-3,cefcapene-pivoxil,Astatech,83157,"(pivaloyloxy)methyl (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)pent-2-enamido)-3-((carbamoyloxy)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride",-5.702405,x0678,8.344298,active-noncovalent
CC/C=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@H](CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C,BRD-K27515606-311-02-8,cefcapene-pivoxil,Sigma,MFCD01682041,"[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride; hydrate",-5.702405,x0678,8.344298,active-noncovalent
CC/C=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@H](CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C,BRD-K27515606-311-01-0,cefcapene-pivoxil,AKSci,Q717,,-5.702405,x0678,8.344298,active-noncovalent
CN(C)c1nc(nc(n1)N(C)C)N(C)C,BRD-K67043667-001-26-4,altretamine,MicroSource,1503065,ALTRETAMINE,-5.702348,x0195,0.87418,active-noncovalent
CN(C)c1nc(nc(n1)N(C)C)N(C)C,BRD-K67043667-001-25-6,altretamine,Selleck,S1278,Altretamine,-5.702348,x0195,0.87418,active-noncovalent
CC(=O)/N=c\1/n(nc(s1)S(=O)(=O)N)C,BRD-K13356952-001-26-9,methazolamide,MicroSource,1503252,METHAZOLAMIDE,-5.699786,x0195,-0.186703,active-noncovalent
CC(=O)/N=c\1/n(nc(s1)S(=O)(=O)N)C,BRD-K13356952-001-27-7,methazolamide,Selleck,S4039,Methazolamide,-5.699786,x0195,-0.186703,active-noncovalent
CC(=O)/N=c\1/n(nc(s1)S(=O)(=O)N)C,BRD-K13356952-001-25-1,methazolamide,Selleck,S4039,Methazolamide,-5.699786,x0195,-0.186703,active-noncovalent
C(NC(=O)N[C@@H]1C(=O)NC(=O)N1CO)NC(=O)N[C@@H]2C(=O)NC(=O)N2CO,BRD-A65444648-001-11-4,imidurea,Prestwick,Prestw-1071,Imidurea,-5.698697,x0874,8.097265,active-noncovalent
C(CO)N(c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I)C(=O)CO,BRD-A65818372-001-05-3,ioversol,MicroSource,1503837,IOVERSOL,-5.697652,x1077,5.773098,active-noncovalent
C[N+]1(CCCC1)C[C@@H]2CS[C@H]3/C(=N\C(=O)/C(=N/OC)/c4csc(n4)N)/C(=O)N3[C@@H]2C(=O)[O-],BRD-A12077521-003-01-5,cefepime,MicroSource,1502420,CEFEPIME HYDROCHLORIDE,-5.694093,x0107,6.73155,active-noncovalent
CC[NH+](CC)CCCCC1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,BRD-K81729199-001-03-6,AQ-RA741,Tocris,2292,AQ-RA 741,-5.690072,x1077,7.455862,active-noncovalent
CC[NH+](CC)CCCCC1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,BRD-K81729199-001-02-8,AQ-RA741,Tocris,2292,AQ-RA 741,-5.690072,x1077,7.455862,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)CCC[NH+]2CCC(CC2)OC(c3ccccc3)c4ccccc4,BRD-K13314656-001-01-0,ebastine,Selleck,S4262,Ebastine,-5.686779,x0104,10.232224,active-noncovalent
C(=[NH2+])(N)N,BRD-K76037122-001-02-5,guanidine,Selleck,S4070,Guanidine HCl,-5.680868,x0104,1.12435,active-noncovalent
C(=[NH2+])(N)N,BRD-K76037122-001-01-7,guanidine,MicroSource,1300022,GUANIDINE HYDROCHLORIDE,-5.680868,x0104,1.12435,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3nc4ccsc4c(n3)Oc5cccc(c5)NC(=O)C=C,BRD-K60421517-001-02-2,olmutinib,MedChemEx,HY-19730,Olmutinib,-5.678802,x0104,6.797501,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3nc4ccsc4c(n3)Oc5cccc(c5)NC(=O)C=C,BRD-K60421517-001-01-4,olmutinib,MedChemEx,HY-19730,Olmutinib,-5.678802,x0104,6.797501,active-noncovalent
C(=O)(C(Cl)(Cl)Cl)[O-],BRD-K42090719-001-07-3,trichloroacetic-acid,Enamine,Z104473288,trichloroacetic acid,-5.678425,x1478,-0.369152,active-covalent
C(=O)(C(Cl)(Cl)Cl)[O-],BRD-K42090719-001-06-5,trichloroacetic-acid,Enamine,Z104473288,,-5.678425,x1478,-0.369152,active-covalent
COc1cc(ccc1O)C[C@@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@H](Cc3ccc(c(c3)OC)O)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,BRD-K77320845-001-01-2,secoisolariciresinol-diglucoside,AvaChem,2539,"(2R,3R)-4-(beta-D-glucopyranosyloxy)-2,3-bis(4-hydroxy-3-methoxybenzyl)butyl beta-D-glucopyranoside",-5.674377,x0104,15.447317,active-noncovalent
Cn1cc(cn1)c2cc3c(ccc4ccc(cc4c3=O)CS(=O)(=O)NCc5ccccn5)nc2,BRD-K55512740-001-01-6,MK-8033,MedChemEx,HY-13299,MK-8033,-5.673971,x0161,11.157153,active-noncovalent
Cc1cc(ccc1CNC(=O)N2CCC[C@H]2C(=S)N3CCC[N@H+](CC3)C)C(=O)N4Cc5cnn(c5Nc6c4cccc6)C,BRD-K55013981-001-01-3,TC-OT-39,Tocris,4625,TC OT 39,-5.673542,x0072,12.984656,active-noncovalent
Cc1ccc(nc1)S(=O)(=O)Nc2c(c(nc(n2)c3ccncc3)OC)Oc4ccccc4OC,BRD-K19203487-001-01-4,SPP301,MedChemEx,HY-15195,Avosentan,-5.672186,x0397,5.73985,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@@](O1)(COP(=O)([O-])[O-])O)O)O)OP(=O)([O-])[O-],BRD-A19086570-314-01-0,fosfructose,SantaCruz,sc-214805,,-5.670793,x1392,1.295433,active-covalent
CC(C)(c1ccccc1CC[C@H](c2cccc(c2)/C=C/c3ccc4ccc(cc4n3)Cl)SCC5(CC5)CC(=O)[O-])O,BRD-K69470111-001-01-2,montelukast,MicroSource,1505391,MONTELUKAST SODIUM,-5.666364,x0104,12.795161,active-noncovalent
CC(C)(c1ccccc1CC[C@H](c2cccc(c2)/C=C/c3ccc4ccc(cc4n3)Cl)SCC5(CC5)CC(=O)[O-])O,BRD-K69470111-236-08-9,montelukast,Selleck,S4211,Montelukast Sodium,-5.666364,x0104,12.795161,active-noncovalent
CC(C)(c1ccccc1CC[C@H](c2cccc(c2)/C=C/c3ccc4ccc(cc4n3)Cl)SCC5(CC5)CC(=O)[O-])O,BRD-K69470111-236-09-7,montelukast,Selleck,S4211,Montelukast Sodium,-5.666364,x0104,12.795161,active-noncovalent
Cc1cc(=O)c(c[nH]1)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],BRD-K92872987-236-03-9,cefpiramide,MedChemEx,HY-B0798,Cefpiramide (sodium),-5.666209,x0434,11.062231,active-noncovalent
Cc1cc(=O)c(c[nH]1)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],BRD-K92872987-001-01-1,cefpiramide,Sigma,MFCD00864893,"(6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methyl-3-pyridinyl)carbonyl]amino}-2-(4-hydroxyphenyl)ethanoyl]amino}-3-{[(1-methyl-1H-tetraazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-car",-5.666209,x0434,11.062231,active-noncovalent
Cc1cc(=O)c(c[nH]1)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],BRD-K92872987-001-02-9,cefpiramide,MicroSource,1503869,CEFPIRAMIDE,-5.666209,x0434,11.062231,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,BRD-K61868322-050-01-7,tenofovir-disoproxil,Selleck,S1400,Tenofovir Disoproxil Fumarate,-5.662706,x0072,9.401819,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,BRD-K61868322-051-06-4,tenofovir-disoproxil,Selleck,S1400,Tenofovir Disoproxil Fumarate,-5.662706,x0072,9.401819,active-noncovalent
C[N+](C)(C)CCO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2ccc(nc2=O)N)O)O,BRD-A91728607-001-01-8,citicoline,TargetMol,T0136,"2-(((((((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium",-5.661891,x0397,4.443691,active-noncovalent
C[N+](C)(C)CCO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2ccc(nc2=O)N)O)O,BRD-A91728607-236-11-9,citicoline,Cayman,14629,,-5.661891,x0397,4.443691,active-noncovalent
C[N+](C)(C)CCO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2ccc(nc2=O)N)O)O,BRD-A91728607-396-01-2,citicoline,MicroSource,1505244,CITICOLINE,-5.661891,x0397,4.443691,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)C,BRD-A18056626-003-22-3,methacholine,MicroSource,1500391,METHACHOLINE CHLORIDE,-5.659296,x0195,0.847942,active-noncovalent
COc1cc(ccc1OCC[NH+]2CCCC2)n3cnc4cc(sc4c3=O)c5ccc(cc5)Cl,BRD-K65576800-001-01-6,GW-803430,Tocris,4242,"6-(4-chlorophenyl)-3-{3-methoxy-4-[2-(1-pyrrolidinyl)ethoxy]phenyl}thieno[3,2-d]pyrimidin-4(3H)-one",-5.657758,x0104,10.31381,active-noncovalent
CN1CCCC1=O,BRD-K52732207-001-01-9,N-methylpyrrolidone,Sigma,V001494,1-methyl-2-pyrrolidinone,-5.654041,x0678,-0.711176,active-noncovalent
C(C#N)C(=O)NN,BRD-K39371216-001-01-3,cyacetacide,MicroSource,1502372,CYACETACIDE,-5.650732,x0195,-1.279936,active-noncovalent
C(C(=O)C(=O)[O-])Br,BRD-K92980438-001-05-8,3-bromopyruvate,MedChemEx,HY-19992,3-Bromopyruvic acid,-5.647339,x0397,-0.788671,active-noncovalent
C(C(=O)C(=O)[O-])Br,BRD-K92980438-001-03-3,3-bromopyruvate,Enamine,EN300-67360,,-5.647339,x0397,-0.788671,active-noncovalent
C(C(=O)C(=O)[O-])Br,BRD-K92980438-001-04-1,3-bromopyruvate,MedChemEx,HY-19992,3-Bromopyruvic acid,-5.647339,x0397,-0.788671,active-noncovalent
CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2nc(nc3NCc4cccc(c4)I)Cl)O)O,BRD-K52396582-001-06-7,CF102,Tocris,1104,2-Cl-IB-MECA,-5.646518,x0104,7.550439,active-noncovalent
C[NH+](C)CCCC(=O)Nc1ccc(cc1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,BRD-K02135007-001-01-8,THZ1-R,MedChemEx,HY-19988,THZ1-R,-5.643341,x0104,14.501166,active-noncovalent
Cc1[nH]ccn1,BRD-K68534611-001-07-8,2-methylimidazole,Sigma,Y0001320,2-methyl-1H-imidazole,-5.640254,x0195,-1.596818,active-noncovalent
COC(C(Cl)Cl)(F)F,BRD-K06152156-001-02-6,methoxyflurane,Sigma,MFCD00040144,"2,2-dichloro-1,1-difluoro-1-methoxyethane",-5.638490,x0195,1.265227,active-noncovalent
COC(C(Cl)Cl)(F)F,BRD-K06152156-001-01-8,methoxyflurane,MatrixSci,8896,,-5.638490,x0195,1.265227,active-noncovalent
CO/N=C(/c1nc(sn1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Cn4cc[n+]5c4cccn5)C(=O)[O-],BRD-K46970505-003-01-9,cefozopran,MedChemEx,HY-B0771A,Cefozopran (hydrochloride),-5.637285,x1077,6.013709,active-noncovalent
Cn1c2ccc(cc2nc1CNc3ccc(cc3)C(=[NH2+])N)C(=O)N(CCC(=O)[O-])c4ccccn4,BRD-K38168441-001-05-2,dabigatran,MedChemEx,HY-10163,Dabigatran,-5.636972,x0104,8.341557,active-noncovalent
Cn1c2ccc(cc2nc1CNc3ccc(cc3)C(=[NH2+])N)C(=O)N(CCC(=O)[O-])c4ccccn4,BRD-K38168441-001-04-5,dabigatran,MedChemEx,HY-10163,Dabigatran,-5.636972,x0104,8.341557,active-noncovalent
Cn1c2ccc(cc2nc1CNc3ccc(cc3)C(=[NH2+])N)C(=O)N(CCC(=O)[O-])c4ccccn4,BRD-K38168441-001-02-9,dabigatran,Selleck,S2196,"BIBR 953 (Dabigatran etexilate, Pradaxa)",-5.636972,x0104,8.341557,active-noncovalent
Cn1c2ccc(cc2nc1CNc3ccc(cc3)C(=[NH2+])N)C(=O)N(CCC(=O)[O-])c4ccccn4,BRD-K38168441-001-03-7,dabigatran,Selleck,S2196,"BIBR 953 (Dabigatran etexilate, Pradaxa)",-5.636972,x0104,8.341557,active-noncovalent
CNC(=O)N(C)N=O,BRD-K08927448-001-01-9,nitrosodimethylurea,Enamine,Z2306534399,1-methyl-1-[(methylamino)carbonyl]-2-oxohydrazine,-5.633204,x0397,-0.606594,active-noncovalent
Cc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C4CCCC4)c5ccc(cc5)C[NH+]6CCOCC6)C,BRD-K57754230-001-02-7,EPZ005687,Selleck,S7004,EPZ005687,-5.629704,x0104,9.958644,active-noncovalent
[C@@H](C(F)(F)F)(Cl)Br,BRD-A20550616-001-02-9,halothane,MicroSource,1505434,HALOTHANE,-5.628587,x0678,2.099345,active-noncovalent
[C@@H](C(F)(F)F)(Cl)Br,BRD-A20550616-001-03-7,halothane,MedChemEx,HY-B1010,Halothane,-5.628587,x0678,2.099345,active-noncovalent
Cc1nnc(s1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cn4cnnn4)/C(=O)N3[C@H]2C(=O)[O-],BRD-K99750640-236-19-5,cefazolin,MedChemEx,HY-B1078,Cefazolin (sodium),-5.628471,x0072,6.958273,active-noncovalent
Cc1nnc(s1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cn4cnnn4)/C(=O)N3[C@H]2C(=O)[O-],BRD-K99750640-236-20-3,cefazolin,MedChemEx,HY-B1078,Cefazolin (sodium),-5.628471,x0072,6.958273,active-noncovalent
Cc1nnc(s1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cn4cnnn4)/C(=O)N3[C@H]2C(=O)[O-],BRD-K99750640-236-18-7,cefazolin,MicroSource,1500164,CEFAZOLIN SODIUM,-5.628471,x0072,6.958273,active-noncovalent
CCCCCCCCCCCCCCCCNc1ccc(cc1)C(=O)[O-],BRD-K86954340-001-01-7,cetaben,Adooq,A11137,4-(hexadecylamino)benzoic acid,-5.628390,x0395,9.531787,active-noncovalent
c1(=O)n(c(=O)n(c(=O)n1Cl)Cl)Cl,BRD-K33642804-001-01-1,symclosene,MicroSource,1506189,SYMCLOSENE,-5.627815,x0195,0.0802,active-noncovalent
Cc1ccccc1S(=O)(=O)NC(=O)c2ccc(c(c2)OC)Cc3cn(c4c3cc(cc4)NC(=O)OC5CCCC5)C,BRD-K71289571-001-11-4,zafirlukast,Selleck,S1633,Zafirlukast,-5.621678,x0104,14.563928,active-noncovalent
CN(C)C(=O)CCS[C@@H](c1cccc(c1)/C=C/c2ccc3ccc(cc3n2)Cl)SCCC(=O)[O-],BRD-A73679382-236-01-8,MK-571,MedChemEx,HY-19989A,MK-571 (sodium salt),-5.610676,x0395,8.17347,active-noncovalent
Cc1ccc(cn1)Oc2ccc(cc2C)Nc3c4cc(ccc4ncn3)/C=C/CNC(=O)COC,BRD-K76908866-001-07-6,CP-724714,Selleck,S1167,CP-724714,-5.607467,x0072,12.245624,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)NC(=O)C)I)C(=O)[O-])I,BRD-K48247567-001-01-9,diatrizoic-acid,MicroSource,1505777,DIATRIZOIC ACID,-5.603374,x0195,1.022403,active-noncovalent
CN(C)c1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](Cc4ccc(cc4)OC)[NH3+])O,BRD-A28970875-300-04-9,puromycin,MicroSource,1501105,PUROMYCIN DIHYDROCHLORIDE,-5.601845,x0387,7.120242,active-noncovalent
CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,BRD-K38287497-001-01-2,narlaprevir,MedChemEx,HY-10300,Narlaprevir,-5.600502,x0395,19.616932,active-noncovalent
Cc1c(cccc1NC(=O)C)Nc2ncnc(n2)N3CCC(CC3)OCc4ccc(cc4)OC(F)(F)F,BRD-K78161388-001-01-2,TC-N-1752,Tocris,4435,TC-N 1752,-5.599213,x0104,14.961386,active-noncovalent
C([C@H](C(=O)[O-])NC(=O)CP(=O)([O-])[O-])C(=O)[O-],BRD-A81539525-433-01-5,sparfosate,AMS,A001089261,lithium (2-phosphonatoacetyl)aspartate,-5.590744,x0734,0.652169,active-covalent
Cc1c(c(ncn1)C)C(=O)N2CCC(CC2)(C)[N@H+]3CC[N@@]([C@H](C3)C)[C@@H](COC)c4ccc(cc4)C(F)(F)F,BRD-K84748119-050-01-1,vicriviroc,MedChemEx,HY-17377,Vicriviroc (maleate),-5.589211,x0104,14.667574,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)C(=O)[O-])I)C(=O)NC)I,BRD-K98250023-001-01-0,iothalamic-acid-d3,Toronto,I736202,Iothalamic Acid-d3,-5.586296,x0967,0.840239,active-noncovalent
C(CSCCO)O,BRD-K54521836-001-02-1,thiodiglycol,MicroSource,1503325,THIODIGLYCOL,-5.582596,x0195,0.404234,active-noncovalent
CCC(=O)O[C@H](C(C)C)O[P@@](=O)(CCCCc1ccccc1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3,BRD-A51382177-236-04-8,fosinopril,Selleck,S2095,Fosinopril sodium (Monopril),-5.570315,x0678,7.501105,active-noncovalent
CCC(=O)O[C@H](C(C)C)O[P@@](=O)(CCCCc1ccccc1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3,BRD-A51382177-236-03-0,fosinopril,Selleck,S2095,Fosinopril sodium (Monopril),-5.570315,x0678,7.501105,active-noncovalent
Cc1c(ccc(n1)S(=O)(=O)C)Nc2c(c(ncn2)OC3CCN(CC3)C(=O)OC(C)C)OC,BRD-K86226872-001-01-6,APD597,MedChemEx,HY-15566,APD597,-5.565404,x0104,13.815508,active-noncovalent
CCCN(CCC)C(=O)C1=Cc2ccc(cc2[NH+]=C(C1)N)c3ccc(cc3)C(=O)N4CCCC4,BRD-K11785681-001-01-2,motolimod,MedChemEx,HY-13773,Motolimod,-5.565011,x0104,11.222723,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@@H](c4ccc(cc4)O)C(=O)[O-])OC)OC2)C(=O)[O-],BRD-K40831222-304-06-2,moxalactam,MedChemEx,HY-B1484,Moxalactam (sodium salt),-5.560779,x0387,8.333063,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@@H](c4ccc(cc4)O)C(=O)[O-])OC)OC2)C(=O)[O-],BRD-K40831222-304-04-7,moxalactam,Selleck,S4340,Moxalactam Disodium,-5.560779,x0387,8.333063,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@@H](c4ccc(cc4)O)C(=O)[O-])OC)OC2)C(=O)[O-],BRD-K40831222-304-05-4,moxalactam,Selleck,S4340,moxalactam disodium,-5.560779,x0387,8.333063,active-noncovalent
c1cnc([nH]1)N(=O)=O,BRD-K26824830-001-02-0,azomycin-(2-nitroimidazole),Selleck,S2267,Azomycin,-5.558534,x0195,-1.331164,active-noncovalent
c1cnc([nH]1)N(=O)=O,BRD-K26824830-001-03-8,azomycin-(2-nitroimidazole),Selleck,S2267,Azomycin (2-Nitroimidazole),-5.558534,x0195,-1.331164,active-noncovalent
COC1[C@@H]([C@H](C([C@@H]([C@@H]1O)O)O)O)O,BRD-A69275535-001-01-5,pinitol,InterBioScreen,STOCK1N-00601,,-5.556323,x0354,1.841598,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@H]([C@H](O2)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O,BRD-A29125379-314-01-7,INS316,Enzo,AC998,Uridine-5'-triphosphate Na,-5.550751,x0397,3.675505,active-noncovalent
CCOc1c2ccccc2c(c3c1CN(C3=O)c4ccc(cc4)CC(=O)NS(=O)(=O)c5ccccc5)OCC,BRD-K50005760-001-01-1,GW-627368,Tocris,4668,GW 627368,-5.549321,x1077,9.610855,active-noncovalent
c1nnc(s1)N,BRD-K94837153-001-01-0,aminothiadiazole,Vitas-M,STK398099,,-5.542072,x0397,-0.798767,active-noncovalent
c1nnc(s1)N,BRD-K94837153-001-02-8,aminothiadiazole,Enamine,EN300-17228,"1,3,4-thiadiazol-2-amine",-5.542072,x0397,-0.798767,active-noncovalent
CC(=CCOc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)[O-])OCC=C(C)C)C,BRD-K01039503-001-01-2,sofalcone,Cayman,11882,,-5.541036,x0395,9.802168,active-noncovalent
CC(C)(CC(=O)[O-])O,BRD-M02899238-238-01-6,beta-hydroxy-beta-methylbutyrate,CombiBlocks,QC-1944,calcium bis(3-hydroxy-3-methylbutanoate),-5.539313,x0107,-0.311703,active-noncovalent
CC(=O)Nc1nnc(s1)S(=O)(=O)N,BRD-K43457670-001-27-8,acetazolamide,MicroSource,1500102,ACETAZOLAMIDE,-5.539082,x0195,-0.839371,active-noncovalent
CN([C@@H](C[NH+]1CCCC1)c2ccc(cc2)c3cccc(c3)C(=O)N)C(=O)CN4c5cc(c(cc5OCC4=O)Cl)Cl,BRD-K36697397-003-01-1,GSK-1562590,Tocris,5110,GSK 1562590 hydrochloride,-5.538746,x0072,10.133482,active-noncovalent
CC/C(=C/[C@H](C)CC/C=C(\C)/C=C(\C)/C(=O)[C@H](C)[C@H]([C@H](C)C/C(=C/C(=O)[O-])/C)O)/C=C/[C@@H]1[C@H](C=CC(=O)O1)C,BRD-K63876426-001-01-6,elactocin,EMDBio,431050-5UG,"InSolution Leptomycin B, Streptomyces sp.",-5.538477,x0434,6.818971,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)OC[C@@H]3CO[C@@](O3)(Cn4cncn4)c5ccc(cc5Cl)Cl,BRD-K07400595-001-02-7,terconazole,Kemprotec,67915-31-5,"1-(4-(((2S,4R)-2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-isopropylpiperazine",-5.535218,x0072,12.400144,active-noncovalent
c1cc(c(nc1)N2CCN(CC2)C(=O)Nc3ccc(cn3)C(F)(F)F)C(F)(F)F,BRD-K51770398-001-02-7,JNJ-17203212,Tocris,3361,JNJ 17203212,-5.534068,x1077,8.632743,active-noncovalent
c1cc(c(nc1)N2CCN(CC2)C(=O)Nc3ccc(cn3)C(F)(F)F)C(F)(F)F,BRD-K51770398-001-01-9,JNJ-17203212,Tocris,3361,JNJ 17203212,-5.534068,x1077,8.632743,active-noncovalent
CCC(CC)(C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)NC1(CCCC1)C(=O)NC(c2ccc(cc2)F)c3ccc(cc3)F)NC(=O)C(C)C,BRD-K68474068-001-01-8,MM-102,Selleck,S7265,MM-102,-5.533144,x0072,17.291231,active-noncovalent
C(P(=O)([O-])[O-])(P(=O)([O-])[O-])(Cl)Cl,BRD-K72542090-304-02-4,clodronic-acid,Selleck,S4108,Clodronate Disodium,-5.513465,x0397,2.661488,active-noncovalent
C(P(=O)([O-])[O-])(P(=O)([O-])[O-])(Cl)Cl,BRD-K72542090-304-03-2,clodronic-acid,Selleck,S4108,Clodronate Disodium,-5.513465,x0397,2.661488,active-noncovalent
CCCSc1nc(c2c(n1)n(nn2)[C@@H]3C[C@@H]([C@@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@@H]4c5ccc(c(c5)F)F,BRD-K44974079-001-01-3,ticagrelor,Selleck,S4079,Ticagrelor,-5.513294,x0434,10.333918,active-noncovalent
C(C(CO)(N(=O)=O)Br)O,BRD-K33457401-001-01-1,bronopol,MicroSource,1503732,BRONOPOL,-5.511801,x0678,1.815495,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)OCc6c(oc(=O)o6)C,BRD-K25723200-237-01-9,azilsartan-medoxomil,MicroSource,1504108,AZILSARTAN MEDOXOMIL,-5.507347,x0967,10.662064,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)OCc6c(oc(=O)o6)C,BRD-K25723200-001-02-7,azilsartan-medoxomil,Selleck,S3057,Azilsartan Medoxomil,-5.507347,x0967,10.662064,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)OCc6c(oc(=O)o6)C,BRD-K25723200-001-03-5,azilsartan-medoxomil,Selleck,S3057,Azilsartan Medoxomil (TAK-491),-5.507347,x0967,10.662064,active-noncovalent
COc1cccc(c1c2cc(nn2c3ccnc4c3ccc(c4)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)[O-])OC,BRD-K25075681-001-02-0,meclinertant,Sigma,S____SML0278,"2-({[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)-2-adamantanecarboxylic acid",-5.507149,x0678,10.668277,active-noncovalent
CO/N=C(\c1csc(n1)N)/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4cccc5c4CCC5)C(=O)[O-],BRD-K56542719-065-01-4,cefpirome,ChemImpex,15154,,-5.504015,x0874,7.893802,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CN([C@H]3CCCc4c3cccc4)C(=O)c5cc(c(cc5C(=O)[O-])C(=O)[O-])C(=O)[O-],BRD-K38019854-323-01-4,A-317491,MedChemEx,HY-15568A,A-317491 (sodium salt hydrate),-5.503983,x1093,8.802188,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CN([C@H]3CCCc4c3cccc4)C(=O)c5cc(c(cc5C(=O)[O-])C(=O)[O-])C(=O)[O-],BRD-K38019854-001-01-6,A-317491,MedChemEx,HY-15568,A-317491,-5.503983,x1093,8.802188,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CC[NH3+])O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],BRD-K88043978-315-02-8,amikacin,Selleck,S3065,Amikacin sulfate,-5.502557,x1077,10.661568,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CC[NH3+])O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],BRD-K88043978-315-03-6,amikacin,Selleck,S3065,Amikacin sulfate,-5.502557,x1077,10.661568,active-noncovalent
c1ccc(c(c1)CC(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSc4nnnn4CC(=O)[O-])C(=O)[O-])C[NH3+],BRD-K37848908-001-05-6,ceforanide,AvaChem,2438,"(6R,7R)-7-({[2-(aminomethyl)phenyl]acetyl}amino)-3-({[1-(carboxymethyl)-1H-tetraazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",-5.496529,x0161,10.649683,active-noncovalent
c1ccc(c(c1)CC(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSc4nnnn4CC(=O)[O-])C(=O)[O-])C[NH3+],BRD-K37848908-001-06-4,ceforanide,MicroSource,1502423,CEFORANIDE,-5.496529,x0161,10.649683,active-noncovalent
C[C@H](CC(C)(C)O)O,BRD-A14234430-001-01-4,hexylene-glycol,MicroSource,1506161,HEXYLENE GLYCOL,-5.492071,x0397,1.333003,active-noncovalent
C1C(CN1C(=O)CBr)(N(=O)=O)N(=O)=O,BRD-K06894065-001-01-5,RRx-001,MedChemEx,HY-16438,RRx-001,-5.483812,x0678,1.652833,active-noncovalent
C1C(CN1C(=O)CBr)(N(=O)=O)N(=O)=O,BRD-K06894065-001-02-3,RRx-001,MedChemEx,HY-16438,RRx-001,-5.483812,x0678,1.652833,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)Nc5ccccc5P(=O)(C)C)Cl,BRD-K56981171-001-01-0,brigatinib,MedChemEx,HY-12857,Brigatinib,-5.483525,x0104,14.558535,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)Nc5ccccc5P(=O)(C)C)Cl,BRD-K56981171-001-02-8,brigatinib,MedChemEx,HY-12857,Brigatinib,-5.483525,x0104,14.558535,active-noncovalent
c1ccc(cc1)C(C[N@H+](CCCOc2cccc(c2)CC(=O)[O-])Cc3cccc(c3Cl)C(F)(F)F)c4ccccc4,BRD-K33818169-003-03-8,GW-3965,Selleck,S2630,GW3965 HCl,-5.479935,x0434,11.960326,active-noncovalent
c1ccc(cc1)C(C[N@H+](CCCOc2cccc(c2)CC(=O)[O-])Cc3cccc(c3Cl)C(F)(F)F)c4ccccc4,BRD-K33818169-003-05-3,GW-3965,Tocris,2474,GW 3965 hydrochloride,-5.479935,x0434,11.960326,active-noncovalent
c1ccc(cc1)C(C[N@H+](CCCOc2cccc(c2)CC(=O)[O-])Cc3cccc(c3Cl)C(F)(F)F)c4ccccc4,BRD-K33818169-003-04-6,GW-3965,Tocris,2474,GW 3965 hydrochloride,-5.479935,x0434,11.960326,active-noncovalent
c1cc(oc1/C=N/NC(=O)c2cc(cc(c2[O-])N(=O)=O)N(=O)=O)N(=O)=O,BRD-K85757157-001-01-7,nifursol,MicroSource,1502316,NIFURSOL,-5.476471,x0874,5.062882,active-noncovalent
C[N+](C)(C)CCO,BRD-K77300776-001-02-5,choline,Selleck,S4171,Choline Chloride,-5.472346,x0678,0.776081,active-noncovalent
C[N+](C)(C)CCO,BRD-K77300776-001-01-7,choline,MicroSource,1503428,CHOLINE CHLORIDE,-5.472346,x0678,0.776081,active-noncovalent
C([C@H]([C@H](CO)O)O)O,BRD-K79315489-001-07-8,erythritol,Selleck,S4224,Erythritol,-5.464944,x0397,0.835779,active-noncovalent
C([C@H]([C@H](CO)O)O)O,BRD-K79315489-001-08-6,erythritol,Selleck,S4224,Erythritol,-5.464944,x0397,0.835779,active-noncovalent
C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](CO)C(=O)[O-])[NH3+])CNC(=[NH2+])N,BRD-K08859203-001-01-9,DU-728,MedChemEx,HY-12290,Arg-Gly-Asp-Ser,-5.458110,x0678,5.247283,active-noncovalent
CC(C)c1nc(on1)N2CCC(CC2)COc3ccc(nc3)c4ccc(cc4)S(=O)(=O)C,BRD-K60341624-001-02-2,GSK1292263,Selleck,S2149,GSK1292263,-5.456628,x0104,12.615204,active-noncovalent
CCOC(=O)C(=O)C,BRD-K47738867-001-01-5,ethyl-pyruvate,Sigma,W245735,ethyl 2-oxopropanoate,-5.455226,x0195,0.345847,active-noncovalent
CNC(=O)c1c(cccc1F)Nc2c3cc[nH]c3nc(n2)Nc4cc5c(cc4OC)CCN5C(=O)C[NH+](C)C,BRD-K06749501-001-02-1,GSK1838705A,Selleck,S2703,GSK1838705A,-5.454655,x0104,8.968495,active-noncovalent
CNC(=O)c1c(cccc1F)Nc2c3cc[nH]c3nc(n2)Nc4cc5c(cc4OC)CCN5C(=O)C[NH+](C)C,BRD-K06749501-001-03-9,GSK1838705A,Selleck,S2703,GSK1838705A,-5.454655,x0104,8.968495,active-noncovalent
CNC(=O)c1c(cccc1F)Nc2c3cc[nH]c3nc(n2)Nc4cc5c(cc4OC)CCN5C(=O)C[NH+](C)C,BRD-K06749501-001-05-4,GSK1838705A,Tocris,5111,GSK 1838705,-5.454655,x0104,8.968495,active-noncovalent
C1CCN(C1)C#N,BRD-K90042229-001-01-1,N-cyanopyrrolidine,Maybridge,SB00582,,-5.454401,x0195,-0.728891,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCc2cnc3c(n2)c(nc(n3)N)N,BRD-K87544030-001-01-0,aminopterin,Sigma,MFCD00036692,"(2S)-2-[(4-{[(2,4-diamino-6-pteridinyl)methyl]amino}benzoyl)amino]pentanedioic acid",-5.449107,x0104,12.810692,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCc2cnc3c(n2)c(nc(n3)N)N,BRD-K87544030-001-02-8,aminopterin,MicroSource,1500679,AMINOPTERIN,-5.449107,x0104,12.810692,active-noncovalent
CC(=O)C(=O)[O-],BRD-K86587225-236-02-5,2-oxopropanoate,Sigma,MFCD00002586,sodium 2-oxopropanoate,-5.448891,x0689,-0.494791,active-covalent
CC(=O)N1CC[NH+](CC1)CCOc2ccc(cc2)C3CCN(CC3)C4=[NH+]n5c(nnc5C(F)(F)F)CC4,BRD-K84996356-001-01-1,AZD3514,Selleck,S7040,AZD3514,-5.446208,x0104,15.523939,active-noncovalent
CS(=O)(=O)CS(=O)(=O)OCCCl,BRD-K39230570-001-01-1,clomesone,Enamine,Z2306534522,2-chloroethyl (methylsulfonyl)methanesulfonate,-5.445204,x0161,-0.224794,active-noncovalent
CC#CC(=O)N1CCC[C@H]1c2nc(c3n2ccnc3N)c4ccc(cc4)C(=O)Nc5ccccn5,BRD-K64034691-001-01-9,acalabrutinib,MedChemEx,HY-17600,Acalabrutinib,-5.444638,x0104,8.524684,active-noncovalent
Cc1ccn(n1)c2cc(ccc2[C@H](C(F)(F)F)Oc3cc(nc(n3)N)c4ccc(cc4)C[C@@H](C(=O)[O-])[NH3+])Cl,BRD-K63178091-001-01-1,telotristat,MedChemEx,HY-13055B,Telotristat,-5.439402,x0072,7.056301,active-noncovalent
CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,BRD-K91188791-001-18-3,aloxistatin,Selleck,S7393,Aloxistatin,-5.434238,x0107,3.240834,active-noncovalent
CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,BRD-K91188791-001-14-2,aloxistatin,Selleck,S7393,"E-64d(Aloxistatin,Loxistatin??",-5.434238,x0107,3.240834,active-noncovalent
CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,BRD-K91188791-001-17-5,aloxistatin,MedChemEx,HY-100229,Aloxistatin,-5.434238,x0107,3.240834,active-noncovalent
CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,BRD-K91188791-001-15-9,aloxistatin,Adooq,A13259,"ethyl (2S,3S)-3-[({(1S)-1-[(isopentylamino)carbonyl]-3-methylbutyl}amino)carbonyl]-2-oxiranecarboxylate",-5.434238,x0107,3.240834,active-noncovalent
[O-]P(=O)([O-])F,BRD-K99308954-304-04-0,sodium-monofluorophosphate,Selleck,S4013,Sodium Monofluorophosphate,-5.433599,x0397,0.728608,active-noncovalent
[O-]P(=O)([O-])F,BRD-K99308954-304-03-2,sodium-monofluorophosphate,MicroSource,1506192,SODIUM MONOFLUOROPHOSPHATE,-5.433599,x0397,0.728608,active-noncovalent
[O-]P(=O)([O-])F,BRD-K99308954-304-02-4,sodium-monofluorophosphate,Selleck,S4013,Sodium Monofluorophosphate,-5.433599,x0397,0.728608,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)c3ccc(cc3)C[NH2+]Cc4cn[nH]n4,BRD-K84683831-001-01-0,radezolid,MedChemEx,HY-14800,Radezolid,-5.433087,x0395,10.405668,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,BRD-K47178855-001-01-8,isosorbide,Selleck,S4204,Isosorbide,-5.423580,x0195,1.425448,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,BRD-K47178855-001-04-2,isosorbide,Selleck,S4204,Isosorbide,-5.423580,x0195,1.425448,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,BRD-K47178855-001-02-6,isosorbide,MedChemEx,HY-B1469,Isosorbide,-5.423580,x0195,1.425448,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,BRD-K47178855-001-03-4,isosorbide,MedChemEx,HY-B1469,Isosorbide,-5.423580,x0195,1.425448,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2c(c(nc(n2)c3ncccn3)OCCO)Oc4ccccc4OC,BRD-K74763371-002-04-0,bosentan,Selleck,S3051,Bosentan Hydrate,-5.420772,x0874,7.340006,active-noncovalent
COc1cc(c(cc1C(=O)CCCC[NH+]2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)c4ccc(cc4)C(F)(F)F)OC,BRD-K87048468-003-04-3,RS-102221,Tocris,1050,"N-{5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-(trifluoromethyl)benzenesulfonamide hydroch",-5.419090,x0678,13.248268,active-noncovalent
COc1cc(c(cc1C(=O)CCCC[NH+]2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)c4ccc(cc4)C(F)(F)F)OC,BRD-K87048468-003-02-7,RS-102221,Tocris,1050,RS 102221 hydrochloride,-5.419090,x0678,13.248268,active-noncovalent
COc1cc(c(cc1C(=O)CCCC[NH+]2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)c4ccc(cc4)C(F)(F)F)OC,BRD-K87048468-003-03-5,RS-102221,Tocris,1050,RS 102221 hydrochloride,-5.419090,x0678,13.248268,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,BRD-K23848629-401-02-9,fosaprepitant-dimeglumine,Selleck,S3038,Fosaprepitant dimeglumine salt,-5.410882,x0107,10.501625,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,BRD-K23848629-401-04-5,fosaprepitant-dimeglumine,MedChemEx,HY-14407A,Fosaprepitant (dimeglumine),-5.410882,x0107,10.501625,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,BRD-K23848629-401-05-2,fosaprepitant-dimeglumine,MedChemEx,HY-14407A,Fosaprepitant (dimeglumine),-5.410882,x0107,10.501625,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,BRD-K23848629-401-03-7,fosaprepitant-dimeglumine,Selleck,S3038,Fosaprepitant dimeglumine salt,-5.410882,x0107,10.501625,active-noncovalent
CNC(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc4c(c3OC)CCC[C@@H](C4)N5CC[NH+](CC5)CCO)Cl,BRD-K72827473-001-01-0,CEP-37440,MedChemEx,HY-15841,CEP-37440,-5.407353,x0967,14.198461,active-noncovalent
Cc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2c(cn3C(C)C)C)c4ccc(nc4)N5CC[NH+](CC5)C)C,BRD-K72293620-001-01-7,GSK503,MedChemEx,HY-12856,GSK503,-5.406768,x0305,13.572675,active-noncovalent
CS(=O)(=O)OCOS(=O)(=O)C,BRD-K70840370-001-01-9,MDMS,Enamine,Z2327531735,[(methylsulfonyl)oxy]methyl methanesulfonate,-5.404891,x0195,0.315223,active-noncovalent
CC(=O)N(C[C@H](CO)O)c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NCCO)I,BRD-A09370961-001-01-0,ioxilan,MicroSource,1503838,IOXILAN,-5.403805,x1077,3.419309,active-noncovalent
CCCC(=O)C1(CCN(CC1)C(=O)[C@@H](Cc2ccc(cc2)OC)NC(=O)[C@H](Cc3cncn3C)[NH3+])c4ccccc4,BRD-K22000702-300-01-4,BMS-470539,Tocris,4053,BMS 470539 dihydrochloride,-5.397507,x0072,12.840991,active-noncovalent
C[C@@H]1[C@H](O1)P(=O)([O-])[O-],BRD-A10652366-238-04-1,fosfomycin,MicroSource,1502039,FOSFOMYCIN CALCIUM,-5.397497,x0397,0.531806,active-noncovalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)O,BRD-K96631475-001-03-2,10-deacetylbaccatin,MedChemEx,HY-16565,10-Deacetylbaccatin III,-5.397257,x0831,5.947549,active-covalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)O,BRD-K96631475-001-02-4,10-deacetylbaccatin,Selleck,S2409,10-DAB (10-Deacetylbaccatin),-5.397257,x0831,5.947549,active-covalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)O,BRD-K96631475-001-04-0,10-deacetylbaccatin,Selleck,S2409,10-Deacetylbaccatin-III,-5.397257,x0831,5.947549,active-covalent
CC(=O)NCCCS(=O)(=O)[O-],BRD-K26262077-238-01-5,acamprosate,MicroSource,1505711,ACAMPROSATE CALCIUM,-5.396482,x0831,-1.276804,active-covalent
CC(=O)NCCCS(=O)(=O)[O-],BRD-K26262077-001-01-7,acamprosate,Sigma,MFCD00867423,3-(acetylamino)-1-propanesulfonic acid,-5.396482,x0831,-1.276804,active-covalent
C(CN(CC(=O)[O-])CC(=O)[O-])[NH+](CC(=O)[O-])CC(=O)[O-],BRD-K82603084-408-01-1,ethylenediaminetetraacetic-acid,MicroSource,1500270,ETHYLENEDIAMINE TETRACETATE TETRA-ETHANOLAMINE,-5.394145,x0195,1.587287,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC[N@@H+](C)Cc2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OC,BRD-A26711594-003-08-0,nicardipine,Selleck,S4181,Nicardipine HCl,-5.390266,x0195,6.156439,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC[N@@H+](C)Cc2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OC,BRD-A26711594-003-10-6,nicardipine,MicroSource,1501135,NICARDIPINE HYDROCHLORIDE,-5.390266,x0195,6.156439,active-noncovalent
C[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)Cc2cnc[nH]2)NC(=O)C)C(=O)N)C(C)C,BRD-K81795818-019-01-4,exherin,MedChemEx,HY-13541A,Exherin (trifluoroacetate),-5.372185,x0161,8.481688,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K86873305-236-18-8,piperacillin,Selleck,S4222,Piperacillin Sodium,-5.370619,x0072,9.339981,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K86873305-236-14-7,piperacillin,Selleck,S4222,Piperacillin Sodium,-5.370619,x0072,9.339981,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K86873305-236-15-4,piperacillin,Sigma,MFCD00917471,"sodium (2S,5R,6R)-6-[((2R)-2-{[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino}-2-phenylethanoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",-5.370619,x0072,9.339981,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-A99949740-236-04-6,piperacillin,MicroSource,1500489,PIPERACILLIN SODIUM,-5.370619,x0072,9.339981,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K86873305-236-16-2,piperacillin,MedChemEx,HY-B1286,Piperacillin (sodium),-5.370619,x0072,9.339981,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],BRD-K86873305-236-17-0,piperacillin,MedChemEx,HY-B1286,Piperacillin (sodium),-5.370619,x0072,9.339981,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,BRD-K33277808-001-02-0,ouabain,Selleck,S4016,Ouabain,-5.369911,x0072,8.151026,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,BRD-K33277808-001-01-2,ouabain,Tocris,1076,Ouabain,-5.369911,x0072,8.151026,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,BRD-K33277808-331-01-3,ouabain,MicroSource,1500676,OUABAIN OCTAHYDRATE,-5.369911,x0072,8.151026,active-noncovalent
CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccc(c(c1)Cl)Cl,BRD-K07609981-001-01-7,dexloxiglumide,AdvChemBlocks,G-6604,,-5.368523,x0161,6.270571,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCC[NH+]2CCC(CC2)(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-K59333713-003-03-8,niguldipine-(S)-(+),Tocris,1123,(S)-(+)-Niguldipine hydrochloride,-5.364377,x0104,13.40086,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCC[NH+]2CCC(CC2)(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-K59333713-003-02-0,niguldipine-(S)-(+),Tocris,1123,(S)-(+)-Niguldipine hydrochloride,-5.364377,x0104,13.40086,active-noncovalent
COc1cccc(c1)c2ccc(cc2)[C@H](C(F)(F)F)Oc3cc(nc(n3)N)c4ccc(cc4)C[C@@H](C(=O)[O-])[NH3+],BRD-K32101625-001-01-6,LX1031,MedChemEx,HY-13041,LX-1031,-5.352212,x0072,14.985111,active-noncovalent
C([C@H](C=O)O)O,BRD-K18637542-001-01-7,dihydroxyacetone,Sigma,MFCD00004670,"1,3-dihydroxyacetone",-5.349813,x0397,0.570562,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H](c1ccc(cc1)N(=O)=O)O)NC(=O)C(Cl)Cl,BRD-K96424892-001-02-9,chloramphenicol-palmitate,MicroSource,1500172,CHLORAMPHENICOL PALMITATE,-5.337623,x0967,9.245115,active-noncovalent
CCNC(=O)Nc1ccc(cc1)c2nc3c(c(n2)N4CCOC[C@@H]4C)CC[N@H+](C3)C5COC5,BRD-K43187018-001-03-3,GDC-0349,Selleck,S8040,GDC-0349,-5.336406,x0678,8.789373,active-noncovalent
CCNC(=O)Nc1ccc(cc1)c2nc3c(c(n2)N4CCOC[C@@H]4C)CC[N@H+](C3)C5COC5,BRD-K43187018-001-02-5,GDC-0349,Selleck,S8040,GDC-0349,-5.336406,x0678,8.789373,active-noncovalent
Cc1cc(ccc1c2ccccc2)CCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N[C@H](C)c3ccccc3)C(C)(C)C,BRD-K57011718-001-02-3,UK-356618,Tocris,4187,UK 356618,-5.334187,x0678,10.743385,active-noncovalent
CCCCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1[C@@H]([C@H](CO1)O)O)O,BRD-A70197423-001-01-3,sorbitan-monostearate,InterBioScreen,STOCK1N-15360,,-5.331585,x0305,8.323642,active-noncovalent
C[C@@H]1Cc2c(c(cc(c2O)NC(=O)/C(=C/C=C\[C@@H]([C@H](/C(=C/[C@@H]([C@H]([C@H](C1)OC)O)C)/C)OC(=O)N)OC)/C)O)NCC=C,BRD-K67935717-003-02-8,retaspimycin,MedChemEx,HY-10210,Retaspimycin (Hydrochloride),-5.325270,x0967,10.039264,active-noncovalent
C[C@@H]1Cc2c(c(cc(c2O)NC(=O)/C(=C/C=C\[C@@H]([C@H](/C(=C/[C@@H]([C@H]([C@H](C1)OC)O)C)/C)OC(=O)N)OC)/C)O)NCC=C,BRD-K67935717-003-01-0,retaspimycin,MedChemEx,HY-10210,Retaspimycin (Hydrochloride),-5.325270,x0967,10.039264,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,BRD-K92723993-001-12-5,imatinib,Selleck,S2475,Imatinib,-5.324320,x0104,13.457001,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,BRD-K92723993-066-22-7,imatinib,Selleck,S1026,Imatinib Mesylate (STI571),-5.324320,x0104,13.457001,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,BRD-K92723993-001-06-7,imatinib,Selleck,S2475,Imatinib (STI571),-5.324320,x0104,13.457001,active-noncovalent
C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=O)C(=C4[O-])C(=O)NC[NH2+]CCCC[C@@H](C(=O)[O-])[NH3+])[NH+](C)C)O)[O-])[O-])O,BRD-A15750551-001-01-1,lymecycline,Prestwick,Prestw-1000,Lymecycline,-5.316617,x0678,9.184973,active-noncovalent
CCNC(=O)NS(=O)(=O)c1c(cc(s1)CC(C)C)c2ccc(cc2)Cn3c(c(nc3c4ccccc4)OC)C=O,BRD-K36154108-001-01-7,AVE-0991,MedChemEx,HY-15778,AVE 0991,-5.311554,x0072,10.350869,active-noncovalent
CC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)NCCCC[NH+]3CCN(CC3)c4ccccc4OC,BRD-K50891186-001-04-4,GR-103691,Tocris,1109,GR 103691,-5.308193,x0104,15.240854,active-noncovalent
C(CN(CC[NH+](CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])[NH+](CC(=O)[O-])CC(=O)[O-],BRD-K40621224-001-06-7,pentetic-acid,MicroSource,1506082,PENTETIC ACID,-5.307211,x0107,4.785733,active-noncovalent
C(F)(F)(F)S(=O)(=O)O,BRD-M56276249-001-01-1,bismuth(iii)-trifluoromethanesulfonate,AlfaAesar,L19687,"Bismuth(III) trifluoromethanesulfonate, 99%",-5.307137,x0354,0.707204,active-noncovalent
C[C@@H](C(=O)Nc1c(c(c(c(c1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O,BRD-K75868704-001-05-3,iopamidol,MedChemEx,HY-B0684,Iopamidol,-5.305582,x0749,5.629335,active-covalent
CN(CCOc1ccc(cc1)C[C@H](C(=O)[O-])Nc2ccccc2C(=O)c3ccccc3)c4ccccn4,BRD-A15415227-003-02-9,GW-1929,Tocris,1664,GW 1929 hydrochloride,-5.300721,x0759,11.593021,active-covalent
C(C[NH3+])CS(=O)(=O)[O-],BRD-K82234479-001-09-4,tramiprosate,MicroSource,1501125,TRAMIPROSATE,-5.272611,x0397,-0.178676,active-noncovalent
B1(OC(=O)C[C@](O1)(CC(=O)[O-])C(=O)[O-])[C@H](CC(C)C)NC(=O)CNC(=O)c2cc(ccc2Cl)Cl,BRD-A66419424-001-02-4,ixazomib-citrate,Selleck,S2181,MLN9708,-5.260876,x0107,6.987353,active-noncovalent
Cc1cc(ccn1)Cn2c(c(c3ccnc(c3c2=O)OCc4ncccn4)c5cc(c(c(c5)OC)OC)OC)C(=O)OC,BRD-K63516691-003-02-0,T-0156,Tocris,1676,T 0156 hydrochloride,-5.246767,x1077,13.016493,active-noncovalent
Cc1cc(ccn1)Cn2c(c(c3ccnc(c3c2=O)OCc4ncccn4)c5cc(c(c(c5)OC)OC)OC)C(=O)OC,BRD-K63516691-003-03-8,T-0156,Tocris,1676,T 0156 hydrochloride,-5.246767,x1077,13.016493,active-noncovalent
COc1ncc(cc1)[C@]2(CC[C@H](CC2)[N@H+]3C[C@@H](CC3)NC(=O)CNC(=O)c4cc(ccc4)C(F)(F)F)O,BRD-K67628093-001-01-9,INCB-3284,MedChemEx,HY-15450A,INCB 3284,-5.239776,x0395,16.546831,active-noncovalent
CC(C)(c1ccc(cc1)C(=O)CCC[NH+]2CCC(CC2)OC(c3ccccc3)c4ccccc4)C(=O)[O-],BRD-K49554218-001-01-0,carebastine,ChemImpex,24186,,-5.224197,x0395,13.008702,active-noncovalent
CC(C)CC(=O)N,BRD-K90069354-001-03-7,isovaleramide,Selleck,S4116,Isovaleramide,-5.209608,x0397,-1.151641,active-noncovalent
CC(C)CC(=O)N,BRD-K90069354-001-02-9,isovaleramide,MicroSource,1506177,ISOVALERAMIDE,-5.209608,x0397,-1.151641,active-noncovalent
CC(C)CC(=O)N,BRD-K90069354-001-04-5,isovaleramide,PrincetonBio,OSSL_789699,3-methylbutanamide,-5.209608,x0397,-1.151641,active-noncovalent
CC(C)CC(=O)N,BRD-K90069354-001-01-1,isovaleramide,Selleck,S4116,Isovaleramide,-5.209608,x0397,-1.151641,active-noncovalent
c1cc(c(cc1CC[NH2+]CCC(=O)N(CC[NH2+]CCc2ccc(c3c2OCC(=O)N3)O)C4CCCCC4)Cl)Cl,BRD-K76244476-362-02-5,AZ505,MedChemEx,HY-15226A,AZ505 (ditrifluoroacetate),-5.205215,x0072,9.864078,active-noncovalent
c1cc(c(cc1CC[NH2+]CCC(=O)N(CC[NH2+]CCc2ccc(c3c2OCC(=O)N3)O)C4CCCCC4)Cl)Cl,BRD-K76244476-362-01-7,AZ505,MedChemEx,HY-15226A,AZ505 (ditrifluoroacetate),-5.205215,x0072,9.864078,active-noncovalent
c1cc(ccc1CC(=O)N2CCC[C@]23C[C@@H]4N(C3=O)[C@H](CCS4)C(=O)N)NC(=O)COc5ccc(cc5Cl)Cl,BRD-K68470841-001-01-0,ST-2825,MedChemEx,HY-50937,ST 2825,-5.198265,x0104,13.881731,active-noncovalent
c1ccc2c(c1)cccc2Oc3nc(c4c(n3)n(cn4)C5CCCCC5)Nc6ccc(cc6)N7CCOCC7,BRD-K73397362-001-07-4,purmorphamine,Selleck,S3042,Purmorphamine,-5.197366,x0104,8.472745,active-noncovalent
c1ccc2c(c1)cccc2Oc3nc(c4c(n3)n(cn4)C5CCCCC5)Nc6ccc(cc6)N7CCOCC7,BRD-K73397362-001-08-2,purmorphamine,Tocris,4551,Purmorphamine,-5.197366,x0104,8.472745,active-noncovalent
c1ccc2c(c1)cccc2Oc3nc(c4c(n3)n(cn4)C5CCCCC5)Nc6ccc(cc6)N7CCOCC7,BRD-K73397362-001-06-6,purmorphamine,Selleck,S3042,Purmorphamine,-5.197366,x0104,8.472745,active-noncovalent
CC(=O)N(C(=O)NC)OC(=O)NC,BRD-K62790656-001-01-1,caracemide,Enamine,Z2327673243,1-([(methylamino)carbonyl]{[(methylamino)carbonyl]oxy}amino)-1-oxoethane,-5.193930,x0831,-1.156715,active-covalent
c1cc(cc(c1)NC(=O)c2ccc(nc2)N)c3nc4c5cccnc5oc4c(n3)N6CCOCC6,BRD-K48488978-001-05-3,YM-201636,Selleck,S1219,YM201636,-5.187902,x0161,9.803797,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO)O)O,BRD-K68764924-001-05-7,pantethine,MedChemEx,HY-B1028,Pantethine,-5.179900,x0104,9.663679,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO)O)O,BRD-K68764924-001-03-2,pantethine,Sigma,P3280,"(2R)-N-[(17R)-17,19-dihydroxy-18,18-dimethyl-3,12,16-trioxo-7,8-dithia-4,11,15-triazanonadec-1-yl]-2,4-dihydroxy-3,3-dimethylbutanamide",-5.179900,x0104,9.663679,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO)O)O,BRD-K68764924-001-04-0,pantethine,MedChemEx,HY-B1028,Pantethine,-5.179900,x0104,9.663679,active-noncovalent
COc1ccc(cc1)/C=C/CCCCOc2ccc(cc2CCC(=O)[O-])C(=O)c3cccc(c3)C(=O)[O-],BRD-K35367061-001-01-1,LY223982,Cayman,10010024,3-(3-(2-carboxyethyl)-4-{[(5E)-6-(4-methoxyphenyl)-5-hexenyl]oxy}benzoyl)benzoic acid,-5.179435,x0104,10.41428,active-noncovalent
C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)[O-])/C)[C@H](C)O,BRD-K15262564-001-14-3,mupirocin,MicroSource,1505706,MUPIROCIN,-5.174232,x0104,13.046923,active-noncovalent
C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)[O-])/C)[C@H](C)O,BRD-K15262564-001-15-0,mupirocin,MedChemEx,HY-B0958,Mupirocin,-5.174232,x0104,13.046923,active-noncovalent
C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)[O-])/C)[C@H](C)O,BRD-K15262564-001-16-8,mupirocin,Selleck,S4297,Mupirocin,-5.174232,x0104,13.046923,active-noncovalent
COc1ccc(cc1)C(=O)C2CC[NH+](CC2)CC(=O)N(Cc3[nH]c(=O)c4c(n3)CCOC4)CC5CC5,BRD-K87454346-001-01-1,NVP-TNKS656,MedChemEx,HY-13990,NVP-TNKS656,-5.171504,x0678,9.704266,active-noncovalent
c1ccc(cc1)CCc2ccc(cc2)COc3ccccc3CC[N@@H+](CCCCC(=O)[O-])Cc4ccc(cc4)C(=O)[O-],BRD-K73440166-001-01-3,cinaciguat,MedChemEx,HY-14181,Cinaciguat,-5.161856,x0104,10.113083,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],BRD-K02292852-001-04-7,cefoperazone,MicroSource,1502042,CEFOPERAZONE,-5.156762,x1077,15.090311,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],BRD-K02292852-001-02-1,cefoperazone,Selleck,S1611,Cefoperazone,-5.156762,x1077,15.090311,active-noncovalent
C(CS(=O)(=O)[O-])CS(=O)(=O)[O-],BRD-K11463116-304-03-5,eprodisate,MedChemEx,HY-B1141,Eprodisate (disodium),-5.151101,x0397,0.599612,active-noncovalent
C(CS(=O)(=O)[O-])CS(=O)(=O)[O-],BRD-K11463116-304-01-9,eprodisate,MicroSource,1506180,EPRODISATE DISODIUM,-5.151101,x0397,0.599612,active-noncovalent
C(CS(=O)(=O)[O-])CS(=O)(=O)[O-],BRD-K11463116-304-02-7,eprodisate,Sigma,MFCD00191483,"disodium 1,3-propanedisulfonate",-5.151101,x0397,0.599612,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)O[C@@H]2C[C@@H]3C[N@H+]4CCc5c6ccccc6[nH]c5[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC,BRD-K29462201-001-02-7,deserpidine,Key,MD-0232,"methyl (3beta,16beta,17alpha,18beta,20alpha)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate",-5.150027,x0104,12.191852,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)O[C@@H]2C[C@@H]3C[N@H+]4CCc5c6ccccc6[nH]c5[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC,BRD-K29462201-001-01-9,deserpidine,AKSci,71845,,-5.150027,x0104,12.191852,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-14-3,tigecycline,MedChemEx,HY-B0117,Tigecycline,-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-12-7,tigecycline,MedChemEx,HY-B0117,Tigecycline,-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-09-3,tigecycline,Selleck,S1403,Tigecycline,-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-11-9,tigecycline,Sigma,MFCD00935753,"(4S,4aS,5aR,12aS)-9-{[(tert-butylamino)acetyl]amino}-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide",-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-13-5,tigecycline,MedChemEx,HY-B0117,Tigecycline,-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-08-5,tigecycline,MicroSource,1502394,TIGECYCLINE,-5.149228,x0395,8.327245,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,BRD-A34462049-001-15-0,tigecycline,Selleck,S1403,Tigecycline,-5.149228,x0395,8.327245,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)C(F)(F)F,BRD-K33610132-001-02-9,rociletinib,Selleck,S7284,CO-1686 (AVL-301),-5.144532,x0434,11.45752,active-noncovalent
CCCCCCCCCCCCCCCCO[P@](=O)([O-])OCC[N+](C)(C)C,BRD-A31811760-001-06-7,miltefosine,MicroSource,1505329,MILTEFOSINE [5mM],-5.141628,x1077,5.204849,active-noncovalent
CCOC(=O)N,BRD-K24297741-001-05-2,urethane,MicroSource,1503304,URETHANE,-5.139531,x1077,-1.084665,active-noncovalent
Cn1cc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=S)NC(=O)Cc5ccccc5,BRD-K56277358-001-07-5,MGCD-265,Selleck,S1361,MGCD-265,-5.138147,x0967,9.59102,active-noncovalent
CCC(CON(=O)=O)(CON(=O)=O)CON(=O)=O,BRD-K56276053-001-01-8,propatylnitrate,Sigma,MFCD00137315,"2-ethyl-2-((nitrooxy)methyl)propane-1,3-diyl dinitrate",-5.128494,x1418,0.721899,active-covalent
CC[C@@H]1[C@@H]([C@H]2[C@](O2)(/C=C/C(=O)[C@H](C[C@H]([C@H]([C@@H]([C@@H](CC(=O)O1)O)C)O[C@@H]3[C@H]([C@@H](C[C@@H](O3)C)[NH+](C)C)O)CC=O)C)C)C,BRD-A38799180-001-01-0,rosamicin,Vitas-M,STK256720,"3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl 3,4,6-trideoxy-3-(dimethylamino)hexopyranoside",-5.126755,x0104,9.72367,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CS[C@@H](CN(C2=O)CC(=O)[O-])c3cccs3,BRD-K10784860-003-02-3,temocapril,Selleck,S2099,Temocapril HCl,-5.126462,x0072,7.727417,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)Nc3nc4ccccc4c(n3)c5ccccc5)C[NH2+]C,BRD-K33245965-001-02-6,BMS-833923,Selleck,S7138,BMS-833923 (XL139),-5.120314,x0104,13.816071,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)Nc3nc4ccccc4c(n3)c5ccccc5)C[NH2+]C,BRD-K33245965-001-01-8,BMS-833923,Selleck,S7138,BMS-833923,-5.120314,x0104,13.816071,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)Nc3nc4ccccc4c(n3)c5ccccc5)C[NH2+]C,BRD-K33245965-001-03-4,BMS-833923,MedChemEx,HY-13809,BMS-833923,-5.120314,x0104,13.816071,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)COP(=O)([O-])[O-],BRD-K89121095-001-02-5,tedizolid-phosphate,MedChemEx,HY-14855B,Tedizolid (phosphate),-5.112308,x1077,8.028965,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)COP(=O)([O-])[O-],BRD-K89121095-304-01-5,tedizolid-phosphate,Annova,L06022,,-5.112308,x1077,8.028965,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)COP(=O)([O-])[O-],BRD-K89121095-001-01-7,tedizolid-phosphate,MedChemEx,HY-14855B,Tedizolid (phosphate),-5.112308,x1077,8.028965,active-noncovalent
C(CCO)CO,BRD-K22346679-001-06-3,"1,4-butanediol",Sigma,68891,"1,4-butanediol",-5.108727,x0397,0.333434,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@H](c4ccc(cc4)O)C(=O)[O-])OC)OC2)C(=O)[O-],BRD-A08899266-304-05-0,moxalactam,MicroSource,1500418,MOXALACTAM DISODIUM,-5.105547,x0678,8.171843,active-noncovalent
COc1cc(cc(c1O)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)c8cccs8)O)O)OCO4,BRD-A35588707-001-05-5,teniposide,MicroSource,1504094,TENIPOSIDE,-5.095503,x0072,15.723072,active-noncovalent
CC(C)(C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)C[N@](c4c3cccc4)S(=O)(=O)C)[NH3+],BRD-K44771174-066-02-8,ibutamoren,Tocris,5272,MK 0677,-5.089655,x0104,7.399957,active-noncovalent
CC(C)(C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)C[N@](c4c3cccc4)S(=O)(=O)C)[NH3+],BRD-K44771174-066-01-0,ibutamoren,MedChemEx,HY-50844,Ibutamoren (Mesylate),-5.089655,x0104,7.399957,active-noncovalent
COc1cccc2c1[nH]c3c(c2=O)cccc3C(=O)Nc4ccc(cc4)CC[N@@H+]5CCc6cc(c(cc6C5)OC)OC,BRD-K88807631-001-01-3,elacridar,MedChemEx,HY-50879,Elacridar,-5.088918,x0395,17.493311,active-noncovalent
COc1cccc2c1[nH]c3c(c2=O)cccc3C(=O)Nc4ccc(cc4)CC[N@@H+]5CCc6cc(c(cc6C5)OC)OC,BRD-K88807631-001-02-1,elacridar,Selleck,S7772,elacridar,-5.088918,x0395,17.493311,active-noncovalent
COc1cccc2c1[nH]c3c(c2=O)cccc3C(=O)Nc4ccc(cc4)CC[N@@H+]5CCc6cc(c(cc6C5)OC)OC,BRD-K88807631-001-03-9,elacridar,MedChemEx,HY-50879,Elacridar,-5.088918,x0395,17.493311,active-noncovalent
CCc1c(cc(c(c1CC(=O)N(CCOC)CCOC)C(=O)c2ccc(c(c2)OC)OCC[NH+]3CCOCC3)O)O,BRD-K41213548-001-02-0,KW-2478,Selleck,S2685,KW-2478,-5.088754,x0072,9.131982,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4C[C@H]([C@H]3[C@@H]1CC[C@@H]2O)CCCCCCCCC[S@@](=O)CCCC(C(F)(F)F)(F)F)O,BRD-A85667082-001-13-5,fulvestrant,Selleck,S1191,Fulvestrant,-5.086489,x0104,13.712657,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4C[C@H]([C@H]3[C@@H]1CC[C@@H]2O)CCCCCCCCC[S@@](=O)CCCC(C(F)(F)F)(F)F)O,BRD-A85667082-001-10-1,fulvestrant,Tocris,1047,"ICI 182,780",-5.086489,x0104,13.712657,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4C[C@H]([C@H]3[C@@H]1CC[C@@H]2O)CCCCCCCCC[S@@](=O)CCCC(C(F)(F)F)(F)F)O,BRD-A85667082-001-11-9,fulvestrant,MicroSource,1502281,FULVESTRANT,-5.086489,x0104,13.712657,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4C[C@H]([C@H]3[C@@H]1CC[C@@H]2O)CCCCCCCCC[S@@](=O)CCCC(C(F)(F)F)(F)F)O,BRD-A85667082-001-12-7,fulvestrant,Tocris,1047,"ICI 182,780",-5.086489,x0104,13.712657,active-noncovalent
CC[C@H]([C@@H]1[C@H](C[C@](O1)(CC)[C@@H]2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCc3ccc(c(c3C(=O)[O-])O)C)O,BRD-A72711497-236-03-8,lasalocid,MicroSource,1503244,LASALOCID SODIUM,-5.082517,x0072,10.39917,active-noncovalent
C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C=O)O)OC)O,BRD-A72716251-001-01-5,peruvoside,Enzo,NP227,Peruvoside,-5.080227,x0072,13.761321,active-noncovalent
C(C(CO)(CO)[NH3+])O,BRD-K47978074-001-03-2,trometamol,MicroSource,1300050,TROMETHAMINE,-5.053106,x0397,1.2725,active-noncovalent
C(C(CO)(CO)[NH3+])O,BRD-K47978074-001-02-4,trometamol,Selleck,S4176,Trometamol,-5.053106,x0397,1.2725,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)c6ccc(=O)oc6)C)C)O)O)O,BRD-A11815689-001-01-1,proscillaridin-a,MicroSource,1506084,PROSCILLARIDIN A,-5.049328,x0104,15.529674,active-noncovalent
C[NH+](C)CCn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cc4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K02275692-300-02-6,cefotiam,MedChemEx,HY-B0734A,Cefotiam (hydrochloride),-5.039997,x0072,8.175143,active-noncovalent
C[NH+](C)CCn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cc4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K02275692-300-01-8,cefotiam,Prestwick,Prestw-482,Cefotiam hydrochloride,-5.039997,x0072,8.175143,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)NCc3cc(ccc3Oc4ccc5c(c4)cnn5CCO)F,BRD-K53405000-001-01-0,pexmetinib,Selleck,S7799,Pexmetinib (ARRY-614),-5.023005,x0161,10.476757,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)NCc3cc(ccc3Oc4ccc5c(c4)cnn5CCO)F,BRD-K53405000-001-02-8,pexmetinib,Selleck,S7799,1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(5-fluoro-2-((1-(2-hydroxyethyl)-1H-indazol-5-yl)oxy)benzyl)urea,-5.023005,x0161,10.476757,active-noncovalent
COc1cc(ccc1c2cnco2)NC(=O)Nc3cccc(c3)CNC(=O)O[C@H]4CCOC4,BRD-K09372874-001-01-0,merimepodib,MedChemEx,HY-13986,Merimepodib,-5.021338,x0104,12.298016,active-noncovalent
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc2ccccc2Cl,BRD-K11292736-300-02-8,ambenonium,Tocris,388,Ambenonium dichloride,-5.018453,x0874,6.766983,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCc2cnc3c(n2)c(=O)[nH]c(n3)N,BRD-K18673820-001-15-5,folic-acid,MicroSource,1502020,FOLIC ACID,-5.014051,x0072,8.053512,active-noncovalent
CCCn1c(=O)c2c([nH]c(n2)c3ccc(cc3)S(=O)(=O)N4CCN(CC4)c5ccc(cc5)Cl)[nH]c1=O,BRD-K05419687-001-01-0,PSB-603,Tocris,3198,PSB 603,-5.009697,x0395,13.736358,active-noncovalent
CC[C@](C)(C#C)O,BRD-A11662333-001-03-3,meparfylon,MicroSource,1506158,MEPARFYLON,-5.007377,x1077,1.121843,active-noncovalent
CC(C)(C(Cl)(Cl)Cl)O,BRD-K39495750-001-02-0,chlorobutanol,Enamine,Z1259084902,"1,1,1-trichloro-2-methyl-2-propanol",-5.002996,x0354,1.386267,active-noncovalent
CC(C)(C(Cl)(Cl)Cl)O,BRD-K39495750-001-01-2,chlorobutanol,MicroSource,1502551,CHLOROBUTANOL,-5.002996,x0354,1.386267,active-noncovalent
Cc1c(c2c3c(cc(c2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)c3c1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)O)O,BRD-K38512030-001-01-7,rifamycin,AvaChem,2841,,-5.001520,x0967,14.407241,active-noncovalent
CN1CC[NH+](CC1)CCOc2cc3c(c(c2)OC4CCOCC4)c(ncn3)Nc5c(ccc6c5OCO6)Cl,BRD-K19540840-001-09-4,saracatinib,Selleck,S1006,Saracatinib (AZD0530),-4.996169,x0161,8.335638,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+])NC(=O)[C@H](C[NH3+])O)O,BRD-K74759733-065-01-4,isepamicin,Sigma,MFCD01683537,"sulfuric acid compound with (2S)-3-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycycloh",-4.994531,x0104,10.310407,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+])NC(=O)[C@H](C[NH3+])O)O,BRD-K74759733-001-01-9,isepamicin,Carbosynth,ISEPAMICIN,"(2S)-3-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-3-hydroxycyclohexyl)-2-hydroxypropanamide",-4.994531,x0104,10.310407,active-noncovalent
C[N@H+]1CCc2c(sc(n2)C(=O)N[C@H]3C[C@@H](CC[C@@H]3NC(=O)C(=O)Nc4ccc(cn4)Cl)C(=O)N(C)C)C1,BRD-K29322660-001-01-9,edoxaban,Selleck,S7280,Edoxaban,-4.992864,x0434,9.26327,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSc4nnnn4CS(=O)(=O)[O-])C(=O)[O-])O,BRD-K34058848-304-02-3,cefonicid,MedChemEx,HY-B1300,Cefonicid (sodium),-4.990233,x0387,6.802705,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSc4nnnn4CS(=O)(=O)[O-])C(=O)[O-])O,BRD-K34058848-304-03-1,cefonicid,MicroSource,1505474,CEFONICID SODIUM,-4.990233,x0387,6.802705,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSc4nnnn4CS(=O)(=O)[O-])C(=O)[O-])O,BRD-K34058848-304-01-5,cefonicid,MedChemEx,HY-B1300,Cefonicid (sodium),-4.990233,x0387,6.802705,active-noncovalent
c1ccc(cc1)C2(CC2)NC(=O)c3c4ccc(cc4nc(c3C[NH+]5CCC(CC5)[NH+]6CCCCC6)c7cccc(c7)C(F)(F)F)Br,BRD-K90737788-001-01-9,GSK-2193874,Tocris,5106,GSK 2193874,-4.984833,x0395,15.903696,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C/C=C(/C(=O)/N=C/2\CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)\C)C)O)OC,BRD-K43570081-001-02-4,geldanamycin,Selleck,S2713,Geldanamycin,-4.982176,x0305,8.217888,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C/C=C(/C(=O)/N=C/2\CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)\C)C)O)OC,BRD-K43570081-001-04-0,geldanamycin,Selleck,S2713,Geldanamycin,-4.982176,x0305,8.217888,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSC[C@H](C(=O)[O-])[NH3+])OC)SC2)C(=O)[O-],BRD-K77073709-435-01-2,cefminox,Key,KS-1224,"sodium (6R,7S)-7-[({[(2S)-2-amino-2-carboxyethyl]sulfanyl}acetyl)amino]-7-methoxy-3-{[(1-methyl-1H-tetraazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate heptahydrate",-4.971163,x0434,8.306041,active-noncovalent
CC(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K68405354-001-07-2,spaglumic-acid,Prestwick,Prestw-1091,Spaglumic acid,-4.960925,x0830,1.956668,active-covalent
CC(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],BRD-K68405354-001-06-4,spaglumic-acid,Tocris,391,Spaglumic acid,-4.960925,x0830,1.956668,active-covalent
C(CS(=O)(=O)[O-])[NH3+],BRD-K51474575-001-10-4,taurine,Selleck,S2008,Taurine,-4.958286,x0397,-0.462665,active-noncovalent
C(CS(=O)(=O)[O-])[NH3+],BRD-K51474575-001-11-2,taurine,MicroSource,1505463,TAURINE,-4.958286,x0397,-0.462665,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)OP(=O)([O-])[O-])OC)OCO5)O)O,BRD-K72533376-001-01-2,etoposide-phosphate,ChemImpex,28305,"4-[(5R,5aR,8aR,9S)-9-({4,6-O-[(1R)-ethylidene]-beta-D-glucopyranosyl}oxy)-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]-2,6-dimethoxyphenyl dihydrogen phosphate",-4.954970,x0104,13.64349,active-noncovalent
C([C@@H](CS(=O)(=O)[O-])S)S,BRD-A22971209-001-01-0,DMPS,Vitas-M,STK386918,,-4.937604,x1077,0.379283,active-noncovalent
C(C(Br)(Br)Br)O,BRD-K69632891-001-01-3,tribromoethanol,MicroSource,1504342,TRIBROMOETHANOL,-4.929557,x0354,0.932259,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc(cc3OC)N4CCC(CC4)N5CC[NH+](CC5)C)Cl,BRD-K50140147-001-10-1,NVP-TAE684,Selleck,S1108,TAE684 (NVP-TAE684),-4.926045,x0104,16.082058,active-noncovalent
B1(OC(=O)C(O1)(CC(=O)[O-])CC(=O)[O-])[C@H](CC(C)C)NC(=O)CNC(=O)c2cc(ccc2Cl)Cl,BRD-K15203492-001-01-1,MLN9708,MedChemEx,HY-10452,MLN9708,-4.922093,x0072,6.144392,active-noncovalent
B1(OC(=O)C(O1)(CC(=O)[O-])CC(=O)[O-])[C@H](CC(C)C)NC(=O)CNC(=O)c2cc(ccc2Cl)Cl,BRD-K15203492-001-02-9,MLN9708,MedChemEx,HY-10452,MLN9708,-4.922093,x0072,6.144392,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,BRD-K42728290-001-09-1,NVP-BGJ398,LCLabs,I-1500,Infigratinib,-4.917869,x0104,12.485769,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,BRD-K42728290-001-08-3,NVP-BGJ398,MedChemEx,HY-13311,NVP-BGJ398,-4.917869,x0104,12.485769,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,BRD-K42728290-001-11-7,NVP-BGJ398,MedChemEx,HY-13311,NVP-BGJ398,-4.917869,x0104,12.485769,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,BRD-K42728290-001-06-7,NVP-BGJ398,Selleck,S2183,BGJ398 (NVP-BGJ398),-4.917869,x0104,12.485769,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,BRD-K42728290-001-07-5,NVP-BGJ398,Selleck,S2183,BGJ398 (NVP-BGJ398),-4.917869,x0104,12.485769,active-noncovalent
C(CS)[NH3+],BRD-K92611362-001-02-6,cysteamine,MicroSource,1504226,CYSTEAMINE HYDROCHLORIDE,-4.913909,x1093,-0.80818,active-noncovalent
C(CS)[NH3+],BRD-M77687198-001-10-6,cysteamine,Selleck,S4206,Cysteamine HCl,-4.913909,x1093,-0.80818,active-noncovalent
C(CS)[NH3+],BRD-M77687198-001-12-2,cysteamine,Selleck,S4206,Cysteamine HCl,-4.913909,x1093,-0.80818,active-noncovalent
CCCC(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])OC(=O)CCC,BRD-A94624445-236-17-0,bucladesine,Tocris,1141,"Dibutyryl-cAMP, sodium salt",-4.912111,x1077,7.96348,active-noncovalent
CCCC(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])OC(=O)CCC,BRD-A94624445-236-18-8,bucladesine,Tocris,1141,"Dibutyryl-cAMP, sodium salt",-4.912111,x1077,7.96348,active-noncovalent
COC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CCN(CC4)C(=O)OC)c(n2)N5CCOCC5,BRD-K77008974-001-03-2,WYE-354,Selleck,S1266,WYE-354,-4.907535,x0072,11.167975,active-noncovalent
CCC(C)(C)O,BRD-K93502141-001-02-4,amylene-hydrate,Sigma,MFCD00004478,2-methyl-2-butanol,-4.898151,x0678,1.316536,active-noncovalent
CCC(C)(C)O,BRD-K93502141-001-01-6,amylene-hydrate,MicroSource,1301017,AMYLENE HYDRATE,-4.898151,x0678,1.316536,active-noncovalent
Cc1c(sc(n1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-])CC(=O)[O-],BRD-K22641081-304-01-8,cefodizime,Kemprotec,69739-16-8,"disodium (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-3-({[4-methyl-5-(2-oxido-2-oxoethyl)-1,3-thiazol-2-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-;2-carboxylate",-4.897615,x0397,10.542229,active-noncovalent
Cc1c(sc(n1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-])CC(=O)[O-],BRD-K22641081-001-01-0,cefodizime,AKSci,K170,,-4.897615,x0397,10.542229,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-A90695733-300-02-1,manidipine,Selleck,S2482,Manidipine 2HCl,-4.881680,x0395,17.186342,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-A90695733-001-08-2,manidipine,Selleck,S2481,Manidipine (Manyper),-4.881680,x0395,17.186342,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-A90695733-001-06-6,manidipine,Selleck,S2481,Manidipine,-4.881680,x0395,17.186342,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,BRD-A90695733-001-07-4,manidipine,MicroSource,1502388,MANIDIPINE HYDROCHLORIDE,-4.881680,x0395,17.186342,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)([O-])[O-])O)O)[C@H](C)Cl,BRD-K27771035-001-02-5,clindamycin-phosphate,Selleck,S2048,Clindamycin phosphate,-4.880395,x0830,4.451159,active-covalent
CC1=C([C@@H](C(=C(N1)C)P2(=O)OCC(CO2)(C)C)c3cccc(c3)N(=O)=O)C(=O)OCCN(Cc4ccccc4)c5ccccc5,BRD-M92675308-003-05-5,efonidipine-monoethanolate,Tocris,3733,Efonidipine hydrochloride monoethanolate,-4.864570,x0434,10.924667,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)P2(=O)OCC(CO2)(C)C)c3cccc(c3)N(=O)=O)C(=O)OCCN(Cc4ccccc4)c5ccccc5,BRD-M92675308-003-06-3,efonidipine-monoethanolate,Tocris,3733,"2-(benzylanilino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3-pyridin",-4.864570,x0434,10.924667,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)P2(=O)OCC(CO2)(C)C)c3cccc(c3)N(=O)=O)C(=O)OCCN(Cc4ccccc4)c5ccccc5,BRD-M92675308-003-07-1,efonidipine-monoethanolate,Tocris,3733,Efonidipine hydrochloride monoethanolate,-4.864570,x0434,10.924667,active-noncovalent
CCCC(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@@](=O)(O4)[O-])OC(=O)CCC,BRD-A15931911-001-03-8,bucladesine,MicroSource,1503043,BUCLADESINE,-4.850514,x1077,6.334359,active-noncovalent
C([C@H](CS)S)O,BRD-A56152450-001-03-8,dimercaprol,Sigma,MFCD00004864,"2,3-disulfanyl-1-propanol",-4.841746,x0678,0.326315,active-noncovalent
C([C@H](CS)S)O,BRD-A56152450-001-02-0,dimercaprol,MicroSource,1500252,DIMERCAPROL,-4.841746,x0678,0.326315,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)C(=O)c3ccc(c(c3)OC)Nc4ncc5c(n4)N(c6ccccc6C(=O)N5C)C,BRD-K01436366-001-20-6,LRRK2-IN-1,MedChemEx,HY-10875,LRRK2-IN-1,-4.839262,x0072,16.613029,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)C(=O)c3ccc(c(c3)OC)Nc4ncc5c(n4)N(c6ccccc6C(=O)N5C)C,BRD-K01436366-001-22-2,LRRK2-IN-1,Tocris,4273,LRRK2-IN-1,-4.839262,x0072,16.613029,active-noncovalent
CCc\1c(c2/cc\3/c(c(c(n3)/c(c\4/c(c(c(n4)/cc/5\nc(/cc1\n2)[C@H]([C@@H]5CC)C)C)C(=O)[O-])/CC(=O)[O-])CCC(=O)[O-])C)C,BRD-K23728266-001-01-1,chlorophyllin,Adooq,A14018,"(7S,8S)-8-(2-carboxyethyl)-10-(carboxymethyl)-17-ethyl-3,7,13,18-tetramethyl-2-vinyl-7H,8H-porphyrin-12-carboxylic acid",-4.835413,x0967,9.230525,active-noncovalent
Cc1cccc(c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N4CC[NH+](CC4)CCO)Cl,BRD-K49328571-001-19-2,dasatinib,Selleck,S1021,Dasatinib (BMS-354825),-4.826037,x0104,15.927084,active-noncovalent
Cc1cccc(c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N4CC[NH+](CC4)CCO)Cl,BRD-K49328571-001-15-0,dasatinib,Selleck,S1021,Dasatinib,-4.826037,x0104,15.927084,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O)N,BRD-A31990649-304-04-9,adenosine-triphosphate,MicroSource,1506329,ADENOSINE TRIPHOSPHATE DISODIUM,-4.804915,x0397,4.81017,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O)N,BRD-A31990649-304-03-1,adenosine-triphosphate,Selleck,S1985,ATP (Adenosine-Triphosphate),-4.804915,x0397,4.81017,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O)N,BRD-A31990649-304-02-3,adenosine-triphosphate,Selleck,S1985,ATP (Adenosine-Triphosphate),-4.804915,x0397,4.81017,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(cc5)O)[O-])CO)O)O)O)O)O,BRD-K02953697-001-09-2,naringin,Selleck,S2329,Naringin,-4.796121,x0104,6.941384,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,BRD-K56211775-001-03-8,RTA-408,Selleck,S7672,Omaveloxolone (RTA-408),-4.784365,x0305,8.939431,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,BRD-K56211775-001-02-0,RTA-408,MedChemEx,HY-12212,RTA-408,-4.784365,x0305,8.939431,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,BRD-K56211775-001-01-2,RTA-408,MedChemEx,HY-12212,RTA-408,-4.784365,x0305,8.939431,active-noncovalent
C(=O)(C(=O)O)O,BRD-M02179497-001-01-1,bismuth-oxalate,MPBio,5201335,BISMUTH OXALATE,-4.783651,x0397,0.404105,active-noncovalent
c1cc(ccc1c2cn(cc(c2=O)C(=O)Nc3ccc(c(c3)F)Oc4ccnc(c4Cl)N)COP(=O)([O-])[O-])F,BRD-K81026553-234-01-8,BMS-817378,MedChemEx,HY-18711A,c-Met inhibitor 2,-4.779683,x0072,14.673867,active-noncovalent
CC(C)c1c(c(no1)c2c(cccc2Cl)Cl)COc3ccc(c(c3)Cl)/C=C/c4cccc(c4)C(=O)[O-],BRD-K88186167-001-04-8,GW-4064,Selleck,S2782,GW4064,-4.779024,x0072,11.979081,active-noncovalent
CC(C)c1c(c(no1)c2c(cccc2Cl)Cl)COc3ccc(c(c3)Cl)/C=C/c4cccc(c4)C(=O)[O-],BRD-K88186167-001-05-5,GW-4064,Tocris,2473,GW 4064,-4.779024,x0072,11.979081,active-noncovalent
COc1ncc2cc(c(=O)[nH]c2n1)C(=O)Nc3cc(ccc3Cl)C(=O)NCc4cccc(c4)Cl,BRD-K89517477-001-01-4,TC-S-7004,Tocris,5088,TC-S 7004,-4.778556,x0395,12.821497,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],BRD-A73368467-003-18-4,fexofenadine,MicroSource,1504179,FEXOFENADINE HYDROCHLORIDE,-4.774792,x0072,13.053364,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],BRD-A73368467-003-19-2,fexofenadine,Tocris,2429,Fexofenadine hydrochloride,-4.774792,x0072,13.053364,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],BRD-A73368467-003-17-6,fexofenadine,Tocris,2429,Fexofenadine hydrochloride,-4.774792,x0072,13.053364,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],BRD-A73368467-003-16-8,fexofenadine,Selleck,S3208,Fexofenadine HCl,-4.774792,x0072,13.053364,active-noncovalent
c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F,BRD-K19061412-001-03-2,mubritinib,Tocris,3599,TAK 165,-4.773646,x0305,19.025396,active-noncovalent
c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F,BRD-K19061412-001-04-0,mubritinib,Tocris,3599,TAK 165,-4.773646,x0305,19.025396,active-noncovalent
c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F,BRD-K19061412-001-02-4,mubritinib,Selleck,S2216,Mubritinib (TAK 165),-4.773646,x0305,19.025396,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3ccc4c3ncnc4N)O)O,BRD-K69070623-001-02-9,EPZ004777,Selleck,S7353,EPZ004777,-4.773143,x0104,10.654207,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3ccc4c3ncnc4N)O)O,BRD-K69070623-001-01-1,EPZ004777,Selleck,S7353,EPZ004777,-4.773143,x0104,10.654207,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3ccc4c3ncnc4N)O)O,BRD-K69070623-003-01-7,EPZ004777,Selleck,S7032,EPZ004777 HCl,-4.773143,x0104,10.654207,active-noncovalent
Cc1cc(cc(c1C[C@@H](C(=O)N(Cc2ccc(c(c2)C(=O)[O-])OC)[C@@H](C)c3[nH]cc([nH+]3)c4ccccc4)[NH3+])C)C(=O)N,BRD-K39560679-001-01-1,eluxadoline,MedChemEx,HY-12247,Eluxadoline,-4.770152,x0104,10.99172,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F,BRD-K66175015-332-01-6,afatinib,MedChemEx,HY-10261A,Afatinib (dimaleate),-4.763764,x0104,9.455673,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F,BRD-K66175015-001-09-0,afatinib,Selleck,S1011,Afatinib (BIBW2992),-4.763764,x0104,9.455673,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F,BRD-K66175015-001-13-2,afatinib,Selleck,S1011,afatinib,-4.763764,x0104,9.455673,active-noncovalent
Cc1c(c(c(c2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)CCC(=O)[O-])C,BRD-K64636206-001-02-7,D-alpha-tocopheryl-succinate,SantaCruz,sc-200141,D-??-Tocopheryl Succinate,-4.746251,x0104,15.95388,active-noncovalent
COc1ccc(cn1)C2(CCC(CC2)[N@@H+]3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)O,BRD-K28059174-334-01-2,INCB-003284,EMDBio,504361-5MG,INCB 3284 dimesylate,-4.734503,x0305,17.83618,active-noncovalent
Cc1cc(cc(c1c2cccc(c2)COc3ccc4c(c3)OC[C@H]4CC(=O)[O-])C)OCCCS(=O)(=O)C,BRD-K58501140-002-01-0,TAK-875,Selleck,S2637,TAK-875,-4.731983,x0072,14.566271,active-noncovalent
C[C@@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[O-])NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],BRD-K57927309-001-01-7,BW-180C,Enzo,AC882,"(D-Ala2,D-Leu5)-Enkephalin",-4.725129,x0104,12.717618,active-noncovalent
C1[C@@H](O1)CCl,BRD-M22581557-003-02-5,sevelamer,Selleck,S4129,Sevelamer HCl,-4.719880,x0195,0.856465,active-noncovalent
CC(C)OC(=O)N1CCC(CC1)Oc2c3cnn(c3ncn2)c4ccc(cc4F)S(=O)(=O)C,BRD-K10859802-001-01-0,APD668,MedChemEx,HY-15565,APD668,-4.711292,x0104,13.502076,active-noncovalent
CC(=O)Nc1ccc(cc1)NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C,BRD-K05977823-001-04-6,tenovin-1,Selleck,S8000,Tenovin-1,-4.707722,x0104,9.585572,active-noncovalent
CC(=O)Nc1ccc(cc1)NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C,BRD-K05977823-001-03-8,tenovin-1,Selleck,S8000,Tenovin-1,-4.707722,x0104,9.585572,active-noncovalent
CC(=O)Nc1ccc(cc1)NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C,BRD-K05977823-001-05-3,tenovin-1,Tocris,3365,Tenovin-1,-4.707722,x0104,9.585572,active-noncovalent
CC(C)(C)Sc1c2cc(ccc2n(c1CC(C)(C)C(=O)[O-])Cc3ccc(cc3)Cl)OCc4ccc5ccccc5n4,BRD-K39503511-001-03-9,quiflapon,MedChemEx,HY-10037,MK-0591,-4.698779,x0434,7.849851,active-noncovalent
[H]/N=c\1/ccn(n1CCO)C[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K72339976-065-04-7,cefoselis,AKSci,O697,,-4.689401,x0874,8.705957,active-noncovalent
[H]/N=c\1/ccn(n1CCO)C[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K72339976-065-02-1,cefoselis,Selleck,S1371,Cefoselis Sulfate,-4.689401,x0874,8.705957,active-noncovalent
[H]/N=c\1/ccn(n1CCO)C[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K72339976-065-03-9,cefoselis,Selleck,S1371,Cefoselis sulfate,-4.689401,x0874,8.705957,active-noncovalent
[H]/N=c\1/ccn(n1CCO)C[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],BRD-K72339976-065-01-3,cefoselis,MedChemEx,HY-B0186B,Cefoselis (sulfate),-4.689401,x0874,8.705957,active-noncovalent
Cc1c(c(c(c2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C,BRD-K57305459-001-01-4,tocofersolan,MedChemEx,HY-B0717,Tocofersolan,-4.688037,x0305,15.476989,active-noncovalent
COc1ccc(cc1Cl)CNc2c(cnc(n2)N3CCC[C@H]3CO)C(=O)NCc4ncccn4,BRD-K65781196-001-04-8,avanafil,MicroSource,1506321,AVANAFIL,-4.684586,x0161,6.990294,active-noncovalent
COc1ccc(cc1Cl)CNc2c(cnc(n2)N3CCC[C@H]3CO)C(=O)NCc4ncccn4,BRD-K65781196-001-03-0,avanafil,Selleck,S4019,Avanafil,-4.684586,x0161,6.990294,active-noncovalent
CC(C)(CO)[C@@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](C(C)(C)CO)O)O,BRD-A76244192-001-02-4,pantethine,MicroSource,1505920,PANTETHINE,-4.682490,x0397,8.906681,active-noncovalent
C1CNCC[NH2+]1,BRD-K13249881-001-02-3,piperazine,MicroSource,1500490,PIPERAZINE,-4.675085,x0354,1.488912,active-noncovalent
Cc1cc(c2c(c1)c(cc(n2)c3ccccn3)C(=O)Nc4ccc(cc4)S(=O)(=O)Nc5c(c(no5)C)C)C,BRD-K27539181-001-08-5,ML-193,Tocris,4860,ML 193,-4.674056,x0104,15.060197,active-noncovalent
CC(=O)N(C[C@H](CO)O)c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I,BRD-A60217728-001-11-2,iohexol,MicroSource,1502304,IOHEXOL,-4.673427,x1077,5.515442,active-noncovalent
CC1=C([C@H](C(=C(N1)[NH3+])C(=O)OC2C[NH+](C2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC(C)C,BRD-A01098288-001-06-0,azelnidipine,MedChemEx,HY-B0023,Azelnidipine,-4.652868,x0072,9.184939,active-noncovalent
CC1=C([C@H](C(=C(N1)[NH3+])C(=O)OC2C[NH+](C2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC(C)C,BRD-A01098288-001-04-5,azelnidipine,Selleck,S3053,Azelnidipine,-4.652868,x0072,9.184939,active-noncovalent
CC1=C([C@H](C(=C(N1)[NH3+])C(=O)OC2C[NH+](C2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC(C)C,BRD-A01098288-001-02-9,azelnidipine,Selleck,S3053,Azelnidipine,-4.652868,x0072,9.184939,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3cc(cc(c3)OC)OC,BRD-K97764662-001-21-5,PD-173074,Tocris,3044,PD 173074,-4.648826,x0104,11.518627,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3cc(cc(c3)OC)OC,BRD-K97764662-001-17-3,PD-173074,Selleck,S1264,PD173074,-4.648826,x0104,11.518627,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3cc(cc(c3)OC)OC,BRD-K97764662-001-20-7,PD-173074,Selleck,S1264,PD173074,-4.648826,x0104,11.518627,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,BRD-K89085489-001-24-0,fenretinide,MedChemEx,HY-15373,Fenretinide,-4.648245,x0395,12.481377,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,BRD-K89085489-001-19-0,fenretinide,Tocris,1396,Fenretinide,-4.648245,x0395,12.481377,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,BRD-K89085489-001-23-2,fenretinide,MedChemEx,HY-15373,Fenretinide,-4.648245,x0395,12.481377,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,BRD-K89085489-001-22-4,fenretinide,Adooq,A12163,15-(4-hydroxyanilino)retinal,-4.648245,x0395,12.481377,active-noncovalent
CC(C)C(=O)N,BRD-K54057105-001-01-2,isobutyramide,Otava,1375169,,-4.639351,x0434,-0.851402,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1ccc(cc1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,BRD-K66401437-001-03-3,THZ1,MedChemEx,HY-80013,THZ1,-4.625995,x0395,14.141813,active-noncovalent
C[N@H+](CCCN1CCc2cc(c(cc2CC1=O)OC)OC)C[C@@H]3Cc4c3cc(c(c4)OC)OC,BRD-K31385749-003-01-3,ivabradine,Selleck,S2086,Ivabradine HCl,-4.623213,x1077,8.62527,active-noncovalent
CC(C)(C/C=C/C(=O)N(C)[C@H](Cc1ccc2ccccc2c1)C(=O)N(C)[C@H](Cc3ccccc3)C(=O)NC)[NH3+],BRD-K53600683-051-01-5,tabimorelin,Tocris,2308,Tabimorelin hemifumarate,-4.621974,x0072,7.371719,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3c(cccc3Cl)Cl,BRD-K97152684-001-02-7,PD-161570,Tocris,3724,PD 161570,-4.615630,x0434,9.642145,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3c(cccc3Cl)Cl,BRD-K97152684-001-01-9,PD-161570,Tocris,3724,PD 161570,-4.615630,x0434,9.642145,active-noncovalent
C(=C(Cl)Cl)Cl,BRD-K46435528-001-04-4,trichloroethylene,MicroSource,1301056,TRICHLOROETHYLENE,-4.604517,x0195,1.254842,active-noncovalent
C(=C(Cl)Cl)Cl,BRD-K46435528-001-05-1,trichloroethylene,Sigma,MFCD00000838,"1,1,2-trichloroethylene",-4.604517,x0195,1.254842,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3cc(c4c3ncnc4N)Br)O)O,BRD-K69577666-001-01-3,SGC-0946,Selleck,S7079,SGC 0946,-4.595750,x0434,10.644383,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3cc(c4c3ncnc4N)Br)O)O,BRD-K69577666-001-03-9,SGC-0946,Tocris,4541,SGC 0946,-4.595750,x0434,10.644383,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(\c1csc(n1)N)/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K57502136-345-02-6,ceftazidime,Selleck,S4314,Ceftazidime Pentahydrate,-4.586545,x0072,9.711609,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(\c1csc(n1)N)/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K57502136-345-03-4,ceftazidime,Selleck,S4314,ceftazidime pentahydrate,-4.586545,x0072,9.711609,active-noncovalent
C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)NC(=[NH2+])N)O)NC(=[NH2+])N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)[NH2+]C)(C=O)O,BRD-A98954669-065-04-7,streptomycin,MicroSource,1500541,STREPTOMYCIN SULFATE [5mM; 10% aq DMSO + 5mM ethanolamine],-4.574632,x0434,6.55692,active-noncovalent
CC[NH+]1CCN(CC1)C(=O)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccc(cc4)C(=O)Nc5ccccc5Cl)F,BRD-K53561341-001-09-1,aurora-a-inhibitor-i,Tocris,5286,TC-S 7010,-4.574037,x0161,12.748294,active-noncovalent
CC[NH+]1CCN(CC1)C(=O)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccc(cc4)C(=O)Nc5ccccc5Cl)F,BRD-K53561341-001-07-5,aurora-a-inhibitor-i,Selleck,S1451,Aurora A Inhibitor I,-4.574037,x0161,12.748294,active-noncovalent
CCCCCCCCCCCCCCCCCCO[P@@](=O)([O-])OC1CC[N+](CC1)(C)C,BRD-A89082344-001-08-7,perifosine,MedChemEx,HY-50909,Perifosine,-4.558517,x0104,8.464129,active-noncovalent
CCCCCCCCCCCCCCCCCCO[P@@](=O)([O-])OC1CC[N+](CC1)(C)C,BRD-A89082344-001-06-1,perifosine,MedChemEx,HY-50909,Perifosine,-4.558517,x0104,8.464129,active-noncovalent
CCCCCCCCCCCCCCCCCCO[P@@](=O)([O-])OC1CC[N+](CC1)(C)C,BRD-A89082344-001-07-9,perifosine,MedChemEx,HY-50909,"1,1-dimethylpiperidinium-4-yl octadecyl phosphate",-4.558517,x0104,8.464129,active-noncovalent
C(C(=O)O)(Cl)Cl,BRD-M97302542-001-03-6,dichloroacetate,Tocris,2755,DCA,-4.558117,x0678,0.461881,active-noncovalent
C(C(=O)O)(Cl)Cl,BRD-M97302542-001-04-4,dichloroacetate,Sigma,MFCD00070489,sodium dichloroacetate,-4.558117,x0678,0.461881,active-noncovalent
C1COC1=O,BRD-K76867903-001-03-8,propiolactone,MicroSource,1503234,PROPIOLACTONE,-4.556714,x0195,1.112881,active-noncovalent
CCCc1nc(c2n1nc([nH]c2=O)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)CC)C,BRD-K13926615-394-02-8,vardenafil,Selleck,S2515,Vardenafil HCl Trihydrate,-4.555899,x0072,6.195604,active-noncovalent
CCCc1nc(c2n1nc([nH]c2=O)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)CC)C,BRD-K13926615-003-03-3,vardenafil,MicroSource,1505374,VARDENAFIL HYDROCHLORIDE,-4.555899,x0072,6.195604,active-noncovalent
CCCOCCn1c2cc(ncc2nc(c1=O)N3CC[NH+](CC3)CCO)c4ccc(nc4)OC,BRD-K07070922-001-01-4,PF-03049423,Key,GE-0036,"3-[4-(2-hydroxyethyl)-1-piperazinyl]-7-(6-methoxy-3-pyridinyl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one",-4.553438,x0434,10.194039,active-noncovalent
C[C@H](CO)O,BRD-A19232309-001-08-6,propylene-glycol,Sigma,V003356,propylene glycol,-4.550414,x0397,0.923496,active-noncovalent
CCCCc1nn(c(=O)n1Cc2ccc(cc2)c3ccccc3S(=O)(=O)NC(=O)c4c(ccs4)C)c5ccccc5C(F)(F)F,BRD-K39733634-001-02-6,L-161982,Tocris,2514,"L-161,982",-4.541470,x0434,12.55071,active-noncovalent
CCCCc1nn(c(=O)n1Cc2ccc(cc2)c3ccccc3S(=O)(=O)NC(=O)c4c(ccs4)C)c5ccccc5C(F)(F)F,BRD-K39733634-001-03-4,L-161982,Tocris,2514,"L-161,982",-4.541470,x0434,12.55071,active-noncovalent
C(=N[NH3+])(N)N,BRD-K25114078-003-08-1,aminoguanidine,MicroSource,1506176,PIMAGEDINE HYDROCHLORIDE,-4.528815,x0397,0.398396,active-noncovalent
C(=N[NH3+])(N)N,BRD-K25114078-003-07-3,aminoguanidine,Tocris,787,Aminoguanidine hydrochloride,-4.528815,x0397,0.398396,active-noncovalent
CC(C)[C@@](CCC[N@@H+](C)CCc1ccc(c(c1)OC)OC)(C#N)c2cc(c(c(c2)OC)OC)OC,BRD-A52922642-001-03-7,gallopamil,Enzo,AC103,Methoxy verapamil,-4.519376,x0161,8.101631,active-noncovalent
C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)NC(=[NH2+])N)O)NC(=[NH2+])N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)[NH2+]C)(C=O)O,BRD-K07166362-330-01-0,streptomycin,Selleck,S2572,Streptomycin sulfate,-4.510147,x0434,8.673837,active-noncovalent
C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)NC(=[NH2+])N)O)NC(=[NH2+])N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)[NH2+]C)(C=O)O,BRD-K07166362-330-02-8,streptomycin,Selleck,S2572,Streptomycin sulfate,-4.510147,x0434,8.673837,active-noncovalent
c1cc(cc(c1)N=C=S)NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S,BRD-K91135178-001-03-9,MRS2578,Selleck,S2855,MRS 2578,-4.509168,x0104,7.494547,active-noncovalent
c1cc(cc(c1)N=C=S)NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S,BRD-K91135178-001-02-1,MRS2578,Selleck,S2855,MRS 2578,-4.509168,x0104,7.494547,active-noncovalent
CCC(=O)NO,BRD-K11984358-001-01-3,ZAMI-633,PrincetonBio,OSSM_091798,N-hydroxypropanamide,-4.488156,x0195,-1.14696,active-noncovalent
CCCCCCCCCCCCCCCC(=O)O[C@@H](CC(=O)[O-])C[N+](C)(C)C,BRD-A77577770-003-08-9,palmitoylcarnitine,Tocris,609,(?)-Palmitoylcarnitine chloride,-4.487021,x0434,6.307441,active-noncovalent
CCCCN(CCCC)C(=O)C[N@H+]1C[C@@H]([C@H]([C@@H]1c2ccc(cc2)OC)C(=O)[O-])c3ccc4c(c3)OCO4,BRD-K16295392-003-01-3,atrasentan,MedChemEx,HY-15403A,Atrasentan (hydrochloride),-4.482717,x0678,8.687721,active-noncovalent
Cc1cc(no1)C[NH+]2CCN(CC2)c3c(c[nH+]c4c3[nH]c(n4)c5ccc(cc5)N6CC[NH+](CC6)C)Br,BRD-K03289018-001-02-7,CCT137690,Selleck,S2744,CCT137690,-4.475829,x0395,14.279607,active-noncovalent
Cc1cc(no1)C[NH+]2CCN(CC2)c3c(c[nH+]c4c3[nH]c(n4)c5ccc(cc5)N6CC[NH+](CC6)C)Br,BRD-K03289018-001-03-5,CCT137690,Selleck,S2744,CCT137690,-4.475829,x0395,14.279607,active-noncovalent
Cc1cc(no1)C[NH+]2CCN(CC2)c3c(c[nH+]c4c3[nH]c(n4)c5ccc(cc5)N6CC[NH+](CC6)C)Br,BRD-K03289018-001-04-3,CCT137690,Tocris,4291,CCT 137690,-4.475829,x0395,14.279607,active-noncovalent
Cn1c(nnn1)SC[C@@H]2CS[C@H]3/C(=N\C(=O)/C(=N/OC)/c4csc(n4)N)/C(=O)N3[C@@H]2C(=O)[O-],BRD-A20839672-003-01-5,cefmenoxime,MicroSource,1502422,CEFMENOXIME HYDROCHLORIDE,-4.456473,x0104,9.372732,active-noncovalent
Cc1cc(c(c(c1)C(=O)NO)[N@@](Cc2ccccc2)S(=O)(=O)c3ccc(cc3)OCCNC(=O)c4cc5ccccc5o4)C,BRD-K36198571-001-03-8,WAY-170523,Tocris,2633,WAY 170523,-4.451686,x0678,9.780481,active-noncovalent
Cc1cc(c(c(c1)C(=O)NO)[N@@](Cc2ccccc2)S(=O)(=O)c3ccc(cc3)OCCNC(=O)c4cc5ccccc5o4)C,BRD-K36198571-001-02-0,WAY-170523,Tocris,2633,WAY 170523,-4.451686,x0678,9.780481,active-noncovalent
CCOc1ncc(cn1)Cc2cn(c(nc2=O)SCc3ccc(cc3)F)c4ccc(cc4)C(=O)OCC,BRD-K23614267-001-01-2,GW-1100,MedChemEx,HY-50691,GW-1100,-4.440808,x0434,7.229075,active-noncovalent
C(CS(=O)(=O)[O-])S,BRD-K49954789-001-03-7,mesna,Selleck,S1735,"Mesna (Uromitexan, Mesnex)",-4.433568,x0397,0.337198,active-noncovalent
C(CS(=O)(=O)[O-])S,BRD-K49954789-001-02-9,mesna,MicroSource,1502014,MESNA,-4.433568,x0397,0.337198,active-noncovalent
C(CS(=O)(=O)[O-])S,BRD-K49954789-001-01-1,mesna,Selleck,S1735,Mesna,-4.433568,x0397,0.337198,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3nc2c4ccc(cc4)OC[C@H](C5CC[NH2+]CC5)n6c7ccccc7nc6c8ccccc8,BRD-K90830492-305-01-4,deltarasin,Tocris,5424,Deltarasin,-4.422210,x0305,11.143993,active-noncovalent
C=CC(=O)O,BRD-M00184283-001-01-1,acrylate,Sigma,MFCD00067207,sodium acrylate,-4.420043,x0678,0.219366,active-noncovalent
C(=O)(N)NO,BRD-K51747290-001-13-1,hydroxyurea,MicroSource,1500344,HYDROXYUREA,-4.410717,x0397,-1.103735,active-noncovalent
C(=O)(N)NO,BRD-K51747290-001-15-6,hydroxyurea,Selleck,S1896,Hydroxyurea (Cytodrox),-4.410717,x0397,-1.103735,active-noncovalent
C(=O)(N)NO,BRD-K51747290-001-12-3,hydroxyurea,Selleck,S1896,Hydroxyurea,-4.410717,x0397,-1.103735,active-noncovalent
CC(C)NC(=O)Nc1ccc(cc1C(=O)NCC(=O)N[C@H]2CCCC[C@H]2NC(=O)c3ccc(cc3)SC)C(F)(F)F,BRD-K15119094-001-01-1,BMS-CCR2-22,Tocris,3129,BMS CCR2 22,-4.409105,x0678,12.915223,active-noncovalent
CC(C)c1c2ccccc2n(c1S(=O)(=O)c3ccc(cc3)OCCC[N@@H+](C)CCc4ccc(c(c4)OC)OC)C,BRD-K43002771-034-01-6,SR-33805,Tocris,1806,SR 33805 oxalate,-4.404728,x0104,11.734467,active-noncovalent
CC(C)c1c2ccccc2n(c1S(=O)(=O)c3ccc(cc3)OCCC[N@@H+](C)CCc4ccc(c(c4)OC)OC)C,BRD-K43002771-034-02-4,SR-33805,Tocris,1806,SR 33805 oxalate,-4.404728,x0104,11.734467,active-noncovalent
Cc1cccc(c1NC(=O)CN2CC[NH+](CC2)CCCC(c3ccc(cc3)F)c4ccc(cc4)F)C,BRD-K62996583-001-10-3,lidoflazine,Prestwick,Prestw-381,Lidoflazine,-4.388555,x0967,10.694034,active-noncovalent
Cc1cc(cc(c1)C(=O)N(C)[C@H](Cc2ccc(cc2)c3ccccc3)C(=O)N[C@@H](Cc4c[nH]c5c4cccc5)C(=O)[O-])C,BRD-K98357249-001-02-9,IRL-2500,Tocris,1838,IRL-2500,-4.388355,x0104,10.222955,active-noncovalent
CCOC(=O)[C@H](Cc1ccc(cc1)c2cc(nc(n2)N)O[C@H](c3ccc(cc3n4ccc(n4)C)Cl)C(F)(F)F)[NH3+],BRD-K94559059-091-01-6,telotristat-ethyl,MedChemEx,HY-13055,LX1606 (Hippurate),-4.385844,x0104,13.485196,active-noncovalent
CCOC(=O)[C@H](Cc1ccc(cc1)c2cc(nc(n2)N)O[C@H](c3ccc(cc3n4ccc(n4)C)Cl)C(F)(F)F)[NH3+],BRD-K94559059-091-02-4,telotristat-ethyl,Selleck,S2173,Telotristat Etiprate (LX 1606 Hippurate),-4.385844,x0104,13.485196,active-noncovalent
CCOC(=O)[C@H](Cc1ccc(cc1)c2cc(nc(n2)N)O[C@H](c3ccc(cc3n4ccc(n4)C)Cl)C(F)(F)F)[NH3+],BRD-K94559059-091-03-2,telotristat-ethyl,MedChemEx,HY-13055,"(benzoylamino)acetic acid compound with ethyl (2S)-2-amino-3-{4-[2-amino-6-({(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethyl}oxy)-4-pyrimidinyl]phenyl}propanoate (1:1)",-4.385844,x0104,13.485196,active-noncovalent
CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,BRD-K68552125-001-05-3,12-O-tetradecanoylphorbol-13-acetate,Enzo,PE160,Phorbol 12 myristate 13 acetate,-4.344871,x0072,9.744541,active-noncovalent
c1cc(ccc1N(=O)=O)OC(=O)N2CCC(CC2)C(c3ccc4c(c3)OCO4)(c5ccc6c(c5)OCO6)O,BRD-K45446451-001-06-8,JZL-184,Tocris,3836,JZL 184,-4.341135,x0072,9.46165,active-noncovalent
c1cc(ccc1N(=O)=O)OC(=O)N2CCC(CC2)C(c3ccc4c(c3)OCO4)(c5ccc6c(c5)OCO6)O,BRD-K45446451-001-05-0,JZL-184,Selleck,S4904,JZL184,-4.341135,x0072,9.46165,active-noncovalent
C[C@H]1C(=O)N[C@@H](C(=O)/N=C(/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)[NH3+])[C@H]2CCNC(=[NH2+])N2)\CNC(=O)N)CNC(=O)C[C@@H](CCC[NH3+])[NH3+],BRD-A31362467-065-01-3,capreomycin,MedChemEx,HY-17566,Capreomycin (sulfate),-4.332751,x0104,9.238974,active-noncovalent
CCCC[C@@]1(CS(=O)(=O)c2cc(c(cc2[C@H](N1)c3ccccc3)OC)C[NH2+]C(CC(=O)[O-])CC(=O)[O-])CC,BRD-K05858796-001-01-7,GSK2330672,MedChemEx,HY-16643,GSK2330672,-4.318656,x0072,9.023602,active-noncovalent
CN(Cc1ccccc1)C(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]4CCCN4C(=O)Nc5ccccc5N(=O)=O,BRD-K65820248-001-01-8,SDZ-NKT-343,Tocris,2394,SDZ NKT 343,-4.308163,x0161,9.49703,active-noncovalent
CN(Cc1ccccc1)C(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]4CCCN4C(=O)Nc5ccccc5N(=O)=O,BRD-K65820248-001-02-6,SDZ-NKT-343,Tocris,2394,SDZ NKT 343,-4.308163,x0161,9.49703,active-noncovalent
Cc1c(c2c3c(cc(c2O)NC(=O)/C(=C\C=C/[C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]([C@H]([C@H](/C=C/O[C@@]4(C(=O)c3c1O4)C)OC)C)C(=O)OC)C)O)C)O)C)/C)O)O,BRD-K13277760-001-01-2,rifamycin-sv,Enzo,NP526,Rifamycin sv Na,-4.301668,x0104,14.435106,active-noncovalent
CC(C)C[N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)c3ccc(cc3)N,BRD-K59110290-238-01-7,fosamprenavir,MedChemEx,HY-17431,Fosamprenavir (Calcium Salt),-4.300145,x1093,8.080854,active-noncovalent
CCc1c(nc(c(n1)C(=O)N)Nc2ccc(c(c2)OC)N3CCC(CC3)N4CC[NH+](CC4)C)NC5CCOCC5,BRD-K72280606-001-01-2,gilteritinib,MedChemEx,HY-12432,Gilteritinib,-4.282518,x0104,16.011803,active-noncovalent
c1cc2c(cc[nH+]c2cc1Cl)N3CC[NH+](CC3)CCC[NH+]4CCN(CC4)c5cc[nH+]c6c5ccc(c6)Cl,BRD-K27382019-418-01-9,piperaquine-phosphate,AKSci,H853,,-4.279236,x0395,14.385527,active-noncovalent
CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(c1)NC(=O)Nc2ccc(c(c2)OC)c3cnco3,BRD-K62196610-001-01-6,AVN-944,MedChemEx,HY-13560,AVN-944,-4.277953,x0104,15.193631,active-noncovalent
c1ccc(cc1)Oc2ncc(cn2)C(=O)Nc3ccc(cc3)N4CCC(CC4)C(=O)N5CCOCC5,BRD-K57708067-001-01-3,TFC-007,Tocris,5108,TFC 007,-4.253759,x0305,17.96265,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC=C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,BRD-K81473043-001-19-5,tanespimycin,Selleck,S1141,17-AAG (Tanespimycin),-4.249344,x0072,11.229013,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC=C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,BRD-K81473043-001-14-6,tanespimycin,Selleck,S1141,17-AAG (Tanespimycin),-4.249344,x0072,11.229013,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,BRD-K81849500-001-01-0,verteporfin,Selleck,S1786,Verteporfin (Visudyne),-4.240665,x1249,14.959945,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,BRD-K81849500-001-02-8,verteporfin,Selleck,S1786,Verteporfin (Visudyne),-4.240665,x1249,14.959945,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,BRD-K81849500-001-06-9,verteporfin,Tocris,5305,,-4.240665,x1249,14.959945,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,BRD-K81849500-001-07-7,verteporfin,MedChemEx,HY-B0146,Verteporfin,-4.240665,x1249,14.959945,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,BRD-K81849500-001-05-1,verteporfin,Cayman,17334,,-4.240665,x1249,14.959945,active-noncovalent
CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc2cccc(c2)[N+](C)(C)C,BRD-K51471001-303-04-7,demecarium,Prestwick,Prestw-616,Demecarium bromide,-4.224185,x0831,9.628553,active-covalent
CCCCCCCCCCOc1cc2c(cc1OCC)[nH]cc(c2=O)C(=O)OCC,BRD-K17641316-001-03-0,decoquinate,Selleck,S4145,Decoquinate,-4.221389,x0072,7.130907,active-noncovalent
CCCCCCCCCCOc1cc2c(cc1OCC)[nH]cc(c2=O)C(=O)OCC,BRD-K17641316-001-04-8,decoquinate,MedChemEx,HY-B1036,Decoquinate,-4.221389,x0072,7.130907,active-noncovalent
CCCCCCCCCCOc1cc2c(cc1OCC)[nH]cc(c2=O)C(=O)OCC,BRD-K17641316-001-02-2,decoquinate,Selleck,S4145,Decoquinate,-4.221389,x0072,7.130907,active-noncovalent
CCCCCCCCCCOc1cc2c(cc1OCC)[nH]cc(c2=O)C(=O)OCC,BRD-K17641316-213-01-5,decoquinate,MicroSource,1505356,DECOQUINATE [5mM],-4.221389,x0072,7.130907,active-noncovalent
C[N+]1(CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5OC)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)OC)(C)C)OC)C,BRD-K16484091-001-01-1,metocurine,Specs,AE-562/43459779,,-4.210902,x0395,12.092568,active-noncovalent
CC[C@@]1(C[C@@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)N)O)O)CC)C)C(=O)OC)O,BRD-K59753975-001-02-6,vindesine,AvaChem,2181,"methyl (5S,7S,9S)-9-((3aR,3a1R,4R,5S,5aR,10bR)-5-carbamoyl-3a-ethyl-4,5-dihydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazol-9-yl)-5-ethyl-5-hydroxy-1,4,5,6,7,8,9;,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]",-4.158147,x0072,14.429308,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4C[N@H+]([C@@H]5Cc6c7c(cccc7[nH]c6Br)C5=C4)C)O,BRD-K14496212-066-02-2,bromocriptine,Tocris,427,Bromocriptine mesylate,-4.156972,x0434,13.670049,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4C[N@H+]([C@@H]5Cc6c7c(cccc7[nH]c6Br)C5=C4)C)O,BRD-K14496212-066-04-8,bromocriptine,MicroSource,1500151,BROMOCRIPTINE MESYLATE,-4.156972,x0434,13.670049,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4C[N@H+]([C@@H]5Cc6c7c(cccc7[nH]c6Br)C5=C4)C)O,BRD-K14496212-066-03-0,bromocriptine,Tocris,427,Bromocriptine mesylate,-4.156972,x0434,13.670049,active-noncovalent
Cc1ncc(s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@]3(CO3)C,BRD-A36331462-001-02-1,oprozomib,Selleck,S7049,Oprozomib (ONX 0912),-4.155789,x0678,12.177278,active-noncovalent
CCOc1cc(ccc1C2=[NH+][C@@]([C@](N2C(=O)N3CC[NH+](CC3)CCCS(=O)(=O)C)(C)c4ccc(cc4)Cl)(C)c5ccc(cc5)Cl)C(C)(C)C,BRD-A78210457-001-01-5,RG7112,Selleck,S7030,RG-7112,-4.152674,x0967,20.088173,active-noncovalent
CNC=O,BRD-K33445938-001-01-8,N-methylformamide,Sigma,M46705,methylformamide,-4.152661,x1093,-1.399052,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c4c(c3)O[C@@H](CC4=O)c5cc(cc(c5)OC)O)[O-])CO)O)O)O)O)O,BRD-K96299080-001-02-7,neohesperidin,Selleck,S2332,Neohesperidin,-4.152086,x0104,13.07955,active-noncovalent
CCCCCCCCCCCCCCCCOc1nc2ccc(cc2c(=O)o1)C,BRD-K94863486-001-02-2,cetilistat,Key,KS-1251,"2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one",-4.146159,x0072,9.007248,active-noncovalent
CCCCCCCCCCCCCCCCOc1nc2ccc(cc2c(=O)o1)C,BRD-K94863486-001-01-4,cetilistat,TCI,C2745,,-4.146159,x0072,9.007248,active-noncovalent
Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)c6ccc(o6)CNCCS(=O)(=O)C,BRD-K89709433-001-02-8,HER2-Inhibitor-1,Selleck,S2752,HER2-Inhibitor-1,-4.126129,x0161,17.322569,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)NC(=S)NC(=O)COc3ccc(cc3Cl)Br)C,BRD-K22829793-001-03-6,ZCL-278,Tocris,4794,ZCL 278,-4.119468,x0104,11.287352,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)NC(=S)NC(=O)COc3ccc(cc3Cl)Br)C,BRD-K22829793-001-01-0,ZCL-278,Selleck,S7293,ZCL278,-4.119468,x0104,11.287352,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)NC(=S)NC(=O)COc3ccc(cc3Cl)Br)C,BRD-K22829793-001-02-8,ZCL-278,Selleck,S7293,ZCL 278,-4.119468,x0104,11.287352,active-noncovalent
c1c(ccc(c1)Cl)OCC(=O)N[C@H]2CC[C@@H](CC2)NC(=O)COc3ccc(cc3)Cl,BRD-K12826175-001-02-4,ISRIB,MedChemEx,HY-12495,ISRIB trans-isomer,-4.111131,x0104,14.904017,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,BRD-K80595380-001-09-8,retinyl-palmitate,Sigma,R1512,O~15~-palmitoylretinol,-4.078928,x0072,15.073004,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,BRD-K80595380-001-07-2,retinyl-palmitate,MicroSource,1503604,RETINYL PALMITATE,-4.078928,x0072,15.073004,active-noncovalent
CC(C)Oc1cccc(c1)CC(=O)N2CCC[C@](C2)(CC[N+]34CCC(CC3)(CC4)c5ccccc5)c6ccc(c(c6)Cl)Cl,BRD-K60931454-003-01-3,SR-140333,Tocris,4012,SR 140333,-4.070627,x0395,11.232478,active-noncovalent
CCCCCS(=O)(=O)CCCCCCCCCCn1c2ccc(cc2c(c1c3ccc(cc3)O)C)O,BRD-K05151076-001-02-6,ZK-164015,Tocris,2183,ZK 164015,-4.060063,x0104,9.559905,active-noncovalent
CCCCCS(=O)(=O)CCCCCCCCCCn1c2ccc(cc2c(c1c3ccc(cc3)O)C)O,BRD-K05151076-001-03-4,ZK-164015,Tocris,2183,ZK 164015,-4.060063,x0104,9.559905,active-noncovalent
CCOc1ccc(cc1)n2c(=O)c3cccnc3nc2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(c(c5)C(F)(F)F)F,BRD-A86523169-001-01-0,NBI-74330-(+/-),Tocris,4528,(+/-)-NBI 74330,-4.029470,x0678,9.31138,active-noncovalent
CNC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CCC5(CC4)OCCO5)c(n2)N6C[C@H]7CC[C@@H](C6)O7,BRD-A45498368-001-07-1,WYE-125132,Selleck,S2661,WYE-125132 (WYE-132),-4.008029,x1093,9.523478,active-noncovalent
CN(Cc1cc2c(s1)c(nc(n2)c3ccc(nc3)OC)N4CCOCC4)c5ncc(cn5)C(=O)NO,BRD-K77638923-001-02-0,CUDC-907,Selleck,S2759,CUDC-907,-3.987087,x0104,9.536975,active-noncovalent
C=CC[N@@+]12[C@@H]3[C@@]4([C@H]/5N(c6c4cccc6)/C=C/7\[C@@H]8N(c9c(cccc9)[C@]84[C@H]6[N@+](C/C(=C\CO)/[C@@H]7C6)(CC4)CC=C)/C=C5/[C@@H](C3)/C(=C/CO)/C1)CC2,BRD-A84907376-300-03-8,alcuronium,Prestwick,Prestw-1036,Alcuronium chloride,-3.978959,x0305,13.124684,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(cc1)OCc2ccccc2)C(=O)NC(C)(C)C)[N@@H+](C)Cc3ccc(cc3)C(C)(C)C,BRD-K04426574-001-02-0,PD-173212,Tocris,3552,PD 173212,-3.960006,x0104,10.999812,active-noncovalent
c1ccc(cc1)N(c2ccccc2)c3ncc(cn3)C(=O)NCCCCCCC(=O)NO,BRD-K82928847-001-04-7,ACY-1215,Selleck,S8001,Rocilinostat (ACY-1215),-3.955331,x0072,9.06091,active-noncovalent
CCOc1ccc(cc1)n2c(=O)c3cccnc3nc2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(cc5)OC(F)(F)F,BRD-K90239174-001-01-8,AMG-487,MedChemEx,HY-15319,AMG 487,-3.945235,x0072,11.602209,active-noncovalent
CCOc1ccc(cc1)n2c(=O)c3cccnc3nc2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(cc5)OC(F)(F)F,BRD-A01307728-001-01-4,AMG-487-(+/-),Tocris,4487,(+/-)-AMG 487,-3.945235,x0072,11.602209,active-noncovalent
CCCCCCCCCC(=O)OC1(CC[NH+](CC1)CCCC(=O)c2ccc(cc2)F)c3ccc(cc3)Cl,BRD-K80859331-001-01-5,haloperidol-decanoate,Key,KS-1419,4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl decanoate,-3.936732,x0305,11.270143,active-noncovalent
CC[N+](Cc1ccccc1)(CCC/N=C\2/C(=O)C/C(=N\CCC[N+](Cc3ccccc3)(CC)CC)/C(=O)C2)CC,BRD-K18772613-303-02-4,benzoquinonium-dibromide,Tocris,424,Benzoquinonium dibromide,-3.918353,x0104,19.293797,active-noncovalent
CC(=O)NO,BRD-K21615095-001-08-4,acetohydroxamic-acid,MicroSource,1500103,ACETOHYDROXAMIC ACID,-3.917711,x0397,-0.92173,active-noncovalent
Cc1cc2c(c(c1)C)[N@](CCC[C@@H]2N(c3nn(nn3)C)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)C[C@H]5CC[C@@H](CC5)C(=O)[O-],BRD-K16551357-001-03-2,evacetrapib,Selleck,S2925,Evacetrapib (LY2484595),-3.885365,x1249,9.429461,active-noncovalent
Cc1cc2c(c(c1)C)[N@](CCC[C@@H]2N(c3nn(nn3)C)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)C[C@H]5CC[C@@H](CC5)C(=O)[O-],BRD-K16551357-001-02-4,evacetrapib,Selleck,S2925,Evacetrapib (LY2484595),-3.885365,x1249,9.429461,active-noncovalent
CC(C)[NH+]1CCC(CC1)N(C)c2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,BRD-K02988401-001-01-2,UNC0737,SGC,UNC0737,UNC0737,-3.881845,x0678,8.626967,active-noncovalent
c1cc(c(c(c1)F)F)[C@@H]2CC[C@H](C(=O)N(C2)CC(F)(F)F)NC(=O)N3CCC(CC3)n4c5cccnc5[nH]c4=O,BRD-K91159026-001-01-7,telcagepant,MedChemEx,HY-32709,MK-0974,-3.880137,x0104,16.040977,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)O[C@@H]2C[C@@H](CC[C@H]2C(C)C)C)C(C)C,BRD-A56320380-300-01-6,decamethoxine,Innovapharm,BBS-00029292,"N1,N10-bis(2-(2-isopropyl-5-methylcyclohexyloxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride",-3.879157,x0072,11.154614,active-noncovalent
c1ccc(cc1)NC(=O)Nc2ccc(cc2)c3ccc(cc3)C(=O)[C@@H]4CCC[C@H]4C(=O)[O-],BRD-K81614372-001-02-1,A-922500,Tocris,3587,A 922500,-3.870493,x0072,12.539007,active-noncovalent
CC(C)(C)CC(=O)N(Cc1cccc(c1)OC)[C@H]2C[C@H]([N@@H+](C2)Cc3ccc4c(c3)OCO4)C(=O)N5CC[NH2+]CC5,BRD-K69624312-001-01-1,CUR-61414,Cayman,14931,"N-[(3S,5S)-1-(1,3-benzodioxol-5-ylmethyl)-5-(1-piperazinylcarbonyl)-3-pyrrolidinyl]-N-(3-methoxybenzyl)-3,3-dimethylbutanamide",-3.863431,x1093,9.77713,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)OCc5c(oc(=O)o5)C)C(C)(C)O,BRD-K78485176-001-06-0,olmesartan-medoxomil,Selleck,S1604,Olmesartan Medoxomil,-3.863416,x0434,10.399023,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)OCc5c(oc(=O)o5)C)C(C)(C)O,BRD-K78485176-001-09-4,olmesartan-medoxomil,Tocris,4620,Olmesartan medoxomil,-3.863416,x0434,10.399023,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)OCc5c(oc(=O)o5)C)C(C)(C)O,BRD-K78485176-001-07-8,olmesartan-medoxomil,MicroSource,1505205,OLMESARTAN MEDOXOMIL,-3.863416,x0434,10.399023,active-noncovalent
c1cc(c(c(c1)Cl)COCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O)Cl,BRD-M36487418-001-02-2,vilanterol,MedChemEx,HY-14300A,Vilanterol (trifenatate),-3.849598,x0104,12.738036,active-noncovalent
c1cc(c(c(c1)Cl)COCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O)Cl,BRD-M36487418-001-05-5,vilanterol,MedChemEx,HY-14300A,Vilanterol (trifenatate),-3.849598,x0104,12.738036,active-noncovalent
c1cc(c(c(c1)Cl)COCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O)Cl,BRD-M36487418-001-01-4,vilanterol,MedChemEx,HY-14300A,Vilanterol (trifenatate),-3.849598,x0104,12.738036,active-noncovalent
c1cc(c(c(c1)Cl)COCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O)Cl,BRD-M36487418-001-03-0,vilanterol,MedChemEx,HY-14300A,Vilanterol (trifenatate),-3.849598,x0104,12.738036,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)NC(=S)Nc2ccc(cc2)NC(=O)CCCC[NH+](C)C,BRD-K13949769-001-01-7,tenovin-6,Selleck,S4900,Tenovin-6,-3.848937,x0072,14.936369,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)NC(=S)Nc2ccc(cc2)NC(=O)CCCC[NH+](C)C,BRD-K13949769-003-01-3,tenovin-6,Selleck,S4900,Tenovin-6,-3.848937,x0072,14.936369,active-noncovalent
COc1ccc2c(c1)[nH]c3c2CC[N@H+]4[C@@H]3C[C@H]5[C@@H](C4)C[C@H]([C@@H]([C@H]5C(=O)OC)OC)OC(=O)c6cc(c(c(c6)OC)OC)OC,BRD-K95921201-001-12-0,reserpine,Selleck,S1601,Reserpine,-3.840379,x0104,14.327945,active-noncovalent
COc1ccc2c(c1)[nH]c3c2CC[N@H+]4[C@@H]3C[C@H]5[C@@H](C4)C[C@H]([C@@H]([C@H]5C(=O)OC)OC)OC(=O)c6cc(c(c(c6)OC)OC)OC,BRD-K95921201-001-15-3,reserpine,Selleck,S1601,Reserpine,-3.840379,x0104,14.327945,active-noncovalent
COc1ccc2c(c1)[nH]c3c2CC[N@H+]4[C@@H]3C[C@H]5[C@@H](C4)C[C@H]([C@@H]([C@H]5C(=O)OC)OC)OC(=O)c6cc(c(c(c6)OC)OC)OC,BRD-K95921201-001-14-6,reserpine,MicroSource,1500526,RESERPINE,-3.840379,x0104,14.327945,active-noncovalent
COc1ccc2c(c1)[nH]c3c2CC[N@H+]4[C@@H]3C[C@H]5[C@@H](C4)C[C@H]([C@@H]([C@H]5C(=O)OC)OC)OC(=O)c6cc(c(c(c6)OC)OC)OC,BRD-K95921201-001-13-8,reserpine,Tocris,2742,Reserpine,-3.840379,x0104,14.327945,active-noncovalent
C1[C@H](NC(=[NH+][C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCC[NH3+])[NH3+],BRD-A42379279-065-03-8,viomycin,Prestwick,Prestw-1113,Viomycin sulfate,-3.833158,x0967,17.371134,active-noncovalent
CS(=O)(=O)CCNCc1nc(cs1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,BRD-K79930101-300-03-7,GW-583340,Tocris,2239,GW 583340 dihydrochloride,-3.815665,x0072,17.342066,active-noncovalent
CS(=O)(=O)CCNCc1nc(cs1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,BRD-K79930101-300-04-5,GW-583340,Tocris,2239,GW 583340 dihydrochloride,-3.815665,x0072,17.342066,active-noncovalent
C[C@@H](OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3csc(n3)N)COC)OC(=O)OC(C)C,BRD-A34205213-001-03-9,cefpodoxime,Key,KS-1149,"1-[(isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",-3.812372,x0072,7.205845,active-noncovalent
C[C@@H](OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3csc(n3)N)COC)OC(=O)OC(C)C,BRD-A34205213-001-04-7,cefpodoxime,MicroSource,1505637,CEFPODOXIME PROXETIL,-3.812372,x0072,7.205845,active-noncovalent
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(C)C,BRD-K14276241-001-01-2,daucosterol,MedChemEx,HY-N0410,Daucosterol,-3.811380,x0305,18.40731,active-noncovalent
C(=O)(N)N,BRD-K88052444-001-08-8,urea,MicroSource,1500604,UREA,-3.808804,x0397,-0.818506,active-noncovalent
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCC[NH3+])O)O)O,BRD-K09821361-066-24-1,deferoxamine-mesylate,Sigma,D9533,N~1~-{5-[acetyl(hydroxy)amino]pentyl}-N~4~-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N~4~-hydroxysuccinamide methanesulfonate,-3.798992,x0434,12.203199,active-noncovalent
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCC[NH3+])O)O)O,BRD-K09821361-066-23-3,deferoxamine-mesylate,MicroSource,1500224,DEFEROXAMINE MESYLATE,-3.798992,x0434,12.203199,active-noncovalent
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCC[NH3+])O)O)O,BRD-K09821361-066-25-8,deferoxamine-mesylate,MedChemEx,HY-B0988,Deferoxamine (mesylate),-3.798992,x0434,12.203199,active-noncovalent
CC[N@H+]1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@]([C@H]31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)c7ccccc7n8c(cc(c8O)C)O,BRD-K43192255-048-02-8,methyllycaconitine,Tocris,1029,Methyllycaconitine citrate,-3.792978,x0072,12.160609,active-noncovalent
CC[N@H+]1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@]([C@H]31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)c7ccccc7n8c(cc(c8O)C)O,BRD-K43192255-048-01-0,methyllycaconitine,Tocris,1029,"((3S,6S,6aR,7R,7aR,8S,9R,10S,11aS,12R,12aR,13S,14S)-1-ethyl-11a,12-dihydroxy-6,8,10,13-tetramethoxydodecahydro-2H-3,6a,12-(epie",-3.792978,x0072,12.160609,active-noncovalent
CC[N@H+]1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@]([C@H]31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)c7ccccc7n8c(cc(c8O)C)O,BRD-K43192255-048-03-6,methyllycaconitine,Tocris,1029,Methyllycaconitine citrate,-3.792978,x0072,12.160609,active-noncovalent
CC(C)(c1cc(no1)NC(=O)Nc2cccc(c2)Oc3c4cc(c(cc4ncn3)OC)OC)C(F)(F)F,BRD-K20722021-001-02-1,CEP-32496,Selleck,S8015,CEP-32496,-3.785359,x0104,14.708432,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC)c2ccc(cc2)N(=O)=O)C(=O)NCCC[NH+]3CCC(CC3)(c4ccccc4)c5ccccc5,BRD-A21428877-003-02-7,SNAP-5089,Tocris,2398,SNAP 5089,-3.731285,x0967,12.867901,active-noncovalent
CCCc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccc(nc4)N5CC[NH+](CC5)C(C)C)C,BRD-K26989966-001-03-5,UNC1999,Selleck,S7165,UNC1999,-3.713251,x0305,15.353126,active-noncovalent
CCCc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccc(nc4)N5CC[NH+](CC5)C(C)C)C,BRD-K26989966-001-05-0,UNC1999,Tocris,4904,UNC 1999,-3.713251,x0305,15.353126,active-noncovalent
CCCc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccc(nc4)N5CC[NH+](CC5)C(C)C)C,BRD-K26989966-001-04-3,UNC1999,Selleck,S7165,UNC1999,-3.713251,x0305,15.353126,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C,BRD-A44511856-001-01-4,ginsenoside-rg3,MedChemEx,HY-N0603,Ginsenoside Rg3,-3.710058,x0305,25.674458,active-noncovalent
CCOc1cn(nc1C(=O)Nc2ccc(c(c2)F)Oc3ccnc4c3cc(c(c4)OC)OC)c5ccc(cc5C)F,BRD-K44715996-001-01-0,LDC1267,MedChemEx,HY-12494,LDC1267,-3.710005,x0395,17.523216,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-],BRD-K48470486-236-11-6,cefmetazole,MedChemEx,HY-B1257,Cefmetazole (sodium),-3.703678,x0397,5.721049,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-],BRD-K48470486-236-12-4,cefmetazole,MicroSource,1502040,CEFMETAZOLE SODIUM,-3.703678,x0397,5.721049,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-],BRD-K48470486-236-10-8,cefmetazole,MedChemEx,HY-B1257,Cefmetazole (sodium),-3.703678,x0397,5.721049,active-noncovalent
CS(=O)(=O)F,BRD-K53896891-001-01-2,methanesulfonyl-fluoride,Sigma,MFCD00007423,methanesulfonyl fluoride,-3.693915,x0195,1.273013,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K52117081-396-01-8,ceftazidime,MicroSource,1505782,CEFTAZIDIME,-3.693131,x0104,9.154691,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K52117081-001-02-2,ceftazidime,MedChemEx,HY-B0593,Ceftazidime,-3.693131,x0104,9.154691,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K52117081-001-03-0,ceftazidime,MedChemEx,HY-B0593,Ceftazidime,-3.693131,x0104,9.154691,active-noncovalent
CC(C)(C(=O)[O-])O/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccccc4)C(=O)[O-],BRD-K52117081-345-03-1,ceftazidime,Sigma,MFCD00153936,"(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]ethanoyl}amino)-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate",-3.693131,x0104,9.154691,active-noncovalent
C1C[NH+]=C(N[C@@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)/N=C(/C(=O)N2)\CNC(=O)N)CNC(=O)C[C@@H](CCC[NH3+])[NH3+])CO)[NH3+])N,BRD-A33801468-065-04-1,capreomycin,MicroSource,1500157,CAPREOMYCIN SULFATE [4mM],-3.669968,x0104,10.200433,active-noncovalent
CC(C)O,BRD-M08274809-001-01-7,indium(iii)-isopropoxide,AlfaAesar,42098,"Indium(III) isopropoxide, 99.9% (metals basis)",-3.650518,x1093,0.690026,active-noncovalent
CS(=O)C,BRD-M56212252-001-01-0,DMSO,Sigma,41639,(methylsulfinyl)methane,-3.647074,x0195,0.347408,active-noncovalent
CCc1cccc(c1NC(=O)c2c3c(n(n2)C)-c4c(cnc(n4)Nc5ccc(cc5OC(F)(F)F)C(=O)NC6CC[NH+](CC6)C)CC3)CC,BRD-K54170555-001-01-8,NMS-P715,MedChemEx,HY-12382,NMS-P715,-3.620384,x1249,28.286079,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC[NH+](C)C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,BRD-K83988098-003-03-4,alvespimycin,Selleck,S1142,17-DMAG HCl (Alvespimycin),-3.573339,x0072,14.258962,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC[NH+](C)C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,BRD-K83988098-001-02-0,alvespimycin,Selleck,S1142,17-DMAG (Alvespimycin) HCl,-3.573339,x0072,14.258962,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)O[C@@H](C)OC(=O)OC6CCCCC6,BRD-A65671304-001-08-3,candesartan-cilextil,MicroSource,1504261,CANDESARTAN CILEXTIL,-3.569921,x0967,12.691251,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)O[C@@H](C)OC(=O)OC6CCCCC6,BRD-A65671304-001-07-5,candesartan-cilextil,Selleck,S2037,Candesartan Cilexetil,-3.569921,x0967,12.691251,active-noncovalent
C[C@H]([NH2+][C@H]1CC[C@@H](CC1)Nc2ncc(c(c2)c3nc(ccc3)NCC4(CCOCC4)C#N)Cl)COC,BRD-K43914553-001-01-5,CDK9-IN-6,MedChemEx,HY-12214,CDK9-IN-6,-3.545814,x0395,13.437067,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)Oc2c(=O)c3c(cc(c(c3oc2c4ccc(cc4)OC)CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[O-])O)O)O,BRD-K65639003-001-10-8,icariin,Selleck,S2312,Icariin,-3.530054,x0104,14.573095,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)Oc2c(=O)c3c(cc(c(c3oc2c4ccc(cc4)OC)CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[O-])O)O)O,BRD-K65639003-001-09-0,icariin,Selleck,S2312,Icariin,-3.530054,x0104,14.573095,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,BRD-K15898725-001-01-7,maytansinol-isobutyrate,MedChemEx,HY-15739,Ansamitocin P-3,-3.529337,x0967,12.637466,active-noncovalent
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O,BRD-K98006098-001-01-6,oleandrin,MedChemEx,HY-13719,Oleandrin,-3.473563,x0072,13.524108,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,BRD-K53252847-001-01-3,ansamitocin-p-3,MedChemEx,HY-15739,Ansamitocin P-3,-3.462877,x0104,13.056458,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,BRD-K53252847-001-03-9,ansamitocin-p-3,MedChemEx,HY-15739,Ansamitocin P-3,-3.462877,x0104,13.056458,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,BRD-K53252847-001-02-1,ansamitocin-p-3,MedChemEx,HY-15739,Ansamitocin P-3,-3.462877,x0104,13.056458,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,BRD-K86856088-001-06-9,UNC0638,MedChemEx,HY-15273,UNC0638,-3.459404,x0305,9.125933,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,BRD-K86856088-001-08-5,UNC0638,Tocris,4343,UNC 0638,-3.459404,x0305,9.125933,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,BRD-K86856088-001-07-7,UNC0638,MedChemEx,HY-15273,UNC0638,-3.459404,x0305,9.125933,active-noncovalent
Cc1cccc(c1)NC(=O)Nc2cnn(c2)c3cccc(c3)C(=O)Nc4cc(c(c(c4)OC)OC)OC,BRD-K50378376-001-01-8,SR-3576,Tocris,5044,SR 3576,-3.452864,x0104,15.042464,active-noncovalent
c1cc(ccc1[C@]2(C[C@H]2C3CCCCC3)C(=O)Nc4ncc(s4)SCC[NH+]5CCCC5)S(=O)(=O)C6CC6,BRD-K12068470-001-02-5,LY2608204,Selleck,S2155,LY2608204,-3.419956,x0072,9.70804,active-noncovalent
c1cc(ccc1[C@]2(C[C@H]2C3CCCCC3)C(=O)Nc4ncc(s4)SCC[NH+]5CCCC5)S(=O)(=O)C6CC6,BRD-K12068470-001-03-3,LY2608204,MedChemEx,HY-13529,LY2608204,-3.419956,x0072,9.70804,active-noncovalent
c1cc(ccc1[C@]2(C[C@H]2C3CCCCC3)C(=O)Nc4ncc(s4)SCC[NH+]5CCCC5)S(=O)(=O)C6CC6,BRD-K12068470-001-04-1,LY2608204,Selleck,S2155,LY2608204,-3.419956,x0072,9.70804,active-noncovalent
CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)CC[NH2+]C[C@@H](COc3ccc(cc3)O)O,BRD-K39359968-001-01-8,L-755507,Tocris,2197,"L-755,507",-3.400533,x1077,9.279369,active-noncovalent
CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)CC[NH2+]C[C@@H](COc3ccc(cc3)O)O,BRD-K39359968-001-02-6,L-755507,Tocris,2197,"L-755,507",-3.400533,x1077,9.279369,active-noncovalent
C[NH+]1CCC(CC1)COc2cnc(nc2)c3cccc(c3)Cn4c(=O)ccc(n4)c5cccc(c5)C#N,BRD-K97963946-001-01-3,EMD-1214063,MedChemEx,HY-14721,EMD-1214063,-3.392385,x0104,11.213094,active-noncovalent
COc1cc(cc(c1O)OC)[C@@H]2c3cc4c(cc3[C@H]([C@@H]5[C@@H]2C(=O)OC5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)c8cccs8)O)O)OCO4,BRD-K10362825-001-04-2,teniposide,Selleck,S1787,Teniposide,-3.367583,x0104,14.061766,active-noncovalent
COc1cc(cc(c1O)OC)[C@@H]2c3cc4c(cc3[C@H]([C@@H]5[C@@H]2C(=O)OC5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)c8cccs8)O)O)OCO4,BRD-K10362825-001-03-4,teniposide,Selleck,S1787,Teniposide (Vumon),-3.367583,x0104,14.061766,active-noncovalent
COCc1c(n2c(c1c3ccc(c(c3)F)NC(=O)Nc4cc(ccc4F)C(F)(F)F)c(ncn2)N)C[NH+]5CCOCC5,BRD-K35936936-001-01-6,ACTB-1003,MedChemEx,HY-16025,ACTB-1003,-3.359243,x0072,15.048416,active-noncovalent
C[N@@]([C@@H](Cc1ccc(cc1)OS(=O)(=O)c2cccc3c2ccnc3)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7c6ccnc7,BRD-A81177136-001-12-7,KN-62,MedChemEx,HY-13290,KN-62,-3.346978,x0104,17.599571,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)[O-])OC)C,BRD-A99367815-001-03-1,fumagillin,MedChemEx,HY-B0751,Fumagillin,-3.281434,x1249,9.2621,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)[O-])OC)C,BRD-A99367815-001-01-5,fumagillin,Enzo,CT100,Fumagillin,-3.281434,x1249,9.2621,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)[O-])OC)C,BRD-A99367815-001-04-9,fumagillin,MedChemEx,HY-B0751,Fumagillin,-3.281434,x1249,9.2621,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn(c(=O)n1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,BRD-K32007074-001-01-1,enocitabine,Carbosynth,ENOCITABINE,"N-(1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide",-3.280086,x0104,12.496081,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn(c(=O)n1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,BRD-K32007074-001-02-9,enocitabine,AKSci,67699,,-3.280086,x0104,12.496081,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CCC(=C5)C(=O)N)O)O)O)O)N,BRD-A84188517-304-02-9,coenzyme-i,SantaCruz,sc-215562,,-3.279376,x0195,11.072023,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CCC(=C5)C(=O)N)O)O)O)O)N,BRD-A84188517-304-01-1,coenzyme-i,Apollo,BIB3012,,-3.279376,x0195,11.072023,active-noncovalent
Cc1c(cn2c1c(ncn2)Nc3ccc4c(c3)cnn4Cc5cccc(c5)F)NC(=O)OC[C@@H]6COCC[NH2+]6,BRD-K07106112-300-01-2,BMS-599626,Tocris,5022,BMS 599626 dihydrochloride,-3.237447,x0395,21.021549,active-noncovalent
Cc1c(cn2c1c(ncn2)Nc3ccc4c(c3)cnn4Cc5cccc(c5)F)NC(=O)OC[C@@H]6COCC[NH2+]6,BRD-K07106112-003-03-8,BMS-599626,Selleck,S1056,AC480 (BMS-599626),-3.237447,x0395,21.021549,active-noncovalent
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,BRD-K19687926-001-04-1,lapatinib,Selleck,S2111,Lapatinib,-3.236952,x0072,21.022821,active-noncovalent
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,BRD-K19687926-379-07-4,lapatinib,Selleck,S1028,Lapatinib (GW-572016) Ditosylate,-3.236952,x0072,21.022821,active-noncovalent
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,BRD-K19687926-001-10-8,lapatinib,Selleck,S1028,Lapatinib,-3.236952,x0072,21.022821,active-noncovalent
Cc1ccc(cc1Cl)N(CCC[NH+]2CCC(CC2)Cc3ccc(cc3)C(=O)N)C(=O)C4CCN(CC4)C(=O)C,BRD-K38793468-001-01-4,TAK-220,MedChemEx,HY-19974,TAK-220,-3.225996,x0305,15.483884,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c(c(c3)O)C(=O)CCc4ccc(c(c4)O)OC)O)CO)O)O)O)O)O,BRD-K61032563-001-02-9,neohesperidin-dihydrochalcone,Selleck,S2331,Neohesperidin Dihydrochalcone (Nhdc),-3.191289,x0072,13.087715,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)c7c(c8c([nH]7)[C@H]9[C@@]12CC[N@@H+]([C@@H]([C@@]1(C8)O)Cc1c2c(c(cc1)O)O9)CC1CC1)C5)O)O,BRD-K36381762-300-02-7,nor-Binaltorphimine-dihydrochloride,Tocris,347,nor-Binaltorphimine dihydrochloride,-3.168701,x0072,15.361942,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)c7c(c8c([nH]7)[C@H]9[C@@]12CC[N@@H+]([C@@H]([C@@]1(C8)O)Cc1c2c(c(cc1)O)O9)CC1CC1)C5)O)O,BRD-K36381762-300-03-5,nor-Binaltorphimine-dihydrochloride,Tocris,347,nor-Binaltorphimine dihydrochloride,-3.168701,x0072,15.361942,active-noncovalent
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC,BRD-K76694128-001-05-0,rebastinib,Selleck,S2634,DCC-2036 (Rebastinib),-3.130574,x0305,17.7666,active-noncovalent
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC,BRD-K76694128-001-04-3,rebastinib,Selleck,S2634,DCC-2036 (Rebastinib),-3.130574,x0305,17.7666,active-noncovalent
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC,BRD-K76694128-001-07-6,rebastinib,MedChemEx,HY-13024,DCC-2036,-3.130574,x0305,17.7666,active-noncovalent
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC,BRD-K76694128-001-06-8,rebastinib,MedChemEx,HY-13024,DCC-2036,-3.130574,x0305,17.7666,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3c(cnc(n3)Nc4ccc(cc4OC)N5CCN(CC5)C(=O)C)Cl,BRD-K40604024-001-01-6,KRCA-0008,Tocris,5098,KRCA 0008,-3.120428,x0967,16.759609,active-noncovalent
CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,BRD-K63343048-001-12-2,orlistat,Selleck,S1629,Orlistat,-3.105613,x0831,13.217445,active-covalent
CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,BRD-K63343048-001-13-0,orlistat,Tocris,3540,Orlistat,-3.105613,x0831,13.217445,active-covalent
COc1cc(cc(c1OC)OC)C(=O)OCCC[N@H+]2CCC[N@](CC2)CCCOC(=O)c3cc(c(c(c3)OC)OC)OC,BRD-K48722258-300-11-0,dilazep,MicroSource,1502263,DILAZEP DIHYDROCHLORIDE,-3.073029,x0967,12.505043,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)OCCC[N@H+]2CCC[N@](CC2)CCCOC(=O)c3cc(c(c(c3)OC)OC)OC,BRD-K48722258-300-10-2,dilazep,Tocris,481,Dilazep,-3.073029,x0967,12.505043,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)C(=O)Nc3ccc(c(c3)OCC[NH+](C)C)OC)c4nc(on4)C,BRD-K30867024-003-03-3,SB-216641,Tocris,1242,SB 216641 hydrochloride,-3.017460,x0305,18.393383,active-noncovalent
CON,BRD-K79277568-003-04-7,methoxyamine,Otava,1270718,,-2.995533,x0195,0.888945,active-noncovalent
C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N/OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C,BRD-K61988078-001-01-2,moxidectin,MicroSource,1505394,MOXIDECTIN,-2.927108,x0967,13.55972,active-noncovalent
C[C@@H](C(=O)N[C@@H](Cc1ccc(cc1)OC)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(CO3)C)NC(=O)C[NH+]4CCOCC4,BRD-K60446698-001-01-2,ONX-0914,Selleck,S7172,ONX-0914 (PR-957),-2.914200,x0104,13.617293,active-noncovalent
Cc1ccc(cc1C#Cc2cc3cn[nH]c3nc2)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[NH+]5CCN(CC5)C,BRD-K35329391-334-01-7,GZD824,Selleck,S7194,GZD824,-2.907241,x0395,15.742638,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1C[N@@](CC[N@H+]1C[C@H](C[C@@H](Cc2ccccc2)C(=O)N[C@H]3c4ccccc4C[C@H]3O)O)Cc5cccnc5,BRD-K33226500-001-01-0,indinavir,Enzo,AC2017,INDINAVIR,-2.900762,x0104,15.655647,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCO,BRD-K50050533-001-04-7,docosanol,Selleck,S1637,Docosanol (Abreva),-2.888496,x0395,9.535068,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCO,BRD-K50050533-001-03-9,docosanol,MicroSource,1505729,DOCOSANOL,-2.888496,x0395,9.535068,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCO,BRD-K50050533-001-02-1,docosanol,Selleck,S1637,Docosanol (Abreva),-2.888496,x0395,9.535068,active-noncovalent
CCO/N=C(\c1nc(sn1)NP(=O)([O-])[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Sc4nc(cs4)c5cc[n+](cc5)C)C(=O)[O-],BRD-K37252028-349-01-8,ceftaroline-fosamil,GLSyntech,JN-0957,"4-(2-(((6R,7R)-2-carboxy-7-((E)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)thio)thiazol-4-yl)-1-methylpyridin-1-ium acetate hy;drate",-2.882991,x0072,20.229099,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)N4CCC(CC4)(F)F)OCCC[NH+]5CCCC5)OC,BRD-K60130390-001-02-1,UNC0642,MedChemEx,HY-13980,UNC0642,-2.866310,x0887,12.039933,dimer-interface
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)N4CCC(CC4)(F)F)OCCC[NH+]5CCCC5)OC,BRD-K60130390-001-04-7,UNC0642,Tocris,5132,UNC 0642,-2.866310,x0887,12.039933,dimer-interface
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)N4CCC(CC4)(F)F)OCCC[NH+]5CCCC5)OC,BRD-K60130390-001-03-9,UNC0642,MedChemEx,HY-13980,UNC0642,-2.866310,x0887,12.039933,dimer-interface
c1ccc(cc1)NC(=O)Nc2ccc(cc2)c3ccc(cc3)C(=O)[C@@H]4CCC[C@@H]4C(=O)[O-],BRD-K28861668-001-01-9,A922500,Selleck,S2674,A922500,-2.863720,x1385,13.588096,active-covalent
Cc1c(cccc1NC(=O)c2cc3c(s2)CCCC3)c4cn(c(=O)c(n4)Nc5ccc(cc5)[C@H]6C(=O)N(CC[N@@H+]6C)C)C,BRD-A30984645-001-01-5,GDC-0834,MedChemEx,HY-15427A,GDC-0834 (Racemate),-2.859759,x0305,14.607418,active-noncovalent
Cc1c(cccc1NC(=O)c2cc3c(s2)CCCC3)c4cn(c(=O)c(n4)Nc5ccc(cc5)[C@H]6C(=O)N(CC[N@@H+]6C)C)C,BRD-A30984645-001-02-3,GDC-0834,MedChemEx,HY-15427A,GDC-0834 (Racemate),-2.859759,x0305,14.607418,active-noncovalent
C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])[NH+](CP(=O)([O-])[O-])CP(=O)([O-])[O-],BRD-K54542929-001-01-7,EDTMP,Vitas-M,STK368766,,-2.841277,x0195,3.363294,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)S(=O)(=O)C)OCc3nnc(n3c4cccnc4)SC5CCCC5,BRD-K26253904-001-01-5,NMS-873,Selleck,S7285,NMS-873,-2.797006,x0072,15.613496,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)S(=O)(=O)C)OCc3nnc(n3c4cccnc4)SC5CCCC5,BRD-K26253904-001-03-1,NMS-873,MedChemEx,HY-15713,NMS-873,-2.797006,x0072,15.613496,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(cc1)OC)c2ncccn2,BRD-K13387373-004-15-2,thonzonium,MicroSource,1503873,THONZONIUM BROMIDE,-2.782665,x0305,10.149302,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(cc1)OC)c2ncccn2,BRD-K13387373-004-14-5,thonzonium,Selleck,S4355,Thonzonium Bromide,-2.782665,x0305,10.149302,active-noncovalent
c1cc(c(cc1C[C@H](C(=O)[O-])OC(=O)/C=C/c2ccc(c3c2[C@H]([C@@H](O3)c4ccc(c(c4)O)O)C(=O)O[C@H](Cc5ccc(c(c5)O)O)C(=O)[O-])O)O)O,BRD-K18898553-001-01-1,salvianolic-acid-B,AvaChem,1069,"(2R)-2-({(2E)-3-[(2R,3R)-3-({[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl]oxy}carbonyl)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]-2-propenoyl}oxy)-3-(3,4-dihydroxyphenyl)propano",-2.747507,x0305,18.950724,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@H](Cc1cn(c2c1cccc2)C)C(=O)N[C@H](Cc3ccccn3)C(=O)[O-])NC(=O)N4CCCCCC4,BRD-K19318328-001-01-3,FR-139317,Tocris,1210,FR 139317,-2.719013,x0161,13.130622,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@H](Cc1cn(c2c1cccc2)C)C(=O)N[C@H](Cc3ccccn3)C(=O)[O-])NC(=O)N4CCCCCC4,BRD-K19318328-001-02-1,FR-139317,Tocris,1210,FR 139317,-2.719013,x0161,13.130622,active-noncovalent
C[C@@H](c1cccn2c1[nH+]c(c2)c3ccc(cc3)C[C@@H](CNC(=O)C[NH+](C)C)NC(=O)c4ccc(c(c4)Cl)OC(C)C)O,BRD-K89015388-001-01-7,GSK923295,MedChemEx,HY-10299,GSK-923295,-2.687134,x1249,14.572721,active-noncovalent
CC(Oc1c(cc2c(c1)[C@@H](N(C(=O)C2)c3ccc(cc3)N(C[C@H]4CC[C@@H](CC4)[N@H+]5CC(=O)N(CC5)C)C)c6ccc(cc6)Cl)OC)C,BRD-K79584249-001-01-3,CGM097,MedChemEx,HY-15954,NVP-CGM097,-2.684456,x1249,16.446434,active-noncovalent
CC(Oc1c(cc2c(c1)[C@@H](N(C(=O)C2)c3ccc(cc3)N(C[C@H]4CC[C@@H](CC4)[N@H+]5CC(=O)N(CC5)C)C)c6ccc(cc6)Cl)OC)C,BRD-K79584249-001-02-1,CGM097,MedChemEx,HY-15954,NVP-CGM097,-2.684456,x1249,16.446434,active-noncovalent
COc1c(cnc(n1)OC)c2ccc3c(c2)ncc(c3Nc4cc(cc(c4)Oc5cc(cc(c5)F)F)C(=O)[O-])S(=O)(=O)NC6CC6,BRD-K50679358-001-01-1,GSK-2837808A,Tocris,5189,GSK 2837808A,-2.668043,x0305,10.888965,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(c4c3cccc4)OCC[NH+]5CCOCC5,BRD-K74065929-001-07-2,doramapimod,Selleck,S1574,BIRB 796 (Doramapimod),-2.652793,x0305,14.740535,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(c4c3cccc4)OCC[NH+]5CCOCC5,BRD-K74065929-001-08-0,doramapimod,Selleck,S1574,BIRB 796 (Doramapimod),-2.652793,x0305,14.740535,active-noncovalent
CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,BRD-K01294196-001-01-5,sucrose-octaacetate,Acros,41979,"Sucrose octaacetate, 98%",-2.647281,x0395,12.636116,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)[NH2+][C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO,BRD-K44276885-001-08-2,acarbose,MicroSource,1505172,ACARBOSE,-2.630922,x0104,17.09903,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)[NH2+][C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO,BRD-K44276885-001-07-4,acarbose,Selleck,S1271,Acarbose,-2.630922,x0104,17.09903,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)[NH2+][C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO,BRD-K44276885-001-06-6,acarbose,Tocris,2673,Acarbose,-2.630922,x0104,17.09903,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)[NH2+][C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO,BRD-K44276885-001-05-8,acarbose,Tocris,2673,Acarbose,-2.630922,x0104,17.09903,active-noncovalent
COCCN1CC[NH+](CC1)Cc2ccc(cc2)c3c4c([nH]n3)-c5cccc(c5C4=O)NC(=O)N[NH+]6CCOCC6,BRD-K20986415-001-01-8,RGB-286638,MedChemEx,HY-15504A,RGB-286638 (free base),-2.629794,x0305,16.811008,active-noncovalent
COCCN1CC[NH+](CC1)Cc2ccc(cc2)c3c4c([nH]n3)-c5cccc(c5C4=O)NC(=O)N[NH+]6CCOCC6,BRD-K20986415-001-02-6,RGB-286638,MedChemEx,HY-15504A,RGB-286638 (free base),-2.629794,x0305,16.811008,active-noncovalent
COC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CC[NH+](CC4)Cc5cccnc5)c(n2)N6CCOCC6,BRD-K49900195-300-01-8,WYE-687,Tocris,4282,WYE 687,-2.584447,x0305,13.067108,active-noncovalent
CSCC[C@@H](C(=O)[O-])NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],BRD-A38218502-001-01-2,metenkephalin,MPBio,2190430,[Met5]-ENKEPHALIN,-2.578515,x0434,12.25456,active-noncovalent
CCN(c1cc(cc(c1C)C(=O)NCc2c(cc([nH]c2=O)C)C)c3ccc(cc3)C[NH+]4CCOCC4)C5CCOCC5,BRD-K11215326-001-03-7,tazemetostat,Selleck,S7128,EPZ-6438 (E7438),-2.578074,x0072,11.56185,active-noncovalent
CCN(c1cc(cc(c1C)C(=O)NCc2c(cc([nH]c2=O)C)C)c3ccc(cc3)C[NH+]4CCOCC4)C5CCOCC5,BRD-K11215326-001-02-9,tazemetostat,Selleck,S7128,EPZ-6438,-2.578074,x0072,11.56185,active-noncovalent
Cc1nc(c(cn1)CN(/C(=C(/SS/C(=C(/N(C=O)Cc2c(nc(nc2)C)N)\C)/CCOC(=O)C(C)C)\CCOC(=O)C(C)C)/C)C=O)N,BRD-K12539416-001-01-4,sulbutiamine,AKSci,O483,,-2.550045,x0104,14.437572,active-noncovalent
Cc1cccc(c1OCC(=O)N[C@@H](Cc2ccccc2)[C@H](C[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O)C,BRD-K99451608-001-07-3,lopinavir,Selleck,S1380,Lopinavir,-2.535317,x0104,14.471954,active-noncovalent
N(=O)[O-],BRD-K61230716-236-03-5,sodium-nitrite,Selleck,S4074,Sodium Nitrite,-2.463639,x0397,-0.407618,active-noncovalent
N(=O)[O-],BRD-K61230716-236-02-7,sodium-nitrite,Selleck,S4074,Sodium Nitrite,-2.463639,x0397,-0.407618,active-noncovalent
CC(=O)N(C)c1c(c(c(c(c1I)C(=O)NCC(=O)Nc2c(c(c(c(c2I)C(=O)[O-])I)C(=O)NCCO)I)I)C(=O)NC)I,BRD-K79124250-001-08-9,ioxaglic-acid,Prestwick,Prestw-1062,Ioxaglic acid,-2.435351,x0072,20.760183,active-noncovalent
Cc1ccn2c(c1)nc3c2c4c(c5c3c6c(c(c5O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C\C=C(/C(=O)N4)\C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K92838188-001-02-7,rifaximin,Selleck,S1790,Rifaximin,-2.387988,x0967,18.808136,active-noncovalent
Cc1ccn2c(c1)nc3c2c4c(c5c3c6c(c(c5O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C\C=C(/C(=O)N4)\C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K92838188-001-01-9,rifaximin,MicroSource,1505321,RIFAXIMIN,-2.387988,x0967,18.808136,active-noncovalent
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N3CCOC[C@H]3C(=O)N4CCC(CC4)CC(=O)[O-],BRD-K55216666-001-01-4,TCS-2314,Tocris,3900,TCS 2314,-2.294621,x0104,13.367537,active-noncovalent
CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)C[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC,BRD-K04269837-346-01-8,vinorelbine,MedChemEx,HY-12053A,Vinorelbine (ditartrate),-2.257041,x0072,18.249153,active-noncovalent
CC[N@@H+](CCCOc1ccc2c(c1)ncnc2Nc3cc([nH]n3)CC(=O)Nc4cccc(c4)F)CCO,BRD-K63923597-001-10-0,barasertib-HQPA,Selleck,S1147,Barasertib (AZD1152-HQPA),-2.226013,x0305,18.911572,active-noncovalent
CC[N@@H+](CCCOc1ccc2c(c1)ncnc2Nc3cc([nH]n3)CC(=O)Nc4cccc(c4)F)CCO,BRD-K63923597-001-11-8,barasertib-HQPA,Selleck,S1147,Barasertib (AZD1152-HQPA),-2.226013,x0305,18.911572,active-noncovalent
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC=C)O)O,BRD-K41458421-034-01-6,naloxegol,MedChemEx,HY-A0118A,Naloxegol (oxalate),-2.207886,x0678,15.246779,active-noncovalent
CC(C)(C)CC(C)(C)c1cc(c(c(c1)n2nc3ccccc3n2)O)Cc4cc(cc(c4O)n5nc6ccccc6n5)C(C)(C)CC(C)(C)C,BRD-K00228584-396-01-8,bisoctrizole,MicroSource,1503866,BISOCTRIZOLE,-2.163276,x0967,11.059917,active-noncovalent
CCCCc1c(c2cc(ccc2o1)NS(=O)(=O)C)C(=O)c3ccc(cc3)OCCC[NH+](CCCC)CCCC,BRD-K05524748-003-04-4,dronedarone,Selleck,S2114,Dronedarone HCl,-2.152409,x1249,12.150873,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-003-07-3,irinotecan,MedChemEx,HY-16562A,irinotecan,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-394-03-5,irinotecan,Selleck,S2217,Irinotecan HCl Trihydrate,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-003-06-5,irinotecan,Tocris,2688,CPT 11,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-001-06-9,irinotecan,Selleck,S1198,Irinotecan,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-001-04-4,irinotecan,Selleck,S1198,Irinotecan,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-003-04-0,irinotecan,Tocris,2688,CPT 11,-2.139241,x0305,15.075001,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,BRD-K08547377-003-05-7,irinotecan,MicroSource,1505821,IRINOTECAN HYDROCHLORIDE,-2.139241,x0305,15.075001,active-noncovalent
C[C@H]1[C@@H](C(CC(=O)C1=O)(C)C)/C=C/C(=C/C=C/C(=C/C/C=C/[C@@H](C)/C=C/C=C(\C)/C=C/C2=C(C(=O)C(=O)CC2(C)C)C)/C)/C,BRD-K51832961-001-01-4,astaxanthin,Cayman,70685,,-2.114104,x0887,14.098369,dimer-interface
CC[C@@H]1[C@@]([C@@H]([C@H]([N@@H+](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)C)O)(C)O,BRD-K74501079-001-15-7,azithromycin,MicroSource,1503679,AZITHROMYCIN,-2.093890,x0395,18.651548,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H]([N@@H+](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)C)O)(C)O,BRD-K74501079-001-17-3,azithromycin,Tocris,3771,Azithromycin,-2.093890,x0395,18.651548,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H]([N@@H+](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)C)O)(C)O,BRD-K74501079-001-18-1,azithromycin,Selleck,S1835,Azithromycin,-2.093890,x0395,18.651548,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H]([N@@H+](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)C)O)(C)O,BRD-K74501079-335-01-9,azithromycin,Selleck,S4147,Azithromycin Dihydrate,-2.093890,x0395,18.651548,active-noncovalent
c1cc(cc(c1)C(=O)NCC(=O)N2C[C@H](CC2)[NH2+][C@H]3CC[C@@](CC3)(O)c4ncc(cc4)c5ncccn5)C(F)(F)F,BRD-K94420399-001-01-9,PF-04136309,MedChemEx,HY-13245,PF-4136309,-2.091549,x1249,20.7626,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-],BRD-A78723049-001-01-2,cefotetan,MicroSource,1502424,CEFOTETAN,-2.091514,x0104,8.71284,active-noncovalent
CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N,BRD-K00521308-019-03-5,ATN-161,MedChemEx,HY-13535A,ATN-161 (trifluoroacetate salt),-1.987623,x0072,18.892179,active-noncovalent
CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N,BRD-K00521308-019-01-9,ATN-161,MedChemEx,HY-13535A,ATN-161 (trifluoroacetate salt),-1.987623,x0072,18.892179,active-noncovalent
Cc1c(ccc2c1oc(c(c2=O)NC(=O)c3ccc(c(c3)CC=C(C)C)O)[O-])O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,BRD-K85307935-236-09-5,novobiocin,MicroSource,1500444,NOVOBIOCIN SODIUM,-1.986110,x0305,23.312784,active-noncovalent
Cc1c(ccc2c1oc(c(c2=O)NC(=O)c3ccc(c(c3)CC=C(C)C)O)[O-])O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,BRD-K85307935-236-08-7,novobiocin,Selleck,S2492,Novobiocin Sodium,-1.986110,x0305,23.312784,active-noncovalent
Cc1c(ccc2c1oc(c(c2=O)NC(=O)c3ccc(c(c3)CC=C(C)C)O)[O-])O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,BRD-K85307935-236-10-3,novobiocin,Selleck,S2492,Novobiocin sodium (Albamycin),-1.986110,x0305,23.312784,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[N@H+]6CCO[C@@H](C6)OC)O,BRD-K51911221-001-01-2,nemorubicin,MedChemEx,HY-15794,Nemorubicin,-1.950070,x0104,16.568516,active-noncovalent
CCOc1ccc(cn1)c2ccc(cc2)Cn3c4ccc(cc4c(c3CC(C)(C)C(=O)[O-])SC(C)(C)C)OCc5ccc(cn5)C,BRD-K15691453-236-01-6,GSK2190915,MedChemEx,HY-15874A,GSK2190915 (sodium salt),-1.945213,x0305,14.187382,active-noncovalent
CC[C@]1(CC[C@@H](O1)[C@@]2(CC[C@@]3(O2)C[C@@H]([C@H]([C@H](O3)[C@@H](C)[C@H]([C@H](C)C(=O)[O-])OC)C)O)C)[C@@H]4[C@H](C[C@@H](O4)[C@@H]5[C@H](C[C@H]([C@@](O5)(CO)O)C)C)C,BRD-A06627858-236-03-0,monensin,MicroSource,1502258,MONENSIN SODIUM,-1.936404,x0072,14.90543,active-noncovalent
CC[C@]1(CC[C@@H](O1)[C@@]2(CC[C@@]3(O2)C[C@@H]([C@H]([C@H](O3)[C@@H](C)[C@H]([C@H](C)C(=O)[O-])OC)C)O)C)[C@@H]4[C@H](C[C@@H](O4)[C@@H]5[C@H](C[C@H]([C@@](O5)(CO)O)C)C)C,BRD-A06627858-236-02-2,monensin,Selleck,S2324,Sodium Monensin,-1.936404,x0072,14.90543,active-noncovalent
CC[C@]1(CC[C@@H](O1)[C@@]2(CC[C@@]3(O2)C[C@@H]([C@H]([C@H](O3)[C@@H](C)[C@H]([C@H](C)C(=O)[O-])OC)C)O)C)[C@@H]4[C@H](C[C@@H](O4)[C@@H]5[C@H](C[C@H]([C@@](O5)(CO)O)C)C)C,BRD-A06627858-236-01-4,monensin,Selleck,S2324,Monensin sodium salt (Coban),-1.936404,x0072,14.90543,active-noncovalent
CC[C@H]([C@H]1[C@@H](C[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C)C(=O)[O-],BRD-A25608658-001-01-1,narasin,MicroSource,1502035,NARASIN,-1.919749,x1249,18.51511,active-noncovalent
CN1CC[NH+](CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F,BRD-K69001009-001-02-8,golvatinib,Selleck,S2859,Golvatinib (E7050),-1.847691,x0967,24.338736,active-noncovalent
CC1=C2[C@H](C(=O)[C@@]3([C@@H](C[C@@H]4[C@]([C@H]3[C@H]([C@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](c5ccccc5)NC(=O)OC(C)(C)C)O)O)OC(=O)c6ccccc6)(CO4)OC(=O)C)OC)C)OC,BRD-K06858286-001-01-3,cabazitaxel,Selleck,S3022,Cabazitaxel,-1.826178,x0305,16.006672,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C5CCCC5)C(=O)N6CCC(CC6)N7CC[NH+](CC7)C,BRD-K48449981-001-01-9,XMD17-109,MedChemEx,HY-15665,XMD17-109,-1.823357,x0072,18.850473,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C5CCCC5)C(=O)N6CCC(CC6)N7CC[NH+](CC7)C,BRD-K48449981-001-02-7,XMD17-109,Tocris,5393,ERK5-IN-1,-1.823357,x0072,18.850473,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5cc(ccc5OC)C[C@H]6c7c(cc(c(c7O3)OC)OC)CC[N@@H+]6C)OC,BRD-K08078237-001-20-6,tetrandrine,Selleck,S2403,Tetrandrine,-1.793901,x0104,14.01648,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5cc(ccc5OC)C[C@H]6c7c(cc(c(c7O3)OC)OC)CC[N@@H+]6C)OC,BRD-K08078237-001-19-8,tetrandrine,Selleck,S2403,Tetrandrine (Fanchinine),-1.793901,x0104,14.01648,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)O)(C)O,BRD-K49668410-001-16-2,clarithromycin,MicroSource,1504231,CLARITHROMYCIN,-1.757130,x0395,13.064243,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)O)(C)O,BRD-K49668410-001-18-8,clarithromycin,Selleck,S2555,Clarithromycin,-1.757130,x0395,13.064243,active-noncovalent
CCCC[C@H](C(=O)[O-])NC(=O)[C@@H](Cc1cn(c2c1cccc2)C(=O)OC)NC(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@@H](CCC[C@@H]3C)C,BRD-K02490038-236-03-8,BQ-788,MedChemEx,HY-15894,BQ-788 (sodium salt),-1.751663,x0072,15.5317,active-noncovalent
CCCC[C@H](C(=O)[O-])NC(=O)[C@@H](Cc1cn(c2c1cccc2)C(=O)OC)NC(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@@H](CCC[C@@H]3C)C,BRD-K02490038-236-01-2,BQ-788,MedChemEx,HY-15894,BQ-788 (sodium salt),-1.751663,x0072,15.5317,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCCCC(=O)[O-],BRD-K48996094-001-01-3,pentacosanoic-acid,Cayman,15197,,-1.748420,x0967,17.756411,active-noncovalent
C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@@]6(CC[C@@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O,BRD-K08188887-001-02-4,astragaloside-a,Selleck,S2415,Astragaloside A,-1.728050,x0887,18.035864,dimer-interface
C[C@H](c1ccc(cc1)F)C(=O)Nc2ccc(cc2)c3ccc4nc(nn4c3)Nc5ccc(cc5OC)S(=O)(=O)C,BRD-K43812936-001-01-9,Mps1-IN-5,MedChemEx,HY-12858,Mps1-IN-5,-1.717288,x0305,19.475689,active-noncovalent
C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+])C(=O)NCC(=O)[O-])[C@H](C(=O)[O-])[NH3+],BRD-K11411329-001-01-3,NOV-002,InterBioScreen,STOCK1N-50253,,-1.654280,x0072,13.677316,active-noncovalent
c1cc(cc(c1)O)c2/c3ccc([nH]3)/c(c/4\nc(/c(c\5/cc/c(/[nH]5)c(/c6n\c2\CC6)\c7cccc(c7)O)/c8cccc(c8)O)C=C4)/c9cccc(c9)O,BRD-K63712959-001-01-8,temoporfin,MedChemEx,HY-16488,Temoporfin,-1.650455,x0967,20.864845,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-001-04-2,natamycin,MedChemEx,HY-B0133,Natamycin,-1.649091,x0395,17.980616,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-213-01-9,natamycin,MicroSource,1505560,NATAMYCIN,-1.649091,x0395,17.980616,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-001-02-6,natamycin,Sigma,MFCD00135085,"(1R,3S,5R,7R,12R,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxy;lic acid",-1.649091,x0395,17.980616,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-001-05-9,natamycin,Selleck,S1517,Natamycin,-1.649091,x0395,17.980616,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-001-03-4,natamycin,MedChemEx,HY-B0133,Natamycin,-1.649091,x0395,17.980616,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,BRD-K90563805-001-06-7,natamycin,Selleck,S1517,Natamycin,-1.649091,x0395,17.980616,active-noncovalent
CC[NH+](CC)CCN(Cc1ccc(cc1)c2ccc(cc2)C(F)(F)F)C(=O)Cn3c4c(c(=O)nc3SCc5ccc(cc5)F)CCC4,BRD-K19085898-001-01-8,darapladib,MedChemEx,HY-10521,Darapladib,-1.647938,x0104,14.776832,active-noncovalent
c1cc2c(c(c1)O[C@@H]3[C@@H]([C@H]([C@H]([C@@H](O3)CO)O)O)O)c(c4c(c2c5c6cccc(c6c(c7c5cc(cc7O)C(=O)[O-])O)O[C@@H]8[C@@H]([C@H]([C@H]([C@@H](O8)CO)O)O)O)cc(cc4O)C(=O)[O-])O,BRD-A53504839-001-01-9,sennoside-protonated,Vitas-M,STL453210,"4,4',10,10'-tetrahydroxy-5,5'-bis(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-9,9'-bianthracene-2,2'-dicarboxylic acid",-1.608590,x0305,22.583452,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)C(F)(F)F)C(=O)NC3CC[NH+](CC3)CCCCC4(c5ccccc5-c6c4cccc6)C(=O)NCC(F)(F)F,BRD-K92213669-001-01-3,lomitapide,MedChemEx,HY-14667,Lomitapide,-1.523471,x0395,20.059801,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)c2coc3cc(ccc3c2=O)OCc4cccc(c4)C(=O)[O-],BRD-K60659193-001-02-8,CVT-10216,Tocris,5164,CVT 10216,-1.521028,x0072,16.410856,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)c2coc3cc(ccc3c2=O)OCc4cccc(c4)C(=O)[O-],BRD-K60659193-001-01-0,CVT-10216,Sigma,SML1366,3-(((3-(4-(methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid,-1.521028,x0072,16.410856,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CCC(=C5)C(=O)N)O)O)O)OP(=O)([O-])[O-])N,BRD-M06409173-001-01-9,NADPH,MedChemEx,HY-F0003A,NADPH (tetracyclohexanamine),-1.457710,x0678,15.227906,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@@](=O)([O-])O[P@@](=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CCC(=C5)C(=O)N)O)O)O)OP(=O)([O-])[O-])N,BRD-M06409173-001-02-7,NADPH,MedChemEx,HY-F0003A,NADPH (tetracyclohexanamine),-1.457710,x0678,15.227906,active-noncovalent
CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)C[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC,BRD-K69280563-001-01-8,vinorelbine,Enzo,NP461,Vinorelbine,-1.451192,x0305,17.970608,active-noncovalent
CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)C[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC,BRD-K69280563-346-01-7,vinorelbine,MedChemEx,HY-12053A,Vinorelbine (ditartrate),-1.451192,x0305,17.970608,active-noncovalent
CC(=O)N1c2ccccc2C[C@H]1COc3ccc4c(c3)c(c(n4Cc5ccc(cc5)c6ncc(cn6)OC)CC(C)(C)C(=O)[O-])SC(C)(C)C,BRD-K88443722-001-01-7,AM679,MedChemEx,HY-14460,AM679,-1.447694,x0395,16.338463,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2C[N@H+]1C[C@H]([C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4)O,BRD-K09963420-066-12-5,saquinavir,Tocris,4418,Saquinavir mesylate,-1.441746,x0072,20.025251,active-noncovalent
C[N@H+]1CCc2cc(c(c-3c2[C@@H]1Cc4c3cc(c(c4)Oc5cc(c(cc5C[C@H]6c7cc(c(cc7CC[N@@H+]6C)OC)OC)OC)OC)OC)OC)OC,BRD-K87548127-300-01-1,thaliblastine,InterBioScreen,STOCK1N-51856,,-1.438519,x0104,15.487396,active-noncovalent
Cc1c(cnn1c2ccc(cc2)Cl)C(=O)Nc3ccc(c(c3)C#N)N4CCC(CC4)[NH+]5CCOCC5,BRD-K96259238-001-01-4,Y-320,Selleck,S7516,Y-320,-1.405975,x0305,16.852762,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/c3ccc(c(c3)O)O)CO)OCCc4ccc(c(c4)O)O)O)O)O)O,BRD-K36201510-001-06-7,verbascoside,MedChemEx,HY-N0021,Verbascoside,-1.374299,x0104,16.598904,active-noncovalent
Cc1ccc(cc1N2Cc3cnc(nc3N(C2=O)C)Nc4ccc(nc4)C)NC(=O)c5cccc(c5)C(F)(F)F,BRD-K69075588-001-01-3,GNF-7,Tocris,5607,GNF 7,-1.349858,x0305,16.411476,active-noncovalent
CCCCCCCCCCCCCCCCCCOC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC,BRD-A30403214-001-03-3,edelfosine,Enzo,L108,1-Octadecyl-2-methylglycero-3 PC,-1.311466,x0887,12.958368,dimer-interface
CCCCCCCCCCCCCCCCCCOC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC,BRD-A30403214-001-04-1,edelfosine,Cayman,60912,(R)-2-methoxy-3-(octadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate,-1.311466,x0887,12.958368,dimer-interface
CCCCCCCCCCC[C@@H](C[C@@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O,BRD-K94062100-001-04-3,orlistat,MicroSource,1504300,ORLISTAT,-1.309404,x0305,12.647099,active-noncovalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C5CCCCC5)OC)OCCC[NH+]6CCCCC6,BRD-K87465484-001-03-5,UNC0646,MedChemEx,HY-13807,UNC0646,-1.259492,x0692,15.242785,active-covalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C5CCCCC5)OC)OCCC[NH+]6CCCCC6,BRD-K87465484-001-04-3,UNC0646,Tocris,4342,UNC 0646,-1.259492,x0692,15.242785,active-covalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C5CCCCC5)OC)OCCC[NH+]6CCCCC6,BRD-K87465484-001-02-7,UNC0646,MedChemEx,HY-13807,UNC0646,-1.259492,x0692,15.242785,active-covalent
CCn1c2cc(ncc2nc1c3c(non3)N)Oc4cccc(c4)NC(=O)c5ccc(cc5)OCC[NH+]6CCOCC6,BRD-K89464729-001-03-1,GSK269962,Tocris,4009,GSK 269962,-1.194234,x0305,21.001347,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K38684403-001-04-7,roxithromycin,MicroSource,1503276,ROXITHROMYCIN,-1.179883,x0305,22.132349,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K38684403-001-05-4,roxithromycin,Selleck,S2506,Roxithromycin,-1.179883,x0305,22.132349,active-noncovalent
C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)[NH+](C)C,BRD-A24297246-001-03-9,troleandomycin,MicroSource,1502203,TROLEANDOMYCIN,-1.126679,x0967,19.945526,active-noncovalent
c1c(ccc(c1)[C@H]2CC[C@@H](CC2)CC(=O)[O-])c3ncc(cc3)Nc4cnc(cc4)C(F)(F)F,BRD-K20008181-001-01-3,LCQ908,MedChemEx,HY-16278,LCQ-908,-1.086777,x0305,17.060806,active-noncovalent
CCc1c(n2cc(ccc2n1)Cl)C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(cc5)OC(F)(F)F,BRD-K59853741-001-01-9,Q-203,Enamine,Z2235679010,,-1.071368,x0305,18.684294,active-noncovalent
Cc1cc(cc2c1nc(nn2)Nc3ccc(cc3)OCC[NH+]4CCCC4)c5cc(ccc5Cl)OC(=O)c6ccccc6,BRD-K12735121-001-01-4,TG-100801,MedChemEx,HY-10186,TG 100801,-0.923421,x0305,24.429115,active-noncovalent
CC[C@H]([C@H]1CC[C@@H]([C@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)[O-],BRD-A28301258-001-03-0,salinomycin,Selleck,S2352,Salinomycin,-0.891837,x0072,19.344574,active-noncovalent
CC[C@H]([C@H]1CC[C@@H]([C@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)[O-],BRD-A28301258-236-01-6,salinomycin,MicroSource,1503602,"SALINOMYCIN, SODIUM",-0.891837,x0072,19.344574,active-noncovalent
CC[C@H]([C@H]1CC[C@@H]([C@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)[O-],BRD-A28301258-001-04-8,salinomycin,Selleck,S2352,Salinomycin (Procoxacin),-0.891837,x0072,19.344574,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@@H]([C@@H]([C@@H]([C@@H]([C@H]([C@@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-A23603052-001-03-2,rifampin,MicroSource,1500529,RIFAMPIN,-0.872080,x0967,18.293566,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-001-02-9,vinblastine,Selleck,S1248,Vinblastine,-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-065-01-6,vinblastine,MedChemEx,HY-13780,Vinblastine (sulfate),-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-065-03-2,vinblastine,Tocris,1256,Vinblastine sulfate,-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-065-02-4,vinblastine,MedChemEx,HY-13780,Vinblastine (sulfate),-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-065-04-0,vinblastine,MicroSource,1500611,VINBLASTINE SULFATE,-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-001-01-1,vinblastine,Selleck,S1248,Vinblastine,-0.777073,x0072,18.628103,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,BRD-K06519765-001-03-7,vinblastine,MedChemEx,HY-17418,Vinblastine,-0.777073,x0072,18.628103,active-noncovalent
CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCc3ccccc3)NC(=O)C[NH+]4CCOCC4,BRD-K15179879-001-03-2,carfilzomib,Selleck,S2853,Carfilzomib (PR-171),-0.748310,x1249,20.952557,active-noncovalent
CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,BRD-K91699951-001-10-2,benzonatate,MicroSource,1503864,BENZONATATE,-0.746037,x0967,14.037352,active-noncovalent
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,BRD-K35798650-001-01-4,polidocanol,Sigma,MFCD00043375,"3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol",-0.719652,x0967,15.506777,active-noncovalent
CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCC[NH+]5CCCCC5)OC,BRD-K89162000-001-06-4,tandutinib,Selleck,S1043,Tandutinib (MLN518),-0.700087,x0736,19.37808,active-covalent
CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCC[NH+]5CCCCC5)OC,BRD-K89162000-001-07-2,tandutinib,MicroSource,1502277,TANDUTINIB,-0.700087,x0736,19.37808,active-covalent
CCCC[P+](CCCC)(CCCC)Cc1ccc(cc1)NC(=O)[C@H](Cc2ccc3ccccc3c2)N/C(=[NH+]/C4CCCCC4)/NC5CCCCC5,BRD-K22662557-300-01-7,WIN-64338,Tocris,1057,WIN 64338 hydrochloride,-0.656938,x0305,19.138168,active-noncovalent
CCCC[P+](CCCC)(CCCC)Cc1ccc(cc1)NC(=O)[C@H](Cc2ccc3ccccc3c2)N/C(=[NH+]/C4CCCCC4)/NC5CCCCC5,BRD-K22662557-300-02-5,WIN-64338,Tocris,1057,WIN 64338 hydrochloride,-0.656938,x0305,19.138168,active-noncovalent
CC(C)(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)[C@H](C[N@](Cc2ccc(cc2)c3ccccn3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,BRD-K09757388-065-04-0,atazanavir,Selleck,S1457,Atazanavir Sulfate,-0.611841,x0305,18.165335,active-noncovalent
CCN([C@H]1CC[C@@H](CC1)[N@H+](CCOC)C)c2c(c(cc(c2)C#CC[NH+]3CCOCC3)C(=O)NCc4c(=O)[nH]c(cc4C)C)C,BRD-K87468701-001-01-0,EPZ011989,MedChemEx,HY-16986,EPZ011989,-0.567884,x0395,14.704214,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@H]2C[N@H+]1C[C@H]([C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4)O,BRD-A26690767-066-01-9,saquinavir,Enzo,AC3247,SAQUINAVIR MESYLATE,-0.564934,x0072,19.709263,active-noncovalent
CC(C)C[N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)[C@H](C(C)(C)C)NC(=O)C[NH2+]Cc2cccc(c2)F)O)S(=O)(=O)c3cccc(c3)N,BRD-K37087535-001-01-1,DPC-681,MedChemEx,HY-19400,DPC-681,-0.562422,x0967,21.756586,active-noncovalent
CC[C@@]12C=CC[N@@H+]3[C@@H]1[C@@]4(CC3)c5cc(c(cc5[N@@]([C@H]4[C@]([C@@H]2OC(=O)C)(C(=O)OC)O)C)OC)[C@]6(C[C@@H]7C[C@H](C[N@@H+](C7)CCc8c6[nH]c9c8cccc9)C(C)(F)F)C(=O)OC,BRD-K64120610-001-01-4,vinflunine,AvaChem,2180,"methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-9-((4R,6R,8S)-4-(1,1-difluoroethyl)-8-(methoxycarbonyl)-1,3,4,5,6,7,8,9-octahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-3a-ethyl-5-hydroxy-8-methoxy-6-methyl-;3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]c",-0.527314,x0072,20.828836,active-noncovalent
CC[C@@]12C=CC[N@@H+]3[C@@H]1[C@@]4(CC3)c5cc(c(cc5[N@@]([C@H]4[C@]([C@@H]2OC(=O)C)(C(=O)OC)O)C)OC)[C@]6(C[C@@H]7C[C@H](C[N@@H+](C7)CCc8c6[nH]c9c8cccc9)C(C)(F)F)C(=O)OC,BRD-K64120610-046-01-9,vinflunine,Selleck,S2209,Vinflunine Tartrate,-0.527314,x0072,20.828836,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)ncnc2Nc4ccc(cc4)NC(=O)c5ccccc5,BRD-K72703948-001-10-1,ZM-447439,Tocris,2458,ZM 447439,-0.526793,x1249,21.982029,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)ncnc2Nc4ccc(cc4)NC(=O)c5ccccc5,BRD-K72703948-001-12-7,ZM-447439,Tocris,2458,ZM 447439,-0.526793,x1249,21.982029,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)ncnc2Nc4ccc(cc4)NC(=O)c5ccccc5,BRD-K72703948-001-09-3,ZM-447439,Selleck,S1103,ZM 447439,-0.526793,x1249,21.982029,active-noncovalent
C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](CC(=C5N=O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)\C)O[C@@H]1C7CCCCC7,BRD-A58564983-001-04-6,selamectin,MicroSource,1503720,SELAMECTIN,-0.506328,x0305,14.59739,active-noncovalent
CC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc2c3ccc(cc3[nH]c2c4c(c5ccc(cc5[nH]4)F)C[C@@H]6C[C@@H](CN6C(=O)[C@H](CC)NC(=O)[C@H](C)[NH2+]C)O)F)O)NC(=O)[C@H](C)[NH2+]C,BRD-K71221037-001-01-6,birinapant,Selleck,S7015,Birinapant,-0.505273,x0967,22.619556,active-noncovalent
CC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc2c3ccc(cc3[nH]c2c4c(c5ccc(cc5[nH]4)F)C[C@@H]6C[C@@H](CN6C(=O)[C@H](CC)NC(=O)[C@H](C)[NH2+]C)O)F)O)NC(=O)[C@H](C)[NH2+]C,BRD-K71221037-001-02-4,birinapant,Selleck,S7015,Birinapant (TL32711),-0.505273,x0967,22.619556,active-noncovalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)CC5CCCCC5)OC)OCCC[NH+]6CCCCC6,BRD-K13060017-001-02-1,UNC0631,MedChemEx,HY-13808,UNC 0631,-0.488100,x0305,17.075201,active-noncovalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)CC5CCCCC5)OC)OCCC[NH+]6CCCCC6,BRD-K13060017-001-01-3,UNC0631,MedChemEx,HY-13808,UNC0631,-0.488100,x0305,17.075201,active-noncovalent
CC[C@@H]1[C@@]2([C@H]([C@@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](/C(=C(\C(=O)O1)/C)/[O-])C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nc4)c5cccnc5)C,BRD-A94008949-001-01-9,telithromycin,MicroSource,1505265,TELITHROMYCIN,-0.466725,x1249,22.917149,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@H](CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]4[C@H]([C@@H]([C@H](O4)n5cnc6c5ncnc6N)O)O)O)O)O,BRD-A86545589-001-01-5,flavin-adenine-dinucleotide,Vitas-M,STL069550,,-0.435611,x0305,14.402327,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K63550407-001-12-7,erythromycin,MicroSource,1500280,ERYTHROMYCIN,-0.393077,x0072,14.717651,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K63550407-001-14-3,erythromycin,Selleck,S1635,Erythromycin,-0.393077,x0072,14.717651,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K63550407-001-13-5,erythromycin,Selleck,s1635,Erythromycin,-0.393077,x0072,14.717651,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,BRD-K63550407-028-04-7,erythromycin,MicroSource,1500281,ERYTHROMYCIN STEARATE,-0.393077,x0072,14.717651,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CC[N+](CC4)(C)C)C)CC[C@]5([C@H]3C[C@@H]([C@H]5OC(=O)C)N6CC[N+](CC6)(C)C)C,BRD-A21544762-303-01-5,pipecuronium,Kemprotec,52212-02-9,"4,4'-((2S,3S,5S,8R,9S,10S,13S,14S,16S)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1,1-dimethylpiperazin-1-ium) bromide",-0.322831,x0072,15.20429,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-],BRD-K70007857-001-01-7,hexasodium-phytate,TCI,P0409,,-0.291912,x0387,10.096029,active-noncovalent
C[C@@H](C(=O)NCC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC[NH+]=C(N)N)C(=O)[O-])NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],BRD-A89196962-300-01-7,dalargin,InterBioScreen,STOCK1N-27439,,-0.281180,x0967,22.231079,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)[O-])NC(=O)[C@H](CCSC)NC=O,BRD-K13005598-001-02-3,foxy-5,Tocris,5461,,-0.280158,x0104,24.577021,active-noncovalent
CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)Oc4c5cc(ccc5c(cn4)OC)Cl)NC(=O)OC(C)(C)C,BRD-K87028197-001-01-3,asunaprevir,MedChemEx,HY-14434,Asunaprevir,-0.198820,x0967,17.643261,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)OCCO)OCCO)OCCO)[O-])O)O)O)O)O)O,BRD-K73529671-001-02-9,troxerutin,Selleck,S2369,Troxerutin,-0.193997,x0305,15.358311,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)OCCO)OCCO)OCCO)[O-])O)O)O)O)O)O,BRD-K73529671-001-04-5,troxerutin,MicroSource,1505245,TROXERUTIN,-0.193997,x0305,15.358311,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)OCCO)OCCO)OCCO)[O-])O)O)O)O)O)O,BRD-K73529671-001-03-7,troxerutin,Selleck,S2369,Troxerutin,-0.193997,x0305,15.358311,active-noncovalent
c1cc2c(c(c1)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)c4c(cc(cc4[O-])C(=O)[O-])[C@H]2[C@H]5c6cccc(c6C(=O)c7c5cc(cc7[O-])C(=O)[O-])O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O,BRD-A30370660-001-04-1,sennoside-a,MicroSource,1504078,SENNOSIDE A,-0.057472,x0967,21.70013,active-noncovalent
COc1cc2c(ccnc2cc1OCCC[NH+]3CCOCC3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F,BRD-K03449891-001-08-6,foretinib,Selleck,S1111,Foretinib (GSK1363089),-0.051521,x1249,23.296392,active-noncovalent
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](Cc2ccccc2)c3nccs3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)[NH+](C)C,BRD-K78567475-001-01-4,dolastatin-10,MedChemEx,HY-15580,Dolastatin 10,-0.049036,x1249,28.148445,active-noncovalent
CC[N@@H+](CCCOc1ccc2c(c1)ncnc2Nc3cc(n[nH]3)CC(=O)Nc4cccc(c4)F)CCOP(=O)([O-])[O-],BRD-K31928526-001-02-1,barasertib,MedChemEx,HY-10127,AZD1152,-0.042818,x1249,19.492237,active-noncovalent
c1cc(ccc1c2nc(nc(n2)N3[C@@H]4CC[C@H]3COC4)N5CCOCC5)NC(=O)Nc6ccncc6,BRD-A28467416-002-01-0,PKI-179,EMDBio,526561-5MG,"PI 3-K/mTOR Inhibitor III, PKI-179",0.040004,x0104,13.71744,active-noncovalent
c1c(cnc(c1Cl)N2CCC(CC2)C(=O)[O-])C(=O)Nc3nc(c(s3)N4CC[NH+](CC4)C5CCCCC5)c6cc(cs6)Cl,BRD-K68544925-001-01-1,avatrombopag,MedChemEx,HY-13463,Avatrombopag,0.068045,x0887,22.729393,dimer-interface
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N(C)[C@@H](CC(C)C)C(=O)NCC[C@@H](C(=O)[O-])NC(=O)[C@@H]3CCC[N@]3S(=O)(=O)c4cc(cc(c4)Cl)Cl,BRD-K21318844-001-01-4,BIO-5192,Tocris,5051,BIO 5192,0.078660,x0967,20.685549,active-noncovalent
CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4Cc5cccc(c5C4)F)C(=O)NS(=O)(=O)C6CC6,BRD-K08111240-001-02-8,danoprevir,Selleck,S1183,Danoprevir (ITMN-191),0.136663,x0305,19.914036,active-noncovalent
CC(C)(CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCS)O,BRD-A67956599-002-01-3,coenzyme-a,ChemImpex,644,Coenzyme A hydrate,0.142803,x0104,15.070233,active-noncovalent
c1cc(cc(c1)/c/2c\3/nc(/c(c/4\[nH]/c(c(\c5n/c(c(\c6[nH]c2cc6)/c7cc(ccc7)O)/C=C5)/c8cc(ccc8)O)/cc4)/c9cc(ccc9)O)C=C3)O,BRD-K91147684-001-01-5,m-THP,FrontierSci,T678-1,,0.246221,x0967,20.681694,active-noncovalent
C[C@@H](OC(=O)[C@@H]1[C@@H](CS[C@@H]\2N1C(=O)/C2=N/C(=O)Cc3csc(n3)N)CSc4nnnn4CC[NH+](C)C)OC(=O)OC5CCCCC5,BRD-A76661185-300-02-4,cefotiam-cilexetil,SantaCruz,sc-211042,,0.299327,x0305,15.560249,active-noncovalent
C[C@@H](OC(=O)[C@@H]1[C@@H](CS[C@@H]\2N1C(=O)/C2=N/C(=O)Cc3csc(n3)N)CSc4nnnn4CC[NH+](C)C)OC(=O)OC5CCCCC5,BRD-A76661185-300-01-6,cefotiam-cilexetil,SantaCruz,sc-211042,,0.299327,x0305,15.560249,active-noncovalent
CCCCCCCCCc1ccc(cc1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,BRD-K88625236-001-04-2,nonoxynol-9,MicroSource,1505292,NONOXYNOL-9,0.519851,x1249,17.161453,active-noncovalent
CCCCCCCCCc1ccc(cc1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,BRD-K88625236-001-05-9,nonoxynol-9,MedChemEx,HY-B1027,Nonoxinol 9,0.519851,x1249,17.161453,active-noncovalent
CCCCCCCCCc1ccc(cc1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,BRD-K88625236-001-07-5,nonoxynol-9,LKT,N5655,"26-(4-nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol",0.519851,x1249,17.161453,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-03-9,vincristine,Selleck,S1241,Vincristine Sulfate,0.604120,x0072,18.581203,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-02-1,vincristine,MedChemEx,HY-N0488,Vincristine (sulfate),0.604120,x0072,18.581203,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-05-4,vincristine,Selleck,S1241,Vincristine,0.604120,x0072,18.581203,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-04-7,vincristine,Tocris,1257,Vincristine sulfate,0.604120,x0072,18.581203,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-01-3,vincristine,MedChemEx,HY-N0488,Vincristine (sulfate),0.604120,x0072,18.581203,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,BRD-K12251893-065-06-2,vincristine,MicroSource,1505672,VINCRISTINE SULFATE,0.604120,x0072,18.581203,active-noncovalent
C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,BRD-K69608737-001-08-6,tacrolimus,MedChemEx,HY-13756,tacrolimus,0.604666,x0967,15.949761,active-noncovalent
C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,BRD-K69608737-001-10-2,tacrolimus,MicroSource,1503968,TACROLIMUS,0.604666,x0967,15.949761,active-noncovalent
C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,BRD-K69608737-001-09-4,tacrolimus,Selleck,S5003,Tacrolimus (FK506),0.604666,x0967,15.949761,active-noncovalent
CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@@H]([C@H](Cc3ccccc3)NC(=O)OCc4cncs4)O,BRD-K51485625-001-08-4,ritonavir,Selleck,S1185,Ritonavir,0.619766,x0104,20.843678,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,BRD-K62008436-001-24-7,paclitaxel,Tocris,1097,Taxol,0.685393,x1249,20.139809,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,BRD-K62008436-001-23-9,paclitaxel,Selleck,S1150,Paclitaxel,0.685393,x1249,20.139809,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,BRD-K62008436-001-18-9,paclitaxel,Selleck,S1150,S1150,0.685393,x1249,20.139809,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,BRD-K62008436-001-25-4,paclitaxel,Tocris,1097,Taxol,0.685393,x1249,20.139809,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,BRD-K62008436-001-22-1,paclitaxel,MicroSource,1503908,PACLITAXEL,0.685393,x1249,20.139809,active-noncovalent
CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)c5cnccn5,BRD-K72912098-001-03-1,telaprevir,Selleck,S1538,Telaprevir (VX-950),0.691559,x0104,18.349611,active-noncovalent
CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)c5cnccn5,BRD-K72912098-001-02-3,telaprevir,Selleck,S1538,Telaprevir (VX-950),0.691559,x0104,18.349611,active-noncovalent
c1cncc(c1)C(=O)O[C@H]2[C@@H]([C@@H]([C@@H]([C@H]([C@@H]2OC(=O)c3cnccc3)OC(=O)c4cnccc4)OC(=O)c5cnccc5)OC(=O)c6cnccc6)OC(=O)c7cnccc7,BRD-K82800842-001-01-9,inositol-hexanicotinate,AKSci,H975,,0.819163,x0305,26.69437,active-noncovalent
CCCCCCCC[NH+]=c1ccn(cc1)CCCCCCCCCCn2ccc(=[NH+]CCCCCCCC)cc2,BRD-K04568635-300-01-4,octenidine,TCI,O0388,,0.836347,x0426,21.364431,active-noncovalent
CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](/C(=C(\C(=O)O1)/C)/[O-])C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nc4)c5cccnc5)C,BRD-K82240271-001-01-8,telithromycin,Cayman,17315,"(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-(4-(4-(pyridin-3-yl)-1H-imidazo;l-1-yl)butyl)octahydro-2H-[1]oxacyclotetradecino[4,3-d",0.910923,x0305,19.163471,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CC)(C)O)C)C)O)(C)O,BRD-K39746403-084-04-9,erythromycin-estolate,MicroSource,1501176,ERYTHROMYCIN ESTOLATE,1.003206,x0104,17.593693,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]([C@@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/[NH+]=C/N5CCCCC5)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-A10991937-001-01-1,FCE-22250,Vitas-M,STK177296,,1.128292,x0771,26.339405,active-covalent
CCCCCCCCCCCCCCCC(=O)OCCC1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,BRD-K48429278-001-01-3,pipotiazine-palmitate,Sigma,MFCD00866713,2-[1-(3-{2-[(dimethylamino)sulfonyl]-10H-phenothiazin-10-yl}propyl)-4-piperidinyl]ethyl palmitate,1.136590,x0967,16.21682,active-noncovalent
CCCCCCOC(=O)NC(=[NH2+])c1ccc(cc1)NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c4ccccn4,BRD-K57041787-066-01-1,dabigatran-etexilate,MicroSource,1503900,DABIGATRAN ETEXILATE MESYLATE,1.146603,x0786,25.180643,active-covalent
CCCCCCOC(=O)NC(=[NH2+])c1ccc(cc1)NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c4ccccn4,BRD-K57041787-001-02-6,dabigatran-etexilate,Selleck,S2154,Dabigatran Etexilate,1.146603,x0786,25.180643,active-covalent
c1cc(ccc1/C=C/C(=O)C2=C([C@](C(=O)[C@@H](C2=O)/C=C\3/C(=O)C(=C([C@@](C3=O)([C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)[O-])C(=O)/C=C/c5ccc(cc5)O)([C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)[O-])O,BRD-A96503329-001-01-7,safflower-yellow,MedChemEx,HY-N0938,Safflower Yellow,1.222458,x0887,17.013891,dimer-interface
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)OC(C)(C)C)O,BRD-K30577245-341-01-9,docetaxel,MicroSource,1502273,DOCETAXEL,1.287066,x0072,20.080763,active-noncovalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)OC(C)(C)C)O,BRD-K30577245-001-04-3,docetaxel,Selleck,S1148,Docetaxel (Taxotere),1.287066,x0072,20.080763,active-noncovalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)OC(C)(C)C)O,BRD-K30577245-001-05-0,docetaxel,Selleck,S1148,Docetaxel,1.287066,x0072,20.080763,active-noncovalent
c1ccnc(c1)CC(=O)Nc2nnc(s2)CCCCc3ccc(nn3)NC(=O)Cc4cccc(c4)OC(F)(F)F,BRD-K58070273-001-04-1,CB-839,MedChemEx,HY-12248,CB-839,1.295661,x0887,19.32358,dimer-interface
c1ccnc(c1)CC(=O)Nc2nnc(s2)CCCCc3ccc(nn3)NC(=O)Cc4cccc(c4)OC(F)(F)F,BRD-K58070273-001-03-3,CB-839,Broad Institute,,CB-839,1.295661,x0887,19.32358,dimer-interface
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)NNC(=O)CCCCCN6C(=O)C=CC6=O)O)[NH3+])O,BRD-K68928792-001-01-6,aldoxorubicin,MedChemEx,HY-16261,INNO-206,1.302299,x0749,15.716513,active-covalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)NNC(=O)CCCCCN6C(=O)C=CC6=O)O)[NH3+])O,BRD-K68928792-001-03-2,aldoxorubicin,MedChemEx,HY-16261,INNO-206,1.302299,x0749,15.716513,active-covalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)NNC(=O)CCCCCN6C(=O)C=CC6=O)O)[NH3+])O,BRD-K68928792-001-02-4,aldoxorubicin,MedChemEx,HY-16261,INNO-206,1.302299,x0749,15.716513,active-covalent
CC[C@H]1/C=C(/C[C@@H](C[C@H]([C@@H]2[C@@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H]([C@H]([C@@H](CC1=O)O)C)/C(=C/[C@H]4CC[C@@H]([C@H](C4)OC)O)/C)O)C)OC)OC)C)\C,BRD-A72381333-001-01-0,ascomycin,Selleck,S7411,Ascomycin (FK520),1.368575,x1249,17.435701,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K01507359-001-22-9,rifampin,Selleck,S1764,Rifampin,1.420772,x1249,19.587765,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K01507359-001-23-7,rifampin,Selleck,S1764,Rifampin,1.420772,x1249,19.587765,active-noncovalent
C[C@@H](C(=O)N[C@@H](CC(C)C)[C@H](CC(=O)[O-])O)NC(=O)C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C)O,BRD-K13571841-001-14-4,pepstatin,Enzo,PI120,Pepstatin A,1.514513,x0967,21.553261,active-noncovalent
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)[NH+](C)C,BRD-A67305656-001-02-3,spiramycin,Selleck,S4082,Spiramycin,1.558240,x0887,24.25116,dimer-interface
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)[NH+](C)C,BRD-A67305656-001-03-1,spiramycin,MicroSource,1503423,SPIRAMYCIN,1.558240,x0887,24.25116,dimer-interface
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)[NH+](C)C,BRD-A67305656-001-01-5,spiramycin,Selleck,S4082,Spiramycin,1.558240,x0887,24.25116,dimer-interface
Cc1c(ccc2c1nc(cc2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)c7nc(cs7)C(C)C)OC,BRD-A68493689-001-01-9,simeprevir,MedChemEx,HY-10241,Simeprevir,1.703806,x0967,17.699884,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@H]([C@H](O3)CO[P@](=O)([O-])O[P@@](=O)([O-])O[P@@](=O)([O-])O[P@](=O)([O-])OC[C@@H]4[C@@H]([C@H]([C@@H](O4)n5cnc6c5ncnc6N)O)O)O)O)N,BRD-A15035311-001-01-8,diadenosine-tetraphosphate,Enzo,AC954,"P1,P4-Di(adenosine-5')tetraphosphate ammonium",1.794800,x0967,16.026239,active-noncovalent
CC1(c2c3ccccc3ccc2[N+](=C1/C=C/C=C/C=C/C=C\4/C(c5c6ccccc6ccc5N4CCCCS(=O)(=O)[O-])(C)C)CCCCS(=O)(=O)[O-])C,BRD-K80762071-236-03-3,indocyanine-green,MedChemEx,HY-D0711,Cardiogreen,1.824265,x0305,28.312096,active-noncovalent
CC1(c2c3ccccc3ccc2[N+](=C1/C=C/C=C/C=C/C=C\4/C(c5c6ccccc6ccc5N4CCCCS(=O)(=O)[O-])(C)C)CCCCS(=O)(=O)[O-])C,BRD-K80762071-236-01-7,indocyanine-green,MedChemEx,HY-D0711,Cardiogreen,1.824265,x0305,28.312096,active-noncovalent
CC1(c2c3ccccc3ccc2[N+](=C1/C=C/C=C/C=C/C=C\4/C(c5c6ccccc6ccc5N4CCCCS(=O)(=O)[O-])(C)C)CCCCS(=O)(=O)[O-])C,BRD-K80762071-236-02-5,indocyanine-green,Sigma,MFCD00013078,"sodium 4-((2E)-2-{(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indolium-2-yl]-2,4,6-heptatrienylidene}-1,1-dimethyl-1H-benzo[e]indol-3-yl)-1-butanesulfonate",1.824265,x0305,28.312096,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-A77786295-001-02-9,dirithromycin,MedChemEx,HY-B0643,Dirithromycin,1.906841,x0395,22.570871,active-noncovalent
C/C=C(\C)/C(=O)N[C@@H](c1ccccc1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)/C(=C(/[C@@H]2C)\C3(C)C)/OC(=O)C)C)OC(=O)c6ccccc6)O)O,BRD-K68904758-001-03-5,cephalomannine,Selleck,S2408,Cephalomannine,2.027429,x1249,15.34571,active-noncovalent
C/C=C(\C)/C(=O)N[C@@H](c1ccccc1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)/C(=C(/[C@@H]2C)\C3(C)C)/OC(=O)C)C)OC(=O)c6ccccc6)O)O,BRD-K68904758-001-04-3,cephalomannine,MedChemEx,HY-77554,Cephalomannine,2.027429,x1249,15.34571,active-noncovalent
C/C=C(\C)/C(=O)N[C@@H](c1ccccc1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)/C(=C(/[C@@H]2C)\C3(C)C)/OC(=O)C)C)OC(=O)c6ccccc6)O)O,BRD-K68904758-001-02-7,cephalomannine,Selleck,S2408,Cephalomannine,2.027429,x1249,15.34571,active-noncovalent
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)Oc5c(nc6ccc(cc6n5)OC)CCCCC[C@@H]7C[C@H]7OC(=O)N1,BRD-K24943235-001-01-3,grazoprevir,MedChemEx,HY-15298,MK-5172,2.073240,x0967,20.835403,active-noncovalent
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)Oc5c(nc6ccc(cc6n5)OC)CCCCC[C@@H]7C[C@H]7OC(=O)N1,BRD-K24943235-237-01-3,grazoprevir,MedChemEx,HY-15298A,MK-5172 (potassium salt),2.073240,x0967,20.835403,active-noncovalent
CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@](C(=O)O1)(C)F)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nn4)c5cccc(c5)N)C,BRD-K32256160-001-01-9,solithromycin,MedChemEx,HY-17593,Solithromycin,2.182832,x0305,19.773413,active-noncovalent
CC(C)(C)OC(=O)NCCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](Cc3ccccc3)C(=O)N,BRD-K78789465-001-02-4,pentagastrin,MicroSource,1506100,PENTAGASTRIN,2.210760,x0072,22.071617,active-noncovalent
CC(C)(C)OC(=O)NCCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](Cc3ccccc3)C(=O)N,BRD-K78789465-001-01-6,pentagastrin,Abblis,AB2000162,Pentagastrin,2.210760,x0072,22.071617,active-noncovalent
CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@@H]([C@@H](O[C@@H]1SC)[C@H]([C@@H](C)Cl)NC(=O)[C@H]2C[C@@H](C[N@@H+]2C)CCC)O)O,BRD-A76672327-003-02-0,clindamycin-palmitate,Selleck,S2596,Clindamycin palmitate HCl,2.338536,x0104,17.169725,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,BRD-A10131665-001-02-0,phosphatidylcholine,Selleck,S4411,Phosphatidylcholine.,2.395462,x0691,20.663387,active-covalent
CC(C)C1=C2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC[C@]2(CC1=O)[C@H](C[N@](CC[NH+](C)C)Cc6ccc(cc6)Cl)O)C)C)(C)C)OC(=O)CC(C)(C)C(=O)[O-])C,BRD-K08398903-001-02-9,GSK2838232,MedChemEx,HY-15884,GSK2838232,2.426488,x0305,23.832394,active-noncovalent
CC(C)C1=C2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC[C@]2(CC1=O)[C@H](C[N@](CC[NH+](C)C)Cc6ccc(cc6)Cl)O)C)C)(C)C)OC(=O)CC(C)(C)C(=O)[O-])C,BRD-K08398903-001-01-1,GSK2838232,MedChemEx,HY-15884,GSK2838232,2.426488,x0305,23.832394,active-noncovalent
CCCCC(=O)OCC(=O)[C@@]1(Cc2c(c(c3c(c2[O-])C(=O)c4cccc(c4C3=O)OC)[O-])[C@H](C1)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O,BRD-K72951360-001-01-4,valrubicin,MedChemEx,HY-13772,Valrubicin,2.488130,x0692,22.112871,active-covalent
CC(C)(C)c1cc(no1)NC(=O)Nc2ccc(cc2)c3cn4c5ccc(cc5sc4[nH+]3)OCC[NH+]6CCOCC6,BRD-K93918653-001-08-9,quizartinib,Selleck,S1526,Quizartinib (AC220),2.548322,x0887,21.479273,dimer-interface
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(/C(=O)/N=c(/c2O)\c5=NC6(CC[NH+](CC6)CC(C)C)Nc35)\C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K30563334-001-02-9,rifabutin,Selleck,S1741,Rifabutin,2.551799,x0305,18.309359,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-25-4,dirithromycin,MedChemEx,HY-B0643,Dirithromycin,2.606816,x1249,21.618273,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-27-0,dirithromycin,AvaChem,2876,"(1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-3-ethyl-2,10-dihydroxy-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-5-oxo-",2.606816,x1249,21.618273,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-28-8,dirithromycin,Sigma,MFCD00865041,"(1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2,10-dihydroxy-7-(((2R,4S,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl;tetrahydro-2H-pyran-2-yl)oxy)-15-((2-methoxyethoxy)met",2.606816,x1249,21.618273,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-26-2,dirithromycin,Selleck,S4213,Dirithromycin,2.606816,x1249,21.618273,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-24-7,dirithromycin,MicroSource,1504144,DIRITHROMYCIN,2.606816,x1249,21.618273,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,BRD-K52756523-001-29-6,dirithromycin,Selleck,S4213,Dirithromycin,2.606816,x1249,21.618273,active-noncovalent
c1cc2c(cc1OC(F)(F)F)[nH]c(n2)c3ccc(cn3)OCCOCCOc4ccc(nc4)c5[nH]c6cc(ccc6n5)OC(F)(F)F,BRD-K89899948-001-01-7,AI-10-49,MedChemEx,HY-16786,AI-10-49,2.673892,x0887,25.37422,dimer-interface
CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)/C[C@H]2C[C@@H](OC(=O)C[C@@H](C[C@H]3C[C@@H](C([C@@](O3)(C[C@@H]4C/C(=C/C(=O)OC)/C[C@@H](O4)/C=C\C([C@@]1(O2)O)(C)C)O)(C)C)OC(=O)C)O)[C@@H](C)O,BRD-K47405978-001-02-5,bryostatin-1,EMDBio,203811-10UG,Bryostatin 1,2.740692,x0305,24.794178,active-noncovalent
CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C,BRD-K92107055-001-01-9,pimecrolimus,Selleck,S5004,Pimecrolimus,2.800759,x0967,18.607836,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,BRD-A95886749-001-04-3,colfosceril-palmitate,Sigma,MFCD00036903,"(R)-2,3-bis(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosphate",2.855972,x0708,16.250463,active-covalent
CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,BRD-A95886749-001-03-5,colfosceril-palmitate,Acros,24057,,2.855972,x0708,16.250463,active-covalent
Cc1cnc(cn1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)Oc5c6ccccc6c7ccccc7n5)C(=O)NS(=O)(=O)C8CC8,BRD-K89920762-001-01-4,paritaprevir,MedChemEx,HY-12594,Paritaprevir,2.909720,x0967,24.397356,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,BRD-K51677086-001-14-6,erythromycin-ethylsuccinate,Selleck,S4060,Erythromycin Ethylsuccinate,3.089338,x0967,19.771313,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,BRD-K51677086-001-12-0,erythromycin-ethylsuccinate,MicroSource,1500279,ERYTHROMYCIN ETHYLSUCCINATE,3.089338,x0967,19.771313,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,BRD-K51677086-001-13-8,erythromycin-ethylsuccinate,Selleck,S4060,Erythromycin Ethylsuccinate,3.089338,x0967,19.771313,active-noncovalent
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC(=O)CC(C)C)[NH+](C)C)O)CC=O)C)O,BRD-K25837718-001-03-8,josamycin,Prestwick,Prestw-154,Josamycin,3.100371,x1249,25.311666,active-noncovalent
C[C@@H]1CC[C@@]2([C@@H]([C@@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@@H]5[C@H]4CC=C6[C@@]5(CC[C@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@@H](O7)CO)O[C@H]8[C@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1,BRD-K37723606-001-01-5,dioscin,Selleck,S2379,Dioscin,3.111700,x0967,23.861774,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)[O-])O)O)O)C)(C)C(=O)[O-],BRD-K15318383-201-01-5,ammonium-glycyrrhizinate,Selleck,S2376,Ammonium Glycyrrhizinate,3.131017,x0305,32.054714,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)[O-])O)O)O)C)(C)C(=O)[O-],BRD-K15318383-001-01-9,ammonium-glycyrrhizinate,Selleck,S2302,Glycyrrhizic Acid,3.131017,x0305,32.054714,active-noncovalent
CCCC[C@@H](CC)COc1ccc(c(c1)O)c2nc(nc(n2)c3ccc(cc3O)OC[C@H](CC)CCCC)c4ccc(cc4)OC,BRD-A92974210-396-01-0,bemotrizinol,MicroSource,1503863,BEMOTRIZINOL,3.191931,x0771,21.914473,active-covalent
CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](CC[NH+]2CCOCC2)C(=O)N[C@H](CC[C@H](Cc3ccccc3)NC(=O)OCc4cncs4)Cc5ccccc5,BRD-K51040301-001-02-1,cobicistat,Selleck,S2900,Cobicistat (GS-9350),3.388076,x0354,21.261471,active-noncovalent
CC[C@H]1[N@](c2nc(ncc2N(C1=O)C)Nc3c(cc(cc3)C(=O)N[C@H]4CC[C@@H](CC4)N5CC[NH+](CC5)CC6CC6)OC)C(C)C,BRD-K69776681-001-06-1,volasertib,MedChemEx,HY-12137,Volasertib,3.682001,x0769,25.30611,active-covalent
CC[C@H]1[N@](c2nc(ncc2N(C1=O)C)Nc3c(cc(cc3)C(=O)N[C@H]4CC[C@@H](CC4)N5CC[NH+](CC5)CC6CC6)OC)C(C)C,BRD-K69776681-001-03-8,volasertib,Selleck,S2235,Volasertib (BI 6727),3.682001,x0769,25.30611,active-covalent
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,BRD-K85554912-001-07-1,ivermectin,Selleck,S1351,Ivermectin,3.733904,x0305,23.410923,active-noncovalent
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,BRD-K85554912-001-08-9,ivermectin,MicroSource,1300027,IVERMECTIN,3.733904,x0305,23.410923,active-noncovalent
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,BRD-K85554912-001-05-5,ivermectin,Tocris,1260,Ivermectin,3.733904,x0305,23.410923,active-noncovalent
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,BRD-K85554912-001-06-3,ivermectin,Selleck,S1351,Ivermectin,3.733904,x0305,23.410923,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C6CCCC6)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K28346421-001-06-8,rifapentine,Selleck,S1760,Rifapentine,3.853832,x0305,29.201466,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C6CCCC6)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K28346421-001-07-6,rifapentine,MedChemEx,HY-B0269,Rifapentine,3.853832,x0305,29.201466,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C6CCCC6)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,BRD-K28346421-001-08-4,rifapentine,Selleck,S1760,Rifapentine,3.853832,x0305,29.201466,active-noncovalent
c1ccc2c(c1)CN(C(=O)N2)C3CCN(CC3)C(=O)N[C@H](Cc4cc(c(c(c4)Br)[O-])Br)C(=O)N[C@@H](CCCC[NH3+])C(=O)N5CCN(CC5)c6cc[nH+]cc6,BRD-K43927145-001-02-0,BIBN4096,MedChemEx,HY-10095,Olcegepant,3.950773,x0887,25.421852,dimer-interface
c1ccc2c(c1)CN(C(=O)N2)C3CCN(CC3)C(=O)N[C@H](Cc4cc(c(c(c4)Br)[O-])Br)C(=O)N[C@@H](CCCC[NH3+])C(=O)N5CCN(CC5)c6cc[nH+]cc6,BRD-K43927145-001-03-8,BIBN4096,MedChemEx,HY-10095,Olcegepant,3.950773,x0887,25.421852,dimer-interface
c1ccc2c(c1)CN(C(=O)N2)C3CCN(CC3)C(=O)N[C@H](Cc4cc(c(c(c4)Br)[O-])Br)C(=O)N[C@@H](CCCC[NH3+])C(=O)N5CCN(CC5)c6cc[nH+]cc6,BRD-K43927145-001-01-2,BIBN4096,MedChemEx,HY-10095,Olcegepant,3.950773,x0887,25.421852,dimer-interface
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)Nc4ccc(cc4)OCCOCCOCCOCCNc5cccc6c5C(=O)N(C6=O)[C@H]7CCC(=O)NC7=O)c8ccc(cc8)Cl)C,BRD-A00047421-001-01-7,ARV-825,MedChemEx,HY-16954,ARV-825,4.079103,x1249,25.833164,active-noncovalent
CCc1cc(c(cc1N2CCC(CC2)[NH+]3CCN(CC3)S(=O)(=O)C)OC)Nc4nccc(n4)c5c(nc6n5cccc6)c7ccc(c(c7)C(=O)Nc8c(cccc8F)F)OC,BRD-K04833372-001-06-2,GSK1904529A,Selleck,S1093,GSK1904529A,4.124027,x1249,34.381935,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCCCCCCCO,BRD-K03083257-001-01-6,1-octacosanol,Acros,25813,"1-Octacosanol, 90+%",4.147969,x0786,22.720825,active-covalent
CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)[NH+](C)C)O)CC=O)C)O)C,BRD-K68822425-001-01-6,midecamycin,AvaChem,2013,"(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-(((2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-(propionyloxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-y;l)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-o",4.308069,x1249,26.143929,active-noncovalent
CC[C@H]\1CC[C@H]2[C@@H]([C@H]([C@H]([C@]3(O2)CC[C@H]([C@@H](O3)C[C@H](C)O)C)C)OC(=O)/C=C/[C@H]([C@@H]([C@H](C(=O)[C@@H]([C@H]([C@@H](C(=O)[C@@]([C@@H]([C@H](C/C=C/C=C1)C)O)(C)O)C)O)C)C)O)C)C,BRD-A81541225-001-06-8,oligomycin-a,Selleck,S1478,Oligomycin A,4.363648,x0887,30.175205,dimer-interface
CC(C)[C@@H](C(=O)N1CCC[C@H]1c2[nH]c(c[nH+]2)c3ccc(cc3)c4ccc(cc4)c5c[nH+]c([nH]5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,BRD-K82861010-001-02-5,daclatasvir,Selleck,S1482,Daclatasvir (BMS-790052),4.429354,x1249,35.646141,active-noncovalent
CCCN(CCC)C(=O)[C@H](CCC(=O)OCCCN1CC[NH+](CC1)CCOC(=O)Cc2c(n(c3c2cc(cc3)OC)C(=O)c4ccc(cc4)Cl)C)NC(=O)c5ccccc5,BRD-A19458515-001-01-2,proglumetacin,AKSci,H841,,4.459786,x0305,25.248604,active-noncovalent
C[NH+](C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6,BRD-K07955840-001-03-1,PF-05212384,Selleck,S2628,PF-05212384 (PKI-587),4.537680,x0689,24.419437,active-covalent
C[NH+](C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6,BRD-K07955840-001-02-3,PF-05212384,Selleck,S2628,PF-05212384 (PKI-587),4.537680,x0689,24.419437,active-covalent
C[NH+](C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6,BRD-K07955840-001-04-9,PF-05212384,Key,FE-0013,"N-(4-{[4-(dimethylamino)-1-piperidinyl]carbonyl}phenyl)-N'-{4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}urea",4.537680,x0689,24.419437,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@@H]3C(=O)N4CCC[C@@H]4C(=O)N[C@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N3)CC(=O)[O-])CCCCNC(=[NH2+])N)C(=O)N,BRD-A90547603-001-02-5,eptifibatide,Enzo,AC3111,EPTIFIBATIDE,4.596869,x1249,29.021294,active-noncovalent
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,BRD-A94756469-001-04-7,digoxin,MicroSource,1500247,DIGOXIN,5.015306,x0786,40.525742,active-covalent
CC[NH+]1C(CC(CC1(C)C)Oc2ccc(nc2)C(=O)Nc3ccc(cc3)NC(=O)Nc4cc(on4)C(C)(C)C)(C)C,BRD-K15819326-001-01-6,AC-710,Tocris,5013,AC 710,5.063013,x1351,24.431252,active-covalent
C[C@H](/N=N/C(=[NH2+])N)c1cc(cc(c1)[C@@H](/N=N/C(=[NH2+])N)C)NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)[C@@H](/N=N/C(=[NH2+])N)C)/C(=N/NC(=[NH2+])N)/C,BRD-K21237892-376-01-3,semapimod,Enamine,EN300-260559,"N1,N10-bis(3,5-bis(1-(2-carbamimidoylhydrazinyl)vinyl)phenyl)decanediamide tetrahydrochloride",5.256908,x0426,30.200304,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@@H](C[C@@H](C(=O)[C@@H]([C@H](/C(=C/[C@@H](C(=O)C[C@@H](OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,BRD-A79768653-001-12-0,sirolimus,MicroSource,1504008,SIROLIMUS,5.741323,x0305,30.096577,active-noncovalent
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)[O-],BRD-K03399463-001-01-6,BIO-1211,Tocris,3910,(2S)-1-((2S)-2-{[(2S)-3-carboxy-2-({(2S)-4-methyl-2-[({4-[(2-toluidinocarbonyl)amino]phenyl}acetyl)amino]pentanoyl}amino)propanoyl]amino}-3-methylbutanoyl)-2-pyrrolidinecarboxylic acid,6.085115,x1249,42.22084,active-noncovalent
CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,BRD-A25579302-001-04-8,abamectin,MicroSource,1502260,ABAMECTIN (avermectin B1a shown),6.146558,x1249,24.0793,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,BRD-K84937637-001-13-1,sirolimus,MedChemEx,HY-10219,Rapamycin,6.438233,x0354,28.977268,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,BRD-K84937637-001-09-9,sirolimus,Selleck,S1039,Rapamycin (Sirolimus),6.438233,x0354,28.977268,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,BRD-K84937637-001-11-5,sirolimus,Selleck,S1039,Rapamycin (Sirolimus),6.438233,x0354,28.977268,active-noncovalent
C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)[O-])C)O)C)O[C@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C,BRD-A73871920-236-03-6,nanchangmycin,Selleck,S1450,Nanchangmycin,6.627116,x1249,26.304077,active-noncovalent
CC[C@]1(C[C@H](c2c(cc3c(c2[O-])C(=O)c4c(cccc4[O-])C3=O)[C@@H]1C(=O)OC)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)[NH+](C)C)O,BRD-A80805100-001-01-9,aclarubicin,Vitas-M,STK177207,,6.653972,x0689,24.795889,active-covalent
CC[C@]1(C[C@H](c2c(cc3c(c2[O-])C(=O)c4c(cccc4[O-])C3=O)[C@@H]1C(=O)OC)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)[NH+](C)C)O,BRD-A80805100-001-02-7,aclarubicin,Vitas-M,STK177207,"methyl 2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxotetrahydro-2H-pyran-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydro-1-n;aphthacenecarboxylate",6.653972,x0689,24.795889,active-covalent
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)[NH3+])O,BRD-K25770965-001-01-5,nystatin,Selleck,S1934,Nystatin (Fungicidin),6.715825,x0689,36.549496,active-covalent
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K21656326-001-01-4,nystatin,Sigma,S______N1638,"(1S,3R,4R,7R,9R,11R,15S,16S,17R,18S,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriacont;a-19,21,25,27,29,31-hexaene-36-carboxylic acid",6.774087,x0786,37.252766,active-covalent
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K21656326-001-02-2,nystatin,MedChemEx,HY-17409,Nystatin,6.774087,x0786,37.252766,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O)O)C,BRD-K58775955-001-03-2,gynostemma-extract,Selleck,S2306,Gynostemma Extract,6.813796,x0731,37.142323,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O)O)C,BRD-K58775955-001-02-4,gynostemma-extract,Selleck,S2306,Gynostemma Extract,6.813796,x0731,37.142323,active-covalent
C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@]5(CC[C@H](C6)O[C@@H]7[C@@H]([C@H]([C@H]([C@@H](O7)CO)O[C@@H]8[C@@H]([C@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@@H]9[C@@H]([C@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)[NH2+]C1,BRD-A65562236-001-01-2,solamargine,MedChemEx,HY-N0069,Solamargine,6.953574,x0786,43.869968,active-covalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)n5cnnn5)C)/C)O)OC)C)C)/C)OC,BRD-K46843573-001-01-9,zotarolimus,Adooq,A11950,,7.091252,x0354,32.067898,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,BRD-A84810646-001-01-6,ginsenoside-rd,MedChemEx,HY-N0043,Ginsenoside Rd,7.288797,x0769,50.139351,active-covalent
CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)NC(=O)C)OC)OC)\C)C,BRD-A91366704-001-01-9,eprinomectin,MicroSource,1502382,EPRINOMECTIN,7.298374,x0769,36.049873,active-covalent
C[NH+](C)CC[C@H](CSc1ccccc1)Nc2ccc(cc2N(=O)=O)S(=O)(=O)NC(=O)c3ccc(cc3)N4CC[NH+](CC4)Cc5ccccc5c6ccc(cc6)Cl,BRD-K56301217-001-10-8,ABT-737,Selleck,S1002,ABT-737,7.336386,x0752,31.339859,active-covalent
C[NH+](C)CC[C@H](CSc1ccccc1)Nc2ccc(cc2N(=O)=O)S(=O)(=O)NC(=O)c3ccc(cc3)N4CC[NH+](CC4)Cc5ccccc5c6ccc(cc6)Cl,BRD-K56301217-001-07-4,ABT-737,Selleck,S1002,ABT-737,7.336386,x0752,31.339859,active-covalent
CC[C@H]1[C@H](/C=C(\C=C\C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)[NH+](C)C)O)CC[NH+]3C[C@@H](C[C@@H](C3)C)C)C)/C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,BRD-K26634012-001-03-1,tilmicosin,MicroSource,1505112,TILMICOSIN,7.684663,x0967,25.325499,active-noncovalent
CC[C@H]1[C@H](/C=C(\C=C\C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)[NH+](C)C)O)CC[NH+]3C[C@@H](C[C@@H](C3)C)C)C)/C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,BRD-K26634012-001-04-9,tilmicosin,Selleck,S4122,Tilmicosin,7.684663,x0967,25.325499,active-noncovalent
C[N@+]1(CCc2cc(c(cc2[C@H]1Cc3cc(c(c(c3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N@@+]4(CCc5cc(c(cc5[C@H]4Cc6cc(c(c(c6)OC)OC)OC)OC)OC)C,BRD-A48465967-300-01-1,mivacurium,AKSci,71667,,7.899445,x0354,35.686176,active-noncovalent
C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C8CCCCC8)C)O,BRD-A16350940-001-01-9,doramectin,MicroSource,1505902,DORAMECTIN,8.135318,x1249,27.092003,active-noncovalent
C[N@+]1(CCc2cc(c(cc2[C@@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(CCc5cc(c(cc5[C@@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,BRD-A75935363-344-07-4,atracurium,Selleck,S1832,Atracurium besylate,8.169889,x1351,25.77854,active-covalent
C[N@+]1(CCc2cc(c(cc2[C@@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(CCc5cc(c(cc5[C@@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,BRD-A75935363-344-06-6,atracurium,MicroSource,1505872,ATRACURIUM BESYLATE,8.169889,x1351,25.77854,active-covalent
C[N@+]1(CCc2cc(c(cc2[C@@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(CCc5cc(c(cc5[C@@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,BRD-A75935363-344-05-8,atracurium,Selleck,S1832,Atracurium Besylate,8.169889,x1351,25.77854,active-covalent
CC1(CCC(=C(C1)c2ccc(cc2)Cl)C[NH+]3CCN(CC3)c4ccc(c(c4)Oc5cc6cc[nH]c6nc5)C(=O)NS(=O)(=O)c7ccc(c(c7)N(=O)=O)NCC8CCOCC8)C,BRD-K62391742-001-09-7,venetoclax,Adooq,A12500,"2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfon;yl)benzamide",8.258307,x0354,29.242067,active-noncovalent
CC1(CCC(=C(C1)c2ccc(cc2)Cl)C[NH+]3CCN(CC3)c4ccc(c(c4)Oc5cc6cc[nH]c6nc5)C(=O)NS(=O)(=O)c7ccc(c(c7)N(=O)=O)NCC8CCOCC8)C,BRD-K62391742-001-08-9,venetoclax,Selleck,S8048,Venetoclax,8.258307,x0354,29.242067,active-noncovalent
CC1(CCC(=C(C1)c2ccc(cc2)Cl)C[NH+]3CCN(CC3)c4ccc(c(c4)Oc5cc6cc[nH]c6nc5)C(=O)NS(=O)(=O)c7ccc(c(c7)N(=O)=O)NCC8CCOCC8)C,BRD-K62391742-001-03-0,venetoclax,Selleck,S8048,ABT-199 (GDC-0199),8.258307,x0354,29.242067,active-noncovalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)O)[NH3+])C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K25243230-001-02-0,oxytocin,MedChemEx,HY-17571,Oxytocin,8.315126,x0305,27.67984,active-noncovalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)O)[NH3+])C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K25243230-001-01-2,oxytocin,Sigma,MFCD00076731,"(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-sec-butyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbo;nyl}-N-((1S)-1-{[(2-amino-2-oxoethyl)amino]carbonyl}-3",8.315126,x0305,27.67984,active-noncovalent
C[N@@+]1(CCc2cc(c(cc2[C@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCc5cc(c(cc5[C@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,BRD-K17498618-344-03-4,cisatracurium,Selleck,S2113,Cisatracurium besylate (Nimbex),8.537491,x0305,27.905106,active-noncovalent
C[N@@+]1(CCc2cc(c(cc2[C@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCc5cc(c(cc5[C@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,BRD-K17498618-344-02-6,betaxolol,Selleck,S2113,Cisatracurium Besylate,8.537491,x0305,27.905106,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,BRD-K13514097-001-04-6,everolimus,Selleck,S1120,Everolimus,8.637960,x1384,33.100357,active-covalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,BRD-K13514097-001-05-3,everolimus,Selleck,S1120,Everolimus (RAD001),8.637960,x1384,33.100357,active-covalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,BRD-K75043328-001-03-4,coenzyme-q10,Selleck,S2398,Coenzyme Q10 (CoQ10),8.679152,x0354,30.313881,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,BRD-K75043328-001-05-9,coenzyme-q10,Sigma,MFCD00042919,"2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methylbenzo-1,4-quinone",8.679152,x0354,30.313881,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,BRD-K75043328-001-04-2,coenzyme-q10,Selleck,S2398,Coenzyme Q10(CoQ10),8.679152,x0354,30.313881,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC,BRD-K62304154-001-04-2,deforolimus,Selleck,S1022,"Ridaforolimus (Deforolimus, MK-8669)",8.736231,x0771,35.845833,active-covalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC,BRD-K62304154-001-03-4,deforolimus,Selleck,S1022,Deforolimus (MK-8669),8.736231,x0771,35.845833,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1c2[nH]c(c[nH+]2)c3ccc4c(c3)cc-5n4[C@@H](Oc6c5ccc(c6)c7c[nH+]c([nH]7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)c9ccccc9)NC(=O)OC,BRD-K09735259-001-01-3,elbasvir,MedChemEx,HY-15789,Elbasvir,9.039070,x0769,42.529083,active-covalent
CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,BRD-K37753391-046-03-2,tylosin,Selleck,S3162,Tylosin tartrate,9.065078,x1425,30.401752,active-covalent
CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,BRD-K37753391-046-02-4,tylosin,MicroSource,1505312,TYLOSIN TARTRATE,9.065078,x1425,30.401752,active-covalent
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,BRD-A93236127-001-04-5,digitoxin,MicroSource,1500246,DIGITOXIN,9.350161,x0786,29.350058,active-covalent
Cc1c(c2ccccc2[nH]1)C[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3c[nH]c4c3cccc4)C(=O)N[C@H](Cc5ccccc5)C(=O)N[C@@H](CCCC[NH3+])C(=O)N)NC(=O)[C@H](Cc6c[nH]cn6)[NH3+],BRD-K35304636-001-01-0,examorelin,Sigma,80666,"(S)-2-((2R,5S,8S,11R,14S)-5-((1H-indol-3-yl)methyl)-14-amino-2-benzyl-15-(1H-imidazol-5-yl)-8-methyl-11-((2-methyl-1H-indol-3-yl)methyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecanamido)-6-aminohex;anamide",9.432355,x0731,35.919762,active-covalent
CC(=O)N(CC(CN(c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I)C(=O)C)O)c2c(c(c(c(c2I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I,BRD-A08660406-001-06-7,iodixanol,Sigma,MFCD00867965,"5-{acetyl[3-(acetyl-3,5-bis{[(2,3-dihydroxypropyl)amino]carbonyl}-2,4,6-triiodoanilino)-2-hydroxypropyl]amino}-N~1~,N~3~-bis(2,",9.509068,x0426,31.358103,active-noncovalent
CC(=O)N(CC(CN(c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I)C(=O)C)O)c2c(c(c(c(c2I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I,BRD-A08660406-001-05-9,iodixanol,MicroSource,1503835,IODIXANOL,9.509068,x0426,31.358103,active-noncovalent
C[C@H](C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)[O-])[NH3+])O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](Cc1ccccc1)C(=O)[O-],BRD-K89071957-001-01-1,CTS21166,EMDBio,496000-250UG,InSolution OM99-2,9.675095,x1384,33.603779,active-covalent
C[C@@H](C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@H](Cc3ccccc3)C(=O)N[C@@H](CCCC[NH3+])C(=O)N)NC(=O)[C@@H](Cc4c[nH]c5c4cccc5)NC(=O)[C@H](Cc6c[nH]cn6)[NH3+],BRD-K77070363-001-01-5,U-75799E,Adooq,A13464,"(2S,5R,8S,11S,14R,17S)-17-amino-2-(4-aminobutyl)-5-benzyl-18-(1H-imidazol-5-yl)-8,14-bis(1H-indol-3-ylmethyl)-11-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-amide",10.023323,x0731,32.610828,active-covalent
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@@H](C[C@@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-A78080706-001-04-5,nystatin,MicroSource,1500446,NYSTATIN,10.098737,x0887,24.411102,dimer-interface
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@@](O2)(C[C@H]([C@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)[NH3+])O,BRD-K45107378-001-01-7,nystatin,Selleck,S1934,Nystatin (Fungicidin),10.246754,x0978,31.255959,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@@H](Cc4c[nH]c5c4cccc5)NC(=O)[C@H](CCC[NH+]=C(N)N)[NH3+],BRD-K25863791-001-01-8,antagonist-g,Tocris,1954,"(6S,9R,12S,15R,18S,21S)-1,6-diamino-12-benzyl-1-imino-9,15-bis(1H-indol-3-ylmethyl)-18-isobutyl-11-methyl-21-[2-(methylsulfanyl)ethyl]-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosan-22-amide",10.837076,x1351,35.998821,active-covalent
C[C@@H](C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](c3ccccc3)c4cn(nn4)CCCCc5ccc(cc5)CCCCn6cc(nn6)[C@H](c7ccccc7)NC(=O)[C@@H]8CC[C@H]9N8C(=O)[C@H](CCCC9)NC(=O)[C@H](C)[NH2+]C)[NH2+]C,BRD-K06191411-001-01-7,SM-164,MedChemEx,HY-15989,SM-164,10.933208,x0354,44.48111,active-noncovalent
C[C@@H](C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](c3ccccc3)c4cn(nn4)CCCCc5ccc(cc5)CCCCn6cc(nn6)[C@H](c7ccccc7)NC(=O)[C@@H]8CC[C@H]9N8C(=O)[C@H](CCCC9)NC(=O)[C@H](C)[NH2+]C)[NH2+]C,BRD-K06191411-001-02-5,SM-164,MedChemEx,HY-15989,SM-164,10.933208,x0354,44.48111,active-noncovalent
CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)[NH+](C)C)O)CC=O)C)OC(=O)C)C,BRD-K30764557-001-01-5,miocamycin,AvaChem,2845,"(2S,3S,4R,6S)-4-acetoxy-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-acetoxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-(propionyloxy)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimet;hylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)o",11.194629,x0689,27.739977,active-covalent
CC(=O)N[C@H]1[C@@H]([C@@H]([C@@H](O[C@H]1O)COS(=O)(=O)[O-])O[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)C(=O)[O-])O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O[C@@H]4[C@H]([C@@H]([C@H]([C@H](O4)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O,BRD-A83644949-236-01-6,ardeparin,MedChemEx,HY-17567A,Heparin (sodium salt),11.269651,x0305,43.107052,active-noncovalent
C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@H]3[C@@H](O[C@H]([C@H]([C@@H]3O)O)O[C@H]4[C@H](O[C@H]([C@@H]([C@@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@@H]6O)O)O[C@H]7[C@@H](O[C@@H]([C@H]([C@@H]7O)O)O[C@H]8[C@@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O,BRD-A08079565-001-01-8,CDBA,EMDBio,239760-25GM,Cyclodextrin,11.283535,x0426,41.074455,active-noncovalent
CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc2cnc[nH]2)Cc3ccccc3)CCCNC(=[NH2+])N)Cc4c[nH]c5c4cccc5)C(=O)[O-])NC(=O)C,BRD-K06328344-015-01-7,bremelanotide,MedChemEx,HY-18678A,Bremelanotide (Acetate),11.543972,x0540,36.150478,active-noncovalent
CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2CCC[C@H]2C(=O)[O-])NC(=O)[C@H](Cc3ccc(cc3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC[NH+]=C(N)N)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K36040345-001-02-9,TXA127,MedChemEx,HY-12403,Angiotensin (1-7),11.802439,x0769,38.81963,active-covalent
CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2CCC[C@H]2C(=O)[O-])NC(=O)[C@H](Cc3ccc(cc3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC[NH+]=C(N)N)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K36040345-001-01-1,TXA127,MedChemEx,HY-12403,Angiotensin (1-7),11.802439,x0769,38.81963,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)OC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K56107812-001-01-7,carbetocin,MedChemEx,HY-17573,Carbetocin,11.826138,x0354,28.961252,active-noncovalent
CC1(CCC(=C(C1)C[NH+]2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(c(c4)S(=O)(=O)C(F)(F)F)N[C@H](CC[NH+]5CCOCC5)CSc6ccccc6)c7ccc(cc7)Cl)C,BRD-K82746043-001-15-1,navitoclax,Selleck,S1001,ABT-263 (Navitoclax),11.900876,x0771,55.193127,active-covalent
CC1(CCC(=C(C1)C[NH+]2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(c(c4)S(=O)(=O)C(F)(F)F)N[C@H](CC[NH+]5CCOCC5)CSc6ccccc6)c7ccc(cc7)Cl)C,BRD-K82746043-001-19-3,navitoclax,Selleck,S1001,ABT-263 (Navitoclax),11.900876,x0771,55.193127,active-covalent
C[C@@H]1CC[C@@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,BRD-K42898655-001-01-8,temsirolimus,Selleck,S1044,"Temsirolimus (CCI-779, NSC 683864)",11.933160,x0689,32.592369,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc2ccc(cc2)[C@@H]3CC[C@H](N3c4ccc(cc4)C(C)(C)C)c5ccc(cc5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,BRD-K11072003-001-02-4,ombitasvir,MedChemEx,HY-13997,Ombitasvir,12.023849,x0691,38.487953,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc2ccc(cc2)[C@@H]3CC[C@H](N3c4ccc(cc4)C(C)(C)C)c5ccc(cc5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,BRD-K11072003-001-01-6,ombitasvir,MedChemEx,HY-13997,Ombitasvir,12.023849,x0691,38.487953,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K93331255-001-02-0,lypressin,Apollo,BITH3033,,12.642646,x0689,36.979786,active-covalent
C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K27352494-001-06-9,amphotericin-b,Selleck,S1636,Amphotericin B,12.829427,x0354,47.984074,active-noncovalent
C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K27352494-001-04-4,amphotericin-b,MicroSource,1500122,AMPHOTERICIN B,12.829427,x0354,47.984074,active-noncovalent
C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K27352494-001-03-6,amphotericin-b,Selleck,S1636,Amphotericin B,12.829427,x0354,47.984074,active-noncovalent
C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,BRD-K27352494-001-05-1,amphotericin-b,MedChemEx,HY-B0221,Amphotericin B,12.829427,x0354,47.984074,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@H]3c4ccccc4C[C@H]3OCC#CC#CCO[C@@H]5Cc6ccccc6[C@@H]5NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)[NH2+]C)[NH2+]C,BRD-K88767641-001-01-7,AZD5582,MedChemEx,HY-12600,AZD5582,13.027397,x0354,33.262779,active-noncovalent
c1cc(ccc1c2/c3cc/c(/n3)c(/c4cc/c(/n4)c(/c5n/c(c(\c6cc/c2/n6)/c7ccc(cc7)S(=O)(=O)[O-])/CC5)\c8ccc(cc8)S(=O)(=O)[O-])\c9ccc(cc9)S(=O)(=O)[O-])S(=O)(=O)[O-],BRD-K39805756-001-01-6,TPPS4,Vitas-M,STK568251,,13.273376,x0354,36.378242,active-noncovalent
CCCCCCCCCCCCCCCCCC[NH+](CCCCCCCCCCCCCCCCCC)CCC[NH+](CCO)CCO,BRD-K26665484-001-01-8,avridine,Sigma,PZ0123,"2,2'-((3-(dioctadecylamino)propyl)azanediyl)bis(ethan-1-ol)",13.296442,x0749,30.889793,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,BRD-K74225533-001-08-8,beta-carotene,Selleck,S1767,Beta Carotene,13.741607,x0749,30.06546,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,BRD-K74225533-001-09-6,beta-carotene,MicroSource,1500143,beta-CAROTENE [2mM],13.741607,x0749,30.06546,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,BRD-K74225533-001-12-0,beta-carotene,MedChemEx,HY-N0411,?-Carotene,13.741607,x0749,30.06546,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,BRD-K74225533-001-10-4,beta-carotene,Selleck,S1767,Beta Carotene,13.741607,x0749,30.06546,active-covalent
CC[C@@H](C)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5CO[C@](O5)(Cn6cncn6)c7ccc(cc7Cl)Cl,BRD-A23067620-001-03-3,itraconazole,Selleck,S2476,Itraconazole,13.965454,x0786,35.740974,active-covalent
CC[C@@H](C)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5CO[C@](O5)(Cn6cncn6)c7ccc(cc7Cl)Cl,BRD-A23067620-300-01-3,itraconazole,MicroSource,1505756,ITRACONAZOLE HYDROCHLORIDE,13.965454,x0786,35.740974,active-covalent
CC[C@@H](C)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5CO[C@](O5)(Cn6cncn6)c7ccc(cc7Cl)Cl,BRD-A23067620-001-04-1,itraconazole,Selleck,S2476,Itraconazole (Sporanox),13.965454,x0786,35.740974,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)Cc2ccc(cc2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,BRD-A85261566-001-03-3,atosiban,MedChemEx,HY-17572,Atosiban,14.140432,x0354,35.492691,active-noncovalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)Cc2ccc(cc2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,BRD-A85261566-001-01-7,atosiban,MedChemEx,HY-17572,Atosiban,14.140432,x0354,35.492691,active-noncovalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)Cc2ccc(cc2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,BRD-A85261566-001-02-5,atosiban,MedChemEx,HY-17572,Atosiban,14.140432,x0354,35.492691,active-noncovalent
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)[NH3+])O,BRD-K37151368-001-01-7,adaptavir,Tocris,2423,"(2S)-N~1~-[(1S)-2-{[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]amino}-1-(4-hydroxybenzyl)-2-oxoethyl]-2-{[(2S,5S,8S,11S,14R)-14-amino-2,5,8-tris[(1R)-1-hydroxyethyl]-11-(hydroxymethyl)-4,7,10,13-tetrao",14.253608,x0771,34.63747,active-covalent
CC[C@@H]1C(=O)N(CC(=O)N([C@@H](C(=O)N[C@@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@@H](C(=O)N([C@@H](C(=O)N1)[C@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,BRD-A69815203-001-08-4,cyclosporin-a,MicroSource,1502202,CYCLOSPORINE,14.538705,x0354,56.056984,active-noncovalent
CC[C@@H]1C(=O)N(CC(=O)N([C@@H](C(=O)N[C@@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@@H](C(=O)N([C@@H](C(=O)N1)[C@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,BRD-A69815203-001-07-6,cyclosporin-a,Tocris,1101,Cyclosporin A,14.538705,x0354,56.056984,active-noncovalent
c1ccc(cc1)C[C@H]2C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)Cc4ccc(cc4)OCc5ccccc5)CCCC[NH3+])Cc6c[nH]c7c6cccc7)c8ccccc8)OC(=O)NCC[NH3+],BRD-K59715032-362-01-4,pasireotide,MedChemEx,HY-79135,Pasireotide (ditrifluoroacetate),14.828497,x1358,43.470131,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K73028949-001-02-8,vasopressin,Sigma,MFCD00076738,,14.996686,x0771,37.876194,active-covalent
CC[C@@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@H]([C@@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,BRD-A31685486-402-02-7,caspofungin,MedChemEx,HY-17006,Caspofungin (Acetate),15.384632,x0540,37.279621,active-noncovalent
CC[C@@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@H]([C@@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,BRD-A31685486-402-01-9,caspofungin,MedChemEx,HY-17006,Caspofungin (Acetate),15.384632,x0540,37.279621,active-noncovalent
C[C@H]([C@@H]1C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCC[NH3+])Cc2c[nH]c3c2cccc3)Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)[NH3+])C(=O)N[C@H](CO)[C@@H](C)O)O,BRD-A64173453-015-03-1,octreotide,MedChemEx,HY-17365,Octreotide (acetate),15.578240,x0354,42.481567,active-noncovalent
C[C@H]([C@@H]1C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCC[NH3+])Cc2c[nH]c3c2cccc3)Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)[NH3+])C(=O)N[C@H](CO)[C@@H](C)O)O,BRD-A64173453-015-01-5,octreotide,MedChemEx,HY-17365,Octreotide (acetate),15.578240,x0354,42.481567,active-noncovalent
C[C@H]([C@@H]1C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCC[NH3+])Cc2c[nH]c3c2cccc3)Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)[NH3+])C(=O)N[C@H](CO)[C@@H](C)O)O,BRD-A64173453-015-02-3,octreotide,MedChemEx,HY-17365,Octreotide (acetate),15.578240,x0354,42.481567,active-noncovalent
CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,BRD-K49793107-402-03-4,caspofungin-acetate,Selleck,S3073,Caspofungin Acetate,15.918592,x1358,43.389839,active-covalent
CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,BRD-K49793107-402-02-6,caspofungin-acetate,Selleck,S3073,Caspofungin Acetate,15.918592,x1358,43.389839,active-covalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@H]4[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@@H](NC6=O)C(C)C)C)C)C(C)C)C,BRD-K16547679-001-01-5,actinomycin-d,MedChemEx,HY-17559,Actinomycin D,17.370586,x0354,49.75713,active-noncovalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@@H]4[C@@H](OC(=O)[C@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@@H]6[C@@H](OC(=O)[C@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C,BRD-A42383464-001-06-3,actinomycin-d,MedChemEx,HY-17559,Actinomycin D,17.841331,x0691,54.287449,active-covalent
CC[C@H]1[C@@H](C[C@](O[C@@H]1C)(O)[C@H]([C@H](O)[C@@H]([C@H]2OC(=O)/C=C/C=C/[C@@H]([C@@H](OC(=O)/C=C/C=C/[C@H]2C)[C@H]([C@@H](O)[C@@H]([C@@]3(O[C@@H]([C@H]([C@@H](C3)O[C@@H]4O[C@H]([C@H]([C@H](C4)O)O)C)CC)C)O)C)C)C)C)C)O[C@@H]5O[C@H]([C@H]([C@H](C5)O)O)C,BRD-K96104201-001-01-5,azalomycin-b,Selleck,S1448,Elaiophylin,18.087122,x0691,50.485783,active-covalent
CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC[C@H](C(=O)N[C@@H](C(=O)N1)CC[NH3+])NC(=O)[C@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC[NH3+])NC(=O)CCCCC(C)C)[C@@H](C)O)CC[NH3+])CC[NH3+])[C@@H](C)CC,BRD-A45201156-315-02-0,colistin-sulfate,MicroSource,1505955,COLISTIN SULFATE,18.149612,x0769,44.994755,active-covalent
CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,BRD-K13533483-001-17-0,cyclosporine,Selleck,S1514,Cyclosporine,18.272326,x0689,42.260864,active-covalent
CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,BRD-K13533483-001-16-2,cyclosporine,Selleck,S2286,Cyclosporin A,18.272326,x0689,42.260864,active-covalent
Cc1ccc(cc1NC(=O)c2cccc(c2)NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6c5c(cc(c6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)Nc7ccc(c8c7c(cc(c8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],BRD-K70327167-348-13-4,suramin,MicroSource,1502032,SURAMIN HEXASODIUM,18.599680,x0354,52.010719,active-noncovalent
Cc1ccc(cc1NC(=O)c2cccc(c2)NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6c5c(cc(c6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)Nc7ccc(c8c7c(cc(c8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],BRD-K70327167-348-12-6,suramin,Tocris,1472,Suramin hexasodium salt,18.599680,x0354,51.365665,active-noncovalent
CCc1c(c(c(c(c1Cl)[O-])Cl)O)C(=O)O[C@@H]2[C@H](O[C@H]([C@H]([C@H]2O)OC)OC/C/3=C\C=C\C[C@@H](/C(=C\[C@@H]([C@@H](/C(=C/C(=C/C[C@@H](OC3=O)[C@@H](C)O)/C)/C)O[C@H]4[C@@H]([C@H]([C@@H](C(O4)(C)C)OC(=O)C(C)C)O)O)CC)/C)O)C,BRD-K57371763-001-01-7,fidaxomicin,Selleck,S4227,Fidaxomicin,18.676615,x1358,47.426296,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,BRD-K96874295-015-01-0,gonadorelin,MedChemEx,HY-12555,Gonadorelin (acetate),18.739880,x1425,53.378159,active-covalent
C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,BRD-K19412342-001-02-4,valspodar,MedChemEx,HY-17384,Valspodar,18.943077,x0354,49.735874,active-noncovalent
C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,BRD-K19412342-001-01-6,valspodar,MedChemEx,HY-17384,Valspodar,18.943077,x0354,49.735874,active-noncovalent
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC(=O)[C@@H]6CCC(=O)N6,BRD-K42140276-402-01-4,alarelin,MedChemEx,HY-17405,Alarelin (Acetate),18.975462,x0755,49.281712,active-covalent
C[C@H]([C@H]1C(=O)NCC[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC[NH3+])CC[NH3+])C(C)C)CC(C)C)CC[NH3+])NC(=O)[C@@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC[NH3+])NC(=O)CCCCC(C)C)O,BRD-K57773246-001-02-9,colistin-sulfate,Selleck,S4029,Colistin Sulfate,19.938244,x1358,42.986473,active-covalent
C[C@H]([C@H]1C(=O)NCC[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC[NH3+])CC[NH3+])C(C)C)CC(C)C)CC[NH3+])NC(=O)[C@@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC[NH3+])NC(=O)CCCCC(C)C)O,BRD-K57773246-001-01-1,colistin-sulfate,Selleck,S4029,Colistin Sulfate,19.938244,x1358,42.986473,active-covalent
CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N2CCC[C@@H]2C(=O)N[C@H](Cc3ccccc3)C(=O)[O-])NC(=O)[C@H](Cc4ccc(cc4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(=O)[O-])[NH3+],BRD-K45503887-001-01-1,delivert,MedChemEx,HY-13948,Angiotensin II human,19.959675,x0786,54.67852,active-covalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@H]4[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C,BRD-K70578146-001-06-7,dactinomycin,MicroSource,330001,DACTINOMYCIN,20.049067,x0540,49.073147,active-noncovalent
c1ccc2c(c1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@@H](CCC[NH+]=C(N)N)[NH3+])O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-],BRD-K63772874-001-03-0,icatibant-acetate,MedChemEx,HY-17446,Icatibant,21.704247,x1384,57.330181,active-covalent
c1ccc2c(c1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@@H](CCC[NH+]=C(N)N)[NH3+])O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-],BRD-K63772874-001-02-2,icatibant-acetate,MedChemEx,HY-17446,Icatibant,21.704247,x1384,57.330181,active-covalent
c1ccc2c(c1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@@H](CCC[NH+]=C(N)N)[NH3+])O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-],BRD-K63772874-001-01-4,icatibant-acetate,MedChemEx,HY-17446,Icatibant,21.704247,x1384,57.330181,active-covalent
C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCC[NH3+])Cc2c[nH]c3c2cccc3)Cc4ccccc4)Cc5ccccc5)CC(=O)N)CCCC[NH3+])NC(=O)CNC(=O)[C@H](C)[NH3+])C(=O)[O-])CO)[C@@H](C)O)Cc6ccccc6)O,BRD-K14681867-001-01-6,somatostatin,Key,HS-2027,"(4R,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[({[(2S)-2-aminopropanoyl]amino}acetyl)amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydro;xymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,",21.756920,x0354,58.62664,active-noncovalent
c1ccc(cc1)C[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N2)Cc3ccc(cc3)O)C(=O)N4CCC[C@@H]4C(=O)N[C@H](CCCNC(=[NH2+])N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-A49399758-015-01-8,desmopressin-acetate,MedChemEx,HY-17370,Desmopressin (Acetate),23.158699,x1351,58.485451,active-covalent
CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1c3[nH]c(c[nH+]3)c4ccc-5c(c4)C(c6c5ccc(c6)c7ccc8c(c7)nc([nH]8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)(F)F)NC(=O)OC,BRD-K05446112-001-01-8,ledipasvir,MedChemEx,HY-15602,Ledipasvir,23.521370,x0786,63.628201,active-covalent
C[C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](Cc4ccc(cc4)O)C(=O)[O-])C(=O)N[C@@H](CSSC[C@@H](C(=O)N3)[NH3+])C(=O)N[C@H](C(=O)N5CCC[C@H]5C(=O)N1)CC(=O)N)Cc6ccc(cc6)O)CCC(=O)[O-],BRD-A55468767-001-01-1,linaclotide,MedChemEx,HY-17584,Linaclotide,24.575813,x0731,58.874084,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,BRD-K99504665-001-01-2,goserelin-acetate,Enzo,DL282,Goserelin acetate,24.895494,x0354,55.953598,active-noncovalent
C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@@H](CC(C)C)[NH2+]C)O)CO)O)O)(C)[NH3+])O,BRD-K91065602-001-01-8,vancomycin,MicroSource,1500607,VANCOMYCIN HYDROCHLORIDE,25.291874,x1384,55.767021,active-covalent
C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@@H](CC(C)C)[NH2+]C)O)CO)O)O)(C)[NH3+])O,BRD-K91065602-003-04-8,vancomycin,Selleck,S2575,Vancomycin HCl (Vancocin),25.291874,x1384,55.767021,active-covalent
C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@@H](CC(C)C)[NH2+]C)O)CO)O)O)(C)[NH3+])O,BRD-K91065602-003-05-5,vancomycin,Selleck,S2575,Vancomycin HCl (Vancocin),25.291874,x1384,55.767021,active-covalent
Cc1c(cc2cc3c(c(c2c1O)[O-])C(=O)[C@H]([C@@H](C3)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]4C[C@H]([C@@H]([C@H](O4)C)O)O[C@H]5C[C@H]([C@@H]([C@H](O5)C)O)O[C@H]6C[C@]([C@@H]([C@H](O6)C)O)(C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@H]([C@@H]([C@H](O8)C)O)O,BRD-K36368047-001-01-7,plicamycin,Enzo,GR305,Plicamycin (Mithramycin A),25.442841,x0786,45.956432,active-covalent
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,BRD-K26323068-001-01-8,leuprolide,Sigma,1358503,"(2S)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-{[amino(imino)methyl]amino}propyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5,8-diisobutyl-4,7,10,13,16,19,2",25.672380,x0354,54.80867,active-noncovalent
C[C@H](COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)O)O)O,BRD-A01412266-001-01-0,hydroxypropyl-beta-cyclodextrin,Cayman,16169,,27.344244,x0769,68.180733,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](Cc2c[nH]c3c2cccc3)NC(=O)[C@H](Cc4ccc(cc4)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5c[nH]c6c5cccc6)NC(=O)[C@H](Cc7cnc[nH]7)NC(=O)[C@@H]8CCC(=O)N8,BRD-K62685538-001-01-7,triptorelin,Enzo,DL310,Triptorelin acetate,28.267122,x1425,62.417,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)NC(=O)CNC(=O)CNC(=O)C[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,BRD-K73451719-001-01-2,terlipressin,Key,HS-2028,"(S)-N-((S)-6-amino-1-(2-amino-2-oxoethylamino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-19-(2-(2-(2-aminoacetamido)acetamido)acetamido)-13-benzyl-16-;(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8",28.423651,x0759,47.023827,active-covalent
CCCCCOc1ccc(cc1)c2cc(no2)c3ccc(cc3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](c7ccc(c(c7)OS(=O)(=O)[O-])O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,BRD-A06596811-236-03-3,micafungin,MedChemEx,HY-16321,Micafungin (sodium),31.177338,x0771,73.544296,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@@H]2c4csc(n4)[C@H]([C@H](OC(=O)c5cc(c6c(n5)[C@H]([C@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@@H](NC(=O)[C@H]8CSC(=N8)/C(=C/C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,BRD-K58049875-001-02-1,thiostrepton,Selleck,S4354,thiostrepton,32.741310,x0705,76.293983,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@@H]2c4csc(n4)[C@H]([C@H](OC(=O)c5cc(c6c(n5)[C@H]([C@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@@H](NC(=O)[C@H]8CSC(=N8)/C(=C/C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,BRD-K58049875-001-03-9,thiostrepton,MedChemEx,HY-B0990,Thiostrepton,32.741310,x0705,76.293983,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@@H]2c4csc(n4)[C@H]([C@H](OC(=O)c5cc(c6c(n5)[C@H]([C@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@@H](NC(=O)[C@H]8CSC(=N8)/C(=C/C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,BRD-K58049875-001-04-7,thiostrepton,Selleck,S4354,Thiostrepton,32.741310,x0705,76.293983,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@@H]2c4csc(n4)[C@H]([C@H](OC(=O)c5cc(c6c(n5)[C@H]([C@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@@H](NC(=O)[C@H]8CSC(=N8)/C(=C/C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,BRD-K58049875-001-01-3,thiostrepton,MedChemEx,HY-B0990,Thiostrepton,32.741310,x0705,76.293983,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCC[NH3+])NC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H](CCC(=O)[O-])NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CN=C(S2)[C@@H](C(C)C)[NH3+])CC(=O)N)CC(=O)[O-])Cc3c[nH]cn3)Cc4ccccc4,BRD-A30186914-001-01-1,bacitracin,Selleck,S4146,Bacitracin,35.560600,x0771,67.509468,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@H]2c4csc(n4)[C@H]([C@@H](OC(=O)c5cc(c6c(n5)[C@H]([C@@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@H](NC(=O)[C@H]8CSC(=N8)/C(=C\C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,BRD-A20697603-001-07-2,thiostrepton,MicroSource,1505111,THIOSTREPTON,36.081772,x0771,70.596352,active-covalent
Cc1c(nc(nc1N)[C@H](CC(=O)N)[NH2+]C[C@@H](C(=O)N)N)C(=O)N[C@H]([C@H](c2cnc[nH]2)O[C@@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)O)O)O[C@@H]4[C@H]([C@@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCC[NH2+]CCCC[NH3+])O,BRD-A94813917-001-01-0,bleomycetin,InterBioScreen,STOCK1N-47291,,36.713348,x1358,62.396938,active-covalent
CC[C@H](C)CCCC(=O)N[C@@H](CC[NH3+])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC[NH3+])C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC[NH3+])CC(C)C)CC(C)C)CC[NH3+])CC[NH3+])[C@@H](C)O,BRD-A18924964-065-01-5,colistin,MedChemEx,HY-A0089,Colistin (sulfate),37.457230,x1380,57.385876,active-covalent
CC[C@H](C)CCCC(=O)N[C@@H](CC[NH3+])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC[NH3+])C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC[NH3+])CC(C)C)CC(C)C)CC[NH3+])CC[NH3+])[C@@H](C)O,BRD-A18924964-065-02-3,colistin,MedChemEx,HY-A0089,Colistin (sulfate),37.457230,x1380,57.385876,active-covalent
CC[C@@H](c1cc(c(c(c1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc3ccc(c(c3)OC)OC)c4cccc(c4)OCC(=O)NCCNC(=O)COc5cccc(c5)[C@@H](CCc6ccc(c(c6)OC)OC)OC(=O)[C@@H]7CCCCN7C(=O)[C@@H](CC)c8cc(c(c(c8)OC)OC)OC,BRD-K28383148-001-01-4,AP1903,MedChemEx,HY-16046,AP1903,40.394569,x1375,61.159527,active-covalent
C/C=C(/C)\C(=O)O[C@@H]1[C@@H]([C@@]2([C@@H](C[C@@]3(C(=CC[C@H]4[C@]3(CC[C@H]5[C@@]4(CC[C@@H]([C@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C)C)[C@H]2CC1(C)C)C)O)CO)OC(=O)C,BRD-A90796352-001-04-7,escin,MicroSource,1504030,ESCIN,42.507744,x1385,51.377037,active-covalent
C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc3cccnc3)NC(=O)[C@@H](Cc4ccc(cc4)Cl)NC(=O)[C@@H](Cc5ccc6ccccc6c5)NC(=O)C,BRD-K76315403-015-02-5,cetrorelix,Sigma,MFCD08459466,(S)-1-(((R)-2-((S)-2-((S)-2-((R)-2-((R)-2-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanam;ido)-5-ureidopentanoyl)-L-leucyl-L-arginyl)-N-((R)-1-a,42.572292,x0786,87.190903,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCC[NH3+])NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)[O-])NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@H](C)CC)[NH3+])CC(=O)N)CC(=O)[O-])Cc3cnc[nH]3)Cc4ccccc4,BRD-A23712469-001-08-7,bacitracin,Selleck,S4146,Bacitracin,43.333775,x0771,78.35997,active-covalent
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@H](CC(=O)N)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCC[NH3+])CC(=O)[O-])C)CC(=O)[O-])CO)[C@@H](C)CC(=O)[O-])CC(=O)c4ccccc4N)C,BRD-K94358652-001-02-1,daptomycin,Selleck,S1373,Daptomycin,48.051788,x0771,76.014732,active-covalent
CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@H](CC(=O)N)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCC[NH3+])CC(=O)[O-])C)CC(=O)[O-])CO)[C@@H](C)CC(=O)[O-])CC(=O)c4ccccc4N)C,BRD-K94358652-001-03-9,daptomycin,Selleck,S1373,Daptomycin,48.051788,x0771,76.014732,active-covalent
C[C@@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@H]([C@@H](O[C@@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@@H]5C(=O)N[C@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@H](CC(C)C)[NH3+])O)CO)O)O)(C)[NH3+])O,BRD-A08791201-003-01-4,norvancomycin,MedChemEx,HY-B1924,Norvancomycin (hydrochloride),48.590725,x0749,75.914047,active-covalent
CC[C@@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@@H]([C@H](C)CC)N)CC(=O)N)CC(=O)O)Cc3cnc[nH]3)Cc4ccccc4,BRD-M45010341-001-01-5,bacitracin-zinc,MedChemEx,HY-B0278,Bacitracin (Zinc),48.635643,x1334,63.873081,active-covalent
CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCC[NH3+])CCCCNC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@H](C)CC)[NH3+])CC(=O)N)CC(=O)[O-])Cc3c[nH]cn3)Cc4ccccc4,BRD-A49374018-001-04-1,bacitracin,MicroSource,1500134,BACITRACIN,54.832169,x1311,77.728561,active-covalent
C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC[NH3+])CC[NH3+])CC(C)C)CC(C)C)CC[NH3+])NC(=O)[C@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC[NH3+])NC(=O)CCCCC(C)C)O,BRD-A36456202-001-01-3,colistin-b-sulfate,Enzo,ALX-380-272,,55.385895,x0749,55.385895,active-covalent
c1c(cc(c(c1O)O)O)C(=O)Oc2cc(cc(c2O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@H](O3)OC(=O)c4cc(c(c(c4)OC(=O)c5cc(c(c(c5)O)O)O)O)O)OC(=O)c6cc(c(c(c6)OC(=O)c7cc(c(c(c7)O)O)O)O)O)OC(=O)c8cc(c(c(c8)OC(=O)c9cc(c(c(c9)O)O)O)O)O)OC(=O)c1cc(c(c(c1)OC(=O)c1cc(c(c(c1)O)O)O)O)O,BRD-K67392463-001-04-8,tannic-acid,MicroSource,1504105,TANNIC ACID,57.632347,x0749,83.423157,active-covalent
CCCCCOc1ccc(cc1)c2cc(no2)c3ccc(cc3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](c7ccc(c(c7)OS(=O)(=O)[O-])O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,BRD-A11207520-001-01-4,micafungin,Enzo,AC2328,MICAFUNGIN,58.817287,x0749,64.733276,active-covalent
CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1[C@@H]([C@H]([C@H]([C@@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@H]([C@@H](O2)CO)O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O[C@@H]4[C@@H]([C@H]([C@H]([C@@H](O4)CO)O)O)O)NC(=O)C)O[C@]5(C[C@@H]([C@H]([C@@H](O5)[C@H]([C@H](CO)O)O)NC(=O)C)O)C(=O)[O-])O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O,BRD-A30703952-201-01-2,ganglioside-gm1,EMDBio,345724-1MG,"Ganglioside GM1, Ammonium Salt, Bovine Brain",64.244286,x0774,72.892609,active-covalent
CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1Oc2c3cc4cc2Oc5ccc(cc5Cl)[C@H]([C@H]6C(=O)N[C@@H](c7cc(cc(c7-c8cc(ccc8O)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9c1cc(cc(c1Cl)O)Oc1cc(ccc1O)[C@H](C(=O)N[C@H](Cc1ccc(cc1)O3)C(=O)N9)[NH2+]C)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)C(=O)NCCC[NH+](C)C)O)C(=O)[O-])O)O,BRD-K30177383-001-01-0,dalbavancin,MedChemEx,HY-17586,Dalbavancin,66.039413,x0749,94.62944,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCC[NH3+])NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC[NH+]=C(N)N)[NH3+],BRD-K23106423-001-01-0,substance-p,Tocris,1156,"2-({5-amino-2-[({1-[6-amino-2-({[1-(2-amino-5-{[amino(imino)methyl]amino}pentanoyl)-2-pyrrolidinyl]carbonyl}amino)hexanoyl]-2-pyrrolidinyl}carbonyl)amino]-5-oxopentanoyl}amino)-N~1~-[13-(aminocarbonyl;)-1,4-dibenzyl-10-isobutyl-2,5,8,11-tetraoxo-16-thia-3",71.406853,x1385,82.133553,active-covalent
CCCCC/C=C/CCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1Oc2c3cc4cc2Oc5ccc(cc5Cl)[C@H]([C@H]6C(=O)N[C@@H](c7cc(cc(c7-c8cc(ccc8O)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9c1cc(cc(c1)Oc1cc(ccc1O)[C@H](C(=O)N[C@@H](Cc1ccc(c(c1)Cl)O3)C(=O)N9)[NH3+])O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)C(=O)[O-])O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)CO)O)O,BRD-A09761158-001-02-1,teicoplanin-A2-1,MicroSource,1505707,TEICOPLANIN [A(2-1) shown],81.402069,x1385,84.619637,active-covalent
